PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Adams, WJ; Graf, EW; Ernst, MO				Adams, WJ; Graf, EW; Ernst, MO			Experience can change the 'light-from-above' prior	NATURE NEUROSCIENCE			English	Article								To interpret complex and ambiguous input, the human visual system uses prior knowledge or assumptions about the world. We show that the `light-from-above' prior, used to extract information about shape from shading is modified in response to active experience with the scene. The resultant adaptation is not specific to the learned scene but generalizes to a different task, demonstrating that priors are constantly adapted by interactive experience with the environment.	Univ Southampton, Dept Psychol, Southampton SO17 1BJ, Hants, England; Max Planck Inst Biol Cybernet, Tubingen, Germany	University of Southampton; Max Planck Society	Adams, WJ (corresponding author), Univ Southampton, Dept Psychol, Southampton SO17 1BJ, Hants, England.	w.adams@soton.ac.uk		Graf, Erich/0000-0002-3162-4233; Ernst, Marc/0000-0003-4197-8569				ADELSON EH, 1993, SCIENCE, V262, P2042, DOI 10.1126/science.8266102; Brewster D., 1826, EDINBURGH J SCI, V4, P99; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; HERSHBERGER W, 1970, J COMP PHYSIOL PSYCH, V73, P407, DOI 10.1037/h0030223; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Langer MS, 2001, PERCEPTION, V30, P403, DOI 10.1068/p3178; Sun J, 1998, NAT NEUROSCI, V1, P183, DOI 10.1038/630; van Ee R, 2003, J OPT SOC AM A, V20, P1398, DOI 10.1364/JOSAA.20.001398; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858	10	253	255	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1057	1058		10.1038/nn1312	http://dx.doi.org/10.1038/nn1312			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15361877				2022-12-24	WOS:000224156900014
J	Zhan, XL; Clemens, JC; Neves, G; Hattori, D; Flanagan, JJ; Hummel, T; Vasconcelos, ML; Chess, A; Zipursky, SL				Zhan, XL; Clemens, JC; Neves, G; Hattori, D; Flanagan, JJ; Hummel, T; Vasconcelos, ML; Chess, A; Zipursky, SL			Analysis of Dscam diversity in regulating axon guidance in Drosophila mushroom bodies	NEURON			English	Article							HOMOPHILIC INTERCELLULAR-ADHESION; GROWTH CONE GUIDANCE; KENYON CELLS; HONEY-BEE; EXPRESSION PATTERNS; ANOPHELES-GAMBIAE; GENE-EXPRESSION; NERVOUS-SYSTEM; FASCICLIN-II; ORGANIZATION	Dscam is an immunoglobulin (Ig) superfamily member that regulates axon guidance and targeting in Drosophila. Alternative splicing potentially generates 38,016 isoforms differing in their extracellular Ig and transmembrane domains. We demonstrate that Dscam mediates the sorting of axons in the developing mushroom body (MB). This correlates with the precise spatiotemporal pattern of Dscam protein expression. We demonstrate that MB neurons express different arrays of Dscam isoforms and that single MB neurons express multiple isoforms. Two different Dscam isoforms differing in their extracellular domains introduced as transgenes into single mutant cells partially rescued the mutant phenotype. Expression of one isoform of Dscam in a cohort of MB neurons induced dominant phenotypes, while expression of a single isoform in a single cell did not. We propose that different extracellular domains of Dscam share a common function and that differences in isoforms expressed on the surface of neighboring axons influence interactions between them.	Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA; MIT, Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA 02142 USA; Univ Munster, Inst Neurobiol, D-48149 Munster, Germany	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Munster	Zipursky, SL (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA.	zipursky@hhmi.ucla.edu	Neves, Guilherme/G-8957-2011	Neves, Guilherme/0000-0001-6463-6997; Vasconcelos, Maria Luisa/0000-0001-6248-3667; Zipursky, Stephen/0000-0001-5630-7181				Agarwala KL, 2001, BIOCHEM BIOPH RES CO, V285, P760, DOI 10.1006/bbrc.2001.5214; Agarwala KL, 2000, MOL BRAIN RES, V79, P118, DOI 10.1016/S0169-328X(00)00108-X; Boulanger LM, 2001, CURR OPIN NEUROBIOL, V11, P568, DOI 10.1016/S0959-4388(00)00251-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brotz TM, 1997, J COMP NEUROL, V383, P42, DOI 10.1002/(SICI)1096-9861(19970623)383:1<42::AID-CNE3>3.0.CO;2-L; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Farris SM, 1999, J COMP NEUROL, V414, P97, DOI 10.1002/(SICI)1096-9861(19991108)414:1&lt;97::AID-CNE8&gt;3.0.CO;2-Q; Farris SM, 2001, J COMP NEUROL, V439, P331, DOI 10.1002/cne.1354; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Francesconi A, 2002, J NEUROSCI, V22, P2196, DOI 10.1523/JNEUROSCI.22-06-02196.2002; Ganeshina O, 2000, J COMP NEUROL, V417, P349, DOI 10.1002/(SICI)1096-9861(20000214)417:3&lt;349::AID-CNE8&gt;3.0.CO;2-E; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Heisenberg M, 2002, J COMP NEUROL, V450, P1, DOI 10.1002/cne.10326; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Ito K, 1998, LEARN MEMORY, V5, P52; Ito K, 1997, DEVELOPMENT, V124, P761; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; Jasper H, 2002, DEV CELL, V3, P511, DOI 10.1016/S1534-5807(02)00297-6; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; KLICKSTEIN LB, 1995, CURRENT PROTOCOLS MO; Kurusu M, 2002, DEVELOPMENT, V129, P409; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Malaterre J, 2002, J COMP NEUROL, V452, P215, DOI 10.1002/cne.10319; NEVES G, 2004, STOCHASTIC YET BIASE; Noveen A, 2000, DEVELOPMENT, V127, P3475; Orioli D, 1997, TRENDS GENET, V13, P354, DOI 10.1016/S0168-9525(97)01220-1; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; Rein K, 2002, CURR BIOL, V12, P227, DOI 10.1016/S0960-9822(02)00656-5; Rhoades KL, 2000, CURR BIOL, V10, P789, DOI 10.1016/S0960-9822(00)00565-0; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; Sinakevitch I, 2001, J COMP NEUROL, V439, P352, DOI 10.1002/cne.1355; Strausfeld NJ, 2000, J COMP NEUROL, V424, P179, DOI 10.1002/1096-9861(20000814)424:1&lt;179::AID-CNE13&gt;3.0.CO;2-K; Strausfeld NJ, 1999, J COMP NEUROL, V409, P603; Strausfeld NJ, 1999, J COMP NEUROL, V409, P626, DOI 10.1002/(SICI)1096-9861(19990712)409:4<626::AID-CNE8>3.0.CO;2-B; Strausfeld NJ, 2003, MICROSC RES TECHNIQ, V62, P151, DOI 10.1002/jemt.10368; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Strausfeld NJ, 2002, J COMP NEUROL, V450, P4, DOI 10.1002/cne.10285; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; WOJTOWICZ WM, 2004, IN PRESS CELL, V118; Yagi T, 2003, GENES CELLS, V8, P1, DOI 10.1046/j.1365-2443.2003.00614.x; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; YANG MY, 1995, NEURON, V15, P45; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zhu SJ, 2003, DEVELOPMENT, V130, P2603, DOI 10.1242/dev.00466	61	169	169	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 2	2004	43	5					673	686		10.1016/j.neuron.2004.07.020	http://dx.doi.org/10.1016/j.neuron.2004.07.020			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339649	Bronze			2022-12-24	WOS:000223691900013
J	van den Pol, AN; Acuna-Goycolea, C; Clark, KR; Ghosh, PK				van den Pol, AN; Acuna-Goycolea, C; Clark, KR; Ghosh, PK			Physiological properties of hypothalamic MCH neurons identified with selective expression of reporter gene after recombinant virus infection	NEURON			English	Article							MELANIN-CONCENTRATING-HORMONE; GREEN FLUORESCENT PROTEIN; RAT LATERAL HYPOTHALAMUS; HYPOCRETIN-OREXIN; NEUROPEPTIDE-Y; FEEDING-BEHAVIOR; ARCUATE NUCLEUS; TRANSGENIC MICE; ENERGY-BALANCE; IN-VITRO	Neurons that synthesize melanin-concentrating hormone (MCH) may modulate arousal and energy homeostasis. The scattered MCH neurons have been difficult to study, as they have no defining morphological characteristics. We have developed a viral approach with AAV for selective long-term reporter gene (GFP) expression in MCH neurons, allowing the study of their cellular physiology in hypothalamic slices. MCH neurons showed distinct membrane properties compared to other neurons infected with the same virus with a cytomegalovirus promoter. Transmitters of extrahypothalamic arousal systems, including norepinephrine, serotonin, and the acetylcholine agonist muscarine, evoked direct inhibitory actions. Orexigenic neuropeptide Y was inhibitory by pre- and postsynaptic mechanisms; an anorexigenic melanocortin agonist had no effect. In contrast, the hypothalamic arousal peptide hypocretin/orexin evoked a direct inward current and increased excitatory synaptic activity and spike frequency in the normally silent MCH neurons. Together, these data support the view that MCH neurons may integrate information within the arousal system in favor of energy conservation.	Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA; Ohio State Univ, Columbus Childrens Res Inst, Columbus, OH 43205 USA	Yale University; University System of Ohio; Ohio State University	van den Pol, AN (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, 333 Cedar St, New Haven, CT 06520 USA.	anthony.vandenpol@yale.edu	Clark, Kelly/E-2900-2011		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041454, R01NS037788] Funding Source: NIH RePORTER; NIAID NIH HHS [AI48854] Funding Source: Medline; NINDS NIH HHS [NS41454, NS37788] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Borowsky B, 2002, NAT MED, V8, P825, DOI 10.1038/nm741; Broberger C, 1998, J COMP NEUROL, V402, P460; Burlet S, 2002, J NEUROSCI, V22, P2862, DOI 10.1523/JNEUROSCI.22-07-02862.2002; Chambers J, 1999, NATURE, V400, P261, DOI 10.1038/22313; Clark KR, 1999, HUM GENE THER, V10, P1031, DOI 10.1089/10430349950018427; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; During MJ, 1996, CLIN NEUROSCI, V3, P292; Eggermann E, 2003, J NEUROSCI, V23, P1557; Ehlers CL, 1997, NEUROPSYCHOPHARMACOL, V17, P34; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Elias CF, 2001, J COMP NEUROL, V432, P1, DOI 10.1002/cne.1085; Fulton S, 2000, SCIENCE, V287, P125, DOI 10.1126/science.287.5450.125; Gallopin T, 2000, NATURE, V404, P992, DOI 10.1038/35010109; Gao XB, 2003, J NEUROPHYSIOL, V90, P3978, DOI 10.1152/jn.00593.2003; Gao XB, 2001, J PHYSIOL-LONDON, V533, P237, DOI 10.1111/j.1469-7793.2001.0237b.x; Guan JL, 2002, INT J OBESITY, V26, P1523, DOI 10.1038/sj.ijo.0802155; Huang QL, 1999, NEUROENDOCRINOLOGY, V69, P145, DOI 10.1159/000054413; Li Y, 2002, NEURON, V36, P1169, DOI 10.1016/S0896-6273(02)01132-7; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Liu HY, 2003, J NEUROSCI, V23, P7143, DOI 10.1523/JNEUROSCI.23-18-07143.2003; Liu RJ, 2002, J NEUROSCI, V22, P9453; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Marsh DJ, 2002, P NATL ACAD SCI USA, V99, P3240, DOI 10.1073/pnas.052706899; Mochizuki T, 2003, CURR BIOL, V13, pR563, DOI 10.1016/S0960-9822(03)00474-3; Naveilhan P, 2001, EUR J NEUROSCI, V13, P2241, DOI 10.1046/j.0953-816x.2001.01601.x; Peyron C, 1998, J NEUROSCI, V18, P9996; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; Rhim H, 1997, J NEUROSCI, V17, P2980; ROLLS ET, 1972, J COMP PHYSIOL PSYCH, V81, P173, DOI 10.1037/h0033527; ROLLS ET, 1984, INT J OBESITY, V8, P139; Rosin DL, 2003, J COMP NEUROL, V465, P593, DOI 10.1002/cne.10860; Saito Y, 1999, NATURE, V400, P265, DOI 10.1038/22321; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Samulski RJ, 2000, NAT BIOTECHNOL, V18, P497, DOI 10.1038/75352; Sawchenko PE, 1998, J COMP NEUROL, V402, P435; Schwartz MW, 2002, NAT MED, V8, P779, DOI 10.1038/nm0802-779; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Segal-Lieberman G, 2003, P NATL ACAD SCI USA, V100, P10085, DOI 10.1073/pnas.1633636100; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; THOMPSON RC, 1990, DNA CELL BIOL, V9, P637, DOI 10.1089/dna.1990.9.637; Torrealba F, 2003, NEUROSCIENCE, V119, P1033, DOI 10.1016/S0306-4522(03)00238-0; VALENSTE.ES, 1966, AM J PHYSIOL, V210, P270, DOI 10.1152/ajplegacy.1966.210.2.270; van den Pol AN, 1999, J NEUROSCI, V19, P10948, DOI 10.1523/JNEUROSCI.19-24-10948.1999; van den Pol AN, 1998, J NEUROSCI, V18, P10640; van den Pol AN, 2002, J PHYSIOL-LONDON, V541, P169, DOI 10.1113/jphysiol.2002.017426; van den Pol AN, 1998, J NEUROSCI, V18, P7962; van den Pol AN, 1999, J NEUROSCI, V19, P3171; vandenPol AN, 1996, J NEUROSCI, V16, P5883; Verret L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-19; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3	56	165	169	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 27	2004	42	4					635	652		10.1016/S0896-6273(04)00251-X	http://dx.doi.org/10.1016/S0896-6273(04)00251-X			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157424	Bronze			2022-12-24	WOS:000221708300013
J	Andermann, ML; Ritt, J; Neimark, MA; Moore, CI				Andermann, ML; Ritt, J; Neimark, MA; Moore, CI			Neural correlates of vibrissa resonance: Band-pass and somatotopic representation of high-frequency stimuli	NEURON			English	Article							ROUGHNESS DISCRIMINATION; AUDITORY-CORTEX; SENSORY SIGNALS; NEURONS; AFFERENTS; ORGANIZATION; RATS; INTERNEURONS; INFORMATION; INTEGRATION	The array of vibrissae on a rat's face is the first stage of a high-resolution tactile sensing system. Recently, it was discovered that vibrissae (whiskers) resonate when stimulated at specific frequencies, generating several-fold increases in motion amplitude. We investigated the neural correlates of vibrissa resonance in trigeminal ganglion and primary somatosensory cortex (SI) neurons (regular and fast spiking units) by presenting low-amplitude, high-frequency vibrissa stimulation. We found that somatosensory neurons showed band-pass tuning and enhanced sensitivity to small amplitude stimuli, reflecting the resonance amplification of vibrissa motion. Further, a putative somatotopic map of frequency selectivity was observed in SI, with isofrequency columns extending along the representations of arcs of vibrissae, in agreement with the gradient in vibrissa resonance across the vibrissa pad. These findings suggest several parallels between frequency processing in the vibrissa system and the auditory system and have important implications for detection and discrimination of tactile information.	MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Harvard Univ, Program Biophys, Cambridge, MA 02115 USA; Massachusetts Gen Hosp, Martinos Ctr, Charlestown, MA 02129 USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Massachusetts General Hospital	Moore, CI (corresponding author), MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cim@ai.mit.edu	Moore, Christopher/C-5588-2009	Moore, Christopher/0000-0003-4534-1602	NINDS NIH HHS [1R01 NS 45130-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045130] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABELES M, 1970, J NEUROPHYSIOL, V33, P172, DOI 10.1152/jn.1970.33.1.172; Ahissar E, 2001, NEURON, V32, P185, DOI 10.1016/S0896-6273(01)00466-4; Arabzadeh E, 2003, J NEUROSCI, V23, P9146; ARMSTRONGJAMES M, 1987, J COMP NEUROL, V263, P265, DOI 10.1002/cne.902630209; Bermejo R, 1998, J NEUROSCI METH, V83, P89, DOI 10.1016/S0165-0270(98)00050-8; Brosch M, 1999, EUR J NEUROSCI, V11, P3517, DOI 10.1046/j.1460-9568.1999.00770.x; Bruno RM, 2002, J NEUROSCI, V22, P10966; CARVELL GE, 1995, SOMATOSENS MOT RES, V12, P1, DOI 10.3109/08990229509063138; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Dehnhardt G, 2001, SCIENCE, V293, P102, DOI 10.1126/science.1060514; Deschenes M, 2003, J NEUROSCI, V23, P6778; DIAMOND ME, 1995, SOMATOSENSORY THALAM, V11; GEISLER C, 1998, SOUDN SYNAPSE; Ghazanfar AA, 1997, J NEUROPHYSIOL, V78, P506, DOI 10.1152/jn.1997.78.1.506; GIBSON JM, 1983, SOMATOSENS RES, V1, P95, DOI 10.3109/07367228309144543; GOTTSCHALDT KM, 1981, SCIENCE, V214, P183, DOI 10.1126/science.7280690; GUICROBLES E, 1989, BEHAV BRAIN RES, V31, P285, DOI 10.1016/0166-4328(89)90011-9; GUICROBLES E, 1992, BEHAV BRAIN RES, V48, P145, DOI 10.1016/S0166-4328(05)80150-0; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Jones MS, 2000, J NEUROPHYSIOL, V84, P1505, DOI 10.1152/jn.2000.84.3.1505; KONDOH Y, 1991, J COMP PHYSIOL A, V169, P653; LANDAU L, 1975, THEORY ELASTICITY, V9; LEVAY S, 1975, J COMP NEUROL, V159, P559, DOI 10.1002/cne.901590408; LICHTENSTEIN SH, 1990, SOMATOSENS MOT RES, V7, P47, DOI 10.3109/08990229009144697; Linden JF, 2003, CEREB CORTEX, V13, P83, DOI 10.1093/cercor/13.1.83; LINDEN SH, 2003, J NEUROPHYSIOL, V91, P223; Mehta SB, 2004, NEURON, V41, P181, DOI 10.1016/S0896-6273(04)00002-9; MERZENICH MM, 1973, BRAIN RES, V50, P275, DOI 10.1016/0006-8993(73)90731-2; Minnery BS, 2003, J NEUROPHYSIOL, V89, P40, DOI 10.1152/jn.00272.2002; Moore CI, 1999, TRENDS NEUROSCI, V22, P513, DOI 10.1016/S0166-2236(99)01452-6; Moore CI, 2004, J NEUROPHYSIOL, V91, P2390, DOI 10.1152/jn.00925.2003; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; Neimark MA, 2003, J NEUROSCI, V23, P6499; NEIMARK MA, 2001, MECH MODE VIBRISSAE; Oshinsky ML, 2002, J NEUROSCI, V22, P7254; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; PLUMMER MR, 1981, J COMP PHYSIOL, V142, P347, DOI 10.1007/BF00605447; Roddey JC, 1996, J NEUROPHYSIOL, V75, P1365, DOI 10.1152/jn.1996.75.4.1365; Sachdev RNS, 2001, SOMATOSENS MOT RES, V18, P91; Shimegi S, 1999, J NEUROSCI, V19, P10164; SHIMOZAWA T, 1984, J COMP PHYSIOL, V155, P485, DOI 10.1007/BF00611913; Shoykhet M, 2000, SOMATOSENS MOT RES, V17, P171; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; SIMONS DJ, 1985, J NEUROPHYSIOL, V54, P615, DOI 10.1152/jn.1985.54.3.615; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; VONBEKESY G, 1947, J ACOUST SOC AM, V19, P452; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; YOHRO T, 1977, J MORPHOL, V153, P333, DOI 10.1002/jmor.1051530211; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171; ZUCKER E, 1969, BRAIN RES, V12, P138, DOI 10.1016/0006-8993(69)90061-4	51	100	100	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2004	42	3					451	463		10.1016/S0896-6273(04)00198-9	http://dx.doi.org/10.1016/S0896-6273(04)00198-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KH	15134641	Bronze			2022-12-24	WOS:000221458700011
J	Zheng, J; Zagotta, WN				Zheng, J; Zagotta, WN			Stoichiometry and assembly of olfactory cyclic nucleotide-gated channels	NEURON			English	Article							SUBUNIT STOICHIOMETRY; FUNCTIONAL EXPRESSION; POTASSIUM CHANNELS; ACTIVATED CHANNEL; STRUCTURAL BASIS; CATION CHANNEL; MODULATION; CA2+-CALMODULIN; RECEPTOR; PROTEIN	Native ion channels are precisely tuned to their physiological role in neuronal signaling. This tuning frequently involves the controlled assembly of heteromeric channels comprising multiple types of subunits. Cyclic nucleotide-gated (CNG) channels of olfactory neurons are tetramers and require three types of subunits, CNGA2, CNGA4, and CNGB1b, to exhibit properties necessary for olfactory transduction. Using fluorescently tagged subunits and fluorescence resonance energy transfer (FRET), we find the subunit composition of heteromeric olfactory channels in the surface membrane is fixed, with 2:11:11 CNGA2: CNGA4:CNGB1b. Furthermore, when expressed individually with CNGA2, CNGA4 and CNGB1b subunits were still present in only a single copy and, when expressed alone, did not self-assemble. These results suggest that the precise assembly of heteromeric olfactory channels results from a mechanism where CNGA4 and CNGB1b subunits have a high affinity for CNGA2 but not for self-assembly, precluding more than one CNGA4 or CNGB1b subunit in the channel complex.	Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Physiol & Biophys, POB 357290, Seattle, WA 98195 USA.	zagotta@u.washington.edu			NATIONAL EYE INSTITUTE [R01EY010329] Funding Source: NIH RePORTER; NEI NIH HHS [EY 10329, R01 EY010329, R01 EY010329-11] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bauer PJ, 1996, J PHYSIOL-LONDON, V494, P675, DOI 10.1113/jphysiol.1996.sp021523; Bonigk W, 1999, J NEUROSCI, V19, P5332; BRADLEY J, 1994, P NATL ACAD SCI USA, V91, P8890, DOI 10.1073/pnas.91.19.8890; Bradley J, 2001, SCIENCE, V294, P2176, DOI 10.1126/science.1063415; BROWN RL, 1995, BIOCHEMISTRY-US, V34, P8365, DOI 10.1021/bi00026a018; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; CHEN TY, 1994, P NATL ACAD SCI USA, V91, P11757, DOI 10.1073/pnas.91.24.11757; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Finn JT, 1998, BIOPHYS J, V74, P1333, DOI 10.1016/S0006-3495(98)77846-4; GOULDING EH, 1992, NEURON, V8, P45, DOI 10.1016/0896-6273(92)90107-O; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; KREIENKAMP HJ, 1995, NEURON, V14, P635, DOI 10.1016/0896-6273(95)90320-8; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LIMAN ER, 1994, NEURON, V13, P611, DOI 10.1016/0896-6273(94)90029-9; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; Matulef K, 2003, ANNU REV CELL DEV BI, V19, P23, DOI 10.1146/annurev.cellbio.19.110701.154854; Matulef K, 2002, NEURON, V36, P93, DOI 10.1016/S0896-6273(02)00878-4; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Sautter A, 1998, P NATL ACAD SCI USA, V95, P4696, DOI 10.1073/pnas.95.8.4696; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Shammat IM, 1999, NEURON, V23, P809, DOI 10.1016/S0896-6273(01)80038-6; Shapiro MS, 2000, BIOPHYS J, V78, P2307, DOI 10.1016/S0006-3495(00)76777-4; Shapiro MS, 1998, P NATL ACAD SCI USA, V95, P14546, DOI 10.1073/pnas.95.24.14546; SINE SM, 1995, NEURON, V15, P205, DOI 10.1016/0896-6273(95)90077-2; Trudeau MC, 2003, J BIOL CHEM, V278, P18705, DOI 10.1074/jbc.R300001200; Trudeau MC, 2002, P NATL ACAD SCI USA, V99, P8424, DOI 10.1073/pnas.122015999; Trudeau MC, 2002, NEURON, V34, P197, DOI 10.1016/S0896-6273(02)00647-5; Varnum MD, 1996, BIOPHYS J, V70, P2667, DOI 10.1016/S0006-3495(96)79836-3; Varnum MD, 1997, SCIENCE, V278, P110, DOI 10.1126/science.278.5335.110; Weitz D, 2002, NEURON, V36, P881, DOI 10.1016/S0896-6273(02)01098-X; XU J, 1995, J BIOL CHEM, V270, P24761, DOI 10.1074/jbc.270.42.24761; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zheng J, 2003, J NEUROSCI, V23, P8167; Zheng J, 2002, NEURON, V36, P891, DOI 10.1016/S0896-6273(02)01099-1; ZHENG J, 2003, SCI STKE, pPL7; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201; Zhong HN, 2003, P NATL ACAD SCI USA, V100, P5509, DOI 10.1073/pnas.0931279100; Zhou L, 2002, BIOPHYS J, V82, p183A; Zufall F, 2001, TRENDS NEUROSCI, V24, P191, DOI 10.1016/S0166-2236(00)01765-3	50	131	143	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2004	42	3					411	421		10.1016/S0896-6273(04)00253-3	http://dx.doi.org/10.1016/S0896-6273(04)00253-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KH	15134638	Bronze			2022-12-24	WOS:000221458700008
J	Bai, JH; Wang, CT; Richards, DA; Jackson, MB; Chapman, ER				Bai, JH; Wang, CT; Richards, DA; Jackson, MB; Chapman, ER			Fusion pore dynamics are regulated by synaptotagmin center dot t-SNARE interactions	NEURON			English	Article							MEMBRANE-PENETRATION ACTIVITY; NEUROTRANSMITTER RELEASE; SYNAPTIC-TRANSMISSION; PHOSPHOLIPID-BINDING; TRANSMITTER RELEASE; PLASMA-MEMBRANE; CA2+ BINDING; C2B DOMAIN; CRYSTAL-STRUCTURE; CALCIUM SENSOR	Exocytosis involves the formation of a fusion pore that connects the lumen of secretory vesicles with the extracellular space. Exocytosis from neurons and neuroendocrine cells is tightly regulated by intracellular [Ca2+] and occurs rapidly, but the molecular events that mediate the opening and subsequent dilation of fusion pores remain to be determined. A putative Ca2+ sensor for release, synaptotagmin l (syt), binds directly to syntaxin and SNAP-25, which are components of a conserved membrane fusion complex. Here, we show that Ca2+-triggered syt.SNAP-25 interactions occur rapidly. The tandem C2 domains of syt cooperate to mediate binding to syntaxin/SNAP-25; lengthening the linker that connects C2A and C2B selectively disrupts this interaction. Expression of the linker mutants in PC12 cells results in graded reductions in the stability of fusion pores. Thus, the final step of Call-triggered exocytosis is regulated, at least in part, by direct contacts between syt and SNAP-25/syntaxin.	Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Chapman, ER (corresponding author), Univ Wisconsin, Dept Physiol, 1300 Univ Ave, Madison, WI 53706 USA.	chapman@physiology.wise.edu	Wang, Chih-Tien/GRE-8232-2022	Wang, Chih-Tien/0000-0001-7639-7508; Richards, David/0000-0001-6154-7112; Chapman, Edwin/0000-0001-9787-8140	NIGMS NIH HHS [GM 56827] Funding Source: Medline; NIMH NIH HHS [MH61876] Funding Source: Medline; NINDS NIH HHS [NS30016, NS44057] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030016, R37NS030016, R01NS044057] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; Bai JH, 2002, P NATL ACAD SCI USA, V99, P1665, DOI 10.1073/pnas.032541099; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; BARK IC, 1994, GENE, V139, P291, DOI 10.1016/0378-1119(94)90773-0; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Chieregatti E, 2002, TRAFFIC, V3, P496, DOI 10.1034/j.1600-0854.2002.30706.x; Chow Robert H., 1995, P245; Colliver TL, 2000, J NEUROCHEM, V74, P1086; COLQUHOUN D, 1982, PHILOS T ROY SOC B, V300, P1, DOI 10.1098/rstb.1982.0156; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Desai RC, 2000, J CELL BIOL, V150, P1125, DOI 10.1083/jcb.150.5.1125; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; Earles CA, 2001, J CELL BIOL, V154, P1117, DOI 10.1083/jcb.200105020; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2002, J NEUROSCI, V22, P8438; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; FERRONOVICK S, 1994, NATURE, V370, P191, DOI 10.1038/370191a0; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Hilfiker S, 1999, NAT NEUROSCI, V2, P104, DOI 10.1038/5659; JACKSON MB, 1992, METHOD ENZYMOL, V207, P729; Katz B., 1969, RELEASE NEURAL TRANS; Littleton JT, 2001, J NEUROSCI, V21, P1421, DOI 10.1523/JNEUROSCI.21-05-01421.2001; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; Littleton JT, 1999, NATURE, V400, P757, DOI 10.1038/23462; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Mahal LK, 2002, J CELL BIOL, V158, P273, DOI 10.1083/jcb.200203135; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; RICKMAN C, 2004, IN PRESS J BIOL CHEM; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Stevens CF, 2003, NEURON, V39, P299, DOI 10.1016/S0896-6273(03)00432-X; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Sutton RB, 1999, J CELL BIOL, V147, P589, DOI 10.1083/jcb.147.3.589; Tucker WC, 2003, J CELL BIOL, V162, P199, DOI 10.1083/jcb.200302060; VICIAN L, 1995, P NATL ACAD SCI USA, V92, P2164, DOI 10.1073/pnas.92.6.2164; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; Wu Y, 2003, P NATL ACAD SCI USA, V100, P2082, DOI 10.1073/pnas.0435872100; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2; Zhang XY, 1998, BIOCHEMISTRY-US, V37, P12395, DOI 10.1021/bi9807512	60	158	167	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 25	2004	41	6					929	942		10.1016/S0896-6273(04)00117-5	http://dx.doi.org/10.1016/S0896-6273(04)00117-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046725	Bronze			2022-12-24	WOS:000221458300012
J	Akum, BF; Chen, M; Gunderson, SI; Riefler, GM; Scerri-Hansen, MM; Firestein, BL				Akum, BF; Chen, M; Gunderson, SI; Riefler, GM; Scerri-Hansen, MM; Firestein, BL			Cypin regulates dendrite patterning in hippocampal neurons by promoting microtubule assembly	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; PRE-MESSENGER-RNA; GUANINE DEAMINASE; MAMMALIAN-CELLS; BRAIN TUBULIN; IN-VIVO; RHO; PROTEIN; GROWTH; MOUSE	Dendrite branching has an important role in normal brain function. Here we report that overexpression of cypin, a protein that has guanine deaminase activity and is expressed in developing processes in rat hippocampal neurons, results in increased dendrite branching in primary culture. Mutant cypin proteins that lack guanine deaminase activity act in a dominant-negative manner when expressed in primary neurons. Furthermore, we knocked down cypin protein levels using a new strategy: expressing a 5' end-mutated U1 small nuclear RNA (snRNA) to inhibit maturation of cypin mRNA. Neurons that express this mutant snRNA show little or no detectable cypin protein and fewer dendrites than normal. In addition, we found that cypin binds directly to tubulin heterodimers and promotes microtubule polymerization. Thus, our results demonstrate a new pathway by which dendrite patterning is regulated, and we also introduce a new method for decreasing endogenous protein expression in neurons.	Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; Rutgers State Univ, Mol Biosci Grad Program, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Firestein, BL (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, 604 Allison Rd, Piscataway, NJ 08854 USA.	firestein@biology.rutgers.edu		Firestein, Bonnie/0000-0002-1679-3565	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057286] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM57286] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; CLAIBORNE BJ, 1992, METHODS NEUROSCIENCE, V10, P315; El-Hussein AE, 2000, SCIENCE, V290, P1364; Ellezam B, 2002, PROG BRAIN RES, V137, P371; FELIPO V, 1990, NEUROCHEM RES, V15, P945, DOI 10.1007/BF00965917; Firestein BL, 1999, NEURON, V24, P659, DOI 10.1016/S0896-6273(00)81120-4; Fortes P, 2003, P NATL ACAD SCI USA, V100, P8264, DOI 10.1073/pnas.1332669100; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; Hernandez-Deviez DJ, 2002, NAT NEUROSCI, V5, P623, DOI 10.1038/nn865; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Karlin S, 1997, P NATL ACAD SCI USA, V94, P14231, DOI 10.1073/pnas.94.26.14231; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; LI W, 1992, GENETICS, V132, P675; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MINANA MD, 1989, NEUROCHEM RES, V14, P235, DOI 10.1007/BF00971316; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Paletzki RF, 2002, NEUROSCIENCE, V109, P15, DOI 10.1016/S0306-4522(01)00352-9; Petrausch B, 2000, J NEUROSCI, V20, P8031; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; SCHMIDT CJ, 1994, J NEUROSCI RES, V38, P182, DOI 10.1002/jnr.490380208; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Vaillant AR, 2002, NEURON, V34, P985, DOI 10.1016/S0896-6273(02)00717-1; VOLONTE C, 1989, J CELL BIOL, V109, P2395, DOI 10.1083/jcb.109.5.2395; Wang LH, 1997, J NEUROCHEM, V69, P2261; Will CL, 1997, CURR OPIN CELL BIOL, V9, P320, DOI 10.1016/S0955-0674(97)80003-8; Wong WT, 2000, J NEUROSCI, V20, P5024; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Yuan G, 1999, J BIOL CHEM, V274, P8175, DOI 10.1074/jbc.274.12.8175; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	33	108	111	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					145	152		10.1038/nn1179	http://dx.doi.org/10.1038/nn1179			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14730308				2022-12-24	WOS:000188468500012
J	Gomeza, J; Hulsmann, S; Ohno, K; Eulenburg, V; Szoke, K; Richter, D; Betz, H				Gomeza, J; Hulsmann, S; Ohno, K; Eulenburg, V; Szoke, K; Richter, D; Betz, H			Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in Glycinergic inhibition	NEURON			English	Article							RESPIRATORY RHYTHM GENERATION; EXCITATORY AMINO-ACIDS; NONKETOTIC HYPERGLYCINEMIA; NEUROTRANSMITTER TRANSPORTERS; DOPAMINE TRANSPORTER; MICE LACKING; NMDA RECEPTOR; SPINAL-CORD; MEDULLARY SLICES; CLEAVAGE SYSTEM	The glycine transporter subtype 1 (GIyT1) is widely expressed in astroglial cells throughout the mammalian central nervous system and has been implicated in the regulation of N-methyl-D-aspartate (NMDA) receptor activity. Newborn mice deficient in GIyT1 are anatomically normal but show severe motor and respiratory deficits and die during the first postnatal day. In brainstem slices from GIyT1-deficient mice, in vitro respiratory activity is strikingly reduced but normalized by the glycine receptor (GlyR) antagonist strychnine. Conversely, glycine or the GIyT1 inhibitor sarcosine suppress respiratory activity in slices from wild-type mice. Thus, during early postnatal life, GIyT1 is essential for regulating glycine concentrations at inhibitory GlyRs, and GIyT1 deletion generates symptoms found in human glycine encephalopathy.	Max Planck Inst Brain Res, Dept Neurochem, D-50528 Frankfurt, Germany; Univ Gottingen, Dept Neuro & Sensory Physiol, D-37073 Gottingen, Germany	Max Planck Society; University of Gottingen	Gomeza, J (corresponding author), Max Planck Inst Brain Res, Dept Neurochem, D-50528 Frankfurt, Germany.		Eulenburg, Volker/B-7263-2013; Hülsmann, Swen/F-7169-2010; Eulenburg, Volker/B-7263-2013	Eulenburg, Volker/0000-0002-4878-5746; Hülsmann, Swen/0000-0001-5042-8724; Eulenburg, Volker/0000-0001-6314-566X				ADAMS RH, 1995, J NEUROSCI, V15, P2524, DOI 10.1523/JNEUROSCI.15-03-02524.1995; AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Applegarth DA, 2001, MOL GENET METAB, V74, P139, DOI 10.1006/mgme.2001.3224; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; Berger AJ, 1998, J NEUROPHYSIOL, V80, P3336, DOI 10.1152/jn.1998.80.6.3336; Betz H., 2000, PHARM GABA GLYCINE N, P375; Boneh A, 1996, PEDIATR NEUROL, V15, P137, DOI 10.1016/0887-8994(96)00158-0; BUCKWALTER MS, 1994, HUM MOL GENET, V3, P2025, DOI 10.1093/hmg/3.11.2025; Chatonnet F, 2002, EUR J NEUROSCI, V15, P684, DOI 10.1046/j.1460-9568.2002.01909.x; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Dumoulin A, 1999, J CELL SCI, V112, P811; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; FORTIN G, 1994, NEUROREPORT, V5, P1137, DOI 10.1097/00001756-199405000-00029; Friauf E, 1999, J COMP NEUROL, V412, P17; FUNK GD, 1993, J NEUROPHYSIOL, V70, P1497, DOI 10.1152/jn.1993.70.4.1497; Funk GD, 1997, J NEUROPHYSIOL, V78, P1414, DOI 10.1152/jn.1997.78.3.1414; Gainetdinov RR, 1998, BRAIN RES REV, V26, P148, DOI 10.1016/S0165-0173(97)00063-5; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; GREER JJ, 1991, J PHYSIOL-LONDON, V437, P727, DOI 10.1113/jphysiol.1991.sp018622; GUASTELLA J, 1992, P NATL ACAD SCI USA, V89, P7189, DOI 10.1073/pnas.89.15.7189; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Hulsmann S, 2000, EUR J NEUROSCI, V12, P856, DOI 10.1046/j.1460-9568.2000.00973.x; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; JOHNSTON GA, 1971, J NEUROCHEM, V18, P1951, DOI 10.1111/j.1471-4159.1971.tb09601.x; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Jones SR, 1999, NAT NEUROSCI, V2, P649, DOI 10.1038/10204; JURSKY F, 1995, J NEUROCHEM, V64, P1026; KIRSCH J, 1995, J NEUROSCI, V15, P4148; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; Legendre P, 2001, CELL MOL LIFE SCI, V58, P760, DOI 10.1007/PL00000899; LEWIS SA, 1984, P NATL ACAD SCI-BIOL, V81, P2743, DOI 10.1073/pnas.81.9.2743; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; LIU QR, 1993, J BIOL CHEM, V268, P22802; LIU QR, 1992, FEBS LETT, V305, P110, DOI 10.1016/0014-5793(92)80875-H; Lopez-Corcuera B, 2001, MOL MEMBR BIOL, V18, P13, DOI 10.1080/09687680120521; Lu FL, 1999, PEDIATR NEUROL, V20, P295, DOI 10.1016/S0887-8994(98)00157-X; MAYOR F, 1984, NEUROCHEM PATHOL, V2, P233; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Nelson N, 1998, J NEUROCHEM, V71, P1785; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; PATON JFR, 1994, NEUROSCI LETT, V170, P167, DOI 10.1016/0304-3940(94)90265-8; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Ramirez JM, 1996, J PHYSIOL-LONDON, V491, P799, DOI 10.1113/jphysiol.1996.sp021258; Richter DW, 2001, TRENDS NEUROSCI, V24, P464, DOI 10.1016/S0166-2236(00)01867-1; Ritter B, 2000, EUR J NEUROSCI, V12, P2975, DOI 10.1046/j.1460-9568.2000.00152.x; Roux MJ, 2000, NEURON, V25, P373, DOI 10.1016/S0896-6273(00)80901-0; Sakata Y, 2001, MOL BRAIN RES, V94, P119, DOI 10.1016/S0169-328X(01)00225-X; SATO K, 1991, BRAIN RES, V567, P64, DOI 10.1016/0006-8993(91)91436-5; SCHLOSS P, 1994, CURR OPIN CELL BIOL, V6, P595, DOI 10.1016/0955-0674(94)90081-7; Singer JH, 1998, J NEUROPHYSIOL, V80, P2608, DOI 10.1152/jn.1998.80.5.2608; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; SMITH KE, 1992, NEURON, V8, P927, DOI 10.1016/0896-6273(92)90207-T; Spike RC, 1997, NEUROSCIENCE, V77, P543, DOI 10.1016/S0306-4522(96)00501-5; TADA K, 1992, EARLY HUM DEV, V29, P75, DOI 10.1016/0378-3782(92)90060-T; VERDOORN TA, 1987, SCIENCE, V238, P1114, DOI 10.1126/science.2825347; Xu F, 2000, NAT NEUROSCI, V3, P465, DOI 10.1038/74839; ZAFRA F, 1995, EUR J NEUROSCI, V7, P1342, DOI 10.1111/j.1460-9568.1995.tb01125.x; Zafra F, 1997, MOL NEUROBIOL, V14, P117, DOI 10.1007/BF02740653; ZAFRA F, 1995, J NEUROSCI, V15, P3952; Zhang W, 2002, J PHYSIOL-LONDON, V540, P435, DOI 10.1113/jphysiol.2001.013225; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4; [No title captured]	66	247	256	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 13	2003	40	4					785	796		10.1016/S0896-6273(03)00672-X	http://dx.doi.org/10.1016/S0896-6273(03)00672-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	744UL	14622582	Green Published, hybrid			2022-12-24	WOS:000186651200013
J	Blanchi, B; Kelly, LM; Viemari, JC; Lafon, I; Burnet, H; Bevengut, M; Tillmanns, S; Daniel, L; Graf, T; Hilaire, G; Sieweke, MH				Blanchi, B; Kelly, LM; Viemari, JC; Lafon, I; Burnet, H; Bevengut, M; Tillmanns, S; Daniel, L; Graf, T; Hilaire, G; Sieweke, MH			MafB deficiency causes defective respiratory rhythmogenesis and fatal central apnea at birth	NATURE NEUROSCIENCE			English	Article							PRE-BOTZINGER COMPLEX; INFANT-DEATH-SYNDROME; IN-VIVO; PREBOTZINGER COMPLEX; EXPRESSION PATTERN; SEGMENTATION GENE; PACEMAKER NEURONS; RHYTHM GENERATION; REVEALS; MATURATION	The genetic basis for the development of brainstem neurons that generate respiratory rhythm is unknown. Here we show that mice deficient for the transcription factor MafB die from central apnea at birth and are defective for respiratory rhythmogenesis in vitro. MafB is expressed in a subpopulation of neurons in the preBotzinger complex (preBotC), a putative principal site of rhythmogenesis. Brainstems from Mafb(-/-) mice are insensitive to preBotC electrolytic lesion or stimulation and modulation of rhythmogenesis by hypoxia or peptidergic input. Furthermore, in Mafb(-/-) mice the preBotC, but not major neuromodulatory groups, presents severe anatomical defects with loss of cellularity. Our results show an essential role of MafB in central respiratory control, possibly involving the specification of rhythmogenic preBotC neurons.	Univ Mediterrane, INSERM, CNRS, Ctr Immunol Marseille Luminy, F-13288 Marseille 09, France; CNRS, Grp Etud Reseaux Moteurs, F-13009 Marseille, France; Fac Med Timone, IBDM, Lab Pathol Nerveuse & Musculaire, F-13005 Marseille, France; Yeshiva Univ Albert Einstein Coll Med, Bronx, NY 10461 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Yeshiva University; Albert Einstein College of Medicine	Sieweke, MH (corresponding author), Univ Mediterrane, INSERM, CNRS, Ctr Immunol Marseille Luminy, Campus Luminy,Case 906, F-13288 Marseille 09, France.	sieweke@ciml.univ-mrs.fr	Sieweke, Michael/AAR-7515-2020; Graf, Thomas/B-4252-2015; daniel, laurent/R-2826-2016	Sieweke, Michael/0000-0002-3228-9537; Graf, Thomas/0000-0003-2774-4117; blanchi, bruno/0000-0002-0814-5525; Viemari, Jean-Charles/0000-0001-6614-1461; daniel, laurent/0000-0002-7539-0109				Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; BIANCHI AL, 1995, PHYSIOL REV, V75, P1, DOI 10.1152/physrev.1995.75.1.1; Champagnat J, 1997, TRENDS NEUROSCI, V20, P119, DOI 10.1016/S0166-2236(96)10078-3; Chatonnet F, 2002, EUR J NEUROSCI, V15, P684, DOI 10.1046/j.1460-9568.2002.01909.x; CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7; del Toro ED, 2001, J NEUROSCI, V21, P5637, DOI 10.1523/JNEUROSCI.21-15-05637.2001; DIPASQUALE E, 1992, EXP BRAIN RES, V89, P459; Eichmann A, 1997, MECH DEVELOP, V65, P111, DOI 10.1016/S0925-4773(97)00063-4; ERRCHIDI S, 1990, J PHYSIOL-LONDON, V429, P497, DOI 10.1113/jphysiol.1990.sp018269; FELDMAN JL, 2003, ANN REV NEUROSCI; FILIANO JJ, 1994, BIOL NEONATE, V65, P194; Fortin G, 2000, RESP PHYSIOL, V122, P247, DOI 10.1016/S0034-5687(00)00163-8; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Guyenet PG, 2002, J NEUROSCI, V22, P3806; Guyenet PG, 2001, J NEUROPHYSIOL, V86, P438, DOI 10.1152/jn.2001.86.1.438; Hertwig P., 1942, ZEITSCHR INDUKT ABSTAMM U VERERBUNGSL, V80, P220, DOI 10.1007/BF01741984; Hilaire G, 1997, NEUROSCI LETT, V224, P13, DOI 10.1016/S0304-3940(97)13458-9; Hilaire G, 1999, PHYSIOL REV, V79, P325, DOI 10.1152/physrev.1999.79.2.325; Jacquin TD, 1996, NEURON, V17, P747, DOI 10.1016/S0896-6273(00)80206-8; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; KINNEY HC, 1995, SCIENCE, V269, P1446, DOI 10.1126/science.7660131; Kinney HC, 2001, J NEUROPATH EXP NEUR, V60, P228, DOI 10.1093/jnen/60.3.228; Koshiya N, 1996, J PHYSIOL-LONDON, V491, P859, DOI 10.1113/jphysiol.1996.sp021263; Koshiya N, 1999, NATURE, V400, P360, DOI 10.1038/22540; Lieske SP, 2000, NAT NEUROSCI, V3, P600, DOI 10.1038/75776; McCrimmon DR, 2000, BIOESSAYS, V22, P6, DOI 10.1002/(SICI)1521-1878(200001)22:1<6::AID-BIES3>3.0.CO;2-Q; Mellen NM, 2003, NEURON, V37, P821, DOI 10.1016/S0896-6273(03)00092-8; MONTEAU R, 1991, PROG NEUROBIOL, V37, P83, DOI 10.1016/0301-0082(91)90024-U; ONIMARU H, 1995, EXP BRAIN RES, V106, P57; Onimaru H, 2003, J NEUROSCI, V23, P1478, DOI 10.1523/JNEUROSCI.23-04-01478.2003; Pabst O, 2003, DEVELOPMENT, V130, P1193, DOI 10.1242/dev.00346; Poon CS, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-09-j0003.2000; Ptak K, 2002, EUR J NEUROSCI, V16, P2245, DOI 10.1046/j.1460-9568.2002.02305.x; Qian Y, 2001, GENE DEV, V15, P2533, DOI 10.1101/gad.921501; Ramirez JM, 1998, J PHYSIOL-LONDON, V507, P895, DOI 10.1111/j.1469-7793.1998.895bs.x; Rekling JC, 1998, ANNU REV PHYSIOL, V60, P385, DOI 10.1146/annurev.physiol.60.1.385; Ren J, 2003, J NEUROSCI, V23, P1569; Richter DW, 2001, TRENDS NEUROSCI, V24, P464, DOI 10.1016/S0166-2236(00)01867-1; Sadl VS, 2002, DEV BIOL, V249, P16, DOI 10.1006/dbio.2002.0751; Shirasawa S, 2000, NAT GENET, V24, P287, DOI 10.1038/73516; Sieweke MH, 1996, CELL, V85, P49, DOI 10.1016/S0092-8674(00)81081-8; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Solomon IC, 1999, J NEUROPHYSIOL, V81, P1150, DOI 10.1152/jn.1999.81.3.1150; St-John WM, 1998, PROG NEUROBIOL, V56, P97, DOI 10.1016/S0301-0082(98)00031-8; Thoby-Brisson M, 2000, J NEUROSCI, V20, P5858, DOI 10.1523/JNEUROSCI.20-15-05858.2000; Tiveron MC, 1996, J NEUROSCI, V16, P7649; Viemari JC, 2003, EUR J NEUROSCI, V17, P1233, DOI 10.1046/j.1460-9568.2003.02561.x; Wang H, 2001, J COMP NEUROL, V434, P128, DOI 10.1002/cne.1169; WANG WG, 1993, J APPL PHYSIOL, V74, P2801, DOI 10.1152/jappl.1993.74.6.2801	50	133	140	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1091	1099		10.1038/nn1129	http://dx.doi.org/10.1038/nn1129			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	14513037				2022-12-24	WOS:000185633600022
J	Weimer, RM; Richmond, JE; Davis, WS; Hadwiger, G; Nonet, ML; Jorgensen, EM				Weimer, RM; Richmond, JE; Davis, WS; Hadwiger, G; Nonet, ML; Jorgensen, EM			Defects in synaptic vesicle docking in unc-18 mutants	NATURE NEUROSCIENCE			English	Article							NEUROTRANSMITTER RELEASE; SYNAPTOTAGMIN MUTANTS; LOCUS ENCODES; SYNTAXIN 1A; PROTEIN; FUSION; ROP; SYNAPTOBREVIN; EXOCYTOSIS; INTERACTS	Sec1-related proteins function in most, if not all, membrane trafficking pathways in eukaryotic cells. The Sec1-related protein required in neurons for synaptic vesicle exocytosis is UNC-18. Several models for UNC-18 function during vesicle exocytosis are under consideration. We have tested these models by characterizing unc-18 mutants of the nematode Caenorhabditis elegans. In the absence of UNC-18, the size of the readily releasable pool is severely reduced. Our results show that the near absence of fusion-competent vesicles is not caused by a reduction in syntaxin levels, by a mislocalization of syntaxin, by a defect in fusion or by a failure to open syntaxin during priming. Rather, we found a reduction of docked vesicles at the active zone in unc-18 mutants, suggesting that UNC-18 functions, directly or indirectly, as a facilitator of vesicle docking.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Utah System of Higher Education; University of Utah; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Washington University (WUSTL)	Jorgensen, EM (corresponding author), Univ Utah, Dept Biol, 257 South 1400 East, Salt Lake City, UT 84112 USA.	jorgensen@biology.utah.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041477] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS041477-01A1, R01 NS041477] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bamber BA, 1999, J NEUROSCI, V19, P5348; BEKKERS JM, 1969, PRACTICAL ELECT METH, P150; BRENNER S, 1974, GENETICS, V77, P71; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; Bryant NJ, 2001, EMBO J, V20, P3380, DOI 10.1093/emboj/20.13.3380; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Fisher RJ, 2001, SCIENCE, V291, P875, DOI 10.1126/science.291.5505.875; GENGYOANDO K, 1993, NEURON, V11, P703, DOI 10.1016/0896-6273(93)90080-B; Grote E, 2000, J CELL BIOL, V151, P439, DOI 10.1083/jcb.151.2.439; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; HUNT JM, 1994, NEURON, V12, P1269, DOI 10.1016/0896-6273(94)90443-X; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; KOENIG JH, 1989, J NEUROSCI, V9, P1937; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Li J, 1999, PHILOS T ROY SOC B, V354, P299, DOI 10.1098/rstb.1999.0381; Lickteig KM, 2001, J NEUROSCI, V21, P2001, DOI 10.1523/JNEUROSCI.21-06-02001.2001; Lonart G, 2000, J BIOL CHEM, V275, P27703; Marsal J, 1997, P NATL ACAD SCI USA, V94, P14871, DOI 10.1073/pnas.94.26.14871; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Nonet ML, 1997, J NEUROSCI, V17, P8061; Nonet ML, 1998, J NEUROSCI, V18, P70; OConnor V, 1997, P NATL ACAD SCI USA, V94, P12186, DOI 10.1073/pnas.94.22.12186; Ogawa H, 1998, J BIOL CHEM, V273, P2192, DOI 10.1074/jbc.273.4.2192; OSSIG R, 1991, MOL CELL BIOL, V11, P2980, DOI 10.1128/MCB.11.6.2980; Peng RW, 2002, J CELL BIOL, V157, P645, DOI 10.1083/jcb.200202006; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Reist NE, 1998, J NEUROSCI, V18, P7662; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Robinson LJ, 1998, CURR OPIN CELL BIOL, V10, P483, DOI 10.1016/S0955-0674(98)80063-X; Rowe J, 2001, J CELL SCI, V114, P3323; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; Sassa T, 1999, J NEUROSCI, V19, P4772; SCHULZE KL, 1994, NEURON, V13, P1099, DOI 10.1016/0896-6273(94)90048-5; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimer RM, 2003, J CELL SCI, V116, P3661, DOI 10.1242/jcs.00687; Wu MN, 2001, EUR J CELL BIOL, V80, P196, DOI 10.1078/0171-9335-00143; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	49	191	203	0	20	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1023	1030		10.1038/nn1118	http://dx.doi.org/10.1038/nn1118			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	12973353	Green Accepted			2022-12-24	WOS:000185633600013
J	Ruiz, A; Fabian-Fine, R; Scott, R; Walker, MC; Rusakov, DA; Kullmann, DM				Ruiz, A; Fabian-Fine, R; Scott, R; Walker, MC; Rusakov, DA; Kullmann, DM			GABA(A) receptors at hippocampal mossy fibers	NEURON			English	Article							PRESYNAPTIC KAINATE RECEPTOR; ACTION-POTENTIAL PROPAGATION; RAT NEOCORTICAL NEURONS; LONG-TERM POTENTIATION; K-CL COTRANSPORTER; SYNAPTIC-TRANSMISSION; NERVE-TERMINALS; HETEROSYNAPTIC DEPRESSION; TRANSMITTER RELEASE; CALCIUM-CHANNELS	Presynaptic GABA(A) receptors modulate synaptic transmission in several areas of the CNS but are not known to have this action in the cerebral cortex. We report that GABAA receptor activation reduces hippocampal mossy fibers excitability but has the opposite effect when intracellular Cl(-) is experimentally elevated. Synaptically released GABA mimics the effect of exogenous agonists. GABA(A) receptors modulating axonal excitability are tonically active in the absence of evoked GABA release or exogenous agonist application. Presynaptic action potential-dependent Ca(2+) transients in individual mossy fiber varicosities exhibit a biphasic dependence on membrane potential and are altered by GABA(A) receptors. Antibodies against the alpha(2) subunit of GABA(A) receptors stain mossy fibers. Axonal GABAA receptors thus play a potentially important role in tonic and activity-dependent heterosynaptic modulation of information flow to the hippocampus.	UCL, Neurol Inst, Dept Clin & Expt Epilepsy, London WC1N 3BG, England; Dalhousie Univ, Dept Psychol, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Inst Neurosci, Halifax, NS B3H 4H7, Canada	University of London; University College London; Dalhousie University; Dalhousie University	Kullmann, DM (corresponding author), UCL, Neurol Inst, Dept Clin & Expt Epilepsy, London WC1N 3BG, England.	d.kullmann@ion.ucl.ac.uk	Kullmann, Dimitri M/A-3162-2009; Rusakov, Dmitri/AAH-4529-2021; Rusakov, Dmitri A/E-1987-2011; Scott, Ricardo/B-6723-2011; Walker, Matthew C/C-1577-2008	Kullmann, Dimitri M/0000-0001-6696-3545; Rusakov, Dmitri/0000-0001-9539-9947; Rusakov, Dmitri A/0000-0001-9539-9947; Scott, Ricardo/0000-0002-0713-0671; Walker, Matthew C/0000-0002-0812-0352; Ruiz, Arnaud J/0000-0001-9058-9303	Medical Research Council [G0400627(76527)] Funding Source: Medline; Wellcome Trust [071179] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Avoli M, 1998, EUR J NEUROSCI, V10, P2714, DOI 10.1046/j.1460-9568.1998.t01-1-00275.x; Bergersen L, 2003, EUR J NEUROSCI, V18, P931, DOI 10.1046/j.1460-9568.2003.02828.x; Bohlhalter S, 1996, J NEUROSCI, V16, P283, DOI 10.1523/jneurosci.16-01-00283.1996; Cattaert D, 1999, J NEUROSCI, V19, P6079, DOI 10.1523/JNEUROSCI.19-14-06079.1999; Chevaleyre V, 2002, P NATL ACAD SCI USA, V99, P9538, DOI 10.1073/pnas.142213199; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Cox CL, 2000, P NATL ACAD SCI USA, V97, P9724, DOI 10.1073/pnas.170278697; CURTIS DR, 1982, EXP BRAIN RES, V46, P215; Debanne D, 1997, NATURE, V389, P286, DOI 10.1038/38502; Ebert B, 1997, MOL PHARMACOL, V52, P1150, DOI 10.1124/mol.52.6.1150; ECCLES JC, 1963, J PHYSIOL-LONDON, V168, P500, DOI 10.1113/jphysiol.1963.sp007205; Eghbali M, 1997, NATURE, V388, P71, DOI 10.1038/40404; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; Fabian-Fine R, 2001, J NEUROSCI, V21, P7993, DOI 10.1523/JNEUROSCI.21-20-07993.2001; Fassio A, 1999, J NEUROSCI RES, V57, P324, DOI 10.1002/(SICI)1097-4547(19990801)57:3<324::AID-JNR4>3.0.CO;2-Z; FUNG SC, 1983, NEUROSCI LETT, V42, P61, DOI 10.1016/0304-3940(83)90422-6; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; GRAHAM B, 1994, J NEUROPHYSIOL, V71, P538, DOI 10.1152/jn.1994.71.2.538; Gutierrez R, 2001, EUR J NEUROSCI, V13, P1371, DOI 10.1046/j.0953-816x.2001.01508.x; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Jackson MB, 2003, J NEUROSCI, V23, P1612; Jang IS, 2001, J NEUROSCI, V21, P5962, DOI 10.1523/JNEUROSCI.21-16-05962.2001; KAILA K, 1993, J PHYSIOL-LONDON, V464, P273, DOI 10.1113/jphysiol.1993.sp019634; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; Koester HJ, 1999, BIOPHYS J, V77, P2226, DOI 10.1016/S0006-3495(99)77063-3; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; LANTHORN TH, 1984, BRAIN RES, V290, P174, DOI 10.1016/0006-8993(84)90750-9; Lauri SE, 2001, NEURON, V32, P697, DOI 10.1016/S0896-6273(01)00511-6; LUKASIEWICZ PD, 1994, J NEUROSCI, V14, P1213, DOI 10.1523/JNEUROSCI.14-03-01213.1994; Mellor J, 2002, SCIENCE, V295, P143, DOI 10.1126/science.1064285; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; MISGELD U, 1986, SCIENCE, V232, P1413, DOI 10.1126/science.2424084; Nicoll R A, 1979, Int Rev Neurobiol, V21, P217; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; Overstreet LS, 2001, J NEUROPHYSIOL, V86, P596, DOI 10.1152/jn.2001.86.2.596; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Pouzat C, 1999, J NEUROSCI, V19, P1675; PRITCHETT DB, 1990, J NEUROCHEM, V54, P1802, DOI 10.1111/j.1471-4159.1990.tb01237.x; Reid CA, 2001, J NEUROSCI, V21, P2206, DOI 10.1523/JNEUROSCI.21-07-02206.2001; RUDOMIN P, 1981, J NEUROPHYSIOL, V46, P532, DOI 10.1152/jn.1981.46.3.532; Rusakov DA, 2003, NEURON, V37, P287, DOI 10.1016/S0896-6273(03)00025-4; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; SANDLER R, 1991, J COMP NEUROL, V303, P177, DOI 10.1002/cne.903030202; SARIDAKI E, 1989, J ENDOCRINOL, V121, P343, DOI 10.1677/joe.0.1210343; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; SEGEV I, 1990, J NEUROPHYSIOL, V63, P987, DOI 10.1152/jn.1990.63.5.987; Sloviter RS, 1996, J COMP NEUROL, V373, P593; Sperk G, 1997, NEUROSCIENCE, V80, P987, DOI 10.1016/S0306-4522(97)00146-2; STASHEFF SF, 1993, J NEUROPHYSIOL, V70, P976, DOI 10.1152/jn.1993.70.3.976; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; TACHIBANA M, 1987, P NATL ACAD SCI USA, V84, P3501, DOI 10.1073/pnas.84.10.3501; TSIEN RY, 1989, ANNU REV NEUROSCI, V12, P227, DOI 10.1146/annurev.neuro.12.1.227; Turecek R, 2002, P NATL ACAD SCI USA, V99, P13884, DOI 10.1073/pnas.212419699; Turecek R, 2001, NATURE, V411, P587, DOI 10.1038/35079084; Verdier D, 2003, J NEUROSCI, V23, P2002; Vignes M, 1998, NEUROPHARMACOLOGY, V37, P1269, DOI 10.1016/S0028-3908(98)00148-8; Vogt KE, 1999, P NATL ACAD SCI USA, V96, P1118, DOI 10.1073/pnas.96.3.1118; Voipio J, 2000, PROG BRAIN RES, V125, P329; Walker MC, 2001, NEURON, V29, P703, DOI 10.1016/S0896-6273(01)00245-8; WEISSKOPF MG, 1993, NATURE, V362, P423, DOI 10.1038/362423a0; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; YAMAMOTO C, 1983, EXP BRAIN RES, V51, P128; Yokoi M, 1996, SCIENCE, V273, P645, DOI 10.1126/science.273.5275.645; ZHANG SLJ, 1993, SCIENCE, V259, P531, DOI 10.1126/science.8380942; ZHANG SLJ, 1995, J PHYSIOL-LONDON, V483, P583, DOI 10.1113/jphysiol.1995.sp020608	68	128	135	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 11	2003	39	6					961	973		10.1016/S0896-6273(03)00559-2	http://dx.doi.org/10.1016/S0896-6273(03)00559-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	721BA	12971896	Green Accepted, Bronze			2022-12-24	WOS:000185296100010
J	Ditterich, J; Mazurek, ME; Shadlen, MN				Ditterich, J; Mazurek, ME; Shadlen, MN			Microstimulation of visual cortex affects the speed of perceptual decisions	NATURE NEUROSCIENCE			English	Article							TRANSPARENT MOTION PERCEPTION; SACCADIC EYE-MOVEMENTS; AREA MT; MACAQUE MT; DIRECTION; PSYCHOPHYSICS; SIGNALS; PROBABILITY; RESPONSES; NEURONS	Direction-selective neurons in the middle temporal visual area (MT) are crucially involved in motion perception, although it is not known exactly how the activity of these neurons is interpreted by the rest of the brain. Here we report that in a two-alternative task, the activity of MT neurons is interpreted as evidence for one direction and against the other. We measured the speed and accuracy of decisions as rhesus monkeys performed a direction- discrimination task. On half of the trials, we stimulated direction- selective neurons in area MT, thereby causing the monkeys to choose the neurons' preferred direction more often. Microstimulation quickened decisions in favor of the preferred direction and slowed decisions in favor of the opposite direction. Even on trials in which microstimulation did not induce a preferred direction choice, it still affected response times. Our findings suggest that during the formation of a decision, sensory evidence for competing propositions is compared and accumulates to a decision-making threshold.	Univ Washington, Natl Primate Res Ctr, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Shadlen, MN (corresponding author), Univ Washington, Natl Primate Res Ctr, Howard Hughes Med Inst, 1959 NE Pacific St, Seattle, WA 98195 USA.	shadlen@u.washington.edu	Shadlen, Michael Neil/AAL-1870-2020	Shadlen, Michael/0000-0002-2002-2210	NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011378] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00166] Funding Source: Medline; NEI NIH HHS [EY11378] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Albright T D, 1993, Rev Oculomot Res, V5, P177; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; CELEBRINI S, 1995, J NEUROPHYSIOL, V73, P437, DOI 10.1152/jn.1995.73.2.437; Churchland MM, 2001, J NEUROSCI, V21, P9387, DOI 10.1523/JNEUROSCI.21-23-09387.2001; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; Escobar, 1999, STAT METHODS RELIABI; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; GOOD IJ, 1979, BIOMETRIKA, V66, P393, DOI 10.1093/biomet/66.2.393; Green DM, 1966, SIGNAL DETECTION THE; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2543, DOI 10.1152/jn.2001.86.5.2543; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; LAMING DRJ, 1969, J MATH PSYCHOL, V6, P81, DOI 10.1016/0022-2496(69)90030-3; LEVINSON E, 1975, J PHYSIOL-LONDON, V250, P347, DOI 10.1113/jphysiol.1975.sp011058; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; PANTLE A, 1974, VISION RES, V14, P1229, DOI 10.1016/0042-6989(74)90221-1; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Press W.H, 1992, NUMERICAL RECIPES C, P666; QIAN N, 1994, J NEUROSCI, V14, P7367; QIAN N, 1994, J NEUROSCI, V14, P7357; Rudolph K, 1999, CEREB CORTEX, V9, P90, DOI 10.1093/cercor/9.1.90; SNOWDEN RJ, 1991, J NEUROSCI, V11, P2768; Van Essen DC, 2002, CURR OPIN NEUROBIOL, V12, P574, DOI 10.1016/S0959-4388(02)00361-6; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Van Wezel RJA, 2002, J NEUROPHYSIOL, V88, P3469, DOI 10.1152/jn.00276.2002; Wald A., 1947, SEQUENTIAL ANAL	30	156	192	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					891	898		10.1038/nn1094	http://dx.doi.org/10.1038/nn1094			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	705UP	12858179				2022-12-24	WOS:000184413700020
J	Jin, RS; Banke, TG; Mayer, ML; Traynelis, SF; Gouaux, E				Jin, RS; Banke, TG; Mayer, ML; Traynelis, SF; Gouaux, E			Structural basis for partial agonist action at ionotropic glutamate receptors	NATURE NEUROSCIENCE			English	Article							POTASSIUM CHANNELS I; LIGAND-BINDING CORE; AMPA RECEPTORS; HIPPOCAMPAL-NEURONS; CRYSTAL-STRUCTURES; ION-CHANNEL; ACTIVATION; GLUR2; DESENSITIZATION; KAINATE	An unresolved problem in understanding neurotransmitter receptor function concerns the mechanism(s) by which full and partial agonists elicit different amplitude responses at equal receptor occupancy. The widely held view of 'partial agonism' posits that resting and active states of the receptor are in equilibrium, and partial agonists simply do not shift the equilibrium toward the active state as efficaciously as full agonists. Here we report findings from crystallographic and electrophysiological studies of the mechanism of activation of an AMPA-subtype glutamate receptor ion channel. In these experiments, we used 5-substituted willardiines, a series of partial agonists that differ by only a single atom. Our results show that the GluR2 ligand-binding core can adopt a range of ligand-dependent conformational states, which in turn control the open probability of discrete subconductance states of the intact ion channel. Our findings thus provide a structure-based model of partial agonism.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Emory Univ, Sch Med, Dept Pharmacol, Rollins Res Ctr, Atlanta, GA 30322 USA; Natl Inst Child Hlth & Dev, Lab Cellular & Mol Neurophysiol, NIH, Bethesda, MD 20892 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; Emory University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Gouaux, E (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 650 W 168 St, New York, NY 10032 USA.		Mayer, Mark/AAE-7356-2019; Gouaux, Eric/Y-4370-2019; Jin, Rongsheng/M-7797-2013; Mayer, Mark L/H-5500-2013	Mayer, Mark/0000-0003-4378-8451; Gouaux, Eric/0000-0002-8549-2360; Jin, Rongsheng/0000-0003-0348-7363; Banke, Tue/0000-0001-8417-4400	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000707] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000707] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Brauner-Osborne H, 2000, J MED CHEM, V43, P2609, DOI 10.1021/jm000007r; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen GQ, 1997, P NATL ACAD SCI USA, V94, P13431, DOI 10.1073/pnas.94.25.13431; Colquhoun David, 1995, P483; Cox DH, 1997, J GEN PHYSIOL, V110, P257, DOI 10.1085/jgp.110.3.257; CULLCANDY SG, 1988, J PHYSIOL-LONDON, V400, P189, DOI 10.1113/jphysiol.1988.sp017117; DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P369; Dingledine R, 1999, PHARMACOL REV, V51, P7; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; EVANS RH, 1980, J PHYSIOL-LONDON, V308, pP71; GMELIN R, 1961, ACTA CHEM SCAND, V15, P1188, DOI 10.3891/acta.chem.scand.15-1188; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hogner A, 2002, J MOL BIOL, V322, P93, DOI 10.1016/S0022-2836(02)00650-2; Horrigan FT, 1999, J GEN PHYSIOL, V114, P277, DOI 10.1085/jgp.114.2.277; Jin RS, 2002, BIOCHEMISTRY-US, V41, P15635, DOI 10.1021/bi020583k; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kizelsztein P, 2000, BIOCHEMISTRY-US, V39, P12819, DOI 10.1021/bi000962i; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATNEAU DK, 1992, J NEUROSCI, V12, P595; PATNEAU DK, 1991, NEURON, V6, P785, DOI 10.1016/0896-6273(91)90175-Y; Robert A, 2001, J NEUROSCI, V21, P5574, DOI 10.1523/JNEUROSCI.21-15-05574.2001; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Schoppa NE, 1998, J GEN PHYSIOL, V111, P271, DOI 10.1085/jgp.111.2.271; Smith TC, 2000, J NEUROSCI, V20, P2073; STEPHENSON RP, 1956, BRIT J PHARM CHEMOTH, V11, P379, DOI 10.1111/j.1476-5381.1956.tb00006.x; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Traynelis SF, 1998, TRENDS NEUROSCI, V21, P137, DOI 10.1016/S0166-2236(98)01238-7; WONG LA, 1994, J NEUROSCI, V14, P3881; WYMAN J, 1951, J POLYM SCI, V7, P499, DOI 10.1002/pol.1951.120070506; ZORUMSKI CF, 1988, J NEUROSCI, V8, P4277	43	321	329	0	13	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					803	810		10.1038/nn1091	http://dx.doi.org/10.1038/nn1091			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12872125				2022-12-24	WOS:000184413700008
J	Delcroix, JD; Valletta, JS; Wu, CB; Hunt, SJ; Kowal, AS; Mobley, WC				Delcroix, JD; Valletta, JS; Wu, CB; Hunt, SJ; Kowal, AS; Mobley, WC			NGF signaling in sensory neurons: Evidence that early endosomes carry NGF retrograde signals	NEURON			English	Article							NERVE GROWTH-FACTOR; FAST AXONAL-TRANSPORT; ACTIVATED PROTEIN-KINASE; RAT SYMPATHETIC NEURONS; TRANSCRIPTION FACTOR; CYTOPLASMIC DYNEIN; TYROSINE PHOSPHORYLATION; COMPARTMENTED CULTURES; NEURITE GROWTH; TETANUS TOXIN	Target-derived NGF promotes the phenotypic maintenance of mature dorsal root ganglion (DRG) nociceptive neurons. Here, we provide in vivo and in vitro evidence for the presence within DRG neurons of endosomes containing NGF, activated TrkA, and signaling proteins of the Rap1/Erk1/2, p38MAPK, and PI3K/ Akt pathways. Signaling endosomes were shown to be retrogradely transported in the isolated sciatic nerve in vitro. NGF injection in the peripheral target of DRG neurons increased the retrograde transport of p-Erk1/2, p-p38, and pAkt in these membranes. Conversely, NGF antibody injections decreased the retrograde transport of p-Erk1/2 and p-p38. Our results are evidence that signaling endosomes, with the characteristics of early endosomes, convey NGF signals from the target of nociceptive neurons to their cell bodies.	Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Delcroix, JD (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, 1201 Welch Rd,MSLS Bldg, Stanford, CA 94305 USA.		Hunt, Stephen/K-3608-2012	Hunt, Stephen/0000-0002-6400-4321	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024054, R01NS038869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016999] Funding Source: NIH RePORTER; NIA NIH HHS [AG16999] Funding Source: Medline; NINDS NIH HHS [NS24054, NS38869] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Averill S, 2001, MOL CELL NEUROSCI, V18, P183, DOI 10.1006/mcne.2001.1015; Bhattacharyya A, 2002, J NEUROBIOL, V51, P302, DOI 10.1002/neu.10062; BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; Callaghan L, 1999, EUR J BIOCHEM, V265, P361; CAMPENOT RB, 1994, J NEUROCHEM, V63, P868; CLAUDE P, 1982, J NEUROSCI, V2, P431; Crowder RJ, 1998, J NEUROSCI, V18, P2933; CURTIS R, 1994, NEURON, V12, P191, DOI 10.1016/0896-6273(94)90163-5; DEHOOP MJ, 1994, NEURON, V13, P11, DOI 10.1016/0896-6273(94)90456-1; Delcroix JD, 1997, MOL BRAIN RES, V51, P82, DOI 10.1016/S0169-328X(97)00215-5; DISTEFANO PS, 1994, PROG BRAIN RES, V103, P35; EHLERS MD, 1995, J CELL BIOL, V130, P149, DOI 10.1083/jcb.130.1.149; Fuchs SY, 2000, J BIOL CHEM, V275, P12560, DOI 10.1074/jbc.275.17.12560; GOLDBERG DJ, 1982, P NATL ACAD SCI-BIOL, V79, P4818, DOI 10.1073/pnas.79.15.4818; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GRAFSTEIN B, 1980, PHYSIOL REV, V60, P1167, DOI 10.1152/physrev.1980.60.4.1167; Grimes ML, 1997, P NATL ACAD SCI USA, V94, P9909, DOI 10.1073/pnas.94.18.9909; Grimes ML, 1996, J NEUROSCI, V16, P7950; GULBENKIAN S, 1986, J NEUROCYTOL, V15, P535, DOI 10.1007/BF01611735; Gurd JW, 1997, NEUROCHEM INT, V31, P635, DOI 10.1016/S0197-0186(97)00022-3; Habermann A, 2001, J CELL SCI, V114, P229; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; HENDRY IA, 1974, BRAIN RES, V68, P103, DOI 10.1016/0006-8993(74)90536-8; Hirashima N, 2000, BIOL PHARM BULL, V23, P1097; HOLCOMBE RF, 1993, CLIN IMMUNOL IMMUNOP, V67, P31, DOI 10.1006/clin.1993.1042; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Johanson SO, 1996, NEUROCHEM RES, V21, P779, DOI 10.1007/BF02532300; JOHANSON SO, 1995, BRAIN RES, V690, P55, DOI 10.1016/0006-8993(95)00587-G; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kimpinski K, 1997, J NEUROBIOL, V33, P395, DOI 10.1002/(SICI)1097-4695(199710)33:4<395::AID-NEU5>3.0.CO;2-5; Klesse LJ, 1999, MICROSC RES TECHNIQ, V45, P210, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<210::AID-JEMT4>3.3.CO;2-6; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; Lalli G, 2002, J CELL BIOL, V156, P233, DOI 10.1083/jcb.200106142; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Liu RY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-17-j0003.2001; MacInnis BL, 2002, SCIENCE, V295, P1536, DOI 10.1126/science.1064913; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Miller FD, 2002, SCIENCE, V295, P1471, DOI 10.1126/science.1069897; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; NAGATSU I, 1978, ARCH HISTOL JAPON, V41, P439, DOI 10.1679/aohc1950.41.439; Neet KE, 2001, CELL MOL LIFE SCI, V58, P1021, DOI 10.1007/PL00000917; OVERLY CC, 1995, P NATL ACAD SCI USA, V92, P3156, DOI 10.1073/pnas.92.8.3156; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; RABINOWITZ S, 1992, J CELL BIOL, V116, P95, DOI 10.1083/jcb.116.1.95; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Sandow SL, 2000, IMMUNOL CELL BIOL, V78, P430, DOI 10.1046/j.1440-1711.2000.00924.x; Senger DL, 1997, J CELL BIOL, V138, P411, DOI 10.1083/jcb.138.2.411; Shadiack AM, 2001, J NEUROSCI, V21, P363, DOI 10.1523/JNEUROSCI.21-02-00363.2001; Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123; Shu XQ, 1999, P NATL ACAD SCI USA, V96, P7693, DOI 10.1073/pnas.96.14.7693; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; STOCKEL K, 1975, BRAIN RES, V99, P1, DOI 10.1016/0006-8993(75)90604-6; Tsui-Pierchala BA, 1999, J NEUROSCI, V19, P8207; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; VIANCOUR TA, 1993, BRAIN RES, V628, P209, DOI 10.1016/0006-8993(93)90957-O; Watson FL, 1999, J NEUROSCI, V19, P7889; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Wu CB, 2001, J NEUROSCI, V21, P5406, DOI 10.1523/JNEUROSCI.21-15-05406.2001; Xia ZG, 1996, J NEUROSCI, V16, P5425; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Yano H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-03-j0003.2001; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	65	357	364	1	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 3	2003	39	1					69	84		10.1016/S0896-6273(03)00397-0	http://dx.doi.org/10.1016/S0896-6273(03)00397-0			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699LB	12848933	Bronze			2022-12-24	WOS:000184057400010
J	Duncan, RO; Boynton, GM				Duncan, RO; Boynton, GM			Cortical magnification within human primary visual cortex correlates with acuity thresholds	NEURON			English	Article							NASO-TEMPORAL ASYMMETRY; RECEPTIVE-FIELD SIZE; STRIATE CORTEX; VERNIER ACUITY; PERIPHERAL-VISION; MACAQUE MONKEY; RETINOTOPIC ORGANIZATION; CONTRAST DISCRIMINATION; INDIVIDUAL VARIABILITY; GANGLION-CELLS	We measured linear cortical magnification factors in V1 with fMRI, and we measured visual acuity (Vernier and grating) in the same observers. The cortical representation of both Vernier and grating acuity thresholds in V1 was found to be roughly constant across all eccentricities. We also found a within-observer correlation between cortical magnification and Vernier acuity, further supporting claims that Vernier acuity is limited by cortical magnification in V1.	Salk Inst Biol Studies, Syst Neurobiol Lab B, La Jolla, CA 92037 USA	Salk Institute	Duncan, RO (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab B, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rob@salk.edu			NATIONAL EYE INSTITUTE [R01EY012925, F32EY007028] Funding Source: NIH RePORTER; NEI NIH HHS [F32 EY007028, EY 12925, EY 07028-02] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARUN KS, 1987, IEEE T PATTERN ANAL, V9, P699, DOI 10.1109/TPAMI.1987.4767965; AZZOPARDI P, 1993, NATURE, V361, P719, DOI 10.1038/361719a0; Beard BL, 1997, VISION RES, V37, P325, DOI 10.1016/S0042-6989(96)00109-5; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRINDLEY GS, 1968, J PHYSIOL-LONDON, V196, P479, DOI 10.1113/jphysiol.1968.sp008519; COLETTA NJ, 1987, J OPT SOC AM A, V4, P1503, DOI 10.1364/JOSAA.4.001503; CONNOLLY M, 1984, J COMP NEUROL, V226, P544, DOI 10.1002/cne.902260408; COWEY A, 1974, EXP BRAIN RES, V21, P447; CURCIO CA, 1987, SCIENCE, V236, P579, DOI 10.1126/science.3576186; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; DOW BM, 1981, EXP BRAIN RES, V44, P213; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; FAHLE M, 1988, VISION RES, V28, P293, DOI 10.1016/0042-6989(88)90157-5; Filimonoff IN, 1932, J PSYCHOL NEUROL, V44, P1; GRINVALD A, 1994, J NEUROSCI, V14, P2545; GRUSSER OJ, 1995, VISION RES, V35, P1125, DOI 10.1016/0042-6989(94)00187-Q; He S, 1996, J OPT SOC AM A, V13, P1139, DOI 10.1364/JOSAA.13.001139; HUBEL DH, 1974, J COMP NEUROL, V158, P295, DOI 10.1002/cne.901580305; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; KERR JL, 1971, PERCEPT PSYCHOPHYS, V9, P375, DOI 10.3758/BF03212671; LEVI DM, 1985, VISION RES, V25, P963, DOI 10.1016/0042-6989(85)90207-X; LEVI DM, 1982, INVEST OPHTH VIS SCI, V23, P398; Levi DM, 2000, VISION RES, V40, P973, DOI 10.1016/S0042-6989(99)00225-4; LEVI DM, 1985, VISION RES, V25, P979, DOI 10.1016/0042-6989(85)90208-1; LEVI DM, 1984, VISION RES, V24, P789, DOI 10.1016/0042-6989(84)90150-0; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Popovic Z, 2001, VISION RES, V41, P1313, DOI 10.1016/S0042-6989(00)00290-X; ROCKEL AJ, 1980, BRAIN, V103, P221, DOI 10.1093/brain/103.2.221; ROLLS ET, 1970, EXP BRAIN RES, V10, P298; ROVAMO J, 1978, NATURE, V271, P54, DOI 10.1038/271054a0; SCHWARTZ EL, 1980, VISION RES, V20, P645, DOI 10.1016/0042-6989(80)90090-5; Schwartz Eric L., 1994, Cerebral Cortex, V10, P359; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Sholl DA, 1956, ORG CEREBRAL CORTEX; SIRETEANU R, 1981, VISION RES, V21, P1055, DOI 10.1016/0042-6989(81)90010-9; Smith AT, 2001, CEREB CORTEX, V11, P1182, DOI 10.1093/cercor/11.12.1182; STENSAAS SS, 1974, J NEUROSURG, V40, P747, DOI 10.3171/jns.1974.40.6.0747; Stevens CF, 2001, NATURE, V411, P193, DOI 10.1038/35075572; Teo PC, 1997, IEEE T MED IMAGING, V16, P852, DOI 10.1109/42.650881; THIBOS LN, 1987, J OPT SOC AM A, V4, P1524, DOI 10.1364/JOSAA.4.001524; TOOTELL RBH, 1982, SCIENCE, V218, P902, DOI 10.1126/science.7134981; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; Wandell BA, 2000, J COGNITIVE NEUROSCI, V12, P739, DOI 10.1162/089892900562561; Wertheim T., 1894, Z PSYCHOL, V7, P172; WESTHEIMER G, 1982, VISION RES, V22, P157, DOI 10.1016/0042-6989(82)90177-8; WEYMOUTH FRANK W., 1928, AMER JOUR OPHTHALMOL, V11, P947; WHITAKER D, 1992, VISION RES, V32, P1481, DOI 10.1016/0042-6989(92)90204-V; WILHELM H, 1993, CLIN VISION SCI, V8, P609	51	250	254	1	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 22	2003	38	4					659	671		10.1016/S0896-6273(03)00265-4	http://dx.doi.org/10.1016/S0896-6273(03)00265-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	682QV	12765616	Bronze, Green Published			2022-12-24	WOS:000183104000015
J	Ikeda, M; Sugiyama, T; Wallace, CS; Gompf, HS; Yoshioka, T; Miyawaki, A; Allen, CN				Ikeda, M; Sugiyama, T; Wallace, CS; Gompf, HS; Yoshioka, T; Miyawaki, A; Allen, CN			Circadian dynamics of cytosolic and nuclear Ca2+ in single suprachiasmatic nucleus neurons	NEURON			English	Article							INDUCED PHASE DELAYS; CYCLIC-ADP-RIBOSE; CREB PHOSPHORYLATION; BIOLOGICAL CLOCK; PROTEIN-KINASE; CALCIUM; RAT; LIGHT; GLUTAMATE; RHYTHMS	Intracellular free Ca2+ regulates diverse cellular processes, including membrane potential, neurotransmitter release, and gene expression. To examine the cellular mechanisms underlying the generation of circadian rhythms, nucleus-targeted and untargeted cDNAs encoding a Ca2+-sensitive fluorescent protein (cameleon) were transfected into organotypic cultures of mouse suprachiasmatic nucleus (SCN), the primary circadian pacemaker. Circadian rhythms in cytosolic but not nuclear Ca2+ concentration were observed in SCN neurons. The cytosolic Ca2+ rhythm period matched the circadian multiple-unit-activity (MUA)-rhythm period monitored using a multiple-electrode array, with a mean advance in phase of 4 hr. Tetrodotoxin blocked MUA, but not Ca2+ rhythms, while ryanodine damped both Ca2+ and MUA rhythms. These results demonstrate cytosolic Ca2+ rhythms regulated by the release of Ca2+ from ryanodine-sensitive stores in SCN neurons.	Osaka Biosci Inst, Dept Mol Behav Biol, Osaka, Japan; Waseda Univ, Adv Res Inst Sci & Engn, Shinjyuku Ku, Tokyo 1698555, Japan; Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA; RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan	Waseda University; Oregon Health & Science University; RIKEN	Ikeda, M (corresponding author), Osaka Biosci Inst, Dept Mol Behav Biol, 6-2-4 Furuedai, Osaka, Japan.	msikeda@obi.or.jp	Miyawaki, Atsushi/K-3569-2014	Miyawaki, Atsushi/0000-0002-2329-3235; Sugiyama, Takashi/0000-0002-7872-1540; Ikeda, Masayuki/0000-0002-6833-9495	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS036607, R01NS036607] Funding Source: NIH RePORTER; NINDS NIH HHS [NS036607] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Allen CN, 1999, J NEUROSCI, V19, P2152; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; BADMINTON MN, 1995, EXP CELL RES, V216, P236, DOI 10.1006/excr.1995.1030; Belenky M, 1996, NEUROSCIENCE, V70, P127, DOI 10.1016/0306-4522(95)00327-F; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BRINI M, 1993, EMBO J, V12, P4813, DOI 10.1002/j.1460-2075.1993.tb06170.x; BRINI M, 1994, CELL CALCIUM, V16, P259, DOI 10.1016/0143-4160(94)90089-2; CHEUNG WT, 1993, EUR J BIOCHEM, V215, P401, DOI 10.1111/j.1432-1033.1993.tb18047.x; Colwell CS, 2000, EUR J NEUROSCI, V12, P571, DOI 10.1046/j.1460-9568.2000.00939.x; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; DELAMORA MP, 1981, NEUROSCIENCE, V6, P875, DOI 10.1016/0306-4522(81)90169-X; Diaz-Munoz M, 1999, NEUROREPORT, V10, P481, DOI 10.1097/00001756-199902250-00007; Ding JM, 1997, J NEUROSCI, V17, P667; Ding JM, 1998, NATURE, V394, P381, DOI 10.1038/28639; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; EARNEST DJ, 1986, BRAIN RES, V382, P129, DOI 10.1016/0006-8993(86)90119-8; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GREEN DJ, 1982, BRAIN RES, V245, P198, DOI 10.1016/0006-8993(82)90361-4; HATEM SN, 1995, AM J PHYSIOL-HEART C, V268, pH1195, DOI 10.1152/ajpheart.1995.268.3.H1195; Herzog ED, 1997, BRAIN RES, V757, P285, DOI 10.1016/S0006-8993(97)00337-5; Honma S, 1998, NEUROSCI LETT, V250, P157, DOI 10.1016/S0304-3940(98)00464-9; Ikeda M, 2003, EUR J NEUROSCI, V17, P58, DOI 10.1046/j.1460-9568.2003.02427.x; Ikeda M, 2000, NEUROREPORT, V11, P907, DOI 10.1097/00001756-200004070-00002; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Jiang ZG, 1997, J PHYSIOL-LONDON, V499, P141, DOI 10.1113/jphysiol.1997.sp021917; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; JOHNSON CH, 1995, SCIENCE, V269, P1863, DOI 10.1126/science.7569925; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Kopp MDA, 1999, J NEUROSCI, V19, P206, DOI 10.1523/JNEUROSCI.19-01-00206.1999; LeSauter J, 1999, J NEUROSCI, V19, P5574; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; MOORE RY, 1993, NEUROSCI LETT, V150, P112, DOI 10.1016/0304-3940(93)90120-A; NAKAMURA Y, 1995, NEUROSCIENCE, V68, P181, DOI 10.1016/0306-4522(95)00092-W; Oka H, 1999, J NEUROSCI METH, V93, P61, DOI 10.1016/S0165-0270(99)00113-2; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; Pennartz CMA, 2001, J PHYSIOL-LONDON, V532, P181, DOI 10.1111/j.1469-7793.2001.0181g.x; Reyes-Harde M, 1999, P NATL ACAD SCI USA, V96, P4061, DOI 10.1073/pnas.96.7.4061; SABBADINI RA, 1992, J BIOL CHEM, V267, P15475; SAKIMURA K, 1995, MOL BRAIN RES, V28, P19, DOI 10.1016/0169-328X(94)00177-G; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; SHINOHARA K, 1995, P NATL ACAD SCI USA, V92, P7396, DOI 10.1073/pnas.92.16.7396; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Tsuchiya R, 2002, BRAIN RES, V956, P221, DOI 10.1016/S0006-8993(02)03518-7; VANDENPOL AN, 1980, J COMP NEUROL, V191, P661, DOI 10.1002/cne.901910410; von Gall C, 1998, J NEUROSCI, V18, P10389; WALSETH TF, 1993, BIOCHIM BIOPHYS ACTA, V1178, P235, DOI 10.1016/0167-4889(93)90199-Y; WALSH IB, 1995, NEUROSCIENCE, V69, P915, DOI 10.1016/0306-4522(95)00243-C; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; WILLIAMS DA, 1985, NATURE, V318, P558, DOI 10.1038/318558a0; Wood NT, 2001, PLANT PHYSIOL, V125, P787, DOI 10.1104/pp.125.2.787; Yokota S, 2001, J NEUROCHEM, V77, P618, DOI 10.1046/j.1471-4159.2001.00270.x	56	203	207	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 24	2003	38	2					253	263		10.1016/S0896-6273(03)00164-8	http://dx.doi.org/10.1016/S0896-6273(03)00164-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672AM	12718859	Bronze			2022-12-24	WOS:000182498300014
J	Simonen, M; Pedersen, V; Weinmann, O; Schnell, L; Buss, A; Ledermann, B; Christ, F; Sansig, G; van der Putten, H; Schwab, ME				Simonen, M; Pedersen, V; Weinmann, O; Schnell, L; Buss, A; Ledermann, B; Christ, F; Sansig, G; van der Putten, H; Schwab, ME			Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury	NEURON			English	Article							NEURITE GROWTH-INHIBITORS; CENTRAL NERVOUS-SYSTEM; AXONAL REGENERATION; ADULT-RAT; FUNCTIONAL RECOVERY; GLYCOPROTEIN; RECEPTOR; ANTIBODY; PROTEIN; CNS	To investigate the role of the myelin-associated protein Nogo-A on axon sprouting and regeneration in the adult central nervous system (CNS), we generated Nogo-A-deficient mice. Nogo-A knockout (KO) mice were viable, fertile, and not obviously afflicted by major developmental or neurological disturbances. The shorter splice form Nogo-B was strongly upregulated in the CNS. The inhibitory effect of spinal cord extract for growing neurites was decreased in the KO mice. Two weeks following adult dorsal hemisection of the thoracic spinal cord, Nogo-A KO mice displayed more corticospinal tract (CST) fibers growing toward and into the lesion compared to their wild-type littermates. CST fibers caudal to the lesion-regenerating and/or sprouting from spared intact fibers-were also found to be more frequent in Nogo-A-deficient animals.	Univ Zurich, Inst Brain Res, CH-8057 Zurich, Switzerland; Swiss Fed Inst Technol Zurich, Dept Biol, CH-8057 Zurich, Switzerland; Univ Zurich, Inst Lab Anim Sci, CH-8057 Zurich, Switzerland; Novartis Pharma AG, CH-4002 Basel, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Novartis	Schwab, ME (corresponding author), Univ Zurich, Inst Brain Res, CH-8057 Zurich, Switzerland.		Schwab, Martin E/B-6818-2016; Pedersen, Vera/AAA-9026-2022	Pedersen, Vera/0000-0003-0542-5684				Bartsch U, 1995, NEURON, V15, P1375, DOI 10.1016/0896-6273(95)90015-2; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BRAY GM, 1987, J EXP BIOL, V132, P5; Buffo A, 2000, J NEUROSCI, V20, P2275; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Gordon-Weeks PR, 2000, MICROSC RES TECHNIQ, V48, P63, DOI 10.1002/(SICI)1097-0029(20000115)48:2<63::AID-JEMT2>3.0.CO;2-1; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Herzog A, 1997, J NEUROSCI METH, V72, P57, DOI 10.1016/S0165-0270(96)00156-2; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; Huber AB, 2002, J NEUROSCI, V22, P3553; Kim JE, 2003, NEURON, V38, P187, DOI 10.1016/S0896-6273(03)00147-8; Li M, 1996, J NEUROSCI RES, V46, P404, DOI 10.1002/(SICI)1097-4547(19961115)46:4<404::AID-JNR2>3.3.CO;2-W; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Merkler D, 2001, J NEUROSCI, V21, P3665, DOI 10.1523/JNEUROSCI.21-10-03665.2001; Niederost B, 2002, J NEUROSCI, V22, P10368; Niederost BP, 1999, J NEUROSCI, V19, P8979, DOI 10.1523/JNEUROSCI.19-20-08979.1999; Oertle T, 2003, J MOL BIOL, V325, P299, DOI 10.1016/S0022-2836(02)01179-8; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pot C, 2002, J CELL BIOL, V159, P29, DOI 10.1083/jcb.200206068; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Qiu J, 2000, GLIA, V29, P166, DOI 10.1002/(SICI)1098-1136(20000115)29:2<166::AID-GLIA10>3.0.CO;2-G; RABINOWITZ SS, 1991, J EXP MED, V174, P827, DOI 10.1084/jem.174.4.827; Raineteau O, 2001, P NATL ACAD SCI USA, V98, P6929, DOI 10.1073/pnas.111165498; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHWAB ME, 1985, J NEUROSCI, V5, P2415; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; Spillmann AA, 1998, J BIOL CHEM, V273, P19283, DOI 10.1074/jbc.273.30.19283; Steward O, 1999, EXP NEUROL, V157, P19, DOI 10.1006/exnr.1999.7040; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; van der Haar ME, 1998, J NEUROSCI RES, V51, P371, DOI 10.1002/(SICI)1097-4547(19980201)51:3<371::AID-JNR10>3.0.CO;2-A; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wang XX, 2002, J NEUROSCI, V22, P5505; Werner H, 2001, MOL CELL NEUROSCI, V18, P593, DOI 10.1006/mcne.2001.1044; Wolfer DP, 2002, TRENDS NEUROSCI, V25, P336, DOI 10.1016/S0166-2236(02)02192-6; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3; ZILLES K, 1994, RAT NERVOUS SYSTEM, P649	43	322	350	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 24	2003	38	2					201	211		10.1016/S0896-6273(03)00226-5	http://dx.doi.org/10.1016/S0896-6273(03)00226-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672AM	12718855	Bronze			2022-12-24	WOS:000182498300010
J	Sheth, SA; Nemoto, M; Guiou, M; Walker, M; Pouratian, N; Toga, AW				Sheth, SA; Nemoto, M; Guiou, M; Walker, M; Pouratian, N; Toga, AW			Linear and nonlinear relationships between neuronal activity, oxygen metabolism, and hemodynamic responses	NEURON			English	Article							CEREBRAL-BLOOD-FLOW; CONSUMPTION FOLLOWING ACTIVATION; ACTIVITY-DEPENDENT INCREASES; SOMATOSENSORY STIMULATION; IMAGING SPECTROSCOPY; OXIDATIVE-METABOLISM; SENSORY STIMULATION; EVOKED-POTENTIALS; NEGATIVE RESPONSE; NEURAL ACTIVITY	We investigated the relationship between neuronal activity, oxygen metabolism, and hemodynamic responses in rat somatosensory cortex with simultaneous optical intrinsic signal imaging and spectroscopy, laser Doppler flowmetry, and local field potential recordings. Changes in cerebral oxygen consumption increased linearly with synaptic activity but with a threshold effect consistent with the existence of a tissue oxygen buffer. Modeling analysis demonstrated that the coupling between neuronal activity and hemodynamic response magnitude may appear linear over a narrow range but incorporates nonlinear effects that are better described by a threshold or power law relationship. These results indicate that caution is required in the interpretation of perfusion-based indicators of brain activity, such as functional magnetic resonance imaging (fMRI), and may help to refine quantitative models of neurovascular coupling.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Lab Neuro Imaging, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Toga, AW (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Lab Neuro Imaging, Los Angeles, CA 90024 USA.	toga@loni.ucla.edu		Pouratian, Nader/0000-0002-0426-3241	NIGMS NIH HHS [GM08042] Funding Source: Medline; NIMH NIH HHS [MH52083, MH67432] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH067432, R01MH052083] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Buxton RB, 2001, NEUROIMAGE, V13, P953, DOI 10.1006/nimg.2001.0814; Buxton RB, 1997, J CEREBR BLOOD F MET, V17, P64, DOI 10.1097/00004647-199701000-00009; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; Devor A, 2003, NEURON, V39, P353, DOI 10.1016/S0896-6273(03)00403-3; Duong TQ, 2000, MAGN RESON MED, V44, P231, DOI 10.1002/1522-2594(200008)44:2<231::AID-MRM10>3.0.CO;2-T; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Gjedde A, 2002, J CEREBR BLOOD F MET, V22, P1, DOI 10.1097/00004647-200201000-00001; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Hoge RD, 1999, P NATL ACAD SCI USA, V96, P9403, DOI 10.1073/pnas.96.16.9403; Jones M, 2001, NEUROIMAGE, V13, P1002, DOI 10.1006/nimg.2001.0808; Lindauer U, 2003, BRAIN RES, V975, P135, DOI 10.1016/S0006-8993(03)02602-7; Lindauer U, 2001, NEUROIMAGE, V13, P988, DOI 10.1006/nimg.2000.0709; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Malonek D, 1997, P NATL ACAD SCI USA, V94, P14826, DOI 10.1073/pnas.94.26.14826; Mandeville JB, 1999, J CEREBR BLOOD F MET, V19, P679, DOI 10.1097/00004647-199906000-00012; Mandeville JB, 1999, MAGN RESON MED, V42, P944, DOI 10.1002/(SICI)1522-2594(199911)42:5<944::AID-MRM15>3.0.CO;2-W; Marota JJA, 1999, MAGNET RESON MED, V41, P247, DOI 10.1002/(SICI)1522-2594(199902)41:2<247::AID-MRM6>3.0.CO;2-U; Mathiesen C, 1998, J PHYSIOL-LONDON, V512, P555, DOI 10.1111/j.1469-7793.1998.555be.x; Mayhew J, 2001, NEUROIMAGE, V13, P975, DOI 10.1006/nimg.2001.0807; Mayhew J, 2000, NEUROIMAGE, V12, P664, DOI 10.1006/nimg.2000.0656; Mayhew JEW, 1996, NEUROIMAGE, V4, P183, DOI 10.1006/nimg.1996.0069; MENON RS, 1995, MAGNET RESON MED, V33, P453, DOI 10.1002/mrm.1910330323; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Ngai AC, 1999, BRAIN RES, V837, P221, DOI 10.1016/S0006-8993(99)01649-2; Nielsen AN, 2001, J PHYSIOL-LONDON, V533, P773, DOI 10.1111/j.1469-7793.2001.00773.x; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Ogawa S, 1998, ANNU REV BIOPH BIOM, V27, P447, DOI 10.1146/annurev.biophys.27.1.447; Parri R, 2003, NAT NEUROSCI, V6, P5, DOI 10.1038/nn0103-5; Sheth S, 2003, NEUROIMAGE, V19, P884, DOI 10.1016/S1053-8119(03)00086-7; Sheth SA, 2004, J NEUROSCI, V24, P634, DOI 10.1523/JNEUROSCI.4526-03.2004; Silva AC, 2000, J CEREBR BLOOD F MET, V20, P201, DOI 10.1097/00004647-200001000-00025; SIMONS DJ, 1985, J NEUROPHYSIOL, V54, P615, DOI 10.1152/jn.1985.54.3.615; UEKI M, 1992, ACTA ANAESTH SCAND, V36, P318, DOI 10.1111/j.1399-6576.1992.tb03474.x; Vanzetta I, 1999, SCIENCE, V286, P1555, DOI 10.1126/science.286.5444.1555; VILLRINGER A, 1995, CEREBROVAS BRAIN MET, V7, P240; Yacoub E, 1999, MAGN RESON MED, V41, P436, DOI 10.1002/(SICI)1522-2594(199903)41:3<436::AID-MRM2>3.0.CO;2-#; Yacoub E, 2001, MAGN RESON MED, V45, P184, DOI 10.1002/1522-2594(200102)45:2<184::AID-MRM1024>3.0.CO;2-C; Yacoub E, 1999, MAGNET RESON MED, V41, P1088, DOI 10.1002/(SICI)1522-2594(199906)41:6<1088::AID-MRM3>3.0.CO;2-Q	43	229	244	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 22	2004	42	2					347	355		10.1016/S0896-6273(04)00221-1	http://dx.doi.org/10.1016/S0896-6273(04)00221-1			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KG	15091348	Bronze			2022-12-24	WOS:000221458500017
J	Ito, R; Robbins, TW; Everitt, BJ				Ito, R; Robbins, TW; Everitt, BJ			Differential control over cocaine-seeking behavior by nucleus accumbens core and shell	NATURE NEUROSCIENCE			English	Article							PAVLOVIAN APPROACH BEHAVIOR; KAINIC ACID LESIONS; EXCITOTOXIC LESIONS; EXTRACELLULAR DOPAMINE; BASOLATERAL AMYGDALA; INTRAVENOUS COCAINE; 2ND-ORDER SCHEDULE; CONDITIONED REINFORCEMENT; LOCOMOTOR-ACTIVITY; VENTRAL STRIATUM	Nucleus accumbens (NAc) dopamine is widely implicated in mediating the reinforcing effects of drugs of abuse. However, the precise function of the NAc itself in drug self-administration has been difficult to establish. Here we show a neural double-dissociation of the behavioral processes that underlie cocaine self-administration in rats. Whereas selective excitotoxic lesions of the NAc core had only a minor effect on the acquisition of responding for cocaine under a standard schedule of continuous reinforcement, these lesions profoundly impaired the acquisition of drug-seeking behavior that was maintained by drug-associated conditioned reinforcers and assessed using a second-order schedule of cocaine reinforcement. In contrast, selective excitotoxic lesions of the NAc shell did not impair drug self-administration or the acquisition of cocaine-seeking, but they did attenuate the psychostimulant effects of cocaine. These results further our understanding of how the NAc controls drug-seeking and drug-taking behavior.	Univ Cambridge, Dept Expt Psychol, Cambridge CB1 1BB, England	University of Cambridge	Everitt, BJ (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB1 1BB, England.	bje10@cam.ac.uk	Robbins, Trevor W/A-7551-2008; Ito, Rutsuko/E-7296-2013	Ito, Rutsuko/0000-0003-1769-5470; Robbins, Trevor/0000-0003-0642-5977; Everitt, Barry/0000-0003-4431-6536	MRC [G9537855] Funding Source: UKRI; Medical Research Council [G9537855] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alderson HL, 2001, PSYCHOPHARMACOLOGY, V153, P455, DOI 10.1007/s002130000634; ANNETT LE, 1989, BEHAV BRAIN RES, V31, P231, DOI 10.1016/0166-4328(89)90005-3; Arroyo M, 1998, PSYCHOPHARMACOLOGY, V140, P331, DOI 10.1007/s002130050774; Bradberry CW, 2000, J NEUROSCI, V20, P3874, DOI 10.1523/JNEUROSCI.20-10-03874.2000; BURNS LH, 1993, BEHAV BRAIN RES, V55, P167, DOI 10.1016/0166-4328(93)90113-5; CADOR M, 1989, NEUROSCIENCE, V30, P77, DOI 10.1016/0306-4522(89)90354-0; CAINE SB, 1994, J EXP ANAL BEHAV, V61, P213, DOI 10.1901/jeab.1994.61-213; CAINE SB, 1995, BRAIN RES, V692, P47; CAINE SB, 1992, BEHAV NEUROSCIENCE P, V2, P117; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Carlezon WA, 1996, J NEUROSCI, V16, P3112; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Cornish JL, 1999, NEUROSCIENCE, V93, P1359, DOI 10.1016/S0306-4522(99)00214-6; Dalley JW, 2002, PSYCHOPHARMACOLOGY, V161, P425, DOI 10.1007/s00213-002-1078-2; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; DICHIARA G, 1993, PSYCHOPHARMACOLOGY, V112, P398, DOI 10.1007/BF02244939; DWORKIN SI, 1988, PHARMACOL BIOCHEM BE, V29, P175, DOI 10.1016/0091-3057(88)90292-4; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; Everitt BJ, 2000, PSYCHOPHARMACOLOGY, V153, P17, DOI 10.1007/s002130000566; Grant S, 1996, P NATL ACAD SCI USA, V93, P12040, DOI 10.1073/pnas.93.21.12040; Haber SN, 2000, J NEUROSCI, V20, P2369; Hall J, 2001, EUR J NEUROSCI, V13, P1984, DOI 10.1046/j.0953-816x.2001.01577.x; HEIMER L, 1991, NEUROSCIENCE, V41, P89, DOI 10.1016/0306-4522(91)90202-Y; HURD YL, 1989, BRAIN RES, V498, P199, DOI 10.1016/0006-8993(89)90422-8; Hutcheson DM, 2001, PSYCHOPHARMACOLOGY, V153, P464, DOI 10.1007/s002130000635; Ito R, 2000, J NEUROSCI, V20, P7489; MALDONADOIRIZARRY CS, 1995, BRAIN RES BULL, V38, P551, DOI 10.1016/0361-9230(95)02030-2; Meil WM, 1997, BEHAV BRAIN RES, V87, P139, DOI 10.1016/S0166-4328(96)02270-X; Parkinson JA, 1999, J NEUROSCI, V19, P2401; Parkinson JA, 2000, BEHAV NEUROSCI, V114, P42, DOI 10.1037/0735-7044.114.1.42; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PETTIT HO, 1984, PSYCHOPHARMACOLOGY, V84, P167, DOI 10.1007/BF00427441; PETTIT HO, 1989, PHARMACOL BIOCHEM BE, V34, P899, DOI 10.1016/0091-3057(89)90291-8; Pontieri FE, 1995, P NATL ACAD SCI USA, V92, P12304, DOI 10.1073/pnas.92.26.12304; PULVIRENTI L, 1992, BRAIN RES, V594, P327, DOI 10.1016/0006-8993(92)91145-5; READING PJ, 1991, BEHAV BRAIN RES, V46, P17, DOI 10.1016/S0166-4328(05)80093-2; Robbins TW, 1999, NATURE, V398, P567, DOI 10.1038/19208; ROBERTS DCS, 1977, PHARMACOL BIOCHEM BE, V6, P615, DOI 10.1016/0091-3057(77)90084-3; ROBLEDO P, 1992, ANN NY ACAD SCI, V654, P509, DOI 10.1111/j.1749-6632.1992.tb26015.x; Rodd-Henricks ZA, 2002, J PHARMACOL EXP THER, V303, P1216, DOI 10.1124/jpet.102.038950; See RE, 2002, PHARMACOL BIOCHEM BE, V71, P517, DOI 10.1016/S0091-3057(01)00682-7; STEWART J, 1984, PSYCHOL REV, V91, P251, DOI 10.1037/0033-295X.91.2.251; VOORN P, 1989, J COMP NEUROL, V289, P189, DOI 10.1002/cne.902890202; Weiss F, 2000, P NATL ACAD SCI USA, V97, P4321, DOI 10.1073/pnas.97.8.4321; Whitelaw RB, 1996, PSYCHOPHARMACOLOGY, V127, P213, DOI 10.1007/BF02805996; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469; Wyvell CL, 2000, J NEUROSCI, V20, P8122; ZITO KA, 1985, PHARMACOL BIOCHEM BE, V23, P1029, DOI 10.1016/0091-3057(85)90110-8	49	362	372	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					389	397		10.1038/nn1217	http://dx.doi.org/10.1038/nn1217			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15034590				2022-12-24	WOS:000220482500018
J	McCabe, BD; Hom, S; Aberle, H; Fetter, RD; Marques, G; Haerry, TE; Wan, H; O'Connor, MB; Goodman, CS; Haghighi, AP				McCabe, BD; Hom, S; Aberle, H; Fetter, RD; Marques, G; Haerry, TE; Wan, H; O'Connor, MB; Goodman, CS; Haghighi, AP			Highwire regulates presynaptic BMP signaling essential for synaptic growth	NEURON			English	Article							II RECEPTOR; THICK VEINS; SERINE/THREONINE KINASES; DENDRITIC SPINES; GENETIC-ANALYSIS; CELL FATE; DROSOPHILA; DPP; UBIQUITIN; PROTEIN	Highwire (Hiw), a putative RING finger E3 ubiquitin ligase, negatively regulates synaptic growth at the neuromuscular junction (NMJ) in Drosophila. hiw mutants have dramatically larger synaptic size and increased numbers of synaptic boutons. Here we show that Hiw binds to the Smad protein Medea (Med). Med is part of a presynaptic bone morphogenetic protein (BMP) signaling cascade consisting of three receptor subunits, Wit, Tkv, and Sax, in addition to the Smad transcription factor Mad. When compared to wildtype, mutants of BMP signaling components have smaller NMJ size, reduced neurotransmitter release, and aberrant synaptic ultrastructure. BMP signaling mutants suppress the excessive synaptic growth in hiw mutants. Activation of BMP signaling, which in wild-type does not cause additional, growth, in hiw mutants does lead to further synaptic expansion. These results reveal a balance between positive BMP signaling and negative regulation by Highwire, governing the growth of neuromuscular synapses.	Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA; Howard Hughes Med Inst, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities	McCabe, BD (corresponding author), Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA.	bmccabe@socrates.berkeley.edu; pejmunh@socrates.berkeley.edu	Aberle, Hermann/L-8461-2017; O'Connor, Michael B/C-9977-2014	Aberle, Hermann/0000-0002-4864-6105; O'Connor, Michael B/0000-0002-3067-5506; McCabe, Brian/0000-0003-1620-0501				Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; AGATEP R, 1998, TRANSFORMATION SACCH; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; deCelis JF, 1997, DEVELOPMENT, V124, P1007; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Feng XH, 1996, J BIOL CHEM, V271, P13123, DOI 10.1074/jbc.271.22.13123; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; GUAN K, 1991, J BIOL CHEM, V266, P12964; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Haghighi AP, 2003, NEURON, V39, P255, DOI 10.1016/S0896-6273(03)00427-6; Hegde AN, 2002, NAT REV NEUROSCI, V3, P854, DOI 10.1038/nrn961; Henderson KD, 1999, DEV BIOL, V205, P10, DOI 10.1006/dbio.1998.9113; Holley SA, 1996, CELL, V86, P607, DOI 10.1016/S0092-8674(00)80134-8; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; HUANG YZ, 1995, SCIENCE, V270, P1828, DOI 10.1126/science.270.5243.1828; James P, 2001, METH MOL B, V177, P41; Jazwinska A, 1999, DEVELOPMENT, V126, P3323; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; LETSOU A, 1995, CELL, V80, P899, DOI 10.1016/0092-8674(95)90293-7; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Marques G, 2003, DEVELOPMENT, V130, P5457, DOI 10.1242/dev.00772; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Mel BW, 2002, NEURON, V34, P175, DOI 10.1016/S0896-6273(02)00669-4; Myat A, 2002, NEURON, V35, P447, DOI 10.1016/S0896-6273(02)00795-X; NELLEN D, 1994, CELL, V78, P225, DOI 10.1016/0092-8674(94)90293-3; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; RAFTERY LA, 1995, GENETICS, V139, P241; Rawson JM, 2003, J NEUROBIOL, V55, P134, DOI 10.1002/neu.10189; RUBERTE E, 1995, CELL, V80, P889, DOI 10.1016/0092-8674(95)90292-9; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; SEKELSKY JJ, 1995, GENETICS, V139, P1347; Simin K, 1998, GENETICS, V148, P801; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; Speese SD, 2003, CURR BIOL, V13, P899, DOI 10.1016/S0960-9822(03)00338-5; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Tomoyasu Y, 1998, DEVELOPMENT, V125, P4215; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; Twombly V, 1996, DEVELOPMENT, V122, P1555; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Wisotzkey RG, 1998, DEVELOPMENT, V125, P1433; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wrana JL, 2000, CYTOKINE GROWTH F R, V11, P5, DOI 10.1016/S1359-6101(99)00024-6; WRANA JL, 1994, MOL CELL BIOL, V14, P944, DOI 10.1128/MCB.14.2.944; Wu ZR, 1999, DEV GENET, V25, P312, DOI 10.1002/(SICI)1520-6408(1999)25:4<312::AID-DVG5>3.0.CO;2-Z; XIE T, 1994, SCIENCE, V263, P1756, DOI 10.1126/science.8134837; Yang HT, 2002, DEV BRAIN RES, V136, P35, DOI 10.1016/S0165-3806(02)00311-5; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2; Zito K, 2002, NEURON, V35, P1015, DOI 10.1016/S0896-6273(02)00903-0	70	166	174	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 25	2004	41	6					891	905		10.1016/S0896-6273(04)00073-X	http://dx.doi.org/10.1016/S0896-6273(04)00073-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046722	Bronze			2022-12-24	WOS:000221458300009
J	Carrasco, M; Ling, S; Read, S				Carrasco, M; Ling, S; Read, S			Attention alters appearance	NATURE NEUROSCIENCE			English	Article							COVERT ATTENTION; CONTRAST; SENSITIVITY; BRIGHTNESS	Does attention alter appearance? This critical issue, debated for over a century, remains unsettled. From psychophysical evidence that covert attention affects early vision-it enhances contrast sensitivity and spatial resolution- and from neurophysiological evidence that attention increases the neuronal contrast sensitivity (contrast gain), one could infer that attention changes stimulus appearance. Surprisingly, few studies have directly investigated this issue. Here we developed a psychophysical method to directly assess the phenomenological correlates of attention in humans. We show that attention alters appearance; it boosts the apparent stimulus contrast. These behavioral results are consistent with neurophysiological findings suggesting that attention changes the strength of a stimulus by increasing its 'effective contrast' or salience.	NYU, Dept Psychol, New York, NY 10003 USA; NYU, Dept Neural Sci, New York, NY 10003 USA	New York University; New York University	Carrasco, M (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	marisa.carrasco@nyu.edu			NATIONAL EYE INSTITUTE [R01EY016200] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY016200] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Baldassi S, 2000, VISION RES, V40, P1293, DOI 10.1016/S0042-6989(00)00029-8; Blaser E, 1999, P NATL ACAD SCI USA, V96, P11681, DOI 10.1073/pnas.96.20.11681; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Cameron EL, 2002, VISION RES, V42, P949, DOI 10.1016/S0042-6989(02)00039-1; Carrasco M, 2000, VISION RES, V40, P1203, DOI 10.1016/S0042-6989(00)00024-9; Carrasco M, 1998, J EXP PSYCHOL HUMAN, V24, P673, DOI 10.1037/0096-1523.24.2.673; Carrasco M, 2001, P NATL ACAD SCI USA, V98, P5363, DOI 10.1073/pnas.081074098; CARRASCO M, IN PRESS VISION RES; Carrasco M, 2002, J VISION, V2, DOI 10.1167/2.6.4; CHEAL ML, 1991, Q J EXP PSYCHOL-A, V43, P859, DOI 10.1080/14640749108400960; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Helmholtz H., 1866, TREATISE PHYSL OPTIC, V2; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; James W., 1890, PRINCIPLES PSYCHOL; Jonides J., 1981, ATTENTION PERFORM, P187, DOI DOI 10.1037/0096-1523.29.5.835; Joseph JS, 1997, NATURE, V387, P805, DOI 10.1038/42940; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; MACKEBEN M, 1993, VISION RES, V33, P85, DOI 10.1016/0042-6989(93)90061-Z; Mangun GR, 1998, HUM BRAIN MAPP, V6, P383, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<383::AID-HBM10>3.0.CO;2-Z; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; Mayfrank L., 1987, EYE MOVEMENTS PHYSL, P37, DOI DOI 10.1167/4.12.12; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Mood A. M., 1974, INTRO THEORY STAT, P440; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Pashler HE, 1998, PSYCHOL ATTENTION; PELLI DG, 1991, VISION RES, V31, P1337, DOI 10.1016/0042-6989(91)90055-A; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Princ FG, 1998, J PINEAL RES, V24, P1, DOI 10.1111/j.1600-079X.1998.tb00359.x; Prinzmetal W, 1997, CONSCIOUS COGN, V6, P372, DOI 10.1006/ccog.1997.0313; PRINZMETAL W, 1986, J EXP PSYCHOL HUMAN, V12, P361, DOI 10.1037/0096-1523.12.3.361; REMINGTON RW, 1992, PERCEPT PSYCHOPHYS, V51, P279, DOI 10.3758/BF03212254; Reynolds JH, 1999, NEURON, V24, P19, DOI 10.1016/S0896-6273(00)80819-3; Reynolds JH, 2003, NEURON, V37, P853, DOI 10.1016/S0896-6273(03)00097-7; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; Sperling G., 1986, HDB PERCEPTION PERFO, V1, P1; TALGAR C, 2004, J VIS, V41, P23; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2; TSAL Y, 1994, Q J EXP PSYCHOL-A, V47, P865, DOI 10.1080/14640749408401100; von Helmholtz H., 1866, TREATISE PHYSL OPTIC, VIII; Yeshurun Y, 2000, NAT NEUROSCI, V3, P622, DOI 10.1038/75804; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936	46	667	673	17	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					308	313		10.1038/nn1194	http://dx.doi.org/10.1038/nn1194			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	777UU	14966522	Green Accepted			2022-12-24	WOS:000189197900022
J	Nakahara, H; Itoh, H; Kawagoe, R; Takikawa, Y; Hikosaka, O				Nakahara, H; Itoh, H; Kawagoe, R; Takikawa, Y; Hikosaka, O			Dopamine neurons can represent context-dependent prediction error	NEURON			English	Article							SUPPLEMENTARY EYE FIELD; MONKEY CAUDATE-NUCLEUS; PREFRONTAL CORTEX; BASAL GANGLIA; ANTERIOR CINGULATE; REWARD EXPECTANCY; NEURAL CORRELATE; MOTOR AREA; RESPONSES; MOVEMENTS	Midbrain dopamine (DA) neurons are thought to encode reward prediction error. Reward prediction can be improved if any relevant context is taken into account. We found that monkey DA neurons can encode a context-dependent prediction error. In the first noncontextual task, a light stimulus was randomly followed by reward, with a fixed equal probability. The response of DA neurons was positively correlated with the number of preceding unrewarded trials and could be simulated by a conventional temporal difference (TD) model. In the second contextual task, a reward-indicating light stimulus was presented with the probability that, while fixed overall, was incremented as a function of the number of preceding unrewarded trials. The DA neuronal response then was negatively correlated with this number. This history effect corresponded to the prediction error based on the conditional probability of reward and could be simulated only by implementing the relevant context into the TD model.	RIKEN, Brain Sci Inst, Lab Math Neurosci, Wako, Saitama 3510198, Japan; Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 2268502, Japan; Juntendo Univ, Sch Med, Dept Physiol, Tokyo 1138421, Japan; NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	RIKEN; Tokyo Institute of Technology; Juntendo University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Nakahara, H (corresponding author), RIKEN, Brain Sci Inst, Lab Math Neurosci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	hiro@brain.riken.go.jp	Nakahara, Hiroyuki/N-5411-2015	Nakahara, Hiroyuki/0000-0001-6891-1175; Itoh, Hideaki/0000-0001-8623-2408	NATIONAL EYE INSTITUTE [Z01EY000415, ZIAEY000415] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARBIB MA, 1995, MODELS INFORMATION P, P149; Beiser, 1995, MODELS INFORM PROCES, P215; Berns GS, 1998, J COGNITIVE NEUROSCI, V10, P108, DOI 10.1162/089892998563815; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; DAYAN P, 2002, NIPS, V14, P11; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Houk JC, 1995, MODELS INFORMATION P, P249; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; KAWAGOE R, 2003, IN PRESS J NEUROPHYS; Kobayashi S, 2002, J NEUROPHYSIOL, V87, P1488, DOI 10.1152/jn.00472.2001; Lauwereyns J, 2002, NEURON, V33, P463, DOI 10.1016/S0896-6273(02)00571-8; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Lu XF, 2002, NEURON, V34, P317, DOI 10.1016/S0896-6273(02)00657-8; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; MONTAGUE PR, 1995, NATURE, V377, P725, DOI 10.1038/377725a0; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Nakahara H, 2001, J COGNITIVE NEUROSCI, V13, P626, DOI 10.1162/089892901750363208; Nakamura K, 1998, J NEUROPHYSIOL, V80, P2671, DOI 10.1152/jn.1998.80.5.2671; Nieder A, 2003, NEURON, V37, P149, DOI 10.1016/S0896-6273(02)01144-3; PARENT A, 1994, J COMP NEUROL, V344, P305, DOI 10.1002/cne.903440211; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; ROMO R, 1990, J NEUROPHYSIOL, V63, P592, DOI 10.1152/jn.1990.63.3.592; Satoh T, 2003, J NEUROSCI, V23, P9913; Schall JD, 2002, NEURON, V36, P309, DOI 10.1016/S0896-6273(02)00964-9; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1987, J NEUROPHYSIOL, V57, P201, DOI 10.1152/jn.1987.57.1.201; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Shima K, 1996, P NATL ACAD SCI USA, V93, P8694, DOI 10.1073/pnas.93.16.8694; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Stuphorn V, 2000, NATURE, V408, P857, DOI 10.1038/35048576; Suri RE, 1998, EXP BRAIN RES, V121, P350, DOI 10.1007/s002210050467; Suri RE, 2001, NEURAL COMPUT, V13, P841, DOI 10.1162/089976601300014376; Suri RE, 2001, EXP BRAIN RES, V140, P234, DOI 10.1007/s002210100814; Sutton R.S., 1991, SIGART B, V2, P160, DOI [10.1145/122344.122377, DOI 10.1145/122344.122377]; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Takikawa Y, 2002, EXP BRAIN RES, V142, P284, DOI 10.1007/s00221-001-0928-1; Takikawa Y, 2002, J NEUROPHYSIOL, V87, P508, DOI 10.1152/jn.00288.2001; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; TESAURO G, 1994, NEURAL COMPUT, V6, P215, DOI 10.1162/neco.1994.6.2.215; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; [No title captured]	57	191	192	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 22	2004	41	2					269	280		10.1016/S0896-6273(03)00869-9	http://dx.doi.org/10.1016/S0896-6273(03)00869-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741107	Bronze			2022-12-24	WOS:000221457800012
J	Grunwald, IC; Korte, M; Adelmann, G; Plueck, A; Kullander, K; Adams, RH; Frotscher, M; Bonhoeffer, T; Klein, R				Grunwald, IC; Korte, M; Adelmann, G; Plueck, A; Kullander, K; Adams, RH; Frotscher, M; Bonhoeffer, T; Klein, R			Hippocampal plasticity requires postsynaptic ephrinBs	NATURE NEUROSCIENCE			English	Article							RECEPTOR TYROSINE KINASE; LONG-TERM DEPRESSION; EPHB RECEPTORS; CORTICOSPINAL TRACT; SYNAPSE FORMATION; DENSITY FRACTION; NERVOUS-SYSTEM; AMPA RECEPTORS; MULTIPLE ROLES; AREA CA1	Chemical synapses contain specialized pre- and postsynaptic structures that regulate synaptic transmission and plasticity. EphB receptor tyrosine kinases are important molecular components in this process. Previously, EphB receptors were shown to act postsynaptically, whereas their transmembrane ligands, the ephrinBs, were presumed to act presynaptically. Here we show that in mouse hippocampal CA1 neurons, the Eph/ephrin system is used in an inverted manner: ephrinBs are predominantly localized postsynaptically and are required for synaptic plasticity. We further demonstrate that EphA4, a candidate receptor, is also critically involved in long-term plasticity independent of its cytoplasmic domain, suggesting that ephrinBs are the active signaling partner. This work raises the intriguing possibility that depending on the type of synapse, Eph/ephrins can be involved in activity-dependent plasticity in converse ways, with ephrinBs on the pre- or the postsynaptic side.	Max Planck Inst Neurobiol, Dept Cellular & Syst Neurobiol, D-82152 Munich, Germany; Max Planck Inst Neurobiol, Dept Mol Neurobiol, D-82152 Munich, Germany; Univ Freiburg, Inst Anat & Cell Biol, D-79001 Freiburg, Germany; Univ Cologne, Inst Genet, D-50931 Cologne, Germany; Univ Gothenburg, Dept Med Biochem, S-40530 Gothenburg, Sweden; Canc Res UK, London Res Inst, London WC2A 3PX, England	Max Planck Society; Max Planck Society; University of Freiburg; University of Cologne; University of Gothenburg; Cancer Research UK	Bonhoeffer, T (corresponding author), Max Planck Inst Neurobiol, Dept Cellular & Syst Neurobiol, D-82152 Munich, Germany.		Adams, Ralf H/AAE-9274-2019; Bonhoeffer, Tobias/B-9481-2009; Grunwald, Iris/AAY-2521-2021; Klein, Ruediger/C-6147-2008	Bonhoeffer, Tobias/0000-0001-7897-6634; Grunwald, Iris/0000-0002-3404-7590; Klein, Ruediger/0000-0002-3109-0163; Grunwald Kadow, Ilona/0000-0002-9085-4274; Kullander, Klas/0000-0001-6418-5460				Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dong HL, 1999, ANN NY ACAD SCI, V868, P535, DOI 10.1111/j.1749-6632.1999.tb11323.x; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Dymecki SM, 1996, GENE, V171, P197, DOI 10.1016/0378-1119(96)00035-2; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Ghosh A, 2002, SCIENCE, V295, P449, DOI 10.1126/science.1069391; Godenschwege TA, 2002, NAT NEUROSCI, V5, P1294, DOI 10.1038/nn976; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; HENKEMEYER M, IN PRESS J CELL BIOL; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Murai KK, 2002, NEURON, V33, P159, DOI 10.1016/S0896-6273(02)00565-2; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	38	206	212	0	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					33	40		10.1038/nn1164	http://dx.doi.org/10.1038/nn1164			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14699416				2022-12-24	WOS:000187636000010
J	Zhang, XF; Schaefer, AW; Burnette, DT; Schoonderwoert, VT; Forscher, P				Zhang, XF; Schaefer, AW; Burnette, DT; Schoonderwoert, VT; Forscher, P			Rho-dependent contractile responses in the neuronal growth cone are independent of classical peripheral retrograde actin flow	NEURON			English	Article							BINDING PROTEIN-RHO; LIGHT-CHAIN KINASE; MYOSIN-II; NERVE GROWTH; LYSOPHOSPHATIDIC ACID; FOCAL ADHESIONS; STRESS FIBERS; AXON GUIDANCE; MICROTUBULES; PHOSPHORYLATION	Rho family GTPases have been implicated in neuronal growth cone guidance; however, the underlying cytoskeletal mechanisms are unclear. We have used multimode fluorescent speckle microscopy (FSM) to directly address this problem. We report that actin arcs that form in the transition zone are incorporated into central actin bundles in the C domain. These actin structures are Rho/Rho Kinase (ROCK) effectors. Specifically, LPA mediates growth cone retraction by ROCK-dependent increases in actin arc and central actin bundle contractility and stability. In addition, these treatments had marked effects on MT organization as a consequence of strong MT-actin arc interactions. In contrast, LPA or constitutively active Rho had no effect on P domain retrograde actin flow or filopodium bundle number. This study reveals a novel mechanism for domain-specific spatial control of actin-based motility in the growth cone with implications for understanding chemorepellant growth cone responses and nerve regeneration.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Forscher, P (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.		; Zhang, Xiao-Feng/P-7407-2015	Forscher, Paul/0000-0003-1988-5155; Zhang, Xiao-Feng/0000-0001-7240-1397	NINDS NIH HHS [NS1F32 NS11122, R01-NS28695, R01 NS051786] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS011122, R01NS028695] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKASU T, 1993, NEURON, V11, P1133, DOI 10.1016/0896-6273(93)90226-H; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; AXELROD D, 1983, J MICROSC-OXFORD, V129, P19, DOI 10.1111/j.1365-2818.1983.tb04158.x; Borisoff JF, 2003, MOL CELL NEUROSCI, V22, P405, DOI 10.1016/S1044-7431(02)00032-5; Bridgman PC, 2002, CELL MOTIL CYTOSKEL, V52, P91, DOI 10.1002/cm.10038; Brown J, 2003, J HISTOCHEM CYTOCHEM, V51, P421, DOI 10.1177/002215540305100403; Brown ME, 2003, J CELL SCI, V116, P1087, DOI 10.1242/jcs.00335; Buck KB, 2002, J NEUROSCI, V22, P9358; DE LA CRUZ EM, 1994, BIOCHEMISTRY-US, V33, P14387, DOI 10.1021/bi00252a003; Dergham P, 2002, J NEUROSCI, V22, P6570; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Diefenbach TJ, 2002, J CELL BIOL, V158, P1207, DOI 10.1083/jcb.200202028; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Evans LL, 1997, J CELL SCI, V110, P439; FORSCHER P, 1987, J NEUROSCI, V7, P3600; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Goldberg JL, 2003, GENE DEV, V17, P941, DOI 10.1101/gad.1062303; Gupton SL, 2002, CURR BIOL, V12, P1891, DOI 10.1016/S0960-9822(02)01276-9; HEATH JP, 1993, SYM SOC EXP BIOL, V47, P35; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Krarup T, 1998, AM J PHYSIOL-CELL PH, V275, pC239, DOI 10.1152/ajpcell.1998.275.1.C239; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Lin CH, 1996, NEURON, V16, P769, DOI 10.1016/S0896-6273(00)80097-5; LIN CH, 1993, J CELL BIOL, V121, P1369, DOI 10.1083/jcb.121.6.1369; LIN CH, 1995, NEURON, V14, P763, DOI 10.1016/0896-6273(95)90220-1; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Parizi M, 2000, EXP CELL RES, V254, P210, DOI 10.1006/excr.1999.4754; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rochlin MW, 1999, MOL BIOL CELL, V10, P2309, DOI 10.1091/mbc.10.7.2309; ROCHLIN MW, 1995, J CELL SCI, V108, P3661; Saito S, 1997, NEUROSCI LETT, V229, P73, DOI 10.1016/S0304-3940(97)00397-2; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Schmidt JT, 2002, J NEUROBIOL, V52, P175, DOI 10.1002/neu.10083; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Takizawa N, 2003, AM J PHYSIOL-CELL PH, V284, pC250, DOI 10.1152/ajpcell.00153.2002; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; Waterman-Storer CM, 1998, BIOPHYS J, V75, P2059, DOI 10.1016/S0006-3495(98)77648-9; Weiner JA, 2001, J NEUROSCI, V21, P7069, DOI 10.1523/JNEUROSCI.21-18-07069.2001; Welnhofer EA, 1999, J NEUROSCI, V19, P7971; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014; Zhou FQ, 2001, J CELL BIOL, V153, P1071, DOI 10.1083/jcb.153.5.1071	58	128	132	1	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 4	2003	40	5					931	944		10.1016/S0896-6273(03)00754-2	http://dx.doi.org/10.1016/S0896-6273(03)00754-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659092	Bronze			2022-12-24	WOS:000187042200010
J	Hirsch, JA; Martinez, LM; Pillai, C; Alonso, JM; Wang, QB; Sommer, FT				Hirsch, JA; Martinez, LM; Pillai, C; Alonso, JM; Wang, QB; Sommer, FT			Functionally distinct inhibitory neurons at the first stage of visual cortical processing	NATURE NEUROSCIENCE			English	Article							CAT STRIATE CORTEX; RAT SOMATOSENSORY CORTEX; ORIENTATION SELECTIVITY; RECEPTIVE-FIELDS; SIMPLE CELLS; IN-VIVO; SYNAPTIC INTEGRATION; MACAQUE MONKEY; BASKET CELLS; CONTRAST	Here we explore inhibitory circuits at the thalamocortical stage of processing in layer 4 of the cat's visual cortex, focusing on the anatomy and physiology of the interneurons themselves. Our immediate aim was to explore the inhibitory mechanisms that contribute to orientation selectivity, perhaps the most dramatic response property to emerge across the thalamocortical synapse. The broader goal was to understand how inhibitory circuits operate. Using whole-cell recording in cats in vivo, we found that layer 4 contains two populations of inhibitory cells defined by receptive field class-simple and complex. The simple cells were selective for stimulus orientation, whereas the complex cells were not. Our observations help to explain how neurons become sensitive to stimulus orientation and maintain that selectivity as stimulus contrast changes. Overall, the work suggests that different sources of inhibition, either selective for specific features or broadly tuned, interact to provide appropriate representations of elements within the environment.	Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ A Coruna, Dept Med, La Coruna 15006, Spain; SUNY Optometry, Dept Biol Sci, New York, NY 10036 USA; Redwood Neurosci Inst, Menlo Pk, CA 94025 USA	University of Southern California; Universidade da Coruna; State University of New York (SUNY) System	Hirsch, JA (corresponding author), Univ So Calif, Dept Biol Sci, 3641 Watt Way, Los Angeles, CA 90089 USA.	jhirsch@usc.edu	Hirsch, Judith/E-9006-2013	Pillai, Cinthi/0000-0002-7662-443X	NEI NIH HHS [EY09593] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009593, R29EY009593] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Azouz R, 1997, CEREB CORTEX, V7, P534, DOI 10.1093/cercor/7.6.534; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Bruno RM, 2002, J NEUROSCI, V22, P10966; BULLIER J, 1979, J NEUROPHYSIOL, V42, P1251, DOI 10.1152/jn.1979.42.5.1251; BURR D, 1981, EXP BRAIN RES, V43, P455; Buzas P, 2001, J COMP NEUROL, V437, P259, DOI 10.1002/cne.1282; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Carandini M, 2002, J NEUROSCI, V22, P10053; Chisum HJ, 2003, J NEUROSCI, V23, P2947; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FERSTER D, 1986, J NEUROSCI, V6, P1284; GABBOTT PLA, 1986, EXP BRAIN RES, V61, P323; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; HENRY GH, 1977, BRAIN RES, V133, P1, DOI 10.1016/0006-8993(77)90045-2; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Hirsch JA, 2003, CEREB CORTEX, V13, P63, DOI 10.1093/cercor/13.1.63; HIRSCH JA, 1995, J PHYSIOL-LONDON, V483, P183, DOI 10.1113/jphysiol.1995.sp020577; Hirsch JA, 2002, J PHYSIOL-LONDON, V540, P335, DOI 10.1113/jphysiol.2001.012777; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Kayser AS, 2002, NEURON, V33, P131, DOI 10.1016/S0896-6273(01)00570-0; LAURITZEN TZ, IN PRESS J NEUROSCI; LUND JS, 1979, J COMP NEUROL, V184, P599, DOI 10.1002/cne.901840402; MARTIN KAC, 1983, EXP BRAIN RES, V50, P193; Martinez LM, 2002, J PHYSIOL-LONDON, V540, P321, DOI 10.1113/jphysiol.2001.012776; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Moore CI, 1999, TRENDS NEUROSCI, V22, P513, DOI 10.1016/S0166-2236(99)01452-6; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; Porter JT, 2001, J NEUROSCI, V21, P2699, DOI 10.1523/JNEUROSCI.21-08-02699.2001; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 2003, J NEUROPHYSIOL, V90, P342, DOI 10.1152/jn.01018.2002; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; SCLAR G, 1982, EXP BRAIN RES, V46, P457; SILLITO AM, 1992, PROG BRAIN RES, V90, P349; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Swadlow HA, 2002, NAT NEUROSCI, V5, P403, DOI 10.1038/nn847; TANAKA K, 1985, VISION RES, V25, P357, DOI 10.1016/0042-6989(85)90060-4; Thomson AM, 2003, CEREB CORTEX, V13, P136, DOI 10.1093/cercor/13.2.136; Troyer TW, 2002, J NEUROPHYSIOL, V87, P2741, DOI 10.1152/jn.2002.87.6.2741; Troyer TW, 1998, J NEUROSCI, V18, P5908; Usrey WM, 2003, J NEUROPHYSIOL, V89, P1003, DOI 10.1152/jn.00749.2002; VOLGUSHEV M, 1993, VISUAL NEUROSCI, V10, P1151, DOI 10.1017/S0952523800010257; Wielaard DJ, 2001, J NEUROSCI, V21, P5203, DOI 10.1523/JNEUROSCI.21-14-05203.2001	50	144	144	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1300	1308		10.1038/nn1152	http://dx.doi.org/10.1038/nn1152			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	746BC	14625553				2022-12-24	WOS:000186725600015
J	Sippy, T; Cruz-Martin, A; Jeromin, A; Schweizer, FE				Sippy, T; Cruz-Martin, A; Jeromin, A; Schweizer, FE			Acute changes in short-term plasticity at synapses with elevated levels of neuronal calcium sensor-1	NATURE NEUROSCIENCE			English	Article							ADRENAL CHROMAFFIN CELLS; CULTURED HIPPOCAMPAL-NEURONS; PAIRED-PULSE FACILITATION; TRANSMITTER RELEASE; SYNAPTIC PLASTICITY; EXCITATORY SYNAPSES; BINDING-PROTEINS; NERVE-TERMINALS; PYRAMIDAL CELLS; CA2+ CHANNELS	Short-term synaptic plasticity is a defining feature of neuronal activity, but the underlying molecular mechanisms are poorly understood. Depression of synaptic activity might be due to limited vesicle availability, whereas facilitation is thought to result from elevated calcium levels. However, it is unclear whether the strength and direction (facilitation versus depression) of plasticity at a given synapse result from preexisting synaptic strength or whether they are regulated by separate mechanisms. Here we show, in rat hippocampal cell cultures, that increases in the calcium binding protein neuronal calcium sensor-1 (NCS-1) can switch paired-pulse depression to facilitation without altering basal synaptic transmission or initial neurotransmitter release probability. Facilitation persisted during high-frequency trains of stimulation, indicating that NCS-1 can recruit 'dormant' vesicles. Our results suggest that NCS-1 acts as a calcium sensor for short-term plasticity by facilitating neurotransmitter output independent of initial release. We conclude that separate mechanisms are responsible for determining basal synaptic strength and short-term plasticity.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Interdept Ph D Program Neurosci, Los Angeles, CA 90095 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Baylor College of Medicine	Schweizer, FE (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, 650 Charles E Young Dr S, Los Angeles, CA 90095 USA.		Cruz-Martín, Alberto/AAO-5320-2020	Cruz-Martin, Alberto/0000-0002-3271-7220	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041317] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS041317, NS41317, R01 NS041317-02] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Atluri PP, 1996, J NEUROSCI, V16, P5661; Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; Blatow M, 2003, NEURON, V38, P79, DOI 10.1016/S0896-6273(03)00196-X; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; Burgoyne RD, 2001, BIOCHEM J, V353, P1; COX JA, 1994, J BIOL CHEM, V269, P32807; Cummings DD, 1996, J NEUROSCI, V16, P5312; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Felmy F, 2003, NEURON, V37, P801, DOI 10.1016/S0896-6273(03)00085-0; Genin A, 2001, NEUROSCIENCE, V106, P571, DOI 10.1016/S0306-4522(01)00301-3; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; Jinno S, 2002, NEUROSCIENCE, V113, P449, DOI 10.1016/S0306-4522(02)00172-0; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Koh PO, 2003, P NATL ACAD SCI USA, V100, P313, DOI 10.1073/pnas.232693499; Koizumi S, 2002, J BIOL CHEM, V277, P30315, DOI 10.1074/jbc.M201132200; Marder E, 1998, ANNU REV NEUROSCI, V21, P25, DOI 10.1146/annurev.neuro.21.1.25; McFerran BW, 1999, J BIOL CHEM, V274, P30258, DOI 10.1074/jbc.274.42.30258; McFerran BW, 1998, J BIOL CHEM, V273, P22768, DOI 10.1074/jbc.273.35.22768; OLAFSSON P, 1995, P NATL ACAD SCI USA, V92, P8001, DOI 10.1073/pnas.92.17.8001; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; Rajebhosale M, 2003, J BIOL CHEM, V278, P6075, DOI 10.1074/jbc.M204702200; RIVOSECCHI R, 1994, J PHYSIOL-LONDON, V474, P223, DOI 10.1113/jphysiol.1994.sp020015; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; Vyshedskiy A, 2000, J NEUROSCI, V20, P6326, DOI 10.1523/JNEUROSCI.20-17-06326.2000; Waldeck RF, 2000, J NEUROSCI, V20, P5312, DOI 10.1523/JNEUROSCI.20-14-05312.2000; Weiss JL, 2001, J BIOL CHEM, V276, P44804, DOI 10.1074/jbc.M103262200; Weiss JL, 2000, J BIOL CHEM, V275, P40082, DOI 10.1074/jbc.M008603200; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WILCOX KS, 1994, J NEUROSCI, V14, P1775, DOI 10.1523/JNEUROSCI.14-03-01775.1994; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547; Zucker RS, 2001, J PHYSIOL-LONDON, V531, P583, DOI 10.1111/j.1469-7793.2001.0583h.x; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	42	140	146	0	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1031	1038		10.1038/nn1117	http://dx.doi.org/10.1038/nn1117			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	12947410	Green Accepted			2022-12-24	WOS:000185633600014
J	Hirai, H; Launey, T; Mikawa, S; Torashima, T; Yanagihara, D; Kasaura, T; Miyamoto, A; Yuzaki, M				Hirai, H; Launey, T; Mikawa, S; Torashima, T; Yanagihara, D; Kasaura, T; Miyamoto, A; Yuzaki, M			New role of delta 2-glutamate receptors in AMPA receptor trafficking and cerebellar function	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; ORNITHINE-BINDING PROTEIN; CULTURED PURKINJE-CELLS; DELTA 2 SUBUNIT; GLUTAMATE-RECEPTOR; LIGAND-BINDING; CRYSTAL-STRUCTURE; MUTANT MICE; SYNAPTIC PLASTICITY; NMDA RECEPTOR	Previous gene knockout studies have shown that the orphan glutamate receptor delta2 (GluRdelta2) is critically involved in synaptogenesis between parallel fibers and Purkinje cells during development. However, the precise function of GluRdelta2 and whether it is functional in the mature cerebellum remain unclear. To address these issues, we developed an antibody specific for the putative ligand-binding region of GluRdelta2, and application of this antibody to cultured Purkinje cells induced AMPA receptor endocytosis, attenuated synaptic transmission and abrogated long-term depression. Moreover, injection of this antibody into the subarachnoidal supracerebellar space of adult mice caused transient cerebellar dysfunction, such as ataxic gait and poor performance in the rotorod test. These results indicate that GluRdelta2 is involved in AMPA receptor trafficking and cerebellar function in adult mice.	RIKEN, Brain Sci Inst, Lab Memory & Learning, Saitama 3510198, Japan; St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Toyohashi Univ Technol, Neurophysiol Lab, Toyohashi, Aichi 4418580, Japan; Japan Sci & Technol Corp, CREST, Saitama 3320012, Japan; Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan	RIKEN; St Jude Children's Research Hospital; Toyohashi University of Technology; Japan Science & Technology Agency (JST); Keio University	Hirai, H (corresponding author), Kobe Univ, Grad Sch Med, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	hirai@med.kobe-u.ac.jp	Hirai, Hirokazu/ABP-1143-2022; Yuzaki, Michisuke/K-5328-2013; Launey, Thomas/A-2605-2010	Yuzaki, Michisuke/0000-0002-5750-3544; Launey, Thomas/0000-0001-9153-9260; Hirai, Hirokazu/0000-0002-0721-4293	NCI NIH HHS [CA 21765] Funding Source: Medline; NINDS NIH HHS [NS36925] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036925] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Atluri PP, 1996, J NEUROSCI, V16, P5661; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; Furuya S, 1998, BRAIN RES PROTOC, V3, P192, DOI 10.1016/S1385-299X(98)00040-3; Goossens J, 2001, J NEUROSCI, V21, P5813, DOI 10.1523/JNEUROSCI.21-15-05813.2001; HANSEN SH, 1993, J CELL BIOL, V121, P61, DOI 10.1083/jcb.121.1.61; Hirai H, 1996, P NATL ACAD SCI USA, V93, P6031, DOI 10.1073/pnas.93.12.6031; Hirai H, 2001, EUR J NEUROSCI, V14, P73, DOI 10.1046/j.0953-816x.2001.01630.x; HIRANO T, 1995, NEUROREPORT, V6, P524, DOI 10.1097/00001756-199502000-00029; Hsiao CD, 1996, J MOL BIOL, V262, P225, DOI 10.1006/jmbi.1996.0509; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Ito M, 1984, CEREBELLUM NEURAL CO; Jeromin A, 1996, J NEUROPHYSIOL, V76, P3578, DOI 10.1152/jn.1996.76.5.3578; KANG CH, 1991, J BIOL CHEM, V266, P23893; KANO M, 1987, NATURE, V325, P276, DOI 10.1038/325276a0; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Kawamoto Susumu, 1997, Molecular Brain Research, V47, P339, DOI 10.1016/S0169-328X(97)00103-4; Kohda K, 2000, NAT NEUROSCI, V3, P315, DOI 10.1038/73877; Kurihara H, 1997, J NEUROSCI, V17, P9613; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; Landsend AS, 1997, J NEUROSCI, V17, P834, DOI 10.1523/jneurosci.17-02-00834.1997; Larkum ME, 1998, J NEUROPHYSIOL, V80, P924, DOI 10.1152/jn.1998.80.2.924; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; Linden DJ, 2001, P NATL ACAD SCI USA, V98, P14066, DOI 10.1073/pnas.241384598; LOMELI H, 1993, FEBS LETT, V315, P318, DOI 10.1016/0014-5793(93)81186-4; Matsumoto M, 2000, INORG REACT MECH, V2, P19; MAYAT E, 1995, J NEUROSCI, V15, P2533, DOI 10.1523/JNEUROSCI.15-03-02533.1995; Murashima M, 1999, J NEUROSCI, V19, P7326, DOI 10.1523/JNEUROSCI.19-17-07326.1999; OH BH, 1993, J BIOL CHEM, V268, P11348; Paas Y, 2000, TRENDS PHARMACOL SCI, V21, P87, DOI 10.1016/S0165-6147(99)01443-1; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; Smitt PS, 2000, NEW ENGL J MED, V342, P21, DOI 10.1056/NEJM200001063420104; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; YAMAZAKI M, 1992, BIOCHEM BIOPH RES CO, V183, P886, DOI 10.1016/0006-291X(92)90566-4; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	39	102	106	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					869	876		10.1038/nn1086	http://dx.doi.org/10.1038/nn1086			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12833050				2022-12-24	WOS:000184413700017
J	Melcher, D; Morrone, MC				Melcher, D; Morrone, MC			Spatiotopic temporal integration of visual motion across saccadic eye movements	NATURE NEUROSCIENCE			English	Article							PARIETAL CORTEX; SUCCESSIVE FIXATIONS; RECEPTIVE-FIELDS; OPTIC FLOW; NEURONS; SPACE; INFORMATION; REPRESENTATION; PERCEPTION; FAILURE	Saccadic eye movements pose many challenges for stable and continuous vision, such as how information from successive fixations is amalgamated into a single precept. Here we show in humans that motion signals are temporally integrated across separate fixations, but only when the motion stimulus falls either on the same retinal region (retinotopic integration) or on different retinal positions that correspond to the same external spatial coordinates (spatiotopic integration). We used individual motion signals that were below detection threshold, implicating spatiotopic trans-saccadic integration in relatively early stages of visual processing such as the middle temporal area (MT) or V5 of visual cortex. The trans-saccadic buildup of important congruent visual information while irrelevant non-congruent information fades could provide a simple and robust strategy to stabilize perception during eye movements.	Univ Vita Salute San Raffaele, Fac Psychol, Milan, Italy; CNR, Inst Neurosci, Pisa, Italy	Vita-Salute San Raffaele University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Morrone, MC (corresponding author), Univ Vita Salute San Raffaele, Fac Psychol, Via Olgettina 58, Milan, Italy.		Melcher, David/D-1775-2010; Morrone, Maria Concetta/C-6756-2014	Melcher, David/0000-0003-0926-585X; Morrone, Maria Concetta/0000-0002-1025-0316				BARLOW HB, 1958, J PHYSIOL-LONDON, V141, P337, DOI 10.1113/jphysiol.1958.sp005978; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; BRIDGEMAN B, 1983, B PSYCHONOMIC SOC, V21, P285; Brockmole JR, 2002, J EXP PSYCHOL HUMAN, V28, P315, DOI 10.1037//0096-1523.28.2.315; Burr DC, 1998, VISION RES, V38, P1731, DOI 10.1016/S0042-6989(97)00346-5; Burr DC, 2001, VISION RES, V41, P1891, DOI 10.1016/S0042-6989(01)00072-4; BURR DC, 1982, J PHYSIOL-LONDON, V333, P1; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; GALLETTI C, 1993, EXP BRAIN RES, V96, P221; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; HAYHOE M, 1991, PERCEPTION, V20, P393, DOI 10.1068/p200393; IRWIN DE, 1991, COGNITIVE PSYCHOL, V23, P420, DOI 10.1016/0010-0285(91)90015-G; JONIDES J, 1983, SCIENCE, V222, P188, DOI 10.1126/science.6623072; Land MF., 2001, ANIMAL EYES; Melcher D, 2001, NATURE, V412, P401, DOI 10.1038/35086646; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; SALZMAN CD, 1990, NATURE, V346, P106; SHIOIRI S, 1989, VISION RES, V29, P915, DOI 10.1016/0042-6989(89)90106-5; Snyder LH, 1998, NATURE, V394, P887, DOI 10.1038/29777; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Wexler M, 2001, NATURE, V409, P85, DOI 10.1038/35051081; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	29	147	151	1	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					877	881		10.1038/nn1098	http://dx.doi.org/10.1038/nn1098			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12872128				2022-12-24	WOS:000184413700018
J	Tashiro, A; Dunaevsky, A; Blazeski, R; Mason, CA; Yuste, R				Tashiro, A; Dunaevsky, A; Blazeski, R; Mason, CA; Yuste, R			Bidirectional regulation of hippocampal mossy fiber filopodial motility by kainate receptors: A two-step model of synaptogenesis	NEURON			English	Article							ACTIN-BASED PLASTICITY; DENDRITIC SPINES; SYNAPSES; DYNAMICS; CALCIUM; CORTEX; CELLS; LTP; RAC	The rapid motility of axonal filopodia and dendritic spines is prevalent throughout the developing CNS, although the function of this motility remains controversial. Using two-photon microscopy, we imaged hippocampal mossy fiber axons in slice cultures and discovered that filopodial extensions are highly motile. Axonal filopodial motility is actin based and is down-regulated with development, although it remains in mature cultures. This motility is correlated with free extracellular space yet is inversely correlated with contact with postsynaptic targets, indicating a potential role in synaptogenesis. Filopodial motility is differentially regulated by kainate receptors: synaptic stimulation of kainate receptors enhances motility in younger slices, but it inhibits it in mature slices. We propose that neuronal activity controls filopodial motility in a developmentally regulated manner, in order to establish synaptic contacts in a two-step process. A two-step model of synaptogenesis can also explain the opposite effects of neuronal activity on the motility of dendritic protrusions.	Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Sci Biol, New York, NY 10027 USA; Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Pathol, New York, NY 10027 USA; Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Anat & Cell Biol, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University	Tashiro, A (corresponding author), Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Sci Biol, New York, NY 10027 USA.	at226@columbia.edu	Tashiro, Ayumu/A-2675-2008; Tashiro, Ayumu/Z-2900-2019	Tashiro, Ayumu/0000-0001-7967-7409; Tashiro, Ayumu/0000-0001-7967-7409	NATIONAL EYE INSTITUTE [R01EY013237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016951] Funding Source: NIH RePORTER; NEI NIH HHS [EY13237] Funding Source: Medline; NINDS NIH HHS [NS16951] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acsady L, 1998, J NEUROSCI, V18, P3386; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Cajal SR, 1923, RECUERDOS MI VIDA HI; Chang S, 2001, NAT NEUROSCI, V4, P787, DOI 10.1038/90489; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Dailey ME, 1996, J NEUROSCI, V16, P2983; Dunaevsky A, 2003, TRENDS NEUROSCI, V26, P155, DOI 10.1016/S0166-2236(03)00028-6; Dunaevsky A, 2001, NAT NEUROSCI, V4, P685, DOI 10.1038/89460; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 2002, NAT NEUROSCI, V5, P297, DOI 10.1038/nn830; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Frerking M, 2001, J NEUROSCI, V21, P2958, DOI 10.1523/JNEUROSCI.21-09-02958.2001; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Gomez TM, 2000, J NEUROBIOL, V44, P174, DOI 10.1002/1097-4695(200008)44:2<174::AID-NEU7>3.3.CO;2-I; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Jessell TM, 2000, CURR OPIN NEUROBIOL, V10, P599, DOI 10.1016/S0959-4388(00)00136-7; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Lerma J, 2001, PHYSIOL REV, V81, P971, DOI 10.1152/physrev.2001.81.3.971; Majewska A, 2000, PFLUG ARCH EUR J PHY, V441, P398, DOI 10.1007/s004240000435; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; REPRESA A, 1987, NEUROSCIENCE, V20, P739, DOI 10.1016/0306-4522(87)90237-5; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Schmitz D, 2001, P NATL ACAD SCI USA, V98, P11003, DOI 10.1073/pnas.191351498; Segal M, 2000, CURR OPIN NEUROBIOL, V10, P582, DOI 10.1016/S0959-4388(00)00123-9; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Wong WT, 2000, J NEUROSCI, V20, P5024; Wong WT, 2000, CURR OPIN NEUROBIOL, V10, P118, DOI 10.1016/S0959-4388(99)00059-8; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	47	130	133	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 5	2003	38	5					773	784		10.1016/S0896-6273(03)00299-X	http://dx.doi.org/10.1016/S0896-6273(03)00299-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	687DU	12797961	Bronze			2022-12-24	WOS:000183361400012
J	Hu, KL; Huang, CS; Jan, YN; Jan, LY				Hu, KL; Huang, CS; Jan, YN; Jan, LY			ATP-sensitive potassium channel traffic regulation by adenosine and protein kinase C	NEURON			English	Article							DOPAMINERGIC MIDBRAIN NEURONS; DI-LEUCINE MOTIF; K+ CHANNELS; CARDIOVASCULAR-SYSTEM; HIPPOCAMPAL SLICES; MYOCARDIAL PROTECTION; SUBUNIT STOICHIOMETRY; SULFONYLUREA RECEPTOR; METABOLIC INHIBITION; SIGNAL-TRANSDUCTION	ATP-sensitive potassium (K-ATP) channels activate under metabolic stress to protect neurons and cardiac myocytes. However, excessive channel activation may cause arrhythmia in the heart and silence neurons in the brain. Here, we report that PKC-mediated downregulation of K-ATP channel number, via dynamin-dependent channel internalization, can act as a brake mechanism to control K-ATP activation. A dileucine motif in the pore-lining Kir6.2 subunit of K-ATP, but not the site of PKC phosphorylation for channel activation, is essential for PKC downregulation. Whereas K-ATP activation results in a rapid shortening of the action potential duration (APD) in metabolically inhibited ventricular myocytes, adenosine receptor stimulation and consequent PKC-mediated K-ATP channel internalization can act as a brake to lessen this APD shortening. Likewise, in hippocampal CA1 neurons under metabolic stress, PKC-mediated, dynamin-dependent K-ATP channel internalization can also act as a brake to dampen the rapid decline of excitability due to K-ATP activation.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.			Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498				Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Aguilar-Bryan L, 1998, PHYSIOL REV, V78, P227, DOI 10.1152/physrev.1998.78.1.227; ALZHEIMER C, 1988, N-S ARCH PHARMACOL, V337, P429, DOI 10.1007/BF00169535; ASHCROFT FM, 1988, ANNU REV NEUROSCI, V11, P97, DOI 10.1146/annurev.neuro.11.1.97; ASHCROFT SJH, 1990, CELL SIGNAL, V2, P197, DOI 10.1016/0898-6568(90)90048-F; ASHFORD MLJ, 1990, BRIT J PHARMACOL, V101, P531, DOI 10.1111/j.1476-5381.1990.tb14116.x; Babenko AP, 1998, ANNU REV PHYSIOL, V60, P667, DOI 10.1146/annurev.physiol.60.1.667; Blondeau N, 2000, NEUROSCIENCE, V100, P465, DOI 10.1016/S0306-4522(00)00304-3; BONEV AD, 1993, AM J PHYSIOL, V265, pC1723, DOI 10.1152/ajpcell.1993.265.6.C1723; BREMNES B, 1994, J CELL SCI, V107, P2021; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Collins A, 1997, P NATL ACAD SCI USA, V94, P5456, DOI 10.1073/pnas.94.10.5456; DEWEILLE JR, 1989, P NATL ACAD SCI USA, V86, P2971; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; Downey JM, 1997, ADV EXP MED BIOL, V430, P39; DUNNE MJ, 1994, AM J PHYSIOL, V267, pC501, DOI 10.1152/ajpcell.1994.267.2.C501; EDWARDS G, 1993, ANNU REV PHARMACOL, V33, P597, DOI 10.1146/annurev.pa.33.040193.003121; Englund M, 2001, NEUROSCIENCE, V106, P89, DOI 10.1016/S0306-4522(01)00259-7; Fujita A, 2000, PHARMACOL THERAPEUT, V85, P39, DOI 10.1016/S0163-7258(99)00050-9; GODFRAIND JM, 1993, NEUROSCI LETT, V162, P101, DOI 10.1016/0304-3940(93)90570-B; GOLDMAN L, 1984, ANN INTERN MED, V101, P825, DOI 10.7326/0003-4819-101-6-825; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; GROVER GJ, 1995, J CARDIOVASC PHARM, V25, P40, DOI 10.1097/00005344-199501000-00008; Guatteo E, 1998, J NEUROPHYSIOL, V79, P1239, DOI 10.1152/jn.1998.79.3.1239; HANSEN AJ, 1982, ACTA PHYSIOL SCAND, V115, P301, DOI 10.1111/j.1748-1716.1982.tb07082.x; HEARSE DJ, 1995, CARDIOVASC RES, V30, P1; Heilker R, 1996, EMBO J, V15, P2893, DOI 10.1002/j.1460-2075.1996.tb00650.x; Hiraoka M, 1998, NEWS PHYSIOL SCI, V13, P131; HONORE E, 1993, PFLUG ARCH EUR J PHY, V424, P113, DOI 10.1007/BF00374601; Hu K, 1999, AM J PHYSIOL-HEART C, V276, pH488, DOI 10.1152/ajpheart.1999.276.2.H488; Hu KL, 1996, CIRC RES, V78, P492, DOI 10.1161/01.RES.78.3.492; Hyllienmark L, 1996, J PHYSIOL-LONDON, V496, P155, DOI 10.1113/jphysiol.1996.sp021673; JANSE MJ, 1989, PHYSIOL REV, V69, P1049, DOI 10.1152/physrev.1989.69.4.1049; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; Kittler JT, 2000, J NEUROSCI, V20, P7972; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Light PE, 2000, P NATL ACAD SCI USA, V97, P9058, DOI 10.1073/pnas.160068997; Light PE, 1996, CIRC RES, V79, P399, DOI 10.1161/01.RES.79.3.399; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Liss B, 1999, EMBO J, V18, P833, DOI 10.1093/emboj/18.4.833; Liss B, 1999, J NEUROSCI, V19, P8839, DOI 10.1523/JNEUROSCI.19-20-08839.1999; Liu YG, 1996, CIRC RES, V78, P443, DOI 10.1161/01.RES.78.3.443; Loussouarn G, 2002, TRENDS CARDIOVAS MED, V12, P253, DOI 10.1016/S1050-1738(02)00170-6; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Miki T, 2002, NAT MED, V8, P466, DOI 10.1038/nm0502-466; MOURRE C, 1991, BRAIN RES, V540, P340, DOI 10.1016/0006-8993(91)90533-2; Mubagwa K, 1996, CARDIOVASC RES, V32, P797; Mubagwa K, 2001, CARDIOVASC RES, V52, P25, DOI 10.1016/S0008-6363(01)00358-3; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Nakano A, 2000, PHARMACOL THERAPEUT, V86, P263, DOI 10.1016/S0163-7258(00)00058-9; NELSON MT, 1995, AM J PHYSIOL, V268, P799; NICHOLS CG, 1991, CIRC RES, V68, P280, DOI 10.1161/01.RES.68.1.280; NICHOLS CG, 1991, AM J PHYSIOL, V261, pH1675, DOI 10.1152/ajpheart.1991.261.6.H1675; Nieber K, 1999, PROG BRAIN RES, V120, P287; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; Olusanya O, 2001, CURR BIOL, V11, P896, DOI 10.1016/S0960-9822(01)00240-8; Pang CY, 1997, AM J PHYSIOL-HEART C, V273, pH44, DOI 10.1152/ajpheart.1997.273.1.H44; Perez-Pinzon MA, 1999, NEUROSCIENCE, V89, P453, DOI 10.1016/S0306-4522(98)00560-0; PerezPinzon MA, 1996, NEUROSCIENCE, V75, P687; Ping PP, 2001, CIRC RES, V88, P59, DOI 10.1161/01.RES.88.1.59; POND L, 1995, J BIOL CHEM, V270, P19989, DOI 10.1074/jbc.270.34.19989; Rejdak R, 2001, POL J PHARMACOL, V53, P73; Reshef A, 1998, ADV EXP MED BIOL, V431, P365; ROPER J, 1995, PFLUG ARCH EUR J PHY, V430, P44, DOI 10.1007/BF00373838; Rossen R, 1943, ARCH NEURO PSYCHIATR, V50, P510; SANDOVAL IV, 1994, J BIOL CHEM, V269, P6622; Schulz R, 2001, CARDIOVASC RES, V52, P181, DOI 10.1016/S0008-6363(01)00384-4; SCHWANSTECHER C, 1993, N-S ARCH PHARMACOL, V348, P113, DOI 10.1007/BF00168546; Schwanstecher M, 1999, Methods Enzymol, V294, P445; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Shryock JC, 1997, AM J CARDIOL, V79, P2, DOI 10.1016/S0002-9149(97)00256-7; Simkhovich BZ, 1998, CARDIOVASC RES, V40, P9, DOI 10.1016/S0008-6363(98)00142-4; SIMPSON P, 1982, CIRC RES, V50, P101, DOI 10.1161/01.RES.50.1.101; Smythe E, 2002, TRENDS CELL BIOL, V12, P352, DOI 10.1016/S0962-8924(02)02333-4; Suzuki M, 2002, J CLIN INVEST, V109, P509, DOI 10.1172/JC1200214270; TERZIC A, 1995, AM J PHYSIOL-CELL PH, V269, pC525, DOI 10.1152/ajpcell.1995.269.3.C525; THEODORE WH, 1991, EPILEPSIA, V32, P392, DOI 10.1111/j.1528-1157.1991.tb04668.x; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; Tucker SJ, 1998, CURR OPIN NEUROBIOL, V8, P316, DOI 10.1016/S0959-4388(98)80055-X; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; WANG WH, 1991, P NATL ACAD SCI USA, V88, P9722, DOI 10.1073/pnas.88.21.9722; WANG YG, 1995, AM J PHYSIOL-HEART C, V268, pH1322; WANN KT, 1993, BRIT J ANAESTH, V71, P2, DOI 10.1093/bja/71.1.2; WILDE AAM, 1993, CARDIOVASC DRUG THER, V7, P521, DOI 10.1007/BF00877617; Yamada K, 2001, SCIENCE, V292, P1543, DOI 10.1126/science.1059829; Yamada K, 2002, NEWS PHYSIOL SCI, V17, P127, DOI 10.1152/nips.01384.2001; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	91	99	103	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 8	2003	38	3					417	432		10.1016/S0896-6273(03)00256-3	http://dx.doi.org/10.1016/S0896-6273(03)00256-3			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	677HF	12741989	Bronze			2022-12-24	WOS:000182800300007
J	Bergeron, A; Matsuo, S; Guitton, D				Bergeron, A; Matsuo, S; Guitton, D			Superior colliculus encodes distance to target, not saccade amplitude, in multi-step gaze shifts	NATURE NEUROSCIENCE			English	Article							HEAD-FREE CAT; CAUDAL FASTIGIAL NUCLEUS; STEM OMNIPAUSE NEURONS; EYE-MOVEMENTS; TECTORETICULOSPINAL SYSTEM; REVERSIBLE INACTIVATION; VESTIBULOOCULAR REFLEX; MUSCIMOL INACTIVATION; FIXATION NEURONS; MOTOR MAP	The superior colliculus (SC) is important for generating coordinated eye-head gaze saccades. Its deeper layers contain a retinotopically organized motor map in which each site is thought to encode a specific gaze saccade vector. Here we show that this fundamental assumption in current models of collicular function does not hold true during horizontal multi-step gaze shifts in darkness that are directed to a goal and composed of a sequence of gaze saccades separated by periods of steady fixation. At the start of a muiti-step gaze shift in cats, neural activity on the SC's map was located caudally to encode the overall amplitude of the gaze displacement, not the first saccade in the sequence. As the gaze shift progressed, the locus of activity moved to encode the error between the goal and the current gaze position. Contrary to common belief, the locus of activity never encoded gaze saccade amplitude, except for the last saccade in the sequence.	McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Guitton, D (corresponding author), McGill Univ, Dept Neurol & Neurosurg, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	daniel.guitton@mcgill.ca						Aizawa H, 1998, J NEUROPHYSIOL, V79, P2082, DOI 10.1152/jn.1998.79.4.2082; Anderson RW, 1998, J NEUROPHYSIOL, V80, P798, DOI 10.1152/jn.1998.80.2.798; Bergeron A, 2002, J NEUROPHYSIOL, V88, P1726, DOI 10.1152/jn.2002.88.4.1726; Bergeron A, 2001, PROG BRAIN RES, V134, P97; Bergeron A, 2000, NAT NEUROSCI, V3, P932, DOI 10.1038/78847; CHUN KS, 1978, BIOL CYBERN, V28, P209, DOI 10.1007/BF00344268; Edelman JA, 2001, J NEUROPHYSIOL, V86, P676, DOI 10.1152/jn.2001.86.2.676; FAKHRI S, 1994, PERG S NEUR, P53; Freedman EG, 1996, J NEUROPHYSIOL, V76, P927, DOI 10.1152/jn.1996.76.2.927; Freedman EG, 1997, J NEUROPHYSIOL, V78, P1669, DOI 10.1152/jn.1997.78.3.1669; GALIANA HL, 1991, IEEE T BIO-MED ENG, V38, P532, DOI 10.1109/10.81578; Gandhi NJ, 1999, J NEUROPHYSIOL, V82, P3236, DOI 10.1152/jn.1999.82.6.3236; Goffart L, 1998, J NEUROPHYSIOL, V79, P1959, DOI 10.1152/jn.1998.79.4.1959; Goffart L, 1998, J NEUROPHYSIOL, V79, P1942, DOI 10.1152/jn.1998.79.4.1942; Goossens HHLM, 2000, J NEUROPHYSIOL, V83, P3430, DOI 10.1152/jn.2000.83.6.3430; GUITTON D, 1991, J NEUROPHYSIOL, V66, P1605, DOI 10.1152/jn.1991.66.5.1605; GUITTON D, 1984, J NEUROPHYSIOL, V52, P1030, DOI 10.1152/jn.1984.52.6.1030; Keller EL, 1996, J NEUROPHYSIOL, V76, P3573, DOI 10.1152/jn.1996.76.5.3573; KELLER EL, 1994, J NEUROPHYSIOL, V72, P2754, DOI 10.1152/jn.1994.72.6.2754; Klier EM, 2001, NAT NEUROSCI, V4, P627, DOI 10.1038/88450; Krauzlis RJ, 1997, SCIENCE, V276, P1693, DOI 10.1126/science.276.5319.1693; Krauzlis RJ, 2000, J NEUROPHYSIOL, V84, P876, DOI 10.1152/jn.2000.84.2.876; LEE CK, 1988, NATURE, V332, P357, DOI 10.1038/332357a0; MACPHERSON JM, 1979, BRAIN RES, V175, P183, DOI 10.1016/0006-8993(79)90530-4; Moschovakis AK, 1996, PROG NEUROBIOL, V50, P133, DOI 10.1016/S0301-0082(96)00034-2; Munoz DP, 1998, J NEUROPHYSIOL, V79, P1193, DOI 10.1152/jn.1998.79.3.1193; MUNOZ DP, 1991, SCIENCE, V251, P1358, DOI 10.1126/science.2003221; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P559, DOI 10.1152/jn.1993.70.2.559; Munoz DP, 1996, J NEUROPHYSIOL, V75, P2562, DOI 10.1152/jn.1996.75.6.2562; MUNOZ DP, 1991, J NEUROPHYSIOL, V66, P1624, DOI 10.1152/jn.1991.66.5.1624; MUNOZ DP, 1989, REV NEUROL-FRANCE, V145, P567; MUNOZ DP, 1991, J NEUROPHYSIOL, V66, P1642, DOI 10.1152/jn.1991.66.5.1642; Pare M, 1998, J NEUROPHYSIOL, V79, P3060, DOI 10.1152/jn.1998.79.6.3060; PARE M, 1994, EXP BRAIN RES, V101, P123; PECK CK, 1989, J PHYSIOL-LONDON, V414, P301, DOI 10.1113/jphysiol.1989.sp017689; Peck CK, 1997, EXP BRAIN RES, V113, P291, DOI 10.1007/BF02450327; Pelisson D, 1998, J NEUROPHYSIOL, V80, P1180, DOI 10.1152/jn.1998.80.3.1180; Quaia C, 1999, J NEUROPHYSIOL, V82, P999, DOI 10.1152/jn.1999.82.2.999; Quaia C, 1998, J NEUROPHYSIOL, V79, P2097, DOI 10.1152/jn.1998.79.4.2097; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P132, DOI 10.1152/jn.1987.57.1.132; ROUCOUX A, 1980, EXP BRAIN RES, V39, P75; Scudder CA, 2002, EXP BRAIN RES, V142, P439, DOI 10.1007/s00221-001-0912-9; STANFORD TR, 1994, VISION RES, V34, P93, DOI 10.1016/0042-6989(94)90260-7	43	54	55	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					404	413		10.1038/nn1027	http://dx.doi.org/10.1038/nn1027			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12627166				2022-12-24	WOS:000181833100019
J	Hartley, T; Maguire, EA; Spiers, HJ; Burgess, N				Hartley, T; Maguire, EA; Spiers, HJ; Burgess, N			The well-worn route and the path less traveled: Distinct neural bases of route following and wayfinding in humans	NEURON			English	Article							CAUDATE-NUCLEUS; SPATIAL NAVIGATION; RIGHT HIPPOCAMPUS; EPISODIC MEMORY; COGNITIVE MAPS; PLACE; MOTOR; STIMULATION; ACTIVATION; RETRIEVAL	Finding one's way in a large-scale environment may engage different cognitive processes than following a familiar route. The neural bases of these processes were investigated using functional MRI (fMRI). Subjects found their way in one virtual-reality town and followed a well-learned route in another. In a control condition, subjects followed a visible trail. Within subjects, accurate wayfinding activated the right posterior hippocampus. Between-subjects correlations with performance showed that good navigators (i.e., accurate wayfinders) activated the anterior hippocampus during wayfinding and head of caudate during route following. These results coincide with neurophysiological evidence for distinct response (caudate) and place (hippocampal) representations supporting navigation. We argue that the type of representation used influences both performance and concomitant fMRI activation patterns.	UCL, Inst Cognit Neurosci, London WC1E 6BT, England; UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; UCL, Wellcome Dept Imaging Neurosci, Inst Neurol, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Hartley, T (corresponding author), UCL, Inst Cognit Neurosci, Mortimer St, London WC1E 6BT, England.	t.hartley@ucl.ac.uk	Hartley, Tom/B-7811-2008; Spiers, Hugo J/E-4448-2014; Burgess, Neil/B-2420-2009	Hartley, Tom/0000-0002-4072-6637; Spiers, Hugo J/0000-0002-6792-6356; Burgess, Neil/0000-0003-0646-6584	Wellcome Trust [071173] Funding Source: Medline; Medical Research Council [G117/433] Funding Source: researchfish; MRC [G117/433] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abrahams S, 1997, NEUROPSYCHOLOGIA, V35, P11, DOI 10.1016/S0028-3932(96)00051-6; Aguirre GK, 1997, J NEUROSCI, V17, P2512; Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Bottini G, 2001, BRAIN, V124, P1182, DOI 10.1093/brain/124.6.1182; Brandt T, 1998, BRAIN, V121, P1749, DOI 10.1093/brain/121.9.1749; BUGMANN G, 1994, NEURAL NETWORKS, P217; Burgess N, 2001, PHILOS T R SOC B, V356, P1493, DOI 10.1098/rstb.2001.0948; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; COOK D, 1988, BEHAV NEURAL BIOL, V49, P332, DOI 10.1016/S0163-1047(88)90338-X; Dieterich M, 1998, BRAIN, V121, P1479, DOI 10.1093/brain/121.8.1479; Epstein R, 2001, COGNITIVE NEUROPSYCH, V18, P481, DOI 10.1080/02643290125929; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Fletcher PC, 1996, BRAIN, V119, P1587, DOI 10.1093/brain/119.5.1587; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Ghaem O, 1997, NEUROREPORT, V8, P739, DOI 10.1097/00001756-199702100-00032; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Gron G, 2000, NAT NEUROSCI, V3, P404, DOI 10.1038/73980; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1325, DOI 10.1152/jn.1997.77.3.1325; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1313, DOI 10.1152/jn.1997.77.3.1313; KESNER RP, 1993, EXP BRAIN RES, V93, P462; Maguire EA, 2003, HIPPOCAMPUS, V13, P250, DOI 10.1002/hipo.10087; Maguire EA, 1999, CURR OPIN NEUROBIOL, V9, P171, DOI 10.1016/S0959-4388(99)80023-3; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Maguire EA, 1998, J COGNITIVE NEUROSCI, V10, P61, DOI 10.1162/089892998563789; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maguire EA, 1997, J NEUROSCI, V17, P7103; Mellet E, 2000, NEUROIMAGE, V12, P588, DOI 10.1006/nimg.2000.0648; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; Pine DS, 2002, NEUROIMAGE, V15, P396, DOI 10.1006/nimg.2001.0988; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; POTEGAL M, 1972, Acta Neurobiologiae Experimentalis (Warsaw), V32, P479; Rombouts SARB, 2001, NEUROIMAGE, V14, P67, DOI 10.1006/nimg.2001.0799; Rosenbaum RS, 2000, NAT NEUROSCI, V3, P1044, DOI 10.1038/79867; Shelton AL, 2002, J NEUROSCI, V22, P2711, DOI 10.1523/JNEUROSCI.22-07-02711.2002; SMITH ML, 1981, NEUROPSYCHOLOGIA, V19, P781, DOI 10.1016/0028-3932(81)90090-7; Spiers HJ, 2001, HIPPOCAMPUS, V11, P715, DOI 10.1002/hipo.1087; Spiers HJ, 2001, BRAIN, V124, P2476, DOI 10.1093/brain/124.12.2476; Teng E, 1999, NATURE, V400, P675, DOI 10.1038/23276; TOLMAN EC, 1946, J EXP PSYCHOL, V36, P221, DOI 10.1037/h0060262; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; TOLMAN EC, 1947, J EXP PSYCHOL, V37, P285, DOI 10.1037/h0057434	45	576	582	1	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 6	2003	37	5					877	888		10.1016/S0896-6273(03)00095-3	http://dx.doi.org/10.1016/S0896-6273(03)00095-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	653TH	12628177	Bronze			2022-12-24	WOS:000181452800016
J	Huang, FD; Matthies, HJG; Speese, SD; Smith, MA; Broadie, K				Huang, FD; Matthies, HJG; Speese, SD; Smith, MA; Broadie, K			Rolling blackout, a newly identified PIP2-DAG pathway lipase required for Drosophila phototransduction	NATURE NEUROSCIENCE			English	Article							SENSITIVE CHANNELS TRP; VISUAL TRANSDUCTION; CA2+ CHANNEL; IN-VIVO; PROTEIN; GENE; NORPA; RECEPTOR; MUTANTS; PHOTORECEPTORS	The rolling blackout (rbo) gene encodes an integral plasma membrane lipase required for Drosophila phototransduction. Photoreceptors are enriched for the RBO protein, and temperature-sensitive rbo mutants show reversible elimination of phototransduction within minutes, demonstrating an acute requirement for the protein. The block is activity dependent, indicating that the action of RBO is use dependent. Conditional rbo mutants show activity-dependent depletion of diacylglycerol and concomitant accumulation of phosphatidylinositol phosphate and phosphatidylinositol 4,5-bisphosphate within minutes of induction, suggesting rapid downregulation of phospholipase C (PLC) activity. The RBO requirement identifies an essential regulatory step in G-protein-coupled, PLC-dependent inositol lipid signaling mediating activation of TRP and TRPL channels during phototransduction.	Vanderbilt Univ, Vanderbilt Brain Inst, Vanderbilt Kennedy Ctr, Dept Biol Sci, Nashville, TN 37235 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Vanderbilt University; Utah System of Higher Education; University of Utah	Broadie, K (corresponding author), Vanderbilt Univ, Vanderbilt Brain Inst, Vanderbilt Kennedy Ctr, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	kendal.broadie@vanderbilt.edu	Matthies, Heinrich/AAD-2375-2019; Matthies, Heinrich/B-7284-2017	Matthies, Heinrich/0000-0003-3615-7571; Matthies, Heinrich/0000-0003-3615-7571; Speese, Sean/0000-0002-3965-9828	NIGMS NIH HHS [GM54544] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054544] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acharya JK, 1997, NEURON, V18, P881, DOI 10.1016/S0896-6273(00)80328-1; Agam K, 2000, J NEUROSCI, V20, P5748, DOI 10.1523/JNEUROSCI.20-15-05748.2000; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BROADIE K, 2000, DROSOPHILA PROTOCOLS, P297; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Cygler M, 1997, METHOD ENZYMOL, V284, P3; de Turco EBR, 2001, P NATL ACAD SCI USA, V98, P4740, DOI 10.1073/pnas.081536298; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Faulkner DL, 1998, DEV GENET, V23, P264, DOI 10.1002/(SICI)1520-6408(1998)23:4<264::AID-DVG2>3.0.CO;2-6; FUKAMI K, 1988, P NATL ACAD SCI USA, V85, P9057, DOI 10.1073/pnas.85.23.9057; Hardie RC, 2003, ANNU REV PHYSIOL, V65, P735, DOI 10.1146/annurev.physiol.65.092101.142505; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; Hardie RC, 2001, J EXP BIOL, V204, P3403; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; HOTTA Y, 1969, NATURE, V222, P354, DOI 10.1038/222354a0; Huber A, 1998, FEBS LETT, V425, P317, DOI 10.1016/S0014-5793(98)00248-8; INOUE H, 1989, J BIOL CHEM, V264, P5996; Kumar M, 2001, J GENET, V80, P83, DOI 10.1007/BF02728334; Liu MY, 2000, J BIOL CHEM, V275, P12194, DOI 10.1074/jbc.275.16.12194; LOUGHNEY K, 1989, CELL, V58, P1143, DOI 10.1016/0092-8674(89)90512-6; MARTINEZ C, 1992, NATURE, V356, P615, DOI 10.1038/356615a0; MCKAY RR, 1994, NEUROSCIENCE, V61, P141, DOI 10.1016/0306-4522(94)90067-1; MINKE B, 1991, PROG RETIN RES, V11, P99, DOI 10.1016/0278-4327(91)90026-X; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; ORDWAY RW, 1994, P NATL ACAD SCI USA, V91, P5715, DOI 10.1073/pnas.91.12.5715; PAK WL, 1969, NATURE, V222, P351, DOI 10.1038/222351a0; Pearn MT, 1996, J BIOL CHEM, V271, P4937; PREISS J, 1986, J BIOL CHEM, V261, P8597; Raghu P, 2000, NEURON, V26, P169, DOI 10.1016/S0896-6273(00)81147-2; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; SHYNGLE J, 1985, INDIAN J EXP BIOL, V23, P235; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; WU L, 1995, NATURE, V373, P216, DOI 10.1038/373216a0; YOSHIOKA T, 1984, BIOCHEM BIOPH RES CO, V119, P389, DOI 10.1016/0006-291X(84)91664-4; YOSHIOKA T, 1985, J BIOCHEM-TOKYO, V97, P1251, DOI 10.1093/oxfordjournals.jbchem.a135171	43	52	54	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1070	1078		10.1038/nn1313	http://dx.doi.org/10.1038/nn1313			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15361878				2022-12-24	WOS:000224156900016
J	Okamoto, KI; Nagai, T; Miyawaki, A; Hayashi, Y				Okamoto, KI; Nagai, T; Miyawaki, A; Hayashi, Y			Rapid and persistent modulation of actin dynamics regulates postsynaptic reorganization underlying bidirectional plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; DEPENDENT PROTEIN-KINASE; CENTRAL-NERVOUS-SYSTEM; DENDRITIC SPINES; AMPA RECEPTORS; F-ACTIN; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL-NEURONS; NMDA RECEPTORS; LTP	The synapse is a highly organized cellular specialization whose structure and composition are reorganized, both positively and negatively, depending on the strength of input signals. The mechanisms orchestrating these changes are not well understood. A plausible locus for the reorganization of synapse components and structure is actin, because it serves as both cytoskeleton and scaffold for synapses and exists in a dynamic equilibrium between F-actin and G-actin that is modulated bidirectionally by cellular signaling. Using a new FRET-based imaging technique to monitor F-actin/G-actin equilibrium, we show here that tetanic stimulation causes a rapid, persistent shift of actin equilibrium toward F-actin in the dendritic spines of rat hippocampal neurons. This enlarges the spines and increases postsynaptic binding capacity. In contrast, prolonged low-frequency stimulation shifts the equilibrium toward G-actin, resulting in a loss of postsynaptic actin and of structure. This bidirectional regulation of actin is actively involved in protein assembly and disassembly and provides a substrate for bidirectional synaptic plasticity.	MIT, Dept Brain & Cognit Sci, Picower Ctr Learning & Memory, RIKEN MIT Neurosci Res Ctr, Cambridge, MA 02139 USA; RIKEN, Brain Sci Inst, Adv Technol Dev Grp, Lab Cell Funct Dynam, Saitama 3510198, Japan	Massachusetts Institute of Technology (MIT); RIKEN; RIKEN	Hayashi, Y (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Ctr Learning & Memory, RIKEN MIT Neurosci Res Ctr, E25-618, Cambridge, MA 02139 USA.	yhayashi@mit.edu	Okamoto, Kenichi/E-4582-2013; Miyawaki, Atsushi/K-3569-2014; Hayashi, Yasunori/C-2249-2008; Hayashi, Yasunori/AAF-1408-2019	Miyawaki, Atsushi/0000-0002-2329-3235; Hayashi, Yasunori/0000-0002-7560-3004; Hayashi, Yasunori/0000-0002-7560-3004; Nagai, Takeharu/0000-0003-2650-9895; Okamoto, Kenichi/0000-0001-9527-2444				Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Allison DW, 1998, J NEUROSCI, V18, P2423; Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; Capani F, 2001, J COMP NEUROL, V435, P156, DOI 10.1002/cne.1199; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; FIFKOVA E, 1992, INT REV CYTOL, V139, P267, DOI 10.1016/S0074-7696(08)61414-X; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Furukawa K, 1997, J NEUROSCI, V17, P8178, DOI 10.1523/jneurosci.17-21-08178.1997; Furuyashiki T, 2002, P NATL ACAD SCI USA, V99, P14458, DOI 10.1073/pnas.212148999; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; Halpain S, 1998, J NEUROSCI, V18, P9835; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hering H, 2003, J NEUROSCI, V23, P11759; HOSOKAWA T, 1995, J NEUROSCI, V15, P5560; KAUER JA, 1988, NATURE, V334, P250, DOI 10.1038/334250a0; Kim CH, 1999, J NEUROSCI, V19, P4314; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; LISMAN J, 1988, J PHYSIOL-PARIS, V83, P187; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; Piccini A, 2002, J NEUROSCI, V22, P5387; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; Rao A, 2000, HIPPOCAMPUS, V10, P527, DOI 10.1002/1098-1063(2000)10:5<527::AID-HIPO3>3.0.CO;2-B; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shen K, 2000, NAT NEUROSCI, V3, P881, DOI 10.1038/78783; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; WANG YL, 1981, CELL, V27, P429, DOI 10.1016/0092-8674(81)90384-6; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	51	605	620	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1104	1112		10.1038/nn1311	http://dx.doi.org/10.1038/nn1311			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15361876				2022-12-24	WOS:000224156900020
J	Kerns, JG; Cohen, JD; Stenger, VA; Carter, CS				Kerns, JG; Cohen, JD; Stenger, VA; Carter, CS			Prefrontal cortex guides context-appropriate responding during language production	NEURON			English	Article							WORKING-MEMORY; COGNITIVE CONTROL; COMPREHENSION; DEFICITS; FMRI; SCHIZOPHRENIA; DISSOCIATION; ORGANIZATION; COMPLETION; REPETITION	Although language processing is thought to frequently require cognitive control, little is known about the cognitive and neural basis of the control of language. Here, we demonstrate that processing of context by the PFC plays an important role in the control of language comprehension and production. Using a missing letter paradigm and fMRI, we found that increased activation in the PFC (but not in posterior regions), while encoding and maintaining context information, predicted context-appropriate responses. Furthermore, greater selection demands increased activity during responding in the same regions engaged during the encoding and maintenance of context. Overall, as in other cognitive task domains, these results suggest that PFC context processing plays an important role in the control of language.	Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15213 USA; Univ Missouri, Dept Psychol Sci, Columbia, MO 65211 USA; Princeton Univ, Ctr Study Mind Brain & Behav, Dept Psychol, Princeton, NJ 08544 USA; Univ Pittsburgh, Med Ctr, Dept Radiol, Pittsburgh, PA 15213 USA; Univ Calif Davis, Dept Psychiat, Dept Psychol, Sacramento, CA 95817 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Missouri System; University of Missouri Columbia; Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Davis	Carter, CS (corresponding author), Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15213 USA.	cameron.carter@ucdmc.ucdavis.edu						Barch DM, 2001, ARCH GEN PSYCHIAT, V58, P280, DOI 10.1001/archpsyc.58.3.280; Barch DM, 2002, J ABNORM PSYCHOL, V111, P478, DOI 10.1037//0021-843X.111.3.478; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; BUCKNER RL, 1995, J NEUROSCI, V15, P12; BUCKNER RL, 1995, J NEUROPHYSIOL, V74, P2163, DOI 10.1152/jn.1995.74.5.2163; Chein JM, 2002, PHYSIOL BEHAV, V77, P635, DOI 10.1016/S0031-9384(02)00899-5; Chein JM, 2001, CEREB CORTEX, V11, P1003, DOI 10.1093/cercor/11.11.1003; Cohen JD, 1996, PHILOS T R SOC B, V351, P1515, DOI 10.1098/rstb.1996.0138; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; Cohen JD, 1999, J ABNORM PSYCHOL, V108, P120, DOI 10.1037/0021-843X.108.1.120; Cohen Jonathan D., 1992, P99; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dell GS, 1997, PSYCHOL REV, V104, P123, DOI 10.1037/0033-295X.104.1.123; Desmond JE, 1998, NEUROIMAGE, V7, P368, DOI 10.1006/nimg.1998.0340; Ferstl EC, 2002, NEUROPSYCHOLOGY, V16, P292, DOI 10.1037//0894-4105.16.3.292; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Gernsbacher MA, 2003, ANNU REV PSYCHOL, V54, P91, DOI 10.1146/annurev.psych.54.101601.145128; Hashimoto R, 2002, NEURON, V35, P589, DOI 10.1016/S0896-6273(02)00788-2; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; KARNI A, 1995, NATURE, V377, P155; Kerns JG, 2002, J ABNORM PSYCHOL, V111, P211, DOI 10.1037//0021-843X.111.2.211; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Leung HC, 2002, J COGNITIVE NEUROSCI, V14, P659, DOI 10.1162/08989290260045882; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Martin RC, 2003, ANNU REV PSYCHOL, V54, P55, DOI 10.1146/annurev.psych.54.101601.145201; Michael EB, 2001, HUM BRAIN MAPP, V13, P239, DOI 10.1002/hbm.1036; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nathaniel-James DA, 2002, NEUROIMAGE, V16, P1094, DOI 10.1006/nimg.2002.1167; Newman SD, 2002, NEUROIMAGE, V15, P810, DOI 10.1006/nimg.2001.0997; O'Reilly RC, 2002, CEREB CORTEX, V12, P246, DOI 10.1093/cercor/12.3.246; Ojemann JG, 1998, HUM BRAIN MAPP, V6, P203, DOI 10.1002/(SICI)1097-0193(1998)6:4<203::AID-HBM2>3.0.CO;2-7; OReilly R., 1999, MODELS WORKING MEMOR, P375, DOI [10.1017/cbo9781139174909.014, DOI 10.1017/CBO9781139174909.014]; Palmer ED, 2001, NEUROIMAGE, V14, P182, DOI 10.1006/nimg.2001.0779; Pessoa L, 2002, NEURON, V35, P975, DOI 10.1016/S0896-6273(02)00817-6; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Robinson G, 1998, BRAIN, V121, P77, DOI 10.1093/brain/121.1.77; Rossell SL, 2003, NEUROPSYCHOLOGIA, V41, P550, DOI 10.1016/S0028-3932(02)00181-1; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; ServanSchreiber D, 1996, ARCH GEN PSYCHIAT, V53, P1105; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Thompson-Schill SL, 1999, NEURON, V23, P513, DOI 10.1016/S0896-6273(00)80804-1; van Turennout M, 2000, NAT NEUROSCI, V3, P1329, DOI 10.1038/81873; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936; Wagner AD, 2001, NEURON, V31, P329, DOI 10.1016/S0896-6273(01)00359-2; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; WISE R, 1991, BRAIN, V114, P1803, DOI 10.1093/brain/114.4.1803; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027	51	55	56	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 22	2004	43	2					283	291		10.1016/j.neuron.2004.06.032	http://dx.doi.org/10.1016/j.neuron.2004.06.032			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841BX	15260963	Bronze			2022-12-24	WOS:000222905400016
J	Liu, J; Lillo, C; Jonsson, PA; Velde, CV; Ward, CM; Miller, TM; Subramaniam, JR; Rothstein, JD; Marklund, S; Andersen, PM; Brannstrom, T; Gredal, O; Wong, PC; Williams, DS; Cleveland, DW				Liu, J; Lillo, C; Jonsson, PA; Velde, CV; Ward, CM; Miller, TM; Subramaniam, JR; Rothstein, JD; Marklund, S; Andersen, PM; Brannstrom, T; Gredal, O; Wong, PC; Williams, DS; Cleveland, DW			Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria	NEURON			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU/ZN SUPEROXIDE-DISMUTASE; TRANSGENIC MOUSE MODEL; MOLECULAR-WEIGHT COMPLEXES; DEAFNESS DYSTONIA SYNDROME; MOTOR-NEURON DEATH; CU,ZN-SUPEROXIDE DISMUTASE; DISEASE PROGRESSION; COPPER CHAPERONE; MUTATIONS	One cause of amyotrophic lateral sclerosis (ALS) is mutation in ubiquitously expressed copper/zinc superoxide dismutase (SOD1), but the mechanism of toxicity to motor neurons is unknown. Multiple disease-causing mutants, but not wild-type SOD1, are now demonstrated to be recruited to mitochondria, but only in affected tissues. This is independent of the copper chaperone for SOD1 and dismutase activity. Highly preferential association with spinal cord mitochondria is seen in human ALS for a mutant SOD1 that accumulates only to trace cytoplasmic levels. Despite variable proportions that are successfully imported, nearly constant amounts of SOD1 mutants and covalently damaged adducts of them accumulate as apparent import intermediates and/or are tightly aggregated or crosslinked onto integral membrane components on the cytoplasmic face of those mitochondria. These findings implicate damage from action of spinal cord-specific factors that recruit mutant SOD1 to spinal mitochondria as the basis for their selective toxicity in ALS.	Ludwig Inst Canc Res, Dept Neurosci Med & Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; Umea Univ, Univ Hosp, Inst Clin Neurosci, Dept Med Biosci, S-90187 Umea, Sweden; Umea Univ, Univ Hosp, Inst Clin Neurosci, Dept Neurol, S-90187 Umea, Sweden; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Bispebjerg Hosp, Dept Neurol, Copenhagen, Denmark	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Umea University; Umea University; Johns Hopkins University; University of Copenhagen; Bispebjerg Hospital	Cleveland, DW (corresponding author), Ludwig Inst Canc Res, Dept Neurosci Med & Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021; Velde, Christine Vande/AAB-8828-2020; rothstein, jeffrey d/C-9470-2013; Lillo, Concepcion/A-6321-2009; Vande Velde, Christine/F-2721-2016	Lillo, Concepcion/0000-0001-5814-9826; Vande Velde, Christine/0000-0001-5926-1529; Subramaniam, Jamuna R/0000-0003-0343-2469; Cleveland, Don/0000-0002-1934-3682; Jonsson, Andreas/0000-0002-1938-0707	NEI NIH HHS [EY07042, R01 EY007042, EY12598] Funding Source: Medline; NIA NIH HHS [AG 000975] Funding Source: Medline; NINDS NIH HHS [NS40014, R37 NS027036, NS27036] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY012598, R01EY007042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036, R01NS040014, R01NS027036] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andersen PM, 2003, AMYOTROPH LATERAL SC, V4, P62, DOI 10.1080/14660820310011700; Andersen PM, 1997, BRAIN, V120, P1723, DOI 10.1093/brain/120.10.1723; Andrus PK, 1998, J NEUROCHEM, V71, P2041; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; Guegan C, 2002, MOL CELL NEUROSCI, V20, P553, DOI 10.1006/mcne.2002.1136; Guegn C, 2001, J NEUROSCI, V21, P6569, DOI 10.1523/JNEUROSCI.21-17-06569.2001; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Higgins CMJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-06-j0001.2002; Hortnagel K, 2003, HUM MOL GENET, V12, P321, DOI 10.1093/hmg/ddg026; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Jaarsma D, 2001, ACTA NEUROPATHOL, V102, P293; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Koehler CM, 1999, P NATL ACAD SCI USA, V96, P2141, DOI 10.1073/pnas.96.5.2141; Kong JM, 1998, J NEUROSCI, V18, P3241; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; Orr HT, 2002, NAT NEUROSCI, V5, P287, DOI 10.1038/nn0402-287; Pasinelli P, 2000, P NATL ACAD SCI USA, V97, P13901, DOI 10.1073/pnas.240305897; Pfanner N, 2002, CURR OPIN CELL BIOL, V14, P400, DOI 10.1016/S0955-0674(02)00355-1; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; Puccio H, 2002, CURR OPIN GENET DEV, V12, P272, DOI 10.1016/S0959-437X(02)00298-8; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Ratovitski T, 1999, HUM MOL GENET, V8, P1451, DOI 10.1093/hmg/8.8.1451; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; Rodriguez JA, 2002, J BIOL CHEM, V277, P15932, DOI 10.1074/jbc.M112088200; Roesch K, 2002, HUM MOL GENET, V11, P477, DOI 10.1093/hmg/11.5.477; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Subramaniam JR, 2002, NAT NEUROSCI, V5, P301, DOI 10.1038/nn823; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Van Landeghem GF, 1999, EUR J NEUROL, V6, P639; Vukosavic S, 2000, J NEUROSCI, V20, P9119; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	62	395	405	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 8	2004	43	1					5	17		10.1016/j.neuron.2004.06.016	http://dx.doi.org/10.1016/j.neuron.2004.06.016			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233913	Bronze			2022-12-24	WOS:000222549800003
J	Raivich, G; Bohatschek, M; Da Costa, C; Iwata, O; Galiano, M; Hristova, M; Nateri, AS; Makwana, M; Riera-Sans, L; Wolfer, DP; Lipp, HP; Aguzzi, A; Wagner, EF; Behrens, A				Raivich, G; Bohatschek, M; Da Costa, C; Iwata, O; Galiano, M; Hristova, M; Nateri, AS; Makwana, M; Riera-Sans, L; Wolfer, DP; Lipp, HP; Aguzzi, A; Wagner, EF; Behrens, A			The AP-1 transcription factor c-jun is required for efficient axonal regeneration	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; FACIAL MOTOR NUCLEUS; AMYOTROPHIC-LATERAL-SCLEROSIS; IMMUNE SURVEILLANCE; MOUSE DEVELOPMENT; NEURONAL DEATH; SPINAL-CORD; BRAIN; MICE; GENE	Nerve injury triggers numerous changes in the injured neurons and surrounding nonneuronal cells that ultimately result in successful target reinnervation or cell death. c-Jun is a component of the heterodimeric AP-1 transcription factor, and c-Jun is highly expressed in response to neuronal trauma. Here we have investigated the role of c-jun during axonal regeneration using mice lacking c-jun in the central nervous system. After transection of the facial nerve, the absence of c-Jun caused severe defects in several aspects of the axonal response, including perineuronal sprouting, lymphocyte recruitment, and microglial activation. c-Jun-deficient motorneurons were atrophic, resistant to axotomy-induced cell death, and showed reduced target muscle reinnervation. Expression of CD44, galanin, and alpha7beta1 integrin, molecules known to be involved in regeneration, was greatly impaired, suggesting a mechanism for c-Jun-mediated axonal growth. Taken together, our results identify c-Jun as an important regulator of axonal regeneration in the injured central nervous system.	London Res Inst, Mammalian Genet Lab, Canc Res UK, Lincolns Inn Fields Labs, London WC2A 3PX, England; UCL, Dept Obstet & Gynaecol, Perinatal Brain Repair Grp, London WC1E 6HX, England; UCL, Dept Anat, London WC1E 6HX, England; UCL, London WC1E 6JJ, England; Univ Zurich, Inst Anat, CH-8057 Zurich, Switzerland; Univ Spital Zurich, Inst Neuropathol, CH-8091 Zurich, Switzerland; Res Inst Mol Pathol, A-1030 Vienna, Austria	Cancer Research UK; University of London; University College London; University of London; University College London; University of London; University College London; University of Zurich; University of Zurich; University Zurich Hospital; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Behrens, A (corresponding author), London Res Inst, Mammalian Genet Lab, Canc Res UK, Lincolns Inn Fields Labs, 44 Lincolns Inn Fields, London WC2A 3PX, England.	axel.behrens@cancer.org.uk	Aguzzi, Adriano/A-3351-2008; Raivich, Gennadij/AAL-7229-2021; Wolfer, David P/B-3293-2016; Raivich, Gennadij/A-6770-2011	Wolfer, David P/0000-0002-5957-1401; Makwana, Milan/0000-0002-5198-5466; Aguzzi, Adriano/0000-0002-0344-6708; Behrens, Axel/0000-0002-1557-1143; Wagner, Erwin F/0000-0001-7872-0196; Da Costa, Clive/0000-0002-0435-6747; Shams Nateri, Abdolrahman/0000-0002-6422-6813				ALDSKOGIUS H, 1986, BRAIN RES, V375, P126, DOI 10.1016/0006-8993(86)90965-0; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Anouar Y, 1999, MOL PHARMACOL, V56, P162, DOI 10.1124/mol.56.1.162; Bechmann I, 2001, EUR J NEUROSCI, V14, P1651, DOI 10.1046/j.0953-816x.2001.01793.x; Behrens A, 2003, DEVELOPMENT, V130, P103, DOI 10.1242/dev.00186; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Bohatschek M, 2004, J COMP NEUROL, V470, P382, DOI 10.1002/cne.20017; Butterworth NJ, 1996, MOL BRAIN RES, V43, P1, DOI 10.1016/S0169-328X(96)00143-X; Cajal S., 1928, DEGENERATION REGENER; Crocker SJ, 2001, P NATL ACAD SCI USA, V98, P13385, DOI 10.1073/pnas.231177098; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; ENGELHARDT JI, 1993, ARCH NEUROL-CHICAGO, V50, P30, DOI 10.1001/archneur.1993.00540010026013; Fawcett JW, 1997, CELL TISSUE RES, V290, P371, DOI 10.1007/s004410050943; Flugel A, 2001, J NEUROSCI RES, V66, P74, DOI 10.1002/jnr.1198; Galiano M, 2001, EUR J NEUROSCI, V14, P327, DOI 10.1046/j.0953-816x.2001.01647.x; Gass P, 2000, EMBO REP, V1, P447, DOI 10.1093/embo-reports/kvd088; Gendelman HE, 2002, J NEUROVIROL, V8, P474, DOI 10.1080/13550280290168631; Goldberg JL, 2003, GENE DEV, V17, P941, DOI 10.1101/gad.1062303; Goldstein LSB, 2001, SCIENCE, V291, P2102, DOI 10.1126/science.1059766; Hai T, 1999, GENE EXPRESSION, V7, P321; Herdegen T, 1997, TRENDS NEUROSCI, V20, P227, DOI 10.1016/S0166-2236(96)01000-4; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; Jones LL, 2000, J COMP NEUROL, V426, P468, DOI 10.1002/1096-9861(20001023)426:3<468::AID-CNE9>3.0.CO;2-I; Jones LL, 1997, EUR J NEUROSCI, V9, P1854, DOI 10.1111/j.1460-9568.1997.tb00752.x; KAWAMATA T, 1992, AM J PATHOL, V140, P691; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; LEE TH, 1993, J BIOL CHEM, V268, P6154; Lin L, 2003, EUR J NEUROSCI, V17, P2299, DOI 10.1046/j.1460-9568.2003.02686.x; LINDA H, 1985, BRAIN RES, V358, P329, DOI 10.1016/0006-8993(85)90978-3; MAEHLEN J, 1989, J NEUROIMMUNOL, V23, P125, DOI 10.1016/0165-5728(89)90031-3; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Moller JC, 1996, GLIA, V17, P121; Moran LB, 2004, BRAIN RES REV, V44, P154, DOI 10.1016/j.brainresrev.2003.11.004; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Palmada M, 2002, J CELL BIOL, V158, P453, DOI 10.1083/jcb.200112129; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Raivich G, 1998, J NEUROSCI, V18, P5804; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Schwaiger FW, 1998, PROG BRAIN RES, V117, P197; Schweizer U, 2002, J CELL BIOL, V156, P287, DOI 10.1083/jcb.200107009; Sendtner M, 1996, CURR BIOL, V6, P686, DOI 10.1016/S0960-9822(09)00450-3; Serpe CJ, 1999, J NEUROSCI, V19; Stoll G, 1999, BRAIN PATHOL, V9, P313; Streit WJ, 2000, TOXICOL PATHOL, V28, P28, DOI 10.1177/019262330002800104; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Verhey KJ, 2001, TRENDS BIOCHEM SCI, V26, P545, DOI 10.1016/S0968-0004(01)01931-4; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Werner A, 2000, J NEUROSCI, V20, P1822; Wolfer DP, 2001, PHYSIOL BEHAV, V73, P745, DOI 10.1016/S0031-9384(01)00531-5; Wynick D, 2001, Curr Opin Pharmacol, V1, P73, DOI 10.1016/S1471-4892(01)00006-6	61	350	358	3	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 8	2004	43	1					57	67		10.1016/j.neuron.2004.06.005	http://dx.doi.org/10.1016/j.neuron.2004.06.005			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233917	Bronze			2022-12-24	WOS:000222549800007
J	Bezzi, P; Gundersen, V; Galbete, JL; Seifert, G; Steinhauser, C; Pilati, E; Volterra, A				Bezzi, P; Gundersen, V; Galbete, JL; Seifert, G; Steinhauser, C; Pilati, E; Volterra, A			Astrocytes contain a vesicular compartment that is competent for regulated exocytosis of glutamate	NATURE NEUROSCIENCE			English	Article							CALCIUM OSCILLATIONS; SYNAPTIC VESICLES; RELEASE; TRANSPORTERS; MEMBRANE; CA2+; LOCALIZATION; EXPRESSION; RECEPTORS; SUGGESTS	Astrocytes establish rapid cell-to-cell communication through the release of chemical transmitters. The underlying mechanisms and functional significance of this release are, however, not well understood. Here we identify an astrocytic vesicular compartment that is competent for glutamate exocytosis. Using postembedding immunogold labeling of the rat hippocampus, we show that vesicular glutamate transporters (VGLUT1/2) and the vesicular SNARE protein, cellubrevin, are both expressed in small vesicular organelles that resemble synaptic vesicles of glutamatergic terminals. Astrocytic vesicles, which are not as densely packed as their neuronal counterparts, can be observed in small groups at sites adjacent to neuronal structures bearing glutamate receptors. Fluorescently tagged VGLUT-containing vesicles were studied dynamically in living astrocytes by total internal reflection fluorescence (TIRF) microscopy. After activation of metabotropic glutamate receptors, astrocytic vesicles underwent rapid (milliseconds) Ca2+- and SNARE-dependent exocytic fusion that was accompanied by glutamate release. These data document the existence of a Ca2+-dependent quantal glutamate release activity in glia that was previously considered to be specific to synapses.	Univ Lausanne, Dept Cell Biol & Morphol, CH-1005 Lausanne, Switzerland; UNIL CHUV Technol Dev Unit, Cellular Imaging Facil, CH-1005 Lausanne, Switzerland; Univ Oslo, Inst Anat, N-0317 Oslo, Norway; Univ Oslo, Ctr Mol Biol & Neurosci, N-0317 Oslo, Norway; Univ Bonn, Dept Expt Neurobiol, D-53105 Bonn, Germany; Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy; Univ Milan, Ctr Excellence Neurodegenerat Dis, I-20133 Milan, Italy	University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Oslo; University of Oslo; University of Bonn; University of Milan; University of Milan	Volterra, A (corresponding author), Univ Lausanne, Dept Cell Biol & Morphol, Rue Bugnon 9, CH-1005 Lausanne, Switzerland.	Andrea.Volterra@ibcm.unil.ch	Bezzi, Paola/AAP-2440-2020	Volterra, Andrea/0000-0003-1069-1602				Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Avery J, 2000, J CELL BIOL, V148, P317, DOI 10.1083/jcb.148.2.317; Becherer U, 2003, NAT NEUROSCI, V6, P846, DOI 10.1038/nn1087; Bellocchio EE, 1998, J NEUROSCI, V18, P8648; Bergersen L, 2003, EUR J NEUROSCI, V18, P931, DOI 10.1046/j.1460-9568.2003.02828.x; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; CHILTON BJ, 1995, CIVIL ENG SYST, V12, P219, DOI 10.1080/02630259508970172; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fremeau RT, 2002, P NATL ACAD SCI USA, V99, P14488, DOI 10.1073/pnas.222546799; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Gundersen V, 1998, J NEUROSCI, V18, P6059; Humeau Y, 2000, BIOCHIMIE, V82, P427, DOI 10.1016/S0300-9084(00)00216-9; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kasai H, 1999, TRENDS NEUROSCI, V22, P88, DOI 10.1016/S0166-2236(98)01293-4; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Matthias K, 2003, J NEUROSCI, V23, P1750; Muyderman H, 2001, J BIOL CHEM, V276, P46504, DOI 10.1074/jbc.M103849200; Nedergaard M, 2002, NAT REV NEUROSCI, V3, P748, DOI 10.1038/nrn916; Newman EA, 2001, J NEUROSCI, V21, P2215, DOI 10.1523/JNEUROSCI.21-07-02215.2001; Newman EA, 2003, TRENDS NEUROSCI, V26, P536, DOI 10.1016/S0166-2236(03)00237-6; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Pasti L, 2001, J NEUROSCI, V21, P477, DOI 10.1523/JNEUROSCI.21-02-00477.2001; Pasti L, 1997, J NEUROSCI, V17, P7817; Randhawa VK, 2000, MOL BIOL CELL, V11, P2403, DOI 10.1091/mbc.11.7.2403; ROSENTHAL L, 1989, PHARMACOL THERAPEUT, V42, P115, DOI 10.1016/0163-7258(89)90024-7; Schipke CG, 2001, FASEB J, V15, P255, DOI 10.1096/fj.01-0514fje; Schroder W, 1999, GLIA, V28, P166, DOI 10.1002/(SICI)1098-1136(199911)28:2<166::AID-GLIA8>3.0.CO;2-T; SEIFERT G, 2002, NEUROMETHODS PATCH C, V35, P301; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; STOUT AL, 1989, APPL OPTICS, V28, P5237, DOI 10.1364/AO.28.005237; Tse FT, 1999, BIOESSAYS, V21, P861, DOI 10.1002/(SICI)1521-1878(199910)21:10<861::AID-BIES8>3.0.CO;2-9; Tse FW, 1997, NEURON, V18, P121, DOI 10.1016/S0896-6273(01)80051-9; Tsuboi T, 2000, CURR BIOL, V10, P1307, DOI 10.1016/S0960-9822(00)00756-9; Valtorta F, 2001, TRENDS CELL BIOL, V11, P324, DOI 10.1016/S0962-8924(01)02058-X; VOLTERRA A, 2004, NEUROGLIA, P190; Volterra A., 2002, TRIPARTITE SYNAPSE G, P164; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7	47	535	556	2	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					613	620		10.1038/nn1246	http://dx.doi.org/10.1038/nn1246			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15156145				2022-12-24	WOS:000221640300015
J	Saghatelyan, A; de Chevigny, A; Schachner, M; Lledo, PM				Saghatelyan, A; de Chevigny, A; Schachner, M; Lledo, PM			Tenascin-R mediates activity-dependent recruitment of neuroblasts in the adult mouse forebrain	NATURE NEUROSCIENCE			English	Article							EXTRACELLULAR-MATRIX; OLFACTORY-BULB; CELL-ADHESION; MICE DEFICIENT; NEURONS; MIGRATION; INDUCTION; BRAIN; GLYCOPROTEINS; LOCALIZATION	Neuroblasts arising in the adult forebrain that travel to the olfactory bulb use two modes of migration: tangentially, along the rostral migratory stream, and radially, in the core of the olfactory bulb where they start to ascend to the outer layers. Although the mechanisms of tangential migration have been extensively studied, the factors controlling radial migration remain unexplored. Here we report that the extracellular matrix glycoprotein tenascin-R, expressed in the adult mouse olfactory bulb, initiates both the detachment of neuroblasts from chains and their radial migration. Expression of tenascin-R is activity dependent, as it is markedly reduced by odor deprivation. Furthermore, grafting of tenascin-R-transfected cells into non-neurogenic regions reroutes migrating neuroblasts toward these regions. The identification of an extracellular microenvironment capable of directing migrating neuroblasts provides insights into the mechanisms regulating radial migration in the adult olfactory bulb and offers promising therapeutic venues for brain repair.	Inst Pasteur, CNRS, URA 2182, Lab Percept & Memory, F-75015 Paris, France; Univ Hamburg, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Hamburg; University Medical Center Hamburg-Eppendorf	Lledo, PM (corresponding author), Inst Pasteur, CNRS, URA 2182, Lab Percept & Memory, 25 Rue Dr Roux, F-75015 Paris, France.	pmlledo@pasteur.fr	; de Chevigny, Antoine/M-7477-2016	Saghatelyan, Armen/0000-0003-4962-0465; de Chevigny, Antoine/0000-0002-7413-0591				Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Boudreau N, 1998, CURR OPIN CELL BIOL, V10, P640, DOI 10.1016/S0955-0674(98)80040-9; Bruckner G, 2000, J COMP NEUROL, V428, P616, DOI 10.1002/1096-9861(20001225)428:4<616::AID-CNE3>3.0.CO;2-K; BRUNJES PC, 1994, BRAIN RES REV, V19, P146; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Chazal G, 2000, J NEUROSCI, V20, P1446; Cummings DM, 1997, J NEUROSCI, V17, P7433; Cummings DM, 1997, EXP NEUROL, V148, P360, DOI 10.1006/exnr.1997.6660; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; FRAZIER LL, 1988, J COMP NEUROL, V269, P355, DOI 10.1002/cne.902690304; FUSS B, 1993, J CELL BIOL, V120, P1237, DOI 10.1083/jcb.120.5.1237; Hack I, 2002, NAT NEUROSCI, V5, P939, DOI 10.1038/nn923; HENEGAR JR, 1991, BRAIN RES, V568, P230, DOI 10.1016/0006-8993(91)91402-M; Jones FS, 2000, DEV DYNAM, V218, P235, DOI 10.1002/(SICI)1097-0177(200006)218:2<235::AID-DVDY2>3.3.CO;2-7; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kennedy Timothy E., 1995, Current Opinion in Neurobiology, V5, P83, DOI 10.1016/0959-4388(95)80091-3; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; MEISAMI E, 1976, BRAIN RES, V107, P437, DOI 10.1016/0006-8993(76)90243-2; Milev P, 1998, J BIOL CHEM, V273, P6998, DOI 10.1074/jbc.273.12.6998; MORGANTI MC, 1990, EXP NEUROL, V109, P98, DOI 10.1016/S0014-4886(05)80012-3; Murase S, 2002, J NEUROSCI, V22, P3568; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nikonenko A, 2003, J COMP NEUROL, V456, P338, DOI 10.1002/cne.10537; Pesheva P, 2000, PROG NEUROBIOL, V61, P465, DOI 10.1016/S0301-0082(99)00061-1; PESHEVA P, 1993, NEURON, V10, P69, DOI 10.1016/0896-6273(93)90243-K; Probstmeier R, 1999, EUR J NEUROSCI, V11, P2474, DOI 10.1046/j.1460-9568.1999.00670.x; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Saghatelyan AK, 2003, MOL CELL NEUROSCI, V24, P271, DOI 10.1016/S1044-7431(03)00163-5; Saghatelyan AK, 2001, MOL CELL NEUROSCI, V17, P226, DOI 10.1006/mcne.2000.0922; Srinivasan J, 1998, P NATL ACAD SCI USA, V95, P15753, DOI 10.1073/pnas.95.26.15753; Svendsen CN, 1996, PERSPECT DEV NEUROBI, V3, P133; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Thomas LB, 1996, GLIA, V17, P1; Weber P, 1999, J NEUROSCI, V19, P4245, DOI 10.1523/jneurosci.19-11-04245.1999; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Xiao ZC, 1997, J BIOL CHEM, V272, P32092, DOI 10.1074/jbc.272.51.32092; Xiao ZC, 1999, J BIOL CHEM, V274, P26511, DOI 10.1074/jbc.274.37.26511; Xiao ZC, 1998, J NEUROSCI RES, V52, P390, DOI 10.1002/(SICI)1097-4547(19980515)52:4<390::AID-JNR3>3.3.CO;2-6	41	166	182	1	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					347	356		10.1038/nn1211	http://dx.doi.org/10.1038/nn1211			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15034584				2022-12-24	WOS:000220482500013
J	Tanaka, T; Serneo, FF; Tseng, HC; Kulkarni, AB; Tsai, LH; Gleeson, JG				Tanaka, T; Serneo, FF; Tseng, HC; Kulkarni, AB; Tsai, LH; Gleeson, JG			Cdk5 phosphorylation of doublecortin ser297 regulates its effect on neuronal migration	NEURON			English	Article							CYCLIN-DEPENDENT KINASE-5; MICROTUBULE-ASSOCIATED PROTEIN; DYNEIN HEAVY-CHAIN; DEVELOPMENTAL-CHANGES; TAU-PHOSPHORYLATION; C-ELEGANS; LOCALIZATION; EXPRESSION; LIS1; P35	Mutations in the doublecortin (DCX) gene in human or targeted disruption of the cdk5 gene in mouse lead to similar cortical lamination defects in the developing brain. Here we show that Dcx is phosphorylated by Cdk5. Dcx phosphorylation is developmentally regulated and corresponds to the timing of expression of p35, the major activating subunit for Cdk5. Mass spectrometry and Western blot analysis indicate phosphorylation at Dcx residue Ser297. Phosphorylation of Dcx lowers its affinity to microtubules in vitro, reduces its effect on polymerization, and displaces it from microtubules in cultured neurons. Mutation of Ser297 blocks the effect of Dcx on migration in a fashion similar to pharmacological inhibition of Cdk5 activity. These results suggest that Dcx phosphorylation by Cdk5 regulates its actions on migration through an effect on microtubules.	Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol, Boston, MA 02115 USA; Natl Inst Dent & Craniofacial Res, Funct Genom Unit, NIH, Bethesda, MD 20892 USA	University of California System; University of California San Diego; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Gleeson, JG (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	jogleeson@ucsd.edu			NINDS NIH HHS [R01 NS041537] Funding Source: Medline; PHS HHS [N5047101] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041537] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akagi T, 2000, P NATL ACAD SCI USA, V97, P7290, DOI 10.1073/pnas.140210297; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bhaskar K, 2004, NEUROCHEM INT, V44, P35, DOI 10.1016/S0197-0186(03)00099-8; Bix GJ, 1998, J NEUROSCI, V18, P307; BRADY ST, 1984, J CELL BIOL, V99, P1716, DOI 10.1083/jcb.99.5.1716; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Caspi M, 2000, HUM MOL GENET, V9, P2205, DOI 10.1093/oxfordjournals.hmg.a018911; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Corbo JC, 2002, J NEUROSCI, V22, P7548; Delalle I, 1997, J NEUROCYTOL, V26, P283, DOI 10.1023/A:1018500617374; Dobyns WB, 1996, NEUROLOGY, V47, P331, DOI 10.1212/WNL.47.2.331; Ebneth A, 1999, CELL MOTIL CYTOSKEL, V44, P209, DOI 10.1002/(SICI)1097-0169(199911)44:3<209::AID-CM6>3.0.CO;2-4; EGELHOFF TT, 1993, CELL, V75, P363, DOI 10.1016/0092-8674(93)80077-R; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Friocourt G, 2001, MOL CELL NEUROSCI, V18, P307, DOI 10.1006/mcne.2001.1022; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Gilmore EC, 2001, J NEUROSCI, V21, P9690, DOI 10.1523/JNEUROSCI.21-24-09690.2001; Glantz SA, 1996, PRIMER BIOSTATISTICS; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gonczy P, 2001, DEV CELL, V1, P363, DOI 10.1016/S1534-5807(01)00046-6; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Han GS, 2001, CURR BIOL, V11, P719, DOI 10.1016/S0960-9822(01)00200-7; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Horesh D, 1999, HUM MOL GENET, V8, P1599, DOI 10.1093/hmg/8.9.1599; HOSHI M, 1988, EUR J BIOCHEM, V174, P225, DOI 10.1111/j.1432-1033.1988.tb14086.x; HUANG WD, 1994, P NATL ACAD SCI USA, V91, P8960, DOI 10.1073/pnas.91.19.8960; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; Illenberger S, 1996, J BIOL CHEM, V271, P10834, DOI 10.1074/jbc.271.18.10834; Keshvara L, 2002, J NEUROSCI, V22, P4869, DOI 10.1523/JNEUROSCI.22-12-04869.2002; Kizhatil K, 2002, J NEUROSCI, V22, P7948; Ko J, 2001, J NEUROSCI, V21, P6758; Leger J, 1997, J BIOL CHEM, V272, P8441, DOI 10.1074/jbc.272.13.8441; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; MATSUSHITA M, 1995, NEUROREPORT, V6, P1267, DOI 10.1097/00001756-199506090-00009; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; Ohshima T, 1999, J NEUROSCI, V19, P6017, DOI 10.1523/JNEUROSCI.19-14-06017.1999; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Patzke H, 2003, J NEUROSCI, V23, P2769; Sapir T, 2000, HUM MOL GENET, V9, P703, DOI 10.1093/hmg/9.5.703; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; SIMMONS DM, 1990, GENE DEV, V4, P695, DOI 10.1101/gad.4.5.695; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Takahashi S, 2003, J BIOL CHEM, V278, P10506, DOI 10.1074/jbc.M211964200; Tanaka T, 2001, J NEUROSCI, V21, P550, DOI 10.1523/JNEUROSCI.21-02-00550.2001; Taylor KR, 2000, J BIOL CHEM, V275, P34442, DOI 10.1074/jbc.M007078200; Tomizawa K, 1996, NEUROSCIENCE, V74, P519, DOI 10.1016/0306-4522(96)00136-4; Tomoda T, 1999, NEURON, V24, P833, DOI 10.1016/S0896-6273(00)81031-4; TSAI LH, 1993, DEVELOPMENT, V119, P1029; VALLEE RB, 1986, METHODS ENZYMOL, V134, P89; Yeh E, 2000, MOL BIOL CELL, V11, P3949, DOI 10.1091/mbc.11.11.3949; Zaharevitz DW, 1999, CANCER RES, V59, P2566; Zaman K, 1999, J NEUROSCI, V19, P9821	63	183	192	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 22	2004	41	2					215	227		10.1016/S0896-6273(03)00852-3	http://dx.doi.org/10.1016/S0896-6273(03)00852-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741103	Bronze			2022-12-24	WOS:000221457800008
J	Ross, J; Ma-Wyatt, A				Ross, J; Ma-Wyatt, A			Saccades actively maintain perceptual continuity	NATURE NEUROSCIENCE			English	Article							VISUAL SPACE; TERM-MEMORY; EYE; MONKEY; MAINTENANCE; COMPRESSION; INFORMATION; ATTENTION; MOTION	People make saccades-rapid eye movements to a new fixation-approximately three times per second. This would seemingly disrupt perceptual continuity, yet our brains construct a coherent, stable view of the world from these successive fixations. There is conflicting evidence regarding the effects of saccades on perceptual continuity: some studies report that they are disruptive, with little information carryover between saccades; others report that carryover is substantial. Here we show that saccades actively contribute to perceptual continuity in humans in two different ways. When bistable stimuli are presented intermittently, saccades executed during the blank interval shorten the duration of states of ambiguous figures, indicating that saccades can erase immediately past perceptual states. On the other hand, they prolong the McCollough effect, indicating that saccades strengthen learned contingencies. Our results indicate that saccades help, rather than hinder, perceptual continuity.	Univ Western Australia, Sch Psychol, Crawley, WA 6009, Australia; Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA	University of Western Australia; The Smith-Kettlewell Eye Research Institute	Ma-Wyatt, A (corresponding author), Univ Western Australia, Sch Psychol, 35 Stirling Highway, Crawley, WA 6009, Australia.	anna@ski.org						Balan PF, 2003, J NEUROSCI, V23, P5446; BRIDGEMAN B, 1975, VISION RES, V15, P719, DOI 10.1016/0042-6989(75)90290-4; BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; Burr DC, 2001, CURR BIOL, V11, P798, DOI 10.1016/S0960-9822(01)00183-X; BURR DC, 1982, J PHYSIOL-LONDON, V333, P1; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; DUTOUR EF, 1760, ACAD SCI MEMOIRES MA, V3, P514; GOLDBERG ME, 1990, J NEUROPHYSIOL, V64, P489, DOI 10.1152/jn.1990.64.2.489; Goldberg ME, 2002, ANN NY ACAD SCI, V956, P205, DOI 10.1111/j.1749-6632.2002.tb02820.x; HAYHOE M, 1991, PERCEPTION, V20, P393, DOI 10.1068/p200393; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; JONIDES J, 1982, SCIENCE, V215, P192, DOI 10.1126/science.7053571; JUTTNER M, 1993, PERCEPT PSYCHOPHYS, V53, P210, DOI 10.3758/BF03211731; Krekelberg B, 2003, NEURON, V37, P537, DOI 10.1016/S0896-6273(03)00003-5; Lappe M, 2000, NATURE, V403, P892, DOI 10.1038/35002588; Leopold DA, 2002, NAT NEUROSCI, V5, P605, DOI 10.1038/nn0602-851; Logothetis NK, 1998, PHILOS T R SOC B, V353, P1801, DOI 10.1098/rstb.1998.0333; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Ma-Wyatt A, 2003, INVEST OPHTH VIS SCI, V44, pU443; MACKAY D M, 1974, Journal of Physiology (Cambridge), V237, P38; Maier A, 2003, CURR BIOL, V13, P1076, DOI 10.1016/S0960-9822(03)00414-7; MATIN L, 1965, SCIENCE, V148, P1485, DOI 10.1126/science.148.3676.1485; MAWYATT A, 2002, J VIS, V2, P569; MCCOLLOUGH C, 1965, SCIENCE, V176, P541; McPeek RM, 1999, VISION RES, V39, P1555, DOI 10.1016/S0042-6989(98)00228-4; Melcher D, 2001, NATURE, V412, P401, DOI 10.1038/35086646; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Morrone MC, 1997, J NEUROSCI, V17, P7941; Necker LA., 1832, LONDON EDINBURGH, V1, P329, DOI [10.1080/14786443208647909, DOI 10.1080/14786443208647909]; Parker AJ, 2002, PHILOS T ROY SOC B, V357, P1053, DOI 10.1098/rstb.2002.1112; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Ross J, 2000, CURR BIOL, V10, P679, DOI 10.1016/S0960-9822(00)00524-8; SCHLAG J, 1995, VISION RES, V35, P2347, DOI 10.1016/0042-6989(95)00021-Q; SHUTE CCD, 1979, MCCOLLOUGHD EFFECT; Thiele A, 2002, SCIENCE, V295, P2460, DOI 10.1126/science.1068788; Umeno MM, 2001, J NEUROPHYSIOL, V86, P2344, DOI 10.1152/jn.2001.86.5.2344; WOLF W, 1980, VISION RES, V20, P117, DOI 10.1016/0042-6989(80)90153-4	39	39	40	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					65	69		10.1038/nn1163	http://dx.doi.org/10.1038/nn1163			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14661023				2022-12-24	WOS:000187636000014
J	Thilo, KV; Santoro, L; Walsh, V; Blakemore, C				Thilo, KV; Santoro, L; Walsh, V; Blakemore, C			The site of saccadic suppression	NATURE NEUROSCIENCE			English	Article							EYE-MOVEMENTS; VISION	During rapid eye movements, or saccades, stable vision is maintained by active reduction of visual sensitivity. The site of this saccadic suppression remains uncertain. Here we show that phosphenes-small illusory visual perceptions-induced by transcranial magnetic stimulation (TMS) to the human occipital cortex are immune to saccadic suppression, whereas phosphenes induced by retinal stimulation are not, thus providing direct physiological evidence that saccadic suppression occurs between the retina and the occipital visual cortex.	Univ Oxford, Physiol Lab, Oxford OX1 3PT, England; UCL, Inst Cognit Neurosci, London WC1N 3AR, England; UCL, Dept Psychol, London WC1N 3AR, England	University of Oxford; University of London; University College London; University of London; University College London	Thilo, KV (corresponding author), Univ Oxford, Physiol Lab, Parks Rd, Oxford OX1 3PT, England.	kai.thilo@physiol.ox.ac.uk		Blakemore, Colin/0000-0003-2659-7899				ADRIAN DJ, 1977, RADIO SCI, V12, P243, DOI 10.1029/RS012i06Sp00243; Bodis-Wollner I, 1999, NEUROLOGY, V53, P1800, DOI 10.1212/WNL.53.8.1800; BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; CAMPBELL FW, 1978, VISION RES, V18, P1297, DOI 10.1016/0042-6989(78)90219-5; Castet E, 2000, NAT NEUROSCI, V3, P177, DOI 10.1038/72124; Diamond MR, 2000, J NEUROSCI, V20, P3449, DOI 10.1523/JNEUROSCI.20-09-03449.2000; JUDGE SJ, 1980, J NEUROPHYSIOL, V43, P1133, DOI 10.1152/jn.1980.43.4.1133; Lee D, 1998, J NEUROPHYSIOL, V79, P922, DOI 10.1152/jn.1998.79.2.922; MEYER BU, 1991, ELECTROEN CLIN NEURO, P121; RICHARDS W, 1968, J OPT SOC AM, V58, P1159, DOI 10.1364/JOSA.58.001159; RIGGS LA, 1974, VISION RES, V14, P997, DOI 10.1016/0042-6989(74)90169-2; Thiele A, 2002, SCIENCE, V295, P2460, DOI 10.1126/science.1068788; TYRRELL RA, 1988, BEHAV RES METH INSTR, V20, P137, DOI 10.3758/BF03203817; VOLKMANN FC, 1962, J OPT SOC AM, V52, P571, DOI 10.1364/JOSA.52.000571	14	82	82	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					13	U3		10.1038/nn1171	http://dx.doi.org/10.1038/nn1171			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14699413				2022-12-24	WOS:000187636000006
J	Boehning, D; Moon, C; Sharma, S; Hurt, KJ; Hester, LD; Ronnett, GV; Shugar, D; Snyder, SH				Boehning, D; Moon, C; Sharma, S; Hurt, KJ; Hester, LD; Ronnett, GV; Shugar, D; Snyder, SH			Carbon monoxide neurotransmission activated by CK2 phosphorylation of heme oxygenase-2	NEURON			English	Article							OLFACTORY RECEPTOR NEURONS; INTERNAL ANAL-SPHINCTER; NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE CK2; LONG-TERM POTENTIATION; CASEIN KINASE-2; HIPPOCAMPAL-NEURONS; NERVOUS-SYSTEM; RELAXATION; INHIBITORS	Carbon monoxide (CO) is a putative gaseous neurotransmitter that lacks vesicular storage and must be synthesized rapidly following neuronal depolarization. We show that the biosynthetic enzyme for CO, heme oxygenase-2 (HO2), is activated during neuronal stimulation by phosphorylation by CK2 (formerly casein kinase 2). Phorbol ester treatment of hippocampal cultures results in the phosphorylation and activation of HO2 by CK2, implicating protein kinase C (PKC) in CK2 stimulation. Odorant treatment of olfactory receptor neurons augments HO2 phosphorylation and activity as well as cyclic guanosine monophosphate (cGMP) levels, with all of these effects selectively blocked by CK2 inhibitors. Likewise, CO-mediated nonadrenergic, noncholinergic (NANC) relaxation of the internal anal sphincter requires CK2 activity. Our findings provide a molecular mechanism for the rapid neuronal activation of CO biosynthesis, as required for a gaseous neurotransmitter.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.		Hurt, K. Joseph/J-8266-2019; Boehning, Darren/I-8539-2015	Hurt, K. Joseph/0000-0001-6906-350X; Moon, Cheil/0000-0002-9741-7229; Boehning, Darren/0000-0001-7920-6922	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039657, F32NS043850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-000266, DA-00074] Funding Source: Medline; NIDCD NIH HHS [DC-02979] Funding Source: Medline; NINDS NIH HHS [NS-043850, NS-39657] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baranano DE, 2001, P NATL ACAD SCI USA, V98, P10996, DOI 10.1073/pnas.191351298; Baranano DE, 2000, J BIOL CHEM, V275, P15166, DOI 10.1074/jbc.275.20.15166; Battish R, 2000, AM J PHYSIOL-GASTR L, V278, pG148, DOI 10.1152/ajpgi.2000.278.1.G148; Blanquet PR, 2000, PROG NEUROBIOL, V60, P211, DOI 10.1016/S0301-0082(99)00026-X; Blanquet PR, 2000, NEUROSCIENCE, V95, P705; Blanquet PR, 1998, NEUROSCIENCE, V86, P739, DOI 10.1016/S0306-4522(98)00087-6; BREDT DS, 1991, NEURON, V7, P615, DOI 10.1016/0896-6273(91)90374-9; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Bren GD, 2000, J MOL BIOL, V297, P1245, DOI 10.1006/jmbi.2000.3630; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cary SPL, 2001, J CLIN INVEST, V107, P1071, DOI 10.1172/JCI12823; CHARRIAUTMARLANGUE C, 1991, P NATL ACAD SCI USA, V88, P10232, DOI 10.1073/pnas.88.22.10232; DOBROWOLSKA G, 1991, BIOCHIM BIOPHYS ACTA, V1080, P221, DOI 10.1016/0167-4838(91)90005-K; Dore S, 1997, P NATL ACAD SCI USA, V94, P4772, DOI 10.1073/pnas.94.9.4772; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; FERRIS CD, 1991, BIOCHEM BIOPH RES CO, V175, P192, DOI 10.1016/S0006-291X(05)81219-7; Ferris CD, 1999, NAT CELL BIOL, V1, P152, DOI 10.1038/11072; Gelperin A, 2000, J NEUROPHYSIOL, V83, P116, DOI 10.1152/jn.2000.83.1.116; Ingi T, 1996, J NEUROSCI, V16, P5621; Ingi T, 1996, NEURON, V16, P835, DOI 10.1016/S0896-6273(00)80103-8; Ingi T, 1995, J NEUROSCI, V15, P8214; Leffler CW, 1999, AM J PHYSIOL-HEART C, V276, pH1641, DOI 10.1152/ajpheart.1999.276.5.H1641; LEINDERSZUFALL T, 1995, J NEUROPHYSIOL, V74, P1498, DOI 10.1152/jn.1995.74.4.1498; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; MEFFERT MK, 1994, NEURON, V13, P1225, DOI 10.1016/0896-6273(94)90060-4; MEGGIO F, 1990, EUR J BIOCHEM, V187, P89, DOI 10.1111/j.1432-1033.1990.tb15280.x; Moon C, 1998, J NEUROSCI, V18, P3195; Ny L, 1997, J AUTONOM NERV SYST, V65, P49, DOI 10.1016/S0165-1838(97)00034-9; Ny L, 1996, BRIT J PHARMACOL, V118, P392, DOI 10.1111/j.1476-5381.1996.tb15415.x; OKELLY T, 1993, GUT, V34, P689, DOI 10.1136/gut.34.5.689; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Rattan S, 2000, J PHARMACOL EXP THER, V294, P1009; RATTAN S, 1993, AM J PHYSIOL, V265, pG799, DOI 10.1152/ajpgi.1993.265.4.G799; RONNETT GV, 1991, J NEUROSCI, V11, P1243; SANGHERA JS, 1992, BIOCHEM J, V283, P829, DOI 10.1042/bj2830829; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Silva-Neto MAC, 2002, BIOCHEM BIOPH RES CO, V293, P1358, DOI 10.1016/S0006-291X(02)00395-9; Song DH, 2000, J BIOL CHEM, V275, P23790, DOI 10.1074/jbc.M909107199; SZYSZKA R, 1995, BIOCHEM BIOPH RES CO, V208, P418, DOI 10.1006/bbrc.1995.1354; Tomita R, 1999, HEPATO-GASTROENTEROL, V46, P2999; Uberall F, 1997, J BIOL CHEM, V272, P4072, DOI 10.1074/jbc.272.7.4072; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; Werkstrom V, 1997, BRIT J PHARMACOL, V120, P312, DOI 10.1038/sj.bjp.0700893; Xue L, 2000, P NATL ACAD SCI USA, V97, P1851, DOI 10.1073/pnas.97.4.1851; Zakhary R, 1996, P NATL ACAD SCI USA, V93, P795, DOI 10.1073/pnas.93.2.795; Zakhary R, 1997, P NATL ACAD SCI USA, V94, P14848, DOI 10.1073/pnas.94.26.14848; Zufall F, 1997, J NEUROSCI, V17, P2703	47	115	122	1	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 25	2003	40	1					129	137		10.1016/S0896-6273(03)00596-8	http://dx.doi.org/10.1016/S0896-6273(03)00596-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	726TA	14527438	Bronze			2022-12-24	WOS:000185614700014
J	Schoenbaum, G; Setlow, B; Saddoris, MP; Gallagher, M				Schoenbaum, G; Setlow, B; Saddoris, MP; Gallagher, M			Encoding predicted outcome and acquired value in orbitofrontal cortex during cue sampling depends upon input from basolateral amygdala	NEURON			English	Article							MEDIAL PREFRONTAL CORTEX; CENTRAL NUCLEUS; CONDITIONED BEHAVIOR; EXCITOTOXIC LESIONS; VENTRAL STRIATUM; REWARD; MONKEYS; RATS; DEVALUATION; STIMULUS	Certain goal-directed behaviors depend critically upon interactions between orbitofrontal cortex (OFC) and basolateral amygdala (ABL). Here we describe direct neurophysiological evidence of this cooperative function. We recorded from OFC in intact and ABL-lesioned rats learning odor discrimination problems. As rats learned these problems, we found that lesioned rats exhibited marked changes in the information represented in OFC during odor cue sampling. Lesioned rats had fewer cue-selective neurons in OFC after learning; the cue-selective population in lesioned rats did not include neurons that were also responsive in anticipation of the predicted outcome; and the cue-activated representations that remained in lesioned rats were less associative and more often bound to cue identity. The results provide a neural substrate for representing acquired value and features of the predicted outcome during cue sampling, disruption of which could account for deficits in goal-directed behavior after damage to this system.	Johns Hopkins Univ, Dept Psychol, Baltimore, MD 21218 USA	Johns Hopkins University	Schoenbaum, G (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, 685 W Baltimore St,HSF-1,Room 280K, Baltimore, MD 21201 USA.			Setlow, Barry/0000-0001-9133-9445	NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH012699, R01MH060179] Funding Source: NIH RePORTER; NIA NIH HHS [AG00882] Funding Source: Medline; NIMH NIH HHS [MH12699, MH60179] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amorapanth P, 2000, NAT NEUROSCI, V3, P74, DOI 10.1038/71145; Balleine BW, 2003, J NEUROSCI, V23, P666, DOI 10.1523/JNEUROSCI.23-02-00666.2003; BARBAS H, 1993, NEUROSCIENCE, V56, P841, DOI 10.1016/0306-4522(93)90132-Y; Baxter MG, 2000, J NEUROSCI, V20, P4311; Bechara A, 1999, J NEUROSCI, V19, P5473; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Blundell P, 2001, J NEUROSCI, V21, P9018, DOI 10.1523/JNEUROSCI.21-22-09018.2001; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Cardinal RN, 2002, BEHAV NEUROSCI, V116, P553, DOI 10.1037/0735-7044.116.4.553; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; DAVIS M, 1992, P255; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; EVERITT B J, 1992, P401; Everitt B.J., 2000, AMYGDALA FUNCTIONAL, P353; Fuster JM, 2000, PSYCHOBIOLOGY, V28, P125; Gallagher M, 1996, CURR OPIN NEUROBIOL, V6, P221, DOI 10.1016/S0959-4388(96)80076-6; GALLAGHER M, 1990, J NEUROSCI, V10, P1906; Gallagher M, 1999, J NEUROSCI, V19, P6610; Gallagher M, 2000, AMYGDALA FUNCTIONAL, P311; Gewirtz JC, 2000, LEARN MEMORY, V7, P257, DOI 10.1101/lm.35200; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Goldman-Rakic P. S., 2011, COMPR PHYSIOL, DOI [10.1002/CPHY.CP010509, DOI 10.1002/CPHY.CP010509]; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; Hatfield T, 1996, J NEUROSCI, V16, P5256; Hikosaka K, 2000, CEREB CORTEX, V10, P263, DOI 10.1093/cercor/10.3.263; HOLLAND PC, 1993, BEHAV NEUROSCI, V107, P246, DOI 10.1037/0735-7044.107.2.246; HOLLAND PC, 1979, J EXP PSYCHOL ANIM B, V5, P65, DOI 10.1037/0097-7403.5.1.65; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; Killcross S, 1997, NATURE, V388, P377, DOI 10.1038/41097; KITA H, 1990, J COMP NEUROL, V298, P40, DOI 10.1002/cne.902980104; Kluver H, 1939, ARCH NEURO PSYCHIATR, V42, P979; KRETTEK JE, 1977, J COMP NEUROL, V172, P225; LeDoux J. E., 1996, EMOTIONAL BRAIN; Malkova L, 1997, J NEUROSCI, V17, P6011; McGaugh JL, 2002, TRENDS NEUROSCI, V25, P456, DOI 10.1016/S0166-2236(02)02211-7; Nobre AC, 1999, NAT NEUROSCI, V2, P11, DOI 10.1038/4513; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Donnell P, 1999, PSYCHOBIOLOGY, V27, P187; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Parkinson JA, 2000, EUR J NEUROSCI, V12, P405, DOI 10.1046/j.1460-9568.2000.00960.x; Parkinson JA, 2001, J NEUROSCI, V21, P7770, DOI 10.1523/JNEUROSCI.21-19-07770.2001; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pears A, 2001, BRAIN COGNITION, V47, P44; PREUSS TM, 1995, J COGNITIVE NEUROSCI, V7, P1, DOI 10.1162/jocn.1995.7.1.1; PRICE JL, 1991, OLFACTION, P101; Rolls ET, 1996, J NEUROPHYSIOL, V75, P1970, DOI 10.1152/jn.1996.75.5.1970; Sage JR, 2000, BEHAV NEUROSCI, V114, P295, DOI 10.1037/0735-7044.114.2.295; Salinas JA, 1998, BEHAV NEUROSCI, V112, P812, DOI 10.1037/0735-7044.112.4.812; Schoenbaum G, 2003, LEARN MEMORY, V10, P129, DOI 10.1101/lm.55203; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Schoenbaum G, 2000, J NEUROSCI, V20, P5179; SCHOENBAUM G, 2002, NEUROPSYCHOLOGY MEMO, P463; Setlow B, 2002, EUR J NEUROSCI, V15, P1841, DOI 10.1046/j.1460-9568.2002.02010.x; Setlow B, 2003, NEURON, V38, P625, DOI 10.1016/S0896-6273(03)00264-2; Shi CJ, 1998, J COMP NEUROL, V399, P440, DOI 10.1002/(SICI)1096-9861(19981005)399:4<440::AID-CNE2>3.0.CO;2-1; Swanson L. W., 1992, BRAIN MAPS STRUCTURE; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Watanabe M, 2001, EXP BRAIN RES, V140, P511, DOI 10.1007/s002210100856; WEISKRANTZ L, 1956, J COMP PHYSIOL PSYCH, V49, P381, DOI 10.1037/h0088009	63	337	342	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 28	2003	39	5					855	867		10.1016/S0896-6273(03)00474-4	http://dx.doi.org/10.1016/S0896-6273(03)00474-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	717GN	12948451	Bronze			2022-12-24	WOS:000185079300014
J	Lee, SJ; Xu, H; Kang, LW; Amzel, LM; Montell, C				Lee, SJ; Xu, H; Kang, LW; Amzel, LM; Montell, C			Light adaptation through phosphoinositide-regulated translocation of Drosophila visual arrestin	NEURON			English	Article							ROD PHOTORECEPTOR CELLS; RECEPTOR ENDOCYTOSIS; PROTEIN; BINDING; PHOTOTRANSDUCTION; GENE; TRP; DEGENERATION; KINASE; DOMAIN	Photoreceptor cells adapt to bright or continuous light, although the molecular mechanisms underlying this phenomenon are incompletely understood. Here, we report a mechanism of light adaptation in Drosophila, which is regulated by phosphoinositides (Pis). We found that light-dependent translocation of arrestin was defective in mutants that disrupt PI metabolism or trafficking. Arrestin bound to PIP3 in vitro, and mutation of this site delayed arrestin shuttling and resulted in defects in the termination of the light response, which is normally accelerated by prior exposure to light. Disruption of the arrestin/PI interaction also suppressed retinal degeneration caused by excessive endocytosis of rhodopsin/arrestin complexes. These findings indicate that light-dependent trafficking of arrestin is regulated by direct interaction with Pis and is required for light adaptation. Since phospholipase C activity is required for activation of Drosophila phototransduction, these data point to a dual role of Pis in phototransduction.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Biophys, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	cmontell@jhmi.edu	Montell, Craig/AAH-3357-2021; Xu, Hong/H-9997-2016; Lee, Seung Jae V/E-2468-2019	Montell, Craig/0000-0001-5637-1482; Xu, Hong/0000-0003-1049-1184; Amzel, L. Mario/0000-0002-0129-9572; Lee, Seung-Jae/0000-0002-6103-156X	NEI NIH HHS [EY08117] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008117] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; Alloway PG, 1999, P NATL ACAD SCI USA, V96, P6072, DOI 10.1073/pnas.96.11.6072; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Bahner M, 2002, NEURON, V34, P83, DOI 10.1016/S0896-6273(02)00630-X; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BROEKHUYSE RM, 1985, CURR EYE RES, V4, P613, DOI 10.3109/02713688508999993; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Dolph PJ, 2002, NEUROSCIENTIST, V8, P347, DOI 10.1177/107385840200800410; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; FERREIRA PA, 1994, J BIOL CHEM, V269, P3129; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; FRANCESCHINI N, 1971, KYBERNETIK, V9, P159, DOI 10.1007/BF02215177; Gaidarov I, 1999, EMBO J, V18, P871, DOI 10.1093/emboj/18.4.871; Gaidarov I, 1996, J BIOL CHEM, V271, P20922, DOI 10.1074/jbc.271.34.20922; GLUSTO NM, 2000, PROG LIPID RES, V39, P315; Hall RA, 2002, CIRC RES, V91, P672, DOI 10.1161/01.RES.0000037000.74258.03; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Huang H, 1999, DEVELOPMENT, V126, P5365; Huang Z, 2000, J NEUROCHEM, V75, P355, DOI 10.1046/j.1471-4159.2000.0750355.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P14598, DOI 10.1073/pnas.93.25.14598; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kahn ES, 1997, J NEUROCHEM, V68, P169; Kiselev A, 1997, BIOCHEMISTRY-US, V36, P2188, DOI 10.1021/bi9621268; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; Kosloff M, 2003, EMBO J, V22, P459, DOI 10.1093/emboj/cdg054; Lee SJ, 2001, NEURON, V32, P1097, DOI 10.1016/S0896-6273(01)00538-4; Lu C, 2001, NEUROSCIENCE, V107, P35, DOI 10.1016/S0306-4522(01)00337-2; Lu CW, 1999, J NEUROSCI, V19, P7317, DOI 10.1523/JNEUROSCI.19-17-07317.1999; MANGINI NJ, 1988, INVEST OPHTH VIS SCI, V29, P1221; MATSUMOTO H, 1994, NEURON, V12, P997, DOI 10.1016/0896-6273(94)90309-3; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; McGinnis JF, 2002, J NEUROSCI RES, V67, P290, DOI 10.1002/jnr.10120; Mendez A, 2003, J NEUROSCI, V23, P3124; Milligan SC, 1997, J CELL BIOL, V139, P351, DOI 10.1083/jcb.139.2.351; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; PAK WL, 1994, MOL GENETICS INHERIT, P29; PALCZEWSKI K, 1991, FEBS LETT, V295, P195, DOI 10.1016/0014-5793(91)81416-6; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Pelletier L, 2000, NAT CELL BIOL, V2, P840, DOI 10.1038/35041089; Peterson JJ, 2003, EXP EYE RES, V76, P553, DOI 10.1016/S0014-4835(03)00032-0; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; PHILP NJ, 1987, FEBS LETT, V225, P127, DOI 10.1016/0014-5793(87)81144-4; PORTER JA, 1993, J CELL BIOL, V122, P601, DOI 10.1083/jcb.122.3.601; Prasad SVN, 2002, J CELL BIOL, V158, P563, DOI 10.1083/jcb.200202113; Rajala RVS, 2001, INVEST OPHTH VIS SCI, V42, P3110; RANGANATHAN R, 1995, CELL, V81, P841, DOI 10.1016/0092-8674(95)90004-7; Rodieck R.W., 1998, 1 STEPS SEEING; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Stocker H, 2002, SCIENCE, V295, P2088, DOI 10.1126/science. 1068094; Wes PD, 1999, NAT NEUROSCI, V2, P447, DOI 10.1038/8116; WHELAN JP, 1988, J NEUROSCI RES, V20, P263, DOI 10.1002/jnr.490200216	58	89	89	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2003	39	1					121	132		10.1016/S0896-6273(03)00390-8	http://dx.doi.org/10.1016/S0896-6273(03)00390-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699LB	12848937	Bronze			2022-12-24	WOS:000184057400014
J	Noble, W; Olm, V; Takata, K; Casey, E; O, M; Meyerson, J; Gaynor, K; LaFrancois, J; Wang, LL; Kondo, T; Davies, P; Burns, M; Nixon, VR; Dickson, D; Matsuoka, Y; Ahlijanian, M; Lau, LF; Duff, K				Noble, W; Olm, V; Takata, K; Casey, E; O, M; Meyerson, J; Gaynor, K; LaFrancois, J; Wang, LL; Kondo, T; Davies, P; Burns, M; Nixon, VR; Dickson, D; Matsuoka, Y; Ahlijanian, M; Lau, LF; Duff, K			Cdk5 is a key factor in tau aggregation and tangle formation in vivo	NEURON			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; ALZHEIMER-LIKE PHOSPHORYLATION; CYCLIN-DEPENDENT KINASE-5; NEUROFIBRILLARY TANGLES; ACTIVATOR P35; PROTEIN-TAU; BETA; HYPERPHOSPHORYLATION; PATHOLOGY; P25	Tau aggregation is a common feature of neurodegenerative diseases such as Alzheimer's disease, and hyperphosphorylation of tau has been implicated as a fundamental pathogenic mechanism in this process. To examine the impact of cdk5 in tau aggregation and tangle formation, we crossed transgenic mice overexpressing the cdk5 activator p25, with transgenic mice overexpressing mutant (P301L) human tau. Tau was hyperphosphorylated at several sites in the double transgenics, and there was a highly significant accumulation of aggregated tau in brainstem and cortex. This was accompanied by increased numbers of silver-stained neurofibrillary tangles (NFTs). Insoluble tau was also associated with active GSK. Thus, cdk5 can initiate a major impact on tau pathology progression that probably involves several kinases. Kinase inhibitors may thus be beneficial therapeutically.	NYU, Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; Mayo Clin, Jacksonville, FL 32224 USA; Pfizer Inc, Global Res & Dev, Groton, CT 06340 USA	Nathan Kline Institute for Psychiatric Research; New York University; Yeshiva University; Albert Einstein College of Medicine; Mayo Clinic; Pfizer	Duff, K (corresponding author), NYU, Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, 140 Old Orangeburg Rd, Orangeburg, NY 10962 USA.	duff@nki.rfmh.org	Noble, Wendy/C-3756-2009; Duff, Karen EK/C-2510-2009	Noble, Wendy/0000-0002-7898-4295; Dickson, Dennis W/0000-0001-7189-7917; Duff, Karen/0000-0002-6177-868X; Burns, Mark P/0000-0003-4750-2000	NIA NIH HHS [AG 172116] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Alvarez A, 2001, EXP CELL RES, V264, P266, DOI 10.1006/excr.2001.5152; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Bancroft JD, 1990, THEORY PRACTICE HIST; BAUMANN K, 1993, FEBS LETT, V336, P417, DOI 10.1016/0014-5793(93)80849-P; Bian F, 2002, J COMP NEUROL, V446, P257, DOI 10.1002/cne.10186; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Billingsley ML, 1997, BIOCHEM J, V323, P577, DOI 10.1042/bj3230577; BRAAK H, 1988, STAIN TECHNOL, V63, P197, DOI 10.3109/10520298809107184; Bu BT, 2002, J NEUROSCI, V22, P6515; Duff K, 2000, NEUROBIOL DIS, V7, P87, DOI 10.1006/nbdi.1999.0279; Flaherty DB, 2000, J NEUROSCI RES, V62, P463, DOI 10.1002/1097-4547(20001101)62:3<463::AID-JNR16>3.0.CO;2-7; Friedhoff P, 2000, BBA-MOL BASIS DIS, V1502, P122, DOI 10.1016/S0925-4439(00)00038-7; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gotz J, 2001, NEUROREPORT, V12, P2007; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Grynspan F, 1997, BRAIN RES, V763, P145, DOI 10.1016/S0006-8993(97)00384-3; Hashiguchi M, 2002, J BIOL CHEM, V277, P44525, DOI 10.1074/jbc.M207426200; Ishiguro K, 1995, NEUROSCI LETT, V202, P81, DOI 10.1016/0304-3940(95)12206-0; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Lee KY, 1999, NEUROSCI RES, V34, P21, DOI 10.1016/S0168-0102(99)00026-7; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Liu F, 2002, FEBS LETT, V530, P209, DOI 10.1016/S0014-5793(02)03487-7; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Lund ET, 2001, J NEUROCHEM, V76, P1221, DOI 10.1046/j.1471-4159.2001.00130.x; Michel G, 1998, BBA-GEN SUBJECTS, V1380, P177, DOI 10.1016/S0304-4165(97)00139-6; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; PAUDEL HK, 1993, J BIOL CHEM, V268, P23512; Pei JJ, 1997, J NEUROPATH EXP NEUR, V56, P70, DOI 10.1097/00005072-199701000-00007; Planel E, 2002, DRUG DEVELOP RES, V56, P491, DOI 10.1002/ddr.10100; Rank KB, 2002, FEBS LETT, V514, P263, DOI 10.1016/S0014-5793(02)02376-1; Ratner N, 1998, J NEUROSCI, V18, P7717; Sengupta A, 1997, MOL CELL BIOCHEM, V167, P99, DOI 10.1023/A:1006883924775; Sengupta A, 1998, ARCH BIOCHEM BIOPHYS, V357, P299, DOI 10.1006/abbi.1998.0813; Spittaels K, 2000, J BIOL CHEM, V275, P41340, DOI 10.1074/jbc.M006219200; TAKASHIMA A, 1993, P NATL ACAD SCI USA, V90, P7789, DOI 10.1073/pnas.90.16.7789; Tomidokoro Y, 2001, NEUROSCI LETT, V299, P169, DOI 10.1016/S0304-3940(00)01767-5; Town T, 2002, J NEUROSCI RES, V69, P362, DOI 10.1002/jnr.10299; Tseng HC, 2002, FEBS LETT, V523, P58, DOI 10.1016/S0014-5793(02)02934-4; Tsuji T, 1998, NEUROSCI LETT, V248, P109, DOI 10.1016/S0304-3940(98)00348-6; Veeranna, 1998, J NEUROSCI, V18, P4008; Veeranna, 1996, NEUROCHEM RES, V21, P629, DOI 10.1007/BF02527763; Williamson R, 2002, J NEUROSCI, V22, P10, DOI 10.1523/JNEUROSCI.22-01-00010.2002; Yamaguchi H, 1996, ACTA NEUROPATHOL, V92, P232, DOI 10.1007/s004010050513	49	395	424	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 22	2003	38	4					555	565		10.1016/S0896-6273(03)00259-9	http://dx.doi.org/10.1016/S0896-6273(03)00259-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	682QV	12765608	Bronze			2022-12-24	WOS:000183104000007
J	Lodovichi, C; Belluscio, L; Katz, LC				Lodovichi, C; Belluscio, L; Katz, LC			Functional topography of connections linking mirror-symmetric maps in the mouse olfactory bulb	NEURON			English	Article							INTRABULBAR ASSOCIATIONAL SYSTEM; ODORANT RECEPTOR EXPRESSION; DOMAIN ORGANIZATION; MICE DEFICIENT; VISUAL-CORTEX; AXON GUIDANCE; SENSORY MAPS; CHANNEL; INFORMATION; PROJECTIONS	In rodents, each main olfactory bulb contains two mirror-symmetric glomerular maps, a feature not found in the initial topographic maps of other sensory systems. Targeting tracer injections to identified glomeruli revealed that isofunctional odor columns - translaminar assemblies connected to a given glomerulus-were specifically and reciprocally interconnected through a mutually inhibitory circuit with exquisite topographic specificity. Thus, instead of containing two mirror-symmetric maps, we propose that the olfactory bulb contains a single integrated map in which isofunctional odor columns are connected through an intrabulbar link, analogous to the specific horizontal connections linking iso-orientation columns in primary visual cortex.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA; NINDS, Dev Neural Plast Unit, NIH, Bethesda, MD 20892 USA	Duke University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Katz, LC (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA.	larry@neuro.duke.edu		Lodovichi, Claudia/0000-0002-0490-4846	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003002, ZIANS003002] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adrian ED, 1942, J PHYSIOL-LONDON, V100, P459, DOI 10.1113/jphysiol.1942.sp003955; Barth AL, 1997, NEURON, V19, P359, DOI 10.1016/S0896-6273(00)80945-9; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Belluscio L, 2002, NATURE, V419, P296, DOI 10.1038/nature01001; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; BUONVISO N, 1991, J COMP NEUROL, V307, P57, DOI 10.1002/cne.903070106; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Freeman WJ, 1975, MASS ACTION NERVOUS; Friedrich RW, 2001, CURR OPIN NEUROBIOL, V11, P468, DOI 10.1016/S0959-4388(00)00236-1; GILBERT CD, 1990, COLD SPRING HARB SYM, V55, P663; GILBERT CD, 1992, NEURON, V9, P1, DOI 10.1016/0896-6273(92)90215-Y; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; Grillner S, 2000, BRAIN RES, V886, P224, DOI 10.1016/S0006-8993(00)03088-2; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Lei H, 2002, NAT NEUROSCI, V5, P557, DOI 10.1038/nn859; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; LIU WL, 1994, J COMP NEUROL, V346, P541, DOI 10.1002/cne.903460407; Luo M, 2001, NEURON, V32, P1165, DOI 10.1016/S0896-6273(01)00537-2; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; MCGUIRE BA, 1991, J COMP NEUROL, V305, P370, DOI 10.1002/cne.903050303; McQuiston AR, 2001, J NEUROPHYSIOL, V86, P1899, DOI 10.1152/jn.2001.86.4.1899; Meister M, 2001, J NEUROSCI, V21, P1351; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Nagao H, 2000, NEUROREPORT, V11, P3023, DOI 10.1097/00001756-200009110-00039; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; O'Leary DDM, 1999, CELL, V96, P255, DOI 10.1016/S0092-8674(00)80565-6; Pasterkamp RJ, 1999, CELL MOL BIOL, V45, P763; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Royal SJ, 1999, J NEUROSCI, V19, P9856; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Schaefer ML, 2001, J COMP NEUROL, V436, P351; SCHOENFELD TA, 1985, J COMP NEUROL, V235, P503, DOI 10.1002/cne.902350408; SHATZ CJ, 1986, ANNU REV NEUROSCI, V9, P171, DOI 10.1146/annurev.ne.09.030186.001131; Shepherd G. M., 1998, SYNAPTIC ORG BRAIN; St John JA, 2002, DEV BRAIN RES, V138, P1, DOI 10.1016/S0165-3806(02)00454-6; Strotmann J, 2000, J NEUROSCI, V20, P6927, DOI 10.1523/JNEUROSCI.20-18-06927.2000; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; UDIN SB, 1988, ANNU REV NEUROSCI, V11, P289, DOI 10.1146/annurev.ne.11.030188.001445; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Yoshihara Y, 1997, CELL TISSUE RES, V290, P457, DOI 10.1007/s004410050953; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	58	86	90	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 24	2003	38	2					265	276		10.1016/S0896-6273(03)00194-6	http://dx.doi.org/10.1016/S0896-6273(03)00194-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672AM	12718860	Bronze			2022-12-24	WOS:000182498300015
J	Shepherd, GMG; Pologruto, TA; Svoboda, K				Shepherd, GMG; Pologruto, TA; Svoboda, K			Circuit analysis of experience-dependent plasticity in the developing rat barrel cortex	NEURON			English	Article							DEVELOPING SOMATOSENSORY CORTEX; SOMATIC SENSORY RESPONSES; PRIMARY VISUAL-CORTEX; POSTERIOR GROUP POM; MEDIAL NUCLEUS VPM; LAYER-IV; CRITICAL PERIOD; FIELD CORTEX; FUNCTIONAL CONNECTIVITY; SYNAPTIC CONNECTIONS	Sensory deprivation during a critical period reduces spine motility and disrupts receptive field structure of layer 2/3 neurons in rat barrel cortex. To determine the locus of plasticity, we used laser scanning photostimulation, allowing us to rapidly map intracortical synaptic connectivity in brain slices. Layer 2/3 neurons differed in their spatial distributions of presynaptic partners: neurons directly above barrels received, on average, significantly more layer 4 input than those above the septa separating barrels. Complementary connectivity was found in deprived cortex: neurons above septa were now strongly coupled to septal regions, while connectivity between barrel regions and layer 2/3 was reduced. These results reveal competitive interactions between barrel and septal circuits in the establishment of precise intracortical circuits.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Harvard University	Svoboda, K (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.		Shepherd, Gordon/F-2679-2010					AGMON A, 1993, J NEUROSCI, V13, P5365, DOI 10.1523/JNEUROSCI.13-12-05365.1993; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; ARMSTRONGJAMES M, 1987, J COMP NEUROL, V263, P265, DOI 10.1002/cne.902630209; BERNARDO KL, 1990, J COMP NEUROL, V291, P231, DOI 10.1002/cne.902910207; BOURASSA J, 1995, EUR J NEUROSCI, V7, P19, DOI 10.1111/j.1460-9568.1995.tb01016.x; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Brumberg JC, 1999, J NEUROPHYSIOL, V82, P1808, DOI 10.1152/jn.1999.82.4.1808; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Canepari M, 2001, J NEUROSCI METH, V112, P29, DOI 10.1016/S0165-0270(01)00451-4; CHAPIN JK, 1987, J COMP NEUROL, V263, P326, DOI 10.1002/cne.902630303; CHIAIA NL, 1991, J COMP NEUROL, V314, P217, DOI 10.1002/cne.903140203; CHMIELOWSKA J, 1989, J COMP NEUROL, V285, P325, DOI 10.1002/cne.902850304; CRANDALL JE, 1986, NEUROSCI LETT, V67, P19, DOI 10.1016/0304-3940(86)90201-6; CUSICK CG, 1990, J COMP NEUROL, V292, P83, DOI 10.1002/cne.902920106; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DIAMOND ME, 1992, J COMP NEUROL, V319, P66, DOI 10.1002/cne.903190108; DIAMOND ME, 1992, J COMP NEUROL, V318, P462, DOI 10.1002/cne.903180410; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; Dodt HU, 1999, SCIENCE, V286, P110, DOI 10.1126/science.286.5437.110; Feldman DE, 2001, NEURON, V31, P171, DOI 10.1016/S0896-6273(01)00363-4; Feldmeyer D, 2002, J PHYSIOL-LONDON, V538, P803, DOI 10.1113/jphysiol.2001.012959; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; FOX K, 1992, J NEUROSCI, V12, P1826; JEANMONOD D, 1981, NEUROSCIENCE, V6, P1503, DOI 10.1016/0306-4522(81)90222-0; JHAVERI S, 1991, P NATL ACAD SCI USA, V88, P4489, DOI 10.1073/pnas.88.10.4489; Kaas J, 1998, NAT NEUROSCI, V1, P341, DOI 10.1038/1546; KATZ LC, 1994, J NEUROSCI METH, V54, P205, DOI 10.1016/0165-0270(94)90194-5; Kim U, 1999, J COMP NEUROL, V408, P489; KORALEK KA, 1988, BRAIN RES, V463, P346, DOI 10.1016/0006-8993(88)90408-8; Kotter R, 1998, NEUROSCIENCE, V86, P265, DOI 10.1016/S0306-4522(98)00010-4; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; KRUBITZER LA, 1992, J COMP NEUROL, V319, P123, DOI 10.1002/cne.903190111; Laaris N, 2000, J NEUROSCI, V20, P1529; Laaris N, 2002, J NEUROPHYSIOL, V87, P1028, DOI 10.1152/jn.00512.2001; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LU SM, 1992, SOMATOSENS MOT RES, V10, P1; Lubke J, 2000, J NEUROSCI, V20, P5300, DOI 10.1523/JNEUROSCI.20-14-05300.2000; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; O'Leary D D, 1994, Curr Opin Neurobiol, V4, P535, DOI 10.1016/0959-4388(94)90054-X; OLAVARRIA J, 1984, BRAIN RES, V291, P364, DOI 10.1016/0006-8993(84)91270-8; Petersen CCH, 2001, J NEUROSCI, V21, P8435, DOI 10.1523/JNEUROSCI.21-21-08435.2001; Petersen CCH, 2000, J NEUROSCI, V20, P7579; Porter JT, 2001, J NEUROSCI, V21, P2699, DOI 10.1523/JNEUROSCI.21-08-02699.2001; RICE FL, 1977, J COMP NEUROL, V171, P545, DOI 10.1002/cne.901710408; RICE FL, 1995, BARREL CORTEX RODENT, P1; Roerig B, 2002, CEREB CORTEX, V12, P187, DOI 10.1093/cercor/12.2.187; Sawatari A, 2000, NEURON, V25, P459, DOI 10.1016/S0896-6273(00)80908-3; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; Schubert D, 2001, J NEUROSCI, V21, P3580, DOI 10.1523/JNEUROSCI.21-10-03580.2001; Sherman S., 2000, EXPLORING THALAMUS; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Wang Y, 2002, CEREB CORTEX, V12, P395, DOI 10.1093/cercor/12.4.395; WELKER C, 1974, J COMP NEUROL, V158, P437, DOI 10.1002/cne.901580405; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	60	251	289	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 24	2003	38	2					277	289		10.1016/S0896-6273(03)00152-1	http://dx.doi.org/10.1016/S0896-6273(03)00152-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672AM	12718861	Bronze			2022-12-24	WOS:000182498300016
J	Tietjen, I; Rihel, JM; Cao, YX; Koentges, G; Zakhary, L; Dulac, C				Tietjen, I; Rihel, JM; Cao, YX; Koentges, G; Zakhary, L; Dulac, C			Single-cell transcriptional analysis of neuronal progenitors	NEURON			English	Article							LIM HOMEOBOX GENE; POLYCOMB-GROUP; EXPRESSION; PROTEIN; MOUSE; SPECIFICATION; EYE; HYBRIDIZATION; NEUROGENESIS; FOREBRAIN	The extraordinary cellular heterogeneity of the mammalian nervous system has largely hindered the molecular analysis of neuronal identity and diversity. In order to uncover mechanisms involved in neuronal differentiation and diversification, we have monitored the expression profiles of individual neurons and progenitor cells collected from dissociated tissue or captured from intact slices. We demonstrate that this technique provides a sensitive and reproducible representation of the single-cell transcriptome. In the olfactory system, hundreds of transcriptional differences were identified between olfactory progenitors and mature sensory neurons, enabling us to define the large variety of signaling pathways expressed by individual progenitors at a precise developmental stage. Finally, we show that regional differences in gene expression can be predicted from transcriptional analysis of single neuronal precursors isolated by laser capture from defined areas of the developing brain.	Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Affymetrix Inc, Dept Appl Res, Santa Clara, CA 95051 USA; UCL, Wolfson Inst Biomed Res, London WC1E 6AU, England	Harvard University; Howard Hughes Medical Institute; Affymetrix; University of London; University College London	Dulac, C (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	dulac@fas.harvard.edu	Rihel, Jason/G-7106-2011	Tietjen, Ian/0000-0002-8991-6490; Dulac, Catherine/0000-0001-5024-5418; Rihel, Jason/0000-0003-4067-2066				Bae SK, 2000, DEVELOPMENT, V127, P2933; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Beuchle D, 2001, DEVELOPMENT, V128, P993; Buck LB, 2000, PRINCIPLES NEURAL SC, P625; Cao YX, 2001, CURR OPIN NEUROBIOL, V11, P615, DOI 10.1016/S0959-4388(00)00258-0; Cau E, 2000, DEVELOPMENT, V127, P2323; Cau E, 1997, DEVELOPMENT, V124, P1611; Cau E, 2002, DEVELOPMENT, V129, P1871; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Guss KA, 2001, SCIENCE, V292, P1164, DOI 10.1126/science.1058312; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; Heberlein U, 2000, Results Probl Cell Differ, V31, P37; HINDS JW, 1968, J COMP NEUROL, V134, P305, DOI 10.1002/cne.901340305; Hinks GL, 1997, J NEUROSCI, V17, P5549; Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639; Iscove NN, 2002, NAT BIOTECHNOL, V20, P940, DOI 10.1038/nbt729; Klein CA, 2002, NAT BIOTECHNOL, V20, P387, DOI 10.1038/nbt0402-387; Koyano-Nakagawa N, 2000, DEVELOPMENT, V127, P4203; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mody M, 2001, P NATL ACAD SCI USA, V98, P8862, DOI 10.1073/pnas.141244998; Murray RC, 1999, SEMIN CELL DEV BIOL, V10, P421, DOI 10.1006/scdb.1999.0329; Norlin EM, 2001, MOL CELL NEUROSCI, V18, P283, DOI 10.1006/mcne.2001.1019; Norton JD, 1998, TRENDS CELL BIOL, V8, P58, DOI 10.1016/S0962-8924(97)01183-5; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Porter FD, 1997, DEVELOPMENT, V124, P2935; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; RIABOWOL K, 1989, CELL, V57, P393, DOI 10.1016/0092-8674(89)90914-8; Rosner B., 2000, FUNDAMENTALS BIOSTAT; Sagasti A, 1999, GENE DEV, V13, P1794, DOI 10.1101/gad.13.14.1794; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schumacher A, 1997, TRENDS GENET, V13, P167, DOI 10.1016/S0168-9525(97)01133-5; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; WOLFF T, 1997, MOL CELLULAR APPROAC, P474; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; YASUNAMI M, 1995, J BIOL CHEM, V270, P18649, DOI 10.1074/jbc.270.31.18649	42	189	204	2	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 24	2003	38	2					161	175		10.1016/S0896-6273(03)00229-0	http://dx.doi.org/10.1016/S0896-6273(03)00229-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672AM	12718852	Bronze			2022-12-24	WOS:000182498300007
J	Bult, C; Kibbe, WA; Snoddy, J; Vitaterna, M; Swanson, D; Pretel, S; Li, YX; Hohman, MM; Rinchik, E; Takahashi, JS; Frankel, WN; Goldowitz, D				Bult, C; Kibbe, WA; Snoddy, J; Vitaterna, M; Swanson, D; Pretel, S; Li, YX; Hohman, MM; Rinchik, E; Takahashi, JS; Frankel, WN; Goldowitz, D			A genome end-game: understanding gene function in the nervous system	NATURE NEUROSCIENCE			English	Article							MOUSE		Jackson Lab, Neurosci Mutagenesis Facil, Bar Harbor, ME 04609 USA; Northwestern Univ, Howard Hughes Med Inst, Ctr Funct Genome, Evanston, IL 60208 USA; Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Ctr Genom & Bioinformat, Memphis, TN 38163 USA	Jackson Laboratory; Howard Hughes Medical Institute; Northwestern University; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Health Science Center	Bult, C (corresponding author), Jackson Lab, Neurosci Mutagenesis Facil, 600 Main St, Bar Harbor, ME 04609 USA.	dgold@nb.utmem.edu	Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019; Kibbe, Warren/B-2106-2010	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; Goldowitz, Daniel/0000-0003-4756-4017; Kibbe, Warren/0000-0001-5622-7659	Howard Hughes Medical Institute Funding Source: Medline; NIMH NIH HHS [U01 MH061915] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH061915] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bult CJ, 2004, NUCLEIC ACIDS RES, V32, pD476, DOI 10.1093/nar/gkh125; Noveroske JK, 2000, MAMM GENOME, V11, P478, DOI 10.1007/s003350010093; RUSSELL WL, 1979, P NATL ACAD SCI USA, V76, P5818, DOI 10.1073/pnas.76.11.5818	3	17	17	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					484	485		10.1038/nn0504-484	http://dx.doi.org/10.1038/nn0504-484			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15114363	Green Accepted			2022-12-24	WOS:000221101300018
J	Govindaiah; Cox, CL				Govindaiah; Cox, CL			Synaptic activation of metabotropic glutamate receptors regulates dendritic outputs of thalamic interneurons	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; CENTRAL-NERVOUS-SYSTEM; EXCITATORY POSTSYNAPTIC POTENTIALS; IN-VITRO; THALAMOCORTICAL NEURONS; MESSENGER-RNA; RELAY CELLS; Y-CELLS; X-CELLS; RETINOGENICULATE TRANSMISSION	Information gating through the thalamus is dependent on the output of thalamic relay neurons. These relay neurons receive convergent innervation from a number of sources, including GABA-containing interneurons that provide feed-forward inhibition. These interneurons are unique in that they have two distinct outputs: axonal and dendritic. In addition to conventional axonal outputs, these interneurons have presynaptic dendrites that may provide localized inhibitory influences. Our study indicates that synaptic activation of metabotropic glutamate receptors (mGluRs) increases inhibitory activity in relay neurons by increasing output of presynaptic dendrites of interneurons. Optic tract stimulation increases inhibitory activity in thalamic relay neurons in a frequency- and intensity-dependent manner and is attenuated by mGluR antagonists. Our data suggest that synaptic activation of mGluRs selectively alters dendritic output but not axonal output of thalamic interneurons. This mechanism could serve an important role in focal, feed-forward information processing in addition to dynamic information processing in thalamocortical circuits.	Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; Univ Illinois, Dept Pharmacol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cox, CL (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	clcox@life.uiuc.edu		Cox, Charles/0000-0002-1179-7014	NATIONAL EYE INSTITUTE [R56EY014024, R01EY014024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS042356] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY014024-02, R01 EY014024-03, EY014024, R01 EY014024, R01 EY014024-01A1, R01 EY014024-04] Funding Source: Medline; NINDS NIH HHS [NS42356] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BERARDI N, 1984, J PHYSIOL-LONDON, V357, P505, DOI 10.1113/jphysiol.1984.sp015514; BLOOMFIELD SA, 1989, P NATL ACAD SCI USA, V86, P3911, DOI 10.1073/pnas.86.10.3911; CHARPAK S, 1990, NATURE, V347, P765, DOI 10.1038/347765a0; CLELAND BG, 1973, J PHYSIOL-LONDON, V228, P649, DOI 10.1113/jphysiol.1973.sp010105; Cox CL, 1996, J COMP NEUROL, V366, P416; Cox CL, 1998, NATURE, V394, P478, DOI 10.1038/28855; Cox CL, 1997, J NEUROSCI, V17, P70, DOI 10.1523/JNEUROSCI.17-01-00070.1997; Cox CL, 1999, J NEUROSCI, V19, P6694; Cox CL, 2000, NEURON, V27, P597, DOI 10.1016/S0896-6273(00)00069-6; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; FAMIGLIETTI EV, 1972, J COMP NEUROL, V144, P285, DOI 10.1002/cne.901440304; FRIEDLANDER MJ, 1981, J NEUROPHYSIOL, V46, P80, DOI 10.1152/jn.1981.46.1.80; Gabriel S, 1996, EXP BRAIN RES, V109, P43; Godwin DW, 1996, J NEUROSCI, V16, P8181; Godwin DW, 1996, J NEUROPHYSIOL, V76, P1800, DOI 10.1152/jn.1996.76.3.1800; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; GUILLERY RW, 1969, Z ZELLFORSCH MIK ANA, V96, P1, DOI 10.1007/BF00321474; HAMOS JE, 1985, NATURE, V317, P618, DOI 10.1038/317618a0; HOFFMANN KP, 1972, J NEUROPHYSIOL, V35, P518, DOI 10.1152/jn.1972.35.4.518; HOLDEFER RN, 1989, BRAIN RES, V488, P341, DOI 10.1016/0006-8993(89)90727-0; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; HUGUENARD JR, 1994, J NEUROPHYSIOL, V71, P2576, DOI 10.1152/jn.1994.71.6.2576; Huntsman MM, 1999, SCIENCE, V283, P541, DOI 10.1126/science.283.5401.541; Jones EG, 1985, THALAMUS; KAPLAN E, 1987, J PHYSIOL-LONDON, V391, P267, DOI 10.1113/jphysiol.1987.sp016737; Kinoshita A, 1998, J COMP NEUROL, V393, P332; Lee KH, 1997, NEUROSCIENCE, V77, P335, DOI 10.1016/S0306-4522(96)00481-2; LEHMKUHLE S, 1980, J NEUROPHYSIOL, V43, P520, DOI 10.1152/jn.1980.43.2.520; LENNIE P, 1981, J PHYSIOL-LONDON, V315, P69, DOI 10.1113/jphysiol.1981.sp013733; LEVAY S, 1977, J COMP NEUROL, V172, P563, DOI 10.1002/cne.901720402; LIU XB, 1995, J COMP NEUROL, V352, P69, DOI 10.1002/cne.903520106; MARTIN LJ, 1992, NEURON, V9, P259, DOI 10.1016/0896-6273(92)90165-A; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; MONTERO VM, 1986, J COMP NEUROL, V254, P228, DOI 10.1002/cne.902540207; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; Neto FL, 2000, BRAIN RES, V854, P93, DOI 10.1016/S0006-8993(99)02326-4; NORTON TT, 1992, PROG BRAIN RES, V90, P193; OHISHI H, 1993, J COMP NEUROL, V335, P252, DOI 10.1002/cne.903350209; OHISHI H, 1993, NEUROSCIENCE, V53, P1009, DOI 10.1016/0306-4522(93)90485-X; PAPE HC, 1995, NEUROSCIENCE, V68, P1105, DOI 10.1016/0306-4522(95)00205-W; PARE D, 1991, J NEUROPHYSIOL, V66, P1190, DOI 10.1152/jn.1991.66.4.1190; Petralia RS, 1996, NEUROSCIENCE, V71, P949, DOI 10.1016/0306-4522(95)00533-1; RALSTON HJ, 1971, NATURE, V230, P585, DOI 10.1038/230585a0; SALT TE, 1991, EUR J NEUROSCI, V3, P1104, DOI 10.1111/j.1460-9568.1991.tb00045.x; SALT TE, 1995, NEUROSCIENCE, V65, P5, DOI 10.1016/0306-4522(94)00464-G; SCHARFMAN HE, 1990, P NATL ACAD SCI USA, V87, P4548, DOI 10.1073/pnas.87.12.4548; Sherman S.M., 2001, EXPLORING THALAMUS, V1st Edn; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; SHIGEMOTO R, 1992, J COMP NEUROL, V322, P121, DOI 10.1002/cne.903220110; SILLITO AM, 1990, J NEUROPHYSIOL, V63, P347, DOI 10.1152/jn.1990.63.2.347; SILLITO AM, 1990, NEUROSCIENCE, V34, P273, DOI 10.1016/0306-4522(90)90137-S; SILLITO AM, 1983, BRAIN RES, V277, P63, DOI 10.1016/0006-8993(83)90908-3; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 1997, THALAMUS, VI; TURNER JP, 1994, J PHYSIOL-LONDON, V480, P281, DOI 10.1113/jphysiol.1994.sp020359; Turner JP, 1998, J PHYSIOL-LONDON, V510, P829, DOI 10.1111/j.1469-7793.1998.829bj.x; Turner JP, 2000, NEUROSCIENCE, V100, P493, DOI 10.1016/S0306-4522(00)00280-3; Turner JP, 1999, J PHYSIOL-LONDON, V519, P481, DOI 10.1111/j.1469-7793.1999.0481m.x; UHLRICH DJ, 1995, J NEUROPHYSIOL, V73, P2428, DOI 10.1152/jn.1995.73.6.2428; Van Horn SC, 2000, J COMP NEUROL, V416, P509; Vidnyanszky Z, 1996, EUR J NEUROSCI, V8, P1061, DOI 10.1111/j.1460-9568.1996.tb01273.x; Von Krosigk M, 1999, NEUROSCIENCE, V91, P7, DOI 10.1016/S0306-4522(98)00557-0; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; WHITE CA, 1992, P NATL ACAD SCI USA, V89, P9850, DOI 10.1073/pnas.89.20.9850; Williams SR, 1996, J PHYSIOL-LONDON, V490, P129, DOI 10.1113/jphysiol.1996.sp021131; WILSON JR, 1984, PROC R SOC SER B-BIO, V221, P411, DOI 10.1098/rspb.1984.0042; Zhu JJ, 1999, NEUROSCIENCE, V91, P1445, DOI 10.1016/S0306-4522(98)00665-4; Zhu JJ, 1998, J NEUROPHYSIOL, V80, P1122, DOI 10.1152/jn.1998.80.3.1122; Zhu JJ, 1997, NEUROSCIENCE, V80, P191, DOI 10.1016/S0306-4522(97)00095-X	72	52	52	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 19	2004	41	4					611	623		10.1016/S0896-6273(04)00013-3	http://dx.doi.org/10.1016/S0896-6273(04)00013-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980209	Bronze			2022-12-24	WOS:000221458100013
J	Noctor, SC; Martinez-Cerdeno, V; Ivic, L; Kriegstein, AR				Noctor, SC; Martinez-Cerdeno, V; Ivic, L; Kriegstein, AR			Cortical neurons arise in symmetric and asymmetric division zones and migrate through specific phases	NATURE NEUROSCIENCE			English	Article							DEVELOPING CEREBRAL-CORTEX; RADIAL GLIAL-CELLS; SUBVENTRICULAR ZONE; BASAL FOREBRAIN; MAMMALIAN BRAIN; VISUAL-CORTEX; NEOCORTEX; NEUROGENESIS; ASTROCYTES; MOUSE	Precise patterns of cell division and migration are crucial to transform the neuroepithelium of the embryonic forebrain into the adult cerebral cortex. Using time-lapse imaging of clonal cells in rat cortex over several generations, we show here that neurons are generated in two proliferative zones by distinct patterns of division. Neurons arise directly from radial glial cells in the ventricular zone (VZ) and indirectly from intermediate progenitor cells in the subventricular zone (SVZ). Furthermore, newborn neurons do not migrate directly to the cortex; instead, most exhibit four distinct phases of migration, including a phase of retrograde movement toward the ventricle before migration to the cortical plate. These findings provide a comprehensive and new view of the dynamics of cortical neurogenesis and migration.	Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Noctor, SC (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurol, 630 W 168th St, New York, NY 10032 USA.	scn8@columbia.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035710, R01NS021223, R37NS038658] Funding Source: NIH RePORTER; NINDS NIH HHS [NS21223, NS38658, NS35710] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bayer S.A., 1991, NEOCORTICAL DEV; BERRY M, 1965, J ANAT, V99, P691; BOULDER C, 1970, ANAT REC, V166, P257; Cai L, 2002, J NEUROSCI RES, V69, P731, DOI 10.1002/jnr.10398; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Kakita A, 2002, ACTA NEUROPATHOL, V104, P649, DOI 10.1007/s00401-002-0594-9; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MILLER MW, 1986, DEV BRAIN RES, V25, P271, DOI 10.1016/0165-3806(86)90217-8; MIONE MC, 1994, J NEUROSCI, V14, P107; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; MOREST DK, 1970, Z ANAT ENTWICKLUNGS, V130, P265, DOI 10.1007/BF00520999; Nadarajah B, 2002, NAT REV NEUROSCI, V3, P423, DOI 10.1038/nrn845; Nadarajah B, 2002, NAT NEUROSCI, V5, P218, DOI 10.1038/nn813; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; Parnavelas JG, 1991, CEREB CORTEX, V1, P463, DOI 10.1093/cercor/1.6.463; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; PARNAVELAS JG, 1979, ANAT EMBRYOL, V157, P311, DOI 10.1007/BF00304996; PRIVAT A, 1975, INT REV CYTOL, V40, P281, DOI 10.1016/S0074-7696(08)60955-9; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Reid CB, 1997, DEVELOPMENT, V124, P2441; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; SCHWARTZ ML, 1991, P NATL ACAD SCI USA, V88, P1354, DOI 10.1073/pnas.88.4.1354; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shen Q, 2002, DEVELOPMENT, V129, P4843; SHOUKIMAS GM, 1978, J COMP NEUROL, V179, P795, DOI 10.1002/cne.901790407; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; SPANA EP, 1995, DEVELOPMENT, V121, P3187; Tabata H, 2003, J NEUROSCI, V23, P9996; Takahashi T, 1996, J NEUROSCI, V16, P6183; TAN SS, 1993, NATURE, V362, P638, DOI 10.1038/362638a0; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Zhong WM, 1997, DEVELOPMENT, V124, P1887; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	50	1544	1578	5	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					136	144		10.1038/nn1172	http://dx.doi.org/10.1038/nn1172			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14703572				2022-12-24	WOS:000188468500011
J	LoTurco, J				LoTurco, J			Doublecortin and a tale of two serines	NEURON			English	Editorial Material							SUBCORTICAL LAMINAR HETEROTOPIA; MICROTUBULE-ASSOCIATED PROTEIN; RADIAL MIGRATION; NEURONAL MIGRATION; CEREBRAL-CORTEX; NEOCORTEX		Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA	University of Connecticut	LoTurco, J (corresponding author), Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA.							Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Corbo JC, 2002, J NEUROSCI, V22, P7548; des Portes V, 1998, HUM MOL GENET, V7, P1063, DOI 10.1093/hmg/7.7.1063; des Portes V, 1998, CELL, V92, P51; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Gupta A, 2003, NAT NEUROSCI, V6, P1284, DOI 10.1038/nn1151; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Noctor S.C., 2004, NAT NEUROSCI; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; Tabata H, 2003, J NEUROSCI, V23, P9996; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3	14	26	27	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 22	2004	41	2					175	177		10.1016/S0896-6273(04)00006-6	http://dx.doi.org/10.1016/S0896-6273(04)00006-6			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741096	Bronze			2022-12-24	WOS:000221457800001
J	Hanz, S; Perlson, E; Willis, D; Zheng, JQ; Massarwa, R; Huerta, JJ; Koltzenburg, M; Kohler, M; van-Minnen, J; Twiss, JL; Fainzilber, M				Hanz, S; Perlson, E; Willis, D; Zheng, JQ; Massarwa, R; Huerta, JJ; Koltzenburg, M; Kohler, M; van-Minnen, J; Twiss, JL; Fainzilber, M			Axoplasmic importins enable retrograde injury signaling in lesioned nerve	NEURON			English	Article							P75 NEUROTROPHIN RECEPTOR; NUCLEAR TRANSPORT FACTOR; PROTEIN-SYNTHESIS; APLYSIA NEURONS; GROWTH CONES; IN-VIVO; AXON; LOCALIZATION; REGENERATION; ALPHA	Axoplasmic proteins containing nuclear localization signals (NLS) signal retrogradely by an unknown mechanism in injured nerve. Here we demonstrate that the importin/karyopherin alpha and beta families underlie this process. We show that importins are found in axons at significant distances from the cell body and that importin beta protein is increased after nerve lesion by local translation of axonal mRNA. This leads to formation of a high-affinity NLS binding complex that traffics retrogradely with the motor protein dynein. Trituration of synthetic NLS peptide at the injury site of axotomized dorsal root ganglion (DRG) neurons delays their regenerative outgrowth, and NLS introduction to sciatic nerve concomitantly with a crush injury suppresses the conditioning lesion induced transition from arborizing to elongating growth in L4/L5 DRG neurons. These data suggest a model whereby lesion-induced upregulation of axonal importin beta may enable retrograde transport of signals that modulate the regeneration of injured neurons.	Weizmann Inst Sci, Mol Neurobiol Grp, Dept Biol Chem, IL-76100 Rehovot, Israel; Alfred I DuPont Hosp Children, Neurosci Res Labs, Nemours Biomed Res, Wilmington, DE 19899 USA; UCL, Inst Child Hlth, London WC1N 1EH, England; HELIOS Franz Volhard Clin, Max Delbrueck Ctr, Charite Med Fac, D-13122 Berlin, Germany; Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Mol & Cellular Neurobiol, NL-1081 HV Amsterdam, Netherlands	Weizmann Institute of Science; Nemours Alfred I. duPont Hospital for Children; University of London; University College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Vrije Universiteit Amsterdam	Fainzilber, M (corresponding author), Weizmann Inst Sci, Mol Neurobiol Grp, Dept Biol Chem, IL-76100 Rehovot, Israel.	mike.fainzilber@weizmann.ac.il	Koltzenburg, Martin/C-1349-2008	Koltzenburg, Martin/0000-0001-9181-5966; Fainzilber, Mike/0000-0001-8173-8557; Perlson, Eran/0000-0001-6047-9613	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041596] Funding Source: NIH RePORTER; NINDS NIH HHS [NS41596] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ambron RT, 1996, MOL NEUROBIOL, V13, P61, DOI 10.1007/BF02740752; Bassell GJ, 1998, J NEUROSCI, V18, P251; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Bronfman FC, 2003, J NEUROSCI, V23, P3209; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Caroni P, 1998, ESSAYS BIOCHEM, V33, P53, DOI 10.1042/bse0330053; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; DILLMAN JF, 1994, J CELL BIOL, V127, P1671, DOI 10.1083/jcb.127.6.1671; Geles KG, 2001, DEVELOPMENT, V128, P1817; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Giuditta A, 2002, TRENDS NEUROSCI, V25, P400, DOI 10.1016/S0166-2236(02)02188-4; Goldberg JL, 2003, GENE DEV, V17, P941, DOI 10.1101/gad.1062303; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Goslin K., 1998, CULTURING NERVE CELL, P339; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kamei Y, 1999, J HISTOCHEM CYTOCHEM, V47, P363, DOI 10.1177/002215549904700310; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kenney AM, 1998, J NEUROSCI, V18, P1318; Koenig E, 2000, J NEUROSCI, V20, P8390, DOI 10.1523/JNEUROSCI.20-22-08390.2000; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Kohler M, 1997, FEBS LETT, V417, P104, DOI 10.1016/S0014-5793(97)01265-9; Kumar JP, 2001, DEV BIOL, V240, P315, DOI 10.1006/dbio.2001.0468; Lam MHC, 2002, MOL ENDOCRINOL, V16, P390, DOI 10.1210/me.16.2.390; Mathe E, 2000, DEV BIOL, V223, P307, DOI 10.1006/dbio.2000.9743; Mavlyutov TA, 2002, TRAFFIC, V3, P630, DOI 10.1034/j.1600-0854.2002.30905.x; Nachury MV, 1998, P NATL ACAD SCI USA, V95, P582, DOI 10.1073/pnas.95.2.582; PERLSON E, 2003, IN PRESS J NEUROBIOL; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Schmied R, 1997, J NEUROBIOL, V33, P151, DOI 10.1002/(SICI)1097-4695(199708)33:2<151::AID-NEU4>3.0.CO;2-1; SCHMIED R, 1993, J NEUROSCI, V13, P4064; Smith DS, 1997, J NEUROSCI, V17, P646; Smith HMS, 1998, PLANT CELL, V10, P1791, DOI 10.1105/tpc.10.11.1791; Snider WD, 2002, NEURON, V35, P13, DOI 10.1016/S0896-6273(02)00762-6; Steward O, 2002, CELL, V110, P537, DOI 10.1016/S0092-8674(02)00934-0; Sung YJ, 2001, J NEUROBIOL, V47, P67, DOI 10.1002/neu.1016; Tcherpakov M, 2002, J BIOL CHEM, V277, P49101, DOI 10.1074/jbc.C200533200; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Wellmann H, 2001, J BIOL CHEM, V276, P11821, DOI 10.1074/jbc.M009253200; Zhang XP, 2000, J NEUROBIOL, V45, P84, DOI 10.1002/1097-4695(20001105)45:2<84::AID-NEU3>3.0.CO;2-4; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001	41	371	382	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 18	2003	40	6					1095	1104		10.1016/S0896-6273(03)00770-0	http://dx.doi.org/10.1016/S0896-6273(03)00770-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756UZ	14687545	Bronze			2022-12-24	WOS:000187503400009
J	Adelman, TL; Bialek, W; Olberg, RM				Adelman, TL; Bialek, W; Olberg, RM			The information content of receptive fields	NEURON			English	Article							INTERNEURONS; RESPONSES; NEURONS	The nervous system must observe a complex world and produce appropriate, sometimes complex, behavioral responses. In contrast to this complexity, neural responses are often characterized through very simple descriptions such as receptive fields or tuning curves. Do these characterizations adequately reflect the true dimensionality reduction that takes place in the nervous system, or are they merely convenient oversimplifications? Here we address this question for the target-selective descending neurons (TSDNs) of the dragonfly. Using extracellular multielectrode recordings of a population of TSDNs, we quantify the completeness of the receptive field description of these cells and conclude that the information in independent instantaneous position and velocity receptive fields accounts for 70%-90% of the total information in single spikes. Thus, we demonstrate that this simple receptive field model is close to a complete description of the features in the stimulus that evoke TSDN response.	Princeton Univ, Dept Biol Mol, Princeton, NJ 08544 USA; Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; Union Coll, Dept Sci Biol, Schenectady, NY 12308 USA	Princeton University; Princeton University; Union College	Adelman, TL (corresponding author), Princeton Univ, Dept Biol Mol, Princeton, NJ 08544 USA.	tadelman@princeton.edu						ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Arcas BAY, 2003, NEURAL COMPUT, V15, P1715, DOI 10.1162/08997660360675017; ARMSTRONGJAMES M, 1987, J COMP NEUROL, V263, P265, DOI 10.1002/cne.902630209; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; Brenner N, 2000, NEURAL COMPUT, V12, P1531, DOI 10.1162/089976600300015259; Buracas GT, 1999, TRENDS NEUROSCI, V22, P303, DOI 10.1016/S0166-2236(98)01376-9; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; FRYE MA, 1995, J COMP PHYSIOL A, V177, P569; Golomb D, 1997, NEURAL COMPUT, V9, P649, DOI 10.1162/neco.1997.9.3.649; Gordon AD, 1999, CLASSIFICATION; HARTLINE HK, 1958, J GEN PHYSIOL, V41, P1049, DOI 10.1085/jgp.41.5.1049; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; KOLTON L, 1995, J COMP PHYSIOL A, V176, P691, DOI 10.1007/BF01021589; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Olberg RM, 2000, J COMP PHYSIOL A, V186, P155, DOI 10.1007/s003590050015; OLBERG RM, 1986, J COMP PHYSIOL A, V159, P827, DOI 10.1007/BF00603736; Rieke F., 1997, SPIKES EXPLORING NEU; RODIECK R. W., 1965, VISION RES, V5, P583, DOI 10.1016/0042-6989(65)90033-7; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHARPEE T, 2003, IN PRESS ADV NEURAL, V15; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Theunissen FE, 2000, J NEUROSCI, V20, P2315; VANSTEVENINCK RD, 1988, PROC R SOC SER B-BIO, V234, P379	24	43	44	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 13	2003	40	4					823	833		10.1016/S0896-6273(03)00680-9	http://dx.doi.org/10.1016/S0896-6273(03)00680-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	744UL	14622585	Bronze			2022-12-24	WOS:000186651200016
J	Gan, WB; Kwon, E; Feng, GP; Sanes, JR; Lichtman, JW				Gan, WB; Kwon, E; Feng, GP; Sanes, JR; Lichtman, JW			Synaptic dynamism measured over minutes to months: age-dependent decline in an autonomic ganglion	NATURE NEUROSCIENCE			English	Article							LIVING MICE; NEUROMUSCULAR-JUNCTIONS; CRITICAL PERIODS; STRIATE CORTEX; VISUAL-CORTEX; ADULT CORTEX; PLASTICITY; NEURONS; EXPERIENCE; SYNAPSES	Naturally occurring rearrangements of synaptic terminals are common in the nervous systems of young mammals, but little is known about their incidence in adults. Using transgenic mice that express yellow fluorescent protein (YFP) in axons, we repeatedly imaged nerve terminals in the parasympathetic submandibular ganglion. We found that the pattern of synaptic branches underwent significant rearrangements over several weeks in young adult mice. In older mice, rearrangements were less common, and synaptic patterns on individual neurons were recognizable for many months to years. Axonal branches frequently retracted or extended on a time scale of minutes in young adult mice, but seldom in mature animals. These results provide direct evidence for a decrease in plasticity of interneuronal connections as animals make the transition from young adulthood to middle age. The long-term stability of synaptic patterns could provide a structural basis for the persistence of memory in the adult nervous system.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Lichtman, JW (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid,Box 8108, St Louis, MO 63110 USA.		Feng, Guoping/Y-2827-2019		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041846] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS41846-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALICEGORDON RJ, 1990, J NEUROSCI, V10, P894; BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; BertoniFreddari C, 1996, GERONTOLOGY, V42, P170; Bruses JL, 2000, CURR OPIN CELL BIOL, V12, P593, DOI 10.1016/S0955-0674(00)00137-X; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; Daw NW, 1998, ARCH OPHTHALMOL-CHIC, V116, P502, DOI 10.1001/archopht.116.4.502; DAWAKI L, 2003, ANN NEUROL, V53, P521; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Jones EG, 1998, SCIENCE, V282, P1121, DOI 10.1126/science.282.5391.1121; Jones TA, 1997, NEUROBIOL LEARN MEM, V68, P13, DOI 10.1006/nlme.1997.3774; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; LICHTMAN JW, 1977, J PHYSIOL-LONDON, V273, P155, DOI 10.1113/jphysiol.1977.sp012087; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; PURVES D, 1987, SCIENCE, V238, P1122, DOI 10.1126/science.3685967; PURVES D, 1986, J NEUROSCI, V6, P1051; PURVES D, 1987, J NEUROSCI, V7, P1492; PURVES D, 1985, NATURE, V315, P404, DOI 10.1038/315404a0; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Snider WD, 1996, MOL CELL NEUROSCI, V7, P433, DOI 10.1006/mcne.1996.0031; SNIDER WD, 1987, J NEUROSCI, V7, P1760; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001	34	55	56	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					956	960		10.1038/nn1115	http://dx.doi.org/10.1038/nn1115			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715KH	12925856				2022-12-24	WOS:000184970400014
J	Greka, A; Navarro, B; Oancea, E; Duggan, A; Clapham, DE				Greka, A; Navarro, B; Oancea, E; Duggan, A; Clapham, DE			TRPC5 is a regulator of hippocampal neurite length and growth cone morphology	NATURE NEUROSCIENCE			English	Article							CALCIUM TRANSIENTS; CATION CHANNEL; FUNCTIONAL-CHARACTERIZATION; NEURONAL DIFFERENTIATION; SYNAPTIC VESICLE; STATHMIN FAMILY; NERVOUS-SYSTEM; PROTEIN; CORTACTIN; RECEPTOR	Growth cone motility is regulated by both fast voltage-dependent Ca2+ channels and by unknown receptor-operated Ca2+ entry mechanisms. Transient receptor potential (TRP) homomeric TRPC5 ion channels are receptor-operated, Ca2+-permeable channels predominantly expressed in the brain. Here we show that TRPC5 is expressed in growth cones of young rat hippocampal neurons. Our results indicate that TRPC5 channel subunits interact with the growth cone-enriched protein stathmin 2, are packaged into vesicles and are carried to newly forming growth cones and synapses. Once in the growth cone, TRPC5 channels regulate neurite extension and growth-cone morphology. Dominant-negative TRPC5 expression allowed significantly longer neurites and filopodia to form. We conclude that TRPC5 channels are important components of the mechanism controlling neurite extension and growth cone morphology.	Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard MIT Div Hlth Sci & Technol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute	Clapham, DE (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Enders 1309,320 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Clapham, David/R-5974-2019; Clapham, David/S-1123-2019	Clapham, David/0000-0002-4459-9428				Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Antonsson B, 1997, PROTEIN EXPRES PURIF, V9, P363, DOI 10.1006/prep.1996.0710; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BIXBY JL, 1984, DEV BIOL, V106, P89, DOI 10.1016/0012-1606(84)90065-4; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Du YR, 1998, MOL CELL BIOL, V18, P5838, DOI 10.1128/MCB.18.10.5838; Gavet O, 1998, J CELL SCI, V111, P3333; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kuhn TB, 1998, J NEUROBIOL, V37, P524, DOI 10.1002/(SICI)1097-4695(199812)37:4<524::AID-NEU3>3.0.CO;2-H; Lorenz E, 1998, MOL CELL BIOL, V18, P1652, DOI 10.1128/MCB.18.3.1652; Lutjens R, 2000, EUR J NEUROSCI, V12, P2224, DOI 10.1046/j.1460-9568.2000.00112.x; Martin TFJ, 2002, NEURON, V34, P9, DOI 10.1016/S0896-6273(02)00651-7; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; Okada T, 1998, J BIOL CHEM, V273, P10279, DOI 10.1074/jbc.273.17.10279; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; Ozon S, 1998, J NEUROCHEM, V70, P2386; Ozon S, 1997, EUR J BIOCHEM, V248, P794, DOI 10.1111/j.1432-1033.1997.t01-2-00794.x; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Spitzer NC, 2000, BIOESSAYS, V22, P811; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Weed SA, 1998, J CELL SCI, V111, P2433	42	293	308	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					837	845		10.1038/nn1092	http://dx.doi.org/10.1038/nn1092			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12858178				2022-12-24	WOS:000184413700013
J	Kinouchi, R; Takeda, M; Yang, L; Wilhelmsson, U; Lundkvist, A; Pekny, M; Chen, DF				Kinouchi, R; Takeda, M; Yang, L; Wilhelmsson, U; Lundkvist, A; Pekny, M; Chen, DF			Robust neural integration from retinal transplants in mice deficient in GFAP and vimentin	NATURE NEUROSCIENCE			English	Article							FIBRILLARY ACIDIC PROTEIN; STEM-CELLS; PROGENITOR CELLS; INTERMEDIATE-FILAMENTS; NEURONAL SURVIVAL; NEURITE OUTGROWTH; SPINAL-CORD; ASTROCYTES; DIFFERENTIATION; DEVELOP	With recent progress in neuroscience and stem-cell research, neural transplantation has emerged as a promising therapy for treating CNS diseases. The success of transplantation has been limited, however, by the restricted ability of neural implants to survive and establish neuronal connections with the host. Little is known about the mechanisms responsible for this failure. Neural implantation triggers reactive gliosis, a process accompanied by upregulation of intermediate filaments in astrocytes and formation of astroglial scar tissue. Here we show that the retinas of adult mice deficient in glial fibrillary acidic protein and vimentin, and consequently lacking intermediate filaments in reactive astrocytes and Muller cells, provide a permissive environment for grafted neurons to migrate and extend neurites. The transplanted cells integrated robustly into the host retina with distinct neuronal identity and appropriate neuronal projections. Our results indicate an essential role for reactive astroglial cells in preventing neural graft integration after transplantation.	Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Ophthalmol, Program Neurosci, Boston, MA 02114 USA; Univ Gothenburg, Dept Med Biochem, SE-41390 Gothenburg, Sweden; Asahikawa Med Coll, Dept Ophthalmol, Asahikawa, Hokkaido 0788510, Japan	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School; University of Gothenburg; Asahikawa Medical College	Pekny, M (corresponding author), Harvard Univ, Sch Med, Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA.	Milos.Pekny@medkem.gu.se; dfchen@vision.eri.harvard.edu	Kinouchi, Reiko/R-6833-2019; Chen, Dong/AAJ-2444-2020	Chen, Dong/0000-0001-6283-8843; Wilhelmsson, Ulrika/0000-0003-3227-2687; kinouchi, reiko/0000-0003-1344-1641	NATIONAL EYE INSTITUTE [R01EY012983] Funding Source: NIH RePORTER; NEI NIH HHS [EY012983] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Barker RA, 1996, EXP NEUROL, V141, P79, DOI 10.1006/exnr.1996.0141; BARNSTABLE CJ, 1984, NEUROSCIENCE, V11, P847, DOI 10.1016/0306-4522(84)90195-7; Berson EL, 1999, OPHTHALMOLOGY, V106, P445, DOI 10.1016/S0161-6420(99)90134-3; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Dunnett SB, 1999, NEUROPATH APPL NEURO, V25, P351; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fournier AE, 2001, CURR OPIN NEUROBIOL, V11, P89, DOI 10.1016/S0959-4388(00)00178-1; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Ghosh F, 2002, GLIA, V40, P78, DOI 10.1002/glia.10121; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; GOURAS P, 1994, INVEST OPHTH VIS SCI, V35, P3145; Kurimoto Y, 2001, NEUROSCI LETT, V306, P57, DOI 10.1016/S0304-3940(01)01857-2; Lu B, 2002, BRAIN RES, V943, P292, DOI 10.1016/S0006-8993(02)02906-2; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Menet V, 2000, GLIA, V31, P267, DOI 10.1002/1098-1136(200009)31:3<267::AID-GLIA80>3.0.CO;2-N; Menet V, 2001, J NEUROSCI, V21, P6147; Nishida A, 2000, INVEST OPHTH VIS SCI, V41, P4268; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Pekny M, 1998, EXP CELL RES, V239, P332, DOI 10.1006/excr.1997.3922; Pekny M, 2001, Prog Brain Res, V132, P23; Qiu J, 2000, GLIA, V29, P166, DOI 10.1002/(SICI)1098-1136(20000115)29:2<166::AID-GLIA10>3.0.CO;2-G; SEILER M, 1988, DEV BRAIN RES, V43, P111, DOI 10.1016/0165-3806(88)90156-3; SMITHTHOMAS LC, 1994, J CELL SCI, V107, P1687; Studer L, 1998, NAT NEUROSCI, V1, P290, DOI 10.1038/1105; Svendsen CN, 2001, NAT REV NEUROSCI, V2, P831, DOI 10.1038/35097581; Takahashi M, 1998, MOL CELL NEUROSCI, V12, P340, DOI 10.1006/mcne.1998.0721; Van Hoffelen SJ, 2003, INVEST OPHTH VIS SCI, V44, P426, DOI 10.1167/iovs.02-0269; Wang X, 1997, EXP NEUROL, V148, P568, DOI 10.1006/exnr.1997.6702; Xu KX, 1999, GLIA, V25, P390, DOI 10.1002/(SICI)1098-1136(19990215)25:4<390::AID-GLIA8>3.0.CO;2-7; Young MJ, 2000, MOL CELL NEUROSCI, V16, P197, DOI 10.1006/mcne.2000.0869; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Zhang YQ, 2003, INVEST OPHTH VIS SCI, V44, P324, DOI 10.1167/iovs.02-0132	39	186	189	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					863	868		10.1038/nn1088	http://dx.doi.org/10.1038/nn1088			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12845328				2022-12-24	WOS:000184413700016
J	Freeman, MR; Delrow, J; Kim, J; Johnson, E; Doe, CQ				Freeman, MR; Delrow, J; Kim, J; Johnson, E; Doe, CQ			Unwrapping glial biology: Gcm target genes regulating glial development, diversification, and function	NEURON			English	Article							NERVOUS-SYSTEM LINEAGES; GENOME-WIDE ANALYSIS; DROSOPHILA-MELANOGASTER; CELL DIFFERENTIATION; APOPTOTIC CELLS; AXON GUIDANCE; RECEPTOR; PROTEIN; OLIGODENDROCYTE; ENGULFMENT	Glia are the most abundant cell type in the mammalian brain. They regulate neuronal development and function, CNS immune surveillance, and stem cell biology, yet we know surprisingly little about glia in any organism. Here we identify over 40 new Drosophila glial genes. We use glial cells missing (gcm) mutants and misexpression to verify they are Gcm regulated in vivo. Many genes show unique spatiotemporal responsiveness to Gcm in the CNS, and thus glial subtype diversification requires spatially or temporally restricted Gcm cofactors. These genes provide insights into glial biology: we show unc-5 (a repulsive netrin receptor) orients glial migrations and the draper gene mediates glial engulfment of apoptotic neurons and larval locomotion. Many identified Drosophila glial genes have homologs expressed in mammalian glia, revealing conserved molecular features of glial cells. 80% of these Drosophila glial genes have mammalian homologs; these are now excellent candidates for regulating human glial development, function, or disease.	Univ Oregon, Inst Neurosci & Mol Biol, Eugene, OR 97403 USA; Univ Oregon, Howard Hughes Med Inst, Eugene, OR 97403 USA; Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Oregon; Howard Hughes Medical Institute; University of Oregon; University of Oregon; Fred Hutchinson Cancer Center; University of Pennsylvania	Freeman, MR (corresponding author), Univ Oregon, Inst Neurosci & Mol Biol, Eugene, OR 97403 USA.	freeman@uoneuro.uoregon.edu		Freeman, Marc/0000-0003-3481-3715	NCI NIH HHS [P30 CA 15704-30] Funding Source: Medline; NICHD NIH HHS [HD 27056] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD027056] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027056] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alfonso TB, 2002, DEV BIOL, V248, P369, DOI 10.1006/dbio.2002.0740; AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; Barres BA, 1999, J CELL BIOL, V147, P1123, DOI 10.1083/jcb.147.6.1123; BASTIANI MJ, 1986, J NEUROSCI, V6, P3542; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Bernardoni R, 1997, DEV BIOL, V191, P118; Booth GE, 2000, DEVELOPMENT, V127, P237; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; Broadus J, 1998, NATURE, V391, P792, DOI 10.1038/35861; CAMPBELL G, 1994, DEVELOPMENT, V120, P2957; Carninci P, 1996, GENOMICS, V37, P327, DOI 10.1006/geno.1996.0567; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; Conradt B, 2001, DEV CELL, V1, P445, DOI 10.1016/S1534-5807(01)00065-X; EBENS AJ, 1993, CELL, V74, P15, DOI 10.1016/0092-8674(93)90291-W; Egger B, 2002, DEVELOPMENT, V129, P3295; Fazzio TG, 2001, MOL CELL BIOL, V21, P6450, DOI 10.1128/MCB.21.19.6450-6460.2001; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Furlong EEM, 2001, SCIENCE, V293, P1629, DOI 10.1126/science.1062660; GANDERATH S, 1999, DEVELOPMENT, V126, P1781; Giesen K, 1997, DEVELOPMENT, V124, P2307; Gilmour DT, 2002, NEURON, V34, P577, DOI 10.1016/S0896-6273(02)00683-9; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; ITO K, 1995, ROUX ARCH DEV BIOL, V204, P284, DOI 10.1007/BF02179499; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; Jones BW, 2001, BIOESSAYS, V23, P877, DOI 10.1002/bies.1129; Jones J, 2002, INT J ONCOL, V20, P697; Kammerer M, 2001, EMBO J, V20, P4664, DOI 10.1093/emboj/20.17.4664; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Kim JS, 1998, P NATL ACAD SCI USA, V95, P12364, DOI 10.1073/pnas.95.21.12364; KLAES A, 1994, CELL, V78, P149, DOI 10.1016/0092-8674(94)90581-9; KLAMBT C, 1993, DEVELOPMENT, V117, P163; Kopczynski CC, 1998, P NATL ACAD SCI USA, V95, P9973, DOI 10.1073/pnas.95.17.9973; LANE ME, 1993, GENE DEV, V7, P1229, DOI 10.1101/gad.7.7a.1229; Leiserson WM, 2000, NEURON, V28, P793, DOI 10.1016/S0896-6273(00)00154-9; Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199; Nagase T, 2001, DNA RES, V8, P85, DOI 10.1093/dnares/8.2.85; Naimi B, 2001, MOL BIOL CELL, V12, P1529, DOI 10.1091/mbc.12.5.1529; Noordermeer JN, 1998, NEURON, V21, P991, DOI 10.1016/S0896-6273(00)80618-2; Oland LA, 2003, ANNU REV ENTOMOL, V48, P89, DOI 10.1146/annurev.ento.48.091801.112654; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0; Rehorn KP, 1996, DEVELOPMENT, V122, P4023; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; Shishido E, 1997, DEVELOPMENT, V124, P2119; SONNENFELD MJ, 1995, J COMP NEUROL, V359, P644, DOI 10.1002/cne.903590410; SPANA EP, 1995, DEVELOPMENT, V121, P3489; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Su HP, 2002, J BIOL CHEM, V277, P11772, DOI 10.1074/jbc.M109336200; Sugimoto Y, 2001, DEVELOPMENT, V128, P3321; Vincent S, 1996, DEVELOPMENT, V122, P131; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wingerchuk DM, 2001, LAB INVEST, V81, P263, DOI 10.1038/labinvest.3780235; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; Yasothornsrikul S, 1997, GENE, V198, P17, DOI 10.1016/S0378-1119(97)00274-6; Yuan LL, 1999, SCIENCE, V283, P1343, DOI 10.1126/science.283.5406.1343; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	65	291	296	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 22	2003	38	4					567	580		10.1016/S0896-6273(03)00289-7	http://dx.doi.org/10.1016/S0896-6273(03)00289-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	682QV	12765609	Bronze			2022-12-24	WOS:000183104000008
J	Popescu, G; Auerbach, A				Popescu, G; Auerbach, A			Modal gating of NMDA receptors and the shape of their synaptic response	NATURE NEUROSCIENCE			English	Article							D-ASPARTATE RECEPTORS; BURST-KINETICS; TIME COURSE; XENOPUS-OOCYTES; ION CHANNELS; K+ CHANNEL; GLUTAMATE; ACETYLCHOLINE; CURRENTS; NEURONS	N-methyl-D-aspartate receptor (NMDAR) channels mediate the slow component of excitatory potentials at glutamatergic synapses. They have complex kinetic behavior, and much remains to be understood about NMDAR gating mechanisms and the molecular events that shape the synaptic current. Here we show that an individual NMDAR produces at least three stable patterns of activity. For all modes, channels gate by the same mechanism and can occupy either of two open states. The relative stability of the open states differs across modes because of a common perturbation to the NMDAR structure that may be subject to cellular control. Simulations indicate that native NMDAR-mediated synaptic responses arise mainly from the most common mode, and that the slow rise and decay of the current can be attributed to multiple transitions between fully liganded open and closed states rather than to agonist dissociation.	SUNY Buffalo, Ctr Single Mol Biophys, Sch Med & Biomed Sci, Buffalo, NY 14214 USA; SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Popescu, G (corresponding author), SUNY Buffalo, Ctr Single Mol Biophys, Sch Med & Biomed Sci, Buffalo, NY 14214 USA.		popescu, gabriela k/AAB-6155-2022	popescu, gabriela k/0000-0003-4658-2002	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA015164] Funding Source: NIH RePORTER; NIDA NIH HHS [F32 DA015164, DA015164] Funding Source: Medline; NINDS NIH HHS [NS036554] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; AUERBACH A, 1986, J PHYSIOL-LONDON, V378, P119, DOI 10.1113/jphysiol.1986.sp016211; Banke TG, 2003, NAT NEUROSCI, V6, P144, DOI 10.1038/nn1000; BEHE P, 1995, P ROY SOC B-BIOL SCI, V262, P205, DOI 10.1098/rspb.1995.0197; Catacuzzeno L, 1999, J MEMBRANE BIOL, V170, P165, DOI 10.1007/s002329900546; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; DELCOUR AH, 1993, J NEUROSCI, V13, P181; DELCOUR AH, 1993, SCIENCE, V259, P980, DOI 10.1126/science.8094902; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dreyer I, 2001, FEBS LETT, V505, P233, DOI 10.1016/S0014-5793(01)02832-0; FORSYTHE ID, 1988, J PHYSIOL-LONDON, V396, P515, DOI 10.1113/jphysiol.1988.sp016975; GIBB AJ, 1991, P ROY SOC B-BIOL SCI, V243, P39, DOI 10.1098/rspb.1991.0007; Grosman C, 2001, P NATL ACAD SCI USA, V98, P14102, DOI 10.1073/pnas.251402498; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; HOWE JR, 1991, J PHYSIOL-LONDON, V432, P143, DOI 10.1113/jphysiol.1991.sp018381; HOWE JR, 1992, J PHYSIOL-LONDON, V455, P529, DOI 10.1113/jphysiol.1992.sp019315; HOWE JR, 1988, PROC R SOC SER B-BIO, V233, P407, DOI 10.1098/rspb.1988.0030; Ivanova-Nikolova TT, 1998, J GEN PHYSIOL, V112, P199, DOI 10.1085/jgp.112.2.199; JAHR CE, 1990, J NEUROSCI, V10, P1830; JAHR CE, 1992, SCIENCE, V255, P470, DOI 10.1126/science.1346477; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; KLECKNER NW, 1995, J PHYSIOL-LONDON, V486, P411, DOI 10.1113/jphysiol.1995.sp020822; Leffler J. E., 1963, RATES EQUILIBRIA ORG; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LESTER RAJ, 1992, J NEUROSCI, V12, P635; MAGLEBY KL, 1983, J PHYSIOL-LONDON, V344, P605, DOI 10.1113/jphysiol.1983.sp014958; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; NARANJO D, 1993, SCIENCE, V260, P1811, DOI 10.1126/science.8511590; Premkumar LS, 1996, NEURON, V16, P869, DOI 10.1016/S0896-6273(00)80107-5; Premkumar LS, 1997, J GEN PHYSIOL, V110, P485, DOI 10.1085/jgp.110.5.485; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; SAKMANN B, 1980, NATURE, V286, P71, DOI 10.1038/286071a0; STERN P, 1994, J PHYSIOL-LONDON, V476, P391, DOI 10.1113/jphysiol.1994.sp020140; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Wyllie DJA, 1998, J PHYSIOL-LONDON, V510, P1, DOI 10.1111/j.1469-7793.1998.001bz.x; Yakubovich D, 2000, J PHYSIOL-LONDON, V524, P737, DOI 10.1111/j.1469-7793.2000.00737.x; Zhu YL, 2001, J GEN PHYSIOL, V117, P275, DOI 10.1085/jgp.117.3.275	44	137	139	1	13	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					476	483		10.1038/nn1044	http://dx.doi.org/10.1038/nn1044			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12679783				2022-12-24	WOS:000182553200014
J	Nakazawa, K; Sun, LD; Quirk, MC; Rondi-Reig, L; Wilson, MA; Tonegawa, S				Nakazawa, K; Sun, LD; Quirk, MC; Rondi-Reig, L; Wilson, MA; Tonegawa, S			Hippocampal CA3 NMDA receptors are crucial for memory acquisition of one-time experience	NEURON			English	Article							LONG-TERM POTENTIATION; EPISODIC-LIKE MEMORY; PLACE CELLS; SPATIAL MEMORY; NEURONS; IMPAIRMENT; SPACE; TASKS; PLASTICITY; ANIMALS	Lesion and pharmacological intervention studies have suggested that in both human patients and animals the hippocampus plays a crucial role in the rapid acquisition and storage of information from a novel one-time experience. However, how the hippocampus plays this role is poorly known. Here, we show that mice with NMDA receptor (NR) deletion restricted to CA3 pyramidal cells in adulthood are impaired in rapidly acquiring the memory of novel hidden platform locations in a delayed matching-to-place version of the Morris water maze task but are normal when tested with previously experienced platform locations. CA1 place cells in the mutant animals had place field sizes that were significantly larger in novel environments, but normal in familiar environments relative to those of control mice. These results suggest that CA3 NRs play a crucial role in rapid hippocampal encoding of novel information for fast learning of one-time experience.	MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA; MIT, RIKEN, Neurosci Res Ctr, Cambridge, MA 02139 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); RIKEN; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Tonegawa, S (corresponding author), MIT, Howard Hughes Med Inst, 77 Massachusetts AVe, Cambridge, MA 02139 USA.	tonegawa@mit.edu	Rondi-Reig, Laure/G-2816-2011; Nakazawa, Kazutoshi/J-6195-2015; Rondi-Reig, Laure/M-6141-2016	Nakazawa, Kazutoshi/0000-0001-5699-9093; Rondi-Reig, Laure/0000-0003-1006-0501	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032925] Funding Source: NIH RePORTER; NINDS NIH HHS [P50-NS32925, R01-NS32925] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARNES CA, 1990, PROG BRAIN RES, V83, P287; BERGER TW, 1991, LONG TERM POTENTIATI, P327; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Fyhn M, 2002, NEURON, V35, P555, DOI 10.1016/S0896-6273(02)00784-5; Garcia J, 1966, PSYCHON SCI, V4, P123, DOI [10.3758/BF03342209, DOI 10.3758/BF03342209]; Gray JA, 1982, NEUROPSYCHOLOGY ANXI, DOI 10.1002/9780470720394.ch2; Griffiths D, 1999, TRENDS COGN SCI, V3, P74, DOI 10.1016/S1364-6613(98)01272-8; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lee I, 2002, NAT NEUROSCI, V5, P162, DOI 10.1038/nn790; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; LOUIE K, 2002, THESIS MIT CAMBRIDGE; MACVICAR BA, 1980, BRAIN RES, V184, P220, DOI 10.1016/0006-8993(80)90602-2; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCNAUGHTON BL, 1989, EXP BRAIN RES, V76, P485, DOI 10.1007/BF00248904; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; MORRIS RG, 1983, NEUROBIOLOGY HIPPOCA; Morris RGM, 2001, PHILOS T R SOC B, V356, P1453, DOI 10.1098/rstb.2001.0945; Morris RGM, 1997, PHILOS T ROY SOC B, V352, P1489, DOI 10.1098/rstb.1997.0136; Moser EI, 2001, CURR OPIN NEUROBIOL, V11, P745, DOI 10.1016/S0959-4388(01)00279-3; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; NAKAZAWA K, 2003, IN PRESS NEUROBIOLOG; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; PANAKHOVA E, 1984, INT J PSYCHOPHYSIOL, V2, P5, DOI 10.1016/0167-8760(84)90066-7; Poucet B, 2000, REV NEUROSCIENCE, V11, P95; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Sokolov E.N., 1963, PERCEPTION CONDITION; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Sybirska E, 2000, J NEUROSCI, V20, P5827, DOI 10.1523/JNEUROSCI.20-15-05827.2000; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Tulving E., 1972, ORG MEMORY, DOI DOI 10.1017/S0140525X00047257; VINOGRADOVA OS, 1970, SHORT TERM CHANGES N, P95; WHISHAW IQ, 1985, PHYSIOL BEHAV, V35, P139, DOI 10.1016/0031-9384(85)90186-6; WILLIAMS S, 1988, SCIENCE, V242, P84, DOI 10.1126/science.2845578; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Xavier GF, 1999, HIPPOCAMPUS, V9, P668, DOI 10.1002/(SICI)1098-1063(1999)9:6<668::AID-HIPO8>3.0.CO;2-9; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950; [No title captured]	49	353	361	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 24	2003	38	2					305	315		10.1016/S0896-6273(03)00165-X	http://dx.doi.org/10.1016/S0896-6273(03)00165-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672AM	12718863	Bronze			2022-12-24	WOS:000182498300018
J	Yang, YF; Nishimura, I; Imai, Y; Takahashi, R; Lu, BW				Yang, YF; Nishimura, I; Imai, Y; Takahashi, R; Lu, BW			Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila	NEURON			English	Article							UBIQUITIN-PROTEIN LIGASE; ALPHA-SYNUCLEIN; LEWY BODIES; DISEASE; NEURODEGENERATION; EXPRESSION; MUTATION; TOXICITY; STRESS; MICE	Parkin, an E3 ubiquitin ligase that degrades proteins with aberrant conformations, is associated with autosomal recessive juvenile Parkinsonism (AR-JP). The molecular basis of selective neuronal death in AR-JP is unknown. Here we show in an organismal system that panneuronal expression of Parkin substrate Pael-R causes age-dependent selective degeneration of Drosophila dopaminergic (DA) neurons. Coexpression of Parkin degrades Pael-R and suppresses its toxicity, whereas interfering with endogenous Drosophila Parkin function promotes Pael-R accumulation and augments its toxicity. Furthermore, overexpression of Parkin can mitigate a.-Synuclein-induced neuritic pathology and suppress its toxicity. Our study implicates Parkin as a central player in the molecular pathway of Parkinson's disease (PD) and suggests that manipulating Parkin expression may provide a novel avenue of PD therapy.	Rockefeller Univ, Dev Neurobiol Lab, New York, NY 10021 USA; RIKEN, Brain Sci Inst, Lab Motor Syst Neurodegenerat, Wako, Saitama 3510198, Japan	Rockefeller University; RIKEN	Lu, BW (corresponding author), Rockefeller Univ, Dev Neurobiol Lab, 1230 York Ave, New York, NY 10021 USA.	lub@mail.rockefeller.edu	Imai, Yuzuru/AAA-6472-2019	Imai, Yuzuru/0000-0003-2924-5231; Lu, Bingwei/0000-0002-5807-7014				Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Baba M, 1998, AM J PATHOL, V152, P879; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Giasson BI, 2001, NEURON, V31, P885, DOI 10.1016/S0896-6273(01)00439-1; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HUFF R, 1989, DEV BIOL, V134, P146, DOI 10.1016/0012-1606(89)90085-7; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kubo S, 2001, J NEUROCHEM, V78, P42, DOI 10.1046/j.1471-4159.2001.00364.x; Lansbury PT, 2002, CURR OPIN GENET DEV, V12, P299, DOI 10.1016/S0959-437X(02)00302-7; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Mizuno Y, 1998, J NEUROCHEM, V71, P893; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Schlossmacher MG, 2002, AM J PATHOL, V160, P1655, DOI 10.1016/S0002-9440(10)61113-3; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Wolff T, 2000, DROSOPHILA PROTOCOLS, P229; Yasuyama K, 1996, J NEUROBIOL, V30, P205, DOI 10.1002/(SICI)1097-4695(199606)30:2<205::AID-NEU3>3.0.CO;2-9; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zhang Y, 2000, NEUROBIOL DIS, V7, P240, DOI 10.1006/nbdi.2000.0319; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	50	295	309	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 27	2003	37	6					911	924		10.1016/S0896-6273(03)00143-0	http://dx.doi.org/10.1016/S0896-6273(03)00143-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	661PU	12670421	Bronze			2022-12-24	WOS:000181899600006
J	Chase, DL; Pepper, JS; Koelle, MR				Chase, DL; Pepper, JS; Koelle, MR			Mechanism of extrasynaptic dopamine signaling in Caenorhabditis elegans	NATURE NEUROSCIENCE			English	Article							C-ELEGANS; NERVOUS-SYSTEM; LOCOMOTOR-ACTIVITY; SYNAPTIC-TRANSMISSION; ACETYLCHOLINE-RELEASE; MULTIPLE ASPECTS; RAT STRIATUM; RECEPTORS; PROTEIN; G(Q)ALPHA	D1-like and D2-like dopamine receptors have synergistic and antagonistic effects on behavior. To understand the mechanisms underlying these effects, we studied dopamine signaling genetically in Caenorhabditis elegans. Knocking out a D2-like receptor, DOP-3, caused locomotion defects similar to those observed in animals lacking dopamine. Knocking out a D1-like receptor, DOP-1, reversed the defects of the DOP-3 knockout. DOP-3 and DOP-1 have their antagonistic effects on locomotion by acting in the same motor neurons, which coexpress the receptors and which are not postsynaptic to dopaminergic neurons. In a screen for mutants unable to respond to dopamine, we identified four genes that encode components of the antagonistic Galpha(o) and Galpha(q) signaling pathways, including Galpha(o) itself and two subunits of the regulator of G protein signaling (RGS) complex that inhibits Galpha(q). Our results indicate that extrasynaptic dopamine regulates C. elegans locomotion through D1- and D2-like receptors that activate the antagonistic Galpha(q) and Galpha(o) signaling pathways, respectively.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Chase, DL (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	daniel.chase@yale.edu						Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; AVERY L, 1993, GENETICS, V133, P897; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; Caille I, 1996, BRAIN RES, V730, P17, DOI 10.1016/0006-8993(96)00424-6; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chase DL, 2001, CURR BIOL, V11, P222, DOI 10.1016/S0960-9822(01)00071-9; Corvol JC, 2001, J NEUROCHEM, V76, P1585, DOI 10.1046/j.1471-4159.2001.00201.x; Eastman C, 1999, J NEUROSCI, V19, P6225; GIRAULT JA, 1986, NEUROSCIENCE, V19, P1109, DOI 10.1016/0306-4522(86)90127-2; Gong W, 1999, NEUROSCIENCE, V93, P1349, DOI 10.1016/S0306-4522(99)00235-3; Gonon F, 1997, J NEUROSCI, V17, P5972; Hajdu-Cronin YM, 1999, GENE DEV, V13, P1780, DOI 10.1101/gad.13.14.1780; Hallam S, 2000, DEVELOPMENT, V127, P4239; Ikarashi Y, 1997, BRAIN RES BULL, V43, P107, DOI 10.1016/S0361-9230(96)00351-6; Jiang MS, 2001, P NATL ACAD SCI USA, V98, P3577, DOI 10.1073/pnas.051632598; Kelly MA, 1998, J NEUROSCI, V18, P3470; KIMURA K, 1995, J BIOL CHEM, V270, P14672, DOI 10.1074/jbc.270.24.14672; Knable MB, 1997, J PSYCHOPHARMACOL, V11, P123, DOI 10.1177/026988119701100205; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; LEWIS JA, 1980, NEUROSCIENCE, V5, P967, DOI 10.1016/0306-4522(80)90180-3; Lints R, 1999, DEVELOPMENT, V126, P5819; LIU YF, 1994, J BIOL CHEM, V269, P13880; LOCHRIE MA, 1991, CELL REGUL, V2, P135, DOI 10.1091/mbc.2.2.135; McNamara FN, 2003, NEUROPSYCHOPHARMACOL, V28, P86, DOI 10.1038/sj.npp.1300008; MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; Nass R, 2003, ANNU REV PHARMACOL, V43, P521, DOI 10.1146/annurev.pharmtox.43.100901.135934; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; PLAZNIK A, 1989, PSYCHOPHARMACOLOGY, V99, P558, DOI 10.1007/BF00589908; Robatzek M, 2000, GENETICS, V156, P1069; Robatzek M, 2001, CURR BIOL, V11, P288, DOI 10.1016/S0960-9822(01)00074-4; Sanyal S, 2004, EMBO J, V23, P473, DOI 10.1038/sj.emboj.7600057; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; SENOGLES SE, 1994, J BIOL CHEM, V269, P23120; Suo S, 2003, J NEUROCHEM, V86, P869, DOI 10.1046/j.1471-4159.2003.01896.x; Suo S, 2002, NEUROSCI LETT, V319, P13, DOI 10.1016/S0304-3940(01)02477-6; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; van der Linden AM, 2001, GENETICS, V158, P221; Wang HY, 1995, MOL PHARMACOL, V48, P988; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wintle RF, 2001, PARKINSONISM RELAT D, V7, P177, DOI 10.1016/S1353-8020(00)00055-9; YUNG KKL, 1995, NEUROSCIENCE, V65, P709, DOI 10.1016/0306-4522(94)00536-E; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	50	192	224	1	25	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1096	1103		10.1038/nn1316	http://dx.doi.org/10.1038/nn1316			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15378064				2022-12-24	WOS:000224156900019
J	Hanson, MG; Landmesser, LT				Hanson, MG; Landmesser, LT			Normal patterns of spontaneous activity are required for correct motor axon guidance and the expression of specific guidance molecules	NEURON			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; LATERAL GENICULATE-NUCLEUS; SPONTANEOUS RETINAL WAVES; LIM HOMEOBOX GENES; SPINAL-CORD; POLYSIALIC ACID; NEURONAL-ACTIVITY; ORIENTATION SELECTIVITY; GLYCINE TRANSPORTER; ACTION-POTENTIALS	Rhythmic spontaneous electrical activity occurs in many parts of the developing nervous system, where it plays essential roles in the refinement of neural connections. By blocking or slowing this bursting activity, via in ovo drug applications at precise developmental periods, we show that such activity is also required at much earlier stages for spinal motoneurons to accurately execute their first major dorsal-ventral pathfinding decision. Blockade or slowing of rhythmic bursting activity also prevents the normal expression patterns of EphA4 and polysialic acid on NCAM, which may contribute to the pathfinding errors observed. More prolonged (E2-5) blockade resulted in a downregulation of LIM homeodomain transcription factors, but since this occurred only after the pathfinding errors and alterations in guidance molecules, it cannot have contributed to them.	Case Western Reserve Univ, Dept Neurosci, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University	Landmesser, LT (corresponding author), Case Western Reserve Univ, Dept Neurosci, Sch Med, Cleveland, OH 44106 USA.	lynn.landmesser@cwru.edu			NINDS NIH HHS [NS19640, NS23678] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023678, R01NS019640] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bansal A, 2000, J NEUROSCI, V20, P7672; BEHAR TN, 1994, J NEUROSCI, V14, P29; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Chang KT, 2001, NEURON, V32, P855, DOI 10.1016/S0896-6273(01)00516-5; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; Chapman B, 2000, J NEUROSCI, V20, P1922; Chub N, 1998, J NEUROSCI, V18, P294; Crair MC, 1999, CURR OPIN NEUROBIOL, V9, P88, DOI 10.1016/S0959-4388(99)80011-7; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Eberhart J, 2002, DEV BIOL, V247, P89, DOI 10.1006/dbio.2002.0695; Eberhart J, 2000, DEV NEUROSCI-BASEL, V22, P237, DOI 10.1159/000017446; Erzurumlu RS, 2001, TRENDS NEUROSCI, V24, P589, DOI 10.1016/S0166-2236(00)01958-5; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Fueshko SM, 1998, J NEUROSCI, V18, P2560; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; Hanson MG, 2003, J NEUROSCI, V23, P587, DOI 10.1523/JNEUROSCI.23-02-00587.2003; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Itoh K, 1997, J NEUROBIOL, V33, P735, DOI 10.1002/(SICI)1097-4695(19971120)33:6<735::AID-NEU3>3.0.CO;2-A; ITOH K, 1995, SCIENCE, V270, P1369, DOI 10.1126/science.270.5240.1369; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; LANDMESSER LT, 1984, J PHYSIOL-LONDON, V347, P189, DOI 10.1113/jphysiol.1984.sp015061; Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3; LOPEZCORCUERA B, 1989, BIOCHIM BIOPHYS ACTA, V983, P247, DOI 10.1016/0005-2736(89)90240-X; MAFFEI L, 1990, P NATL ACAD SCI USA, V87, P2861, DOI 10.1073/pnas.87.7.2861; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Milner LD, 1999, J NEUROSCI, V19, P3007; MILNER LD, 1999, THESIS CASE W RESERV; Nishimaru H, 1996, J PHYSIOL-LONDON, V497, P131, DOI 10.1113/jphysiol.1996.sp021755; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sengpiel F, 2002, CURR BIOL, V12, pR818, DOI 10.1016/S0960-9822(02)01318-0; Sharma K, 2000, NATURE, V406, P515, DOI 10.1038/35020078; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; STOKER AW, 1995, DEVELOPMENT, V121, P1833; Stoker AW, 2001, CURR OPIN NEUROBIOL, V11, P95, DOI 10.1016/S0959-4388(00)00179-3; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; TANG JC, 1994, NEURON, V13, P405, DOI 10.1016/0896-6273(94)90356-5; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Watt SD, 2000, MOL CELL NEUROSCI, V16, P376, DOI 10.1006/mcne.2000.0871; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976	57	300	305	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 2	2004	43	5					687	701		10.1016/j.neuron.2004.08.018	http://dx.doi.org/10.1016/j.neuron.2004.08.018			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339650	Bronze			2022-12-24	WOS:000223691900014
J	Aguiar, PD; Sweadner, KJ; Penniston, JT; Zaremba, J; Liu, L; Caton, M; Linazasoro, G; Borg, M; Tijssen, MAJ; Bressman, SB; Dobyns, WB; Brashear, A; Ozelius, LJ				Aguiar, PD; Sweadner, KJ; Penniston, JT; Zaremba, J; Liu, L; Caton, M; Linazasoro, G; Borg, M; Tijssen, MAJ; Bressman, SB; Dobyns, WB; Brashear, A; Ozelius, LJ			Mutations in the Na+/K+-ATPase alpha 3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism	NEURON			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; SARCOPLASMIC-RETICULUM; SCANNING MUTAGENESIS; CALCIUM-PUMP; NA,K-ATPASE; SUBUNIT; DOMAIN; CA2+-ATPASE; RESOLUTION; SYSTEM	Rapid-onset dystonia-parkinsonism (RDP, DYT12) is a distinctive autosomal-dominant movement disorder with variable expressivity and reduced penetrance characterized by abrupt onset of dystonia, usually accompanied by signs of parkinsonism. The sudden onset of symptoms over hours to a few weeks, often associated with physical or emotional stress, suggests a trigger initiating a nervous system insult resulting in permanent neurologic disability. We report the finding of six missense mutations in the gene for the Na+/K+-ATPase alpha3 subunit (ATP1A3) in seven unrelated families with RDP. Functional studies and structural analysis of the protein suggest that these mutations impair enzyme activity or stability. This finding implicates the Na+/K+ pump, a crucial protein responsible for the electrochemical gradient across the cell membrane, in dystonia and parkinsonism.	Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; Univ Fed Sao Paulo, Dept Neurol & Neurosurg, Sao Paulo, Brazil; Massachusetts Gen Hosp, Ctr Neurosci, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Inst Psychiat & Neurol, Dept Genet, PL-02957 Warsaw, Poland; Clin Quiron, Ctr Neurol & Neurocirugia, San Sebastian 20012, Spain; CHU Nice, Neurol Serv, F-06002 Nice, France; Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1100 DD Amsterdam, Netherlands; Beth Israel Deaconess Med Ctr, Dept Neurol, New York, NY 10003 USA; Univ Chicago, Dept Human Genet Neurol & Pediat, Chicago, IL 60637 USA; Indiana Univ, Sch Med, Dept Neurol, Indianapolis, IN 46202 USA	Yeshiva University; Albert Einstein College of Medicine; Universidade Federal de Sao Paulo (UNIFESP); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Institute of Psychiatry & Neurology; CHU Nice; University of Amsterdam; Academic Medical Center Amsterdam; Harvard University; Beth Israel Deaconess Medical Center; University of Chicago; Indiana University System; Indiana University-Purdue University Indianapolis	Ozelius, LJ (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	ozelius@aecom.yu.edu	de Carvalho Aguiar, Patricia/B-2350-2013; Dobyns, William/AAI-2768-2020; de Carvalho Aguiar, Patricia/E-8520-2010; Dobyns, William Brian/ABC-6525-2021; Brashear, Allison/G-3853-2015	de Carvalho Aguiar, Patricia/0000-0003-2957-9573; Dobyns, William/0000-0002-7681-2844; de Carvalho Aguiar, Patricia/0000-0003-2957-9573; Zaremba, Jacek/0000-0002-9546-7767	NHLBI NIH HHS [HL36251] Funding Source: Medline; NIA NIH HHS [AG10133] Funding Source: Medline; NIGMS NIH HHS [GM28835] Funding Source: Medline; NINDS NIH HHS [NS26636] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010133] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aguiar PMD, 2002, LANCET NEUROL, V1, P316, DOI 10.1016/S1474-4422(02)00137-0; Arystarkhova E, 2002, AM J PHYSIOL-RENAL, V282, pF393, DOI 10.1152/ajprenal.00146.2001; Brashear A, 1998, Adv Neurol, V78, P335; Brashear A, 1997, NEUROLOGY, V48, P1066, DOI 10.1212/WNL.48.4.1066; Brashear A, 1999, MOVEMENT DISORD, V14, P132, DOI 10.1002/1531-8257(199901)14:1<132::AID-MDS1022>3.0.CO;2-J; Chen L, 1996, J BIOL CHEM, V271, P10745, DOI 10.1074/jbc.271.18.10745; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; DOBYNS WB, 1993, NEUROLOGY, V43, P2596, DOI 10.1212/WNL.43.12.2596; Grimes DA, 2002, NEUROLOGY, V59, P1183, DOI 10.1212/WNL.59.8.1183; Guennoun S, 2000, FEBS LETT, V482, P144, DOI 10.1016/S0014-5793(00)02050-0; Hakansson KO, 2003, J MOL BIOL, V332, P1175, DOI 10.1016/j.jmb.2003.07.012; Hilge M, 2003, NAT STRUCT BIOL, V10, P468, DOI 10.1038/nsb924; Ikeda K, 2003, J NEUROSCI, V23, P4667; Ivanov AV, 2002, BIOCHEM J, V364, P293, DOI 10.1042/bj3640293; KAMM C, 2004, IN PRESS MOV DISORD; Kockskamper J, 1997, BBA-BIOMEMBRANES, V1325, P197, DOI 10.1016/S0005-2736(96)00259-3; Kramer PL, 1999, ANN NEUROL, V46, P176, DOI 10.1002/1531-8249(199908)46:2<176::AID-ANA6>3.0.CO;2-2; Linazasoro G, 2002, MOVEMENT DISORD, V17, P608, DOI 10.1002/mds.10103; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; Moseley AE, 2003, J BIOL CHEM, V278, P5317, DOI 10.1074/jbc.M211315200; Nolte D, 2003, P NATL ACAD SCI USA, V100, P10347, DOI 10.1073/pnas.1831949100; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Palladino MJ, 2003, J NEUROSCI, V23, P1276, DOI 10.1523/JNEUROSCI.23-04-01276.2003; Pittock SJ, 2000, NEUROLOGY, V55, P991, DOI 10.1212/WNL.55.7.991; PRICE EM, 1990, J BIOL CHEM, V265, P6638; Rice WJ, 1996, J BIOL CHEM, V271, P31412, DOI 10.1074/jbc.271.49.31412; Sweadner KJ, 2001, BIOCHEM J, V356, P685, DOI 10.1042/0264-6021:3560685; TAKEYASU K, 1988, J BIOL CHEM, V263, P4347; Taniguchi K, 2001, J BIOCHEM, V129, P335, DOI 10.1093/oxfordjournals.jbchem.a002862; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Vanmolkot KRJ, 2003, ANN NEUROL, V54, P360, DOI 10.1002/ana.10674; ZAREMBA J, 2004, IN PRESS MOV DISORD	34	336	344	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 22	2004	43	2					169	175		10.1016/j.neuron.2004.06.028	http://dx.doi.org/10.1016/j.neuron.2004.06.028			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841BX	15260953	Bronze			2022-12-24	WOS:000222905400006
J	Stepanyants, A; Tamas, G; Chklovskii, DB				Stepanyants, A; Tamas, G; Chklovskii, DB			Class-specific features of neuronal wiring	NEURON			English	Article							CAT VISUAL-CORTEX; GABAERGIC SYNAPSES; QUANTITATIVE DISTRIBUTION; SYNAPTIC CONNECTIVITY; CORTICAL INTERNEURONS; INHIBITORY SYNAPSES; PYRAMIDAL NEURONS; DENDRITIC SPINES; CEREBRAL-CORTEX; GAP-JUNCTIONS	Brain function relies on specificity of synaptic connectivity patterns among different classes of neurons. Yet, the substrates of specificity in complex neuropil remain largely unknown. We search for imprints of specificity in the layout of axonal and dendritic arbors from the rat neocortex. An analysis of 3D reconstructions of pairs consisting of pyramidal cells (PCs) and GABAergic interneurons (GIs) revealed that the layout of GI axons is specific. This specificity is manifested in a relatively high tortuosity, small branch length of these axons, and correlations of their trajectories with the positions of postsynaptic neuron dendrites. Axons of PCs show no such specificity, usually taking a relatively straight course through neuropil. However, wiring patterns among PCs hold a large potential for circuit remodeling and specificity through growth and retraction of dendritic spines. Our results define distinct class-specific rules in establishing synaptic connectivity, which could be crucial in formulating a canonical cortical circuit.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Northeastern Univ, Dept Phys, Boston, MA 02115 USA; Northeastern Univ, Ctr Interdisciplinary Res Complex Syst, Boston, MA 02115 USA; Univ Szeged, Dept Comparat Physiol, H-6726 Szeged, Hungary	Cold Spring Harbor Laboratory; Northeastern University; Northeastern University; Szeged University	Chklovskii, DB (corresponding author), Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA.	mitya@cshl.edu	Tamas, Gabor/AAG-9305-2020	Tamas, Gabor/0000-0002-7905-6001	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K25NS047138] Funding Source: NIH RePORTER; NIMH NIH HHS [MH69838] Funding Source: Medline; NINDS NIH HHS [NS047138] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Anderson JC, 2002, J NEUROCYTOL, V31, P211, DOI 10.1023/A:1024113707630; BEAULIEU C, 1992, CEREB CORTEX, V2, P295, DOI 10.1093/cercor/2.4.295; BEAULIEU C, 1990, EUR J NEUROSCI, V2, P296, DOI 10.1111/j.1460-9568.1990.tb00421.x; Benavides-Piccione R, 2002, J NEUROCYTOL, V31, P337, DOI 10.1023/A:1024134312173; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Buhl EH, 1997, J PHYSIOL-LONDON, V500, P689, DOI 10.1113/jphysiol.1997.sp022053; CAJAL SRY, 1891, CELLULE, V7, P125; Callaway EM, 2002, CURR OPIN NEUROBIOL, V12, P587, DOI 10.1016/S0959-4388(02)00364-1; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DENO RL, 1949, CEREBRAL CORTEX ARCH; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; Fiala JC, 1998, J NEUROSCI, V18, P8900; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Hellwig B, 2000, BIOL CYBERN, V82, P111, DOI 10.1007/PL00007964; JACOBS G, 2002, STRUCTURAL BIOPHYSIC; Kalisman N, 2003, BIOL CYBERN, V88, P210, DOI 10.1007/s00422-002-0377-3; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; MILES R, 1990, J PHYSIOL-LONDON, V431, P659, DOI 10.1113/jphysiol.1990.sp018353; Nelson Sacha B., 2002, Neuron, V36, P19, DOI 10.1016/S0896-6273(02)00944-3; Peterlin ZA, 2000, P NATL ACAD SCI USA, V97, P3619, DOI 10.1073/pnas.97.7.3619; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Peters A., 1991, FINE STRUCTURE NERVO; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Silberberg G, 2002, TRENDS NEUROSCI, V25, P227, DOI 10.1016/S0166-2236(02)02151-3; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; SOMOGYI P, 1977, BRAIN RES, V136, P345, DOI 10.1016/0006-8993(77)90808-3; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; SPACEK J, 1983, ANAT EMBRYOL, V167, P289, DOI 10.1007/BF00298517; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Stepanyants A, 2002, NEUROCOMPUTING, V44, P661, DOI 10.1016/S0925-2312(02)00454-X; Szabadics J, 2001, J NEUROSCI, V21, P5824, DOI 10.1523/JNEUROSCI.21-15-05824.2001; SZENTAGOTHAI J, 1990, Acta Morphologica Hungarica, V38, P159; Szentagothai J, 1974, Neurosci Res Program Bull, V12, P305; Szentagothai J, 1978, ARCHITECTONICS CEREB, P77; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Tamas G, 1998, J NEUROSCI, V18, P4255; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thomassen L, 2002, CONTEMP SOCIOL, V31, P239, DOI 10.2307/3089548; Thomson AM, 1999, J PHYSIOL-LONDON, V519, P57, DOI 10.1111/j.1469-7793.1999.0057o.x; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Wang Y, 2002, CEREB CORTEX, V12, P395, DOI 10.1093/cercor/12.4.395	54	94	96	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 22	2004	43	2					251	259		10.1016/j.neuron.2004.06.013	http://dx.doi.org/10.1016/j.neuron.2004.06.013			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841BX	15260960	Bronze			2022-12-24	WOS:000222905400013
J	Rosoff, WJ; Urbach, JS; Esrick, MA; McAllister, RG; Richards, LJ; Goodhill, GJ				Rosoff, WJ; Urbach, JS; Esrick, MA; McAllister, RG; Richards, LJ; Goodhill, GJ			A new chemotaxis assay shows the extreme sensitivity of axons to molecular gradients	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; GUIDANCE MOLECULES; CONE; CHEMOATTRACTANT; RECEPTORS; ORIENT; FIBRIN; TRK	Axonal chemotaxis is believed to be important in wiring up the developing and regenerating nervous system, but little is known about how axons actually respond to molecular gradients. We report a new quantitative assay that allows the long-term response of axons to gradients of known and controllable shape to be examined in a three-dimensional gel. Using this assay, we show that axons may be nature's most-sensitive gradient detectors, but this sensitivity exists only within a narrow range of ligand concentrations. This assay should also be applicable to other biological processes that are controlled by molecular gradients, such as cell migration and morphogenesis.	Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; Georgetown Univ, Dept Phys, Washington, DC 20057 USA; Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA	Georgetown University; Georgetown University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Goodhill, GJ (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA.	geoff@georgetown.edu	Goodhill, Geoffrey J/D-9984-2013; Richards AO, Linda/P-6372-2014	Richards AO, Linda/0000-0002-7590-7390; Urbach, Jeffrey/0000-0002-1593-520X; Goodhill, Geoffrey/0000-0001-9789-9355				Bagnard D, 2000, J NEUROSCI, V20, P1030, DOI 10.1523/JNEUROSCI.20-03-01030.2000; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; Cao X, 2001, NEUROSCIENCE, V103, P831, DOI 10.1016/S0306-4522(01)00029-X; Caton A, 2000, DEVELOPMENT, V127, P1751; Conti AM, 1997, ANN NEUROL, V42, P838, DOI 10.1002/ana.410420604; Crank J., 1975, MATH DIFFUSION; Dertinger SKW, 2002, P NATL ACAD SCI USA, V99, P12542, DOI 10.1073/pnas.192457199; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Esposito D, 2001, J BIOL CHEM, V276, P32687, DOI 10.1074/jbc.M011674200; Firtel RA, 2000, BIOESSAYS, V22, P603, DOI 10.1002/1521-1878(200007)22:7<603::AID-BIES3>3.0.CO;2-#; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Gallo G, 1997, J NEUROSCI, V17, P5445; Goodhill GJ, 1998, TRENDS NEUROSCI, V21, P226, DOI 10.1016/S0166-2236(97)01203-4; Goodhill GJ, 1999, J NEUROBIOL, V41, P230, DOI 10.1002/(SICI)1097-4695(19991105)41:2<230::AID-NEU6>3.0.CO;2-9; GUNDERSEN RW, 1979, SCIENCE, V206, P1079, DOI 10.1126/science.493992; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Knapp DM, 1999, EXP CELL RES, V247, P543, DOI 10.1006/excr.1998.4364; LETOURNEAU PC, 1978, DEV BIOL, V66, P183, DOI 10.1016/0012-1606(78)90283-X; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; MOGHE PV, 1995, J IMMUNOL METHODS, V180, P193, DOI 10.1016/0022-1759(94)00314-M; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Paves H, 1997, CELL TISSUE RES, V290, P285, DOI 10.1007/s004410050933; Phillips HS, 1996, PHILOS T ROY SOC B, V351, P413, DOI 10.1098/rstb.1996.0036; Rosentreter SM, 1998, J NEUROBIOL, V37, P541, DOI 10.1002/(SICI)1097-4695(199812)37:4<541::AID-NEU4>3.3.CO;2-C; Soeda H, 2002, NEUROSCI LETT, V325, P5, DOI 10.1016/S0304-3940(02)00215-X; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; TESSIERLAVIGNE M, 1991, TRENDS NEUROSCI, V14, P303, DOI 10.1016/0166-2236(91)90142-H; TRANQUILLO RT, 1990, BIOL MOTION, P415; Weaver CM, 2003, J NEUROSCI METH, V124, P197, DOI 10.1016/S0165-0270(03)00017-7; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	32	200	208	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					678	682		10.1038/nn1259	http://dx.doi.org/10.1038/nn1259			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15162167				2022-12-24	WOS:000221640300024
J	John, J; Wu, MF; Boehmer, LN; Siegel, JM				John, J; Wu, MF; Boehmer, LN; Siegel, JM			Cataplexy-active neurons in the hypothalamus: Implications for the role of histamine in sleep and waking behavior	NEURON			English	Article							LOCUS-COERULEUS NEURONS; IN-VIVO MICRODIALYSIS; VENTROLATERAL PREOPTIC NUCLEUS; MUSCLE TONE SUPPRESSION; AMINO-ACID RELEASE; RAT HYPOTHALAMUS; HUMAN NARCOLEPSY; HYPOCRETIN NEURONS; OREXIN-2 RECEPTOR; REM-SLEEP	Noradrenergic, serotonergic, and histaminergic neurons are continuously active during waking, reduce discharge during NREM sleep, and cease discharge during REM sleep. Cataplexy, a symptom associated with narcolepsy, is a waking state in which muscle tone is lost, as it is in REM sleep, while environmental awareness continues, as in alert waking. In prior work, we reported that, during cataplexy, noradrenergic neurons cease discharge, and serotonergic neurons greatly reduce activity. We now report that, in contrast to these other monoaminergic "REM-off" cell groups, histamine neurons are active in cataplexy at a level similar to or greater than that in quiet waking. We hypothesize that the activity of histamine cells is linked to the maintenance of waking, in contrast to activity in noradrenergic and serotonergic neurons, which is more tightly coupled to the maintenance of muscle tone in waking and its loss in REM sleep and cataplexy.	Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; Vet Adm Greater Los Angeles, Neurobiol Res 151A3, Healthcare Syst, Sepulveda, CA 91343 USA; Univ Calif Los Angeles, Inst Brain Res, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles	Siegel, JM (corresponding author), Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA.	jsiegel@ucla.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041370, R37HL041370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS014610, R01NS014610] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL041370, HL41370, R37 HL041370] Funding Source: Medline; NIMH NIH HHS [R01 MH064109, MH64109] Funding Source: Medline; NINDS NIH HHS [R37 NS014610, R01 NS014610, NS14610] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aldrich MS, 1998, NEUROLOGY, V50, pS2, DOI 10.1212/WNL.50.2_Suppl_1.S2; ANDRE P, 1992, PFLUG ARCH EUR J PHY, V420, P376, DOI 10.1007/BF00374473; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; ASTONJONES G, 1981, J NEUROSCI, V1, P876; BAUST W, 1972, PFLUG ARCH EUR J PHY, V331, P113, DOI 10.1007/BF00587254; Bayer L, 2001, EUR J NEUROSCI, V14, P1571, DOI 10.1046/j.0953-816x.2001.01777.x; Bender BG, 2003, J ALLERGY CLIN IMMUN, V111, P770, DOI 10.1067/mai.2003.1408; BOEHMER LN, 2004, IN PRESS EXPT NEUROL; Bourgin P, 2000, J NEUROSCI, V20, P7760; Chase M. H., 2000, PRINCIPLES PRACTICE, P155; Chou TC, 2002, J NEUROSCI, V22, P977, DOI 10.1523/JNEUROSCI.22-03-00977.2002; D'Ascanio P., 1988, PROG BRAIN RES, P361; Eggermann E, 2001, NEUROSCIENCE, V108, P177, DOI 10.1016/S0306-4522(01)00512-7; Eriksson KS, 2001, J NEUROSCI, V21, P9273, DOI 10.1523/JNEUROSCI.21-23-09273.2001; GUILLEMINAULT C, 1976, NARCOLEPSY, P125; Guilleminault C, 2000, PRINCIPLES PRACTICE, P676; Gulyani S, 2002, NEUROSCIENCE, V112, P355, DOI 10.1016/S0306-4522(02)00089-1; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; Horvath TL, 1999, J COMP NEUROL, V415, P145; Huang ZL, 2001, P NATL ACAD SCI USA, V98, P9965, DOI 10.1073/pnas.181330998; Ishizuka T, 2002, NEUROSCI LETT, V323, P93, DOI 10.1016/S0304-3940(01)02552-6; Ivanov A, 2000, NEUROREPORT, V11, P1755, DOI 10.1097/00001756-200006050-00031; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; John J, 2003, J PHYSIOL-LONDON, V548, P557, DOI 10.1113/jphysiol.2002.038729; John J, 2000, Sleep Res Online, V3, P23; Kisanuki YY, 2001, SLEEP, V24, pA22; Kodama T, 2003, J NEUROSCI, V23, P1548, DOI 10.1523/JNEUROSCI.23-04-01548.2003; Kohyama J, 1998, SLEEP, V21, P695, DOI 10.1093/sleep/21.7.695; KUSHIDA CA, 1985, ELECTROEN CLIN NEURO, V61, P61, DOI 10.1016/0013-4694(85)91073-9; LAI YY, 1991, J NEUROSCI, V11, P2931; Lai YY, 2001, J NEUROSCI, V21, P7384, DOI 10.1523/JNEUROSCI.21-18-07384.2001; LANTOS TA, 1995, BRAIN RES REV, V20, P209, DOI 10.1016/0165-0173(94)00013-F; Li Y, 2002, NEURON, V36, P1169, DOI 10.1016/S0896-6273(02)01132-7; LIM RKS, 1960, STEROTAXIC ATALS DOG; LIN JS, 1994, EUR J NEUROSCI, V6, P618, DOI 10.1111/j.1460-9568.1994.tb00306.x; LIN JS, 1988, NEUROPHARMACOLOGY, V27, P111, DOI 10.1016/0028-3908(88)90159-1; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Mileykovskiy BY, 2000, J NEUROSCI, V20, P8551, DOI 10.1523/JNEUROSCI.20-22-08551.2000; NISHINO S, 1993, SLEEP, V16, P706, DOI 10.1093/sleep/16.8.706; Nishino S, 2001, NEUROSCI LETT, V313, P125, DOI 10.1016/S0304-3940(01)02270-4; Nishino SS, 2002, SLEEP, V25, pA476; Nitz D, 1996, AM J PHYSIOL-REG I, V271, pR1707, DOI 10.1152/ajpregu.1996.271.6.R1707; PANULA P, 1984, P NATL ACAD SCI-BIOL, V81, P2572, DOI 10.1073/pnas.81.8.2572; PANULA P, 1990, NEUROSCIENCE, V34, P127, DOI 10.1016/0306-4522(90)90307-P; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; PROSPEROGARCIA O, 1993, NEUROSCI LETT, V156, P158, DOI 10.1016/0304-3940(93)90462-T; REINER PB, 1987, NEUROSCI LETT, V73, P43, DOI 10.1016/0304-3940(87)90028-0; SAKAI K, 1990, DIENCEPHALON AND SLEEP, P171; Salin-Pascual R, 2001, NEUROPSYCHOPHARMACOL, V25, pS21, DOI 10.1016/S0893-133X(01)00318-9; Sherin JE, 1998, J NEUROSCI, V18, P4705; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; SIEGEL JM, 1983, BRAIN RES, V268, P344, DOI 10.1016/0006-8993(83)90501-2; SIEGEL JM, 1991, SCIENCE, V252, P1315, DOI 10.1126/science.1925546; SIEGEL JM, 1992, J NEUROSCI, V12, P1640; SIEGEL JM, 1983, J NEUROPHYSIOL, V50, P696, DOI 10.1152/jn.1983.50.3.696; Siegel JM, 1999, CELL, V98, P409, DOI 10.1016/S0092-8674(00)81969-8; SIEGEL JM, 2000, PRINCIPLES PRACTICE, P112; Steininger TL, 1999, BRAIN RES, V840, P138, DOI 10.1016/S0006-8993(99)01648-0; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Strecker RE, 2002, NEUROSCIENCE, V113, P663, DOI 10.1016/S0306-4522(02)00158-6; Thannickal T.C., 2000, SLEEP, V23, pA296; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Thannickal TC, 2003, BRAIN PATHOL, V13, P340; UTESHEV V, 1995, NEUROSCIENCE, V66, P143, DOI 10.1016/0306-4522(94)00593-T; van den Pol AN, 2002, J PHYSIOL-LONDON, V541, P169, DOI 10.1113/jphysiol.2002.017426; Vanni-Mercier G, 2003, BEHAV BRAIN RES, V144, P227, DOI 10.1016/S0166-4328(03)00091-3; WATANABE T, 1984, BRAIN RES, V295, P13, DOI 10.1016/0006-8993(84)90811-4; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Wu MF, 1999, NEUROSCIENCE, V91, P1389, DOI 10.1016/S0306-4522(98)00600-9; Wu MF, 2004, J PHYSIOL-LONDON, V554, P202, DOI 10.1113/jphysiol.2003.052134; Yamanaka A, 2002, BIOCHEM BIOPH RES CO, V290, P1237, DOI 10.1006/bbrc.2001.6318	71	139	145	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 27	2004	42	4					619	634		10.1016/S0896-6273(04)00247-8	http://dx.doi.org/10.1016/S0896-6273(04)00247-8			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157423	Green Accepted, Bronze			2022-12-24	WOS:000221708300012
J	Liu, GS				Liu, GS			Local structural balance and functional interaction of excitatory and inhibitory synapses in hippocampal dendrites	NATURE NEUROSCIENCE			English	Article							VISUAL-CORTEX; QUANTITATIVE DISTRIBUTION; DIRECTION SELECTIVITY; SYNAPTIC PLASTICITY; GABAERGIC SYNAPSES; ACTIVE DENDRITES; PYRAMIDAL CELLS; IN-VIVO; NEURONS; TRANSMISSION	Theoretical and experimental studies on the computation of neural networks suggest that neural computation results from a dynamic interplay of excitatory and inhibitory(E/I) synaptic inputs. Precisely how E/I synapses are organized structurally and functionally to facilitate meaningful interaction remains elusive. Here we show that E/I synapses are regulated across dendritic trees to maintain a constant ratio of inputs in cultured rat hippocampal neurons. This structural arrangement is accompanied by an E/I functional balance maintained by a 'push-pull' feedback regulatory mechanism that is capable of adjusting E/I efficacies in a coordinated fashion. We also found that during activity, inhibitory synapses can determine the impact of adjacent excitatory synapses only if they are colocalized on the same dendritic branch and are activated simultaneously. These fundamental relationships among E/I synapses provide organizational principles relevant to deciphering the structural and functional basis for neural computation within dendritic branches.	MIT, Picower Ctr Learning & Memory, RIKEN,MIT Neurosci Res Ctr, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Picower Ctr Learning & Memory, RIKEN,MIT Neurosci Res Ctr, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); RIKEN; Massachusetts Institute of Technology (MIT); RIKEN	Liu, GS (corresponding author), MIT, Picower Ctr Learning & Memory, RIKEN,MIT Neurosci Res Ctr, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	liu@mit.edu	babakinejad, babak/G-2674-2012					Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; BEAULIEU C, 1992, CEREB CORTEX, V2, P295, DOI 10.1093/cercor/2.4.295; BEAULIEU C, 1990, EUR J NEUROSCI, V2, P296, DOI 10.1111/j.1460-9568.1990.tb00421.x; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; BUSH PC, 1994, J NEUROPHYSIOL, V71, P2183, DOI 10.1152/jn.1994.71.6.2183; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Davis GW, 1998, CURR OPIN NEUROBIOL, V8, P149, DOI 10.1016/S0959-4388(98)80018-4; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gabbiani F, 2002, NATURE, V420, P320, DOI 10.1038/nature01190; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; LARKMAN AU, 1991, J COMP NEUROL, V306, P332, DOI 10.1002/cne.903060209; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Morales B, 2002, J NEUROSCI, V22, P8084; Murnick JG, 2002, J NEUROSCI METH, V116, P65, DOI 10.1016/S0165-0270(02)00028-6; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; RUMSEY CC, 2003, J NEUROPHYSIOL; SCHULTE F J, 1969, Neuropaediatrie, V1, P36, DOI 10.1055/s-0028-1091862; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Taylor WR, 2000, SCIENCE, V289, P2347, DOI 10.1126/science.289.5488.2347; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796	40	219	224	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					373	379		10.1038/nn1206	http://dx.doi.org/10.1038/nn1206			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15004561				2022-12-24	WOS:000220482500016
J	Badre, D; Wagner, AD				Badre, D; Wagner, AD			Selection, integration, and conflict monitoring: Assessing the nature and generality of prefrontal cognitive control mechanisms	NEURON			English	Article							ANTERIOR CINGULATE CORTEX; RESPONSE CONFLICT; FRONTOPOLAR CORTEX; EXECUTIVE CONTROL; FMRI EVIDENCE; MEMORY; RETRIEVAL; TASK; INTERFERENCE; ACTIVATION	Prefrontal cortex (PFC) supports flexible behavior by mediating cognitive control, though the elemental forms of control supported by PFC remain a central debate. Dorsolateral PFC (DLPFC) is thought to guide response selection under conditions of response conflict or, alternatively, may refresh recently active representations within working memory. Lateral frontopolar cortex (FPC) may also adjudicate response conflict, though others propose that FPC supports higher order control processes such as subgoaling and integration. Anterior cingulate cortex (ACC) is hypothesized to upregulate response selection by detecting response conflict; it remains unclear whether ACC functions generalize beyond monitoring response conflict. The present fMRI experiment directly tested these competing theories regarding the functional roles of DLPFC, FPC, and ACC. Results reveal dissociable control processes in PFC, with mid-DLPFC selectively mediating resolution of response conflict and FPC further mediating subgoaling/integration. ACC demonstrated a broad sensitivity to control demands, suggesting a generalized role in modulating cognitive control.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Stanford Univ, Program Neurosci, Stanford, CA 94305 USA	Massachusetts Institute of Technology (MIT); Stanford University; Stanford University	Badre, D (corresponding author), MIT, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	badred@mit.edu		Wagner, Anthony/0000-0003-0624-4543				Ardekani BA, 2002, COGNITIVE BRAIN RES, V14, P347, DOI 10.1016/S0926-6410(02)00137-4; Banich MT, 2000, J COGNITIVE NEUROSCI, V12, P988, DOI 10.1162/08989290051137521; Barch DM, 2001, CEREB CORTEX, V11, P837, DOI 10.1093/cercor/11.9.837; Barch DM, 2000, J COGNITIVE NEUROSCI, V12, P298, DOI 10.1162/089892900562110; Barch DM, 1999, NEUROIMAGE, V10, P642, DOI 10.1006/nimg.1999.0500; BENCH CJ, 1993, NEUROPSYCHOLOGIA, V31, P907, DOI 10.1016/0028-3932(93)90147-R; Berns GS, 1997, SCIENCE, V276, P1272, DOI 10.1126/science.276.5316.1272; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; BUCKNER RL, 1995, J NEUROSCI, V15, P12; Bunge SA, 2002, NEUROIMAGE, V17, P1562, DOI 10.1006/nimg.2002.1252; BUNGE SA, 2004, IN PRESS BRAIN COGN; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 1995, NEUROIMAGE, V2, P264, DOI 10.1006/nimg.1995.1034; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Christoff K, 2001, NEUROIMAGE, V14, P1136, DOI 10.1006/nimg.2001.0922; Cocosco C. A., 1997, NEUROIMAGE, V5, P425; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; DALE W, 1999, PROSTATE J, V1, P179, DOI DOI 10.1046/J.1525-1411.1999.14005.X; Dehaene S, 1995, ANN NY ACAD SCI, V769, P305, DOI 10.1111/j.1749-6632.1995.tb38147.x; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dobbins IG, 2002, NEURON, V35, P989, DOI 10.1016/S0896-6273(02)00858-9; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gehring WJ, 2002, COGNITIVE BRAIN RES, V13, P267, DOI 10.1016/S0926-6410(01)00132-X; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Horn H, 2003, EUR ARCH PSY CLIN N, V253, P154, DOI 10.1007/s00406-003-0419-4; Huettel SA, 2002, NAT NEUROSCI, V5, P485, DOI 10.1038/nn841; Johnson MK, 2002, PSYCHOL SCI, V13, P64, DOI 10.1111/1467-9280.00411; Johnson MK, 2003, CEREB CORTEX, V13, P265, DOI 10.1093/cercor/13.3.265; Jonides J, 2002, PRINCIPLES FRONTAL L, P233, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0015; Kiehl KA, 2003, HUM BRAIN MAPP, V18, P42, DOI 10.1002/hbm.10074; Kirino E, 2000, J NEUROSCI, V20, P6612, DOI 10.1523/JNEUROSCI.20-17-06612.2000; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; KORNBLUM S, 1994, PSYCHOL RES-PSYCH FO, V56, P130, DOI 10.1007/BF00419699; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; McCarthy G, 1997, J NEUROPHYSIOL, V77, P1630, DOI 10.1152/jn.1997.77.3.1630; Michelon P, 2003, NEUROIMAGE, V19, P1612, DOI 10.1016/S1053-8119(03)00111-3; Milham MP, 2001, COGNITIVE BRAIN RES, V12, P467, DOI 10.1016/S0926-6410(01)00076-3; Milham MP, 2002, BRAIN COGNITION, V49, P277, DOI 10.1006/brcg.2001.1501; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; Passingham R.E., 2002, PRINCIPLES FRONTAL L, P221; PAUS T, 1993, J NEUROPHYSIOL, V70, P453, DOI 10.1152/jn.1993.70.2.453; Petrides M, 2000, J NEUROSCI, V20, P7496; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Raye CL, 2002, NEUROIMAGE, V15, P447, DOI 10.1006/nimg.2001.0983; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Rugg MD, 1996, BRAIN, V119, P2073, DOI 10.1093/brain/119.6.2073; Rugg MD, 2000, TRENDS COGN SCI, V4, P108, DOI 10.1016/S1364-6613(00)01445-5; SHALLICE T, 1991, FRONTAL LOBE FUNCTIO, P92; Shimamura AP., 2002, PRINCIPLES FRONTAL L, P210, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0013; Shimamura Arthur P., 1995, P803; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; Stephan KE, 2003, SCIENCE, V301, P384, DOI 10.1126/science.1086025; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; STUSS DT, 1987, FRONTAL LOBES REVIS; Talairach I., 1988, COPLANAR STEREOTACTI; Taylor SF, 1997, NEUROIMAGE, V6, P81, DOI 10.1006/nimg.1997.0285; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936; Wagner AD, 1998, BRAIN, V121, P1985, DOI 10.1093/brain/121.10.1985; Wagner AD, 1999, NEURON, V22, P19, DOI 10.1016/S0896-6273(00)80674-1	70	323	337	3	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 5	2004	41	3					473	487		10.1016/S0896-6273(03)00851-1	http://dx.doi.org/10.1016/S0896-6273(03)00851-1			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KA	14766185	Bronze			2022-12-24	WOS:000221457900017
J	Quinlan, EM; Lebel, D; Brosh, I; Barkai, E				Quinlan, EM; Lebel, D; Brosh, I; Barkai, E			A molecular mechanism for stabilization of learning-induced synaptic modifications	NEURON			English	Article							LONG-TERM POTENTIATION; ASPARTATE RECEPTOR ANTAGONIST; ASSOCIATIVE MEMORY FUNCTION; HETEROMERIC NMDA RECEPTORS; PYRAMIDAL NEURONS; PIRIFORM CORTEX; VISUAL-CORTEX; SELECTIVE IMPAIRMENT; DEPENDENT REGULATION; GLUTAMATE RECEPTORS	Olfaction is a principal sensory modality in rodents, and rats quickly learn to discriminate between odors and to associate odor with reward. Here we show that such olfactory discrimination (OD) learning consists of two phases with distinct cellular mechanisms: an initial NMDAR-sensitive phase in which the animals acquire a successful behavioral strategy (rule learning), followed by an NMDAR-insensitive phase in which the animals learn to distinguish between individual odors (pair learning). Rule learning regulates the composition of synaptic NMDARs in the piriform cortex, resulting in receptors with a higher complement of the NR2a subunit protein relative to NR2b. Rule learning also reduces long-term potentiation (LTP) induced by high-frequency stimulation of the intracortical axons in slices of piriform cortex. As NR2a-containing NMDARs mediate shorter excitatory postsynaptic currents than those containing NR2b, we suggest that learning-induced regulation of NMDAR composition constrains subsequent synaptic plasticity, thereby maintaining the memory encoded by experience.	Univ Maryland, Dept Biol, Neurosci & Cognit Sci Program, College Pk, MD 20742 USA; Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; Univ Haifa, Fac Sci, Ctr Brain & Behav, IL-31905 Haifa, Israel	University System of Maryland; University of Maryland College Park; Ben Gurion University; Ben Gurion University; University of Haifa	Quinlan, EM (corresponding author), Univ Maryland, Dept Biol, Neurosci & Cognit Sci Program, College Pk, MD 20742 USA.	eq5@umail.umd.edu						BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; BARKAI E, 1994, J NEUROPHYSIOL, V72, P659, DOI 10.1152/jn.1994.72.2.659; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Brun VH, 2001, J NEUROSCI, V21, P356, DOI 10.1523/JNEUROSCI.21-01-00356.2001; Cain DP, 1997, BEHAV BRAIN RES, V84, P179, DOI 10.1016/S0166-4328(96)00149-0; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Castellani GC, 2001, P NATL ACAD SCI USA, V98, P12772, DOI 10.1073/pnas.201404598; Flint AC, 1997, J NEUROSCI, V17, P2469; HASSELMO ME, 1995, J NEUROSCI, V15, P6592; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Hoh T, 1999, J Neurosci, V19, pRC2; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; Knafo S, 2001, EUR J NEUROSCI, V13, P633, DOI 10.1046/j.1460-9568.2001.01422.x; Lebel D, 2001, CEREB CORTEX, V11, P485, DOI 10.1093/cercor/11.6.485; Linster C, 2001, CHEM SENSES, V26, P585, DOI 10.1093/chemse/26.5.585; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Power JM, 1997, J NEUROPHYSIOL, V78, P1184, DOI 10.1152/jn.1997.78.2.1184; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Saar D, 2002, J NEUROPHYSIOL, V87, P2358, DOI 10.1152/jn.2002.87.5.2358; Saar D, 1999, J NEUROSCI, V19, P8616; Saar D, 1998, EUR J NEUROSCI, V10, P1518, DOI 10.1046/j.1460-9568.1998.00149.x; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; SAUCIER D, 1995, NATURE, V378, P186, DOI 10.1038/378186a0; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; STAUBLI U, 1987, BEHAV NEUROSCI, V101, P757, DOI 10.1037/0735-7044.101.6.757; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tsien JZ, 2000, CURR OPIN NEUROBIOL, V10, P266, DOI 10.1016/S0959-4388(00)00070-2; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555	46	120	128	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 22	2004	41	2					185	192		10.1016/S0896-6273(03)00874-2	http://dx.doi.org/10.1016/S0896-6273(03)00874-2			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741100	Bronze			2022-12-24	WOS:000221457800005
J	Tricomi, EM; Delgado, MR; Fiez, JA				Tricomi, EM; Delgado, MR; Fiez, JA			Modulation of caudate activity by action contingency	NEURON			English	Article							COCAINE-SEEKING BEHAVIOR; FUNCTIONAL-PROPERTIES; ORBITOFRONTAL CORTEX; DOPAMINE RELEASE; NEURAL RESPONSES; DORSAL STRIATUM; PARIETAL CORTEX; BRAIN ACTIVITY; REWARD; ACTIVATION	Research has increasingly implicated the striatum in the processing of reward-related information in both animals and humans. However, it is unclear whether human striatal activation is driven solely by the hedonic properties of rewards or whether such activation is reliant on other factors, such as anticipation of upcoming reward or performance of an action to earn a reward. We used event-related functional magnetic resonance imaging to investigate hemodynamic responses to monetary rewards and punishments in three experiments that made use of an oddball paradigm. We presented reward and punishment displays randomly in time, following an anticipatory cue, or following a button press response. Robust and differential activation of the caudate nucleus occurred only when a perception of contingency existed between the button press response and the outcome. This finding suggests that the caudate is involved in reinforcement of action potentially leading to reward, rather than in processing reward per se.	Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; NYU, Dept Psychol, New York, NY 10003 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; New York University	Tricomi, EM (corresponding author), Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA.	elt6@pitt.edu		Tricomi, Elizabeth/0000-0002-3659-2656	NIDA NIH HHS [R01 DA14103] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014103] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Beiser, 1995, MODELS INFORM PROCES, P215; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; COURCHESNE E, 1975, ELECTROEN CLIN NEURO, V39, P131, DOI 10.1016/0013-4694(75)90003-6; COX W, 1998, COMPUT BIOMED RES, V29, P162; Critchley HD, 2000, J NEUROSCI, V20, P3033; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Elliott R, 2003, J NEUROSCI, V23, P303; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Fissell K, 2003, NEUROINFORMATICS, V1, P111, DOI 10.1385/NI:1:1:111; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Haber SN, 1997, CRIT REV NEUROBIOL, V11, P323, DOI 10.1615/CritRevNeurobiol.v11.i4.40; Hikosaka O, 2002, EPILEPSIA, V43, P9, DOI 10.1046/j.1528-1157.43.s.9.4.x; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Ito R, 2002, J NEUROSCI, V22, P6247; Ito R, 2000, J NEUROSCI, V20, P7489; JOHNSON R, 1986, PSYCHOPHYSIOLOGY, V23, P367, DOI 10.1111/j.1469-8986.1986.tb00649.x; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Kiehl KA, 2003, HUM BRAIN MAPP, V18, P42, DOI 10.1002/hbm.10074; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; KOOB GF, 1992, SEMIN NEUROSCI, V4, P139; Lane RD, 1999, NEUROPSYCHOLOGIA, V37, P989, DOI 10.1016/S0028-3932(99)00017-2; Lauwereyns J, 2002, NEURON, V33, P463, DOI 10.1016/S0896-6273(02)00571-8; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; LESIEUR HR, 1987, AM J PSYCHIAT, V144, P1184; MacWhinney B, 1997, SPATIAL VISION, V11, P99, DOI 10.1163/156856897X00113; Maratos EJ, 2001, NEUROPSYCHOLOGIA, V39, P910, DOI 10.1016/S0028-3932(01)00025-2; McCarthy G, 1997, J NEUROPHYSIOL, V77, P1630, DOI 10.1152/jn.1997.77.3.1630; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Menon V, 1997, NEUROREPORT, V8, P3029, DOI 10.1097/00001756-199709290-00007; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Patterson JC, 2002, NEUROIMAGE, V17, P1797, DOI 10.1006/nimg.2002.1306; ROBBINS TW, 1992, SEMIN NEUROSCI, V4, P119; Rolls ET, 1999, NEUROCASE, V5, P301, DOI 10.1080/13554799908411984; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, NEUROPHARMACOLOGY, V37, P421, DOI 10.1016/S0028-3908(98)00071-9; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Strange BA, 2000, NEUROIMAGE, V12, P425, DOI 10.1006/nimg.2000.0637; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Takikawa Y, 2002, J NEUROPHYSIOL, V87, P508, DOI 10.1152/jn.00288.2001; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor SF, 1998, NEUROIMAGE, V8, P188, DOI 10.1006/nimg.1998.0356; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024; Zink CF, 2003, J NEUROSCI, V23, P8092	53	423	426	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 22	2004	41	2					281	292		10.1016/S0896-6273(03)00848-1	http://dx.doi.org/10.1016/S0896-6273(03)00848-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741108	Bronze			2022-12-24	WOS:000221457800013
J	Shea, SD; Margoliash, D				Shea, SD; Margoliash, D			Basal forebrain cholineraic modulation of auditory activity in the zebra finch song system	NEURON			English	Article							VOCAL CONTROL-SYSTEM; NUCLEUS BASALIS; LEARNED VOCALIZATIONS; SOMATOSENSORY CORTEX; MOTOR SYSTEM; BIRD SONG; PLASTICITY; BRAIN; SLEEP; ACETYLCHOLINE	The cholinergic basis of auditory "gating" in the sensorimotor nucleus HVc and its efferent target robustus archistriatalis (RA) was investigated in anesthetized zebra finches. Injections of cholinergic agonists carbachol or muscarine into HVc strongly affected discharge rates and diminished auditory responsiveness in both HVc and its target RA, changes toward an awake-like condition. HVc nicotine injections produced similar strong effects in HVc, but weaker and inconsistent effects in RA. Stimulation of basal forebrain (BF) produced an initial transient network shutdown followed by diminished auditory responsiveness in HVc and RA. All stimulation effects were blocked when preceded by HVc injections of nicotinic or muscarinic antagonists. Thus, BF cholinergic modulation of song system auditory activity acting via functionally distinct HVc circuits can contribute to auditory gating. We hypothesize that wakeful BF activity levels block sensory input to motor systems and adaptively change during behavior to allow sensorimotor feedback such as auditory feedback during singing.	Univ Chicago, Committee Neurobiol, Chicago, IL 60637 USA; Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Shea, SD (corresponding author), Univ Chicago, Committee Neurobiol, 1027 E 27th St, Chicago, IL 60637 USA.			Shea, Stephen/0000-0001-6927-0189	NIDCD NIH HHS [DC 05098] Funding Source: Medline; NIMH NIH HHS [MH59831] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC005098] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Appeltants D, 2000, J CHEM NEUROANAT, V18, P117, DOI 10.1016/S0891-0618(99)00054-X; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; BALL GF, 1990, J COMP NEUROL, V298, P431, DOI 10.1002/cne.902980405; BALL GF, 1994, BRAIN BEHAV EVOLUT, V44, P234, DOI 10.1159/000113579; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Brainard MS, 2000, NATURE, V404, P762, DOI 10.1038/35008083; Conner JM, 2003, NEURON, V38, P819, DOI 10.1016/S0896-6273(03)00288-5; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Dave AS, 1998, SCIENCE, V282, P2250, DOI 10.1126/science.282.5397.2250; DOUPE AJ, 1991, P NATL ACAD SCI USA, V88, P11339, DOI 10.1073/pnas.88.24.11339; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; HARS B, 1993, NEUROSCIENCE, V56, P61, DOI 10.1016/0306-4522(93)90562-T; Janata P, 1999, J NEUROSCI, V19, P5108; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Kimpo RR, 2003, J NEUROSCI, V23, P5750; KITT CA, 1981, NEUROSCIENCE, V6, P1551, DOI 10.1016/0306-4522(81)90224-4; Li R, 1999, NEUROREPORT, V10, P165, DOI 10.1097/00001756-199901180-00032; Li R, 1997, BRAIN RES, V763, P239, DOI 10.1016/S0006-8993(97)00417-4; Ma XF, 2003, J NEUROPHYSIOL, V89, P90, DOI 10.1152/jn.00968.2001; Margoliash D, 2002, J COMP PHYSIOL A, V188, P851, DOI 10.1007/s00359-002-0351-5; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; METHERATE R, 1991, BRAIN RES, V559, P163, DOI 10.1016/0006-8993(91)90301-B; Mooney R, 2002, J COMP PHYSIOL A, V188, P879, DOI 10.1007/s00359-002-0353-3; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; Nick TA, 2001, P NATL ACAD SCI USA, V98, P14012, DOI 10.1073/pnas.251525298; NORDEEN KW, 1992, BEHAV NEURAL BIOL, V57, P58, DOI 10.1016/0163-1047(92)90757-U; Rasmusson DD, 2000, BEHAV BRAIN RES, V115, P205, DOI 10.1016/S0166-4328(00)00259-X; Rauske PL, 2003, J NEUROPHYSIOL, V89, P1688, DOI 10.1152/jn.00655.2002; RECANZONE GH, 1993, J NEUROSCI, V13, P87; REINER A, 1983, NEUROSCIENCE, V9, P61, DOI 10.1016/0306-4522(83)90047-7; RYAN SM, 1981, J COMP NEUROL, V202, P211, DOI 10.1002/cne.902020207; Schmidt MF, 1998, NAT NEUROSCI, V1, P513, DOI 10.1038/2232; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Szymusiak R, 2000, BEHAV BRAIN RES, V115, P171, DOI 10.1016/S0166-4328(00)00257-6; TREMBLAY N, 1990, J NEUROPHYSIOL, V64, P1212, DOI 10.1152/jn.1990.64.4.1212; Vates GE, 1997, J COMP NEUROL, V380, P275; WATSON JT, 1988, J COMP NEUROL, V274, P255, DOI 10.1002/cne.902740209; Wenk GL, 1997, NEUROBIOL LEARN MEM, V67, P85, DOI 10.1006/nlme.1996.3757; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871; ZUSCHRATTER W, 1990, BRAIN RES, V513, P193, DOI 10.1016/0006-8993(90)90457-M	41	42	44	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 18	2003	40	6					1213	1226		10.1016/S0896-6273(03)00723-2	http://dx.doi.org/10.1016/S0896-6273(03)00723-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756UZ	14687554	Bronze			2022-12-24	WOS:000187503400018
J	Zhang, JM; Wang, HK; Ye, CQ; Ge, WP; Chen, YR; Jiang, ZL; Wu, CP; Poo, MM; Duan, SM				Zhang, JM; Wang, HK; Ye, CQ; Ge, WP; Chen, YR; Jiang, ZL; Wu, CP; Poo, MM; Duan, SM			ATP released by Astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression	NEURON			English	Article							RAT SPINAL-CORD; DORSAL-HORN NEURONS; CALCIUM WAVES; HIPPOCAMPAL ASTROCYTES; SYNAPTIC TRANSMISSION; IN-VITRO; RECEPTORS; INHIBITION; ACTIVATION; ADENOSINE	Extracellular ATIP released from axons is known to assist activity-dependent signaling between neurons and Schwann cells in the peripheral nervous system. Here we report that ATP released from astrocytes as a result of neuronal activity can also modulate central synaptic transmission. In cultures of hippocampal neurons, endogenously released ATP tonically suppresses glutamatergic synapses via presynaptic P2Y receptors, an effect that depends on the presence of cocultured astrocytes. Glutamate release accompanying neuronal activity also activates non-NMDA receptors of nearby astrocytes and triggers ATIP release from these cells, which in turn causes homo- and heterosynaptic suppression. In CA1 pyramidal neurons of hippocampal slices, a similar synaptic suppression was also produced by adenosine, an immediate degradation product of ATIP released by glial cells. Thus, neuron-glia crosstalk may participate in activity-dependent synaptic modulation.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of California System; University of California Berkeley	Duan, SM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.		Wang, Huikun/V-3677-2017	Wang, Huikun/0000-0001-8556-3504				Araque A, 2001, ANNU REV PHYSIOL, V63, P795, DOI 10.1146/annurev.physiol.63.1.795; Bardoni R, 1997, J NEUROSCI, V17, P5297; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Burnstock G, 1995, J PHYSIOL PHARMACOL, V46, P365; Connolly GP, 2000, EUR J PHARMACOL, V397, P271, DOI 10.1016/S0014-2999(00)00273-9; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Cunha RA, 1998, J NEUROSCI, V18, P1987; Cunha RA, 2000, LIFE SCI, V68, P119, DOI 10.1016/S0024-3205(00)00923-1; Currie KPM, 1996, NEURON, V16, P1027, DOI 10.1016/S0896-6273(00)80126-9; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; Deuchars SA, 2001, J NEUROSCI, V21, P6308, DOI 10.1523/JNEUROSCI.21-16-06308.2001; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Duan SM, 1999, J NEUROSCI, V19, P10193; Duan SM, 2003, J NEUROSCI, V23, P1320, DOI 10.1523/JNEUROSCI.23-04-01320.2003; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; EDWARDS FA, 1992, NATURE, V359, P144, DOI 10.1038/359144a0; Fields RD, 2000, TRENDS NEUROSCI, V23, P625, DOI 10.1016/S0166-2236(00)01674-X; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; Giaume C, 1998, GLIA, V24, P50, DOI 10.1002/(SICI)1098-1136(199809)24:1<50::AID-GLIA6>3.0.CO;2-4; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Hugel S, 2000, J NEUROSCI, V20, P2121; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Jo YH, 1999, NAT NEUROSCI, V2, P241, DOI 10.1038/6344; KATO K, 1993, NEUROSCIENCE, V53, P39, DOI 10.1016/0306-4522(93)90282-K; Li H, 2001, NAT NEUROSCI, V4, P612, DOI 10.1038/88432; Luscher C, 1998, NEURON, V21, P435, DOI 10.1016/S0896-6273(00)80552-8; MANZONI OJ, 1994, SCIENCE, V265, P2098, DOI 10.1126/science.7916485; Mendoza-Fernandez V, 2000, J PHARMACOL EXP THER, V293, P172; MITCHELL JB, 1993, J NEUROSCI, V13, P3439; Mitchell SJ, 2000, NATURE, V404, P498, DOI 10.1038/35006649; Nakatsuka T, 2001, J NEUROSCI, V21, P6522, DOI 10.1523/JNEUROSCI.21-17-06522.2001; NAKAZAWA K, 1995, N-S ARCH PHARMACOL, V351, P202; NEDERGAARD M, 1994, SCIENCE, V263, P1768, DOI 10.1126/science.8134839; Newman EA, 2003, J NEUROSCI, V23, P1659, DOI 10.1523/jneurosci.23-05-01659.2003; Pappas CA, 1996, GLIA, V16, P7, DOI 10.1002/(SICI)1098-1136(199601)16:1<7::AID-GLIA2>3.0.CO;2-2; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Porter JT, 1996, J NEUROSCI, V16, P5073; Queiroz G, 1997, NEUROSCIENCE, V78, P1203, DOI 10.1016/S0306-4522(96)00637-9; Satake S, 2000, NAT NEUROSCI, V3, P551, DOI 10.1038/75718; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Silinsky EM, 1996, J PHYSIOL-LONDON, V492, P815, DOI 10.1113/jphysiol.1996.sp021348; STENHAUSER C, 1996, TRENDS NEUROSCI, V19, P339; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; SWANSON RA, 1994, BRAIN RES, V664, P94, DOI 10.1016/0006-8993(94)91958-5; SZERB JC, 1987, BRAIN RES, V410, P116, DOI 10.1016/S0006-8993(87)80030-6; Trendelenburg AU, 2000, NEUROSCIENCE, V96, P249, DOI 10.1016/S0306-4522(99)00577-1; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Vogt KE, 1999, P NATL ACAD SCI USA, V96, P1118, DOI 10.1073/pnas.96.3.1118; Wang ZR, 2003, NEURON, V37, P463, DOI 10.1016/S0896-6273(02)01189-3; Westfall TD, 1997, EUR J PHARMACOL, V329, P169, DOI 10.1016/S0014-2999(97)89178-9; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	56	460	493	1	37	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 4	2003	40	5					971	982		10.1016/S0896-6273(03)00717-7	http://dx.doi.org/10.1016/S0896-6273(03)00717-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659095	Bronze			2022-12-24	WOS:000187042200013
J	Mehring, C; Rickert, J; Vaadia, E; de Oliveira, SC; Aertsen, A; Rotter, S				Mehring, C; Rickert, J; Vaadia, E; de Oliveira, SC; Aertsen, A; Rotter, S			Inference of hand movements from local field potentials in monkey motor cortex	NATURE NEUROSCIENCE			English	Article							OSCILLATIONS	The spiking of neuronal populations in motor cortex provides accurate information about movement parameters. Here we show that hand movement target and velocity can be inferred from multiple local field potentials (LFPs) in single trials approximately as efficiently as from multiple single-unit activity (SUA) recorded from the same electrodes. Our results indicate that LFPs can be used as an additional signal for decoding brain activity, particularly for new neuroprosthetic applications.	Univ Freiburg, Inst Biol 3, D-79104 Freiburg, Germany; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Interdisciplinary Ctr Neural Computat, IL-91120 Jerusalem, Israel; Univ Dortmund, Inst Arbeitsphysiol, D-44139 Dortmund, Germany; Inst Frontier Areas Psychol & Mental Hlth, D-79098 Freiburg, Germany	University of Freiburg; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Dortmund University of Technology	Mehring, C (corresponding author), Univ Freiburg, Inst Biol 3, Schanzlestr 1, D-79104 Freiburg, Germany.	carsten.mehring@biologie.uni-freiburg.de	Mehring, Carsten/R-8986-2019; Vaadia, Eilon/E-9347-2011	Mehring, Carsten/0000-0001-8125-5205; 				Baker SN, 1999, EXP BRAIN RES, V128, P109, DOI 10.1007/s002210050825; de Oliveira SC, 2001, EUR J NEUROSCI, V14, P1881, DOI 10.1046/j.0953-816x.2001.01801.x; Donchin O, 1998, NATURE, V395, P274, DOI 10.1038/26220; Donchin O, 2001, EXP BRAIN RES, V140, P46, DOI 10.1007/s002210100784; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3949, DOI 10.1152/jn.1996.76.6.3949; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; SANES JN, 1993, P NATL ACAD SCI USA, V90, P4470, DOI 10.1073/pnas.90.10.4470; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582	10	298	318	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1253	1254		10.1038/nn1158	http://dx.doi.org/10.1038/nn1158			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	746BC	14634657				2022-12-24	WOS:000186725600008
J	Diez del Corral, R; Olivera-Martinez, I; Goriely, A; Gale, E; Maden, M; Storey, K				Diez del Corral, R; Olivera-Martinez, I; Goriely, A; Gale, E; Maden, M; Storey, K			Opposing FGF and retinoid pathways control ventral neural pattern, neuronal differentiation, and segmentation during body axis extension	NEURON			English	Article							PROMOTE PRIMARY NEUROGENESIS; RECEPTOR-GAMMA TRANSCRIPTS; PROGENITOR-CELL IDENTITY; DEVELOPING SPINAL-CORD; CHICK SKIN DEVELOPMENT; CENTRAL-NERVOUS-SYSTEM; EMBRYONIC STEM-CELLS; MOTOR-NEURON; GENE-EXPRESSION; SONIC HEDGEHOG	Vertebrate body axis extension involves progressive generation and subsequent differentiation of new cells derived from a caudal stem zone; however, molecular mechanisms that preserve caudal progenitors and coordinate differentiation are poorly understood. FGF maintains caudal progenitors and its attenuation is required for neuronal and mesodermal differentiation and to position segment boundaries. Furthermore, somitic mesoderm promotes neuronal differentiation in part by downregulating Fgf8. Here we identify retinoic acid (RA) as this somitic signal and show that retinoid and FGF pathways have opposing actions. FGF is a general repressor of differentiation, including ventral neural patterning, while RA attenuates Fgf8 in neuroepithelium and paraxial mesoderm, where it controls somite boundary position. RA is further required for neuronal differentiation and expression of key ventral neural patterning genes. Our data demonstrate that FGF and RA pathways are mutually inhibitory and suggest that their opposing actions provide a global mechanism that controls differentiation during axis extension.	Univ Dundee, Wellcome Trust Bioctr, Fac Life Sci, Div Cell & Dev Biol, Dundee DD1 5EH, Scotland; Univ Oxford, Dept Human Anat & Genet, Oxford OX1 3QX, England; Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 1UL, England	University of Dundee; University of Oxford; University of London; King's College London	Storey, K (corresponding author), Univ Dundee, Wellcome Trust Bioctr, Fac Life Sci, Div Cell & Dev Biol, Dow St, Dundee DD1 5EH, Scotland.	k.g.storey@dundee.ac.uk	Goriely, Anne/AAR-1133-2020; DIEZ DEL CORRAL, RUTH/K-7974-2014	Goriely, Anne/0000-0001-9229-7216; Storey, Kate/0000-0003-3506-1287; DIEZ DEL CORRAL, RUTH/0000-0003-2649-7214				Abu-Abed S, 2003, DEVELOPMENT, V130, P1449, DOI 10.1242/dev.00357; Bai CB, 2002, DEVELOPMENT, V129, P4753; Bertrand N, 2000, DEVELOPMENT, V127, P4837; Boardman PE, 2002, CURR BIOL, V12, P1965, DOI 10.1016/S0960-9822(02)01296-4; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Brown JM, 2000, CURR BIOL, V10, P869, DOI 10.1016/S0960-9822(00)00601-1; Cai J, 1999, DEV DYNAM, V216, P459, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<459::AID-DVDY14>3.3.CO;2-Z; Calle-Mustienes ED, 2002, MECH DEVELOP, V119, P69, DOI 10.1016/S0925-4773(02)00296-4; Cambray N, 2002, DEVELOPMENT, V129, P4855; Cavodeassi F, 2001, DEVELOPMENT, V128, P2847; Chambers D, 2000, MECH DEVELOP, V91, P361, DOI 10.1016/S0925-4773(99)00288-9; Chapman SC, 2002, DEV BIOL, V245, P187, DOI 10.1006/dbio.2002.0641; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; CHIANG C, 1996, NATURE, V381, P155; DERSCH H, 1993, DEV BIOL, V160, P424, DOI 10.1006/dbio.1993.1318; Diez del Corral R, 2002, DEVELOPMENT, V129, P1681; Dubrulle J, 2002, CURR OPIN GENET DEV, V12, P519, DOI 10.1016/S0959-437X(02)00335-0; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Dupe V, 2001, DEVELOPMENT, V128, P2199; EAGER NSC, 1991, FEBS LETT, V292, P103, DOI 10.1016/0014-5793(91)80844-S; Ensini M, 1998, DEVELOPMENT, V125, P969; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1997, COLD SPRING HARB SYM, V62, P451; Franco PG, 1999, DEVELOPMENT, V126, P4257; Gale E, 1996, DEVELOPMENT, V122, P783; Gavalas A, 2002, TRENDS NEUROSCI, V25, P61, DOI 10.1016/S0166-2236(02)02067-2; Gould A, 1998, NEURON, V21, P39, DOI 10.1016/S0896-6273(00)80513-9; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Irving C, 2000, DEVELOPMENT, V127, P177; Itasaki N, 1996, NEURON, V16, P487, DOI 10.1016/S0896-6273(00)80069-0; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kawakami A, 1997, MECH DEVELOP, V66, P119, DOI 10.1016/S0925-4773(97)00097-X; LAWSON KA, 1992, CIBA F SYMP, V165, P3; Lewis J, 1996, CURR OPIN NEUROBIOL, V6, P3, DOI 10.1016/S0959-4388(96)80002-X; Liem KF, 2000, DEVELOPMENT, V127, P4855; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Maden M, 1996, CURR BIOL, V6, P417, DOI 10.1016/S0960-9822(02)00509-2; Maden M, 2001, INT REV CYTOL, V209, P1; Maden M, 1998, DEVELOPMENT, V125, P4133; Maden M, 2000, INT J DEV BIOL, V44, P151; MADEN M, 1989, DEV BIOL, V135, P124, DOI 10.1016/0012-1606(89)90163-2; MAHMOOD R, 1995, DEVELOPMENT, V121, P1399; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Mathis L, 2000, DEVELOPMENT, V127, P1277; Mathis L, 2001, NAT CELL BIOL, V3, P559, DOI 10.1038/35078535; Mercader N, 2000, DEVELOPMENT, V127, P3961; MICHAILLE JJ, 1995, INT J DEV BIOL, V39, P587; MICHAILLE JJ, 1994, DEV DYNAM, V201, P334, DOI 10.1002/aja.1002010405; Minowada G, 1999, DEVELOPMENT, V126, P4465; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Muhr J, 1999, NEURON, V23, P689, DOI 10.1016/S0896-6273(01)80028-3; Nicolas JF, 1996, DEVELOPMENT, V122, P2933; Niederreither K, 2002, P NATL ACAD SCI USA, V99, P16111, DOI 10.1073/pnas.252626599; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Ohuchi H, 2000, MECH DEVELOP, V95, P55, DOI 10.1016/S0925-4773(00)00331-2; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Papalopulu N, 1996, DEVELOPMENT, V122, P3409; Patten I, 2002, CURR BIOL, V12, P47, DOI 10.1016/S0960-9822(01)00631-5; Perez SE, 1999, DEVELOPMENT, V126, P1715; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Pituello F, 1999, DEVELOPMENT, V126, P587; Qiu MS, 1998, MECH DEVELOP, V72, P77, DOI 10.1016/S0925-4773(98)00018-5; Renoncourt Y, 1998, MECH DEVELOP, V79, P185, DOI 10.1016/S0925-4773(98)00189-0; RIESE J, 1995, MECH DEVELOP, V49, P13, DOI 10.1016/0925-4773(94)00296-Y; ROWE A, 1991, DEVELOPMENT, V111, P771; ROWE A, 1991, DEVELOPMENT, V111, P1007; Roztocil T, 1997, DEVELOPMENT, V124, P3263; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; SCHOENWOLF GC, 1992, ANAT REC, V233, P281, DOI 10.1002/ar.1092330211; SECHRIST J, 1991, NEURON, V7, P947, DOI 10.1016/0896-6273(91)90340-6; SELLECK MAJ, 1991, DEVELOPMENT, V112, P615; Shamim H, 1999, MECH DEVELOP, V85, P189, DOI 10.1016/S0925-4773(99)00093-3; Sharpe C, 2000, INT J DEV BIOL, V44, P463; Sharpe CR, 1997, DEVELOPMENT, V124, P515; SHIGA T, 1995, J COMP NEUROL, V360, P463, DOI 10.1002/cne.903600308; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; STERN CD, 1992, DEVELOPMENT, P151; Storey KG, 1998, DEVELOPMENT, V125, P473; Stratford T, 1996, CURR BIOL, V6, P1124, DOI 10.1016/S0960-9822(02)70679-9; Swindell EC, 1999, DEV BIOL, V216, P282, DOI 10.1006/dbio.1999.9487; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Teillet MA, 1998, P NATL ACAD SCI USA, V95, P11733, DOI 10.1073/pnas.95.20.11733; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; YAGINUMA H, 1990, DEVELOPMENT, V108, P705; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7	95	403	404	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 25	2003	40	1					65	79						15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	726TA	14527434				2022-12-24	WOS:000185614700010
J	Kleim, JA; Bruneau, R; Calder, K; Pocock, D; VandenBerg, PM; MacDonald, E; Monfils, MH; Sutherland, RJ; Nader, K				Kleim, JA; Bruneau, R; Calder, K; Pocock, D; VandenBerg, PM; MacDonald, E; Monfils, MH; Sutherland, RJ; Nader, K			Functional organization of adult motor cortex is dependent upon continued protein synthesis	NEURON			English	Article							LONG-TERM POTENTIATION; PYRAMIDAL TRACT CELLS; IN-VIVO; MOVEMENT REPRESENTATIONS; CORTICAL PLASTICITY; CRITICAL PERIOD; BARREL CORTEX; RAT; EXPERIENCE; FACILITATION	The functional organization of adult cerebral cortex is characterized by the presence of highly ordered sensory and motor maps. Despite their archetypical organization, the maps maintain the capacity to rapidly reorganize, suggesting that the neural circuitry underlying cortical representations is inherently plastic. Here we show that the circuitry supporting motor maps is dependent upon continued protein synthesis. Injections of two different protein synthesis inhibitors into adult rat forelimb motor cortex caused an immediate and enduring loss of movement representations. The disappearance of the motor map was accompanied by a significant reduction in synapse number, synapse size, and cortical field potentials and caused skilled forelimb movement impairments. Further, motor skill training led to a reappearance of movement representations. We propose that the circuitry of adult motor cortex is perpetually labile and requires continued protein synthesis in order to maintain its functional organization.	Univ Lethbridge, Dept Psychol & Neurosci, Canandian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada; McGill Univ, Dept Psychol, Montreal, PQ H3A 1B1, Canada	University of Lethbridge; McGill University	Kleim, JA (corresponding author), Univ Lethbridge, Dept Psychol & Neurosci, Canandian Ctr Behav Neurosci, 4401 Univ Dr, Lethbridge, AB T1K 3M4, Canada.	jeffrey.kleim@uleth.ca	Hines, Rochelle/AAE-3784-2020; Monfils, Marie/F-1282-2013	Monfils, Marie-H./0000-0001-8971-6651; Hines, Rochelle/0000-0002-0459-7911				Barea-Rodriguez EJ, 2000, J NEUROSCI, V20, P8528, DOI 10.1523/JNEUROSCI.20-22-08528.2000; Beiko J, 1998, CEREB CORTEX, V8, P407, DOI 10.1093/cercor/8.5.407; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Brown TG, 1912, P R SOC LOND B-CONTA, V85, P250, DOI 10.1098/rspb.1912.0050; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Cantello R, 2002, J CLIN NEUROPHYSIOL, V19, P272, DOI 10.1097/00004691-200208000-00003; Chapman CA, 1998, CEREB CORTEX, V8, P730, DOI 10.1093/cercor/8.8.730; CHENEY PD, 1985, J NEUROPHYSIOL, V53, P786, DOI 10.1152/jn.1985.53.3.786; CLASSEN J, 1999, CLIN NEUROPHYSIOL, V51, P162; Conner JM, 2003, NEURON, V38, P819, DOI 10.1016/S0896-6273(03)00288-5; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Friel KM, 2000, NEUROREHAB NEURAL RE, V14, P187, DOI 10.1177/154596830001400304; GATTER KC, 1978, BRAIN, V101, P513, DOI 10.1093/brain/101.3.513; GHOSH S, 1988, J COMP NEUROL, V269, P290, DOI 10.1002/cne.902690212; Hallett M, 2001, BRAIN RES REV, V36, P169, DOI 10.1016/S0165-0173(01)00092-3; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Huntley GW, 1997, J NEUROSCI, V17, P9220; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; JANKOWSKA E, 1975, J PHYSIOL-LONDON, V249, P617, DOI 10.1113/jphysiol.1975.sp011034; Keyvani K, 2002, NEUROREPORT, V13, P953, DOI 10.1097/00001756-200205240-00010; Keyvani K, 2002, J CEREBR BLOOD F MET, V22, P153, DOI 10.1097/00004647-200202000-00003; Kleim JA, 2002, NEUROBIOL LEARN MEM, V77, P63, DOI 10.1006/nlme.2000.4004; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321, DOI 10.1152/jn.1998.80.6.3321; LEMON RN, 1987, EXP BRAIN RES, V66, P621, DOI 10.1007/BF00270695; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Liu Y, 2002, EXP NEUROL, V178, P150, DOI 10.1006/exnr.2002.7977; Loftus M, 2000, EXP NEUROL, V163, P180, DOI 10.1006/exnr.2000.7361; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; NUDO RJ, 1990, SOMATOSENS MOT RES, V7, P463, DOI 10.3109/08990229009144720; Nudo RJ, 1996, J NEUROSCI, V16, P785; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; PHILLIPS C, 1981, PROGR ANATOMY, P61; RACINE RJ, 1994, BRAIN RES, V637, P83, DOI 10.1016/0006-8993(94)91220-3; Rauschecker JP, 2002, PROG BRAIN RES, V138, P73, DOI 10.1016/S0079-6123(02)38072-5; Remple MS, 2001, BEHAV BRAIN RES, V123, P133, DOI 10.1016/S0166-4328(01)00199-1; RICCIO RV, 1985, NEUROSCIENCE, V16, P1027, DOI 10.1016/0306-4522(85)90113-7; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rocamora N, 1996, J NEUROSCI, V16, P4411; Schacher S, 2002, J NEUROSCI, V22, P1831, DOI 10.1523/JNEUROSCI.22-05-01831.2002; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schroeder JP, 2002, HIPPOCAMPUS, V12, P280, DOI 10.1002/hipo.10024; STANTON PK, 1984, J NEUROSCI, V4, P3080; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; STONEY SD, 1968, J NEUROPHYSIOL, V31, P659, DOI 10.1152/jn.1968.31.5.659; Swanson L. W., 1992, BRAIN MAPS STRUCTURE; Tamburin S, 2002, BRAIN, V125, P2719, DOI 10.1093/brain/awf279; Tang SJ, 2002, PHILOS T R SOC B, V357, P521, DOI 10.1098/rstb.2001.0887; Teskey GC, 2002, CEREB CORTEX, V12, P98, DOI 10.1093/cercor/12.1.98; Tolwani RJ, 2002, NEUROSCIENCE, V114, P795, DOI 10.1016/S0306-4522(02)00301-9; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; WHISHAW IQ, 1990, BEHAV BRAIN RES, V41, P49, DOI 10.1016/0166-4328(90)90053-H	56	117	118	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 25	2003	40	1					167	176		10.1016/S0896-6273(03)00592-0	http://dx.doi.org/10.1016/S0896-6273(03)00592-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	726TA	14527441	Bronze			2022-12-24	WOS:000185614700017
J	Lambe, EK; Aghajanian, GK				Lambe, EK; Aghajanian, GK			Hypocretin (orexin) induces calcium transients in single spines postsynaptic to identified thalamocortical boutons in prefrontal slice	NEURON			English	Article							INTRALAMINAR THALAMIC NUCLEI; ANTERIOR CINGULATE CORTEX; IN-VIVO; GLUTAMATE RELEASE; ACTION-POTENTIALS; RELAY NEURONS; GENE-TRANSFER; RAT-BRAIN; SLEEP; NARCOLEPSY	In vivo, thalamocortical axons are susceptible to the generation of terminal spikes which antidromically promote bursting in the thalamus. Although neurotransmitters could elicit such ectopic action potentials at thalamocortical boutons, this hypothesis has never been confirmed. Prefrontal cortex is the cortical area most implicated in arousal and is innervated by thalamic neurons that are unusual since they burst rhythmically during waking. We show that a neurotransmitter critical for alertness, hypocretin (orexin), directly excites prefrontal thalamocortical synapses in acute slice. This TTX-sensitive activation of thalamic axons was demonstrated electrophysiologically and by two-photon sampling of calcium transients at single spines in apposition to thalamic boutons anterogradely labeled in vivo. Spines receiving these long-range projections constituted a unique population in terms of the presynaptic excitatory action of hypocretin. By this mechanism, the hypocretin projection to prefrontal cortex may play a larger role in prefrontal or "executive" aspects of alertness and attention than previously anticipated.	Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06519 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06519 USA	Yale University; Yale University	Lambe, EK (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06519 USA.		Lambe, Evelyn K/K-3699-2015	Lambe, Evelyn K/0000-0002-5994-6090	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH017871, R01MH017871] Funding Source: NIH RePORTER; NIMH NIH HHS [MH17871] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bayer L, 2002, J NEUROSCI, V22, P7835; BERENDSE HW, 1991, NEUROSCIENCE, V42, P73, DOI 10.1016/0306-4522(91)90151-D; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Deschenes M, 1996, NEUROSCIENCE, V72, P679, DOI 10.1016/0306-4522(96)00001-2; Fadel J, 2002, J NEUROSCI, V22, P6742; Fadel J, 2002, NEUROSCIENCE, V111, P379, DOI 10.1016/S0306-4522(02)00017-9; Giacchino JL, 1998, PROG NEURO-PSYCHOPH, V22, P1157, DOI 10.1016/S0278-5846(98)00053-0; Groenewegen HJ, 2000, PROG BRAIN RES, V126, P3; GROENEWEGEN HJ, 1994, TRENDS NEUROSCI, V17, P52, DOI 10.1016/0166-2236(94)90074-4; GUTNICK MJ, 1972, SCIENCE, V176, P424, DOI 10.1126/science.176.4033.424; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Haas K, 2002, DIFFERENTIATION, V70, P148, DOI 10.1046/j.1432-0436.2002.700404.x; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Hofle N, 1997, J NEUROSCI, V17, P4800; Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6; Kiyashchenko LI, 2002, J NEUROSCI, V22, P5282; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Lambe EK, 2003, NEUROPSYCHOPHARMACOL, V28, P216, DOI 10.1038/sj.npp.1300032; Lambe EK, 2001, J NEUROSCI, V21, P9955, DOI 10.1523/JNEUROSCI.21-24-09955.2001; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Marek GJ, 2001, NEUROSCIENCE, V105, P379, DOI 10.1016/S0306-4522(01)00199-3; Marini G, 1996, NEUROSCI LETT, V203, P81, DOI 10.1016/0304-3940(95)12266-4; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; MCGINTY JF, 1984, J NEUROSCI, V4, P1104; Naumann A, 2001, NEUROREPORT, V12, P2807, DOI 10.1097/00001756-200109170-00011; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Paus T, 1998, NEUROREPORT, V9, pR37, DOI 10.1097/00001756-199806220-00001; Peyron C, 1998, J NEUROSCI, V18, P9996; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; PINAULT D, 1995, BRAIN RES REV, V21, P42, DOI 10.1016/0165-0173(95)00004-M; PINAULT D, 1989, NEUROSCIENCE, V31, P625, DOI 10.1016/0306-4522(89)90428-4; Rieger M, 2003, SLEEP, V26, P36; Ripley B, 2001, NEUROLOGY, V57, P2253, DOI 10.1212/WNL.57.12.2253; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; STERIADE M, 1993, NEUROSCIENCE, V56, P1, DOI 10.1016/0306-4522(93)90556-U; Sutcliffe JG, 2002, NAT REV NEUROSCI, V3, P339, DOI 10.1038/nrn808; TANAKA E, 1994, J NEUROSCI, V14, P1106, DOI 10.1523/JNEUROSCI.14-03-01106.1994; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Trivedi P, 1998, FEBS LETT, V438, P71, DOI 10.1016/S0014-5793(98)01266-6; Wu MF, 2002, AM J PHYSIOL-REG I, V283, pR1079, DOI 10.1152/ajpregu.00207.2002; Yamasaki H, 2002, P NATL ACAD SCI USA, V99, P11447, DOI 10.1073/pnas.182176499; Yoshida Y, 2001, EUR J NEUROSCI, V14, P1075, DOI 10.1046/j.0953-816x.2001.01725.x; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Zubieta JK, 2001, SCIENCE, V293, P311, DOI 10.1126/science.1060952	48	86	94	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 25	2003	40	1					139	150		10.1016/S0896-6273(03)00598-1	http://dx.doi.org/10.1016/S0896-6273(03)00598-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	726TA	14527439	Bronze			2022-12-24	WOS:000185614700015
J	Graham, V; Khudyakov, J; Ellis, P; Pevny, L				Graham, V; Khudyakov, J; Ellis, P; Pevny, L			SOX2 functions to maintain neural progenitor identity	NEURON			English	Article							CHICKEN SOX2; STEM-CELLS; DROSOPHILA-MELANOGASTER; EMBRYONIC EXPRESSION; NERVOUS-SYSTEM; NEURONAL FATE; GENE; TRANSCRIPTION; DIFFERENTIATION; PROTEIN	Neural progenitors of the vertebrate CNS are defined by generic cellular characteristics, including their pseudoepithelial morphology and their ability to divide and differentiate. SOXB1 transcription factors, including the three closely related genes Sox1, Sox2, and Sox3, universally mark neural progenitor and stem cells throughout the vertebrate CNS. We show here that constitutive expression of SOX2 inhibits neuronal differentiation and results in the maintenance of progenitor characteristics. Conversely, inhibition of SOX2 signaling results in the delamination of neural progenitor cells from the ventricular zone and exit from cell cycle, which is associated with a loss of progenitor markers and the onset of early neuronal differentiation markers. The phenotype elicited by inhibition of SOX2 signaling can be rescued by coexpression of SOX1, providing evidence for redundant SOXB1 function in CNS progenitors. Taken together, these data indicate that SOXB1 signaling is both necessary and sufficient to maintain panneural properties of neural progenitor cells.	Univ N Carolina, Dept Genet, Ctr Neurosci, Chapel Hill, NC 27599 USA; Univ Sheffield, Dev Genet Ctr, Sheffield S10 2TN, S Yorkshire, England	University of North Carolina; University of North Carolina Chapel Hill; University of Sheffield	Pevny, L (corresponding author), Univ N Carolina, Dept Genet, Ctr Neurosci, Chapel Hill, NC 27599 USA.	larysa_pevny@med.unc.edu	Khudyakov, Jane/C-1213-2014	Khudyakov, Jane/0000-0001-7038-102X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064798] Funding Source: NIH RePORTER; NIMH NIH HHS [R01-MH64798-01] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; ALTMAN J, 1984, DEV RAT SPINAL CORD; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Barres BA, 1999, CELL, V97, P667, DOI 10.1016/S0092-8674(00)80777-1; Bellefroid EJ, 1996, CELL, V87, P1191, DOI 10.1016/S0092-8674(00)81815-2; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Buescher M, 2002, DEVELOPMENT, V129, P4193; Burstyn-Cohen T, 2002, DEV CELL, V3, P383, DOI 10.1016/S1534-5807(02)00221-6; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Collignon J, 1996, DEVELOPMENT, V122, P509; Conlon FL, 1996, DEVELOPMENT, V122, P2427; Cremazy F, 2000, MECH DEVELOP, V93, P215, DOI 10.1016/S0925-4773(00)00268-9; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Gage FH, 1998, CURR OPIN NEUROBIOL, V8, P671, DOI 10.1016/S0959-4388(98)80098-6; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Gregg CT, 2002, J NEUROSCI RES, V69, P708, DOI 10.1002/jnr.10340; Guillemot F, 1999, EXP CELL RES, V253, P357, DOI 10.1006/excr.1999.4717; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HAN KY, 1993, EMBO J, V12, P2723, DOI 10.1002/j.1460-2075.1993.tb05934.x; Hardcastle Z, 2000, DEVELOPMENT, V127, P1303; Hitoshi S, 2002, DEVELOPMENT, V129, P233; Itasaki N, 1999, NAT CELL BIOL, V1, pE203, DOI 10.1038/70231; JAYNES JB, 1991, EMBO J, V10, P1427, DOI 10.1002/j.1460-2075.1991.tb07663.x; KAMACHI Y, 1995, EMBO J, V14, P3510, DOI 10.1002/j.1460-2075.1995.tb07357.x; Kamachi Y, 1999, MOL CELL BIOL, V19, P107; Kawakami A, 1997, MECH DEVELOP, V66, P119, DOI 10.1016/S0925-4773(97)00097-X; Kessaris N, 2001, NEURON, V31, P677, DOI 10.1016/S0896-6273(01)00430-5; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kishi M, 2000, DEVELOPMENT, V127, P791; LEBER SM, 1990, J NEUROSCI, V10, P2451; LovellBadge R, 1995, PHILOS T R SOC B, V350, P205, DOI 10.1098/rstb.1995.0153; Malas S, 2003, NEUROSCIENCE, V119, P421, DOI 10.1016/S0306-4522(03)00158-1; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Mizuseki K, 1998, DEVELOPMENT, V125, P579; MORAISDASILVA S, 1997, NAT GENET, V14, P62; Mujtaba T, 1999, DEV BIOL, V214, P113, DOI 10.1006/dbio.1999.9418; Nambu PA, 1996, DEVELOPMENT, V122, P3467; Nishiguchi S, 1998, GENE DEV, V12, P776, DOI 10.1101/gad.12.6.776; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Osumi N, 1997, DEVELOPMENT, V124, P2961; Overton PM, 2002, DEVELOPMENT, V129, P4219; PARSONS M, 1997, THESIS U LONDON LOND; Penzel R, 1997, INT J DEV BIOL, V41, P667; Pevny L, 2003, TRENDS NEUROSCI, V26, P351, DOI 10.1016/S0166-2236(03)00169-3; Pevny LH, 1998, DEVELOPMENT, V125, P1967; PRICE J, 1992, BRAIN PATHOL, V2, P23; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Redies C, 2000, PROG NEUROBIOL, V61, P611, DOI 10.1016/S0301-0082(99)00070-2; Rex M, 1997, MECH DEVELOP, V66, P39, DOI 10.1016/S0925-4773(97)00086-5; Rex M, 1997, DEV DYNAM, V209, P323, DOI 10.1002/(SICI)1097-0177(199707)209:3<323::AID-AJA7>3.3.CO;2-B; Rimini R, 1999, MECH DEVELOP, V89, P167, DOI 10.1016/S0925-4773(99)00199-9; Rowitch DH, 2002, TRENDS NEUROSCI, V25, P417, DOI 10.1016/S0166-2236(02)02201-4; Russell SRH, 1996, DEVELOPMENT, V122, P3669; Soriano NS, 1998, DEVELOPMENT, V125, P3989; Streit A, 1997, DEVELOPMENT, V124, P1191; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; TUCKER RP, 1984, DEV BIOL, V104, P390, DOI 10.1016/0012-1606(84)90094-0; Uchikawa M, 1999, MECH DEVELOP, V84, P103, DOI 10.1016/S0925-4773(99)00083-0; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; UWANOGHO D, 1995, MECH DEVELOP, V49, P23, DOI 10.1016/0925-4773(94)00299-3; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wehrli BM, 2003, HUM PATHOL, V34, P263, DOI 10.1053/hupa.2003.41; Wiebe MS, 2000, GENE, V246, P383, DOI 10.1016/S0378-1119(00)00086-X; Wood H, 2002, NAT REV NEUROSCI, V3, P86, DOI 10.1038/nrn735; WRIGHT EM, 1993, NUCLEIC ACIDS RES, V21, P744, DOI 10.1093/nar/21.3.744; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Zappone MV, 2000, DEVELOPMENT, V127, P2367	74	958	991	0	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 28	2003	39	5					749	765		10.1016/S0896-6273(03)00497-5	http://dx.doi.org/10.1016/S0896-6273(03)00497-5			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	717GN	12948443	Green Published, Bronze			2022-12-24	WOS:000185079300006
J	Chen, K; Ratzliff, A; Hilgenberg, L; Gulyas, A; Freund, TF; Smith, M; Dinh, TP; Piomelli, D; Mackie, K; Soltesz, I				Chen, K; Ratzliff, A; Hilgenberg, L; Gulyas, A; Freund, TF; Smith, M; Dinh, TP; Piomelli, D; Mackie, K; Soltesz, I			Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures	NEURON			English	Article							CB1 CANNABINOID RECEPTOR; ACID AMIDE HYDROLASE; ENDOGENOUS CANNABINOIDS; HIPPOCAMPAL SYNAPSES; GABAERGIC INTERNEURONS; INVERSE AGONIST; RAT-BRAIN; INHIBITION; ANANDAMIDE; NEURONS	Febrile (fever-induced) seizures are the most common form of childhood seizures, affecting 3%-5% of infants and young children. Here we show that the activity-dependent, retrograde inhibition of GABA release by endogenous cannabinoids is persistently enhanced in the rat hippocampus following a single episode of experimental prolonged febrile seizures during early postnatal development. The potentiation of endocannabinoid signaling results from an increase in the number of presynaptic cannabinoid type 1 receptors associated with cholecystokinin-containing perisomatic inhibitory inputs, without an effect on the endocannabinoid-mediated inhibition of glutamate release. These results demonstrate a selective, long-term increase in the gain of endocannabinoid-mediated retrograde signaling at GABAergic synapses in a model of a human neurological disease.	Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Washington; University of Washington Seattle; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Soltesz, I (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.	isoltesz@uci.edu	Mackie, Kenneth P/B-7358-2011; Mackie, Ken/E-3715-2013	Mackie, Ken/0000-0001-8501-6199; Gulyas, Attila/0000-0003-4961-636X; Ratzliff, Anna/0000-0002-6654-8007	NIDA NIH HHS [DA00286, DA11322, DA12447, DA3412] Funding Source: Medline; NINDS NIH HHS [NS33213, NS38580] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033213, R01NS038580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012447, R01DA011322] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ameri A, 1999, BRIT J PHARMACOL, V126, P1831, DOI 10.1038/sj.bjp.0702478; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Bouaboula M, 1997, J BIOL CHEM, V272, P22330, DOI 10.1074/jbc.272.35.22330; Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661; Chen HM, 2000, P NATL ACAD SCI USA, V97, P12810, DOI 10.1073/pnas.230260397; Chen K, 1999, NAT MED, V5, P888, DOI 10.1038/11330; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Clement AB, 2003, J NEUROSCI, V23, P3916; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; DESARNAUD F, 1995, J BIOL CHEM, V270, P6030, DOI 10.1074/jbc.270.11.6030; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Egertova M, 1998, P ROY SOC B-BIOL SCI, V265, P2081, DOI 10.1098/rspb.1998.0543; Fitzjohn SM, 1998, NEUROPHARMACOLOGY, V37, P1445, DOI 10.1016/S0028-3908(98)00145-2; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Giuffrida A, 2000, ANAL BIOCHEM, V280, P87, DOI 10.1006/abio.2000.4509; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Hajos N, 2002, NEUROPHARMACOLOGY, V43, P503, DOI 10.1016/S0028-3908(02)00157-0; Hampson RE, 2003, J NEUROPHYSIOL, V90, P55, DOI 10.1152/jn.01161.2002; Hoffman AF, 2000, J NEUROSCI, V20, P2470; Holmes GL, 1998, NEURON, V21, P1231, DOI 10.1016/S0896-6273(00)80642-X; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Katona I, 2000, NEUROSCIENCE, V100, P797, DOI 10.1016/S0306-4522(00)00286-4; Katona I, 1999, J NEUROSCI, V19, P4544; Kim J, 2002, J NEUROSCI, V22, P10182; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Le Beau FEN, 1998, J NEUROPHYSIOL, V79, P659, DOI 10.1152/jn.1998.79.2.659; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; Ohno-Shosaku T, 2002, J NEUROSCI, V22, P3864, DOI 10.1523/JNEUROSCI.22-10-03864.2002; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Pan XH, 1998, MOL PHARMACOL, V54, P1064, DOI 10.1124/mol.54.6.1064; Piomelli D, 2000, TRENDS PHARMACOL SCI, V21, P218, DOI 10.1016/S0165-6147(00)01482-6; PITLER TA, 1992, J NEUROSCI, V12, P4122; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Shinnar S, 1998, ANN NEUROL, V43, P411, DOI 10.1002/ana.410430402; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Toth Z, 1998, J NEUROSCI, V18, P4285; Tsou K, 1999, NEUROSCIENCE, V93, P969, DOI 10.1016/S0306-4522(99)00086-X; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; Varma N, 2002, NEUROPHARMACOLOGY, V43, P550, DOI 10.1016/S0028-3908(02)00168-5; Vasquez C, 1999, J NEUROSCI, V19, P9271; Walker MC, 1999, NAT MED, V5, P871, DOI 10.1038/11308; Wallace MJ, 2002, EUR J PHARMACOL, V452, P295, DOI 10.1016/S0014-2999(02)02331-2; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	48	148	155	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 14	2003	39	4					599	611		10.1016/S0896-6273(03)00499-9	http://dx.doi.org/10.1016/S0896-6273(03)00499-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	712CQ	12925275	Green Published, Bronze			2022-12-24	WOS:000184779500006
J	Heynen, AJ; Yoon, BJ; Liu, CH; Chung, HJ; Huganir, RL; Bear, MF				Heynen, AJ; Yoon, BJ; Liu, CH; Chung, HJ; Huganir, RL; Bear, MF			Molecular mechanism for loss of visual cortical responsiveness following brief monocular deprivation	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; OCULAR DOMINANCE PLASTICITY; KITTEN STRIATE CORTEX; RECEPTIVE-FIELD PROPERTIES; SOURCE DENSITY ANALYSIS; HIPPOCAMPUS IN-VIVO; SYNAPTIC PLASTICITY; GLUTAMATE RECEPTORS; POSTNATAL-DEVELOPMENT; PROTEIN-KINASE	A dramatic form of experience-dependent synaptic plasticity is revealed in visual cortex when one eye is temporarily deprived of vision during early postnatal life. Monocular deprivation (MD) alters synaptic transmission such that cortical neurons cease to respond to stimulation of the deprived eye, but how this occurs is poorly understood. Here we show in rat visual cortex that brief MD sets in motion the same molecular and functional changes as the experimental model of homosynaptic long-term depression (LTD), and that prior synaptic depression by MD occludes subsequent induction of LTD. The mechanisms of LTD, about which there is now a detailed understanding, therefore contribute to visual cortical plasticity.	MIT, Picower Ctr Learning & Memory, Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Bear, MF (corresponding author), MIT, Picower Ctr Learning & Memory, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Yoon, Bong June/L-7126-2017	Chung, Hee Jung/0000-0002-5555-9907; Bear, Mark/0000-0002-9903-2541				Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; Antonini A, 1999, J NEUROSCI, V19, P4388; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bear MF, 1999, J NEUROBIOL, V41, P83, DOI 10.1002/(SICI)1097-4695(199910)41:1<83::AID-NEU11>3.0.CO;2-Z; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; BEAR MF, 1990, J NEUROSCI, V10, P909; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Blais BS, 1999, P NATL ACAD SCI USA, V96, P1083, DOI 10.1073/pnas.96.3.1083; Chung HJ, 2000, J NEUROSCI, V20, P7258; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Dodt HU, 1999, SCIENCE, V286, P110, DOI 10.1126/science.286.5437.110; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1996, NEURON, V16, P1; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; FREEMAN RD, 1981, J NEUROPHYSIOL, V45, P1074, DOI 10.1152/jn.1981.45.6.1074; GUILLERY RW, 1972, J COMP NEUROL, V144, P117, DOI 10.1002/cne.901440106; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Heynen AJ, 2001, J NEUROSCI, V21, P9801, DOI 10.1523/JNEUROSCI.21-24-09801.2001; Heynen AJ, 1996, NATURE, V381, P163, DOI 10.1038/381163a0; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Kandler K, 1998, NAT NEUROSCI, V1, P119, DOI 10.1038/368; KENANVAKNIN G, 1994, BRAIN RES, V635, P37, DOI 10.1016/0006-8993(94)91421-4; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; KIRKWOOD A, 1994, J NEUROSCI, V14, P3404; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Kirkwood A, 1999, J NEUROSCI, V19, P1599; KOSSUT M, 1991, EXP BRAIN RES, V85, P519; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; MIOCHE L, 1989, J NEUROPHYSIOL, V62, P185, DOI 10.1152/jn.1989.62.1.185; Mitchell DE, 2001, P NATL ACAD SCI USA, V98, P11662, DOI 10.1073/pnas.201392698; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Philpot BD, 2003, J NEUROSCI, V23, P5583; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Prusky GT, 2003, EUR J NEUROSCI, V17, P167, DOI 10.1046/j.1460-9568.2003.02420.x; RAMOA AS, 1988, EXP BRAIN RES, V73, P285; Rittenhouse CD, 1999, NATURE, V397, P347, DOI 10.1038/16922; Rozas C, 2001, J NEUROSCI, V21, P6791, DOI 10.1523/JNEUROSCI.21-17-06791.2001; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; YINON U, 1973, EXP NEUROL, V38, P231, DOI 10.1016/0014-4886(73)90148-9	50	237	246	1	13	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					854	862		10.1038/nn1100	http://dx.doi.org/10.1038/nn1100			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12886226				2022-12-24	WOS:000184413700015
J	Xiao, J; Zhen, XG; Yang, J				Xiao, J; Zhen, XG; Yang, J			Localization of PIP2 activation gate in inward rectifier K+ channels	NATURE NEUROSCIENCE			English	Article							SHAKER POTASSIUM CHANNELS; BETA-GAMMA-SUBUNITS; SELECTIVITY FILTER; STRUCTURAL DETERMINANTS; DEPENDENT CHANGES; ION PERMEATION; G-PROTEINS; PORE; ATP; RECTIFICATION	Ion channels respond to changes in transmembrane voltage or ligand concentration by opening or closing an activation gate. In voltage-gated K+ channels, this gate has been localized to an intracellular bundle crossing. Here we examined whether this bundle crossing, or the more internal cytoplasmic pore, acts as a gate for PIP2 activation of inward rectifier K+ (Kir) channels expressed in Xenopus laevis oocytes. We studied the open/closed state-dependence of the accessibility of intracellular cationic modifiers to a position (residue Ile176 in the TM2 helix of Kir2.1) more external to the bundle crossing. Cd2+ blocked I176C mutant channels much more weakly in the closed state than in the open state, but Ag+ and sulfhydryl-specific methanethiosulfonate reagents modified the channels with similar rates in both states. These results suggest that the TM2 helices undergo conformation changes upon PIP2 binding/unbinding, but neither they nor the cytoplasmic pore close fully to form a physical gate for K+ conduction.	Columbia Univ, Dept Biol Sci, Fairchild Ctr 915, New York, NY 10027 USA	Columbia University	Yang, J (corresponding author), Columbia Univ, Dept Biol Sci, Fairchild Ctr 915, MC2462, New York, NY 10027 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045383] Funding Source: NIH RePORTER; NINDS NIH HHS [NS45383] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Bruening-Wright A, 2002, J NEUROSCI, V22, P6499; Chapman ML, 1997, BIOPHYS J, V72, P708, DOI 10.1016/S0006-3495(97)78707-1; Choe H, 1999, BIOPHYS J, V76, P1988, DOI 10.1016/S0006-3495(99)77357-1; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Enkvetchakul D, 2000, BIOPHYS J, V78, P2334, DOI 10.1016/S0006-3495(00)76779-8; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Immke D, 1999, J GEN PHYSIOL, V113, P819, DOI 10.1085/jgp.113.6.819; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kiss L, 1999, BIOPHYS J, V76, P253, DOI 10.1016/S0006-3495(99)77194-8; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Liu YS, 2001, NAT STRUCT BIOL, V8, P883, DOI 10.1038/nsb1001-883; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; Loussouarn G, 2001, P NATL ACAD SCI USA, V98, P4227, DOI 10.1073/pnas.061452698; Lu T, 1999, P NATL ACAD SCI USA, V96, P9926, DOI 10.1073/pnas.96.17.9926; Lu T, 1999, NEURON, V22, P571, DOI 10.1016/S0896-6273(00)80711-4; Lu T, 2001, J GEN PHYSIOL, V118, P509, DOI 10.1085/jgp.118.5.509; Lu T, 2001, NAT NEUROSCI, V4, P239, DOI 10.1038/85080; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Phillips LR, 2003, NEURON, V37, P953, DOI 10.1016/S0896-6273(03)00155-7; Proks P, 2003, EMBO REP, V4, P70, DOI 10.1038/embor708; Proks P, 2001, J GEN PHYSIOL, V118, P341, DOI 10.1085/jgp.118.4.341; Sadja R, 2001, NEURON, V29, P669, DOI 10.1016/S0896-6273(01)00242-2; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; So I, 2001, J PHYSIOL-LONDON, V531, P37, DOI 10.1111/j.1469-7793.2001.0037j.x; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Trapp S, 1998, J GEN PHYSIOL, V112, P333, DOI 10.1085/jgp.112.3.333; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; Yakubovich D, 2000, J PHYSIOL-LONDON, V524, P737, DOI 10.1111/j.1469-7793.2000.00737.x; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zheng J, 1997, J GEN PHYSIOL, V110, P101, DOI 10.1085/jgp.110.2.101; Zheng J, 1998, J GEN PHYSIOL, V112, P457, DOI 10.1085/jgp.112.4.457; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	50	70	72	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					811	818		10.1038/nn1090	http://dx.doi.org/10.1038/nn1090			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12858177				2022-12-24	WOS:000184413700009
J	Rozas, JL; Paternain, AV; Lerma, J				Rozas, JL; Paternain, AV; Lerma, J			Noncanonical signaling by ionotropic kainate receptors	NEURON			English	Article							MOSSY FIBER SYNAPSES; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL INTERNEURONS; PRESYNAPTIC INHIBITION; MEDIATED INHIBITION; CALCIUM CHANNELS; PYRAMIDAL CELLS; RAT HIPPOCAMPUS; AMPA RECEPTORS; NERVOUS-SYSTEM	The potent neurotoxin kainate activates ion channel-forming receptors. However, it can also activate a G protein-coupled signaling pathway to inhibit transmitter release in central neurons. It remains unclear whether the same receptor complex is involved in both signaling activities. Here we show that in a population of dorsal root ganglion cells, exposure to kainate elicits a G protein-dependent increase in intracellular Ca2+. Furthermore, in these cells a brief exposure to kainate inhibited the K+-induced Ca2+ increase, a process that was sensitive to the G protein inhibitor Pertussis toxin and inhibitors of protein kinase C. This metabotropic action did not require ion channel activity and was not observed in neurons prepared from mice deficient for the ion channel-forming subunit GluR5. These results indicate that GluR5, an ion channelforming subunit, signals through a second messenger cascade, inhibiting voltage-dependent Ca2+ channels. Thus, such a system represents a noncanonical signaling route of ion channel-forming receptors.	CSIC, Inst Cajal, Madrid 28002, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Lerma, J (corresponding author), CSIC, Inst Cajal, Plaza Murillo 2, Madrid 28002, Spain.		Lerma, Juan/G-7907-2015	Lerma, Juan/0000-0001-7838-5199				BAHN S, 1994, J NEUROSCI, V14, P5525; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; Bureau I, 2000, P NATL ACAD SCI USA, V97, P6838, DOI 10.1073/pnas.97.12.6838; Bureau I, 1999, J NEUROSCI, V19, P653; Burnashev N, 1996, CURR OPIN NEUROBIOL, V6, P311, DOI 10.1016/S0959-4388(96)80113-9; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; Cunha RA, 2000, FEBS LETT, V469, P159; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; DIVERSEPIERLUISSI M, 1995, NEURON, V14, P191, DOI 10.1016/0896-6273(95)90254-6; Flynn ERM, 2001, J BIOL CHEM, V276, P36411, DOI 10.1074/jbc.M104308200; Frerking M, 1998, NAT NEUROSCI, V1, P479, DOI 10.1038/2194; Frerking M, 1999, P NATL ACAD SCI USA, V96, P12917, DOI 10.1073/pnas.96.22.12917; Frerking M, 2000, CURR OPIN NEUROBIOL, V10, P342, DOI 10.1016/S0959-4388(00)00094-5; Frerking M, 2001, J NEUROSCI, V21, P2958, DOI 10.1523/JNEUROSCI.21-09-02958.2001; Greif GJ, 2000, J NEUROPHYSIOL, V83, P1010, DOI 10.1152/jn.2000.83.2.1010; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; JEFTINIJA S, 1994, BRAIN RES, V639, P125, DOI 10.1016/0006-8993(94)91772-8; Jonas P, 1999, HDB EXPT PHARM, V141; Kamiya H, 1998, J PHYSIOL-LONDON, V509, P833, DOI 10.1111/j.1469-7793.1998.833bm.x; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; Kerchner GA, 2002, J NEUROSCI, V22, P8010; Kerchner GA, 2001, J NEUROSCI, V21, P59, DOI 10.1523/JNEUROSCI.21-01-00059.2001; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Lerma J, 2001, PHYSIOL REV, V81, P971, DOI 10.1152/physrev.2001.81.3.971; LERMA J, 1994, EUR J NEUROSCI, V6, P1080, DOI 10.1111/j.1460-9568.1994.tb00605.x; Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118; Li H, 2001, NAT NEUROSCI, V4, P612, DOI 10.1038/88432; Li P, 1999, NATURE, V397, P161, DOI 10.1038/16469; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; McCarron JG, 2000, J PHYSIOL-LONDON, V525, P113, DOI 10.1111/j.1469-7793.2000.00113.x; Melyan Z, 2002, NEURON, V34, P107, DOI 10.1016/S0896-6273(02)00624-4; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; MORRIS AJ, 2000, PHYSL REV, V80; Mouton J, 2001, J BIOL CHEM, V276, P22359, DOI 10.1074/jbc.M100755200; Mulle C, 2000, NEURON, V28, P475, DOI 10.1016/S0896-6273(00)00126-4; Olivera BM, 1997, MOL BIOL CELL, V8, P2101, DOI 10.1091/mbc.8.11.2101; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; PATERNAIN AN, 2003, IN PRESS J NEUROSCI; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; Paternain AV, 2000, J NEUROSCI, V20, P196, DOI 10.1523/JNEUROSCI.20-01-00196.2000; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Rodriguez-Moreno A, 2000, P NATL ACAD SCI USA, V97, P1293, DOI 10.1073/pnas.97.3.1293; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Scholz A, 1998, EUR J NEUROSCI, V10, P2547, DOI 10.1046/j.1460-9568.1998.t01-1-00268.x; SHAPIRO MS, 1994, J NEUROSCI, V14, P7109; Simmons RMA, 1998, NEUROPHARMACOLOGY, V37, P25, DOI 10.1016/S0028-3908(97)00188-3; Smolders I, 2002, NAT NEUROSCI, V5, P796, DOI 10.1038/nn880; SOMMER B, 1992, EMBO J, V11, P1651, DOI 10.1002/j.1460-2075.1992.tb05211.x; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Wilding TJ, 2001, J PHYSIOL-LONDON, V532, P411, DOI 10.1111/j.1469-7793.2001.0411f.x; WILDING TJ, 1995, MOL PHARMACOL, V47, P582	62	94	99	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 31	2003	39	3					543	553		10.1016/S0896-6273(03)00436-7	http://dx.doi.org/10.1016/S0896-6273(03)00436-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	709LC	12895426	Bronze			2022-12-24	WOS:000184625800015
J	Ungless, MA; Singh, V; Crowder, TL; Yaka, R; Ron, D; Bonci, A				Ungless, MA; Singh, V; Crowder, TL; Yaka, R; Ron, D; Bonci, A			Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons	NEURON			English	Article							LIGAND INHIBITOR; STRESS; BRAIN; ACTIVATION; UROCORTIN; GLUTAMATE; FAMILY; DRUGS; ABUSE; CELLS	Stress increases addictive behaviors and is a common cause of relapse. Corticotropin-releasing factor (CRF) plays a key role in the modulation of drug taking by stress. However, the mechanism by which CRF modulates neuronal activity in circuits involved in drug addiction is poorly understood. Here we show that CRF induces a potentiation of NMDAR (N-methyl-D-aspartate receptor)-mediated synaptic transmission in dopamine neurons of the ventral tegmental area (VTA). This effect involves CRF receptor 2 (CRF-R2) and activation of the phospholipase C (PLC)-protein kinase C (PKC) pathway. We also find that this potentiation requires CRF binding protein (CRF-BP). Accordingly, CRF-like peptides, which do not bind the CRF-BP with high affinity, do not potentiate NMDARs. These results provide evidence of the first specific roles for CRF-R2 and CRF-BP in the modulation of neuronal activity and suggest that NMDARs in the VTA may be a target for both drugs of abuse and stress.	Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94110 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94110 USA; Univ Calif San Francisco, Wheeler Ctr Neurobiol Addict, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bonci, A (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94110 USA.	bonci@itsa.ucsf.edu	Ungless, Mark/A-1985-2009	singh, vineeta/0000-0003-3470-3532; Ungless, Mark/0000-0002-1730-3353	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS042072] Funding Source: NIH RePORTER; NINDS NIH HHS [K23 NS42072] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALDENHOFF JB, 1983, SCIENCE, V221, P875, DOI 10.1126/science.6603658; Austin MC, 1997, NEUROPSYCHOPHARMACOL, V17, P326, DOI 10.1016/S0893-133X(97)00083-3; BEHAN DP, 1995, NATURE, V378, P284, DOI 10.1038/378284a0; Blank T, 2002, J NEUROSCI, V22, P3788; Bonci A, 1999, J NEUROSCI, V19, P3723; Chan RKW, 2000, NEUROSCIENCE, V101, P115, DOI 10.1016/S0306-4522(00)00322-5; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Dautzenberg FM, 2002, TRENDS PHARMACOL SCI, V23, P71, DOI 10.1016/S0165-6147(02)01946-6; DUNN AJ, 1987, PHARMACOL BIOCHEM BE, V27, P685, DOI 10.1016/0091-3057(87)90195-X; Fitzgerald LW, 1996, J NEUROSCI, V16, P274; Georges F, 2002, J NEUROSCI, V22, P5173, DOI 10.1523/JNEUROSCI.22-12-05173.2002; Heinrichs SC, 1996, P NATL ACAD SCI USA, V93, P15475, DOI 10.1073/pnas.93.26.15475; Heinrichs SC, 2001, BEHAV BRAIN RES, V122, P43, DOI 10.1016/S0166-4328(01)00174-7; Jahn O, 2002, P NATL ACAD SCI USA, V99, P12055, DOI 10.1073/pnas.192449299; Kemp CF, 1998, PEPTIDES, V19, P1119, DOI 10.1016/S0196-9781(98)00057-6; Koob GF, 1999, BRAIN RES, V848, P141, DOI 10.1016/S0006-8993(99)01991-5; LINTON EA, 1990, J CLIN ENDOCR METAB, V70, P1574, DOI 10.1210/jcem-70-6-1574; LOVENBERG TW, 1995, P NATL ACAD SCI USA, V92, P836, DOI 10.1073/pnas.92.3.836; Lowry PJ, 1996, J MOL ENDOCRINOL, V16, P39, DOI 10.1677/jme.0.0160039; MORROW BA, 1993, EUR J PHARMACOL, V238, P255, DOI 10.1016/0014-2999(93)90855-C; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; Overton PG, 1997, BRAIN RES REV, V25, P312, DOI 10.1016/S0165-0173(97)00039-8; Peto CA, 1999, J COMP NEUROL, V413, P241; POTTER E, 1992, P NATL ACAD SCI USA, V89, P4192, DOI 10.1073/pnas.89.9.4192; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; Ritchie JC, 2003, NEUROPSYCHOPHARMACOL, V28, P22, DOI 10.1038/sj.npp.1300014; Ruhmann A, 1998, P NATL ACAD SCI USA, V95, P15264, DOI 10.1073/pnas.95.26.15264; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Schulz DW, 1996, P NATL ACAD SCI USA, V93, P10477, DOI 10.1073/pnas.93.19.10477; Shaham Y, 2000, BRAIN RES REV, V33, P13, DOI 10.1016/S0165-0173(00)00024-2; Sillaber I, 2002, SCIENCE, V296, P931, DOI 10.1126/science.1069836; Spanagel R, 1999, TRENDS NEUROSCI, V22, P521, DOI 10.1016/S0166-2236(99)01447-2; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; VALENTINO RJ, 1983, BRAIN RES, V270, P363, DOI 10.1016/0006-8993(83)90615-7; Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0	36	231	236	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 31	2003	39	3					401	407		10.1016/S0896-6273(03)00461-6	http://dx.doi.org/10.1016/S0896-6273(03)00461-6			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	709LC	12895416	Bronze			2022-12-24	WOS:000184625800005
J	Soucek, T; Cumming, R; Dargusch, R; Maher, P; Schubert, D				Soucek, T; Cumming, R; Dargusch, R; Maher, P; Schubert, D			The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide	NEURON			English	Article							OXIDATIVE STRESS; ALZHEIMERS-DISEASE; DOWNS-SYNDROME; PC12 CELLS; HYPOXIA; PROTEIN; BRAIN; EXPRESSION; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; HIF-1-ALPHA	It is frequently argued that both amyloid beta (Abeta) and oxidative stress are involved in the pathogenesis of Alzheimer's disease (AD). We show here that clonal nerve cell lines and primary cortical neurons that are resistant to Abeta toxicity have an enhanced flux of glucose through both the glycolytic pathway and the hexose monophosphate shunt. AD brain also has increased enzymatic activities in both pathways relative to age-matched controls. The Abeta-induced changes in glucose metabolism are due to the activation of the transcription factor hypoxia inducible factor 1 (HIF-1). As a result of Abeta-induced changes in glucose metabolism, Abeta-resistant cells are more readily killed by glucose starvation and by classes of antipsychotic drugs that inhibit glucose uptake.	Salk Inst Biol Studies, La Jolla, CA 92037 USA; Scripps Res Inst, La Jolla, CA 92037 USA	Salk Institute; Scripps Research Institute	Schubert, D (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schubert@salk.edu	Cumming, Robert/G-2185-2010		NIA NIH HHS [P50-AG5142] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P50AG005142] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ardizzone TD, 2001, BRAIN RES, V923, P82, DOI 10.1016/S0006-8993(01)03026-8; ARNESON GA, 1964, J NEUROPSYCHIATRY, V5, P181; ASHCROFT SJ, 1972, BIOCHEM J, V126, P525, DOI 10.1042/bj1260525; BEHL C, 1993, NEUROSCI LETT, V154, P1, DOI 10.1016/0304-3940(93)90156-F; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Bernaudin M, 2002, J BIOL CHEM, V277, P39728, DOI 10.1074/jbc.M204619200; Blass JP, 2001, J NEUROSCI RES, V66, P851, DOI 10.1002/jnr.10087; BOWEN DM, 1979, LANCET, V1, P11; Brand K, 1997, J BIOENERG BIOMEMBR, V29, P355, DOI 10.1023/A:1022498714522; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Craft S, 1996, NEUROBIOL AGING, V17, P123, DOI 10.1016/0197-4580(95)02002-0; Dargusch R, 2002, J NEUROCHEM, V81, P1394, DOI 10.1046/j.1471-4159.2002.00950.x; Drutel G, 2000, EUR J NEUROSCI, V12, P3701, DOI 10.1046/j.1460-9568.2000.00266.x; Dufour E, 2000, P NATL ACAD SCI USA, V97, P4138, DOI 10.1073/pnas.070501997; Duyndam MCA, 2001, J BIOL CHEM, V276, P48066, DOI 10.1074/jbc.M106282200; Dwyer DS, 1999, PROG NEURO-PSYCHOPH, V23, P69, DOI 10.1016/S0278-5846(98)00092-X; DYKENS JA, 1997, NEURODEGENERATIVE DI, P319; ESMANN V, 1978, REGULATORY MECH CARB; Gibson GE, 2002, FREE RADICAL BIO MED, V32, P1061, DOI 10.1016/S0891-5849(02)00802-X; HILES BW, 1956, JAMA-J AM MED ASSOC, V162, P1651, DOI 10.1001/jama.1956.02970350067022; Honegger P, 2002, J NEUROCHEM, V81, P1141, DOI 10.1046/j.1471-4159.2002.00888.x; HORWOOD N, 1994, VIRCHOWS ARCH, V425, P69; HYSLOP PA, 1988, J BIOL CHEM, V263, P1665; Katschinski DM, 2002, J BIOL CHEM, V277, P9262, DOI 10.1074/jbc.M110377200; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Li YH, 1997, NEURON, V19, P453, DOI 10.1016/S0896-6273(00)80953-8; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; MAHER F, 1991, Molecular and Cellular Neuroscience, V2, P351, DOI 10.1016/1044-7431(91)90066-W; MANNING CA, 1993, NEUROBIOL AGING, V14, P523, DOI 10.1016/0197-4580(93)90034-9; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MCLACHLAN DRC, 1991, CAN MED ASSOC J, V145, P793; Michiels C, 2002, FREE RADICAL BIO MED, V33, P1231, DOI 10.1016/S0891-5849(02)01045-6; MIELKE R, 1992, NEUROBIOL AGING, V13, P93, DOI 10.1016/0197-4580(92)90015-P; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Palmer AM, 1999, J NEURAL TRANSM, V106, P317, DOI 10.1007/s007020050161; ParpuraGill A, 1997, BRAIN RES, V754, P65, DOI 10.1016/S0006-8993(97)00043-7; Piret JP, 2002, BIOCHEM PHARMACOL, V64, P889, DOI 10.1016/S0006-2952(02)01155-3; Russell RL, 1999, ARCH BIOCHEM BIOPHYS, V370, P236, DOI 10.1006/abbi.1999.1404; Sagara Y, 1996, J NEUROSCI, V16, P497; Salvemini F, 1999, J BIOL CHEM, V274, P2750, DOI 10.1074/jbc.274.5.2750; SCHUBERT D, 1995, BIOCHEM BIOPH RES CO, V216, P702, DOI 10.1006/bbrc.1995.2678; Schulingkamp RJ, 2000, NEUROSCI BIOBEHAV R, V24, P855, DOI 10.1016/S0149-7634(00)00040-3; SCHWARTZ M, 1983, SCIENCE, V221, P781, DOI 10.1126/science.6224294; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; SIMS NR, 1981, BIOCHEM J, V196, P867, DOI 10.1042/bj1960867; SIMS NR, 1987, BRAIN RES, V436, P30, DOI 10.1016/0006-8993(87)91553-8; SIMS NR, 1983, J NEUROCHEM, V41, P1329, DOI 10.1111/j.1471-4159.1983.tb00829.x; Smith MA, 1997, J NEUROSCI, V17, P2653; Srinivas V, 1999, BIOCHEM BIOPH RES CO, V260, P557, DOI 10.1006/bbrc.1999.0878; Strohman R, 2002, SCIENCE, V296, P701, DOI 10.1126/science.1070534; Tan S, 2001, J CELL BIOL, V152, P997, DOI 10.1083/jcb.152.5.997; Terry RD, 2000, J NEUROPATH EXP NEUR, V59, P1118, DOI 10.1093/jnen/59.12.1118; Terry Robert D., 1994, P179; THONNARDNEUMANN E, 1968, AM J PSYCHIAT, V124, P978, DOI 10.1176/ajp.124.7.978; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WEBSTER KA, 1990, J CELL PHYSIOL, V142, P566, DOI 10.1002/jcp.1041420316; WISNIEWSKI KE, 1985, NEUROLOGY, V35, P957, DOI 10.1212/WNL.35.7.957; WONG WL, 1993, BIOCHEM J, V289, P71, DOI 10.1042/bj2890071; WORTHINGTON C, 1947, WORTHINGTON ENZYME M; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Zhang ZQ, 2000, ANAL BIOCHEM, V285, P163, DOI 10.1006/abio.2000.4701	64	184	193	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2003	39	1					43	56		10.1016/S0896-6273(03)00367-2	http://dx.doi.org/10.1016/S0896-6273(03)00367-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699LB	12848931	Bronze			2022-12-24	WOS:000184057400008
J	Putcha, GV; Le, SY; Frank, S; Besirli, CG; Clark, K; Chu, BY; Alix, S; Youle, RJ; LaMarche, A; Maroney, AC; Johnson, EM				Putcha, GV; Le, SY; Frank, S; Besirli, CG; Clark, K; Chu, BY; Alix, S; Youle, RJ; LaMarche, A; Maroney, AC; Johnson, EM			JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis	NEURON			English	Article							N-TERMINAL KINASE; CEREBELLAR GRANULE CELLS; BCL-2 FAMILY MEMBERS; CYTOCHROME-C RELEASE; SYMPATHETIC NEURONS; CEP-1347 KT7515; PHOSPHATIDYLINOSITOL 3-KINASE; INDUCE APOPTOSIS; DEATH PATHWAY; RELATIVE BIM	Trophic factor deprivation (TFD) activates c-Jun N-terminal kinases (JNKs), culminating in coordinate AP1- dependent transactivation of the BH3-only BCL-2 proteins BIMEL and HRK, which in turn are critical for BAX-dependent cytochrome c release, caspase activation, and apoptosis. Here, we report that TFD caused not only induction but also phosphorylation of BIMEL. Mitochondrially localized JNKs but not upstream activators, like mixed-lineage kinases (MLKs) or mitogen-activated protein kinase kinases (MKKs), specifically phosphorylated BIMEL at Ser65, potentiating its proapoptotic activity. Inhibition of the JNK pathway attenuated BIMEL expression, prevented BIMEL phosphorylation, and abrogated TFD-induced apoptosis. Conversely, activation of this pathway promoted BIMEL expression and phosphorylation, causing BIM- and BAX-dependent cell death. Thus, JNKs regulate the proapoptotic activity of BIMEL during TFD, both transcriptionally and posttranslationally.	Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Cephalon Inc, W Chester, PA 19380 USA; NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; Upstate USA, Lake Placid, NY 12946 USA	Washington University (WUSTL); Washington University (WUSTL); Teva Pharmaceutical Industries; Cephalon Inc.; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Johnson, EM (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.			Besirli, Cagri/0000-0001-7154-2024	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002859, R01NS038651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG012947] Funding Source: NIH RePORTER; NIA NIH HHS [R37AG-12947] Funding Source: Medline; NINDS NIH HHS [R01NS38651] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2001, MAMM GENOME, V12, P163, DOI 10.1007/s003350010242; Coffey ET, 2002, J NEUROSCI, V22, P4335, DOI 10.1523/JNEUROSCI.22-11-04335.2002; Coffey ET, 2000, J NEUROSCI, V20, P7602; Crowder RJ, 1999, J NEUROCHEM, V73, P466, DOI 10.1046/j.1471-4159.1999.0730466.x; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Deverman BE, 2002, CELL, V111, P51, DOI 10.1016/S0092-8674(02)00972-8; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Eilers A, 1998, J NEUROSCI, V18, P1713; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Haase M, 1997, VIRCHOWS ARCH, V431, P441, DOI 10.1007/s004280050121; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI12466; Harris C, 2002, J NEUROCHEM, V83, P992, DOI 10.1046/j.1471-4159.2002.01219.x; Harris CA, 2001, J BIOL CHEM, V276, P37754; Harris CA, 2002, J NEUROSCI, V22, P103, DOI 10.1523/JNEUROSCI.22-01-00103.2002; Imaizumi K, 1997, J BIOL CHEM, V272, P18842, DOI 10.1074/jbc.272.30.18842; JOHNSON MI, 1983, METHOD ENZYMOL, V103, P334; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Le S, 2001, J BIOL CHEM, V276, P48332, DOI 10.1074/jbc.M106612200; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu DX, 2001, NEURON, V32, P425, DOI 10.1016/S0896-6273(01)00495-0; Maroney AC, 1999, J NEUROCHEM, V73, P1901; Maroney AC, 2001, J BIOL CHEM, V276, P25302, DOI 10.1074/jbc.M011601200; Miller TM, 1996, J NEUROSCI, V16, P7487; Miller TM, 1997, J BIOL CHEM, V272, P9847; Miller TM, 1997, J CELL BIOL, V139, P205, DOI 10.1083/jcb.139.1.205; Mota M, 2001, J NEUROSCI, V21, P4949, DOI 10.1523/JNEUROSCI.21-14-04949.2001; Moulder KL, 1999, J NEUROSCI, V19, P705; Nechushtan A, 2001, J CELL BIOL, V153, P1265, DOI 10.1083/jcb.153.6.1265; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Ogita K, 2002, J NEUROSCI, V22, P2561, DOI 10.1523/JNEUROSCI.22-07-02561.2002; Putcha GV, 2002, J CELL BIOL, V157, P441, DOI 10.1083/jcb.200110108; Putcha GV, 2001, NEURON, V29, P615, DOI 10.1016/S0896-6273(01)00238-0; Putcha GV, 2000, J CELL BIOL, V149, P1011, DOI 10.1083/jcb.149.5.1011; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Shinjyo T, 2001, MOL CELL BIOL, V21, P854, DOI 10.1128/MCB.21.3.854-864.2001; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Trotter L, 2002, NEUROSCI LETT, V320, P29, DOI 10.1016/S0304-3940(02)00005-8; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Xu X, 1997, P NATL ACAD SCI USA, V94, P12655, DOI 10.1073/pnas.94.23.12655; Xu ZH, 2001, MOL CELL BIOL, V21, P4713, DOI 10.1128/MCB.21.14.4713-4724.2001; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	53	429	438	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 19	2003	38	6					899	914		10.1016/S0896-6273(03)00355-6	http://dx.doi.org/10.1016/S0896-6273(03)00355-6			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	693AA	12818176	Bronze			2022-12-24	WOS:000183691400010
J	Lee, RC; Clandinin, TR; Lee, CH; Chen, PL; Meinertzhagen, IA; Zipursky, SL				Lee, RC; Clandinin, TR; Lee, CH; Chen, PL; Meinertzhagen, IA; Zipursky, SL			The protocadherin Flamingo is required for axon target selection in the Drosophila visual system	NATURE NEUROSCIENCE			English	Article							LAMINA-SPECIFIC CONNECTIVITY; GLIAL-CELLS; N-CADHERIN; POLARITY; EXPRESSION; GUIDANCE; EYE; ULTRASTRUCTURE; MELANOGASTER; RECEPTORS	Photoreceptor neurons (R cells) in the Drosophila visual system elaborate a precise map of visual space in the brain. The eye contains some 750 identical modules called ommatidia, each containing eight photoreceptor cells (R1-R8). Cells R1-R6 synapse in the lamina; R7 and R8 extend through the lamina and terminate in the underlying medulla. In a screen for visual behavior mutants, we identified alleles of flamingo (fmi) that disrupt the precise maps elaborated by these neurons. These mutant R1-R6 neurons select spatially inappropriate targets in the lamina. During target selection, Flamingo protein is dynamically expressed in R1-R6 growth cones. Loss of fmi function in R cells also disrupts the local pattern of synaptic terminals in the medulla, and Flamingo is transiently expressed in R8 axons as they enter the target region. We propose that Flamingo-mediated interactions between R-cell growth cones within the target field regulate target selection.	Univ Calif Los Angeles, Howard Hughes Med Inst, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; Dalhousie Univ, Life Sci Ctr, Inst Neurosci, Halifax, NS B3H 4J1, Canada	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Stanford University; Dalhousie University	Zipursky, SL (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, David Geffen Sch Med, Dept Biol Chem, Box 951662, Los Angeles, CA 90095 USA.		Lee, Chi-Hon/G-9190-2012	Meinertzhagen, Ian/0000-0002-6578-4526; Chen, Pei-Ling/0000-0001-6025-4318; Zipursky, Stephen/0000-0001-5630-7181; Lee, Chi-Hon/0000-0002-6138-711X	NEI NIH HHS [EY03592] Funding Source: Medline; NIGMS NIH HHS [GM08042] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008754] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY003592] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chae J, 1999, DEVELOPMENT, V126, P5421; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Clandinin TR, 2002, NEURON, V35, P827, DOI 10.1016/S0896-6273(02)00876-0; Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Das G, 2002, DEV CELL, V2, P655, DOI 10.1016/S1534-5807(02)00147-8; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Formstone CJ, 2001, MECH DEVELOP, V109, P91, DOI 10.1016/S0925-4773(01)00515-9; FROHLICH A, 1993, J NEUROBIOL, V24, P1642; Gao FB, 2000, NEURON, V28, P91, DOI 10.1016/S0896-6273(00)00088-X; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIRSCHFELD K, 1967, EXP BRAIN RES, V3, P248; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; MARTIN KA, 1995, NEURON, V14, P229, DOI 10.1016/0896-6273(95)90281-3; Meinertzhagen I A, 2001, Prog Brain Res, V131, P53; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Meinertzhagen IA, 1996, J NEUROSCI METH, V69, P59, DOI 10.1016/S0165-0270(96)00021-0; Meinertzhagen Ian A., 1993, P1363; Newsome TP, 2000, DEVELOPMENT, V127, P851; Perez SE, 1996, J NEUROBIOL, V30, P359, DOI 10.1002/(SICI)1097-4695(199607)30:3<359::AID-NEU5>3.0.CO;2-3; Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; STARK WS, 1986, CELL TISSUE RES, V246, P481, DOI 10.1007/BF00215187; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tissir F, 2002, MECH DEVELOP, V112, P157, DOI 10.1016/S0925-4773(01)00623-2; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; White NM, 2000, DEVELOPMENT, V127, P1681; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X	39	136	136	0	7	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					557	563		10.1038/nn1063	http://dx.doi.org/10.1038/nn1063			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12754514				2022-12-24	WOS:000183140400011
J	Vuilleumier, P; Armony, JL; Driver, J; Dolan, RJ				Vuilleumier, P; Armony, JL; Driver, J; Dolan, RJ			Distinct spatial frequency sensitivities for processing faces and emotional expressions	NATURE NEUROSCIENCE			English	Article							BILATERAL AMYGDALA DAMAGE; RETINAL GANGLION-CELLS; SUPERIOR COLLICULUS; MEDIAL PULVINAR; RECOGNITION; PERCEPTION; CORTEX; MONKEY; INPUT; IDENTIFICATION	High and low spatial frequency information in visual images is processed by distinct neural channels. Using event-related functional magnetic resonance imaging (fMRI) in humans, we show dissociable roles of such visual channels for processing faces and emotional fearful expressions. Neural responses in fusiform cortex, and effects of repeating the same face identity upon fusiform activity, were greater with intact or high-spatial-frequency face stimuli than with low-frequency faces, regardless of emotional expression. In contrast, amygdala responses to fearful expressions were greater for intact or low-frequency faces than for high-frequency faces. An activation of pulvinar and superior colliculus by fearful expressions occurred specifically with low-frequency faces, suggesting that these subcortical pathways may provide coarse fear-related inputs to the amygdala.	Univ Geneva, Ctr Med, Dept Clin Neurosci & Physiol, Lab Neurol & Imaging Cognit, CH-1211 Geneva, Switzerland; UCL, Inst Cognit Neurosci, London WC1N 3AR, England; McGill Univ, Douglas Hosp, Res Ctr, Verdun, PQ H4H 1R3, Canada; UCL, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England	University of Geneva; University of London; University College London; McGill University; University of London; University College London	Vuilleumier, P (corresponding author), Univ Geneva, Ctr Med, Dept Clin Neurosci & Physiol, Lab Neurol & Imaging Cognit, 1 Michel Servet, CH-1211 Geneva, Switzerland.	patrik.vuilleumier@medecine.unige.ch	Driver, Jon/A-4779-2010; Vuilleumier, Patrik/AAJ-1839-2021	Vuilleumier, Patrik/0000-0002-8198-9214; Dolan, Ray/0000-0001-9356-761X				Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1111, DOI 10.1016/S0028-3932(99)00039-1; BENEVENTO LA, 1983, J COMP NEUROL, V217, P307, DOI 10.1002/cne.902170307; BERSON DM, 1988, PROG BRAIN RES, V75, P17; BISTI S, 1976, VISION RES, V16, P247, DOI 10.1016/0042-6989(76)90107-3; BRUCE V, 1991, PERCEPTION, V20, P755, DOI 10.1068/p200755; Burton AM, 2001, VISION RES, V41, P3185, DOI 10.1016/S0042-6989(01)00186-9; Calder AJ, 2000, J EXP PSYCHOL HUMAN, V26, P527, DOI 10.1037/0096-1523.26.2.527; COWEY A, 1994, NEUROSCIENCE, V61, P691, DOI 10.1016/0306-4522(94)90445-6; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; FIORENTINI A, 1983, PERCEPTION, V12, P195, DOI 10.1068/p120195; George N, 1999, NAT NEUROSCI, V2, P574, DOI 10.1038/9230; Goshen-Gottstein Y, 2000, J EXP PSYCHOL LEARN, V26, P1198, DOI 10.1037//0278-7393.26.5.1198; Hamann SB, 1999, NEUROPSYCHOLOGIA, V37, P1135, DOI 10.1016/S0028-3932(99)00027-5; HARTING JK, 1980, J COMP NEUROL, V192, P853, DOI 10.1002/cne.901920414; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; HAYES T, 1986, PERCEPTION, V15, P595, DOI 10.1068/p150595; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Hill H, 1997, COGNITION, V62, P201, DOI 10.1016/S0010-0277(96)00785-8; JOHNSON MH, 1993, CORTICAL PARCELLATIO; JONES EG, 1976, BRAIN RES, V104, P142, DOI 10.1016/0006-8993(76)90654-5; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kawasaki H, 2001, NAT NEUROSCI, V4, P15, DOI 10.1038/82850; KLINE DW, 1993, HUM FACTORS, V35, P25, DOI 10.1177/001872089303500102; LeDoux J. E., 1996, EMOTIONAL BRAIN; LEVENTHAL AG, 1985, J COMP NEUROL, V237, P216, DOI 10.1002/cne.902370206; Linke R, 2000, EXP BRAIN RES, V134, P520, DOI 10.1007/s002210000475; Liu CH, 2000, J EXP PSYCHOL HUMAN, V26, P956, DOI 10.1037//0096-1523.26.3.956; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Lomber SG, 2002, P NATL ACAD SCI USA, V99, P4049, DOI 10.1073/pnas.062551899; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Morris JS, 2001, BRAIN, V124, P1241, DOI 10.1093/brain/124.6.1241; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; MORRIS JS, 1998, J COMP NEUROL, V394, P91; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Nasanen R, 1999, VISION RES, V39, P3824, DOI 10.1016/S0042-6989(99)00096-6; NORMAN J, 1987, VISION RES, V27, P87, DOI 10.1016/0042-6989(87)90145-3; O'Brien BJ, 2001, NEUROSCI LETT, V312, P145, DOI 10.1016/S0304-3940(01)02220-0; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; ROBINSON DL, 1992, TRENDS NEUROSCI, V15, P127, DOI 10.1016/0166-2236(92)90354-B; Sahraie A, 2002, EXP BRAIN RES, V143, P249, DOI 10.1007/s00221-001-0989-1; SCHILLER PH, 1979, J NEUROPHYSIOL, V42, P1124, DOI 10.1152/jn.1979.42.4.1124; Schyns PG, 1999, COGNITION, V69, P243, DOI 10.1016/S0010-0277(98)00069-9; SERGENT J, 1985, J EXP PSYCHOL HUMAN, V11, P846, DOI 10.1037/0096-1523.11.6.846; TIEGER T, 1979, PERCEPT PSYCHOPHYS, V26, P163, DOI 10.3758/BF03208310; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Weiskrantz L., 1986, BLINDSIGHT CASE STUD; Whalen PJ, 1998, J NEUROSCI, V18, P411	50	804	823	4	109	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					624	631		10.1038/nn1057	http://dx.doi.org/10.1038/nn1057			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	683GQ	12740580	Green Published			2022-12-24	WOS:000183140400020
J	Chevaleyre, V; Castillo, PE				Chevaleyre, V; Castillo, PE			Heterosynaptic LTD of hippocampal GABAergic synapses: A novel role of endocannabinoids in regulating excitability	NEURON			English	Article							LONG-TERM POTENTIATION; METABOTROPIC GLUTAMATE RECEPTORS; CANNABINOID CB1 RECEPTORS; NEONATAL RAT HIPPOCAMPUS; SYNAPTIC TRANSMISSION; ENDOGENOUS CANNABINOIDS; PYRAMIDAL CELLS; CA1 NEURONS; LASTING POTENTIATION; PURKINJE-CELLS	Neuronal excitability and long-term synaptic plasticity at excitatory synapses are critically dependent on the level of inhibition, and accordingly, changes of inhibitory synaptic efficacy should have great impact on neuronal function and neural network processing. We describe here a form of activity-dependent long-term depression at hippocampal inhibitory synapses that is triggered postsynaptically via glutamate receptor activation but is expressed presynaptically. That is, glutamate released by repetitive activation of Schaffer collaterals activates group I metabotropic glutamate receptors at CA1 pyramidal cells, triggering a persistent reduction of GABA release that is mediated by endocannabinoids. This heterosynaptic form of plasticity is involved in changes of pyramidal cell excitability associated with long-term potentiation at excitatory synapses and could account for the effects of cannabinoids on learning and memory.	Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Castillo, PE (corresponding author), Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA.			Castillo, Pablo/0000-0002-9834-1801; Chevaleyre, Vivien/0000-0002-3679-4856				ABRAHAM WC, 1987, J PHYSIOL-LONDON, V394, P367, DOI 10.1113/jphysiol.1987.sp016875; Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; Belan PV, 2002, PFLUG ARCH EUR J PHY, V444, P26, DOI 10.1007/s00424-002-0783-3; BERNARD C, 1995, J NEUROSCI, V15, P6542; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Breakwell NA, 1996, J NEUROPHYSIOL, V76, P3126, DOI 10.1152/jn.1996.76.5.3126; Breivogel CS, 1999, J NEUROCHEM, V73, P2447, DOI 10.1046/j.1471-4159.1999.0732447.x; Caillard O, 1999, J NEUROSCI, V19, P7568, DOI 10.1523/JNEUROSCI.19-17-07568.1999; Caillard O, 1999, J PHYSIOL-LONDON, V518, P109, DOI 10.1111/j.1469-7793.1999.0109r.x; Caillard O, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-17-j0002.2000; Carlson G, 2002, NAT NEUROSCI, V5, P723, DOI 10.1038/nn879; CHAVEZNORIEGA LE, 1989, NEUROSCI LETT, V104, P58, DOI 10.1016/0304-3940(89)90329-7; COLLINS DR, 1995, BRIT J PHARMACOL, V115, P869, DOI 10.1111/j.1476-5381.1995.tb15889.x; Cope DW, 2002, NEUROSCIENCE, V109, P63, DOI 10.1016/S0306-4522(01)00440-7; DAVIES CH, 1993, J PHYSIOL-LONDON, V472, P245, DOI 10.1113/jphysiol.1993.sp019945; DEISZ RA, 1989, J PHYSIOL-LONDON, V412, P513, DOI 10.1113/jphysiol.1989.sp017629; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; DINGLEDINE R, 1980, J PHYSIOL-LONDON, V305, P297, DOI 10.1113/jphysiol.1980.sp013364; GALARSA JL, 2002, TRENDS NEUROSCI, V25, P564; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; Glaum SR, 1996, J NEUROPHYSIOL, V76, P30, DOI 10.1152/jn.1996.76.1.30; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Holmgren CD, 2001, J NEUROSCI, V21, P8270; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Irving AJ, 2000, NEUROSCIENCE, V98, P253, DOI 10.1016/S0306-4522(00)00120-2; Katona I, 1999, J NEUROSCI, V19, P4544; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Komatsu Y, 1996, J NEUROSCI, V16, P6342; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; Lichtman AH, 2002, PROSTAG LEUKOTR ESS, V66, P269, DOI 10.1054/plef.2001.0351; LIU YB, 1993, J NEUROPHYSIOL, V69, P1000, DOI 10.1152/jn.1993.69.3.1000; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Mechoulam R, 1998, EUR J PHARMACOL, V359, P1, DOI 10.1016/S0014-2999(98)00649-9; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Misner DL, 1999, J NEUROSCI, V19, P6795, DOI 10.1523/JNEUROSCI.19-16-06795.1999; Ohno-Shosaku T, 2002, EUR J NEUROSCI, V15, P953, DOI 10.1046/j.1460-9568.2002.01929.x; Ouardouz M, 2000, J NEUROPHYSIOL, V84, P1414, DOI 10.1152/jn.2000.84.3.1414; Pawelzik H, 2002, J COMP NEUROL, V443, P346, DOI 10.1002/cne.10118; Pertwee R G., 2002, FATTY ACIDS, V66, P101; PITLER TA, 1992, J NEUROSCI, V12, P4122; PONCER JC, 1995, J PHYSIOL-LONDON, V485, P121, DOI 10.1113/jphysiol.1995.sp020717; PRESCOTT SM, 1983, J BIOL CHEM, V258, P764; PRINCE DA, 1978, ANNU REV NEUROSCI, V1, P395, DOI 10.1146/annurev.ne.01.030178.002143; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; ROMERO J, 1995, PHARMACOL BIOCHEM BE, V51, P731, DOI 10.1016/0091-3057(95)00023-P; Schlicker E, 2001, TRENDS PHARMACOL SCI, V22, P565, DOI 10.1016/S0165-6147(00)01805-8; Shew T, 2000, J NEUROPHYSIOL, V83, P3388, DOI 10.1152/jn.2000.83.6.3388; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; STELZER A, 1994, P NATL ACAD SCI USA, V91, P3058, DOI 10.1073/pnas.91.8.3058; STELZER A, 1987, NATURE, V326, P698, DOI 10.1038/326698a0; SUGIURA T, 2002, FATTY ACIDS, V66, P173; Sullivan JM, 2000, LEARN MEMORY, V7, P132, DOI 10.1101/lm.7.3.132; Takahashi KA, 2000, J NEUROPHYSIOL, V83, P1167, DOI 10.1152/jn.2000.83.3.1167; TERRANOVA JP, 1995, N-S ARCH PHARMACOL, V352, P576, DOI 10.1007/BF00169393; Tsou K, 1999, NEUROSCIENCE, V93, P969, DOI 10.1016/S0306-4522(99)00086-X; Vaughan CW, 1999, BRIT J PHARMACOL, V127, P935, DOI 10.1038/sj.bjp.0702636; Wang JH, 1996, J NEUROPHYSIOL, V75, P1687, DOI 10.1152/jn.1996.75.4.1687; WIGSTROM H, 1985, ACTA PHYSIOL SCAND, V125, P159, DOI 10.1111/j.1748-1716.1985.tb07703.x; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545	68	494	508	1	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 8	2003	38	3					461	472		10.1016/S0896-6273(03)00235-6	http://dx.doi.org/10.1016/S0896-6273(03)00235-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	677HF	12741992	Bronze			2022-12-24	WOS:000182800300010
J	Patel, TD; Kramer, I; Kucera, J; Niederkofler, V; Jessell, TM; Arber, S; Snider, WD				Patel, TD; Kramer, I; Kucera, J; Niederkofler, V; Jessell, TM; Arber, S; Snider, WD			Peripheral NT3 signaling is required for ETS protein expression and central patterning of proprioceptive sensory afferents	NEURON			English	Article							DORSAL-ROOT GANGLIA; TRANSCRIPTION FACTOR EGR3; MESSENGER-RNA EXPRESSION; MOTOR-NEURON POOLS; MICE LACKING; IN-VIVO; NERVOUS-SYSTEM; RECEPTOR GENE; TERMINAL ARBORIZATION; NEUROTROPHIN-3	To study the role of NT3 in directing axonal projections of proprioceptive dorsal root ganglion (DRG) neurons, NT3(-/-) mice were crossed with mice carrying a targeted deletion of the proapoptotic gene Bax. In Bax(-/-)/NT3(-/-) mice, NT3-dependent neurons survived and expressed the proprioceptive neuronal marker parvalbumin. Initial extension and collateralization of proprioceptive axons into the spinal cord occurred normally, but proprioceptive axons extended only as far as the intermediate spinal cord. This projection defect is similar to the defect in mice lacking the ETS transcription factor ER81 (Arber et al., 2000). Few if any DRG neurons from Sax(-/-)/NT3-/mice expressed ER81 protein. Expression of a NT3 transgene in muscle restored DRG ER81 expression in NTZ3(-/-) mice. Finally, addition of NT3 to DRG explant cultures resulted in induction of ER81 protein. Our data indicate that NT3 mediates the formation of proprioceptive afferent-motor neuron connections via regulation of ER81.	Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; Friedrich Miescher Inst, CH-4058 Basel, Switzerland; VA Med Ctr, Boston, MA 02130 USA; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Basel; Friedrich Miescher Institute for Biomedical Research; Columbia University; Howard Hughes Medical Institute	Snider, WD (corresponding author), Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA.			Arber, Silvia/0000-0002-6261-250X	NINDS NIH HHS [NS11025, NS31768] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS011025, R01NS031768] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Bartel FO, 2000, ONCOGENE, V19, P6443, DOI 10.1038/sj.onc.1204038; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Brown AG, 1981, ORG SPINAL CORD; Chen HH, 2002, J NEUROSCI, V22, P3512; COPRAY JCVM, 1994, DEV BRAIN RES, V81, P57, DOI 10.1016/0165-3806(94)90068-X; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794; ElShamy WM, 1996, NEURON, V16, P963, DOI 10.1016/S0896-6273(00)80119-1; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; Hippenmeyer S, 2002, NEURON, V36, P1035, DOI 10.1016/S0896-6273(02)01101-7; HONDA CN, 1995, NEUROSCIENCE, V68, P883, DOI 10.1016/0306-4522(95)00180-Q; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; KUCERA J, 1987, ANAT EMBRYOL, V176, P449, DOI 10.1007/BF00310086; KUCERA J, 1988, NEUROSCI LETT, V95, P88, DOI 10.1016/0304-3940(88)90637-4; Lentz SI, 1999, J NEUROSCI, V19, P1038; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Ma L, 2002, NEURON, V36, P623, DOI 10.1016/S0896-6273(02)01021-8; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Mendell LM, 1999, J NEUROSCI, V19, P3162; MU XJ, 1993, J NEUROSCI, V13, P4029; O'Connor R, 1999, NEURON, V24, P165, DOI 10.1016/S0896-6273(00)80830-2; OAKLEY RA, 1995, DEVELOPMENT, V121, P1341; Oakley RA, 1997, J NEUROSCI, V17, P4262; Oakley RA, 2002, DEV BIOL, V249, P255, DOI 10.1006/dbio.2002.0775; Ockel M, 1996, DEVELOPMENT, V122, P301; Patapoutian A, 1999, SCIENCE, V283, P1180, DOI 10.1126/science.283.5405.1180; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Pun S, 2002, NEURON, V34, P357, DOI 10.1016/S0896-6273(02)00670-0; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; TESSAROLLO L, 1994, P NATL ACAD SCI USA, V91, P11844, DOI 10.1073/pnas.91.25.11844; Tessarollo L, 1997, P NATL ACAD SCI USA, V94, P14776, DOI 10.1073/pnas.94.26.14776; Tourtellotte WG, 1998, NAT GENET, V20, P87, DOI 10.1038/1757; Tourtellotte WG, 2001, DEV BIOL, V232, P388, DOI 10.1006/dbio.2001.0202; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Verdi JM, 1996, NEURON, V16, P515, DOI 10.1016/S0896-6273(00)80071-9; White FA, 1996, J NEUROSCI, V16, P4662; White FA, 1998, J NEUROSCI, V18, P1428; Wright DE, 1997, NEURON, V19, P503, DOI 10.1016/S0896-6273(00)80367-0; WRIGHT DE, 1995, J COMP NEUROL, V351, P329, DOI 10.1002/cne.903510302; YAN Q, 1993, J NEUROBIOL, V24, P1555, DOI 10.1002/neu.480241202; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Zelena J, 1994, NERVES MECHANORECEPT	59	158	162	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 8	2003	38	3					403	416		10.1016/S0896-6273(03)00261-7	http://dx.doi.org/10.1016/S0896-6273(03)00261-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	677HF	12741988	Bronze, Green Published			2022-12-24	WOS:000182800300006
J	Thierry, G; Giraud, AL; Price, C				Thierry, G; Giraud, AL; Price, C			Hemispheric dissociation in access to the human semantic system	NEURON			English	Article							PURE WORD DEAFNESS; HUMAN AUDITORY-CORTEX; DUAL-CODING THEORY; FUNCTIONAL NEUROANATOMY; SPEECH-PERCEPTION; TEMPORAL-LOBE; BILATERAL LESIONS; AGNOSIA; LANGUAGE; ANATOMY	Patient studies suggest that speech and environmental sounds are differentially processed by the left and right hemispheres. Here, using functional imaging in normal subjects, we compared semantic processing of spoken words to equivalent processing of environmental sounds, after controlling for low-level perceptual differences. Words enhanced activation in left anterior and posterior superior temporal regions, while environmental sounds enhanced activation in a right posterior superior temporal region. This left/right dissociation was unchanged by different attentional/working memory contexts, but it was specific to tasks requiring semantic analysis. While semantic processing involves widely distributed networks in both hemispheres, our results support the hypothesis of a dual access route specific for verbal and nonverbal material, respectively.	Univ Wales, Sch Psychol, Bangor, Gwynedd, Wales; Univ Frankfurt, Cognit Neurol Unit, D-6000 Frankfurt, Germany; Neurol Inst, Wellcome Dept Imaging Neurosci, London, England	Bangor University; Goethe University Frankfurt; University of London; University College London	Thierry, G (corresponding author), Univ Wales, Sch Psychol, Bangor, Gwynedd, Wales.		Thierry, Guillaume/C-2688-2008	Thierry, Guillaume/0000-0003-1325-2656; Price, Catherine/0000-0001-7448-4835	Wellcome Trust [051067] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AUERBACH SH, 1982, BRAIN, V105, P271, DOI 10.1093/brain/105.2.271; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Broca P., 1861, B SOCI T ANTHROPOLOG, V2, P235; Clarke S, 2000, NEUROPSYCHOLOGIA, V38, P797, DOI 10.1016/S0028-3932(99)00141-4; COSLETT HB, 1984, NEUROLOGY, V34, P347, DOI 10.1212/WNL.34.3.347; DEMONET JF, 1994, NEUROSCI LETT, V182, P25, DOI 10.1016/0304-3940(94)90196-1; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; DIGIOVANNI M, 1992, ITAL J NEUROL SCI, V13, P507, DOI 10.1007/BF02230872; Engelien A, 1995, BRAIN, V118, P1395, DOI 10.1093/brain/118.6.1395; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; FRISTON KJ, 1995, HUMAN BRAIN MAPPING, V2, P165; FUJII T, 1990, CORTEX, V26, P263, DOI 10.1016/S0010-9452(13)80355-3; Giraud AL, 2001, J COGNITIVE NEUROSCI, V13, P754, DOI 10.1162/08989290152541421; Griffiths TD, 1997, BRAIN, V120, P785, DOI 10.1093/brain/120.5.785; Heilman KM, 1998, J CLIN NEUROPHYSIOL, V15, P409, DOI 10.1097/00004691-199809000-00005; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; HINES D, 1984, NEUROPSYCHOLOGIA, V22, P427, DOI 10.1016/0028-3932(84)90037-X; Humphries C, 2001, NEUROREPORT, V12, P1749, DOI 10.1097/00001756-200106130-00046; Jessen F, 2000, BRAIN LANG, V74, P103, DOI 10.1006/brln.2000.2340; KOUNIOS J, 1994, J EXP PSYCHOL LEARN, V20, P804, DOI 10.1037/0278-7393.20.4.804; Lichtheim Ludwig, 1885, BRAIN, V7, P433, DOI DOI 10.1093/BRAIN/7.4.433; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; MCFARLAND HR, 1982, ARCH NEUROL-CHICAGO, V39, P725, DOI 10.1001/archneur.1982.00510230051016; METZLUTZ MN, 1984, BRAIN LANG, V23, P13, DOI 10.1016/0093-934X(84)90002-6; Mummery CJ, 1999, J ACOUST SOC AM, V106, P449, DOI 10.1121/1.427068; Mummery CJ, 1998, J COGNITIVE NEUROSCI, V10, P766, DOI 10.1162/089892998563059; NISHIZAWA Y, 1982, J NEUROPHYSIOL, V48, P458, DOI 10.1152/jn.1982.48.2.458; PAIVIO A, 1991, CAN J PSYCHOL, V45, P255, DOI 10.1037/h0084295; Pell MD, 1999, CORTEX, V35, P455, DOI 10.1016/S0010-9452(08)70813-X; Pinard M, 2002, NEUROCASE, V8, P40, DOI 10.1076/neur.8.1.40.16243; Price CJ, 1996, BRAIN, V119, P919, DOI 10.1093/brain/119.3.919; ROBERTS M, 1987, J NEUROL NEUROSUR PS, V50, P1708, DOI 10.1136/jnnp.50.12.1708; Ross ED, 1997, BRAIN LANG, V56, P27, DOI 10.1006/brln.1997.1731; ROSS ED, 1981, ARCH NEUROL-CHICAGO, V38, P561, DOI 10.1001/archneur.1981.00510090055006; SAFFRAN EM, 1976, BRAIN LANG, V3, P209, DOI 10.1016/0093-934X(76)90018-3; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; SELIGER G M, 1991, Brain Injury, V5, P53, DOI 10.3109/02699059108998511; Shibahara N, 2001, PERCEPT MOTOR SKILL, V93, P649, DOI 10.2466/PMS.93.7.649-659; SPREEN O, 1965, ARCH NEUROL-CHICAGO, V13, P84, DOI 10.1001/archneur.1965.00470010088012; TAKAHASHI N, 1992, CORTEX, V28, P295, DOI 10.1016/S0010-9452(13)80056-1; Talairach J., 1988, COPLANAR STEREOTAXIC; TANAKA Y, 1987, BRAIN, V110, P381, DOI 10.1093/brain/110.2.381; Taniwaki T, 2000, CLIN NEUROL NEUROSUR, V102, P156, DOI 10.1016/S0303-8467(00)00090-1; Thierry G, 1998, NEUROIMAGE, V8, P391, DOI 10.1006/nimg.1998.0371; Thierry G, 1999, NEUROREPORT, V10, P2599, DOI 10.1097/00001756-199908200-00029; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Wernicke C., 1874, APHASICHE SYMPTOMENC; YAQUB BA, 1988, BRAIN, V111, P457, DOI 10.1093/brain/111.2.457; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	52	102	103	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 8	2003	38	3					499	506		10.1016/S0896-6273(03)00199-5	http://dx.doi.org/10.1016/S0896-6273(03)00199-5			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	677HF	12741995	Bronze			2022-12-24	WOS:000182800300013
J	He, XLL; Bazan, JF; McDermott, G; Park, JB; Wang, K; Tessier-Lavigne, M; He, ZG; Garcia, KC				He, XLL; Bazan, JF; McDermott, G; Park, JB; Wang, K; Tessier-Lavigne, M; He, ZG; Garcia, KC			Structure of the Nogo receptor ectodomain: A recognition module implicated in myelin inhibition	NEURON			English	Article							PROTEIN; GLYCOPROTEIN; IDENTIFICATION; COMPLEX; LIGAND; REGENERATION; INTERACTS	Failure of axon regeneration in the adult mammalian central nervous system (CNS) is at least partly due to inhibitory molecules associated with myelin. Recent studies suggest that an axon surface protein, the Nogo receptor (NgR), may play a role in this process through an unprecedented degree of crossreactivity with myelin-associated inhibitory ligands. Here, we report the 1.5 Angstrom crystal structure and functional characterization of a soluble extracellular domain of the human Nogo receptor. Nogo receptor adopts a leucine-rich repeat (LRR) module whose concave exterior surface contains a broad region of evolutionarily conserved patches of aromatic residues, possibly suggestive of degenerate ligand binding sites. A deep cleft at the C-terminal base of the LRR may play a role in NgR association with the p75 coreceptor. These results now provide a detailed framework for focused structure-function studies aimed at assessing the physiological relevance of NgR-mediated protein-protein interactions to axon regeneration inhibition.	Stanford Univ, Dept Microbiol & Immunol, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA; Harvard Univ, Childrens Hosp, Div Neurosci, Sch Med, Boston, MA 02115 USA; Stanford Univ, Howard Hughes Med Inst, Dept Sci Biol, Stanford, CA 94305 USA	Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Bazan, J. Fernando/B-4562-2010	Wang, Kevin/0000-0002-5305-6791				Attwood TK, 2003, NUCLEIC ACIDS RES, V31, P400, DOI 10.1093/nar/gkg030; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Fournier AE, 2002, J NEUROSCI, V22, P8876; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; Kossiakoff AA, 1999, ADV PROTEIN CHEM, V52, P67; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; MCGEE AW, 2003, IN PRESS TRENDS NEUR, V26; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oertle T, 2003, TRENDS CELL BIOL, V13, P187, DOI 10.1016/S0962-8924(03)00035-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Schwab ME, 2002, PROG BRAIN RES, V137, P351; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tessier-Lavigne M, 2000, SCIENCE, V287, P813, DOI 10.1126/science.287.5454.813; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Watari A, 2003, APOPTOSIS, V8, P5, DOI 10.1023/A:1021639016300; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Xenarios L, 2001, CURR OPIN BIOTECH, V12, P334, DOI 10.1016/S0958-1669(00)00224-X; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010	39	167	181	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 24	2003	38	2					177	185		10.1016/S0896-6273(03)00232-0	http://dx.doi.org/10.1016/S0896-6273(03)00232-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672AM	12718853	Bronze			2022-12-24	WOS:000182498300008
J	Bayley, PJ; Hopkins, RO; Squire, LR				Bayley, PJ; Hopkins, RO; Squire, LR			Successful recollection of remote autobiographical memories by amnesic patients with medial temporal lobe lesions	NEURON			English	Article							RETROGRADE-AMNESIA; HIPPOCAMPAL COMPLEX; EPISODIC MEMORIES; DAMAGE; CONSOLIDATION; HM; ACQUISITION; INFORMATION; IMPAIRMENT; RECALL	Current views about the organization of human memory make strikingly different predictions about the integrity of remote autobiographical memory following damage to the medial temporal lobe. We have carried out a detailed analysis of narrative content in memory-impaired patients for whom neuropsychological and neuroanatomical information is available. All eight patients were able to recall detailed memories from their early lives. The recollections of the patients and the recollections of 25 matched controls contained the same number of details (+/-5%) and were also similar by several other measures. The results support the view that autobiographical memories eventually become independent of the medial temporal lobe as time passes after learning. A number of other considerations suggest that the neocortex ultimately supports the capacity for recollecting remote autobiographical memory.	Univ Calif San Diego, La Jolla, CA 92093 USA; Brigham Young Univ, Provo, UT 84602 USA; Latter Day St Hosp, Salt Lake City, UT 84143 USA; Vet Affairs Med Ctr, La Jolla, CA 92161 USA	University of California System; University of California San Diego; Brigham Young University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Squire, LR (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.				PHS HHS [24600] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Amaral D.G., 1990, HUMAN NERVOUS SYSTEM; [Anonymous], 1881, MALADIES MEMOIRE; [Anonymous], 1983, CANADIAN PSYCHOL; Bayley PJ, 2002, J NEUROSCI, V22, P5741; BEATTY WW, 1987, PSYCHOL MED, V17, P657, DOI 10.1017/S0033291700025897; Cermak LS, 1984, NEUROPSYCHOLOGY MEMO, P55; Cipolotti L, 2001, NEUROPSYCHOLOGIA, V39, P151, DOI 10.1016/S0028-3932(00)00103-2; Corkin S, 2002, NAT REV NEUROSCI, V3, P153, DOI 10.1038/nrn726; Corkin S, 1997, J NEUROSCI, V17, P3964; CROVITZ HF, 1974, B PSYCHONOMIC SOC, V4, P517; Fujii T, 1999, CORTEX, V35, P599, DOI 10.1016/S0010-9452(08)70822-0; Fujii T, 2000, HDB NEUROPSYCHOLOGY; Graham KS, 1997, NEUROPSYCHOLOGY, V11, P77, DOI 10.1037/0894-4105.11.1.77; Henke K, 1999, J COGNITIVE NEUROSCI, V11, P682, DOI 10.1162/089892999563643; Hirano M, 1998, PERCEPT MOTOR SKILL, V87, P99, DOI 10.2466/pms.1998.87.1.99; HODGES JR, 1994, HDB MEMORY DISORDERS, P81; Insausti R, 1998, AM J NEURORADIOL, V19, P659; JOHNSON RE, 1970, J VERB LEARN VERB BE, V9, P12, DOI 10.1016/S0022-5371(70)80003-2; Kapur N, 1999, HIPPOCAMPUS, V9, P247, DOI 10.1002/(SICI)1098-1063(1999)9:3<247::AID-HIPO5>3.0.CO;2-W; Kopelman MD, 2002, BRAIN, V125, P2152, DOI 10.1093/brain/awf229; Kopelman MD, 2001, PHILOS T R SOC B, V356, P1409, DOI 10.1098/rstb.2001.0942; KOPELMAN MD, 1989, J CLIN EXP NEUROPSYC, V11, P724, DOI 10.1080/01688638908400928; Kopelman MD, 1999, NEUROPSYCHOLOGIA, V37, P939, DOI 10.1016/S0028-3932(98)00143-2; Levine B, 2002, PSYCHOL AGING, V17, P677, DOI 10.1037//0882-7974.17.4.677; MACKINNON DF, 1989, PSYCHOBIOLOGY, V17, P247, DOI 10.1007/BF03337776; Mayes AR, 1997, CORTEX, V33, P197, DOI 10.1016/S0010-9452(08)70001-7; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Moscovitch M, 2000, MEMORY, CONSCIOUSNESS, AND THE BRAIN, P331; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Reed JM, 1998, J NEUROSCI, V18, P3943; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Rubin DC, 1998, P NATL ACAD SCI USA, V95, P5413, DOI 10.1073/pnas.95.9.5413; SAGAR HJ, 1985, ANN NY ACAD SCI, V444, P533, DOI 10.1111/j.1749-6632.1985.tb37637.x; Schmolck H, 2002, HIPPOCAMPUS, V12, P520, DOI 10.1002/hipo.10039; SCHNIDER A, 1995, J NEUROL NEUROSUR PS, V59, P644, DOI 10.1136/jnnp.59.6.644-a; Spiers HJ, 2001, NEUROCASE, V7, P357, DOI 10.1076/neur.7.5.357.16245; Squire L. R., 1984, MEMORY CONSOLIDATION, P185; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; SQUIRE LR, 1989, EXP NEUROL, V105, P23, DOI 10.1016/0014-4886(89)90168-4; SQUIRE LR, 1986, BEHAV NEUROSCI, V100, P866, DOI 10.1037/0735-7044.100.6.866; Squire LR, 2001, HIPPOCAMPUS, V11, P50, DOI 10.1002/1098-1063(2001)11:1<50::AID-HIPO1019>3.0.CO;2-G; Stefanacci L, 2000, J NEUROSCI, V20, P7024, DOI 10.1523/JNEUROSCI.20-18-07024.2000; TULVING E, 1991, J EXP PSYCHOL LEARN, V17, P595, DOI 10.1037/0278-7393.17.4.595; Verfaellie M, 2000, NEUROPSYCHOLOGIA, V38, P484, DOI 10.1016/S0028-3932(99)00089-5; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D., 1997, WAIS 3 WECHSLER ADUL, V3rd, DOI 10.1111/j.1749-6632.1989.tb21005.x; ZOLAMORGAN S, 1983, NEUROPSYCHOLOGIA, V21, P487, DOI 10.1016/0028-3932(83)90005-2; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	48	129	134	0	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 10	2003	38	1					135	144		10.1016/S0896-6273(03)00156-9	http://dx.doi.org/10.1016/S0896-6273(03)00156-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	666XT	12691671	Bronze			2022-12-24	WOS:000182202300016
J	Gauthier, I; Curran, T; Curby, KM; Collins, D				Gauthier, I; Curran, T; Curby, KM; Collins, D			Perceptual interference supports a non-modular account of face processing	NATURE NEUROSCIENCE			English	Article							EXPERT OBJECT RECOGNITION; SELECTIVE ATTENTION; BRAIN; MECHANISMS; COMPONENT; AREA	The perception of faces and of nonface objects share common early visual processing stages. Some argue, however, that the brain eventually processes faces separately from other objects, within a domain-specific module dedicated to face perception. This apparent specialization for faces could, alternatively, result from people's expertise with this category of stimuli. Here we used behavioral and electrophysiological measures of interference to address the functional independence of face and object processing. If the expert processing of faces and cars depend on common mechanisms related to holistic perception (obligatory processing of all parts), then for human subjects who are presumed to be face experts, car perception should interfere with concurrent face perception. Furthermore, such interference should increase with greater expertise in car identification, and indeed this is what we found. Event-related potentials (ERPs) suggest that this interference arose from perceptual processes contributing to the holistic processing of both objects of expertise and faces.	Vanderbilt Univ, Vanderbilt Vis Res Ctr, Dept Psychol, Nashville, TN 37203 USA; Univ Colorado, Dept Psychol, Boulder, CO 80309 USA	Vanderbilt University; University of Colorado System; University of Colorado Boulder	Gauthier, I (corresponding author), Vanderbilt Univ, Vanderbilt Vis Res Ctr, Dept Psychol, 301 Wilson Hall, Nashville, TN 37203 USA.			Curby, Kim/0000-0001-7830-2533; Gauthier, Isabel/0000-0002-6249-4769	NEI NIH HHS [EY13441] Funding Source: Medline; NIMH NIH HHS [MH64812] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064812] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Carmel D, 2002, COGNITION, V83, P1, DOI 10.1016/S0010-0277(01)00162-7; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Gauthier I, 2002, J EXP PSYCHOL HUMAN, V28, P431, DOI 10.1037//0096-1523.28.2.431; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Kanwisher N, 1997, J NEUROSCI, V17, P4302; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; Moscovitch M, 1997, J COGNITIVE NEUROSCI, V9, P555, DOI 10.1162/jocn.1997.9.5.555; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Rossion B, 2002, PSYCHOL SCI, V13, P250, DOI 10.1111/1467-9280.00446; Tanaka JW, 2001, PSYCHOL SCI, V12, P43, DOI 10.1111/1467-9280.00308; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; Velleman P. F., 1981, APPL BASICS COMPUTIN; Wenger MJ, 2002, J EXP PSYCHOL LEARN, V28, P872, DOI 10.1037//0278-7393.28.5.872	20	301	306	1	25	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					428	432		10.1038/nn1029	http://dx.doi.org/10.1038/nn1029			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12627167				2022-12-24	WOS:000181833100022
J	Churchland, AK; Gardner, JL; Chou, IH; Priebe, NJ; Lisberger, SG				Churchland, AK; Gardner, JL; Chou, IH; Priebe, NJ; Lisberger, SG			Directional anisotropies reveal a functional segregation of visual motion processing for perception and action	NEURON			English	Article							PURSUIT EYE-MOVEMENTS; CORTICAL AREAS MT; SMOOTH-PURSUIT; MACAQUE MONKEY; NEURONS; ORIENTATION; MECHANISMS; ILLUSIONS; LESIONS; MICROSTIMULATION	Humans exhibit an anisotropy in direction perception: discrimination is superior when motion is around horizontal or vertical rather than diagonal axes. In contrast to the consistent directional anisotropy in perception, we found only small idiosyncratic anisotropies in smooth pursuit eye movements, a motor action requiring accurate discrimination of visual motion direction. Both pursuit and perceptual direction discrimination rely on signals from the middle temporal visual area (MT), yet analysis of multiple measures of MT neuronal responses in the macaque failed to provide evidence of a directional anisotropy. We conclude that MT represents different motion directions uniformly, and subsequent processing creates a directional anisotropy in pathways unique to perception. Our data support the hypothesis that, at least for visual motion, perception and action are guided by inputs from separate sensory streams. The directional anisotropy of perception appears to originate after the two streams have segregated and downstream from area MT.	Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Howard Hughes Med Inst, Dept Physiol,Neurosci Grad Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Bioengn Grad Grp, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Churchland, AK (corresponding author), Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Howard Hughes Med Inst, Dept Physiol,Neurosci Grad Program, San Francisco, CA 94143 USA.			Gardner, Justin/0000-0003-2220-5050	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		AGGLETON JP, 1983, NEUROPSYCHOLOGIA, V21, P189, DOI 10.1016/0028-3932(83)90037-4; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; BALL K, 1980, PSYCHOL REV, V87, P435, DOI 10.1037/0033-295X.87.5.435; Beutter BR, 1998, VISION RES, V38, P1273, DOI 10.1016/S0042-6989(97)00276-9; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Bruno N, 2001, TRENDS COGN SCI, V5, P379, DOI 10.1016/S1364-6613(00)01725-3; Burr DC, 2001, CURR BIOL, V11, P798, DOI 10.1016/S0960-9822(01)00183-X; Churchland AK, 2002, J NEUROPHYSIOL, V87, P2936, DOI 10.1152/jn.2002.87.6.2936; Duda R. O., 1973, PATTERN CLASSIFICATI; Dyde RT, 2002, EXP BRAIN RES, V144, P518, DOI 10.1007/s00221-002-1065-1; FARAH MJ, 1990, NEUROPSYCHOLOGIA, V28, P335, DOI 10.1016/0028-3932(90)90060-2; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Franz VH, 2001, TRENDS COGN SCI, V5, P457, DOI 10.1016/S1364-6613(00)01772-1; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; GREEN DM, 1966, SIGNAL DETECTION THE; Gros BL, 1998, J OPT SOC AM A, V15, P2003, DOI 10.1364/JOSAA.15.002003; HALLETT PE, 1976, VISION RES, V16, P99, DOI 10.1016/0042-6989(76)90083-3; HEELEY DW, 1992, VISION RES, V32, P97, DOI 10.1016/0042-6989(92)90117-2; HUK AC, 2002, J VISION, V2, pA228; INGLE D, 1982, ANAL VISUAL BEHAV, P834; Kaminski H. J., 2002, NEUROBIOLOGY EYE MOV; KELLER EL, 1991, NEUROSCI RES, V11, P79, DOI 10.1016/0168-0102(91)90048-4; Kiorpes L, 1996, J NEUROSCI, V16, P6537; KOMATSU H, 1989, J NEUROPHYSIOL, V62, P31, DOI 10.1152/jn.1989.62.1.31; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; KOWLER E, 1987, VISION RES, V27, P993, DOI 10.1016/0042-6989(87)90014-9; Krauzlis RJ, 2001, VISUAL NEUROSCI, V18, P365, DOI 10.1017/S0952523801183033; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; LISBERGER SG, 1985, J NEUROSCI, V5, P1662; LISBERGER SG, 1981, J NEUROPHYSIOL, V46, P229, DOI 10.1152/jn.1981.46.2.229; Macmillan N. A., 1991, DETECTION THEORY USE; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MILNER AD, 1991, BRAIN, V114, P405, DOI 10.1093/brain/114.1.405; MORRIS EJ, 1987, J NEUROPHYSIOL, V58, P1351, DOI 10.1152/jn.1987.58.6.1351; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; NEWSOME WT, 1985, J NEUROSCI, V5, P825; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; Priebe NJ, 2002, J NEUROPHYSIOL, V88, P354, DOI 10.1152/jn.00852.2001; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; Watamaniuk SNJ, 1999, VISION RES, V39, P59, DOI 10.1016/S0042-6989(98)00128-X; WEISKRANTZ L, 1984, BRAIN, V107, P1033, DOI 10.1093/brain/107.4.1033; ZEKI SM, 1978, NATURE, V274, P423, DOI 10.1038/274423a0	45	35	35	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 27	2003	37	6					1001	1011		10.1016/S0896-6273(03)00145-4	http://dx.doi.org/10.1016/S0896-6273(03)00145-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	661PU	12670428	Bronze			2022-12-24	WOS:000181899600013
J	Kamenetz, F; Tomita, T; Hsieh, H; Seabrook, G; Borchelt, D; Iwatsubo, T; Sisodia, S; Malinow, R				Kamenetz, F; Tomita, T; Hsieh, H; Seabrook, G; Borchelt, D; Iwatsubo, T; Sisodia, S; Malinow, R			APP processing and synaptic function	NEURON			English	Article							AMYLOID PRECURSOR PROTEIN; LONG-TERM POTENTIATION; FAMILIAL ALZHEIMERS-DISEASE; BETA-PROTEIN; AMPA RECEPTORS; A-BETA; TRANSGENIC MICE; NEUROTOXICITY; GENERATION; SECRETASE	A large body of evidence has implicated Abeta peptides and other derivatives of the amyloid precursor protein (APP) as central to the pathogenesis of Alzheimer's disease (AD). However, the functional relationship of APP and its proteolytic derivatives to neuronal electrophysiology is not known. Here, we show that neuronal activity modulates the formation and secretion of Abeta peptides in hippocampal slice neurons that overexpress APP. In turn, Abeta selectively depresses excitatory synaptic transmission onto neurons that overexpress APP, as well as nearby neurons that do not. This depression depends on NMDA-R activity and can be reversed by blockade of neuronal activity. Synaptic depression from excessive Abeta could contribute to cognitive decline during early AD. In addition, we propose that activity-dependent modulation of endogenous Abeta production may normally participate in a negative feedback that could keep neuronal hyperactivity in check. Disruption of this feedback system could contribute to disease progression in AD.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; SUNY Stony Brook, Grad Program Neurosci, Stony Brook, NY 11794 USA; Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Tokyo, Japan; Merck & Co Inc, Merck Res Labs, West Point, PA 19486 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA; Univ Chicago, Ctr Mol Neurobiol, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tokyo; Merck & Company; Johns Hopkins University; University of Chicago	Malinow, R (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	malinow@cshl.org	Tomita, Taisuke/L-5427-2015	Tomita, Taisuke/0000-0002-0075-5943	NIGMS NIH HHS [T32 GM008444] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Backskai BJ, 2001, NAT MED, V7, P369, DOI 10.1038/85525; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; COTMAN CW, 1992, NEUROBIOL AGING, V13, P587, DOI 10.1016/0197-4580(92)90060-B; Cullen WK, 1997, NEUROREPORT, V8, P3213, DOI 10.1097/00001756-199710200-00006; Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4; DESTROOPER B, 1995, EMBO J, V14, P4932, DOI 10.1002/j.1460-2075.1995.tb00176.x; Fastbom J, 1998, ALZ DIS ASSOC DIS, V12, P14, DOI 10.1097/00002093-199803000-00002; Fezoui Y, 2000, AMYLOID, V7, P166, DOI 10.3109/13506120009146831; Fitzjohn SM, 2001, J NEUROSCI, V21, P4691, DOI 10.1523/JNEUROSCI.21-13-04691.2001; Freir DB, 2001, J NEUROPHYSIOL, V85, P708, DOI 10.1152/jn.2001.85.2.708; Furukawa K, 1996, NATURE, V379, P74, DOI 10.1038/379074a0; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Howland DS, 1998, J BIOL CHEM, V273, P16576, DOI 10.1074/jbc.273.26.16576; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Iwata H, 2001, J BIOL CHEM, V276, P21678, DOI 10.1074/jbc.M007989200; JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x; JOHNSTONE EM, 1991, MOL BRAIN RES, V10, P299, DOI 10.1016/0169-328X(91)90088-F; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kim JH, 2001, J NEUROSCI, V21, P1327; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Larson J, 1999, BRAIN RES, V840, P23, DOI 10.1016/S0006-8993(99)01698-4; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Malinow R, 1999, INTRO GREEN FLUORESC; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; NITSCH RM, 1993, P NATL ACAD SCI USA, V90, P5191, DOI 10.1073/pnas.90.11.5191; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; REISBERG M, 2000, WORLD ALZH C WASH DC; Sabo SL, 2001, J CELL BIOL, V153, P1403, DOI 10.1083/jcb.153.7.1403; Sastre M, 1998, J BIOL CHEM, V273, P22351, DOI 10.1074/jbc.273.35.22351; Scanziani M, 1996, NATURE, V380, P446, DOI 10.1038/380446a0; Schlesinger S, 1999, CURR OPIN BIOTECH, V10, P434, DOI 10.1016/S0958-1669(99)00006-3; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2000, ANN NY ACAD SCI, V924, P17; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SISODIA SS, 1993, J NEUROSCI, V13, P3136; Steinbach JP, 1998, CELL DEATH DIFFER, V5, P858, DOI 10.1038/sj.cdd.4400391; Stephan A, 2001, J NEUROSCI, V21, P5703, DOI 10.1523/JNEUROSCI.21-15-05703.2001; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Winblad B, 1999, INT J GERIATR PSYCH, V14, P135, DOI 10.1002/(SICI)1099-1166(199902)14:2<135::AID-GPS906>3.0.CO;2-0; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zheng H, 1996, ANN NY ACAD SCI, V777, P421, DOI 10.1111/j.1749-6632.1996.tb34456.x; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614; Zoghbi HY, 2000, CURR OPIN NEUROBIOL, V10, P655, DOI 10.1016/S0959-4388(00)00135-5	66	1215	1275	0	88	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 27	2003	37	6					925	937		10.1016/S0896-6273(03)00124-7	http://dx.doi.org/10.1016/S0896-6273(03)00124-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	661PU	12670422	Bronze			2022-12-24	WOS:000181899600007
J	Kanai, Y; Dohmae, N; Hirokawa, N				Kanai, Y; Dohmae, N; Hirokawa, N			Kinesin transports RNA: Isolation and characterization of an RNA-transporting granule	NEURON			English	Article							LOCAL PROTEIN-SYNTHESIS; DENDRITIC TARGETING ELEMENT; IMMEDIATE-EARLY GENE; MESSENGER-RNA; PUR-ALPHA; ORGANELLE TRANSPORT; SUPERFAMILY PROTEIN; AXONAL-TRANSPORT; BINDING PROTEIN; STAUFEN PROTEIN	RNA transport is an important and fundamental event for local protein synthesis, especially in neurons. RNA is transported as large granules, but little is known about them. Here, we isolated a large RNase-sensitive granule (size: 1000Ssimilar to) as a binding partner of conventional kinesin (KIF5). We identified a total of 42 proteins with mRNAs for CaMKIIalpha and Arc in the granule. Seventeen of the proteins (hnRNP-U, Pur alpha and beta, PSF, DDX1, DDX3, SYNCRIP, TLS, NonO, HSPC117, ALY, CGI-99, staufen, three FMRPs, and EF-1alpha) were extensively investigated, including their classification, binding combinations, and necessity for the "transport" of RNA. These proteins and the mRNAs were colocalized to the kinesin-associated granules in dendrites. The granules moved bidirectionally, and the distally directed movement was enhanced by the overexpression of KIF5 and reduced by its functional blockage. Thus, kinesin transports RNA via this granule in dendrites coordinately with opposite motors, such as dynein.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan; RIKEN, Inst Phys & Chem Res, Biomol Characterizat Div, Wako, Saitama 3510198, Japan	University of Tokyo; RIKEN	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hirokawa@m.u-tokyo.ac.jp	Dohmae, Naoshi/C-2040-2011; Kanai, Yoshimitsu/W-3486-2019	Dohmae, Naoshi/0000-0002-5242-9410; Kanai, Yoshimitsu/0000-0002-0375-6853				Ainger K, 1997, J CELL BIOL, V138, P1077, DOI 10.1083/jcb.138.5.1077; BARBARESE E, 1995, J CELL SCI, V108, P2781; Bardoni B, 2001, BRAIN RES BULL, V56, P375, DOI 10.1016/S0361-9230(01)00647-5; Bassell G J, 2001, Results Probl Cell Differ, V34, P41; Bassell GJ, 1998, J NEUROSCI, V18, P251; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Blichenberg A, 2001, EUR J NEUROSCI, V13, P1881, DOI 10.1046/j.0953-816x.2001.01565.x; BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; Breitwieser W, 1996, GENE DEV, V10, P2179, DOI 10.1101/gad.10.17.2179; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640; BURGIN KE, 1990, J NEUROSCI, V10, P1788; Carson JH, 1997, CELL MOTIL CYTOSKEL, V38, P318, DOI 10.1002/(SICI)1097-0169(1997)38:4<318::AID-CM2>3.0.CO;2-#; Carson JH, 2001, CURR OPIN NEUROBIOL, V11, P558, DOI 10.1016/S0959-4388(00)00249-X; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Chanas-Sacre G, 1999, J NEUROSCI RES, V57, P62, DOI 10.1002/(SICI)1097-4547(19990701)57:1<62::AID-JNR7>3.0.CO;2-Y; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; Fukaya M, 2000, J COMP NEUROL, V426, P572; Gallia GL, 1999, J CELL BIOCHEM, V74, P334, DOI 10.1002/(SICI)1097-4644(19990901)74:3<334::AID-JCB3>3.0.CO;2-O; Gardiol A, 2001, Results Probl Cell Differ, V34, P105; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; GODBOUT R, 1993, P NATL ACAD SCI USA, V90, P7578, DOI 10.1073/pnas.90.16.7578; Goslin K., 1998, CULTURING NERVE CELL, P339; Gupta AK, 1998, J VIROL, V72, P8532, DOI 10.1128/JVI.72.11.8532-8540.1998; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hirokawa N, 1996, J CELL BIOL, V132, P667, DOI 10.1083/jcb.132.4.667; Hoek KS, 1998, BIOCHEMISTRY-US, V37, P7021, DOI 10.1021/bi9800247; Huang JD, 1999, NATURE, V397, P267, DOI 10.1038/16722; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; KANAI Y, 1995, NEURON, V14, P421, DOI 10.1016/0896-6273(95)90298-8; KANAI Y, 1992, EMBO J, V11, P3953, DOI 10.1002/j.1460-2075.1992.tb05489.x; KANAI Y, 1989, J CELL BIOL, V109, P1173, DOI 10.1083/jcb.109.3.1173; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kelm RJ, 1997, J BIOL CHEM, V272, P26727, DOI 10.1074/jbc.272.42.26727; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Kindler S, 2001, Results Probl Cell Differ, V34, P83; KISLAUSKIS EH, 1993, J CELL BIOL, V123, P165, DOI 10.1083/jcb.123.1.165; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Lai CH, 2000, GENOME RES, V10, P703, DOI 10.1101/gr.10.5.703; Li P, 1997, CELL, V90, P437, DOI 10.1016/S0092-8674(00)80504-8; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Macioce P, 2003, J CELL SCI, V116, P4847, DOI 10.1242/jcs.00805; Mallardo M, 2003, P NATL ACAD SCI USA, V100, P2100, DOI 10.1073/pnas.0334355100; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; MASAKI T, 1981, BIOCHIM BIOPHYS ACTA, V660, P44, DOI 10.1016/0005-2744(81)90106-6; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Mizutani A, 2000, J BIOL CHEM, V275, P9823, DOI 10.1074/jbc.275.13.9823; Mori Y, 2000, NAT NEUROSCI, V3, P1079, DOI 10.1038/80591; Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Ohashi S, 2002, J BIOL CHEM, V277, P37804, DOI 10.1074/jbc.M203608200; Ong LL, 2000, J BIOL CHEM, V275, P32854, DOI 10.1074/jbc.M005650200; Ouyang Y, 1999, J NEUROSCI, V19, P7823; Raymond CR, 2000, J NEUROSCI, V20, P969, DOI 10.1523/JNEUROSCI.20-03-00969.2000; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Shan JG, 2000, J BIOL CHEM, V275, P38286, DOI 10.1074/jbc.M007642200; SOWDEN J, 1995, BIOCHEM J, V308, P839, DOI 10.1042/bj3080839; Steward O, 1998, NEUROREPORT, V9, P477, DOI 10.1097/00001756-199802160-00022; Steward O, 2001, Results Probl Cell Differ, V34, P1; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Tang SJ, 2001, NEURON, V32, P463, DOI 10.1016/S0896-6273(01)00493-7; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Wallace CS, 1998, J NEUROSCI, V18, P26; WIDNELL CC, 1964, BIOCHEM J, V92, P313, DOI 10.1042/bj0920313; WilschBrauninger M, 1997, J CELL BIOL, V139, P817, DOI 10.1083/jcb.139.3.817; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Yang L, 1998, J BIOL CHEM, V273, P27761, DOI 10.1074/jbc.273.43.27761; YANG YS, 1993, MOL CELL BIOL, V13, P5593, DOI 10.1128/MCB.13.9.5593; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9; Zhang QH, 2000, GENOME RES, V10, P1546, DOI 10.1101/gr.140200	77	804	824	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 19	2004	43	4					513	525		10.1016/j.neuron.2004.07.022	http://dx.doi.org/10.1016/j.neuron.2004.07.022			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	847ZK	15312650	Bronze			2022-12-24	WOS:000223436400010
J	Marie, B; Sweeney, ST; Poskanzer, KE; Roos, J; Kelly, RB; Davis, GW				Marie, B; Sweeney, ST; Poskanzer, KE; Roos, J; Kelly, RB; Davis, GW			Dap160/intersectin scaffolds the periactive zone to achieve high-fidelity endocytosis and normal synaptic growth	NEURON			English	Article							ADAPTER PROTEIN; GENETIC-ANALYSIS; EPS15 HOMOLOGY; INTERSECTIN; MACHINERY; ENDOPHILIN; MECHANISMS; PLASTICITY; COMPONENTS; RECEPTORS	Dap160/Intersectin is a multidomain adaptor protein that colocalizes with endocytic machinery in the periactive zone at the Drosophila NMJ. We have generated severe loss-of-function mutations that eliminate Dap160 protein from the NMJ. dap160 mutant synapses have decreased levels of essential endocytic proteins, including dynamin, endophilin, synaptojanin, and AP180, while other markers of the active zone and periactive zone are generally unaltered. Functional analyses demonstrate that dap160 mutant synapses are unable to sustain high-frequency transmitter release, show impaired FM4-64 loading, and show a dramatic increase in presynaptic quantal size consistent with defects in synaptic vesicle recycling. The dap160 mutant synapse is grossly malformed with abundant, highly ramified, small synaptic boutons. We present a model in which Dap160 scaffolds both endocytic machinery and essential synaptic signaling systems to the periactive zone to coordinately control structural and functional synapse development.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Davis, GW (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 1550 4th St,GDBS 4th Floor N, San Francisco, CA 94143 USA.	gdavis@biochem.ucsf.edu		Sweeney, Sean/0000-0003-2673-9578; Marie, Bruno/0000-0002-6550-3851	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015927] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 15927] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beumer KJ, 1999, DEVELOPMENT, V126, P5833; Conroy WG, 2003, NEURON, V38, P759, DOI 10.1016/S0896-6273(03)00324-6; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Davis GW, 1997, NEURON, V19, P561, DOI 10.1016/S0896-6273(00)80372-4; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; Dustin ML, 2002, SCIENCE, V298, P785, DOI 10.1126/science.1076386; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Hussain NK, 1999, J BIOL CHEM, V274, P15671, DOI 10.1074/jbc.274.22.15671; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Koh YH, 2002, J NEUROSCI, V22, P2496, DOI 10.1523/JNEUROSCI.22-07-02496.2002; Marek KW, 2000, NEURON, V25, P537, DOI 10.1016/S0896-6273(00)81058-2; McPherson PS, 2002, TRENDS CELL BIOL, V12, P312, DOI 10.1016/S0962-8924(02)02309-7; Okamoto M, 1999, J BIOL CHEM, V274, P18446, DOI 10.1074/jbc.274.26.18446; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Preston CR, 1996, GENETICS, V144, P1623; Pucharcos C, 2000, FEBS LETT, V478, P43, DOI 10.1016/S0014-5793(00)01793-2; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Salcini AE, 1999, INT J BIOCHEM CELL B, V31, P805, DOI 10.1016/S1357-2725(99)00042-4; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Sengar AS, 1999, EMBO J, V18, P1159, DOI 10.1093/emboj/18.5.1159; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Sone M, 2000, DEVELOPMENT, V127, P4157; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Tong XK, 2000, EMBO J, V19, P1263, DOI 10.1093/emboj/19.6.1263; Torroja L, 1999, J NEUROSCI, V19, P7793; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401; Zamanian JL, 2003, MOL BIOL CELL, V14, P1624, DOI 10.1091/mbc.E02-08-0494; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9	44	163	170	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 22	2004	43	2					207	219		10.1016/j.neuron.2004.07.001	http://dx.doi.org/10.1016/j.neuron.2004.07.001			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841BX	15260957	Bronze			2022-12-24	WOS:000222905400010
J	Foster, KA; Regehr, WG				Foster, KA; Regehr, WG			Variance-mean analysis in the presence of a rapid antagonist indicates vesicle depletion underlies depression at the climbing fiber synapse	NEURON			English	Article							PAIRED-PULSE DEPRESSION; PURKINJE-CELL SYNAPSES; PROBABILITY FLUCTUATION ANALYSIS; SINGLE HIPPOCAMPAL SYNAPSES; SHORT-TERM DEPRESSION; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; HELD SYNAPSE; RECEPTOR DESENSITIZATION; MULTIVESICULAR RELEASE	Many types of synapses throughout the nervous system are transiently depressed during high-frequency stimulation. Several mechanisms have been proposed to account for this depression, including depletion of release-ready vesicles. However, numerous studies have raised doubts about the importance of depletion in depression of central synapses and have implicated alternative mechanisms, such as decreased release probability. We use variance-mean analysis to determine the mechanism of depression at the climbing fiber to Purkinje cell synapse. We find that postsynaptic receptor saturation makes it difficult to distinguish between a decrease in available vesicles and a reduction in release probability. When AMPA receptor saturation is relieved with a low-affinity antagonist, variance-mean analysis reveals that depression arises from a decrease in the number of release-ready vesicles. Vesicle depletion is prominent, despite numerous docked vesicles at each release site, due to multivesicular release. We conclude that vesicle depletion can contribute significantly to depression of central synapses.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Regehr, WG (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	wade_regehr@hms.harvard.edu			NINDS NIH HHS [R01-NS432405] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Auger C, 1998, J NEUROSCI, V18, P4532; Bellingham MC, 1999, NEURON, V23, P159, DOI 10.1016/S0896-6273(00)80762-X; Brody DL, 2000, J NEUROSCI, V20, P2480; Burrone J, 2000, J NEUROSCI, V20, P568, DOI 10.1523/JNEUROSCI.20-02-00568.2000; Chen CF, 2002, NEURON, V33, P779, DOI 10.1016/S0896-6273(02)00611-6; Chen G, 2004, P NATL ACAD SCI USA, V101, P1063, DOI 10.1073/pnas.0307149101; Clements JD, 2000, TRENDS NEUROSCI, V23, P105, DOI 10.1016/S0166-2236(99)01520-9; Conti R, 2003, P NATL ACAD SCI USA, V100, P4885, DOI 10.1073/pnas.0630290100; Dittman JS, 1998, J NEUROSCI, V18, P6147; Dzubay JA, 1999, J NEUROSCI, V19, P5265; Foster KA, 2002, NEURON, V36, P1115, DOI 10.1016/S0896-6273(02)01106-6; Glantz SA., 1997, PRIMER BIOSTATISTICS; Harrison J, 2003, J NEUROSCI, V23, P377, DOI 10.1523/JNEUROSCI.23-02-00377.2003; Hashimoto K, 2003, NEURON, V38, P785, DOI 10.1016/S0896-6273(03)00298-8; Hashimoto K, 1998, J PHYSIOL-LONDON, V506, P391, DOI 10.1111/j.1469-7793.1998.391bw.x; HERRINGTON J, 1995, PULSE CONTROL V4 5 I; Humeau Y, 2001, P NATL ACAD SCI USA, V98, P15300, DOI 10.1073/pnas.261358698; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; Kreitzer AC, 2000, NEURON, V27, P25, DOI 10.1016/S0896-6273(00)00006-4; Larramendi LMH, 1969, NEUROBIOLOGY CEREBEL, P803; LILEY AW, 1953, J NEUROPHYSIOL, V16, P509, DOI 10.1152/jn.1953.16.5.509; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Matveev V, 2000, J NEUROSCI, V20, P1575; Meyer AC, 2001, J NEUROSCI, V21, P7889, DOI 10.1523/JNEUROSCI.21-20-07889.2001; MILEDI R, 1966, NATURE, V212, P1233, DOI 10.1038/2121233a0; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Palay S.L., 1974, CEREBELLAR CORTEX; Quastel DMJ, 1997, BIOPHYS J, V72, P728, DOI 10.1016/S0006-3495(97)78709-5; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; REGEHR WG, 1994, NEURON, V12, P605, DOI 10.1016/0896-6273(94)90216-X; ROSSI F, 1993, NEUROSCIENCE, V53, P759, DOI 10.1016/0306-4522(93)90622-M; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Scheuss V, 2002, J NEUROSCI, V22, P728, DOI 10.1523/JNEUROSCI.22-03-00728.2002; Scheuss V, 2001, BIOPHYS J, V81, P1970, DOI 10.1016/S0006-3495(01)75848-1; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schneggenburger R, 2002, TRENDS NEUROSCI, V25, P206, DOI 10.1016/S0166-2236(02)02139-2; Silver RA, 2003, J NEUROSCI METH, V130, P127, DOI 10.1016/j.jneumeth.2003.09.030; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Sippy T, 2003, NAT NEUROSCI, V6, P1031, DOI 10.1038/nn1117; Thomson AM, 1999, J PHYSIOL-LONDON, V519, P57, DOI 10.1111/j.1469-7793.1999.0057o.x; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; VEREJONE.D, 1966, AUST J STAT, V8, P53, DOI 10.1111/j.1467-842X.1966.tb00164.x; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Waldeck RF, 2000, J NEUROSCI, V20, P5312, DOI 10.1523/JNEUROSCI.20-14-05312.2000; Watkins J C, 1990, Adv Exp Med Biol, V268, P49; Wong AYC, 2003, J NEUROSCI, V23, P4868; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001; ZENGEL JE, 1980, J GEN PHYSIOL, V76, P175, DOI 10.1085/jgp.76.2.175; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	54	71	72	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 8	2004	43	1					119	131		10.1016/j.neuron.2004.06.022	http://dx.doi.org/10.1016/j.neuron.2004.06.022			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233922	Bronze			2022-12-24	WOS:000222549800012
J	Lee, SJ; Montell, C				Lee, SJ; Montell, C			Light-dependent translocation of visual arrestin regulated by the NINAC myosin III	NEURON			English	Article							ROD PHOTORECEPTOR CELLS; RHODOPSIN PHOSPHORYLATION; ACTIN-FILAMENTS; S-ANTIGEN; DROSOPHILA; BINDING; ADAPTATION; PROTEINS; RETINA; PHOTOTRANSDUCTION	The rhodopsin regulatory protein, visual arrestin, undergoes light-dependent trafficking in mammalian and Drosophila photoreceptor cells, though the mechanisms underlying these movements are poorly understood. In Drosophila, the movement of the visual arrestin, Arr2, functions in long-term adaptation and is dependent on interaction with phosphoinositides (PIs). However, the basis for the requirement for PIs for light-dependent shuttling was unclear. Here, we demonstrated that the dynamic trafficking of Arr2 into the phototransducing compartment, the rhabdomere, required the eye-enriched myosin III, NINAC. We showed that defects in ninaC resulted in a long-term adaptation phenotype similar to that which occurred in arr2 mutants. The interaction between Arr2 and NINAC was PI dependent and NINAC bound directly to PIs. These data demonstrate that the light-dependent translocation of Arr2 into the rhabdomeres requires PI-mediated interactions between Arr2 and the NINAC myosin III.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	cmontell@jhmi.edu	Lee, Seung Jae V/E-2468-2019; Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482; Lee, Seung-Jae/0000-0002-6103-156X	NATIONAL EYE INSTITUTE [R01EY008117] Funding Source: NIH RePORTER; NEI NIH HHS [EY08117] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Alloway PG, 1999, P NATL ACAD SCI USA, V96, P6072, DOI 10.1073/pnas.96.11.6072; ARIKAWA K, 1990, J CELL BIOL, V110, P1993, DOI 10.1083/jcb.110.6.1993; Arshavsky VY, 2002, TRENDS NEUROSCI, V25, P124, DOI 10.1016/S0166-2236(00)02094-4; ARSHAVSKY VY, 2003, SCI STKE, pPE43; Bahner M, 2002, NEURON, V34, P83, DOI 10.1016/S0896-6273(02)00630-X; BROEKHUYSE RM, 1985, CURR EYE RES, V4, P613, DOI 10.3109/02713688508999993; Deng WM, 1999, J CELL SCI, V112, P3677; Dose AC, 2003, MOL BIOL CELL, V14, P1058, DOI 10.1091/mbc.E02-06-0317; Dose AC, 2002, GENOMICS, V79, P621, DOI 10.1006/geno.2002.6749; Dose AC, 2000, GENOMICS, V67, P333, DOI 10.1006/geno.2000.6256; Hardie RC, 2003, CURR BIOL, V13, pR775, DOI 10.1016/j.cub.2003.09.021; Hicks JL, 1996, CELL MOTIL CYTOSKEL, V35, P367, DOI 10.1002/(SICI)1097-0169(1996)35:4<367::AID-CM8>3.0.CO;2-3; KAMPS MP, 1986, MOL CELL BIOL, V6, P751, DOI 10.1128/MCB.6.3.751; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; Komaba S, 2003, J BIOL CHEM, V278, P21352, DOI 10.1074/jbc.M300757200; Kosloff M, 2003, EMBO J, V22, P459, DOI 10.1093/emboj/cdg054; Lee SJ, 2003, NEURON, V39, P121, DOI 10.1016/S0896-6273(03)00390-8; Lee SJ, 2001, NEURON, V32, P1097, DOI 10.1016/S0896-6273(01)00538-4; MANGINI NJ, 1994, VISUAL NEUROSCI, V11, P561, DOI 10.1017/S0952523800002467; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; McGinnis JF, 2002, J NEUROSCI RES, V67, P290, DOI 10.1002/jnr.10120; Mendez A, 2003, J NEUROSCI, V23, P3124; MONTELL C, 1988, CELL, V52, P757, DOI 10.1016/0092-8674(88)90413-8; PALCZEWSKI K, 1991, FEBS LETT, V295, P195, DOI 10.1016/0014-5793(91)81416-6; PHILP NJ, 1987, FEBS LETT, V225, P127, DOI 10.1016/0014-5793(87)81144-4; PORTER JA, 1992, J CELL BIOL, V116, P683, DOI 10.1083/jcb.116.3.683; PORTER JA, 1995, EMBO J, V14, P4450, DOI 10.1002/j.1460-2075.1995.tb00124.x; PORTER JA, 1993, SCIENCE, V262, P1038, DOI 10.1126/science.8235618; PORTER JA, 1993, J CELL BIOL, V122, P601, DOI 10.1083/jcb.122.3.601; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Walsh T, 2002, P NATL ACAD SCI USA, V99, P7518, DOI 10.1073/pnas.102091699; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; WHELAN JP, 1988, J NEUROSCI RES, V20, P263, DOI 10.1002/jnr.490200216; Wolfrum U, 2000, CELL MOTIL CYTOSKEL, V46, P95, DOI 10.1002/1097-0169(200006)46:2<95::AID-CM2>3.0.CO;2-Q; Zhang HB, 2003, MOL VIS, V9, P231	36	65	67	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 8	2004	43	1					95	103		10.1016/j.neuron.2004.06.014	http://dx.doi.org/10.1016/j.neuron.2004.06.014			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233920	Bronze			2022-12-24	WOS:000222549800010
J	Beauchamp, MS; Lee, KE; Argall, BD; Martin, A				Beauchamp, MS; Lee, KE; Argall, BD; Martin, A			Integration of auditory and visual information about objects in superior temporal sulcus	NEURON			English	Article							HUMAN CEREBRAL-CORTEX; HUMAN NEURAL SYSTEMS; MACAQUE MONKEY; HUMAN BRAIN; AUDIOVISUAL INTEGRATION; MANIPULATABLE OBJECTS; HEMISPHERIC LESIONS; CROSSMODAL BINDING; PROCESSING STREAMS; PREFRONTAL CORTEX	Two categories of objects in the environment-animals and man-made manipulable objects (tools)-are easily recognized by either their auditory or visual features. Although these features differ across modalities, the brain integrates them into a coherent percept. In three separate fMRI experiments, posterior superior temporal sulcus and middle temporal gyrus (pSTS/MTG) fulfilled objective criteria for an integration site. pSTS/MTG showed signal increases in response to either auditory or visual stimuli and responded more to auditory or visual objects than to meaningless (but complex) control stimuli. pSTS/MTG showed an enhanced response when auditory and visual object features were presented together, relative to presentation in a single modality. Finally, pSTS/MTG responded more to object identification than to other components of the behavioral task. We suggest that pSTS/MTG is specialized for integrating different types of information both within modalities (e.g., visual form, visual motion) and across modalities (auditory and visual).	NIMH, Lab Brain & Cognit, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Beauchamp, MS (corresponding author), NIMH, Lab Brain & Cognit, Bethesda, MD 20892 USA.	mbeauchamp@nih.gov	Beauchamp, Michael/AAK-9813-2020; martin, alex/B-6176-2009; Argall, Brenna/G-2543-2011	Beauchamp, Michael/0000-0002-7599-9934; 	NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002588, Z01MH002588] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adams RB, 2002, NEUROIMAGE, V16, P361, DOI 10.1006/nimg.2002.1088; Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Amedi A, 2002, CEREB CORTEX, V12, P1202, DOI 10.1093/cercor/12.11.1202; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Baumgart F, 1999, NATURE, V400, P724, DOI 10.1038/23390; Beauchamp MS, 2003, J COGNITIVE NEUROSCI, V15, P991, DOI 10.1162/089892903770007380; Beauchamp MS, 2002, NEURON, V34, P149, DOI 10.1016/S0896-6273(02)00642-6; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; BELLN P, 2002, BRAIN RES COGN BRAIN, V13, P17; BENEVENTO LA, 1977, EXP NEUROL, V57, P849, DOI 10.1016/0014-4886(77)90112-1; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; Buchel C, 1998, NATURE, V394, P274, DOI 10.1038/28389; Buckner RL, 2000, BRAIN, V123, P620, DOI 10.1093/brain/123.3.620; Bushara KO, 1999, NAT NEUROSCI, V2, P759, DOI 10.1038/11239; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 1999, NEUROREPORT, V10, P2619, DOI 10.1097/00001756-199908200-00033; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Carpenter PA, 1999, J COGNITIVE NEUROSCI, V11, P9, DOI 10.1162/089892999563210; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Clarke S, 2000, NEUROPSYCHOLOGIA, V38, P797, DOI 10.1016/S0028-3932(99)00141-4; Clarke S, 2002, EXP BRAIN RES, V147, P8, DOI 10.1007/s00221-002-1203-9; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Depireux DA, 2001, J NEUROPHYSIOL, V85, P1220, DOI 10.1152/jn.2001.85.3.1220; Devlin JT, 2002, NEUROIMAGE, V15, P675, DOI 10.1006/nimg.2001.1002; Engelien A, 1995, BRAIN, V118, P1395, DOI 10.1093/brain/118.6.1395; Erickson CA, 1999, J NEUROSCI, V19, P10404; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Goldman-Rakic PS, 1999, BIOL PSYCHIAT, V46, P650, DOI 10.1016/S0006-3223(99)00130-4; Griffiths TD, 1996, NATURE, V383, P425, DOI 10.1038/383425a0; Hall DA, 2002, CEREB CORTEX, V12, P140, DOI 10.1093/cercor/12.2.140; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; Ishai A, 2000, NEURON, V28, P979, DOI 10.1016/S0896-6273(00)00168-9; James TW, 2002, NEUROPSYCHOLOGIA, V40, P1706, DOI 10.1016/S0028-3932(02)00017-9; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Klein DJ, 2000, J COMPUT NEUROSCI, V9, P85, DOI 10.1023/A:1008990412183; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Lewis JW, 2000, CEREB CORTEX, V10, P873, DOI 10.1093/cercor/10.9.873; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Martin A, 2001, CURR OPIN NEUROBIOL, V11, P194, DOI 10.1016/S0959-4388(00)00196-3; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Naya Y, 2003, J NEUROSCI, V23, P2861; Naya Y, 2001, SCIENCE, V291, P661, DOI 10.1126/science.291.5504.661; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; Oram MW, 1996, J NEUROPHYSIOL, V76, P109, DOI 10.1152/jn.1996.76.1.109; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PETERSEN SE, 1993, ANNU REV NEUROSCI, V16, P509, DOI 10.1146/annurev.ne.16.030193.002453; Poremba A, 2003, SCIENCE, V299, P568, DOI 10.1126/science.1078900; Puce A, 2003, NEUROIMAGE, V19, P861, DOI 10.1016/S1053-8119(03)00189-7; Puce A, 1996, J NEUROSCI, V16, P5205; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192, DOI 10.1152/jn.1995.74.3.1192; Puce A, 1998, J NEUROSCI, V18, P2188; Raij T, 2000, NEURON, V28, P617, DOI 10.1016/S0896-6273(00)00138-0; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rauschecker JP, 1997, ACTA OTO-LARYNGOL, P34; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2723, DOI 10.1152/jn.2000.83.5.2723; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Saygin AP, 2003, BRAIN, V126, P928, DOI 10.1093/brain/awg082; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; SELFRITZ E, 2002, SCIENCE, V297, P1706; Seltzer B, 1996, J COMP NEUROL, V370, P173, DOI 10.1002/(SICI)1096-9861(19960624)370:2<173::AID-CNE4>3.0.CO;2-#; Stein BE., 1993, MERGING SENSES; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanaka K, 2003, CEREB CORTEX, V13, P90, DOI 10.1093/cercor/13.1.90; Thompson-Schill SL, 2003, NEUROPSYCHOLOGIA, V41, P280, DOI 10.1016/S0028-3932(02)00161-6; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Tranel D, 2003, NEUROPSYCHOLOGIA, V41, P847, DOI 10.1016/S0028-3932(02)00223-3; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Wagner AD, 1999, PHILOS T R SOC B, V354, P1307, DOI 10.1098/rstb.1999.0481; Warren JD, 2002, NEURON, V34, P139, DOI 10.1016/S0896-6273(02)00637-2; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Zatorre RJ, 2002, NAT NEUROSCI, V5, P905, DOI 10.1038/nn904; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946	90	528	531	3	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 4	2004	41	5					809	823		10.1016/S0896-6273(04)00070-4	http://dx.doi.org/10.1016/S0896-6273(04)00070-4			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KD	15003179	Bronze			2022-12-24	WOS:000221458200015
J	Binder, JR; Liebenthal, E; Possing, ET; Medler, DA; Ward, BD				Binder, JR; Liebenthal, E; Possing, ET; Medler, DA; Ward, BD			Neural correlates of sensory and decision processes in auditory object identification	NATURE NEUROSCIENCE			English	Article							TEMPORAL-LOBE; REACTION-TIME; HUMAN-BRAIN; PREFRONTAL CORTEX; RHESUS-MONKEY; SPEECH; TASK; FMRI; ACTIVATION; SOUNDS	Physiological studies of auditory perception have not yet clearly distinguished sensory from decision processes. In this experiment, human participants identified speech sounds masked by varying levels of noise while blood oxygenation signals in the brain were recorded with functional magnetic resonance imaging (fMRI). Accuracy and response time were used to characterize the behavior of sensory and decision components of this perceptual system. Oxygenation signals in a cortical subregion just anterior and lateral to primary auditory cortex predicted accuracy of sound identification, whereas signals in an inferior frontal region predicted response time. Our findings provide neurophysiological evidence for a functional distinction between sensory and decision mechanisms underlying auditory object identification. The present results also indicate a link between inferior frontal lobe activation and response-selection processes during auditory perception tasks.	Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Binder, JR (corresponding author), Med Coll Wisconsin, Dept Neurol, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.	jbinder@mcw.edu	Liebenthal, Einat/AAO-9781-2020; Binder, Jeff/CAJ-3303-2022	Binder, Jeffrey/0000-0002-2233-5640; Liebenthal, Einat/0000-0003-4917-8160	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH051358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006287] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00058] Funding Source: Medline; NIDCD NIH HHS [R01 DC006287] Funding Source: Medline; NIMH NIH HHS [P01 MH51358] Funding Source: Medline; NINDS NIH HHS [R01 NS33576] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adler CM, 2001, SYNAPSE, V42, P266, DOI 10.1002/syn.1112; Belin P, 2002, COGNITIVE BRAIN RES, V13, P17, DOI 10.1016/S0926-6410(01)00084-2; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Binder JR, 2001, HDB FUNCTIONAL NEURO, P187; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Burton MW, 2000, J COGNITIVE NEUROSCI, V12, P679, DOI 10.1162/089892900562309; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Davis MH, 2003, J NEUROSCI, V23, P3423; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; DONDERS FC, 1969, ACTA PSYCHOL, V30, P412, DOI 10.1016/0001-6918(69)90065-1; Fant G., 1973, SPEECH SOUNDS FEATUR; FIEZ JA, 1995, J COGNITIVE NEUROSCI, V7, P357, DOI 10.1162/jocn.1995.7.3.357; GALABURDA AM, 1983, J COMP NEUROL, V221, P169, DOI 10.1002/cne.902210206; GALABURDA AM, 1978, ARCH NEUROL-CHICAGO, V35, P812, DOI 10.1001/archneur.1978.00500360036007; Grabowski TJ., 2000, BRAIN MAPPING SYSTEM, P425, DOI [10.1016/B978-012692545-6/50016-7, DOI 10.1016/B978-012692545-6/50016-7]; GREEN DM, 1966, SIGNAL DETECTION THE; GRICE GR, 1982, J EXP PSYCHOL GEN, V111, P135, DOI 10.1037/0096-3445.111.1.135; Hall DA, 2000, HUM BRAIN MAPP, V10, P107, DOI 10.1002/1097-0193(200007)10:3<107::AID-HBM20>3.0.CO;2-8; Honey GD, 2000, NEUROIMAGE, V12, P495, DOI 10.1006/nimg.2000.0624; Horovitz SG, 2002, MAGN RESON IMAGING, V20, P319, DOI 10.1016/S0730-725X(02)00496-4; Ito SI, 2001, NEUROSCI RES, V41, P257, DOI 10.1016/S0168-0102(01)00287-5; Johnson PWM, 1997, ANN ONCOL, V8, P65, DOI 10.1023/A:1008234301024; Kaas JH, 1998, AUDIOL NEURO-OTOL, V3, P73, DOI 10.1159/000013783; Kleist K, 1962, SENSORY APHASIA AMUS; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Lewis JW, 2000, CEREB CORTEX, V10, P873, DOI 10.1093/cercor/10.9.873; Liebenthal E, 2003, J COGNITIVE NEUROSCI, V15, P549, DOI 10.1162/089892903321662930; MECKLINGER A, 1994, PSYCHOPHYSIOLOGY, V31, P23, DOI 10.1111/j.1469-8986.1994.tb01021.x; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Meyer A, 1908, J PSYCHOL NEUROL, V13, P203; Naatanen R, 2001, PSYCHOPHYSIOLOGY, V38, P1, DOI 10.1017/S0048577201000208; NORRIS D, 2000, NEW COGNITIVE NEUROS, P867; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Price CJ, 1996, BRAIN, V119, P919, DOI 10.1093/brain/119.3.919; RADEMACHER J, 1993, CEREB CORTEX, V3, P313, DOI 10.1093/cercor/3.4.313; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Talairach J., 1988, COPLANAR STEREOTAXIC; TALLAL P, 1993, ANN NY ACAD SCI, V682, P27, DOI 10.1111/j.1749-6632.1993.tb22957.x; TAYLOR SF, 1994, NEUROPSYCHOLOGIA, V32, P249, DOI 10.1016/0028-3932(94)90010-8; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Warren JD, 2003, J NEUROSCI, V23, P5799; YELLOTT JI, 1971, J MATH PSYCHOL, V8, P159, DOI 10.1016/0022-2496(71)90011-3; Zatorre R. J., 2000, BRAIN MAPPING SYSTEM, P365; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	50	363	365	0	33	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					295	301		10.1038/nn1198	http://dx.doi.org/10.1038/nn1198			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14966525				2022-12-24	WOS:000189197900020
J	Guo, H; Liu, D; Gelbard, H; Cheng, T; Insalaco, R; Fernandez, JA; Griffin, JH; Zlokovic, BV				Guo, H; Liu, D; Gelbard, H; Cheng, T; Insalaco, R; Fernandez, JA; Griffin, JH; Zlokovic, BV			Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3	NEURON			English	Article							METHYL-D-ASPARTATE; STAUROSPORINE-INDUCED APOPTOSIS; TISSUE-PLASMINOGEN ACTIVATOR; HUMAN BRAIN ENDOTHELIUM; CELL-DEATH; CEREBROCORTICAL NEURONS; SIGNALING PATHWAYS; THROMBIN RECEPTOR; ISCHEMIC-STROKE; SEVERE SEPSIS	Activated protein C (APC), a serine protease with anticoagulant and anti-inflammatory activities, exerts direct cytoprotective effects on endothelium via endothelial protein C receptor-dependent activation of protease activated receptor 1 (PAR1). Here, we report that APC protects mouse cortical neurons from two divergent inducers of apoptosis, N-methyl-D-aspartate (NMDA) and staurosporine. APC blocked several steps in NMDA-induced apoptosis downstream to nitric oxide, i.e., caspase-3 activation, nuclear translocation of apoptosis-inducing factor (AIF), and induction of p53, and prevented staurosporine-induced apoptosis by blocking caspase-8 activation upstream of caspase-3 activation and AIF nuclear translocation. Intracerebral APC infusion dose dependently reduced NMDA excitotoxicity in mice. By using different anti-PARs antibodies and mice with single PAR1, PAR3, or PAR4 deletion, we demonstrated that direct neuronal protective effects of APC in vitro and in vivo require PAR1 and PAR3. Thus, PAR1 and PAR3 mediate anti-apoptotic signaling by APC in neurons, which may suggest novel treatments for neurodegenerative disorders.	Socratech Lab, Rochester, NY 14620 USA; Univ Rochester, Med Ctr, Ctr Aging & Dev Biol,Dept Nrurosurg, Div Neurovasc Biol,Frank P Smith Neurosurg Res La, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	University of Rochester; University of Rochester; Scripps Research Institute	Zlokovic, BV (corresponding author), Socratech Lab, Rochester, NY 14620 USA.	berislav_zlokovic@urmc.rochester.edu	Fernandez, Jose A/A-3211-2008; Gelbard, Harris/M-9260-2019	Fernandez, Jose A/0000-0002-0804-1865; Griffin, John/0000-0002-4302-2547; Gelbard, Harris/0000-0001-5095-7976	NHLBI NIH HHS [HL63290] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063290] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Arnoult D, 2002, J CELL BIOL, V159, P923, DOI 10.1083/jcb.200207071; Ayata C, 1997, J NEUROSCI, V17, P6908; Bahou WF, 2003, CURR TOP DEV BIOL, V54, P343, DOI 10.1016/S0070-2153(03)54014-5; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Brune B, 2003, TOXICOL LETT, V139, P119, DOI 10.1016/S0378-4274(02)00426-5; Budd SL, 2000, P NATL ACAD SCI USA, V97, P6161, DOI 10.1073/pnas.100121097; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Coughlin SR, 2003, J CLIN INVEST, V111, P25, DOI 10.1172/JCI200317564; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; da Costa CA, 2003, J BIOL CHEM, V278, P12064, DOI 10.1074/jbc.M212379200; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Djebaili M, 2000, NEUROREPORT, V11, P2973, DOI 10.1097/00001756-200009110-00029; Domotor E, 2003, BLOOD, V101, P4797, DOI 10.1182/blood-2002-12-3680; Donovan FM, 1998, J BIOL CHEM, V273, P12746, DOI 10.1074/jbc.273.21.12746; Du YS, 1997, P NATL ACAD SCI USA, V94, P11657, DOI 10.1073/pnas.94.21.11657; Fernandez JA, 2003, BLOOD CELL MOL DIS, V30, P271, DOI 10.1016/S1079-9796(03)00034-2; Gabriel B, 2003, EXP CELL RES, V289, P195, DOI 10.1016/S0014-4827(03)00255-6; Griffin JH, 2002, SEMIN HEMATOL, V39, P197, DOI 10.1053/shem.2002.34093; Isermann B, 2003, NAT MED, V9, P331, DOI 10.1038/nm825; Jordan J, 2003, NEUROSCIENCE, V122, P707, DOI 10.1016/j.neuroscience.2003.08.030; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Le DA, 2001, DRUG AGING, V18, P717, DOI 10.2165/00002512-200118100-00001; Matys T, 2003, NAT MED, V9, P371, DOI 10.1038/nm0403-371; McInnis J, 2002, J PHARMACOL EXP THER, V301, P478, DOI 10.1124/jpet.301.2.478; Morrison RS, 2003, NEUROCHEM RES, V28, P15, DOI 10.1023/A:1021687810103; Mosnier LO, 2003, BIOCHEM J, V373, P65, DOI 10.1042/BJ20030341; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Okamoto S, 2002, P NATL ACAD SCI USA, V99, P3974, DOI 10.1073/pnas.022036399; Paitel E, 2004, J BIOL CHEM, V279, P612, DOI 10.1074/jbc.M310453200; Penninger JM, 2003, NAT CELL BIOL, V5, P97, DOI 10.1038/ncb0203-97; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Ruf W, 2003, NAT MED, V9, P257, DOI 10.1038/nm0303-258; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Sakhi S, 1997, EXP NEUROL, V145, P81, DOI 10.1006/exnr.1997.6451; Shibata M, 2001, CIRCULATION, V103, P1799, DOI 10.1161/01.CIR.103.13.1799; Striggow F, 2001, EUR J NEUROSCI, V14, P595, DOI 10.1046/j.0953-816x.2001.01676.x; Striggow F, 2000, P NATL ACAD SCI USA, V97, P2264, DOI 10.1073/pnas.040552897; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tenneti L, 2000, J NEUROCHEM, V74, P134, DOI 10.1046/j.1471-4159.2000.0740134.x; Tieu K, 1999, J NEUROSCI RES, V58, P426, DOI 10.1002/(SICI)1097-4547(19991101)58:3<426::AID-JNR8>3.3.CO;2-6; Uberti D, 1998, EUR J NEUROSCI, V10, P246, DOI 10.1046/j.1460-9568.1998.00042.x; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wang XD, 2001, GENE DEV, V15, P2922; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	51	224	232	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 19	2004	41	4					563	572		10.1016/S0896-6273(04)00019-4	http://dx.doi.org/10.1016/S0896-6273(04)00019-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980205	Bronze			2022-12-24	WOS:000221458100009
J	Beedle, AM; McRory, JE; Poirot, O; Doering, CJ; Altier, C; Barrere, C; Hamid, J; Nargeot, J; Bourinet, E; Zamponi, GW				Beedle, AM; McRory, JE; Poirot, O; Doering, CJ; Altier, C; Barrere, C; Hamid, J; Nargeot, J; Bourinet, E; Zamponi, GW			Agonist-independent modulation of N-type calcium channels by ORL1 receptors	NATURE NEUROSCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; 2ND INTRACELLULAR LOOP; RAT SPINAL-CORD; NOCICEPTIN/ORPHANIN FQ; MORPHINE-TOLERANCE; SENSORY NEURONS; CA2+ CHANNELS; ORPHANIN FQ; INHIBITION; EXPRESSION	We have investigated modulation of voltage-gated calcium channels by nociceptin (ORL1) receptors. In rat DRG neurons and in tsA-201 cells, nociceptin mediated a pronounced inhibition of N-type calcium channels, whereas other calcium channel subtypes were unaffected. In tsA-201 cells, expression of N-type channels with human ORL1 resulted in a voltage-dependent G-protein inhibition of the channel that occurred in the absence of nociceptin, the ORL1 receptor agonist. Consistent with this observation, native N-type channels of small nociceptive dorsal root ganglion (DRG) neurons also had tonic inhibition by G proteins. Biochemical characterization showed the existence of an N-type calcium channel-ORL1 receptor signaling complex, which efficiently exposes N-type channels to constitutive ORL1 receptor activity. Calcium channel activity is thus regulated by changes in ORL1 receptor expression, which provides a possible molecular mechanism for the development of tolerance to opioid receptor agonists.	Univ Calgary, Dept Physiol & Biophys, Cellular & Mol Neurobiol Res Grp, Calgary, AB T2N 4N1, Canada; CNRS, UPR2580, LGF, Dept Physiol, F-34396 Montpellier, France	University of Calgary; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Zamponi, GW (corresponding author), Univ Calgary, Dept Physiol & Biophys, Cellular & Mol Neurobiol Res Grp, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	zamponi@ucalgary.ca	Beedle, Aaron/AAI-7014-2020; Beedle, Aaron M/K-1902-2015	Beedle, Aaron M/0000-0002-1019-3235; Zamponi, Gerald W./0000-0002-0644-9066; Barrere, Christian/0000-0001-8710-0976; Nargeot, Joel/0000-0003-2893-5636; bourinet, emmanuel/0000-0001-8021-0419				Abdulla FA, 1997, J NEUROSCI, V17, P8721; Ahmadi S, 2001, EUR J PHARMACOL, V412, P39, DOI 10.1016/S0014-2999(00)00946-8; Albert PR, 1998, ANN NY ACAD SCI, V861, P146, DOI 10.1111/j.1749-6632.1998.tb10186.x; Arnot MI, 2000, J PHYSIOL-LONDON, V527, P203, DOI 10.1111/j.1469-7793.2000.00203.x; BEECH DJ, 1992, NEURON, V8, P97, DOI 10.1016/0896-6273(92)90111-P; Beedle A. M., 2003, CALCIUM CHANNEL PHAR; Beedle AM, 2002, J MEMBRANE BIOL, V187, P225, DOI 10.1007/s00232-001-0166-2; Bertorelli R, 1999, BRIT J PHARMACOL, V128, P1252, DOI 10.1038/sj.bjp.0702884; Borgland SL, 2001, J PHYSIOL-LONDON, V536, P35, DOI 10.1111/j.1469-7793.2001.t01-1-00035.x; Briscini L, 2002, EUR J PHARMACOL, V447, P59, DOI 10.1016/S0014-2999(02)01833-2; BUNZOW JR, 1994, FEBS LETT, V347, P284, DOI 10.1016/0014-5793(94)00561-3; Connell J., 1998, NEW APPROACHES EVALU; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; DIVERSEPIERLUISSI M, 1995, NEURON, V14, P191, DOI 10.1016/0896-6273(95)90254-6; Emmerson PJ, 1999, J PHYSIOL-LONDON, V517, P431, DOI 10.1111/j.1469-7793.1999.0431t.x; Gouarderes C, 1999, BRAIN RES, V838, P85, DOI 10.1016/S0006-8993(99)01713-8; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Jarvis SE, 2000, J BIOL CHEM, V275, P6388, DOI 10.1074/jbc.275.9.6388; Jia YP, 1998, NEUROSCI LETT, V250, P21, DOI 10.1016/S0304-3940(98)00430-3; Kammermeier PJ, 2000, J NEUROSCI, V20, P5623, DOI 10.1523/JNEUROSCI.20-15-05623.2000; Kaneko S, 2002, J NEUROSCI, V22, P82, DOI 10.1523/JNEUROSCI.22-01-00082.2002; Kest B, 2001, NEUROSCIENCE, V104, P217, DOI 10.1016/S0306-4522(01)00037-9; Knoflach F, 1996, J NEUROSCI, V16, P6657; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Larsson KP, 2000, NEUROSCI LETT, V296, P121, DOI 10.1016/S0304-3940(00)01640-2; Latour I, 2003, GLIA, V41, P347, DOI 10.1002/glia.10162; Lavine N, 2002, J BIOL CHEM, V277, P46010, DOI 10.1074/jbc.M205035200; Lembo PMC, 1997, MOL PHARMACOL, V52, P164, DOI 10.1124/mol.52.1.164; LUEBKE JI, 1994, PFLUG ARCH EUR J PHY, V428, P499, DOI 10.1007/BF00374571; Magga JM, 2000, NEURON, V28, P195, DOI 10.1016/S0896-6273(00)00096-9; Manabe T, 1998, NATURE, V394, P577, DOI 10.1038/29073; Meis S, 2001, J PHYSIOL-LONDON, V532, P701, DOI 10.1111/j.1469-7793.2001.0701e.x; Mollereau C, 1996, FEBS LETT, V395, P17, DOI 10.1016/0014-5793(96)00993-3; Monteil A, 2000, J BIOL CHEM, V275, P16530, DOI 10.1074/jbc.C000090200; Monteillet-Agius G, 1998, J COMP NEUROL, V399, P373, DOI 10.1002/(SICI)1096-9861(19980928)399:3<373::AID-CNE6>3.0.CO;2-Y; Morikawa H, 1998, EUR J PHARMACOL, V351, P247, DOI 10.1016/S0014-2999(98)00306-9; Neal CR, 1999, J COMP NEUROL, V406, P503; Ouardouz M, 2003, NEURON, V40, P53, DOI 10.1016/j.neuron.2003.08.016; Schiff ML, 2000, NATURE, V408, P723, DOI 10.1038/35047093; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Tallent MK, 2001, J NEUROSCI, V21, P6940, DOI 10.1523/JNEUROSCI.21-17-06940.2001; Ueda H, 2000, J NEUROSCI, V20, P7640; Venkatesan P, 2002, J PHARMACOL EXP THER, V300, P78, DOI 10.1124/jpet.300.1.78; WICK MJ, 1994, MOL BRAIN RES, V27, P37, DOI 10.1016/0169-328X(94)90181-3; Wu X, 2002, J PHYSIOL-LONDON, V538, P41, DOI 10.1113/jphysiol.2001.012668; Xu XJ, 1996, NEUROREPORT, V7, P2092; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zamponi GW, 2001, CELL BIOCHEM BIOPHYS, V34, P79, DOI 10.1385/CBB:34:1:79	50	111	114	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					118	125		10.1038/nn1180	http://dx.doi.org/10.1038/nn1180			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14730309				2022-12-24	WOS:000188468500009
J	Kaiser, M; Lappe, M				Kaiser, M; Lappe, M			Perisaccadic mislocalization orthogonal to saccade direction	NEURON			English	Article							VISUAL SPACE; SUPERIOR COLLICULUS; APPARENT POSITION; EYE; LOCALIZATION; TARGET; REPRESENTATION; DISPLACEMENT; COMPRESSION; PERCEPTION	Saccadic eye movements transiently distort perceptual space. Visual objects flashed shortly before or during a saccade are mislocalized along the saccade direction, resembling a compression of space around the saccade target. These mislocalizations reflect transient errors of processes that construct spatial stability across eye movements. They may arise from errors of reference signals associated with saccade direction and amplitude or from visual or visuomotor remapping processes focused on the saccade target's position. The second case would predict apparent position shifts toward the target also in directions orthogonal to the saccade. We report that such orthogonal mislocalization indeed occurs. Surprisingly, however, the orthogonal mislocalization is restricted to only part of the visual field. This part comprises distant positions in saccade direction but does not depend on the target's position. Our findings can be explained by a combination of directional and positional reference signals that varies in time course across the visual field.	Ruhr Univ Bochum, Dept Zool & Neurobiol, D-44780 Bochum, Germany; Int Jacobs Univ Bremen, D-28759 Bremen, Germany; Univ Munster, Inst Psychol 2, D-48149 Munster, Germany	Ruhr University Bochum; University of Munster	Lappe, M (corresponding author), Ruhr Univ Bochum, Dept Zool & Neurobiol, D-44780 Bochum, Germany.	mlappe@psy.uni-muenster.de	Kaiser, Marcus/A-7166-2008	Kaiser, Marcus/0000-0002-4654-3110				Anderson RW, 1998, J NEUROPHYSIOL, V80, P798, DOI 10.1152/jn.1998.80.2.798; Cai RH, 1997, NATURE, V386, P601, DOI 10.1038/386601a0; COLBY CL, 1995, CEREB CORTEX, V5, P470, DOI 10.1093/cercor/5.5.470; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Deubel H, 1998, VISION RES, V38, P3147, DOI 10.1016/S0042-6989(98)00048-0; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Hamker FH, 2003, J VISION, V3, P808, DOI 10.1167/3.11.14; HONDA H, 1989, PERCEPT PSYCHOPHYS, V45, P162, DOI 10.3758/BF03208051; HONDA H, 1995, VISION RES, V35, P3021, DOI 10.1016/0042-6989(95)00108-C; HONDA H, 1991, VISION RES, V31, P1915, DOI 10.1016/0042-6989(91)90186-9; HONDA H, 1993, VISION RES, V33, P709, DOI 10.1016/0042-6989(93)90190-8; Krekelberg B, 2003, NEURON, V37, P537, DOI 10.1016/S0896-6273(03)00003-5; Lappe M, 2000, NATURE, V403, P892, DOI 10.1038/35002588; MACH E, 1885, ANAL EMPFINDUNGEN; MATIN L, 1965, SCIENCE, V148, P1485, DOI 10.1126/science.148.3676.1485; Medendorp WP, 2003, J NEUROSCI, V23, P6209; Merriam EP, 2003, NEURON, V39, P361, DOI 10.1016/S0896-6273(03)00393-3; Morrone MC, 1997, J NEUROSCI, V17, P7941; Niemeier M, 2003, NATURE, V422, P76, DOI 10.1038/nature01439; OSAKA N, 1977, J PSYCHOL, V95, P59, DOI 10.1080/00223980.1977.9915860; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; SCHLAG J, 1995, VISION RES, V35, P2347, DOI 10.1016/0042-6989(95)00021-Q; Schlag J, 2002, NAT REV NEUROSCI, V3, P191, DOI 10.1038/nrn750; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Thiele A, 2002, SCIENCE, V295, P2460, DOI 10.1126/science.1068788; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373; VONHELMHOLTZ H, 1966, HDB PHYSL OPTIK; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; WALKER MF, 1995, J NEUROPHYSIOL, V73, P1988, DOI 10.1152/jn.1995.73.5.1988	32	81	81	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 22	2004	41	2					293	300		10.1016/S0896-6273(03)00849-3	http://dx.doi.org/10.1016/S0896-6273(03)00849-3			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741109	Green Submitted, Bronze			2022-12-24	WOS:000221457800014
J	Gongidi, V; Ring, C; Moody, M; Brekken, R; Sage, EH; Rakic, P; Anton, ES				Gongidi, V; Ring, C; Moody, M; Brekken, R; Sage, EH; Rakic, P; Anton, ES			SPARC-like 1 regulates the terminal phase of radial glia-guided migration in the cerebral cortex	NEURON			English	Article							NEURONAL MIGRATION; CELL-MIGRATION; LAMINAR ORGANIZATION; NEOCORTEX; SPARC; SC1; PROTEIN; MATRIX; MOUSE; BRAIN	Differential adhesion between migrating neurons and transient radial glial fibers enables the deployment of neurons into appropriate layers in the developing cerebral cortex. The identity of radial glial signals that regulate the termination of migration remains unclear. Here, we identified a radial glial surface antigen, SPARC (secreted protein acidic and rich in cysteine)like 1, distributed predominantly in radial glial fibers passing through the upper strata of the cortical plate (CP) where neurons end their migration. Neuronal migration and adhesion assays indicate that SPARC-like 1 functions to terminate neuronal migration by reducing the adhesivity of neurons at the top of the CP. Cortical neurons fail to achieve appropriate positions in the absence of SPARC-like 1 function in vivo. Together, these data suggest that antiadhesive signaling via SPARC-like 1 on radial glial cell surfaces may enable neurons to recognize the end of migration in the developing cerebral cortex.	Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA; Hope Heart Inst, Dept Vasc Biol, Seattle, WA 98104 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Yale University	Anton, ES (corresponding author), Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA.	anton@med.unc.edu			NIMH NIH HHS [MH63660] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063660] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Ang ESBC, 2003, J NEUROSCI, V23, P5805; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Anton ES, 1997, DEVELOPMENT, V124, P3501; ANTON ES, 1994, DEV BIOL, V164, P133, DOI 10.1006/dbio.1994.1186; Bradshaw Amy D., 2000, Molecular Cell Biology Research Communications, V3, P345, DOI 10.1006/mcbr.2000.0237; Brekken RA, 2000, MATRIX BIOL, V19, P569, DOI 10.1016/S0945-053X(00)00105-0; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; EMERLING DE, 1994, DEVELOPMENT, V120, P2811; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; Friedlander DR, 1998, J NEUROBIOL, V37, P291, DOI 10.1002/(SICI)1097-4695(19981105)37:2<291::AID-NEU8>3.0.CO;2-F; Gilles C, 1998, CANCER RES, V58, P5529; Girard JP, 1996, J BIOL CHEM, V271, P4511; Halfter W, 2002, J NEUROSCI, V22, P6029; Hambrock HO, 2003, J BIOL CHEM, V278, P11351, DOI 10.1074/jbc.M212291200; Hartfuss E, 2003, DEVELOPMENT, V130, P4597, DOI 10.1242/dev.00654; HATTEN ME, 1990, EXPERIENTIA, V46, P907, DOI 10.1007/BF01939383; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; JOHNSTON IG, 1990, NEURON, V4, P165, DOI 10.1016/0896-6273(90)90452-L; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; Kriegstein AR, 2003, GLIA, V43, P37, DOI 10.1002/glia.10250; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; MAURER P, 1995, J MOL BIOL, V253, P347, DOI 10.1006/jmbi.1995.0557; MCCONNELL SK, 1990, EXPERIENTIA, V46, P922, DOI 10.1007/BF01939385; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; McKinnon PJ, 1996, BRAIN RES, V709, P27, DOI 10.1016/0006-8993(95)01224-9; McKinnon PJ, 1996, GENOME RES, V6, P1077, DOI 10.1101/gr.6.11.1077; McKinnon PJ, 2000, MOL CELL BIOL, V20, P656, DOI 10.1128/MCB.20.2.656-660.2000; Mendis DB, 1996, BRAIN RES, V713, P53, DOI 10.1016/0006-8993(95)01472-1; Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mothe AJ, 2001, BRAIN RES, V892, P27, DOI 10.1016/S0006-8993(00)03141-3; Muneoka K., 1990, POSTIMPLANTATION MAM, P41; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Olson EC, 2002, CURR OPIN GENET DEV, V12, P320, DOI 10.1016/S0959-437X(02)00305-2; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; RAKIC P, 1995, NEURON, V14, P1101, DOI 10.1016/0896-6273(95)90258-9; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1974, GLIA, V83, P425; RAKIC P, 1988, PROG BRAIN RES, V73, P15; Sasaki T, 1998, EMBO J, V17, P1625, DOI 10.1093/emboj/17.6.1625; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; Soderling JA, 1997, J HISTOCHEM CYTOCHEM, V45, P823, DOI 10.1177/002215549704500607; TAKAHASHI T, 1990, J COMP NEUROL, V302, P15, DOI 10.1002/cne.903020103; Valcanis H, 2003, J NEUROSCI, V23, P5113; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yan Q, 1999, J HISTOCHEM CYTOCHEM, V47, P1495, DOI 10.1177/002215549904701201; Zheng C, 1996, SCIENCE, V272, P417, DOI 10.1126/science.272.5260.417	53	94	94	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2004	41	1					57	69		10.1016/S0896-6273(03)00818-3	http://dx.doi.org/10.1016/S0896-6273(03)00818-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715135	Bronze, Green Published			2022-12-24	WOS:000187942800009
J	Llobet, A; Beaumont, V; Lagnado, L				Llobet, A; Beaumont, V; Lagnado, L			Real-time measurement of exocytosis and endocytosis using interference of light	NEURON			English	Article							RETINAL BIPOLAR CELLS; ADRENAL CHROMAFFIN CELLS; SINGLE SYNAPTIC VESICLES; DENSE-CORE VESICLES; REFLECTION MICROSCOPY; SECRETORY GRANULES; ENDOCRINE-CELLS; GOLDFISH RETINA; CALCIUM CURRENT; PC12 CELLS	We describe a new approach for making real-time measurements of exocytosis and endocytosis in neurons and neuroendocrine cells. The method utilizes interference reflection microscopy (IRM) to image surface membrane in close contact with a glass coverslip (the "footprint"). At the synaptic terminal of retinal bipolar cells, the footprint expands during exocytosis and retracts during endocytosis, paralleling changes in total surface area measured by capacitance. In chromaffin cells, IRM detects the fusion of individual granules as the appearance of bright spots within the footprint with spatial and temporal resolution similar to total internal reflection fluorescence microscopy. Advantages of IRM over capacitance are that it can monitor changes in surface area while cells are electrically active and it can be applied to mammalian neurons with relatively small synaptic terminals. IRM reveals that vesicles at the synapse of bipolar cells rapidly collapse into the surface membrane while secretory granules in chromaffin cells do not.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Lagnado, L (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ll1@mrc-lmb.cam.ac.uk	Llobet, Artur/D-4339-2014	Llobet, Artur/0000-0001-5797-6782; Beaumont, Vahri/0000-0002-6488-2175				Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; Anderson KI, 2000, CURR BIOL, V10, P253, DOI 10.1016/S0960-9822(00)00357-2; Angleson JK, 1997, TRENDS NEUROSCI, V20, P281, DOI 10.1016/S0166-2236(97)01083-7; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; ASHMORE JF, 1980, J PHYSIOL-LONDON, V300, P115, DOI 10.1113/jphysiol.1980.sp013155; Avery J, 2000, J CELL BIOL, V148, P317, DOI 10.1083/jcb.148.2.317; AXELROD D, 1989, METHOD CELL BIOL, V30, P245; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Bader MF, 2002, ANN NY ACAD SCI, V971, P178, DOI 10.1111/j.1749-6632.2002.tb04461.x; Barg S, 2002, NEURON, V33, P287, DOI 10.1016/S0896-6273(02)00563-9; Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; Burrone J, 1997, J PHYSIOL-LONDON, V505, P571, DOI 10.1111/j.1469-7793.1997.571ba.x; Burrone J, 2000, J NEUROSCI, V20, P568, DOI 10.1523/JNEUROSCI.20-02-00568.2000; Burrone J, 2002, NEURON, V33, P101, DOI 10.1016/S0896-6273(01)00565-7; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; CURTIS ASG, 1964, J CELL BIOL, V20, P199, DOI 10.1083/jcb.20.2.199; de Kock CPJ, 2003, J NEUROSCI, V23, P2726; Duncan RR, 2003, NATURE, V422, P176, DOI 10.1038/nature01389; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Gillis Kevin D., 1995, P155; GINGELL D, 1979, BIOPHYS J, V26, P507, DOI 10.1016/S0006-3495(79)85268-6; HEUSER J, 1993, J CELL BIOL, V121, P1311, DOI 10.1083/jcb.121.6.1311; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Holroyd P, 2002, P NATL ACAD SCI USA, V99, P16806, DOI 10.1073/pnas.222677399; HORRIGAN FT, 1994, NEURON, V13, P1119, DOI 10.1016/0896-6273(94)90050-7; IZZARD CS, 1976, J CELL SCI, V21, P129; KANEKO A, 1989, J PHYSIOL-LONDON, V410, P613, DOI 10.1113/jphysiol.1989.sp017551; Katz B., 1969, RELEASE NEURAL TRANS; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; Koenig JH, 1998, P NATL ACAD SCI USA, V95, P12677, DOI 10.1073/pnas.95.21.12677; Llobet A, 2003, J NEUROSCI, V23, P2706; Mennerick S, 1997, J NEUROPHYSIOL, V78, P51, DOI 10.1152/jn.1997.78.1.51; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Neves G, 2001, P NATL ACAD SCI USA, V98, P15282, DOI 10.1073/pnas.261311698; Neves G, 1999, J PHYSIOL-LONDON, V515, P181, DOI 10.1111/j.1469-7793.1999.181ad.x; Neves G, 2001, J PHYSIOL-LONDON, V535, P809, DOI 10.1111/j.1469-7793.2001.t01-1-00809.x; Niewohner J, 1997, J CELL BIOL, V138, P349, DOI 10.1083/jcb.138.2.349; Pan YV, 2001, BIOMACROMOLECULES, V2, P32, DOI 10.1021/bm0000642; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; Ploem J. S., 1975, MONONUCLEAR PHAGOCYT, P405; Rettig J, 2002, SCIENCE, V298, P781, DOI 10.1126/science.1075375; Ryan TA, 2001, CURR OPIN NEUROBIOL, V11, P544, DOI 10.1016/S0959-4388(00)00247-6; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Seward EP, 1996, J NEUROSCI, V16, P553; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; Vaidyanathan VV, 1999, J NEUROCHEM, V72, P327, DOI 10.1046/j.1471-4159.1999.0720327.x; Valtorta F, 2001, TRENDS CELL BIOL, V11, P324, DOI 10.1016/S0962-8924(01)02058-X; VERSCHUEREN H, 1985, J CELL SCI, V75, P279; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; Weber I, 2003, METHOD ENZYMOL, V361, P34; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6; Zenisek D, 2003, J NEUROSCI, V23, P2538	60	53	55	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 18	2003	40	6					1075	1086		10.1016/S0896-6273(03)00765-7	http://dx.doi.org/10.1016/S0896-6273(03)00765-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756UZ	14687543	Bronze			2022-12-24	WOS:000187503400007
J	Greger, IH; Khatri, L; Kong, XP; Ziff, EB				Greger, IH; Khatri, L; Kong, XP; Ziff, EB			AMPA receptor tetramerization is mediated by Q/R editing	NEURON			English	Article							GLUTAMATE-RECEPTOR; ENDOPLASMIC-RETICULUM; ION CHANNELS; SUBUNIT STOICHIOMETRY; POTASSIUM CHANNEL; RECOMBINANT AMPA; K+ CHANNELS; BINDING; GLUR2; SELECTIVITY	AMPA-type glutamate receptors (AMPARs) play a major role in excitatory synaptic transmission and plasticity. Channel properties are largely dictated by their composition of the four subunits, GluR1-4 (or A-D). Here we show that AMPAR assembly and subunit stoichiometry are determined by RNA editing in the pore loop. We demonstrate that editing at the GluR2 Q/R site regulates AMPAR assembly at the step of tetramerization. Specifically, edited R subunits are largely unassembled and ER retained, whereas unedited Q subunits readily tetramerize, and traffic to synapses. This assembly mechanism restricts the number of the functionally critical R subunits in AMPAR tetramers. Therefore, a single amino acid residue affects channel composition and, in turn, controls ion conduction through the majority of AMPARs in the brain.	NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University; New York University	Ziff, EB (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, 550 1St Ave, New York, NY 10016 USA.	ig@mrc-imb.cam.ac.uk; edward.ziff@med.nyu.edu		Ziff, Edward/0000-0001-7389-8649; Kong, Xiang-Peng/0000-0001-5773-2681	NATIONAL INSTITUTE ON AGING [R37AG013620, R01AG013620] Funding Source: NIH RePORTER; NIA NIH HHS [AG13620] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abagyan R, 1997, PROTEINS, P29; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; BAEUERLE PA, 1987, J CELL BIOL, V105, P2655, DOI 10.1083/jcb.105.6.2655; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Burnashev N, 1996, J PHYSIOL-LONDON, V496, P165, DOI 10.1113/jphysiol.1996.sp021674; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Creighton T. E., 1993, PROTEINS STRUCTURES; Deutsch C, 2002, ANNU REV PHYSIOL, V64, P19, DOI 10.1146/annurev.physiol.64.081501.155934; Dingledine R, 1999, PHARMACOL REV, V51, P7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Engelman DM, 2003, MOL CELL, V11, P5, DOI 10.1016/S1097-2765(03)00016-9; GREEN WN, 1993, CELL, V74, P57, DOI 10.1016/0092-8674(93)90294-Z; Green WN, 1999, J GEN PHYSIOL, V113, P163, DOI 10.1085/jgp.113.2.163; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Heginbotham L, 1997, BIOCHEMISTRY-US, V36, P10335, DOI 10.1021/bi970988i; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; Kuner T, 2001, J NEUROSCI, V21, P4162, DOI 10.1523/JNEUROSCI.21-12-04162.2001; Kuner T, 2003, TRENDS NEUROSCI, V26, P27, DOI 10.1016/S0166-2236(02)00010-3; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Lee MCS, 2002, J BIOL CHEM, V277, P22395, DOI 10.1074/jbc.M200450200; Leuschner WD, 1999, J BIOL CHEM, V274, P16907, DOI 10.1074/jbc.274.24.16907; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; Mano I, 1998, NEUROREPORT, V9, P327, DOI 10.1097/00001756-199801260-00027; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Ozawa S, 1998, PROG NEUROBIOL, V54, P581, DOI 10.1016/S0301-0082(97)00085-3; Panchenko VA, 2001, J GEN PHYSIOL, V117, P345, DOI 10.1085/jgp.117.4.345; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Safferling M, 2001, BIOCHEMISTRY-US, V40, P13948, DOI 10.1021/bi011143g; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Seeburg PH, 2002, NEURON, V35, P17, DOI 10.1016/S0896-6273(02)00760-2; Seeburg PH, 1996, J NEUROCHEM, V66, P1; Seeburg PH, 2001, BRAIN RES, V907, P233, DOI 10.1016/S0006-8993(01)02445-3; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tanaka H, 2000, BRAIN RES, V886, P190, DOI 10.1016/S0006-8993(00)02951-6; Tatu U, 1997, J CELL BIOL, V136, P555, DOI 10.1083/jcb.136.3.555; Tikhonov DB, 2002, BIOPHYS J, V82, P1884, DOI 10.1016/S0006-3495(02)75538-0; Washburn MS, 1997, J NEUROSCI, V17, P9393; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; WOOD MW, 1995, P NATL ACAD SCI USA, V92, P4882, DOI 10.1073/pnas.92.11.4882; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	53	235	248	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 13	2003	40	4					763	774		10.1016/S0896-6273(03)00668-8	http://dx.doi.org/10.1016/S0896-6273(03)00668-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	744UL	14622580	Bronze			2022-12-24	WOS:000186651200011
J	Xu, DS; Hopf, C; Reddy, R; Cho, RW; Guo, LP; Lanahan, A; Petralia, RS; Wenthold, RJ; O'Brien, RJ; Worley, P				Xu, DS; Hopf, C; Reddy, R; Cho, RW; Guo, LP; Lanahan, A; Petralia, RS; Wenthold, RJ; O'Brien, RJ; Worley, P			Narp and NP1 form heterocomplexes that function in developmental and activity-dependent synaptic plasticity	NEURON			English	Article							CULTURED SPINAL NEURONS; BINDING PROTEIN 49; HIPPOCAMPAL-NEURONS; EXCITATORY SYNAPSES; AMPA RECEPTORS; GLUTAMATE; PENTRAXIN; MATURATION; GENES; MECHANISMS	Narp is a neuronal immediate early gene that plays a role in excitatory synaptogenesis. Here, we report that native Narp in brain is part of a pentraxin complex that includes NP1. These proteins are covalently linked by disulfide bonds into highly organized complexes, and their relative ratio in the complex is dynamically dependent upon the neuron's activity history and developmental stage. Complex formation is dependent on their distinct N-terminal coiled-coil domains, while their closely homologous C-terminal pentraxin domains mediate association with AMPA-type glutamate receptors. Narp is substantially more effective in assays of cell surface cluster formation, coclustering of AMPA receptors, and excitatory synaptogenesis, yet their combined expression results in supraadditive effects. These studies support a model in which Narp can regulate the latent synaptogenic activity of NP1 by forming mixed pentraxin assemblies. This mechanism appears to contribute to both activity-independent and activity-dependent excitatory synaptogenesis.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Natl Inst Deafness & Other Commun Disorders, Neurochem Lab, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Worley, P (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.		Hopf, Carsten/A-3275-2015	Hopf, Carsten/0000-0003-0802-6451	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039156, R01NS037694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000003, ZIADC000003] Funding Source: NIH RePORTER; NIMH NIH HHS [KO2 MH01153] Funding Source: Medline; NINDS NIH HHS [R01-NS37694, R01-NSNS39156] Funding Source: Medline; PHS HHS [R01-K02 53608] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Bose CM, 2000, J NEUROSCI, V20, P9086; Bruses JL, 2000, CURR OPIN CELL BIOL, V12, P593, DOI 10.1016/S0955-0674(00)00137-X; Cantallops I, 2000, NAT NEUROSCI, V3, P1004, DOI 10.1038/79823; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dodds DC, 1997, J BIOL CHEM, V272, P21488, DOI 10.1074/jbc.272.34.21488; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Ethell IM, 1999, J CELL BIOL, V144, P575, DOI 10.1083/jcb.144.3.575; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Ferreira A, 1999, J CELL SCI, V112, P4729; GEWURZ H, 1995, CURR OPIN IMMUNOL, V7, P54, DOI 10.1016/0952-7915(95)80029-8; HSU YC, 1995, GENOMICS, V28, P220, DOI 10.1006/geno.1995.1134; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kirkpatrick LL, 2000, J BIOL CHEM, V275, P17786, DOI 10.1074/jbc.M002254200; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mammen AL, 1997, J NEUROSCI, V17, P7351; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; O'Brien R, 2002, J NEUROSCI, V22, P4487, DOI 10.1523/JNEUROSCI.22-11-04487.2002; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; OBrien RJ, 1997, J NEUROSCI, V17, P7339; Petralia RS, 2001, EUR J NEUROSCI, V13, P1722, DOI 10.1046/j.0953-816x.2001.01553.x; Rao A, 2000, NAT NEUROSCI, V3, P747, DOI 10.1038/77636; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SCHLIMGEN AK, 1995, NEURON, V14, P519, DOI 10.1016/0896-6273(95)90308-9; Serpinskaya AS, 1999, DEV BIOL, V205, P65, DOI 10.1006/dbio.1998.9112; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; TSUL CC, 1996, J NEUROSCI, V16, P2463; WANG BL, 1985, HISTOCHEMISTRY, V83, P47, DOI 10.1007/BF00495299; Yagi T, 2000, GENE DEV, V14, P1169; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614; Ziv NE, 2001, CURR OPIN NEUROBIOL, V11, P536, DOI 10.1016/S0959-4388(00)00246-4	37	177	182	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 31	2003	39	3					513	528		10.1016/S0896-6273(03)00463-X	http://dx.doi.org/10.1016/S0896-6273(03)00463-X			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	709LC	12895424	Bronze			2022-12-24	WOS:000184625800013
J	Fischer, MH; Castel, AD; Dodd, MD; Pratt, J				Fischer, MH; Castel, AD; Dodd, MD; Pratt, J			Perceiving numbers causes spatial shifts of attention	NATURE NEUROSCIENCE			English	Article								Number symbols are part of our everyday visual world. Here we show that merely looking at numbers causes a shift in covert attention to the left or right side, depending upon the number's magnitude. This observation implies obligatory activation of number meaning and signals a tight coupling of internal and external representations of space.	Univ Dundee, Dept Psychol, Dundee DD1 4HN, Scotland; Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada	University of Dundee; University of Toronto	Fischer, MH (corresponding author), Univ Dundee, Dept Psychol, Dundee DD1 4HN, Scotland.	m.h.fischer@dundee.ac.uk	Fischer, Martin H./D-9965-2017	Fischer, Martin H./0000-0003-3818-7272; Pratt, Jay/0000-0002-4902-5095				Bachtold D, 1998, NEUROPSYCHOLOGIA, V36, P731, DOI 10.1016/S0028-3932(98)00002-5; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Dehaene S, 2001, PSYCHOL SCI, V12, P244, DOI 10.1111/1467-9280.00343; DEHAENE S, 2000, NEW COGNITIVE NEUROS, P987; Fias W., 1996, MATH COGNITION, V2, P95, DOI [DOI 10.1080/135467996387552, 10.1080/135467996387552]; Fischer MH, 2001, NEUROLOGY, V57, P822, DOI 10.1212/WNL.57.5.822; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; Gevers W, 2003, COGNITION, V87, pB87, DOI 10.1016/S0010-0277(02)00234-2; Hommel B, 2001, PSYCHOL SCI, V12, P360, DOI 10.1111/1467-9280.00367; Pratt J, 1999, J EXP PSYCHOL HUMAN, V25, P730, DOI 10.1037/0096-1523.25.3.730; YANTIS S, 1994, J EXP PSYCHOL HUMAN, V20, P95, DOI 10.1037/0096-1523.20.1.95; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a	12	512	537	4	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					555	556		10.1038/nn1066	http://dx.doi.org/10.1038/nn1066			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	683GQ	12754517				2022-12-24	WOS:000183140400010
J	Kania, A; Jessell, TM				Kania, A; Jessell, TM			Topographic motor projections in the limb imposed by LIM homeodomain protein regulation of ephrin-A : EphA interactions	NEURON			English	Article							VENTRAL NEURAL-TUBE; CHICK HIND LIMB; HOMEOBOX GENES; AXON GUIDANCE; NEURONAL MIGRATION; PATHWAY SELECTION; TYROSINE KINASES; SUBTYPE IDENTITY; VERTEBRATE LIMB; RETINAL AXONS	The formation of topographic neural maps relies on the coordinate assignment of neuronal cell body position and axonal trajectory. The projection of motor neurons of the lateral motor column (LMC) along the dorsoventral axis of the limb mesenchyme constitutes a simple topographic map that is organized in a binary manner. We show that LIM homeodomain proteins establish motor neuron topography by coordinating the medio-lateral settling position of motor neurons within the LMC with the dorsoventral selection of axon pathways in the limb. These topographic projections are established, in part, through LIM homeodomain protein control of EphA receptors and ephrin-A ligands in motor neurons and limb mesenchymal cells.	Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Jessell, TM (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA.			Kania, Artur/0000-0002-5209-2520				Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Coonan JR, 2003, J COMP NEUROL, V458, P98, DOI 10.1002/cne.10571; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Eberhart J, 2000, DEV NEUROSCI-BASEL, V22, P237, DOI 10.1159/000017446; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feng GP, 2000, NEURON, V25, P295, DOI 10.1016/S0896-6273(00)80895-8; Grunwald IC, 2002, CURR OPIN NEUROBIOL, V12, P250, DOI 10.1016/S0959-4388(02)00323-9; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hamburger V., 1977, NEUROSCI RES PROG S3, V15, piii; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Hobert O, 1998, J NEUROSCI, V18, P2084; Iwamasa H, 1999, DEV GROWTH DIFFER, V41, P685; Jurata LW, 2000, CURR OPIN NEUROBIOL, V10, P72, DOI 10.1016/S0959-4388(99)00053-7; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P1, DOI 10.1098/rspb.1981.0079; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Logan C, 1996, CURR BIOL, V6, P1006, DOI 10.1016/S0960-9822(02)00645-0; Momose T, 1999, DEV GROWTH DIFFER, V41, P335; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; O'Leary DDM, 1999, CELL, V96, P255, DOI 10.1016/S0092-8674(00)80565-6; Park HT, 2002, BIOESSAYS, V24, P821, DOI 10.1002/bies.10141; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; RIDDLE RD, 1995, CELL, V83, P631, DOI 10.1016/0092-8674(95)90103-5; Schulte D, 2000, DEVELOPMENT, V127, P5033; Sharma K, 2000, NATURE, V406, P515, DOI 10.1038/35020078; Sharma K, 2001, CURR OPIN CELL BIOL, V13, P204, DOI 10.1016/S0955-0674(00)00198-8; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; Shigetani Y, 1997, NEUROSCI RES, V27, P211, DOI 10.1016/S0168-0102(96)01151-0; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Swartz ME, 2001, DEVELOPMENT, V128, P4669; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; TOSNEY KW, 1985, DEV BIOL, V109, P193, DOI 10.1016/0012-1606(85)90360-4; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; WALTER J, 1987, DEVELOPMENT, V101, P685; WALTER J, 1987, DEVELOPMENT, V101, P909; William CM, 2003, DEVELOPMENT, V130, P1523, DOI 10.1242/dev.00358; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748	52	227	228	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 22	2003	38	4					581	596		10.1016/S0896-6273(03)00292-7	http://dx.doi.org/10.1016/S0896-6273(03)00292-7			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	682QV	12765610	Bronze			2022-12-24	WOS:000183104000009
J	Paller, KA; Hutson, CA; Miller, BB; Boehm, SG				Paller, KA; Hutson, CA; Miller, BB; Boehm, SG			Neural manifestations of memory with and without awareness	NEURON			English	Article							EVENT-RELATED POTENTIALS; VISUAL WORD-FORM; BRAIN POTENTIALS; CONSCIOUS RECOLLECTION; RECOGNITION MEMORY; UNFAMILIAR FACES; COGNITIVE NEUROSCIENCE; PERCEPTUAL MEMORY; IMPLICIT MEMORY; TIME-COURSE	Neurophysiological events responsible for different types of human memory tend to occur concurrently and are therefore difficult to measure independently. To surmount this problem, we produced perceptual priming (indicated by speeded responses) in the absence of conscious remembering. At encoding, faces appeared briefly while subjects' attention was diverted to other stimuli. Faces appeared again in either an implicit or explicit memory test. Neural correlates of priming were identified as brain potentials beginning 270 ms after face onset with more negative amplitudes for repeated than for new faces. Remembered faces, in contrast, activated a different configuration of intracranial sources producing positive potentials maximal at 600-700 ms. We thus disentangled and characterized distinct neural events associated with memory with and without awareness.	Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA; Northwestern Univ, Inst Neurosci, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Paller, KA (corresponding author), Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA.		Paller, Ken/M-2676-2019	Paller, Ken/0000-0003-4415-4143	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS034639, R01NS034639] Funding Source: NIH RePORTER; NINDS NIH HHS [NS34639] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Badgaiyan RD, 1997, J NEUROSCI, V17, P4904; BEGLEITER H, 1995, ELECTROEN CLIN NEURO, V94, P41, DOI 10.1016/0013-4694(94)00240-L; Bentin S, 2000, COGN NEUROPSYCHOL, V17, P35, DOI 10.1080/026432900380472; Buchel C, 1999, SCIENCE, V283, P1538, DOI 10.1126/science.283.5407.1538; Debruille JB, 1998, NEUROREPORT, V9, P3349, DOI 10.1097/00001756-199810260-00002; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Donaldson DI, 2001, NEURON, V31, P1047, DOI 10.1016/S0896-6273(01)00429-9; ELMER M, 1999, CLIN NEUROPHYSIOL, V110, P1; Friedman D, 2000, MICROSC RES TECHNIQ, V51, P6, DOI 10.1002/1097-0029(20001001)51:1<6::AID-JEMT2>3.0.CO;2-R; Gabrieli JDE, 1998, ANNU REV PSYCHOL, V49, P87, DOI 10.1146/annurev.psych.49.1.87; Goshen-Gottstein Y, 2000, J EXP PSYCHOL LEARN, V26, P1198, DOI 10.1037//0278-7393.26.5.1198; Hamann SB, 1997, BEHAV NEUROSCI, V111, P850, DOI 10.1037/0735-7044.111.4.850; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; JACOBY LL, 1992, AM PSYCHOL, V47, P802, DOI 10.1037/0003-066X.47.6.802; James TW, 1999, NEUROREPORT, V10, P1019, DOI 10.1097/00001756-199904060-00023; Joyce CA, 1999, PSYCHOPHYSIOLOGY, V36, P655, DOI 10.1017/S0048577299981015; Knowlton BJ, 1998, ACTA PSYCHOL, V98, P253, DOI 10.1016/S0001-6918(97)00045-0; MAYES AR, 1997, THEORIES ORGANIC AMN; Mecklinger A, 2000, PSYCHOPHYSIOLOGY, V37, P565, DOI 10.1111/1469-8986.3750565; Mills DL, 2000, J COGNITIVE NEUROSCI, V12, P47, DOI 10.1162/089892900561977; Munte TF, 1997, NEUROSCI RES, V28, P223, DOI 10.1016/S0168-0102(97)00047-3; MUNTE TF, 2000, HDB NEUROPSYCHOLOGY, P139; Olivares EI, 1999, COGNITIVE BRAIN RES, V7, P343, DOI 10.1016/S0926-6410(98)00038-X; Olivares EI, 2003, J COGNITIVE NEUROSCI, V15, P136, DOI 10.1162/089892903321107873; Ostergaard AL, 1999, J INT NEUROPSYCH SOC, V5, P175, DOI 10.1017/S1355617799533018; Paller KA, 1998, CONSCIOUS COGN, V7, P54, DOI 10.1006/ccog.1998.0329; PALLER KA, 1995, PSYCHOL SCI, V6, P107, DOI 10.1111/j.1467-9280.1995.tb00315.x; Paller KA, 1998, NEUROPSYCHOLOGIA, V36, P559, DOI 10.1016/S0028-3932(97)00132-2; Paller KA, 1999, COGNITIVE BRAIN RES, V7, P519, DOI 10.1016/S0926-6410(98)00050-0; Paller KA, 2000, NEUROIMAGE, V11, P98, DOI 10.1006/nimg.1999.0521; PALLER KA, 1992, J COGNITIVE NEUROSCI, V4, P375, DOI 10.1162/jocn.1992.4.4.375; Paller KA, 2000, BEHAV NEUROL, V12, P127, DOI 10.1155/2000/865250; PALLER KA, 1992, BRAIN COGNITION, V18, P46, DOI 10.1016/0278-2626(92)90110-8; PALLER KA, 2003, IN PRESS LEARN MEM; Penney TB, 2001, COGNITIVE BRAIN RES, V10, P239, DOI 10.1016/S0926-6410(00)00041-0; Pfutze EM, 2002, PSYCHOL AGING, V17, P140, DOI 10.1037//0882-7974.17.1.140; Picton TW, 2000, AUDIOL NEURO-OTOL, V5, P111, DOI 10.1159/000013875; ROLLS ET, 1989, EXP BRAIN RES, V76, P153; Rugg MD, 1995, COGNITIVE BRAIN RES, V3, P17, DOI 10.1016/0926-6410(95)00014-3; Rugg MD, 2000, TRENDS COGN SCI, V4, P108, DOI 10.1016/S1364-6613(00)01445-5; Rugg MD, 1998, NATURE, V392, P595, DOI 10.1038/33396; Rugg MD, 1999, NEUROREPORT, V10, P2661, DOI 10.1097/00001756-199908200-00041; Rugg MD, 2000, OXFORD HDB MEMORY, P521; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; SCHACTER DL, 1993, ANNU REV NEUROSCI, V16, P159, DOI 10.1146/annurev.ne.16.030193.001111; SCHWEINBERGER SR, 1995, J EXP PSYCHOL LEARN, V21, P722, DOI 10.1037/0278-7393.21.3.722; SHIMAMURA AP, 1986, Q J EXP PSYCHOL-A, V38, P619, DOI 10.1080/14640748608401617; SQUIRE LR, 2002, NEUROPSYCHOL MEMORY; Stark CEL, 2000, BEHAV NEUROSCI, V114, P459, DOI 10.1037/0735-7044.114.3.459; Thiel CM, 2001, J NEUROSCI, V21, P6846, DOI 10.1523/JNEUROSCI.21-17-06846.2001; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; VanPetten C, 1996, PSYCHOPHYSIOLOGY, V33, P491; Viggiano MP, 2000, J EXP PSYCHOL GEN, V129, P107, DOI 10.1037/0096-3445.129.1.107; Wagner AD, 1997, J EXP PSYCHOL LEARN, V23, P305, DOI 10.1037/0278-7393.23.2.305; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X	56	62	66	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 8	2003	38	3					507	516		10.1016/S0896-6273(03)00198-3	http://dx.doi.org/10.1016/S0896-6273(03)00198-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	677HF	12741996	Bronze			2022-12-24	WOS:000182800300014
J	Carleton, A; Petreanu, LT; Lansford, R; Alvarez-Buylla, A; Lledo, PM				Carleton, A; Petreanu, LT; Lansford, R; Alvarez-Buylla, A; Lledo, PM			Becoming a new neuron in the adult olfactory bulb	NATURE NEUROSCIENCE			English	Article							ANTERIOR SUBVENTRICULAR ZONE; POSTNATAL-DEVELOPMENT; PROGENITOR CELLS; PRECURSOR CELLS; DENTATE GYRUS; STEM-CELLS; IN-VITRO; NEUROGENESIS; MIGRATION; HIPPOCAMPUS	New neurons are continually recruited throughout adulthood in certain regions of the adult mammalian brain. How these cells mature and integrate into preexisting functional circuits remains unknown. Here we describe the physiological properties of newborn olfactory bulb interneurons at five different stages of their maturation in adult mice. Patch-clamp recordings were obtained from tangentially and radially migrating young neurons and from neurons in three subsequent maturation stages. Tangentially migrating neurons expressed extrasynaptic GABA(A) receptors and then AMPA receptors, before NMDA receptors appeared in radially migrating neurons. Spontaneous synaptic activity emerged soon after migration was complete, and spiking activity was the last characteristic to be acquired. This delayed excitability is unique to cells born in the adult and may protect circuits from uncontrolled neurotransmitter release and neural network disruption. Our results show that newly born cells recruited into the olfactory bulb become neurons, and a unique sequence of events leads to their functional integration.	Inst Pasteur, Lab Percept & Memory, CNRS UMR 2182, F-75015 Paris, France; Rockefeller Univ, New York, NY 10021 USA; CALTECH, Beckman Inst, Div Biol, Biol Imaging Ctr, Pasadena, CA 91125 USA; UCSF, San Francisco, CA 94134 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Rockefeller University; California Institute of Technology; University of California System; University of California San Francisco	Lledo, PM (corresponding author), Inst Pasteur, Lab Percept & Memory, CNRS UMR 2182, 25 Rue Dr Roux, F-75015 Paris, France.	pmlledo@pasteur.fr	Lansford, Rusty/C-6956-2014; Carleton, Alan/C-9721-2010	Carleton, Alan/0000-0001-5633-9159; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Petreanu, Leopoldo/0000-0003-1434-4691; Lansford, Rusty/0000-0002-2159-3699	NICHD NIH HHS [HD32116] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032116] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alonso G, 1999, J COMP NEUROL, V405, P508, DOI 10.1002/(SICI)1096-9861(19990322)405:4<508::AID-CNE5>3.0.CO;2-5; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Carlen M, 2002, CURR BIOL, V12, P606, DOI 10.1016/S0960-9822(02)00771-6; Castillo PE, 1999, J NEUROSCI, V19, P9180; Cecchi GA, 2001, J COMPUT NEUROSCI, V11, P175, DOI 10.1023/A:1012849801892; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; De Marchis S, 2001, J NEUROBIOL, V49, P326, DOI 10.1002/neu.10012; Didier A, 2001, P NATL ACAD SCI USA, V98, P6441, DOI 10.1073/pnas.101126398; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gutierrez R, 2002, J NEUROPHYSIOL, V87, P2562, DOI 10.1152/jn.2002.87.5.2562; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Khazipov R, 2001, J NEUROSCI, V21, P9770, DOI 10.1523/JNEUROSCI.21-24-09770.2001; KISHI K, 1987, J COMP NEUROL, V258, P112, DOI 10.1002/cne.902580109; Koester J., 1991, PRINCIPLES NEURAL SC, V3, P81; Komuro H, 1998, J NEUROBIOL, V37, P110, DOI 10.1002/(SICI)1097-4695(199810)37:1<110::AID-NEU9>3.3.CO;2-Q; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Liu RH, 1999, EXP NEUROL, V158, P143, DOI 10.1006/exnr.1999.7078; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Nottebohm F, 2002, J NEUROSCI, V22, P624, DOI 10.1523/JNEUROSCI.22-03-00624.2002; Nusser Z, 2001, J NEUROPHYSIOL, V86, P2823, DOI 10.1152/jn.2001.86.6.2823; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; PATON JA, 1984, SCIENCE, V225, P1046, DOI 10.1126/science.6474166; Petreanu L, 2002, J NEUROSCI, V22, P6106; Pirchio M, 1997, J NEUROSCI, V17, P5428; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Roy NS, 2000, NAT MED, V6, P271; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; SPIGELMAN I, 1992, J NEUROPHYSIOL, V68, P55, DOI 10.1152/jn.1992.68.1.55; Stewart RR, 1999, J NEUROPHYSIOL, V81, P95, DOI 10.1152/jn.1999.81.1.95; Stewart RR, 2002, J NEUROBIOL, V50, P305, DOI 10.1002/neu.10038; Tyzio R, 1999, J NEUROSCI, V19, P10372; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Walker MC, 2001, NEURON, V29, P703, DOI 10.1016/S0896-6273(01)00245-8; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	47	618	641	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					507	518		10.1038/nn1048	http://dx.doi.org/10.1038/nn1048			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12704391				2022-12-24	WOS:000182553200018
J	Battaglia, AA; Sehayek, K; Grist, J; McMahon, SB; Gavazzi, I				Battaglia, AA; Sehayek, K; Grist, J; McMahon, SB; Gavazzi, I			EphB receptors and ephrin-B ligands regulate spinal sensory connectivity and modulate pain processing	NATURE NEUROSCIENCE			English	Article							NEURAL DEVELOPMENT; NMDA; EXPRESSION		Kings Coll London, Neurosci Res Ctr, London SE1 1UL, England	University of London; King's College London	Gavazzi, I (corresponding author), Kings Coll London, Neurosci Res Ctr, Guys Campus, London SE1 1UL, England.	Isabella.Gavazzi@kcl.ac.uk		Gavazzi, Isabella/0000-0002-7728-7682; McMahon, Stephen/0000-0003-4656-5536				Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Ghosh A, 2002, SCIENCE, V295, P449, DOI 10.1126/science.1069391; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; HONORE P, 1995, EUR J PHARMACOL, V272, P249, DOI 10.1016/0014-2999(94)00656-R; McMahon S B, 1993, Curr Opin Neurobiol, V3, P602, DOI 10.1016/0959-4388(93)90062-4; Murai KK, 2002, NEURON, V33, P159, DOI 10.1016/S0896-6273(02)00565-2; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515	13	95	102	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					339	340		10.1038/nn1034	http://dx.doi.org/10.1038/nn1034			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12640461				2022-12-24	WOS:000181833100008
J	Mellen, NM; Janczewski, WA; Bocchiaro, CM; Feldman, JL				Mellen, NM; Janczewski, WA; Bocchiaro, CM; Feldman, JL			Opioid-induced quantal slowing reveals dual networks for respiratory rhythm generation	NEURON			English	Article							STEM-SPINAL-CORD; IN-VITRO; PREBOTZINGER COMPLEX; NEWBORN RATS; PATTERN GENERATION; NEURON ACTIVITY; BRAIN; MODULATION; PACEMAKER	Current consensus holds that a single medullary network generates respiratory rhythm in mammals. Pre-Botzinger Complex inspiratory (I) neurons, isolated in transverse slices, and preinspiratory (pre-I) neurons, found only in more intact en bloc preparations and in vivo, are each proposed as necessary for rhythm generation. Opioids slow I, but not pre-I, neuronal burst periods. In slices, opioids gradually lengthened respiratory periods, whereas in more intact preparations, periods jumped nondeterministically to integer multiples of the control period (quantal slowing). These findings suggest that opioid-induced quantal slowing results from transmission failure of rhythmic drive from pre-I neurons to preBotC I networks, depressed below threshold for spontaneous rhythmic activity. Thus, both I (in the slice), and pre-I neurons are sufficient for respiratory rhythmogenesis.	Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Mellen, NM (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, POB 951763, Los Angeles, CA 90095 USA.		feldman, jack/AAO-7505-2021	feldman, jack/0000-0003-3692-9412	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040959, R01HL070029] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL040959, R01 HL040959-12, R01 HL070029-02, R01 HL070029] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ballanyi K, 1999, PROG NEUROBIOL, V59, P583, DOI 10.1016/S0301-0082(99)00009-X; Bruce EN, 1996, J APPL PHYSIOL, V80, P1079, DOI 10.1152/jappl.1996.80.4.1079; Cazalets JR, 2000, BRAIN RES BULL, V53, P627, DOI 10.1016/S0361-9230(00)00396-8; Chen SW, 1996, EUR J PHARMACOL, V312, P241, DOI 10.1016/0014-2999(96)00571-7; Del Negro CA, 2002, BIOPHYS J, V82, P206, DOI 10.1016/S0006-3495(02)75387-3; GARFINKEL A, 1992, SCIENCE, V257, P1230, DOI 10.1126/science.1519060; Gdovin MJ, 1999, COMP BIOCHEM PHYS A, V124, P275, DOI 10.1016/S1095-6433(99)00116-6; Goldman MS, 2001, J NEUROSCI, V21, P5229, DOI 10.1523/JNEUROSCI.21-14-05229.2001; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Hokkanen JEI, 2000, J THEOR BIOL, V203, P451, DOI 10.1006/jtbi.2000.1096; Koshiya N, 1999, NATURE, V400, P360, DOI 10.1038/22540; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; MATSUMURA K, 1992, HYPERTENSION, V19, P648, DOI 10.1161/01.HYP.19.6.648; Mellen NM, 2000, J NEUROPHYSIOL, V83, P3165, DOI 10.1152/jn.2000.83.5.3165; Mellen NM, 2001, J NEUROSCI, V21, P7363, DOI 10.1523/JNEUROSCI.21-18-07363.2001; Nayfeh A. H., 2008, APPL NONLINEAR DYNAM; NIIZEKI K, 1993, J APPL PHYSIOL, V75, P1815, DOI 10.1152/jappl.1993.75.4.1815; ONIMARU H, 1995, EXP BRAIN RES, V106, P57; Onimaru H, 1997, JPN J PHYSIOL, V47, P385, DOI 10.2170/jjphysiol.47.385; Onimaru H, 1998, PFLUG ARCH EUR J PHY, V435, P485, DOI 10.1007/s004240050543; PERKEL DH, 1967, BIOPHYS J, V7, P391, DOI 10.1016/S0006-3495(67)86596-2; Rekling JC, 1998, ANNU REV PHYSIOL, V60, P385, DOI 10.1146/annurev.physiol.60.1.385; Rekling JC, 1996, J NEUROPHYSIOL, V75, P795, DOI 10.1152/jn.1996.75.2.795; Schulte-Frohlinde V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.068104; SMITH JC, 1987, J NEUROSCI METH, V21, P321, DOI 10.1016/0165-0270(87)90126-9; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Surawicz B, 1978, Am J Cardiol, V41, P130, DOI 10.1016/0002-9149(78)90147-9; SUZUE T, 1984, J PHYSIOL-LONDON, V354, P173, DOI 10.1113/jphysiol.1984.sp015370; Takeda S, 2001, ANESTHESIOLOGY, V95, P740, DOI 10.1097/00000542-200109000-00029; Wilson RJA, 2002, J PHYSIOL-LONDON, V540, P557, DOI 10.1113/jphysiol.2001.013512	31	271	283	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 6	2003	37	5					821	826		10.1016/S0896-6273(03)00092-8	http://dx.doi.org/10.1016/S0896-6273(03)00092-8			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	653TH	12628172	Green Accepted, Bronze			2022-12-24	WOS:000181452800011
J	Larsson, MC; Domingos, AI; Jones, WD; Chiappe, ME; Amrein, H; Vosshall, LB				Larsson, MC; Domingos, AI; Jones, WD; Chiappe, ME; Amrein, H; Vosshall, LB			Or83b encodes a broadly expressed odorant receptor essential for Drosophila olfaction	NEURON			English	Article							VECTOR ANOPHELES-GAMBIAE; C-ELEGANS; SENSORY NEURONS; PHEROMONE RECEPTORS; MAMMALIAN SWEET; GENE-EXPRESSION; MAXILLARY PALP; ANTENNAL LOBE; FLY BRAIN; MELANOGASTER	Fruit flies are attracted by a diversity of odors that signal the presence of food, potential mates, or attractive egg-laying sites. Most Drosophila olfactory neurons express two types of odorant receptor genes: Or83b, a broadly expressed receptor of unknown function, and one or more members of a family of 61 selectively expressed receptors. While the conventional odorant receptors are highly divergent, Or83b is remarkably conserved between insect species. Two models could account for Or83b function: it could interact with specific odor stimuli independent of conventional odorant receptors, or it could act in concert with these receptors to mediate responses to all odors. Our results support the second model. Dendritic localization of conventional odorant receptors is abolished in Or83b mutants. Consistent with this cellular defect, the Or83b mutation disrupts behavioral and electrophysiological responses to many odorants. Or83b therefore encodes an atypical odorant receptor that plays an essential general role in olfaction.	Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10021 USA	Rockefeller University	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave, New York, NY 10021 USA.	leslie@mail.rockefeller.edu	Jones, Walton/A-2417-2011; Amrein, Hubert/AAG-9480-2021; Larsson, Mattias C/E-4791-2014	Jones, Walton/0000-0001-8642-627X; Amrein, Hubert/0000-0001-8799-7250; Vosshall, Leslie/0000-0002-6060-8099; Domingos, Ana/0000-0002-7938-4814; Chiappe, M Eugenia/0000-0003-1761-0457	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005036] Funding Source: NIH RePORTER; NIDCD NIH HHS [5 R01 DC05036-03] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; AYER RK, 1992, J NEUROBIOL, V23, P965, DOI 10.1002/neu.480230804; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; BRAND AH, 1993, DEVELOPMENT, V118, P401; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Elmore T, 2003, J NEUROSCI, V23, P9906; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Galizia CG, 1998, EUR J NEUROSCI, V10, P2964, DOI 10.1111/j.1460-9568.1998.00303.x; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Gross SP, 2003, CURR BIOL, V13, P1660, DOI 10.1016/j.cub.2003.08.032; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Hummer TR, 2000, KENYON REV, V22, P1; Ishii T, 2003, CURR BIOL, V13, P394, DOI 10.1016/S0960-9822(03)00092-7; KELLER A, 2003, CURR OPIN NEUROBIOL, V40, P463; Kline DL, 2003, J MED ENTOMOL, V40, P463, DOI 10.1603/0022-2585-40.4.463; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Martini S, 2001, J NEUROSCI, V21, P843, DOI 10.1523/JNEUROSCI.21-03-00843.2001; MONTE P, 1989, BEHAV GENET, V19, P267, DOI 10.1007/BF01065910; Mukabana WR, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-1; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Park SK, 2002, J NEUROBIOL, V51, P248, DOI 10.1002/neu.10057; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Rostelien T, 2000, J COMP PHYSIOL A, V186, P833, DOI 10.1007/s003590000136; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Speca DJ, 1999, NEURON, V23, P487, DOI 10.1016/S0896-6273(00)80802-8; Stensmyr MC, 2003, P ROY SOC B-BIOL SCI, V270, P2333, DOI 10.1098/rspb.2003.2512; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; TAKKEN W, 1989, J AM MOSQUITO CONTR, V5, P311; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Warr C, 2001, CHEM SENSES, V26, P201, DOI 10.1093/chemse/26.2.201; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zhu JW, 2003, J CHEM ECOL, V29, P899, DOI 10.1023/A:1022931816351	56	883	973	11	179	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 2	2004	43	5					703	714		10.1016/j.neuron.2004.08.019	http://dx.doi.org/10.1016/j.neuron.2004.08.019			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339651	Bronze			2022-12-24	WOS:000223691900015
J	Ye, HH; Kuruvilla, R; Zweifel, LS; Ginty, DD				Ye, HH; Kuruvilla, R; Zweifel, LS; Ginty, DD			Evidence in support of signaling endosome-based retrograde survival of sympathetic neurons	NEURON			English	Article							NERVE GROWTH-FACTOR; TRK TYROSINE KINASE; AXONAL-TRANSPORT; INDUCED DIFFERENTIATION; NEUROTROPHIN RECEPTORS; ADRENERGIC-NEURONS; PROTEIN-KINASE; PATHWAY; PHOSPHORYLATION; PROPAGATION	The mechanism by which target-derived Nerve Growth Factor (NGF) signaling is propagated retrogradely, over extremely long distances, to cell bodies to support survival of neurons is unclear. Here we show that survival of sympathetic neurons supported by NGF on distal axons requires the kinase activity of the NGF receptor, TrkA, in both distal axons and cell bodies. In contrast, disruption of TrkA activity exclusively in proximal axonal segments affects neither retrograde NGF-TrkA signaling in cell bodies nor neuronal survival. Ligand-receptor internalization is necessary for survival of neurons supported by NGF on distal axons. Furthermore, antibody neutralization experiments indicate that retrogradely transported NGF, within cell bodies, is critical for neuronal survival but not for growth of distal axons. Taken together, our results indicate that retrogradely transported NGF-TrkA complexes promote sympathetic neuron survival.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu	Zweifel, Larry/O-3284-2017	Zweifel, Larry/0000-0003-3465-5331; Kuruvilla, Rejji/0000-0002-2851-675X; Ye, Haihong/0000-0001-7282-6280	NINDS NIH HHS [NS34814] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034814, R29NS034814, R37NS034814] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Bhattacharyya A, 1997, J NEUROSCI, V17, P7007; Bhattacharyya A, 2002, J NEUROBIOL, V51, P302, DOI 10.1002/neu.10062; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; CLARY DO, 1994, MOL BIOL CELL, V5, P549, DOI 10.1091/mbc.5.5.549; CLAUDE P, 1982, J NEUROSCI, V2, P431; Crowder RJ, 1998, J NEUROSCI, V18, P2933; EHLERS MD, 1995, J CELL BIOL, V130, P149, DOI 10.1083/jcb.130.1.149; Encinas M, 2001, J NEUROSCI, V21, P1464, DOI 10.1523/JNEUROSCI.21-05-01464.2001; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Grimes ML, 1997, P NATL ACAD SCI USA, V94, P9909, DOI 10.1073/pnas.94.18.9909; Grimes ML, 1996, J NEUROSCI, V16, P7950; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; HENDRY IA, 1974, BRAIN RES, V68, P103, DOI 10.1016/0006-8993(74)90536-8; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; JOHNSON EM, 1978, BRAIN RES, V150, P319, DOI 10.1016/0006-8993(78)90283-4; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; MacInnis BL, 2002, SCIENCE, V295, P1536, DOI 10.1126/science.1064913; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; Miller FD, 2002, SCIENCE, V295, P1471, DOI 10.1126/science.1069897; Miller FD, 2001, NEURON, V32, P767, DOI 10.1016/S0896-6273(01)00529-3; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; OHMICHI M, 1992, BIOCHEMISTRY-US, V31, P4034, DOI 10.1021/bi00131a019; Reynolds AJ, 1998, BRAIN RES, V798, P67, DOI 10.1016/S0006-8993(98)00396-5; Reynolds AJ, 2000, BRAIN RES REV, V33, P169, DOI 10.1016/S0165-0173(00)00028-X; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Sawano A, 2002, DEV CELL, V3, P245, DOI 10.1016/S1534-5807(02)00224-1; Schlessinger J, 2002, MOL CELL, V10, P218, DOI 10.1016/S1097-2765(02)00607-X; SCHWAB ME, 1977, BRAIN RES, V130, P190, DOI 10.1016/0006-8993(77)90857-5; Senger DL, 1997, J CELL BIOL, V138, P411, DOI 10.1083/jcb.138.2.411; Shao YF, 2002, J CELL BIOL, V157, P679, DOI 10.1083/jcb.200201063; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; STOCKEL K, 1975, BRAIN RES, V99, P1, DOI 10.1016/0006-8993(75)90604-6; TAPLEY P, 1992, ONCOGENE, V7, P371; Tsui-Pierchala BA, 1999, J NEUROSCI, V19, P8207; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; Watson FL, 1999, J NEUROSCI, V19, P7889; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Wellmann H, 2001, J BIOL CHEM, V276, P11821, DOI 10.1074/jbc.M009253200; Yano H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-03-j0003.2001; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	44	176	179	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2003	39	1					57	68		10.1016/S0896-6273(03)00266-6	http://dx.doi.org/10.1016/S0896-6273(03)00266-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699LB	12848932	Bronze			2022-12-24	WOS:000184057400009
J	Bissiere, S; Humeau, Y; Luthi, A				Bissiere, S; Humeau, Y; Luthi, A			Dopamine gates LTP induction in lateral amygdala by suppressing feedforward inhibition	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RAT BASOLATERAL AMYGDALA; LASTING POTENTIATION; SYNAPTIC PLASTICITY; CONSCIOUS CATS; FEAR; NEURONS; INTERNEURONS; MODULATION; RESPONSES	Fear conditioning involves the induction of long-term potentiation (LTP) of excitatory synaptic transmission in the lateral amygdala, a brain structure which is tightly controlled by GABAergic inhibition. Here we show that dopamine gates the induction of LTP in the mouse lateral amygdala by suppressing feedforward inhibition from local interneurons. Our findings provide a cellular mechanism for the dopaminergic modulation of fear conditioning and indicate that suppression of feedforward inhibition represents a key mechanism for the induction of associative synaptic plasticity in the lateral amygdala.	Univ Basel, Bioctr, Dept Pharmacol Neurobiol, CH-4056 Basel, Switzerland	University of Basel	Luthi, A (corresponding author), Univ Basel, Bioctr, Dept Pharmacol Neurobiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.	andreas.luthi@unibas.ch						Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brinley-Reed M, 1999, BRAIN RES, V850, P127, DOI 10.1016/S0006-8993(99)02112-5; Collins DR, 2000, LEARN MEMORY, V7, P97, DOI 10.1101/lm.7.2.97; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; DAVIS M, 2000, AMYGDALA, P231; El-Ghundi M, 2001, BRAIN RES, V892, P86, DOI 10.1016/S0006-8993(00)03234-0; Fi XF, 1996, SYNAPSE, V24, P115, DOI 10.1002/(SICI)1098-2396(199610)24:2<115::AID-SYN3>3.0.CO;2-I; Frohardt RJ, 2000, BEHAV NEUROSCI, V114, P227, DOI 10.1037/0735-7044.114.2.227; Greba Q, 2001, BRAIN RES, V899, P218, DOI 10.1016/S0006-8993(01)02243-0; Greba Q, 2000, BEHAV NEUROSCI, V114, P262, DOI 10.1037//0735-7044.114.2.262; Guarraci FA, 1999, BRAIN RES, V827, P28, DOI 10.1016/S0006-8993(99)01291-3; Heidbreder CA, 2000, NEUROSCIENCE, V100, P749, DOI 10.1016/S0306-4522(00)00336-5; Inglis FM, 1999, J NEUROCHEM, V72, P1088, DOI 10.1046/j.1471-4159.1999.0721088.x; Kemppainen S, 2000, J COMP NEUROL, V426, P441, DOI 10.1002/1096-9861(20001023)426:3<441::AID-CNE8>3.0.CO;2-7; Klimek V, 2002, BIOL PSYCHIAT, V52, P740, DOI 10.1016/S0006-3223(02)01383-5; Lang EJ, 1997, J NEUROPHYSIOL, V77, P341, DOI 10.1152/jn.1997.77.1.341; Lang EJ, 1998, NEUROSCIENCE, V83, P877, DOI 10.1016/S0306-4522(97)00420-X; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McDonald AJ, 2001, NEUROSCIENCE, V105, P681, DOI 10.1016/S0306-4522(01)00214-7; MCDONALD AJ, 1982, J COMP NEUROL, V212, P293, DOI 10.1002/cne.902120307; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Nader K, 1999, BEHAV NEUROSCI, V113, P891, DOI 10.1037/0735-7044.113.5.891; Pare D, 1996, J NEUROSCI, V16, P3334; Pare D, 2000, J NEUROSCI, V20, P2701; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; RAINNIE DG, 1991, J NEUROPHYSIOL, V66, P986, DOI 10.1152/jn.1991.66.3.986; RAINNIE DG, 1993, J NEUROPHYSIOL, V69, P1350, DOI 10.1152/jn.1993.69.4.1350; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rosenkranz JA, 1999, J NEUROSCI, V19, P11027, DOI 10.1523/JNEUROSCI.19-24-11027.1999; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Rosenkranz JA, 2001, J NEUROSCI, V21, P4090, DOI 10.1523/JNEUROSCI.21-11-04090.2001; Seamans JK, 2001, J NEUROSCI, V21, P3628, DOI 10.1523/JNEUROSCI.21-10-03628.2001; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; SUGITA S, 1993, J PHYSIOL-LONDON, V460, P705, DOI 10.1113/jphysiol.1993.sp019495; Szinyei C, 2000, J NEUROSCI, V20, P8909; Tessitore A, 2002, J NEUROSCI, V22, P9099, DOI 10.1523/jneurosci.22-20-09099.2002; WASHBURN MS, 1992, J NEUROSCI, V12, P4066; Weisskopf MG, 1999, J NEUROSCI, V19, P10512; WIGSTROM H, 1983, NATURE, V301, P603, DOI 10.1038/301603a0; Yamada J, 1999, NEUROPHARMACOLOGY, V38, P1743, DOI 10.1016/S0028-3908(99)00126-4	45	295	300	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					587	592		10.1038/nn1058	http://dx.doi.org/10.1038/nn1058			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12740581				2022-12-24	WOS:000183140400015
J	Romo, R; Hernandez, A; Zainos, A; Salinas, E				Romo, R; Hernandez, A; Zainos, A; Salinas, E			Correlated neuronal discharges that increase coding efficiency during perceptual discrimination	NEURON			English	Article							2ND SOMATOSENSORY CORTEX; DECISION-MAKING; PSYCHOPHYSICAL MEASUREMENTS; PREFRONTAL CORTEX; CORTICAL AREAS; MONKEYS; SENSE; SII; PERFORMANCE; FREQUENCY	During a sensory discrimination task, the responses of multiple sensory neurons must be combined to generate a choice. The optimal combination of responses is determined both by their dependence on the sensory stimulus and by their cofluctuations across trials-that is, the noise correlations. Positively correlated noise is considered deleterious, because it limits the coding accuracy of populations of similarly tuned neurons. However, positively correlated fluctuations between differently tuned neurons actually increase coding accuracy, because they allow the common noise to be subtracted without signal loss. This is demonstrated with data recorded from the secondary somatosensory cortex of monkeys performing a vibrotactile discrimination task. The results indicate that positive correlations are not always harmful and may be exploited by cortical networks to enhance the neural representation of features to be discriminated.	Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; Wake Forest Univ, Bowman Gray Sch Med, Dept Neurobiol & Anat, Winston Salem, NC 27157 USA	Universidad Nacional Autonoma de Mexico; Wake Forest University; Wake Forest Baptist Medical Center	Romo, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.			romo, ranulfo/0000-0003-3529-3635; zainos, antonio/0000-0001-6137-1794; Salinas, Emilio/0000-0001-7411-5693				Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BURTON H, 1995, J COMP NEUROL, V355, P539, DOI 10.1002/cne.903550405; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Hernandez A, 1997, J NEUROSCI, V17, P6391; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; Hernandez A, 2002, NEURON, V33, P959, DOI 10.1016/S0896-6273(02)00613-X; Jiang W, 1997, J NEUROPHYSIOL, V77, P1656, DOI 10.1152/jn.1997.77.3.1656; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MOUNTCASTLE VB, 1990, J NEUROSCI, V10, P3032; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; PONS TP, 1987, SCIENCE, V237, P417, DOI 10.1126/science.3603028; PONS TP, 1992, J NEUROPHYSIOL, V68, P518, DOI 10.1152/jn.1992.68.2.518; Pruett JR, 2001, J NEUROPHYSIOL, V86, P2069, DOI 10.1152/jn.2001.86.4.2069; RIDLEY RM, 1978, EXP BRAIN RES, V31, P475; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Romo R, 2002, NAT NEUROSCI, V5, P1217, DOI 10.1038/nn950; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; SINCLAIR RJ, 1993, J NEUROPHYSIOL, V70, P331, DOI 10.1152/jn.1993.70.1.331; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; WATSON AB, 1992, VISUAL NEUROSCI, V8, P65, DOI 10.1017/S0952523800006507; Zhang HQ, 1996, J NEUROPHYSIOL, V76, P3633, DOI 10.1152/jn.1996.76.6.3633; Zhang HQ, 2001, J NEUROPHYSIOL, V85, P1805, DOI 10.1152/jn.2001.85.5.1805; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0; [No title captured]; [No title captured]	30	162	162	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 22	2003	38	4					649	657		10.1016/S0896-6273(03)00287-3	http://dx.doi.org/10.1016/S0896-6273(03)00287-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	682QV	12765615	Bronze			2022-12-24	WOS:000183104000014
J	Butler, SJ; Dodd, J				Butler, SJ; Dodd, J			A role for BMP heterodimers in roof plate-mediated repulsion of commissural axons	NEURON			English	Article							BONE MORPHOGENETIC PROTEINS; PRIMITIVE STREAK FORMATION; SPINAL-CORD; FLOOR PLATE; OSTEOGENIC PROTEIN-1; SIGNALING PATHWAYS; NERVOUS-SYSTEM; I RECEPTORS; TGF-BETA; MOUSE LIMB	During spinal cord development, commissural neurons extend their axons ventrally, away from the roof plate. The roof plate is the source of a diffusible repellent that orients commissural axons in vitro and, thus, may regulate the trajectory of commissural axons in vivo. Of three Bmps expressed in the roof plate, BMP7, but not BMP6 or GDF7, mimics the roof plate activity in vitro. We show here that expression of both Bmp7 and Gdf7 by roof plate cells is required for the fidelity of commissural axon growth in vivo. We also demonstrate that BMP7 and GDF7 heterodimerize in vitro and that, under these conditions, GDF7 enhances the axon-orienting activity of BMP7. Our findings suggest that a GDF7:BMP7 heterodimer functions as a roof plate-derived repellent that establishes the initial ventral trajectory of commissural axons.	Columbia Univ, Ctr Neurobiol & Behav, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University	Dodd, J (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, Dept Physiol & Cellular Biophys, New York, NY 10032 USA.	jd18@columbia.edu			NINDS NIH HHS [NS 27113] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027113] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alder J, 1999, NAT NEUROSCI, V2, P535, DOI 10.1038/9189; Aoki H, 2001, J CELL SCI, V114, P1483; AONO A, 1995, BIOCHEM BIOPH RES CO, V210, P670, DOI 10.1006/bbrc.1995.1712; Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Baur ST, 2000, DEVELOPMENT, V127, P605; BOVOLENTA P, 1991, DEVELOPMENT, V113, P625; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Chang CB, 1999, DEVELOPMENT, V126, P3347; COLAMARINO SA, 1995, ANNU REV NEUROSCI, V18, P497, DOI 10.1146/annurev.ne.18.030195.002433; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; CUNNINGHAM NS, 1992, P NATL ACAD SCI USA, V89, P11740, DOI 10.1073/pnas.89.24.11740; DALESSANDRO JS, 1994, GROWTH FACTORS, V11, P53, DOI 10.3109/08977199409015051; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Ebisawa T, 1999, J CELL SCI, V112, P3519; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Gitelman SE, 1997, MAMM GENOME, V8, P212, DOI 10.1007/s003359900391; HATTA K, 1991, NATURE, V350, P339, DOI 10.1038/350339a0; Helms AW, 1998, DEVELOPMENT, V125, P919; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; HOLLEY JA, 1982, J COMP NEUROL, V205, P371, DOI 10.1002/cne.902050406; HUME CR, 1993, DEVELOPMENT, V119, P1147; Israel DI, 1996, GROWTH FACTORS, V13, P291, DOI 10.3109/08977199609003229; Katagiri T, 1998, DEV GENET, V22, P340, DOI 10.1002/(SICI)1520-6408(1998)22:4<340::AID-DVG4>3.0.CO;2-6; KATAYAMA T, 1994, ENDOCRINOLOGY, V134, P119, DOI 10.1210/en.134.1.119; Kim BC, 2001, J IND ENG CHEM, V7, P449; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; LIU F, 1995, MOL CELL BIOL, V15, P3479; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; MOGAMI H, 1995, ENDOCRINOLOGY, V136, P2960, DOI 10.1210/en.136.7.2960; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Nishitoh H, 1996, J BIOL CHEM, V271, P21345, DOI 10.1074/jbc.271.35.21345; NOHNO T, 1995, J BIOL CHEM, V270, P22522, DOI 10.1074/jbc.270.38.22522; Nonner D, 2001, J NEUROCHEM, V77, P691, DOI 10.1046/j.1471-4159.2001.00273.x; NORNES HO, 1978, BRAIN RES, V159, P1, DOI 10.1016/0006-8993(78)90105-1; PLACZEK M, 1991, DEVELOPMENT, P105; POSTLETHWAITE AE, 1994, J CELL PHYSIOL, V161, P562, DOI 10.1002/jcp.1041610320; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Schmid B, 2000, DEVELOPMENT, V127, P957; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Settle S, 2001, DEV BIOL, V234, P138, DOI 10.1006/dbio.2001.0244; Shah SB, 1997, DEVELOPMENT, V124, P5127; Solloway MJ, 1998, DEV GENET, V22, P321, DOI 10.1002/(SICI)1520-6408(1998)22:4<321::AID-DVG3>3.3.CO;2-7; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Suzuki A, 1997, DEV BIOL, V189, P112, DOI 10.1006/dbio.1997.8652; Suzuki A, 1997, BIOCHEM BIOPH RES CO, V232, P153, DOI 10.1006/bbrc.1997.6219; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Yabe T, 2002, J NEUROSCI RES, V68, P161, DOI 10.1002/jnr.10210; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217; Yi SE, 2000, DEVELOPMENT, V127, P621; Ying Y, 2001, P NATL ACAD SCI USA, V98, P7858, DOI 10.1073/pnas.151242798; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748	59	207	214	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 8	2003	38	3					389	401		10.1016/S0896-6273(03)00254-X	http://dx.doi.org/10.1016/S0896-6273(03)00254-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	677HF	12741987	Bronze			2022-12-24	WOS:000182800300005
J	Fukazawa', Y; Saitoh, Y; Ozawa, F; Ohta, Y; Mizuno, K; Inokuchi, K				Fukazawa', Y; Saitoh, Y; Ozawa, F; Ohta, Y; Mizuno, K; Inokuchi, K			Hippocampal LTP is accompanied by enhanced F-actin content within the dendritic spine that is essential for late LTP maintenance in vivo	NEURON			English	Article							LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENE; AMPA RECEPTOR TRAFFICKING; LIM-KINASE; LATE-PHASE; COFILIN PHOSPHORYLATION; PERFORANT PATHWAYS; ENTORHINAL AREA; MESSENGER-RNA; DENTATE GYRUS	The dendritic spine is an important site of neuronal plasticity and contains extremely high levels of cytoskeletal actin. However, the dynamics of the actin cytoskeleton during synaptic plasticity and its in vivo function remain unclear. Here we used an in vivo dentate gyrus LTP model to show that LTP induction is associated with actin cytoskeletal reorganization characterized by a long-lasting increase in F-actin content within dendritic spines. This increase in F-actin content is dependent on NMDA receptor activation and involves the inactivation of actin depolymerizing factor/cofilin. Inhibition of actin polymerization with latrunculin A impaired late phase of LTP without affecting the initial amplitude and early maintenance of LTP. These observations suggest that mechanisms regulating the spine actin cytoskeleton contribute to the persistence of LTP.	Mitsubishi Kaguku Inst Life Sci, Machida, Tokyo 1948511, Japan; Inst Nat Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 4448585, Japan; Tottori Univ, Lab Anim Sci, Tottori 6808553, Japan; Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan; Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Tottori University; Tohoku University; Yokohama National University	Inokuchi, K (corresponding author), Mitsubishi Kaguku Inst Life Sci, Machida, Tokyo 1948511, Japan.	kaoru@libra.ls.m-kagaku.co.jp	Inokuchi, Kaoru/AAI-9693-2020; Fukazawa, Yugo/H-9899-2012; Mizuno, Kensaku/G-8631-2015	Inokuchi, Kaoru/0000-0002-5393-3133; Fukazawa, Yugo/0000-0001-7436-8797; 				ABE H, 1989, J BIOCHEM-TOKYO, V106, P696, DOI 10.1093/oxfordjournals.jbchem.a122919; ABRAHAM WC, 1993, NEUROSCIENCE, V56, P717, DOI 10.1016/0306-4522(93)90369-Q; AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Allison DW, 1998, J NEUROSCI, V18, P2423; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; BAMBURG JR, 1987, J CELL BIOL, V105, P2817, DOI 10.1083/jcb.105.6.2817; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; Capani F, 2001, J COMP NEUROL, V435, P156, DOI 10.1002/cne.1199; Carlier MF, 1997, J MOL BIOL, V269, P459, DOI 10.1006/jmbi.1997.1062; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Chen H, 2000, TRENDS BIOCHEM SCI, V25, P19, DOI 10.1016/S0968-0004(99)01511-X; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Cremona O, 2001, J CELL SCI, V114, P1041; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; ERRINGTON ML, 1987, NEUROSCIENCE, V20, P279, DOI 10.1016/0306-4522(87)90019-4; FIFKOVA E, 1985, BRAIN RES REV, V9, P187, DOI 10.1016/0165-0173(85)90012-8; FIFKOVA E, 1992, INT REV CYTOL, V139, P267, DOI 10.1016/S0074-7696(08)61414-X; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Frey U, 1996, J PHYSIOL-LONDON, V490, P703, DOI 10.1113/jphysiol.1996.sp021179; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Geinisman Y, 1996, J COMP NEUROL, V368, P413; Gomez LL, 2002, J NEUROSCI, V22, P7027; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HJORTHSIMONSEN A, 1972, J COMP NEUROL, V144, P215, DOI 10.1002/cne.901440206; HJORTHSIMONSEN A, 1972, J COMP NEUROL, V146, P219, DOI 10.1002/cne.901460206; Inokuchi K, 1996, FEBS LETT, V382, P48, DOI 10.1016/0014-5793(96)00135-4; Kaech S, 2001, P NATL ACAD SCI USA, V98, P7086, DOI 10.1073/pnas.111146798; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Kim CH, 1999, J NEUROSCI, V19, P4314; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; KRUG M, 1984, BRAIN RES BULL, V13, P39, DOI 10.1016/0361-9230(84)90005-4; Langford GM, 1998, BRAIN RES REV, V28, P1, DOI 10.1016/S0165-0173(98)00020-4; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Matsuo R, 2000, J NEUROCHEM, V74, P2239, DOI 10.1046/j.1471-4159.2000.0742239.x; Matsuo R, 1998, NEUROSCI LETT, V244, P173, DOI 10.1016/S0304-3940(98)00159-1; Matsushita M, 2001, J NEUROSCI, V21, P6000, DOI 10.1523/JNEUROSCI.21-16-06000.2001; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; MCNAUGHTON BL, 1977, J COMP NEUROL, V175, P439, DOI 10.1002/cne.901750404; MCNAUGHTON BL, 1980, BRAIN RES, V199, P1, DOI 10.1016/0006-8993(80)90226-7; Meberg PJ, 2000, J NEUROSCI, V20, P2459; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Nguyen PV, 1996, J NEUROSCI, V16, P3189; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Simone NL, 2000, AM J PATHOL, V156, P445, DOI 10.1016/S0002-9440(10)64749-9; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; STEWARD O, 1976, J COMP NEUROL, V167, P285, DOI 10.1002/cne.901670303; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Takiguchi-Hayashi K, 1998, BRAIN RES, V801, P9, DOI 10.1016/S0006-8993(98)00496-X; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Trommald M, 1996, LEARN MEMORY, V3, P218, DOI 10.1101/lm.3.2-3.218; van Rossum D, 1999, TRENDS NEUROSCI, V22, P290, DOI 10.1016/S0166-2236(99)01404-6; Weeks ACW, 1998, BRAIN RES, V798, P211, DOI 10.1016/S0006-8993(98)00425-9; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Yamagata K, 1999, J BIOL CHEM, V274, P19473, DOI 10.1074/jbc.274.27.19473; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; Yamazaki M, 2001, J NEUROCHEM, V79, P192, DOI 10.1046/j.1471-4159.2001.00552.x; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2	95	534	553	4	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 8	2003	38	3					447	460		10.1016/S0896-6273(03)00206-X	http://dx.doi.org/10.1016/S0896-6273(03)00206-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	677HF	12741991	Bronze			2022-12-24	WOS:000182800300009
J	Shu, TZ; Ayala, R; Nguyen, MD; Xie, ZG; Gleeson, JG; Tsai, LH				Shu, TZ; Ayala, R; Nguyen, MD; Xie, ZG; Gleeson, JG; Tsai, LH			Ndel1 operates in a common pathway with LIS1 and cytoplasmic dynein to regulate cortical neuronal positioning	NEURON			English	Article							DIEKER LISSENCEPHALY GENE; ASPERGILLUS-NIDULANS; NUCLEAR MIGRATION; MICROTUBULE ORGANIZATION; HEAVY-CHAIN; CELL; DYNACTIN; PROTEIN; NUDEL; CENTROSOME	Correct neuronal migration and positioning during cortical development are essential for proper brain function. Mutations of the LIS1 gene result in human lissencephaly (smooth brain), which features misplaced cortical neurons and disarrayed cerebral lamination. However, the mechanism by which LIS1 regulates neuronal migration remains unknown. Using RNA interference (RNAi), we found that the binding partner of LIS1, NudE-like protein (Ndel1, formerly known as NUDEL), positively regulates dynein activity by facilitating the interaction between LIS1 and dynein. Loss of function of Ndel1, LIS1, or dynein in developing neocortex impairs neuronal positioning and causes the uncoupling of the centrosome and nucleus. Overexpression of LIS1 partially rescues the positioning defect caused by Ndel1 RNAi but not dynein RNAi, whereas overexpression of Ndel1 does not rescue the phenotype induced by LIS1 RNAi These results provide strong evidence that Ndel1 interacts with LIS1 to sustain the function of dynein, which in turn impacts microtubule organization, nuclear translocation, and neuronal positioning.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California San Diego	Tsai, LH (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	li-huei_tsai@hms.harvard.edu						Abal M, 2002, J CELL BIOL, V159, P731, DOI 10.1083/jcb.200207076; Ahmad FJ, 1998, J CELL BIOL, V140, P391, DOI 10.1083/jcb.140.2.391; Aumais JP, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0002.2001; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; BERLIN V, 1990, J CELL BIOL, V111, P2573, DOI 10.1083/jcb.111.6.2573; Bloom K, 2001, CURR BIOL, V11, pR326, DOI 10.1016/S0960-9822(01)00176-2; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; Cahana A, 2001, P NATL ACAD SCI USA, V98, P6429, DOI 10.1073/pnas.101122598; Caviness VS, 2003, CEREB CORTEX, V13, P592, DOI 10.1093/cercor/13.6.592; Clark GD, 2002, NEUROL CLIN, V20, P917, DOI 10.1016/S0733-8619(02)00024-5; Coquelle FM, 2002, MOL CELL BIOL, V22, P3089, DOI 10.1128/MCB.22.9.3089-3102.2002; de Rouvroit CL, 2001, MECH DEVELOP, V105, P47, DOI 10.1016/S0925-4773(01)00396-3; Dujardin DL, 2003, J CELL BIOL, V163, P1205, DOI 10.1083/jcb.200310097; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Efimov VP, 2000, J CELL BIOL, V150, P681, DOI 10.1083/jcb.150.3.681; Efimov VP, 2003, MOL BIOL CELL, V14, P871, DOI 10.1091/mbc.E02-06-0359; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; HATTORI M, 1994, NATURE, V370, P216, DOI 10.1038/370216a0; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Ligon LA, 2003, MOL BIOL CELL, V14, P1405, DOI 10.1091/mbc.E02-03-0155; Malone CJ, 2003, CELL, V115, P825, DOI 10.1016/S0092-8674(03)00985-1; Nguyen MD, 2004, NAT CELL BIOL, V6, P595, DOI 10.1038/ncb1139; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Reinsch S, 1997, CURR BIOL, V7, P211, DOI 10.1016/S0960-9822(97)70092-7; Reinsch S, 1998, J CELL SCI, V111, P2283; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Robinson JT, 1999, J CELL BIOL, V146, P597, DOI 10.1083/jcb.146.3.597; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; Sapir T, 1997, EMBO J, V16, P6977, DOI 10.1093/emboj/16.23.6977; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Tai CY, 2002, J CELL BIOL, V156, P959, DOI 10.1083/jcb.200109046; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; TIMAUER JS, 2000, J CELL BIOL, V149, P761; Toyo-oka K, 2003, NAT GENET, V34, P274, DOI 10.1038/ng1169; Vallee RB, 2001, TRENDS CELL BIOL, V11, P155, DOI 10.1016/S0962-8924(01)01956-0; Willins DA, 1997, MOL GEN GENET, V255, P194, DOI 10.1007/s004380050489; WILLINS DA, 1995, GENETICS, V141, P1287; Wynshaw-Boris A, 2001, GENE DEV, V15, P639, DOI 10.1101/gad.886801; XIANG X, 1995, MOL BIOL CELL, V6, P297, DOI 10.1091/mbc.6.3.297; XIANG X, 1994, P NATL ACAD SCI USA, V91, P2100, DOI 10.1073/pnas.91.6.2100; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Yan XM, 2003, MOL CELL BIOL, V23, P1239, DOI 10.1128/MCB.23.4.1239-1250.2003; Zhang J, 2003, MOL BIOL CELL, V14, P1479, DOI 10.1091/mbc.E02-08-0516	57	289	298	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 14	2004	44	2					263	277		10.1016/j.neuron.2004.09.030	http://dx.doi.org/10.1016/j.neuron.2004.09.030			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473966	Bronze			2022-12-24	WOS:000224635800010
J	Abe, K; Chisaka, O; van Roy, F; Takeichi, M				Abe, K; Chisaka, O; van Roy, F; Takeichi, M			Stability of dendritic spines and synaptic contacts is controlled by alpha N-catenin	NATURE NEUROSCIENCE			English	Article							ACTIN-BASED PLASTICITY; CULTURED HIPPOCAMPAL-NEURONS; BETA-CATENIN; IN-VIVO; POSTSYNAPTIC DENSITIES; ADHESION COMPLEX; NERVOUS-SYSTEM; SMALL GTPASES; ADULT CORTEX; CADHERIN	Morphological plasticity of dendritic spines and synapses is thought to be crucial for their physiological functions. Here we show that alphaN-catenin, a linker between cadherin adhesion receptors and the actin cytoskeleton, is essential for stabilizing dendritic spines in rodent hippocampal neurons in culture. In the absence of alphaN-catenin, spine heads were abnormally motile, actively protruding filopodia from their synaptic contact sites. Conversely, alphaN-catenin overexpression in dendrites reduced spine turnover, causing an increase in spine and synapse density. Tetrodotoxin (TTX), a neural activity blocker, suppressed the synaptic accumulation of alphaN-catenin, whereas bicuculline, a GABA antagonist, promoted it. Furthermore, excess alphaN-catenin rendered spines resistant to the TTX treatment. These results suggest that alphaN-catenin is a key regulator for the stability of synaptic contacts.	RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; VIB Ghent Univ, Dept Mol Biomed Res, B-9000 Ghent, Belgium	RIKEN; Kyoto University; Flanders Institute for Biotechnology (VIB); Ghent University	Takeichi, M (corresponding author), RIKEN, Ctr Dev Biol, Chuo Ku, 2-2-3 Minatojima, Kobe, Hyogo 6500047, Japan.	takeichi@cdb.riken.jp	Abe, Kentaro/A-6197-2008; van Roy, Frans M/C-6123-2009; Takeichi, Masatoshi/G-5903-2012; Abe, Kentaro/T-2247-2019	van Roy, Frans M/0000-0003-4358-1039; Takeichi, Masatoshi/0000-0002-9931-3378; Abe, Kentaro/0000-0002-3923-6323				Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Bek S, 2002, J CELL SCI, V115, P4743, DOI 10.1242/jcs.00154; Benson DL, 1998, J NEUROSCI, V18, P6892; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Ebihara T, 2003, J NEUROSCI, V23, P2170; El-Hussein AE, 2000, SCIENCE, V290, P1364; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Ethell IM, 1999, J CELL BIOL, V144, P575, DOI 10.1083/jcb.144.3.575; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hayashi K, 1999, J NEUROSCI, V19, P3918; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; Huntley GW, 1999, J COMP NEUROL, V407, P453; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Iwai Y, 2002, MOL CELL NEUROSCI, V19, P375, DOI 10.1006/mcne.2001.1081; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Korkotian E, 2001, J NEUROSCI, V21, P6115, DOI 10.1523/JNEUROSCI.21-16-06115.2001; Kussel-Andermann P, 2000, EMBO J, V19, P6020, DOI 10.1093/emboj/19.22.6020; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nagafuchi A, 2001, CURR OPIN CELL BIOL, V13, P600, DOI 10.1016/S0955-0674(00)00257-X; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Papa M, 1996, NEUROSCIENCE, V71, P1005, DOI 10.1016/0306-4522(95)00490-4; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Provost E, 1999, CURR OPIN CELL BIOL, V11, P567, DOI 10.1016/S0955-0674(99)00015-0; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; UCHIDA N, 1994, DEV BIOL, V163, P75, DOI 10.1006/dbio.1994.1124; YAMAGATA M, 1995, J NEUROSCI, V15, P4556; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	50	194	197	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					357	363		10.1038/nn1212	http://dx.doi.org/10.1038/nn1212			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15034585				2022-12-24	WOS:000220482500014
J	Johansen, JP; Fields, HL				Johansen, JP; Fields, HL			Glutamatergic activation of anterior cingulate cortex produces an aversive teaching signal	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; NOCICEPTIVE NEURONS; PAIN; RAT; RESPONSES; STIMULATION; AMYGDALA; BRAIN; PROJECTIONS; MODULATION	Noxious stimuli have motivational power and can support associative learning, but the neural circuitry mediating such avoidance learning is poorly understood. The anterior cingulate cortex (ACC) is implicated in the affective response to noxious stimuli and the motivational properties of conditioned stimuli that predict noxious stimulation. Using conditioned place aversion (CPA) in rats, we found that excitatory amino acid microinjection into the ACC during conditioning produces avoidance learning in the absence of a peripheral noxious stimulus. Furthermore, microinjection of an excitatory amino acid antagonist into the ACC during conditioning blocked learning elicited by a noxious stimulus. ACC lesions made after conditioning did not impair expression of CPA. Thus, ACC neuronal activity is necessary and sufficient for noxious stimuli to produce an aversive teaching signal. Our results support the idea that a shared ACC pathway mediates both pain-induced negative affect and a nociceptor-driven aversive teaching signal.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Fields, HL (corresponding author), Univ Calif San Francisco, Dept Neurol, 513 Parnassus Ave,S-784, San Francisco, CA 94143 USA.	hlf@itsa.ucsf.edu	Johansen, Joshua/N-8010-2015; Fields, Howard/ABG-9073-2020	Johansen, Joshua/0000-0003-4240-1550; 	NINDS NIH HHS [NS 21445] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS021445, P50NS021445] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEN GV, 1989, J COMP NEUROL, V286, P311, DOI 10.1002/cne.902860303; Barros DM, 2000, BEHAV BRAIN RES, V114, P183, DOI 10.1016/S0166-4328(00)00226-6; BERENDSE HW, 1991, NEUROSCIENCE, V42, P73, DOI 10.1016/0306-4522(91)90151-D; BUCHANAN SL, 1982, J COMP PHYSIOL PSYCH, V96, P755, DOI 10.1037/h0077925; Calejesan AA, 2000, EUR J PAIN, V4, P83, DOI 10.1053/eujp.1999.0158; Casey KL, 1999, P NATL ACAD SCI USA, V96, P7668, DOI 10.1073/pnas.96.14.7668; CASSELL MD, 1986, BRAIN RES BULL, V17, P321, DOI 10.1016/0361-9230(86)90237-6; CHRISTIE MJ, 1987, NEUROSCIENCE, V22, P425, DOI 10.1016/0306-4522(87)90345-9; CLIFFER KD, 1991, J NEUROSCI, V11, P852; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Donahue RR, 2001, BRAIN RES, V897, P131, DOI 10.1016/S0006-8993(01)02103-5; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Fields H. L., 1999, PAIN S, P61; FOLTZ EL, 1962, J NEUROSURG, V19, P89, DOI 10.3171/jns.1962.19.2.0089; GABRIEL M, 1991, EXP BRAIN RES, V86, P585; GIGG J, 1992, CEREB CORTEX, V2, P477, DOI 10.1093/cercor/2.6.477; HARDY SGP, 1985, BRAIN RES, V339, P285; HARDY SGP, 1985, BRAIN RES, V339, P281; Hsu MM, 1997, NEUROREPORT, V8, P2701, DOI 10.1097/00001756-199708180-00013; Hurt R W, 1974, Clin Neurosurg, V21, P334; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; Johansen JP, 2001, P NATL ACAD SCI USA, V98, P8077, DOI 10.1073/pnas.141218998; Kandel E., 2000, PRINCIPLES NEURAL SC; Koyama T, 1998, NEUROREPORT, V9, P2663, DOI 10.1097/00001756-199808030-00044; Kung JC, 2003, BRAIN RES, V970, P58, DOI 10.1016/S0006-8993(02)04276-2; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee DE, 1999, BRAIN RES, V845, P117, DOI 10.1016/S0006-8993(99)01956-3; Manning BH, 1998, J NEUROSCI, V18, P9453; MAO JR, 1993, J NEUROSCI, V13, P2689, DOI 10.1523/JNEUROSCI.13-06-02689.1993; MORGAN MA, 1995, BEHAV NEUROSCI, V109, P681, DOI 10.1037/0735-7044.109.4.681; Nishijo H, 1997, NEUROSCI LETT, V227, P79, DOI 10.1016/S0304-3940(97)00310-8; Pastoriza LN, 1996, PAIN, V64, P11, DOI 10.1016/0304-3959(95)00070-4; PERETZ E, 1960, J COMP PHYSIOL PSYCH, V53, P540, DOI 10.1037/h0040297; PESCHANSKI M, 1985, J COMP NEUROL, V236, P29, DOI 10.1002/cne.902360104; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Puig S, 1996, PAIN, V64, P345, DOI 10.1016/0304-3959(95)00121-2; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Reep RL, 1999, BRAIN RES, V841, P43, DOI 10.1016/S0006-8993(99)01779-5; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; SALAS PJ, 1997, J CELL BIOL, V21, P359; SIKES RW, 1992, J NEUROPHYSIOL, V68, P1720, DOI 10.1152/jn.1992.68.5.1720; Takenouchi K, 1999, NEUROSCIENCE, V93, P1271, DOI 10.1016/S0306-4522(99)00216-X; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; VACCARINO AL, 1989, PAIN, V39, P213, DOI 10.1016/0304-3959(89)90008-0; Vogt BA, 2000, PROG BRAIN RES, V122, P223; Wei F, 1999, J NEUROSCI, V19, P9346; Wei F, 2001, J PHYSIOL-LONDON, V532, P823, DOI 10.1111/j.1469-7793.2001.0823e.x; Yamamura H, 1996, BRAIN RES, V735, P83	50	264	274	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					398	403		10.1038/nn1207	http://dx.doi.org/10.1038/nn1207			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15004562				2022-12-24	WOS:000220482500019
J	Celie, PHN; van Rossum-Fikkert, SE; van Dijk, WJ; Brejc, K; Smit, AB; Sixma, TK				Celie, PHN; van Rossum-Fikkert, SE; van Dijk, WJ; Brejc, K; Smit, AB; Sixma, TK			Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures	NEURON			English	Article							AGONIST-BINDING; EXTRACELLULAR DOMAIN; PROTEIN; SITE; RESIDUES; IDENTIFICATION; ACTIVATION; AFFINITY; GABA(A); SUBUNIT	Nicotinic acetylcholine receptors are prototypes for the pharmaceutically important family of pentameric ligand-gated ion channels. Here we present atomic resolution structures of nicotine and carbamylcholine binding to AChBP, a water-soluble homolog of the ligand binding domain of nicotinic receptors and their family members, GABA(A), GABA(C), 5HT(3) serotonin, and glycine receptors. Ligand binding is driven by enthalpy and is accompanied by conformational changes in the ligand binding site. Residues in the binding site contract around the ligand, with the largest movement in the C loop. As expected, the binding is characterized by substantial aromatic and hydrophobic contributions, but additionally there are close contacts between protein oxygens and positively charged groups in the ligands. The higher affinity of nicotine is due to a main chain hydrogen bond with the B loop and a closer packing of the aromatic groups. These structures will be useful tools for the development of new drugs involving nicotinic acetylcholine receptor-associated diseases.	Netherlands Canc Inst, Div Mol Carinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; Vrije Univ Amsterdam, Fac Earth & Life Sci, Inst Neurosci, Dept Mol & Cellular Neurobiol, NL-1081 HV Amsterdam, Netherlands	Netherlands Cancer Institute; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Vrije Universiteit Amsterdam	Sixma, TK (corresponding author), Netherlands Canc Inst, Div Mol Carinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	t.sixma@nki.nl	Smit, August B/E-8410-2011; Celie, Patrick/AAY-9559-2021	Brejc, Katjusa/0000-0002-4562-6109; Sixma, Titia K/0000-0001-6180-0632				Abreo MA, 1996, J MED CHEM, V39, P817, DOI 10.1021/jm9506884; Arias HR, 2000, NEUROCHEM INT, V36, P595, DOI 10.1016/S0197-0186(99)00154-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; COHEN JB, 1991, J BIOL CHEM, V266, P23354; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Cromer BA, 2002, TRENDS BIOCHEM SCI, V27, P280, DOI 10.1016/S0968-0004(02)02092-3; DAMLE VN, 1980, BIOCHEMISTRY-US, V19, P3924, DOI 10.1021/bi00558a006; GALZI JL, 1991, FEBS LETT, V294, P198, DOI 10.1016/0014-5793(91)80668-S; Glennon R A, 2000, Pharm Acta Helv, V74, P103, DOI 10.1016/S0031-6865(99)00022-9; Hansen SB, 2002, J BIOL CHEM, V277, P41299, DOI 10.1074/jbc.C200462200; Harel M, 2001, NEURON, V32, P265, DOI 10.1016/S0896-6273(01)00461-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Le Novere N, 2001, PHILOS T R SOC B, V356, P1121; Le Novere N, 2002, P NATL ACAD SCI USA, V99, P3210, DOI 10.1073/pnas.042699699; Martin M, 1996, J BIOL CHEM, V271, P13497, DOI 10.1074/jbc.271.23.13497; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; OLEARY ME, 1992, J BIOL CHEM, V267, P8360; Osaka H, 1998, J BIOL CHEM, V273, P12758, DOI 10.1074/jbc.273.21.12758; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker MJ, 2001, J PHARMACOL EXP THER, V299, P385; Prince RJ, 1996, J BIOL CHEM, V271, P25770, DOI 10.1074/jbc.271.42.25770; Reeves DC, 2002, MOL MEMBR BIOL, V19, P11, DOI 10.1080/09687680110110048; Schapira Matthieu, 2002, BMC Structural Biology, V2, P1, DOI 10.1186/1472-6807-2-1; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P195, DOI 10.1107/S0907444901019291; SINE SM, 1994, J BIOL CHEM, V269, P8808; Sine SM, 2002, J NEUROBIOL, V53, P431, DOI 10.1002/neu.10139; Sixma TK, 2003, ANNU REV BIOPH BIOM, V32, P311, DOI 10.1146/annurev.biophys.32.110601.142536; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; TAYLOR R, 1982, J AM CHEM SOC, V104, P5063, DOI 10.1021/ja00383a012; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9; Vafa B, 1998, INT REV NEUROBIOL, V42, P285, DOI 10.1016/S0074-7742(08)60613-3; Xie Y, 2001, J BIOL CHEM, V276, P2417, DOI 10.1074/jbc.M009085200; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	36	686	709	3	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 25	2004	41	6					907	914		10.1016/S0896-6273(04)00115-1	http://dx.doi.org/10.1016/S0896-6273(04)00115-1			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046723	Bronze			2022-12-24	WOS:000221458300010
J	Temereanca, S; Simons, DJ				Temereanca, S; Simons, DJ			Functional topography of corticothalamic feedback enhances thalamic spatial response tuning in the somatosensory whisker/barrel system	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; METABOTROPIC GLUTAMATE RECEPTORS; RAT THALAMUS; CORTICOFUGAL MODULATION; CORTICAL ACTIVATION; RELAY NEURONS; BARREL FIELD; S1 CORTEX; PROJECTIONS; ORGANIZATION	Corticothalamic (CT) projections are similar to10 times more numerous than thalamocortical projections, yet their function in sensory processing is poorly understood. In particular, the functional significance of the topographic precision of CT feedback is unknown. We addressed these issues in the rodent somatosensory whisker/barrel system by deflecting individual whiskers and pharmacologically enhancing activity in layer VI of single whisker-related cortical columns. Enhancement of corticothalamic activity in a cortical column facilitated whisker-evoked responses in topographically aligned thalamic barreloid neurons, while activation of an adjacent column weakly suppressed activity at the same thalamic site. Both effects were more pronounced when stimulating the preferred, or principal, whisker than for adjacent whiskers. Thus, facilitation by homologous CT feedback sharpens thalamic receptive field focus, while suppression by nonhomologous feedback diminishes it. Our findings demonstrate that somatosensory cortex can selectively regulate thalamic spatial response tuning by engaging topographically specific excitatory and inhibitory mechanisms in the thalamus.	Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Temereanca, S (corresponding author), Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15261 USA.	temerean@nmr.mgh.harvard.edu		Temereanca, Simona/0000-0002-4671-5971	NIMH NIH HHS [MH61372] Funding Source: Medline; NINDS NIH HHS [NS19950] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019950] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahissar E, 2003, CEREB CORTEX, V13, P53, DOI 10.1093/cercor/13.1.53; BARTH DS, 1989, BRAIN RES, V484, P13, DOI 10.1016/0006-8993(89)90344-2; BOURASSA J, 1995, EUR J NEUROSCI, V7, P19, DOI 10.1111/j.1460-9568.1995.tb01016.x; Bruno RM, 2002, J NEUROSCI, V22, P10966; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Carvell GE, 1996, SOMATOSENS MOT RES, V13, P115, DOI 10.3109/08990229609051399; Castro-Alamancos MA, 2001, J NEUROPHYSIOL, V85, P1489, DOI 10.1152/jn.2001.85.4.1489; CHMIELOWSKA J, 1989, J COMP NEUROL, V285, P325, DOI 10.1002/cne.902850304; Deschenes M, 1998, BRAIN RES REV, V28, P286, DOI 10.1016/S0165-0173(98)00017-4; Desilets-Roy B, 2002, J NEUROSCI, V22; DIAMOND ME, 1992, J COMP NEUROL, V319, P66, DOI 10.1002/cne.903190108; Eaton SA, 1996, NEUROSCIENCE, V73, P1, DOI 10.1016/0306-4522(96)00123-6; Ergenzinger ER, 1998, NAT NEUROSCI, V1, P226, DOI 10.1038/673; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Ghazanfar AA, 2001, EXP BRAIN RES, V141, P88, DOI 10.1007/s002210100849; GHOSH S, 1994, EXP BRAIN RES, V100, P276; Godwin DW, 1996, J NEUROPHYSIOL, V76, P1800, DOI 10.1152/jn.1996.76.3.1800; GUILLERY RW, 1967, J COMP NEUROL, V130, P197, DOI 10.1002/cne.901300303; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Harkness J.E., 1989, BIOL MED RABBITS ROD, V3rd ed.; Hartings JA, 2000, J NEUROPHYSIOL, V83, P2791, DOI 10.1152/jn.2000.83.5.2791; He JF, 1997, J NEUROPHYSIOL, V77, P896, DOI 10.1152/jn.1997.77.2.896; He JF, 2003, EXP BRAIN RES, V153, P579, DOI 10.1007/s00221-003-1680-5; HOOGLAND PV, 1987, EXP BRAIN RES, V68, P73, DOI 10.1007/BF00255235; Kao CQ, 1997, J NEUROPHYSIOL, V77, P2661, DOI 10.1152/jn.1997.77.5.2661; Keller A, 1999, J COMP NEUROL, V412, P83, DOI 10.1002/(SICI)1096-9861(19990913)412:1<83::AID-CNE6>3.0.CO;2-7; Kelly MK, 2001, SOMATOSENS MOT RES, V18, P202; Kyriazi HT, 1996, BRAIN RES, V712, P325, DOI 10.1016/0006-8993(95)01562-0; LAND PW, 1995, J COMP NEUROL, V355, P573, DOI 10.1002/cne.903550407; LIU XB, 1995, J COMP NEUROL, V352, P69, DOI 10.1002/cne.903520106; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; Moore CI, 1999, TRENDS NEUROSCI, V22, P513, DOI 10.1016/S0166-2236(99)01452-6; MURPHY PC, 1987, NATURE, V329, P727, DOI 10.1038/329727a0; Murphy PC, 1999, SCIENCE, V286, P1552, DOI 10.1126/science.286.5444.1552; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; PESCHANSKI M, 1983, BRAIN RES, V270, P325, DOI 10.1016/0006-8993(83)90607-8; Pinto DJ, 2003, CEREB CORTEX, V13, P33, DOI 10.1093/cercor/13.1.33; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; Rivadulla C, 2002, J NEUROSCI, V22, P2956, DOI 10.1523/JNEUROSCI.22-07-02956.2002; Rouiller EM, 2000, BRAIN RES BULL, V53, P727, DOI 10.1016/S0361-9230(00)00364-6; Roy SA, 2001, J NEUROSCI, V21, P2462, DOI 10.1523/JNEUROSCI.21-07-02462.2001; SHIN HC, 1990, SOMATOSENS MOT RES, V7, P421, DOI 10.3109/08990229009144717; Sillito AM, 2002, PHILOS T R SOC B, V357, P1739, DOI 10.1098/rstb.2002.1170; SILLITO AM, 1994, NATURE, V369, P479, DOI 10.1038/369479a0; SIMONS DJ, 1983, BRAIN RES, V276, P178, DOI 10.1016/0006-8993(83)90561-9; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; Temereanca S, 2003, J NEUROPHYSIOL, V89, P2137, DOI 10.1152/jn.00582.2002; TSUMOTO T, 1978, EXP BRAIN RES, V32, P345; Turner JP, 1998, J PHYSIOL-LONDON, V510, P829, DOI 10.1111/j.1469-7793.1998.829bj.x; Usrey WM, 2002, CURR OPIN NEUROBIOL, V12, P411, DOI 10.1016/S0959-4388(02)00339-2; WHITE EL, 1987, J COMP NEUROL, V262, P13, DOI 10.1002/cne.902620103; Yan J, 1996, SCIENCE, V273, P1100, DOI 10.1126/science.273.5278.1100; YUAN B, 1986, J NEUROSCI, V6, P3611; YUAN B, 1985, J NEUROSCI, V5, P2971; Zhang YF, 1997, NATURE, V387, P900, DOI 10.1038/43180; Zhang YF, 2000, J NEUROPHYSIOL, V84, P325, DOI 10.1152/jn.2000.84.1.325; Zhang ZW, 1997, J NEUROSCI, V17, P6365	57	117	118	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 19	2004	41	4					639	651		10.1016/S0896-6273(04)00046-7	http://dx.doi.org/10.1016/S0896-6273(04)00046-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980211	Bronze			2022-12-24	WOS:000221458100015
J	Johansson, RS; Birznieks, I				Johansson, RS; Birznieks, I			First spikes in ensembles of human tactile afferents code complex spatial fingertip events	NATURE NEUROSCIENCE			English	Article							GLABROUS SKIN; HUMAN HAND; PRECISION GRIP; MECHANORECEPTIVE UNITS; CEREBRAL-CORTEX; STIMULUS LOCATION; OBJECT SHAPE; RESPONSES; DIRECTION; RECEPTORS	It is generally assumed that primary sensory neurons transmit information by their firing rates. However, during natural object manipulations, tactile information from the fingertips is used faster than can be readily explained by rate codes. Here we show that the relative timing of the first impulses elicited in individual units of ensembles of afferents reliably conveys information about the direction of fingertip force and the shape of the surface contacting the fingertip. The sequence in which different afferents initially discharge in response to mechanical fingertip events provides information about these events faster than the fastest possible rate code and fast enough to account for the use of tactile signals in natural manipulation.	Umea Univ, Dept Integrat Med Biol, Physiol Sect, SE-90187 Umea, Sweden	Umea University	Johansson, RS (corresponding author), Umea Univ, Dept Integrat Med Biol, Physiol Sect, SE-90187 Umea, Sweden.	roland.s.johansson@physiol.umu.se	B, Ingvars/Q-8634-2019; Johansson, Roland S/A-5890-2009; Birznieks, Ingvars/D-4181-2012	B, Ingvars/0000-0003-4916-1254; Johansson, Roland S/0000-0003-3288-8326; Birznieks, Ingvars/0000-0003-4916-1254				ADKINS RJ, 1966, SCIENCE, V153, P1020, DOI 10.1126/science.153.3739.1020; Adrian E.D., 1928, BASIS SENSATION; Birznieks I, 2001, J NEUROSCI, V21, P8222, DOI 10.1523/JNEUROSCI.21-20-08222.2001; CARR CE, 1993, ANNU REV NEUROSCI, V16, P223, DOI 10.1146/annurev.ne.16.030193.001255; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Ergenzinger ER, 1998, NAT NEUROSCI, V1, P226, DOI 10.1038/673; Gerstner W., 2002, SPIKING NEURON MODEL; GOODWIN AW, 1995, J NEUROSCI, V15, P798; HagerRoss C, 1996, EXP BRAIN RES, V110, P142; HARRIS F, 1965, NATURE, V208, P1215, DOI 10.1038/2081215a0; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Jenmalm P, 2003, EUR J NEUROSCI, V18, P164, DOI 10.1046/j.1460-9568.2003.02721.x; Jenmalm P, 1997, J NEUROSCI, V17, P4486; JOHANSSON RS, 1994, J PHYSIOL-LONDON, V481, P761, DOI 10.1113/jphysiol.1994.sp020480; Johansson RS, 1998, NOVART FDN SYMP, V218, P45; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; JOHANSSON RS, 1987, EXP BRAIN RES, V66, P141; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; JOHANSSON RS, 1992, CURR OPIN NEUROBIOL, V2, P815, DOI 10.1016/0959-4388(92)90139-C; JOHANSSON RS, 1983, TRENDS NEUROSCI, V6, P27, DOI 10.1016/0166-2236(83)90011-5; JOHANSSON RS, 1978, J PHYSIOL-LONDON, V281, P101, DOI 10.1113/jphysiol.1978.sp012411; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619; JOHANSSON RS, 1980, BRAIN RES, V184, P353, DOI 10.1016/0006-8993(80)90804-5; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V297, P405, DOI 10.1113/jphysiol.1979.sp013048; JOHANSSON RS, 1992, EXP BRAIN RES, V89, P192, DOI 10.1007/BF00229016; JOHANSSON RS, 1982, BRAIN RES, V244, P17, DOI 10.1016/0006-8993(82)90899-X; KAKUDA N, 1992, NEUROSCI RES, V15, P179, DOI 10.1016/0168-0102(92)90003-U; Kennedy PM, 2002, J PHYSIOL-LONDON, V538, P995, DOI 10.1113/jphysiol.2001.013087; Macefield VG, 1996, EXP BRAIN RES, V108, P155; Maeno T, 1998, JSME INT J C-MECH SY, V41, P94, DOI 10.1299/jsmec.41.94; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Nakazawa N, 2000, BIOL CYBERN, V82, P207, DOI 10.1007/s004220050020; Nielsen J, 1997, J PHYSIOL-LONDON, V501, P473, DOI 10.1111/j.1469-7793.1997.473bn.x; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; Pawluk DTV, 1999, J BIOMECH ENG-T ASME, V121, P178, DOI 10.1115/1.2835100; Petersen RS, 2001, NEURON, V32, P503, DOI 10.1016/S0896-6273(01)00481-0; PHILLIPS JR, 1992, J NEUROSCI, V12, P827; PUBOLS BH, 1982, J NEUROPHYSIOL, V47, P530, DOI 10.1152/jn.1982.47.3.530; Reich DS, 2001, J NEUROPHYSIOL, V85, P1039, DOI 10.1152/jn.2001.85.3.1039; ROLLS ET, 1994, P ROY SOC B-BIOL SCI, V257, P9, DOI 10.1098/rspb.1994.0087; Rowe MJ, 2002, BEHAV BRAIN RES, V135, P197, DOI 10.1016/S0166-4328(02)00166-3; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Thorpe S, 2001, NEURAL NETWORKS, V14, P715, DOI 10.1016/S0893-6080(01)00083-1; Trulsson M, 1997, J NEUROPHYSIOL, V77, P737, DOI 10.1152/jn.1997.77.2.737; Usrey WM, 2002, CURR OPIN NEUROBIOL, V12, P411, DOI 10.1016/S0959-4388(02)00339-2; VALLBO AB, 1968, EXP NEUROL, V21, P270, DOI 10.1016/0014-4886(68)90041-1; WESTLING G, 1987, EXP BRAIN RES, V66, P128; Zar J. H., 1996, BIOSTATISTICAL ANAL	48	363	373	2	33	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					170	177		10.1038/nn1177	http://dx.doi.org/10.1038/nn1177			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14730306				2022-12-24	WOS:000188468500015
J	Frost, WN; Tian, LM; Hoppe, TA; Mongeluzi, DL; Wang, J				Frost, WN; Tian, LM; Hoppe, TA; Mongeluzi, DL; Wang, J			A cellular mechanism for prepulse inhibition	NEURON			English	Article							CENTRAL PATTERN GENERATOR; DORSAL SWIM INTERNEURONS; ACOUSTIC STARTLE REFLEX; CENTRAL NERVOUS-SYSTEM; TRITONIA ESCAPE SWIM; PRESYNAPTIC INHIBITION; TRANSMITTER RELEASE; INTRINSIC NEUROMODULATION; NEUROLEPTIC MEDICATION; SCHIZOPHRENIA-PATIENTS	In prepulse inhibition (PPI), startle responses to sudden, unexpected stimuli are markedly attenuated if immediately preceded by a weak stimulus of almost any modality. This experimental paradigm exposes a potent inhibitory process, present in nervous systems from invertebrates to humans, that is widely considered to play an important role in reducing distraction during the processing of sensory input. The neural mechanisms mediating PPI are of considerable interest given evidence linking PPI deficits with some of the cognitive disorders of schizophrenia. Here, in the marine mollusk Tritonia diomedea, we describe a detailed cellular mechanism for PPI-a combination of presynaptic inhibition of startle afferent neurons together with distributed postsynaptic inhibition of several downstream interneuronal sites in the startle circuit.	Finch Univ Hlth Sci Chicago Med Sch, Dept Cell Biol & Anat, Abbott Pk, IL 60064 USA; Univ Texas, Sch Med, Dept Neurobiol & Anat, Houston, TX 77225 USA	University of Texas System	Frost, WN (corresponding author), Finch Univ Hlth Sci Chicago Med Sch, Dept Cell Biol & Anat, 3333 Green Bay Rd, Abbott Pk, IL 60064 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA016320] Funding Source: NIH RePORTER; NIDA NIH HHS [DA16320] Funding Source: Medline; NINDS NIH HHS [NS36500] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAXTER DA, 1991, SYNAPSE, V7, P244, DOI 10.1002/syn.890070309; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; CALABRESI P, 1992, ANN NEUROL, V31, P366, DOI 10.1002/ana.410310404; CARPENTER DO, 1977, J NEUROBIOL, V8, P119, DOI 10.1002/neu.480080204; Cattaert D, 1999, J NEUROSCI, V19, P6079, DOI 10.1523/JNEUROSCI.19-14-06079.1999; Clarac F, 1996, EXP BRAIN RES, V112, P163; Eaton RC., 1984, NEURAL MECH STARTLE, DOI [10.1007/978-1-4899-2286-1, DOI 10.1007/978-1-4899-2286-1]; Fendt M, 2001, PSYCHOPHARMACOLOGY, V156, P216, DOI 10.1007/s002130100794; Frost WN, 2001, AM ZOOL, V41, P952, DOI 10.1668/0003-1569(2001)041[0952:SINITD]2.0.CO;2; Frost WN, 1996, P NATL ACAD SCI USA, V93, P422, DOI 10.1073/pnas.93.1.422; FUCHS PA, 1980, J NEUROPHYSIOL, V43, P1547, DOI 10.1152/jn.1980.43.6.1547; GETTING PA, 1976, J COMP PHYSIOL, V110, P271, DOI 10.1007/BF00659144; GETTING PA, 1983, NEURAL ORIGIN RHYTHM, V37, P89; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; GRAHAM FK, 1992, ATTENTION INFORMATIO; Hamm AO, 2001, PSYCHOPHARMACOLOGY, V156, P259, DOI 10.1007/s002130100827; HOFFMAN HS, 1980, PSYCHOL REV, V87, P175, DOI 10.1037/0033-295X.87.2.175; HOFFMAN HS, 1992, ATTENTION INFORMATIO; HUE B, 1983, J INSECT PHYSIOL, V29, P741, DOI 10.1016/0022-1910(83)90002-1; Kallstrand J, 2002, PSYCHIAT RES, V113, P115, DOI 10.1016/S0165-1781(02)00248-2; KALTENBACH JA, 1993, HEARING RES, V67, P35, DOI 10.1016/0378-5955(93)90229-T; Karper LP, 1996, J NEUROPSYCH CLIN N, V8, P60; Katz PS, 1997, J NEUROSCI, V17, P7703; Katz PS, 1995, J NEUROPHYSIOL, V74, P2281, DOI 10.1152/jn.1995.74.6.2281; KATZ PS, 1994, NATURE, V367, P729, DOI 10.1038/367729a0; KATZ PS, 1995, J NEUROSCI, V15, P6035; KEMENES G, 1991, J NEUROSCI METH, V39, P207, DOI 10.1016/0165-0270(91)90099-L; KRETZ R, 1986, J NEUROPHYSIOL, V55, P113, DOI 10.1152/jn.1986.55.1.113; KRETZ R, 1986, J NEUROPHYSIOL, V55, P131, DOI 10.1152/jn.1986.55.1.131; Leumann L, 2001, BRAIN RES BULL, V56, P101, DOI 10.1016/S0361-9230(01)00607-4; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; Martinez ZA, 2002, PSYCHOPHARMACOLOGY, V161, P38, DOI 10.1007/s00213-001-0977-y; Miller RJ, 1998, ANNU REV PHARMACOL, V38, P201, DOI 10.1146/annurev.pharmtox.38.1.201; Mongeluzi DL, 1998, J NEUROSCI, V18, P8467; NELSON SB, 1991, J NEUROSCI, V11, P369; NICHOLLS J, 1978, J PHYSIOL-LONDON, V281, P157, DOI 10.1113/jphysiol.1978.sp012414; Nodal FR, 2003, J COMP NEUROL, V460, P80, DOI 10.1002/cne.10656; Ouagazzal AM, 2001, PSYCHOPHARMACOLOGY, V156, P273, DOI 10.1007/s002130100763; Perry W, 1999, ARCH GEN PSYCHIAT, V56, P277, DOI 10.1001/archpsyc.56.3.277; PERRY W, 1994, AM J PSYCHIAT, V151, P363; Popescu IR, 2002, J NEUROSCI, V22, P1985, DOI 10.1523/JNEUROSCI.22-05-01985.2002; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; Rudomin P., 1998, PRESYNAPTIC INHIBITI; SCHELL AM, 1995, PSYCHOPHYSIOLOGY, V32, P266, DOI 10.1111/j.1469-8986.1995.tb02955.x; Schicatano EJ, 2000, J NEUROSCI, V20, P4240; SEGEV I, 1990, J NEUROPHYSIOL, V63, P987, DOI 10.1152/jn.1990.63.5.987; SHAPIRO E, 1980, P NATL ACAD SCI-BIOL, V77, P629, DOI 10.1073/pnas.77.1.629; Shore SE, 1998, J ACOUST SOC AM, V104, P378, DOI 10.1121/1.423294; SIMONS RF, 1992, PSYCHOPHYSIOLOGY, V29, P8, DOI 10.1111/j.1469-8986.1992.tb02004.x; SLAWSKY MT, 1979, THESIS STANFORD U ST; SWERDLOW NR, 1995, BIOL PSYCHIAT, V37, P286, DOI 10.1016/0006-3223(94)00138-S; WATSON AHD, 1992, COMP BIOCHEM PHYS A, V103, P227, DOI 10.1016/0300-9629(92)90573-9; Weike AI, 2000, BIOL PSYCHIAT, V47, P61, DOI 10.1016/S0006-3223(99)00229-2; WILLOWS AOD, 1973, J NEUROBIOL, V4, P207, DOI 10.1002/neu.480040306; Yeomans JS, 2002, NEUROSCI BIOBEHAV R, V26, P1, DOI 10.1016/S0149-7634(01)00057-4; ZOLTAY G, 1990, J NEUROCHEM, V55, P1008, DOI 10.1111/j.1471-4159.1990.tb04590.x	57	46	48	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 4	2003	40	5					991	1001		10.1016/S0896-6273(03)00731-1	http://dx.doi.org/10.1016/S0896-6273(03)00731-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659097	Bronze			2022-12-24	WOS:000187042200015
J	Gandhi, CS; Clark, E; Loots, E; Pralle, A; Isacoff, EY				Gandhi, CS; Clark, E; Loots, E; Pralle, A; Isacoff, EY			The orientation and molecular movement of a K+ channel voltage-sensing domain	NEURON			English	Article							SHAKER POTASSIUM CHANNEL; GATED ION CHANNELS; S4 SEGMENT; GATING CHARGE; HELICAL STRUCTURE; CRYSTAL-STRUCTURE; PORE DOMAIN; CONFORMATIONS; RESIDUES; REARRANGEMENT	Voltage-gated channels operate through the action of a voltage-sensing domain (membrane segments S1-S4) that controls the conformation of gates located in the pore domain (membrane segments S5-S6). Recent structural studies on the bacterial K(v)AP potassium channel have led to a new model of voltage sensing in which S4 lies in the lipid at the channel periphery and moves through the membrane as a unit with a portion of S3. Here we describe accessibility probing and disulfide scanning experiments aimed at determining how well the K(v)AP model describes the Drosophila Shaker potassium channel. We find that the S1-S3 helices have one end that is externally exposed, S3 does not undergo a transmembrane motion, and S4 lies in close apposition to the pore domain in the resting and activated state.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Isacoff, EY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 271 LSA,MC 3200, Berkeley, CA 94720 USA.		Pralle, Arnd/M-9832-2013; isacoff, ehud/AAP-1459-2020	Pralle, Arnd/0000-0002-6079-109X; Isacoff, Ehud Y./0000-0003-4775-9359	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035549] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS035549-07, R01 NS35549] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; Bezanilla F, 2002, J GEN PHYSIOL, V120, P465, DOI 10.1085/jgp.20028660; CAREAGA CL, 1992, BIOPHYS J, V62, P209, DOI 10.1016/S0006-3495(92)81806-4; Cohen BE, 2003, NEURON, V39, P395, DOI 10.1016/S0896-6273(03)00472-0; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 1998, J STRUCT BIOL, V121, P263, DOI 10.1006/jsbi.1998.3962; Elinder F, 2001, J GEN PHYSIOL, V118, P1, DOI 10.1085/jgp.118.1.1; Gandhi CS, 2000, NEURON, V27, P585, DOI 10.1016/S0896-6273(00)00068-4; Gandhi CS, 2002, J GEN PHYSIOL, V120, P455, DOI 10.1085/jgp.20028678; Gonzalez C, 2001, P NATL ACAD SCI USA, V98, P9617, DOI 10.1073/pnas.171306298; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; Horn R, 2000, J GEN PHYSIOL, V116, P461, DOI 10.1085/jgp.116.3.461; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Li-Smerin Y, 2001, J GEN PHYSIOL, V117, P205, DOI 10.1085/jgp.117.3.205; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Monks SA, 1999, J GEN PHYSIOL, V113, P415, DOI 10.1085/jgp.113.3.415; Neale EJ, 2003, J BIOL CHEM, V278, P29079, DOI 10.1074/jbc.M301991200/6493; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; SANTACRUZTOLOZA L, 1994, BIOCHEMISTRY-US, V33, P5607, DOI 10.1021/bi00184a033; Schonherr R, 2002, NEURON, V35, P935, DOI 10.1016/S0896-6273(02)00869-3; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Shih TM, 1997, J CELL BIOL, V136, P1037, DOI 10.1083/jcb.136.5.1037; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; Tiwari-Woodruff SK, 2000, J GEN PHYSIOL, V115, P123, DOI 10.1085/jgp.115.2.123; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Wang MH, 1999, J PHYSIOL-LONDON, V521, P315, DOI 10.1111/j.1469-7793.1999.00315.x; White SH, 1998, BBA-REV BIOMEMBRANES, V1376, P339, DOI 10.1016/S0304-4157(98)00021-5; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253	40	102	106	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 30	2003	40	3					515	525		10.1016/S0896-6273(03)00646-9	http://dx.doi.org/10.1016/S0896-6273(03)00646-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	740AQ	14642276	Bronze			2022-12-24	WOS:000186379000011
J	Brown, SP; Brenowitz, SD; Regehr, WG				Brown, SP; Brenowitz, SD; Regehr, WG			Brief presynaptic bursts evoke synapse-specific retrograde inhibition mediated by endogenous cannabinoids	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; CEREBELLAR PURKINJE-CELLS; PARALLEL FIBER; CALCIUM TRANSIENTS; DEPRESSION; RELEASE; SPINES; SIGNAL; ENDOCANNABINOIDS; DENDRITES	Many types of neurons can release endocannabinoids that act as retrograde signals to inhibit neurotransmitter release from presynaptic terminals. Little is known, however, about the properties or role of such inhibition under physiological conditions. Here we report that brief bursts of presynaptic activity evoked endocannabinoid release, which strongly inhibited parallel fiber-to-Purkinje cell synapses in rat cerebellar slices. This retrograde inhibition was triggered by activation of either postsynaptic metabotropic or ionotropic glutamate receptors and was restricted to synapses activated with high-frequency bursts. Thus, endocannabinoids allow neurons to inhibit specific synaptic inputs in response to a burst, thereby dynamically fine-tuning the properties of synaptic integration.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Regehr, WG (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	wade_regehr@hms.harvard.edu	Brown, Solange/H-1615-2012		NINDS NIH HHS [R01 NS 32405, 5 T32 NS07484-02, R01 NS 44396] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032405, R01NS044396, T32NS007484] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alger BE, 2002, PROG NEUROBIOL, V68, P247; BATCHELOR AM, 1994, NEUROSCIENCE, V63, P911, DOI 10.1016/0306-4522(94)90558-4; Batchelor AM, 1997, NATURE, V385, P74, DOI 10.1038/385074a0; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Carlson G, 2002, NAT NEUROSCI, V5, P723, DOI 10.1038/nn879; Carter AG, 2000, J NEUROSCI, V20, P4423, DOI 10.1523/JNEUROSCI.20-12-04423.2000; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; Eccles JC, 1967, CEREBELLUM NEURONAL; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; KASE M, 1980, J PHYSIOL-LONDON, V300, P539, DOI 10.1113/jphysiol.1980.sp013178; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; Kreitzer AC, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0005.2001; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; Kreitzer AC, 2002, NEURON, V34, P787, DOI 10.1016/S0896-6273(02)00695-5; LEVENES C, 1998, J PHYSL, V510, P876; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; MERRILL EG, 1978, J PHYSIOL-LONDON, V284, P127, DOI 10.1113/jphysiol.1978.sp012531; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; Neale SA, 2001, EUR J NEUROSCI, V14, P1313, DOI 10.1046/j.0953-816x.2001.01769.x; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Palay S.L., 1974, CEREBELLAR CORTEX; PITLER TA, 1992, J NEUROSCI, V12, P4122; REGEHR WG, 2000, IMAGING NEURONS LAB; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Takahashi KA, 2000, J NEUROPHYSIOL, V83, P1167, DOI 10.1152/jn.2000.83.3.1167; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; TANABE Y, 1993, J NEUROSCI, V13, P1372; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; Tempia F, 1998, J NEUROPHYSIOL, V80, P520, DOI 10.1152/jn.1998.80.2.520; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; VINCENT P, 1993, NEURON, V11, P885, DOI 10.1016/0896-6273(93)90118-B; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	50	176	184	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1048	1057		10.1038/nn1126	http://dx.doi.org/10.1038/nn1126			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	14502290				2022-12-24	WOS:000185633600016
J	Geleoc, GSG; Holt, JR				Geleoc, GSG; Holt, JR			Developmental acquisition of sensory transduction in hair cells of the mouse inner ear	NATURE NEUROSCIENCE			English	Article							MECHANOELECTRICAL TRANSDUCTION; TIP LINKS; ADAPTATION; CHANNELS; MICE	Sensory transduction in hair cells requires assembly of membrane-bound transduction channels, extracellular tip-links and intracellular adaptation motors with sufficient precision to confer nanometer displacement sensitivity. Here we present evidence based on FM1-43 fluorescence, scanning electron microscopy and RT-PCR that these three essential elements are acquired concurrently between embryonic day 16 and 17, several days after the appearance of hair bundles(1), and that their acquisition coincides with the onset of mechanotransduction.	Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Dept Otolaryngol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Holt, JR (corresponding author), Univ Virginia, Sch Med, Dept Neurosci, Box 801392, Charlottesville, VA 22908 USA.				NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R56DC005439, R01DC005439] Funding Source: NIH RePORTER; NIDCD NIH HHS [R56 DC005439, DC05439-03, R01 DC005439, R01 DC005439-03] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; Denk W, 1995, NEURON, V15, P1311, DOI 10.1016/0896-6273(95)90010-1; Denman-Johnson K, 1999, J NEUROCYTOL, V28, P821, DOI 10.1023/A:1007061819934; Geleoc GSG, 1997, P ROY SOC B-BIOL SCI, V264, P611, DOI 10.1098/rspb.1997.0087; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Holt JR, 1997, J NEUROSCI, V17, P8739; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Holt JR, 2000, P NATL ACAD SCI USA, V97, P11730, DOI 10.1073/pnas.97.22.11730; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Meyers JR, 2003, J NEUROSCI, V23, P4054; RATTO GM, 1991, NATURE, V351, P654, DOI 10.1038/351654a0; Sahly I, 1997, ANAT EMBRYOL, V196, P159, DOI 10.1007/s004290050088; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171	14	108	112	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1019	1020		10.1038/nn1120	http://dx.doi.org/10.1038/nn1120			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	12973354	Green Accepted			2022-12-24	WOS:000185633600011
J	Conroy, WG; Liu, ZP; Nai, Q; Coggan, JS; Berg, DK				Conroy, WG; Liu, ZP; Nai, Q; Coggan, JS; Berg, DK			PDZ-containing proteins provide a functional postsynaptic scaffold for nicotinic receptors in neurons	NEURON			English	Article							CILIARY GANGLION NEURONS; ACETYLCHOLINE-RECEPTORS; ALPHA-BUNGAROTOXIN; CREB PHOSPHORYLATION; SOMATIC SPINES; SYNAPTIC PLASTICITY; GENE-EXPRESSION; IN-VIVO; BINDING; PSD-95	Protein scaffolds are essential for specific and efficient downstream signaling at synapses. Though nicotinic receptors are widely expressed in the nervous system and influence numerous cellular events due in part to their calcium permeability, no scaffolds have yet been identified for the receptors in neurons. Here we show that specific members of the PSD-95 family of PDZ-containing proteins are associated with specific nicotinic receptor subtypes. At postsynaptic sites, the PDZ scaffolds are essential for maturation of functional nicotinic synapses on neurons. They also help mediate downstream signaling as exemplified by activation of transcription factors. By tethering components to postsynaptic nicotinic receptors, PDZ scaffolds can organize synaptic structure and determine which calcium-dependent processes will be subject to nicotinic modulation.	Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Berg, DK (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	dberg@ucsd.edu		Coggan, Jay S/0000-0002-2270-1989	NINDS NIH HHS [NS12601, NS35469] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035469, R01NS012601] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Berg DK, 2002, J NEUROBIOL, V53, P512, DOI 10.1002/neu.10116; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Bruses JL, 2001, J NEUROSCI, V21, P504, DOI 10.1523/JNEUROSCI.21-02-00504.2001; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Chang KT, 2001, NEURON, V32, P855, DOI 10.1016/S0896-6273(01)00516-5; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen M, 2001, J NEUROBIOL, V47, P265, DOI 10.1002/neu.1034; Conroy WG, 1999, J NEUROCHEM, V73, P1399, DOI 10.1046/j.1471-4159.1999.0731399.x; Conroy WG, 1998, MOL PHARMACOL, V53, P392, DOI 10.1124/mol.53.3.392; Coyle JE, 2002, NEURON, V33, P63, DOI 10.1016/S0896-6273(01)00558-X; Delmas P, 2002, NEURON, V36, P787, DOI 10.1016/S0896-6273(02)01097-8; El-Hussein AE, 2000, SCIENCE, V290, P1364; El-Husseini AE, 2000, J BIOL CHEM, V275, P23904, DOI 10.1074/jbc.M909919199; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Feng GP, 1998, J NEUROSCI, V18, P4166; Gingras J, 2001, J NEUROBIOL, V48, P228, DOI 10.1002/neu.1053; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Greenberg ME, 2001, SYNAPSES, P357; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Horch HLW, 1995, J NEUROSCI, V15, P7778; Huk KH, 2002, MOL NEUROBIOL, V25, P79; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; JACOB MH, 1984, P NATL ACAD SCI-BIOL, V81, P3223, DOI 10.1073/pnas.81.10.3223; JACOB MH, 1983, J NEUROSCI, V3, P260; Jeanclos EM, 2001, J BIOL CHEM, V276, P28281, DOI 10.1074/jbc.M011549200; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Kassner PD, 1998, MOL CELL NEUROSCI, V10, P258, DOI 10.1006/mcne.1998.0664; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; Kneussel M, 2000, J PHYSIOL-LONDON, V525, P1, DOI 10.1111/j.1469-7793.2000.t01-4-00001.x; LICHTMAN JW, 1977, J PHYSIOL-LONDON, V273, P155, DOI 10.1113/jphysiol.1977.sp012087; Lin L, 2002, J BIOL CHEM, V277, P41872, DOI 10.1074/jbc.M206857200; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Marek KW, 2000, NEURON, V25, P537, DOI 10.1016/S0896-6273(00)81058-2; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; Nai Q, 2003, MOL PHARMACOL, V63, P311, DOI 10.1124/mol.63.2.311; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; NISHI R, 1981, J NEUROSCI, V1, P505; Passafaro M, 1999, NAT NEUROSCI, V2, P1063, DOI 10.1038/15990; Rousset R, 1998, ONCOGENE, V16, P643, DOI 10.1038/sj.onc.1201567; SCHOEPFER R, 1990, NEURON, V5, P35, DOI 10.1016/0896-6273(90)90031-A; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shoop RD, 1999, J NEUROSCI, V19, P692; Shoop RD, 2000, J NEUROSCI, V20, P4021; Shoop RD, 2001, J NEUROSCI, V21, P771, DOI 10.1523/JNEUROSCI.21-03-00771.2001; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Tomita S, 2001, J CELL BIOL, V153, pF19, DOI 10.1083/jcb.153.5.F19; TZARTOS SJ, 1981, J BIOL CHEM, V256, P8635; VERNALLIS AB, 1993, NEURON, V10, P451, DOI 10.1016/0896-6273(93)90333-M; Williams BM, 1998, NAT NEUROSCI, V1, P557, DOI 10.1038/2792; ZHANG ZW, 1994, NEURON, V12, P167, DOI 10.1016/0896-6273(94)90161-9; Zhang ZW, 1996, NEURON, V17, P1231, DOI 10.1016/S0896-6273(00)80253-6	54	75	79	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 5	2003	38	5					759	771		10.1016/S0896-6273(03)00324-6	http://dx.doi.org/10.1016/S0896-6273(03)00324-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	687DU	12797960	Bronze			2022-12-24	WOS:000183361400011
J	Li, SM; Cullen, WK; Anwyl, R; Rowan, MJ				Li, SM; Cullen, WK; Anwyl, R; Rowan, MJ			Dopamine-dependent facilitation of LTP induction in hippocampal CA1 by exposure to spatial novelty	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; ACETYLCHOLINE-RELEASE; SYNAPTIC PLASTICITY; BRAIN TEMPERATURE; RAT HIPPOCAMPUS; MOTOR-ACTIVITY; DENTATE GYRUS; MEMORY; RECEPTORS; NEURONS	In addition to its role in memory formation, the hippocampus may act as a novelty detector. Here we investigated whether attention to novel events can promote the associative synaptic plasticity mechanisms believed to be necessary for storing those events in memory. We therefore examined whether exposure to a novel spatial environment promoted the induction of activity-dependent persistent increases in glutamatergic transmission (long-term potentiation, LTP) at CA1 synapses in the rat hippocampus. We found that brief exposure to a novel environment lowered the threshold for the induction of LTP. This facilitatory effect was present for a short period following novelty exposure but was absent in animals that explored a familiar environment. Furthermore, the facilitation was dependent on activation of D1/D5 receptors. These findings support an important role for dopamine-regulated synaptic plasticity in the storage of unpredicted information in the CA1 area.	Univ Dublin Trinity Coll, Dept Pharmacol & Therapeut, Dublin 2, Ireland; Univ Dublin Trinity Coll, Inst Neurosci, Dublin 2, Ireland; Univ Dublin Trinity Coll, Dept Physiol, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Rowan, MJ (corresponding author), Univ Dublin Trinity Coll, Dept Pharmacol & Therapeut, Biotechnol Bldg, Dublin 2, Ireland.			Rowan, Michael Joseph/0000-0002-3867-9536				Abraham WC, 2002, J NEUROSCI, V22, P9626; Acquas E, 1996, J NEUROSCI, V16, P3089; Athos J, 2002, NAT NEUROSCI, V5, P1119, DOI 10.1038/nn951; Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Dong HW, 2001, BRAIN RES, V893, P1, DOI 10.1016/S0006-8993(00)03036-5; Fischer H, 2003, BRAIN RES BULL, V59, P387, DOI 10.1016/S0361-9230(02)00940-1; Frey S, 2001, J NEUROSCI, V21, P3697, DOI 10.1523/JNEUROSCI.21-10-03697.2001; FREY U, 1991, NEUROSCI LETT, V129, P111, DOI 10.1016/0304-3940(91)90732-9; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Gasbarri A, 1996, NEUROSCIENCE, V74, P1037, DOI 10.1016/0306-4522(96)00202-3; HARGREAVES EL, 1990, J NEUROSCI, V10, P1472; HERSI AI, 1995, NEUROSCIENCE, V69, P1067, DOI 10.1016/0306-4522(95)00319-E; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Ihalainen JA, 1999, NEUROSCI LETT, V277, P71, DOI 10.1016/S0304-3940(99)00840-X; Kim JH, 2001, J NEUROSCI, V21, P1327; Knight RT, 1998, REV NEUROSCIENCE, V9, P57; Kulla A, 2000, CEREB CORTEX, V10, P614, DOI 10.1093/cercor/10.6.614; Kusuki T, 1997, NEUROREPORT, V8, P2037, DOI 10.1097/00001756-199705260-00046; Lee I, 2002, NAT NEUROSCI, V5, P162, DOI 10.1038/nn790; LEUNG LS, 1980, BRAIN RES, V198, P95; LI S, 2001, BRIT J PHARM S, V34, P150; LI S, 2002, IRISH J MED SCI, V171, P172; Lisman JE, 2001, HIPPOCAMPUS, V11, P551; Manahan-Vaughan D, 1999, P NATL ACAD SCI USA, V96, P8739, DOI 10.1073/pnas.96.15.8739; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MOSER E, 1993, SCIENCE, V259, P1324, DOI 10.1126/science.8446900; Moser EI, 2001, CURR OPIN NEUROBIOL, V11, P745, DOI 10.1016/S0959-4388(01)00279-3; MOSER EI, 1994, LEARN MEMORY, V1, P55; Moses SN, 2002, BRAIN RES BULL, V58, P517, DOI 10.1016/S0361-9230(02)00820-1; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Oswald CJP, 2002, EUR J NEUROSCI, V15, P1983, DOI 10.1046/j.1460-9568.2002.02028.x; Otmakhova NA, 2000, J NEUROSCI, V20, P4446, DOI 10.1523/JNEUROSCI.20-12-04446.2000; Otmakhova NA, 1996, J NEUROSCI, V16, P7478; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Ploghaus A, 2000, P NATL ACAD SCI USA, V97, P9281, DOI 10.1073/pnas.160266497; Sah P, 1996, J NEUROSCI, V16, P4537; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Seidenbecher T, 1997, P NATL ACAD SCI USA, V94, P1494, DOI 10.1073/pnas.94.4.1494; Swanson-Park JL, 1999, NEUROSCIENCE, V92, P485, DOI 10.1016/S0306-4522(99)00010-X; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.3.CO;2-J; VANKOV A, 1995, EUR J NEUROSCI, V7, P1180, DOI 10.1111/j.1460-9568.1995.tb01108.x; Vinogradova OS, 2001, HIPPOCAMPUS, V11, P578, DOI 10.1002/hipo.1073; Watabe AM, 2000, J NEUROSCI, V20, P5924, DOI 10.1523/JNEUROSCI.20-16-05924.2000; Xu L, 1998, NATURE, V394, P891, DOI 10.1038/29783; Xu L, 1997, NATURE, V387, P497, DOI 10.1038/387497a0	48	372	388	1	38	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					526	531		10.1038/nn1049	http://dx.doi.org/10.1038/nn1049			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12704392				2022-12-24	WOS:000182553200020
J	Machens, CK; Schutze, H; Franz, A; Kolesnikova, O; Stemmler, MB; Ronacher, B; Herz, AVM				Machens, CK; Schutze, H; Franz, A; Kolesnikova, O; Stemmler, MB; Ronacher, B; Herz, AVM			Single auditory neurons rapidly discriminate conspecific communication signals	NATURE NEUROSCIENCE			English	Article							ACOUSTIC COMMUNICATION		Humboldt Univ, Inst Theoret Biol, D-10099 Berlin, Germany; Humboldt Univ, Dept Biol, D-10099 Berlin, Germany	Humboldt University of Berlin; Humboldt University of Berlin	Herz, AVM (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	a.herz@biologie.hu-berlin.de	Kolesnikova, Olga/F-2283-2011	Machens, Christian/0000-0003-1717-1562				Haykin S., 1994, COMMUNICATION SYSTEM; KRIEGBAUM H, 1992, ETHOLOGY, V76, P248; Machens CK, 2001, J NEUROSCI, V21, P3215, DOI 10.1523/JNEUROSCI.21-09-03215.2001; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; van Rossum MCW, 2001, NEURAL COMPUT, V13, P751, DOI 10.1162/089976601300014321; Victor JD, 1997, NETWORK-COMP NEURAL, V8, P127, DOI 10.1088/0954-898X/8/2/003; vonHelversen D, 1997, J COMP PHYSIOL A, V180, P373, DOI 10.1007/s003590050056; VONHELVERSEN O, 1994, FORTS ZOOL, V39, P253	8	91	91	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					341	342		10.1038/nn1036	http://dx.doi.org/10.1038/nn1036			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12652305				2022-12-24	WOS:000181833100009
J	Ulanovsky, N; Las, L; Nelken, I				Ulanovsky, N; Las, L; Nelken, I			Processing of low-probability sounds by cortical neurons	NATURE NEUROSCIENCE			English	Article							PRIMARY AUDITORY-CORTEX; MISMATCH NEGATIVITY; VISUAL-CORTEX; INTRACORTICAL MECHANISMS; STIMULUS DEVIANCE; ACOUSTIC CHANGE; CAT; ADAPTATION; FREQUENCY; PLASTICITY	The ability to detect rare auditory events can be critical for survival. We report here that neurons in cat primary auditory cortex (A1) responded more strongly to a rarely presented sound than to the same sound when it was common. For the rare stimuli, we used both frequency and amplitude deviants. Moreover, some A1 neurons showed hyperacuity for frequency deviants-a frequency resolution one order of magnitude better than receptive field widths in A1. In contrast, auditory thalamic neurons were insensitive to the probability of frequency deviants. These phenomena resulted from stimulus-specific adaptation in A1, which may be a single-neuron correlate of an extensively studied cortical potential-mismatch negativity-that is evoked by rare sounds. Our results thus indicate that A1 neurons, in addition to processing the acoustic features of sounds, may also be involved in sensory memory and novelty detection.	Hebrew Univ Jerusalem, Dept Physiol, Hadassah Med Sch, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Nelken, I (corresponding author), Hebrew Univ Jerusalem, Dept Physiol, Hadassah Med Sch, Box 12272, IL-91120 Jerusalem, Israel.		Nelken, Israel/B-7753-2011	Nelken, Israel/0000-0002-6645-107X; Ulanovsky, Nachum/0000-0001-8598-4667				Ahissar M, 2000, P NATL ACAD SCI USA, V97, P6832, DOI 10.1073/pnas.97.12.6832; Amitay S, 2002, JARO-J ASSOC RES OTO, V3, P302, DOI 10.1007/s101620010093; ANDERSEN RA, 1980, J COMP NEUROL, V194, P663, DOI 10.1002/cne.901940312; Bar-Yosef O, 2002, J NEUROSCI, V22, P8619; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; CONDON CD, 1991, BEHAV NEUROSCI, V105, P416, DOI 10.1037/0735-7044.105.3.416; CSEPE V, 1987, ELECTROEN CLIN NEURO, V66, P571, DOI 10.1016/0013-4694(87)90103-9; CSEPE V, 1989, SLEEP 88, P210; Delgutte B., 1996, AUDITORY COMPUTATION, P157, DOI DOI 10.1007/978-1-4612-4070-9_5; Deouell LY, 2000, AUDIOL NEURO-OTOL, V5, P225, DOI 10.1159/000013884; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2001, NATURE, V411, P80, DOI 10.1038/35075070; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fischer C, 2000, AUDIOL NEURO-OTOL, V5, P192, DOI 10.1159/000013880; GREEN DM, 1966, SIGNAL DETECTION THE; Jacobsen T, 2001, PSYCHOPHYSIOLOGY, V38, P723, DOI 10.1017/S0048577201000993; JAVITT DC, 1994, BRAIN RES, V667, P192, DOI 10.1016/0006-8993(94)91496-6; Javitt DC, 2000, AUDIOL NEURO-OTOL, V5, P207, DOI 10.1159/000013882; KING C, 1995, HEARING RES, V85, P45, DOI 10.1016/0378-5955(95)00028-3; KRAUS N, 1994, J ACOUST SOC AM, V96, P2758, DOI 10.1121/1.411282; KRAUS N, 1994, J NEUROPHYSIOL, V72, P1270, DOI 10.1152/jn.1994.72.3.1270; Kujala T, 2001, NEUROSCI BIOBEHAV R, V25, P535, DOI 10.1016/S0149-7634(01)00032-X; LIBERMAN MC, 1978, J ACOUST SOC AM, V63, P442, DOI 10.1121/1.381736; Malone BJ, 2002, J NEUROSCI, V22, P4625, DOI 10.1523/JNEUROSCI.22-11-04625.2002; Malone BJ, 2001, J NEUROPHYSIOL, V86, P1113, DOI 10.1152/jn.2001.86.3.1113; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; MASTERTON RB, 1992, HEARING RES, V63, P57, DOI 10.1016/0378-5955(92)90074-W; May P, 1999, J COMPUT NEUROSCI, V6, P99, DOI 10.1023/A:1008896417606; Moore BCJ., 1993, HUMAN PSYCHOPHYSICS, P56, DOI 10.1007/978-1-4612-2728-1_3; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; Naatanen R., 2018, ATTENTION BRAIN FUNC; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; PHILLIPS DP, 1985, EXP BRAIN RES, V58, P443; Picton TW, 2000, AUDIOL NEURO-OTOL, V5, P111, DOI 10.1159/000013875; Pincze Z, 2001, CLIN NEUROPHYSIOL, V112, P778, DOI 10.1016/S1388-2457(01)00509-0; Sanes DH, 1998, J NEUROSCI, V18, P794; SAUL AB, 1989, VISUAL NEUROSCI, V2, P593, DOI 10.1017/S0952523800003527; TIITINEN H, 1994, NATURE, V372, P90, DOI 10.1038/372090a0	42	703	721	3	47	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					391	398		10.1038/nn1032	http://dx.doi.org/10.1038/nn1032			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12652303				2022-12-24	WOS:000181833100017
J	Gardner, D				Gardner, D			Neurodatabase.org: networking the microelectrode	NATURE NEUROSCIENCE			English	Database Review									Cornell Univ, Weill Med Coll, Dept Physiol, Lab Neuroinformat, New York, NY 10021 USA	Cornell University	Gardner, D (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol, Lab Neuroinformat, New York, NY 10021 USA.	dan@aplysia.med.cornell.edu			NIMH NIH HHS [MH57153, MH60538, MH68012] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R43MH060538, R01MH068012, R01MH057153, R44MH060538] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Gardner D, 2003, BIOPHYS J, V84, p305A; Gardner D, 2003, NEUROINFORMATICS, V1, P289, DOI 10.1385/NI:1:3:289; Gardner D, 2001, PHILOS T ROY SOC B, V356, P1229, DOI 10.1098/rstb.2001.0911; Martone ME, 2004, NAT NEUROSCI, V7, P467, DOI 10.1038/nn1229	5	16	17	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					486	487		10.1038/nn0504-486	http://dx.doi.org/10.1038/nn0504-486			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15114365				2022-12-24	WOS:000221101300020
J	Hughes, SW; Lorincz, M; Cope, DW; Blethyn, KL; Kekesi, KA; Parri, HR; Juhasz, G; Crunelli, V				Hughes, SW; Lorincz, M; Cope, DW; Blethyn, KL; Kekesi, KA; Parri, HR; Juhasz, G; Crunelli, V			Synchronized oscillations at alpha and theta frequencies in the lateral geniculate nucleus	NEURON			English	Article							NEURONS IN-VITRO; THALAMOCORTICAL NEURONS; PYRAMIDAL NEURONS; ELECTRICAL SYNAPSES; CORTICAL-NEURONS; METABOLIC-RATE; ION CHANNELS; NEOCORTEX; RHYTHMS; NETWORKS	In relaxed wakefulness, the EEG exhibits robust rhythms in the a band (8-13 Hz), which decelerate to theta (similar to2-7 Hz) frequencies during early sleep. In animal models, these rhythms occur coherently with synchronized activity in the thalamus. However, the mechanisms of this thalamic activity are unknown. Here we show that, in slices of the lateral geniculate nucleus maintained in vitro, activation of the metabotropic glutamate receptor (mGluR) mGluR1 a induces synchronized oscillations at alpha and theta frequencies that share similarities with thalamic alpha and theta rhythms recorded in vivo. These in vitro oscillations are driven by an unusual form of burst firing that is present in a subset of thalamocortical neurons and are synchronized by gap junctions. We propose that mGluR1a-induced oscillations are a potential mechanism whereby the thalamus promotes EEG alpha and theta rhythms in the intact brain.	Cardiff Univ, Sch Biosci, Cardiff CF10 3US, S Glam, Wales; Hungarian Acad Sci, Res Grp Neurobiol, H-1117 Budapest, Hungary	Cardiff University; Hungarian Academy of Sciences	Hughes, SW (corresponding author), Cardiff Univ, Sch Biosci, Cardiff CF10 3US, S Glam, Wales.	hughessw@cardiff.ac.uk	Crunelli, Vincenzo/A-7258-2010; Juhász, Gábor/I-7781-2017; Kékesi, Katalin Adrienna A/H-3484-2017; Lőrincz, Magor L/C-7746-2012; Parri, Rheinallt/D-1748-2013	Juhász, Gábor/0000-0002-0849-6931; Kékesi, Katalin Adrienna A/0000-0003-3042-4878; Lőrincz, Magor L/0000-0001-5240-1904; Hughes, Stuart/0000-0003-0423-777X; Crunelli, Vincenzo/0000-0001-7154-9752; Parri, Rheinallt/0000-0002-1412-2688				Amzica F, 1998, NEUROSCIENCE, V82, P671; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Berger H, 1935, ARCH PSYCHIAT NERVEN, V103, P444, DOI 10.1007/BF02024891; Berman AL, 1982, THALAMUS BASAL TELEN; BOUYER JJ, 1982, ARCH ITAL BIOL, V120, P95; BOUYER JJ, 1983, ELECTROEN CLIN NEURO, V55, P180, DOI 10.1016/0013-4694(83)90186-4; Brumberg JC, 2000, J NEUROSCI, V20, P4829; BUZSAKI G, 1991, NEUROSCIENCE, V41, P351, DOI 10.1016/0306-4522(91)90332-I; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; CHATILA M, 1993, CR ACAD SCI III-VIE, V316, P51; CYMBALYUK GS, 1994, BIOL CYBERN, V71, P153, DOI 10.1007/BF00197318; Danos P, 2001, NEUROPSYCHOBIOLOGY, V43, P265, DOI 10.1159/000054901; DASILVA FHL, 1980, ELECTROEN CLIN NEURO, V50, P449, DOI 10.1016/0013-4694(80)90011-5; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gillies MJ, 2002, J PHYSIOL-LONDON, V543, P779, DOI 10.1113/jphysiol.2002.024588; Godwin DW, 1996, J NEUROSCI, V16, P8181; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Hughes SW, 2002, NEUROSCIENCE, V110, P395, DOI 10.1016/S0306-4522(01)00577-2; Hughes SW, 2002, NEURON, V33, P947, DOI 10.1016/S0896-6273(02)00623-2; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; JUHASZ G, 1985, BRAIN RES BULL, V15, P437, DOI 10.1016/0361-9230(85)90032-2; Kanamori N, 1993, Int J Neurosci, V68, P117; Larson CL, 1998, PSYCHOPHYSIOLOGY, V35, P162, DOI 10.1017/S0048577298001620; Liley DTJ, 1999, NETWORK-COMP NEURAL, V10, P79, DOI 10.1088/0954-898X/10/1/005; Lindgren KA, 1999, BIOL PSYCHIAT, V45, P943, DOI 10.1016/S0006-3223(98)00350-3; Long MA, 2004, J NEUROSCI, V24, P341, DOI 10.1523/JNEUROSCI.3358-03.2004; LOPESDASILVA FH, 1973, ELECTROEN CLIN NEURO, V35, P627, DOI 10.1016/0013-4694(73)90216-2; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; MCCARLEY RW, 1983, J NEUROPHYSIOL, V50, P798, DOI 10.1152/jn.1983.50.4.798; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; Niedermeyer E, 1993, ELECTROENCEPHALOGRAP, P97; NIEDERMEYER E, 1993, ELECTROENCEPHALOGRAP, P153; RougeulBuser A, 1997, INT J PSYCHOPHYSIOL, V26, P191, DOI 10.1016/S0167-8760(97)00764-2; Rozental R, 2001, METH MOL B, V154, P447; SHERMAN A, 1992, P NATL ACAD SCI USA, V89, P2471, DOI 10.1073/pnas.89.6.2471; SILVA LR, 1991, SCIENCE, V251, P432, DOI 10.1126/science.1824881; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Traub RD, 2000, J NEUROSCI, V20, P2086; Turner JP, 2000, NEUROSCIENCE, V100, P493, DOI 10.1016/S0306-4522(00)00280-3; Venance L, 2000, P NATL ACAD SCI USA, V97, P10260, DOI 10.1073/pnas.160037097; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Williams SR, 2000, J NEUROSCI, V20, P1307; Zhan XJ, 2000, J NEUROSCI, V20, P3909, DOI 10.1523/JNEUROSCI.20-10-03909.2000; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P702, DOI 10.1152/jn.1999.81.2.702	48	194	201	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 22	2004	42	2					253	268		10.1016/S0896-6273(04)00191-6	http://dx.doi.org/10.1016/S0896-6273(04)00191-6			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KG	15091341	Bronze			2022-12-24	WOS:000221458500010
J	Uka, T; DeAngelis, GC				Uka, T; DeAngelis, GC			Contribution of area MT to stereoscopic depth perception: Choice-related response modulations reflect task strategy	NEURON			English	Article							STRUCTURE-FROM-MOTION; ATTENTIONAL MODULATION; NEURONAL-ACTIVITY; VISUAL AREA; MONKEY; DECISION; SIGNALS; CORTEX; SENSITIVITY; STRIATE	Due to the diversity of tuning properties in sensory cortex, only a fraction of neurons are engaged in a particular task. Characterizing the tuning properties of neurons that are functionally linked to behavior is essential for understanding how activity is "read out" from sensory maps to guide decisions. We recorded from middle temporal (MT) neurons while monkeys performed a depth discrimination task, and we characterized the linkage between MT responses and behavioral choices. Trial-to-trial response fluctuations of MT neurons with odd-symmetric ("Near," "Far") disparity tuning were predictive of monkeys' choices, whereas responses of neurons with even-symmetric tuning were not. This result cannot be explained by neuronal sensitivity or any other response property of MT neurons that we examined but is simply explained by the task strategy that monkeys learned during training. We suggest that this approach provides a physiological means to explore how task strategies are implemented in the brain.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	DeAngelis, GC (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.	gregd@cabernet.wustl.edu		DeAngelis, Gregory/0000-0002-1635-1273	NATIONAL EYE INSTITUTE [R01EY013644] Funding Source: NIH RePORTER; NEI NIH HHS [EY-013644] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Basso MA, 1998, J NEUROSCI, V18, P7519; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; Cook EP, 2002, J NEUROSCI, V22, P1994, DOI 10.1523/JNEUROSCI.22-05-01994.2002; DEAN AF, 1981, EXP BRAIN RES, V44, P437; DeAngelis GC, 2003, J NEUROPHYSIOL, V89, P1094, DOI 10.1152/jn.00717.2002; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Grunewald A, 2002, J NEUROSCI, V22, P6195; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; Parker AJ, 2002, PHILOS T ROY SOC B, V357, P1053, DOI 10.1098/rstb.2002.1112; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; POGGIO GF, 1988, J NEUROSCI, V8, P4531; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; SCHILLER PH, 1976, BRAIN RES, V105, P347, DOI 10.1016/0006-8993(76)90432-7; Seidemann E, 1998, NATURE, V394, P72, DOI 10.1038/27906; Seidemann E, 1999, J NEUROPHYSIOL, V81, P1783, DOI 10.1152/jn.1999.81.4.1783; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Thiele A, 1999, EUR J NEUROSCI, V11, P2044, DOI 10.1046/j.1460-9568.1999.00630.x; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Uka T, 2003, J NEUROSCI, V23, P3515; Williams ZM, 2003, NAT NEUROSCI, V6, P616, DOI 10.1038/nn1055; ZOHARY E, 1994, SCIENCE, V263, P1289, DOI 10.1126/science.8122114	34	159	159	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 22	2004	42	2					297	310		10.1016/S0896-6273(04)00186-2	http://dx.doi.org/10.1016/S0896-6273(04)00186-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KG	15091344	Bronze			2022-12-24	WOS:000221458500013
J	Khalilov, I; Holmes, GL; Ben-Ari, Y				Khalilov, I; Holmes, GL; Ben-Ari, Y			In vitro formation of a secondary epileptogenic mirror focus by interhippocampal propagation of seizures	NATURE NEUROSCIENCE			English	Article							TEMPORAL-LOBE EPILEPSY; CA3 HIPPOCAMPAL-NEURONS; EXCITATORY ACTIONS; DEVELOPING BRAIN; NMDA RECEPTORS; GABAERGIC INHIBITION; NEONATAL SEIZURES; KAINIC ACID; GABA; ANTAGONISTS	We have determined whether seizures generate an epileptogenic focus in distal structures using an in vitro preparation composed of three independent chambers that accommodate two intact hippocampi and their connecting commissures. This enabled us to apply a convulsive agent to one hippocampus, allow the propagation of a given number of seizures to the other side and block the connections reversibly by applying tetrodotoxin (TTX) to the commissural chamber. The propagation of seizures from the kainate-treated side to the naive side transformed the latter into an independent epileptogenic focus that was capable of generating spontaneous and evoked seizures. The induction mechanism required activation of NMDA receptors and the epileptogenic transformation was associated with long-term alterations in GABAergic synapses, which became excitatory because of a shift in the chloride reversal potential, E-Cl. These data indicate that the excitatory actions of GABA may be a fundamental property of epileptogenic structures.	INSERM, INMED, U29, F-13273 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Ben-Ari, Y (corresponding author), INSERM, INMED, U29, 163 Route Luminy, F-13273 Marseille, France.	ben-ari@inmed.univ-mrs.fr	Khalilov, Ilgam/B-5267-2015	Khalilov, Ilgam/0000-0002-9468-4778; Ben-Ari, Yehezkel/0000-0001-6208-8480				BARBIN G, 1993, NEUROSCI LETT, V152, P150, DOI 10.1016/0304-3940(93)90505-F; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; BENARI Y, 1988, J PHYSIOL-LONDON, V404, P365, DOI 10.1113/jphysiol.1988.sp017294; BENARI Y, 1979, CAN J PHYSIOL PHARM, V57, P1462, DOI 10.1139/y79-218; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Bittigau P, 2002, P NATL ACAD SCI USA, V99, P15089, DOI 10.1073/pnas.222550499; CENDES F, 1995, NEUROLOGY, V45, P2058, DOI 10.1212/WNL.45.11.2058; Chen K, 1999, NAT MED, V5, P888, DOI 10.1038/11330; CLANCY RR, 1987, EPILEPSIA, V28, P537, DOI 10.1111/j.1528-1157.1987.tb03685.x; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Dzhala VI, 2003, J NEUROSCI, V23, P1840; Esclapez M, 1997, P NATL ACAD SCI USA, V94, P12151, DOI 10.1073/pnas.94.22.12151; Esclapez M, 1999, J COMP NEUROL, V408, P449, DOI 10.1002/(SICI)1096-9861(19990614)408:4<449::AID-CNE1>3.0.CO;2-R; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; HAUSER WA, 1995, NEUROSURG CLIN N AM, V6, P419; Hirsch JC, 1999, NAT NEUROSCI, V2, P499, DOI 10.1038/9142; Holmes GL, 1998, NEURON, V21, P1231, DOI 10.1016/S0896-6273(00)80642-X; Houser CR, 1996, EPILEPSY RES, V26, P207, DOI 10.1016/S0920-1211(96)00054-X; Khalilov I, 1997, NEURON, V19, P743, DOI 10.1016/S0896-6273(00)80956-3; Khalilov I, 1999, DEV NEUROSCI-BASEL, V21, P310, DOI 10.1159/000017380; Khazipov R, 1999, J NEUROPHYSIOL, V81, P921, DOI 10.1152/jn.1999.81.2.921; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; Lemos T, 1996, Epilepsy Res Suppl, V12, P137; Louvel J, 2001, NEUROSCIENCE, V105, P803, DOI 10.1016/S0306-4522(01)00247-0; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MODY I, 1987, NATURE, V326, P701, DOI 10.1038/326701a0; MOSHE SL, 1983, DEV BRAIN RES, V7, P81, DOI 10.1016/0165-3806(83)90083-4; MOSHE SL, 1982, DEV BRAIN RES, V4, P67, DOI 10.1016/0165-3806(82)90097-9; NEUMAN R, 1988, BRAIN RES, V459, P265, DOI 10.1016/0006-8993(88)90642-7; RAFIQ A, 1993, J NEUROPHYSIOL, V70, P1962, DOI 10.1152/jn.1993.70.5.1962; RAYMOND AA, 1994, NEUROLOGY, V44, P1841, DOI 10.1212/WNL.44.10.1841; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Shinnar S, 1996, PEDIATRICS, V98, P216; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; STASHEFF SF, 1989, SCIENCE, V245, P648, DOI 10.1126/science.2569762; SZENTE MB, 1994, BRAIN RES, V648, P203, DOI 10.1016/0006-8993(94)91119-3; TROMMER BL, 1990, DEV BRAIN RES, V53, P248, DOI 10.1016/0165-3806(90)90014-P; Villeneuve N, 2000, ANN NEUROL, V47, P729, DOI 10.1002/1531-8249(200006)47:6<729::AID-ANA5>3.3.CO;2-3; Wang C, 2002, DEV BRAIN RES, V139, P59, DOI 10.1016/S0165-3806(02)00536-9; Wieser HG, 2003, J NEUROSURG, V98, P751, DOI 10.3171/jns.2003.98.4.0751	45	218	231	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1079	1085		10.1038/nn1125	http://dx.doi.org/10.1038/nn1125			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	14502289				2022-12-24	WOS:000185633600020
J	Novitch, BG; Wichterle, H; Jessell, TM; Sockanathan, S				Novitch, BG; Wichterle, H; Jessell, TM; Sockanathan, S			A requirement for retinoic acid-mediated transcriptional activation in ventral neural patterning and motor neuron specification	NEURON			English	Article							PROGENITOR-CELL IDENTITY; DEVELOPING SPINAL-CORD; FGF SIGNALING CONTROLS; SONIC HEDGEHOG; REPRESSOR ACTIVITY; MOUSE DEVELOPMENT; SUBTYPE IDENTITY; FLOOR PLATE; FATE SPECIFICATION; GENE-EXPRESSION	The specification of neuronal fates in the ventral spinal cord depends on the regulation of homeodomain (HD) and basic-helix-loop-helix (bHLH) proteins by Sonic hedgehog (Shh). Most of these transcription factors function as repressors, leaving unresolved the link between inductive signaling pathways and transcriptional activators involved in ventral neuronal specification. We show here that retinoid signaling and the activator functions of retinoid receptors are required to pattern the expression of HD and bHLH proteins and to specify motor neuron identity. We also show that fibroblast growth factors (FGFs) repress progenitor HID protein expression, implying that evasion of FGF signaling and exposure to retinoid and Shh signals are obligate steps in the emergence of ventral neural pattern. Moreover, joint exposure of neural progenitors to retinoids and FGFs suffices to induce motor neuron differentiation in a Shh-independent manner.	Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Columbia University; Howard Hughes Medical Institute; Johns Hopkins University	Jessell, TM (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, 701 W 168th St, New York, NY 10032 USA.	tmj1@columbia.edu		Novitch, Bennett/0000-0002-2696-3708; Wichterle, Hynek/0000-0002-7817-0080				BALKAN W, 1992, P NATL ACAD SCI USA, V89, P3347, DOI 10.1073/pnas.89.8.3347; Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; Bel-Vialar S, 2002, DEVELOPMENT, V129, P5103; Bertrand N, 2000, DEVELOPMENT, V127, P4837; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Bueno D, 1996, DEV DYNAM, V207, P291, DOI 10.1002/(SICI)1097-0177(199611)207:3<291::AID-AJA6>3.0.CO;2-C; Busslinger M, 2000, CURR OPIN IMMUNOL, V12, P151, DOI 10.1016/S0952-7915(99)00065-5; Castro DS, 1999, J BIOL CHEM, V274, P37483, DOI 10.1074/jbc.274.52.37483; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; DAMM K, 1993, P NATL ACAD SCI USA, V90, P2989, DOI 10.1073/pnas.90.7.2989; Davidson EH, 2002, DEV BIOL, V246, P162, DOI 10.1006/dbio.2002.0635; Deschamps J, 1999, INT J DEV BIOL, V43, P635; Diez del Corral R, 2002, DEVELOPMENT, V129, P1681; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Eggenschwiler JT, 2001, NATURE, V412, P194, DOI 10.1038/35084089; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Farah MH, 2000, DEVELOPMENT, V127, P693; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Gould A, 1998, NEURON, V21, P39, DOI 10.1016/S0896-6273(00)80513-9; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Han Z, 2002, DEV BIOL, V252, P225, DOI 10.1006/dbio.2002.0846; HELMS J, 1994, DEVELOPMENT, V120, P3267; Helms JA, 1997, DEV BIOL, V187, P25, DOI 10.1006/dbio.1997.8589; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Kudoh T, 2002, DEVELOPMENT, V129, P4335; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Mannervik M, 1999, SCIENCE, V284, P606, DOI 10.1126/science.284.5414.606; MARTI E, 1995, NATURE, V375, P322, DOI 10.1038/375322a0; Mathis L, 2001, NAT CELL BIOL, V3, P559, DOI 10.1038/35078535; Matise MP, 1999, ONCOGENE, V18, P7852, DOI 10.1038/sj.onc.1203243; MENDELSOHN C, 1991, DEVELOPMENT, V113, P723; Mercader N, 2000, DEVELOPMENT, V127, P3961; Meyer NP, 2003, DEV BIOL, V257, P343, DOI 10.1016/S0012-1606(03)00065-4; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Muhr J, 1999, NEURON, V23, P689, DOI 10.1016/S0896-6273(01)80028-3; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Niederreither K, 2002, NAT GENET, V31, P84, DOI 10.1038/ng876; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Niederreither K, 2002, DEVELOPMENT, V129, P3563; NISWANDER L, 1992, DEVELOPMENT, V114, P755; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Patten I, 2000, CELL MOL LIFE SCI, V57, P1695, DOI 10.1007/PL00000652; Pattyn A, 2003, DEVELOPMENT, V130, P4149, DOI 10.1242/dev.00641; Persson M, 2002, GENE DEV, V16, P2865, DOI 10.1101/gad.243402; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; RIESE J, 1995, MECH DEVELOP, V49, P13, DOI 10.1016/0925-4773(94)00296-Y; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; Schneider RA, 2001, DEVELOPMENT, V128, P2755; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Sharpe CR, 1997, DEVELOPMENT, V124, P515; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Solomin L, 1998, NATURE, V395, P398, DOI 10.1038/26515; Swindell EC, 1999, DEV BIOL, V216, P282, DOI 10.1006/dbio.1999.9487; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Tsukui T, 1999, P NATL ACAD SCI USA, V96, P11376, DOI 10.1073/pnas.96.20.11376; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; William CM, 2003, DEVELOPMENT, V130, P1523, DOI 10.1242/dev.00358; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	76	248	260	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 25	2003	40	1					81	95		10.1016/j.neuron.2003.08.006	http://dx.doi.org/10.1016/j.neuron.2003.08.006			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	726TA	14527435	Bronze			2022-12-24	WOS:000185614700011
J	Watanabe, D; Nakanishi, S				Watanabe, D; Nakanishi, S			mGIuR2 postswaptically senses granule cell inputs at Golgi cell synapses	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM POTENTIATION; RAT CEREBELLUM; IMMUNOHISTOCHEMICAL LOCALIZATION; GABA(A) RECEPTORS; DOPAMINE NEURONS; MGLUR2; BRAIN; ANTAGONIST; INHIBITION	In the cerebellar circuit, Golgi cells are thought to contribute to information processing and integration via feedback mechanisms. In these mechanisms, dynamic modulation of Golgi cell excitability is necessary because GABA from Golgi cells causes tonic inhibition on granule cells. We studied the role and synaptic mechanisms of postsynaptic metabotropic glutamate receptor subtype 2 (mGluR2) at granule cell-Golgi cell synapses, using whole-cell recording of green fluorescent protein-positive Golgi cells of wild-type and mGluR2-deficient mice. Postsynaptic mGluR2 was activated by glutamate from granule cells and hyperpolarized Golgi cells via G protein-coupled inwardly rectifying K+ channels (GIRKs). This hyperpolarization conferred long-lasting silencing of Golgi cells, the duration and extents of which were dependent on stimulus strengths. Postsynaptic mGluR2 thus senses inputs from granule cells and is most likely important for spatiotemporal modulation of mossy fiber-granule cell transmission before distributing inputs to Purkinje cells.	Kyoto Univ, Fac Med, Dept Biol Sci, Kyoto 6068501, Japan	Kyoto University	Nakanishi, S (corresponding author), Kyoto Univ, Fac Med, Dept Biol Sci, Kyoto 6068501, Japan.							ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Armano S, 2000, J NEUROSCI, V20, P5208, DOI 10.1523/JNEUROSCI.20-14-05208.2000; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; D'Angelo E, 1999, J NEUROPHYSIOL, V81, P277, DOI 10.1152/jn.1999.81.1.277; De Schutter E, 2001, Prog Brain Res, V130, P279; Dieudonne S, 1998, J PHYSIOL-LONDON, V510, P845, DOI 10.1111/j.1469-7793.1998.845bj.x; Dino MR, 1999, J NEUROCYTOL, V28, P99, DOI 10.1023/A:1007072105919; DOLPHIN AC, 1988, PFLUG ARCH EUR J PHY, V411, P628, DOI 10.1007/BF00580858; Fiorillo CD, 1998, NATURE, V394, P78, DOI 10.1038/27919; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; Geurts FJ, 2001, NEUROSCIENCE, V104, P499, DOI 10.1016/S0306-4522(01)00058-6; HAYASHI Y, 1993, NATURE, V366, P687, DOI 10.1038/366687a0; Kaneko S, 2000, SCIENCE, V289, P633, DOI 10.1126/science.289.5479.633; Karschin C, 1996, J NEUROSCI, V16, P3559; Kingston AE, 1998, NEUROPHARMACOLOGY, V37, P1, DOI 10.1016/S0028-3908(97)00191-3; Knoflach F, 1998, J PHYSIOL-LONDON, V509, P347, DOI 10.1111/j.1469-7793.1998.347bn.x; Knoflach F, 2001, NEUROPHARMACOLOGY, V40, P163, DOI 10.1016/S0028-3908(00)00152-0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; Litschig S, 1999, MOL PHARMACOL, V55, P453; Lujan R, 1997, J CHEM NEUROANAT, V13, P219, DOI 10.1016/S0891-0618(97)00051-3; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Mitchell SJ, 2000, NATURE, V404, P498, DOI 10.1038/35006649; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NAPPER RMA, 1988, J COMP NEUROL, V274, P168, DOI 10.1002/cne.902740204; Neki A, 1996, NEUROSCIENCE, V75, P815, DOI 10.1016/0306-4522(96)00316-8; NUSSER Z, 1995, J NEUROSCI, V15, P2948; OHISHI H, 1994, NEURON, V13, P55, DOI 10.1016/0896-6273(94)90459-6; OHISHI H, 1993, NEUROSCIENCE, V53, P1009, DOI 10.1016/0306-4522(93)90485-X; Paladini CA, 2001, NAT NEUROSCI, V4, P275, DOI 10.1038/85124; Petralia RS, 1996, NEUROSCIENCE, V71, P949, DOI 10.1016/0306-4522(95)00533-1; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; SHIGEMOTO R, 1993, NEUROSCI LETT, V163, P53, DOI 10.1016/0304-3940(93)90227-C; Vos BP, 1999, EUR J NEUROSCI, V11, P2621, DOI 10.1046/j.1460-9568.1999.00678.x; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; Yokoi M, 1996, SCIENCE, V273, P645, DOI 10.1126/science.273.5275.645; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6	41	70	86	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 28	2003	39	5					821	829		10.1016/S0896-6273(03)00530-0	http://dx.doi.org/10.1016/S0896-6273(03)00530-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	717GN	12948448	Bronze			2022-12-24	WOS:000185079300011
J	Kohn, A; Movshon, JA				Kohn, A; Movshon, JA			Neuronal adaptation to visual motion in area MT of the macaque	NEURON			English	Article							CAT STRIATE CORTEX; UNDERLYING CONTRAST ADAPTATION; POSITION-SPECIFIC ADAPTATION; SUPERIOR TEMPORAL SULCUS; CELL RECEPTIVE-FIELDS; TRANSPARENT MOTION; GAIN-CONTROL; SELECTIVE ADAPTATION; SYNAPTIC DEPRESSION; CORTICAL-NEURONS	The responsivity of primary sensory cortical neurons is reduced following prolonged adaptation, but such adaptation has been little studied in higher sensory areas. Adaptation to visual motion has strong perceptual effects, so we studied the effect of prolonged stimulation on neuronal responsivity in the macaque's area MT, a cortical area whose importance to visual motion perception is well established. We adapted MT neurons with sinusoidal gratings drifting in the preferred or null direction. Preferred adaptation reduced the responsiveness of MT cells, primarily by changing their contrast gain, and this effect was spatially specific within the receptive field. Null adaptation reduced the ability of null gratings to inhibit the response to a simultaneously presented preferred stimulus. While both preferred and null adaptation alter MT responses, these effects probably do not occur in MT neurons but are likely to reflect adaptation-induced changes in contrast gain earlier in the visual pathway.	NYU, Howard Hughes Med Inst, New York, NY 10003 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA	Howard Hughes Medical Institute; New York University; New York University	Kohn, A (corresponding author), NYU, Howard Hughes Med Inst, New York, NY 10003 USA.				NATIONAL EYE INSTITUTE [R01EY002017] Funding Source: NIH RePORTER; NEI NIH HHS [EY02017] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ALBRECHT DG, 1984, J PHYSIOL-LONDON, V347, P713, DOI 10.1113/jphysiol.1984.sp015092; ALBRIGHT TD, 1987, EXP BRAIN RES, V65, P582; ASHIDA H, 1994, PERCEPTION, V23, P1313, DOI 10.1068/p231313; Barlow H., 1990, VISION CODING EFFICI; BARLOW HB, 1963, NATURE, V200, P1345, DOI 10.1038/2001345a0; BONDS AB, 1991, VISUAL NEUROSCI, V6, P239, DOI 10.1017/S0952523800006258; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Chance FS, 1998, J NEUROSCI, V18, P4785; Chander D, 2001, J NEUROSCI, V21, P9904, DOI 10.1523/JNEUROSCI.21-24-09904.2001; CHANDLER JP, 1969, BEHAV SCI, V14, P81; Culham JC, 1999, J NEUROPHYSIOL, V81, P388, DOI 10.1152/jn.1999.81.1.388; DEALY RS, 1974, J PHYSIOL-LONDON, V241, P261, DOI 10.1113/jphysiol.1974.sp010652; DEBRUYN EJ, 1986, BRAIN RES, V383, P339, DOI 10.1016/0006-8993(86)90036-3; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Gallyas F, 1979, Neurol Res, V1, P203; GIASCHI D, 1993, J NEUROPHYSIOL, V70, P2024, DOI 10.1152/jn.1993.70.5.2024; Grunewald A, 1996, NATURE, V384, P358, DOI 10.1038/384358a0; HAMMOND P, 1988, EXP BRAIN RES, V72, P1, DOI 10.1007/BF00248495; Harris RA, 2000, NEURON, V28, P595, DOI 10.1016/S0896-6273(00)00136-7; He S, 1998, CURR BIOL, V8, P1215, DOI 10.1016/S0960-9822(07)00512-X; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Heuer HW, 2002, J NEUROPHYSIOL, V88, P3398, DOI 10.1152/jn.00255.2002; Huk AC, 2001, NEURON, V32, P161, DOI 10.1016/S0896-6273(01)00452-4; LEE CJ, 1992, CEREB CORTEX, V2, P81, DOI 10.1093/cercor/2.2.81; Lisberger SG, 1999, J NEUROSCI, V19, P2224; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; Malone BJ, 2002, J NEUROSCI, V22, P4625, DOI 10.1523/JNEUROSCI.22-11-04625.2002; MARLIN S, 1993, J NEUROPHYSIOL, V69, P2209, DOI 10.1152/jn.1993.69.6.2209; MARLIN SG, 1991, J NEUROPHYSIOL, V66, P1769, DOI 10.1152/jn.1991.66.5.1769; MARTIN SG, 1988, J NEUROPHYSIOL, V39, P1314; Mather G., 1998, MOTION AFTEREFFECT M; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; McLean J, 1996, VISUAL NEUROSCI, V13, P1069, DOI 10.1017/S0952523800007720; MERRILL EG, 1972, MED BIOL ENG, V10, P662, DOI 10.1007/BF02476084; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; PETERSEN SE, 1985, BRAIN RES, V346, P146, DOI 10.1016/0006-8993(85)91105-9; Priebe NJ, 2002, J NEUROPHYSIOL, V88, P354, DOI 10.1152/jn.00852.2001; QIAN N, 1994, J NEUROSCI, V14, P7367; QIAN N, 1994, J NEUROSCI, V14, P7381; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; SAUL AB, 1989, VISUAL NEUROSCI, V2, P593, DOI 10.1017/S0952523800003527; SAUL AB, 1989, VISUAL NEUROSCI, V2, P609, DOI 10.1017/S0952523800003539; SCLAR G, 1989, VISION RES, V29, P747, DOI 10.1016/0042-6989(89)90087-4; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; SEKULER RW, 1963, SCIENCE, V139, P419, DOI 10.1126/science.139.3553.419; Shapley R, 1984, PROG RETIN RES, V3, P263, DOI DOI 10.1016/0278-4327(84)90011-7; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Snowden RJ, 1996, VISION RES, V36, P1797, DOI 10.1016/0042-6989(95)00263-4; SNOWDEN RJ, 1991, J NEUROSCI, V11, P2768; SUTHERLAND NS, 1961, Q J EXP PSYCHOL, V13, P222, DOI 10.1080/17470216108416498; Taylor JG, 2000, NEUROIMAGE, V11, P257, DOI 10.1006/nimg.1999.0529; Thiele A, 2000, NEURON, V26, P715, DOI 10.1016/S0896-6273(00)81207-6; TOLHURST DJ, 1973, J PHYSIOL-LONDON, V231, P385, DOI 10.1113/jphysiol.1973.sp010239; Tolias AS, 2001, J NEUROSCI, V21, P8594, DOI 10.1523/JNEUROSCI.21-21-08594.2001; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Van Wezel RJA, 2002, J NEUROPHYSIOL, V88, P3469, DOI 10.1152/jn.00276.2002; VAUTIN RG, 1977, J NEUROPHYSIOL, V40, P1051, DOI 10.1152/jn.1977.40.5.1051; VIDYASAGAR TR, 1990, NEUROSCIENCE, V36, P175, DOI 10.1016/0306-4522(90)90360-G; VONDERHEYDT R, 1978, ARCH ITAL BIOL, V116, P248; WAINWRIGHT M, 2002, PROBABILISTIC MODELS; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452	73	250	252	0	29	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 14	2003	39	4					681	691		10.1016/S0896-6273(03)00438-0	http://dx.doi.org/10.1016/S0896-6273(03)00438-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	712CQ	12925281	Green Published, Bronze			2022-12-24	WOS:000184779500012
J	Richards, DA; Guatimosim, C; Rizzoli, SO; Betz, WJ				Richards, DA; Guatimosim, C; Rizzoli, SO; Betz, WJ			Synaptic vesicle pools at the frog neuromuscular junction	NEURON			English	Article							MOTOR-NERVE TERMINALS; READILY RELEASABLE POOL; HIPPOCAMPAL SYNAPSES; TRANSMITTER RELEASE; TETANIC STIMULATION; DROSOPHILA MUTANT; DISTINCT POOLS; ENDOCYTOSIS; EXOCYTOSIS; DEPRESSION	We have characterized the morphological and functional properties of the readily releasable pool (RRP) and the reserve pool of synaptic vesicles in frog motor nerve terminals using fluorescence microscopy, electron microscopy, and electrophysiology. At rest, about 20% of vesicles reside in the RRP, which is depleted in about 10 s by high-frequency nerve stimulation (30 Hz); the RRP refills in about 1 min, and surprisingly' refilling occurs almost entirely by recycling, not mobilization from the reserve pool. The reserve pool is depleted during 30 Hz stimulation with a time constant of about 40s,and it refills slowly (half-time about 8 min) as nascent vesicles bud from randomly distributed cisternae and surface membrane infoldings and enter vesicle clusters spaced at regular intervals along the terminal. Transmitter output during low-frequency stimulation (2-5 Hz) is maintained entirely by RRP recycling; few if any vesicles are mobilized from the reserve pool.	Univ Colorado, Sch Med, Dept Physiol & Biophys, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Betz, WJ (corresponding author), Univ Colorado, Sch Med, Dept Physiol & Biophys, C-240,4200 E 9th Ave, Denver, CO 80262 USA.		Rizzoli, Silvio/ABG-2227-2020	Rizzoli, Silvio/0000-0002-1667-7839; Richards, David/0000-0001-6154-7112				Becherer U, 2001, J NEUROSCI, V21, P782, DOI 10.1523/JNEUROSCI.21-03-00782.2001; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BETZ WJ, 1994, J CELL BIOL, V124, P833; BIRKS R, 1961, CAN J BIOCHEM PHYS, V39, P787, DOI 10.1139/o61-081; Burrone J, 2000, J NEUROSCI, V20, P568, DOI 10.1523/JNEUROSCI.20-02-00568.2000; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; GENNARO JF, 1978, J PHYSIOL-LONDON, V280, P237, DOI 10.1113/jphysiol.1978.sp012382; Harata N, 2001, TRENDS NEUROSCI, V24, P637, DOI 10.1016/S0166-2236(00)02030-0; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Henkel AW, 1996, J NEUROSCI, V16, P3960; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HEUSER JE, 1981, J CELL BIOL, V88, P564, DOI 10.1083/jcb.88.3.564; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; Koenig JH, 1999, J NEUROPHYSIOL, V81, P1495, DOI 10.1152/jn.1999.81.4.1495; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Kuromi H, 2000, NEURON, V27, P133, DOI 10.1016/S0896-6273(00)00015-5; Kuromi H, 2002, NEURON, V35, P333, DOI 10.1016/S0896-6273(02)00777-8; Kuromi H, 1999, J NEUROSCI, V19, P1557; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sakaba T, 2002, NEUROSCI RES, V44, P343, DOI 10.1016/S0168-0102(02)00174-8; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Sara Y, 2002, J NEUROSCI, V22, P1608, DOI 10.1523/JNEUROSCI.22-05-01608.2002; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schneggenburger R, 2002, TRENDS NEUROSCI, V25, P206, DOI 10.1016/S0166-2236(02)02139-2; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; SWARTZ KJ, 1992, MOL PHARMACOL, V41, P1130; Teng HB, 1999, J NEUROSCI, V19, P4855; Trommershauser J, 2003, BIOPHYS J, V84, P1563, DOI 10.1016/S0006-3495(03)74967-4; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1; Wu LG, 1998, BIOPHYS J, V74, P3003, DOI 10.1016/S0006-3495(98)78007-5	44	130	134	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 31	2003	39	3					529	541		10.1016/S0896-6273(03)00405-7	http://dx.doi.org/10.1016/S0896-6273(03)00405-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	709LC	12895425	Bronze			2022-12-24	WOS:000184625800014
J	Erickson, MG; Liang, HY; Mori, MX; Yue, DT				Erickson, MG; Liang, HY; Mori, MX; Yue, DT			FRET two-hybrid mapping reveals function and location of L-type Ca2+ channel CaM preassociation	NEURON			English	Article							RESONANCE ENERGY-TRANSFER; CA2+-DEPENDENT INACTIVATION; CA2+-SENSITIVE INACTIVATION; CALCIUM CHANNELS; FLUORESCENT PROTEIN; CALMODULIN-BINDING; POTASSIUM CHANNELS; ALPHA(1C) SUBUNIT; MOTIF; DETERMINANTS	L-type Ca2+ channels possess a Ca2+-dependentinactivation (CDI) mechanism, affording feedback in diverse neurobiological settings and serving as prototype or unconventional calmodulin (CaM) regulation emerging in many Ca2+ channels. Crucial to such regulation is the preassociation of Ca2+-free CaM (apoCaM) to channels, facilitating rapid triggering of CDI as Ca2+/CaM shifts to a channel 10 site (10). Progress has been hindered by controversy over the preassociation site, as identified by in vitro assays. Most critical has been the failure to resolve a functional signature of preassociation. Here, we deploy novel FRET assays in live cells to identify a 73 aa channel segment, containing IQ, as the critical preassociation pocket. IQ mutations disrupting preassociation revealed accelerated voltage-dependent inactivation (VDI) as the functional hallmark of channels lacking preassociated CaM. Hence, the otic 10 segment is multifunctional-serving as ligand for preassociation and as Ca2+/CaM effector site for CDI.	Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Calcium Signals Lab, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Yue, DT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Ross 713,720 Rutland Ave, Baltimore, MD 21205 USA.							ALLEN JB, 1995, TRENDS BIOCHEM SCI, V20, P511, DOI 10.1016/S0968-0004(00)89119-7; Bastiaens PIH, 1996, P NATL ACAD SCI USA, V93, P8407, DOI 10.1073/pnas.93.16.8407; Billo E.J., 2001, EXCEL CHEM COMPREHEN, V2nd; Budde T, 2002, NAT REV NEUROSCI, V3, P873, DOI 10.1038/nrn959; CHAO SH, 1984, MOL PHARMACOL, V26, P75; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; EPE B, 1983, P NATL ACAD SCI-BIOL, V80, P2579, DOI 10.1073/pnas.80.9.2579; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; ERICKSON MG, 2003, IN PRESS BIOPHYS J; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Laird DW, 2001, MICROSC RES TECHNIQ, V52, P263, DOI 10.1002/1097-0029(20010201)52:3<263::AID-JEMT1012>3.0.CO;2-Q; Malmendal A, 1999, BIOCHEMISTRY-US, V38, P11844, DOI 10.1021/bi9909288; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Mouton J, 2001, J BIOL CHEM, V276, P22359, DOI 10.1074/jbc.M100755200; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Qin H, 2001, CELL COMMUN ADHES, V8, P433, DOI 10.3109/15419060109080766; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rodney GG, 2001, J BIOL CHEM, V276, P2069, DOI 10.1074/jbc.M008891200; Romanin C, 2000, FEBS LETT, V487, P301, DOI 10.1016/S0014-5793(00)02361-9; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Soldatov NM, 1998, J BIOL CHEM, V273, P957, DOI 10.1074/jbc.273.2.957; Soldatov NM, 2000, J MEMBRANE BIOL, V177, P129, DOI 10.1007/s002320001106; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Xu Yao, 2002, Methods Mol Biol, V183, P121; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1998, P NATL ACAD SCI USA, V95, P3287, DOI 10.1073/pnas.95.6.3287; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	41	188	188	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 3	2003	39	1					97	107		10.1016/S0896-6273(03)00395-7	http://dx.doi.org/10.1016/S0896-6273(03)00395-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699LB	12848935	Bronze			2022-12-24	WOS:000184057400012
J	van Swinderen, B; Greenspan, RJ				van Swinderen, B; Greenspan, RJ			Salience modulates 20-30 Hz brain activity in Drosophila	NATURE NEUROSCIENCE			English	Article							TARGETED EXPRESSION; NEURAL ACTIVITY; MINI-BRAIN; SHIBIRE; MELANOGASTER; INFORMATION; MECHANISM; ATTENTION; BEHAVIOR; CIRCUIT	Fruit flies selectively orient toward the visual stimuli that are most salient in their environment. We recorded local field potentials (LFPs) from the brains of Drosophila melanogaster as they responded to the presentation of visual stimuli. Coupling of salience effects (odor, heat or novelty) to these stimuli modulated LFPs in the 20-30 Hz range by evoking a transient, selective increase. We demonstrated the association of these responses with behavioral tracking and initiated a genetic approach to investigating neural correlates of perception.	Inst Neurosci, San Diego, CA 92121 USA		Greenspan, RJ (corresponding author), Inst Neurosci, 10640 John Jay Hopkins Dr, San Diego, CA 92121 USA.	greenspan@nsi.edu		van Swinderen, Bruno/0000-0001-6552-7418	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009754] Funding Source: NIH RePORTER; NCRR NIH HHS [P41-RR09754] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Borst A, 2002, J COMP PHYSIOL A, V188, P419, DOI 10.1007/s00359-002-0316-8; Bushnell PJ, 1998, PSYCHOPHARMACOLOGY, V138, P231, DOI 10.1007/s002130050668; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; COLLETT TS, 1980, J COMP PHYSIOL, V138, P271, DOI 10.1007/BF00657045; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crick F., 1990, Seminars in the Neurosciences, V2, P263; DILL M, 1995, PHILOS T ROY SOC B, V349, P143, DOI 10.1098/rstb.1995.0100; Edelman G. M, 1989, REMEMBERED PRESENT; Egelhaaf M, 2002, TRENDS NEUROSCI, V25, P96, DOI 10.1016/S0166-2236(02)02063-5; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Fiala A, 2002, CURR BIOL, V12, P1877, DOI 10.1016/S0960-9822(02)01239-3; Gatti S, 2000, CURR BIOL, V10, P667, DOI 10.1016/S0960-9822(00)00517-0; GOETZ KG, 1994, NEURAL BASIS BEHAV A, P47; Guo A, 1997, LEARN MEMORY, V4, P192, DOI 10.1101/lm.4.2.192; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; James W., 1890, PRINCIPLES PSYCHOL; Joiner MLA, 1997, J NEUROSCI, V17, P9384; Joiner MLA, 1999, LEARN MEMORY, V6, P177; KAISER W, 1983, NATURE, V301, P707, DOI 10.1038/301707a0; Keller A, 2002, J NEUROBIOL, V50, P221, DOI 10.1002/neu.10029; KIM YT, 1990, J NEUROGENET, V7, P1, DOI 10.3109/01677069009084149; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Lee TS, 2002, NAT NEUROSCI, V5, P589, DOI 10.1038/nn860; Lehmann FO, 1997, J EXP BIOL, V200, P1133; Littleton JT, 1998, NEURON, V21, P401, DOI 10.1016/S0896-6273(00)80549-8; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; LOUGHNEY K, 1989, CELL, V58, P1143, DOI 10.1016/0092-8674(89)90512-6; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Menzel R, 2001, TRENDS COGN SCI, V5, P62, DOI 10.1016/S1364-6613(00)01601-6; MIMURA K, 1982, J COMP PHYSIOL, V146, P229, DOI 10.1007/BF00610242; Niebur E, 2002, CURR OPIN NEUROBIOL, V12, P190, DOI 10.1016/S0959-4388(02)00310-0; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Waddell S, 2001, ANNU REV NEUROSCI, V24, P1283, DOI 10.1146/annurev.neuro.24.1.1283; Wang YL, 2001, NEURON, V29, P267, DOI 10.1016/S0896-6273(01)00196-9; Wolf R, 1998, LEARN MEMORY, V5, P166; WOLF R, 1980, J COMP PHYSIOL, V140, P69, DOI 10.1007/BF00613749; WOLF R, 1991, J COMP PHYSIOL A, V169, P699; Wu ZH, 2000, BIOL CYBERN, V82, P61, DOI 10.1007/s004220050006	42	127	129	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					579	586		10.1038/nn1054	http://dx.doi.org/10.1038/nn1054			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12717438				2022-12-24	WOS:000183140400014
J	Yang, ZY; Purves, D				Yang, ZY; Purves, D			A statistical explanation of visual space	NATURE NEUROSCIENCE			English	Article							DISTANCE PERCEPTION; EGOCENTRIC DISTANCE; IMAGE STATISTICS; NATURAL IMAGES; OCULOMOTOR; ILLUSIONS; MODELS; CUES	The subjective visual space perceived by humans does not reflect a simple transformation of objective physical space; rather, perceived space has an idiosyncratic relationship with the real world. To date, there is no consensus about either the genesis of perceived visual space or the implications of its peculiar characteristics for visually guided behavior. Here we used laser range scanning to measure the actual distances from the image plane of all unoccluded points in a series of natural scenes. We then asked whether the differences between real and apparent distances could be explained by the statistical relationship of scene geometry and the observer. We were able to predict perceived distances in a variety of circumstances from the probability distribution of physical distances. This finding lends support to the idea that the characteristics of human visual space are determined probabilistically.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Yang, ZY (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	yang@neuro.duke.edu						Belhumeur PN, 1996, INT J COMPUT VISION, V19, P237, DOI 10.1007/BF00055146; Bloj MG, 1999, NATURE, V402, P877, DOI 10.1038/47245; Brainard DH, 1997, J OPT SOC AM A, V14, P1393, DOI 10.1364/JOSAA.14.001393; EPSTEIN W, 1969, PERCEPT PSYCHOPHYS, V6, P269, DOI 10.3758/BF03210096; FOLEY JM, 1985, J EXP PSYCHOL HUMAN, V11, P133, DOI 10.1037/0096-1523.11.2.133; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; Geisler WS, 2002, NAT NEUROSCI, V5, P508, DOI 10.1038/nn0602-508; Gibson JJ, 1950, PERCEPTION VISUAL WO; Gillam B., 1995, PERCEPTION SPACE MOT, P23; GOGEL W C, 1965, Psychol Bull, V64, P153, DOI 10.1037/h0022197; GOGEL WC, 1979, VISION RES, V19, P1161, DOI 10.1016/0042-6989(79)90013-0; Hershenson M., 1999, VISUAL SPACE PERCEPT; Howe CQ, 2002, P NATL ACAD SCI USA, V99, P13184, DOI 10.1073/pnas.162474299; Huang JG, 2000, PROC CVPR IEEE, P324, DOI 10.1109/CVPR.2000.855836; INDOW T, 1991, PSYCHOL REV, V98, P430, DOI 10.1037/0033-295X.98.3.430; Kersten D, 1999, NEW COGNITIVE NEUROS, P353; Knill DC, 1996, PERCEPTION BAYESIAN; Loomis JM, 1996, CURR DIR PSYCHOL SCI, V5, P72, DOI 10.1111/1467-8721.ep10772783; Luneberg RK., 1947, MATH ANAL BINOCULAR; Meng JC, 2001, PERCEPT PSYCHOPHYS, V63, P1, DOI 10.3758/BF03200497; MORRISON JD, 1984, PERCEPTION, V13, P555, DOI 10.1068/p130555; Mumford D, 2001, Q APPL MATH, V59, P85, DOI 10.1090/qam/1811096; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Ooi TL, 2001, NATURE, V414, P197, DOI 10.1038/35102562; OWENS DA, 1976, PERCEPT PSYCHOPHYS, V20, P2, DOI 10.3758/BF03198694; Philbeck JW, 1997, J EXP PSYCHOL HUMAN, V23, P72, DOI 10.1037/0096-1523.23.1.72; Purves D., 2003, WHY WE SEE WHAT WE D; Sedgwick H., 1986, HDB PERCEPTION HUMAN, V1; Sigman M, 2001, P NATL ACAD SCI USA, V98, P1935, DOI 10.1073/pnas.031571498; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Sinai MJ, 1998, NATURE, V395, P497, DOI 10.1038/26747; Todd JT, 2001, PSYCHOL SCI, V12, P191, DOI 10.1111/1467-9280.00335; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; WAGNER M, 1985, PERCEPT PSYCHOPHYS, V38, P483, DOI 10.3758/BF03207058; WALLACH H, 1982, PERCEPT PSYCHOPHYS, V31, P145, DOI 10.3758/BF03206214; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858	37	107	109	5	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					632	640		10.1038/nn1059	http://dx.doi.org/10.1038/nn1059			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	683GQ	12754512				2022-12-24	WOS:000183140400021
J	Sato, TR; Schall, JD				Sato, TR; Schall, JD			Effects of stimulus-response compatibility on neural selection in frontal eye field	NEURON			English	Article							SACCADE TARGET SELECTION; PRIMATE SUPERIOR COLLICULUS; LATERAL INTRAPARIETAL AREA; NEURONAL-ACTIVITY; VISUAL SELECTION; PREPARATORY SET; ANTI-SACCADES; REACTION-TIME; PRO-SACCADES; SEARCH TASK	We investigated the neural basis of visual and saccade selection in the frontal eye field of macaque monkeys using a singleton search task with prosaccade or antisaccade responses. Two types of neurons were distinguished. The first initially selected the singleton even in antisaccade trials, although most subsequently selected the endpoint of the saccade. The time the singleton was located was not affected by stimulus-response compatibility and did not vary with reaction time across trials. The second type of neuron selected only the endpoint of the saccade. The time of endpoint selection by these neurons accounted for most of the effect of stimulus-response compatibility on reaction time. These results indicate that visual selection and saccade selection are different processes.	Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Ctr Integrat & Cognit Neurosci, Nashville, TN 37240 USA	Vanderbilt University	Schall, JD (corresponding author), Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Ctr Integrat & Cognit Neurosci, 111 21st Ave S,301 Wilson Hall, Nashville, TN 37240 USA.				NATIONAL EYE INSTITUTE [P30EY008126, R01EY008890] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY 08890, P30 EY 08126] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amador N, 1998, J NEUROPHYSIOL, V80, P1775, DOI 10.1152/jn.1998.80.4.1775; Bell AH, 2000, J NEUROPHYSIOL, V84, P2595, DOI 10.1152/jn.2000.84.5.2595; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; COLES MGH, 1988, BIOL PSYCHOL, V26, P69, DOI 10.1016/0301-0511(88)90014-2; Connolly JD, 2002, NAT NEUROSCI, V5, P1345, DOI 10.1038/nn969; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; CRAMMOND DJ, 1994, J NEUROPHYSIOL, V71, P1281, DOI 10.1152/jn.1994.71.3.1281; CRIST CF, 1988, J NEUROSCI METH, V26, P117, DOI 10.1016/0165-0270(88)90160-4; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Dorris MC, 1998, J NEUROSCI, V18, P7015; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; Everling S, 1999, J NEUROSCI, V19, P2740; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; GOLDBERG ME, 1981, J NEUROPHYSIOL, V46, P773, DOI 10.1152/jn.1981.46.4.773; Gottlieb J, 1999, NAT NEUROSCI, V2, P906, DOI 10.1038/13209; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hanes DP, 1998, J NEUROPHYSIOL, V79, P817, DOI 10.1152/jn.1998.79.2.817; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1268; Hooge LTC, 1996, PERCEPT PSYCHOPHYS, V58, P969, DOI 10.3758/BF03206825; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2527, DOI 10.1152/jn.2001.86.5.2527; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2543, DOI 10.1152/jn.2001.86.5.2543; HUBEL DH, 1960, J PHYSIOL-LONDON, V154, P572, DOI 10.1113/jphysiol.1960.sp006596; Kodaka Y, 1997, NEUROSCI RES, V28, P291, DOI 10.1016/S0168-0102(97)00055-2; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Krauzlis RJ, 2002, NEURON, V35, P355, DOI 10.1016/S0896-6273(02)00756-0; LECAS JC, 1986, J NEUROPHYSIOL, V56, P1680, DOI 10.1152/jn.1986.56.6.1680; MCCARTHY G, 1981, SCIENCE, V211, P77, DOI 10.1126/science.7444452; McPeek RM, 2002, J NEUROPHYSIOL, V88, P2019, DOI 10.1152/jn.2002.88.4.2019; MEYER DE, 1988, BIOL PSYCHOL, V26, P3, DOI 10.1016/0301-0511(88)90013-0; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Mouret I, 2000, J EXP PSYCHOL HUMAN, V26, P1622, DOI 10.1037/0096-1523.26.5.1622; Murthy A, 2001, J NEUROPHYSIOL, V86, P2634, DOI 10.1152/jn.2001.86.5.2634; Olson CR, 2002, PHYSIOL BEHAV, V77, P663, DOI 10.1016/S0031-9384(02)00945-9; Riehle A, 1997, J EXP PSYCHOL HUMAN, V23, P1708, DOI 10.1037/0096-1523.23.6.1708; Roitman JD, 2002, J NEUROSCI, V22, P9475; Sato T, 2001, EXP BRAIN RES, V139, P53, DOI 10.1007/s002210100750; Sato T, 2001, NEURON, V30, P583, DOI 10.1016/S0896-6273(01)00304-X; SATO T, 2003, IN PRESS EXP BRAIN R; SAYER RJ, 1990, J NEUROSCI, V10, P826; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; Schall JD, 2002, PHILOS T ROY SOC B, V357, P1073, DOI 10.1098/rstb.2002.1098; SCHALL JD, 1995, J NEUROSCI, V15, P6905; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shen LM, 1997, J NEUROPHYSIOL, V77, P1171, DOI 10.1152/jn.1997.77.3.1171; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Sternberg S, 2001, ACTA PSYCHOL, V106, P147, DOI 10.1016/S0001-6918(00)00045-7; Theeuwes J, 2002, PERCEPT PSYCHOPHYS, V64, P764, DOI 10.3758/BF03194743; Thompson KG, 1997, J NEUROPHYSIOL, V77, P1046, DOI 10.1152/jn.1997.77.2.1046; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Thompson KG, 2001, VISUAL ATTENTION AND CORTICAL CIRCUITS, P137; Zhang MS, 2000, NATURE, V408, P971, DOI 10.1038/35050097	55	196	197	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 22	2003	38	4					637	648		10.1016/S0896-6273(03)00237-X	http://dx.doi.org/10.1016/S0896-6273(03)00237-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	682QV	12765614	Bronze			2022-12-24	WOS:000183104000013
J	Freed, MA; Smith, RG; Sterling, P				Freed, MA; Smith, RG; Sterling, P			Timing of quantal release from the retinal bipolar terminal is regulated by a feedback circuit	NEURON			English	Article							SPONTANEOUS SYNAPTIC ACTIVITY; RECEPTOR RHO-SUBUNITS; GANGLION-CELLS; AMACRINE CELLS; GABA(C) RECEPTORS; IMMUNOCYTOCHEMICAL LOCALIZATION; SPECTRAL SENSITIVITY; ROD; RESPONSES; SYNAPSES	In isolation, a presynaptic terminal generally releases quanta according to Poisson statistics, but in a circuit its release statistics might be shaped by synaptic interactions. We monitored quantal glutamate release from retinal bipolar cell terminals (which receive GABAergic feedback from amacrine cells) by recording spontaneous EPSCs (sEPSCs) in their postsynaptic amacrine and ganglion cells. In about one-third of these cells, sEPSCs were temporally correlated, arriving in brief bursts (10-55 ms) more often than expected from a Poisson process. Correlations were suppressed by antagonizing the GABA(c) receptor (expressed on bipolar terminals), and correlations were induced by raising extracellular calcium or osmolarity. Simulations of the feedback circuit produced "bursty" release when the bipolar cell escaped intermittently from inhibition. Correlations of similar duration were present in the light-evoked sEPSCs and spike trains of sluggish-type ganglion cells. These correlations were suppressed by antagonizing GABAc receptors, indicating that glutamate bursts from bipolar terminals induce spike bursts in ganglion cells.	Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Freed, MA (corresponding author), Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.	michael@retina.anatomy.upenn.edu			NEI NIH HHS [EY00828, EY13333, P30 EY001583] Funding Source: Medline; NIMH NIH HHS [MH48168] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY001583, R01EY000828, R01EY013333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048168] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abenavoli A, 2002, J NEUROSCI, V22, P6336; AMES A, 1981, J NEUROCHEM, V37, P867, DOI 10.1111/j.1471-4159.1981.tb04473.x; AMTHOR FR, 1989, J COMP NEUROL, V280, P97, DOI 10.1002/cne.902800108; Awatramani GB, 2001, J NEUROSCI, V21, P741, DOI 10.1523/JNEUROSCI.21-02-00741.2001; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P665, DOI 10.1113/jphysiol.1972.sp010053; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; Berntson A, 2000, J PHYSIOL-LONDON, V524, P879, DOI 10.1111/j.1469-7793.2000.00879.x; Berry MJ, 1997, P NATL ACAD SCI USA, V94, P5411, DOI 10.1073/pnas.94.10.5411; BORNSTEIN JC, 1978, J PHYSIOL-LONDON, V282, P375, DOI 10.1113/jphysiol.1978.sp012470; Calkins DJ, 1998, J NEUROSCI, V18, P3373; Calkins DJ, 1996, NATURE, V381, P613, DOI 10.1038/381613a0; Chebib M, 1998, EUR J PHARMACOL, V357, P227, DOI 10.1016/S0014-2999(98)00552-4; CLELAND BG, 1974, J PHYSIOL-LONDON, V240, P421, DOI 10.1113/jphysiol.1974.sp010617; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; COHEN E, 1990, PHILOS T R SOC B, V330, P323, DOI 10.1098/rstb.1990.0202; COHEN E, 1990, PHILOS T R SOC B, V330, P305, DOI 10.1098/rstb.1990.0201; COHEN I, 1974, J PHYSIOL-LONDON, V236, P341, DOI 10.1113/jphysiol.1974.sp010438; COOK PB, 1994, J NEUROSCI, V14, P3852; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Demb JB, 1999, J NEUROSCI, V19, P9756; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; Enz R, 1996, J NEUROSCI, V16, P4479; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Euler T, 1998, J NEUROPHYSIOL, V79, P1384, DOI 10.1152/jn.1998.79.3.1384; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Fischer KF, 1998, J NEUROSCI, V18, P3767; Fishman RA, 1980, CEREBROSPINAL FLUID; Fletcher EL, 1999, J COMP NEUROL, V413, P155, DOI 10.1002/(SICI)1096-9861(19991011)413:1<155::AID-CNE11>3.0.CO;2-6; Frech MJ, 2001, J NEUROPHYSIOL, V86, P1632, DOI 10.1152/jn.2001.86.4.1632; FREED MA, 1987, J COMP NEUROL, V266, P445, DOI 10.1002/cne.902660310; Freed MA, 2000, J NEUROPHYSIOL, V83, P2956, DOI 10.1152/jn.2000.83.5.2956; FRISHMAN LJ, 1983, J PHYSIOL-LONDON, V339, P475, DOI 10.1113/jphysiol.1983.sp014728; FRISHMAN LJ, 1987, J GEN PHYSIOL, V89, P599, DOI 10.1085/jgp.89.4.599; Gao F, 1999, BRAIN RES, V821, P487, DOI 10.1016/S0006-8993(99)01067-7; GHOSE GM, 1994, J NEUROPHYSIOL, V71, P330, DOI 10.1152/jn.1994.71.1.330; GRUNERT U, 1993, J COMP NEUROL, V335, P523, DOI 10.1002/cne.903350405; Hammond C, 2001, CELL MOL NEUROBIOL, V2nd ed.; Hartveit E, 1999, J NEUROPHYSIOL, V81, P2923, DOI 10.1152/jn.1999.81.6.2923; JACOBS GH, 1994, BEHAV NEUROSCI, V108, P993, DOI 10.1037/0735-7044.108.5.993; KAILA K, 1984, INVEST OPHTH VIS SCI, V25, P1395; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Koch Christof, 1999, P1; Koulen P, 1998, EUR J NEUROSCI, V10, P115, DOI 10.1046/j.1460-9568.1998.00005.x; Koulen P, 1999, P NATL ACAD SCI USA, V96, P9909, DOI 10.1073/pnas.96.17.9909; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; LLINAS R, 1981, J PHYSIOL-LONDON, V315, P549, DOI 10.1113/jphysiol.1981.sp013763; Lukasiewicz PD, 1998, J NEUROPHYSIOL, V79, P3157, DOI 10.1152/jn.1998.79.6.3157; Manwani A, 2001, NEURAL COMPUT, V13, P1, DOI 10.1162/089976601300014619; Marty Alain, 1995, P31; MASLAND RH, 1977, J COMP NEUROL, V175, P275, DOI 10.1002/cne.901750303; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P325, DOI 10.1152/jn.1983.49.2.325; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; McGillem GS, 2000, VISUAL NEUROSCI, V17, P381, DOI 10.1017/S0952523800173067; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; O'Brien BJ, 2002, J PHYSIOL-LONDON, V538, P787, DOI 10.1113/jphysiol.2001.013009; Parry JWL, 2002, INVEST OPHTH VIS SCI, V43, P1662; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Picaud S, 1998, J PHYSIOL-LONDON, V513, P33, DOI 10.1111/j.1469-7793.1998.033by.x; Protti DA, 1997, J NEUROSCI, V17, P6075; Protti DA, 2000, NEURON, V25, P215, DOI 10.1016/S0896-6273(00)80884-3; Rockhill RL, 2002, J NEUROSCI, V22, P3831; RODIECK RW, 1967, J NEUROPHYSIOL, V30, P1043, DOI 10.1152/jn.1967.30.5.1043; ROHLICH P, 1994, NEURON, V13, P1159, DOI 10.1016/0896-6273(94)90053-1; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Sernagor E, 1996, CURR BIOL, V6, P1503, DOI 10.1016/S0960-9822(96)00755-5; SPENCER WA, 1968, INT J NEUROL, V6, P266; STERLING P, 1988, J NEUROSCI, V8, P623; STEVENS CF, 1993, CELL, V72, P55, DOI 10.1016/S0092-8674(05)80028-5; TACHIBANA M, 1991, J NEUROSCI, V11, P2199; TAYLOR WR, 1995, J PHYSIOL-LONDON, V486, P207, DOI 10.1113/jphysiol.1995.sp020803; Tian N, 1998, J NEUROPHYSIOL, V80, P1327, DOI 10.1152/jn.1998.80.3.1327; TROY JB, 1989, VISUAL NEUROSCI, V3, P213, DOI 10.1017/S0952523800009974; Tsukamoto Y, 2001, J NEUROSCI, V21, P8616, DOI 10.1523/JNEUROSCI.21-21-08616.2001; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; WERBLIN FS, 1978, J PHYSIOL-LONDON, V280, P449, DOI 10.1113/jphysiol.1978.sp012394; Wong WT, 2000, J NEUROSCI, V20, P351, DOI 10.1523/JNEUROSCI.20-01-00351.2000; Zador A, 1998, J NEUROPHYSIOL, V79, P1219, DOI 10.1152/jn.1998.79.3.1219; Zhou ZJ, 1998, J NEUROSCI, V18, P4155	82	36	37	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 10	2003	38	1					89	101		10.1016/S0896-6273(03)00166-1	http://dx.doi.org/10.1016/S0896-6273(03)00166-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	666XT	12691667	Bronze			2022-12-24	WOS:000182202300012
J	Gong, XM; Tang, XL; Wiedmann, M; Wang, XM; Peng, JM; Zheng, D; Blair, LAC; Marshall, J; Mao, ZX				Gong, XM; Tang, XL; Wiedmann, M; Wang, XM; Peng, JM; Zheng, D; Blair, LAC; Marshall, J; Mao, ZX			Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis	NEURON			English	Article							CYCLIN-DEPENDENT KINASE-5; CEREBELLAR GRANULE NEURONS; CELL-CYCLE; NEURODEGENERATIVE DISORDERS; ALZHEIMERS-DISEASE; SIGNALING PATHWAY; DNA-BINDING; CDK5; SURVIVAL; PROTEIN	Neurotoxic insults deregulate Cdk5 activity, which leads to neuronal apoptosis and may contribute to neurodegeneration. The biological activity of Cdk5 has been ascribed to its phosphorylation of cytoplasmic substrates. However, its roles in the nucleus remain unknown. Here we investigate the mechanism by which Cdk5 promotes neuronal apoptosis. We have identified the prosurvival transcription factor MEF2 as a direct nuclear target of Cdk5. Cdk5 phosphorylates MEF2 at a distinct serine in its transactivation domain to inhibit MIEF2 activity. Neurotoxicity enhances nuclear Cdk5 activity, leading to Cdk5-dependent phosphorylation and inhibition of MIEF2 function in neurons. MEF2 mutants resistant to Cdk5 phosphorylation restore MIEF2 activity and protect primary neurons from Cdk5 and neurotoxin-induced apoptosis. Our studies reveal a nuclear pathway by which neurotoxin/Cdk5 induces neuronal apoptosis through inhibiting prosurvival nuclear machinery.	Brown Univ, Rhode Isl Hosp, Sch Med, Liver Res Ctr,Dept Med, Providence, RI 02903 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Harvard University; Harvard Medical School; Brown University	Mao, ZX (corresponding author), Brown Univ, Rhode Isl Hosp, Sch Med, Liver Res Ctr,Dept Med, Providence, RI 02903 USA.	zixu_mao@brown.edu	Peng, Junmin/N-2614-2018	Peng, Junmin/0000-0003-0472-7648; Zheng, Dong/0000-0002-1668-0843	NICHD NIH HHS [HD39446-01] Funding Source: Medline; NINDS NIH HHS [R01 NS37676-01A1, R01 NS39063-01A2] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037676, R01NS039063] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahuja HS, 1997, DEV GENET, V21, P258, DOI 10.1002/(SICI)1520-6408(1997)21:4<258::AID-DVG3>3.0.CO;2-6; Alvarez A, 1999, FEBS LETT, V459, P421, DOI 10.1016/S0014-5793(99)01279-X; Athanasiou MC, 1998, MOL CELL NEUROSCI, V12, P16, DOI 10.1006/mcne.1998.0699; Bajaj NPS, 1998, NEUROSCI LETT, V245, P45, DOI 10.1016/S0304-3940(98)00176-1; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Blair LAC, 1999, J NEUROSCI, V19, P1940; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRION JP, 1995, AM J PATHOL, V147, P1465; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Bu BT, 2002, J NEUROSCI, V22, P6515; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Gao C, 2001, J CELL SCI, V114, P1145; Grant P, 2001, EUR J BIOCHEM, V268, P1534, DOI 10.1046/j.1432-1033.2001.02025.x; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Ino H, 1996, BRAIN RES, V732, P179, DOI 10.1016/0006-8993(96)00523-9; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Ko J, 2001, J NEUROSCI, V21, P6758; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Lee KY, 1997, J BIOL CHEM, V272, P5622, DOI 10.1074/jbc.272.9.5622; LEIFER D, 1993, P NATL ACAD SCI USA, V90, P1546, DOI 10.1073/pnas.90.4.1546; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Li BS, 2002, EMBO J, V21, P324, DOI 10.1093/emboj/21.3.324; Li MT, 2001, J NEUROSCI, V21, P6544, DOI 10.1523/JNEUROSCI.21-17-06544.2001; Liu DX, 2001, CELL TISSUE RES, V305, P217, DOI 10.1007/s004410100396; Liu F, 2001, P NATL ACAD SCI USA, V98, P11062, DOI 10.1073/pnas.191353898; Maccioni RB, 2001, EUR J BIOCHEM, V268, P1518, DOI 10.1046/j.1432-1327.2001.02024.x; Mandelkow E, 1999, NATURE, V402, P588, DOI 10.1038/45095; Mao ZX, 1999, J BIOL CHEM, V274, P31102, DOI 10.1074/jbc.274.43.31102; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Mattson MP, 2001, APOPTOSIS, V6, P69, DOI 10.1023/A:1009676112184; Mattson MP, 2000, J NEUROCHEM, V74, P443, DOI 10.1046/j.1471-4159.2000.740443.x; MCDERMOTT JC, 1993, MOL CELL BIOL, V13, P2564, DOI 10.1128/MCB.13.4.2564; Miller FD, 2000, CELL DEATH DIFFER, V7, P880, DOI 10.1038/sj.cdd.4400736; Molkentin JD, 1996, MOL CELL BIOL, V16, P2627; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Okamoto S, 2000, P NATL ACAD SCI USA, V97, P7561, DOI 10.1073/pnas.130502697; Okamoto S, 2002, P NATL ACAD SCI USA, V99, P3974, DOI 10.1073/pnas.022036399; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Qu DB, 2002, J BIOL CHEM, V277, P7324, DOI 10.1074/jbc.M107270200; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Sharma P, 1999, J BIOL CHEM, V274, P9600, DOI 10.1074/jbc.274.14.9600; Sisodiya SM, 2002, NEUROSCI LETT, V328, P217, DOI 10.1016/S0304-3940(02)00520-7; Tanaka T, 2001, J NEUROSCI, V21, P550, DOI 10.1523/JNEUROSCI.21-02-00550.2001; Yoshikawa K, 2000, NEUROSCI RES, V37, P1, DOI 10.1016/S0168-0102(00)00101-2; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhang JW, 2000, J NEUROCHEM, V75, P2346, DOI 10.1046/j.1471-4159.2000.0752346.x; Zhang JW, 2002, J NEUROCHEM, V81, P307, DOI 10.1046/j.1471-4159.2002.00824.x; Zhang Q, 1997, DEV BIOL, V183, P222, DOI 10.1006/dbio.1996.8494; Zhu XW, 1999, AM J PATHOL, V155, P327, DOI 10.1016/S0002-9440(10)65127-9	54	216	239	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 10	2003	38	1					33	46		10.1016/S0896-6273(03)00191-0	http://dx.doi.org/10.1016/S0896-6273(03)00191-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	666XT	12691662	Bronze			2022-12-24	WOS:000182202300007
J	Zhang, HL; Craciun, LC; Mirshahi, T; Rohacs, T; Lopes, CMB; Jin, TH; Logothetis, DE				Zhang, HL; Craciun, LC; Mirshahi, T; Rohacs, T; Lopes, CMB; Jin, TH; Logothetis, DE			PIP2 activates KCNQ channels, and its hydrolysis underlies receptor-mediated inhibition of M currents	NEURON			English	Article							KCNQ2/KCNQ3 K+ CHANNELS; VOLTAGE-SENSITIVE K; POTASSIUM CHANNEL; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PHOSPHOLIPASE-C; PHOSPHOINOSITIDE TURNOVER; MUSCARINIC SUPPRESSION; ACH CHANNEL; SUBUNITS; MODULATION	KCNO channels belong to a family of potassium ion channels with crucial roles in physiology and disease. Heteromers of KCNQ2/3 subunits constitute the neuronal M channels. Inhibition of M currents, by pathways that stimulate phospholipase C activity, controls excitability throughout the nervous system. Here we show that a common feature of all KCNQ channels is their activation by the signaling membrane phospholipid phosphatidylinositol-bis-phosphate (PIP2). We show that wortmannin, at concentrations that prevent recovery from receptor-mediated inhibition of M currents, blocks PIP2 replenishment to the cell surface. Moreover, we identify a C-terminal histidine residue, immediately proximal to the plasma membrane, mutation of which renders M channels less sensitive to PIP2 and more sensitive to receptor-mediated inhibition. Finally, native or recombinant channels inhibited by muscarinic agonists can be activated by PIP2. Our data strongly suggest that PIP2 acts as a membrane-diffusible second messenger to regulate directly the activity of KCNQ currents.	NYU, Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; New York University	Logothetis, DE (corresponding author), NYU, Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA.	diomedes@inka.mssm.edu			NHLBI NIH HHS [HL10307, HL-59949] Funding Source: Medline; NIGMS NIH HHS [GM20856] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059949, F32HL010307] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMS PR, 1980, BRIT J PHARMACOL, V68, P353, DOI 10.1111/j.1476-5381.1980.tb14547.x; ADAMS PR, 1983, BRIT J PHARMACOL, V79, P330, DOI 10.1111/j.1476-5381.1983.tb11004.x; Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; BOSMA MM, 1989, P NATL ACAD SCI USA, V86, P2943, DOI 10.1073/pnas.86.8.2943; Brown BS, 2000, PROG BIOPHYS MOL BIO, V73, P135, DOI 10.1016/S0079-6107(00)00004-3; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Cooper EC, 2000, P NATL ACAD SCI USA, V97, P4914, DOI 10.1073/pnas.090092797; Cruzblanca H, 1998, P NATL ACAD SCI USA, V95, P7151, DOI 10.1073/pnas.95.12.7151; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; del Rio E, 1999, J PHYSIOL-LONDON, V520, P101, DOI 10.1111/j.1469-7793.1999.00101.x; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; Filippov AK, 1998, J NEUROSCI, V18, P5170, DOI 10.1523/JNEUROSCI.18-14-05170.1998; Hadley JK, 2000, BRIT J PHARMACOL, V129, P413, DOI 10.1038/sj.bjp.0703086; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Haruna T, 2002, CIRC RES, V91, P232, DOI 10.1161/01.RES.0000029971.60214.49; Hawrot E, 1979, Methods Enzymol, V58, P574; HIGASHIDA H, 1986, NATURE, V323, P333, DOI 10.1038/323333a0; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Hilgemann DW, 1997, ANNU REV PHYSIOL, V59, P193, DOI 10.1146/annurev.physiol.59.1.193; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Ikeda SR, 2002, NEURON, V35, P411, DOI 10.1016/S0896-6273(02)00792-4; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lerche C, 2000, J BIOL CHEM, V275, P22395, DOI 10.1074/jbc.M002378200; LOGOTHETIS DE, 1992, NEURON, V8, P531, DOI 10.1016/0896-6273(92)90281-H; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lupu VD, 1998, J BIOL CHEM, V273, P14067, DOI 10.1074/jbc.273.23.14067; Ma HP, 2002, J BIOL CHEM, V277, P7641, DOI 10.1074/jbc.C100737200; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; MARRION NV, 1993, NEURON, V11, P77, DOI 10.1016/0896-6273(93)90272-S; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Oketani N, 2002, AM J PHYSIOL-HEART C, V282, pH757, DOI 10.1152/ajpheart.00246.2001; PFAFFINGER PJ, 1988, NEURON, V1, P477, DOI 10.1016/0896-6273(88)90178-X; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rohacs T, 2002, METHOD ENZYMOL, V345, P71; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; SELYANKO AA, 1993, J PHYSIOL-LONDON, V472, P711, DOI 10.1113/jphysiol.1993.sp019968; SELYANKO AA, 1992, P ROY SOC B-BIOL SCI, V250, P119, DOI 10.1098/rspb.1992.0139; Selyanko AA, 2001, J PHYSIOL-LONDON, V534, P15, DOI 10.1111/j.1469-7793.2001.00015.x; Shapiro MS, 2000, J NEUROSCI, V20, P1710; SOEJIMA M, 1984, PFLUG ARCH EUR J PHY, V400, P424, DOI 10.1007/BF00587544; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; TOKIMASA T, 1995, BRIT J PHARMACOL, V114, P489, DOI 10.1111/j.1476-5381.1995.tb13253.x; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Womack KB, 2000, J NEUROSCI, V20, P2792; Xie LH, 1999, P NATL ACAD SCI USA, V96, P15292, DOI 10.1073/pnas.96.26.15292; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200; Zhang Y, 1999, TUMOR TARGET, V4, P158	63	414	427	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 27	2003	37	6					963	975		10.1016/S0896-6273(03)00125-9	http://dx.doi.org/10.1016/S0896-6273(03)00125-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	661PU	12670425	Bronze			2022-12-24	WOS:000181899600010
J	Dissel, S; Codd, V; Fedic, R; Garner, KJ; Costa, R; Kyriacou, CP; Rosato, E				Dissel, S; Codd, V; Fedic, R; Garner, KJ; Costa, R; Kyriacou, CP; Rosato, E			A constitutively active cryptochrome in Drosophila melanogaster	NATURE NEUROSCIENCE			English	Article							CIRCADIAN CLOCK; BEHAVIORAL RHYTHMS; LIGHT; ENTRAINMENT; TIMELESS; GENE; PROTEIN; PERIOD; PHOTORECEPTOR; NEURONS	Light-activated cryptochrome (CRY) regulates circadian photoresponses in Drosophila melanogaster. Removing the carboxy (C) terminus to create CRYDelta produces, in yeast, a light-independent, constitutively active form. Here we show that flies overexpressing CRYDelta have a longer free-running period of locomotor activity, as well as altered cycling kinetics of the clock proteins timeless (TIM) and period (PER). Moreover, at the cellular level, they show a reduction in the level of TIM and in the nuclear localization of TIM and PER in two significant clusters of behavioral pacemaker cells: the large and the small ventral lateral neurons (LN(v)s). These effects are similar to those seen in wild-type flies under continuous light and suggest a regulatory role for the C terminus of CRY on the photosensitive, photolyase-like part of the protein.	Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Univ Padua, Dept Biol, I-35131 Padua, Italy	University of Leicester; University of Leicester; University of Padua	Rosato, E (corresponding author), Univ Leicester, Dept Biol, Univ Rd, Leicester LE1 7RH, Leics, England.	er6@le.ac.uk		Codd, Veryan/0000-0002-9430-8254; Dissel, Stephane/0000-0002-4486-5052; Rosato, Ezio/0000-0001-7297-4697				Akten B, 2003, NAT NEUROSCI, V6, P251, DOI 10.1038/nn1007; Allada R, 2003, CELL, V112, P284, DOI 10.1016/S0092-8674(03)00076-X; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; Blanchardon E, 2001, EUR J NEUROSCI, V13, P871, DOI 10.1046/j.0953-816x.2000.01450.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; DIRCKSEN H, 1987, CELL TISSUE RES, V250, P377; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Helfrich-Forster C, 2002, J NEUROSCI, V22, P9255; Helfrich-Forster C, 2003, MICROSC RES TECHNIQ, V62, P94, DOI 10.1002/jemt.10357; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; Lin FJ, 2001, MOL CELL BIOL, V21, P7287, DOI 10.1128/MCB.21.21.7287-7294.2001; Marrus SB, 1996, EMBO J, V15, P6877, DOI 10.1002/j.1460-2075.1996.tb01080.x; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rieger D, 2003, J BIOL RHYTHM, V18, P377, DOI 10.1177/0748730403256997; Rosato E, 2001, CURR BIOL, V11, P909, DOI 10.1016/S0960-9822(01)00259-7; Rothenfluh A, 2000, NEURON, V26, P505, DOI 10.1016/S0896-6273(00)81182-4; Shafer OT, 2002, J NEUROSCI, V22, P5946; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky R, 1997, J NEUROSCI, V17, P676; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Young MW, 1998, ANNU REV BIOCHEM, V67, P135, DOI 10.1146/annurev.biochem.67.1.135; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	34	92	95	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					834	840		10.1038/nn1285	http://dx.doi.org/10.1038/nn1285			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15258584				2022-12-24	WOS:000222930800013
J	Komiyama, T; Carlson, JR; Luo, LQ				Komiyama, T; Carlson, JR; Luo, LQ			Olfactory receptor neuron axon targeting: intrinsic transcriptional control and hierarchical interactions	NATURE NEUROSCIENCE			English	Article							SENSORY MAP; PROJECTION NEURONS; DROSOPHILA-ANTENNA; WIRING SPECIFICITY; ODORANT RECEPTORS; N-CADHERIN; FLY BRAIN; SYSTEM; GLOMERULI; GUIDANCE	From insects to mammals, olfactory receptor neurons (ORNs) expressing a common olfactory receptor target their axons to specific glomeruli with high precision. Here we show in Drosophila that the POU transcription factor Acj6 controls the axon targeting specificity of a subset of ORN classes, as defined by the olfactory receptors that they express. Of these classes, some require Acj6 cell-autonomously, whereas others require Acj6 cell-nonautonomously. Mosaic analyses show that cooperative targeting occurs between axon terminals of the same ORN classes and that there are hierarchical interactions among different ORN classes. We propose that the precision of ORN axon targeting derives from both intrinsic transcriptional control and extensive axon-axon interactions.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Stanford University; Stanford University; Yale University	Luo, LQ (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	lluo@stanford.edu		Luo, Liqun/0000-0001-5467-9264; Komiyama, Takaki/0000-0001-9609-4600				Ang LH, 2003, DEVELOPMENT, V130, P1307, DOI 10.1242/dev.00356; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; AYER RK, 1991, P NATL ACAD SCI USA, V88, P5467, DOI 10.1073/pnas.88.12.5467; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Ebrahimi FAW, 2000, CURR BIOL, V10, P219, DOI 10.1016/S0960-9822(00)00342-0; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Hummel T, 2004, NEURON, V42, P77, DOI 10.1016/S0896-6273(04)00158-8; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jhaveri D, 2004, DEVELOPMENT, V131, P1903, DOI 10.1242/dev.01083; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Newsome TP, 2000, DEVELOPMENT, V127, P851; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	35	83	84	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					819	825		10.1038/nn1284	http://dx.doi.org/10.1038/nn1284			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15247920				2022-12-24	WOS:000222930800011
J	Morris, G; Arkadir, D; Nevet, A; Vaadia, E; Bergman, H				Morris, G; Arkadir, D; Nevet, A; Vaadia, E; Bergman, H			Coincident but distinct messages of midbrain dopamine and striatal tonically active neurons	NEURON			English	Article							CORTICOSTRIATAL SYNAPTIC PLASTICITY; LONG-TERM POTENTIATION; MONKEY STRIATUM; RAT NEOSTRIATUM; IN-VITRO; CHOLINERGIC INTERNEURONS; MUSCARINIC RECEPTORS; PARKINSONS-DISEASE; PRIMATES STRIATUM; BASAL GANGLIA	Midbrain dopamine and striatal tonically active neurons (TANs, presumed acetylcholine interneurons) signal behavioral significance of environmental events. Since striatal dopamine and acetylcholine affect plasticity of cortico-striatal transmission and are both crucial to learning, they may serve as teachers in the basal ganglia circuits. We recorded from both neuronal populations in monkeys performing a probabilistic instrumental conditioning task. Both neuronal types respond robustly to reward-related events. Although different events yielded responses with different latencies, the responses of the two populations coincided, indicating integration at the target level. Yet, while the dopamine neurons' response reflects mismatch between expectation and outcome in the positive domain, the TANs are invariant to reward predictability. Finally, TAN pairs are synchronized, compared to a minority of dopamine neuron pairs. We conclude that the striatal cholinergic and dopaminergic systems carry distinct messages by different means, which can be integrated differently to shape the basal ganglia responses to reward-related events.	Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Morris, G (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, IL-91120 Jerusalem, Israel.	genela@md.huji.ac.il	Morris, Genela/B-7844-2008; Vaadia, Eilon/E-9347-2011	Morris, Genela/0000-0002-5417-8977				ALEXANDER GE, 1985, J NEUROPHYSIOL, V53, P1417, DOI 10.1152/jn.1985.53.6.1417; [Anonymous], 2002, Mov Disord, V17 Suppl 4, pS7; AOSAKI T, 1995, J NEUROPHYSIOL, V73, P1234, DOI 10.1152/jn.1995.73.3.1234; AOSAKI T, 1994, J NEUROSCI, V14, P3969; Apicella P, 1998, J NEUROPHYSIOL, V80, P3341, DOI 10.1152/jn.1998.80.6.3341; Apicella P, 1997, EXP BRAIN RES, V116, P456, DOI 10.1007/PL00005773; ATKINS PT, 1990, NATURE, V344, P240; BARBEAU A, 1962, CAN MED ASSOC J, V87, P802; BAUM WM, 1979, J EXP ANAL BEHAV, V32, P269, DOI 10.1901/jeab.1979.32-269; Bennett BD, 1999, J NEUROSCI, V19, P5586; Blazquez PM, 2002, NEURON, V33, P973, DOI 10.1016/S0896-6273(02)00627-X; Calabresi P, 1998, EUR J NEUROSCI, V10, P3020, DOI 10.1046/j.1460-9568.1998.00348.x; Calabresi P, 2000, TRENDS NEUROSCI, V23, P120, DOI 10.1016/S0166-2236(99)01501-5; Calabresi P, 1999, NEUROPHARMACOLOGY, V38, P323, DOI 10.1016/S0028-3908(98)00199-3; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Centonze D, 2003, REV NEUROSCIENCE, V14, P207; Centonze D, 1999, BRAIN RES REV, V31, P1, DOI 10.1016/S0165-0173(99)00018-1; Centonze D, 1999, J NEUROPHYSIOL, V82, P3575, DOI 10.1152/jn.1999.82.6.3575; Cragg SJ, 2000, J NEUROSCI, V20, P8209; CRUTCHER MD, 1984, EXP BRAIN RES, V53, P244, DOI 10.1007/BF00238154; DeBoer P, 1996, J PHARMACOL EXP THER, V277, P775; DRUKARCH B, 1989, J NEUROCHEM, V52, P1680, DOI 10.1111/j.1471-4159.1989.tb07244.x; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Flores-Hernandez J, 2000, J NEUROPHYSIOL, V83, P2996, DOI 10.1152/jn.2000.83.5.2996; Goodie AS, 2004, J GEN PSYCHOL, V131, P18, DOI 10.3200/GENP.131.1.18-28; GRACE AA, 1983, NEUROSCIENCE, V10, P333, DOI 10.1016/0306-4522(83)90137-9; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Herrnstein RJ, 1970, J EXP ANAL BEHAV, V13, P243, DOI 10.1901/jeab.1970.13-243; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Holt DJ, 1997, J COMP NEUROL, V384, P1, DOI 10.1002/(SICI)1096-9861(19970721)384:1<1::AID-CNE1>3.0.CO;2-5; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Jones IW, 2001, J COMP NEUROL, V439, P235, DOI 10.1002/cne.1345; Kerr JND, 2001, J NEUROPHYSIOL, V85, P117, DOI 10.1152/jn.2001.85.1.117; Kimura M, 2003, NEUROREPORT, V14, P799, DOI 10.1097/00001756-200305060-00004; Kitabatake Y, 2003, P NATL ACAD SCI USA, V100, P7965, DOI 10.1073/pnas.1032899100; KITAI ST, 1993, ADV NEUROL, V60, P40; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; KUDERNATSCH M, 1994, NEUROSCI LETT, V181, P107, DOI 10.1016/0304-3940(94)90571-1; LAVOIE B, 1989, J COMP NEUROL, V289, P36, DOI 10.1002/cne.902890104; Lee IH, 2003, J NEUROPHYSIOL, V89, P2528, DOI 10.1152/jn.01055.2002; Martin RF, 2000, PRIMATE BRAIN MAPS S; Matsumoto N, 1999, J NEUROPHYSIOL, V82, P978, DOI 10.1152/jn.1999.82.2.978; NISENBAUM LK, 1995, MOL CELLULAR MECH NE, P273; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Pisani A, 2003, NEUROPHARMACOLOGY, V45, P45, DOI 10.1016/S0028-3908(03)00137-0; Pisani A, 2000, J NEUROSCI, V20, part. no.; Ravel S, 1999, EXP BRAIN RES, V128, P531, DOI 10.1007/s002210050876; Ravel S, 2003, J NEUROSCI, V23, P8489; Ravel S, 2001, J NEUROSCI, V21, P5730, DOI 10.1523/JNEUROSCI.21-15-05730.2001; Raz A, 1996, J NEUROPHYSIOL, V76, P2083, DOI 10.1152/jn.1996.76.3.2083; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Roitman JD, 2002, J NEUROSCI, V22, P9475; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shimo Y, 2001, J NEUROSCI, V21, P7804, DOI 10.1523/JNEUROSCI.21-19-07804.2001; Suri RE, 2001, NEURAL COMPUT, V13, P841, DOI 10.1162/089976601300014376; Sutton R.S., 2017, REINFORCEMENT LEARNI, V2nd, DOI [10.1109/TNN.1998.712192, DOI 10.1109/TNN.1998.712192]; SZABO J, 1984, J COMP NEUROL, V222, P265, DOI 10.1002/cne.902220208; Tobler PN, 2003, J NEUROSCI, V23, P10402; Venton BJ, 2003, J NEUROCHEM, V87, P1284, DOI 10.1046/j.1471-4159.2003.02109.x; Vulkan N, 2000, J ECON SURV, V14, P101, DOI 10.1111/1467-6419.00106; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; WILSON CJ, 1990, J NEUROSCI, V10, P508; Wolford G, 2000, J NEUROSCI, V20, part. no.; Zhou FM, 2003, NEUROSCIENTIST, V9, P23, DOI 10.1177/1073858402239588; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	69	399	402	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 8	2004	43	1					133	143		10.1016/j.neuron.2004.06.012	http://dx.doi.org/10.1016/j.neuron.2004.06.012			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233923	Bronze			2022-12-24	WOS:000222549800013
J	Ren, TY				Ren, TY			Reverse propagation of sound in the gerbil cochlea	NATURE NEUROSCIENCE			English	Article							BASILAR-MEMBRANE; OTOACOUSTIC EMISSIONS; 2-TONE DISTORTION; MECHANISMS; VIBRATION; WAVES	It is commonly believed that the cochlea emits sounds through backward-traveling waves. In the present experiment using a scanning-laser interferometer, I detected forward-traveling but not backward-traveling waves and found that the stapes vibrates earlier than the basilar membrane. These results contradict the current theory and show that the ear emits sounds through the cochlear fluids as compression waves rather than along the basilar membrane as backward-traveling waves.	Oregon Hlth & Sci Univ, Dept Otolaryngol & Head & Neck Surg, Oregon Hearing Res Ctr, Portland, OR 97239 USA	Oregon Health & Science University	Ren, TY (corresponding author), Oregon Hlth & Sci Univ, Dept Otolaryngol & Head & Neck Surg, Oregon Hearing Res Ctr, 3181 SW Sam Jackson Pk Rd,NRC 04, Portland, OR 97239 USA.	rent@ohsu.edu			NIDCD NIH HHS [R21 DC006695-01, R21 DC006695, R01 DC004554, R01 DC004554-02] Funding Source: Medline; NIDDK NIH HHS [DK55819, DK62179] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062179, P01DK055819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC006695, R01DC004554] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Cooper NP, 1997, J NEUROPHYSIOL, V78, P261, DOI 10.1152/jn.1997.78.1.261; KEMP DT, 1986, HEARING RES, V22, P95, DOI 10.1016/0378-5955(86)90087-0; KHANNA SM, 1982, SCIENCE, V215, P305, DOI 10.1126/science.7053580; Knight RD, 2001, J ACOUST SOC AM, V109, P1513, DOI 10.1121/1.1354197; Narayan SS, 1998, SCIENCE, V282, P1882, DOI 10.1126/science.282.5395.1882; Olson ES, 1999, NATURE, V402, P526, DOI 10.1038/990092; PROBST R, 1991, J ACOUST SOC AM, V89, P2027, DOI 10.1121/1.400897; Ren TY, 2002, P NATL ACAD SCI USA, V99, P17101, DOI 10.1073/pnas.262663699; RHODE WS, 1971, J ACOUST SOC AM, V49, P1218, DOI 10.1121/1.1912485; Robles L, 1997, J NEUROPHYSIOL, V77, P2385, DOI 10.1152/jn.1997.77.5.2385; Russell IJ, 1997, P NATL ACAD SCI USA, V94, P2660, DOI 10.1073/pnas.94.6.2660; Shera CA, 1999, J ACOUST SOC AM, V105, P782, DOI 10.1121/1.426948; von Bekesy G, 1960, EXPT HEARING; ZWISLOCKI J, 1953, J ACOUST SOC AM, V25, P986, DOI 10.1121/1.1907231	14	121	130	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					333	334		10.1038/nn1216	http://dx.doi.org/10.1038/nn1216			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15034589				2022-12-24	WOS:000220482500008
J	Shin, KS; Maertens, C; Proenza, C; Rothberg, BS; Yellen, G				Shin, KS; Maertens, C; Proenza, C; Rothberg, BS; Yellen, G			Inactivation in HCN channels results from reclosure of the activation gate: Desensitization to voltage	NEURON			English	Article							CATION CURRENT; PACEMAKER; IDENTIFICATION; MECHANISMS; RECEPTOR; CELLS	Hyperpolarization-activated HCN channels are modulated by direct binding of cyclic nucleotides. For HCN2 channels, cAMP shifts the voltage dependence for activation, with relatively little change in the maximal conductance. By contrast, in spHCN channels, cAMP relieves a rapid inactivation process and produces a large increase in maximum conductance. Our results suggest that these two effects of cAMP represent the same underlying process. We also find that spHCN inactivation occurs not by closure of a specialized inactivation gate, as for other voltage-dependent channels, but by reclosure of the same intracellular gate opened upon activation. Effectively, the activation gate exhibits a "desensitization to voltage," perhaps by slippage of the coupling between the voltage sensors and the gate. Differences in the initial coupling efficiency could allow cAMP to produce either the inactivation or the shift phenotype by strengthening effective coupling: a shift would naturally occur if coupling is already strong in the absence of cAMP.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Yellen, G (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	gary_yellen@hms.harvard.edu	Rothberg, Brad/AAD-1260-2022	Proenza, Catherine/0000-0003-4324-6206; Rothberg, Brad/0000-0003-1982-2269; Yellen, Gary/0000-0003-4228-7866	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL071365, R01HL070320] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL070320, HL71365, HL70320] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BROWN HF, 1979, NATURE, V280, P235, DOI 10.1038/280235a0; COLE KS, 1960, BIOPHYS J, V1, P1, DOI 10.1016/S0006-3495(60)86871-3; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P497, DOI 10.1113/jphysiol.1952.sp004719; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Malcolm AT, 2003, BBA-BIOMEMBRANES, V1609, P183, DOI 10.1016/S0005-2736(02)00687-9; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; Rothberg BS, 2003, J GEN PHYSIOL, V122, P501, DOI 10.1085/jgp.200308928; Rothberg BS, 2002, J GEN PHYSIOL, V119, P83, DOI 10.1085/jgp.119.1.83; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448	21	91	93	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 4	2004	41	5					737	744		10.1016/S0896-6273(04)00083-2	http://dx.doi.org/10.1016/S0896-6273(04)00083-2			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KD	15003173	Bronze			2022-12-24	WOS:000221458200009
J	Ohno, M; Sametsky, EA; Younkin, LH; Oakley, H; Younkin, SG; Citron, M; Vassar, R; Disterhoft, JF				Ohno, M; Sametsky, EA; Younkin, LH; Oakley, H; Younkin, SG; Citron, M; Vassar, R; Disterhoft, JF			BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease	NEURON			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE ACTIVITY; LONG-TERM POTENTIATION; A-BETA; TRANSGENIC MICE; SPONTANEOUS-ALTERNATION; CORTICAL-NEURONS; SOCIAL RECOGNITION; KNOCKOUT MICE; IN-VIVO	beta-site APP cleaving enzyme 1 (BACE1) is the beta-secretase enzyme required for generating pathogenic beta-amyloid (Abeta) peptides in Alzheimer's disease (AD). BACE1 knockout mice lack Abeta and are phenotypically normal, suggesting that therapeutic inhibition of BACE1 may be free of mechanism-based side effects. However, direct evidence that BACE1 inhibition would improve cognition is lacking. Here we show that BACE1 null mice engineered to overexpress human APP (BACE1(-/-.)Tg2576(+)) are rescued from Abeta-dependent hippocampal memory deficits. Moreover, impaired hippocampal cholinergic regulation of neuronal excitability found in the Tg2576 AD model is ameliorated in BACE1(-/-.)Tg2576(+) bigenic mice. The behavioral and electrophysiological rescue of deficits in BACE1(-/-.)Tg2576(+) mice is correlated with a dramatic reduction of cerebral Abeta40 and Abeta42 levels and occurs before amyloid deposition in Tg2576 mice. Our gene-based approach demonstrates that lower Abeta levels are beneficial for AD-associated memory impairments, validating BACE1 as a therapeutic target for AD.	Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Mayo Clin, Jacksonville, FL 32224 USA; Amgen Inc, Dept Neurosci, Thousand Oaks, CA 91320 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Mayo Clinic; Amgen	Ohno, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	ohno@northwestern.edu; r-vassar@northwestern.edu; jdisterhoft@northwestern.edu		Disterhoft, John/0000-0002-8817-7913	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG008796] Funding Source: NIH RePORTER; NIA NIH HHS [R37 AG08796] Funding Source: Medline; NIMH NIH HHS [R01 MH067251] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ashe KH, 2001, LEARN MEMORY, V8, P301, DOI 10.1101/lm.43701; Auld DS, 1998, TRENDS NEUROSCI, V21, P43, DOI 10.1016/S0166-2236(97)01144-2; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Citron M, 2002, NAT NEUROSCI, V5, P1055, DOI 10.1038/nn940; Colling SB, 1996, NEUROSCI LETT, V209, P49, DOI 10.1016/0304-3940(96)12596-9; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; Dewachter I, 2002, J NEUROSCI, V22, P3445; Dineley KT, 2002, J BIOL CHEM, V277, P22768, DOI 10.1074/jbc.M200164200; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Dodel RC, 2003, LANCET NEUROL, V2, P215, DOI 10.1016/S1474-4422(03)00349-1; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Holcomb LA, 1999, BEHAV GENET, V29, P177, DOI 10.1023/A:1021691918517; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang HM, 2000, NEUROCHEM RES, V25, P303, DOI 10.1023/A:1007592007956; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Janus C, 2001, PHYSIOL BEHAV, V73, P873, DOI 10.1016/S0031-9384(01)00524-8; John V, 2003, J MED CHEM, V46, P4625, DOI 10.1021/jm030247h; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kelly JF, 1996, P NATL ACAD SCI USA, V93, P6753, DOI 10.1073/pnas.93.13.6753; Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lelong V, 2003, N-S ARCH PHARMACOL, V367, P621, DOI 10.1007/s00210-003-0743-2; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Luo Y, 2003, NEUROBIOL DIS, V14, P81, DOI 10.1016/S0969-9961(03)00104-9; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Nalbantoglu J, 1997, NATURE, V387, P500, DOI 10.1038/387500a0; NICOLL JA, 2003, NAT MED, V9, P389; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Saar D, 2001, J NEUROSCI, V21, P1385; Savage LM, 2003, LEARN MEMORY, V10, P242, DOI 10.1101/lm.60003; Schenk D, 2002, NAT REV NEUROSCI, V3, P824, DOI 10.1038/nrn938; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Suh YH, 1997, J NEUROCHEM, V68, P1781; Tang J, 2003, J MOL NEUROSCI, V20, P299, DOI 10.1385/JMN:20:3:299; Tran MH, 2002, PEPTIDES, V23, P1271, DOI 10.1016/S0196-9781(02)00062-1; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2000, NEURON, V27, P419, DOI 10.1016/S0896-6273(00)00051-9; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; WINSLOW JT, 1995, PSYCHOPHARMACOLOGY, V121, P164, DOI 10.1007/BF02245626; Wolfe MS, 2002, NAT REV DRUG DISCOV, V1, P859, DOI 10.1038/nrd938; Wong PC, 2002, NAT NEUROSCI, V5, P633, DOI 10.1038/nn0702-633; Wu WW, 2002, AGEING RES REV, V1, P181, DOI 10.1016/S1568-1637(01)00009-5; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; Zhong P, 2003, J BIOL CHEM, V278, P26888, DOI 10.1074/jbc.M302789200	61	424	477	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2004	41	1					27	33		10.1016/S0896-6273(03)00810-9	http://dx.doi.org/10.1016/S0896-6273(03)00810-9			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715132	Bronze			2022-12-24	WOS:000187942800006
J	Romo, R; Hernandez, A; Zainos, A				Romo, R; Hernandez, A; Zainos, A			Neuronal correlates of a perceptual decision in ventral premotor cortex	NEURON			English	Article							PARAMETRIC WORKING-MEMORY; INFERIOR AREA-6; PSYCHOPHYSICAL MEASUREMENTS; CORTICOSPINAL PROJECTIONS; FUNCTIONAL-ORGANIZATION; PREFRONTAL CORTEX; MACAQUE MONKEY; NEURAL CODES; DISCRIMINATION; FLUTTER	The ventral premotor cortex (VPC) is involved in the transformation of sensory information into action, although the exact neuronal operation is not known. We addressed this problem by recording from single neurons in VPC while trained monkeys report a decision based on the comparison of two mechanical vibrations applied sequentially to the fingertips. Here we report that the activity of VPC neurons reflects current and remembered sensory inputs, their comparison, and motor commands expressing the result; that is, the entire processing cascade linking the evaluation of sensory stimuli with a motor report. These findings provide a fairly complete panorama of the neural dynamics that underlies the transformation of sensory information into an action and emphasize the role of VPC in perceptual decisions.	Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Romo, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.	rromo@ifc.unam.mx		romo, ranulfo/0000-0003-3529-3635; zainos, antonio/0000-0001-6137-1794				Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; DUM RP, 1991, J NEUROSCI, V11, P667; Fogassi L, 2001, BRAIN, V124, P571, DOI 10.1093/brain/124.3.571; Fuster JM, 1997, TRENDS NEUROSCI, V20, P451, DOI 10.1016/S0166-2236(97)01128-4; GENTILUCCI M, 1988, EXP BRAIN RES, V71, P475, DOI 10.1007/BF00248741; GODSCHALK M, 1984, EXP BRAIN RES, V56, P410; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; HE SQ, 1993, J NEUROSCI, V13, P952; Hernandez A, 1997, J NEUROSCI, V17, P6391; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; Hernandez A, 2002, NEURON, V33, P959, DOI 10.1016/S0896-6273(02)00613-X; Kakei S, 2001, NAT NEUROSCI, V4, P1020, DOI 10.1038/nn726; KEIZER K, 1989, EXP BRAIN RES, V74, P311; LU MT, 1994, J COMP NEUROL, V341, P375, DOI 10.1002/cne.903410308; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; MATELLI M, 1986, J COMP NEUROL, V251, P281, DOI 10.1002/cne.902510302; McFarland NR, 2000, J NEUROSCI, V20, P3798, DOI 10.1523/JNEUROSCI.20-10-03798.2000; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MOUNTCASTLE VB, 1990, J NEUROSCI, V10, P3032; Ohbayashi M, 2003, SCIENCE, V301, P233, DOI 10.1126/science.1084884; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Romo R, 2002, NAT NEUROSCI, V5, P1217, DOI 10.1038/nn950; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; WISE SP, 1992, J NEUROPHYSIOL, V68, P969, DOI 10.1152/jn.1992.68.3.969; [No title captured]	34	240	240	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2004	41	1					165	173		10.1016/S0896-6273(03)00817-1	http://dx.doi.org/10.1016/S0896-6273(03)00817-1			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715143	Bronze			2022-12-24	WOS:000187942800017
J	Telgkamp, P; Padgett, DE; Ledoux, VA; Woolley, CS; Raman, IM				Telgkamp, P; Padgett, DE; Ledoux, VA; Woolley, CS; Raman, IM			Maintenance of high-frequency transmission at Purkinje to cerebellar nuclear synapses by spillover from boutons with multiple release sites	NEURON			English	Article							INHIBITORY SYNAPTIC-TRANSMISSION; POSTSYNAPTIC GABA(A) RECEPTORS; PAIRED-PULSE DEPRESSION; CALYX-TYPE SYNAPSE; MULTIVESICULAR RELEASE; ASTROCYTIC PROCESSES; GABAERGIC SYNAPSES; QUANTAL RELEASE; MINIATURE IPSCS; MINI AMPLITUDE	Cerebellar Purkinje neurons maintain high firing rates but their synaptic terminals depress only moderately, raising the question of how vesicle depletion is minimized. To identify mechanisms that limit synaptic depression, we evoked 100 Hz trains of GABAergic inhibitory postsynaptic currents (IPSCs) in cerebellar nuclear neurons by stimulating Purkinje axons in mouse brain slices. The paired-pulse ratio (IPSC2/ IPSC1) of the total IPSC was similar to1 and the steady-state ratio (IPSC20/IPSC1) was similar to0.5, suggesting a high response probability of postsynaptic receptors, without an unusually high release probability. Three-dimensional electron microscopic reconstructions of Purkinje boutons revealed multiple active zones without intervening transporters, suggestive of "spillover"-mediated transmission. Simulations of boutons with 10-16 release sites, in which transmitter from any site can reach all receptors opposite the bouton, replicated multiple-pulse depression during normal, high, and low presynaptic Ca influx. These results suggest that release from multiple-site boutons limits depletion-based depression, permitting prolonged, high-frequency inhibition at corticonuclear synapses.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Northwestern Univ, Inst Neurosci, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Raman, IM (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA.	i-raman@northwestern.edu		Woolley, Catherine/0000-0002-8069-2646	NINDS NIH HHS [NS39395, NS37324] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039395, R01NS037324, R29NS037324] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Auger C, 1998, J NEUROSCI, V18, P4532; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; Borst JGG, 1999, J PHYSIOL-LONDON, V521, P123, DOI 10.1111/j.1469-7793.1999.00123.x; Brenowitz S, 1998, NEURON, V20, P135, DOI 10.1016/S0896-6273(00)80441-9; Bruns D, 2000, NEURON, V28, P205, DOI 10.1016/S0896-6273(00)00097-0; Chan-Palay V, 1977, CEREBELLAR DENTATE N; CLARK JA, 1994, MOL PHARMACOL, V46, P550; CREPEL F, 1972, EXP BRAIN RES, V14, P463, DOI 10.1007/BF00236588; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P574, DOI 10.1113/jphysiol.1954.sp005130; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; Dittman JS, 2000, J NEUROSCI, V20, P1374; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Foster KA, 2002, NEURON, V36, P1115, DOI 10.1016/S0896-6273(02)01106-6; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Galarreta M, 1997, J NEUROSCI, V17, P7220; Garin N, 2001, NEUROSCIENCE, V105, P431, DOI 10.1016/S0306-4522(01)00127-0; GILBERT PFC, 1977, BRAIN RES, V128, P309, DOI 10.1016/0006-8993(77)90997-0; Hefft S, 2002, J PHYSIOL-LONDON, V539, P201, DOI 10.1113/jphysiol.2001.013455; HESTRIN S, 1992, NEURON, V9, P991, DOI 10.1016/0896-6273(92)90250-H; JAHNSEN H, 1986, J PHYSIOL-LONDON, V372, P129, DOI 10.1113/jphysiol.1986.sp016001; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; Jones MV, 1998, J NEUROSCI, V18, P8590; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Kirischuk S, 2002, J PHYSIOL-LONDON, V543, P99, DOI 10.1113/jphysiol.2002.021576; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; Mellor JR, 1998, J PHYSIOL-LONDON, V506, P377, DOI 10.1111/j.1469-7793.1998.377bw.x; Mellor JR, 2001, J NEUROPHYSIOL, V85, P1847, DOI 10.1152/jn.2001.85.5.1847; Minelli A, 1996, J NEUROSCI, V16, P6255, DOI 10.1523/jneurosci.16-19-06255.1996; MORISHITA W, 1995, NEUROSCIENCE, V68, P1127, DOI 10.1016/0306-4522(95)00206-X; MOUGINOT D, 1995, NEUROSCIENCE, V64, P699, DOI 10.1016/0306-4522(94)00456-F; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Otis T, 1996, J NEUROSCI, V16, P7496; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Ouardouz M, 2000, J NEUROPHYSIOL, V84, P1414, DOI 10.1152/jn.2000.84.3.1414; PALKOVITS M, 1977, EXP BRAIN RES, V28, P189; Park D, 1998, J NEUROSCI, V18, P6757; Pedroarena CM, 2003, J NEUROPHYSIOL, V89, P704, DOI 10.1152/jn.00558.2002; Perrais D, 2000, EUR J NEUROSCI, V12, P400, DOI 10.1046/j.1460-9568.2000.00957.x; Perrais D, 1999, J NEUROSCI, V19, P578; Reid CA, 1999, J PHYSIOL-LONDON, V518, P121, DOI 10.1111/j.1469-7793.1999.0121r.x; Ribak CE, 1996, ANAT EMBRYOL, V194, P379; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; TANG CM, 1994, NEURON, V13, P1385, DOI 10.1016/0896-6273(94)90423-5; Telgkamp P, 2002, J NEUROSCI, V22, P8447; THACH WT, 1968, J NEUROPHYSIOL, V31, P785, DOI 10.1152/jn.1968.31.5.785; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Varela JA, 1999, J NEUROSCI, V19, P4293; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Waldeck RF, 2000, J NEUROSCI, V20, P5312, DOI 10.1523/JNEUROSCI.20-14-05312.2000; WALMSLEY B, 1988, J NEUROPHYSIOL, V60, P889, DOI 10.1152/jn.1988.60.3.889; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Yankova M, 2001, P NATL ACAD SCI USA, V98, P3525, DOI 10.1073/pnas.051624598; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	61	91	91	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 8	2004	41	1					113	126		10.1016/S0896-6273(03)00802-X	http://dx.doi.org/10.1016/S0896-6273(03)00802-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715139	Bronze			2022-12-24	WOS:000187942800013
J	Krueger, SR; Kolar, A; Fitzsimonds, RM				Krueger, SR; Kolar, A; Fitzsimonds, RM			The presynaptic release apparatus is functional in the absence of dendritic contact and highly mobile within isolated axons	NEURON			English	Article							HIPPOCAMPAL-NEURONS; SYNAPTIC VESICLES; MOLECULAR-MECHANISMS; EXCITATORY SYNAPSES; GROWTH CONES; ACTIVE ZONES; DYNAMICS; SYNAPTOGENESIS; PLASTICITY; RAT	Whether contact of an axon with a dendrite is a necessary inductive signal for the assembly of functional presynaptic machinery is controversial. Combining FM1-43 imaging with retrospective immunocytochemistry, we observe many functional synaptic vesicle (SV) release sites lacking postsynaptic specializations in cultured hippocampal neurons. These "orphan" release sites share the same exocytic machinery and mechanisms of endocytic recycling as mature synaptic sites. Moreover, quantitative analysis of FM1-43 destaining at these orphan release sites reveals similar kinetics with slightly lower release probabilities. Time-lapse imaging of FM1-43 reveals that orphans are generated by complete or partial mobilization of synaptic release sites that retain their functionality in transit. Orphan clusters fuse with existing synaptic release sites or form novel release sites onto dendrites. Mobilization and stabilization of orphan boutons to new sites of dendritic contact may represent a necessary presynaptic counterpart to postsynaptic changes observed during development and plasticity in the CNS.	Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Fitzsimonds, RM (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA.	reiko.fitzsimonds@yale.edu		Fitzsimonds, Reiko/0000-0002-0576-9885; Krueger, Stefan/0000-0001-8739-7052	NIMH NIH HHS [MH-59800] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059800] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Benson DL, 1998, J NEUROSCI, V18, P6892; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; BURRY RW, 1982, BRAIN RES, V247, P1, DOI 10.1016/0006-8993(82)91022-8; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Craig AM, 1996, J NEUROSCI, V16, P3166; Dai ZS, 1996, MOL CELL NEUROSCI, V7, P443, DOI 10.1006/mcne.1996.0032; Dailey ME, 1996, J NEUROSCI, V16, P2983; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fernandez-Chacon R, 1999, ANNU REV PHYSIOL, V61, P753, DOI 10.1146/annurev.physiol.61.1.753; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fitzsimonds RM, 1998, PHYSIOL REV, V78, P143, DOI 10.1152/physrev.1998.78.1.143; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; GARCIA EP, 1995, J CELL BIOL, V129, P105, DOI 10.1083/jcb.129.1.105; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; HUME RI, 1983, NATURE, V305, P632, DOI 10.1038/305632a0; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Lee HW, 2002, J BIOL CHEM, V277, P32624, DOI 10.1074/jbc.M200353200; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Nikonenko I, 2003, J NEUROSCI, V23, P8498; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; OBrien RJ, 1997, J NEUROSCI, V17, P7339; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; PICHITPORNCHAI C, 1994, J COMP NEUROL, V342, P206, DOI 10.1002/cne.903420205; Polo-Parada L, 2001, NEURON, V32, P815, DOI 10.1016/S0896-6273(01)00521-9; Rao A, 1998, J NEUROSCI, V18, P1217; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schikorski T, 1997, J NEUROSCI, V17, P5858; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; SUN YA, 1987, P NATL ACAD SCI USA, V84, P2540, DOI 10.1073/pnas.84.8.2540; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Verderio C, 1999, J NEUROSCI, V19, P6723, DOI 10.1523/JNEUROSCI.19-16-06723.1999; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zakharenko S, 1999, J CELL BIOL, V144, P507, DOI 10.1083/jcb.144.3.507; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	54	130	134	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 4	2003	40	5					945	957		10.1016/S0896-6273(03)00729-3	http://dx.doi.org/10.1016/S0896-6273(03)00729-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659093	Bronze			2022-12-24	WOS:000187042200011
J	Sabo, SL; McAllister, AK				Sabo, SL; McAllister, AK			Mobility and cycling of synaptic protein-containing vesicles in axonal growth cone filopodia	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL-NEURONS; ACTIN-FILAMENTS; NMDA RECEPTORS; TRANSPORT; MICROTUBULES; DYNAMICS; RELEASE; SYNAPTOGENESIS; ORGANIZATION; ORGANELLES	The spatial distribution and coordination of vesicular dynamics within growth cones are poorly understood. It has long been thought that membranous organelles are concentrated in the central regions of growth cones and excluded from filopodia; this view has dramatically shaped conceptual models of the cellular mechanisms of axonal growth and presynaptic terminal formation. To begin to test these models, we studied membrane dynamics within axonal growth cones of living rat cortical neurons. We demonstrate that growth cone filopodia contain vesicles that transport synaptic vesicle proteins bidirectionally along filopodia and fuse with the filopodial surface in response to focal stimulation, allowing for both local secretion of vesicular contents and rapid changes in the plasma membrane composition of individual filopodia. Our results suggest a new model in which growth cone filopodia are actively involved in both emitting and responding to local signals related to axon growth and early synapse formation.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA	University of California System; University of California Davis	McAllister, AK (corresponding author), Univ Calif Davis, Ctr Neurosci, 1544 Newton Court, Davis, CA 95616 USA.			Sabo, Shasta/0000-0001-6386-7443; McAllister, A. Kimberley/0000-0001-9177-9889				BANKER G, 1998, CULTURING NERVE CELL; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BRIDGMAN PC, 1989, J CELL BIOL, V108, P95, DOI 10.1083/jcb.108.1.95; BUNGE MB, 1977, J NEUROCYTOL, V6, P407, DOI 10.1007/BF01178226; Chang S, 2001, NAT NEUROSCI, V4, P787, DOI 10.1038/90489; CHENG TP, 1987, J NEUROSCI, V7, P752; CHENG TPO, 1985, J CELL BIOL, V101, P1473, DOI 10.1083/jcb.101.4.1473; COOPER MW, 1992, J NEUROBIOL, V23, P814, DOI 10.1002/neu.480230704; DAILEY ME, 1993, J NEUROSCI, V13, P3375; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; Diefenbach TJ, 1999, J NEUROSCI, V19, P9436; FORSCHER P, 1987, J NEUROSCI, V7, P3600; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Gallo G, 1999, J NEUROSCI, V19, P3860; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; Gordon-Weeks P. R., 2000, NEURONAL GROWTH CONE; Hazuka CD, 1999, J NEUROSCI, V19, P1324; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; HUME RI, 1983, NATURE, V305, P632, DOI 10.1038/305632a0; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Kater S. B., 1995, Current Opinion in Neurobiology, V5, P68, DOI 10.1016/0959-4388(95)80089-1; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; LANDIS SC, 1978, J CELL BIOL, V78, P8; Lin SY, 1998, J NEUROSCI, V18, P3725; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; NUTTALL RP, 1979, EXP CELL RES, V119, P163, DOI 10.1016/0014-4827(79)90345-8; OCONNOR TP, 1990, J NEUROSCI, V10, P3935, DOI 10.1523/JNEUROSCI.10-12-03935.1990; Peretti D, 2000, J CELL BIOL, V149, P141, DOI 10.1083/jcb.149.1.141; REES RP, 1981, NEUROSCIENCE, V6, P247, DOI 10.1016/0306-4522(81)90060-9; Rochlin MW, 1999, MOL BIOL CELL, V10, P2309, DOI 10.1091/mbc.10.7.2309; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Tashiro A, 2003, NEURON, V38, P773, DOI 10.1016/S0896-6273(03)00299-X; TAYLOR J, 1990, J NEUROCHEM, V54, P1689, DOI 10.1111/j.1471-4159.1990.tb01223.x; TENNYSON VM, 1970, J CELL BIOL, V44, P62, DOI 10.1083/jcb.44.1.62; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; Wong WT, 2001, NAT NEUROSCI, V4, P351, DOI 10.1038/85987; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0; Zakharenko S, 1998, J CELL BIOL, V143, P1077, DOI 10.1083/jcb.143.4.1077	38	83	83	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1264	1269		10.1038/nn1149	http://dx.doi.org/10.1038/nn1149			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	746BC	14608359				2022-12-24	WOS:000186725600010
J	Becherer, U; Moser, T; Stuhmer, W; Oheim, M				Becherer, U; Moser, T; Stuhmer, W; Oheim, M			Calcium regulates exocytosis at the level of single vesicles	NATURE NEUROSCIENCE			English	Article							BUFFERED CA2+ DIFFUSION; CHROMAFFIN CELLS; SYNAPTIC VESICLES; TIME-COURSE; SECRETION; RELEASE; MEMBRANE; MICRODOMAINS; GRANULES; CHANNELS	Ca2+ microdomains that form during the opening of voltage-gated Ca2+ channels have been implicated in regulating the kinetics of hormone and transmitter release. Direct assessment of the interaction between a single Ca2+ microdomain and a single secretory vesicle has been impossible because of technical limitations. Using evanescent field imaging of near-membrane micromolar Ca2+ concentration ([Ca2+]) and fluorescently labeled vesicles, we have observed exocytosis of individual chromaffin dense-core vesicles that was triggered by Ca2+ microdomains. Ca2+ microdomains selectively triggered the release of vesicles that were docked within 300 nm. Not all vesicles exposed to a Ca2+ microdomain were released, indicating that some vesicles are docked but are not ready for release. In addition to its established role as a trigger for release, elevated near-membrane [Ca2+] reduced the distance between docked vesicles and Ca2+ entry sites. Our results suggest a new mechanism for stimulation-dependent facilitation of exocytosis, whereby vesicles are moved closer to Ca2+ entry sites, thereby increasing a Ca2+ microdomain's efficacy to trigger vesicle fusion.	Ecole Super Phys & Chim Ind Ville Paris, CNRS, FRE 2500, INSERM,EPI 0002, F-75005 Paris, France; Max Planck Inst Expt Med, D-37075 Gottingen, Germany; Univ Gottingen, Dept Otolaryngol, D-37075 Gottingen, Germany	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Max Planck Society; University of Gottingen	Oheim, M (corresponding author), Ecole Super Phys & Chim Ind Ville Paris, CNRS, FRE 2500, INSERM,EPI 0002, 10 Rue Vauquelin, F-75005 Paris, France.	martin.oheim@espci.fr	Becherer, Ute/AGW-2576-2022; Stuehmer, Walter/A-2176-2009; Moser, Tobias/L-5068-2014; Becherer, Ute/F-6711-2010	Stuehmer, Walter/0000-0002-0642-7764; Moser, Tobias/0000-0001-7145-0533; Becherer, Ute/0000-0001-6005-7517				ADLER EM, 1991, J NEUROSCI, V11, P1496; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Atlas D, 2001, J NEUROCHEM, V77, P972, DOI 10.1046/j.1471-4159.2001.00347.x; Augustine G J, 1992, Curr Opin Neurobiol, V2, P302, DOI 10.1016/0959-4388(92)90119-6; Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; Barg S, 2001, BIOPHYS J, V81, P3308, DOI 10.1016/S0006-3495(01)75964-4; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; CHAD JE, 1984, BIOPHYS J, V45, P993, DOI 10.1016/S0006-3495(84)84244-7; Cheng H, 1999, BIOPHYS J, V76, P606, DOI 10.1016/S0006-3495(99)77229-2; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Cleemann L, 1997, ADV EXP MED BIOL, V430, P57; ETTER EF, 1994, J BIOL CHEM, V269, P10141; GHOSH RN, 1994, BIOPHYS J, V66, P1301, DOI 10.1016/S0006-3495(94)80939-7; Gomis A, 1999, J NEUROSCI, V19, P6309; HORRIGAN FT, 1994, NEURON, V13, P1119, DOI 10.1016/0896-6273(94)90050-7; Johns LM, 2001, J CELL BIOL, V153, P177, DOI 10.1083/jcb.153.1.177; Khanna B, 2002, BIOPHYS J, V82, p10A; Klingauf J, 1997, BIOPHYS J, V72, P674, DOI 10.1016/S0006-3495(97)78704-6; LEVRAM V, 1992, J NEUROPHYSIOL, V68, P1167, DOI 10.1152/jn.1992.68.4.1167; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Melamed-Book N, 1999, P NATL ACAD SCI USA, V96, P15217, DOI 10.1073/pnas.96.26.15217; MONCK JR, 1994, BIOPHYS J, V67, P505, DOI 10.1016/S0006-3495(94)80554-5; Naraghi M, 1997, J NEUROSCI, V17, P6961; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; NOWYCKY MC, 1993, BIOPHYS J, V64, P77, DOI 10.1016/S0006-3495(93)81342-0; Oheim M, 2000, EUR BIOPHYS J BIOPHY, V29, P67, DOI 10.1007/s002490050253; Oheim M, 1999, EUR BIOPHYS J BIOPHY, V28, P91, DOI 10.1007/s002490050188; Omann GM, 1996, BIOPHYS J, V71, P2885, DOI 10.1016/S0006-3495(96)79485-7; Parnas I, 1999, J PHYSIOL-LONDON, V517, P629, DOI 10.1111/j.1469-7793.1999.0629s.x; Rettig J, 2002, SCIENCE, V298, P781, DOI 10.1126/science.1075375; ROBERTS WM, 1994, J NEUROSCI, V14, P3246; ROBINSON IM, 1995, P NATL ACAD SCI USA, V92, P2474, DOI 10.1073/pnas.92.7.2474; SALA F, 1990, BIOPHYS J, V57, P313, DOI 10.1016/S0006-3495(90)82533-9; SCHROEDER TJ, 1994, J BIOL CHEM, V269, P17215; Schulte A, 1998, ANAL CHEM, V70, P985, DOI 10.1021/ac970934e; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; Smith C, 1998, NEURON, V20, P1243, DOI 10.1016/S0896-6273(00)80504-8; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; Tucker T, 1995, NEURON, V15, P1323, DOI 10.1016/0896-6273(95)90011-X; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; Wick PF, 1997, NEUROSCIENCE, V80, P847, DOI 10.1016/S0306-4522(97)00062-6; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6; Zenisek D, 2003, J NEUROSCI, V23, P2538	49	112	116	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					846	853		10.1038/nn1087	http://dx.doi.org/10.1038/nn1087			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12845327				2022-12-24	WOS:000184413700014
J	Goltz, HC; DeSouza, JFX; Menon, RS; Tweed, DB; Vilis, T				Goltz, HC; DeSouza, JFX; Menon, RS; Tweed, DB; Vilis, T			Interaction of retinal image and eye velocity in motion perception	NEURON			English	Article							VISUAL CORTICAL AREAS; RESPONSE PROPERTIES; MACAQUE MONKEYS; HUMAN BRAIN; HUMAN MT; MOVEMENTS; CELLS; REAL; CORTEX; NEURONS	When we move our eyes, why does the world look stable even as its image flows across our retinas, and why do afterimages, which are stationary on the retinas, appear to move? Current theories say this is because we perceive motion by summation: if an object slips across the retina at rdegrees/s while the eye turns at edegrees/s, the object's perceived velocity in space should be r + e. We show that activity in MT+, the visual-motion complex in human cortex, does reflect a mix of r and e rather than r alone. But we show also that, for optimal perception, r and e should not summate; rather, the signals coding e interact multiplicatively with the spatial gradient of illumination.	Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; Univ Western Ontario, CIHR Grp Act & Percept, London, ON N6A 5C1, Canada; Univ Western Ontario, Dept Med Biophys, London, ON N6A 5C1, Canada; Univ Western Ontario, Robarts Res Inst, London, ON N6A 5C1, Canada; Univ Toronto, Dept Physiol, Dept Med, Toronto, ON M5S 1A8, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto	Vilis, T (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada.		Menon, Ravi S/K-5500-2013; Menon, Ravi/ABA-8654-2020; DeSouza, Joseph FX/B-5615-2009	Menon, Ravi S/0000-0002-7916-0263; Menon, Ravi/0000-0002-7916-0263; DeSouza, Joseph FX/0000-0001-6931-0849; Goltz, Herbert/0000-0002-6496-754X				BAKER JF, 1981, J NEUROPHYSIOL, V45, P397, DOI 10.1152/jn.1981.45.3.397; BROWN JL, 1966, VISION VISUAL PERCEP, P479; Carpenter RHS, 1988, MOVEMENTS EYES; Culham J, 2001, ACTA PSYCHOL, V107, P69, DOI 10.1016/S0001-6918(01)00022-1; Descartes R., 1664, TREATISE MAN; DeSouza JFX, 2000, J NEUROSCI, V20, P5835, DOI 10.1523/JNEUROSCI.20-15-05835.2000; Dukelow SP, 2001, J NEUROPHYSIOL, V86, P1991, DOI 10.1152/jn.2001.86.4.1991; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; ERICKSON RG, 1991, EXP BRAIN RES, V86, P608; Freeman TCA, 1998, VISION RES, V38, P941, DOI 10.1016/S0042-6989(97)00395-7; GALLETTI C, 1990, EXP BRAIN RES, V82, P67; GALLETTI C, 1984, BRAIN RES, V301, P95, DOI 10.1016/0006-8993(84)90406-2; GALLETTI C, 1988, EXP BRAIN RES, V69, P279; GAUTHIER GM, 1976, PERCEPT MOTOR SKILL, V42, P963, DOI 10.2466/pms.1976.42.3.963; GIBSON JJ, 1968, PSYCHOL REV, V75, P335, DOI 10.1037/h0025893; Haarmeier T, 1997, NATURE, V389, P849, DOI 10.1038/39872; Haarmeier T, 2001, NEURON, V32, P527, DOI 10.1016/S0896-6273(01)00486-X; HILDRETH EC, 1987, ANNU REV NEUROSCI, V10, P477, DOI 10.1146/annurev.ne.10.030187.002401; Huk AC, 2001, NEURON, V32, P161, DOI 10.1016/S0896-6273(01)00452-4; Ilg UJ, 1996, EUR J NEUROSCI, V8, P1156; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; SHEBILSKE WL, 1977, STABILITY CONSTANCY, P23; Sherrington CS, 1918, BRAIN, V41, P332, DOI 10.1093/brain/41.3-4.332; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; ULLMAN S, 1983, TRENDS NEUROSCI, V6, P177, DOI 10.1016/0166-2236(83)90081-4; VONHELMHOLTZ H, 1867, HDB PHYSL OPTIK, V2, P234; VONHOLST E, 1950, BEHAV PHYSL ANIMALS, V1; Wallach H., 1976, PERCEPTION; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; WERTHEIM AH, 1994, BEHAV BRAIN SCI, V17, P293, DOI 10.1017/S0140525X00034646; ZEKI S, 1980, PROC R SOC SER B-BIO, V207, P239, DOI 10.1098/rspb.1980.0022	33	19	19	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 31	2003	39	3					569	576		10.1016/S0896-6273(03)00460-4	http://dx.doi.org/10.1016/S0896-6273(03)00460-4			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	709LC	12895428	Bronze			2022-12-24	WOS:000184625800017
J	Marinkovic, K; Dhond, RP; Dale, AM; Glessner, M; Carr, V; Halgren, E				Marinkovic, K; Dhond, RP; Dale, AM; Glessner, M; Carr, V; Halgren, E			Spatiotemporal dynamics of modality-specific and supramodal word processing	NEURON			English	Article							LEFT PREFRONTAL CORTEX; MEDIAL TEMPORAL-LOBE; DEPTH-RECORDED POTENTIALS; INFERIOR FRONTAL-CORTEX; SURFACE-BASED ANALYSIS; FUNCTIONAL NEUROANATOMY; FIELD POTENTIALS; MEG LOCALIZATION; SEMANTIC MEMORY; MAGNETIC-FIELDS	The ability of written and spoken words to access the same semantic meaning provides a test case for the multimodal convergence of information from sensory to associative areas. Using anatomically constrained magnetoencephalography (aMEG), the present study investigated the stages of word comprehension in real time in the auditory and visual modalities, as subjects participated in a semantic judgment task. Activity spread from the primary sensory areas along the respective ventral processing streams and converged in anterior temporal and inferior prefrontal regions, primarily on the left at around 400 ms. Comparison of response patterns during repetition priming between the two modalities suggest that they are initiated by modality-specific memory systems, but that they are eventually elaborated mainly in supramodal areas.	Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; Univ Utah, Dept Radiol, Salt Lake City, UT 84108 USA; INSERM, E9926, Marseille, France	Utah System of Higher Education; University of Utah; Institut National de la Sante et de la Recherche Medicale (Inserm)	Marinkovic, K (corresponding author), Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA.	xenia@nmr.mgh.harvard.edu	Marinkovic, Ksenija/AAD-4701-2020; Dale, Anders M/A-5180-2010	Marinkovic, Ksenija/0000-0003-1658-4496; Dhond, Rupali/0000-0002-8186-1296; Carr, Valerie/0000-0002-2969-2181	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000790, R01EB000307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039581, R01NS018741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA013402] Funding Source: NIH RePORTER; NIAAA NIH HHS [K01 AA013402, AA13402] Funding Source: Medline; NIBIB NIH HHS [EB00790, EB00307, R01 EB000790, R01 EB000307] Funding Source: Medline; NINDS NIH HHS [NS18741, R01 NS039581, R01 NS018741, NS39581] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; BENSON DF, 1979, APHASIA ALEXIA AGRAP; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Bokde ALW, 2001, NEURON, V30, P609, DOI 10.1016/S0896-6273(01)00288-4; BROWN C, 1993, J COGNITIVE NEUROSCI, V5, P34, DOI 10.1162/jocn.1993.5.1.34; Buckner RL, 2000, BRAIN, V123, P620, DOI 10.1093/brain/123.3.620; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; CARAMAZZA A, 1990, COGNITIVE NEUROPSYCH, V7, P161, DOI 10.1080/02643299008253441; Chee MWL, 1999, HUM BRAIN MAPP, V7, P15, DOI 10.1002/(SICI)1097-0193(1999)7:1<15::AID-HBM2>3.3.CO;2-Y; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dale AM, 2001, CURR OPIN NEUROBIOL, V11, P202, DOI 10.1016/S0959-4388(00)00197-5; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Devlin JT, 2002, NEUROPSYCHOLOGIA, V40, P54, DOI 10.1016/S0028-3932(01)00066-5; Devlin JT, 2000, NEUROIMAGE, V11, P589, DOI 10.1006/nimg.2000.0595; Dhond RP, 2001, J NEUROSCI, V21, P3564, DOI 10.1523/JNEUROSCI.21-10-03564.2001; DOMALSKI P, 1991, PSYCHOL SCI, V2, P173, DOI 10.1111/j.1467-9280.1991.tb00126.x; Fiez JA, 1998, P NATL ACAD SCI USA, V95, P914, DOI 10.1073/pnas.95.3.914; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; FRANCIS WN, 1982, FREQUENCY ANAL ENGLI; Friederici AD, 2000, BRAIN LANG, V74, P289, DOI 10.1006/brln.2000.2313; Frost JA, 1999, BRAIN, V122, P199, DOI 10.1093/brain/122.2.199; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; Gomes H, 1997, COGNITIVE BRAIN RES, V6, P121, DOI 10.1016/S0926-6410(97)00023-2; Hagoort P, 2000, NEUROPSYCHOLOGIA, V38, P1518, DOI 10.1016/S0028-3932(00)00052-X; Hagoort P, 1999, J COGNITIVE NEUROSCI, V11, P383, DOI 10.1162/089892999563490; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P51, DOI 10.1016/0928-4257(94)90093-0; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P1, DOI 10.1016/0928-4257(94)90092-2; Halgren E, 2002, NEUROIMAGE, V17, P1101, DOI 10.1006/nimg.2002.1268; Halgren E., 1990, NEUROBIOLOGY COGNITI, P103; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Helenius P, 1998, BRAIN, V121, P1133, DOI 10.1093/brain/121.6.1133; Helenius P, 2002, J NEUROSCI, V22, P2936, DOI 10.1523/JNEUROSCI.22-07-02936.2002; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; HODGES JR, 1992, BRAIN, V115, P1783, DOI 10.1093/brain/115.6.1783; HOLCOMB PJ, 1993, PSYCHOPHYSIOLOGY, V30, P47, DOI 10.1111/j.1469-8986.1993.tb03204.x; HUMPHREYS GW, 1985, BEHAV BRAIN SCI, V8, P689, DOI 10.1017/S0140525X00045684; Ingvar D H, 1983, Hum Neurobiol, V2, P177; KAPUR S, 1994, NEUROREPORT, V5, P2193, DOI 10.1097/00001756-199410270-00051; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Liu AK, 2002, HUM BRAIN MAPP, V16, P47, DOI 10.1002/hbm.10024; Makela AM, 2001, NEUROREPORT, V12, P249; MARSLENWILSON WD, 1987, COGNITION, V25, P71, DOI 10.1016/0010-0277(87)90005-9; MCCARTHY G, 1995, J NEUROSCI, V15, P1080; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; NAGY ME, 1989, PSYCHOPHYSIOLOGY, V26, P431, DOI 10.1111/j.1469-8986.1989.tb01946.x; NOBRE AC, 1995, J NEUROSCI, V15, P1090; OOSTENDORP T, 1991, IEEE T BIO-MED ENG, V38, P409, DOI 10.1109/10.81559; Perani D, 1999, BRAIN, V122, P2337, DOI 10.1093/brain/122.12.2337; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Poldrack RA, 1998, CEREB CORTEX, V8, P1, DOI 10.1093/cercor/8.1.1; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price CJ, 1996, BRAIN, V119, P919, DOI 10.1093/brain/119.3.919; Raichle ME, 1996, COLD SPRING HARB SYM, V61, P9; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; Romanski LM, 2002, NAT NEUROSCI, V5, P15, DOI 10.1038/nn781; Roskies AL, 2001, J COGNITIVE NEUROSCI, V13, P829, DOI 10.1162/08989290152541485; Rugg M. D., 1994, COGNITIVE ELECTROPHY; Rugg MD, 1999, NEUROREPORT, V10, P2661, DOI 10.1097/00001756-199908200-00041; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Sekiguchi T, 2001, NEUROIMAGE, V14, P118, DOI 10.1006/nimg.2001.0774; Simos PG, 1997, BRAIN RES, V762, P29, DOI 10.1016/S0006-8993(97)00349-1; SMITH ME, 1986, ELECTROEN CLIN NEURO, V63, P145, DOI 10.1016/0013-4694(86)90008-8; Tagamets MA, 2000, J COGNITIVE NEUROSCI, V12, P281, DOI 10.1162/089892900562101; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Tzourio N, 1998, NEUROIMAGE, V8, P1, DOI 10.1006/nimg.1998.0343; Van Petten C, 1999, J EXP PSYCHOL LEARN, V25, P394, DOI 10.1037/0278-7393.25.2.394; Veltman DJ, 2000, NEUROIMAGE, V11, P575, DOI 10.1006/nimg.2000.0581; Wagner AD, 2001, NEURON, V31, P329, DOI 10.1016/S0896-6273(01)00359-2; Wagner AD, 2000, CEREB CORTEX, V10, P1176, DOI 10.1093/cercor/10.12.1176; Warburton E, 1996, BRAIN, V119, P159, DOI 10.1093/brain/119.1.159; WARRINGTON EK, 1980, BRAIN, V103, P99, DOI 10.1093/brain/103.1.99; WISE R, 1991, BRAIN, V114, P1803, DOI 10.1093/brain/114.4.1803; Woodward JA, 1990, INTRO LINEAR MODELS; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	82	355	359	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 8	2003	38	3					487	497		10.1016/S0896-6273(03)00197-1	http://dx.doi.org/10.1016/S0896-6273(03)00197-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	677HF	12741994	Green Accepted, Bronze			2022-12-24	WOS:000182800300012
J	Hutter-Paier, B; Huttunen, HJ; Puglielli, L; Eckman, CB; Kim, DY; Hofmeister, A; Moir, RD; Domnitz, SB; Frosch, MP; Windisch, M; Kovacs, DM				Hutter-Paier, B; Huttunen, HJ; Puglielli, L; Eckman, CB; Kim, DY; Hofmeister, A; Moir, RD; Domnitz, SB; Frosch, MP; Windisch, M; Kovacs, DM			The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease	NEURON			English	Article							SECRETASE-LIKE CLEAVAGE; PRECURSOR-PROTEIN; TRANSGENIC MICE; BETA-PROTEIN; IN-VITRO; CHOLESTEROL; PRESENILIN-1; DEPOSITION; APP; PURIFICATION	Amyloid beta-peptide (Abeta) accumulation in specific brain regions is a pathological hallmark of Alzheimer's disease (AD). We have previously reported that a well characterized acyl-coenzyme A: cholesterol acyltransferase (ACAT) inhibitor, CP-113,818, inhibits Abeta production in cell-based experiments. Here, we assessed the efficacy of CP-113,818 in reducing AD-like pathology in the brains of transgenic mice expressing human APP(751) containing the London (V7171) and Swedish (K670M/N671L) mutations. Two months of treatment with CP-113,818 reduced the accumulation of amyloid plaques by 88%-99% and membrane/insoluble Abeta levels by 83%-96%, while also decreasing brain cholesteryl-esters by 86%. Additionally, soluble Abeta(42) was reduced by 34% in brain homogenates. Spatial learning was slightly improved and correlated with decreased Abeta levels. In nontransgenic littermates, CP-113,818 also reduced ectodomain shedding of endogenous APP in the brain. Our results suggest that ACAT inhibition may be effective in the prevention and treatment of AD by inhibiting generation of the Abeta peptide.	Harvard Univ, Sch Med, Neurobiol Dis Lab, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Genet & Aging Res Unit, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Neurol, MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Pathol, Massachusetts Gen Hosp, Charlestown, MA 02129 USA; Mayo Clin Jacksonville, Dept Neurosci, Jacksonville, FL 32224 USA; JSW Res Forsch Labor GmbH, Inst Expt Pharmacol, A-8020 Graz, Austria	Harvard University; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; Mayo Clinic	Kovacs, DM (corresponding author), Harvard Univ, Sch Med, Neurobiol Dis Lab, Charlestown, MA 02129 USA.	dora_kovacs@hms.harvard.edu	Frosch, Matthew P/ABD-7456-2021; Moir, Robert D./M-7612-2017	Frosch, Matthew P/0000-0002-3940-9861; Moir, Robert D./0000-0001-5431-3553; Huttunen, Henri/0000-0002-9867-4438				Aguzzi A, 2003, SCIENCE, V302, P814, DOI 10.1126/science.1087348; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Burns M, 2002, ANN NY ACAD SCI, V977, P367, DOI 10.1111/j.1749-6632.2002.tb04839.x; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Champagne D, 2003, NEUROSCIENCE, V121, P99, DOI 10.1016/S0306-4522(03)00361-0; Chang CCY, 2000, J BIOL CHEM, V275, P28083; Chang TY, 2001, J LIPID RES, V42, P1933; Citron M, 2002, NAT NEUROSCI, V5, P1055, DOI 10.1038/nn940; Citron M, 2004, TRENDS PHARMACOL SCI, V25, P92, DOI 10.1016/j.tips.2003.12.004; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Harter D, 2001, BEHAV BRAIN SCI, V24, P45, DOI 10.1017/S0140525X01303916; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kim DY, 2002, J BIOL CHEM, V277, P49976, DOI 10.1074/jbc.M210179200; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; Ling Y, 2003, INT J BIOCHEM CELL B, V35, P1505, DOI 10.1016/S1357-2725(03)00133-X; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; MARZETTA CA, 1994, J LIPID RES, V35, P1829; Park IH, 2003, NEUROBIOL AGING, V24, P637, DOI 10.1016/S0197-4580(02)00155-0; Petanceska SS, 2002, J MOL NEUROSCI, V19, P155, DOI 10.1007/s12031-002-0026-2; Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345; Puglielli L, 2001, NAT CELL BIOL, V3, P905, DOI 10.1038/ncb1001-905; Refolo LM, 2001, NEUROBIOL DIS, V8, P890, DOI 10.1006/nbdi.2001.0422; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Saido TC, 1998, NEUROBIOL AGING, V19, pS69, DOI 10.1016/S0197-4580(98)00033-5; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Shah Prediman K, 2003, Rev Cardiovasc Med, V4, P136; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Vassar R, 2004, J MOL NEUROSCI, V23, P105, DOI 10.1385/JMN:23:1-2:105; Wang J, 2003, NEUROBIOL DIS, V14, P318, DOI 10.1016/j.nbd.2003.08.009; Wolozin B, 2004, NEURON, V41, P7, DOI 10.1016/S0896-6273(03)00840-7; Xia WM, 2003, J CELL SCI, V116, P2839, DOI 10.1242/jcs.00651	45	199	210	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 14	2004	44	2					227	238		10.1016/j.neuron.2004.08.043	http://dx.doi.org/10.1016/j.neuron.2004.08.043			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473963	Bronze			2022-12-24	WOS:000224635800007
J	Sivasankaran, R; Pei, J; Wang, KC; Zhang, YP; Shields, CB; Xu, XM; He, ZG				Sivasankaran, R; Pei, J; Wang, KC; Zhang, YP; Shields, CB; Xu, XM; He, ZG			PKC mediates inhibitory effects of myelin and chondroitin sulfate proteoglycans on axonal regeneration	NATURE NEUROSCIENCE			English	Article							SPINAL-CORD-INJURY; PROTEIN-KINASE-C; NEURITE GROWTH-INHIBITORS; NOGO RECEPTOR; GLYCOPROTEIN INTERACTS; CONE COLLAPSE; CELL-ADHESION; RHO-GTPASES; CYCLIC-AMP; OUTGROWTH	Successful axon regeneration in the mammalian central nervous system (CNS) is at least partially compromised due to the inhibitors associated with myelin and glial scar. However, the intracellular signaling mechanisms underlying these inhibitory activities are largely unknown. Here we provide biochemical and functional evidence that conventional isoforms of protein kinase C (PKC) are key components in the signaling pathways that mediate the inhibitory activities of myelin components and chondroitin sulfate proteoglycans (CSPGs), the major class of inhibitors in the glial scar. Both the myelin inhibitors and CSPGs induce PKC activation. Blocking PKC activity pharmacologically and genetically attenuates the ability of CNS myelin and CSPGs to activate Rho and inhibit neurite outgrowth. Intrathecal infusion of a PKC inhibitor, Go6976, into the site of dorsal hemisection promotes regeneration of dorsal column axons across and beyond the lesion site in adult rats. Thus, perturbing PKC activity could represent a therapeutic approach to stimulating axon regeneration after brain and spinal cord injuries.	Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Univ Louisville, Sch Med, Dept Neurol Surg, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; University of Louisville; Harvard University; Harvard Medical School	He, ZG (corresponding author), Childrens Hosp, Div Neurosci, 320 Longwood Ave, Boston, MA 02115 USA.	xmxu0001@louisville.edu; zhigang.he@tch.harvard.edu		Xu, Xiao-ming/0000-0002-7229-0081; Wang, Kevin/0000-0002-5305-6791	NINDS NIH HHS [NS36350] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036350] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bamber NI, 2001, EUR J NEUROSCI, V13, P257, DOI 10.1046/j.1460-9568.2001.01387.x; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Dergham P, 2002, J NEUROSCI, V22, P6570; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; Kaneto H, 2002, J BIOL CHEM, V277, P3680, DOI 10.1074/jbc.M109647200; Kottis V, 2002, J NEUROCHEM, V82, P1566, DOI 10.1046/j.1471-4159.2002.01146.x; Kuhn TB, 1999, J NEUROSCI, V19, P1965; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Prang P, 2001, EXP NEUROL, V169, P135, DOI 10.1006/exnr.2001.7648; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; SAVIO T, 1989, J NEUROSCI, V9, P1126; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Slater SJ, 2001, BIOCHEMISTRY-US, V40, P4437, DOI 10.1021/bi001654n; SNOW DM, 1994, DEV BIOL, V166, P87, DOI 10.1006/dbio.1994.1298; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Spencer T, 2003, CURR OPIN NEUROBIOL, V13, P133, DOI 10.1016/S0959-4388(03)00012-6; Ughrin YM, 2003, J NEUROSCI, V23, P175; Vinson M, 2001, J BIOL CHEM, V276, P20280, DOI 10.1074/jbc.M100345200; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Winton MJ, 2002, J BIOL CHEM, V277, P32820, DOI 10.1074/jbc.M201195200; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x; Yiu G, 2003, CURR OPIN NEUROBIOL, V13, P545, DOI 10.1016/j.conb.2003.09.006	50	250	261	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					261	268		10.1038/nn1193	http://dx.doi.org/10.1038/nn1193			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14770187				2022-12-24	WOS:000189197900016
J	Verderio, C; Pozzi, D; Pravettoni, E; Inverardi, F; Schenk, U; Coco, S; Proux-Gillardeaux, V; Galli, T; Rossetto, O; Frassoni, C; Matteoli, M				Verderio, C; Pozzi, D; Pravettoni, E; Inverardi, F; Schenk, U; Coco, S; Proux-Gillardeaux, V; Galli, T; Rossetto, O; Frassoni, C; Matteoli, M			SNAP-25 modulation of calcium dynamics underlies differences in GABAergic and glutamatergic responsiveness to depolarization	NEURON			English	Article							CULTURED HIPPOCAMPAL-NEURONS; SYNAPTIC VESICLES; PROTEIN SNAP-25; CA2+ CHANNELS; SYNAPTOTAGMIN-I; SNARE PROTEIN; TETANUS TOXIN; RELEASE; MEMBRANE; CELLS	SNAP-25 is a component of the SNARE complex implicated in synaptic vesicle exocytosis. In this study, we demonstrate that hippocampal GABAergic synapses, both in culture and in brain, lack SNAP-25 and are resistant to the action of botulinum toxins type A and E, which cleave this SNARE protein. Relative to glutamatergic neurons, which express SNAP-25, GABAergic cells were characterized by a higher calcium responsiveness to depolarization. Exogenous expression of SNAP-25 in GABAergic interneurons lowered calcium responsiveness, and SNAP-25 silencing in glutamatergic neurons increased calcium elevations evoked by depolarization. Expression of SNAP-25(1-197) but not of SNAP-25(1-180) inhibited calcium responsiveness, pointing to the involvement of the 180-197 residues in the observed function. These data indicate that SNAP-25 is crucial for the regulation of intracellular calcium dynamics and, possibly, of network excitability. SNAP-25 is therefore a multifunctional protein that participates in exocytotic function both at the mechanistic and at the regulatory level.	Univ Milan, CNR Inst Neurosci, Ctr Excellence Neurodegenerat Dis, Dept Med Pharmacol, I-20129 Milan, Italy; Inst Nacl Neurol C Besta, Dip Neurofisiol Sperimentale, I-20133 Milan, Italy; INSERM, U536, Inst Fer Moulin, F-75005 Paris, France; Univ Padua, Dip Sci Biomed Sperimentali, I-35121 Padua, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Milan; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Padua	Matteoli, M (corresponding author), Univ Milan, CNR Inst Neurosci, Ctr Excellence Neurodegenerat Dis, Dept Med Pharmacol, Via Vanvitelli 32, I-20129 Milan, Italy.	m.matteoli@in.cnr.it	Coco, Silvia/AAD-6719-2022; Galli, Thierry/Q-2249-2019; Pozzi, Davide/A-7021-2016; Galli, Thierry/G-8842-2011; rossetto, ornella/AAC-3866-2022; Frassoni, Carolina CF/J-8337-2016; Matteoli, Michela/K-4526-2018; verderio, claudia/K-4415-2016	Galli, Thierry/0000-0001-8514-7455; Pozzi, Davide/0000-0001-6436-0556; Galli, Thierry/0000-0001-8514-7455; rossetto, ornella/0000-0002-6113-3857; Frassoni, Carolina CF/0000-0002-9300-5139; Matteoli, Michela/0000-0002-3569-7843; verderio, claudia/0000-0001-7216-5873; COCO, SILVIA/0000-0002-3883-9472				[Anonymous], 1977, HDB PHYSL NERVOUS SY; Armano S, 2002, J BIOL CHEM, V277, P10467, DOI 10.1074/jbc.M110942200; ASHTON AC, 1988, J NEUROCHEM, V50, P1808, DOI 10.1111/j.1471-4159.1988.tb02482.x; Atlas D, 2001, J NEUROCHEM, V77, P972, DOI 10.1046/j.1471-4159.2001.00347.x; Bacci A, 2001, J NEUROSCI, V21, P6588, DOI 10.1523/JNEUROSCI.21-17-06588.2001; BARK IC, 1994, GENE, V139, P291, DOI 10.1016/0378-1119(94)90773-0; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; Benson DL, 1998, J NEUROSCI, V18, P6892; BIGALKE H, 1981, N-S ARCH PHARMACOL, V316, P244, DOI 10.1007/BF00505657; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Charvin N, 1997, EMBO J, V16, P4591, DOI 10.1093/emboj/16.15.4591; CHIEREGATTI E, 2004, IN PRESS MOL BIOL CE; Deitcher DL, 1998, J NEUROSCI, V18, P2028; Galli T, 1998, MOL BIOL CELL, V9, P1437, DOI 10.1091/mbc.9.6.1437; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Ji JZ, 2002, DIABETES, V51, P1425, DOI 10.2337/diabetes.51.5.1425; Ji JZ, 2002, J BIOL CHEM, V277, P20195, DOI 10.1074/jbc.M201034200; JONES EG, 1994, J NEUROSCI, V14, P611; Kavalali ET, 2002, BIOESSAYS, V24, P926, DOI 10.1002/bies.10165; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Nonet ML, 1998, J NEUROSCI, V18, P70; Ortino B, 2003, EUR J NEUROSCI, V18, P323, DOI 10.1046/j.1460-9568.2003.02748.x; OsenSand A, 1996, J COMP NEUROL, V367, P222, DOI 10.1002/(SICI)1096-9861(19960401)367:2<222::AID-CNE5>3.0.CO;2-7; Proux-Gillardeaux V, 2003, BIOCHEM J, V370, P213, DOI 10.1042/BJ20021309; Sadoul K, 1997, J BIOL CHEM, V272, P33023, DOI 10.1074/jbc.272.52.33023; Schenk U, 2003, EMBO J, V22, P558, DOI 10.1093/emboj/cdg059; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Sheng ZH, 1997, P NATL ACAD SCI USA, V94, P5405, DOI 10.1073/pnas.94.10.5405; Sheng ZH, 1998, J BIOENERG BIOMEMBR, V30, P335, DOI 10.1023/A:1021985521748; Sik A, 1998, P NATL ACAD SCI USA, V95, P3245, DOI 10.1073/pnas.95.6.3245; Sorensen JB, 2002, P NATL ACAD SCI USA, V99, P1627, DOI 10.1073/pnas.251673298; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Steegmaier M, 1998, J BIOL CHEM, V273, P34171, DOI 10.1074/jbc.273.51.34171; Su QN, 2001, P NATL ACAD SCI USA, V98, P14038, DOI 10.1073/pnas.251532398; Takamori S, 2000, J NEUROSCI, V20, P4904; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Verderio C, 1999, J NEUROSCI, V19, P6723, DOI 10.1523/JNEUROSCI.19-16-06723.1999; WALCHSOLIMENA C, 1995, J CELL BIOL, V128, P637, DOI 10.1083/jcb.128.4.637; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721	42	161	167	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 19	2004	41	4					599	610		10.1016/S0896-6273(04)00077-7	http://dx.doi.org/10.1016/S0896-6273(04)00077-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980208	Bronze			2022-12-24	WOS:000221458100012
J	de Lafuente, V; Romo, R				de Lafuente, V; Romo, R			Language abilities of motor cortex	NEURON			English	Editorial Material							VENTRAL PREMOTOR CORTEX; MOVEMENT		Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	de Lafuente, V (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.		de la Fuente, Javier/GQP-6328-2022	romo, ranulfo/0000-0003-3529-3635; de Lafuente, Victor/0000-0002-1047-1354				Georgopoulos AP, 1999, NEWS PHYSIOL SCI, V14, P64; Graziano MSA, 2002, NEURON, V36, P349, DOI 10.1016/S0896-6273(02)01003-6; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Naito E, 2002, NEURON, V36, P979, DOI 10.1016/S0896-6273(02)00980-7; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; Romo R, 2004, NEURON, V41, P165, DOI 10.1016/S0896-6273(03)00817-1; Salinas E, 1998, J NEUROSCI, V18, P499; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239	12	25	25	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 22	2004	41	2					178	180		10.1016/S0896-6273(04)00004-2	http://dx.doi.org/10.1016/S0896-6273(04)00004-2			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741098	Bronze			2022-12-24	WOS:000221457800003
J	Kuromi, H; Honda, A; Kidokoro, Y				Kuromi, H; Honda, A; Kidokoro, Y			Ca2+ influx through distinct routes controls exocytosis and endocytosis at Drosophila presynaptic terminals	NEURON			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; SYNAPTIC VESICLE EXOCYTOSIS; CALCIUM-CHANNEL; TRANSMITTER RELEASE; NERVE-TERMINALS; LANTHANUM IONS; MULTIPLE FORMS; MUTANT; LOCALIZATION; DYNAMIN	Endocytosis of synaptic vesicles follows exocytosis, and both processes require external Ca2+. However, it is not known whether Ca2+ influx through one route initiates both processes. At larval Drosophila neuromuscular junctions, we separately measured exocytosis and endocytosis using FM1-43. In a temperature-sensitive Ca2+ channel mutant, cacophony(TS2), exocytosis induced by high K+ decreased at nonpermissive temperatures, while endocytosis remained unchanged. In wild-type larvae, a spider toxin, PLTXII, preferentially inhibited exocytosis, whereas the Ca2+ channel blockers flunarizine and La3+ selectively depressed endocytosis. None of these blockers affected exocytosis or endocytosis induced by a Ca2+ ionophore. Evoked synaptic potentials were depressed regardless of stimulus frequency in cacophony(TS2) at nonpermissive temperatures and in wild-type by PLTXII, whereas flunarizine or La3+ gradually depressed synaptic potentials only during high-frequency stimulation, suggesting depletion of synaptic vesicles due to blockade of endocytosis. In shibire(ts1), a dynamin mutant, flunarizine or La3+ inhibited assembly of clathrin at the plasma membrane during stimulation without affecting dynamin function.	Gunma Univ, Sch Med, Inst Behav Sci, Maebashi, Gumma 3718511, Japan	Gunma University	Kuromi, H (corresponding author), Gunma Univ, Sch Med, Inst Behav Sci, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	kuromi@med.gunma-u.ac.jp						BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BRANTON WD, 1987, J NEUROSCI, V7, P4195; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; COHEN MW, 1991, J NEUROSCI, V11, P1032; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Estes PS, 1996, J NEUROSCI, V16, P5443; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; HAYDON PG, 1994, NEURON, V13, P1275, DOI 10.1016/0896-6273(94)90414-6; HEUSER J, 1980, J CELL BIOL, V84, P560, DOI 10.1083/jcb.84.3.560; HEUSER J, 1971, PROC R SOC SER B-BIO, V179, P247, DOI 10.1098/rspb.1971.0096; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hsu SF, 1996, J PHYSIOL-LONDON, V494, P539, DOI 10.1113/jphysiol.1996.sp021512; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; JOHNSON LV, 1980, P NATL ACAD SCI-BIOL, V77, P990, DOI 10.1073/pnas.77.2.990; KATZ B, 1965, PROC R SOC SER B-BIO, V161, P496, DOI 10.1098/rspb.1965.0017; Kawasaki F, 2000, J NEUROSCI, V20, P4885; KOENIG JH, 1983, J CELL BIOL, V96, P1517, DOI 10.1083/jcb.96.6.1517; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; KOSAKA T, 1983, J CELL BIOL, V97, P499, DOI 10.1083/jcb.97.2.499; KRIEBEL ME, 1983, NEUROSCIENCE, V9, P535, DOI 10.1016/0306-4522(83)90172-0; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Kuromi H, 2000, NEURON, V27, P133, DOI 10.1016/S0896-6273(00)00015-5; Kuromi H, 2002, NEURON, V35, P333, DOI 10.1016/S0896-6273(02)00777-8; LEUNG HT, 1989, NEURON, V3, P767, DOI 10.1016/0896-6273(89)90245-6; MUNDIGL O, 1995, EUR J CELL BIOL, V66, P246; NARAHASHI T, 1974, PHYSIOL REV, V54, P813, DOI 10.1152/physrev.1974.54.4.813; Neale EA, 1999, J CELL BIOL, V147, P1249, DOI 10.1083/jcb.147.6.1249; POODRY CA, 1979, J CELL BIOL, V81, P520, DOI 10.1083/jcb.81.3.520; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Sand O, 2001, J PHYSIOL-LONDON, V536, P21, DOI 10.1111/j.1469-7793.2001.00021.x; Santi CM, 2002, J NEUROSCI, V22, P396, DOI 10.1523/JNEUROSCI.22-02-00396.2002; Smith C, 1997, J CELL BIOL, V139, P885, DOI 10.1083/jcb.139.4.885; Smith LA, 1996, J NEUROSCI, V16, P7868; Sone M, 2000, DEVELOPMENT, V127, P4157; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Stimson DT, 2001, J NEUROSCI, V21, P3034, DOI 10.1523/JNEUROSCI.21-09-03034.2001; Teng HB, 2000, J NEUROSCI, V20, P7986; Thaler C, 2001, J NEUROSCI, V21, P412, DOI 10.1523/JNEUROSCI.21-02-00412.2001; THOMAS P, 1990, NEURON, V5, P723, DOI 10.1016/0896-6273(90)90226-6; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Wu LG, 1999, J NEUROSCI, V19, P726	44	48	50	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2004	41	1					101	111		10.1016/S0896-6273(03)00815-8	http://dx.doi.org/10.1016/S0896-6273(03)00815-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715138	Bronze			2022-12-24	WOS:000187942800012
J	Ramnani, N; Miall, RC				Ramnani, N; Miall, RC			A system in the human brain for predicting the actions of others	NATURE NEUROSCIENCE			English	Article							PREMOTOR CORTEX; CORTICAL MECHANISMS; PREFRONTAL CORTEX; BIOLOGICAL MOTION; NEURONAL-ACTIVITY; RHESUS-MONKEY; MIND; AREAS; PERCEPTION; MOVEMENT	The ability to attribute mental states to others, and therefore to predict others' behavior, is particularly advanced in humans. A controversial but untested idea is that this is achieved by simulating the other person's mental processes in one's own mind. If this is the case, then the same neural systems activated by a mental function should re-activate when one thinks about that function performed by another. Here, using functional magnetic resonance imaging (fMRI), we tested whether the neural processes involved in preparing one's own actions are also used for predicting the future actions of others. We provide compelling evidence that areas within the action control system of the human brain are indeed activated when predicting others' actions, but a different action sub-system is activated when preparing one's own actions.	Univ Oxford, John Radcliffe Hosp, Ctr FMRI Brain, Oxford OX3 9DU, England; Univ Oxford, Physiol Lab, Oxford OX1 3TP, England	University of Oxford; University of Oxford	Ramnani, N (corresponding author), Univ Oxford, John Radcliffe Hosp, Ctr FMRI Brain, Headley Way, Oxford OX3 9DU, England.		Miall, R. Chris/B-7449-2013	Miall, R. Chris/0000-0003-3002-1251; Ramnani, Narender/0000-0003-0425-203X				Abell F, 1999, NEUROREPORT, V10, P1647, DOI 10.1097/00001756-199906030-00005; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Barbas H, 1999, J COMP NEUROL, V410, P343, DOI 10.1002/(SICI)1096-9861(19990802)410:3<343::AID-CNE1>3.0.CO;2-1; BARBAS H, 1987, J COMP NEUROL, V256, P211, DOI 10.1002/cne.902560203; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; CARRUTHERS P, 1996, THEORIES THEORIES MI; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; CHEN CT, 1991, J CHEM ENG JPN, V24, P284, DOI 10.1252/jcej.24.284; Davies M., 1995, FOLK PSYCHOL THEORY; Davies M., 1995, FOLK PSYCHOL; Dennett Daniel C., 1987, INTENTIONAL STANCE; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Frith U, 2001, NEURON, V32, P969, DOI 10.1016/S0896-6273(01)00552-9; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallagher HL, 2002, NEUROIMAGE, V16, P814, DOI 10.1006/nimg.2002.1117; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; GEFFEN GM, 1994, BEHAV BRAIN RES, V64, P131, DOI 10.1016/0166-4328(94)90125-2; Gerloff C, 1998, J PHYSIOL-LONDON, V510, P249, DOI 10.1111/j.1469-7793.1998.249bz.x; Grafton ST, 1998, J NEUROPHYSIOL, V79, P1092, DOI 10.1152/jn.1998.79.2.1092; Grezes J, 2001, NEUROIMAGE, V13, P775, DOI 10.1006/nimg.2000.0740; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Happe F, 1996, NEUROREPORT, V8, P197, DOI 10.1097/00001756-199612200-00040; Hoshi E, 2002, J NEUROPHYSIOL, V87, P1123, DOI 10.1152/jn.00496.2001; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2001, P NATL ACAD SCI USA, V98, P13995, DOI 10.1073/pnas.241474598; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Josephs O, 1999, PHILOS T R SOC B, V354, P1215, DOI 10.1098/rstb.1999.0475; LU T, 1994, J COMP NEUROL, V341, P375; Luppino G, 2001, EUR J NEUROSCI, V14, P1035, DOI 10.1046/j.0953-816x.2001.01734.x; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Miall RC, 2003, NEUROREPORT, V14, P2135, DOI 10.1097/00001756-200312020-00001; MITZ AR, 1991, J NEUROSCI, V11, P1855; Passingham R., 1995, FRONTAL LOBES VOLUNT; Passingham RE, 1996, PHILOS T ROY SOC B, V351, P1473, DOI 10.1098/rstb.1996.0132; PASSINGHAM RE, 1986, BEHAV NEUROSCI, V100, P695, DOI 10.1037/0735-7044.100.5.695; PETRIDES M, 1985, BEHAV BRAIN RES, V16, P95, DOI 10.1016/0166-4328(85)90085-3; Petrides M, 1999, EUR J NEUROSCI, V11, P1011, DOI 10.1046/j.1460-9568.1999.00518.x; Ramnani N, 2003, CEREB CORTEX, V13, P318, DOI 10.1093/cercor/13.3.318; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Schmahmann J.D., 2000, MRI ATLAS HUMAN CERE; Stich S., 1992, MIND LANG, V7, P35, DOI [DOI 10.1111/J.1468-0017.1992.TB00196, DOI 10.1111/J.1468-0017.1992.TB00196.X]; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; Wise SP, 1996, CAN J PHYSIOL PHARM, V74, P469, DOI 10.1139/cjpp-74-4-469	50	197	199	0	20	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					85	90		10.1038/nn1168	http://dx.doi.org/10.1038/nn1168			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14699420				2022-12-24	WOS:000187636000018
J	Muller, MB; Zimmermann, S; Sillaber, I; Hagemeyer, TP; Deussing, JM; Timpl, P; Kormann, MSD; Droste, SK; Kuhn, R; Reul, JMHM; Holsboer, F; Wurst, W				Muller, MB; Zimmermann, S; Sillaber, I; Hagemeyer, TP; Deussing, JM; Timpl, P; Kormann, MSD; Droste, SK; Kuhn, R; Reul, JMHM; Holsboer, F; Wurst, W			Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress	NATURE NEUROSCIENCE			English	Article							PARAVENTRICULAR NUCLEUS; MINERALOCORTICOID RECEPTOR; ANTAGONIST R121919; CHRONIC INFUSION; REDUCED ANXIETY; MICE DEFICIENT; NERVOUS-SYSTEM; MATERNAL-CARE; PITUITARY; AMYGDALA	Corticotropin-releasing hormone (CRH) is centrally involved in coordinating responses to a variety of stress-associated stimuli. Recent clinical data implicate CRH in the pathophysiology of human affective disorders. To differentiate the CNS pathways involving CRH and CRH receptor 1 (Crhr1) that modulate behavior from those that regulate neuroendocrine function, we generated a conditional knockout mouse line (Crhr1(loxP/loxP) Camk2a-cre) in which Crhr1 function is inactivated postnatally in anterior forebrain and limbic brain structures, but not in the pituitary. This leaves the hypothalamic-pituitary-adrenocortical (HPA) system intact. Crhr1(loxP/loxP) Camk2a-cre mutants showed reduced anxiety, and the basal activity of their HPA system was normal. In contrast to Crhr1 null mutants, conditional mutants were hypersensitive to stress corticotropin and corticosterone levels remained significantly elevated after stress. Our data clearly show that limbic Crhr1 modulates anxiety-related behavior and that this effect is independent of HPA system function. Furthermore, we provide evidence for a new role of limbic Crhr1 in neuroendocrine adaptation to stress.	Max Planck Inst Psychiat, D-80804 Munich, Germany; GSF Forschungszentrum, Inst Dev Genet, D-85764 Neuherberg, Germany	Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Wurst, W (corresponding author), Max Planck Inst Psychiat, Kraepelinstr 2-10, D-80804 Munich, Germany.	wurst@gsf.de	Reul, Johannes/B-4132-2019; Kühn, Ralf/U-1278-2017; Kormann, Michael SD/C-7723-2014; Deussing, Jan M/ABB-5993-2021; Müller, Marianne B./AAL-8911-2021	Reul, Johannes/0000-0002-8787-4012; Kühn, Ralf/0000-0003-1694-9803; Müller, Marianne B./0000-0002-0269-6131; Wurst, Wolfgang/0000-0003-4422-7410; Deussing, Jan/0000-0002-9329-5252				Avishai-Eliner S, 2002, TRENDS NEUROSCI, V25, P518, DOI 10.1016/S0166-2236(02)02241-5; Brunson KL, 2001, MOL PSYCHIATR, V6, P647, DOI 10.1038/sj.mp.4000942; Caldji C, 2000, BIOL PSYCHIAT, V48, P1164, DOI 10.1016/S0006-3223(00)01084-2; Chen JC, 2000, J COMP NEUROL, V420, P305, DOI 10.1002/(SICI)1096-9861(20000508)420:3<305::AID-CNE3>3.0.CO;2-8; COLE JC, 1995, PHARMACOL BIOCHEM BE, V52, P473, DOI 10.1016/0091-3057(95)00163-Q; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; DEKLOET ER, 1987, PSYCHONEUROENDOCRINO, V12, P83, DOI 10.1016/0306-4530(87)90040-0; DUNN AJ, 1990, BRAIN RES REV, V15, P71, DOI 10.1016/0165-0173(90)90012-D; Gesing A, 2001, J NEUROSCI, V21, P4822, DOI 10.1523/JNEUROSCI.21-13-04822.2001; Gray TS, 1996, CRIT REV NEUROBIOL, V10, P155, DOI 10.1615/CritRevNeurobiol.v10.i2.10; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; Hascoet M, 2001, PROG NEURO-PSYCHOPH, V25, P141, DOI 10.1016/S0278-5846(00)00151-2; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; HERMAN JP, 1992, BRAIN RES, V592, P228, DOI 10.1016/0006-8993(92)91680-D; HILL DP, 1993, METHOD ENZYMOL, V225, P664; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Holsboer F, 1999, J PSYCHIATR RES, V33, P181, DOI 10.1016/S0022-3956(98)90056-5; JOELS M, 1992, TRENDS NEUROSCI, V15, P25, DOI 10.1016/0166-2236(92)90345-9; Joels M, 2001, J NEUROENDOCRINOL, V13, P657, DOI 10.1046/j.1365-2826.2001.00688.x; Keck ME, 2001, EUR J NEUROSCI, V13, P373, DOI 10.1046/j.0953-816X.2000.01383.x; Korte SM, 2001, NEUROSCI BIOBEHAV R, V25, P117, DOI 10.1016/S0149-7634(01)00002-1; Korte SM, 1996, PHARMACOL BIOCHEM BE, V54, P261, DOI 10.1016/0091-3057(95)02172-8; KRESSE A, 1995, BRAIN RES BULL, V36, P261, DOI 10.1016/0361-9230(94)00201-B; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; LIEBSCH G, 1995, REGUL PEPTIDES, V59, P229, DOI 10.1016/0167-0115(95)00099-W; Liebsch G, 1999, J PSYCHIAT RES, V33, P153, DOI 10.1016/S0022-3956(98)80047-2; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lopez JF, 1998, BIOL PSYCHIAT, V43, P547, DOI 10.1016/S0006-3223(97)00484-8; Lopez JF, 1999, BIOL PSYCHIAT, V46, P1461, DOI 10.1016/S0006-3223(99)00266-8; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Muller MB, 2000, ENDOCRINOLOGY, V141, P4262, DOI 10.1210/en.141.11.4262; OWENS MJ, 1991, PHARMACOL REV, V43, P425; Preil J, 2001, ENDOCRINOLOGY, V142, P4946, DOI 10.1210/en.142.11.4946; RAADSHEER FC, 1995, AM J PSYCHIAT, V152, P1372; RAADSHEER FC, 1994, NEUROENDOCRINOLOGY, V60, P436, DOI 10.1159/000126778; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Sillaber I, 2002, SCIENCE, V296, P931, DOI 10.1126/science.1069836; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; Sola C, 1999, J NEUROSCI RES, V57, P651, DOI 10.1002/(SICI)1097-4547(19990901)57:5<651::AID-JNR7>3.0.CO;2-G; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U; Zobel AW, 2000, J PSYCHIATR RES, V34, P171, DOI 10.1016/S0022-3956(00)00016-9	44	353	364	0	20	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1100	1107		10.1038/nn1123	http://dx.doi.org/10.1038/nn1123			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	12973355				2022-12-24	WOS:000185633600023
J	Comoli, E; Coizet, V; Boyes, J; Bolam, JP; Canteras, NS; Quirk, RH; Overton, PG; Redgrave, P				Comoli, E; Coizet, V; Boyes, J; Bolam, JP; Canteras, NS; Quirk, RH; Overton, PG; Redgrave, P			A direct projection from superior colliculus to substantia nigra for detecting salient visual events	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; DOPAMINERGIC-NEURONS; BASAL GANGLIA; REWARD; RAT; RESPONSES; CORTEX; BRAIN; CAT; ORGANIZATION	Midbrain dopaminergic neurons respond to unexpected and biologically salient events, but little is known about the sensory systems underlying this response. Here we describe, in the rat, a direct projection from a primary visual structure, the midbrain superior colliculus (SC), to the substantia nigra pars compacta (SNc) where direct synaptic contacts are made with both dopaminergic and non-dopaminergic neurons. Complementary electrophysiological data reveal that short-latency visual responses in the SNc are abolished by ipsilateral lesions of the SC and increased by local collicular stimulation. These results show that the tectonigral projection is ideally located to relay short-latency visual information to dopamine-containing regions of the ventral midbrain. We conclude that it is within this afferent sensory circuitry that the critical perceptual discriminations that identify stimuli as both unpredicted and biologically salient are made.	Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England; Univ Oxford, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England; Univ Sao Paulo, Dept Physiol & Biophys, Inst Biomed Sci, BR-05508900 Sao Paulo, Brazil	University of Sheffield; University of Oxford; Universidade de Sao Paulo	Redgrave, P (corresponding author), Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England.		Canteras, Newton/F-2402-2013; Comoli, Eliane/D-4405-2012; Coizet, Véronique/T-1601-2019	Coizet, Véronique/0000-0001-5192-6610; Canteras, Newton/0000-0002-7205-5372; Comoli, Eliane/0000-0002-3254-7487; Overton, Paul/0000-0003-4334-261X; Bolam, J Paul/0000-0002-5008-8405				ADAMS JC, 1992, J HISTOCHEM CYTOCHEM, V40, P1457, DOI 10.1177/40.10.1527370; Bar-Gad I, 2001, CURR OPIN NEUROBIOL, V11, P689, DOI 10.1016/S0959-4388(01)00270-7; Basso MA, 1998, NEURON, V21, P665, DOI 10.1016/S0896-6273(00)80583-8; BOLAM JP, 1992, EXPT NEUROANATOMY PR, P1; CAMERON AA, 1995, J COMP NEUROL, V351, P568, DOI 10.1002/cne.903510407; Ciaramitaro VM, 1997, J COMP NEUROL, V387, P568, DOI 10.1002/(SICI)1096-9861(19971103)387:4<568::AID-CNE7>3.0.CO;2-0; Clarke NP, 1996, EUR J NEUROSCI, V8, P1363, DOI 10.1111/j.1460-9568.1996.tb01599.x; Coizet V, 2003, EUR J NEUROSCI, V17, P28, DOI 10.1046/j.1460-9568.2003.02415.x; DEAN P, 1989, TRENDS NEUROSCI, V12, P137, DOI 10.1016/0166-2236(89)90052-0; Dreher JC, 2002, EUR J NEUROSCI, V16, P1609, DOI 10.1046/j.1460-9568.2002.02212.x; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; FREEMAN AS, 1985, LIFE SCI, V36, P1983, DOI 10.1016/0024-3205(85)90448-5; Gonzalez-Hernandez T, 2000, J COMP NEUROL, V421, P107, DOI 10.1002/(SICI)1096-9861(20000522)421:1<107::AID-CNE7>3.0.CO;2-F; GOODALE MA, 1973, EXP BRAIN RES, V17, P75; Guarraci FA, 1999, BEHAV BRAIN RES, V99, P169, DOI 10.1016/S0166-4328(98)00102-8; HARDY SC, 1988, J COMP NEUROL, V273, P527, DOI 10.1002/cne.902730408; Heilman K, 1994, NEUROPSYCHOLOGY, P139; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Horvitz JC, 1997, BRAIN RES, V759, P251, DOI 10.1016/S0006-8993(97)00265-5; HSU SM, 1981, AM J CLIN PATHOL, V75, P816, DOI 10.1093/ajcp/75.6.816; JAY MF, 1987, J NEUROPHYSIOL, V57, P22, DOI 10.1152/jn.1987.57.1.22; Mana S, 2001, NEUROSCIENCE, V103, P673, DOI 10.1016/S0306-4522(01)00026-4; Matsuura T, 1999, JPN J PHYSIOL, V49, P289, DOI 10.2170/jjphysiol.49.289; Overton PG, 1997, BRAIN RES REV, V25, P312, DOI 10.1016/S0165-0173(97)00039-8; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; REDGRAVE P, 1993, PROG BRAIN RES, V95, P69, DOI 10.1016/S0079-6123(08)60358-1; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; SCHNEIDER GE, 1969, SCIENCE, V163, P895, DOI 10.1126/science.163.3870.895; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SPRAGUE JM, 1966, SCIENCE, V153, P1544, DOI 10.1126/science.153.3743.1544; Stein BE., 1993, MERGING SENSES; Thorpe SJ, 2001, SCIENCE, V291, P260, DOI 10.1126/science.1058249; Tsumori T, 2001, BRAIN RES, V903, P168, DOI 10.1016/S0006-8993(01)02437-4; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; WEINBERG RJ, 1991, J HISTOCHEM CYTOCHEM, V39, P1143, DOI 10.1177/39.8.1906909; Wittmann M, 1999, CHRONOBIOL INT, V16, P17, DOI 10.3109/07420529908998709; WURTZ RH, 1972, INVEST OPHTH VISUAL, V11, P441; ZILLES K, 1990, CEREBRAL CORTEX RAT, P77	43	206	209	0	19	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					974	980		10.1038/nn1113	http://dx.doi.org/10.1038/nn1113			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715KH	12925855				2022-12-24	WOS:000184970400017
J	Setlow, B; Schoenbaum, G; Gallagher, M				Setlow, B; Schoenbaum, G; Gallagher, M			Neural encoding in ventral striatum during olfactory discrimination learning	NEURON			English	Article							RAT NUCLEUS-ACCUMBENS; CONDITIONED PLACE PREFERENCE; TO-SAMPLE TASK; ORBITOFRONTAL CORTEX; BASOLATERAL AMYGDALA; PREFRONTAL CORTEX; NEURONAL-ACTIVITY; BASAL GANGLIA; EXCITOTOXIC LESIONS; REWARD MAGNITUDE	A growing body of evidence implicates the ventral striatum in using information acquired through associative learning. The present study examined the activity of ventral striatal neurons in awake, behaving rats during go/no-go odor discrimination learning and reversal. Many neurons fired selectively to odor cues predictive of either appetitive (sucrose) or aversive (quinine) outcomes. Few neurons were selective when first exposed to the odors, but many acquired this differential activity as rats learned the significance of the cues. A substantial proportion of these neurons encoded the cues' learned motivational significance, and these neurons tended to reverse their firing selectivity after reversal of odor-outcome contingencies. Other neurons that became selectively activated during learning did not reverse, but instead appeared to encode specific combinations of cues and associated motor responses. The results support a role for ventral striatum in using the learned significance, both appetitive and aversive, of predictive cues to guide behavior.	Johns Hopkins Univ, Dept Psychol, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Brain Sci, Baltimore, MD 21218 USA; Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore	Setlow, B (corresponding author), Johns Hopkins Univ, Dept Psychol, Baltimore, MD 21218 USA.	bsetlow@jhu.edu		Setlow, Barry/0000-0001-9133-9445	NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH012699, R01MH060179] Funding Source: NIH RePORTER; NIA NIH HHS [AG 00882] Funding Source: Medline; NIMH NIH HHS [MH 60179, MH 12699] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Apicella P, 2002, EUR J NEUROSCI, V16, P2017, DOI 10.1046/j.1460-9568.2002.02262.x; BERENDSE HW, 1992, J COMP NEUROL, V316, P314, DOI 10.1002/cne.903160305; Blazquez PM, 2002, NEURON, V33, P973, DOI 10.1016/S0896-6273(02)00627-X; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Carelli RM, 2002, PHYSIOL BEHAV, V76, P379, DOI 10.1016/S0031-9384(02)00760-6; Chang JY, 2002, EXP BRAIN RES, V142, P67, DOI 10.1007/s00221-001-0918-3; Corbit LH, 2000, J NEUROSCI, V20, P4233; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; de Borchgrave R, 2002, EXP BRAIN RES, V144, P50, DOI 10.1007/s00221-002-1031-y; DeCoteau WE, 1997, BEHAV BRAIN RES, V88, P239, DOI 10.1016/S0166-4328(97)00044-2; Fuchs RA, 2002, BRAIN RES, V929, P15, DOI 10.1016/S0006-8993(01)03366-2; Goto Y, 2002, P NATL ACAD SCI USA, V99, P13189, DOI 10.1073/pnas.202303199; Hassani OK, 2001, J NEUROPHYSIOL, V85, P2477, DOI 10.1152/jn.2001.85.6.2477; Hauber W, 2000, J NEUROSCI, V20, P6282, DOI 10.1523/JNEUROSCI.20-16-06282.2000; Hernandez PJ, 2002, NAT NEUROSCI, V5, P1327, DOI 10.1038/nn973; HOLLAND PC, 1979, J EXP PSYCHOL ANIM B, V5, P65, DOI 10.1037/0097-7403.5.1.65; Horvitz JC, 2002, BEHAV BRAIN RES, V137, P65, DOI 10.1016/S0166-4328(02)00285-1; Jackson ME, 2001, J NEUROSCI, V21, P676, DOI 10.1523/JNEUROSCI.21-02-00676.2001; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; Kelley AE, 1999, ANN NY ACAD SCI, V877, P71, DOI 10.1111/j.1749-6632.1999.tb09262.x; KELLEY AE, 1982, NEUROSCIENCE, V7, P615, DOI 10.1016/0306-4522(82)90067-7; LAVOIE AM, 1994, BRAIN RES, V638, P157, DOI 10.1016/0006-8993(94)90645-9; LORENZINI CA, 1995, NEUROBIOL LEARN MEM, V63, P87, DOI 10.1006/nlme.1995.1008; Miyazaki K, 1998, NEUROREPORT, V9, P3943, DOI 10.1097/00001756-199812010-00032; Mobini S, 2002, PSYCHOPHARMACOLOGY, V160, P290, DOI 10.1007/s00213-001-0983-0; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; O'Donnell P, 1999, PSYCHOBIOLOGY, V27, P187; ODONNELL P, 1995, J NEUROSCI, V15, P3622; ONO T, 1995, PROG NEUROBIOL, V46, P401, DOI 10.1016/0301-0082(95)00008-J; OTTO T, 1992, BEHAV NEUROSCI, V106, P762, DOI 10.1037/0735-7044.106.5.762; Parkinson JA, 1999, PSYCHOBIOLOGY, V27, P256; Paxinos G., 1998, RAT BRAIN STEROTAXIC; PENNARTZ CMA, 1994, PROG NEUROBIOL, V42, P719, DOI 10.1016/0301-0082(94)90025-6; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Ravel S, 1999, EXP BRAIN RES, V128, P531, DOI 10.1007/s002210050876; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Sage JR, 2000, BEHAV NEUROSCI, V114, P295, DOI 10.1037/0735-7044.114.2.295; Salamone JD, 1997, NEUROSCI BIOBEHAV R, V21, P341, DOI 10.1016/S0149-7634(96)00017-6; Schoenbaum G, 2003, LEARN MEMORY, V10, P129, DOI 10.1101/lm.55203; Schoenbaum G, 2001, LEARN MEMORY, V8, P134, DOI 10.1101/lm.39901; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Schoenbaum G, 2000, J NEUROSCI, V20, P5179; Schoenbaum G, 2001, METH NE FRO NEUROSCI, P371; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Setlow B, 2002, EUR J NEUROSCI, V15, P1841, DOI 10.1046/j.1460-9568.2002.02010.x; Setlow B, 2002, BEHAV NEUROSCI, V116, P267, DOI 10.1037//0735-7044.116.2.267; Shidara M, 1998, J NEUROSCI, V18, P2613; Tremblay L, 1998, J NEUROPHYSIOL, V80, P964, DOI 10.1152/jn.1998.80.2.964; Tzschentke TM, 1998, PROG NEUROBIOL, V56, P613, DOI 10.1016/S0301-0082(98)00060-4; Watanabe M, 2001, EXP BRAIN RES, V140, P511, DOI 10.1007/s002210100856; WHITE IM, 1994, EXP BRAIN RES, V99, P179; WILLIAMS GV, 1993, BEHAV BRAIN RES, V55, P243, DOI 10.1016/0166-4328(93)90120-F; WILSON CJ, 1990, J NEUROSCI, V10, P508; Woodward DJ, 1999, ANN NY ACAD SCI, V877, P91, DOI 10.1111/j.1749-6632.1999.tb09263.x; Wright CI, 1996, J NEUROSCI, V16, P1877; Wyvell CL, 2000, J NEUROSCI, V20, P8122	62	176	177	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 22	2003	38	4					625	636		10.1016/S0896-6273(03)00264-2	http://dx.doi.org/10.1016/S0896-6273(03)00264-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	682QV	12765613	Bronze			2022-12-24	WOS:000183104000012
J	Chi, P; Greengard, P; Ryan, TA				Chi, P; Greengard, P; Ryan, TA			Synaptic vesicle mobilization is regulated by distinct synapsin I phosphorylation pathways at different frequencies	NEURON			English	Article							TERMINAL-SPECIFIC PHOSPHOPROTEIN; ISOLATED NERVE-TERMINALS; F-ACTIN; GENE FAMILY; PROTEIN-I; SITES; KINASE; PHOSPHOLIPIDS; ASSOCIATION; CALMODULIN	During action potential firing, the rate of synapsin dissociation from synaptic vesicles and dispersion into axons controls the rate of vesicle availability for exocytosis at the plasma membrane. Here we show that synapsin la's dispersion rate tracks the synaptic vesicle pool turnover rate linearly over the range 5-20 Hz and that the molecular basis for this lies in regulation at both the calcium-calmodulin-dependent kinase (CaM kinase) and the mitogen-activated protein (MAP) kinase/calcineurin sites. Our results show that CaM kinase sites control vesicle mobilization at low stimulus frequency, while MAP kinase/calcineurin sites are critical at both lower and higher stimulus frequencies. Thus, multiple signaling pathways serve to allow synapsin's control of vesicle mobilization over different stimulus frequencies.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Rockefeller Univ, Lab Cellular & Mol Neurosci, New York, NY 10021 USA	Cornell University; Rockefeller University	Ryan, TA (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10021 USA.	taryan@med.cornell.edu	Ryan, Timothy/AAO-8286-2020	Ryan, Timothy/0000-0003-2533-9548	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH039327, R01MH039327] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM61925] Funding Source: Medline; NIMH NIH HHS [MH39327] Funding Source: Medline; NINDS NIH HHS [NS24692] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAHLER M, 1987, NATURE, V326, P704, DOI 10.1038/326704a0; BAHLER M, 1989, J CELL BIOL, V108, P1841, DOI 10.1083/jcb.108.5.1841; BENFENATI F, 1989, J CELL BIOL, V108, P1863, DOI 10.1083/jcb.108.5.1863; BENFENATI F, 1989, J CELL BIOL, V108, P1851, DOI 10.1083/jcb.108.5.1851; BENFENATI F, 1993, J CELL BIOL, V123, P1845, DOI 10.1083/jcb.123.6.1845; BENFENATI F, 1989, CELL BIOL INT REP, V13, P1007, DOI 10.1016/0309-1651(89)90016-7; CECCALDI PE, 1995, J CELL BIOL, V128, P905, DOI 10.1083/jcb.128.5.905; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; CHILCOTE TJ, 1994, J NEUROCHEM, V63, P1568; CZERNIK AJ, 1987, P NATL ACAD SCI USA, V84, P7518, DOI 10.1073/pnas.84.21.7518; CZERNIK AJ, 1991, METHOD ENZYMOL B, V201, P264; DECAMILLI P, 1983, J CELL BIOL, V96, P1337, DOI 10.1083/jcb.96.5.1337; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; GREENGARD P, 1987, MOL NEUROBIOL, V1, P81, DOI 10.1007/BF02935265; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; Hilfiker S, 1998, NAT NEUROSCI, V1, P29, DOI 10.1038/229; Hosaka M, 1999, J BIOL CHEM, V274, P16747, DOI 10.1074/jbc.274.24.16747; Hosaka M, 1999, NEURON, V24, P377, DOI 10.1016/S0896-6273(00)80851-X; Hosaka M, 1998, J BIOL CHEM, V273, P13371, DOI 10.1074/jbc.273.22.13371; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; Jovanovic JN, 2001, J NEUROSCI, V21, P7944, DOI 10.1523/JNEUROSCI.21-20-07944.2001; Kao HT, 1999, J EXP ZOOL, V285, P360, DOI 10.1002/(SICI)1097-010X(19991215)285:4<360::AID-JEZ4>3.3.CO;2-V; Kao HT, 1998, P NATL ACAD SCI USA, V95, P4667, DOI 10.1073/pnas.95.8.4667; MANDELL JW, 1992, J NEUROSCI, V12, P1736; MANDELL JW, 1990, NEURON, V5, P19, DOI 10.1016/0896-6273(90)90030-J; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; Ryan TA, 1999, J NEUROSCI, V19, P1317; Ryan TA, 1996, J CELL BIOL, V134, P1219, DOI 10.1083/jcb.134.5.1219; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; SCHIEBLER W, 1986, J BIOL CHEM, V261, P8383; SIHRA TS, 1989, P NATL ACAD SCI USA, V86, P8108, DOI 10.1073/pnas.86.20.8108; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; THIEL G, 1990, J BIOL CHEM, V265, P16527; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1	36	252	260	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 10	2003	38	1					69	78		10.1016/S0896-6273(03)00151-X	http://dx.doi.org/10.1016/S0896-6273(03)00151-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	666XT	12691665	Bronze			2022-12-24	WOS:000182202300010
J	Herson, PS; Virk, M; Rustay, NR; Bond, CT; Crabbe, JC; Adelman, JP; Maylie, J				Herson, PS; Virk, M; Rustay, NR; Bond, CT; Crabbe, JC; Adelman, JP; Maylie, J			A mouse model of episodic ataxia type-1	NATURE NEUROSCIENCE			English	Article							CEREBELLAR PURKINJE-CELLS; POTASSIUM CHANNEL; GABA(A) RECEPTORS; K+ CHANNELS; KV1.1; MUTATIONS; NEURONS; HIPPOCAMPUS; ALTER; POTENTIALS	Episodic ataxia type-1 (EA1) is a dominant human neurological disorder characterized by stress-induced attacks of ataxia. EA1 is caused by mutations in the voltage-gated potassium channel Kv1.1, and affected individuals are heterozygous. Here we introduced the V408A EA1 mutation into mice using homologous recombination. In contrast to Kv1.1 null mice, homozygous V408A/V408A mice died after embryonic day 3 (E3). V408A/+ mice showed stress-induced loss of motor coordination that was ameliorated by acetazolamide, a carbonic anhydrase inhibitor that minimizes EA1 symptoms in human patients. We made electrophysiological recordings from cerebellar Purkinje cells in both V408A/+ mice and their wild-type littermates. V408A/+ mice showed a greater frequency and amplitude of spontaneous GABAergic inhibitory postsynaptic currents (IPSCs) than did wild type; however, the amplitude or frequency of miniature IPSCs and the basket cell firing frequency did not differ between groups. The stress-induced motor dysfunction in V408A mice is similar to that of family members harboring the EA1 allele, and our findings suggest that these behavioral changes are linked to changes in GABA release.	Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97239 USA; Vet Affairs Med Ctr, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Maylie, J (corresponding author), Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.				NIAAA NIH HHS [P60 AA010760] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA010760] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Adelman JP, 1995, NEURON, V15, P1449, DOI 10.1016/0896-6273(95)90022-5; ALGER BE, 1982, J PHYSIOL-LONDON, V328, P125, DOI 10.1113/jphysiol.1982.sp014256; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; BRUNT ERP, 1990, BRAIN, V113, P1361, DOI 10.1093/brain/113.5.1361; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; D'Adamo MC, 1998, EMBO J, V17, P1200, DOI 10.1093/emboj/17.5.1200; Gancher S T, 1986, Mov Disord, V1, P239, DOI 10.1002/mds.870010404; Hallows JL, 1998, J NEUROSCI, V18, P5682; LLANO I, 1993, J PHYSIOL-LONDON, V468, P201, DOI 10.1113/jphysiol.1993.sp019767; Llano I, 1997, J PHYSIOL-LONDON, V502, P509, DOI 10.1111/j.1469-7793.1997.509bj.x; Maylie B, 2002, J NEUROSCI, V22, P4786, DOI 10.1523/JNEUROSCI.22-12-04786.2002; MICHELSON HB, 1991, SCIENCE, V253, P1420, DOI 10.1126/science.1654594; Munsch T, 1999, J PHYSIOL-LONDON, V519, P505, DOI 10.1111/j.1469-7793.1999.0505m.x; RUSTAY NR, IN PRESS BEHAV BRAIN; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Sun MK, 2001, J PHARMACOL EXP THER, V296, P811; Tan YP, 1999, J PHYSIOL-LONDON, V520, P65, DOI 10.1111/j.1469-7793.1999.00065.x; TSAUR ML, 1992, NEURON, V8, P1055, DOI 10.1016/0896-6273(92)90127-Y; VINCENT P, 1992, J PHYSIOL-LONDON, V456, P453, DOI 10.1113/jphysiol.1992.sp019346; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WANG H, 1994, J NEUROSCI, V14, P4588; Zerr P, 1998, J NEUROSCI, V18, P2842; Zhang CL, 1999, J NEUROSCI, V19, P2852; Zhou L, 2001, J NEUROPHYSIOL, V85, P197, DOI 10.1152/jn.2001.85.1.197	27	105	107	0	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					378	383		10.1038/nn1025	http://dx.doi.org/10.1038/nn1025			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12612586				2022-12-24	WOS:000181833100015
J	Tomizawa, K; Iga, N; Lu, YF; Moriwaki, A; Matsushita, M; Li, ST; Miyamoto, O; Itano, T; Matsui, H				Tomizawa, K; Iga, N; Lu, YF; Moriwaki, A; Matsushita, M; Li, ST; Miyamoto, O; Itano, T; Matsui, H			Oxytocin improves long-lasting spatial memory during motherhood through MAP kinase cascade	NATURE NEUROSCIENCE			English	Article							RAT-BRAIN; SYNAPTIC PLASTICITY; TERM POTENTIATION; MATERNAL-BEHAVIOR; RECEPTOR GENE; ESTROUS-CYCLE; LATE-PHASE; EXPRESSION; MOUSE; TRANSCRIPTION	Oxytocin is an essential hormone for mammalian labor and lactation. Here, we show a new function of oxytocin in causing plastic changes in hippocampal synapses during motherhood. In oxytocin-perfused hippocampal slices, one-train tetanus stimulation induced long-lasting, long-term potentiation (L-LTP) and phosphorylation of cyclic AMP-responsive element binding protein (CREB), and MAP kinase inhibitors blocked these inductions. An increase in CREB phosphorylation and L-LTP induced by one-train tetanus were observed in the multiparous mouse hippocampus without oxytocin application. Furthermore, intracerebroventricular injection of oxytocin in virgin mice improved long-term spatial learning in vivo, whereas an injection of oxytocin antagonist in multiparous mice significantly inhibited the improved spatial memory, L-LTP and CREB phosphorylation. These findings indicate that oxytocin is critically involved in improving hippocampus-dependent learning and memory during motherhood in mice.	Okayama Univ, Grad Sch Med & Dent, Dept Physiol, Okayama 7008558, Japan; Kagawa Med Univ, Dept Biol, Kagawa 7610793, Japan; Japan Sci & Technol Corp, New Technoventure Oriented Res & Dev, Prot Therapy, Okayama 7008558, Japan	Okayama University; Kagawa University; Japan Science & Technology Agency (JST)	Tomizawa, K (corresponding author), Okayama Univ, Grad Sch Med & Dent, Dept Physiol, Shikata Cho 2-5-1, Okayama 7008558, Japan.		Tomizawa, Kazuhito/F-2405-2015	Tomizawa, Kazuhito/0000-0002-5663-2627; Li, Sheng Tian/0000-0002-2836-3802				ABLE T, 1997, CELL, V88, P615; ARGIOLAS A, 1991, NEUROSCI BIOBEHAV R, V15, P217, DOI 10.1016/S0149-7634(05)80002-8; BALE TL, 1995, ENDOCRINOLOGY, V136, P27, DOI 10.1210/en.136.1.27; Bale TL, 2001, J NEUROSCI, V21, P2546, DOI 10.1523/JNEUROSCI.21-07-02546.2001; BARNES CA, 1988, TRENDS NEUROSCI, V11, P163, DOI 10.1016/0166-2236(88)90143-9; Borroni AM, 2000, J NEUROSCI, V20, P9272; Breton C, 1997, ENDOCRINOLOGY, V138, P1857, DOI 10.1210/en.138.5.1857; Diaz-Cabiale Z, 2000, BRAIN RES, V887, P421, DOI 10.1016/S0006-8993(00)03017-1; DURHAM DA, 1991, NEUROENDOCRINOLOGY, V53, P447, DOI 10.1159/000125756; FAHRBACH SE, 1985, NEUROENDOCRINOLOGY, V40, P526, DOI 10.1159/000124125; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Ferguson JN, 2001, J NEUROSCI, V21, P8278; Gainer Harold, 1994, P1099; Gass P, 1998, LEARN MEMORY, V5, P274; Grattan DR, 2002, REPRODUCTION, V123, P497, DOI 10.1530/rep.0.1230497; Guerra-Araiza C, 2000, LIFE SCI, V66, P1743, DOI 10.1016/S0024-3205(00)00497-5; Huang YY, 1996, LEARN MEMORY, V3, P74, DOI 10.1101/lm.3.2-3.74; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; INSEL TR, 1992, PSYCHONEUROENDOCRINO, V17, P3, DOI 10.1016/0306-4530(92)90073-G; JIRIKOWSKI GF, 1991, CELL TISSUE RES, V266, P399, DOI 10.1007/BF00318196; Kinsley CH, 1999, NATURE, V402, P137, DOI 10.1038/45957; KREMARIK P, 1993, J COMP NEUROL, V333, P343, DOI 10.1002/cne.903330304; Kubota Y, 1996, MOL CELL ENDOCRINOL, V124, P25, DOI 10.1016/S0303-7207(96)03923-8; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Masaki T, 2001, DIABETES, V50, P376, DOI 10.2337/diabetes.50.2.376; Matsushita M, 2001, J NEUROSCI, V21, P6000, DOI 10.1523/JNEUROSCI.21-16-06000.2001; Nguyen PV, 1997, LEARN MEMORY, V4, P230, DOI 10.1101/lm.4.2.230; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Olton D.S., 1983, NEUROBIOLOGY HIPPOCA, P335; PEDERSEN CA, 1994, BEHAV NEUROSCI, V108, P1163, DOI 10.1037/0735-7044.108.6.1163; PERDERSEN CA, 1988, P NATL ACAD SCI USA, V76, P6661; Pi XJ, 2002, MOL BRAIN RES, V103, P130, DOI 10.1016/S0169-328X(02)00194-8; Schulkin J, 1999, NEUROENDOCRINE REGUL, P123; SHAPIRO ML, 1992, BEHAV NEUROSCI, V106, P604, DOI 10.1037/0735-7044.106.4.604; Shapiro ML, 1999, HIPPOCAMPUS, V9, P365, DOI 10.1002/(SICI)1098-1063(1999)9:4<365::AID-HIPO4>3.3.CO;2-K; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Tomizawa K, 1996, NEUROSCIENCE, V74, P519, DOI 10.1016/0306-4522(96)00136-4; Tomizawa K, 2002, J NEUROSCI, V22, P2590, DOI 10.1523/JNEUROSCI.22-07-02590.2002; Vaccari C, 1998, ENDOCRINOLOGY, V139, P5015, DOI 10.1210/en.139.12.5015; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	40	277	289	4	33	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					384	390		10.1038/nn1023	http://dx.doi.org/10.1038/nn1023			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12598900				2022-12-24	WOS:000181833100016
J	Bandell, M; Story, GM; Hwang, SW; Viswanath, V; Eid, SR; Petrus, MJ; Earley, TJ; Patapoutian, A				Bandell, M; Story, GM; Hwang, SW; Viswanath, V; Eid, SR; Petrus, MJ; Earley, TJ; Patapoutian, A			Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin	NEURON			English	Article							CAPSAICIN RECEPTOR; PAIN; NEURONS; STIMULATION; MECHANISMS; VEINS	Six members of the mammalian transient receptor potential (TRP) ion channels respond to varied temperature thresholds. The natural compounds capsaicin and menthol activate noxious heat-sensitive TRPV1 and cold-sensitive TRPM8, respectively. The burning and cooling perception of capsaicin and menthol demonstrate that these ion channels mediate thermosensation. We show that, in addition to noxious cold, pungent natural compounds present in cinnamon oil, wintergreen oil, clove oil, mustard oil, and ginger all activate TRPA1 (ANKTM1). Bradykinin, an inflammatory peptide acting through its G protein-coupled receptor, also activates TRPA1. We further show that phospholipase C is an important signaling component for TRPA1 activation. Cinnamaldehyde, the most specific TRPA1 activator, excites a subset of sensory neurons highly enriched in cold-sensitive neurons and elicits nociceptive behavior in mice. Collectively, these data demonstrate that TRPA1 activation elicits a painful sensation and provide a potential molecular model for why noxious cold can paradoxically be perceived as burning pain.	Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Novartis; Scripps Research Institute	Patapoutian, A (corresponding author), Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA.	ardem@scripps.edu		Hwang, Sun Wook/0000-0001-8460-7480	NINDS NIH HHS [NS046303, NS42822] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042822, R01NS046303] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARNDT JO, 1991, J PHYSIOL-LONDON, V440, P467, DOI 10.1113/jphysiol.1991.sp018719; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cliff M., 1992, Journal of Sensory Studies, V7, P279, DOI 10.1111/j.1745-459X.1992.tb00195.x; Corey DP, 2003, NEURON, V39, P585, DOI 10.1016/S0896-6273(03)00505-1; Couture R, 2001, EUR J PHARMACOL, V429, P161, DOI 10.1016/S0014-2999(01)01318-8; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Hardie RC, 2003, ANNU REV PHYSIOL, V65, P735, DOI 10.1146/annurev.physiol.65.092101.142505; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kandel E., 2000, PRINCIPLES NEURAL SC; Kasai M, 1998, NEUROSCI RES, V32, P231, DOI 10.1016/S0168-0102(98)00092-3; KLEMENT W, 1991, NEUROSCI LETT, V123, P119, DOI 10.1016/0304-3940(91)90172-P; Kollarik M, 2004, J PHYSIOL-LONDON, V555, P115, DOI 10.1113/jphysiol.2003.054890; LEVINE JD, 1993, J NEUROSCI, V13, P2273, DOI 10.1523/JNEUROSCI.13-06-02273.1993; Liang YF, 2001, J PHYSIOL-LONDON, V532, P229, DOI 10.1111/j.1469-7793.2001.0229g.x; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Minke B, 2001, CELL MOL NEUROBIOL, V21, P629, DOI 10.1023/A:1015191702536; Nealen ML, 2003, J NEUROPHYSIOL, V90, P515, DOI 10.1152/jn.00843.2002; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Prescott J, 2000, CHEM SENSES, V25, P239, DOI 10.1093/chemse/25.3.239; Sprague J, 2001, EUR J PHARMACOL, V423, P121, DOI 10.1016/S0014-2999(01)01123-2; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Sullivan E, 1999, METH MOL B, V114, P125; Tominaga M, 2001, P NATL ACAD SCI USA, V98, P6951, DOI 10.1073/pnas.111025298; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807	29	1338	1412	5	103	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 25	2004	41	6					849	857		10.1016/S0896-6273(04)00150-3	http://dx.doi.org/10.1016/S0896-6273(04)00150-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046718	Bronze			2022-12-24	WOS:000221458300005
J	Yao, WD; Gainetdinov, RR; Arbuckle, MI; Sotnikova, TD; Cyr, M; Beaulieu, JM; Torres, GE; Grant, SGN; Caron, MG				Yao, WD; Gainetdinov, RR; Arbuckle, MI; Sotnikova, TD; Cyr, M; Beaulieu, JM; Torres, GE; Grant, SGN; Caron, MG			Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity	NEURON			English	Article							LONG-TERM POTENTIATION; NUCLEUS-ACCUMBENS; GENE-EXPRESSION; NMDA RECEPTOR; NITRIC-OXIDE; POSTSYNAPTIC DENSITY-95; MICE LACKING; CHRONIC COCAINE; SENSITIZATION; BRAIN	To identify the molecular mechanisms underlying psychostimulant-elicited plasticity in the brain reward system, we undertook a phenotype-driven approach using genome-wide microarray profiling of striatal transcripts from three genetic and one pharmacological mouse models of psychostimulant or dopamine supersensitivity. A small set of co-affected genes was identified. One of these genes encoding the synaptic scaffolding protein PSD-95 is downregulated in the striatum of all three mutants and in chronically, but not acutely, cocaine-treated mice. At the synaptic level, enhanced long-term potentiation (LTP) of the fronto-cortico-accumbal glutamatergic synapses correlates with PSD-95 reduction in every case. Finally, targeted deletion of PSD-95 in an independent line of mice enhances LTP, augments the acute locomotor-stimulating effects of cocaine, but leads to no further behavioral plasticity in response to chronic cocaine. Our findings uncover a previously unappreciated role of PSD-95 in psychostimulant action and identify a molecular and cellular mechanism shared between drug-related plasticity and learning.	Duke Univ, Howard Hughes Med Inst Labs, Ctr Med, Dept Cell Biol, Durham, NC 27710 USA; Univ Edinburgh, Div Neurosci, Edinburgh EH8 9J2, Midlothian, Scotland; Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England	Duke University; University of Edinburgh; Wellcome Trust Sanger Institute	Caron, MG (corresponding author), Duke Univ, Howard Hughes Med Inst Labs, Ctr Med, Dept Cell Biol, Durham, NC 27710 USA.	caron002@mc.duke.edu	Beaulieu, Jean-Martin/A-7598-2008; Sotnikova, Tatyana D/T-9992-2017; Gainetdinov, Raul R/G-5875-2011; Jansen, Heiko T./A-5770-2008	Beaulieu, Jean-Martin/0000-0002-0446-7447; Gainetdinov, Raul R/0000-0003-2951-6038; Jansen, Heiko T./0000-0003-0178-396X; Grant, Seth/0000-0001-8732-8735	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013511] Funding Source: NIH RePORTER; NIDA NIH HHS [DA13511] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Abarca C, 2002, P NATL ACAD SCI USA, V99, P9026, DOI 10.1073/pnas.142039099; AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Beinfeld MC, 2002, J NEUROCHEM, V81, P1021, DOI 10.1046/j.1471-4159.2002.00894.x; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; BURT DR, 1977, SCIENCE, V196, P327, DOI 10.1126/science.847477; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Carlsson A, 2001, ANNU REV PHARMACOL, V41, P237, DOI 10.1146/annurev.pharmtox.41.1.237; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Collins SL, 2002, PSYCHOPHARMACOLOGY, V159, P361, DOI 10.1007/s00213-001-0935-8; CREESE I, 1977, SCIENCE, V197, P596, DOI 10.1126/science.877576; D'Aquila PS, 2000, EUR J PHARMACOL, V405, P365, DOI 10.1016/S0014-2999(00)00566-5; DAUNAIS JB, 1994, SYNAPSE, V18, P35, DOI 10.1002/syn.890180106; El-Hussein AE, 2000, SCIENCE, V290, P1364; Fiorentini C, 2003, J BIOL CHEM, V278, P20196, DOI 10.1074/jbc.M213140200; Fuhrmann JC, 2002, J NEUROSCI, V22, P5393; Gainetdinov RR, 2002, TRENDS PHARMACOL SCI, V23, P367, DOI 10.1016/S0165-6147(02)02044-8; Gainetdinov RR, 1999, BIOL PSYCHIAT, V46, P303, DOI 10.1016/S0006-3223(99)00122-5; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gainetdinov RR, 2003, NEURON, V38, P291, DOI 10.1016/S0896-6273(03)00192-2; Garner CC, 1996, TRENDS CELL BIOL, V6, P429, DOI 10.1016/S0962-8924(96)10036-2; Garry EM, 2003, CURR BIOL, V13, P321, DOI 10.1016/S0960-9822(03)00084-8; Gerdeman GL, 2003, TRENDS NEUROSCI, V26, P184, DOI 10.1016/S0166-2236(03)00065-1; Gholami A, 2002, EUR J PHARMACOL, V449, P269, DOI 10.1016/S0014-2999(02)02038-1; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Grimm JW, 2003, J NEUROSCI, V23, P742; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jaffrey SR, 1996, SCIENCE, V274, P774, DOI 10.1126/science.274.5288.774; Kandel ER, 1997, J CELL PHYSIOL, V173, P124, DOI 10.1002/(SICI)1097-4652(199711)173:2<124::AID-JCP6>3.3.CO;2-5; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Kim DS, 2000, J NEUROSCI, V20, P4405, DOI 10.1523/JNEUROSCI.20-12-04405.2000; Kim HS, 2002, P NATL ACAD SCI USA, V99, P4602, DOI 10.1073/pnas.072083799; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; KOVOOR KH, 2003, NEURON, V38, P941; Laakso A, 2002, NEURON, V36, P213, DOI 10.1016/S0896-6273(02)00972-8; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; McNamara FN, 2002, SYNAPSE, V46, P19, DOI 10.1002/syn.10108; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nishioku T, 1999, NEUROSCI LETT, V268, P81, DOI 10.1016/S0304-3940(99)00386-9; OBRIEN JS, 1991, FASEB J, V5, P301, DOI 10.1096/fasebj.5.3.2001789; Prast H, 2001, PROG NEUROBIOL, V64, P51, DOI 10.1016/S0301-0082(00)00044-7; Robbins TW, 2002, NEUROBIOL LEARN MEM, V78, P625, DOI 10.1006/nlme.2002.4103; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rocha BA, 1998, NAT NEUROSCI, V1, P132, DOI 10.1038/381; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; RUBINSTEIN M, 1988, EUR J PHARMACOL, V148, P419, DOI 10.1016/0014-2999(88)90121-5; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; SPYRAKI C, 1981, EUR J PHARMACOL, V74, P195, DOI 10.1016/0014-2999(81)90531-8; Stein V, 2003, J NEUROSCI, V23, P5503; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Tzschentke TM, 2003, MOL PSYCHIATR, V8, P373, DOI 10.1038/sj.mp.4001269; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; Wang YM, 1997, NEURON, V19, P1285, DOI 10.1016/S0896-6273(00)80419-5; Wei F, 2002, NEURON, V36, P713, DOI 10.1016/S0896-6273(02)01019-X; White FJ, 1998, DRUG ALCOHOL DEPEN, V51, P141, DOI 10.1016/S0376-8716(98)00072-6; WHITE FJ, 1995, J PHARMACOL EXP THER, V273, P445; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; WISE RA, 1993, BEHAV PHARMACOL, V4, P339; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; WOOLVERTON WL, 1992, TRENDS PHARMACOL SCI, V13, P193, DOI 10.1016/0165-6147(92)90063-C; Xu F, 2000, NAT NEUROSCI, V3, P465, DOI 10.1038/74839; Yuferov V, 2003, SYNAPSE, V48, P157, DOI 10.1002/syn.10198; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967	84	288	294	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 19	2004	41	4					625	638		10.1016/S0896-6273(04)00048-0	http://dx.doi.org/10.1016/S0896-6273(04)00048-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980210	Bronze			2022-12-24	WOS:000221458100014
J	McCoy, AN; Crowley, JC; Haghighian, G; Dean, HL; Platt, ML				McCoy, AN; Crowley, JC; Haghighian, G; Dean, HL; Platt, ML			Saccade reward signals in posterior cingulate cortex	NEURON			English	Article							MONKEY CAUDATE NEURONS; NIGRA PARS RETICULATA; FUNCTIONAL-PROPERTIES; ANTERIOR CINGULATE; ALZHEIMERS-DISEASE; CORTICAL ATROPHY; PARIETAL CORTEX; RHESUS-MONKEY; EXPECTATION; CONNECTIONS	Movement selection depends on the outcome of prior behavior. Posterior cingulate cortex (CGp) is strongly connected with both limbic and oculomotor circuitry, and CGp neurons respond following saccades, suggesting a role in signaling the motivational outcome of gaze shifts. To test this hypothesis, single CGp neurons were studied in monkeys while they shifted gaze to visual targets for liquid rewards that varied in size or were delivered probabilistically. CGp neurons responded following saccades as well as following reward delivery, and these responses were correlated with reward size. CGp neurons also responded following the omission of predicted rewards. The timing of CGp activation and its modulation by reward could provide signals useful for updating representations of expected saccade value.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Duke University; Carnegie Mellon University	Platt, ML (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	platt@neuro.duke.edu			NEI NIH HHS [EY-013496] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013496] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amador N, 2000, J NEUROPHYSIOL, V84, P2166, DOI 10.1152/jn.2000.84.4.2166; ARNAULD A, 1562, ART THINKING PORT RO; BALEYDIER C, 1980, BRAIN, V103, P525, DOI 10.1093/brain/103.3.525; Basso MA, 2002, J NEUROSCI, V22, P1883, DOI 10.1523/JNEUROSCI.22-05-01883.2002; BERNOUILLI D, 1738, WORKS; Braak H, 1996, J NEURAL TRANSM, V103, P455, DOI 10.1007/BF01276421; CAVADA C, 1989, J COMP NEUROL, V287, P393, DOI 10.1002/cne.902870402; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; DEVILLIERS PA, 1976, PSYCHOL BULL, V83, P1131, DOI DOI 10.1037/0033-2909.83.6.1131; FINCH DM, 1984, EXP NEUROL, V83, P468, DOI 10.1016/0014-4886(84)90116-X; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fletcher W A, 1994, Curr Opin Ophthalmol, V5, P38; FUCHS AF, 1966, J APPL PHYSIOL, V21, P1068, DOI 10.1152/jappl.1966.21.3.1068; GABRIEL M, 1991, BEHAV BRAIN RES, V46, P175, DOI 10.1016/S0166-4328(05)80111-1; Gabriel M, 1996, BEHAV BRAIN RES, V82, P23, DOI 10.1016/S0166-4328(97)81105-9; Glimcher PW, 2001, J NEUROSCI METH, V108, P131, DOI 10.1016/S0165-0270(01)00365-X; Herrnstein R. J., 1997, MATCHING LAW PAPERS; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P799, DOI 10.1152/jn.1989.61.4.799; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P780, DOI 10.1152/jn.1989.61.4.780; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Hof PR, 1997, VISION RES, V37, P3609, DOI 10.1016/S0042-6989(96)00240-4; HOF PR, 1993, ACTA NEUROPATHOL, V86, P215, DOI 10.1007/BF00304135; Ikeda T, 2003, NEURON, V39, P693, DOI 10.1016/S0896-6273(03)00464-1; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Lauwereyns J, 2002, NEURON, V33, P463, DOI 10.1016/S0896-6273(02)00571-8; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Mackintosh N. J., 1974, PSYCHOL ANIMAL LEARN; MINOSHIMA S, 1994, LANCET, V344, P895, DOI 10.1016/S0140-6736(94)92871-1; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; MORECRAFT RJ, 1993, ARCH NEUROL-CHICAGO, V50, P279, DOI 10.1001/archneur.1993.00540030045013; MUSIL SY, 1988, J COMP NEUROL, V272, P203, DOI 10.1002/cne.902720205; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; Olson CR, 1996, J NEUROPHYSIOL, V76, P3285, DOI 10.1152/jn.1996.76.5.3285; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; PANDYA DN, 1982, J COMP NEUROL, V204, P196, DOI 10.1002/cne.902040208; PANDYA DN, 1981, EXP BRAIN RES, V42, P319, DOI 10.1007/BF00237497; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rescorla R. A., 1972, CLASSICAL CONDITIONI; Sato M, 2002, J NEUROSCI, V22, P2363, DOI 10.1523/JNEUROSCI.22-06-02363.2002; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Stephens D.W., 1986, pi; Stuphorn V, 2000, NATURE, V408, P857, DOI 10.1038/35048576; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Takikawa Y, 2002, J NEUROPHYSIOL, V87, P508, DOI 10.1152/jn.00288.2001; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1877, DOI 10.1152/jn.2000.83.4.1877; VOGT BA, 1983, J COMP NEUROL, V216, P192, DOI 10.1002/cne.902160207; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; VOGT BA, 1987, J COMP NEUROL, V262, P271, DOI 10.1002/cne.902620208	58	139	143	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 4	2003	40	5					1031	1040		10.1016/S0896-6273(03)00719-0	http://dx.doi.org/10.1016/S0896-6273(03)00719-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659101	Bronze			2022-12-24	WOS:000187042200019
J	Ricci, AJ; Crawford, AC; Fettiplace, R				Ricci, AJ; Crawford, AC; Fettiplace, R			Tonotopic variation in the conductance of the hair cell mechanotransducer channel	NEURON			English	Article							MECHANOELECTRICAL TRANSDUCTION; JUNCTION CHANNELS; FAST ADAPTATION; CALCIUM; TURTLE; CURRENTS; COCHLEA; DROSOPHILA; KINETICS; BUNDLE	Hair cells in the vertebrate cochlea are arranged tonotopically with their characteristic frequency (CF), the sound frequency to which they are most sensitive, changing systematically with position. Single mechanotransducer channels of hair cells were characterized at different locations in the turtle cochlea. In 2.8 mM external Ca2+, the channel's chord conductance was 118 pS (range 80-163 pS), which nearly doubled (range 149-300 pS) on reducing Ca2+ to 50 muM. In both Ca2+ concentrations, the conductance was positively correlated with hair cell CF. Variation in channel conductance can largely explain the increases in size of the macroscopic transducer current and speed of adaptation with CF. It suggests diversity of transducer channel structure or environment along the cochlea that may be an important element of its tonotopic organization.	Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA; Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA 70112 USA; Univ Cambridge, Physiol Lab, Cambridge CB2 3EG, England	University of Wisconsin System; University of Wisconsin Madison; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Cambridge	Fettiplace, R (corresponding author), Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA.			ricci, anthony/0000-0002-1706-8904	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001362, R01DC003896] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC 03896, R01 DC 01362] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ashcroft FM, 2000, ION CHANNELS DIS; ASSAD JA, 1989, P NATL ACAD SCI USA, V86, P2918, DOI 10.1073/pnas.86.8.2918; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Bonigk W, 1999, J NEUROSCI, V19, P5332; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; COREY DP, 1983, J NEUROSCI, V3, P962; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; CRAWFORD AC, 1980, J PHYSIOL-LONDON, V306, P79, DOI 10.1113/jphysiol.1980.sp013387; Denk W, 1995, NEURON, V15, P1311, DOI 10.1016/0896-6273(95)90010-1; DEVRIES SH, 1992, J PHYSIOL-LONDON, V445, P201, DOI 10.1113/jphysiol.1992.sp018920; Fettiplace R, 2003, CURR OPIN NEUROBIOL, V13, P446, DOI 10.1016/S0959-4388(03)00094-1; Fettiplace R, 2003, BIOPHYSICS OF THE COCHLEA: FROM MOLECULES TO MODELS, P65, DOI 10.1142/9789812704931_0007; Fettiplace R, 2001, TRENDS NEUROSCI, V24, P169, DOI 10.1016/S0166-2236(00)01740-9; Geleoc GSG, 1997, P ROY SOC B-BIOL SCI, V264, P611, DOI 10.1098/rspb.1997.0087; HACKNEY CM, 1993, HEARING RES, V69, P163, DOI 10.1016/0378-5955(93)90104-9; HACKNEY CM, 1995, ACTIVE HEARING, P103; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOLTON T, 1986, J PHYSIOL-LONDON, V375, P195, DOI 10.1113/jphysiol.1986.sp016113; JARAMILLO F, 1993, P NATL ACAD SCI USA, V90, P1330, DOI 10.1073/pnas.90.4.1330; Jones EMC, 1999, J PHYSIOL-LONDON, V518, P653, DOI 10.1111/j.1469-7793.1999.0653p.x; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; KROESE ABA, 1989, HEARING RES, V37, P203, DOI 10.1016/0378-5955(89)90023-3; KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; LUMPKIN EA, 1995, P NATL ACAD SCI USA, V92, P10297, DOI 10.1073/pnas.92.22.10297; Marty A., 1983, SINGLE CHANNEL RECOR, P107; Meyer J, 1998, J NEUROSCI, V18, P6748; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Muller DJ, 2002, EMBO J, V21, P3598, DOI 10.1093/emboj/cdf365; OHMORI H, 1985, J PHYSIOL-LONDON, V359, P189, DOI 10.1113/jphysiol.1985.sp015581; Ricci A, 2002, J NEUROPHYSIOL, V87, P1738, DOI 10.1152/jn.00574.2001; Ricci AJ, 1998, J PHYSIOL-LONDON, V506, P159, DOI 10.1111/j.1469-7793.1998.159bx.x; Ricci AJ, 1998, J NEUROSCI, V18, P8261; Ricci AJ, 1997, J PHYSIOL-LONDON, V501, P111, DOI 10.1111/j.1469-7793.1997.111bo.x; Sidi S, 2003, SCIENCE, V301, P96, DOI 10.1126/science.1084370; Strassmaier M, 2002, CURR OPIN NEUROBIOL, V12, P380, DOI 10.1016/S0959-4388(02)00344-6; Verselis V.K., 2000, ADV MOL CEL, V30, P129; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171; WU YC, 1995, PROG BIOPHYS MOL BIO, V63, P131, DOI 10.1016/0079-6107(95)00002-5; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yue LX, 2001, NATURE, V410, P705, DOI 10.1038/35070596; Zhou XL, 2003, P NATL ACAD SCI USA, V100, P7105, DOI 10.1073/pnas.1230540100	45	145	152	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 4	2003	40	5					983	990		10.1016/S0896-6273(03)00721-9	http://dx.doi.org/10.1016/S0896-6273(03)00721-9			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659096	Bronze			2022-12-24	WOS:000187042200014
J	Chiao, CC; Masland, RH				Chiao, CC; Masland, RH			Contextual tuning of direction-selective retinal ganglion cells	NATURE NEUROSCIENCE			English	Article							RABBIT RETINA; RESPONSES	A direction-selective (DS) retinal ganglion cell responds well to a small object moving within its receptive field center, but less well when there is also a moving stimulus in the surrounding area; this has been described as tuning for local motion. We show here an additional selectivity, such that the surround has less effect if there is a discontinuity-that is, a difference in spatial phase, spatial frequency or velocity-between the center stimulus and that present in the surround.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02114 USA; Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 300, Taiwan	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute; National Tsing Hua University	Masland, RH (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Howard Hughes Med Inst, 50 Blossom St,Wellman 429, Boston, MA 02114 USA.		Chiao, Chuan-Chin/L-7708-2019					BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Chiao CC, 2002, J NEUROSCI, V22, P10509; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Grzywacz NM, 1997, VISUAL NEUROSCI, V14, P39, DOI 10.1017/S0952523800008749; He SG, 2000, NEUROSCI LETT, V285, P25, DOI 10.1016/S0304-3940(00)01030-2; Stasheff SF, 2002, J NEUROPHYSIOL, V88, P1026, DOI 10.1152/jn.2002.88.2.1026; Taylor WR, 2003, TRENDS NEUROSCI, V26, P379, DOI 10.1016/S0166-2236(03)00167-X; WERBLIN F, 1988, VISUAL NEUROSCI, V1, P317, DOI 10.1017/S0952523800001978; WERBLIN FS, 1972, SCIENCE, V175, P1008, DOI 10.1126/science.175.4025.1008; WYATT HJ, 1975, J NEUROPHYSIOL, V38, P613, DOI 10.1152/jn.1975.38.3.613	11	35	35	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1251	1252		10.1038/nn1147	http://dx.doi.org/10.1038/nn1147			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	746BC	14595442				2022-12-24	WOS:000186725600007
J	Meffert, MK; Chang, JM; Wiltgen, BJ; Fanselow, MS; Baltimore, D				Meffert, MK; Chang, JM; Wiltgen, BJ; Fanselow, MS; Baltimore, D			NF-kappa B functions in synaptic signaling and behavior	NATURE NEUROSCIENCE			English	Article							CALMODULIN KINASE-II; TRANSCRIPTION FACTOR; HIPPOCAMPAL-NEURONS; GENE-EXPRESSION; NUCLEAR TRANSLOCATION; CREB PHOSPHORYLATION; INHIBITOR PROTEIN; MICE LACKING; CALCIUM; BRAIN	Ca2+-regulated gene transcription is essential to diverse physiological processes, including the adaptive plasticity associated with learning. We found that basal synaptic input activates the NF-kappaB transcription factor by a pathway requiring the Ca2+ /calmodulin-dependent kinase CaMKII and local submembranous Ca2+ elevation. The p65: p50 NF-kappaB form is selectively localized at synapses; p65-deficient mice have no detectable synaptic NF-kappaB. Activated NF-kappaB moves to the nucleus and could directly transmute synaptic signals into altered gene expression. Mice lacking p65 show a selective learning deficit in the spatial version of the radial arm maze. These observations suggest that long-term changes to adult neuronal function caused by synaptic stimulation can be regulated by NF-kappaB nuclear translocation and gene activation.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	California Institute of Technology; University of California System; University of California Los Angeles	Baltimore, D (corresponding author), CALTECH, Div Biol, MC204-31, Pasadena, CA 91125 USA.			Rudell, Jolene/0000-0003-3022-4649				Albensi BC, 2000, SYNAPSE, V35, P151; Alcamo E, 2001, J IMMUNOL, V167, P1592, DOI 10.4049/jimmunol.167.3.1592; AXELROD D, 1976, P NATL ACAD SCI USA, V73, P4594, DOI 10.1073/pnas.73.12.4594; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BASARSKY TA, 1994, J NEUROSCI, V14, P6402; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bhakar AL, 2002, J NEUROSCI, V22, P8466; Brown JR, 1996, CELL, V86, P297, DOI 10.1016/S0092-8674(00)80101-4; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chang BH, 2001, NEUROSCIENCE, V102, P767, DOI 10.1016/S0306-4522(00)00520-0; Cheng HYM, 2002, CELL, V108, P31, DOI 10.1016/S0092-8674(01)00629-8; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; FINK CC, IN PRESS NEURON; Freudenthal R, 2000, BRAIN RES, V855, P274, DOI 10.1016/S0006-8993(99)02358-6; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Goslin K., 1990, CULTURING NERVE CELL; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Guerrini L, 1997, J NEUROSCI, V17, P6057; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; KALTSCHMIDT C, 1993, MECH DEVELOP, V43, P135, DOI 10.1016/0925-4773(93)90031-R; KALTSCHMIDT C, 1994, MOL CELL BIOL, V14, P3981, DOI 10.1128/MCB.14.6.3981; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Lerant A, 2001, BRAIN RES, V904, P259, DOI 10.1016/S0006-8993(01)02470-2; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu D, 1998, J NEUROSCI, V18, P1329; Maldonado R, 1999, P NATL ACAD SCI USA, V96, P14094, DOI 10.1073/pnas.96.24.14094; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; Meberg PJ, 1996, MOL BRAIN RES, V38, P179, DOI 10.1016/0169-328X(95)00229-L; MEFFERT MK, 1994, NEURON, V12, P1235, DOI 10.1016/0896-6273(94)90440-5; Nelson G, 2002, J CELL SCI, V115, P1137; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; PAYLOR R, 1994, BRAIN RES, V651, P275, DOI 10.1016/0006-8993(94)90707-2; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Sage JR, 2000, BEHAV NEUROSCI, V114, P295, DOI 10.1037/0735-7044.114.2.295; SchmidtUllrich R, 1996, DEVELOPMENT, V122, P2117; Teruel MN, 2000, CELL, V103, P181, DOI 10.1016/S0092-8674(00)00109-4; VAN AD, 1996, SCIENCE, V274, P787; WALDMANN R, 1990, BIOCHEMISTRY-US, V29, P1679, DOI 10.1021/bi00459a002; Wellmann H, 2001, J BIOL CHEM, V276, P11821, DOI 10.1074/jbc.M009253200; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987	47	534	552	1	41	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1072	1078		10.1038/nn1110	http://dx.doi.org/10.1038/nn1110			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	12947408				2022-12-24	WOS:000185633600019
J	Marshall, J; Dolan, BM; Garcia, EP; Sathe, S; Tang, XL; Mao, ZX; Blair, LAC				Marshall, J; Dolan, BM; Garcia, EP; Sathe, S; Tang, XL; Mao, ZX; Blair, LAC			Calcium channel and NMDA receptor activities differentially regulate nuclear C/EBP beta levels to control neuronal survival	NEURON			English	Article							BINDING-PROTEIN-BETA; CEREBELLAR GRANULE NEURONS; FAMILY TRANSCRIPTION FACTOR; HIPPOCAMPAL-NEURONS; KINASE-IV; CREB PHOSPHORYLATION; SYNAPTIC PLASTICITY; GENE-EXPRESSION; DEPENDENT MECHANISM; NEUROBLASTOMA-CELLS	Insulin-like growth factor-1 (IGF-1) promotes the survival of cerebellar granule neurons by enhancing calcium influx through L-type calcium channels, whereas NMDA receptor-mediated calcium influx can lead to excitotoxic death. Here we demonstrate that L and NMDA receptor channel activities differentially regulate the transcription factor C/EBPbeta to control neuronal survival. Specifically, we show that L channel-dependent calcium influx results in increased CaMKIV activity, which acts to decrease nuclear C/EBPbeta levels. Conversely, NMDA receptor-mediated influx rapidly elevates nuclear C/EBPbeta and induces excitotoxic death via activation of the calcium-dependent phosphatase, calcineurin. Moderate levels of AMPA receptor activity stimulate L channels to improve survival, whereas higher levels stimulate NMDA receptors and reduce neuronal survival, suggesting differential synaptic effects. Finally, N-type calcium channel activity reduces survival, potentially by increasing glutamate release. Together, these results show that the L-type calcium channel-dependent survival and NMDA receptor death pathways converge to regulate nuclear C/EBPbeta levels, which appears to be pivotal in these mechanisms.	Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Marshall, J (corresponding author), Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039446] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037676, R01NS039063] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR 15578] Funding Source: Medline; NICHD NIH HHS [HD39446] Funding Source: Medline; NINDS NIH HHS [R01 NS37676, R01 NS39063-01A2] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ankarcrona M, 1996, FEBS LETT, V394, P321, DOI 10.1016/0014-5793(96)00959-3; Bence-Hanulec KK, 2000, NEURON, V27, P121, DOI 10.1016/S0896-6273(00)00014-3; Blaeser F, 2000, J BIOL CHEM, V275, P197, DOI 10.1074/jbc.275.1.197; Blair LAC, 1997, NEURON, V19, P421, DOI 10.1016/S0896-6273(00)80950-2; Blair LAC, 1999, J NEUROSCI, V19, P1940; BLAIR LAC, 2001, CURR PROTOCOLS NEURO, V5; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Buck M, 2001, EMBO J, V20, P6712, DOI 10.1093/emboj/20.23.6712; Bureau I, 1999, J NEUROSCI, V19, P653; Chatila T, 1996, J BIOL CHEM, V271, P21542, DOI 10.1074/jbc.271.35.21542; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Cortes-Canteli M, 2002, J BIOL CHEM, V277, P5460, DOI 10.1074/jbc.M108761200; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Curtis J, 1999, J NEUROSCI RES, V58, P88, DOI 10.1002/(SICI)1097-4547(19991001)58:1<88::AID-JNR9>3.3.CO;2-I; DAngelo E, 1997, J NEUROPHYSIOL, V78, P1631, DOI 10.1152/jn.1997.78.3.1631; DAWSON TM, 1993, P NATL ACAD SCI USA, V90, P9808, DOI 10.1073/pnas.90.21.9808; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dudek H, 1997, AKT SCI, V275, P661; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; GALLI C, 1995, J NEUROSCI, V15, P1172; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Guo SD, 2001, J BIOL CHEM, V276, P8516, DOI 10.1074/jbc.M008542200; Guo X, 2001, ANN NEUROL, V50, P6, DOI 10.1002/ana.1030; Hallak H, 2001, J NEUROCHEM, V77, P63, DOI 10.1046/j.1471-4159.2001.00208.x; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Krichevsky AM, 2002, P NATL ACAD SCI USA, V99, P11926, DOI 10.1073/pnas.182272699; Lakkaraju A, 2001, J BIOL CHEM, V276, P32000, DOI 10.1074/jbc.M100138200; Mao ZX, 1999, J BIOL CHEM, V274, P31102, DOI 10.1074/jbc.274.43.31102; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; McDonald JW, 1996, ANN NEUROL, V40, P750, DOI 10.1002/ana.410400511; McGinnis KM, 1998, J BIOL CHEM, V273, P19993, DOI 10.1074/jbc.273.32.19993; Mellor JR, 1998, J NEUROSCI, V18, P2822; Menard C, 2002, NEURON, V36, P597, DOI 10.1016/S0896-6273(02)01026-7; Mermelstein PG, 2001, P NATL ACAD SCI USA, V98, P15342, DOI 10.1073/pnas.211563998; Mermelstein PG, 2000, J NEUROSCI, V20, P266, DOI 10.1523/JNEUROSCI.20-01-00266.2000; MISRA RP, 1994, J BIOL CHEM, V269, P25483; Niehof M, 2001, J MOL BIOL, V309, P855, DOI 10.1006/jmbi.2001.4708; Norris CM, 2002, NEUROSCIENCE, V110, P213, DOI 10.1016/S0306-4522(01)00574-7; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Ogawa S, 1998, CHEM SENSES, V23, P249, DOI 10.1093/chemse/23.2.249; Olive M, 1996, J BIOL CHEM, V271, P2040, DOI 10.1074/jbc.271.4.2040; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Piwien-Pilipuk G, 2001, J BIOL CHEM, V276, P19664, DOI 10.1074/jbc.M010193200; Pohnke Y, 1999, J BIOL CHEM, V274, P24808, DOI 10.1074/jbc.274.35.24808; Rajadhyaksha A, 1999, J NEUROSCI, V19, P6348; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Ruiz F, 2000, EUR J PHARMACOL, V404, P29, DOI 10.1016/S0014-2999(00)00584-7; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; See V, 2001, FASEB J, V15, P134, DOI 10.1096/fj.00-0106com; Sinor JD, 2000, J NEUROSCI, V20, P8831; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; Sterneck E, 1998, J NEUROCHEM, V70, P2424; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Taubenfeld SM, 2001, J NEUROSCI, V21, P84, DOI 10.1523/JNEUROSCI.21-01-00084.2001; Wang DX, 2000, J NEUROCHEM, V74, P1418, DOI 10.1046/j.1471-4159.2000.0741418.x; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Williams SC, 1997, GENE EXPRESSION, V6, P371; Xiong W, 2001, NUCLEIC ACIDS RES, V29, P3087, DOI 10.1093/nar/29.14.3087; Yin M, 1996, J BIOL CHEM, V271, P17974, DOI 10.1074/jbc.271.30.17974; Yoshida H, 2000, BBA-MOL CELL RES, V1497, P155, DOI 10.1016/S0167-4889(00)00051-3; Youn HD, 2000, J BIOL CHEM, V275, P22563, DOI 10.1074/jbc.C000304200; Yukawa K, 1998, J BIOL CHEM, V273, P31345, DOI 10.1074/jbc.273.47.31345; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299	74	79	82	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 14	2003	39	4					625	639		10.1016/S0896-6273(03)00496-3	http://dx.doi.org/10.1016/S0896-6273(03)00496-3			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	712CQ	12925277	Bronze			2022-12-24	WOS:000184779500008
J	Do, MTH; Bean, BP				Do, MTH; Bean, BP			Subthreshold sodium currents and pacemaking of subthalamic neurons: Modulation by slow inactivation	NEURON			English	Article							CEREBELLAR PURKINJE NEURONS; HIGH-FREQUENCY STIMULATION; EXTERNAL GLOBUS-PALLIDUS; DEEP BRAIN-STIMULATION; SINGLE-SPIKE ACTIVITY; GRANULE CELLS; IN-VITRO; PYRAMIDAL NEURONS; ACTION-POTENTIALS; SUBSTANTIA-NIGRA	Neurons of the subthalamic nucleus (STN) are spontaneously active. By voltage clamping dissociated rat STN neurons with their own firing patterns, we found that pacemaking is driven by two kinds of subthreshold sodium current: a steady-state "persistent" sodium current and a dynamic "resurgent" sodium current, which promotes rapid firing by flowing immediately after a spike. These currents are strongly regulated by a process of slow inactivation that is active at physiological firing frequencies. Slow inactivation of the pacemaking sodium currents promotes a constant frequency of tonic firing in the face of small, steady changes in input and constitutes a form of adaptation at the single-cell level. Driving cells at a high rate (75 Hz) produced pronounced slow inactivation (60%-70%) of resurgent, persistent, and transient components of sodium current. This inactivation is likely to contribute to effects of clinical deep-brain stimulation on STN excitability.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Do, MTH (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 222 Longwood Ave, Boston, MA 02115 USA.		H, Michael Tri/A-5917-2009; Oka, Yoshitaka/C-9670-2010	H, Michael Tri/0000-0001-6418-0977; Oka, Yoshitaka/0000-0002-3482-3051	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036855, R37NS036855, P01NS038312] Funding Source: NIH RePORTER; NINDS NIH HHS [NS38312, NS36855] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AFSHARPOUR S, 1985, J COMP NEUROL, V236, P1, DOI 10.1002/cne.902360102; Baufreton J, 2003, J NEUROSCI, V23, P816; Benazzouz A, 2000, NEUROLOGY, V55, pS13; BENAZZOUZ A, 1993, EUR J NEUROSCI, V5, P382, DOI 10.1111/j.1460-9568.1993.tb00505.x; Benazzouz A, 2000, NEUROSCIENCE, V99, P289, DOI 10.1016/S0306-4522(00)00199-8; BERGMAN H, 1994, J NEUROPHYSIOL, V72, P507, DOI 10.1152/jn.1994.72.2.507; BERGMAN H, 1990, SCIENCE, V249, P1436, DOI 10.1126/science.2402638; Beurrier C, 2000, J NEUROPHYSIOL, V83, P1951, DOI 10.1152/jn.2000.83.4.1951; Beurrier C, 2001, J NEUROPHYSIOL, V85, P1351, DOI 10.1152/jn.2001.85.4.1351; Beurrier C, 1999, J NEUROSCI, V19, P599, DOI 10.1523/jneurosci.19-02-00599.1999; Bevan MD, 1999, J NEUROSCI, V19, P7617, DOI 10.1523/JNEUROSCI.19-17-07617.1999; Bevan MD, 2002, J NEUROPHYSIOL, V87, P1348, DOI 10.1152/jn.00582.2001; Bevan MD, 2000, J NEUROPHYSIOL, V83, P3169, DOI 10.1152/jn.2000.83.5.3169; Bevan MD, 2002, TRENDS NEUROSCI, V25, P525, DOI 10.1016/S0166-2236(02)02235-X; Brumberg JC, 2000, J NEUROSCI, V20, P4829; Colbert CM, 1997, J NEUROSCI, V17, P6512; D'Angelo E, 1998, J NEUROPHYSIOL, V80, P493, DOI 10.1152/jn.1998.80.2.493; D'Angelo E, 2001, J NEUROSCI, V21, P759, DOI 10.1523/JNEUROSCI.21-03-00759.2001; Ellerkmann RK, 2001, J PHYSIOL-LONDON, V532, P385, DOI 10.1111/j.1469-7793.2001.0385f.x; Fleidervish IA, 1996, J PHYSIOL-LONDON, V493, P83, DOI 10.1113/jphysiol.1996.sp021366; Grieco TM, 2002, J NEUROSCI, V22, P3100, DOI 10.1523/JNEUROSCI.22-08-03100.2002; Hashimoto T, 2003, J NEUROSCI, V23, P1916; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Jung HY, 1997, J NEUROSCI, V17, P6639; KHALIQ ZM, 2003, IN PRESS J NEUROSCI; Kim KJ, 2003, J NEUROSCI, V23, P1506, DOI 10.1523/JNEUROSCI.23-04-01506.2003; KUO CC, 1994, MOL PHARMACOL, V46, P716; Madeja M, 2000, EUR J NEUROSCI, V12, P1, DOI 10.1046/j.1460-9568.2000.00871.x; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; MANTHEI RC, 1972, PHYSIOL BEHAV, V10, P517; NAKANISHI H, 1987, BRAIN RES, V437, P35, DOI 10.1016/0006-8993(87)91524-1; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Ong BH, 2000, J GEN PHYSIOL, V116, P653, DOI 10.1085/jgp.116.5.653; Otsuka T, 2001, J NEUROPHYSIOL, V86, P1816, DOI 10.1152/jn.2001.86.4.1816; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Plenz D, 1999, NATURE, V400, P677, DOI 10.1038/23281; Pollak P, 2002, MOVEMENT DISORD, V17, pS155, DOI 10.1002/mds.10158; Raman IM, 1997, NEURON, V19, P881, DOI 10.1016/S0896-6273(00)80969-1; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Raman IM, 2001, BIOPHYS J, V80, P729, DOI 10.1016/S0006-3495(01)76052-3; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Sidach SS, 2000, J NEUROSCI, V20, P7174; Song WJ, 2000, J NEUROPHYSIOL, V84, P2630, DOI 10.1152/jn.2000.84.5.2630; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3; Vilin YY, 2001, CELL BIOCHEM BIOPHYS, V35, P171, DOI 10.1385/CBB:35:2:171; Vitek JL, 2002, MOVEMENT DISORD, V17, pS69, DOI 10.1002/mds.10144; Williams SR, 2002, J PHYSIOL-LONDON, V539, P469, DOI 10.1113/jphysiol.2001.013136; Windels F, 2000, EUR J NEUROSCI, V12, P4141, DOI 10.1046/j.1460-9568.2000.00296.x	49	208	236	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 3	2003	39	1					109	120		10.1016/S0896-6273(03)00360-X	http://dx.doi.org/10.1016/S0896-6273(03)00360-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699LB	12848936	Bronze			2022-12-24	WOS:000184057400013
J	Kingdom, FAA				Kingdom, FAA			Color brings relief to human vision	NATURE NEUROSCIENCE			English	Article							PERCEPTION; SHAPE	In natural scenes, chromatic variations, and the luminance variations that are aligned with them, mainly arise from surfaces such as flowers or painted objects. Pure or near-pure luminance variations, on the other hand, mainly arise from inhomogeneous illumination such as shadows or shading. Here, I provide evidence that knowledge of these color-luminance relationships is built into the machinery of the human visual system. When a pure-luminance grating is added to a differently oriented chromatic grating, the resulting 'plaid' appears to spring into three-dimensional relief, an example of 'shape-from-shading'. By psychophysical measurements, I found that the perception of shape-from-shading in the plaid was triggered when the chromatic and luminance gratings were not aligned, and suppressed when the gratings were aligned. This finding establishes a new role for color vision in determining the three-dimensional structure of an image: one that exploits the natural relationships that exist between color and luminance in the visual world.	McGill Vis Res Unit, Montreal, PQ H3A 1A1, Canada	McGill University	Kingdom, FAA (corresponding author), McGill Vis Res Unit, 687 Pine Ave W,Room H4-14, Montreal, PQ H3A 1A1, Canada.							ATTICK JJ, 1996, NEURAL COMPUT, V8, P1321; BARLOW HB, 1989, COMPUTING NEURON, P217; CAVANAGH P, 1989, J EXP PSYCHOL HUMAN, V15, P3, DOI 10.1037/0096-1523.15.1.3; CAVANAGH P, 1991, VISION VISUAL DYSFUN, V5, P234; Dominy NJ, 2001, NATURE, V410, P363, DOI 10.1038/35066567; FIELD DJ, 1994, NEURAL COMPUT, V6, P559, DOI 10.1162/neco.1994.6.4.559; FINE I, IN PRESS J OPT SOC A; Gegenfurtner KR, 2000, CURR BIOL, V10, P805, DOI 10.1016/S0960-9822(00)00563-7; GREGORY RL, 1977, PERCEPTION, V6, P113, DOI 10.1068/p060113; JOHNSTON A, 1992, PERCEPTION, V21, P365, DOI 10.1068/p210365; KINGDOM FAA, 2000, J SOC 3D BROADCASTIN, V1, P10; Knill DC, 1996, PERCEPTION BAYESIAN; LEHKY SR, 1988, NATURE, V333, P452, DOI 10.1038/333452a0; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; LU C, 1972, INVEST OPHTH VISUAL, V11, P482; MOLLON JD, 1989, J EXP BIOL, V146, P21; Mullen K. T., 1991, VISION VISUAL DYSFUN, V6, P198; Parraga CA, 2002, CURR BIOL, V12, P483, DOI 10.1016/S0960-9822(02)00718-2; RAMACHANDRAN VS, 1978, NATURE, V275, P55, DOI 10.1038/275055a0; RAMACHANDRAN VS, 1988, NATURE, V331, P163, DOI 10.1038/331163a0; Regan David, 2000, HUMAN PERCEPTION OBJ; RUBIN JM, 1982, BIOL CYBERN, V45, P215, DOI 10.1007/BF00336194; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Sumner P, 2000, J EXP BIOL, V203, P1963; Sun J, 1997, PERCEPTION, V26, P519, DOI 10.1068/p260519; SWITKES E, 1988, J OPT SOC AM A, V5, P1149, DOI 10.1364/JOSAA.5.001149	26	94	94	0	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					641	644		10.1038/nn1060	http://dx.doi.org/10.1038/nn1060			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	683GQ	12740582				2022-12-24	WOS:000183140400022
J	Blatow, M; Caputi, A; Burnashev, N; Monyer, H; Rozov, A				Blatow, M; Caputi, A; Burnashev, N; Monyer, H; Rozov, A			Ca2+ buffer saturation underlies paired pulse facilitation in calbindin-D28k-containing terminals	NEURON			English	Article							MOSSY FIBER SYNAPSES; TERM SYNAPTIC PLASTICITY; TRANSMITTER RELEASE; RAT HIPPOCAMPUS; IN-VITRO; NEURONS; PARVALBUMIN; CALBINDIN-D-28K; INTERNEURONS; TRANSMISSION	Ca2+ buffer saturation was proposed as a mechanism of paired pulse facilitation (PPF). However, whether it operates under native conditions remained unclear. Here we show that saturation of the endogenous fast Ca2+ buffer calbindin-D28k (CB) plays a major role in PPF at CB-containing synapses. Paired recordings from synaptically connected interneurons and pyramidal neurons in the mouse neocortex revealed that dialysis increased the amplitude of the first response and decreased PPF. Loading the presynaptic terminals with BAPTA or CB rescued the effect of the CB washout. We extended the study to the CB-positive facilitating excitatory mossy fiber-CA3 pyramidal cell synapse. The effects of different extracellular Ca2+ concentrations and of EGTA indicated that PPF in CB-containing terminals depended on Ca2+ influx rather than on the initial release probability. Experiments in CB knockout mice confirmed that buffer saturation is a novel basic presynaptic mechanism for activity-dependent control of synaptic gain.	Univ Heidelberg, Hosp Neurol, Dept Clin Neurobiol, D-69120 Heidelberg, Germany; Free Univ Amsterdam, Fac Earth & Life Sci, Dept Expt Neurophysiol, NL-1081 HV Amsterdam, Netherlands	Ruprecht Karls University Heidelberg; Vrije Universiteit Amsterdam	Rozov, A (corresponding author), Univ Heidelberg, Hosp Neurol, Dept Clin Neurobiol, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.		Burnashev, Nail/G-4056-2013; Rozov, Andrei/C-1997-2015	Monyer, Hannah/0000-0002-9332-5749; Blatow, Maria/0000-0003-3371-5697				Acsady L, 1998, J NEUROSCI, V18, P3386; Alcantara S, 1996, EUR J NEUROSCI, V8, P1329, DOI 10.1111/j.1460-9568.1996.tb01595.x; Atluri PP, 1996, J NEUROSCI, V16, P5661; Caillard O, 2000, P NATL ACAD SCI USA, V97, P13372, DOI 10.1073/pnas.230362997; CATANIA MV, 1995, J NEUROSCI, V15, P7046; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Fisher SA, 1997, TRENDS NEUROSCI, V20, P170, DOI 10.1016/S0166-2236(96)01001-6; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Jiang M, 1997, NEUROSCIENCE, V81, P1137, DOI 10.1016/S0306-4522(97)00231-5; JONES HC, 1988, PHYSIOL BOHEMOSLOV, V37, P213; JONES HC, 1988, J PHYSIOL-LONDON, V402, P579, DOI 10.1113/jphysiol.1988.sp017223; Kamiya H, 2002, J NEUROSCI, V22, P9237; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Klapstein GJ, 1998, NEUROSCIENCE, V85, P361, DOI 10.1016/S0306-4522(97)00632-5; Lee SH, 2000, J PHYSIOL-LONDON, V525, P419, DOI 10.1111/j.1469-7793.2000.t01-2-00419.x; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; MACCAFERRI G, 1995, NEURON, V15, P137, DOI 10.1016/0896-6273(95)90071-3; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Nagerl UV, 2000, BIOPHYS J, V79, P3009, DOI 10.1016/S0006-3495(00)76537-4; Naraghi M, 1997, J NEUROSCI, V17, P6961; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; RAHAMIMOFF R, 1968, J PHYSIOL-LONDON, V195, P471, DOI 10.1113/jphysiol.1968.sp008468; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Sansig G, 2001, J NEUROSCI, V21, P8734, DOI 10.1523/JNEUROSCI.21-22-08734.2001; Schmitz D, 2001, P NATL ACAD SCI USA, V98, P11003, DOI 10.1073/pnas.191351498; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; THOMSON AM, 1993, NEUROSCIENCE, V54, P347, DOI 10.1016/0306-4522(93)90257-G; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; WINSLOW JL, 1994, J NEUROPHYSIOL, V72, P1769, DOI 10.1152/jn.1994.72.4.1769; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	39	194	196	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 10	2003	38	1					79	88		10.1016/S0896-6273(03)00196-X	http://dx.doi.org/10.1016/S0896-6273(03)00196-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	666XT	12691666	Bronze			2022-12-24	WOS:000182202300011
J	Manns, JR; Hopkins, RO; Squire, LR				Manns, JR; Hopkins, RO; Squire, LR			Semantic memory and the human hippocampus	NEURON			English	Article							FOCAL RETROGRADE-AMNESIA; RECOGNITION MEMORY; ACQUISITION; IMPAIRMENT; VOCABULARY; SINGLE; DAMAGE; FACTS	It has been unclear whether the hippocampus is uniquely important for episodic memory (memory for events that are specific to time and place) or whether the hippocampus is also important for learning and remembering facts (semantic memory). In two studies, we assessed the capacity for semantic memory in patients with bilateral damage thought to be restricted primarily to the hippocampal region who developed memory impairment at a known time. Since the onset of their memory impairment, the patients have acquired less factual knowledge than controls. The patients also exhibit temporally limited retrograde amnesia for factual information from the several years preceding the onset of memory impairment. Remote memory for factual knowledge (from 11-30 years before amnesia) is intact. The results show that the hippocampal region supports semantic memory as well as episodic memory and that its role in the acquisition and storage of semantic knowledge is time limited.	Univ Calif San Diego, La Jolla, CA 92093 USA; Brigham Young Univ, Provo, UT 84602 USA; Latter Day St Hosp, Salt Lake City, UT 84143 USA; Vet Affairs Med Ctr, La Jolla, CA 92161 USA	University of California System; University of California San Diego; Brigham Young University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Squire, LR (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	lsquire@ucsd.edu			PHS HHS [24600] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Amaral DG, 1990, HUMAN NERVOUS SYSTEM, P711; [Anonymous], 1983, CANADIAN PSYCHOL; Baddeley AD, 2001, J COGNITIVE NEUROSCI, V13, P357, DOI 10.1162/08989290151137403; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Cipolotti L, 2001, NEUROPSYCHOLOGIA, V39, P151, DOI 10.1016/S0028-3932(00)00103-2; Eichenbaum HE, 2001, CONDITIONING CONSCIO; HAYMAN CAG, 1993, J COGNITIVE NEUROSCI, V5, P375, DOI 10.1162/jocn.1993.5.4.375; Holdstock JS, 2002, NEUROPSYCHOLOGIA, V40, P748, DOI 10.1016/S0028-3932(01)00192-0; Insausti R, 1998, AM J NEURORADIOL, V19, P659; KAPUR N, 1989, CORTEX, V25, P387, DOI 10.1016/S0010-9452(89)80053-X; KAPUR N, 1993, CORTEX, V29, P217, DOI 10.1016/S0010-9452(13)80177-3; Kapur N, 1999, HIPPOCAMPUS, V9, P247, DOI 10.1002/(SICI)1098-1063(1999)9:3<247::AID-HIPO5>3.0.CO;2-W; Kitchener EG, 1998, BRAIN, V121, P1313, DOI 10.1093/brain/121.7.1313; Kopelman MD, 2001, PHILOS T R SOC B, V356, P1409, DOI 10.1098/rstb.2001.0942; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Manns JR, 2003, NEURON, V37, P171, DOI 10.1016/S0896-6273(02)01147-9; MANNS JR, 2002, HDB MEMORY DISORDERS, P81; NORMAN KA, 2003, IN PRESS PSYCH REV; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; Reed JM, 1998, J NEUROSCI, V18, P3943; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Schmolck H, 2002, HIPPOCAMPUS, V12, P520, DOI 10.1002/hipo.10039; SHIMAMURA AP, 1987, J EXP PSYCHOL LEARN, V13, P464, DOI 10.1037/0278-7393.13.3.464; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; SQUIRE LR, 1975, SCIENCE, V187, P77, DOI 10.1126/science.1109228; SQUIRE LR, 1989, EXP NEUROL, V105, P23, DOI 10.1016/0014-4886(89)90168-4; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Squire LR, 1998, HIPPOCAMPUS, V8, P205, DOI 10.1002/(SICI)1098-1063(1998)8:3<205::AID-HIPO3>3.0.CO;2-I; Squire LR, 2001, HIPPOCAMPUS, V11, P50, DOI 10.1002/1098-1063(2001)11:1<50::AID-HIPO1019>3.0.CO;2-G; Stark CEL, 2001, LEARN MEMORY, V8, P190, DOI 10.1101/lm.40701; Stark CEL, 2002, LEARN MEMORY, V9, P238, DOI 10.1101/lm.51802; Suzuki WA, 2000, ANN NY ACAD SCI, V911, P175; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.3.CO;2-J; TULVING E, 1989, AM SCI, V77, P361; Tulving E, 1991, MEMORY ORG LOCUS CHA, P3; Van der Linden M, 2001, NEUROCASE, V7, P283, DOI 10.1093/neucas/7.4.283; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Verfaellie M, 2000, NEUROPSYCHOLOGIA, V38, P484, DOI 10.1016/S0028-3932(99)00089-5; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	41	253	257	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 10	2003	38	1					127	133		10.1016/S0896-6273(03)00146-6	http://dx.doi.org/10.1016/S0896-6273(03)00146-6			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	666XT	12691670	Bronze			2022-12-24	WOS:000182202300015
J	Soler-Llavina, GJ; Holmgren, M; Swartz, KJ				Soler-Llavina, GJ; Holmgren, M; Swartz, KJ			Defining the conductance of the closed state in a voltage-gated K+ channel	NEURON			English	Article							SCORPION TOXIN RECEPTOR; POTASSIUM CHANNEL; CHARYBDOTOXIN BLOCK; ACTIVATION GATE; GATING CHARGE; SHAKER; PORE; MECHANISM; PEPTIDE; INACTIVATION	The opening and closing of the ion conduction pathway in ion channels underlies the generation and propagation of electrical signals in biological systems. Although electrophysiological approaches to measuring the flow of ions in the open state have contributed profoundly to our understanding of ion permeation and gating, it remains unclear how much the ion-throughput rate decreases upon closure of the ion conduction pore. To address this fundamental question, we expressed the Shaker Kv channel at high levels and then measured macroscopic K+ currents at negative membrane voltages and counted the number of channels by quantifying the translocation of gating charge. Our results show that the conductance of the closed state is between 0 and 0.16 fS, or at least 100,000 times lower than for the open state of the channel, indicating that the flow of ions is very tightly regulated in this class of K+ channels.	NINDS, Mol Physiol & Biophys Unit, NIH, Bethesda, MD 20892 USA; NINDS, Mol Neurophysiol Unit, NIH, Bethesda, MD 20892 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Harvard University; Harvard Medical School	Swartz, KJ (corresponding author), NINDS, Mol Physiol & Biophys Unit, NIH, Bethesda, MD 20892 USA.	swartzk@ninds.nih.gov			Intramural NIH HHS [ZIA NS002945-13] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002993, Z01NS002945] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ANDERSON CS, 1988, J GEN PHYSIOL, V91, P317, DOI 10.1085/jgp.91.3.317; ARMSTRON.CM, 1969, J GEN PHYSIOL, V54, P553, DOI 10.1085/jgp.54.5.553; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; ARMSTRONG CM, 1992, PHYSIOL REV, V72, pS5, DOI 10.1152/physrev.1992.72.suppl_4.S5; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; ARMSTRONG CM, 1972, J GEN PHYSIOL, V59, P388, DOI 10.1085/jgp.59.4.388; Bezanilla F, 1998, METHOD ENZYMOL, V293, P331; Chapman ML, 1997, BIOPHYS J, V72, P708, DOI 10.1016/S0006-3495(97)78707-1; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; GOLDSTEIN SAN, 1993, BIOPHYS J, V65, P1613, DOI 10.1016/S0006-3495(93)81200-1; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; Gross A, 1996, NEURON, V16, P399, DOI 10.1016/S0896-6273(00)80057-4; GROSS A, 1994, NEURON, V13, P961, DOI 10.1016/0896-6273(94)90261-5; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; HEGINBOTHAM L, 1993, BIOPHYS J, V65, P2089, DOI 10.1016/S0006-3495(93)81244-X; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Holmgren M, 1998, NEURON, V21, P617, DOI 10.1016/S0896-6273(00)80571-1; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; Horrigan FT, 1999, J GEN PHYSIOL, V114, P277, DOI 10.1085/jgp.114.2.277; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; Kitaguchi T, 2003, BIOPHYS J, V84, p219A; Legros C, 2000, J BIOL CHEM, V275, P16918, DOI 10.1074/jbc.275.22.16918; Li-Smerin Y, 2001, J GEN PHYSIOL, V117, P205, DOI 10.1085/jgp.117.3.205; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; MILLER C, 1988, NEURON, V1, P1003, DOI 10.1016/0896-6273(88)90157-2; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; Naranjo D, 1996, NEURON, V16, P123, DOI 10.1016/S0896-6273(00)80029-X; PARK CS, 1992, NEURON, V9, P307, DOI 10.1016/0896-6273(92)90169-E; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Roux B, 2000, BIOCHEMISTRY-US, V39, P13295, DOI 10.1021/bi001567v; Sakmann B., 1995, SINGLE CHANNEL RECOR; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; STOCKER M, 1991, P ROY SOC B-BIOL SCI, V245, P101, DOI 10.1098/rspb.1991.0094; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; Zheng J, 1997, J GEN PHYSIOL, V110, P101, DOI 10.1085/jgp.110.2.101; Zheng J, 1998, J GEN PHYSIOL, V112, P457, DOI 10.1085/jgp.112.4.457; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	55	27	28	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 10	2003	38	1					61	67		10.1016/S0896-6273(03)00157-0	http://dx.doi.org/10.1016/S0896-6273(03)00157-0			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	666XT	12691664	Bronze			2022-12-24	WOS:000182202300009
J	Xu, YL; Reinscheid, RK; Huitron-Resendiz, S; Clark, SD; Wang, ZW; Lin, SH; Brucher, FA; Zeng, JA; Ly, NK; Henriksen, SJ; Lecea, LC; Civelli, O				Xu, YL; Reinscheid, RK; Huitron-Resendiz, S; Clark, SD; Wang, ZW; Lin, SH; Brucher, FA; Zeng, JA; Ly, NK; Henriksen, SJ; Lecea, LC; Civelli, O			Neuropeptide S: A neuropeptide promoting arousal and anxiolytic-like effects	NEURON			English	Article							PROTEIN-COUPLED RECEPTORS; LOCUS-CERULEUS NEURONS; BARRINGTONS NUCLEUS; COERULEUS; ANXIETY; SLEEP; STRESS; MICE; SUSCEPTIBILITY; PROJECTIONS	Arousal and anxiety are behavioral responses that involve complex neurocircuitries and multiple neurochemical components. Here, we report that a neuropeptide, neuropeptide S (NPS), potently modulates wakefulness and could also regulate anxiety. NIPS acts by activating its cognate receptor (NPSR) and inducing mobilization of intracellular Ca2+. The NPSR mRNA is widely distributed in the brain, including the amygdala and the midline thalamic nuclei. Central administration of NPS increases locomotor activity in mice and decreases paradoxical (REM) sleep and slow wave sleep in rats. NPS was further shown to produce anxiolytic-like effects in mice exposed to four different stressful paradigms. Interestingly, NPS is expressed in a previously undefined cluster of cells located between the locus coeruleus (LC) and Barrington's nucleus. These results indicate that NIPS could be a new modulator of arousal and anxiety. They also show that the LC region encompasses distinct nuclei expressing different arousal-promoting neurotransmitters.	Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Biol Mol, La Jolla, CA 92037 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Scripps Research Institute; Scripps Research Institute	Reinscheid, RK (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA.	rreinsch@uci.edu	Civelli, Olivier/A-8392-2012; de Lecea, Luis/B-3171-2009; de Lecea, Luis/ABE-4005-2021	de Lecea, Luis/0000-0002-8921-5942; de Lecea, Luis/0000-0002-8921-5942				ASTONJONES G, 1991, PROG BRAIN RES, V88, P47; ASTONJONES G, 1991, PROG BRAIN RES, V88, P501; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; BING O, 1993, NEUROSCI LETT, V164, P17, DOI 10.1016/0304-3940(93)90846-D; Borsini F, 2002, PSYCHOPHARMACOLOGY, V163, P121, DOI 10.1007/s00213-002-1155-6; Bourgin P, 2000, J NEUROSCI, V20, P7760; Chaouloff F, 1997, BEHAV BRAIN RES, V85, P27, DOI 10.1016/S0166-4328(96)00160-X; Charney DS, 1996, CRIT REV NEUROBIOL, V10, P419; Chojnacka-Wojcik E, 2001, Curr Opin Investig Drugs, V2, P1112; Cirelli C, 1996, SCIENCE, V274, P1211, DOI 10.1126/science.274.5290.1211; Civelli O, 2001, TRENDS NEUROSCI, V24, P230, DOI 10.1016/S0166-2236(00)01763-X; Clark SD, 2001, BRAIN RES, V923, P120, DOI 10.1016/S0006-8993(01)03208-5; FOOTE SL, 1980, P NATL ACAD SCI-BIOL, V77, P3033, DOI 10.1073/pnas.77.5.3033; Gottesmann C, 2002, NEUROSCIENCE, V111, P231, DOI 10.1016/S0306-4522(02)00034-9; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; HOBSON JA, 1975, SCIENCE, V189, P55, DOI 10.1126/science.1094539; Holmes A, 2003, NEUROPSYCHOPHARMACOL, V28, P1031, DOI 10.1038/sj.npp.1300164; Hunsley MS, 2003, SLEEP, V26, P521; Jones BE, 2003, FRONT BIOSCI-LANDMRK, V8, pS438, DOI 10.2741/1074; JONES BE, 1991, PROG BRAIN RES, V88, P533; Koster A, 1999, P NATL ACAD SCI USA, V96, P10444, DOI 10.1073/pnas.96.18.10444; Laitinen T, 2004, SCIENCE, V304, P300, DOI 10.1126/science.1090010; LAURSEN SE, 1986, J PHARMACOL METHOD, V16, P355, DOI 10.1016/0160-5402(86)90038-0; Millan MJ, 2003, PROG NEUROBIOL, V70, P83, DOI 10.1016/s0301-0082(03)00087-X; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; Ohayon MM, 1998, COMPR PSYCHIAT, V39, P185, DOI 10.1016/S0010-440X(98)90059-1; Paine TA, 2002, BEHAV PHARMACOL, V13, P511, DOI 10.1097/00008877-200211000-00001; Paxinos G., 1998, RAT BRAIN STEROTAXIC; REDMOND DE, 1979, LIFE SCI, V25, P2149, DOI 10.1016/0024-3205(79)90087-0; Reinscheid RK, 2002, NEUROPEPTIDES, V36, P72, DOI 10.1054/npep.2002.0901; RIZVI TA, 1994, J COMP NEUROL, V347, P1, DOI 10.1002/cne.903470102; RODGERS RJ, 1995, PHARMACOL BIOCHEM BE, V52, P297, DOI 10.1016/0091-3057(95)00138-M; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Saito Y, 1999, NATURE, V400, P265, DOI 10.1038/22321; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Sato S, 2002, World Patent Application, Patent No. [WO 02/ 31145 A1, 0231145]; Shimomura Y, 2002, J BIOL CHEM, V277, P35826, DOI 10.1074/jbc.M205337200; Silva AP, 2002, CLIN CHIM ACTA, V326, P3, DOI 10.1016/S0009-8981(02)00301-7; Sutcliffe JG, 2002, NAT REV NEUROSCI, V3, P339, DOI 10.1038/nrn808; SUTIN EL, 1988, J COMP NEUROL, V270, P243, DOI 10.1002/cne.902700206; SWANSON LW, 1975, J COMP NEUROL, V163, P467, DOI 10.1002/cne.901630406; SWANSON LW, 1983, NEUROENDOCRINOLOGY, V36, P165, DOI 10.1159/000123454; Ursin R, 2002, SLEEP MED REV, V6, P57, DOI 10.1053/smrv.2001.0174; Valentino RJ, 1995, J COMP NEUROL, V363, P402, DOI 10.1002/cne.903630306; Valentino RJ, 2000, J COMP NEUROL, V417, P399; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; Wilson S, 1998, BRIT J PHARMACOL, V125, P1387, DOI 10.1038/sj.bjp.0702238	49	424	443	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 19	2004	43	4					487	497		10.1016/j.neuron.2004.08.005	http://dx.doi.org/10.1016/j.neuron.2004.08.005			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	847ZK	15312648	Bronze			2022-12-24	WOS:000223436400008
J	Choi, DS; Cascini, MG; Mailliard, W; Young, H; Paredes, P; McMahon, T; Diamond, I; Bonci, A; Messing, RO				Choi, DS; Cascini, MG; Mailliard, W; Young, H; Paredes, P; McMahon, T; Diamond, I; Bonci, A; Messing, RO			The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; INDUCED MOTOR INCOORDINATION; ADENOSINE A(2A) RECEPTORS; RAT NUCLEUS-ACCUMBENS; EXTRACELLULAR ADENOSINE; PRESYNAPTIC INHIBITION; SEEKING BEHAVIOR; PROTEIN-KINASE; CALCIUM INFLUX; A(1) RECEPTORS	Adenosine is an important mediator of ethanol intoxication. In vitro, ethanol stimulates adenosine signaling by inhibiting the type 1 equilibrative nucleoside transporter (ENT1), whereas chronic ethanol exposure downregulates ENT1. It is not known, however, whether ENT1 is important for ethanol intoxication or consumption in vivo. Here we report that ENT1-null mice show reduced hypnotic and ataxic responses to ethanol and greater consumption of alcohol as compared with their wild-type littermates. These features are associated with a decrease in adenosine tone, as measured indirectly as a reduction in A(1)receptor- mediated inhibition of glutamate excitatory postsynaptic currents (EPSCs) in the nucleus accumbens, leading to increased phosphorylation of CRE-binding protein (CREB) in the striatum. Treatment with an A(1) receptor agonist decreases EPSC amplitude and reduces ethanol consumption in ENT1-null mice. Our results indicate that ENT1 has a physiological role in ethanol-mediated behaviors and suggest that decreased A(1) adenosine receptor function promotes alcohol consumption.	Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Dept Neurol, Emeryville, CA 94608 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Messing, RO (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Dept Neurol, Emeryville, CA 94608 USA.	romes@itsa.ucsf.edu	Choi, Doo-Sup/G-9474-2012; Messing, Robert/D-3642-2015	Choi, Doo-Sup/0000-0002-6796-9938; Messing, Robert/0000-0002-5345-4431	NIAAA NIH HHS [AA013588] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013588, R37AA013588] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Anderson CM, 1999, J NEUROCHEM, V73, P867, DOI 10.1046/j.1471-4159.1999.0730867.x; Backstrom P, 2004, ALCOHOL CLIN EXP RES, V28, P558, DOI 10.1097/01.ALC.0000122101.13164.21; Backstrom P, 2004, NEUROPSYCHOPHARMACOL, V29, P921, DOI 10.1038/sj.npp.1300381; Baldwin SA, 1999, MOL MED TODAY, V5, P216, DOI 10.1016/S1357-4310(99)01459-8; BALLARIN M, 1991, ACTA PHYSIOL SCAND, V142, P97, DOI 10.1111/j.1748-1716.1991.tb09133.x; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Bowers BJ, 2000, ALCOHOL RES HEALTH, V24, P175; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; CARMICHAEL FJ, 1991, J PHARMACOL EXP THER, V259, P403; Choi DS, 2002, J NEUROSCI, V22, P9905; Crabbe JC, 1996, NAT GENET, V14, P98, DOI 10.1038/ng0996-98; Dar MS, 2001, BRAIN RES BULL, V55, P513, DOI 10.1016/S0361-9230(01)00552-4; Dar MS, 1997, BRAIN RES, V749, P263, DOI 10.1016/S0006-8993(96)01263-2; Diao LH, 1996, J PHARMACOL EXP THER, V278, P542; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; El Yacoubi M, 2000, PSYCHOPHARMACOLOGY, V148, P153; Florio C, 1998, PSYCHOPHARMACOLOGY, V136, P311, DOI 10.1007/s002130050572; GEIGER JD, 1984, BRAIN RES BULL, V13, P657, DOI 10.1016/0361-9230(84)90198-9; Harvey J, 1997, J NEUROSCI, V17, P5271; Hodge CW, 1999, NAT NEUROSCI, V2, P997, DOI 10.1038/14795; Jennings LL, 2001, NEUROPHARMACOLOGY, V40, P722, DOI 10.1016/S0028-3908(00)00207-0; LI TK, 1993, BEHAV GENET, V23, P163, DOI 10.1007/BF01067421; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Marston HM, 1998, J PHARMACOL EXP THER, V285, P1023; Naassila M, 2002, J NEUROSCI, V22, P10487; Nagel J, 2002, BEHAV BRAIN RES, V134, P485, DOI 10.1016/S0166-4328(02)00062-1; NAGY LE, 1989, MOL PHARMACOL, V36, P744; NAGY LE, 1990, J BIOL CHEM, V265, P1946; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; SANDERSON G, 1986, PFLUG ARCH EUR J PHY, V406, P25, DOI 10.1007/BF00582948; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; SCHOLZ KP, 1992, NEURON, V8, P1139, DOI 10.1016/0896-6273(92)90134-Y; Schuckit MA, 1998, J STUD ALCOHOL, V59, P485, DOI 10.15288/jsa.1998.59.485; Self DW, 1998, J NEUROSCI, V18, P1848; Shaw-Lutchman TZ, 2003, SYNAPSE, V48, P10, DOI 10.1002/syn.10172; Svenningsson P, 1999, PROG NEUROBIOL, V59, P355, DOI 10.1016/S0301-0082(99)00011-8; Svenningsson P, 2002, P NATL ACAD SCI USA, V99, P3182, DOI 10.1073/pnas.052712799; Walters CL, 2001, J NEUROSCI, V21, P9438, DOI 10.1523/JNEUROSCI.21-23-09438.2001; WU LG, 1994, NEURON, V12, P1139, DOI 10.1016/0896-6273(94)90321-2	39	191	197	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					855	861		10.1038/nn1288	http://dx.doi.org/10.1038/nn1288			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15258586				2022-12-24	WOS:000222930800016
J	Pasinelli, P; Belford, ME; Lennon, N; Bacskai, BJ; Hyman, BT; Trotti, D; Brown, RH				Pasinelli, P; Belford, ME; Lennon, N; Bacskai, BJ; Hyman, BT; Trotti, D; Brown, RH			Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria	NEURON			English	Article							TRANSGENIC MOUSE MODEL; SUPEROXIDE-DISMUTASE GENE; PROGRAMMED CELL-DEATH; MOTOR-NEURON DEATH; ALS-LINKED SOD1; OXIDATIVE DAMAGE; APOPTOTIC DEATH; DEGENERATION; MUTATIONS; MICE	Familial amyotrophic lateral sclerosis (ALS)-linked mutations in the copper-zinc superoxide dismutase (SOD1) gene cause motor neuron death in about 3% of ALS cases. While the wild-type (wt) protein is anti-apoptotic, mutant SOD1 promotes apoptosis. We now demonstrate that both wt and mutant SOD1 bind the anti-apoptotic protein Bcl-2, providing evidence of a direct link between SOD1 and an apoptotic pathway. This interaction is evident in vitro and in vivo in mouse and human spinal cord. We also demonstrate that in mice and humans, Bcl-2 binds to high molecular weight SIDS-resistant mutant SOD1 containing aggregates that are present in mitochondria from spinal cord but not liver. These findings provide new insights into the anti-apoptotic function of SOD1 and suggest that entrapment of Bcl-2 by large SOD1 aggregates may deplete motor neurons of this anti-apoptotic protein.	Harvard Univ, Sch Med, Mass Gen Inst Neurodegenerat Dis, Massachusetts Gen Hosp,Day Lab Neuromusc Res, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Mass Gen Inst Neurodegenerat Dis, Massachusetts Gen Hosp,Dept Neurol, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Pasinelli, P (corresponding author), Harvard Univ, Sch Med, Mass Gen Inst Neurodegenerat Dis, Massachusetts Gen Hosp,Day Lab Neuromusc Res, Charlestown, MA 02129 USA.	ppasinelli@partners.org; rhbrown@partners.org	Bacskai, Brian/AAE-9583-2021	Trotti, Davide/0000-0001-6338-6404; Pasinelli, Piera/0000-0002-3385-2707	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG012406, R43AG022252, P01AG012992, R44AG022252] Funding Source: NIH RePORTER; NIA NIH HHS [R37 AG12406, P01 AG12992-9, R03-AG022252] Funding Source: Medline; NIBIB NIH HHS [EB00768] Funding Source: Medline; NINDS NIH HHS [R01-NS44292] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andersen PM, 2003, AMYOTROPH LATERAL SC, V4, P62, DOI 10.1080/14660820310011700; Appel SH, 2001, AMYOTROPH LATERAL SC, V2, pS47; Bacskai BJ, 2003, J BIOMED OPT, V8, P368, DOI 10.1117/1.1584442; BOWLING AC, 1993, J NEUROCHEM, V61, P2322, DOI 10.1111/j.1471-4159.1993.tb07478.x; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; DALCANTO MC, 1995, BRAIN RES, V676, P25, DOI 10.1016/0006-8993(95)00063-V; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Ekegren T, 1999, ACTA NEUROL SCAND, V100, P317; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Friedlander RM, 1997, NATURE, V388, P31, DOI 10.1038/40299; Ghadge GD, 1997, J NEUROSCI, V17, P8756; GREENLUND LJS, 1995, NEURON, V14, P303, DOI 10.1016/0896-6273(95)90287-2; Guegan C, 2003, J CLIN INVEST, V111, P153, DOI 10.1172/JCI200317610; Guegn C, 2001, J NEUROSCI, V21, P6569, DOI 10.1523/JNEUROSCI.21-17-06569.2001; Higgins CMJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-06-j0001.2002; Hzecka J, 2001, ACTA NEUROL SCAND, V103, P255; Kong JM, 1998, J NEUROSCI, V18, P3241; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Martin LJ, 1999, J NEUROPATH EXP NEUR, V58, P459, DOI 10.1097/00005072-199905000-00005; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Michaelidis TM, 1996, NEURON, V17, P75, DOI 10.1016/S0896-6273(00)80282-2; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Pasinelli P, 2000, P NATL ACAD SCI USA, V97, P13901, DOI 10.1073/pnas.240305897; Pasinelli P, 1998, P NATL ACAD SCI USA, V95, P15763, DOI 10.1073/pnas.95.26.15763; RABIZADEH S, 1995, P NATL ACAD SCI USA, V92, P3024, DOI 10.1073/pnas.92.7.3024; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18, DOI 10.1002/ana.410280106; ROTHSTEIN JD, 1994, P NATL ACAD SCI USA, V91, P4155, DOI 10.1073/pnas.91.10.4155; Schimmer AD, 2001, BLOOD, V98, P3541, DOI 10.1182/blood.V98.13.3541; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Takeuchi H, 2002, J BIOL CHEM, V277, P50966, DOI 10.1074/jbc.M209356200; TROY CM, 1994, P NATL ACAD SCI USA, V91, P6384, DOI 10.1073/pnas.91.14.6384; Vukosavic S, 2000, J NEUROSCI, V20, P9119; Vukosavic S, 1999, J NEUROCHEM, V73, P2460, DOI 10.1046/j.1471-4159.1999.0732460.x; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Yachnis AT, 1998, EXP NEUROL, V150, P82, DOI 10.1006/exnr.1997.6746; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0	43	381	399	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 8	2004	43	1					19	30		10.1016/j.neuron.2004.06.021	http://dx.doi.org/10.1016/j.neuron.2004.06.021			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233914	Bronze			2022-12-24	WOS:000222549800004
J	McMains, SA; Somers, DC				McMains, SA; Somers, DC			Multiple spotlights of attentional selection in human visual cortex	NEURON			English	Article							HUMAN CEREBRAL-CORTEX; MACAQUE AREA V4; SPATIAL ATTENTION; FUNCTIONAL MRI; PHYSIOLOGICAL CORRELATE; EXTRASTRIATE CORTEX; NEURAL MECHANISMS; TARGET DETECTION; FOCAL ATTENTION; CORTICAL AREAS	Spatially directed attention strongly enhances visual perceptual processing. The metaphor of the "spotlight" has long been used to describe spatial attention; however, there has been considerable debate as to whether spatial attention must be unitary or may be split between discrete regions of space. This question was addressed here through functional MR imaging of human subjects as they performed a task that required simultaneous attention to two briefly displayed and masked targets at locations separated by distractor stimuli. These data reveal retinotopically specific enhanced activation in striate and extrastriate visual cortical representations of the two attended stimuli and no enhancement at the intervening representation of distractor stimuli. This finding of two spotlights was obtained within a single cortical hemisphere and across the two hemispheres. This provides direct evidence that spatial attention can select, in parallel, multiple low-level perceptual representations.	Boston Univ, Dept Psychol, Boston, MA 02215 USA; Boston Univ, Program Neurosci, Boston, MA 02215 USA; Massachusetts Gen Hosp, Dept Radiol, Hillsborough 02129, North Ireland	Boston University; Boston University	Somers, DC (corresponding author), Boston Univ, Dept Psychol, 64 Cummington St, Boston, MA 02215 USA.	somers@bu.edu	Somers, David C./G-5802-2010	Somers, David C./0000-0002-4169-5895	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NCRR NIH HHS [P41RR14075] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Awh E, 2000, J EXP PSYCHOL HUMAN, V26, P834, DOI 10.1037/0096-1523.26.2.834; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; BROADBENT DE, 1987, PERCEPT PSYCHOPHYS, V42, P105, DOI 10.3758/BF03210498; CASTIELLO U, 1990, ACTA PSYCHOL, V73, P195, DOI 10.1016/0001-6918(90)90022-8; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Chun MM, 2002, CURR OPIN NEUROBIOL, V12, P184, DOI 10.1016/S0959-4388(02)00309-4; COMTOIS R, 1999, VISIONSHELL MACINTOS; Conner CE, 1997, J NEUROSCI, V17, P3201; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corchs S, 2002, CEREB CORTEX, V12, P339, DOI 10.1093/cercor/12.4.339; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; DALE W, 1999, PROSTATE J, V1, P179, DOI DOI 10.1046/J.1525-1411.1999.14005.X; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DUNCAN J, 1994, NATURE, V369, P313, DOI 10.1038/369313a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; ERIKSEN CW, 1985, J EXP PSYCHOL HUMAN, V11, P583, DOI 10.1037/0096-1523.11.5.583; ERIKSEN CW, 1986, PERCEPT PSYCHOPHYS, V40, P225, DOI 10.3758/BF03211502; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Giesbrecht B, 2003, NEUROIMAGE, V19, P496, DOI 10.1016/S1053-8119(03)00162-9; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; Hahn S, 1998, VIS COGN, V5, P217, DOI 10.1080/713756781; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; James W., 1890, PRINCIPLES PSYCHOL; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; McCormick PA, 1998, J EXP PSYCHOL HUMAN, V24, P350, DOI 10.1037/0096-1523.24.1.350; MCLEAN JP, 1983, Q J EXP PSYCHOL-A, V35, P171, DOI 10.1080/14640748308402123; Moore CM, 1996, PSYCHON B REV, V3, P360, DOI 10.3758/BF03210761; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Muller MM, 2003, NATURE, V424, P309, DOI 10.1038/nature01812; Muller NG, 2003, J NEUROSCI, V23, P3561; Neisser U., 1967, COGNITIVE PSYCHOL; Niebur E, 1994, J Comput Neurosci, V1, P141, DOI 10.1007/BF00962722; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Pashler HE, 1998, PSYCHOL ATTENTION; Peterson MS, 2000, J GEN PSYCHOL, V127, P6, DOI 10.1080/00221300009598568; Posner MI, 1999, P NATL ACAD SCI USA, V96, P2585, DOI 10.1073/pnas.96.6.2585; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; REEVES A, 1986, PSYCHOL REV, V93, P180, DOI 10.1037/0033-295X.93.2.180; Rensink RA, 2002, ANNU REV PSYCHOL, V53, P245, DOI 10.1146/annurev.psych.53.100901.135125; Reynolds JH, 1999, J NEUROSCI, V19, P1736; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; SHAW ML, 1978, J EXP PSYCHOL HUMAN, V4, P586, DOI 10.1037/0096-1523.4.4.586; SHAW ML, 1977, J EXP PSYCHOL HUMAN, V3, P201, DOI 10.1037/0096-1523.3.2.201; SHULMAN GL, 1979, J EXP PSYCHOL HUMAN, V5, P522, DOI 10.1037/0096-1523.5.3.522; Simons DJ, 2000, TRENDS COGN SCI, V4, P147, DOI 10.1016/S1364-6613(00)01455-8; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; TSAL Y, 1983, J EXP PSYCHOL HUMAN, V9, P523, DOI 10.1037/0096-1523.9.4.523; Watanabe T, 1998, J NEUROPHYSIOL, V79, P2218, DOI 10.1152/jn.1998.79.4.2218; WEICHSELGARTNER E, 1987, SCIENCE, V238, P778, DOI 10.1126/science.3672124; Wolfe JM, 2000, NATURE, V406, P691, DOI 10.1038/35021132; Woodman GF, 1999, NATURE, V400, P867, DOI 10.1038/23698; YANTIS S, 1992, COGNITIVE PSYCHOL, V24, P295, DOI 10.1016/0010-0285(92)90010-Y	63	214	216	4	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 27	2004	42	4					677	686		10.1016/S0896-6273(04)00263-6	http://dx.doi.org/10.1016/S0896-6273(04)00263-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157427	Bronze			2022-12-24	WOS:000221708300016
J	Fernandez-Alfonso, T; Ryan, TA				Fernandez-Alfonso, T; Ryan, TA			The kinetics of synaptic vesicle pool depletion at CNS synaptic terminals	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; HIPPOCAMPAL SYNAPSES; RELEASABLE POOL; ENDOCYTOSIS; SINGLE; RAT; TRANSMISSION; MOBILIZATION; NEURONS; REPLENISHMENT	During sustained action potential (AP) firing at nerve terminals, the rates of endocytosis compared to exocytosis determine how quickly the available synaptic vesicle pool is depleted, in turn influencing presynaptic efficacy. Mechanisms, including rapid kiss-and-run endocytosis as well as local, preferential recycling of docked vesicles, have been proposed as a means to allow endocytosis and recycling to keep up with stimulation. We show here that, for CNS nerve terminals at physiological temperatures, endocytosis is sufficiently fast to avoid vesicle pool depletion during continuous AP firing at 10 Hz. This endocytosis-exocytosis balance persists for turnover of the entire releasable pool of vesicles and allows for efficient escape of FM 4-64, indicating that it is a non-kiss-and-run endocytic event. Thus, under physiological conditions, the sustained speed of vesicle membrane retrieval for the entire releasable pool appears to be sufficiently fast to compensate for exocytosis, avoiding significant vesicle pool depletion during robust synaptic activity.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA	Cornell University	Ryan, TA (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA.	taryan@med.cornell.edu	Ryan, Timothy/AAO-8286-2020	Fernandez Alfonso, Tomas/0000-0002-9339-6678; Ryan, Timothy/0000-0003-2533-9548	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036942] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS036942] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Atluri PP, 1996, J NEUROSCI, V16, P5661; Betz WJ, 1998, ANNU REV PHYSIOL, V60, P347, DOI 10.1146/annurev.physiol.60.1.347; Borst JGG, 1998, J PHYSIOL-LONDON, V506, P143, DOI 10.1111/j.1469-7793.1998.143bx.x; Brenowitz S, 1998, NEURON, V20, P135, DOI 10.1016/S0896-6273(00)80441-9; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Cousin MA, 1997, J NEUROCHEM, V69, P1927; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Hardingham NR, 1998, J PHYSIOL-LONDON, V507, P249, DOI 10.1111/j.1469-7793.1998.249bu.x; Heidelberger R, 2002, J NEUROPHYSIOL, V88, P98, DOI 10.1152/jn.2002.88.1.98; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hirase H, 1999, EUR J NEUROSCI, V11, P4373, DOI 10.1046/j.1460-9568.1999.00853.x; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Pyott SJ, 2002, J PHYSIOL-LONDON, V539, P523, DOI 10.1113/jphysiol.2001.013277; Ryan TA, 1999, J NEUROSCI, V19, P1317; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sabatini BL, 1998, BIOPHYS J, V74, P1549, DOI 10.1016/S0006-3495(98)77867-1; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Taschenberger H, 2000, J NEUROSCI, V20, P9162; TENG H, 2000, J PHYSL, V551, P103; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Wiener SI, 1996, PROG NEUROBIOL, V49, P335, DOI 10.1016/0301-0082(96)00019-6; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	36	174	176	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 25	2004	41	6					943	953		10.1016/S0896-6273(04)00113-8	http://dx.doi.org/10.1016/S0896-6273(04)00113-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046726	Bronze			2022-12-24	WOS:000221458300013
J	Bareyre, FM; Kerschensteiner, M; Raineteau, O; Mettenleiter, TC; Weinmann, O; Schwab, ME				Bareyre, FM; Kerschensteiner, M; Raineteau, O; Mettenleiter, TC; Weinmann, O; Schwab, ME			The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; C3-C5 PROPRIOSPINAL NEURONS; PSEUDORABIES VIRUS; MOTOR CORTEX; CAT; PLASTICITY; RECOVERY; ORGANIZATION; LESIONS; AXONS	In contrast to peripheral nerves, central axons do not regenerate. Partial injuries to the spinal cord, however, are followed by functional recovery. We investigated the anatomical basis of this recovery and found that after incomplete spinal cord injury in rats, transected hindlimb corticospinal tract (CST) axons sprouted into the cervical gray matter to contact short and long propriospinal neurons (PSNs). Over 12 weeks, contacts with long PSNs that bridged the lesion were maintained, whereas contacts with short PSNs that did not bridge the lesion were lost. In turn, long PSNs arborize on lumbar motor neurons, creating a new intraspinal circuit relaying cortical input to its original spinal targets. We confirmed the functionality of this circuit by electrophysiological and behavioral testing before and after CST re-lesion. Retrograde transynaptic tracing confirmed its integrity, and revealed changes of cortical representation. Hence, after incomplete spinal cord injury, spontaneous extensive remodeling occurs, based on axonal sprout formation and removal. Such remodeling may be crucial for rehabilitation in humans.	Univ Zurich, Inst Brain Res, Dept Neuromorphol, CH-8057 Zurich, Switzerland; ETH, Dept Biol, CH-8057 Zurich, Switzerland; Univ Zurich, Inst Brain Res, Dept Neurophysiol, CH-8057 Zurich, Switzerland; Fed Res Ctr Virus Dis Anim, Friedrich Loeffler Inst, Inst Mol & Cellular Virol, D-17498 Insel Riems, Germany	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Friedrich Loeffler Institute	Bareyre, FM (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid,Box 8108, St Louis, MO USA.	florence@pcg.wustl.edu	Raineteau, Olivier/I-1190-2014; Schwab, Martin E/B-6818-2016; Mettenleiter, h. c. Thomas C./U-1016-2019	Raineteau, Olivier/0000-0003-4294-2496; 				ALSTERMARK B, 1987, BRAIN RES, V404, P382, DOI 10.1016/0006-8993(87)91400-4; ALSTERMARK B, 1987, BRAIN RES, V404, P395, DOI 10.1016/0006-8993(87)91402-8; ALSTERMARK B, 1990, NEUROSCI RES, V8, P131, DOI 10.1016/0168-0102(90)90065-M; ALSTERMARK B, 1987, NEUROSCI LETT, V74, P291, DOI 10.1016/0304-3940(87)90312-0; AOKI M, 1986, Neuroscience Research, V3, P617, DOI 10.1016/0168-0102(86)90058-1; Bareyre FM, 2002, J NEUROSCI, V22, P7097; Bruehlmeier M, 1998, EUR J NEUROSCI, V10, P3918, DOI 10.1046/j.1460-9568.1998.00454.x; CARD JP, 1990, J NEUROSCI, V10, P1974; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Chen R, 1998, J NEUROSCI, V18, P3443; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; DERYCK M, 1992, BRAIN RES, V573, P44; Dietz V, 1998, SPINAL CORD, V36, P380, DOI 10.1038/sj.sc.3100590; Donoghue JP, 1995, CURR OPIN NEUROBIOL, V5, P749, DOI 10.1016/0959-4388(95)80102-2; Fouad K, 2001, CURR BIOL, V11, P1766, DOI 10.1016/S0960-9822(01)00535-8; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; GIOVANELLIBARIL.M, 1969, BRAIN RES, V14, P321; GORDON T, 1993, BRAIN RES BULL, V30, P477, DOI 10.1016/0361-9230(93)90281-F; Herzog A, 1997, J NEUROSCI METH, V72, P57, DOI 10.1016/S0165-0270(96)00156-2; Hiersemenzel LP, 2000, NEUROLOGY, V54, P1574, DOI 10.1212/WNL.54.8.1574; Holaday J W, 1983, Adv Shock Res, V10, P95; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; JANKOWSKA E, 1973, BRAIN RES, V53, P227, DOI 10.1016/0006-8993(73)90786-5; JANKOWSKA E, 1974, EXP BRAIN RES, V21, P169; Jankowska E, 2002, BRAIN RES REV, V40, P19, DOI 10.1016/S0165-0173(02)00185-6; Jons A, 1997, J VIROL METHODS, V66, P283, DOI 10.1016/S0166-0934(97)00065-7; Kaas JH, 1999, NEURON, V22, P657, DOI 10.1016/S0896-6273(00)80725-4; LAWRENCE DG, 1968, BRAIN, V91, P1, DOI 10.1093/brain/91.1.1; LI WWY, 1994, NEUROSCIENCE, V61, P133, DOI 10.1016/0306-4522(94)90066-3; MARIANI J, 1983, PROG BRAIN RES, V58, P383, DOI 10.1016/S0079-6123(08)60041-2; MASSON RL, 1991, J COMP NEUROL, V307, P120, DOI 10.1002/cne.903070111; Merkler D, 2001, J NEUROSCI, V21, P3665, DOI 10.1523/JNEUROSCI.21-10-03665.2001; MILLER S, 1973, J PHYSIOL-LONDON, V230, pP30; MURRAY M, 1974, J COMP NEUROL, V158, P19, DOI 10.1002/cne.901580103; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Nguyen QT, 2002, NAT NEUROSCI, V5, P861, DOI 10.1038/nn905; Pettersson LG, 1997, NEUROSCI RES, V29, P241, DOI 10.1016/S0168-0102(97)00093-X; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Raineteau O, 2001, P NATL ACAD SCI USA, V98, P6929, DOI 10.1073/pnas.111165498; Roof RL, 2001, STROKE, V32, P2648, DOI 10.1161/hs1101.097397; Rossignol S, 1999, PROG BRAIN RES, V123, P349, DOI 10.1016/S0079-6123(08)62870-8; SANES JN, 1990, EXP BRAIN RES, V79, P479; SCHNELL L, 1993, EUR J NEUROSCI, V5, P1156, DOI 10.1111/j.1460-9568.1993.tb00970.x; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Sloan TB, 1998, J CLIN NEUROPHYSIOL, V15, P217, DOI 10.1097/00004691-199805000-00005; Steward O, 2003, J COMP NEUROL, V459, P1, DOI 10.1002/cne.10593; STRACK AM, 1989, BRAIN RES, V491, P274, DOI 10.1016/0006-8993(89)90063-2; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; WERNIG A, 1992, PARAPLEGIA, V30, P229, DOI 10.1038/sc.1992.61; Z'Graggen WJ, 2000, J NEUROSCI, V20, P6561, DOI 10.1523/JNEUROSCI.20-17-06561.2000	50	818	840	3	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					269	277		10.1038/nn1195	http://dx.doi.org/10.1038/nn1195			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14966523				2022-12-24	WOS:000189197900017
J	Richardson, MP; Strange, BA; Dolan, RJ				Richardson, MP; Strange, BA; Dolan, RJ			Encoding of emotional memories depends on amygdala and hippocampus and their interactions	NATURE NEUROSCIENCE			English	Article							TEMPORAL-LOBE EPILEPSY; DECLARATIVE MEMORY; FUNCTIONAL MRI; T2 RELAXATION; FREE-RECALL; LONG-TERM; RAT; PROJECTIONS; SCLEROSIS; NEUROPATHOLOGY	We have studied patients with variable degrees of left hippocampal and amygdala pathology who performed a verbal encoding task during functional magnetic resonance imaging (fMRI) to assess the impact of pathology on emotional-memory performance and encoding-evoked activity. The severity of left hippocampal pathology predicted memory performance for neutral and emotional items alike, whereas the severity of amygdala pathology predicted memory performance for emotional items alone. Encoding-related hippocampal activity for successfully remembered emotional items correlated with the degree of left amygdala pathology. Conversely, amygdala-evoked activity with respect to subsequently remembered emotional items correlated with the degree of left hippocampal pathology. Our data indicate a reciprocal dependence between amygdala and hippocampus during the encoding of emotional memories.	Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England; Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England	University of London; University College London; University of London; University College London	Richardson, MP (corresponding author), Inst Neurol, Dept Clin & Expt Epilepsy, Queen Sq, London WC1N 3BG, England.	m.richardson@ion.ucl.ac.uk	Richardson, Mark P/E-5385-2010; Strange, Bryan A/L-9466-2014; Strange, Bryan/AAF-3805-2019	Richardson, Mark P/0000-0001-8925-3140; Strange, Bryan A/0000-0001-6476-4091; Strange, Bryan/0000-0001-6476-4091; Dolan, Ray/0000-0001-9356-761X				Adolphs R, 1997, LEARN MEMORY, V4, P291, DOI 10.1101/lm.4.3.291; Alkire MT, 1998, P NATL ACAD SCI USA, V95, P14506, DOI 10.1073/pnas.95.24.14506; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bartlett PA, 2002, J NEUROL NEUROSUR PS, V73, P753, DOI 10.1136/jnnp.73.6.753; Bellgowan PSF, 1998, NEUROLOGY, V51, P479, DOI 10.1212/WNL.51.2.479; Briellmann RS, 2002, NEUROLOGY, V58, P265, DOI 10.1212/WNL.58.2.265; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; CANTERAS NS, 1992, J COMP NEUROL, V324, P180, DOI 10.1002/cne.903240204; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Duncan JS, 1996, AM J NEURORADIOL, V17, P1805; DUNCAN JS, 1997, BRAIN, V120, P376; Dupont S, 2000, BRAIN, V123, P1722, DOI 10.1093/brain/123.8.1722; FRISK V, 1990, NEUROPSYCHOLOGIA, V28, P349, DOI 10.1016/0028-3932(90)90061-R; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gallagher M, 1996, CURR OPIN NEUROBIOL, V6, P221, DOI 10.1016/S0959-4388(96)80076-6; Golby AJ, 2002, EPILEPSIA, V43, P855, DOI 10.1046/j.1528-1157.2002.20501.x; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Helmstaedter C, 2001, CURR OPIN NEUROL, V14, P211, DOI 10.1097/00019052-200104000-00013; HUDSON LP, 1993, ANN NEUROL, V33, P622, DOI 10.1002/ana.410330611; Kalviainen R, 1997, NEUROLOGY, V48, P286, DOI 10.1212/WNL.48.1.286; Kilpatrick C, 1997, SEIZURE, V6, P213, DOI 10.1016/S1059-1311(97)80008-8; KRETTEK JE, 1977, J COMP NEUROL, V172, P723, DOI 10.1002/cne.901720409; LENCZ T, 1992, ANN NEUROL, V31, P629, DOI 10.1002/ana.410310610; MAREN S, 1995, J NEUROSCI, V15, P7548; McGaugh JL, 1996, P NATL ACAD SCI USA, V93, P13508, DOI 10.1073/pnas.93.24.13508; Otten LJ, 2001, BRAIN, V124, P399, DOI 10.1093/brain/124.2.399; Phelps EA, 1997, BRAIN COGNITION, V35, P85, DOI 10.1006/brcg.1997.0929; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Richardson MP, 2003, NEUROIMAGE, V20, pS112, DOI 10.1016/j.neuroimage.2003.09.008; Richter-Levin G, 2000, MOL NEUROBIOL, V22, P11, DOI 10.1385/MN:22:1-3:011; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; SMITH ML, 1981, NEUROPSYCHOLOGIA, V19, P781, DOI 10.1016/0028-3932(81)90090-7; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Strange BA, 2000, NEUROIMAGE, V12, P425, DOI 10.1006/nimg.2000.0637; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; VANGROEN T, 1990, J COMP NEUROL, V302, P515, DOI 10.1002/cne.903020308; VanPaesschen W, 1995, NEUROLOGY, V45, P2233; VanPaesschen W, 1997, ANN NEUROL, V42, P756, DOI 10.1002/ana.410420512; VanPaesschen W, 1997, ANN NEUROL, V41, P41, DOI 10.1002/ana.410410109; Windmann S, 2001, J COGNITIVE NEUROSCI, V13, P577, DOI 10.1162/089892901750363172; Woermann FG, 1998, J NEUROL NEUROSUR PS, V65, P656, DOI 10.1136/jnnp.65.5.656	44	354	369	1	47	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					278	285		10.1038/nn1190	http://dx.doi.org/10.1038/nn1190			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14758364	Green Published			2022-12-24	WOS:000189197900018
J	Jin, P; Zarnescu, DC; Ceman, S; Nakamoto, M; Mowrey, J; Jongens, TA; Nelson, DL; Moses, K; Warren, ST				Jin, P; Zarnescu, DC; Ceman, S; Nakamoto, M; Mowrey, J; Jongens, TA; Nelson, DL; Moses, K; Warren, ST			Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway	NATURE NEUROSCIENCE			English	Article							RNA INTERFERENCE; MESSENGER-RNA; DENDRITIC SPINES; KNOCKOUT MICE; MOUSE MODEL; TRANSLATION; HOMOLOG; IDENTIFICATION; ARGONAUTE1; DEFICITS	Fragile X syndrome is caused by a loss of expression of the fragile X mental retardation protein (FMRP). FMRP is a selective RNA-binding protein which forms a messenger ribonucleoprotein (mRNP) complex that associates with polyribosomes. Recently, mRNA ligands associated with FMRP have been identified. However, the mechanism by which FMRP regulates the translation of its mRNA ligands remains unclear. MicroRNAs are small noncoding RNAs involved in translational control. Here we show that in vivo mammalian FMRP interacts with microRNAs and the components of the microRNA pathways including Dicer and the mammalian ortholog of Argonaute 1 (AGO1). Using two different Drosophila melanogaster models, we show that AGO1 is critical for FMRP function in neural development and synaptogenesis. Our results suggest that FMRP may regulate neuronal translation via microRNAs and links microRNAs with human disease.	Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Emory University; Emory University; University of Pennsylvania; Baylor College of Medicine	Warren, ST (corresponding author), Emory Univ, Dept Human Genet, 615 Michael St, Atlanta, GA 30322 USA.	swarren@emory.edu	Warren, Stephen T/A-2498-2012					Antar LN, 2003, NEURON, V37, P555, DOI 10.1016/S0896-6273(03)00090-4; BAKKER CE, 1994, CELL, V78, P23; Bardoni B, 2002, CURR OPIN GENET DEV, V12, P284, DOI 10.1016/S0959-437X(02)00300-3; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bontekoe CJM, 2002, HUM MOL GENET, V11, P487, DOI 10.1093/hmg/11.5.487; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Cerutti H, 2003, TRENDS GENET, V19, P39, DOI 10.1016/S0168-9525(02)00010-0; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; Doi N, 2003, CURR BIOL, V13, P41, DOI 10.1016/S0960-9822(02)01394-5; Feng Y, 1997, J NEUROSCI, V17, P1539; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Kataoka Y, 2001, GENES CELLS, V6, P313, DOI 10.1046/j.1365-2443.2001.00427.x; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Pasquinelli AE, 2002, ANNU REV CELL DEV BI, V18, P495, DOI 10.1146/annurev.cellbio.18.012502.105832; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; SIOMI MC, 1995, EMBO J, V14, P2401, DOI 10.1002/j.1460-2075.1995.tb07237.x; Sung YJ, 2003, J BIOL CHEM, V278, P15669, DOI 10.1074/jbc.M211117200; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; ZHANG Y, 1995, EMBO J, V14, P5358, DOI 10.1002/j.1460-2075.1995.tb00220.x; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	39	479	521	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					113	117		10.1038/nn1174	http://dx.doi.org/10.1038/nn1174			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14703574				2022-12-24	WOS:000188468500008
J	DeMattos, RB; Cirrito, JR; Parsadanian, M; May, PC; O'Dell, MA; Taylor, JW; Harmony, JAK; Aronow, BJ; Bales, KR; Paul, SM; Holtzman, DM				DeMattos, RB; Cirrito, JR; Parsadanian, M; May, PC; O'Dell, MA; Taylor, JW; Harmony, JAK; Aronow, BJ; Bales, KR; Paul, SM; Holtzman, DM			ApoE and clusterin cooperatively suppress A beta levels and deposition: Evidence that ApoE regulates extracellular A beta metabolism in vivo	NEURON			English	Article							ALZHEIMERS AMYLOID-BETA; TRANSGENIC MOUSE MODEL; CENTRAL-NERVOUS-SYSTEM; HUMAN APOLIPOPROTEIN-E; PLAQUE-FORMATION; BLOOD-BRAIN; PROTEIN; DISEASE; PEPTIDE; PLASMA	Apolipoprotein E (apoE) and clusterin can influence structure, toxicity, and accumulation of the amyloid-P (Abeta) peptide in brain. Both molecules may also be involved in Abeta metabolism prior to its deposition. To assess this possibility, we compared PDAPP transgenic mice that develop age-dependent Abeta accumulation in the absence of apoE or clusterin as well as in the absence of both proteins. apoE(-/-) and clusterin(-/-) mice accumulated similar Abeta levels but much less fibrillar Abeta. In contrast, apoE(-/-)/clusterin(-/-) mice had both earlier onset and markedly increased Abeta and amyloid deposition. Both apoE(-/-) and apoE(-/-)/clusterin(-/-) mice had elevated CSF and brain interstitial fluid Abeta, as well as significant differences in the elimination half-life of interstitial fluid Abeta measured by in vivo microdialysis. These findings demonstrate additive effects of apoE and clusterin on influencing Abeta deposition and that apoE plays an important role in regulating extracellular CNS Abeta metabolism independent of Abeta synthesis.	Eli Lilly & Co, Lilly Res Lab, Neurosci Discovery Res, Indianapolis, IN 46285 USA; Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45627 USA; Childrens Hosp Res Fdn, Div Mol & Dev Biol, Cincinnati, OH 45229 USA; Indiana Univ, Sch Med, Dept Pharmacol, Indianapolis, IN 46285 USA; Indiana Univ, Sch Med, Dept Toxicol, Indianapolis, IN 46285 USA; Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46285 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Ctr Study Nervous Syst Injury, St Louis, MO 63110 USA	Eli Lilly; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Holtzman, DM (corresponding author), Eli Lilly & Co, Lilly Res Lab, Neurosci Discovery Res, Indianapolis, IN 46285 USA.	demattos_ronald-bradley@lilly.com; holtzman@neuro.wustl.edu	Aronow, Bruce J/F-8438-2012; Paul, Steve/ABE-5400-2020		NIA NIH HHS [AG11355, AG13956, AG05681] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG011355, R37AG013956, P50AG005681, R01AG013956] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Beffert U, 1999, MOL BRAIN RES, V68, P181, DOI 10.1016/S0169-328X(99)00073-X; Biere AL, 1995, NEUROBIOL DIS, V2, P177, DOI 10.1006/nbdi.1995.0019; Boggs LN, 1996, J NEUROCHEM, V67, P1324; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; Calero M, 2000, MICROSC RES TECHNIQ, V50, P305, DOI 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L; CASTANO EM, 1995, BIOCHEM J, V306, P599, DOI 10.1042/bj3060599; Cirrito JR, 2003, J NEUROSCI, V23, P8844; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; DeMattos RB, 2002, P NATL ACAD SCI USA, V99, P10843, DOI 10.1073/pnas.162228299; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Fagan AM, 2002, NEUROBIOL DIS, V9, P305, DOI 10.1006/nbdi.2002.0483; Fagan AM, 2000, ANN NEUROL, V48, P201, DOI 10.1002/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X; Fryer JD, 2003, J NEUROSCI, V23, P7889; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GHISO J, 1993, BIOCHEM J, V293, P27, DOI 10.1042/bj2930027; GREENBERG SM, 1995, ANN NEUROL, V38, P254, DOI 10.1002/ana.410380219; Hammad SM, 1997, J BIOL CHEM, V272, P18644, DOI 10.1074/jbc.272.30.18644; Han BH, 2001, NAT MED, V7, P338, DOI 10.1038/85487; Holtzman DM, 2000, ANN NEUROL, V47, P739, DOI 10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8; Holtzman DM, 1999, J CLIN INVEST, V103, pR15, DOI 10.1172/JCI6179; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Holtzman DM, 2001, J MOL NEUROSCI, V17, P147, DOI 10.1385/JMN:17:2:147; JOACHIM CL, 1988, BRAIN RES, V474, P100, DOI 10.1016/0006-8993(88)90673-7; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; LADU MJ, 1994, J BIOL CHEM, V269, P23403; LADU MJ, 1995, J BIOL CHEM, V270, P9039, DOI 10.1074/jbc.270.16.9039; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; Matsubara E, 1999, ANN NEUROL, V45, P537, DOI 10.1002/1531-8249(199904)45:4<537::AID-ANA20>3.0.CO;2-2; Matsubara E, 1996, BIOCHEM J, V316, P671, DOI 10.1042/bj3160671; MAY PC, 1992, TRENDS NEUROSCI, V15, P391, DOI 10.1016/0166-2236(92)90190-J; Mclaughlin L, 2000, J CLIN INVEST, V106, P1105, DOI 10.1172/JCI9037; MENACHERRY S, 1992, ANAL CHEM, V64, P577, DOI 10.1021/ac00030a003; Nicoll JAR, 1997, ANN NEUROL, V41, P716, DOI 10.1002/ana.410410607; ODA T, 1995, EXP NEUROL, V136, P22, DOI 10.1006/exnr.1995.1080; Russo C, 1998, P NATL ACAD SCI USA, V95, P15598, DOI 10.1073/pnas.95.26.15598; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Sisodia SS, 1999, J CLIN INVEST, V104, P1169, DOI 10.1172/JCI8508; SISODIA SS, 1993, J NEUROSCI, V13, P3136; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; Strittmatter WJ, 2002, CURR OPIN LIPIDOL, V13, P119, DOI 10.1097/00041433-200204000-00002; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sun YL, 1998, J NEUROSCI, V18, P3261; Tokuda T, 2000, BIOCHEM J, V348, P359, DOI 10.1042/0264-6021:3480359; Urmoneit B, 1997, LAB INVEST, V77, P157; WILLIAMS DL, 1995, J LIPID RES, V36, P745; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; Wisniewski T, 1997, NEUROBIOL DIS, V4, P313, DOI 10.1006/nbdi.1997.0147; Yang DS, 1999, NEUROSCIENCE, V90, P1217, DOI 10.1016/S0306-4522(98)00561-2; Zlokovic BV, 1996, P NATL ACAD SCI USA, V93, P4229, DOI 10.1073/pnas.93.9.4229	59	342	357	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 22	2004	41	2					193	202		10.1016/S0896-6273(03)00850-X	http://dx.doi.org/10.1016/S0896-6273(03)00850-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741101	Bronze			2022-12-24	WOS:000221457800006
J	Johnson-Frey, SH; Maloof, FR; Newman-Norlund, R; Farrer, C; Inati, S; Grafton, ST				Johnson-Frey, SH; Maloof, FR; Newman-Norlund, R; Farrer, C; Inati, S; Grafton, ST			Actions or hand-object interactions? Human inferior frontal cortex and action observation	NEURON			English	Article							GRASP REPRESENTATIONS; PREMOTOR; LOCALIZATION; MORPHOLOGY; PRECISION; DORSAL; MOTION; MONKEY; AREAS; TASK	Cells in macaque ventral premotor cortex (area F5c) respond to observation or production of specific hand-object interactions. Studies in humans associate the left inferior frontal gyrus, including putative F5 homolog pars opercularis, with observing hand actions. Are these responses related to the realized goal of a prehensile action or to the observation of dynamic hand movements? Rapid, event-related fMRI was used to address this question. Subjects watched static pictures of the same objects being grasped or touched while performing a 1-back orienting task. In all 17 subjects, bilateral inferior frontal cortex was differentially activated in response to realized goals of observed prehensile actions. Bilaterally, precentral gyrus was most frequently activated (82%) followed by pars triangularis (73%) and pars opercularis (65%).	Dartmouth Coll, Ctr Cognit Neurosci, Hanover, NH 03755 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA; NYU, Dept Psychol, New York, NY 10003 USA	Dartmouth College; New York University; New York University	Johnson-Frey, SH (corresponding author), Dartmouth Coll, Ctr Cognit Neurosci, Hanover, NH 03755 USA.	scott.h.johnson@dartmouth.edu	Farrer-Pujol, Chloe/G-5125-2011	Inati, Souheil/0000-0001-5596-9554	NIMH NIH HHS [K01 MH002022-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH002022] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amunts K, 1999, J COMP NEUROL, V412, P319, DOI 10.1002/(SICI)1096-9861(19990920)412:2<319::AID-CNE10>3.0.CO;2-7; Beauchamp MS, 2002, NEURON, V34, P149, DOI 10.1016/S0896-6273(02)00642-6; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Dejerine JJ., 1914, SEMIOLOGIE AFFECTION; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Ehrsson HH, 2001, J NEUROPHYSIOL, V85, P2613, DOI 10.1152/jn.2001.85.6.2613; Fogassi L, 2001, BRAIN, V124, P571, DOI 10.1093/brain/124.3.571; Foundas AL, 2001, J NEUROIMAGING, V11, P153, DOI 10.1111/j.1552-6569.2001.tb00026.x; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Grezes J, 1998, COGN NEUROPSYCHOL, V15, P553, DOI 10.1080/026432998381023; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Hermsdorfer J, 2001, NEUROIMAGE, V14, P149, DOI 10.1006/nimg.2001.0796; Heyes C, 2001, TRENDS COGN SCI, V5, P253, DOI 10.1016/S1364-6613(00)01661-2; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Kellenbach ML, 2003, J COGNITIVE NEUROSCI, V15, P30, DOI 10.1162/089892903321107800; Konorski J., 1967, INTEGRATIVE ACTIVITY; Nishitani N, 2000, P NATL ACAD SCI USA, V97, P913, DOI 10.1073/pnas.97.2.913; Petrides Michael, 1994, Current Opinion in Neurobiology, V4, P207, DOI 10.1016/0959-4388(94)90074-4; Preuss TM, 1996, J COMP NEUROL, V371, P649, DOI 10.1002/(SICI)1096-9861(19960805)371:4<649::AID-CNE12>3.0.CO;2-E; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Rizzolatti G, 1996, EXP BRAIN RES, V111, P246; Schubotz RI, 2002, COGNITIVE BRAIN RES, V14, P357, DOI 10.1016/S0926-6410(02)00138-6; Talairach J., 1988, COPLANAR STEREOTAXIC; Tomaiuolo F, 1999, EUR J NEUROSCI, V11, P3033, DOI 10.1046/j.1460-9568.1999.00718.x	28	268	268	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 11	2003	39	6					1053	1058		10.1016/S0896-6273(03)00524-5	http://dx.doi.org/10.1016/S0896-6273(03)00524-5			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	721BA	12971903	Bronze			2022-12-24	WOS:000185296100017
J	Micheva, KD; Buchanan, J; Holz, RW; Smith, SJ				Micheva, KD; Buchanan, J; Holz, RW; Smith, SJ			Retrograde regulation of synaptic vesicle endocytosis and recycling	NATURE NEUROSCIENCE			English	Article							NITRIC-OXIDE SYNTHASE; HIPPOCAMPAL SYNAPSES; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PLASMA-MEMBRANE; NERVE-TERMINALS; GTPASE ACTIVITY; CALCIUM; PHOSPHOINOSITIDES; BINDING; DOMAIN	Sustained release of neurotransmitter depends upon the recycling of synaptic vesicles. Until now, it has been assumed that vesicle recycling is regulated by signals from the presynaptic bouton alone, but results from rat hippocampal neurons reported here indicate that this need not be the case. Fluorescence imaging and pharmacological analysis show that a nitric oxide (NO) signal generated postsynaptically can regulate endocytosis and at least one later step in synaptic vesicle recycling. The proposed retrograde pathway involves an NMDA receptor (NMDAR)-dependent postsynaptic production of NO, diffusion of NO to a presynaptic site, and a cGMP-dependent increase in presynaptic phosphatidylinositol 4,5-biphosphate (PIP2). These results indicate that the regulation of synaptic vesicle recycling may integrate a much broader range of neural activity signals than previously recognized, including postsynaptic depolarization and the activation of NMDARs at both immediate and nearby postsynaptic active zones.	Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	Stanford University; University of Michigan System; University of Michigan	Micheva, KD (corresponding author), Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.		Micheva, Kristina/ABH-6913-2020	Micheva, Kristina/0000-0003-1138-3732				ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; Burette A, 2002, J NEUROSCI, V22, P8961; CLEMENTI E, 1995, J BIOL CHEM, V270, P22277, DOI 10.1074/jbc.270.38.22277; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Cremona O, 2001, J CELL SCI, V114, P1041; De Camilli P, 2001, SYNAPSES, P217; EICHBERG J, 1965, BIOCHEM J, V96, P644, DOI 10.1042/bj0960644; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755; Goslin K., 1998, CULTURING NERVE CELL, P339; Guo J, 2003, P NATL ACAD SCI USA, V100, P3995, DOI 10.1073/pnas.0230488100; HOKIN LE, 1964, BIOCHIM BIOPHYS ACTA, V84, P563, DOI 10.1016/0926-6542(64)90126-X; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Khvotchev M, 1998, J BIOL CHEM, V273, P21451, DOI 10.1074/jbc.273.34.21451; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klyachko VA, 2001, NEURON, V31, P1015, DOI 10.1016/S0896-6273(01)00449-4; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; Lin HC, 1996, J BIOL CHEM, V271, P27979, DOI 10.1074/jbc.271.45.27979; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Meffert MK, 1996, NEURON, V16, P1229, DOI 10.1016/S0896-6273(00)80149-X; Micheva KD, 2001, J CELL BIOL, V154, P355, DOI 10.1083/jcb.200102098; Osborne SL, 2001, NEURON, V32, P9, DOI 10.1016/S0896-6273(01)00455-X; Paterson HF, 1995, BIOCHEM J, V312, P661, DOI 10.1042/bj3120661; Prast H, 2001, PROG NEUROBIOL, V64, P51, DOI 10.1016/S0301-0082(00)00044-7; Rao A, 1998, J NEUROSCI, V18, P1217; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Ryan TA, 2001, CURR OPIN NEUROBIOL, V11, P544, DOI 10.1016/S0959-4388(00)00247-6; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Son H, 1996, CELL, V87, P1015, DOI 10.1016/S0092-8674(00)81796-1; Sporns O, 1997, NEUROSCIENCE, V80, P1057, DOI 10.1016/S0306-4522(97)00152-8; Tao HZW, 2001, P NATL ACAD SCI USA, V98, P11009, DOI 10.1073/pnas.191351698; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; WENDLAND B, 1994, P NATL ACAD SCI USA, V91, P2151, DOI 10.1073/pnas.91.6.2151; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Wu L, 2002, NATURE, V419, P947, DOI 10.1038/nature01118; Xia ZG, 1996, J NEUROSCI, V16, P5425; Zheng J, 1996, J MOL BIOL, V255, P14, DOI 10.1006/jmbi.1996.0002	42	95	98	1	5	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					925	932		10.1038/nn1114	http://dx.doi.org/10.1038/nn1114			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715KH	12910242				2022-12-24	WOS:000184970400010
J	Kennedy, HJ; Evans, MG; Crawford, AC; Fettiplace, R				Kennedy, HJ; Evans, MG; Crawford, AC; Fettiplace, R			Fast adaptation of mechanoelectrical transducer channels in mammalian cochlear hair cells	NATURE NEUROSCIENCE			English	Article							POSTNATAL-DEVELOPMENT; BUNDLE MOVEMENTS; CURRENTS; CALCIUM; EXPRESSION; INNER; RAT; ELECTROMOTILITY; STIMULI; PRESTIN	Outer hair cells are centrally involved in the amplification and frequency tuning of the mammalian cochlea, but evidence about their transducing properties in animals with fully developed hearing is lacking. Here we describe measurements of mechanoelectrical transducer currents in outer hair cells of rats between postnatal days 5 and 18, before and after the onset of hearing. Deflection of hair bundles using a new rapid piezoelectric stimulator evoked transducer currents with ultra-fast activation and adaptation kinetics. Fast adaptation resembled the same process in turtle hair cells, where it is regulated by changes in stereociliary calcium. It is argued that sub-millisecond transducer adaptation can operate in outer hair cells under the ionic, driving force and temperature conditions that prevail in the intact mammalian cochlea.	Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA; Univ Bristol, Sch Med Sci, Dept Physiol, Bristol BS8 1TD, Avon, England; Univ Keele, Sch Life Sci, MacKay Inst Commun & Neurosci, Keele ST5 5BG, Staffs, England; Univ Cambridge, Dept Physiol, Cambridge CB2 3EG, England	University of Wisconsin System; University of Wisconsin Madison; University of Bristol; Keele University; University of Cambridge	Fettiplace, R (corresponding author), Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA.	fettiplace@physiology.wisc.edu	Evans, Michael/C-4980-2009	Evans, Michael/0000-0002-8755-0034	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001362] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC 01362] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ASHMORE JF, 1993, BIOPHYSICS HAIR CELL, P151; ASSAD JA, 1989, P NATL ACAD SCI USA, V86, P2918, DOI 10.1073/pnas.86.8.2918; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; Benser ME, 1996, J NEUROSCI, V16, P5629; BLATCHLEY BJ, 1987, DEV BRAIN RES, V32, P75, DOI 10.1016/0165-3806(87)90140-4; BOSHER SK, 1978, NATURE, V273, P377, DOI 10.1038/273377a0; BOSHER SK, 1971, J PHYSIOL-LONDON, V212, P739, DOI 10.1113/jphysiol.1971.sp009354; COREY DP, 1983, J NEUROSCI, V3, P962; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; CROWLEY DE, 1966, J COMP PHYSIOL PSYCH, V62, P427, DOI 10.1037/h0023953; DALLOS P, 1986, HEARING RES, V22, P185, DOI 10.1016/0378-5955(86)90095-X; DALLOS P, 1992, J NEUROSCI, V12, P4575; Eatock RA, 2000, ANNU REV NEUROSCI, V23, P285, DOI 10.1146/annurev.neuro.23.1.285; EATOCK RA, 1987, J NEUROSCI, V7, P2821; Fettiplace R, 2003, BIOPHYSICS OF THE COCHLEA: FROM MOLECULES TO MODELS, P65, DOI 10.1142/9789812704931_0007; Fettiplace R, 2001, TRENDS NEUROSCI, V24, P169, DOI 10.1016/S0166-2236(00)01740-9; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Holt JR, 2000, P NATL ACAD SCI USA, V97, P11730, DOI 10.1073/pnas.97.22.11730; HOUSLEY GD, 1992, J PHYSIOL-LONDON, V448, P73, DOI 10.1113/jphysiol.1992.sp019030; Hudspeth AJ, 1997, CURR OPIN NEUROBIOL, V7, P480, DOI 10.1016/S0959-4388(97)80026-8; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; Kikuchi T, 2000, BRAIN RES REV, V32, P163, DOI 10.1016/S0165-0173(99)00076-4; KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Mammano F, 1996, J PHYSIOL-LONDON, V496, P639, DOI 10.1113/jphysiol.1996.sp021715; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; Martin P, 1999, P NATL ACAD SCI USA, V96, P14306, DOI 10.1073/pnas.96.25.14306; Meyer J, 1998, J NEUROSCI, V18, P6748; MULLER M, 1991, HEARING RES, V51, P247, DOI 10.1016/0378-5955(91)90041-7; Nenov AP, 1997, HEARING RES, V105, P146, DOI 10.1016/S0378-5955(96)00207-9; Nobili R, 1998, TRENDS NEUROSCI, V21, P159, DOI 10.1016/S0166-2236(97)01192-2; Nobili R, 1996, J ACOUST SOC AM, V99, P2244, DOI 10.1121/1.415412; Oliver D, 1999, J PHYSIOL-LONDON, V519, P791, DOI 10.1111/j.1469-7793.1999.0791n.x; Ricci AJ, 2000, J NEUROSCI, V20, P7131; Ricci AJ, 1998, J PHYSIOL-LONDON, V506, P159, DOI 10.1111/j.1469-7793.1998.159bx.x; Ricci AJ, 1998, J NEUROSCI, V18, P8261; Ricci AJ, 1997, J PHYSIOL-LONDON, V501, P111, DOI 10.1111/j.1469-7793.1997.111bo.x; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; ROTH B, 1992, ANAT EMBRYOL, V185, P571, DOI 10.1007/BF00185616; RUSSELL IJ, 1986, HEARING RES, V22, P199, DOI 10.1016/0378-5955(86)90096-1; UZIEL A, 1981, AUDIOLOGY, V20, P89; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171; YATES GK, 1992, TRENDS NEUROSCI, V15, P57, DOI 10.1016/0166-2236(92)90027-6; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	50	189	194	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					832	836		10.1038/nn1089	http://dx.doi.org/10.1038/nn1089			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12872124				2022-12-24	WOS:000184413700012
J	Kaur, D; Yantiri, F; Rajagopalan, S; Kumar, J; Mo, JO; Boonplueang, R; Viswanath, V; Jacobs, R; Yang, L; Beal, MF; DiMonte, D; Volitaskis, I; Ellerby, L; Cherny, RA; Bush, AI; Andersen, JK				Kaur, D; Yantiri, F; Rajagopalan, S; Kumar, J; Mo, JO; Boonplueang, R; Viswanath, V; Jacobs, R; Yang, L; Beal, MF; DiMonte, D; Volitaskis, I; Ellerby, L; Cherny, RA; Bush, AI; Andersen, JK			Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: A novel therapy for Parkinson's disease	NEURON			English	Article							SUBSTANTIA-NIGRA; BASAL GANGLIA; BRAIN IRON; RAT-BRAIN; CELLULAR-DISTRIBUTION; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; FREE-RADICALS; MOUSE MODEL; DOPAMINERGIC NEURODEGENERATION	Studies on postmortem brains from Parkinson's patients reveal elevated iron in the substantia nigra (SN). Selective cell death in this brain region is associated with oxidative stress, which may be exacerbated by the presence of excess iron. Whether iron plays a causative role in cell death, however, is controversial. Here, we explore the effects of iron chelation via either transgenic expression of the iron binding protein ferritin or oral administration of the bioavailable metal chelator clioquinol (CO) on susceptibility to the Parkinson's-inducing agent 1 -methyl-4-phenyl-1,2,3,6-tetrapyridine (MPTP). Reduction in reactive iron by either genetic or pharmacological means was found to be well tolerated in animals in our studies and to result in protection against the toxin, suggesting that iron chelation may be an effective therapy for prevention and treatment of the disease.	Buck Inst Age Res, Novato, CA 94945 USA; Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Div Neurogerontol, Los Angeles, CA 90089 USA; CALTECH, Biol Imaging Ctr, Pasadena, CA 91125 USA; Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA; Parkinsons Inst, Sunnyvale, CA 94089 USA; Univ Melbourne, Mental Hlth Res Inst, Dept Pathol, Parkville, Vic 3052, Australia; Harvard Univ, Massachusetts Gen Hosp, Sch Med,Lab Oxidant Biol, Dept Psychiat,Genet & Aging Res Unit, Charlestown, MA 02129 USA	Buck Institute for Research on Aging; University of Southern California; California Institute of Technology; Cornell University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Harvard University; Massachusetts General Hospital	Andersen, JK (corresponding author), Buck Inst Age Res, Novato, CA 94945 USA.	jandersen@buckinstitute.org	Bush, Ashley I/A-1186-2007; Bush, Ashley/Y-2457-2019	Bush, Ashley I/0000-0001-8259-9069; Bush, Ashley/0000-0001-8259-9069; Volitakis, Irene/0000-0003-0766-817X; Boonplueang, Rapee/0000-0002-4384-0363; Di Monte, Donato/0000-0002-8296-836X; Andersen, Julie/0000-0003-1324-4875	NATIONAL INSTITUTE ON AGING [R01AG012141, R01AG012686] Funding Source: NIH RePORTER; NIA NIH HHS [2R01AG12686, R01 AG12141, R01 AG41264] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ADAMS JD, 1991, FREE RADICAL BIO MED, V10, P161, DOI 10.1016/0891-5849(91)90009-R; Agrawal R, 2001, TOXICOLOGY, V168, P223, DOI 10.1016/S0300-483X(01)00412-7; ALI SF, 1992, NEUROTOXICOLOGY, V13, P637; Andersen J K, 2001, Novartis Found Symp, V235, P11; ANDERSEN JK, 1994, BRAIN RES, V656, P108, DOI 10.1016/0006-8993(94)91371-4; BANERJEE SA, 1992, J NEUROSCI, V12, P4460; Bartzokis G, 1997, MAGN RESON IMAGING, V15, P29, DOI 10.1016/S0730-725X(96)00234-2; BAUMGARTNER G, 1979, J NEUROL NEUROSUR PS, V42, P1073, DOI 10.1136/jnnp.42.12.1073; BEAL MF, 1992, ANN NEUROL, V31, P119, DOI 10.1002/ana.410310202; Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550; BEARD JL, 1993, PROG FOOD NUTR SCI, V17, P183; BENKOVIC SA, 1993, J COMP NEUROL, V338, P97, DOI 10.1002/cne.903380108; Berg D, 2001, J NEUROCHEM, V79, P225, DOI 10.1046/j.1471-4159.2001.00608.x; Betarbet R, 2002, BIOESSAYS, V24, P308, DOI 10.1002/bies.10067; Bush AI, 2000, CURR OPIN CHEM BIOL, V4, P184, DOI 10.1016/S1367-5931(99)00073-3; Cassarino DS, 1999, BBA-MOL BASIS DIS, V1453, P49, DOI 10.1016/S0925-4439(98)00083-0; Castellani RJ, 2000, ACTA NEUROPATHOL, V100, P111, DOI 10.1007/s004010050001; CAUGHMAN SW, 1988, J BIOL CHEM, V263, P19048; Cheepsunthorn P, 1998, J COMP NEUROL, V400, P73; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Chiueh C C, 1998, Adv Pharmacol, V42, P796; Christen Y, 2000, AM J CLIN NUTR, V71, p621S, DOI 10.1093/ajcn/71.2.621s; CONNOR JR, 1994, J NEUROSCI RES, V37, P461, DOI 10.1002/jnr.490370405; Connor JR, 2001, PEDIATR NEUROL, V25, P118, DOI 10.1016/S0887-8994(01)00303-4; CONNOR JR, 1995, J NEUROCHEM, V65, P717; CONNOR JR, 1992, J NEUROSCI RES, V31, P327, DOI 10.1002/jnr.490310214; Cozzi A, 2000, J BIOL CHEM, V275, P25122, DOI 10.1074/jbc.M003797200; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; DESOLE MS, 1993, NEUROSCI LETT, V161, P121, DOI 10.1016/0304-3940(93)90274-O; DEXTER DT, 1987, LANCET, V2, P1219; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; DEXTER DT, 1991, BRAIN, V114, P1953, DOI 10.1093/brain/114.4.1953; Double KL, 1998, J NEUROCHEM, V70, P2492; Du YS, 2001, P NATL ACAD SCI USA, V98, P14669, DOI 10.1073/pnas.251341998; Gassen M, 1997, PHARMACOL TOXICOL, V80, P159, DOI 10.1111/j.1600-0773.1997.tb00390.x; GERLACH M, 1994, J NEUROCHEM, V63, P793, DOI 10.1046/j.1471-4159.1994.63030793.x; Gilissen EP, 1998, AM J PRIMATOL, V45, P291, DOI 10.1002/(SICI)1098-2345(1998)45:3<291::AID-AJP5>3.3.CO;2-7; Gitlin JD, 1998, PEDIATR RES, V44, P271, DOI 10.1203/00006450-199809000-00001; GLINKA Y, 1996, METALS OXIDATIVE DAM, P1; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Griffiths PD, 1999, BRAIN, V122, P667, DOI 10.1093/brain/122.4.667; GUTTERIDGE JMC, 1992, ANN NEUROL, V32, pS16, DOI 10.1002/ana.410320705; Han J, 2000, CELL MOL BIOL, V46, P517; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; HENTZE MW, 1986, P NATL ACAD SCI USA, V83, P7226, DOI 10.1073/pnas.83.19.7226; HILL JM, 1984, NEUROSCIENCE, V11, P595, DOI 10.1016/0306-4522(84)90046-0; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Hung HC, 1998, FREE RADICAL BIO MED, V24, P76, DOI 10.1016/S0891-5849(97)00206-2; Janetzky B., 1997, P407; JELLINGER K, 1990, J NEURAL TRANSM-PARK, V2, P327, DOI 10.1007/BF02252926; Jellinger KA, 1999, DRUG AGING, V14, P115, DOI 10.2165/00002512-199914020-00004; JENNER P, 1992, NEUROLOGY, V42, P2241, DOI 10.1212/WNL.42.12.2241; Kato J, 2001, AM J HUM GENET, V69, P191, DOI 10.1086/321261; KIDANI Y, 1974, JPN ANALYST, V23, P1375; Klivenyi P, 2000, J NEUROSCI, V20, P1; Lan J, 1997, J NEURAL TRANSM, V104, P649, DOI 10.1007/BF01291883; MANN VM, 1994, ANN NEUROL, V36, P876, DOI 10.1002/ana.410360612; MARCIANI MG, 1991, HAEMATOLOGICA, V76, P131; MASTERS C, 2002, 8 INT C ALZH DIS REL; MEADE TW, 1975, BRIT J PREV SOC MED, V29, P157; Melov S, 2002, TRENDS NEUROSCI, V25, P121, DOI 10.1016/S0166-2236(00)02086-5; Moos T, 2000, CELL MOL BIOL, V46, P549; Morgan TE, 1999, NEUROSCIENCE, V89, P687, DOI 10.1016/S0306-4522(98)00334-0; NAKAE K, 1973, LANCET, V1, P171; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241; PERRY TL, 1982, NEUROSCI LETT, V33, P305, DOI 10.1016/0304-3940(82)90390-1; Porter J B, 1989, Baillieres Clin Haematol, V2, P459, DOI 10.1016/S0950-3536(89)80027-7; RIEDERER P, 1989, J NEUROCHEM, V52, P515, DOI 10.1111/j.1471-4159.1989.tb09150.x; ROSE FC, 1984, ACTA NEUROL SCAND, V70, P137; Rucker P, 1996, J BIOL CHEM, V271, P33352, DOI 10.1074/jbc.271.52.33352; Sedelis M, 2001, BEHAV BRAIN RES, V125, P109, DOI 10.1016/S0166-4328(01)00309-6; SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; SOFIC E, 1988, J NEURAL TRANSM, V74, P199, DOI 10.1007/BF01244786; SOFIC E, 1991, J NEUROCHEM, V56, P978, DOI 10.1111/j.1471-4159.1991.tb02017.x; Tateishi J, 2000, NEUROPATHOLOGY, V20, pS20; TETRUD JW, 1989, ACTA NEUROL SCAND, V80, P35, DOI 10.1111/j.1600-0404.1989.tb01780.x; Thompson KJ, 2001, BRAIN RES BULL, V55, P155, DOI 10.1016/S0361-9230(01)00510-X; TSUBAKI T, 1971, LANCET, V1, P696, DOI 10.1016/S0140-6736(71)92699-7; Vila M, 2001, P NATL ACAD SCI USA, V98, P2837, DOI 10.1073/pnas.051633998; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Yantiri F, 1999, IUBMB LIFE, V48, P139; Yassin MS, 2000, J NEUROL SCI, V173, P40, DOI 10.1016/S0022-510X(99)00297-X; YONG VW, 1986, NEUROSCI LETT, V63, P56, DOI 10.1016/0304-3940(86)90012-1; Yoshida S, 2001, J SYNCHROTRON RADIAT, V8, P998, DOI 10.1107/S0909049500017726; YOSHIMURA S, 1992, MOL CHEM NEUROPATHOL, V16, P59, DOI 10.1007/BF03159961; YOUDIM MBH, 1993, MOVEMENT DISORD, V8, P1, DOI 10.1002/mds.870080102; Zecca L, 2001, J NEUROCHEM, V76, P1766, DOI 10.1046/j.1471-4159.2001.00186.x	89	514	523	2	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 27	2003	37	6					899	909		10.1016/S0896-6273(03)00126-0	http://dx.doi.org/10.1016/S0896-6273(03)00126-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	661PU	12670420	Bronze			2022-12-24	WOS:000181899600005
J	Grishanin, RN; Kowalchyk, JA; Klenchin, VA; Kyougsook, A; Earles, CA; Chapman, ER; Gerona, RRL; Martin, TFJ				Grishanin, RN; Kowalchyk, JA; Klenchin, VA; Kyougsook, A; Earles, CA; Chapman, ER; Gerona, RRL; Martin, TFJ			CAPS acts at a prefusion step in dense-core vesicle exocytosis as a PIP2 binding protein	NEURON			English	Article							CA2+-DEPENDENT ACTIVATOR PROTEIN; CHROMAFFIN CELLS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; REGULATED EXOCYTOSIS; SECRETORY GRANULES; PLASMA-MEMBRANE; C2 DOMAINS; CALCIUM; RELEASE; SYNAPTOTAGMIN	CAPS-1 is required for Ca2+-triggered fusion of dense-core vesicles with the plasma membrane, but its site of action and mechanism are unknown. We analyzed the kinetics of Ca2+-triggered exocytosis reconstituted in permeable PC12 cells. CAPS-1 increased the initial rate of Ca2+-triggered vesicle exocytosis by acting at a rate-limiting, Ca2+-dependent prefusion step. CAPS-1 activity depended upon prior ATP-dependent priming during which PIP2 synthesis occurs. CAPS-1 activity and binding to the plasma membrane depended upon PIP2- Call Was ineffective in triggering vesicle fusion in the absence of CAPS-1 but instead promoted desensitization to CAPS-1 resulting from decreased plasma membrane PIP2. We conclude that CAPS-1 functions following ATP-dependent priming as a PIP2 binding protein to enhance Ca2+-dependent DCV exocytosis. Essential prefusion steps in dense-core vesicle exocytosis involve sequential ATP-dependent synthesis of PIP2 and the subsequent PIP2-dependent action of CAPS-1. Regulation of PIP2 levels and CAPS-1 activity would control the secretion of neuropeptides and monoaminergic transmitters.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Martin, TFJ (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	tfmartin@facstaff.wisc.edu		Chapman, Edwin/0000-0001-9787-8140	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040428] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK40428] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; AVERY L, 1993, GENETICS, V134, P454; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Banerjee A, 1996, J BIOL CHEM, V271, P20223, DOI 10.1074/jbc.271.34.20223; Barg S, 2001, J CELL SCI, V114, P2145; Berwin B, 1998, NEURON, V21, P137, DOI 10.1016/S0896-6273(00)80521-8; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; Chung SH, 1998, J BIOL CHEM, V273, P10240, DOI 10.1074/jbc.273.17.10240; Cisternas FA, 2003, GENOMICS, V81, P279, DOI 10.1016/S0888-7543(02)00040-X; DECAMILLI P, 1990, ANNU REV PHYSIOL, V52, P625, DOI 10.1146/annurev.ph.52.030190.003205; Earles C, 1998, ANAL BIOCHEM, V264, P191, DOI 10.1006/abio.1998.2850; Earles CA, 2001, J CELL BIOL, V154, P1117, DOI 10.1083/jcb.200105020; Elhamdani A, 2000, J NEUROSCI, V20, P2495; Elhamdani A, 1999, J NEUROSCI, V19, P7375, DOI 10.1523/JNEUROSCI.19-17-07375.1999; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Grishanin RN, 2002, J BIOL CHEM, V277, P22025, DOI 10.1074/jbc.M201614200; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; HEINEMANN C, 1993, PFLUG ARCH EUR J PHY, V424, P105, DOI 10.1007/BF00374600; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; JAN LY, 1982, J PHYSIOL-LONDON, V327, P219, DOI 10.1113/jphysiol.1982.sp014228; JONES PM, 1992, BIOCHEM J, V285, P973, DOI 10.1042/bj2850973; KELLY RB, 1993, CELL, V72, P43, DOI 10.1016/S0092-8674(05)80027-3; Kishimoto T, 2001, J PHYSIOL-LONDON, V533, P627, DOI 10.1111/j.1469-7793.2001.t01-1-00627.x; Klenchin VA, 1998, METHODS, V16, P204, DOI 10.1006/meth.1998.0668; KNIGHT DE, 1982, J MEMBRANE BIOL, V68, P107, DOI 10.1007/BF01872259; Krause M, 1995, METHOD CELL BIOL, V48, P513; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; Loyet KM, 1998, J BIOL CHEM, V273, P8337, DOI 10.1074/jbc.273.14.8337; Martin TFJ, 2003, BBA-MOL CELL RES, V1641, P157, DOI 10.1016/S0167-4889(03)00093-4; Martin TFJ, 1997, J BIOL CHEM, V272, P14447, DOI 10.1074/jbc.272.22.14447; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; MATTEOLI M, 1988, P NATL ACAD SCI USA, V85, P7366, DOI 10.1073/pnas.85.19.7366; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Ng YK, 2002, J NEUROSCI, V22, P3890, DOI 10.1523/JNEUROSCI.22-10-03890.2002; Ninomiya Y, 1997, EMBO J, V16, P929, DOI 10.1093/emboj/16.5.929; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; Olsen HL, 2003, P NATL ACAD SCI USA, V100, P5187, DOI 10.1073/pnas.0931282100; Rebecchi MJ, 1998, ANNU REV BIOPH BIOM, V27, P503, DOI 10.1146/annurev.biophys.27.1.503; Renden R, 2001, NEURON, V31, P421, DOI 10.1016/S0896-6273(01)00382-8; Rettig J, 2002, SCIENCE, V298, P781, DOI 10.1126/science.1075375; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rupnik M, 2000, P NATL ACAD SCI USA, V97, P5627, DOI 10.1073/pnas.090359097; Scales SJ, 2000, NEURON, V26, P457, DOI 10.1016/S0896-6273(00)81177-0; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; SEWARD EP, 1995, J NEUROSCI, V15, P3390; Smith C, 1998, NEURON, V20, P1243, DOI 10.1016/S0896-6273(00)80504-8; Speidel D, 2003, J BIOL CHEM, V278, P52802, DOI 10.1074/jbc.M304727200; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Tandon A, 1998, NEURON, V21, P147, DOI 10.1016/S0896-6273(00)80522-X; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; Tucker WC, 2003, J CELL BIOL, V162, P199, DOI 10.1083/jcb.200302060; VANDERMERWE PA, 1990, BIOCHEM J, V268, P493, DOI 10.1042/bj2680493; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642	64	133	137	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 19	2004	43	4					551	562		10.1016/j.neuron.2004.07.028	http://dx.doi.org/10.1016/j.neuron.2004.07.028			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	847ZK	15312653	Bronze			2022-12-24	WOS:000223436400013
J	Weaver, ICG; Cervoni, N; Champagne, FA; D'Alessio, AC; Sharma, S; Seckl, JR; Dymov, S; Szyf, M; Meaney, MJ				Weaver, ICG; Cervoni, N; Champagne, FA; D'Alessio, AC; Sharma, S; Seckl, JR; Dymov, S; Szyf, M; Meaney, MJ			Epigenetic programming by maternal behavior	NATURE NEUROSCIENCE			English	Article							EARLY ENVIRONMENTAL-REGULATION; RECEPTOR GENE-EXPRESSION; TRANSCRIPTION FACTORS; CARE; METHYLATION; RESPONSES; RAT; 5-METHYLCYTOSINE; TRANSMISSION; SENSITIVITY	Here we report that increased pup licking and grooming (LG) and arched-back nursing (ABN) by rat mothers altered the offspring epigenome at a glucocorticoid receptor (GR) gene promoter in the hippocampus. Offspring of mothers that showed high levels of LG and ABN were found to have differences in DNA methylation, as compared to offspring of 'low-LG-ABN' mothers. These differences emerged over the first week of life, were reversed with cross-fostering, persisted into adulthood and were associated with altered histone acetylation and transcription factor (NGFI-A) binding to the GR promoter. Central infusion of a histone deacetylase inhibitor removed the group differences in histone acetylation, DNA methylation, NGFI-A binding, GR expression and hypothalamic-pituitary- adrenal (HPA) responses to stress, suggesting a causal relation among epigenomic state, GR expression and the maternal effect on stress responses in the offspring. Thus we show that an epigenomic state of a gene can be established through behavioral programming, and it is potentially reversible.	Douglas Hosp, Res Ctr, Montreal, PQ H4H 1R3, Canada; McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; Western Gen Hosp, Mol Med Ctr, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; McGill Univ, McGill Program Study Behav Genes & Environm, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; University of Edinburgh; McGill University	Szyf, M (corresponding author), Douglas Hosp, Res Ctr, 6875 LaSalle Blvd, Montreal, PQ H4H 1R3, Canada.	moshe.szyf@mcgill.ca; michael.meaney@mcgill.ca	Meaney, Michael/N-5931-2019; Seckl, Jonathan R/C-3555-2013; Weaver, Ian/AAH-6671-2020; Champagne, Frances Anne/Q-1220-2018	Weaver, Ian/0000-0001-8709-8941; Champagne, Frances Anne/0000-0002-3922-084X				Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Brinton RD, 1998, MOL BRAIN RES, V57, P73; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; Cervoni N, 2001, J BIOL CHEM, V276, P40778, DOI 10.1074/jbc.M103921200; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; CINTRA A, 1994, ANN NY ACAD SCI, V746, P42; CINTRA A, 1994, NEUROSCIENCE, V62, P843, DOI 10.1016/0306-4522(94)90481-2; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Crane-Robinson C, 1999, METHOD ENZYMOL, V304, P533; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Fleming AS, 1999, NEUROSCI BIOBEHAV R, V23, P673, DOI 10.1016/S0149-7634(99)00011-1; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Hershko AY, 2003, GENE, V302, P65, DOI 10.1016/S0378111902010910; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; KESHET I, 1985, P NATL ACAD SCI USA, V82, P2560, DOI 10.1073/pnas.82.9.2560; Laplante P, 2002, DEV BRAIN RES, V139, P199, DOI 10.1016/S0165-3806(02)00550-3; LEVINE S, 1994, ANN NY ACAD SCI, V746, P275, DOI 10.1111/j.1749-6632.1994.tb39245.x; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; McCormick JA, 2000, MOL ENDOCRINOL, V14, P506, DOI 10.1210/me.14.4.506; Meaney MJ, 2000, J NEUROSCI, V20, P3926, DOI 10.1523/JNEUROSCI.20-10-03926.2000; Meaney MJ, 1996, DEV NEUROSCI-BASEL, V18, P49, DOI 10.1159/000111395; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; MEANEY MJ, 1989, NEUROENDOCRINOLOGY, V50, P597, DOI 10.1159/000125287; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; MYERS MM, 1989, DEV PSYCHOBIOL, V22, P55, DOI 10.1002/dev.420220105; RAZIN A, 1977, P NATL ACAD SCI USA, V74, P2725, DOI 10.1073/pnas.74.7.2725; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Rossiter M.C., 1999, MATERNAL EFFECTS ADA; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; SAPIENZA C, 1990, SCI AM, V263, P52, DOI 10.1038/scientificamerican1090-52; Stern JM, 1997, DEV PSYCHOBIOL, V31, P19, DOI 10.1002/(SICI)1098-2302(199707)31:1<19::AID-DEV3>3.0.CO;2-X; Weaver ICG, 2001, MOL CELL ENDOCRINOL, V185, P205, DOI 10.1016/S0303-7207(01)00635-9	33	4020	4132	6	926	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					847	854		10.1038/nn1276	http://dx.doi.org/10.1038/nn1276			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15220929				2022-12-24	WOS:000222930800015
J	Zhang, H; Sulzer, D				Zhang, H; Sulzer, D			Frequency-dependent modulation of dopamine release by nicotine	NATURE NEUROSCIENCE			English	Article							CHOLINERGIC MODULATION; RAT; RECEPTORS; STRIATUM; ADDICTION; NEURONS	Although nicotine activation of dopamine release is implicated in addiction, it also desensitizes nicotinic acetylcholine receptors (nAChRs), leading to a prolonged depression of evoked dopamine release. Here we show that nicotine's effects depend on the firing pattern of dopamine neurons, so that while desensitization of nAChRs indeed curbs dopamine released by stimuli emulating tonic firing, it allows a rapid rise in dopamine from stimuli emulating phasic firing patterns associated with incentive/salience paradigms. Nicotine may thus enhance the contrast of dopamine signals associated with behavioral cues.	Columbia Univ, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Dept Neurosci, New York, NY 10032 USA	Columbia University; Columbia University; New York State Psychiatry Institute	Sulzer, D (corresponding author), Columbia Univ, Dept Neurol, 650 W 168th St, New York, NY 10032 USA.	ds43@columbia.edu						Cragg SJ, 2003, J NEUROSCI, V23, P4378; Di Chiara G, 2000, EUR J PHARMACOL, V393, P295, DOI 10.1016/S0014-2999(00)00122-9; GRENHOFF J, 1986, ACTA PHYSIOL SCAND, V128, P351, DOI 10.1111/j.1748-1716.1986.tb07988.x; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Jones IW, 2001, J COMP NEUROL, V439, P235, DOI 10.1002/cne.1345; KUDERNATSCH M, 1994, NEUROSCI LETT, V181, P107, DOI 10.1016/0304-3940(94)90571-1; Kulak JM, 2001, J NEUROCHEM, V77, P1581, DOI 10.1046/j.1471-4159.2001.00357.x; Levin ED, 2002, CNS NEUROL DISORD-DR, V1, P423, DOI 10.2174/1568007023339102; Mansvelder HD, 2003, EUR J PHARMACOL, V480, P117, DOI 10.1016/j.ejphar.2003.08.099; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Schilstrom B, 1998, NEUROSCIENCE, V85, P1005, DOI 10.1016/S0306-4522(98)00114-6; Schmitz Y, 2003, J NEUROCHEM, V87, P273, DOI 10.1046/j.1471-4159.2003.02050.x; SCHULTZ W, 1986, J NEUROPHYSIOL, V56, P1439, DOI 10.1152/jn.1986.56.5.1439; Zhang H, 2003, J NEUROSCI, V23, P10585; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	15	256	262	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					581	582		10.1038/nn1243	http://dx.doi.org/10.1038/nn1243			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15146187				2022-12-24	WOS:000221640300008
J	Thoreson, WB; Rabl, K; Townes-Anderson, E; Heidelberger, R				Thoreson, WB; Rabl, K; Townes-Anderson, E; Heidelberger, R			A highly Ca2+-sensitive pool of vesicles contributes to linearity at the rod photoreceptor ribbon synapse	NEURON			English	Article							TRANSMITTER RELEASE; GLUTAMATE RELEASE; CALCIUM-DEPENDENCE; BIPOLAR CELLS; SYNAPTOTAGMIN-III; HORIZONTAL CELLS; CHROMAFFIN CELLS; INNER SEGMENTS; SALAMANDER; EXOCYTOSIS	Studies of the properties of synaptic transmission have been carried out at only a few synapses. We analyzed exocytosis from rod photoreceptors with a combination of physiological and ultrastructural techniques. As at other ribbon synapses, we found that rods exhibited rapid kinetics of release, and the number of vesicles in the releasable pool is comparable to the number of vesicles tethered at ribbon-style active zones. However, unlike other previously studied neurons, we identified a highly Call-sensitive pool of releasable vesicles with a relatively shallow relationship between the rate of exocytosis and [Ca2+], that is nearly linear over a presumed physiological range of intra-terminal [Ca2+]. The low-order [Ca2+] dependence of release promotes a linear relationship between Ca2+ entry and exocytosis that permits rods to relay information about small changes in illumination with high fidelity at the first synapse in vision.	Univ Nebraska, Med Ctr, Dept Ophthalmol, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Dept Pharmacol, Omaha, NE 68198 USA; Univ Med & Dent New Jersey, Dept Neurol & Neurosci, Sch Med, Newark, NJ 07103 USA; Univ Texas, Hlth Sci Ctr, Dept Neurobiol & Anat, Houston, TX 77030 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Texas System; University of Texas Health Science Center Houston	Thoreson, WB (corresponding author), Univ Nebraska, Med Ctr, Dept Ophthalmol, 600 S 42nd St, Omaha, NE 68198 USA.	wbthores@unmc.edu	Thoreson, Wallace B./F-6172-2010	Thoreson, Wallace B./0000-0001-7104-042X; Heidelberger, Ruth/0000-0002-8033-2050	NATIONAL EYE INSTITUTE [R29EY010542, P30EY010608, R01EY012128, R29EY012128, R55EY010542, R01EY012031, R01EY010542] Funding Source: NIH RePORTER; NEI NIH HHS [P30 EY010608, EY-12031, R29 EY010542, EY-10542, R01 EY012031, R01 EY012128, R29 EY012128, R01 EY010542-08, EY-10608, R01 EY010542, EY-12128] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABE H, 1984, J ULTRA MOL STRUCT R, V86, P246, DOI 10.1016/S0022-5320(84)90104-7; Adly MA, 1999, INVEST OPHTH VIS SCI, V40, P2165; Armstrong-Gold CE, 2003, J NEUROSCI, V23, P3796; ATTWELL D, 1987, NATURE, V328, P522, DOI 10.1038/328522a0; AUGUSTINE GJ, 1991, ANN NY ACAD SCI, V635, P365, DOI 10.1111/j.1749-6632.1991.tb36505.x; Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V367, P163, DOI 10.1113/jphysiol.1985.sp015819; BADER CR, 1982, J PHYSIOL-LONDON, V331, P253, DOI 10.1113/jphysiol.1982.sp014372; BELGUM JH, 1988, J PHYSIOL-LONDON, V396, P225, DOI 10.1113/jphysiol.1988.sp016960; Berntson A, 2003, J NEUROSCI RES, V71, P146, DOI 10.1002/jnr.10459; Berntson AK, 2003, J VISION, V3, P274, DOI 10.1167/3.4.3; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Borst JGG, 1999, PHILOS T R SOC B, V354, P347, DOI 10.1098/rstb.1999.0386; Butz S, 1999, J BIOL CHEM, V274, P18290, DOI 10.1074/jbc.274.26.18290; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; COREY DP, 1984, J PHYSIOL-LONDON, V354, P557, DOI 10.1113/jphysiol.1984.sp015393; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; DONNELLY DF, 1994, BIOPHYS J, V66, P873, DOI 10.1016/S0006-3495(94)80863-X; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Gentet LJ, 2000, BIOPHYS J, V79, P314, DOI 10.1016/S0006-3495(00)76293-X; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gillis Kevin D., 1995, P155; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Heidelberger R, 1998, J GEN PHYSIOL, V111, P225, DOI 10.1085/jgp.111.2.225; Heidelberger R, 2003, VISUAL NEUROSCI, V20, P37, DOI 10.1017/S095252380320105X; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Heidelberger R, 2002, J NEUROPHYSIOL, V88, P98, DOI 10.1152/jn.2002.88.1.98; HEIDELBERGER R, 1992, J PHYSIOL-LONDON, V447, P235, DOI 10.1113/jphysiol.1992.sp019000; Heidelberger R, 2001, REV PHYSIOL BIOCH P, V143, P1, DOI 10.1007/BFb0115592; Heidelberger R, 2001, J NEUROSCI, V21, P6467, DOI 10.1523/JNEUROSCI.21-17-06467.2001; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; KIM HG, 1991, BRAIN RES, V538, P141, DOI 10.1016/0006-8993(91)90388-C; KIM HG, 1993, J NEUROPHYSIOL, V69, P352, DOI 10.1152/jn.1993.69.2.352; Kits KS, 1999, BIOPHYS J, V76, P1693, DOI 10.1016/S0006-3495(99)77328-5; Kreft M, 2003, J NEUROPHYSIOL, V90, P218, DOI 10.1152/jn.01025.2002; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; Lenzi D, 2001, BIOESSAYS, V23, P831, DOI 10.1002/bies.1118; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; Messler P, 1996, J NEUROSCI METH, V69, P137, DOI 10.1016/S0165-0270(96)00032-5; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; Morgans CW, 1998, J NEUROSCI, V18, P2467; Morgans CW, 2001, INVEST OPHTH VIS SCI, V42, P2414; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; Nachman-Clewner M, 1999, J COMP NEUROL, V415, P1, DOI 10.1002/(SICI)1096-9861(19991206)415:1<1::AID-CNE1>3.0.CO;2-G; NAKA KI, 1987, J GEN PHYSIOL, V89, P321, DOI 10.1085/jgp.89.2.321; Naraghi M, 1998, BIOPHYS J, V75, P1635, DOI 10.1016/S0006-3495(98)77606-4; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Parsons TD, 2003, NEURON, V37, P379, DOI 10.1016/S0896-6273(03)00062-X; PIERANTONI RL, 1981, PHOTORECEPTORS, P255; Rabl K, 2002, EUR J NEUROSCI, V16, P2070, DOI 10.1046/j.1460-9568.2002.02277.x; RAVIOLA E, 1975, J CELL BIOL, V65, P192, DOI 10.1083/jcb.65.1.192; Rieke F, 1996, J PHYSIOL-LONDON, V493, P1; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; ROHLICEK V, 1994, PFLUG ARCH EUR J PHY, V428, P30, DOI 10.1007/BF00374749; Rouze NC, 1998, J NEUROSCI, V18, P8614; SAKAI HM, 1987, J NEUROPHYSIOL, V58, P1329, DOI 10.1152/jn.1987.58.6.1329; Schmitz Y, 1997, NEUROSCIENCE, V78, P1209, DOI 10.1016/S0306-4522(96)00678-1; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; TATSUOKA H, 1989, J COMP NEUROL, V290, P343, DOI 10.1002/cne.902900304; Thoreson WB, 1999, PROG RETIN EYE RES, V18, P765, DOI 10.1016/S1350-9462(98)00031-7; Thoreson WB, 2003, NEUROSCIENCE, V122, P785, DOI 10.1016/j.neuroscience.2003.08.012; TOWNESANDERSON E, 1985, J CELL BIOL, V100, P175, DOI 10.1083/jcb.100.1.175; TOWNESANDERSON E, 1988, J NEUROSCI, V8, P320; TRANCHINA D, 1981, P NATL ACAD SCI-BIOL, V78, P6540, DOI 10.1073/pnas.78.10.6540; ULLRICH B, 1994, J PHYSIOL-PARIS, V88, P249, DOI 10.1016/0928-4257(94)90088-4; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; Witkovsky P, 1997, J NEUROSCI, V17, P7297; Wu LG, 1999, J NEUROSCI, V19, P726; WU SM, 1985, P NATL ACAD SCI USA, V82, P3944, DOI 10.1073/pnas.82.11.3944; WU SM, 1988, VISION RES, V28, P1; Yang Y, 2002, P NATL ACAD SCI USA, V99, P17060, DOI 10.1073/pnas.242624699; Zenisek D, 2000, NEURON, V25, P229, DOI 10.1016/S0896-6273(00)80885-5	82	148	148	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 27	2004	42	4					595	605		10.1016/S0896-6273(04)00254-5	http://dx.doi.org/10.1016/S0896-6273(04)00254-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157421	Green Accepted, Bronze			2022-12-24	WOS:000221708300010
J	Kali, S; Dayan, P				Kali, S; Dayan, P			Off-line replay maintains declarative memories in a model of hippocampal-neocortical interactions	NATURE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; GRADED RETROGRADE-AMNESIA; SEMANTIC MEMORY; SLEEP; RATS; CONSOLIDATION; REACTIVATION; INFORMATION; ACQUISITION; STORAGE	During sleep, neural activity in the hippocampus and neocortex seems to recapitulate aspects of its earlier, awake form. This replay may be a substrate for the consolidation of long-term declarative memories, whereby they become independent of the hippocampus and are stored in neocortex. In contrast to storage, other crucial facets of competent long-term memory, such as maintenance of access to stored traces and preservation of their correct interpretation, have received little attention. We investigate long-term episodic and semantic memory in a theoretical model of neocortical-hippocampal interaction. We find that, in the absence of regular hippocampal reactivation, even supposedly consolidated episodic memories are fragile in the face of cortical semantic plasticity. Replay allows access to episodes stored in the hippocampus to be maintained, by keeping them in appropriate register with changing neocortical representations. Hippocampal storage and replay also has a constructive role in the recall of structured, semantic information.	Hungarian Acad Sci, Inst Expt Med, H-1450 Budapest, Hungary; UCL, Gatsby Computat Neurosci Unit, London WC1N 3AR, England	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of London; University College London	Kali, S (corresponding author), Hungarian Acad Sci, Inst Expt Med, POB 67, H-1450 Budapest, Hungary.	kali@koki.hu	Káli, Szabolcs/AAW-1138-2020	Káli, Szabolcs/0000-0002-2740-6057; Dayan, Peter/0000-0003-3476-1839				ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Bayley PJ, 2003, NEURON, V38, P135, DOI 10.1016/S0896-6273(03)00156-9; Bayley PJ, 2002, J NEUROSCI, V22, P5741; Cho YH, 1996, BEHAV NEUROSCI, V110, P436, DOI 10.1037/0735-7044.110.3.436; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Freud S, 1966, INTRO LECT PSYCHOANA, P199; GLISKY EL, 1986, J CLIN EXP NEUROPSYC, V8, P292, DOI 10.1080/01688638608401320; GROSSBERG S, 1988, NEURAL NETWORKS, V1, P17, DOI 10.1016/0893-6080(88)90021-4; Haist F, 2001, NAT NEUROSCI, V4, P1139, DOI 10.1038/nn739; Hamann SB, 1995, BEHAV NEUROSCI, V109, P1027, DOI 10.1037/0735-7044.109.6.1027; Hasselmo ME, 1996, HIPPOCAMPUS, V6, P693, DOI 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W; Hinton G. E., 1986, PARALLEL DISTRIBUTED, V1, DOI DOI 10.1234/12345678; Hinton G. E., 1999, UNSUPERVISED LEARNIN; Hinton GE, 2002, NEURAL COMPUT, V14, P1771, DOI 10.1162/089976602760128018; Hobson JA, 2002, NAT REV NEUROSCI, V3, P679, DOI 10.1038/nrn915; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; Holdstock JS, 2002, NEUROPSYCHOLOGIA, V40, P748, DOI 10.1016/S0028-3932(01)00192-0; Kali S, 2003, ADV NEURAL INFORMATI, V15, P19; Kitchener EG, 1998, BRAIN, V121, P1313, DOI 10.1093/brain/121.7.1313; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Manns JR, 2003, NEURON, V38, P127, DOI 10.1016/S0896-6273(03)00146-6; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McCloskey M., 1989, PSYCHOL LEARNING MOT, V24, P109, DOI [10.1016/S0079-7421(08)60536-8, DOI 10.1016/S0079-7421(08)60536-8]; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Nadel L, 2000, HIPPOCAMPUS, V10, P352, DOI 10.1002/1098-1063(2000)10:4<352::AID-HIPO2>3.3.CO;2-4; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; PLAUT DC, 1991, CMUCS91185; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Rao R. P., 2002, PROBABILISTIC MODELS; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Shen B, 1996, HIPPOCAMPUS, V6, P685; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Squire LR, 2001, HIPPOCAMPUS, V11, P50, DOI 10.1002/1098-1063(2001)11:1<50::AID-HIPO1019>3.0.CO;2-G; Stickgold R, 1998, TRENDS COGN SCI, V2, P484, DOI 10.1016/S1364-6613(98)01258-3; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; TULVING E, 1991, J EXP PSYCHOL LEARN, V17, P595, DOI 10.1037/0278-7393.17.4.595; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Verfaellie M, 1995, J Int Neuropsychol Soc, V1, P443; Wiig KA, 1996, LEARN MEMORY, V3, P313, DOI 10.1101/lm.3.4.313; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WINOCUR G, 1990, BEHAV BRAIN RES, V38, P145, DOI 10.1016/0166-4328(90)90012-4; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	50	100	109	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					286	294		10.1038/nn1202	http://dx.doi.org/10.1038/nn1202			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	777UU	14983183				2022-12-24	WOS:000189197900019
J	Marin-Teva, JL; Dusart, I; Colin, C; Gervais, A; van Rooijen, N; Mallat, M				Marin-Teva, JL; Dusart, I; Colin, C; Gervais, A; van Rooijen, N; Mallat, M			Microglia promote the death of developing Purkinje cells	NEURON			English	Article							CHRONIC GRANULOMATOUS-DISEASE; NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; NADPH OXIDASE; NEUROTROPHIC FACTOR; BRAIN MACROPHAGES; SUPEROXIDE GENERATION; OXIDATIVE STRESS; APOPTOTIC CELLS; MICE LACKING	The loss of neuronal cells, a prominent event in the development of the nervous system, involves regulated triggering of programmed cell death, followed by efficient removal of cell corpses. Professional phagocytes, such as microglia, contribute to the elimination of dead cells. Here we provide evidence that, in addition to their phagocytic activity, microglia promote the death of developing neurons engaged in synaptogenesis. In the developing mouse cerebellum, Purkinje cells die, and 60% of these neurons that already expressed activated caspase-3 were engulfed or contacted by spreading processes emitted by microglial cells. Apoptosis of Purkinje cells in cerebellar slices was strongly reduced by selective elimination of microglia. Superoxide ions produced by microglial respiratory bursts played a major role in this Purkinje cell death. Our study illustrates a mammalian form of engulfment-promoted cell death that links the execution of neuron death to the scavenging of dead cells.	INSERM, U495, IFR 70, UPMC, F-75654 Paris 13, France; Hop La Pitie Salpetriere, INSERM, U106, IFR 70, F-75013 Paris, France; Vrije Univ Amsterdam Med Ctr, Dept Mol & Cell Biol, NL-1081 BT Amsterdam, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Mallat, M (corresponding author), INSERM, U495, IFR 70, UPMC, F-75654 Paris 13, France.	michel.mallat@infobiogen.fr	Van Rooijen, Nico/Z-1578-2019; Mallat, Michel/J-3609-2017	Dusart, Isabelle/0000-0002-3211-4323				Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; ARMENGOL JA, 1991, DEV BRAIN RES, V64, P95, DOI 10.1016/0165-3806(91)90213-3; ASHWELL K, 1990, DEV BRAIN RES, V55, P219, DOI 10.1016/0165-3806(90)90203-B; BAPTISTA CA, 1994, NEURON, V12, P243, DOI 10.1016/0896-6273(94)90268-2; Barker V, 2001, NAT NEUROSCI, V4, P1194, DOI 10.1038/nn755; BERTOSSI M, 1986, ANAT EMBRYOL, V175, P25, DOI 10.1007/BF00315453; Bindokas VP, 1996, J NEUROSCI, V16, P1324; BONDY CA, 1991, J NEUROSCI, V11, P3442; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; CHAMAK B, 1995, NEUROSCIENCE, V69, P177, DOI 10.1016/0306-4522(95)00236-C; CHANOCK SJ, 1994, J BIOL CHEM, V269, P24519; CHAO CC, 1992, J IMMUNOL, V149, P2736; Combs CK, 2001, J NEUROSCI, V21, P1179; CUADROS MA, 1991, J ANAT, V177, P145; Cuadros MA, 1998, PROG NEUROBIOL, V56, P173, DOI 10.1016/S0301-0082(98)00035-5; Davies AM, 2003, EMBO J, V22, P2537, DOI 10.1093/emboj/cdg254; Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341; de la Rosa EJ, 2000, TRENDS NEUROSCI, V23, P454, DOI 10.1016/S0166-2236(00)01628-3; DiezRoux G, 1997, DEVELOPMENT, V124, P3633; Doussiere J, 1999, BIOCHEMISTRY-US, V38, P3694, DOI 10.1021/bi9823481; Dusart I, 1997, J NEUROSCI, V17, P3710; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Fadok VA, 2001, J CLIN INVEST, V108, P957, DOI 10.1172/JCI14122; Fan HB, 2001, J COMP NEUROL, V436, P82; Flavin MP, 2000, GLIA, V29, P347, DOI 10.1002/(SICI)1098-1136(20000215)29:4<347::AID-GLIA5>3.3.CO;2-#; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; GARDETTE R, 1985, DEV BRAIN RES, V19, P47, DOI 10.1016/0165-3806(85)90230-5; Gasque P, 2000, IMMUNOPHARMACOLOGY, V49, P171, DOI 10.1016/S0162-3109(00)80302-1; Geiszt M, 2003, J IMMUNOL, V171, P299, DOI 10.4049/jimmunol.171.1.299; Ghoumari AM, 2000, EUR J NEUROSCI, V12, P2935, DOI 10.1046/j.1460-9568.2000.00186.x; Ghoumari AM, 2002, J NEUROSCI, V22, P3531; Hailer NP, 1997, EUR J NEUROSCI, V9, P863, DOI 10.1111/j.1460-9568.1997.tb01436.x; HANCOCK JT, 1987, BIOCHEM J, V242, P103, DOI 10.1042/bj2420103; HENDELMAN WJ, 1980, J COMP NEUROL, V193, P1063, DOI 10.1002/cne.901930417; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Kaal ECA, 1998, J NEUROSCI RES, V54, P778, DOI 10.1002/(SICI)1097-4547(19981215)54:6<778::AID-JNR5>3.0.CO;2-0; Kim SH, 2002, J CELL BIOL, V159, P821, DOI 10.1083/jcb.200112131; LARKFORS L, 1994, EUR J NEUROSCI, V6, P1015, DOI 10.1111/j.1460-9568.1994.tb00596.x; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Lima FRS, 2001, J NEUROSCI, V21, P2028, DOI 10.1523/JNEUROSCI.21-06-02028.2001; Lindholm D, 1997, PERSPECT DEV NEUROBI, V5, P83; MALLAT M, 1994, J LEUKOCYTE BIOL, V56, P416, DOI 10.1002/jlb.56.3.416; Marin-Teva JL, 1999, J COMP NEUROL, V412, P255; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; Morrison ME, 1998, J NEUROSCI, V18, P3563; MOUNT HTJ, 1995, P NATL ACAD SCI USA, V92, P9092, DOI 10.1073/pnas.92.20.9092; Murakami K, 1998, J NEUROSCI, V18, P205; NAVSCUES J, 2002, MICROGLIA DEGENERATI; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Noh KM, 2000, J NEUROSCI, V20; OPPENHEIM RW, 1999, FUNDAMENTAL NEUROSCI, P581; PIANI D, 1991, NEUROSCI LETT, V133, P159, DOI 10.1016/0304-3940(91)90559-C; Polfliet MMJ, 2001, J NEUROIMMUNOL, V116, P188, DOI 10.1016/S0165-5728(01)00282-X; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Rakic S, 2000, EUR J NEUROSCI, V12, P2721, DOI 10.1046/j.1460-9568.2000.00153.x; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; ROTHS JB, 1984, J EXP MED, V159, P1, DOI 10.1084/jem.159.1.1; Sankarapandi S, 1998, ARCH BIOCHEM BIOPHYS, V353, P312, DOI 10.1006/abbi.1998.0658; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schneider SD, 1997, GENE THER, V4, P524, DOI 10.1038/sj.gt.3300432; Sears HC, 2003, DEVELOPMENT, V130, P3557, DOI 10.1242/dev.00586; SEGAL AW, 1993, TRENDS BIOCHEM SCI, V18, P43, DOI 10.1016/0968-0004(93)90051-N; Tammariello SP, 2000, J NEUROSCI, V20; THANOS S, 1993, J NEUROSCI, V13, P455; THERY C, 1991, EUR J NEUROSCI, V3, P1155, DOI 10.1111/j.1460-9568.1991.tb00050.x; TORRESALEMAN I, 1992, EUR J NEUROSCI, V4, P864, DOI 10.1111/j.1460-9568.1992.tb00196.x; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Upender MB, 1999, DEV NEUROSCI-BASEL, V21, P491, DOI 10.1159/000017416; vanRooijen N, 1997, TRENDS BIOTECHNOL, V15, P178, DOI 10.1016/S0167-7799(97)01019-6; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; WHITTEMORE ER, 1995, NEUROSCIENCE, V67, P921, DOI 10.1016/0306-4522(95)00108-U; Yang S, 2001, J BIOL CHEM, V276, P5452, DOI 10.1074/jbc.M001004200; Yu LX, 1998, P NATL ACAD SCI USA, V95, P7993, DOI 10.1073/pnas.95.14.7993; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zanjani HS, 1996, J COMP NEUROL, V374, P332, DOI 10.1002/(SICI)1096-9861(19961021)374:3<332::AID-CNE2>3.0.CO;2-2	80	510	526	3	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 19	2004	41	4					535	547		10.1016/S0896-6273(04)00069-8	http://dx.doi.org/10.1016/S0896-6273(04)00069-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980203	Bronze			2022-12-24	WOS:000221458100007
J	Bishop, S; Duncan, J; Lawrence, AD				Bishop, S; Duncan, J; Lawrence, AD			Prefrontal cortical function and anxiety: controlling attention to threat-related stimuli	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; EMOTION; FMRI; SELECTION; MODEL; FEAR	Threat-related stimuli are strong competitors for attention, particularly in anxious individuals. We used functional magnetic resonance imaging (fMRI) with healthy human volunteers to study how the processing of threat-related distractors is controlled and whether this alters as anxiety levels increase. Our work builds upon prior analyses of the cognitive control functions of lateral prefrontal cortex (lateral PFC) and anterior cingulate cortex (ACC). We found that rostral ACC was strongly activated by infrequent threat-related distractors, consistent with a role for this area in responding to unexpected processing conflict caused by salient emotional stimuli. Participants with higher anxiety levels showed both less rostral ACC activity overall and reduced recruitment of lateral PFC as expectancy of threat- related distractors was established. This supports the proposal that anxiety is associated with reduced top-down control over threat- related distractors. Our results suggest distinct roles for rostral ACC and lateral PFC in governing the processing of task-irrelevant, threat- related stimuli, and indicate reduced recruitment of this circuitry in anxiety.	MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England		Bishop, S (corresponding author), MRC, Cognit & Brain Sci Unit, 15 Chaucer Rd, Cambridge CB2 2EF, England.	sonia.bishop@mrc-cbu.cam.ac.uk	Bishop, Sonia J/I-7729-2012; Lawrence, Andrew/A-1673-2010	Duncan, John S/0000-0002-1373-0681; Duncan, John/0000-0002-9695-2764	MRC [G9439390, G0001237] Funding Source: UKRI; Medical Research Council [G9439390, G0001237] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Armony J.L., 1999, COGNITIVE NEUROSCIEN, P1067; Arnsten AFT, 1998, TRENDS COGN SCI, V2, P436, DOI 10.1016/S1364-6613(98)01240-6; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brett M, 2001, NEUROIMAGE, V13, pS85; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Chen NK, 2003, NEUROIMAGE, V19, P817, DOI 10.1016/S1053-8119(03)00091-0; Compton RJ, 2003, COGN AFFECT BEHAV NE, V3, P81, DOI 10.3758/CABN.3.2.81; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Ekman P., 1976, PICTURES FACIAL AFFE; Eysenck M. W., 1997, ANXIETY COGNITION UN; Henik A., 1997, 2 ABSTRACTS PSYCHONO, P57; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; LANZETTA JT, 1986, J PERS SOC PSYCHOL, V50, P190, DOI 10.1037/0022-3514.50.1.190; LAWRENCE AD, 2001, HDB NEUROPSYCHOLOGY, V5, P235; LOGAN GD, 1979, MEM COGNITION, V7, P166, DOI 10.3758/BF03197535; Luks TL, 2002, NEUROIMAGE, V17, P792, DOI 10.1006/nimg.2002.1210; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mathews A, 1998, COGNITIVE THER RES, V22, P539, DOI 10.1023/A:1018738019346; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Owen AM, 1997, EUR J NEUROSCI, V9, P1329, DOI 10.1111/j.1460-9568.1997.tb01487.x; Posner MI, 1998, ATTENTIVE BRAIN, P401; Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X; Spielberger C. D., 1973, MANUAL STATE TRAIT I; TZELGOV J, 1992, MEM COGNITION, V20, P727, DOI 10.3758/BF03202722; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; VOGT BA, 1997, HAND CHEM N, V13, P455; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	36	667	689	4	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					184	188		10.1038/nn1173	http://dx.doi.org/10.1038/nn1173			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	767TJ	14703573				2022-12-24	WOS:000188468500017
J	Tuch, DS; Reese, TG; Wiegell, MR; Wedeen, VJ				Tuch, DS; Reese, TG; Wiegell, MR; Wedeen, VJ			Diffusion MRI of complex neural architecture	NEURON			English	Article							BRAIN WHITE-MATTER; MAGNETIC-RESONANCE; WATER DIFFUSION; IN-VIVO; AXONAL PROJECTIONS; PROPAGATOR REPRESENTATION; TENSOR; NMR; SPACE; ANISOTROPY	While functional brain imaging methods can locate the cortical regions subserving particular cognitive functions, the connectivity between the functional areas of the human brain remains poorly understood. Recently, investigators have proposed a method to image neural connectivity noninvasively using a magnetic resonance imaging method called diffusion tensor imaging (DTI). DTI measures the molecular diffusion of water along neural pathways. Accurate reconstruction of neural connectivity patterns from DTI has been hindered, however, by the inability of DTI to resolve more than a single axon direction within each imaging voxel. Here, we present a novel magnetic resonance imaging technique that can resolve multiple axon directions within a single voxel. The technique, called q-ball imaging, can resolve intravoxel white matter fiber crossing as well as white matter insertions into cortex. The ability of q-ball imaging to resolve complex intravoxel fiber architecture eliminates a key obstacle to mapping neural connectivity in the human brain noninvasively.	Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University	Tuch, DS (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, 149 13th St,Room 2301, Charlestown, MA 02129 USA.	dtuch@mit.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064044, R56MH064044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K25NS046532] Funding Source: NIH RePORTER; NCRR NIH HHS [RR14075] Funding Source: Medline; NIMH NIH HHS [MH64044] Funding Source: Medline; NINDS NIH HHS [NS46532] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Arfken G.B., 1985, MATH METHODS PHYS, Vthird, P957; Assaf Y, 2000, MAGNET RESON MED, V43, P191, DOI 10.1002/(SICI)1522-2594(200002)43:2<191::AID-MRM5>3.0.CO;2-B; Assaf Y, 1999, NMR BIOMED, V12, P335, DOI 10.1002/(SICI)1099-1492(199910)12:6<335::AID-NBM581>3.0.CO;2-A; Assaf Y, 2000, MAGNET RESON MED, V44, P713, DOI 10.1002/1522-2594(200011)44:5<713::AID-MRM9>3.0.CO;2-6; Assaf Y, 2002, MAGNET RESON MED, V47, P115, DOI 10.1002/mrm.10040; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bracewell R., 1999, FOURIER TRANSFORM IT, P62; Callaghan, 1993, PRINCIPLES NUCL MAGN; Callaghan PT, 1999, REP PROG PHYS, V62, P599, DOI 10.1088/0034-4885/62/4/003; CALLAGHAN PT, 1988, J PHYS E SCI INSTRUM, V21, P820, DOI 10.1088/0022-3735/21/8/017; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; CORY DG, 1990, MAGNET RESON MED, V14, P435, DOI 10.1002/mrm.1910140303; De Boor C., 2001, PRACTICAL GUIDE SPLI; Deans S R, 1993, RADON TRANSFORM SOME; DOUEK P, 1991, J COMPUT ASSIST TOMO, V15, P923, DOI 10.1097/00004728-199111000-00003; Fasshauer GE, 1998, INNOV APPL MATH, P117; Fisher N. I., 1987, STAT ANAL SPHERICAL; Frank LR, 2002, MAGN RESON MED, V47, P1083, DOI 10.1002/mrm.10156; Frank LR, 2001, MAGN RESON MED, V45, P935, DOI 10.1002/mrm.1125; Funk P, 1915, MATH ANN, V77, P129, DOI 10.1007/BF01456824; HARDY RL, 1986, GEOPHYS RES LETT, V13, P18, DOI 10.1029/GL013i001p00018; Helgason S, 1999, RADON TRANSFORM, V5; Hoehn-Berlage M, 1999, NMR BIOMED, V12, P45, DOI 10.1002/(SICI)1099-1492(199902)12:1<45::AID-NBM545>3.0.CO;2-6; Jones DK, 1999, MAGN RESON MED, V42, P37, DOI 10.1002/(SICI)1522-2594(199907)42:1<37::AID-MRM7>3.0.CO;2-O; KARGER J, 1983, J MAGN RESON, V51, P1, DOI 10.1016/0022-2364(83)90094-X; KIMMICH R, 1993, PHYS REV B, V47, P11788, DOI 10.1103/PhysRevB.47.11788; King MD, 1997, MAGN RESON MED, V38, P930, DOI 10.1002/mrm.1910380612; KING MD, 1994, MAGNET RESON MED, V32, P707, DOI 10.1002/mrm.1910320605; Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052; Kubicki M, 2002, HARVARD REV PSYCHIAT, V10, P324, DOI 10.1093/hrp/10.6.324; Kuchel PW, 2000, J MAGN RESON, V145, P291, DOI 10.1006/jmre.2000.2093; LEBIHAN D, 1993, NEUROREPORT, V4, P887; Lim KO, 2002, NMR BIOMED, V15, P587, DOI 10.1002/nbm.789; Mangin JF, 2002, NMR BIOMED, V15, P481, DOI 10.1002/nbm.780; Mardia K. V., 2000, DIRECTIONAL STAT; McKinstry RC, 2002, CEREB CORTEX, V12, P1237, DOI 10.1093/cercor/12.12.1237; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Niewenhuys R., 1996, HUMAN CENTRAL NERVOU; Norris DG, 2001, NMR BIOMED, V14, P77, DOI 10.1002/nbm.682; Parker GJM, 2002, NEUROIMAGE, V15, P797, DOI 10.1006/nimg.2001.0994; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Poupon C, 2000, NEUROIMAGE, V12, P184, DOI 10.1006/nimg.2000.0607; REESE TG, 1995, MAGNET RESON MED, V34, P786, DOI 10.1002/mrm.1910340603; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Thornton JS, 1997, MAGN RESON IMAGING, V15, P433, DOI 10.1016/S0730-725X(96)00378-5; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2001, P NATL ACAD SCI USA, V98, P11697, DOI 10.1073/pnas.171473898; TUCH DS, 2002, THESIS HARVARD U MAS; TURNER R, 1990, J MAGN RESON, V86, P445, DOI 10.1016/0022-2364(90)90023-3; Wiegell MR, 2000, RADIOLOGY, V217, P897, DOI 10.1148/radiology.217.3.r00nv43897; Xue R, 1999, MAGNET RESON MED, V42, P1123, DOI 10.1002/(SICI)1522-2594(199912)42:6<1123::AID-MRM17>3.0.CO;2-H; Zavada T, 1999, PHYS REV E, V60, P1292, DOI 10.1103/PhysRevE.60.1292; Zavada T, 1999, PHYS REV E, V59, P5848, DOI 10.1103/PhysRevE.59.5848	61	533	552	3	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 4	2003	40	5					885	895		10.1016/S0896-6273(03)00758-X	http://dx.doi.org/10.1016/S0896-6273(03)00758-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659088	Bronze			2022-12-24	WOS:000187042200006
J	Wang, JM; Jing, Z; Zhang, LL; Zhou, GD; Braun, J; Yao, Y; Wang, ZZ				Wang, JM; Jing, Z; Zhang, LL; Zhou, GD; Braun, J; Yao, Y; Wang, ZZ			Regulation of acetylcholine receptor clustering by the tumor suppressor APC	NATURE NEUROSCIENCE			English	Article							PHOSPHORYLATION	At the developing neuromuscular junction, motor neuron-derived agrin triggers the differentiation of postsynaptic membrane into a highly specialized structure, where the nicotinic acetylcholine receptors (AChRs) are aggregated into high-density clusters. Agrin acts by activating the muscle-specific kinase MuSK and inducing coaggregation of the 43-kDa protein rapsyn with AChRs on muscle cell membrane(1,2). The signaling mechanism downstream of MuSK is poorly defined. We report here that the mouse tumor suppressor protein adenomatous polyposis coli (APC) has a role in AChR clustering and that the Wnt/beta-catenin pathway may crosstalk with agrin signaling cascade during synapse formation.	Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, ZZ (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurobiol, 3500 Terrace St,Room E1440 BST, Pittsburgh, PA 15261 USA.	zzwang@pitt.edu						Bienz M, 2002, NAT REV MOL CELL BIO, V3, P328, DOI 10.1038/nrm806; Borges LS, 2001, J CELL BIOL, V153, P1, DOI 10.1083/jcb.153.1.1; Dai ZS, 2000, J CELL BIOL, V150, P1321, DOI 10.1083/jcb.150.6.1321; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; JASMIN BJ, 1990, NATURE, V344, P673, DOI 10.1038/344673a0; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Rosin-Arbesfeld R, 2001, EMBO J, V20, P5929, DOI 10.1093/emboj/20.21.5929; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; WALLACE BG, 1991, NEURON, V6, P869, DOI 10.1016/0896-6273(91)90227-Q; Wang JM, 2002, NAT NEUROSCI, V5, P963, DOI 10.1038/nn918	14	92	95	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1017	1018		10.1038/nn1128	http://dx.doi.org/10.1038/nn1128			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	14502292				2022-12-24	WOS:000185633600010
J	Aizenman, CD; Akerman, CJ; Jensen, KR; Cline, HT				Aizenman, CD; Akerman, CJ; Jensen, KR; Cline, HT			Visually driven regulation of intrinsic neuronal excitability improves stimulus detection in vivo	NEURON			English	Article							LONG-TERM POTENTIATION; ACTIVITY-DEPENDENT REGULATION; CA1 PYRAMIDAL NEURONS; DENDRITIC EXCITABILITY; SYNAPTIC TRANSMISSION; NEUROTROPHIC FACTOR; ELECTRICAL-ACTIVITY; QUANTAL AMPLITUDE; CULTURED NEURONS; OPTIC TECTUM	Neurons adapt their electrophysiological properties to maintain stable levels of electrical excitability when faced with a constantly changing environment. We find that exposing freely swimming Xenopus tadpoles to 4-5 hr of persistent visual stimulation increases the intrinsic excitability of optic tectal neurons. This increase is correlated with enhanced voltage-gated Na+ currents. The same visual stimulation protocol also induces a polyamine synthesis-dependent reduction in Ca2+-permeable AMPAR-mediated synaptic drive, suggesting that the increased excitability may compensate for this reduction. Accordingly, the change in excitability was prevented by blocking polyamine synthesis during visual stimulation and was rescued when Ca2+-permeable AMPAR-mediated transmission was selectively reduced. The changes in excitability also rendered tectal cells more responsive to synaptic burst stimuli, improving visual stimulus detection. The synaptic and intrinsic adaptations function together to keep tectal neurons within a constant operating range, while making the intact visual system less responsive to background activity yet more sensitive to burst stimuli.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Cline, HT (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.							Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; Aizenman CD, 2002, NEURON, V34, P623, DOI 10.1016/S0896-6273(02)00674-8; Akerman CJ, 2002, NEURON, V36, P869, DOI 10.1016/S0896-6273(02)01010-3; ALKON DL, 1984, J EXP BIOL, V112, P95; Armano S, 2000, J NEUROSCI, V20, P5208, DOI 10.1523/JNEUROSCI.20-14-05208.2000; Balkowiec A, 2002, J NEUROSCI, V22, P10399; BRODIE C, 1989, BRAIN RES, V488, P186, DOI 10.1016/0006-8993(89)90708-7; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Butt CM, 2001, NEUROSCIENCE, V104, P161, DOI 10.1016/S0306-4522(01)00048-3; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Carr DB, 2002, J NEUROSCI, V22, P6846; Daoudal G, 2002, P NATL ACAD SCI USA, V99, P14512, DOI 10.1073/pnas.222546399; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Debski EA, 2002, CURR OPIN NEUROBIOL, V12, P93, DOI 10.1016/S0959-4388(02)00295-7; DEJONGE MC, 1990, EXP BRAIN RES, V80, P456, DOI 10.1007/BF00227987; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Desai NS, 1999, LEARN MEMORY, V6, P284; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Ganguly K, 2000, NAT NEUROSCI, V3, P1018, DOI 10.1038/79838; GONZALEZ A, 1993, ANAT EMBRYOL, V187, P193; Grusser O.-J, 1976, P297; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; Ireland DR, 2002, J NEUROPHYSIOL, V88, P107, DOI 10.1152/jn.2002.88.1.107; JESTER JM, 1995, J PHYSIOL-LONDON, V484, P689, DOI 10.1113/jphysiol.1995.sp020696; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; LIU Q, 1995, J COMP NEUROL, V352, P280, DOI 10.1002/cne.903520210; Lo FS, 2002, EUR J NEUROSCI, V15, P1421, DOI 10.1046/j.1460-9568.2002.01979.x; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Martina M, 1997, J PHYSIOL-LONDON, V505, P593, DOI 10.1111/j.1469-7793.1997.593ba.x; McBain CJ, 1998, J PHYSIOL-LONDON, V511, P331, DOI 10.1111/j.1469-7793.1998.331bh.x; OFFORD J, 1989, NEURON, V2, P1447, DOI 10.1016/0896-6273(89)90190-6; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Pellegrini-Giampietro DE, 2003, TRENDS NEUROSCI, V26, P9, DOI 10.1016/S0166-2236(02)00004-8; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Raman IM, 1999, J NEUROSCI, V19, P1663; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; Rozov A, 1998, J PHYSIOL-LONDON, V511, P361, DOI 10.1111/j.1469-7793.1998.361bh.x; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Sandrock AW, 1997, SCIENCE, V276, P599, DOI 10.1126/science.276.5312.599; Schreurs BG, 1997, J NEUROPHYSIOL, V77, P86, DOI 10.1152/jn.1997.77.1.86; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Smith MR, 2002, J NEUROPHYSIOL, V87, P2031, DOI 10.1152/jn.00821.2001; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TAUBE JS, 1988, J NEUROSCI, V8, P1632; Thoby-Brisson M, 1998, J NEUROSCI, V18, P2212; Tsubokawa H, 2000, J NEUROSCI, V20, P4878; TURRIGIANO G, 1995, J NEUROSCI, V15, P3640; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Williams K, 1997, CELL SIGNAL, V9, P1, DOI 10.1016/S0898-6568(96)00089-7; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Wu GY, 1999, J NEUROSCI, V19, P4472; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665	63	112	112	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 28	2003	39	5					831	842		10.1016/S0896-6273(03)00527-0	http://dx.doi.org/10.1016/S0896-6273(03)00527-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	717GN	12948449	Bronze			2022-12-24	WOS:000185079300012
J	Miyamoto, H; Katagiri, H; Hensch, T				Miyamoto, H; Katagiri, H; Hensch, T			Experience-dependent slow-wave sleep development	NATURE NEUROSCIENCE			English	Article							RECEPTOR EPSILON-1 SUBUNIT; CAT VISUAL-CORTEX; MICE LACKING; PLASTICITY; STIMULATION; EEG	Sleep enhances plasticity in neocortex, and thereby improves sensory learning(1). Here we show that sleep itself undergoes changes as a consequence of waking experience during a late critical period in cats and mice. Dark-rearing produced a robust and reversible decrement of slow-wave electrical activity during sleep that was restricted to visual cortex and impaired by gene-targeted reduction of NMDA receptor function.	RIKEN, Inst Brain Res, Lab Neuronal Circuit Dev, Wako, Saitama 3510198, Japan	RIKEN	Hensch, T (corresponding author), RIKEN, Inst Brain Res, Lab Neuronal Circuit Dev, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.		Hensch, Takao/L-4182-2019					Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; DAW N, 1995, VISUAL DEV; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Gordon JA, 1996, J NEUROSCI, V16, P3274; Ito I, 1996, NEUROSCI LETT, V203, P69, DOI 10.1016/0304-3940(95)12258-3; Jouvet-Mounier D, 1970, Dev Psychobiol, V2, P216; KATTLER H, 1994, J SLEEP RES, V3, P159, DOI 10.1111/j.1365-2869.1994.tb00123.x; Kiyama Y, 1998, J NEUROSCI, V18, P6704; Mednick SC, 2002, NAT NEUROSCI, V5, P677, DOI 10.1038/nn864; MOWER GD, 1985, J COMP NEUROL, V235, P448, DOI 10.1002/cne.902350404; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Vyazovskiy V, 2000, J SLEEP RES, V9, P367, DOI 10.1046/j.1365-2869.2000.00230.x	15	69	69	0	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					553	554		10.1038/nn1064	http://dx.doi.org/10.1038/nn1064			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12754515				2022-12-24	WOS:000183140400009
J	Gainetdinov, RR; Bohn, LM; Sotnikova, TD; Cyr, M; Laakso, A; Macrae, AD; Torres, GE; Kim, KM; Lefkowitz, RJ; Caron, MG; Premont, RT				Gainetdinov, RR; Bohn, LM; Sotnikova, TD; Cyr, M; Laakso, A; Macrae, AD; Torres, GE; Kim, KM; Lefkowitz, RJ; Caron, MG; Premont, RT			Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice	NEURON			English	Article							PHENOTYPICAL CHARACTERIZATION; DIFFERENTIAL REGULATION; AFFINITY STATES; D-3 RECEPTORS; D2 RECEPTORS; LACKING; D1; EXPRESSION; BRAIN; NEUROBIOLOGY	Brain dopaminergic transmission is a critical component in numerous vital functions, and its dysfunction is involved in several disorders, including addiction and Parkinson's disease. Responses to dopamine are mediated via G protein-coupled dopamine receptors (D1-D5). Desensitization of G protein-coupled receptors is mediated via phosphorylation by members of the family of G protein-coupled receptor kinases (GRK1-GRK7). Here we show that GRK6-deficient mice are supersensitive to the locomotor-stimulating effect of psychostimulants, including cocaine and amphetamine. In addition, these mice demonstrate an enhanced coupling of striatal D2-like dopamine receptors to G proteins and augmented locomotor response to direct dopamine agonists; both in intact and in dopamine-depleted animals. The present study indicates that postsynaptic D2-like dopamine receptors are physiological targets for GRK6 and suggests that this regulatory mechanism contributes to central dopaminergic supersensitivity.	Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Durham, NC 27710 USA.	lefko001@receptor-biol.duke.edu; caron002@mc.duke.edu	Gainetdinov, Raul R/G-5875-2011; Bohn, Laura/A-4412-2008; Lefkowitz, Robert/AAW-2649-2021; Sotnikova, Tatyana D/T-9992-2017; Bohn, Laura M/A-7483-2014	Gainetdinov, Raul R/0000-0003-2951-6038; Bohn, Laura M/0000-0002-6474-8179; Laakso, Aki/0000-0002-5312-4926; Premont, Richard/0000-0002-8053-5026	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, R37HL016037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH040159, P50MH040159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA014600] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-16037] Funding Source: Medline; NIDA NIH HHS [DA-14600] Funding Source: Medline; NIMH NIH HHS [MH-40159] Funding Source: Medline; NINDS NIH HHS [NS-19576] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; Aubert I, 2000, J COMP NEUROL, V418, P22; BENOVIC JL, 1993, J BIOL CHEM, V268, P19521; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; Carlsson A, 2001, SCIENCE, V294, P1021, DOI 10.1126/science.1066969; CARLSSON M, 1991, N-S ARCH PHARMACOL, V343, P568; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; DELEAN A, 1982, MOL PHARMACOL, V22, P290; DICHIARA G, 1994, TRENDS NEUROSCI, V17, P228, DOI 10.1016/0166-2236(94)90005-1; Erdtmann-Vourliotis M, 2001, MOL BRAIN RES, V95, P129, DOI 10.1016/S0006-8993(01)03046-3; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Gainetdinov RR, 1999, NEURON, V24, P1029, DOI 10.1016/S0896-6273(00)81048-X; Gainetdinov RR, 2000, TRENDS PHARMACOL SCI, V21, P366, DOI 10.1016/S0165-6147(00)01538-8; Gainetdinov RR, 2002, TRENDS PHARMACOL SCI, V23, P367, DOI 10.1016/S0165-6147(02)02044-8; Grandy D K, 1992, Curr Opin Neurobiol, V2, P275, DOI 10.1016/0959-4388(92)90115-2; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Halberda CP, 1997, SYNAPSE, V26, P81; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HOGAN B, 1994, MANIPULATION MOUSE E; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Ito K, 1999, EUR J BIOCHEM, V260, P112, DOI 10.1046/j.1432-1327.1999.00125.x; Jaber M, 1996, P NATL ACAD SCI USA, V93, P12974, DOI 10.1073/pnas.93.23.12974; Janssen PAJ, 1999, INT J NEUROPSYCHOPH, V2, P229, DOI 10.1017/S1461145799001522; JENNER P, 1987, NEUROPHARMACOLOGY, V26, P931, DOI 10.1016/0028-3908(87)90072-4; Jones SR, 1998, J NEUROSCI, V18, P1979; KENT RS, 1980, MOL PHARMACOL, V17, P14; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; KIRKPATRICK B, 1992, J NERV MENT DIS, V180, P265, DOI 10.1097/00005053-199204000-00009; Laakso A, 2002, NEURON, V36, P213, DOI 10.1016/S0896-6273(02)00972-8; Lazareno S, 1999, Methods Mol Biol, V106, P231; LEMOINE C, 1991, P NATL ACAD SCI USA, V88, P4205, DOI 10.1073/pnas.88.10.4205; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; Newman-Tancredi A, 1999, MOL PHARMACOL, V55, P564; PANDEY GN, 1977, AM J PSYCHIAT, V134, P518; Penn RB, 2000, TRENDS CARDIOVAS MED, V10, P81, DOI 10.1016/S1050-1738(00)00053-0; Peppel K, 1997, J BIOL CHEM, V272, P25425, DOI 10.1074/jbc.272.41.25425; Picetti R, 1997, CRIT REV NEUROBIOL, V11, P121, DOI 10.1615/CritRevNeurobiol.v11.i2-3.20; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Premont RT, 1999, J BIOL CHEM, V274, P29381, DOI 10.1074/jbc.274.41.29381; Premont RT, 2001, P NATL ACAD SCI USA, V98, P9474, DOI 10.1073/pnas.181356198; PREMONT RT, 1995, FASEB J, V9, P175, DOI 10.1096/fasebj.9.2.7781920; Rivera A, 2002, J NEUROCHEM, V80, P219, DOI 10.1046/j.0022-3042.2001.00702.x; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rockman HA, 1998, J BIOL CHEM, V273, P18180, DOI 10.1074/jbc.273.29.18180; Sandoval V, 2001, J NEUROSCI, V21, P1413; SCHWARTZ JC, 1993, CLIN NEUROPHARMACOL, V16, P295, DOI 10.1097/00002826-199308000-00002; SEEMAN P, 1994, TRENDS PHARMACOL SCI, V15, P264, DOI 10.1016/0165-6147(94)90323-9; Sibley DR, 1999, ANNU REV PHARMACOL, V39, P313, DOI 10.1146/annurev.pharmtox.39.1.313; SINGER HS, 1994, BRAIN DEV-JPN, V16, P353, DOI 10.1016/0387-7604(94)90122-8; STOFFEL RH, 1994, J BIOL CHEM, V269, P27791; Tiberi M, 1996, J BIOL CHEM, V271, P3771; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; VanHartesveldt C, 1997, PHARMACOL BIOCHEM BE, V58, P955, DOI 10.1016/S0091-3057(97)00332-8; Walker JKL, 1999, AM J PHYSIOL-REG I, V276, pR1214, DOI 10.1152/ajpregu.1999.276.4.R1214; WALTERS JR, 1987, SCIENCE, V236, P719; Wang YM, 1997, NEURON, V19, P1285, DOI 10.1016/S0896-6273(00)80419-5; WHITE FJ, 1988, PHARMACOL BIOCHEM BE, V30, P189, DOI 10.1016/0091-3057(88)90442-X; Willner P, 1997, INT CLIN PSYCHOPHARM, V12, pS7, DOI 10.1097/00004850-199707003-00002; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; Xu F, 2000, NAT NEUROSCI, V3, P465, DOI 10.1038/74839; Xu M, 1997, NEURON, V19, P837, DOI 10.1016/S0896-6273(00)80965-4; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	65	186	191	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 24	2003	38	2					291	303		10.1016/S0896-6273(03)00192-2	http://dx.doi.org/10.1016/S0896-6273(03)00192-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672AM	12718862	Bronze			2022-12-24	WOS:000182498300017
J	Tsao, DY; Conway, BR; Livingstone, MS				Tsao, DY; Conway, BR; Livingstone, MS			Receptive fields of disparity-tuned simple cells in macaque V1	NEURON			English	Article							CATS STRIATE CORTEX; VISUAL CORTICAL-NEURONS; RANDOM-DOT STEREOGRAMS; BINOCULAR DISPARITY; NEURAL MECHANISMS; SPATIOTEMPORAL ORGANIZATION; HORIZONTAL DISPARITY; OCCLUDING CONTOURS; SPATIAL SUMMATION; DEPTH-PERCEPTION	Binocular simple cells in primary visual cortex (V1) are the first cells along the mammalian visual pathway to receive input from both eyes. Two models of how binocular simple cells could extract disparity information have been put forward. The phase-shift model proposes that the receptive fields in the two eyes have different subunit organizations, while the position-shift model proposes that they have different overall locations. In five fixating macaque monkeys, we recorded from 30 disparity-tuned simple cells that showed selectivity to the disparity in a random dot stereogram. High-resolution maps of the left and right eye receptive fields indicated that both phase and position shifts were common. Single cells usually showed a combination of the two, and the optimum disparity was best correlated with the sum of receptive field phase and position shift.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Tsao, DY (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	doris@nmr.mgh.harvard.edu	Conway, Bevil/AAG-2412-2020	Conway, Bevil/0000-0001-7715-9253; Livingstone, Margaret/0000-0002-1950-0123	NATIONAL EYE INSTITUTE [R01EY013135] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [EY13135, R01 EY013135] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANDERSON BL, 1994, PSYCHOL REV, V101, P414, DOI 10.1037/0033-295X.101.3.414; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Anzai A, 1999, J NEUROPHYSIOL, V82, P891, DOI 10.1152/jn.1999.82.2.891; Anzai A, 1999, J NEUROPHYSIOL, V82, P874, DOI 10.1152/jn.1999.82.2.874; Anzai A, 2001, NAT NEUROSCI, V4, P513, DOI 10.1038/87462; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; BURR DC, 1979, VISION RES, V19, P523, DOI 10.1016/0042-6989(79)90137-8; Conway BR, 2001, J NEUROSCI, V21, P2768, DOI 10.1523/JNEUROSCI.21-08-02768.2001; CONWAY BR, 2002, IN PRESS J NEUROPHYS; Cumming BG, 1997, NATURE, V389, P280, DOI 10.1038/38487; DAUGMAN JG, 1985, J OPT SOC AM A, V2, P1160, DOI 10.1364/JOSAA.2.001160; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1118, DOI 10.1152/jn.1993.69.4.1118; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; DEANGELIS GC, 1991, NATURE, V352, P156, DOI 10.1038/352156a0; Draper N. R., 1998, APPL REGRESSION; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; JULESZ B, 1960, AT&T TECH J, V39, P1125, DOI 10.1002/j.1538-7305.1960.tb03954.x; Livingstone MS, 1998, NEURON, V20, P509, DOI 10.1016/S0896-6273(00)80991-5; Livingstone MS, 1999, NAT NEUROSCI, V2, P825, DOI 10.1038/12199; MARCELJA S, 1980, J OPT SOC AM, V70, P1297, DOI 10.1364/JOSA.70.001297; MASKE R, 1984, VISION RES, V24, P1921, DOI 10.1016/0042-6989(84)90026-9; MCLEAN J, 1989, VISION RES, V29, P675, DOI 10.1016/0042-6989(89)90029-1; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; NAKAYAMA K, 1990, VISION RES, V30, P1811, DOI 10.1016/0042-6989(90)90161-D; Ning QA, 1997, NEURON, V18, P359, DOI 10.1016/S0896-6273(00)81238-6; Ohzawa I, 1996, J NEUROPHYSIOL, V75, P1779, DOI 10.1152/jn.1996.75.5.1779; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; PETTIGREW J, 1965, BINOCULAR INTERACTIO; POGGIO GF, 1990, COLD SPRING HARB SYM, V55, P749; POGGIO GF, 1984, ANNU REV NEUROSCI, V7, P379, DOI 10.1146/annurev.ne.07.030184.002115; POGGIO GF, 1988, J NEUROSCI, V8, P4531; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; Press W. H., 1992, ART SCI COMPUTING; Prince SJD, 2002, J NEUROPHYSIOL, V87, P209, DOI 10.1152/jn.00466.2000; Prince SJD, 2002, J NEUROPHYSIOL, V87, P191, DOI 10.1152/jn.00465.2000; Qian N, 1997, VISION RES, V37, P1683, DOI 10.1016/S0042-6989(96)00164-2; REID RC, 1991, J NEUROPHYSIOL, V66, P505, DOI 10.1152/jn.1991.66.2.505; SHIMOJO S, 1988, NATURE, V333, P265, DOI 10.1038/333265a0; Zar JH, 1999, BIOSTATISTICAL ANAL	40	46	46	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 10	2003	38	1					103	114		10.1016/S0896-6273(03)00150-8	http://dx.doi.org/10.1016/S0896-6273(03)00150-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	666XT	12691668	Green Accepted, Bronze			2022-12-24	WOS:000182202300013
J	Friedrich, RW; Habermann, CJ; Laurent, G				Friedrich, RW; Habermann, CJ; Laurent, G			Multiplexing using synchrony in the zebrafish olfactory bulb	NATURE NEUROSCIENCE			English	Article							ODORANT REPRESENTATIONS; NEURONAL SYNCHRONY; OSCILLATIONS; DYNAMICS; SYSTEM; CORTEX; BRAIN; DISCRIMINATION; ORGANIZATION; RAT	In the olfactory bulb (OB) of zebrafish and other species, odors evoke fast oscillatory population activity and specific firing rate patterns across mitral cells (MCs). This activity evolves over a few hundred milliseconds from the onset of the odor stimulus. Action potentials of odor-specific MC subsets phase-lock to the oscillation, defining small and distributed ensembles within the MC population output. We found that oscillatory field potentials in the zebrafish OB propagate across the OB in waves. Phase-locked MC action potentials, however, were synchronized without a time lag. Firing rate patterns across MCs analyzed with low temporal resolution were informative about odor identity. When the sensitivity for phase-locked spiking was increased, activity patterns became progressively more informative about odor category. Hence, information about complementary stimulus features is conveyed simultaneously by the same population of neurons and can be retrieved selectively by biologically plausible mechanisms, indicating that seemingly alternative coding strategies operating on different time scales may coexist.	Max Planck Inst Med Res, Dept Biomed Opt, D-69120 Heidelberg, Germany; CALTECH, Div Biol, Pasadena, CA 91125 USA	Max Planck Society; California Institute of Technology	Friedrich, RW (corresponding author), Max Planck Inst Med Res, Dept Biomed Opt, Jahnstr 29, D-69120 Heidelberg, Germany.	Rainer.Friedrich@mpimf-heidelberg.mpg.de	Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X; Friedrich, Rainer/0000-0001-9107-0482				BAIER H, 1994, J NEUROSCI, V14, P219; BYRD CA, 1995, J COMP NEUROL, V358, P247, DOI 10.1002/cne.903580207; Carr W.E.S., 1988, P3; Cleland TA, 2002, BEHAV NEUROSCI, V116, P222, DOI 10.1037//0735-7044.116.2.222; ECKHORN R, 1994, PROG BRAIN RES, V102, P405; Edwards JG, 2002, J COMP NEUROL, V454, P294, DOI 10.1002/cne.10445; EECKMAN FH, 1990, BRAIN RES, V528, P238, DOI 10.1016/0006-8993(90)91663-2; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; FLUHLER E, 1985, BIOCHEMISTRY-US, V24, P5749, DOI 10.1021/bi00342a010; FREEMAN WJ, 1985, BRAIN RES REV, V10, P147, DOI 10.1016/0165-0173(85)90022-0; Friedman D, 2003, J NEUROPHYSIOL, V89, P2601, DOI 10.1152/jn.00887.2002; Friedrich RW, 2004, J NEUROPHYSIOL, V91, P2658, DOI 10.1152/jn.01143.2003; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; GOLDBERG SJ, 1987, EXP NEUROL, V96, P430, DOI 10.1016/0014-4886(87)90060-4; Gray C M, 1994, J Comput Neurosci, V1, P11, DOI 10.1007/BF00962716; Haberly LB, 1998, SYNAPTIC ORG BRAIN, P377; HASEGAWA T, 1994, COMP BIOCHEM PHYS A, V108, P17, DOI 10.1016/0300-9629(94)90048-5; Jvreskog, 1996, APPL FACTOR ANAL NAT; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; KAUER JS, 1974, J PHYSIOL-LONDON, V243, P695, DOI 10.1113/jphysiol.1974.sp010772; Kuhn B, 2003, J PHYS CHEM B, V107, P7903, DOI 10.1021/jp0345811; Lam YW, 2003, EUR J NEUROSCI, V17, P436, DOI 10.1046/j.1460-9568.2003.02457.x; Lam YW, 2000, J NEUROSCI, V20, P749, DOI 10.1523/JNEUROSCI.20-02-00749.2000; Lamme VAF, 1998, NATURE, V396, P362, DOI 10.1038/24608; Laurent G, 1996, TRENDS NEUROSCI, V19, P489, DOI 10.1016/S0166-2236(96)10054-0; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; LAURENT G, 1994, J NEUROSCI; LEVINE RL, 1985, J COMP NEUROL, V237, P427, DOI 10.1002/cne.902370402; Lledo PM, 2003, NEUROREPORT, V14, P1655, DOI 10.1097/00001756-200309150-00001; MATHIESON WB, 1988, J COMP PHYSIOL A, V163, P489, DOI 10.1007/BF00604903; MEREDITH M, 1986, J NEUROPHYSIOL, V56, P572, DOI 10.1152/jn.1986.56.3.572; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; SATOU M, 1990, PROG NEUROBIOL, V34, P115, DOI 10.1016/0301-0082(90)90004-Z; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Valentincic T, 2000, CHEM SENSES, V25, P21, DOI 10.1093/chemse/25.1.21; VANESSEN DC, 1994, NEURON, V13, P1, DOI 10.1016/0896-6273(94)90455-3; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wise PM, 2000, CHEM SENSES, V25, P247, DOI 10.1093/chemse/25.3.247; [No title captured]	50	191	191	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					862	871		10.1038/nn1292	http://dx.doi.org/10.1038/nn1292			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15273692				2022-12-24	WOS:000222930800017
J	Gervais, H; Belin, P; Boddaert, N; Leboyer, M; Coez, A; Sfaello, I; Barthelemy, C; Brunelle, F; Samson, Y; Zilbovicius, M				Gervais, H; Belin, P; Boddaert, N; Leboyer, M; Coez, A; Sfaello, I; Barthelemy, C; Brunelle, F; Samson, Y; Zilbovicius, M			Abnormal cortical voice processing in autism	NATURE NEUROSCIENCE			English	Article							ASPERGER-SYNDROME; AUDITORY-CORTEX; INDIVIDUALS; CHILDREN; SPEECH; MIND	Impairments in social interaction are a key feature of autism and are associated with atypical social information processing. Here we report functional magnetic resonance imaging (fMRI) results showing that individuals with autism failed to activate superior temporal sulcus (STS) voice-selective regions in response to vocal sounds, whereas they showed a normal activation pattern in response to nonvocal sounds. These findings suggest abnormal cortical processing of socially relevant auditory information in autism.	CEA, Serv Hosp Frederic Joliot, ERM 0205,INSERM, DRM,DSV, F-91406 Orsay, France; Univ Montreal, Ctr Rech Neuropsychol & Cognit, Montreal, PQ, Canada; Univ Montreal, Ctr Rech, Inst Univ Geriatrie Montreal, Montreal, PQ, Canada; AP HP, Serv Radiol Pediat, F-75015 Paris, France; Hop Henri Mondor, Psychiat Serv, AP HP, F-94000 Creteil, France; CHU Bretonneau, INSERM, Unite 619, F-37000 Tours, France; Grp Hosp Pitie Salpetriere, Serv Urgences Cerevrovasc, AP HP, F-75013 Paris, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universite de Montreal; Universite de Montreal; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Zilbovicius, M (corresponding author), CEA, Serv Hosp Frederic Joliot, ERM 0205,INSERM, DRM,DSV, 4 Pl Gen Leclerc, F-91406 Orsay, France.	zilbo@shfj.cea.fr	boddaert, nathalie/GWV-2865-2022; Leboyer, Marion/AAW-3648-2021; samson, yves/C-5647-2013; Belin, Pascal/C-6247-2009	Leboyer, Marion/0000-0001-5473-3697; Belin, Pascal/0000-0002-7578-6365; samson, yves/0000-0002-8080-1427; boddaert, nathalie/0000-0003-0991-7774				Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; American Psychiatric Association, 2000, DIAGN STAT MAN; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Belin P, 1999, NEUROIMAGE, V10, P417, DOI 10.1006/nimg.1999.0480; Bonnel A, 2003, J COGNITIVE NEUROSCI, V15, P226, DOI 10.1162/089892903321208169; BOUCHER J, 1992, J CHILD PSYCHOL PSYC, V33, P843, DOI 10.1111/j.1469-7610.1992.tb01960.x; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Ceponiene R, 2003, P NATL ACAD SCI USA, V100, P5567, DOI 10.1073/pnas.0835631100; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; FRITH U, 1994, COGNITION, V50, P115, DOI 10.1016/0010-0277(94)90024-8; Kanner L, 1943, NERV CHILD, V2, P217; KLIN A, 1991, J AUTISM DEV DISORD, V21, P29, DOI 10.1007/BF02206995; Pierce K, 2001, BRAIN, V124, P2059, DOI 10.1093/brain/124.10.2059; Rutherford MD, 2002, J AUTISM DEV DISORD, V32, P189, DOI 10.1023/A:1015497629971; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331	15	311	316	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					801	802		10.1038/nn1291	http://dx.doi.org/10.1038/nn1291			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15258587				2022-12-24	WOS:000222930800008
J	Maier, JX; Neuhoff, JG; Logothetis, NK; Ghazanfar, AA				Maier, JX; Neuhoff, JG; Logothetis, NK; Ghazanfar, AA			Multisensory integration of looming signals by Rhesus monkeys	NEURON			English	Article							VENTRAL INTRAPARIETAL AREA; TEMPORAL POLYSENSORY AREA; IMPENDING COLLISION; PERCEPTION; MACAQUE; RESPONSES; MOTION; DISTANCE; INFANTS; CORTEX	Looming objects produce ecologically important signals that can be perceived in both the visual and auditory domains. Using a preferential looking technique with looming and receding visual and auditory stimuli, we examined the multisensory integration of looming stimuli by rhesus monkeys. We found a strong attentional preference for coincident visual and auditory looming but no analogous preference for coincident stimulus recession. Consistent with previous findings, the effect occurred only with tonal stimuli and not with broadband noise. The results suggest an evolved capacity to integrate multisensory looming objects.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; Coll Wooster, Dept Psychol, Wooster, OH 44691 USA	Max Planck Society; College of Wooster	Ghazanfar, AA (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	asifg@tuebingen.mpg.de	Neuhoff, John G/A-2955-2016; Logothetis, Nikos/U-9282-2019	Neuhoff, John/0000-0003-1123-9044				Anderson KC, 1999, J NEUROSCI, V19, P2681; ASHMEAD DH, 1995, J EXP PSYCHOL HUMAN, V21, P239, DOI 10.1037/0096-1523.21.2.239; BALL W, 1971, SCIENCE, V171, P818, DOI 10.1126/science.171.3973.818; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bregman A.S., 1990, AUDITORY SCENE ANAL; Bremmer F, 2002, EUR J NEUROSCI, V16, P1569, DOI 10.1046/j.1460-9568.2002.02206.x; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; Cooke DF, 2003, P NATL ACAD SCI USA, V100, P6163, DOI 10.1073/pnas.1031751100; DESIMONE R, 1979, BRAIN RES, V178, P363, DOI 10.1016/0006-8993(79)90699-1; ETTLINGER G, 1990, BEHAV BRAIN RES, V40, P169, DOI 10.1016/0166-4328(90)90075-P; Freiberg K, 2001, BRIT J DEV PSYCHOL, V19, P1, DOI 10.1348/026151001165903; Ghazanfar AA, 2003, NATURE, V423, P937, DOI 10.1038/423937a; Ghazanfar AA, 2002, P NATL ACAD SCI USA, V99, P15755, DOI 10.1073/pnas.242469699; Gil-da-Costa R, 2003, P ROY SOC B-BIOL SCI, V270, P605, DOI 10.1098/rspb.2002.2281; Hietanen JK, 1996, EXP BRAIN RES, V108, P341; HIKOSAKA K, 1988, J NEUROPHYSIOL, V60, P1615, DOI 10.1152/jn.1988.60.5.1615; Kitchen DM, 2003, BEHAV ECOL SOCIOBIOL, V53, P374, DOI 10.1007/s00265-003-0588-1; KUHL PK, 1982, SCIENCE, V218, P1138, DOI 10.1126/science.7146899; MISTLIN AJ, 1990, EXP BRAIN RES, V82, P437; Neuhoff JG, 1998, NATURE, V395, P123, DOI 10.1038/25862; Neuhoff JG, 2001, ECOL PSYCHOL, V13, P87, DOI 10.1207/S15326969ECO1302_2; ROSENBLUM LD, 1993, PERCEPTION, V22, P1467, DOI 10.1068/p221467; ROSENBLUM LD, 1987, PERCEPTION, V16, P175, DOI 10.1068/p160175; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; SCHIFF W, 1965, PSYCHOL MONOGR, V79, P1, DOI 10.1037/h0093887; SCHIFF W, 1990, J EXP PSYCHOL HUMAN, V16, P303, DOI 10.1037/0096-1523.16.2.303; SCHIFF W, 1962, SCIENCE, V136, P982, DOI 10.1126/science.136.3520.982; Seifritz E, 2002, CURR BIOL, V12, P2147, DOI 10.1016/S0960-9822(02)01356-8; SPELKE ES, 1983, PERCEPTION, V12, P719, DOI 10.1068/p120719; Stecker GC, 2000, J ACOUST SOC AM, V107, P3358, DOI 10.1121/1.429407; Stein B E, 1989, J Cogn Neurosci, V1, P12, DOI 10.1162/jocn.1989.1.1.12; Tinbergen, 1951, STUDY INSTINCT; Walker-Andrews AS, 1994, DEV INTERSENSORY PER, P39; WALKERANDREWS AS, 1985, CHILD DEV, V56, P544	36	123	125	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 22	2004	43	2					177	181		10.1016/j.neuron.2004.06.027	http://dx.doi.org/10.1016/j.neuron.2004.06.027			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841BX	15260954	Bronze			2022-12-24	WOS:000222905400007
J	Ilg, UJ; Schumann, S; Thier, P				Ilg, UJ; Schumann, S; Thier, P			Posterior parietal cortex neurons encode target motion in world-centered coordinates	NEURON			English	Article							PURSUIT EYE-MOVEMENTS; VISUAL-TRACKING NEURONS; CORTICAL AREAS MT; FUNCTIONAL-PROPERTIES; RESPONSE PROPERTIES; MACAQUE MONKEY; MST; REPRESENTATION; CONNECTIONS; SELECTIVITY	The motion areas of posterior parietal cortex extract information on visual motion for perception as well as for the guidance of movement. It is usually assumed that neurons in posterior parietal cortex represent visual motion relative to the retina. Current models describing action guided by moving objects work successfully based on this assumption. However, here we show that the pursuit-related responses of a distinct group of neurons in area MST of monkeys are at odds with this view. Rather than signaling object image motion on the retina, they represent object motion in world-centered coordinates. This representation may simplify the coordination of object-directed action and ego motion-invariant visual perception.	Univ Tubingen, Dept Cognit Neurol, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Ilg, UJ (corresponding author), Univ Tubingen, Dept Cognit Neurol, Hertie Inst Clin Brain Res, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	uwe.ilg@uni-tuebingen.de		Ilg, Uwe/0000-0003-2623-1627; Schumann, Stefan/0000-0003-0773-7489; Thier, Peter/0000-0001-5909-4222				ALLMAN JM, 1971, BRAIN RES, V35, P89, DOI 10.1016/0006-8993(71)90596-8; Andersen R A, 1993, Curr Opin Neurobiol, V3, P171, DOI 10.1016/0959-4388(93)90206-E; ASSAD JA, 1995, NATURE, V373, P518, DOI 10.1038/373518a0; Bradley DC, 1996, SCIENCE, V273, P1544, DOI 10.1126/science.273.5281.1544; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; DUFFY CJ, 1995, J NEUROSCI, V15, P5192; DURSTELER MR, 1988, J NEUROPHYSIOL, V60, P940, DOI 10.1152/jn.1988.60.3.940; Ilg UJ, 1999, VISION RES, V39, P2143, DOI 10.1016/S0042-6989(98)00321-6; Ilg UJ, 2003, J NEUROPHYSIOL, V90, P1489, DOI 10.1152/jn.00272.2003; KAWANO K, 1984, J NEUROPHYSIOL, V51, P352, DOI 10.1152/jn.1984.51.2.352; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; Krauzlis RJ, 1989, NEURAL COMPUT, V1, P116, DOI 10.1162/neco.1989.1.1.116; Lappe M, 1996, J NEUROSCI, V16, P6265; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; MIKAMI A, 1986, J NEUROPHYSIOL, V55, P1308, DOI 10.1152/jn.1986.55.6.1308; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; SAKATA H, 1983, J NEUROPHYSIOL, V49, P1364, DOI 10.1152/jn.1983.49.6.1364; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; THIER P, 1992, EUR J NEUROSCI, V4, P539, DOI 10.1111/j.1460-9568.1992.tb00904.x; UNGERLEIDER LG, 1986, J COMP NEUROL, V248, P190, DOI 10.1002/cne.902480204; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503	23	92	92	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 8	2004	43	1					145	151		10.1016/j.neuron.2004.06.006	http://dx.doi.org/10.1016/j.neuron.2004.06.006			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233924	Bronze, Green Submitted			2022-12-24	WOS:000222549800014
J	Strasser, GA; Rahim, NA; VanderWaal, KE; Gertler, FB; Lanier, LM				Strasser, GA; Rahim, NA; VanderWaal, KE; Gertler, FB; Lanier, LM			Arp2/3 is a negative regulator of growth cone translocation	NEURON			English	Article							ALDRICH-SYNDROME PROTEIN; ACTIN DEPOLYMERIZING FACTOR; AXON GUIDANCE; N-WASP; LISTERIA-MONOCYTOGENES; ENA/VASP PROTEINS; CULTURED NEURONS; IN-VITRO; F-ACTIN; REQUIRES INTERACTIONS	Arp2/3 is an actin binding complex that is enriched in the peripheral lamellipodia of fibroblasts, where it forms a network of short, branched actin filaments, generating the protrusive force that extends lamellipodia and drives fibroblast motility. Although it has been assumed that Arp2/3 would play a similar role in growth cones, our studies indicate that Arp2/3 is enriched in the central, not the peripheral, region of growth cones and that the growth cone periphery contains few branched actin filaments. Arp2/3 inhibition in fibroblasts severely disrupts actin organization and membrane protrusion. In contrast, Arp2/3 inhibition in growth cones minimally affects actin organization and does not inhibit lamellipodia protrusion or de novo filopodia formation. Surprisingly, Arp2/3 inhibition significantly enhances axon elongation and causes defects in growth cone guidance. These results indicate that Arp2/3 is a negative regulator of growth cone translocation.	Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	University of Minnesota System; University of Minnesota Twin Cities; Massachusetts Institute of Technology (MIT)	Lanier, LM (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	lanie002@umn.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049178] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS049178-01, R01 NS049178-02] Funding Source: Medline; PHS HHS [6895154] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Amann KJ, 2001, NAT CELL BIOL, V3, P306, DOI 10.1038/35060104; ARCE CA, 1978, J NEUROCHEM, V31, P205, DOI 10.1111/j.1471-4159.1978.tb12449.x; Bailly M, 2001, CURR BIOL, V11, P620, DOI 10.1016/S0960-9822(01)00152-X; Bailly M, 1999, J CELL BIOL, V145, P331, DOI 10.1083/jcb.145.2.331; Bamburg JR, 2003, J HISTOCHEM CYTOCHEM, V51, P407, DOI 10.1177/002215540305100401; BAMBURG JR, 1986, NATURE, V321, P788, DOI 10.1038/321788a0; Banzai Y, 2000, J BIOL CHEM, V275, P11987, DOI 10.1074/jbc.275.16.11987; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Buck KB, 2002, J NEUROSCI, V22, P9358; CALDWELL JE, 1989, J BIOL CHEM, V264, P12648; Challacombe JF, 1997, J NEUROSCI, V17, P3085; CHIEN CB, 1993, NEURON, V11, P237, DOI 10.1016/0896-6273(93)90181-P; Cohan CS, 2001, CELL MOTIL CYTOSKEL, V48, P109, DOI 10.1002/1097-0169(200102)48:2<109::AID-CM1002>3.0.CO;2-G; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; Dent EW, 1999, J NEUROSCI, V19, P8894, DOI 10.1523/JNEUROSCI.19-20-08894.1999; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; DENT EW, 2004, IN PRESS J NEUROSCI; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dramsi S, 1998, INFECT IMMUN, V66, P4461; Du YR, 1998, MOL CELL BIOL, V18, P5838, DOI 10.1128/MCB.18.10.5838; Falet H, 2002, P NATL ACAD SCI USA, V99, P16782, DOI 10.1073/pnas.222652499; GOMEZ TM, 1994, J NEUROSCI, V14, P5959; Goslin K., 1998, CULTURING NERVE CELL, P339; Gungabissoon RA, 2003, J HISTOCHEM CYTOCHEM, V51, P411, DOI 10.1177/002215540305100402; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hufner K, 2002, FEBS LETT, V514, P168, DOI 10.1016/S0014-5793(02)02358-X; Hufner K, 2001, J BIOL CHEM, V276, P35761, DOI 10.1074/jbc.M106520200; KIM GJ, 1991, J NEUROBIOL, V22, P629, DOI 10.1002/neu.480220608; Kim MD, 2002, J NEUROSCI, V22, P1794, DOI 10.1523/JNEUROSCI.22-05-01794.2002; Kobayashi H, 1997, J NEUROSCI, V17, P8339; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Koleske Anthony J, 2003, Sci STKE, V2003, ppe20; Kuhn TB, 1998, J NEUROSCI, V18, P184; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; LASALLE GL, 1993, SCIENCE, V259, P988, DOI 10.1126/science.8382374; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; LETOURNEAU PC, 1983, J CELL BIOL, V97, P963, DOI 10.1083/jcb.97.4.963; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; LIN CH, 1993, J CELL BIOL, V121, P1369, DOI 10.1083/jcb.121.6.1369; Lu M, 1997, J CELL BIOL, V138, P1279, DOI 10.1083/jcb.138.6.1279; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Machesky LM, 1997, BIOCHEM J, V328, P105; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; MARSH L, 1984, J CELL BIOL, V99, P2041, DOI 10.1083/jcb.99.6.2041; Mason C, 2000, J NEUROBIOL, V44, P260, DOI 10.1002/1097-4695(200008)44:2<260::AID-NEU14>3.0.CO;2-H; May RC, 1999, CURR BIOL, V9, P759, DOI 10.1016/S0960-9822(99)80337-6; Meberg PJ, 2000, J NEUROSCI, V20, P2459; Miki H, 1998, BIOCHEM BIOPH RES CO, V243, P73, DOI 10.1006/bbrc.1997.8064; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Paglini G, 1998, J CELL BIOL, V143, P443, DOI 10.1083/jcb.143.2.443; Pollard TD, 2003, CELL, V113, P549, DOI 10.1016/S0092-8674(03)00357-X; Pollard TD, 2002, CURR OPIN STRUC BIOL, V12, P768, DOI 10.1016/S0959-440X(02)00396-2; Pollard TD, 2002, NAT CELL BIOL, V4, pE191, DOI 10.1038/ncb0802-e191a; Rochlin MW, 1999, MOL BIOL CELL, V10, P2309, DOI 10.1091/mbc.10.7.2309; Rochlin MW, 1996, J NEUROSCI, V16, P3236; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Suter DM, 1998, J CELL BIOL, V141, P227, DOI 10.1083/jcb.141.1.227; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Svitkina TM, 1998, METHOD ENZYMOL, V298, P570, DOI 10.1016/S0076-6879(98)98045-4; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Svitkina TM, 1995, J STRUCT BIOL, V115, P290, DOI 10.1006/jsbi.1995.1054; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Szebenyi G, 2001, J NEUROSCI, V21, P3932, DOI 10.1523/JNEUROSCI.21-11-03932.2001; TANAKA E, 1995, J CELL BIOL, V128, P127, DOI 10.1083/jcb.128.1.127; TANAKA E, 1995, J CELL BIOL, V128, P139, DOI 10.1083/jcb.128.1.139; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; VIELMETTER J, 1990, EXP BRAIN RES, V81, P283; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zalevsky J, 2001, CURR BIOL, V11, P1903, DOI 10.1016/S0960-9822(01)00603-0; Zallen JA, 2002, J CELL BIOL, V156, P689, DOI 10.1083/jcb.200109057; Zheng JQ, 1996, J NEUROSCI, V16, P1140; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014	91	135	137	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 8	2004	43	1					81	94		10.1016/j.neuron.2004.05.015	http://dx.doi.org/10.1016/j.neuron.2004.05.015			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233919	Green Published, Bronze			2022-12-24	WOS:000222549800009
J	Kennedy, MJ; Dunn, FA				Kennedy, MJ; Dunn, FA			Visual pigment phosphorylation but not transducin translocation can contribute to light adaptation in zebrafish cones	NEURON			English	Article							CYTOPLASMIC CALCIUM-CONCENTRATION; ROD OUTER SEGMENTS; RHODOPSIN-KINASE; RETINAL RODS; G-PROTEIN; IN-VIVO; MULTIPLE PHOSPHORYLATION; BOVINE RHODOPSIN; VERTEBRATE RODS; DARK-ADAPTATION	The ability of cone photoreceptors to adapt to light is extraordinary. In this study we evaluated two biochemical processes, visual pigment phosphorylation and transducin translocation, for their ability to contribute to light adaptation in zebrafish cones. Since cytoplasmic Ca2+ regulates light adaptation, the sensitivities of these processes to both light and Ca2+ were examined. Cytoplasmic Ca2+ regulates the sites of light-stimulated phosphorylation. Unexpectedly, we found that Ca2+ also regulates the extent of phosphorylation of unbleached cone pigments. Immunocytochemical analyses revealed that neither light nor cytoplasmic Ca2+ influences the localization of transducin in zebrafish cones.	Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Dunn, FA (corresponding author), Univ Washington, Dept Biochem, Box 357350, Seattle, WA 98195 USA.	jbhhh@u.washington.edu			NEI NIH HHS [EY06641] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adams RA, 2003, BIOCHEM J, V374, P537, DOI 10.1042/BJ20030408; BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P729, DOI 10.1113/jphysiol.1974.sp010732; BENNETT N, 1988, BIOCHEMISTRY-US, V27, P1710, DOI 10.1021/bi00405a049; BINDER BM, 1990, J BIOL CHEM, V265, P15333; BRANCHEK T, 1984, J COMP NEUROL, V224, P107, DOI 10.1002/cne.902240109; Brockerhoff SE, 2003, J NEUROSCI, V23, P470, DOI 10.1523/JNEUROSCI.23-02-00470.2003; BURKHARDT DA, 1994, J NEUROSCI, V14, P1091, DOI 10.1523/JNEUROSCI.14-03-01091.1994; BURNSIDE B, 1983, INVEST OPHTH VIS SCI, V24, P16; Calvert PD, 1998, J GEN PHYSIOL, V111, P39, DOI 10.1085/jgp.111.1.39; Calvert PD, 2002, ADV EXP MED BIOL, V514, P37; Calvert PD, 2002, J GEN PHYSIOL, V119, P129, DOI 10.1085/jgp.119.2.129; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; CHEN CK, 1995, J BIOL CHEM, V270, P18060, DOI 10.1074/jbc.270.30.18060; Chinen A, 2003, GENETICS, V163, P663; CRESCITELLI F, 1988, EXP EYE RES, V46, P239, DOI 10.1016/S0014-4835(88)80081-2; Erickson MA, 1998, P NATL ACAD SCI USA, V95, P6474, DOI 10.1073/pnas.95.11.6474; FAIN GL, 1989, J PHYSIOL-LONDON, V416, P215, DOI 10.1113/jphysiol.1989.sp017757; Ferguson SSG, 1998, SEMIN CELL DEV BIOL, V9, P119, DOI 10.1006/scdb.1997.0216; Garwin GG, 2000, METHOD ENZYMOL, V316, P313; Gibson SK, 2000, BIOCHEMISTRY-US, V39, P5738, DOI 10.1021/bi991857f; GRAYKELLER MP, 1994, NEURON, V13, P849, DOI 10.1016/0896-6273(94)90251-8; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; Imai H, 1997, BIOCHEMISTRY-US, V36, P12773, DOI 10.1021/bi970809x; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; Kefalov V, 2003, NATURE, V425, P526, DOI 10.1038/nature01992; Kennedy MJ, 2001, NEURON, V31, P87, DOI 10.1016/S0896-6273(01)00340-3; KLENCHIN VA, 1995, J BIOL CHEM, V270, P16147, DOI 10.1074/jbc.270.27.16147; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; Koutalos Y, 1996, TRENDS NEUROSCI, V19, P73; KUHN H, 1987, J RECEPTOR RES, V7, P283, DOI 10.3109/10799898709054990; Kutuzov MA, 1996, EUR J BIOCHEM, V238, P613, DOI 10.1111/j.1432-1033.1996.0613w.x; Lee KA, 2002, PROTEIN SCI, V11, P862, DOI 10.1110/ps.3870102; Li L, 1997, P NATL ACAD SCI USA, V94, P11645, DOI 10.1073/pnas.94.21.11645; Lyubarsky AL, 2000, J NEUROSCI, V20, P2209; MAHROO O, 2003, IN PRESS J PHYSL; MALCHOW RP, 1986, VISION RES, V26, P1655, DOI 10.1016/0042-6989(86)90053-2; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; MATTHEWS HR, 1988, NATURE, V334, P67, DOI 10.1038/334067a0; MATTHEWS HR, 2000, J PHYSL, V420, P4479; MCDOWELL JH, 1993, BIOCHEMISTRY-US, V32, P4968, DOI 10.1021/bi00069a036; McGinnis JF, 1997, J NEUROSCI RES, V50, P487, DOI 10.1002/(SICI)1097-4547(19971101)50:3<487::AID-JNR15>3.0.CO;2-3; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; NORMANN RA, 1974, J GEN PHYSIOL, V63, P37, DOI 10.1085/jgp.63.1.37; NORMANN RA, 1979, J PHYSIOL-LONDON, V286, P491, DOI 10.1113/jphysiol.1979.sp012633; OHGURO H, 1993, BIOCHEMISTRY-US, V32, P5718, DOI 10.1021/bi00072a030; OHGURO H, 1995, J BIOL CHEM, V270, P14259, DOI 10.1074/jbc.270.24.14259; Otto-Bruce AE, 1998, P NATL ACAD SCI USA, V95, P15014, DOI 10.1073/pnas.95.25.15014; PAPAC DI, 1993, BIOCHEMISTRY-US, V32, P5930, DOI 10.1021/bi00074a002; Parry JWL, 2000, VISION RES, V40, P2241, DOI 10.1016/S0042-6989(00)00101-2; RUSHTON WAH, 1977, BIOPHYS STRUCT MECH, V3, P159, DOI 10.1007/BF00535812; Sampath AP, 1999, J GEN PHYSIOL, V113, P267, DOI 10.1085/jgp.113.2.267; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; Senin II, 1997, BIOCHEM J, V321, P551, DOI 10.1042/bj3210551; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; STEELE FR, 1992, CELL, V69, P669, DOI 10.1016/0092-8674(92)90230-A; Tachibanaki S, 2001, P NATL ACAD SCI USA, V98, P14044, DOI 10.1073/pnas.241396898; Vihtelic TS, 1999, VISUAL NEUROSCI, V16, P571, DOI 10.1017/S0952523899163168; Vinos J, 1997, SCIENCE, V277, P687, DOI 10.1126/science.277.5326.687; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; Zhang HB, 2003, INVEST OPHTH VIS SCI, V44, P2858, DOI 10.1167/iovs.03-0072; Zhang LR, 1997, J BIOL CHEM, V272, P14762, DOI 10.1074/jbc.272.23.14762; Zhu XM, 2003, J NEUROSCI, V23, P6152, DOI 10.1523/JNEUROSCI.23-14-06152.2003	64	58	59	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 25	2004	41	6					915	928		10.1016/S0896-6273(04)00086-8	http://dx.doi.org/10.1016/S0896-6273(04)00086-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046724	Bronze			2022-12-24	WOS:000221458300011
J	Ju, W; Morishita, W; Tsui, J; Gaietta, G; Deerinck, TJ; Adams, SR; Garner, CC; Tsien, RY; Ellisman, MH; Malenka, RC				Ju, W; Morishita, W; Tsui, J; Gaietta, G; Deerinck, TJ; Adams, SR; Garner, CC; Tsien, RY; Ellisman, MH; Malenka, RC			Activity-dependent regulation of dendritic synthesis and trafficking of AMPA receptors	NATURE NEUROSCIENCE			English	Article							SYNAPTIC PLASTICITY; PROTEIN-SYNTHESIS; MESSENGER-RNA; HIPPOCAMPAL-NEURONS; GLUTAMATE RECEPTORS; ENDOPLASMIC-RETICULUM; MEMBRANE; SPINES; GLUR2; RAT	Regulation of AMPA receptor (AMPAR) trafficking is important for neural plasticity. Here we examined the trafficking and synthesis of the GluR1 and GluR2 subunits using ReAsH-EDT2 and FlAsH-EDT2 staining. Activity blockade of rat cultured neurons increased dendritic GluR1, but not GluR2, levels. Examination of transected dendrites revealed that both AMPAR subunits were synthesized in dendrites and that activity blockade enhanced dendritic synthesis of GluR1 but not GluR2. In contrast, acute pharmacological manipulations increased dendritic synthesis of both subunits. AMPARs synthesized in dendrites were inserted into synaptic plasma membranes and, after activity blockade, the electrophysiological properties of native synaptic AMPARs changed in the manner predicted by the imaging experiments. In addition to providing a novel mechanism for synaptic modifications, these results point out the advantages of using FlAsH-EDT2 and ReAsH-EDT2 for studying the trafficking of newly synthesized proteins in local cellular compartments such as dendrites.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Friend Pritzker Lab, Palo Alto, CA 94304 USA; Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Dept Neurosci 0608, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, Dept Pharmacol, La Jolla, CA 92093 USA	Stanford University; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Friend Pritzker Lab, 1201 Welch Rd, Palo Alto, CA 94304 USA.	malenka@stanford.edu		Garner, Craig/0000-0003-1970-5417	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063394, R37MH063394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027177, R01NS027177] Funding Source: NIH RePORTER; NCRR NIH HHS [P41-RR04050] Funding Source: Medline; NIMH NIH HHS [MH63394] Funding Source: Medline; NINDS NIH HHS [NS27177] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Benson DL, 1997, NEUROREPORT, V8, P823, DOI 10.1097/00001756-199703030-00004; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Braithwaite SP, 2000, NEUROPHARMACOLOGY, V39, P919, DOI 10.1016/S0028-3908(99)00171-9; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Gardiol A, 1999, J NEUROSCI, V19, P168, DOI 10.1523/JNEUROSCI.19-01-00168.1999; Horton AC, 2003, J NEUROSCI, V23, P6188; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Job C, 2001, NAT REV NEUROSCI, V2, P889, DOI 10.1038/35104069; Kacharmina JE, 2000, P NATL ACAD SCI USA, V97, P11545, DOI 10.1073/pnas.97.21.11545; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Maintz J B, 1998, Med Image Anal, V2, P1, DOI 10.1016/S1361-8415(01)80026-8; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Marek KW, 2002, NEURON, V36, P805, DOI 10.1016/S0896-6273(02)01068-1; Martone ME, 1996, J NEUROSCI, V16, P7437; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; MIYASHIRO K, 1994, P NATL ACAD SCI USA, V91, P10800, DOI 10.1073/pnas.91.23.10800; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Pickard L, 2001, NEUROPHARMACOLOGY, V41, P700, DOI 10.1016/S0028-3908(01)00127-7; Pierce JP, 2000, NAT NEUROSCI, V3, P311, DOI 10.1038/73868; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Steward O, 2002, NEURON, V36, P338, DOI 10.1016/S0896-6273(02)01006-1; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Torre ER, 1996, J NEUROSCI, V16, P5967; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; Washburn MS, 1997, J NEUROSCI, V17, P9393; WEILER IJ, 1993, P NATL ACAD SCI USA, V90, P7168, DOI 10.1073/pnas.90.15.7168; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	37	389	406	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					244	253		10.1038/nn1189	http://dx.doi.org/10.1038/nn1189			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14770185				2022-12-24	WOS:000189197900014
J	Alcedo, J; Kenyon, C				Alcedo, J; Kenyon, C			Regulation of C-elegans longevity by specific gustatory and olfactory neurons	NEURON			English	Article							NUCLEOTIDE-GATED CHANNEL; CAENORHABDITIS-ELEGANS; LIFE-SPAN; CHEMOSENSORY NEURONS; INSULIN-RECEPTOR; LARVAL DEVELOPMENT; GENE; ENCODES; PROTEIN; DAF-16	The life span of C. elegans is extended by mutations that inhibit the function of sensory neurons. In this study, we show that specific subsets of sensory neurons influence longevity. We find that certain gustatory neurons inhibit longevity, whereas others promote longevity, most likely by influencing insulin/IGF-1 signaling. Olfactory neurons also influence life span, and they act in a distinct pathway that involves the reproductive system. In addition, we find that a putative chemosensory G protein-coupled receptor that is expressed in some of these sensory neurons inhibits longevity. Together our findings imply that the life span of C. elegans is regulated by environmental cues and that these cues are perceived and integrated in a complex and sophisticated fashion by specific chemosensory neurons.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kenyon, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	ckenyon@biochem.ucsf.edu		Alcedo, Joy/0000-0002-5279-6640; Kenyon, Cynthia/0000-0003-3446-2636	NIA NIH HHS [AG11816, F32 AG05860] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [F32AG005860, R37AG011816, R01AG011816] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Bargmann C. I., 1997, C ELEGANS, P717; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; BRAND JG, 1982, ANNU REV NUTR, V2, P249, DOI 10.1146/annurev.nu.02.070182.001341; Chou JH, 2001, GENETICS, V157, P211; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colbert HA, 1997, J NEUROSCI, V17, P8259; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Collet J, 1998, GENETICS, V148, P187; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; DRISCOLL M, 1997, NEMATODE C ELEGANS, V2, P645; Dwyer ND, 1998, CELL, V93, P455, DOI 10.1016/S0092-8674(00)81173-3; EPSTEIN HF, ANAL ORGANISM, P225; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Garigan D, 2002, GENETICS, V161, P1101; Gems D, 1998, GENETICS, V150, P129; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Houthoofd K, 2003, EXP GERONTOL, V38, P947, DOI 10.1016/S0531-5565(03)00161-X; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kawano T, 2000, BIOCHEM BIOPH RES CO, V273, P431, DOI 10.1006/bbrc.2000.2971; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; LARSEN PL, 1995, GENETICS, V139, P1567; LAWLESS JF, 1982, MODELS METHODS LIFET; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Riddle DL, 1997, C ELEGANS, P739; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sagasti A, 1999, GENE DEV, V13, P1794, DOI 10.1101/gad.13.14.1794; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; SENGUPTA P, 1994, CELL, V79, P971, DOI 10.1016/0092-8674(94)90028-0; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; TABISH M, 1995, J MOL BIOL, V247, P377, DOI 10.1006/jmbi.1994.0146; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Weindruch R., 1988, RETARDATION AGING DI; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	67	265	292	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2004	41	1					45	55		10.1016/S0896-6273(03)00816-X	http://dx.doi.org/10.1016/S0896-6273(03)00816-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715134	Bronze			2022-12-24	WOS:000187942800008
J	Niu, S; Renfro, A; Quattrocchi, CC; Sheldon, M; D'Arcangelo, G				Niu, S; Renfro, A; Quattrocchi, CC; Sheldon, M; D'Arcangelo, G			Reelin promotes hippocampal dendrite development through the VLDLR/ApoER2-Dab1 pathway	NEURON			English	Article							RADIAL GLIAL SCAFFOLD; APOE RECEPTOR 2; DENTATE GYRUS; BRAIN-DEVELOPMENT; TYROSINE PHOSPHORYLATION; NEURONAL MIGRATION; DOWN-REGULATION; CELL-MIGRATION; NERVOUS-SYSTEM; KNOCKOUT MICE	Reelin is a secreted glycoprotein that regulates neuronal positioning in cortical brain structures through the VLDLR and ApoER2 receptors and the adaptor protein Dab1. In addition to cellular disorganization, dendrite abnormalities are present in the brain of reeler mice lacking Reelin. It is unclear whether these defects are due primarily to cellular ectopia or the absence of Reelin. Here we examined dendrite development in the hippocampus of normal and mutant mice and in dissociated cultures. We found that dendrite complexity is severely reduced in homozygous mice deficient in Reelin signaling both in vivo and in vitro, and it is also reduced in heterozygous mice in the absence of cellular ectopia. Addition of Reelin interfering antibodies, receptor antagonists, and Dab1 phosphorylation inhibitors prevented dendrite outgrowth from normal neurons, whereas addition of recombinant Reelin rescued the deficit in reeler cultures. Thus, the same signaling pathway controls both neuronal migration and dendrite maturation.	Cain Fdn Labs, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Univ Brescia, Program Neurosci, I-25123 Brescia, Italy; Texas Childrens Canc Ctr, Div Hematol Oncol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Brescia; Texas Children's Cancer Center	D'Arcangelo, G (corresponding author), Cain Fdn Labs, Houston, TX 77030 USA.	gangelo@bcm.tmc.edu		Quattrocchi, Carlo Cosimo/0000-0001-6823-7707; D'Arcangelo, Gabriella/0000-0003-1575-1010	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042616] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS042616] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alcantara S, 1998, J NEUROSCI, V18, P7779; Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Costa E, 2001, NEUROBIOL DIS, V8, P723, DOI 10.1006/nbdi.2001.0436; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; D'Arcangelo G, 1998, BIOESSAYS, V20, P235, DOI 10.1002/(SICI)1521-1878(199803)20:3&lt;235::AID-BIES7&gt;3.0.CO;2-Q; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; Drakew A, 2002, EXP NEUROL, V176, P12, DOI 10.1006/exnr.2002.7918; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Fatemi S, 2002, MOL PSYCHIATR, V7, P919, DOI 10.1038/sj.mp.4001248; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Forster E, 2002, P NATL ACAD SCI USA, V99, P13178, DOI 10.1073/pnas.202035899; Frotscher M, 2003, CEREB CORTEX, V13, P634, DOI 10.1093/cercor/13.6.634; Goldowitz D, 1997, J NEUROSCI, V17, P8767; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Hammond V, 2001, J NEUROSCI, V21, P8798, DOI 10.1523/JNEUROSCI.21-22-08798.2001; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Keshvara L, 2001, J BIOL CHEM, V276, P16008, DOI 10.1074/jbc.M101422200; Liu WS, 2001, P NATL ACAD SCI USA, V98, P3477, DOI 10.1073/pnas.051614698; MARIANI J, 1982, J NEUROBIOL, V13, P119, DOI 10.1002/neu.480130204; MARINPADILLA M, 1992, J COMP NEUROL, V321, P223, DOI 10.1002/cne.903210205; McGlashan TH, 2000, ARCH GEN PSYCHIAT, V57, P637, DOI 10.1001/archpsyc.57.7.637; Nakajima K, 1997, P NATL ACAD SCI USA, V94, P8196, DOI 10.1073/pnas.94.15.8196; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Pesold C, 1998, P NATL ACAD SCI USA, V95, P3221, DOI 10.1073/pnas.95.6.3221; Quattrocchi CC, 2003, SCIENCE, V301, P649, DOI 10.1126/science.1082690; Raymond GV, 1996, ACTA NEUROPATHOL, V91, P117; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Rodriguez MA, 2000, P NATL ACAD SCI USA, V97, P3550, DOI 10.1073/pnas.050589797; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; STANFIELD BB, 1979, J COMP NEUROL, V185, P393, DOI 10.1002/cne.901850302; STANFIELD BB, 1979, J COMP NEUROL, V185, P461, DOI 10.1002/cne.901850304; Tabata H, 2002, J NEUROSCI RES, V69, P723, DOI 10.1002/jnr.10345; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Ware ML, 1997, NEURON, V19, P239, DOI 10.1016/S0896-6273(00)80936-8; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Weiss KH, 2003, J COMP NEUROL, V460, P56, DOI 10.1002/cne.10644; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Yang HT, 2002, J NEUROSCI, V22, P464, DOI 10.1523/JNEUROSCI.22-02-00464.2002	50	282	294	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2004	41	1					71	84		10.1016/S0896-6273(03)00819-5	http://dx.doi.org/10.1016/S0896-6273(03)00819-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715136	Bronze			2022-12-24	WOS:000187942800010
J	Nabekura, J; Katsurabayashi, S; Kakazu, Y; Shibata, S; Matsubara, A; Jinno, S; Mizoguchi, Y; Sasaki, A; Ishibashi, H				Nabekura, J; Katsurabayashi, S; Kakazu, Y; Shibata, S; Matsubara, A; Jinno, S; Mizoguchi, Y; Sasaki, A; Ishibashi, H			Developmental switch from GABA to glycine release in single central synaptic terminals	NATURE NEUROSCIENCE			English	Article							LATERAL SUPERIOR OLIVE; AUDITORY BRAIN-STEM; GAMMA-AMINOBUTYRIC-ACID; POSTSYNAPTIC CURRENTS; NEURONS; RECEPTORS; INHIBITION; MOTONEURONS; GLUTAMATE; SYSTEM	Early in postnatal development, inhibitory inputs to rat lateral superior olive (LSO) neurons change from releasing predominantly GABA to releasing predominantly glycine into the synapse. Here we show that spontaneous miniature inhibitory postsynaptic currents (mIPSCs) also change from GABAergic to glycinergic over the first two postnatal weeks. Many 'mixed' mIPSCs, resulting from co-release of glycine and GABA from the same vesicles, are seen during this transition. Immunohistochemistry showed that a large number of terminals contained both GABA and glycine at postnatal day 8 (P8). By P14, both the content of GABA in these mixed terminals and the contribution of GABA to the mixed mIPSCs had decreased. The content of glycine in terminals increased over the same period. Our results indicate that switching from GABAergic to glycinergic inputs to the LSO may occur at the level of a single presynaptic terminal. This demonstrates a new form of developmental plasticity at the level of a single central synapse.	Kyushu Univ, Grad Sch Med Sci, Dept Cellular & Syst Physiol, Fukuoka 8128582, Japan; Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 4448585, Japan; Hirosaki Univ, Sch Med, Dept Otorhinolaryngol, Hirosaki, Aomori 0368562, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Anat & Neurobiol, Fukuoka 8128582, Japan	Kyushu University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Hirosaki University; Kyushu University	Nabekura, J (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Cellular & Syst Physiol, Fukuoka 8128582, Japan.							Akaike N, 2003, TRENDS PHARMACOL SCI, V24, P44, DOI 10.1016/S0165-6147(02)00010-X; Balakrishnan V, 2003, J NEUROSCI, V23, P4134; Chang EH, 2003, J NEUROPHYSIOL, V90, P1479, DOI 10.1152/jn.00386.2003; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Dumoulin A, 2001, J NEUROSCI, V21, P6045, DOI 10.1523/JNEUROSCI.21-16-06045.2001; Friauf E, 1997, J COMP NEUROL, V385, P117, DOI 10.1002/(SICI)1096-9861(19970818)385:1<117::AID-CNE7>3.0.CO;2-5; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Gao XB, 2001, J NEUROPHYSIOL, V85, P425, DOI 10.1152/jn.2001.85.1.425; Gasnier B, 2000, BIOCHIMIE, V82, P327, DOI 10.1016/S0300-9084(00)00221-2; HABECKER BA, 1995, DEV BIOL, V167, P307, DOI 10.1006/dbio.1995.1025; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Kakazu Y, 2000, J NEUROPHYSIOL, V84, P281, DOI 10.1152/jn.2000.84.1.281; Kakazu Y, 1999, J NEUROSCI, V19, P2843; KANDLER K, 1995, J NEUROSCI, V15, P6890; KAUFMAN DL, 1986, SCIENCE, V232, P1138, DOI 10.1126/science.3518061; Keller AF, 2001, J NEUROSCI, V21, P7871, DOI 10.1523/JNEUROSCI.21-20-07871.2001; Kim G, 2003, NAT NEUROSCI, V6, P282, DOI 10.1038/nn1015; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; Kneussel M, 2000, J PHYSIOL-LONDON, V525, P1, DOI 10.1111/j.1469-7793.2000.t01-4-00001.x; Korada S, 1999, J COMP NEUROL, V409, P664, DOI 10.1002/(SICI)1096-9861(19990712)409:4<664::AID-CNE10>3.0.CO;2-S; Kotak VC, 1998, J NEUROSCI, V18, P4646; Kotak VC, 2001, J NEUROPHYSIOL, V86, P536, DOI 10.1152/jn.2001.86.1.536; Kullmann PHM, 2002, EUR J NEUROSCI, V15, P1093, DOI 10.1046/j.1460-9568.2002.01946.x; Lauder JM, 1998, PERSPECT DEV NEUROBI, V5, P247; Levi S, 1999, J NEUROSCI, V19, P7434, DOI 10.1523/JNEUROSCI.19-17-07434.1999; Matsubara A, 1996, J NEUROSCI, V16, P4457; Nabekura J, 1996, J NEUROPHYSIOL, V76, P2447, DOI 10.1152/jn.1996.76.4.2447; O'Brien JA, 1999, J NEUROPHYSIOL, V82, P1638, DOI 10.1152/jn.1999.82.3.1638; Ornung G, 1996, J COMP NEUROL, V365, P413; OTIS TS, 1994, P NATL ACAD SCI USA, V91, P7698, DOI 10.1073/pnas.91.16.7698; OTTERSEN OP, 1992, NEUROSCIENCE, V46, P519, DOI 10.1016/0306-4522(92)90141-N; Rietzel HJ, 1998, J COMP NEUROL, V390, P20; Russier M, 2002, J PHYSIOL-LONDON, V541, P123, DOI 10.1113/jphysiol.2001.016063; SANES DH, 1991, J NEUROBIOL, V22, P837, DOI 10.1002/neu.480220805; Sanes DH, 2000, HEARING RES, V147, P46, DOI 10.1016/S0378-5955(00)00119-2; SCHOTZINGER RJ, 1988, NATURE, V335, P637, DOI 10.1038/335637a0; Smith AJ, 2000, J PHYSIOL-LONDON, V529, P681, DOI 10.1111/j.1469-7793.2000.00681.x; TAKAHASHI T, 1992, NEURON, V9, P1155, DOI 10.1016/0896-6273(92)90073-M; Walmsley B, 1998, TRENDS NEUROSCI, V21, P81, DOI 10.1016/S0166-2236(97)01170-3; Yang HW, 1997, BRAIN RES, V749, P301, DOI 10.1016/S0006-8993(96)01326-1	40	171	177	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					17	23		10.1038/nn1170	http://dx.doi.org/10.1038/nn1170			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14699415				2022-12-24	WOS:000187636000008
J	Bamji, SX; Shimazu, K; Kimes, N; Huelsken, J; Birchmeier, W; Lu, B; Reichardt, LF				Bamji, SX; Shimazu, K; Kimes, N; Huelsken, J; Birchmeier, W; Lu, B; Reichardt, LF			Role of beta-catenin in synaptic vesicle localization and presynaptic assembly	NEURON			English	Article							LONG-TERM POTENTIATION; TYROSINE KINASE SUBSTRATE; CELL-CELL JUNCTIONS; E-CADHERIN; N-CADHERIN; EXCITATORY SYNAPSES; TRANSMITTER RELEASE; ADHESION MOLECULE; ALPHA-CATENIN; PHOSPHATIDYLINOSITOL 3-KINASE	Cadherins and catenins are thought to promote adhesion between pre and postsynaptic elements in the brain. Here we show a role for beta-catenin in localizing the reserved pool of vesicles at presynaptic sites. Deletion of P-catenin in hippocampal pyramidal neurons in vivo resulted in a reduction in the number of reserved pool vesicles per synapse and an impaired response to prolonged repetitive stimulation. This corresponded to a dispersion of vesicles along the axon in cultured neurons. Interestingly, these effects are not due to beta-catenin's involvement in cadherin-mediated adhesion or wnt signaling. Instead, beta-catenin modulates vesicle localization via its PDZ binding domain to recruit PDZ proteins such as Veli to cadherin at synapses. This study defines a specific role for cadherins and catenins in synapse organization beyond their roles in mediating cell adhesion.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; NICHHD, Sect Neural Dev & Plast, NIH, Bethesda, MD 20892 USA; Max Delbrueck Ctr Mol Med, D-13092 Berlin, Germany	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Reichardt, LF (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.		Huelsken, Joerg/AAC-9581-2021; Lu, Bai/A-4018-2012	Huelsken, Joerg/0000-0003-3105-9606; Lu, Bai/0000-0001-5418-9759	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016033] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS016033, P01 NS016033-21] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Barth AI, 1997, CURR OPIN CELL BIOL, V9, P683, DOI 10.1016/S0955-0674(97)80122-6; Benson DL, 1998, J NEUROSCI, V18, P6892; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chauvet N, 2003, MOL CELL NEUROSCI, V22, P467, DOI 10.1016/S1044-7431(03)00030-7; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Coussen F, 2002, J NEUROSCI, V22, P6426, DOI 10.1523/jneurosci.22-15-06426.2002; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; DANIEL JM, 1995, MOL CELL BIOL, V15, P4819; Daniels DL, 2001, TRENDS BIOCHEM SCI, V26, P672, DOI 10.1016/S0968-0004(01)01952-1; Dobrosotskaya IY, 2000, BIOCHEM BIOPH RES CO, V270, P903, DOI 10.1006/bbrc.2000.2471; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; El-Hussein AE, 2000, SCIENCE, V290, P1364; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959; Goodwin M, 2003, J BIOL CHEM, V278, P20533, DOI 10.1074/jbc.M213171200; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Ho A, 2003, P NATL ACAD SCI USA, V100, P1409, DOI 10.1073/pnas.252774899; Honjo Y, 2000, GENES CELLS, V5, P309, DOI 10.1046/j.1365-2443.2000.00327.x; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Iida J, 2002, EUR J NEUROSCI, V15, P1493, DOI 10.1046/j.1460-9568.2002.01987.x; Ivanov DB, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1174, DOI 10.1023/A:1012445316415; Iwai Y, 2002, MOL CELL NEUROSCI, V19, P375, DOI 10.1006/mcne.2001.1081; Izawa I, 2002, GENES CELLS, V7, P475, DOI 10.1046/j.1365-2443.2002.00533.x; Jones TA, 1997, NEUROBIOL LEARN MEM, V68, P13, DOI 10.1006/nlme.1997.3774; Kawajiri A, 2000, BIOCHEM BIOPH RES CO, V273, P712, DOI 10.1006/bbrc.2000.3002; Kirov SA, 1999, NAT NEUROSCI, V2, P878, DOI 10.1038/13178; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Kypta RM, 1996, J CELL BIOL, V134, P1519, DOI 10.1083/jcb.134.6.1519; Larkman AU, 1997, J PHYSIOL-LONDON, V505, P457, DOI 10.1111/j.1469-7793.1997.457bb.x; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; LYNCH MA, 1994, NEUROSCIENCE, V60, P1, DOI 10.1016/0306-4522(94)90197-X; Magie Craig R., 2002, Development (Cambridge), V129, P3771; Manabe T, 2000, MOL CELL NEUROSCI, V15, P534, DOI 10.1006/mcne.2000.0849; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; Meigs TE, 2001, P NATL ACAD SCI USA, V98, P519, DOI 10.1073/pnas.021350998; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; Mok H, 2002, J NEUROSCI, V22, P5253; Montonen O, 2001, J HISTOCHEM CYTOCHEM, V49, P1487, DOI 10.1177/002215540104901202; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nishimura W, 2002, J NEUROSCI, V22, P757, DOI 10.1523/JNEUROSCI.22-03-00757.2002; PAPA M, 1995, J NEUROSCI, V15, P1; Pece S, 1999, J BIOL CHEM, V274, P19347, DOI 10.1074/jbc.274.27.19347; Perego C, 2000, EMBO J, V19, P3978, DOI 10.1093/emboj/19.15.3978; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Polo-Parada L, 2001, NEURON, V32, P815, DOI 10.1016/S0896-6273(01)00521-9; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Ranscht B, 2000, INT J DEV NEUROSCI, V18, P643, DOI 10.1016/S0736-5748(00)00030-7; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; Rico B, 2002, NAT NEUROSCI, V5, P225, DOI 10.1038/nn808; Robinson TE, 1997, J NEUROSCI, V17, P8491; Roche JP, 2002, J NEUROSCI, V22, P6471, DOI 10.1523/jneurosci.22-15-06471.2002; Saegusa C, 2002, J BIOL CHEM, V277, P24499, DOI 10.1074/jbc.M202767200; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sehgal RNM, 1997, J CELL BIOL, V139, P1033, DOI 10.1083/jcb.139.4.1033; Serafini T, 1999, CELL, V98, P133, DOI 10.1016/S0092-8674(00)81008-9; Serafini T, 1997, TRENDS NEUROSCI, V20, P322; Shan WS, 2002, J NEUROSCI RES, V69, P292, DOI 10.1002/jnr.10305; SHIBAMOTO S, 1995, J CELL BIOL, V128, P949, DOI 10.1083/jcb.128.5.949; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sorra KE, 1998, J COMP NEUROL, V398, P225; STADDON JM, 1995, J CELL BIOL, V130, P369, DOI 10.1083/jcb.130.2.369; Steinberg MS, 1999, CURR OPIN CELL BIOL, V11, P554, DOI 10.1016/S0955-0674(99)00027-7; Sudhof TC, 2000, NEURON, V28, P317, DOI 10.1016/S0896-6273(00)00109-4; Tabuchi K, 2002, J NEUROSCI, V22, P4264, DOI 10.1523/JNEUROSCI.22-11-04264.2002; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Toni N, 2001, J NEUROSCI, V21, P6245, DOI 10.1523/JNEUROSCI.21-16-06245.2001; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Wang CY, 2002, J BIOL CHEM, V277, P10614, DOI 10.1074/jbc.M106116200; Woodfield RJ, 2001, BIOCHEM J, V360, P335, DOI 10.1042/0264-6021:3600335; Xie CS, 2000, FREE RADICAL BIO MED, V28, P665, DOI 10.1016/S0891-5849(99)00268-3; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Xu YR, 1997, J BIOL CHEM, V272, P13463, DOI 10.1074/jbc.272.21.13463; Yap AS, 2003, J CELL BIOL, V160, P11, DOI 10.1083/jcb.200208156; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	87	251	264	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 13	2003	40	4					719	731		10.1016/S0896-6273(03)00718-9	http://dx.doi.org/10.1016/S0896-6273(03)00718-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	744UL	14622577	Green Accepted, Bronze			2022-12-24	WOS:000186651200008
J	Rosen, MJ; Mooney, R				Rosen, MJ; Mooney, R			Inhibitory and excitatory mechanisms underlying auditory responses to learned vocalizations in the songbird nucleus HVC	NEURON			English	Article							SLOW SYNAPTIC INHIBITION; MALE ZEBRA FINCHES; CAT VISUAL-CORTEX; K+ CHANNELS; GABAERGIC INHIBITION; ASSOCIATIONAL MODEL; STRIATE CORTEX; GIRK CHANNELS; ATRIAL CELLS; NEURONS	Speech and birdsong require auditory feedback for their development and maintenance, necessitating precise auditory encoding of vocal sounds. In songbirds, the telencephalic song premotor nucleus HVC contains neurons that respond highly selectively to the bird's own song (BOS), a property distinguishing HVC from its auditory afferents. We examined the contribution of inhibitory and excitatory synaptic inputs to BOS-evoked firing in those HVC neurons innervating a pathway essential for audition-dependent vocal plasticity. Using in vivo intracellular techniques, we found that G protein-coupled, potassium-mediated inhibition, tuned to the BOS, interacts with BOS-tuned excitation through several mechanisms to shape neuronal firing patterns. Furthermore, in the absence of this inhibition, the response bias to the BOS increases, reminiscent of cancellation mechanisms in other sensorimotor systems.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Mooney, R (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	mooney@neuro.duke.edu	Rosen, Merri J/N-7309-2015	Rosen, Merri J/0000-0002-1973-2207; Mooney, Richard/0000-0002-3308-1367	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002524] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC002524] Funding Source: Medline; PHS HHS [02524] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Bell C, 1997, BRAIN BEHAV EVOLUT, V50, P17, DOI 10.1159/000113352; BERMAN NJ, 1991, J PHYSIOL-LONDON, V440, P697, DOI 10.1113/jphysiol.1991.sp018731; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Brainard MS, 2000, NATURE, V404, P762, DOI 10.1038/35008083; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; CARVELL GE, 1988, BRAIN RES, V448, P186, DOI 10.1016/0006-8993(88)91118-3; Dutar P, 1999, NEUROPHARMACOLOGY, V38, P467, DOI 10.1016/S0028-3908(98)00206-8; Dutar P, 2000, J NEUROPHYSIOL, V84, P2284, DOI 10.1152/jn.2000.84.5.2284; Dutar P, 1998, J NEUROPHYSIOL, V80, P1828, DOI 10.1152/jn.1998.80.4.1828; FAINGOLD CL, 1991, HEARING RES, V52, P201, DOI 10.1016/0378-5955(91)90200-S; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FUJITA I, 1991, J NEUROSCI, V11, P722; Green DM, 1966, SIGNAL DETECTION THE; Hammond P, 1996, J NEUROPHYSIOL, V75, P1163, DOI 10.1152/jn.1996.75.3.1163; Hartings JA, 2000, J NEUROSCI, V20, part. no.; Hefti BJ, 2000, J NEUROPHYSIOL, V83, P2626, DOI 10.1152/jn.2000.83.5.2626; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; Janata P, 1999, J NEUROSCI, V19, P5108; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; KUBOTA M, 1991, J PHYSIOL-LONDON, V440, P131, DOI 10.1113/jphysiol.1991.sp018700; KURACHI Y, 1986, PFLUG ARCH EUR J PHY, V407, P264, DOI 10.1007/BF00585301; KURACHI Y, 1986, AM J PHYSIOL, V251, pH681, DOI 10.1152/ajpheart.1986.251.3.H681; Lewicki MS, 1996, J NEUROSCI, V16, P5854; LEWICKI MS, 1995, P NATL ACAD SCI USA, V92, P5582, DOI 10.1073/pnas.92.12.5582; Lewicki MS, 1996, J NEUROSCI, V16, P6987; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; Mark MD, 2000, EUR J BIOCHEM, V267, P5830, DOI 10.1046/j.1432-1327.2000.01670.x; MOONEY R, 1992, J NEUROSCI, V12, P2464; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; OLSEN JF, 1991, J NEUROPHYSIOL, V65, P1254, DOI 10.1152/jn.1991.65.6.1254; Pape H C, 1990, J Basic Clin Physiol Pharmacol, V1, P107; Rosen MJ, 2000, J NEUROSCI, V20, P5437, DOI 10.1523/JNEUROSCI.20-14-05437.2000; Scharff C, 1998, J NEUROBIOL, V36, P81, DOI 10.1002/(SICI)1097-4695(199807)36:1<81::AID-NEU7>3.3.CO;2-8; Schmidt MF, 1998, J NEUROSCI, V18, P895; SHUMWAY CA, 1989, J COMP PHYSIOL A, V164, P391, DOI 10.1007/BF00612998; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; STERIADE M, 1984, BRAIN RES REV, V8, P1, DOI 10.1016/0165-0173(84)90017-1; Theunissen FE, 1998, J NEUROSCI, V18, P3786; Troyer TW, 2000, J NEUROPHYSIOL, V84, P1204, DOI 10.1152/jn.2000.84.3.1204; Troyer TW, 2000, J NEUROPHYSIOL, V84, P1224, DOI 10.1152/jn.2000.84.3.1224; VU ET, 1994, J NEUROSCI, V14, P6924; Woolley SMN, 1997, J NEUROSCI, V17, P6380; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	47	54	54	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2003	39	1					177	194		10.1016/S0896-6273(03)00357-X	http://dx.doi.org/10.1016/S0896-6273(03)00357-X			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699LB	12848941	Bronze			2022-12-24	WOS:000184057400018
J	Jeon, D; Yang, YM; Jeong, MJ; Philipson, KD; Rhim, H; Shin, HS				Jeon, D; Yang, YM; Jeong, MJ; Philipson, KD; Rhim, H; Shin, HS			Enhanced learning and memory in mice lacking Na+/Ca2+ exchanger 2	NEURON			English	Article							LONG-TERM POTENTIATION; SODIUM-CALCIUM EXCHANGE; CALMODULIN KINASE-II; CRAYFISH NEUROMUSCULAR-JUNCTION; DEPENDENT SYNAPTIC PLASTICITY; RAT-BRAIN; NA+-CA2+ EXCHANGER; INTRACELLULAR CALCIUM; NEURONAL PREPARATIONS; MOLECULAR-CLONING	The plasma membrane Na+/Ca2+ exchanger (NCX) plays a role in regulation of intracellular Ca2+ concentration via the forward mode (Ca2+ efflux) or the reverse mode (Ca2+ influx). To define the physiological function of the exchanger in vivo, we generated mice deficient for NCX2, the major isoform in the brain. Mutant hippocampal neurons exhibited a significantly delayed clearance of elevated Ca2+ following depolarization. The frequency threshold for LTP and LTD in the hippocampal CA1 region was shifted to a lowered frequency in the mutant mice, thereby favoring LTP. Behaviorally, the mutant mice exhibited enhanced performance in several hippocampus-dependent learning and memory tasks. These results demonstrate that NCX2 can be a temporal regulator of Ca2+ homeostasis and as such is essential for the control of synaptic plasticity and cognition.	Korea Inst Sci & Technol, Natl Creat Res Initiat Ctr Calcium & Learning, Seoul 130791, South Korea; Korea Inst Sci & Technol, Ctr Med Sci Res, Seoul 130791, South Korea; Univ Calif Los Angeles, Sch Med, Cardiovasc Res Labs, Los Angeles, CA 90095 USA	Korea Institute of Science & Technology (KIST); Korea Institute of Science & Technology (KIST); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Shin, HS (corresponding author), Korea Inst Sci & Technol, Natl Creat Res Initiat Ctr Calcium & Learning, Seoul 130791, South Korea.		Jeon, Daejong/C-1814-2011	Jeon, Daejong/0000-0002-6998-7603				ASANO S, 1995, J NEUROCHEM, V64, P2437; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Bejar R, 2002, J NEUROSCI, V22, P5719; Berridge MJ, 1997, NATURE, V386, P759, DOI 10.1038/386759a0; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bouron A, 1996, NEURON, V17, P969, DOI 10.1016/S0896-6273(00)80227-5; Cho K, 2001, J PHYSIOL-LONDON, V532, P459, DOI 10.1111/j.1469-7793.2001.0459f.x; COLVIN RA, 1991, BRAIN RES, V543, P139, DOI 10.1016/0006-8993(91)91056-7; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; DELANEY KR, 1994, J NEUROSCI, V14, P5885; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Domotor E, 1999, J PHYSIOL-LONDON, V515, P147, DOI 10.1111/j.1469-7793.1999.147ad.x; Fierro L, 1998, J PHYSIOL-LONDON, V510, P499, DOI 10.1111/j.1469-7793.1998.499bk.x; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; Gibney GT, 2002, NEUROSCIENCE, V112, P65, DOI 10.1016/S0306-4522(02)00059-3; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Hryshko LV, 1997, BASIC RES CARDIOL, V92, P45, DOI 10.1007/BF00794067; Jun KS, 1998, LEARN MEMORY, V5, P317; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; Kim D, 1997, NATURE, V389, P290, DOI 10.1038/38508; Kim D, 2001, NEURON, V31, P35, DOI 10.1016/S0896-6273(01)00343-9; Kim S, 2002, BIOCHEM BIOPH RES CO, V296, P247, DOI 10.1016/S0006-291X(02)00870-7; LI ZP, 1994, J BIOL CHEM, V269, P17434; Linck B, 1998, AM J PHYSIOL-CELL PH, V274, pC415, DOI 10.1152/ajpcell.1998.274.2.C415; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Lu YM, 1997, J NEUROSCI, V17, P5196; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MEFFERT MK, 1994, NEURON, V12, P1235, DOI 10.1016/0896-6273(94)90440-5; Mizuno T, 2001, EUR J NEUROSCI, V14, P701, DOI 10.1046/j.0953-816x.2001.01679.x; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1992, J NEUROSCI, V12, P4327; Nicoll DA, 1996, J BIOL CHEM, V271, P24914, DOI 10.1074/jbc.271.40.24914; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Podhorna J, 2002, GENES BRAIN BEHAV, V1, P96, DOI 10.1034/j.1601-183X.2002.10205.x; Ranciat-McComb NS, 2000, NEUROSCI LETT, V294, P13, DOI 10.1016/S0304-3940(00)01524-X; Regehr WG, 1997, BIOPHYS J, V73, P2476, DOI 10.1016/S0006-3495(97)78276-6; REGEHR WG, 1994, J NEUROSCI, V14, P523; REUTER H, 1995, NEURON, V15, P1077, DOI 10.1016/0896-6273(95)90096-9; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Sakaue M, 2000, BRAIN RES, V881, P212, DOI 10.1016/S0006-8993(00)02808-0; SANCHEZARMASS S, 1987, AM J PHYSIOL, V252, P595; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Tang YM, 2000, J NEUROCHEM, V74, P702, DOI 10.1046/j.1471-4159.2000.740702.x; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Tsoi M, 1998, J BIOL CHEM, V273, P4155, DOI 10.1074/jbc.273.7.4155; Vnek N, 1996, J NEUROSCI, V16, P2780; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; WOJTOWICZ JM, 1985, J NEUROPHYSIOL, V54, P220, DOI 10.1152/jn.1985.54.2.220; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yu L, 1997, MOL BRAIN RES, V50, P285, DOI 10.1016/S0169-328X(97)00202-7; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	65	115	120	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 19	2003	38	6					965	976		10.1016/S0896-6273(03)00334-9	http://dx.doi.org/10.1016/S0896-6273(03)00334-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	693AA	12818181	Bronze			2022-12-24	WOS:000183691400015
J	Reyes, AD				Reyes, AD			Synchrony-dependent propagation of firing rate in iteratively constructed networks in vitro	NATURE NEUROSCIENCE			English	Article							CAT NEOCORTICAL NEURONS; CORTICAL-NEURONS; IN-VIVO; PYRAMIDAL NEURONS; BEHAVING MONKEYS; NEURAL NETWORKS; CORTEX NEURONS; VISUAL-CORTEX; MOTOR CORTEX; MODULATION	The precise role of synchronous neuronal firing in signal encoding remains unclear. To examine what kinds of signals can be carried by synchrony, I reproduced a multilayer feedforward network of neurons in an in vitro slice preparation of rat cortex using an iterative procedure. When constant and time-varying frequency signals were delivered to the network, the firing of neurons in successive layers became progressively more synchronous. Notably, synchrony in the in vitro network developed even with uncorrelated input, persisted under a wide range of physiological conditions and was crucial for the stable propagation of rate signals. The firing rate was represented by a classical rate code in the initial layers, but switched to a synchrony-based code in the deeper layers.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Reyes, AD (corresponding author), NYU, Ctr Neural Sci, 4 Washington Pl, New York, NY 10003 USA.	reyes@cns.nyu.edu						ABELES M, 1993, J NEUROPHYSIOL, V70, P1629, DOI 10.1152/jn.1993.70.4.1629; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Azouz R, 1999, J NEUROSCI, V19, P2209; Baker SN, 2001, J NEUROPHYSIOL, V85, P869, DOI 10.1152/jn.2001.85.2.869; Baker SN, 1999, EXP BRAIN RES, V128, P109, DOI 10.1007/s002210050825; Baker SN, 1997, J PHYSIOL-LONDON, V504P, pP116; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Cateau H, 2001, NEURAL NETWORKS, V14, P675, DOI 10.1016/S0893-6080(01)00065-X; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Conway BA, 1995, J PHYSIOL-LONDON, V489, P917, DOI 10.1113/jphysiol.1995.sp021104; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; DIESMANN M, 2001, NEUROCOMPUTING, V565, P38; Feige B, 2000, J NEUROPHYSIOL, V84, P2622, DOI 10.1152/jn.2000.84.5.2622; FERSTER D, 1995, SCIENCE, V270, P756, DOI 10.1126/science.270.5237.756; FETZ E, 1991, CEREB CORTEX, V9, P1; Gewaltig MO, 2001, NEURAL NETWORKS, V14, P657, DOI 10.1016/S0893-6080(01)00070-3; Hatsopoulos NG, 1998, P NATL ACAD SCI USA, V95, P15706, DOI 10.1073/pnas.95.26.15706; Holt GR, 1996, J NEUROPHYSIOL, V75, P1806, DOI 10.1152/jn.1996.75.5.1806; Litvak V, 2003, J NEUROSCI, V23, P3006; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Matsumura M, 1996, J NEUROSCI, V16, P7757; Mazurek ME, 2002, NAT NEUROSCI, V5, P463, DOI 10.1038/nn836; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; Oviedo H, 2002, NAT NEUROSCI, V5, P261, DOI 10.1038/nn807; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; PINSKY PF, 1995, BIOL CYBERN, V73, P129, DOI 10.1007/BF00204051; Prut Y, 1998, J NEUROPHYSIOL, V79, P2857, DOI 10.1152/jn.1998.79.6.2857; Reyes A, 1999, J NEUROSCI, V19, P3827; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Reyes AD, 1996, J NEUROSCI, V16, P993; REYES AD, 1993, J NEUROPHYSIOL, V69, P1661, DOI 10.1152/jn.1993.69.5.1661; REYES AD, 1993, J NEUROPHYSIOL, V69, P1673, DOI 10.1152/jn.1993.69.5.1673; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; SCHWARTZ K, 1984, EUR HEART J, V5, P77, DOI 10.1093/eurheartj/5.suppl_F.77; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SHARP AA, 1993, TRENDS NEUROSCI, V16, P389, DOI 10.1016/0166-2236(93)90004-6; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; van Rossum MCW, 2002, J NEUROSCI, V22, P1956, DOI 10.1523/JNEUROSCI.22-05-01956.2002; Van Rullen R, 2001, NEURAL COMPUT, V13, P1255, DOI 10.1162/08997660152002852	49	239	243	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					593	599		10.1038/nn1056	http://dx.doi.org/10.1038/nn1056			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12730700				2022-12-24	WOS:000183140400016
J	Nicholson, DA; Freeman, JH				Nicholson, DA; Freeman, JH			Addition of inhibition in the olivocerebellar system and the ontogeny of a motor memory	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; CLIMBING FIBERS; DEVELOPMENTAL-CHANGES; MULTIPLE INNERVATION; NEURONAL-ACTIVITY; PURKINJE-CELLS; RAT CEREBELLUM; INFERIOR OLIVE; MUTANT MICE; ORGANIZATION	The developmental emergence of learning has traditionally been attributed to the maturation of single brain regions necessary for learning in adults, rather than to the maturation of synaptic interactions within neural systems. Acquisition and retention of a simple form of motor learning, classical conditioning of the eyeblink reflex, depends on the cerebellum and interconnected brainstem structures, including the inferior olive. Here, we combined unit recordings from Purkinje cells in eye regions of the cerebellar cortex and quantitative electron microscopy of the inferior olive to show that the developmental emergence of eyeblink conditioning in rats is associated with the maturation of inhibitory feedback from the cerebellum to the inferior olive. The results are consistent with previous work in adult animals and indicate that the maturation of cerebellar inhibition within the inferior olive may be a critical factor for the formation and retention of learning-specific cerebellar plasticity and eyeblink conditioning.	Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA	University of Iowa	Freeman, JH (corresponding author), Univ Iowa, Dept Psychol, E11 Seashore Hall, Iowa City, IA 52242 USA.			Nicholson, Dan/0000-0002-1963-0569	NINDS NIH HHS [NS38890, F31 NS041713, R01 NS038890, NS41713] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS041713, R01NS038890] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Attwell PJE, 2002, NEURON, V34, P1011, DOI 10.1016/S0896-6273(02)00719-5; BLOEDEL JR, 1984, J PHYSIOL-LONDON, V352, P129, DOI 10.1113/jphysiol.1984.sp015282; CAREW TJ, 1989, TRENDS NEUROSCI, V12, P389, DOI 10.1016/0166-2236(89)90078-7; CAREW TJ, 1998, MECH RELATIONSHIPS D; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; CREPEL F, 1976, J NEUROBIOL, V7, P567, DOI 10.1002/neu.480070609; DEZEEUW CI, 1989, J COMP NEUROL, V284, P12, DOI 10.1002/cne.902840103; DIAMOND A, 1990, DEV NEURAL BASES HIG, V8; Eccles JC, 1967, CEREBELLUM NEURONAL; Fanselow MS, 1998, NEURON, V20, P625, DOI 10.1016/S0896-6273(00)81002-8; FREDETTE BJ, 1991, ANAT EMBRYOL, V184, P225, DOI 10.1007/BF01673258; Freeman JH, 2001, INTEGR PHYS BEH SCI, V36, P15, DOI 10.1007/BF02733945; Freeman JH, 2000, J NEUROSCI, V20, P813, DOI 10.1523/JNEUROSCI.20-02-00813.2000; Geinisman Y, 1996, J NEUROCYTOL, V25, P805, DOI 10.1007/BF02284843; GORMEZANO I, 1983, PROG PSYCHOB PHYSIOL, V10, P197; Hesslow G, 1996, EXP BRAIN RES, V110, P36; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Ito M, 1984, CEREBELLUM NEURAL CO; Kandel ER, 1999, PHILOS T R SOC B, V354, P2027, DOI 10.1098/rstb.1999.0542; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; Kim JJ, 1998, SCIENCE, V279, P570, DOI 10.1126/science.279.5350.570; LANG E, IN PRESS J NEUROPHYS; Lang EJ, 1996, J NEUROPHYSIOL, V76, P255, DOI 10.1152/jn.1996.76.1.255; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LLINAS R, 1989, EUR J NEUROSCI, V1, P587, DOI 10.1111/j.1460-9568.1989.tb00365.x; LLINAS R, 1986, J PHYSIOL-LONDON, V376, P163, DOI 10.1113/jphysiol.1986.sp016147; Loewenstein Y, 2001, P NATL ACAD SCI USA, V98, P8095, DOI 10.1073/pnas.131116898; MARIANI J, 1981, J NEUROSCI, V1, P696, DOI 10.1523/JNEUROSCI.01-07-00696.1981; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Medina JF, 2002, NATURE, V416, P330, DOI 10.1038/416330a; Medina JF, 2002, NAT REV NEUROSCI, V3, P122, DOI 10.1038/nrn728; Medina JF, 1999, J NEUROSCI, V19, P7140, DOI 10.1523/JNEUROSCI.19-16-07140.1999; Nicholson DA, 2000, J NEUROSCI, V20, P8218; PARTON RG, 1992, J CELL BIOL, V119, P123, DOI 10.1083/jcb.119.1.123; Peters A., 1991, FINE STRUCTURE NERVO; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Spoelstra J, 2000, BIOL CYBERN, V82, P321, DOI 10.1007/s004220050586; Stanton ME, 2000, BEHAV BRAIN RES, V110, P25, DOI 10.1016/S0166-4328(99)00182-5; STANTON ME, 1992, BEHAV NEUROSCI, V106, P657, DOI 10.1037/0735-7044.106.4.657; STANTON ME, 2003, EYE BLINK CLASSICAL, P105; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Thompson RF, 1998, NEUROBIOL LEARN MEM, V70, P150, DOI 10.1006/nlme.1998.3845; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; Voogd J, 1998, TRENDS NEUROSCI, V21, P370, DOI 10.1016/S0166-2236(98)01318-6; WELSH JP, 1995, NATURE, V374, P453, DOI 10.1038/374453a0	48	46	46	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					532	537		10.1038/nn1042	http://dx.doi.org/10.1038/nn1042			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12692555	Green Accepted			2022-12-24	WOS:000182553200021
J	Brody, CD; Hopfield, JJ				Brody, CD; Hopfield, JJ			Simple networks for spike-timing-based computation, with application to olfactory processing	NEURON			English	Article							BULB; REPRESENTATIONS; OSCILLATIONS; RECOGNITION; INTEGRATION; SYNCHRONY; RESPONSES; MIXTURES; ODORANTS; NEURONS	Spike synchronization across neurons can be selective for the situation where neurons are driven at similar firing rates, a "many are equal" computation. This can be achieved in the absence of synaptic interactions between neurons, through phase locking to a common underlying oscillatory potential. Based on this principle, we instantiate an algorithm for robust odor recognition into a model network of spiking neurons whose main features are taken from known properties of biological olfactory systems. Here, recognition of odors is signaled by spike synchronization of specific subsets of "mitral cells." This synchronization is highly odor selective and invariant to a wide range of odor concentrations. It is also robust to the presence of strong distractor odors, thus allowing odor segmentation within complex olfactory scenes. Information about odors is encoded in both the identity of glomeruli activated above threshold (1 bit of information per glomerulus) and in the analog degree of activation of the glomeruli (approximately 3 bits per glomerulus).	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Cold Spring Harbor Laboratory; Princeton University	Brody, CD (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.				NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006104] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC06104-01] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Desmaisons D, 1999, J NEUROSCI, V19, P10727, DOI 10.1523/JNEUROSCI.19-24-10727.1999; Duchamp-Viret P, 2000, J NEUROSCI, V20, P2383; Hopfield IJ, 2000, P NATL ACAD SCI USA, V97, P13919, DOI 10.1073/pnas.250483697; Hopfield JJ, 1999, P NATL ACAD SCI USA, V96, P12506, DOI 10.1073/pnas.96.22.12506; Hopfield JJ, 1998, ADV NEUR IN, V10, P166; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; JOHNSON DH, 1980, J ACOUST SOC AM, V68, P1115, DOI 10.1121/1.384982; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Krone D, 2001, PHYTOTHER RES, V15, P135, DOI 10.1002/ptr.716; LAING DG, 1989, PHYSIOL BEHAV, V46, P809, DOI 10.1016/0031-9384(89)90041-3; Laing DG, 2001, CHIMIA, V55, P413; LAVINE RA, 1971, J NEUROPHYSIOL, V34, P467, DOI 10.1152/jn.1971.34.3.467; Meister M, 2001, J NEUROSCI, V21, P1351; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; SICARD G, 1984, BRAIN RES, V292, P283, DOI 10.1016/0006-8993(84)90764-9; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2	21	143	147	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 6	2003	37	5					843	852		10.1016/S0896-6273(03)00120-X	http://dx.doi.org/10.1016/S0896-6273(03)00120-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	653TH	12628174	Bronze			2022-12-24	WOS:000181452800013
J	Lucas, G; Hendolin, P; Harkany, T; Agerman, K; Paratcha, G; Holmgren, C; Zilberter, Y; Sairanen, M; Minichiello, L; Castren, E; Ernfors, P				Lucas, G; Hendolin, P; Harkany, T; Agerman, K; Paratcha, G; Holmgren, C; Zilberter, Y; Sairanen, M; Minichiello, L; Castren, E; Ernfors, P			Neurotrophin-4 mediated TrkB activation reinforces morphine-induced analgesia	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; AUTOPHOSPHORYLATION SITES; TYROSINE PHOSPHORYLATION; RECEPTORS; LOCALIZATION; EFFICACY; NEURONS; KINASE; RAT		Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; Univ Kuopio, Dept Neurobiol, AI Virtanen Inst, FIN-70211 Kuopio, Finland; European Mol Biol Lab, I-00016 Monterotondo, Rome, Italy	Karolinska Institutet; Karolinska Institutet; University of Eastern Finland; European Molecular Biology Laboratory (EMBL)	Ernfors, P (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.		Lucas, Guilherme/N-8827-2014; Castrén, Eero/A-4618-2010; Minichiello, Liliana/AAA-7190-2022	Lucas, Guilherme/0000-0002-1656-9571; Ernfors, Patrik/0000-0002-1140-3986; Paratcha, Gustavo/0000-0002-0804-4433; Castren, Eero/0000-0002-1402-2791				Appleyard SM, 2000, J BIOL CHEM, V275, P38281, DOI 10.1074/jbc.M006756200; Ding YQ, 1996, J COMP NEUROL, V367, P375; GUITON M, 1995, BIOCHEM SOC T, V23, pS176, DOI 10.1042/bst023176s; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; McLaughlin JP, 2001, MOL PHARMACOL, V59, P1360, DOI 10.1124/mol.59.6.1360; MIDDLEMAS DS, 1994, J BIOL CHEM, V269, P5458; Minichiello L, 1998, NEURON, V21, P335, DOI 10.1016/S0896-6273(00)80543-7; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Saarelainen T, 2000, MOL CELL NEUROSCI, V16, P87, DOI 10.1006/mcne.2000.0863; Segal RA, 1996, J BIOL CHEM, V271, P20175, DOI 10.1074/jbc.271.33.20175; SIUCIAK JA, 1994, BRAIN RES, V633, P326, DOI 10.1016/0006-8993(94)91556-3; Yan Q, 1997, J COMP NEUROL, V378, P135	14	16	16	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					221	222		10.1038/nn1021	http://dx.doi.org/10.1038/nn1021			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12601381				2022-12-24	WOS:000181178300009
J	Antony, JM; van Marle, G; Opii, W; Butterfield, DA; Mallet, F; Yong, VW; Wallace, JL; Deacon, RM; Warren, K; Power, C				Antony, JM; van Marle, G; Opii, W; Butterfield, DA; Mallet, F; Yong, VW; Wallace, JL; Deacon, RM; Warren, K; Power, C			Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination	NATURE NEUROSCIENCE			English	Article							NITRIC-OXIDE SYNTHASE; ACTIVE MULTIPLE-SCLEROSIS; HERV-W; CEREBROSPINAL-FLUID; PRIMATE EVOLUTION; EXPRESSION; PROTEIN; ACTIVATION; VIRUS; BRAIN	Human endogenous retroviruses (HERVs) constitute 8% of the human genome and have been implicated in both health and disease. Increased HERV gene activity occurs in immunologically activated glia, although the consequences of HERV expression in the nervous system remain uncertain. Here, we report that the HERV-W encoded glycoprotein syncytin is upregulated in glial cells within acute demyelinating lesions of multiple sclerosis patients. Syncytin expression in astrocytes induced the release of redox reactants, which were cytotoxic to oligodendrocytes. Syncytin-mediated neuroinflammation and death of oligodendrocytes, with the ensuing neurobehavioral deficits, were prevented by the antioxidant ferulic acid in a mouse model of multiple sclerosis. Thus, syncytin's proinflammatory properties in the nervous system demonstrate a novel role for an endogenous retrovirus protein, which may be a target for therapeutic intervention.	Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada; Univ Kentucky, Dept Chem, Lexington, KY 40506 USA; Univ Kentucky, Ctr Membrane Sci, Lexington, KY 40506 USA; Ecole Normale Super Lyon, IFR BioSci Lyon Gerland 128, UMR CNRS bioMerieux, F-69364 Lyon, France; Univ Calgary, Dept Pharmacol & Therapeut, Calgary, AB T2N 4N1, Canada; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Univ Alberta, Dept Med, Edmonton, AB T6G 2B7, Canada	University of Calgary; University of Kentucky; University of Kentucky; Ecole Normale Superieure de Lyon (ENS de LYON); University of Calgary; University of Oxford; University of Alberta	Power, C (corresponding author), Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada.	power@ucalgary.ca	Antony, Joseph Mathew/W-7552-2019; Mallet, Francois/G-4812-2014; Wallace, John/AAL-3763-2021; Power, Christopher/C-7181-2013	Antony, Joseph Mathew/0000-0002-5700-7719; van Marle, Guido/0000-0002-5148-6229; MALLET, Francois/0000-0002-1331-096X; Yong, V. Wee/0000-0002-2600-3563; Power, Christopher/0000-0002-5131-9711				Anlar O, 2003, Electromyogr Clin Neurophysiol, V43, P349; BANSAL R, 1989, J NEUROSCI RES, V24, P548, DOI 10.1002/jnr.490240413; Bar-Or A, 2003, BRAIN, V126, P2738, DOI 10.1093/brain/awg285; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Blond JL, 1999, J VIROL, V73, P1175, DOI 10.1128/JVI.73.2.1175-1185.1999; BO L, 1994, ANN NEUROL, V36, P778, DOI 10.1002/ana.410360515; Bock M, 2000, CURR OPIN GENET DEV, V10, P651, DOI 10.1016/S0959-437X(00)00138-6; Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3; Calabrese V, 2003, NEUROCHEM RES, V28, P1321, DOI 10.1023/A:1024984013069; Calabrese V, 2002, J NEUROSCI RES, V70, P580, DOI 10.1002/jnr.10408; Carson MJ, 2002, GLIA, V40, P218, DOI 10.1002/glia.10145; Costas J, 2002, MOL BIOL EVOL, V19, P526, DOI 10.1093/oxfordjournals.molbev.a004108; Danilov AI, 2003, J NEUROIMMUNOL, V136, P112, DOI 10.1016/S0165-5728(02)00464-2; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Guenther K, 2001, EUR J NEUROSCI, V14, P401, DOI 10.1046/j.0953-816x.2001.01645.x; Hua LWL, 2002, J NEUROCHEM, V83, P1120, DOI 10.1046/j.1471-4159.2002.01226.x; Hughes JF, 2001, NAT GENET, V29, P487, DOI 10.1038/ng775; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Johnston JB, 2001, ANN NEUROL, V50, P434, DOI 10.1002/ana.1131; Kanski J, 2002, J NUTR BIOCHEM, V13, P273, DOI 10.1016/S0955-2863(01)00215-7; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; Lu FM, 2000, J NEUROL SCI, V177, P95, DOI 10.1016/S0022-510X(00)00343-9; Lynch WP, 2000, J VIROL, V74, P1558, DOI 10.1128/JVI.74.3.1558-1565.2000; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Ogiwara T, 2003, ANTICANCER RES, V23, P1317; PATY DW, 1998, MULT SCLER, P68; Power C, 1998, J VIROL, V72, P9045, DOI 10.1128/JVI.72.11.9045-9053.1998; Power C, 2003, ANN NEUROL, V53, P731, DOI 10.1002/ana.10553; Power C, 2001, TRENDS NEUROSCI, V24, P162, DOI 10.1016/S0166-2236(00)01737-9; Ravikumar A., 2000, Indian Journal of Experimental Biology, V38, P438; ROSEN CL, 1989, J NEUROSCI, V9, P3371; Scott GS, 2003, GLIA, V41, P105, DOI 10.1002/glia.10137; Smith KJ, 2002, LANCET NEUROL, V1, P232, DOI 10.1016/S1474-4422(02)00102-3; Sverdlov ED, 2000, BIOESSAYS, V22, P161, DOI 10.1002/(SICI)1521-1878(200002)22:2<161::AID-BIES7>3.0.CO;2-X; TAKACS S, 1988, SUPERCOND SCI TECH, V1, P53, DOI 10.1088/0953-2048/1/1/011; van de Lagemaat LN, 2003, TRENDS GENET, V19, P530, DOI 10.1016/j.tig.2003.08.004; van Marle G, 2003, VIROLOGY, V309, P61, DOI 10.1016/S0042-6822(02)00139-3; Wesselingh SL, 2001, CURR OPIN NEUROL, V14, P375, DOI 10.1097/00019052-200106000-00018; West MJ, 1996, J COMP NEUROL, V370, P11; YONG VW, 1997, PROTOCOLS NEURAL CEL, P81; Zhang KY, 2003, NAT NEUROSCI, V6, P1064, DOI 10.1038/nn1127	43	287	306	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1088	1095		10.1038/nn1319	http://dx.doi.org/10.1038/nn1319			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15452578				2022-12-24	WOS:000224156900018
J	Hawkey, DJC; Amitay, S; Moore, DR				Hawkey, DJC; Amitay, S; Moore, DR			Early and rapid perceptual learning	NATURE NEUROSCIENCE			English	Article							FREQUENCY DISCRIMINATION; IMPAIRED CHILDREN; PLASTICITY; PATTERNS	Major, rapid performance improvements in perceptual training are often dismissed as `task' or `procedural' learning because they are fast and generalize within a task. We assessed the contributions of perceptual and procedural learning to improvement in an auditory tone frequency learning task in humans and found that perceptual learning accounted for between 76% and 98% of the rapid early performance improvement.	MRC, Inst Hearing Res, Nottingham NG7 2RD, England		Amitay, S (corresponding author), MRC, Inst Hearing Res, Univ Pk, Nottingham NG7 2RD, England.	sygal@ihr.mrc.ac.uk	Amitay, Sygal/D-7323-2012	Amitay, Sygal/0000-0001-9482-3435				Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Delhommeau K, 2002, PERCEPT PSYCHOPHYS, V64, P426, DOI 10.3758/BF03194715; Demany L, 2002, J ACOUST SOC AM, V111, P1377, DOI 10.1121/1.1445791; DEMANY L, 1985, J ACOUST SOC AM, V78, P1118, DOI 10.1121/1.393034; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Gottselig JM, 2004, LEARN MEMORY, V11, P162, DOI 10.1101/lm.63304; Irvine DRF, 2000, J ACOUST SOC AM, V108, P2964, DOI 10.1121/1.1323465; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Kujala T, 2001, P NATL ACAD SCI USA, V98, P10509, DOI 10.1073/pnas.181589198; LEEK MR, 1988, PERCEPT PSYCHOPHYS, V43, P389, DOI 10.3758/BF03208810; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; RECANZONE GH, 1993, J NEUROSCI, V13, P87; ROBINSON K, 1996, EAR HEARING, V17, P51; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; Wright BA, 2001, P NATL ACAD SCI USA, V98, P12307, DOI 10.1073/pnas.211220498	15	124	132	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1055	1056		10.1038/nn1315	http://dx.doi.org/10.1038/nn1315			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15361880				2022-12-24	WOS:000224156900013
J	Schaal, S; Sternad, D; Osu, R; Kawato, M				Schaal, S; Sternad, D; Osu, R; Kawato, M			Rhythmic arm movement is not discrete	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; CENTRAL PATTERN GENERATOR; REACHING MOVEMENTS; SEGMENTED-CONTROL; MOTOR AREAS; POWER-LAW; COORDINATION; HUMANS; MODEL; SPACE	Rhythmic movements, such as walking, chewing or scratching, are phylogenetically old motor behaviors found in many organisms, ranging from insects to primates. In contrast, discrete movements, such as reaching, grasping or kicking, are behaviors that have reached sophistication primarily in younger species, particularly primates. Neurophysiological and computational research on arm motor control has focused almost exclusively on discrete movements, essentially assuming similar neural circuitry for rhythmic tasks. In contrast, many behavioral studies have focused on rhythmic models, subsuming discrete movement as a special case. Here, using a human functional neuroimaging experiment, we show that in addition to areas activated in rhythmic movement, discrete movement involves several higher cortical planning areas, even when both movement conditions are confined to the same single wrist joint. These results provide neuroscientific evidence that rhythmic arm movement cannot be part of a more general discrete movement system and may require separate neurophysiological and theoretical treatment.	Univ So Calif, Los Angeles, CA 90089 USA; Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA; ATR Computat Neurosci Labs, Seika, Kyoto 6190288, Japan	University of Southern California; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Schaal, S (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	sschaal@usc.edu	Sternad, Dagmar/D-8341-2013					ABEND W, 1982, BRAIN, V105, P331, DOI 10.1093/brain/105.2.331; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Brett M, 2001, NEUROIMAGE, V13, pS85; Brett M., 2002, 8 INT C FUNC MAPP HU; Brown TG, 1914, J PHYSIOL-LONDON, V48, P18; de Rugy A, 2003, BRAIN RES, V994, P160, DOI 10.1016/j.brainres.2003.09.031; Debaere F, 2001, NEUROIMAGE, V14, P947, DOI 10.1006/nimg.2001.0892; Deiber MP, 1999, J NEUROPHYSIOL, V81, P3065, DOI 10.1152/jn.1999.81.6.3065; Dimitrijevic MR, 1998, ANN NY ACAD SCI, V860, P360, DOI 10.1111/j.1749-6632.1998.tb09062.x; FELDMAN AG, 1980, NEUROSCIENCE, V5, P81, DOI 10.1016/0306-4522(80)90073-1; Fink GR, 1997, J NEUROPHYSIOL, V77, P2164, DOI 10.1152/jn.1997.77.4.2164; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Flash T, 2001, CURR OPIN NEUROBIOL, V11, P655, DOI 10.1016/S0959-4388(01)00265-3; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; Gordon AM, 1998, EXP BRAIN RES, V121, P153, DOI 10.1007/s002210050447; Grafton ST, 1996, CEREB CORTEX, V6, P226, DOI 10.1093/cercor/6.2.226; Ijspeert AJ, 2003, ADV NEURAL INFORM PR, V2003, P1547; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; Kawagoe A, 1999, IEEE T APPL SUPERCON, V9, P727, DOI 10.1109/77.783398; Kelso S., 1995, DYNAMIC PATTERNS SEL; Kertzman C, 1997, EXP BRAIN RES, V114, P170, DOI 10.1007/PL00005617; Kugler P.N., 1987, INFORM NATURAL LAW S; Lam T, 2000, J NEUROPHYSIOL, V83, P2814, DOI 10.1152/jn.2000.83.5.2814; Latash M., 1993, CONTROL HUMAN MOVEME; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Marder E, 2000, CURR OPIN NEUROBIOL, V10, P691, DOI 10.1016/S0959-4388(00)00157-4; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Pinter MM, 1999, SPINAL CORD, V37, P531, DOI 10.1038/sj.sc.3100886; Richardson MJE, 2002, J NEUROSCI, V22, P8201; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Sabes PN, 2000, CURR OPIN NEUROBIOL, V10, P740, DOI 10.1016/S0959-4388(00)00149-5; Schaal S, 2001, EXP BRAIN RES, V136, P60, DOI 10.1007/s002210000505; Seitz RJ, 2000, EXP BRAIN RES, V133, P71, DOI 10.1007/s002210000402; Smits-Engelsman BCM, 2002, EXP BRAIN RES, V145, P222, DOI 10.1007/s00221-002-1115-8; SOECHTING JF, 1987, NEUROSCIENCE, V23, P53, DOI 10.1016/0306-4522(87)90270-3; Sternad D, 2003, BRAIN RES, V989, P152, DOI 10.1016/S0006-8993(03)03292-X; Sternad D, 2002, EXP BRAIN RES, V147, P162, DOI 10.1007/s00221-002-1219-1; Sternad D, 2000, HUM MOVEMENT SCI, V19, P627, DOI 10.1016/S0167-9457(00)00028-2; Sternad D, 1999, EXP BRAIN RES, V124, P118, DOI 10.1007/s002210050606; Talairach J., 1988, COPLANAR STEREOTAXIC; Thickbroom GW, 1999, EXP BRAIN RES, V126, P431, DOI 10.1007/s002210050749; Turner R, 1998, EXP BRAIN RES, V123, P5, DOI 10.1007/s002210050538; TURVEY MT, 1990, AM PSYCHOL, V45, P938, DOI 10.1037/0003-066X.45.8.938; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; Wei KL, 2003, MOTOR CONTROL, V7, P134, DOI 10.1123/mcj.7.2.134	46	265	265	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1137	1144		10.1038/nn1322	http://dx.doi.org/10.1038/nn1322			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15452580				2022-12-24	WOS:000224156900024
J	Moqrich, A; Earley, TJ; Watson, J; Andahazy, M; Backus, C; Martin-Zanca, D; Wright, DE; Reichardt, LF; Patapoutian, A				Moqrich, A; Earley, TJ; Watson, J; Andahazy, M; Backus, C; Martin-Zanca, D; Wright, DE; Reichardt, LF; Patapoutian, A			Expressing TrkC from the TrkA locus causes a subset of dorsal root ganglia neurons to switch fate	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; SENSORY AFFERENTS; GENE; NEUROTROPHIN-3; RECEPTOR; CHANNEL; IDENTIFICATION; PROJECTION; AXONS	Tactile information is perceived by a heterogeneous population of specialized neurons. Neurotrophin receptors (the receptor tyrosine kinases, Trks) mark the major classes of these sensory neurons: TrkA is expressed in neurons that sense temperature and noxious stimuli, and TrkC is expressed in proprioceptive neurons that sense body position. Neurotrophin signaling through these receptors is required for cell survival. To test whether neurotrophins have an instructive role in sensory specification, we expressed rat TrkC from the TrkA (also known as Ntrk1) locus in mice. The surviving presumptive TrkA-expressing neurons adopted a proprioceptive phenotype, indicating that neurotrophin signaling can specify sensory neuron subtypes.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Univ Calif San Francisco, Program Neurosci, Dept Physiol, San Francisco, CA 94141 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94141 USA; Univ Salamanca, Inst Microbiol Bioquim, CSIC, Salamanca 37007, Spain; Univ Kansas, Med Ctr, Kansas City, KS 66160 USA	Scripps Research Institute; Novartis; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; University of Kansas; University of Kansas Medical Center	Patapoutian, A (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	ardem@scripps.edu		moqrich, aziz/0000-0002-1937-1675	NINDS NIH HHS [R01 NS042822, R29NS37910, P01 NS016033, P01 NS016033-22, 5R01NS42822, R01 NS043314] Funding Source: Medline; PHS HHS [P01-16033] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS037910, R01NS043314, R01NS042822, P01NS016033] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALOE L, 1979, P NATL ACAD SCI USA, V76, P1246, DOI 10.1073/pnas.76.3.1246; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen ZF, 2001, NEURON, V31, P59, DOI 10.1016/S0896-6273(01)00341-5; GUNDERSEN RW, 1979, SCIENCE, V206, P1079, DOI 10.1126/science.493992; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Leu M, 2003, DEVELOPMENT, V130, P2291, DOI 10.1242/dev.00447; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; O'Connor R, 1999, NEURON, V24, P165, DOI 10.1016/S0896-6273(00)80830-2; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Patapoutian A, 1999, SCIENCE, V283, P1180, DOI 10.1126/science.283.5405.1180; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Scott SA, 1992, SENSORY NEURONS DIVE; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Song HJ, 1997, NATURE, V389, P412, DOI 10.1038/38788; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; TSOULFAS P, 1993, NEURON, V10, P975, DOI 10.1016/0896-6273(93)90212-A; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Wright DE, 1997, NEURON, V19, P503, DOI 10.1016/S0896-6273(00)80367-0	25	54	57	3	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					812	818		10.1038/nn1283	http://dx.doi.org/10.1038/nn1283			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15247919	Green Accepted, Green Published			2022-12-24	WOS:000222930800010
J	Marillat, V; Sabatier, C; Failli, V; Matsunaga, E; Sotelo, C; Tessier-Lavigne, M; Chedotal, A				Marillat, V; Sabatier, C; Failli, V; Matsunaga, E; Sotelo, C; Tessier-Lavigne, M; Chedotal, A			The slit receptor Rig-1/Robo3 controls midline crossing by hindbrain precerebellar neurons and axons	NEURON			English	Article							INFERIOR OLIVARY NEURONS; FLOOR PLATE; NEURITIC DIFFERENTIATION; MOLECULAR-MECHANISMS; CEREBELLAR SYSTEM; COMMISSURAL AXONS; MIGRATORY STREAM; CAUDAL MEDULLA; RETINAL AXONS; CNS MIDLINE	During development, precerebellar neurons migrate dorsoventrally from the rhombic lip to the floor plate. Some of these neurons cross the midline while others stop. We have identified a role for the slit receptor Rig-1/Robo3 in directing this process. During their tangential migration, neurons of all major hindbrain precerebellar nuclei express high levels of Rig-1 mRNA. Rig-1 expression is rapidly downregulated as their leading process crosses the floor plate. Interestingly, most precerebellar nuclei do not develop normally in Rig-1-deficient mice, as they fail to cross the midline. In addition, inferior olivary neurons, which normally send axons into the contralateral cerebellum, project ipsilaterally in Rig-1 mutant mice. Similarly, neurons of the lateral reticular nucleus and basilar pons are unable to migrate across the floor plate and instead remain ipsilateral. These results demonstrate that Rig-1 controls the ability of both precerebellar neuron cell bodies and their axons to cross the midline.	Univ Paris 06, CNRS, UMR7102, F-75005 Paris, France; Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Howard Hughes Medical Institute; Stanford University	Chedotal, A (corresponding author), Univ Paris 06, CNRS, UMR7102, Bat B,Case 12,9 Quai St Bernard, F-75005 Paris, France.	chedotal@infobiogen.fr	Chedotal, Alain/F-2750-2017; Sotelo, Constantino/G-3397-2015	Chedotal, Alain/0000-0001-7577-3794; Sotelo, Constantino/0000-0001-8051-2492				Alcantara S, 2000, DEVELOPMENT, V127, P1359; ALTMAN J, 1980, J COMP NEUROL, V194, P1, DOI 10.1002/cne.901940102; ALTMAN J, 1987, J COMP NEUROL, V257, P490, DOI 10.1002/cne.902570403; ALTMAN J, 1987, J COMP NEUROL, V257, P529, DOI 10.1002/cne.902570405; ALTMAN J, 1997, DEV CEREBELLAR SYSTE, P300; Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Bloch-Gallego E, 1999, J NEUROSCI, V19, P4407; BOURRAT F, 1990, ARCH ITAL BIOL, V128, P151; BOURRAT F, 1991, J COMP NEUROL, V313, P509, DOI 10.1002/cne.903130311; BOURRAT F, 1988, DEV BRAIN RES, V39, P19, DOI 10.1016/0165-3806(88)90064-8; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Burstyn-Cohen T, 1999, NEURON, V23, P233, DOI 10.1016/S0896-6273(00)80776-X; Causeret F, 2002, DEV BIOL, V246, P429, DOI 10.1006/dbio.2002.0681; Chedotal A, 1996, J NEUROSCI, V16, P3296; de Diego I, 2002, DEVELOPMENT, V129, P297; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Engelkamp D, 1999, DEVELOPMENT, V126, P3585; Gilthorpe JD, 2002, DEVELOPMENT, V129, P4719; Hutson LD, 2002, NEURON, V33, P205, DOI 10.1016/S0896-6273(01)00579-7; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; Jessell TM, 2000, CURR OPIN NEUROBIOL, V10, P599, DOI 10.1016/S0959-4388(00)00136-7; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Kyriakopoulou K, 2002, DEVELOPMENT, V129, P287; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Nguyen-Ba-Charvet KT, 2001, MOL CELL NEUROSCI, V17, P1048, DOI 10.1006/mcne.2001.0994; Nguyen-Ba-Charvet KT, 2002, J NEUROSCI, V22, P5473; ONO K, 1990, ANAT EMBRYOL, V182, P11; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Rodriguez CI, 2000, NEURON, V27, P475, DOI 10.1016/S0896-6273(00)00059-3; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; SCHWANZELFUKUDA M, 1989, NATURE, V338, P161, DOI 10.1038/338161a0; Sekine-Aizawa Y, 1998, EUR J NEUROSCI, V10, P2810, DOI 10.1111/j.1460-9568.1998.00288.x; Shirasaki R, 1996, NEURON, V17, P1079, DOI 10.1016/S0896-6273(00)80241-X; Stoeckli ET, 1998, PROG BRAIN RES, V117, P105; TABERPIERCE E, 1973, PROG BRAIN RES, V40, P53; Taniguchi H, 2002, DEV BIOL, V249, P321, DOI 10.1006/dbio.2002.0763; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; WASSEF M, 1992, J COMP NEUROL, V323, P519, DOI 10.1002/cne.903230405; Wingate RJT, 2001, CURR OPIN NEUROBIOL, V11, P82, DOI 10.1016/S0959-4388(00)00177-X; WOLFER DP, 1994, J COMP NEUROL, V345, P1, DOI 10.1002/cne.903450102; Wong MS, 2002, NANO LETT, V2, P583, DOI 10.1021/nl020244c; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2; Yuan SSF, 1999, DEV BIOL, V207, P62, DOI 10.1006/dbio.1998.9141; Zhu Y, 2002, DEV DYNAM, V225, P365, DOI 10.1002/dvdy.10166; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	52	143	144	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 8	2004	43	1					69	79		10.1016/j.neuron.2004.06.018	http://dx.doi.org/10.1016/j.neuron.2004.06.018			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233918	Bronze			2022-12-24	WOS:000222549800008
J	Polsky, A; Mel, BW; Schiller, J				Polsky, A; Mel, BW; Schiller, J			Computational subunits in thin dendrites of pyramidal cells	NATURE NEUROSCIENCE			English	Article							SYNAPTIC INPUT; POSTSYNAPTIC POTENTIALS; SUPRALINEAR SUMMATION; BASAL DENDRITES; NEURONS; INTEGRATION; LOCATION; SPIKES; RAT; DISTRIBUTIONS	The thin basal and oblique dendrites of cortical pyramidal neurons receive most of the synaptic inputs from other cells, but their integrative properties remain uncertain. Previous studies have most often reported global linear or sublinear summation. An alternative view, supported by biophysical modeling studies, holds that thin dendrites provide a layer of independent computational `subunits' that sigmoidally modulate their inputs prior to global summation. To distinguish these possibilities, we combined confocal imaging and dual-site focal synaptic stimulation of identified thin dendrites in rat neocortical pyramidal neurons. We found that nearby inputs on the same branch summed sigmoidally, whereas widely separated inputs or inputs to different branches summed linearly. This strong spatial compartmentalization effect is incompatible with a global summation rule and provides the first experimental support for a two-layer 'neural network' model of pyramidal neuron thin-branch integration. Our findings could have important implications for the computing and memory-related functions of cortical tissue.	Technion Israel Inst Technol, Sch Med, Dept Physiol, IL-31096 Haifa, Israel; Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA	Technion Israel Institute of Technology; University of Southern California	Schiller, J (corresponding author), Technion Israel Inst Technol, Sch Med, Dept Physiol, IL-31096 Haifa, Israel.	jackie@tx.technion.ac.il		Poleg-Polsky, Alon/0000-0003-1327-5129				Archie KA, 2000, NAT NEUROSCI, V3, P54, DOI 10.1038/71125; Ariav G, 2003, J NEUROSCI, V23, P7750; BEAULIEU C, 1985, J COMP NEUROL, V231, P180, DOI 10.1002/cne.902310206; BERNANDER O, 1994, J NEUROPHYSIOL, V72, P2743, DOI 10.1152/jn.1994.72.6.2743; Borg-Graham L.J., 1992, SINGLE NEURON COMPUT, P347; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; CAULLER LJ, 1994, J NEUROSCI, V14, P751; Cook EP, 1999, J NEUROPHYSIOL, V81, P535, DOI 10.1152/jn.1999.81.2.535; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Jones EG, 1999, CEREB CORTEX, V13, P139; Kepecs A, 2002, J NEUROSCI, V22, P9053; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; LARKMAN AU, 1991, J COMP NEUROL, V306, P332, DOI 10.1002/cne.903060209; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Margulis M, 1998, J NEUROPHYSIOL, V79, P2809, DOI 10.1152/jn.1998.79.5.2809; MCCLELLAND JL, 1985, J EXP PSYCHOL GEN, V114, P159, DOI 10.1037/0096-3445.114.2.159; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; MEL BW, 1992, ADV NEUR IN, V4, P35; Mel BW, 1998, J NEUROSCI, V18, P4325; Migliore M, 2002, NAT REV NEUROSCI, V3, P362, DOI 10.1038/nrn810; Nettleton JS, 2000, J NEUROPHYSIOL, V83, P3310, DOI 10.1152/jn.2000.83.6.3310; Oakley JC, 2001, J NEUROPHYSIOL, V86, P503, DOI 10.1152/jn.2001.86.1.503; Oviedo H, 2002, NAT NEUROSCI, V5, P261, DOI 10.1038/nn807; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Rall W, 1987, SYNAPTIC FUNCTION PP, P605; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 2001, CURR OPIN NEUROBIOL, V11, P343, DOI 10.1016/S0959-4388(00)00217-8; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; SHEPHERD GM, 1987, NEUROSCIENCE, V21, P151, DOI 10.1016/0306-4522(87)90329-0; Single S, 1998, SCIENCE, V281, P1848, DOI 10.1126/science.281.5384.1848; Tamas G, 2002, J NEUROSCI, V22, P740, DOI 10.1523/JNEUROSCI.22-03-00740.2002; Urban NN, 1998, P NATL ACAD SCI USA, V95, P11450, DOI 10.1073/pnas.95.19.11450; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903	44	498	502	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					621	627		10.1038/nn1253	http://dx.doi.org/10.1038/nn1253			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15156147	Green Accepted			2022-12-24	WOS:000221640300016
J	Pawlu, C; DiAntonio, A; Heckmann, M				Pawlu, C; DiAntonio, A; Heckmann, M			Postfusional control of quantal current shape	NEURON			English	Article							TRANSMITTER RELEASE; SYNAPTIC VESICLES; SYNAPTOTAGMIN-I; TIME-COURSE; GLUTAMATE; SIZE; NEUROTRANSMITTER; KINETICS; ACETYLCHOLINE; VARIABILITY	Whether glutamate is released rapidly, in an all-or-none manner, or more slowly, in a regulated manner, is a matter of debate. We analyzed the time course of excitatory postsynaptic currents (EPSCs) at glutamatergic neuromuscular junctions of Drosophila and found that the decay phase of EPSCs was protracted to a variable extent. The protraction was more pronounced in evoked and spontaneous quantal EPSCs than in action potential-evoked multiquantal EPSCs; reduced in quantal EPSCs from endophilin null mutants, which maintain release via kiss-and-run; and dependent on synaptotagmin isoform, calcium, and protein phosphorylation. Our data indicate that glutamate is released from individual synaptic vesicles for milliseconds through a fusion pore. Quantal glutamate discharge time course depends on presynaptic calcium inflow and the molecular composition of the release machinery.	Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	University of Freiburg; Washington University (WUSTL)	Heckmann, M (corresponding author), Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany.	manfred.heckmann@physiologie.uni-freiburg.de		DiAntonio, Aaron/0000-0002-7262-0968; Heckmann, Manfred/0000-0002-4874-1735	NINDS NIH HHS [R01 NS043171] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043171] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Almers W, 2001, NATURE, V409, P567, DOI 10.1038/35054637; ANGLISTER L, 1994, NEURON, V12, P783, DOI 10.1016/0896-6273(94)90331-X; Behrends JC, 1998, J NEUROPHYSIOL, V79, P2999, DOI 10.1152/jn.1998.79.6.2999; Burgoyne RD, 2002, TRENDS NEUROSCI, V25, P176, DOI 10.1016/S0166-2236(00)02126-3; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; CRAWFORD AC, 1977, J PHYSIOL-LONDON, V268, P711, DOI 10.1113/jphysiol.1977.sp011878; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; DiAntonio A, 1999, J NEUROSCI, V19, P3023; DUDEL J, 1961, J PHYSIOL-LONDON, V155, P514, DOI 10.1113/jphysiol.1961.sp006644; DUDEL J, 1992, PFLUG ARCH EUR J PHY, V422, P129, DOI 10.1007/BF00370412; Dudel J, 2000, PFLUG ARCH EUR J PHY, V441, P175, DOI 10.1007/s004240000407; Elhamdani A, 2001, NEURON, V31, P819, DOI 10.1016/S0896-6273(01)00418-4; FERNANDEZCHACON R, 1995, FEBS LETT, V363, P221, DOI 10.1016/0014-5793(95)00319-5; Franks KM, 2003, J NEUROSCI, V23, P3186; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Geiger JRP, 1999, HANDB EXP PHARM, V141, P363; GOVIND CK, 1994, SYNAPSE, V16, P45, DOI 10.1002/syn.890160106; Hanse E, 2001, J PHYSIOL-LONDON, V531, P467, DOI 10.1111/j.1469-7793.2001.0467i.x; HARTZELL HC, 1975, J PHYSIOL-LONDON, V251, P427, DOI 10.1113/jphysiol.1975.sp011102; Heckmann M, 1997, BIOPHYS J, V72, P2160, DOI 10.1016/S0006-3495(97)78859-3; Heckmann M, 1996, BIOPHYS J, V71, P1743, DOI 10.1016/S0006-3495(96)79375-X; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Karunanithi S, 2002, J NEUROSCI, V22, P10267; KATZ B, 1971, SCIENCE, V173, P123, DOI 10.1126/science.173.3992.123; KATZ B, 1963, J PHYSIOL-LONDON, V168, P389, DOI 10.1113/jphysiol.1963.sp007199; KHANIN R, 1994, BIOPHYS J, V67, P966, DOI 10.1016/S0006-3495(94)80562-4; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; Littleton JT, 1999, NATURE, V400, P757, DOI 10.1038/23462; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; LONGSWORTH LG, 1953, J AM CHEM SOC, V75, P5705, DOI 10.1021/ja01118a065; MAGLEBY KL, 1975, J PHYSIOL-LONDON, V244, P467, DOI 10.1113/jphysiol.1975.sp010808; NEHER E, 1993, NATURE, V363, P497, DOI 10.1038/363497a0; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; PARNAS I, 1991, J NEUROSCI, V11, P1309; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Rahamimoff R, 1997, NEURON, V18, P17, DOI 10.1016/S0896-6273(01)80043-X; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Scepek S, 1998, EMBO J, V17, P4340, DOI 10.1093/emboj/17.15.4340; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Stiles JR, 2001, SYNAPSES, P681; Stiles JR, 1996, P NATL ACAD SCI USA, V93, P5747, DOI 10.1073/pnas.93.12.5747; Valtorta F, 2001, TRENDS CELL BIOL, V11, P324, DOI 10.1016/S0962-8924(01)02058-X; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Wang CT, 2003, NATURE, V424, P943, DOI 10.1038/nature01857; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Wong K, 1999, J NEUROPHYSIOL, V82, P1497, DOI 10.1152/jn.1999.82.3.1497; Zakharenko SS, 2002, NEURON, V35, P1099, DOI 10.1016/S0896-6273(02)00898-X; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	58	86	88	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 27	2004	42	4					607	618		10.1016/S0896-6273(04)00269-7	http://dx.doi.org/10.1016/S0896-6273(04)00269-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157422	Bronze			2022-12-24	WOS:000221708300011
J	Bartoletti, A; Medini, P; Berardi, N; Maffei, L				Bartoletti, A; Medini, P; Berardi, N; Maffei, L			Environmental enrichment prevents effects of dark-rearing in the rat visual cortex	NATURE NEUROSCIENCE			English	Article							PLASTICITY; EXERCISE; BDNF	Environmental enrichment potentiates neural plasticity, enhancing acquisition and consolidation of memory traces(1). In the sensory cortices, after cortical circuit maturation and sensory function acquisition are completed, neural plasticity declines and the critical period 'closes'(2). In the visual cortex, this process can be prevented by dark-rearing, and here we show that environmental enrichment can promote physiological maturation and consolidation of visual cortical connections in dark-reared rats, leading to critical period closure.	CNR, Ist Neurosci, I-56100 Pisa, Italy; Scuola Normale Super Pisa, Pisa, Italy; Univ Florence, Dipartimento Psicol, Florence, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Scuola Normale Superiore di Pisa; University of Florence	Berardi, N (corresponding author), CNR, Ist Neurosci, Via G Moruzzi 1, I-56100 Pisa, Italy.	berardi@in.pi.cnr.it	Medini, Paolo/GWC-1936-2022; Medini, Paolo/R-7504-2018		Telethon [GGP030428] Funding Source: Medline	Telethon(Fondazione Telethon)		BENEVENTO LA, 1995, BRAIN RES, V689, P172, DOI 10.1016/0006-8993(95)00553-3; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; Carro E, 2001, J NEUROSCI, V21, P5678, DOI 10.1523/JNEUROSCI.21-15-05678.2001; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; Gianfranceschi L, 2003, P NATL ACAD SCI USA, V100, P12486, DOI 10.1073/pnas.1934836100; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Maurer D, 1999, SCIENCE, V286, P108, DOI 10.1126/science.286.5437.108; Molteni R, 2002, EUR J NEUROSCI, V16, P1107, DOI 10.1046/j.1460-9568.2002.02158.x; Pham TM, 2002, PHARMACOL BIOCHEM BE, V73, P167, DOI 10.1016/S0091-3057(02)00783-9; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699	12	75	76	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					215	216		10.1038/nn1201	http://dx.doi.org/10.1038/nn1201			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14966527				2022-12-24	WOS:000189197900008
J	Niell, CM; Meyer, MP; Smith, SJ				Niell, CM; Meyer, MP; Smith, SJ			In vivo imaging of synapse formation on a growing dendritic arbor	NATURE NEUROSCIENCE			English	Article							POSTSYNAPTIC SPECIALIZATION; HIPPOCAMPAL-NEURONS; ZEBRAFISH EMBRYOS; NMDA RECEPTOR; SYNAPTOGENESIS; DYNAMICS; GROWTH; RECRUITMENT; PLASTICITY; FILOPODIA	The form of a neuron's dendritic arbor determines the set of axons with which it may form synaptic contacts, thus establishing connectivity within neural circuits. However, the dynamic relationship between dendrite growth and synaptogenesis is not well understood. To observe both processes simultaneously, we performed long-term imaging of non-spiny dendritic arbors expressing a fluorescent postsynaptic marker protein as they arborized within the optic tectum of live zebrafish larvae. Our results indicate that almost all synapses form initially on newly extended dendritic filopodia. A fraction of these nascent synapses are maintained, which in turn stabilizes the subset of filopodia on which they form. Stabilized filopodia mature into dendritic branches, and successive iterations of this process result in growth and branching of the arbor. These findings support a `synaptotropic model' in which synapse formation can direct dendrite arborization.	Stanford Univ, Beckman Ctr, Program Neurosci, Stanford, CA 94305 USA; Stanford Univ, Beckman Ctr, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Smith, SJ (corresponding author), Stanford Univ, Beckman Ctr, Program Neurosci, Stanford, CA 94305 USA.	sjsmith@stanford.edu	Meyer, Martin/C-5472-2009	Meyer, Martin/0000-0001-8337-630X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043461] Funding Source: NIH RePORTER; NINDS NIH HHS [NS043461] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; BANKER G, 1998, CULTURING NERVE CELL; Bresler T, 2001, MOL CELL NEUROSCI, V18, P149, DOI 10.1006/mcne.2001.1012; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Douglas R., 1990, VISUAL SYSTEM FISH, DOI [10.1007/978-94-009-0411-8, DOI 10.1007/978-94-009-0411-8]; Dunaevsky A, 2003, TRENDS NEUROSCI, V26, P155, DOI 10.1016/S0166-2236(03)00028-6; Ebihara T, 2003, J NEUROSCI, V23, P2170; Fiala JC, 1998, J NEUROSCI, V18, P8900; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Furrer MP, 2003, NAT NEUROSCI, V6, P223, DOI 10.1038/nn1017; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Gleason MR, 2003, NAT NEUROSCI, V6, P217, DOI 10.1038/nn1011; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Jan YN, 2001, GENE DEV, V15, P2627, DOI 10.1101/gad.916501; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Kaethner RJ, 1997, J NEUROBIOL, V32, P627, DOI 10.1002/(SICI)1097-4695(19970605)32:6<627::AID-NEU7>3.0.CO;2-1; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Lohmann C, 2002, NATURE, V418, P177, DOI 10.1038/nature00850; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; McGee AW, 2003, CURR OPIN NEUROBIOL, V13, P111, DOI 10.1016/S0959-4388(03)00008-4; MEEK J, 1981, J COMP NEUROL, V199, P175, DOI 10.1002/cne.901990203; Micheva KD, 2001, J CELL BIOL, V154, P355, DOI 10.1083/jcb.200102098; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Prange O, 2001, J NEUROSCI, V21, P9325, DOI 10.1523/JNEUROSCI.21-23-09325.2001; Rao A, 1998, J NEUROSCI, V18, P1217; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Tashiro A, 2003, NEURON, V38, P773, DOI 10.1016/S0896-6273(03)00299-X; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; VAUGHN JE, 1988, SYNAPSE, V2, P69, DOI 10.1002/syn.890020110; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; Westerfield M, 1993, ZEBRAFISH BOOK; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wong WT, 2001, NAT NEUROSCI, V4, P351, DOI 10.1038/85987; Wong WT, 2000, CURR OPIN NEUROBIOL, V10, P118, DOI 10.1016/S0959-4388(99)00059-8; Wu GY, 1999, J NEUROSCI, V19, P4472; Yoshii A, 2003, P NATL ACAD SCI USA, V100, P1334, DOI 10.1073/pnas.0335785100; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	50	311	319	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					254	260		10.1038/nn1191	http://dx.doi.org/10.1038/nn1191			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14758365				2022-12-24	WOS:000189197900015
J	Kruman, II; Wersto, RP; Cardozo-Pelaez, F; Smilenov, L; Chan, SL; Chrest, FJ; Emokpae, R; Gorospe, M; Mattson, MP				Kruman, II; Wersto, RP; Cardozo-Pelaez, F; Smilenov, L; Chan, SL; Chrest, FJ; Emokpae, R; Gorospe, M; Mattson, MP			Cell cycle activation linked to neuronal cell death initiated by DNA damage	NEURON			English	Article							BASE-EXCISION-REPAIR; DEPENDENT KINASE INHIBITORS; INDUCED APOPTOSIS; POSTMITOTIC NEURONS; STRAND BREAKS; ATM; REPLICATION; PROTEIN; PHOSPHATASE; CDC25A	Increasing evidence indicates that neurodegeneration involves the activation of the cell cycle machinery in postmitotic neurons. However, the purpose of these cell cycle-associated events in neuronal apoptosis remains unknown. Here we tested the hypothesis that cell cycle activation is a critical component of the DNA damage response in postmitotic neurons. Different genotoxic compounds (etoposide, methotrexate, and homocysteine) induced apoptosis accompanied by cell cycle reentry of terminally differentiated cortical neurons. In contrast, apoptosis initiated by stimuli that do not target DNA (staurosporine and colchicine) did not initiate cell cycle activation. Suppression of the function of ataxia telangiectasia mutated (ATM), a proximal component of DNA damage-induced cell cycle checkpoint pathways, attenuated both apoptosis and cell cycle reentry triggered by DNA damage but did not change the fate of neurons exposed to staurosporine and colchicine. Our data suggest that cell cycle activation is a critical element of the DNA damage response of postmitotic neurons leading to apoptosis.	NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA; NIA, Res Resources Branch, Intramural Res Program, Baltimore, MD 21224 USA; NIA, Cellular & Mol Biol Lab, Intramural Res Program, Baltimore, MD 21224 USA; Univ Montana, Environm Hlth Sci Ctr, Dept Pharmaceut Sci, Missoula, MT 59812 USA; Columbia Univ, Sch Med, Ctr Radiol Res, New York, NY 10032 USA; Sun Hlth Res Inst, Thomas H Christopher Ctr Parkinsons Dis Res, Sun City, AZ 85351 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Montana System; University of Montana; Columbia University; Banner Research; Banner Health; Banner Sun Health Research Institute; Johns Hopkins University	Kruman, II (corresponding author), NIA, Neurosci Lab, Intramural Res Program, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	inna.kruman@sunhealth.org	Mattson, Mark P/F-6038-2012		NATIONAL INSTITUTE ON AGING [ZIAAG000312, Z01AG000312, Z01AG000511, ZIAAG000511, Z01AG000313, ZIAAG000313] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adamec E, 1999, BRAIN RES, V849, P67, DOI 10.1016/S0006-8993(99)02004-1; Almog N, 1997, BBA-REV CANCER, V1333, pF1, DOI 10.1016/S0304-419X(97)00012-7; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Beck WT, 2001, BIOCHEM SOC T, V29, P702, DOI 10.1042/0300-5127:0290702; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; Blomberg I, 1999, MOL CELL BIOL, V19, P6183; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Cangi MG, 2000, J CLIN INVEST, V106, P753, DOI 10.1172/JCI9174; Cardozo-Pelaez F, 1998, NEUROBIOL AGING, V19, P311, DOI 10.1016/S0197-4580(98)00067-0; Cardozo-Pelaez F, 2000, FREE RADICAL BIO MED, V28, P779, DOI 10.1016/S0891-5849(00)00172-6; Choi EK, 2002, J PATHOL, V198, P121, DOI 10.1002/path.1164; Chong MJ, 2000, P NATL ACAD SCI USA, V97, P889, DOI 10.1073/pnas.97.2.889; COMFORTH MN, 1985, SCIENCE, V227, P1589; Cooper-Kuhn CM, 2002, DEV BRAIN RES, V134, P13, DOI 10.1016/S0165-3806(01)00243-7; Copani A, 1999, FASEB J, V13, P2225, DOI 10.1096/fasebj.13.15.2225; Copani A, 2001, TRENDS NEUROSCI, V24, P25, DOI 10.1016/S0166-2236(00)01663-5; Culmsee C, 2001, J NEUROCHEM, V77, P220, DOI 10.1046/j.1471-4159.2001.00220.x; Ding XL, 2000, AM J PATHOL, V157, P1983, DOI 10.1016/S0002-9440(10)64837-7; Donzelli M, 2002, EMBO J, V21, P4875, DOI 10.1093/emboj/cdf491; Fezoui Y, 2000, NAT STRUCT BIOL, V7, P1095, DOI 10.1038/81937; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Gabbita SP, 1998, J NEUROCHEM, V71, P2034, DOI 10.1046/j.1471-4159.1998.71052034.x; GALAKTIONOV K, 1991, CELL, V67, P1181, DOI 10.1016/0092-8674(91)90294-9; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; Gobbel GT, 1998, J NEUROSCI, V18, P147; Gorman AM, 1999, EUR J NEUROSCI, V11, P1067, DOI 10.1046/j.1460-9568.1999.00512.x; GOULIAN M, 1980, P NATL ACAD SCI-BIOL, V77, P1956, DOI 10.1073/pnas.77.4.1956; HANAWALT PC, 1992, ANN NY ACAD SCI, V663, P17, DOI 10.1111/j.1749-6632.1992.tb38644.x; Hayashi T, 2000, NEUROPATH APPL NEURO, V26, P390, DOI 10.1046/j.1365-2990.2000.00264.x; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; HOFFMANN I, 1994, EMBO J, V13, P4302, DOI 10.1002/j.1460-2075.1994.tb06750.x; HUSCHTSCHA LI, 1994, EXP CELL RES, V212, P161, DOI 10.1006/excr.1994.1131; Husseman JW, 2000, NEUROBIOL AGING, V21, P815, DOI 10.1016/S0197-4580(00)00221-9; Katchanov J, 2001, J NEUROSCI, V21, P5045, DOI 10.1523/JNEUROSCI.21-14-05045.2001; Kruman I, 1997, J NEUROSCI, V17, P5089; Kruman II, 2002, J NEUROSCI, V22, P1752, DOI 10.1523/JNEUROSCI.22-05-01752.2002; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; Li X, 1996, EXP CELL RES, V222, P28, DOI 10.1006/excr.1996.0004; Liu DX, 2001, CELL TISSUE RES, V305, P217, DOI 10.1007/s004410100396; Lovell MA, 1999, J NEUROCHEM, V72, P771, DOI 10.1046/j.1471-4159.1999.0720771.x; Macleod MR, 2003, NEUROREPORT, V14, P215, DOI 10.1097/00001756-200302100-00011; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; MATTSON MP, 1993, BRAIN RES, V621, P35, DOI 10.1016/0006-8993(93)90295-X; MCCOMBE P, 1976, INT J RADIAT BIOL, V29, P523, DOI 10.1080/09553007614550621; McShea A, 1999, MED HYPOTHESES, V52, P525, DOI 10.1054/mehy.1997.0680; Morris EJ, 1996, J CELL BIOL, V134, P757, DOI 10.1083/jcb.134.3.757; Morris EJ, 1999, BIOTECHNIQUES, V26, P282, DOI 10.2144/99262st02; Nagayama T, 2000, J NEUROCHEM, V75, P1716, DOI 10.1046/j.1471-4159.2000.0751716.x; Nagelhus TA, 1997, J BIOL CHEM, V272, P6561, DOI 10.1074/jbc.272.10.6561; Nagy Z, 1998, NEUROSCIENCE, V87, P731; Neugroschl J, 2002, AM J GERIAT PSYCHIAT, V10, P660, DOI 10.1176/appi.ajgp.10.6.660; Ninomiya Y, 1997, J CELL PHYSIOL, V172, P25, DOI 10.1002/(SICI)1097-4652(199707)172:1<25::AID-JCP3>3.3.CO;2-P; Nouspikel T, 2000, MOL CELL BIOL, V20, P1562, DOI 10.1128/MCB.20.5.1562-1570.2000; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Park DS, 1998, J CELL BIOL, V143, P457, DOI 10.1083/jcb.143.2.457; Park DS, 1997, J NEUROSCI, V17, P8975; Rhind N, 2000, CURR BIOL, V10, pR908, DOI 10.1016/S0960-9822(00)00849-6; Rideout HJ, 2003, J NEUROSCI, V23, P1237, DOI 10.1523/JNEUROSCI.23-04-01237.2003; Rolig RL, 2000, TRENDS NEUROSCI, V23, P417, DOI 10.1016/S0166-2236(00)01625-8; Roser S, 2001, MUTAT RES-GEN TOX EN, V497, P169, DOI 10.1016/S1383-5718(01)00255-8; Rotman G, 1998, HUM MOL GENET, V7, P1555, DOI 10.1093/hmg/7.10.1555; Ruggiero A, 2001, PEDIATR DRUGS, V3, P237, DOI 10.2165/00128072-200103040-00001; Sakakura C, 1997, SURG TODAY, V27, P773, DOI 10.1007/BF02384996; Sarkaria JN, 1999, CANCER RES, V59, P4375; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SAVITSKY K, 1999, ONCOGENE, V18, P573; Shiloh Y, 2001, ADV CANCER RES, V83, P209, DOI 10.1016/S0065-230X(01)83007-4; Smith DS, 2000, CELL GROWTH DIFFER, V11, P625; Smith MZ, 1999, NEUROSCI LETT, V271, P45, DOI 10.1016/S0304-3940(99)00509-1; Smith ND, 2003, J UROLOGY, V169, P1219, DOI 10.1097/01.ju.0000056085.58221.80; Stedeford T, 2001, FREE RADICAL BIO MED, V31, P1272, DOI 10.1016/S0891-5849(01)00715-8; Uberti D, 2003, TOXICOL LETT, V139, P99, DOI 10.1016/S0378-4274(02)00423-X; UPPULURI S, 1993, P NATL ACAD SCI USA, V90, P11598, DOI 10.1073/pnas.90.24.11598; Van Triest B, 2000, ANN ONCOL, V11, P385, DOI 10.1023/A:1008351221345; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; WALLACE SS, 1997, OXIDATIVE STRESS MOL, P49; WALSH MJ, 1995, J BIOL CHEM, V270, P5289, DOI 10.1074/jbc.270.10.5289; Yamasaki F, 2003, CANCER CHEMOTH PHARM, V51, P271, DOI 10.1007/s00280-002-0562-z; Yang Y, 2001, J NEUROSCI, V21, P2661, DOI 10.1523/JNEUROSCI.21-08-02661.2001	80	284	299	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 19	2004	41	4					549	561		10.1016/S0896-6273(04)00017-0	http://dx.doi.org/10.1016/S0896-6273(04)00017-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980204	Bronze			2022-12-24	WOS:000221458100008
J	Seung, HS				Seung, HS			Learning in spiking neural networks by reinforcement of stochastic synaptic transmission	NEURON			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; TRANSMITTER RELEASE; PLASTICITY; SYNAPSES; FACILITATION; INTELLIGENCE; FEEDFORWARD; RELIABILITY; DEPRESSION	It is well-known that chemical synaptic transmission is an unreliable process, but the function of such unreliability remains unclear. Here I consider the hypothesis that the randomness of synaptic transmission is harnessed by the brain for learning, in analogy to the way that genetic mutation is utilized by Darwinian evolution. This is possible if synapses are "hedonistic," responding to a global reward signal by increasing their probabilities of vesicle release or failure, depending on which action immediately preceded reward. Hedonistic synapses learn by computing a stochastic approximation to the gradient of the average reward. They are compatible with synaptic dynamics such as short-term facilitation and depression and with the intricacies of dendritic integration and action potential generation. A network of hedonistic synapses can be trained to perform a desired computation by administering reward appropriately, as illustrated here through numerical simulations of integrate-and-fire model neurons.	MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Seung, HS (corresponding author), MIT, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.							Bartlett P. L., 2000, BIOL PLAUSIBLE LOCAL; BARTO AG, 1983, IEEE T SYST MAN CYB, V13, P834, DOI 10.1109/TSMC.1983.6313077; Baum EB, 1999, MACH LEARN, V35, P155, DOI 10.1023/A:1007593124513; Baxter J, 2001, J ARTIF INTELL RES, V15, P319, DOI 10.1613/jair.806; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Buchs NJ, 2002, J COMPUT NEUROSCI, V13, P167, DOI 10.1023/A:1020210230751; CAUWENBERGHS G, 1993, ADV NEURAL INFORMATI, V5, P244; Chance FS, 1998, J NEUROSCI, V18, P4785; DALE N, 1988, SCIENCE, V239, P282, DOI 10.1126/science.2892269; Davison M., 1988, ERLBAUM; DAYAN P, 1990, P 1990 CONN MOD SUMM, P45; Fuhrmann G, 2002, J NEUROPHYSIOL, V87, P140, DOI 10.1152/jn.00258.2001; GALLISTEL CR, 1994, COGNITION, V50, P151, DOI 10.1016/0010-0277(94)90026-4; HERMSTEIN RJ, 1991, J ECON PERSPECT, V5, P137; HINTON GE, 1989, ARTIF INTELL, V40, P185, DOI 10.1016/0004-3702(89)90049-0; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; JABRI M, 1992, IEEE T NEURAL NETWOR, V3, P154, DOI 10.1109/72.105429; Johnson F, 2002, BEHAV BRAIN RES, V131, P57, DOI 10.1016/S0166-4328(01)00374-6; KIMURA H, 1995, P 12 INT C MACH LEAR, P295; KLOPF AH, 1982, HEDONISTIC NEURON; Kushner H., 1978, STOCHASTIC APPROXIMA; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MAZZONI P, 1991, P NATL ACAD SCI USA, V88, P4433, DOI 10.1073/pnas.88.10.4433; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; MINSKY M, 1961, P IRE, V49, P8, DOI 10.1109/JRPROC.1961.287775; Minsky M., 1954, THESIS PRINCETON U P; Minsky M., 1988, SOC MIND; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; NARENDRA KS, 1989, LEARNING AUTOMATA IN; Raymond JL, 1998, J NEUROSCI, V18, P9112; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; STEVENS CF, 1993, CELL, V72, P55, DOI 10.1016/S0092-8674(05)80028-5; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Sutton Rs, 1984, TEMPORAL CREDIT ASSI; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; UNNIKRISHNAN KP, 1994, NEURAL COMPUT, V6, P469, DOI 10.1162/neco.1994.6.3.469; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; WERFEL JK, IN PRESS ADV NEURAL; WILLIAMS RJ, 1992, MACH LEARN, V8, P229, DOI 10.1007/BF00992696	47	209	228	0	28	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 18	2003	40	6					1063	1073		10.1016/S0896-6273(03)00761-X	http://dx.doi.org/10.1016/S0896-6273(03)00761-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	756UZ	14687542	Green Published, Bronze			2022-12-24	WOS:000187503400006
J	Formisano, E; Kim, DS; Di Salle, F; van de Moortele, PF; Ugurbil, K; Goebel, R				Formisano, E; Kim, DS; Di Salle, F; van de Moortele, PF; Ugurbil, K; Goebel, R			Mirror-symmetric tonotopic maps in human primary auditory cortex	NEURON			English	Article							LEVEL-DEPENDENT REPRESENTATION; MIDDLE LATENCY COMPONENTS; TIME-RESOLVED FMRI; EVENT-RELATED FMRI; VOLUME MEASUREMENT; INTRINSIC SIGNALS; EVOKED-POTENTIALS; MACAQUE MONKEY; TONE INTENSITY; HUMAN BRAIN	Understanding the functional organization of the human primary auditory cortex (PAC) is an essential step in elucidating the neural mechanisms underlying the perception of sound, including speech and music. Based on invasive research in animals, it is believed that neurons in human PAC that respond selectively with respect to the spectral content of a sound form one or more maps in which neighboring patches on the cortical surface respond to similar frequencies (tonotopic maps). The number and the cortical layout of such tonotopic maps in the human brain, however, remain unknown. Here we use silent, event-related functional magnetic resonance imaging at 7 Tesla and a cortex-based analysis of functional data to delineate with high spatial resolution the detailed topography of two tonotopic maps in two adjacent subdivisions of PAC. These maps share a low-frequency border, are mirror symmetric, and clearly resemble those of presumably homologous fields in the macaque monkey.	Univ Maastricht, Fac Psychol, Dept Cognit Neurosci, NL-6200 MD Maastricht, Netherlands; Univ Minnesota, Sch Med, Ctr Magnet Resonance Res CMRR, Minneapolis, MN 55455 USA; Univ Naples Federico II, Dept Neuroradiol, Nuovo Policlin, I-80131 Naples, Italy	Maastricht University; University of Minnesota System; University of Minnesota Twin Cities; University of Naples Federico II	Goebel, R (corresponding author), Univ Maastricht, Fac Psychol, Dept Cognit Neurosci, Postbus 616, NL-6200 MD Maastricht, Netherlands.		Ugurbil, Kamil/AAD-6058-2022; Van de Moortele, Pierre-François/H-5087-2011; Kim, Dae-Shik/C-2071-2011	Van de Moortele, Pierre-François/0000-0002-6941-5947; Formisano, Elia/0000-0001-5008-2460; Goebel, Rainer/0000-0003-1780-2467; Di Salle, Francesco/0000-0002-0226-8460	NCRR NIH HHS [RR08079] Funding Source: Medline; NIBIB NIH HHS [EB00331] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000331] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Belin P, 1999, NEUROIMAGE, V10, P417, DOI 10.1006/nimg.1999.0480; Bilecen D, 1998, HEARING RES, V126, P19, DOI 10.1016/S0378-5955(98)00139-7; Brechmann A, 2002, J NEUROPHYSIOL, V87, P423, DOI 10.1152/jn.00187.2001; BRODMANN K, 1809, VERGLEICHENDE LOCALI; Dale AM, 2001, CURR OPIN NEUROBIOL, V11, P202, DOI 10.1016/S0959-4388(00)00197-5; Di Salle F, 2001, NEUROIMAGE, V13, P328, DOI 10.1006/nimg.2000.0683; Eggermont JJ, 2002, AUDIOL NEURO-OTOL, V7, P71, DOI 10.1159/000057656; Engelien A, 2002, NEUROIMAGE, V16, P944, DOI 10.1006/nimg.2002.1149; Formisano E, 2002, NEURON, V35, P185, DOI 10.1016/S0896-6273(02)00747-X; GALABURDA A, 1980, J COMP NEUROL, V190, P597, DOI 10.1002/cne.901900312; Gruetter R, 2000, MAGNET RESON MED, V43, P319, DOI 10.1002/(SICI)1522-2594(200002)43:2<319::AID-MRM22>3.0.CO;2-1; Gutschalk A, 1999, CLIN NEUROPHYSIOL, V110, P856, DOI 10.1016/S1388-2457(99)00019-X; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; Hall DA, 2003, AUDIOL NEURO-OTOL, V8, P1, DOI 10.1159/000067894; Hall DA, 2002, CEREB CORTEX, V12, P140, DOI 10.1093/cercor/12.2.140; Harel N, 2000, NEUROIMAGE, V11, P302, DOI 10.1006/nimg.1999.0537; Harrison RV, 1996, HEARING RES, V100, P157, DOI 10.1016/0378-5955(96)00120-7; HEIL P, 1994, HEARING RES, V76, P188, DOI 10.1016/0378-5955(94)90099-X; Howard MA, 1996, BRAIN RES, V724, P260, DOI 10.1016/0006-8993(96)00315-0; HUOTILAINEN M, 1995, NEUROREPORT, V6, P841, DOI 10.1097/00001756-199504190-00004; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; KOWALSKI N, 1995, J NEUROPHYSIOL, V73, P1513, DOI 10.1152/jn.1995.73.4.1513; Kriegeskorte N, 2001, NEUROIMAGE, V14, P329, DOI 10.1006/nimg.2001.0831; LAUTER JL, 1985, HEARING RES, V20, P199, DOI 10.1016/0378-5955(85)90024-3; LIEGEOISCHAUVEL C, 1994, ELECTROEN CLIN NEURO, V92, P204, DOI 10.1016/0168-5597(94)90064-7; LIEGEOISCHAUVEL C, 1991, BRAIN, V114, P139; Lockwood AH, 1999, CEREB CORTEX, V9, P65, DOI 10.1093/cercor/9.1.65; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Luo Y, 2001, MAGNET RESON MED, V45, P1095, DOI 10.1002/mrm.1144; Lutkenhoner B, 2003, NEUROIMAGE, V19, P935, DOI 10.1016/S1053-8119(03)00172-1; Lutkenhoner B, 2003, NEUROIMAGE, V18, P58, DOI 10.1006/nimg.2002.1325; Lutkenhoner B, 1998, AUDIOL NEURO-OTOL, V3, P191, DOI 10.1159/000013790; MERZENICH MM, 1973, BRAIN RES, V50, P275, DOI 10.1016/0006-8993(73)90731-2; MERZENICH MM, 1973, BRAIN RES, V63, P343, DOI 10.1016/0006-8993(73)90101-7; MOREL A, 1993, J COMP NEUROL, V335, P437, DOI 10.1002/cne.903350312; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Pantev C, 1996, HEARING RES, V101, P62, DOI 10.1016/S0378-5955(96)00133-5; PANTEV C, 1995, ELECTROEN CLIN NEURO, V94, P26, DOI 10.1016/0013-4694(94)00209-4; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; Pfeuffer J, 2002, NEUROIMAGE, V17, P272, DOI 10.1006/nimg.2002.1103; PHILLIPS DP, 1994, EXP BRAIN RES, V102, P210; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; Rauschecker JP, 1997, J COMP NEUROL, V382, P89; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Read HL, 2002, CURR OPIN NEUROBIOL, V12, P433, DOI 10.1016/S0959-4388(02)00342-2; Recanzone GH, 1999, J COMP NEUROL, V415, P460, DOI 10.1002/(SICI)1096-9861(19991227)415:4<460::AID-CNE4>3.0.CO;2-F; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2315, DOI 10.1152/jn.2000.83.4.2315; ROMANI GL, 1982, SCIENCE, V216, P1339, DOI 10.1126/science.7079770; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Scheich H, 1991, Curr Opin Neurobiol, V1, P236, DOI 10.1016/0959-4388(91)90084-K; Scherg M, 1989, ADV BIOMAGNETISM, P97, DOI 10.1007/978-1-4613-0581-1_11; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Schonwiesner M, 2002, NEUROIMAGE, V17, P1144, DOI 10.1006/nimg.2002.1250; SCHREINER CE, 1992, EXP BRAIN RES, V92, P105; Seifritz E, 2002, SCIENCE, V297, P1706, DOI 10.1126/science.1074355; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Talairach J., 1988, COPLANAR STEREOTAXIC; Talavage TM, 2000, HEARING RES, V150, P225, DOI 10.1016/S0378-5955(00)00203-3; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Ugurbil K, 2003, TRENDS NEUROSCI, V26, P108, DOI 10.1016/S0166-2236(02)00039-5; Versnel H, 2002, J NEUROPHYSIOL, V88, P1545, DOI 10.1152/jn.2002.88.3.1545; von Economo C, 1925, CYTOARCHITEKTONIK HI; Warren JD, 2002, NEURON, V34, P139, DOI 10.1016/S0896-6273(02)00637-2; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Wessinger CM, 1997, HUM BRAIN MAPP, V5, P18, DOI 10.1002/(SICI)1097-0193(1997)5:1<18::AID-HBM3>3.0.CO;2-Q; YAMAMOTO T, 1992, ACTA OTOLARYNGOL STO, V112, P210; Yvert B, 2001, CEREB CORTEX, V11, P411, DOI 10.1093/cercor/11.5.411	69	324	331	0	36	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 13	2003	40	4					859	869		10.1016/S0896-6273(03)00669-X	http://dx.doi.org/10.1016/S0896-6273(03)00669-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	744UL	14622588	Bronze, Green Published			2022-12-24	WOS:000186651200019
J	Stopfer, M; Jayaraman, V; Laurent, G				Stopfer, M; Jayaraman, V; Laurent, G			Intensity versus identity coding in an olfactory system	NEURON			English	Article							OSCILLATING NEURAL ASSEMBLIES; ODOR REPRESENTATIONS; MUSHROOM BODY; NEURONAL-ACTIVITY; NETWORK DYNAMICS; BULB; MAP; DISCRIMINATION; INFORMATION; BRAIN	We examined the encoding and decoding of odor identity and intensity by neurons in the antennal lobe and the mushroom body, first and second relays, respectively, of the locust olfactory system. Increased odor concentration led to changes in the firing patterns of individual antennal lobe projection neurons (PNs), similar to those caused by changes in odor identity, thus potentially confounding representations for identity and concentration. However, when these time-varying responses were examined across many PNs, concentration-specific patterns clustered by identity, resolving the apparent confound. This is because PN ensemble representations changed relatively continuously over a range of concentrations of each odorant. The PNs' targets in the mushroom body-Kenyon cells (KCs) - had sparse identity-specific responses with diverse degrees of concentration invariance. The tuning of KCs to identity and concentration and the patterning of their responses are consistent with piecewise decoding of their PN inputs over oscillation-cycle length epochs.	CALTECH, Div Biol, Computat & Neural Syst Program, Pasadena, CA 91125 USA	California Institute of Technology	Laurent, G (corresponding author), CALTECH, Div Biol, Computat & Neural Syst Program, Pasadena, CA 91125 USA.		Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X; Stopfer, Mark/0000-0001-9200-1884	NCRR NIH HHS [P41RR09754] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008760] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009754] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Adrian ED, 1942, J PHYSIOL-LONDON, V100, P459, DOI 10.1113/jphysiol.1942.sp003955; BACKER A, 2002, THESIS CALTECH PASAD; Burrows M., 1996, NEUROBIOLOGY INSECT; Cang JH, 2003, J NEUROSCI, V23, P4108; CINELLI AR, 1995, J NEUROPHYSIOL, V73, P2053, DOI 10.1152/jn.1995.73.5.2053; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DRAKE KL, 1988, IEEE T BIO-MED ENG, V35, P719, DOI 10.1109/10.7273; ENGEN T, 1959, J EXP PSYCHOL, V58, P23, DOI 10.1037/h0040080; FREEMAN WJ, 1978, ELECTROEN CLIN NEURO, V44, P586, DOI 10.1016/0013-4694(78)90126-8; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; GRAY CM, 1988, EXP BRAIN RES, V69, P378; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Joliffe I. T., 1986, PRINCIPAL COMPONENT; KAUER JS, 1974, J PHYSIOL-LONDON, V243, P717, DOI 10.1113/jphysiol.1974.sp010773; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; LAURENT G, 1994, J NEUROSCI, V14, P2993; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Laurent G, 1996, J NEUROSCI, V16, P3837; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Meister M, 2001, J NEUROSCI, V21, P1351; MEREDITH M, 1986, J NEUROPHYSIOL, V56, P572, DOI 10.1152/jn.1986.56.3.572; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Pelz C, 1997, J EXP BIOL, V200, P837; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Pouzat C, 2002, J NEUROSCI METH, V122, P43, DOI 10.1016/S0165-0270(02)00276-5; Rabinovich M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.068102; Rodiek R.W., 1998, 1 STEPS SEEING; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Seung HS, 2000, SCIENCE, V290, P2268, DOI 10.1126/science.290.5500.2268; SLOTNICK BM, 1977, PHYSIOL BEHAV, V19, P795, DOI 10.1016/0031-9384(77)90317-1; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Wachowiak M, 2002, J NEUROPHYSIOL, V87, P1035, DOI 10.1152/jn.00522.2001; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; WELLIS DP, 1989, J NEUROPHYSIOL, V61, P1161, DOI 10.1152/jn.1989.61.6.1161; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	49	379	381	2	25	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 11	2003	39	6					991	1004		10.1016/j.neuron.2003.08.011	http://dx.doi.org/10.1016/j.neuron.2003.08.011			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	721BA	12971898	Bronze			2022-12-24	WOS:000185296100012
J	Warburton, EC; Koder, T; Cho, K; Massey, PV; Duguid, G; Barker, GRI; Aggleton, JP; Bashir, ZI; Brown, MW				Warburton, EC; Koder, T; Cho, K; Massey, PV; Duguid, G; Barker, GRI; Aggleton, JP; Bashir, ZI; Brown, MW			Cholinergic neurotransmission is essential for perirhinal cortical plasticity and recognition memory	NEURON			English	Article							LONG-TERM POTENTIATION; RHINAL CORTEX LESIONS; GENE C-FOS; VISUAL RECOGNITION; OBJECT RECOGNITION; RHESUS-MONKEYS; FAMILIARITY DISCRIMINATION; COGNITIVE NEUROSCIENCE; SYNAPTIC PLASTICITY; RAT	We establish the importance of cholinergic neurotransmission to both recognition memory and plasticity within the perirhinal cortex of the temporal lobe. The muscarinic receptor antagonist scopolamine impaired the preferential exploration of novel over familiar objects, disrupted the normal reduced activation of perirhinal neurones to familiar compared to novel pictures, and blocked production of long-term depression (LTD) but not long-term potentiation (LTP) of synaptic transmission in perirhinal slices. The consistency of these effects across the behavioral, systems, and cellular levels of analysis provides strong evidence for the involvement of cholinergic mechanisms in synaptic plastic processes within perirhinal cortex that are necessary for recognition memory.	Univ Bristol, Dept Anat, MRC, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England	University of Bristol	Brown, MW (corresponding author), Univ Bristol, Dept Anat, MRC, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England.		Koder, Tim/T-8360-2019; Warburton, Elizabeth Clea/B-4044-2019	Warburton, Elizabeth Clea/0000-0002-2129-2060; Cho, Kwangwook/0000-0001-6724-7073; Bashir, Zafar/0000-0003-3650-2136; Aggleton, John/0000-0002-5573-1308; Barker, Gareth/0000-0002-0918-2045; Koder, Tim/0000-0001-6152-7365				AIGNER TG, 1986, BEHAV NEURAL BIOL, V45, P81, DOI 10.1016/S0163-1047(86)80008-5; Albright TD, 2000, CURR OPIN NEUROBIOL, V10, P612, DOI 10.1016/S0959-4388(00)00132-X; Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; Auerbach JM, 1996, J PHYSIOL-LONDON, V492, P479, DOI 10.1113/jphysiol.1996.sp021323; Bartus RT, 2000, EXP NEUROL, V163, P495, DOI 10.1006/exnr.2000.7397; Blokland A, 1995, BRAIN RES REV, V21, P285, DOI 10.1016/0165-0173(95)00016-X; Bogacz R, 2001, J COMPUT NEUROSCI, V10, P5, DOI 10.1023/A:1008925909305; BOGACZ R, 2003, IN PRESS HIPPOCAMPUS; BRENNAN PA, 1992, NEUROSCIENCE, V49, P277, DOI 10.1016/0306-4522(92)90095-J; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Brown MW, 1998, PROG NEUROBIOL, V55, P149, DOI 10.1016/S0301-0082(98)00002-1; Brown MW, 1996, SEMIN NEUROSCI, V8, P23, DOI 10.1006/smns.1996.0004; Brown MW, 2002, PHILOS T R SOC B, V357, P1083, DOI 10.1098/rstb.2002.1097; Buffalo EA, 2000, LEARN MEMORY, V7, P375, DOI 10.1101/lm.32100; Cho K, 2000, NAT NEUROSCI, V3, P150, DOI 10.1038/72093; DEUTSCH JA, 1971, SCIENCE, V174, P788, DOI 10.1126/science.174.4011.788; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; DRACHMAN DA, 1974, ARCH NEUROL-CHICAGO, V30, P113, DOI 10.1001/archneur.1974.00490320001001; Easton A, 2001, BEHAV BRAIN RES, V121, P1, DOI 10.1016/S0166-4328(00)00384-3; Ennaceur A, 1996, BEHAV BRAIN RES, V80, P9, DOI 10.1016/0166-4328(96)00006-X; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; FUSTER JM, 1981, SCIENCE, V212, P952, DOI 10.1126/science.7233192; GAFFAN D, 1992, BEHAV NEUROSCI, V106, P30, DOI 10.1037/0735-7044.106.1.30; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; HASSELMO ME, 1995, BEHAV BRAIN RES, V67, P1, DOI 10.1016/0166-4328(94)00113-T; HASSELMO ME, 1995, J NEUROSCI, V15, P6592; Hasselmo ME, 1997, BEHAV BRAIN RES, V89, P1, DOI 10.1016/S0166-4328(97)00048-X; HUNTER AJ, 1989, PSYCHOPHARMACOLOGY, V99, P270, DOI 10.1007/BF00442821; HUSTON AE, 1987, Q J EXP PSYCHOL-B, V39, P297; Kirkwood A, 1999, J NEUROSCI, V19, P1599; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; Massey PV, 2001, EUR J NEUROSCI, V14, P145, DOI 10.1046/j.0953-816x.2001.01631.x; MCCABE BJ, 1994, P NATL ACAD SCI USA, V91, P11417, DOI 10.1073/pnas.91.24.11417; Meunier M, 1996, J NEUROPHYSIOL, V75, P1190, DOI 10.1152/jn.1996.75.3.1190; MEUNIER M, 1993, J NEUROSCI, V13, P5418, DOI 10.1523/JNEUROSCI.13-12-05418.1993; MILLER EK, 1994, SCIENCE, V263, P520, DOI 10.1126/science.8290960; MILLER EK, 1993, NEUROREPORT, V4, P81, DOI 10.1097/00001756-199301000-00021; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; MISHKIN M, 1999, NEURAL PLAST S, V6, P3; MUMBY DG, 1994, BEHAV NEUROSCI, V108, P11, DOI 10.1037/0735-7044.108.1.11; Murray EA, 1999, TRENDS COGN SCI, V3, P142, DOI 10.1016/S1364-6613(99)01303-0; Murray EA, 1996, SEMIN NEUROSCI, V8, P13, DOI 10.1006/smns.1996.0003; Norman G, 2002, J PSYCHOPHARMACOL, V16, P153, DOI 10.1177/026988110201600206; OTTO T, 1992, BEHAV NEUROSCI, V106, P762, DOI 10.1037/0735-7044.106.5.762; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Rasmusson DD, 2000, BEHAV BRAIN RES, V115, P205, DOI 10.1016/S0166-4328(00)00259-X; Shi CJ, 1997, J COMP NEUROL, V382, P153; Steckler T, 1998, PROG NEUROBIOL, V54, P333, DOI 10.1016/S0301-0082(97)00062-2; SUZUKI WA, 1993, J NEUROSCI, V13, P2430, DOI 10.1523/JNEUROSCI.13-06-02430.1993; Swanson L. W, 1998, BRAIN MAPS STRUCTURE; Tang Y, 1997, P NATL ACAD SCI USA, V94, P12667, DOI 10.1073/pnas.94.23.12667; THOMPSON JH, 2002, EUR J NEUROSCI, V180, P21; Voytko ML, 1996, BEHAV BRAIN RES, V75, P13, DOI 10.1016/0166-4328(95)00143-3; Wan HM, 1999, J NEUROSCI, V19, P1142; Xiang JZ, 1998, NEUROPHARMACOLOGY, V37, P657, DOI 10.1016/S0028-3908(98)00030-6; ZHU XO, 1995, NEUROSCIENCE, V69, P821, DOI 10.1016/0306-4522(95)00320-I; Zhu XO, 1996, NEUROREPORT, V7, P1871, DOI 10.1097/00001756-199607290-00037; ZOLAMORGAN S, 1989, J NEUROSCI, V9, P4355	58	180	184	0	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 19	2003	38	6					987	996		10.1016/S0896-6273(03)00358-1	http://dx.doi.org/10.1016/S0896-6273(03)00358-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	693AA	12818183	Bronze			2022-12-24	WOS:000183691400017
J	Blatow, M; Rozov, A; Katona, I; Hormuzdi, SG; Meyer, AH; Whittington, MA; Caputi, A; Monyer, H				Blatow, M; Rozov, A; Katona, I; Hormuzdi, SG; Meyer, AH; Whittington, MA; Caputi, A; Monyer, H			A novel network of multipolar bursting interneurons generates theta frequency oscillations in neocortex	NEURON			English	Article							RAT FRONTAL-CORTEX; CEREBRAL-CORTEX; GAP-JUNCTIONS; IN-VITRO; GABAERGIC INTERNEURONS; CORTICAL INTERNEURONS; SYNAPTIC CONNECTIONS; PYRAMIDAL NEURONS; HIPPOCAMPUS; SYNAPSES	GABAergic interneurons can phase the output of principal cells, giving rise to oscillatory activity in different frequency bands. Here we describe a new subtype of GABAergic interneuron, the multipolar bursting (MB) cell in the mouse neocortex. MB cells are parvalbumin positive but differ from fast-spiking multipolar (FS) cells in their morphological, neurochemical, and physiological properties. MB cells are reciprocally connected with layer 2/3 pyramidal cells and are coupled with each other by chemical and electrical synapses. MB cells innervate FS cells but not vice versa. MB to MB cell as well as MB to pyramidal cell synapses exhibit paired-pulse facilitation. Carbachol selectively induced synchronized theta frequency oscillations in MB cells. Synchrony required both gap junction coupling and GABAergic chemical transmission, but not excitatory glutamatergic input. Hence, MB cells form a distinct inhibitory network, which upon cholinergic drive can generate rhythmic and synchronous theta frequency activity, providing temporal coordination of pyramidal cell output.	Univ Hosp Neurol, Dept Clin Neurobiol, D-69120 Heidelberg, Germany; Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Expt Neurophysiol, NL-1081 HV Amsterdam, Netherlands; Univ Leeds, Sch Biomed Sci, Leeds LS2 9NL, W Yorkshire, England	Ruprecht Karls University Heidelberg; Vrije Universiteit Amsterdam; University of Leeds	Monyer, H (corresponding author), Univ Hosp Neurol, Dept Clin Neurobiol, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.		Rozov, Andrei/C-1997-2015; Katona, Istvan/D-9729-2011	Katona, Istvan/0000-0003-2808-3330; Whittington, Miles Adrian/0000-0002-0247-1362; Monyer, Hannah/0000-0002-9332-5749; Blatow, Maria/0000-0003-3371-5697				Alcantara S, 1996, EUR J NEUROSCI, V8, P1329, DOI 10.1111/j.1460-9568.1996.tb01595.x; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Buhl EH, 1998, J PHYSIOL-LONDON, V513, P117, DOI 10.1111/j.1469-7793.1998.117by.x; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; CAPUTI A, 2000, SOC NEUR M NEW ORL L; Cauli B, 2000, P NATL ACAD SCI USA, V97, P6144, DOI 10.1073/pnas.97.11.6144; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Condorelli DF, 2000, BRAIN RES REV, V32, P72, DOI 10.1016/S0165-0173(99)00068-5; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Du J, 1996, J NEUROSCI, V16, P506; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; Lubke J, 2000, J NEUROSCI, V20, P5300, DOI 10.1523/JNEUROSCI.20-14-05300.2000; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Martina M, 1998, J NEUROSCI, V18, P8111; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; Meyer AH, 2002, J NEUROSCI, V22, P7055; Penttonen M, 1998, EUR J NEUROSCI, V10, P718, DOI 10.1046/j.1460-9568.1998.00096.x; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rozov A, 2001, J NEUROSCI, V21, P8062, DOI 10.1523/JNEUROSCI.21-20-08062.2001; Sik A, 1997, EUR J NEUROSCI, V9, P573, DOI 10.1111/j.1460-9568.1997.tb01634.x; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Skinner FK, 1999, J NEUROPHYSIOL, V81, P1274, DOI 10.1152/jn.1999.81.3.1274; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Szabadics J, 2001, J NEUROSCI, V21, P5824, DOI 10.1523/JNEUROSCI.21-15-05824.2001; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Traub RD, 2001, J NEUROSCI, V21, P9478, DOI 10.1523/JNEUROSCI.21-23-09478.2001; Traub RD, 2000, EUR J NEUROSCI, V12, P4093, DOI 10.1046/j.1460-9568.2000.00300.x; TRAUB RD, 1999, FAST OSCILLATION COR; Tsodyks M, 2000, J NEUROSCI, V20; VANBREDERODE JFM, 1991, NEUROSCIENCE, V44, P157, DOI 10.1016/0306-4522(91)90258-P; Venance L, 2000, P NATL ACAD SCI USA, V97, P10260, DOI 10.1073/pnas.160037097; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; YLINEN A, 1995, HIPPOCAMPUS, V5, P78, DOI 10.1002/hipo.450050110; YLINEN A, 1995, J NEUROSCI, V15, P30	44	229	230	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 5	2003	38	5					805	817		10.1016/S0896-6273(03)00300-3	http://dx.doi.org/10.1016/S0896-6273(03)00300-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	687DU	12797964	Bronze			2022-12-24	WOS:000183361400015
J	Brauer, AU; Savaskan, NE; Kuhn, H; Prehn, S; Ninnemann, O; Nitsch, R				Brauer, AU; Savaskan, NE; Kuhn, H; Prehn, S; Ninnemann, O; Nitsch, R			A new phospholipid phosphatase, PRG-1, is involved in axon growth and regenerative sprouting	NATURE NEUROSCIENCE			English	Article							INDUCED NEURITE RETRACTION; PERFORANT PATH LESION; ADULT-RAT HIPPOCAMPUS; LYSOPHOSPHATIDIC ACID; DENTATE GYRUS; ENTORHINAL CORTEX; MOLECULES; GUIDANCE; CELLS; LYSOPHOSPHOLIPIDS	Outgrowth of axons in the central nervous system is governed by specific molecular cues. Molecules detected so far act as ligands that bind to specific receptors. Here, we report a new membrane-associated lipid phosphate phosphatase that we have named plasticity-related gene 1 (PRG-1), which facilitates axonal outgrowth during development and regenerative sprouting. PRG-1 is specifically expressed in neurons and is located in the membranes of outgrowing axons. There, it acts as an ectoenzyme and attenuates phospholipid-induced axon collapse in neurons and facilitates outgrowth in the hippocampus. Thus, we propose a novel mechanism by which axons are able to control phospholipid-mediated signaling and overcome the growth-inhibiting, phospholipid-rich environment of the extracellular space.	Humboldt Univ, Med Sch Charite, Dept Cell Biol & Neurobiol, Inst Anat, D-10115 Berlin, Germany; Humboldt Univ, Med Sch Charite, Dept Biochem, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Nitsch, R (corresponding author), Humboldt Univ, Med Sch Charite, Dept Cell Biol & Neurobiol, Inst Anat, Philippstr 12, D-10115 Berlin, Germany.	robert.nitsch@charite.de	Bräuer, Anja/N-3692-2019; Braeuer, Anja/K-8339-2013; Nitsch, Robert/AAI-9129-2021; Savaskan, Nicolai/D-2923-2018	Savaskan, Nicolai/0000-0003-1348-094X				BAYER SA, 1982, SCIENCE, V216, P890, DOI 10.1126/science.7079742; BOTHMER J, 1992, NEUROCHEM INT, V21, P223, DOI 10.1016/0197-0186(92)90151-G; Brauer AU, 2001, FASEB J, V15, P2689, DOI 10.1096/fj.01-0235com; Brauer AU, 2001, NEUROSCIENCE, V102, P515, DOI 10.1016/S0306-4522(00)00471-1; Brauer AU, 2000, HIPPOCAMPUS, V10, P632, DOI 10.1002/1098-1063(2000)10:6<632::AID-HIPO1001>3.0.CO;2-6; Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; COTMAN C, 1977, J NEUROCYTOL, V6, P455, DOI 10.1007/BF01178228; DELLER T, 1995, J NEUROSCI, V15, P6868; Frotscher M, 1997, TRENDS NEUROSCI, V20, P218, DOI 10.1016/S0166-2236(96)01018-1; Fukushima N, 2000, DEV BIOL, V228, P6, DOI 10.1006/dbio.2000.9930; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; HAWKINS JW, 1993, ANTISENSE RES DEV, V3, P233; Hla T, 2001, SCIENCE, V294, P1875, DOI 10.1126/science.1065323; Hooks SB, 2001, J BIOL CHEM, V276, P4611, DOI 10.1074/jbc.M007782200; Imai A, 2000, J CLIN ENDOCR METAB, V85, P3370, DOI 10.1210/jc.85.9.3370; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; JALINK K, 1993, CELL GROWTH DIFFER, V4, P247; JALINK K, 1994, BBA-REV CANCER, V1198, P185, DOI 10.1016/0304-419X(94)90013-2; Kanoh H, 1997, BBA-LIPID LIPID MET, V1348, P56, DOI 10.1016/S0005-2760(97)00094-5; Kobayashi H, 1997, J NEUROSCI, V17, P8339; MEIER S, 2003, FASEB J         0408; MOOLENAAR WH, 1995, CURR OPIN CELL BIOL, V7, P203, DOI 10.1016/0955-0674(95)80029-8; Moolenaar WH, 2000, ANN NY ACAD SCI, V905, P1; Moolenaar WH, 1997, CURR OPIN CELL BIOL, V9, P168, DOI 10.1016/S0955-0674(97)80059-2; Neuwald AF, 1997, PROTEIN SCI, V6, P1764, DOI 10.1002/pro.5560060817; Savaskan NE, 2002, FASEB J, V16, P112, DOI 10.1096/fj.02-0067fje; Savaskan NE, 2001, REV NEUROSCIENCE, V12, P195; Savaskan NE, 2000, EUR J NEUROSCI, V12, P1024, DOI 10.1046/j.1460-9568.2000.00998.x; Skutella T, 2001, TRENDS NEUROSCI, V24, P107, DOI 10.1016/S0166-2236(00)01717-3; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Steup A, 2000, MOL CELL NEUROSCI, V15, P141, DOI 10.1006/mcne.1999.0818; SUPER H, 1994, J COMP NEUROL, V344, P101, DOI 10.1002/cne.903440108; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tigyi G, 1996, J NEUROCHEM, V66, P549; VanDoren M, 1997, CURR BIOL, V7, pR148, DOI 10.1016/S0960-9822(97)70075-7; Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0	37	97	102	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					572	578		10.1038/nn1052	http://dx.doi.org/10.1038/nn1052			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12730698				2022-12-24	WOS:000183140400013
J	Robles, E; Huttenlocher, A; Gomez, TM				Robles, E; Huttenlocher, A; Gomez, TM			Filopodial calcium transients regulate growth cone motility and guidance through local activation of calpain	NEURON			English	Article							NERVE GROWTH; ARP2/3 COMPLEX; TYROSINE PHOSPHORYLATION; INTRACELLULAR CALCIUM; SIGNAL-TRANSDUCTION; NEURITE OUTGROWTH; AXON EXTENSION; KINASE; ACTIN; COLLAPSE	Spontaneous intracellular calcium ([Ca2+](i)) transients in growth cone filopodia reduce filopodial motility, slow neurite outgrowth, and promote turning when generated asymmetrically; however, the downstream effectors of these Ca2+-dependent behaviors are unknown. We report that Ca2+ transients in filopodia activate the intracellular protease calpain, which slows neurite outgrowth and promotes repulsive growth cone turning upon local activation. Active calpain alters the balance between tyrosine kinase and phosphatase activities in filopodia, resulting in a net decrease in tyrosine phosphorylation, which mediates both filopodial stabilization and reduced lamellipodial protrusion. Our findings indicate that locally generated Ca2+ signals repel axon outgrowth through calpain-dependent regulation of phosphotyrosine signaling at integrin-mediated adhesion sites.	Univ Wisconsin, Dept Anat, Madison, WI 53713 USA; Univ Wisconsin, Neurosci Training Program, Madison, WI 53713 USA; Univ Wisconsin, Dept Pharmacol, Madison, WI 53713 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Gomez, TM (corresponding author), Univ Wisconsin, Dept Anat, Madison, WI 53713 USA.	tmgomez@facstaff.wisc.edu		Robles, Estuardo/0000-0002-1202-2050; Gomez, Timothy/0000-0002-1515-8228	NINDS NIH HHS [NS 41564, R01 NS041564-02, R01 NS041564] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041564, R56NS041564] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alderton JM, 2000, J BIOL CHEM, V275, P9452, DOI 10.1074/jbc.275.13.9452; Amato A, 1996, DEV BRAIN RES, V92, P101, DOI 10.1016/0165-3806(95)00211-1; Bailly M, 2001, CURR BIOL, V11, P620, DOI 10.1016/S0960-9822(01)00152-X; BANDTLOW CE, 1993, SCIENCE, V259, P80, DOI 10.1126/science.8418499; Behar O, 1999, P NATL ACAD SCI USA, V96, P13501, DOI 10.1073/pnas.96.23.13501; BIXBY JL, 1994, J CELL BIOL, V127, P1461, DOI 10.1083/jcb.127.5.1461; BRAY D, 1985, J NEUROSCI, V5, P3204; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; CAUDY M, 1987, DEV BIOL, V119, P454, DOI 10.1016/0012-1606(87)90049-2; Cheng S, 2002, J NEUROBIOL, V50, P263, DOI 10.1002/neu.10027; CHIEN CB, 1993, NEURON, V11, P237, DOI 10.1016/0896-6273(93)90181-P; Cooray P, 1996, BIOCHEM J, V318, P41, DOI 10.1042/bj3180041; DAVENPORT RW, 1993, NATURE, V361, P721, DOI 10.1038/361721a0; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; FAN JH, 1995, NEURON, V14, P263, DOI 10.1016/0896-6273(95)90284-8; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Gitler D, 1998, NEURON, V20, P1123, DOI 10.1016/S0896-6273(00)80494-8; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Gomez TM, 1996, J NEUROBIOL, V29, P18, DOI 10.1002/(SICI)1097-4695(199601)29:1<18::AID-NEU2>3.0.CO;2-A; GOMEZ TM, 1995, NEURON, V14, P1233, DOI 10.1016/0896-6273(95)90270-8; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; Gomez TM, 2000, J NEUROBIOL, V44, P174, DOI 10.1002/1097-4695(200008)44:2<174::AID-NEU7>3.3.CO;2-I; GOMEZ TM, 2003, IN PRESS METHODS CEL; GU XN, 1994, J NEUROSCI, V14, P6325; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719; ILLC D, 1995, NATURE, V377, P539; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; Jay DG, 2000, J NEUROBIOL, V44, P114, DOI 10.1002/1097-4695(200008)44:2<114::AID-NEU3>3.0.CO;2-8; Kater S. B., 1995, Current Opinion in Neurobiology, V5, P68, DOI 10.1016/0959-4388(95)80089-1; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392; KROTOSKI D, 1990, J EXP ZOOL, V253, P139, DOI 10.1002/jez.1402530204; Kuhn TB, 1998, J NEUROSCI, V18, P184; Lokuta MA, 2003, P NATL ACAD SCI USA, V100, P4006, DOI 10.1073/pnas.0636533100; Menon KP, 1998, DEVELOPMENT, V125, P4121; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Pain S, 1999, FEBS LETT, V453, P119, DOI 10.1016/S0014-5793(99)00698-5; Pellicena P, 2002, FRONT BIOSCI-LANDMRK, V7, pD256, DOI 10.2741/pellicen; Renaudin A, 1999, J NEUROSCI RES, V55, P458, DOI 10.1002/(SICI)1097-4547(19990215)55:4<458::AID-JNR6>3.0.CO;2-D; Sato K, 2001, BIOL CHEM, V382, P743, DOI 10.1515/BC.2001.090; Schmidt R, 1998, INT J CANCER, V76, P91, DOI 10.1002/(SICI)1097-0215(19980330)76:1<91::AID-IJC15>3.0.CO;2-J; SHEA TB, 1995, J NEUROCHEM, V65, P517; SNOW DM, 1994, DEV BIOL, V166, P87, DOI 10.1006/dbio.1994.1298; SOMASEKHAR T, 1995, DEV BRAIN RES, V88, P53, DOI 10.1016/0165-3806(95)00080-W; SONG DK, 1994, J NEUROSCI RES, V39, P474, DOI 10.1002/jnr.490390414; Spitzer NC, 2000, BIOESSAYS, V22, P811; Steketee MB, 1999, J NEUROSCI, V19, P3495; Suter DM, 2001, J CELL BIOL, V155, P427, DOI 10.1083/jcb.200107063; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Volberg T, 2001, J CELL SCI, V114, P2279; Wang Q, 1998, J NEUROSCI, V18, P4973; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Worley T, 1996, J NEUROSCI, V16, P2294; WU DY, 1993, J CELL BIOL, V123, P653, DOI 10.1083/jcb.123.3.653; Wu DY, 1996, J NEUROSCI, V16, P1470; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501; Zheng JQ, 1996, J NEUROSCI, V16, P1140; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0; Zhou FQ, 2001, J CELL BIOL, V153, P1071, DOI 10.1083/jcb.153.5.1071; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	63	129	131	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 22	2003	38	4					597	609		10.1016/S0896-6273(03)00260-5	http://dx.doi.org/10.1016/S0896-6273(03)00260-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	682QV	12765611	Bronze			2022-12-24	WOS:000183104000010
J	Mitchell, SJ; Silver, RA				Mitchell, SJ; Silver, RA			Shunting inhibition modulates neuronal gain during synaptic excitation	NEURON			English	Article							GRANULE CELLS; TIME-COURSE; POSTSYNAPTIC CURRENTS; CONTRAST INVARIANCE; CORTICAL-NEURONS; SILENT SYNAPSES; AMPA RECEPTORS; RAT; CAT; SPILLOVER	Neuronal gain control is important for processing information in the brain. Shunting inhibition is not thought to control gain since it shifts input-output relationships during tonic excitation rather than changing their slope. Here we show that tonic inhibition reduces the gain and shifts the offset of cerebellar granule cell input-output relationships during frequency-dependent excitation with synaptic conductance waveforms. Shunting inhibition scales subthreshold voltage, increasing the excitation frequency required to attain a particular firing rate. This reduces gain because frequency-dependent increases in input variability, which couple mean subthreshold voltage to firing rate, boost voltage fluctuations during inhibition. Moreover, synaptic time course and the number of inputs also influence gain changes by setting excitation variability. Our results suggest that shunting inhibition can multiplicatively scale rate-coded information in neurons with high-variability synaptic inputs.	UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London	Silver, RA (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	a.silver@ucl.ac.uk		Silver, Robin/0000-0002-5480-6638				ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BERGER AJ, 1992, NEUROSCI LETT, V143, P164, DOI 10.1016/0304-3940(92)90257-8; BERMAN NJ, 1992, PROG BRAIN RES, V90, P443; BLOMFIELD S, 1974, BRAIN RES, V69, P115, DOI 10.1016/0006-8993(74)90375-8; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; BURNS BD, 1976, PROC R SOC SER B-BIO, V194, P211, DOI 10.1098/rspb.1976.0074; Capaday C, 2002, EXP BRAIN RES, V143, P67, DOI 10.1007/s00221-001-0970-z; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; CONNORS BW, 1988, J PHYSIOL-LONDON, V406, P443, DOI 10.1113/jphysiol.1988.sp017390; COOMBS JS, 1955, J PHYSIOL-LONDON, V130, P396, DOI 10.1113/jphysiol.1955.sp005414; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; Doiron B, 2001, NEURAL COMPUT, V13, P227, DOI 10.1162/089976601300014691; duLac S, 1996, ANN NY ACAD SCI, V781, P489; Eccles J.C., 1967, CEREBELLUM COMPUTATI; EDGLEY SA, 1987, J PHYSIOL-LONDON, V392, P315, DOI 10.1113/jphysiol.1987.sp016782; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; FATT P, 1953, J PHYSIOL-LONDON, V121, P374, DOI 10.1113/jphysiol.1953.sp004952; FORSYTHE ID, 1993, P ROY SOC B-BIOL SCI, V251, P151, DOI 10.1098/rspb.1993.0022; Gabbiani F, 2002, NATURE, V420, P320, DOI 10.1038/nature01190; GABBIANI F, 1994, J NEUROPHYSIOL, V72, P999, DOI 10.1152/jn.1994.72.2.999; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; GRANIT R, 1966, J PHYSIOL-LONDON, V187, P379, DOI 10.1113/jphysiol.1966.sp008097; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; Harsch A, 2000, J NEUROSCI, V20, P6181, DOI 10.1523/JNEUROSCI.20-16-06181.2000; Ho N, 2000, J NEUROPHYSIOL, V84, P1488, DOI 10.1152/jn.2000.84.3.1488; Holt GR, 1997, NEURAL COMPUT, V9, P1001, DOI 10.1162/neco.1997.9.5.1001; Hsiao CF, 1997, J NEUROPHYSIOL, V77, P2910, DOI 10.1152/jn.1997.77.6.2910; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaacson JS, 1996, J NEUROPHYSIOL, V76, P1566, DOI 10.1152/jn.1996.76.3.1566; KANEDA M, 1995, J PHYSIOL-LONDON, V485, P419, DOI 10.1113/jphysiol.1995.sp020739; Koch Christof, 1999, P1; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Maffei A, 2002, J NEUROPHYSIOL, V88, P627, DOI 10.1152/jn.2002.88.2.627; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; MENNERICK S, 1995, J NEUROSCI, V15, P3178; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; Mitchell SJ, 2000, NATURE, V404, P498, DOI 10.1038/35006649; Mitchell SJ, 2000, J NEUROSCI, V20, P8651; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; PUIA G, 1994, NEURON, V12, P117, DOI 10.1016/0896-6273(94)90157-0; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; Rice SO, 1954, SELECTED PAPERS NOIS, P133; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SILLITO AM, 1977, J PHYSIOL-LONDON, V271, P699, DOI 10.1113/jphysiol.1977.sp012021; SILVER RA, 1992, NATURE, V355, P163, DOI 10.1038/355163a0; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Stacey WC, 2001, J NEUROPHYSIOL, V86, P1104, DOI 10.1152/jn.2001.86.3.1104; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; TOMKO GJ, 1974, BRAIN RES, V79, P405, DOI 10.1016/0006-8993(74)90438-7; TORRE V, 1978, PROC R SOC SER B-BIO, V202, P409, DOI 10.1098/rspb.1978.0075; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; TYRRELL T, 1992, PHILOS T ROY SOC B, V336, P239, DOI 10.1098/rstb.1992.0059; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; WYATT HJ, 1975, J NEUROPHYSIOL, V38, P613, DOI 10.1152/jn.1975.38.3.613; ZHANG S, 1994, J PHYSIOL-LONDON, V480, P123, DOI 10.1113/jphysiol.1994.sp020346	69	415	428	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 8	2003	38	3					433	445		10.1016/S0896-6273(03)00200-9	http://dx.doi.org/10.1016/S0896-6273(03)00200-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	677HF	12741990	Bronze			2022-12-24	WOS:000182800300008
J	Felmy, F; Neher, E; Schneggenburger, R				Felmy, F; Neher, E; Schneggenburger, R			Probing the intracellular calcium sensitivity of transmitter release during synaptic facilitation	NEURON			English	Article							SQUID GIANT SYNAPSE; RAT BRAIN-STEM; PRESYNAPTIC CALCIUM; RESIDUAL CALCIUM; NERVE-TERMINALS; NEUROTRANSMITTER RELEASE; TIME-COURSE; CA2+; CALYX; CURRENTS	In nerve terminals, residual Ca2+ remaining from previous activity can cause facilitation of transmitter release by a mechanism that is still under debate. Here we show that the intracellular Ca2+ sensitivity of transmitter release at the calyx of Held is largely unchanged during facilitation, which leaves an increased microdomain Ca2+ signal as a possible mechanism for facilitation. We measured the Ca2+ dependencies of facilitation, as well as of transmitter release, to estimate the required increment in microdomain Ca2+. These measurements show that linear summation of residual and microdomain Ca2+ accounts for only 30% of the observed facilitation. However, a small degree of supra-linearity in the summation of intracellular Ca2+ signals, which might be caused by saturation of cytosolic Ca2+ buffer(s), is sufficient to explain facilitation at this CNS synapse.	Max Planck Inst Biophys Chem, Abt Membranbiophys, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, AG Synapt Dynam & Modulat, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Schneggenburger, R (corresponding author), Max Planck Inst Biophys Chem, Abt Membranbiophys, Fassberg 11, D-37077 Gottingen, Germany.		Neher, Erwin/A-2109-2013					ADLER EM, 1991, J NEUROSCI, V11, P1496; AHARON S, 1994, B MATH BIOL, V56, P1095, DOI 10.1016/S0092-8240(05)80333-7; Atluri PP, 1996, J NEUROSCI, V16, P5661; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; Bertram R, 1996, J NEUROPHYSIOL, V75, P1919, DOI 10.1152/jn.1996.75.5.1919; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; CHAD JE, 1984, BIOPHYS J, V45, P993, DOI 10.1016/S0006-3495(84)84244-7; Chuhma N, 2001, J PHYSIOL-LONDON, V530, P93, DOI 10.1111/j.1469-7793.2001.0093m.x; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; DELANEY KR, 1994, J NEUROSCI, V14, P5885; Dittman JS, 2000, J NEUROSCI, V20, P1374; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381, DOI 10.1113/jphysiol.1994.sp020303; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; LANDO L, 1994, J NEUROPHYSIOL, V72, P825, DOI 10.1152/jn.1994.72.2.825; Maeda H, 1999, NEURON, V24, P989, DOI 10.1016/S0896-6273(00)81045-4; Matveev V, 2002, BIOPHYS J, V83, P1368, DOI 10.1016/S0006-3495(02)73907-6; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; Naraghi M, 1997, J NEUROSCI, V17, P6961; Neher E, 2001, J NEUROSCI, V21, P444, DOI 10.1523/JNEUROSCI.21-02-00444.2001; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; REGEHR WG, 1994, J NEUROSCI, V14, P523; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; ROBERTS WM, 1994, J NEUROSCI, V14, P3246; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Rozov A, 1998, J PHYSIOL-LONDON, V511, P361, DOI 10.1111/j.1469-7793.1998.361bh.x; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Satzler K, 2002, J NEUROSCI, V22, P10567; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; STANLEY EF, 1986, J NEUROSCI, V6, P782; Stevens CF, 1999, NEURON, V22, P139, DOI 10.1016/S0896-6273(00)80685-6; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; SWANDULLA D, 1991, NEURON, V7, P915, DOI 10.1016/0896-6273(91)90337-Y; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; Tang YG, 2000, BIOPHYS J, V78, P2735, DOI 10.1016/S0006-3495(00)76819-6; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; Vyshedskiy A, 2000, J NEUROSCI, V20, P6326, DOI 10.1523/JNEUROSCI.20-17-06326.2000; WU LG, 1994, J NEUROSCI, V14, P645; Wu LG, 1999, J NEUROSCI, V19, P726; YAMADA WM, 1992, BIOPHYS J, V61, P671, DOI 10.1016/S0006-3495(92)81872-6; ZUCKER RS, 1992, CELL CALCIUM, V13, P29, DOI 10.1016/0143-4160(92)90027-P; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	53	135	137	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 6	2003	37	5					801	811		10.1016/S0896-6273(03)00085-0	http://dx.doi.org/10.1016/S0896-6273(03)00085-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	653TH	12628170	Bronze			2022-12-24	WOS:000181452800009
J	Brunel, N; Hakim, V; Isope, P; Nadal, JP; Barbour, B				Brunel, N; Hakim, V; Isope, P; Nadal, JP; Barbour, B			Optimal information storage and the distribution of synaptic weights: Perceptron versus Purkinje cell	NEURON			English	Article							FIBER RECEPTIVE-FIELDS; RAT VISUAL-CORTEX; PYRAMIDAL NEURONS; SILENT SYNAPSES; NEURAL-NETWORKS; POSTSYNAPTIC EXPRESSION; CEREBELLAR CORTEX; PLASTICITY; GRANULE; AMPA	It is widely believed that synaptic modifications underlie learning and memory. However, few studies have examined what can be deduced about the learning process from the distribution of synaptic weights. We analyze the perceptron, a prototypical feedforward neural network, and obtain the optimal synaptic weight distribution for a perceptron with excitatory synapses. It contains more than 50% silent synapses, and this fraction increases with storage reliability: silent synapses are therefore a necessary byproduct of optimizing learning and reliability. Exploiting the classical analogy between the perceptron and the cerebellar Purkinje cell, we fitted the optimal weight distribution to that measured for granule cell-Purkinje cell synapses. The two distributions agreed well, suggesting that the Purkinje cell can learn up to 5 kilobytes of information, in the form of 40,000 input-output associations.	Ecole Normale Super, Neurobiol Lab, F-75230 Paris 05, France; Univ Paris 05, F-75270 Paris 06, France; Ecole Normale Super, Phys Stat Lab, F-75231 Paris 05, France; Kinsmen Lab Neurol Res, Dept Psychiat, Vancouver, BC V6T 1Z3, Canada	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of British Columbia	Barbour, B (corresponding author), Ecole Normale Super, Neurobiol Lab, 46 Rue Ulm, F-75230 Paris 05, France.	barbour@ens.fr	Nadal, Jean-Pierre/HHM-8804-2022	Isope, Philippe/0000-0002-0630-5935; Nadal, Jean-Pierre/0000-0003-0022-0647; Barbour, Boris/0000-0002-1911-0539; hakim, vincent/0000-0001-7505-8192				Albus JS, 1971, MATH BIOSCI, V10, P26, DOI DOI 10.1016/0025-5564(71)90051-4; ARNIT D, 1989, MODELING BRAIN FUNCT; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; Cateau H, 2003, NEURAL COMPUT, V15, P597, DOI 10.1162/089976603321192095; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Coenen OJMD, 2001, AUTON ROBOT, V11, P291, DOI 10.1023/A:1012403510221; COVER TM, 1965, IEEE TRANS ELECTRON, VEC14, P326, DOI 10.1109/PGEC.1965.264137; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Eccles JC, 1967, CEREBELLUM NEURONAL; Efron B., 1994, INTRO BOOTSTRAP; Ekerot CF, 2001, EUR J NEUROSCI, V13, P1303, DOI 10.1046/j.0953-816x.2001.01499.x; Engel A., 2001, STAT MECH LEARNING; FATT P, 1953, J PHYSIOL-LONDON, V121, P374, DOI 10.1113/jphysiol.1953.sp004952; GARDNER E, 1988, J PHYS A-MATH GEN, V21, P271, DOI 10.1088/0305-4470/21/1/031; GARDNER E, 1988, J PHYS A-MATH GEN, V21, P257, DOI 10.1088/0305-4470/21/1/030; GRINIASTY M, 1991, J PHYS A-MATH GEN, V24, P715, DOI 10.1088/0305-4470/24/3/030; GUTFREUND H, 1990, J PHYS A-MATH GEN, V23, P2613, DOI 10.1088/0305-4470/23/12/036; Gutig R, 2003, J NEUROSCI, V23, P3697; HARVEY RJ, 1988, J COMP NEUROL, V274, P151, DOI 10.1002/cne.902740202; HARVEY RJ, 1991, PROG NEUROBIOL, V36, P437, DOI 10.1016/0301-0082(91)90012-P; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Hebb Donald O., 1949, ORG BEHAV; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Isope P, 2002, ANN NY ACAD SCI, V978, P164, DOI 10.1111/j.1749-6632.2002.tb07564.x; Isope P, 2002, J NEUROSCI, V22, P9668; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1982, NEUROSCI LETT, V33, P253, DOI 10.1016/0304-3940(82)90380-9; Jorntell H, 2003, J NEUROSCI, V23, P9620; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Kharazia VN, 1999, J COMP NEUROL, V412, P292, DOI 10.1002/(SICI)1096-9861(19990920)412:2<292::AID-CNE8>3.0.CO;2-G; KOHLER HM, 1991, J PHYS A-MATH GEN, V24, pL495, DOI 10.1088/0305-4470/24/9/008; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lubke J, 1996, J NEUROSCI, V16, P3209; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MASON A, 1991, J NEUROSCI, V11, P72; Mezard M., 1987, SPIN GLASS THEORY IN; Minsky M., 1988, PERCEPTRONS INTRO CO; MONASSON R, 1992, J PHYS A-MATH GEN, V25, P3701, DOI 10.1088/0305-4470/25/13/019; Montgomery JM, 2001, NEURON, V29, P691, DOI 10.1016/S0896-6273(01)00244-6; Nadal JP, 1990, NETWORK-COMP NEURAL, V1, P61, DOI 10.1088/0954-898X/1/1/005; Nadal JP, 1990, NETWORK-COMP NEURAL, V1, P463, DOI 10.1088/0954-898X/1/4/006; NAPPER RMA, 1988, J COMP NEUROL, V274, P158, DOI 10.1002/cne.902740203; NAPPER RMA, 1988, J COMP NEUROL, V274, P168, DOI 10.1002/cne.902740204; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Press W. H., 1992, ART SCI COMPUTING; Rosenblatt F., 1962, PRINCIPLES NEURODYNA, DOI 10.21236/AD0256582; Rubin J, 2001, PHYS REV LETT, V86, P364, DOI 10.1103/PhysRevLett.86.364; Rumpel S, 1998, J NEUROSCI, V18, P8863; SAYER RJ, 1990, J NEUROSCI, V10, P826; Schweighofer N, 2001, NEUROSCIENCE, V103, P35, DOI 10.1016/S0306-4522(00)00548-0; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; Thier P, 2000, NATURE, V405, P72, DOI 10.1038/35011062; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; 1999, NAT NEUROSCI, V2, P618	67	184	184	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 2	2004	43	5					745	757		10.1016/j.neuron.2004.08.023	http://dx.doi.org/10.1016/j.neuron.2004.08.023			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339654	Bronze			2022-12-24	WOS:000223691900018
J	Mirescu, C; Peters, JD; Gould, E				Mirescu, C; Peters, JD; Gould, E			Early life experience alters response of adult neurogenesis to stress	NATURE NEUROSCIENCE			English	Article							NEONATAL MATERNAL SEPARATION; GENERATED GRANULE CELLS; RAT DENTATE GYRUS; LONG-EVANS RATS; SYNAPTIC PLASTICITY; HIPPOCAMPAL VOLUME; NEGATIVE FEEDBACK; MAJOR DEPRESSION; MEDIAN-EMINENCE; PROLIFERATION	Maternal deprivation produces persistent abnormalities in behavioral and neuroendocrine functions associated with the hippocampus, a brain region that shows considerable structural change in response to experience throughout life. Here we show that adverse experience early in life affects the regulation of adult neurogenesis in the hippocampus. More specifically, a decrease in cell proliferation and immature neuron production are observed in the dentate gyrus of adult rats that are maternally separated as pups. Although maternally separated rats show normal basal levels of corticosterone, the suppression of cell proliferation in these rats can be reversed by lowering corticosterone below the control value. In addition, normal stress-induced suppression of cell proliferation and neurogenesis, despite normal activation of the hypothalamic pituitary adrenal (HPA) axis, is not observed in maternally separated rats. Our results suggest that early adverse experience inhibits structural plasticity via hypersensitivity to glucocorticoids and diminishes the ability of the hippocampus to respond to stress in adulthood.	Princeton Univ, Dept Physiol, Princeton, NJ 08544 USA	Princeton University	Gould, E (corresponding author), Princeton Univ, Dept Physiol, Princeton, NJ 08544 USA.	goulde@princeton.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059740, P50MH058922] Funding Source: NIH RePORTER; NIMH NIH HHS [MH58922, MH59740] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BANNERMAN DM, 2003, BEHAV NEUROSCI, V116, P884; Bremner JD, 2001, AM J PSYCHIAT, V158, P653, DOI 10.1176/appi.ajp.158.4.653; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Deacon RMJ, 2002, BEHAV NEUROSCI, V116, P494, DOI 10.1037//0735-7044.116.3.494; Dobrossy MD, 2003, MOL PSYCHIATR, V8, P974, DOI 10.1038/sj.mp.4001419; GOULD E, 1990, NEUROSCIENCE, V37, P367, DOI 10.1016/0306-4522(90)90407-U; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; GOULD E, 1992, J NEUROSCI, V12, P3642; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Gould E, 1997, J NEUROSCI, V17, P2492; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; HERMAN JP, 1995, J NEUROENDOCRINOL, V7, P475, DOI 10.1111/j.1365-2826.1995.tb00784.x; Huot RL, 2001, PSYCHOPHARMACOLOGY, V158, P366, DOI 10.1007/s002130100701; Huot RL, 2002, BRAIN RES, V950, P52, DOI 10.1016/S0006-8993(02)02985-2; JANS JE, 1990, DEV PSYCHOBIOL, V23, P519, DOI 10.1002/dev.420230607; Levine S, 2000, EUR J PHARMACOL, V405, P149, DOI 10.1016/S0014-2999(00)00548-3; Liu D, 2000, J NEUROENDOCRINOL, V12, P5; Lovic V, 2001, DEV PSYCHOBIOL, V39, P19, DOI 10.1002/dev.1024; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; MAGARINOS AM, 1987, HORM METAB RES, V19, P105, DOI 10.1055/s-2007-1011753; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; MEANEY MJ, 1989, NEUROENDOCRINOLOGY, V50, P597, DOI 10.1159/000125287; Newport DJ, 2002, AM J PSYCHIAT, V159, P1265, DOI 10.1176/appi.ajp.159.8.1265; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SAPOLSKY RM, 1986, BRAIN RES REV, V11, P65, DOI 10.1016/0165-0173(86)90010-X; SAPOLSKY RM, 1989, ENDOCRINOLOGY, V125, P2881, DOI 10.1210/endo-125-6-2881; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Sheline YI, 1996, MOL PSYCHIATR, V1, P298; Sheline YI, 1999, J NEUROSCI, V19, P5034; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Stein MB, 1997, PSYCHOL MED, V27, P951, DOI 10.1017/S0033291797005242; Tanapat P, 2001, J COMP NEUROL, V437, P496, DOI 10.1002/cne.1297; VERNETMAURY E, 1984, J CHEM ECOL, V10, P1007, DOI 10.1007/BF00987509; Viau V, 1996, J NEUROENDOCRINOL, V8, P1, DOI 10.1111/j.1365-2826.1996.tb00680.x; VIAU V, 1993, J NEUROSCI, V13, P1097; Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A	44	470	489	0	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					841	846		10.1038/nn1290	http://dx.doi.org/10.1038/nn1290			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15273691				2022-12-24	WOS:000222930800014
J	van Atteveldt, N; Formisano, E; Goebel, R; Blomert, L				van Atteveldt, N; Formisano, E; Goebel, R; Blomert, L			Integration of letters and speech sounds in the human brain	NEURON			English	Article							SUPERIOR TEMPORAL SULCUS; AUDITORY-CORTEX; AUDIOVISUAL INTEGRATION; CROSSMODAL BINDING; VISUAL INFORMATION; PERCEPTION; ACTIVATION; GRAPHEME; MACAQUE; AREA	Most people acquire literacy skills with remarkable ease, even though the human brain is not evolutionarily adapted to this relatively new cultural phenomenon. Associations between letters and speech sounds form the basis of reading in alphabetic scripts. We investigated the functional neuroanatomy of the integration of letters and speech sounds using functional magnetic resonance imaging (fMRI). Letters and speech sounds were presented unimodally and bimodally in congruent or incongruent combinations. Analysis of single-subject data and group data aligned on the basis of individual cortical anatomy revealed that letters and speech sounds are integrated in heteromodal superior temporal cortex. Interestingly, responses to speech sounds in a modality-specific region of the early auditory cortex were modified by simultaneously presented letters. These results suggest that efficient processing of culturally defined associations between letters and speech sounds relies on neural mechanisms similar to those naturally evolved for integrating audiovisual speech.	Univ Maastricht, Fac Psychol, Dept Cognit Neurosci, NL-6200 MD Maastricht, Netherlands; FC Donders Ctr Cognit Neuroimaging, NL-6500 HB Nijmegen, Netherlands	Maastricht University	van Atteveldt, N (corresponding author), Univ Maastricht, Fac Psychol, Dept Cognit Neurosci, POB 616, NL-6200 MD Maastricht, Netherlands.	n.vanatteveldt@psychology.unimaas.nl	van Atteveldt, Nienke M/K-2124-2014	van Atteveldt, Nienke M/0000-0002-3387-6151; Goebel, Rainer/0000-0003-1780-2467; Formisano, Elia/0000-0001-5008-2460				BAYLIS GC, 1987, J NEUROSCI, V7, P330; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; BLOMERT L, 2002, DYSLEXIE STAND ZAKEN; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; Bushara KO, 2003, NAT NEUROSCI, V6, P190, DOI 10.1038/nn993; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 1999, NEUROREPORT, V10, P2619, DOI 10.1097/00001756-199908200-00033; Calvert GA, 2003, J COGNITIVE NEUROSCI, V15, P57, DOI 10.1162/089892903321107828; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; DIJKSTRA T, 1993, J EXP PSYCHOL HUMAN, V19, P931, DOI 10.1037/0096-1523.19.5.931; DIJKSTRA T, 1989, LANG SPEECH, V32, P89, DOI 10.1177/002383098903200201; Duvemoy H. M., 1999, HUMAN BRAIN SURFACE; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; Fort A, 2002, CEREB CORTEX, V12, P1031, DOI 10.1093/cercor/12.10.1031; Frith U., 1985, SURFACE DYSLEXIA NEU, P301, DOI DOI 10.4324/9781315108346-18; FROST R, 1988, J MEM LANG, V27, P741, DOI 10.1016/0749-596X(88)90018-6; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gros H, 2001, J CEREBR BLOOD F MET, V21, P1330, DOI 10.1097/00004647-200111000-00009; Hadjikhani N, 1998, J NEUROSCI, V18, P1072; HARDY M, 1972, J EDUC PSYCHOL, V63, P433, DOI 10.1037/h0033240; HIKOSAKA K, 1988, J NEUROPHYSIOL, V60, P1615, DOI 10.1152/jn.1988.60.5.1615; Hinton G. E., 1986, FOUNDATIONS, V1, P77; Jancke L, 2002, NEUROIMAGE, V15, P733, DOI 10.1006/nimg.2001.1027; Jones JA, 2003, NEUROREPORT, V14, P1129, DOI 10.1097/00001756-200306110-00006; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kim JJ, 2000, NEUROIMAGE, V11, P271, DOI 10.1006/nimg.2000.0543; King AJ, 2001, CURR BIOL, V11, pR322, DOI 10.1016/S0960-9822(01)00175-0; Liberman A. M., 1992, ADV PSYCHOL, P167; Longcamp M, 2003, NEUROIMAGE, V19, P1492, DOI 10.1016/S1053-8119(03)00088-0; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; MASSARO DW, 1988, VISIBLE LANGUAGE SPE, V22; MCGURK H, 1976, NATURE, V263, P747; Meredith MA, 2002, COGNITIVE BRAIN RES, V14, P31, DOI 10.1016/S0926-6410(02)00059-9; Olson IR, 2002, COGNITIVE BRAIN RES, V14, P129, DOI 10.1016/S0926-6410(02)00067-8; Paulesu E, 2003, J NEUROPHYSIOL, V90, P2005, DOI 10.1152/jn.00926.2002; Perfetti C A, 2000, J Deaf Stud Deaf Educ, V5, P32, DOI 10.1093/deafed/5.1.32; Polk TA, 2002, J COGNITIVE NEUROSCI, V14, P145, DOI 10.1162/089892902317236803; Raij T, 2000, NEURON, V28, P617, DOI 10.1016/S0896-6273(00)00138-0; SAMS M, 1991, NEUROSCI LETT, V127, P141, DOI 10.1016/0304-3940(91)90914-F; Schroeder CE, 2002, COGNITIVE BRAIN RES, V14, P187, DOI 10.1016/S0926-6410(02)00073-3; Sekiyama K, 2003, NEUROSCI RES, V47, P277, DOI 10.1016/S0168-0102(03)00214-1; Shah NJ, 2000, NEUROIMAGE, V12, P100, DOI 10.1006/nimg.2000.0588; Snow C., 1998, PREV READ DIFF YOUNG; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Suzuki M, 2002, HEARING RES, V163, P37, DOI 10.1016/S0378-5955(01)00367-7; Tervaniemi M, 2000, HUM BRAIN MAPP, V10, P74, DOI 10.1002/(SICI)1097-0193(200006)10:2<74::AID-HBM30>3.0.CO;2-2; Wallace MT, 1996, J NEUROPHYSIOL, V76, P1246, DOI 10.1152/jn.1996.76.2.1246; Wright TM, 2003, CEREB CORTEX, V13, P1034, DOI 10.1093/cercor/13.10.1034	54	375	376	1	47	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 22	2004	43	2					271	282		10.1016/j.neuron.2004.06.025	http://dx.doi.org/10.1016/j.neuron.2004.06.025			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841BX	15260962	Green Published, Bronze			2022-12-24	WOS:000222905400015
J	Moulder, KL; Meeks, JP; Shute, AA; Hamilton, CK; de Erausquin, G; Mennerick, S				Moulder, KL; Meeks, JP; Shute, AA; Hamilton, CK; de Erausquin, G; Mennerick, S			Plastic elimination of functional glutamate release sites by depolarization	NEURON			English	Article							EXCITATORY SYNAPTIC CURRENTS; HIPPOCAMPAL-NEURONS; SILENT SYNAPSES; NEUROTRANSMITTER RELEASE; PRESYNAPTIC RELEASE; QUANTAL AMPLITUDE; CALCIUM CURRENTS; TIME-COURSE; TRANSPORTERS; ACTIVATION	To examine persisting effects of depolarizing rises in extracellular potassium concentration ([K+](o)) on synapses, we depolarized cells to simulate ischemia-like rises in [K+](o). Elevated [K+](o) for 1-16 hr severely depressed glutamate signaling, while mildly depressing GABA transmission. The glutamate-specific changes were plastic over several hours and involved a decrease in the size of the pool of releasable vesicles. Rather than a reduction of the number of vesicles per release site, the change involved functional elimination of release sites. This change was clearly dissociable from a second effect, depressed probability of transmitter release, which was common to both glutamate and GABA transmission. Thus, while other recent evidence links alteration of the releasable pool size with changes in p(r), our results suggest the two can be independently manipulated. Selective depression of glutamate release may provide an adaptive mechanism by which neurons limit excitotoxicity.	Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Mennerick, S (corresponding author), Washington Univ, Sch Med, Dept Psychiat, 660 S Euclid Ave, St Louis, MO 63110 USA.	menneris@psychiatry.wustl.edu	Mennerick, Steven/O-2806-2017; Meeks, Julian/ABE-4361-2020; de Erausquin, Gabriel A./Z-1952-2019; de Erausquin, Gabriel A/G-5840-2010	Mennerick, Steven/0000-0003-0868-0664; de Erausquin, Gabriel A./0000-0001-6423-4461; de Erausquin, Gabriel A/0000-0001-6423-4461; Meeks, Julian/0000-0002-7537-4491	NIAAA NIH HHS [AA 12592] Funding Source: Medline; NIDA NIH HHS [5T32 DA 07261, 1F32 DA 15948] Funding Source: Medline; NINDS NIH HHS [NS 40488] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007261, F32DA015948] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; ATLROCK WD, 2003, NEURON, V37, P787; Atwood HL, 1999, LEARN MEMORY, V6, P542, DOI 10.1101/lm.6.6.542; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bacci A, 2001, J NEUROSCI, V21, P6588, DOI 10.1523/JNEUROSCI.21-17-06588.2001; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Calhoun ME, 1996, J NEUROCYTOL, V25, P821, DOI 10.1007/BF02284844; Diamond JS, 1997, J NEUROSCI, V17, P4672; Diamond JS, 1998, NEURON, V21, P425, DOI 10.1016/S0896-6273(00)80551-6; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; Foster KA, 2002, NEURON, V36, P1115, DOI 10.1016/S0896-6273(02)01106-6; FRANKLIN JL, 1992, J NEUROSCI, V12, P1726; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; Gido G, 1997, STROKE, V28, P206, DOI 10.1161/01.STR.28.1.206; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; He YJ, 2002, J NEUROPHYSIOL, V87, P925, DOI 10.1152/jn.00225.2001; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Hopf FW, 2002, J NEUROSCI, V22, P775, DOI 10.1523/JNEUROSCI.22-03-00775.2002; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Krueger SR, 2003, NEURON, V40, P945, DOI 10.1016/S0896-6273(03)00729-3; Leslie KR, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-19-j0005.2001; Li MX, 1996, J NEUROPHYSIOL, V76, P2595, DOI 10.1152/jn.1996.76.4.2595; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Linden DJ, 1998, J NEUROPHYSIOL, V79, P3151, DOI 10.1152/jn.1998.79.6.3151; Luscher C, 1998, NEURON, V21, P435, DOI 10.1016/S0896-6273(00)80552-8; Luthi A, 2001, NAT NEUROSCI, V4, P1102, DOI 10.1038/nn744; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; Mennerick S, 1999, J NEUROSCI, V19, P9242; MENNERICK S, 1995, J NEUROPHYSIOL, V73, P320, DOI 10.1152/jn.1995.73.1.320; MENNERICK S, 1995, J PHYSIOL-LONDON, V488, P85, DOI 10.1113/jphysiol.1995.sp020948; Mennerick S, 1996, J NEUROSCI, V16, P55; MENNERICK S, 1995, J NEUROSCI, V15, P3178; Moulder KL, 2003, J NEUROSCI, V23, P1825; Moulder KL, 2002, NEUROBIOL DIS, V10, P396, DOI 10.1006/nbdi.2002.0523; Mozhayeva MG, 2002, J NEUROSCI, V22, P654, DOI 10.1523/JNEUROSCI.22-03-00654.2002; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Overstreet LS, 1999, J NEUROSCI, V19, P9663; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; Prakriya M, 2000, NEURON, V26, P671, DOI 10.1016/S0896-6273(00)81203-9; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Ryan TA, 1997, NATURE, V388, P478, DOI 10.1038/41335; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; SHARPLESS SK, 1975, DEV NEUROPSYCHOL, P125; Shi J, 2001, J NEUROSCI, V21, P6233, DOI 10.1523/JNEUROSCI.21-16-06233.2001; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wadiche JI, 1998, J NEUROSCI, V18, P7650; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Walz W, 2000, NEUROCHEM INT, V36, P291, DOI 10.1016/S0197-0186(99)00137-0; Xu WY, 2000, J NEUROSCI, V20, P3147, DOI 10.1523/JNEUROSCI.20-09-03147.2000; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	64	49	50	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2004	42	3					423	435		10.1016/S0896-6273(04)00184-9	http://dx.doi.org/10.1016/S0896-6273(04)00184-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KH	15134639	Bronze			2022-12-24	WOS:000221458700009
J	Chambers, CD; Payne, JM; Stokes, MG; Mattingley, JB				Chambers, CD; Payne, JM; Stokes, MG; Mattingley, JB			Fast and slow parietal pathways mediate spatial attention	NATURE NEUROSCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CORTEX	Mechanisms of selective attention are vital for guiding human behavior. The parietal cortex has long been recognized as a neural substrate of spatial attention, but the unique role of distinct parietal subregions has remained unclear. Using single-pulse transcranial magnetic stimulation, we found that the angular gyrus of the right parietal cortex mediates spatial orienting during two distinct time periods after the onset of a behaviorally relevant event. The biphasic involvement of the angular gyrus suggests that both fast and slow visual pathways are necessary for orienting spatial attention.	Univ Melbourne, Dept Psychol, Cognit Neurosci Lab, Melbourne, Vic 3010, Australia	University of Melbourne	Chambers, CD (corresponding author), Univ Melbourne, Dept Psychol, Cognit Neurosci Lab, Melbourne, Vic 3010, Australia.	c.chambers@psych.unimelb.edu.au	Mattingley, Jason/J-1537-2014; Chambers, Chris/E-7827-2010	Mattingley, Jason/0000-0003-0929-9216; Payne, Jonathan/0000-0001-9565-3845; Chambers, Chris/0000-0001-6058-4114				Ashbridge E, 1997, NEUROPSYCHOLOGIA, V35, P1121, DOI 10.1016/S0028-3932(97)00003-1; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Clower DM, 2001, J NEUROSCI, V21, P6283, DOI 10.1523/JNEUROSCI.21-16-06283.2001; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Muri RM, 2002, EXP BRAIN RES, V143, P426, DOI 10.1007/s00221-002-1009-9; ROBINSON DL, 1995, J NEUROPHYSIOL, V74, P698, DOI 10.1152/jn.1995.74.2.698; Rushworth MFS, 2001, NAT NEUROSCI, V4, P656, DOI 10.1038/88492; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; WRIGHT MJ, 1995, BIOL PSYCHOL, V41, P183, DOI 10.1016/0301-0511(95)05128-7	11	190	192	0	11	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					217	218		10.1038/nn1203	http://dx.doi.org/10.1038/nn1203			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14983182				2022-12-24	WOS:000189197900009
J	Critchley, HD; Wiens, S; Rotshtein, P; Ohman, A; Dolan, RJ				Critchley, HD; Wiens, S; Rotshtein, P; Ohman, A; Dolan, RJ			Neural systems supporting interoceptive awareness	NATURE NEUROSCIENCE			English	Article							VOXEL-BASED MORPHOMETRY; VISCERAL PERCEPTION; BRAIN ACTIVATION; HEARTBEAT; FEAR; EMOTION; AROUSAL	Influential theories of human emotion argue that subjective feeling states involve representation of bodily responses elicited by emotional events. Within this framework, individual differences in intensity of emotional experience reflect variation in sensitivity to internal bodily responses. We measured regional brain activity by functional magnetic resonance imaging (fMRI) during an interoceptive task wherein subjects judged the timing of their own heartbeats. We observed enhanced activity in insula, somatomotor and cingulate cortices. In right anterior insular/opercular cortex, neural activity predicted subjects' accuracy in the heartbeat detection task. Furthermore, local gray matter volume in the same region correlated with both interoceptive accuracy and subjective ratings of visceral awareness. Indices of negative emotional experience correlated with interoceptive accuracy across subjects. These findings indicate that right anterior insula supports a representation of visceral responses accessible to awareness, providing a substrate for subjective feeling states.	UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; UCL, Inst Cognit Neurosci, London WC1N 3AR, England; UCL Hosp, Natl Hosp Neurol & Neurosurg, Auton Unit, London WC1N 3BG, England; Karolinska Hosp, Dept Clin Neurosci, Psychol Sect, SE-17176 Stockholm, Sweden	University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Karolinska Institutet; Karolinska University Hospital	Critchley, HD (corresponding author), UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	h.critchley@fil.ion.ucl.ac.uk	Wiens, Stefan/D-1268-2017; critchley, hugo d/G-9267-2011	Wiens, Stefan/0000-0003-4531-4313; critchley, hugo d/0000-0002-2445-9284; Dolan, Ray/0000-0001-9356-761X; Rotshtein, Pia/0000-0002-0301-9511				Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Ashburner J, 1997, NEUROIMAGE, V6, P344, DOI 10.1006/nimg.1997.0299; Aziz Q, 2000, J CLIN NEUROPHYSIOL, V17, P604, DOI 10.1097/00004691-200011000-00006; Barsky AJ, 2001, ANN INTERN MED, V134, P832, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00006; Beck A, 1993, MANUAL BECK DEPRESSI; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; Cameron OG, 2002, PSYCHOSOM MED, V64, P851, DOI 10.1097/01.PSY.0000038939.33335.32; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Critchley HD, 2001, NAT NEUROSCI, V4, P207, DOI 10.1038/84048; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Critchley HD, 2002, NEURON, V33, P653, DOI 10.1016/S0896-6273(02)00588-3; Damasio A.R., 1994, DESCARTES ERROR EMOT; Damasio A. R., 1999, FEELING WHAT HAPPENS; DAMASIO AR, 1994, DESCARTES ERROR; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Ehlers A, 1996, BIOL PSYCHOL, V42, P165, DOI 10.1016/0301-0511(95)05153-8; Ferguson ML, 1996, BIOL PSYCHOL, V42, P131, DOI 10.1016/0301-0511(95)05151-1; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hamilton M. C., 1995, SOURCEBOOK ADULT ASS, P154; Harper RM, 2000, J COMP NEUROL, V417, P195, DOI 10.1002/(SICI)1096-9861(20000207)417:2<195::AID-CNE5>3.0.CO;2-V; JAMES W, 1994, PSYCHOL REV, V101, P205, DOI 10.1037/0033-295X.101.2.205; James W., 1922, EMOTIONS; JENNINGS JR, 1992, PSYCHOPHYSIOLOGY, V29, P369, DOI 10.1111/j.1469-8986.1992.tb01710.x; Jennings JR, 2002, PSYCHOL RES-PSYCH FO, V66, P337, DOI 10.1007/s00426-002-0106-5; Jones G. E., 1994, ADV PSYCHOP, V5, P55; Katkin ES, 2001, PSYCHOL SCI, V12, P366, DOI 10.1111/1467-9280.00368; LUDWICKROSENTHAL R, 1985, INT J PSYCHOPHYSIOL, V3, P57, DOI 10.1016/0167-8760(85)90020-0; MELMED RN, 2002, MIND BODY MED; MUMFORD DB, 1991, BRIT J PSYCHIAT, V158, P379, DOI 10.1192/bjp.158.3.379; Peyron R, 2002, NEUROIMAGE, V17, P1336, DOI 10.1006/nimg.2002.1315; Phillips ML, 1998, P ROY SOC B-BIOL SCI, V265, P1809, DOI 10.1098/rspb.1998.0506; Porges, 1993, BODY PERCEPTION QUES; Stewart SH, 2001, J ANXIETY DISORD, V15, P535, DOI 10.1016/S0887-6185(01)00080-9; Van TK, 2000, J AQUAT PLANT MANAGE, V38, P62; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1020, DOI 10.1037//0022-3514.54.6.1020; WHITEHEAD WE, 1977, BIOFEEDBACK SELF-REG, V2, P371, DOI 10.1007/BF00998623; Wiens S, 2000, COGNITION EMOTION, V14, P417, DOI 10.1080/026999300378905; Wiens S, 2001, BIOL PSYCHOL, V58, P159, DOI 10.1016/S0301-0511(01)00110-7; YATES AJ, 1985, PSYCHOPHYSIOLOGY, V22, P561, DOI 10.1111/j.1469-8986.1985.tb01651.x; Zoellner LA, 1999, BEHAV RES THER, V37, P1141, DOI 10.1016/S0005-7967(98)00202-2	47	2218	2245	3	204	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					189	195		10.1038/nn1176	http://dx.doi.org/10.1038/nn1176			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	767TJ	14730305	Green Submitted			2022-12-24	WOS:000188468500018
J	Gomeza, J; Ohno, K; Hulsmann, S; Armsen, W; Eulenburg, V; Richter, DW; Laube, B; Betz, H				Gomeza, J; Ohno, K; Hulsmann, S; Armsen, W; Eulenburg, V; Richter, DW; Laube, B; Betz, H			Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality	NEURON			English	Article							RECEPTOR-BETA-SUBUNIT; RAT SPINAL-CORD; NEUROTRANSMITTER TRANSPORTERS; HEREDITARY HYPEREKPLEXIA; DOPAMINE TRANSPORTER; FRAMESHIFT MUTATION; STARTLE DISEASE; SPASTIC MOUSE; BRAIN-STEM; GENE GLRA1	The glycine transporter subtype 2 (GlyT2) is localized in the axon terminals of glycinergic neurons. Mice deficient in GlyT2 are normal at birth but during the second postnatal week develop a lethal neuromotor deficiency that resembles severe forms of human hyperekplexia (hereditary startle disease) and is characterized by spasticity, tremor, and an inability to right. Histological and immunological analyses failed to reveal anatomical or biochemical abnormalities, but the amplitudes of glycinergic miniature inhibitory currents (mIPSCs) were strikingly reduced in hypoglossal motoneurons and dissociated spinal neurons from GlyT2-deficient mice. Thus, postnatal GlyT2 function is crucial for efficient transmitter loading of synaptic vesicles in glycinergic nerve terminals, and the GlyT2 gene constitutes a candidate disease gene in human hyperekplexia patients.	Max Planck Inst Brain Res, Dept Neurochem, D-60528 Frankfurt, Germany; Univ Gottingen, Dept Neuro & Sensory Physiol, D-37073 Gottingen, Germany	Max Planck Society; University of Gottingen	Betz, H (corresponding author), Max Planck Inst Brain Res, Dept Neurochem, Deutschordenstr 46, D-60528 Frankfurt, Germany.	neurochemie@mpih-frankfurt.mpg.de	Eulenburg, Volker/B-7263-2013; Hülsmann, Swen/F-7169-2010; Eulenburg, Volker/B-7263-2013	Eulenburg, Volker/0000-0002-4878-5746; Hülsmann, Swen/0000-0001-5042-8724; Eulenburg, Volker/0000-0001-6314-566X				AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Andrew M, 1997, BRIT J PSYCHIAT, V170, P106, DOI 10.1192/bjp.170.2.106; BECKER CM, 1992, NEURON, V8, P283, DOI 10.1016/0896-6273(92)90295-O; BECKER CM, 1988, EMBO J, V7, P3717, DOI 10.1002/j.1460-2075.1988.tb03255.x; Becker L, 2000, EUR J NEUROSCI, V12, P27, DOI 10.1046/j.1460-9568.2000.00877.x; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Breitinger HG, 1998, CURR PHARM DESIGN, V4, P315; BUCKWALTER MS, 1994, HUM MOL GENET, V3, P2025, DOI 10.1093/hmg/3.11.2025; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Dumoulin A, 1999, J CELL SCI, V112, P811; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Friauf E, 1999, J COMP NEUROL, V412, P17; Gainetdinov RR, 1998, BRAIN RES REV, V26, P148, DOI 10.1016/S0165-0173(97)00063-5; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; GRENNINGLOH G, 1990, NEURON, V4, P963, DOI 10.1016/0896-6273(90)90149-A; Hartenstein B, 1996, EMBO J, V15, P1275, DOI 10.1002/j.1460-2075.1996.tb00469.x; Hulsmann S, 2000, EUR J NEUROSCI, V12, P239, DOI 10.1046/j.1460-9568.2000.00902.x; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Jones SR, 1999, NAT NEUROSCI, V2, P649, DOI 10.1038/10204; KINGSMORE SF, 1994, NAT GENET, V7, P136, DOI 10.1038/ng0694-136; KIRSCH J, 1995, J NEUROSCI, V15, P4148; Kling C, 1997, NEUROSCIENCE, V78, P411, DOI 10.1016/S0306-4522(96)00567-2; KUHSE J, 1995, CURR OPIN NEUROBIOL, V5, P318, DOI 10.1016/0959-4388(95)80044-1; LANGOSCH D, 1994, EMBO J, V13, P4223, DOI 10.1002/j.1460-2075.1994.tb06742.x; Laube B, 2002, EUR J NEUROSCI, V16, P1025, DOI 10.1046/j.1460-9568.2002.02170.x; Laube B, 2002, TRENDS PHARMACOL SCI, V23, P519, DOI 10.1016/S0165-6147(02)02138-7; Lewis TM, 1998, J PHYSIOL-LONDON, V507, P25, DOI 10.1111/j.1469-7793.1998.025bu.x; Lim R, 1999, J PHYSIOL-LONDON, V516, P505, DOI 10.1111/j.1469-7793.1999.0505v.x; Mahendrasingam S, 2000, BRAIN RES, V887, P477, DOI 10.1016/S0006-8993(00)03054-7; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; Milani N, 1996, AM J HUM GENET, V58, P420; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MULHARDT C, 1994, NEURON, V13, P1003, DOI 10.1016/0896-6273(94)90265-8; Nelson N, 1998, J NEUROCHEM, V71, P1785; Overstreet LS, 2000, J NEUROSCI, V20, P7914; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; Poyatos I, 1997, MOL BRAIN RES, V49, P63, DOI 10.1016/S0169-328X(97)00124-1; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Rajendra Sundran, 1995, Trends in Neurosciences, V18, P80, DOI 10.1016/0166-2236(95)93880-7; REES MI, 1994, HUM MOL GENET, V3, P2175, DOI 10.1093/hmg/3.12.2175; RYAN SG, 1994, NAT GENET, V7, P131, DOI 10.1038/ng0694-131; Sakata Y, 2001, MOL BRAIN RES, V94, P119, DOI 10.1016/S0169-328X(01)00225-X; SAUL B, 1994, FEBS LETT, V350, P1; SCHLOSS P, 1994, CURR OPIN CELL BIOL, V6, P595, DOI 10.1016/0955-0674(94)90081-7; SCHRODER S, 1991, BIOCHEMISTRY-US, V30, P42, DOI 10.1021/bi00215a007; SHIANG R, 1995, ANN NEUROL, V38, P85, DOI 10.1002/ana.410380115; Singer JH, 1998, J NEUROPHYSIOL, V80, P2608, DOI 10.1152/jn.1998.80.5.2608; Spike RC, 1997, NEUROSCIENCE, V77, P543, DOI 10.1016/S0306-4522(96)00501-5; TAKAHASHI T, 1992, NEURON, V9, P1155, DOI 10.1016/0896-6273(92)90073-M; Tijssen MAJ, 1997, ARCH NEUROL-CHICAGO, V54, P388, DOI 10.1001/archneur.1997.00550160034012; TRILLER A, 1985, J CELL BIOL, V101, P683, DOI 10.1083/jcb.101.2.683; Vergouwe MN, 1997, CLIN NEUROL NEUROSUR, V99, P172, DOI 10.1016/S0303-8467(97)00022-X; ZAFRA F, 1995, EUR J NEUROSCI, V7, P1342, DOI 10.1111/j.1460-9568.1995.tb01125.x; ZAFRA F, 1995, J NEUROSCI, V15, P3952	55	242	248	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 13	2003	40	4					797	806		10.1016/S0896-6273(03)00673-1	http://dx.doi.org/10.1016/S0896-6273(03)00673-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	744UL	14622583	Green Published, hybrid			2022-12-24	WOS:000186651200014
J	Wiest, MC; Nicolelis, MAL				Wiest, MC; Nicolelis, MAL			Behavioral detection of tactile stimuli during 7-12 Hz cortical oscillations in awake rats	NATURE NEUROSCIENCE			English	Article							SOMATOSENSORY SYSTEM; ABSENCE EPILEPSY; BURSTS	Prominent 7-12 Hz oscillations in the primary somatosensory cortex (S1) of awake but immobile rats might represent a seizure-like state(1) in which neuronal burst firing renders animals unresponsive to incoming tactile stimuli; others have proposed(2-4) that these oscillations are analogous to human mu rhythm(5-7). To test whether rats can respond to tactile stimuli during(7-12) Hz oscillatory activity, we trained head-immobilized awake animals to indicate whether they could detect the occurrence of transient whisker deflections while we recorded local field potentials (LFPs) from microelectrode arrays implanted bilaterally in the S1 whisker representation area. They responded rapidly and reliably, suggesting that this brain rhythm represents normal physiological activity that does not preclude perception.	Duke Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Ctr Neuroengn, Duke Med Ctr, Durham, NC 27710 USA; Dept Psychol & Brain Sci, Durham, NC 27708 USA; Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Nicolelis, MAL (corresponding author), Duke Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	nicoleli@neuro.duke.edu	Wiest, Michael/ABC-8101-2020		NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011451, R01DE013810] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE13810, DE11451] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Fanselow EE, 2001, P NATL ACAD SCI USA, V98, P15330, DOI 10.1073/pnas.261273898; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; GASTAUT MH, 1952, REV NEUROL, V87, P176; Hari R, 1997, TRENDS NEUROSCI, V20, P44, DOI 10.1016/S0166-2236(96)10065-5; MARESCAUX C, 1992, J NEURAL TRANSM-GEN, P37; Nicolelis MAL, 2002, NAT NEUROSCI, V5, P517, DOI 10.1038/nn0602-517; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; Pfurtscheller G, 1997, INT J PSYCHOPHYSIOL, V26, P121, DOI 10.1016/S0167-8760(97)00760-5; Pinault D, 2001, NEUROSCIENCE, V105, P181, DOI 10.1016/S0306-4522(01)00182-8; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; SEMBA K, 1980, BRAIN RES, V195, P281, DOI 10.1016/0006-8993(80)90065-7; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Swadlow HA, 2001, NAT NEUROSCI, V4, P402, DOI 10.1038/86054	13	99	101	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					913	914		10.1038/nn1107	http://dx.doi.org/10.1038/nn1107			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715KH	12897789				2022-12-24	WOS:000184970400007
J	Jin, P; Zarnescu, DC; Zhang, FP; Pearson, CE; Lucchesi, JC; Moses, K; Warren, ST				Jin, P; Zarnescu, DC; Zhang, FP; Pearson, CE; Lucchesi, JC; Moses, K; Warren, ST			RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila	NEURON			English	Article							FMR1 MESSENGER-RNA; POLYGLUTAMINE TOXICITY; TREMOR/ATAXIA-SYNDROME; CHAPERONE SUPPRESSION; BINDING-PROTEIN; EXPRESSION; HSP70; INCLUSIONS; HUNTINGTIN; EXPANSION	Fragile X syndrome carriers have FMR1 alleles, called premutations, with an intermediate number of 5' untranslated CGG repeats between patients (>200 repeats) and normal individuals (<60 repeats). A novel neurodegenerative disease has recently been appreciated in some premutation carriers. As no neurodegeneration is seen in fragile X patients, who do not express FMR1, we hypothesize that lengthened rCGG repeats of the premutation transcript may lead to neurodegeneration. Here, using Drosophila melanogaster, we show that 90 rCGG repeats alone are sufficient to cause neurodegeneration. This phenotype is neuron specific and rCGG repeat dosage sensitive. Although devoid of mutant protein, this neurodegeneration exhibits neuronal inclusion bodies that are Hsp70 and ubiquitin positive. Overexpression of Hsp70 could suppress the neurodegeneration. These results demonstrate that neurodegenerative phenotype associated with fragile X premutation is indeed caused by the lengthened rCGG repeats and provide the first in vivo experimental demonstration of RNA-mediated neurodegeneration.	Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA; Emory Univ, Dept Biol, Atlanta, GA 30322 USA; Hosp Sick Children, Dept Genet, Toronto, ON M5G 1X8, Canada	Emory University; Emory University; Emory University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Warren, ST (corresponding author), Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA.		Warren, Stephen T/A-2498-2012; Jin, Peng/B-5977-2012	Jin, Peng/0000-0001-6137-6659; Pearson, Christopher/0000-0001-9545-4205	NICHD NIH HHS [R37 HD20521, P01 HD35576] Funding Source: Medline; NINDS NIH HHS [R21 NS43536] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD020521, P01HD035576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS043536] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bonini NM, 2003, ANNU REV NEUROSCI, V26, P627, DOI 10.1146/annurev.neuro.26.041002.131425; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Chan HYE, 2002, HUM MOL GENET, V11, P2895, DOI 10.1093/hmg/11.23.2895; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Elefant F, 1999, MOL BIOL CELL, V10, P2101, DOI 10.1091/mbc.10.7.2101; ELLIS MC, 1993, DEVELOPMENT, V119, P855; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Gabai VL, 1997, J BIOL CHEM, V272, P18033, DOI 10.1074/jbc.272.29.18033; Greco CM, 2002, BRAIN, V125, P1760, DOI 10.1093/brain/awf184; Hagerman RJ, 2001, NEUROLOGY, V57, P127, DOI 10.1212/WNL.57.1.127; Hsiung F, 2002, HUM MOL GENET, V11, P1207, DOI 10.1093/hmg/11.10.1207; Ito K, 1997, DEVELOPMENT, V124, P761; Jacquemont S, 2003, AM J HUM GENET, V72, P869, DOI 10.1086/374321; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Kenneson A, 2001, HUM MOL GENET, V10, P1449, DOI 10.1093/hmg/10.14.1449; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Muqit MMK, 2002, NAT REV NEUROSCI, V3, P237, DOI 10.1038/nrn751; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Primerano B, 2002, RNA, V8, P1482, DOI 10.1017/s1355838202020642; Ranum LPW, 2002, CURR OPIN GENET DEV, V12, P266, DOI 10.1016/S0959-437X(02)00297-6; Rosser TC, 2002, AM J HUM GENET, V71, P507; Sherman S. L., 2002, FRAGILE X SYNDROME D, P136; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Willemsen R, 2003, HUM MOL GENET, V12, P949, DOI 10.1093/hmg/ddg114; Zhou H, 2001, J BIOL CHEM, V276, P48417, DOI 10.1074/jbc.M104140200; Zoghbi HY, 2002, TRENDS GENET, V18, P463, DOI 10.1016/S0168-9525(02)02729-4	35	279	293	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 28	2003	39	5					739	747		10.1016/S0896-6273(03)00533-6	http://dx.doi.org/10.1016/S0896-6273(03)00533-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	717GN	12948442	Bronze			2022-12-24	WOS:000185079300005
J	Paz, R; Boraud, T; Natan, C; Bergman, H; Vaadia, E				Paz, R; Boraud, T; Natan, C; Bergman, H; Vaadia, E			Preparatory activity in motor cortex reflects learning of local visuomotor skills	NATURE NEUROSCIENCE			English	Article							ADULT SQUIRREL-MONKEYS; REACHING MOVEMENTS; PREMOTOR CORTEX; INTERNAL-MODELS; NEURONAL-ACTIVITY; REPRESENTATIONS; DYNAMICS; ADAPTATION; DIRECTION; CONSOLIDATION	In humans, learning to produce correct visually guided movements to adapt to new sensorimotor conditions requires the formation of an internal model that represents the new transformation between visual input and the required motor command. When the new environment requires adaptation to directional errors, learning generalizes poorly to untrained locations and directions, indicating that such learning is local. Here we replicated these behavioral findings in rhesus monkeys using a visuomotor rotation task and simultaneously recorded neuronal activity. Specific changes in activity were observed only in a subpopulation of cells in the motor cortex with directional properties corresponding to the locally learned rotation. These changes adhered to the dynamics of behavior during learning and persisted between learning and relearning of the same rotation. These findings suggest a neural mechanism for the locality of newly acquired sensorimotor tasks and provide electrophysiological evidence for their retention in working memory.	Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; Univ Victor Segalen, Neurophysiol Lab, CNRS, UMR 5543, Bordeaux, France	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Paz, R (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, Box 12272, IL-91120 Jerusalem, Israel.		Boraud, Thomas/A-6260-2008; Vaadia, Eilon/E-9347-2011					ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P133, DOI 10.1152/jn.1990.64.1.133; Baraduc P, 2002, J NEUROPHYSIOL, V88, P973, DOI 10.1152/jn.2002.88.2.973; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; CRAMMOND DJ, 1994, J NEUROPHYSIOL, V71, P1281, DOI 10.1152/jn.1994.71.3.1281; Flanagan JR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-20-j0005.1999; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Ghahramani Z, 1996, J NEUROSCI, V16, P7085; Gribble PL, 2002, NATURE, V417, P938, DOI 10.1038/nature00834; Hess G, 1996, EUR J NEUROSCI, V8, P658, DOI 10.1111/j.1460-9568.1996.tb01251.x; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Kakei S, 2001, NAT NEUROSCI, V4, P1020, DOI 10.1038/nn726; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; KALASKA JF, 1989, J NEUROSCI, V9, P2080; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; KARNI A, 1995, NATURE, V377, P155; Kawagoe A, 1999, IEEE T APPL SUPERCON, V9, P727, DOI 10.1109/77.783398; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; MITZ AR, 1991, J NEUROSCI, V11, P1855; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Muellbacher W, 2001, EXP BRAIN RES, V136, P431, DOI 10.1007/s002210000614; Nezafat R, 2001, EXP BRAIN RES, V140, P66, DOI 10.1007/s002210100787; Nudo RJ, 1996, J NEUROSCI, V16, P785; Osu R, 2002, J NEUROPHYSIOL, V88, P991, DOI 10.1152/jn.2002.88.2.991; Padoa-Schioppa C, 2002, NEURON, V36, P751, DOI 10.1016/S0896-6273(02)01028-0; Pine ZM, 1996, NEUROREPORT, V7, P2357, DOI 10.1097/00001756-199610020-00016; Plautz EJ, 2000, NEUROBIOL LEARN MEM, V74, P27, DOI 10.1006/nlme.1999.3934; POGGIO T, 1990, SCIENCE, V247, P978, DOI 10.1126/science.247.4945.978; Pouget A, 2000, NAT NEUROSCI, V3, P1192, DOI 10.1038/81469; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Schaal S, 1998, NEURAL COMPUT, V10, P2047, DOI 10.1162/089976698300016963; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; Shadmehr R, 2000, J NEUROSCI, V20, P7807; Shen LM, 1997, J NEUROPHYSIOL, V77, P1195, DOI 10.1152/jn.1997.77.3.1195; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P582, DOI 10.1152/jn.1989.62.2.582; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Thoroughman KA, 1999, J NEUROSCI, V19, P8573; Tong C, 2002, J NEUROSCI, V22, P1108, DOI 10.1523/JNEUROSCI.22-03-01108.2002; Wise SP, 1998, EXP BRAIN RES, V121, P285, DOI 10.1007/s002210050462; Wise SP, 1996, CAN J PHYSIOL PHARM, V74, P469, DOI 10.1139/cjpp-74-4-469; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Yin PB, 2001, EXP BRAIN RES, V141, P250, DOI 10.1007/s002210100892	46	148	148	0	11	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					882	890		10.1038/nn1097	http://dx.doi.org/10.1038/nn1097			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12872127				2022-12-24	WOS:000184413700019
J	Emptage, NJ; Reid, CA; Fine, A; Bliss, TVP				Emptage, NJ; Reid, CA; Fine, A; Bliss, TVP			Optical quantal analysis reveals a presynaptic component of LTP at hippocampal Schaffer-associational synapses	NEURON			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINES; SYNAPTIC TRANSMISSION; POSTSYNAPTIC EXPRESSION; CALCIUM TRANSIENTS; NMDA RECEPTORS; PLASTICITY; ACTIVATION; INDUCTION; ENHANCEMENT	The mechanisms by which long-term potentiation (LTP) is expressed are controversial, with evidence for both presynaptic and postsynaptic involvement. We have used confocal microscopy and Ca2+-sensitive dyes to study LTP at individual visualized synapses. Synaptically evoked Ca2+ transients were imaged in distal dendritic spines of pyramidal cells in cultured hippocampal slices, before and after the induction of LTP. At most synapses, from as early as 10 min to at least 60 min after induction, LTP was associated with an increase in the probability of a single stimulus evoking a postsynaptic Call response. These observations provide compelling evidence of a presynaptic component to the expression of early LTP at Schaffer-associational synapses. In most cases, the store-dependent evoked Ca2+ transient in the spine was also increased after induction, a novel postsynaptic aspect of LTP.	Natl Inst Med Res, Div Neurophysiol, London NW7 1AA, England; Dalhousie Univ, Fac Med, Dept Physiol & Biophys, Halifax, NS B3H 4H7, Canada	MRC National Institute for Medical Research; Dalhousie University	Fine, A (corresponding author), Natl Inst Med Res, Div Neurophysiol, Mill Hill, London NW7 1AA, England.	a.fine@dal.ca	Fine, Alan/P-5936-2014	Fine, Alan/0000-0002-4960-6973; Reid, Christopher/0000-0002-1457-8028				Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; CLARK KA, 1995, J PHYSIOL-LONDON, V482, P39, DOI 10.1113/jphysiol.1995.sp020498; EDWARDS FA, 1995, TRENDS NEUROSCI, V18, P250, DOI 10.1016/0166-2236(95)80003-K; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; GEINISMAN Y, 1991, BRAIN RES, V566, P77, DOI 10.1016/0006-8993(91)91683-R; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; MALINOW R, 1994, P NATL ACAD SCI USA, V91, P8170, DOI 10.1073/pnas.91.17.8170; MCNAUGHTON BL, 1982, J PHYSIOL-LONDON, V324, P249, DOI 10.1113/jphysiol.1982.sp014110; Montgomery JM, 2001, NEURON, V29, P691, DOI 10.1016/S0896-6273(01)00244-6; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Reid CA, 1999, J PHYSIOL-LONDON, V518, P121, DOI 10.1111/j.1469-7793.1999.0121r.x; Reid CA, 2001, J NEUROSCI, V21, P2206, DOI 10.1523/JNEUROSCI.21-07-02206.2001; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; TSIEN RW, 1990, COLD SH Q B, V55, P147; WALMSLEY B, 1995, P ROY SOC B-BIOL SCI, V261, P245, DOI 10.1098/rspb.1995.0144; Wang S, 1999, CAN J PHYSIOL PHARM, V77, P651, DOI 10.1139/cjpp-77-9-651; YAMAMOTO N, 1989, SCIENCE, V245, P192, DOI 10.1126/science.2749258; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 1999, J NEUROSCI, V19, P1976; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498	37	114	116	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 5	2003	38	5					797	804		10.1016/S0896-6273(03)00325-8	http://dx.doi.org/10.1016/S0896-6273(03)00325-8			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	687DU	12797963	Bronze			2022-12-24	WOS:000183361400014
J	Williams, ZM; Elfar, JC; Eskandar, EN; Toth, LJ; Assad, JA				Williams, ZM; Elfar, JC; Eskandar, EN; Toth, LJ; Assad, JA			Parietal activity and the perceived direction of ambiguous apparent motion	NATURE NEUROSCIENCE			English	Article							PERCEPTUAL DECISION; VISUAL GUIDANCE; MACAQUE MONKEY; CORTICAL AREAS; MT; CORTEX; ATTENTION; SIGNALS; PERFORMANCE; MODULATION	We recorded from parietal neurons in monkeys (Macacca mulatta) trained to report the direction of an apparent motion stimulus consisting of regularly spaced columns of dots surrounded by an aperture. Displacing the dots by half their inter-column spacing produced vivid apparent motion that could be perceived in either the preferred or anti-preferred direction for each neuron. Many neurons in the lateral intraparietal area (LIP) responded more strongly on trials in which the animals reported perceiving the neurons' preferred direction, independent of the hand movement used to report their percept. This selectivity was less common in the medial superior temporal area (MST) and virtually absent in the middle temporal area (MT). Variations in activity of LIP and MST neurons just before motion onset were also predictive of the animals' subsequent perceived direction. These data suggest a hierarchy of representation in parietal cortex, whereby neuronal responses become more aligned with subjective perception in higher parietal areas.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Assad, JA (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	jassad@hms.harvard.edu	Elfar, J./Q-7371-2017	Elfar, J./0000-0002-4438-7118; Toth, Louis/0000-0003-4986-7046	NATIONAL EYE INSTITUTE [R01EY012106] Funding Source: NIH RePORTER; NEI NIH HHS [EY12106] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBRIGHT TD, 1993, REV OCULOMOT RES, V51, P77; Andersen RA, 1997, NEURON, V18, P865, DOI 10.1016/S0896-6273(00)80326-8; Bair W, 1998, VISUAL NEUROSCI, V15, P779, DOI 10.1017/S0952523898154160; BARASH S, 1991, J NEUROPHYSIOL, V66, P1109, DOI 10.1152/jn.1991.66.3.1109; Basso MA, 1998, J NEUROSCI, V18, P7519; Battelli L, 2001, NEURON, V32, P985, DOI 10.1016/S0896-6273(01)00536-0; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; CAVANAGH P, 1992, SCIENCE, V257, P1563, DOI 10.1126/science.1523411; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; Cook EP, 2002, J NEUROSCI, V22, P1994, DOI 10.1523/JNEUROSCI.22-05-01994.2002; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Dorris MC, 2000, J NEUROSCI, V20; Eskandar EN, 2002, J NEUROPHYSIOL, V88, P1777, DOI 10.1152/jn.2002.88.4.1777; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Livingstone MS, 2001, NEURON, V30, P781, DOI 10.1016/S0896-6273(01)00313-0; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; MIKAMI A, 1986, J NEUROPHYSIOL, V55, P1328, DOI 10.1152/jn.1986.55.6.1328; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Verstraten FAJ, 2000, VISION RES, V40, P3651, DOI 10.1016/S0042-6989(00)00213-3; WATANABE T, 1995, VISION RES, V35, P2853, DOI 10.1016/0042-6989(95)00064-7	30	128	128	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					616	623		10.1038/nn1055	http://dx.doi.org/10.1038/nn1055			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12730699				2022-12-24	WOS:000183140400019
J	Reynolds, JH; Desimone, R				Reynolds, JH; Desimone, R			Interacting roles of attention and visual salience in V4	NEURON			English	Article							EXTRASTRIATE AREA V4; SELECTIVE ATTENTION; NEURAL MECHANISMS; RECEPTIVE-FIELD; MACAQUE MONKEY; SIMPLE CELLS; CORTEX; RESPONSES; MT; STIMULUS	Attention increases the contrast gain of V4 neurons, causing them to respond to an attended stimulus as though its contrast had increased. When multiple stimuli appear within a neuron's receptive field (RF), the neuron responds primarily to the attended stimulus. This suggests that cortical cells may be "hard wired" to respond preferentially to the highest-contrast stimulus in their RF, and neural systems for attention capitalize on this mechanism by dynamically increasing the effective contrast of the stimulus that is task relevant. To test this, we varied the relative contrast of two stimuli within the recorded neurons' RFs, while the monkeys attended away to another location. Increasing the physical contrast of one stimulus caused V4 neurons to respond preferentially to that stimulus and reduced their responses to competing stimuli. When attention was directed to the lower-contrast stimulus, it partially overcame the influence of a competing, higher-contrast stimulus.	Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA; NIMH, Neuropsychol Lab, NIH, Bethesda, MD 20892 USA	Salk Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Reynolds, JH (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Desimone, Robert/G-1121-2018	Desimone, Robert/0000-0002-5938-4227	NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002036] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALBRECHT DG, 1991, VISUAL NEUROSCI, V7, P531, DOI 10.1017/S0952523800010336; ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; BRAUN J, 1994, J NEUROSCI, V14, P554; Britten KH, 1999, J NEUROSCI, V19, P5074; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Carandini M, 1997, J NEUROSCI, V17, P8621; Conner CE, 1997, J NEUROSCI, V17, P3201; Connor CE, 1996, J NEUROPHYSIOL, V75, P1306, DOI 10.1152/jn.1996.75.3.1306; De Weerd P, 1999, NAT NEUROSCI, V2, P753, DOI 10.1038/11234; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Irwin DE, 2000, VISION RES, V40, P1443, DOI 10.1016/S0042-6989(00)00030-4; Kayser A, 2001, J NEUROPHYSIOL, V85, P2130, DOI 10.1152/jn.2001.85.5.2130; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOUNTCASTLE VB, 1987, J NEUROSCI, V7, P2239; Nothdurft HC, 1999, VISUAL NEUROSCI, V16, P15, DOI 10.1017/S0952523899156189; Recanzone GH, 1997, J NEUROPHYSIOL, V78, P2904, DOI 10.1152/jn.1997.78.6.2904; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; SCHILLER PH, 1991, SCIENCE, V251, P1251, DOI 10.1126/science.2006413; SCHILLER PH, 1993, VISUAL NEUROSCI, V10, P717, DOI 10.1017/S0952523800005423; SPERLING G, 1968, J OPT SOC AM, V58, P1133, DOI 10.1364/JOSA.58.001133; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; THEEUWES J, 1994, J EXP PSYCHOL HUMAN, V20, P799, DOI 10.1037/0096-1523.20.4.799; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; YANTIS S, 1994, J EXP PSYCHOL HUMAN, V20, P95, DOI 10.1037/0096-1523.20.1.95; [No title captured]	33	273	276	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 6	2003	37	5					853	863		10.1016/S0896-6273(03)00097-7	http://dx.doi.org/10.1016/S0896-6273(03)00097-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	653TH	12628175	Bronze			2022-12-24	WOS:000181452800014
J	Weissman, TA; Riquelme, PA; Ivic, L; Flint, AC; Kriegstein, AR				Weissman, TA; Riquelme, PA; Ivic, L; Flint, AC; Kriegstein, AR			Calcium waves propagate through radial glial cells and modulate proliferation in the developing neocortex	NEURON			English	Article							CORTICAL PROGENITOR CELLS; GAP-JUNCTION HEMICHANNELS; VENTRICULAR ZONE; CEREBRAL-CORTEX; DNA-SYNTHESIS; EMBRYONIC NEOCORTEX; PRECURSOR CELLS; NEURONS ARISE; ATP RELEASE; ASTROCYTES	The majority of neurons in the adult neocortex are produced embryonically during a brief but intense period of neuronal proliferation. The radial glial cell, a transient embryonic cell type known for its crucial role in neuronal migration, has recently been shown to function as a neuronal progenitor cell and appears to produce most cortical pyramidal neurons. Radial glial cell modulation could thus affect neuron production, neuronal migration, and overall cortical architecture; however, signaling mechanisms among radial glia have not been studied directly. We demonstrate here that calcium waves propagate through radial glial cells in the proliferative cortical ventricular zone (VZ). Radial glial calcium waves occur spontaneously and require connexin hemichannels, P2Y(1) ATP receptors, and intracellular IP3-mediated calcium release. Furthermore, we show that wave disruption decreases VZ proliferation during the peak of embryonic neurogenesis. Taken together, these results demonstrate a radial glial signaling mechanism that may regulate cortical neuronal production.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Kriegstein, AR (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA.	ark17@columbia.edu		Flint, Alexander/0000-0002-3721-2694; Weissman, Tamily/0000-0001-9361-6071	NINDS NIH HHS [NS21223] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021223] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Arcuino G, 2002, P NATL ACAD SCI USA, V99, P9840, DOI 10.1073/pnas.152588599; Bayer S.A., 1991, NEOCORTICAL DEV; Behar TN, 1996, J NEUROSCI, V16, P1808; Bennett MVL, 2003, TRENDS NEUROSCI, V26, P610, DOI 10.1016/j.tins.2003.09.008; Bentivoglio M, 1999, BRAIN RES BULL, V49, P305, DOI 10.1016/S0361-9230(99)00065-9; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BERRIDGE MJ, 1995, BIOESSAYS, V17, P491, DOI 10.1002/bies.950170605; Bittman K, 1997, J NEUROSCI, V17, P7037; Bittman KS, 1999, CEREB CORTEX, V9, P188, DOI 10.1093/cercor/9.2.188; Cai L, 1997, J NEUROSCI, V17, P2088; Campbell K, 2003, GLIA, V43, P44, DOI 10.1002/glia.10247; Catsicas M, 1998, CURR BIOL, V8, P283, DOI 10.1016/S0960-9822(98)70110-1; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Flint AC, 1998, NEURON, V20, P43, DOI 10.1016/S0896-6273(00)80433-X; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Garcia-Verdugo JM, 2002, BRAIN RES BULL, V57, P765, DOI 10.1016/S0361-9230(01)00769-9; Giaume C, 1998, GLIA, V24, P50, DOI 10.1002/(SICI)1098-1136(199809)24:1<50::AID-GLIA6>3.0.CO;2-4; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Goto T, 2002, J NEUROSCI RES, V69, P714, DOI 10.1002/jnr.10361; Gotz M, 2002, BRAIN RES BULL, V57, P777, DOI 10.1016/S0361-9230(01)00777-8; Grafstein B, 2000, ANN NEUROL, V47, P18, DOI 10.1002/1531-8249(200001)47:1<18::AID-ANA6>3.3.CO;2-E; Gu XN, 1997, DEV NEUROSCI-BASEL, V19, P33, DOI 10.1159/000111183; Hartfuss E, 2003, DEVELOPMENT, V130, P4597, DOI 10.1242/dev.00654; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; Haydar TF, 1999, BRAIN RES PROTOC, V4, P425, DOI 10.1016/S1385-299X(99)00033-1; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Hofer A, 1998, GLIA, V24, P141, DOI 10.1002/(SICI)1098-1136(199809)24:1<141::AID-GLIA13>3.0.CO;2-R; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Moll V, 2002, INVEST OPHTH VIS SCI, V43, P766; Nadarajah B, 1997, J NEUROSCI, V17, P3096; Neary JT, 1996, TRENDS NEUROSCI, V19, P13, DOI 10.1016/0166-2236(96)81861-3; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Owens DF, 1998, J NEUROSCI, V18, P5374, DOI 10.1523/JNEUROSCI.18-14-05374.1998; Pearson R, 2002, J NEUROSCI, V22, P7569; Rakic P, 2003, GLIA, V43, P19, DOI 10.1002/glia.10244; Ralevic V, 1998, PHARMACOL REV, V50, P413; Sanches G, 2002, INT J DEV NEUROSCI, V20, P21, DOI 10.1016/S0736-5748(02)00004-7; Scemes E, 2003, J NEUROSCI, V23, P11444; Schmid RS, 2003, CEREB CORTEX, V13, P219, DOI 10.1093/cercor/13.3.219; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Sugioka M, 1999, INT J DEV NEUROSCI, V17, P135, DOI 10.1016/S0736-5748(98)00066-5; Syed MM, 2004, J NEUROPHYSIOL, V91, P1999, DOI 10.1152/jn.01129.2003; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Takahashi T, 1996, J NEUROSCI, V16, P6183; Tamamaki N, 2001, NEUROSCI RES, V41, P51, DOI 10.1016/S0168-0102(01)00259-0; Uckermann O, 2002, J NEUROSCI RES, V70, P209, DOI 10.1002/jnr.10406; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; Webb SE, 2003, NAT REV MOL CELL BIO, V4, P539, DOI 10.1038/nrm1149; Weissman T, 2003, CEREB CORTEX, V13, P550, DOI 10.1093/cercor/13.6.550; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; Zanotti S, 1997, J NEUROCHEM, V69, P594; Zupanc GKH, 2003, GLIA, V43, P77, DOI 10.1002/glia.10236	67	409	413	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 2	2004	43	5					647	661		10.1016/j.neuron.2004.08.015	http://dx.doi.org/10.1016/j.neuron.2004.08.015			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339647	Bronze			2022-12-24	WOS:000223691900011
J	Bamford, NS; Zhang, H; Schmitz, Y; Wu, NP; Cepeda, C; Levine, MS; Schmauss, C; Zakharenko, SS; Zablow, L; Sulzer, D				Bamford, NS; Zhang, H; Schmitz, Y; Wu, NP; Cepeda, C; Levine, MS; Schmauss, C; Zakharenko, SS; Zablow, L; Sulzer, D			Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals	NEURON			English	Article							NUCLEUS-ACCUMBENS; IN-VIVO; SYNAPTIC PLASTICITY; STRIATAL NEURONS; MICE LACKING; ULTRASTRUCTURAL-LOCALIZATION; PRESYNAPTIC INHIBITION; RECEPTOR ACTIVATION; TRANSMITTER RELEASE; DORSAL STRIATUM	Dopamine input to the striatum is required for voluntary motor movement, behavioral reinforcement, and responses to drugs of abuse. It is speculated that these functions are dependent on either excitatory or inhibitory modulation of corticostriatal synapses onto medium spiny neurons (MSNs). While dopamine modulates MSN excitability, a direct presynaptic effect on the corticostriatal input has not been clearly demonstrated. We combined optical monitoring of synaptic vesicle exocytosis from motor area corticostriatal afferents and electrochemical recordings of striatal dopamine release to directly measure effects of dopamine at the level of individual presynaptic terminals. Dopamine released by either electrical stimulation or amphetamine acted via D2 receptors to inhibit the activity of subsets of corticostriatal terminals. Optical and electrophysiological data suggest that heterosynaptic inhibition was enhanced by higher frequency stimulation and was selective for the least active terminals. Thus, dopamine, by filtering less active inputs, appears to reinforce specific sets of corticostriatal synaptic connections.	Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Univ Washington, Childrens Hosp & Reg Med Ctr, Dept Neurol, Dept Pediat, Seattle, WA 98105 USA; Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, Howard Hughes Med Inst, New York, NY 10032 USA; Univ Calif Los Angeles, Mental Retardat Res Ctr, David Geffen Sch Med, Los Angeles, CA 90095 USA; New York State Psychiat Inst & Hosp, Dept Neurosci, New York, NY 10032 USA	Columbia University; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Columbia University; Columbia University; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; New York State Psychiatry Institute	Sulzer, D (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA.	ds43@columbia.edu	Zakharenko, Stanislav/D-3287-2013; Bamford, Nigel/S-9141-2019; Schmitz, Yvonne/L-6183-2013	Zakharenko, Stanislav/0000-0001-8115-202X; Bamford, Nigel/0000-0003-3375-1022; 	NIDA NIH HHS [DA07418] Funding Source: Medline; NIMH NIH HHS [MH056123] Funding Source: Medline; NINDS NIH HHS [NS33538] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R55DA007418, R01DA007418, R29DA007418] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; Brager DH, 2003, J NEUROSCI, V23, P10475; Caille I, 1996, BRAIN RES, V730, P17, DOI 10.1016/0006-8993(96)00424-6; CALABRESI P, 1993, BRAIN, V116, P433; Calabresi P, 1997, J NEUROSCI, V17, P4536; Cepeda C, 2001, J NEUROPHYSIOL, V85, P659, DOI 10.1152/jn.2001.85.2.659; FISHER RS, 1994, J NEUROSCI RES, V38, P551, DOI 10.1002/jnr.490380508; FloresHernandez J, 1997, SYNAPSE, V25, P185, DOI 10.1002/(SICI)1098-2396(199702)25:2<185::AID-SYN9>3.0.CO;2-8; GARCIAMUNOZ M, 1991, BRAIN RES, V551, P195, DOI 10.1016/0006-8993(91)90933-M; GARRIS PA, 1994, J NEUROSCI, V14, P6084; Gonon F, 1997, J NEUROSCI, V17, P5972; GRAYBIEL AM, 1981, NEUROSCIENCE, V6, P377, DOI 10.1016/0306-4522(81)90131-7; Harvey J, 1996, J PHYSIOL-LONDON, V492, P143, DOI 10.1113/jphysiol.1996.sp021296; HERSCH SM, 1995, J NEUROSCI, V15, P5222; HSU KS, 1995, BRAIN RES, V690, P264, DOI 10.1016/0006-8993(95)00734-8; Isaacson JS, 1997, NEURON, V18, P143, DOI 10.1016/S0896-6273(01)80053-2; Jones SR, 1998, J NEUROSCI, V18, P1979; Jung MY, 1999, NEUROSCIENCE, V91, P911, DOI 10.1016/S0306-4522(98)00705-2; Kay AR, 1999, NEURON, V24, P809, DOI 10.1016/S0896-6273(00)81029-6; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; Lin YQ, 2001, AUTON NEUROSCI-BASIC, V88, P16, DOI 10.1016/S1566-0702(00)00287-3; MAURA G, 1988, J PHARMACOL EXP THER, V247, P680; Neher E, 2001, J NEUROSCI, V21, P9638, DOI 10.1523/JNEUROSCI.21-24-09638.2001; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Nicola SM, 1996, J NEUROSCI, V16, P1591; Nicola SM, 1998, J NEUROPHYSIOL, V79, P1768, DOI 10.1152/jn.1998.79.4.1768; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; ODONNELL P, 1994, BRAIN RES, V634, P105, DOI 10.1016/0006-8993(94)90263-1; Robinson DL, 2001, NEUROREPORT, V12, P2549, DOI 10.1097/00001756-200108080-00051; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Schmitz Y, 2001, J NEUROSCI, V21, P5916, DOI 10.1523/JNEUROSCI.21-16-05916.2001; SESACK SR, 1994, J NEUROSCI, V14, P88; Stern EA, 1997, J NEUROPHYSIOL, V77, P1697, DOI 10.1152/jn.1997.77.4.1697; Tang KC, 2001, P NATL ACAD SCI USA, V98, P1255, DOI 10.1073/pnas.031374698; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; Wang H, 2002, J COMP NEUROL, V442, P392, DOI 10.1002/cne.10086; West AR, 2002, J NEUROSCI, V22, P294, DOI 10.1523/JNEUROSCI.22-01-00294.2002; WILSON CJ, 1987, J COMP NEUROL, V263, P567, DOI 10.1002/cne.902630408; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498; Zhang H, 2003, J NEUROSCI, V23, P10585	40	275	287	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 27	2004	42	4					653	663		10.1016/S0896-6273(04)00265-X	http://dx.doi.org/10.1016/S0896-6273(04)00265-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157425	Bronze			2022-12-24	WOS:000221708300014
J	Anthony, TE; Klein, C; Fishell, G; Heintz, N				Anthony, TE; Klein, C; Fishell, G; Heintz, N			Radial glia serve as neuronal progenitors in all regions of the central nervous system	NEURON			English	Article							FETAL MONKEY NEOCORTEX; CELL MIGRATION; STEM-CELLS; CEREBRAL CORTEX; BASAL FOREBRAIN; EXPRESSION; MOUSE; BRAIN; FATE; GENES	Radial glial cells function during CNS development as neural progenitors, although their precise contribution to neurogenesis remains controversial. Recent work has argued that regional differences may exist regarding the neurogenic potential of radial glia. Here, we show that the vast majority of neurons in all brain regions derive from radial glia. Cre/IoxP fate mapping and clonal analysis demonstrate that radial glia throughout the CNS serve as neuronal progenitors and that radial glia within different regions of the CNS pass through their neurogenic stage of development at distinct time points. Thus, radial glial populations within different CNS regions are not heterogeneous with regard to their potential to generate neurons versus glia.	Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10021 USA; NYU, Ctr Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA	Howard Hughes Medical Institute; Rockefeller University; New York University	Heintz, N (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, 1230 York Ave, New York, NY 10021 USA.	heintz@rockefeller.edu		Fishell, Gordon/0000-0002-9640-9278				Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Bayer S.A., 1991, NEOCORTICAL DEV; Bisconte J C, 1975, J Hirnforsch, V16, P55; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Dymecki SM, 1998, DEV BIOL, V201, P57, DOI 10.1006/dbio.1998.8971; Eisenstat DD, 1999, J COMP NEUROL, V414, P217, DOI 10.1002/(SICI)1096-9861(19991115)414:2<217::AID-CNE6>3.0.CO;2-I; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; FENG L, 1995, DEVELOPMENT, V121, P1719; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; HICKS SP, 1968, ANAT REC, V160, P619, DOI 10.1002/ar.1091600311; Hogan B, 1994, MANIPULATING MOUSE E; Kaech S, 1997, J NEUROSCI, V17, P9565; Kriegstein AR, 2003, GLIA, V43, P37, DOI 10.1002/glia.10250; KURTZ A, 1994, DEVELOPMENT, V120, P2637; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; MARINPADILLA M, 1978, ANAT EMBRYOL, V152, P109, DOI 10.1007/BF00315920; MARINPADILLA M, 1971, Z ANAT ENTWICKLUNGS, V134, P117, DOI 10.1007/BF00519296; MCSHERRY GM, 1984, J EMBRYOL EXP MORPH, V81, P239; MCSHERRY GM, 1986, J ANAT, V144, P1; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Nomes H. O., 1978, BRAIN RES, V159, P1; PORTEUS MH, 1994, J NEUROSCI, V14, P6370; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Takahashi T, 1999, J NEUROSCI, V19, P10357; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6	39	599	618	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 25	2004	41	6					881	890		10.1016/S0896-6273(04)00140-0	http://dx.doi.org/10.1016/S0896-6273(04)00140-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046721	Bronze			2022-12-24	WOS:000221458300008
J	Rajimehr, R				Rajimehr, R			Unconscious orientation processing	NEURON			English	Article							MONKEY VISUAL-CORTEX; INVISIBLE PATTERNS; BINOCULAR-RIVALRY; COLOR; ADAPTATION; MOTION; ATTENTION; AWARENESS; SYSTEM; PERCEPTION	Recent findings have shown that certain attributes of visual stimuli, like orientation, are registered in cortical areas when the stimulus is unresolvable or perceptually invisible; however, there is no evidence to show that complex forms of orientation processing (e.g., modulatory effects of orientation on the processing of other features) could occur in the absence of awareness. To address these questions, different psychophysical paradigms were designed in six experiments to probe unconscious orientation processing. First we demonstrated orientation-selective adaptation and color-contingent orientation adaptation for peripheral unresolvable Gabor patches. The next experiments showed the modulatory effects of perceptually indiscriminable orientations on apparent motion processing and attentional mechanisms. Finally we investigated disappearance patterns of unresolvable Gabor stimuli during motion-induced blindness (MIB). Abrupt changes in local unresolvable orientations truncated MIB; however, orientation-based grouping failed to affect the MIB pattern when the orientations were unresolvable. Overall results revealed that unresolvable orientations substantially influence perception at multiple levels.	Iranian Inst Studies Theoret Phys & Math Niavaran, Sch Intelligent Syst, Dept Cognit Neurosci, Tehran, Iran		Rajimehr, R (corresponding author), Iranian Inst Studies Theoret Phys & Math Niavaran, Sch Intelligent Syst, Dept Cognit Neurosci, POB 19395-5746, Tehran, Iran.	rajimehr@ipm.ir						Blake R, 1999, PSYCHOL SCI, V10, P145, DOI 10.1111/1467-9280.00122; BLAKE R, 1974, NATURE, V249, P488, DOI 10.1038/249488a0; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V200, pP11; Bonneh YS, 2001, NATURE, V411, P798, DOI 10.1038/35081073; BRADLEY A, 1988, VISION RES, V28, P841, DOI 10.1016/0042-6989(88)90031-4; Crick F, 1998, CEREB CORTEX, V8, P97, DOI 10.1093/cercor/8.2.97; Fernandez-Duque D, 2000, VIS COGN, V7, P323, DOI 10.1080/135062800394838; Francis G, 1999, PERCEPTION, V28, P1243, DOI 10.1068/p2980; Friedman HS, 2003, J PHYSIOL-LONDON, V548, P593, DOI 10.1113/jphysiol.2002.033555; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; He S, 2001, NATURE, V411, P473, DOI 10.1038/35078072; HELD R, 1971, SCIENCE, V174, P314, DOI 10.1126/science.174.4006.314; Holcombe AO, 2001, NAT NEUROSCI, V4, P127, DOI 10.1038/83945; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Ives HE, 1912, PHILOS MAG, V24, P149, DOI 10.1080/14786440708637317; Joseph JS, 1996, PERCEPT PSYCHOPHYS, V58, P651, DOI 10.3758/BF03213098; Kaneoke Y, 1997, NEUROREPORT, V8, P677, DOI 10.1097/00001756-199702100-00020; Kentridge RW, 1999, P ROY SOC B-BIOL SCI, V266, P1805, DOI 10.1098/rspb.1999.0850; LEVENTHAL AG, 1995, J NEUROSCI, V15, P1808, DOI 10.1523/JNEUROSCI.15-03-01808.1995; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; MCCOLLOUGH C, 1965, SCIENCE, V149, P1115, DOI 10.1126/science.149.3688.1115; Moore CM, 1997, J EXP PSYCHOL HUMAN, V23, P339, DOI 10.1037/0096-1523.23.2.339; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Posner MI, 1978, MODES PERCEIVING PRO, P137; SCHALL JD, 1993, VISION RES, V33, P2057, DOI 10.1016/0042-6989(93)90004-G; Shady S, 2002, NAT NEUROSCI, V5, P729, DOI 10.1038/nn894; Shioiri S, 2000, VISION RES, V40, P1365, DOI 10.1016/S0042-6989(99)00249-7; Sobel KV, 2002, PERCEPTION, V31, P813, DOI 10.1068/p3279; Tanaka Y, 1998, P NATL ACAD SCI USA, V95, P12729, DOI 10.1073/pnas.95.21.12729; THEEUWES J, 1995, PERCEPT PSYCHOPHYS, V57, P637, DOI 10.3758/BF03213269; Thibos L. N., 1995, VISION MODELS TARGET, P338; WAGNER G, 1972, J OPT SOC AM, V62, P1508, DOI 10.1364/JOSA.62.001508; Wolfe J. M., 1996, BASIC CLIN APPL VISI, P189	33	43	45	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 19	2004	41	4					663	673		10.1016/S0896-6273(04)00041-8	http://dx.doi.org/10.1016/S0896-6273(04)00041-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980213	Bronze			2022-12-24	WOS:000221458100017
J	Gold, JI; Kalwani, RM				Gold, JI; Kalwani, RM			Context matters	NEURON			English	Editorial Material							REWARD; DOPAMINE		Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Gold, JI (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.			Gold, Joshua/0000-0002-6018-0483				Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Wise RA, 1996, CURR OPIN NEUROBIOL, V6, P243, DOI 10.1016/S0959-4388(96)80079-1; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0	9	0	0	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 22	2004	41	2					177	178		10.1016/S0896-6273(04)00009-1	http://dx.doi.org/10.1016/S0896-6273(04)00009-1			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741097	Bronze			2022-12-24	WOS:000221457800002
J	Han, WP; Rhee, JS; Maximov, A; Lao, Y; Mashimo, T; Rosenmund, C; Sudhof, TC				Han, WP; Rhee, JS; Maximov, A; Lao, Y; Mashimo, T; Rosenmund, C; Sudhof, TC			N-glycosylation is essential for vesicular targeting of synaptotagmin 1	NEURON			English	Article							CORE VESICLE EXOCYTOSIS; PHOSPHOLIPID-BINDING; SYNAPTIC VESICLES; PLASMA-MEMBRANE; DISTINCT CA2+; SR2+ BINDING; I FUNCTIONS; PROTEIN; RELEASE; COMPONENTS	Synaptotagmins 1 and 7 are candidate Call sensors for exocytosis localized to synaptic vesicles and plasma membranes, respectively. We now show that the N-terminal intraluminal sequence of synaptotagmin 1, when transplanted onto synaptotagmin 7, redirects synaptotagmin 7 from the plasma membrane to secretory vesicles. Conversely, mutation of the N-terminal N-glycosylation site of synaptotagmin 1 redirects synaptotagmin 1 from vesicles to the plasma membrane. In cultured hippocampal neurons, the plasma membrane-localized mutant of synaptotagmin 1 suppressed the readily releasable pool of synaptic vesicles, whereas wild-type synaptotagmin 1 did not. In addition to the intraluminal N-glycosylation site, the cytoplasmic C-2 domains of synaptotagmin 1 were required for correct targeting but could be functionally replaced by the C-2 domains of synaptotagmin 7. Our data suggest that the intravesicular N-glycosylation site of synaptotagmin I collaborates with its cytoplasmic C-2 domains in directing synaptotagmin 1 to synaptic vesicles via a novel N-glycosylation-dependent mechanism.	Univ Texas, SW Med Ctr, Dept Mol Genet, Ctr Basic Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Ctr Basic Neurosci, Dallas, TX 75390 USA; Max Planck Inst Biophys Chem, D-37070 Gottingen, Germany	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Max Planck Society	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, Ctr Basic Neurosci, Dallas, TX 75390 USA.	thomas.sudhof@utsouthwestern.edu	Rosenmund, Christian/AAC-3596-2020	Rosenmund, Christian/0000-0002-3905-2444				Adolfsen B, 2001, CELL MOL LIFE SCI, V58, P393, DOI 10.1007/PL00000865; Ashery U, 1999, EUR J CELL BIOL, V78, P525, DOI 10.1016/S0171-9335(99)80017-X; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Blagoveshchenskaya AD, 1999, MOL BIOL CELL, V10, P3979, DOI 10.1091/mbc.10.11.3979; Bravo-Zehnder M, 2000, P NATL ACAD SCI USA, V97, P13114, DOI 10.1073/pnas.240455697; Burke NV, 1997, NEURON, V19, P1095, DOI 10.1016/S0896-6273(00)80400-6; Butz S, 1999, J BIOL CHEM, V274, P18290, DOI 10.1074/jbc.274.26.18290; Coorssen JR, 1996, EMBO J, V15, P3787, DOI 10.1002/j.1460-2075.1996.tb00752.x; Dasgupta S, 2003, J CELL SCI, V116, P1327, DOI 10.1242/jcs.00290; Emanuelsson O, 2001, BBA-MOL CELL RES, V1541, P114, DOI 10.1016/S0167-4889(01)00145-8; FEANY MB, 1993, J CELL BIOL, V123, P575, DOI 10.1083/jcb.123.3.575; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fon EA, 2001, MUSCLE NERVE, V24, P581, DOI 10.1002/mus.1044; Fukuda M, 2002, J BIOL CHEM, V277, P4601, DOI 10.1074/jbc.C100588200; GEPPERT M, 1991, J BIOL CHEM, V266, P13548; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Harris TW, 2001, TRAFFIC, V2, P597, DOI 10.1034/j.1600-0854.2001.002009597.x; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Ihrke G, 2001, EMBO J, V20, P6256, DOI 10.1093/emboj/20.22.6256; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jarousse N, 2001, J CELL BIOL, V154, P857, DOI 10.1083/jcb.200103040; JOHNSTON PA, 1989, J BIOL CHEM, V264, P1268; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; LaVallee TM, 1998, J BIOL CHEM, V273, P22217, DOI 10.1074/jbc.273.35.22217; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; LI C, 1995, J BIOL CHEM, V270, P24898, DOI 10.1074/jbc.270.42.24898; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P3248, DOI 10.1073/pnas.070049497; Martina JA, 2001, J CELL BIOL, V153, P1111, DOI 10.1083/jcb.153.5.1111; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; Martinez-Maza R, 2001, J BIOL CHEM, V276, P2168, DOI 10.1074/jbc.M006774200; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; Ninomiya Y, 1996, J BIOL CHEM, V271, P17751, DOI 10.1074/jbc.271.30.17751; PERIN MS, 1991, J BIOL CHEM, V266, P623; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Prudovsky I, 2002, J CELL BIOL, V158, P201, DOI 10.1083/jcb.200203084; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Richmond JE, 2002, CURR OPIN NEUROBIOL, V12, P499, DOI 10.1016/S0959-4388(02)00360-4; Rickman C, 2003, J BIOL CHEM, V278, P5501, DOI 10.1074/jbc.C200692200; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Saegusa C, 2002, J BIOL CHEM, V277, P24499, DOI 10.1074/jbc.M202767200; Shin OH, 2003, NEURON, V37, P99, DOI 10.1016/S0896-6273(02)01145-5; Shin OH, 2002, NAT NEUROSCI, V5, P649, DOI 10.1038/nn869; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sugita S, 2002, EMBO J, V21, P270, DOI 10.1093/emboj/21.3.270; Sugita S, 2001, NEURON, V30, P459, DOI 10.1016/S0896-6273(01)00290-2; Tokuoka H, 2003, NEURON, V38, P521, DOI 10.1016/S0896-6273(03)00290-3; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Voets T, 2001, P NATL ACAD SCI USA, V98, P11680, DOI 10.1073/pnas.201398798; WALCHSOLIMENA C, 1993, J NEUROSCI, V13, P3895; Walther K, 2001, EMBO REP, V2, P634, DOI 10.1093/embo-reports/kve134; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2	58	83	85	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2004	41	1					85	99		10.1016/S0896-6273(03)00820-1	http://dx.doi.org/10.1016/S0896-6273(03)00820-1			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715137	Green Published, Bronze			2022-12-24	WOS:000187942800011
J	Lin, JC; Ho, WH; Gurney, A; Rosenthal, A				Lin, JC; Ho, WH; Gurney, A; Rosenthal, A			The netrin-G1 ligand NGL-1 promotes the outgrowth of thalamocortical axons	NATURE NEUROSCIENCE			English	Article							C-ELEGANS; EXPRESSION; RECEPTOR; IDENTIFICATION; PROTEINS; LAMININ; FAMILY; UNC-5; CHEMOREPELLENT; MIGRATIONS	Netrin-G1 is a lipid-anchored protein that is structurally related to the netrin family of axon guidance molecules. Netrin-G1 does not bind any of the known netrin receptors and its function is not known. Here we identify human netrin-G1 ligand (NGL-1), a transmembrane protein containing leucine-rich repeat (LRR) and immunoglobulin (Ig) domains that specifically interacts with netrin-G1 through its LRR region. Whereas netrin-G1 is expressed highly in mouse thalamic axons, NGL-1 is most abundant in the striatum and the cerebral cortex the intermediate and final targets, respectively, of thalamocortical axons (TCAs). Surface-bound NGL-1 stimulates, but soluble NGL-1 disrupts, the growth of embryonic thalamic axons, and in vitro data indicate that NGL-1 activity may be mediated at least partially by netrin-G1. Our findings provide evidence that netrin-G1 functions as an important component of the NGL-1 receptor to promote TCA outgrowth and that membrane-bound netrins can participate in receiving axonal signaling pathways.	Rinat Neurosci Corp, Palo Alto, CA 94304 USA; Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Lin, JC (corresponding author), Rinat Neurosci Corp, 3155 Porter Dr, Palo Alto, CA 94304 USA.							Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Braisted JE, 2000, J NEUROSCI, V20, P5792, DOI 10.1523/JNEUROSCI.20-15-05792.2000; Braisted JE, 1999, DEV BIOL, V208, P430, DOI 10.1006/dbio.1999.9216; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Klein RD, 1996, P NATL ACAD SCI USA, V93, P7108, DOI 10.1073/pnas.93.14.7108; Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2; Koch M, 2000, J CELL BIOL, V151, P221, DOI 10.1083/jcb.151.2.221; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; Metin C, 1996, J NEUROSCI, V16, P3219; Nakashiba T, 2002, MECH DEVELOP, V111, P47, DOI 10.1016/S0925-4773(01)00600-1; Nakashiba T, 2000, J NEUROSCI, V20, P6540, DOI 10.1523/JNEUROSCI.20-17-06540.2000; Redies C, 1997, J COMP NEUROL, V381, P230, DOI 10.1002/(SICI)1096-9861(19970505)381:2<230::AID-CNE9>3.0.CO;2-4; Rosenthal A, 1999, NEURON, V22, P201, DOI 10.1016/S0896-6273(00)81077-6; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Yin Y, 2000, MECH DEVELOP, V96, P115, DOI 10.1016/S0925-4773(00)00369-5; Yin Y, 2002, MOL CELL NEUROSCI, V19, P344, DOI 10.1006/mcne.2001.1089; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748	24	140	148	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1270	1276		10.1038/nn1148	http://dx.doi.org/10.1038/nn1148			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	746BC	14595443				2022-12-24	WOS:000186725600011
J	Szebenyi, G; Morfini, GA; Babcock, A; Gould, M; Selkoe, K; Stenoien, DL; Young, M; Faber, PW; MacDonald, ME; McPhaul, MJ; Brady, ST				Szebenyi, G; Morfini, GA; Babcock, A; Gould, M; Selkoe, K; Stenoien, DL; Young, M; Faber, PW; MacDonald, ME; McPhaul, MJ; Brady, ST			Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport	NEURON			English	Article							BULBAR MUSCULAR-ATROPHY; KINESIN HEAVY; NUCLEAR-LOCALIZATION; POLYGLUTAMINE TRACT; CYTOPLASMIC DYNEIN; LIGHT-CHAINS; WILD-TYPE; DISEASE; PROTEIN; AXOPLASM	Huntington's and Kennedy's disease are autosomal dominant neurodegenerative diseases caused by pathogenic expansion of polyglutamine tracts. Expansion of glutamine repeats must in some way confer a gain of pathological function that disrupts an essential cellular process and leads to loss of affected neurons. Association of huntingtin with vesicular structures raised the possibility that axonal transport might be altered. Here we show that polypeptides containing expanded polyglutamine tracts, but not normal N-terminal huntingtin or androgen receptor, directly inhibit both fast axonal transport in isolated axoplasm and elongation of neuritic processes in intact cells. Effects were greater with truncated polypeptides and occurred without detectable morphological aggregates.	Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA; Marine Biol Lab, Woods Hole, MA 02543 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Massachusetts Gen Hosp, Lab Mol Neuropathol, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Mol Neurogenet Unit, Charlestown, MA 02129 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Marine Biological Laboratory - Woods Hole; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Brady, ST (corresponding author), Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA.		McPhaul, Michael/AAC-7124-2020		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK003892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023868, R01NS032765, R56NS023868, P50NS016367, R01NS023320, P01NS016367, R01NS041170, R01NS043408] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK03892] Funding Source: Medline; NINDS NIH HHS [NS41170, NS23868, NS32765, NS16367, NS23320, NS43408] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMARATUNGA A, 1993, J BIOL CHEM, V268, P17427; BlockGalarza J, 1997, NEUROREPORT, V8, P2247, DOI 10.1097/00001756-199707070-00031; BRADY S, 1995, NATURE, V375, P12, DOI 10.1038/375012a0; Brady Scott T., 1993, P7; BRADY ST, 1990, P NATL ACAD SCI USA, V87, P1061, DOI 10.1073/pnas.87.3.1061; Brady ST, 2000, NAT CELL BIOL, V2, pE43, DOI 10.1038/35004071; BRADY ST, 1985, CELL MOTIL CYTOSKEL, V5, P81, DOI 10.1002/cm.970050203; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; ELLURU RG, 1995, MOL BIOL CELL, V6, P21, DOI 10.1091/mbc.6.1.21; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; FAHENK Z, 1986, INT J DEV NEUROSCI, V10, P80; FEIGUIN F, 1994, J CELL BIOL, V127, P1021, DOI 10.1083/jcb.127.4.1021; Ferhat L, 2001, J CELL SCI, V114, P3899; Fischbeck KH, 2001, BRAIN RES BULL, V56, P161, DOI 10.1016/S0361-9230(01)00577-9; GOEMAEREVANNESTE J, 1988, J NEUROCHEM, V51, P1746, DOI 10.1111/j.1471-4159.1988.tb01154.x; Grierson AJ, 2001, BBA-MOL BASIS DIS, V1536, P13, DOI 10.1016/S0925-4439(01)00029-1; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Hughes RE, 2001, NAT MED, V7, P419, DOI 10.1038/86486; Huynh DP, 2000, NAT GENET, V26, P44, DOI 10.1038/79162; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; LASEK RJ, 1985, NATURE, V316, P645, DOI 10.1038/316645a0; Li JY, 2000, J NEUROSCI RES, V61, P151, DOI 10.1002/1097-4547(20000715)61:2<151::AID-JNR6>3.3.CO;2-E; MCQUARRIE IG, 1989, NEUROBIOL AGING, V10, P359, DOI 10.1016/0197-4580(89)90049-3; Merry DE, 1998, HUM MOL GENET, V7, P693, DOI 10.1093/hmg/7.4.693; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; MORRIS JR, 1984, J CELL BIOL, V98, P2064, DOI 10.1083/jcb.98.6.2064; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; Orr HT, 2001, GENE DEV, V15, P925, DOI 10.1101/gad.888401; Perez MK, 1999, HUM MOL GENET, V8, P2377, DOI 10.1093/hmg/8.13.2377; PESTRONK A, 1980, EXP NEUROL, V70, P65, DOI 10.1016/0014-4886(80)90006-0; Pfister KK, 1996, J BIOL CHEM, V271, P1687, DOI 10.1074/jbc.271.3.1687; PFISTER KK, 1989, J CELL BIOL, V108, P1453, DOI 10.1083/jcb.108.4.1453; Piccioni F, 2001, BRAIN RES BULL, V56, P215, DOI 10.1016/S0361-9230(01)00652-9; Piccioni F, 2002, FASEB J, V16, P1418, DOI 10.1096/fj.01-1035fje; Pigino G, 2003, J NEUROSCI, V23, P4499; Ratner N, 1998, J NEUROSCI, V18, P7717; Reddy PH, 1999, TRENDS NEUROSCI, V22, P248, DOI 10.1016/S0166-2236(99)01415-0; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Schwab ME, 1996, INT J DEV NEUROSCI, V14, P379, DOI 10.1016/S0736-5748(96)00024-X; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; Sickles DW, 1996, J NEUROSCI RES, V46, P7, DOI 10.1002/(SICI)1097-4547(19961001)46:1<7::AID-JNR2>3.0.CO;2-P; Stenoien DL, 1997, MOL BIOL CELL, V8, P675, DOI 10.1091/mbc.8.4.675; Szebenyi G, 2002, J NEUROSCI RES, V68, P185, DOI 10.1002/jnr.10212; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; Tsai MY, 2000, MOL BIOL CELL, V11, P2161, DOI 10.1091/mbc.11.6.2161; Velier J, 1998, EXP NEUROL, V152, P34, DOI 10.1006/exnr.1998.6832; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Wieacker PF, 1998, EXP CLIN ENDOCR DIAB, V106, P446, DOI 10.1055/s-0029-1212014; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	58	248	261	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 25	2003	40	1					41	52		10.1016/S0896-6273(03)00569-5	http://dx.doi.org/10.1016/S0896-6273(03)00569-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	726TA	14527432	Bronze			2022-12-24	WOS:000185614700008
J	Bray, S; Amrein, H				Bray, S; Amrein, H			A putative Drosophila pheromone receptor expressed in male-specific taste neurons is required for efficient courtship	NEURON			English	Article							SEX-DETERMINATION; GENE-EXPRESSION; FRUITLESS GENE; SWEET TASTE; MELANOGASTER; BEHAVIOR; CONSEQUENCES; SYSTEM; DIFFERENTIATION; IDENTIFICATION	Propagation in higher animals requires the efficient and accurate display of innate mating behaviors. In Drosophila melanogaster, male courtship consists of a stereotypic sequence of behaviors involving multiple sensory modalities, such as vision, audition, and chemosensation. For example, taste bristles located in the male forelegs and the labial palps are thought to recognize nonvolatile pheromones secreted by the female. Here, we report the identification of the putative pheromone receptor GR68a, which is expressed in chemosensory neurons of about 20 male-specific gustatory bristles in the forelegs. Gr68a expression is dependent on the sex determination gene doublesex, which controls many aspects of sexual differentiation and is necessary for normal courtship behavior. Tetanus toxin-mediated inactivation of Gr68a-expressing neurons or transgene-mediated RNA interference of Gr68a RNA leads to a significant reduction in male courtship performance, suggesting that GR68a protein is an essential component of pheromone-driven courtship behavior in Drosophila.	Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University	Amrein, H (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, 252 CARL Bldg,Res Dr, Durham, NC 27710 USA.		Amrein, Hubert/AAG-9480-2021	Amrein, Hubert/0000-0001-8799-7250; Bray, Steven/0000-0002-0854-8121				Ahmad SM, 2002, CELL, V109, P651, DOI 10.1016/S0092-8674(02)00744-4; BRAND AH, 1993, DEVELOPMENT, V118, P401; BURTIS KC, 1991, EMBO J, V10, P2577, DOI 10.1002/j.1460-2075.1991.tb07798.x; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; COYNE JA, 1994, SCIENCE, V265, P1461, DOI 10.1126/science.8073292; COYNE JA, 1995, P NATL ACAD SCI USA, V92, P9505, DOI 10.1073/pnas.92.21.9505; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; Dauwalder B, 2002, GENE DEV, V16, P2879, DOI 10.1101/gad.1010302; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; DIANTONIO A, 1993, J NEUROSCI, V13, P4924; Dulac C, 2000, CURR OPIN NEUROBIOL, V10, P511, DOI 10.1016/S0959-4388(00)00121-5; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Ferveur JF, 1997, SCIENCE, V276, P1555, DOI 10.1126/science.276.5318.1555; Ferveur JF, 1996, P ROY SOC B-BIOL SCI, V263, P967, DOI 10.1098/rspb.1996.0143; Ferveur JF, 1996, GENETICA, V97, P73, DOI 10.1007/BF00132583; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fujii S, 2002, EMBO J, V21, P5353, DOI 10.1093/emboj/cdf556; GAILEY DA, 1989, GENETICS, V121, P773; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; GREENSPAN RJ, 1995, SCI AM, V272, P72, DOI 10.1038/scientificamerican0495-72; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Heinrichs V, 1998, MOL CELL BIOL, V18, P450, DOI 10.1128/MCB.18.1.450; HIHARA F, 1981, Zoological Magazine (Tokyo), V90, P307; MacDougall C, 1995, DEV BIOL, V172, P353, DOI 10.1006/dbio.1995.8047; MARKOW TA, 1988, J COMP PSYCHOL, V102, P169, DOI 10.1037/0735-7036.102.2.169; Martin JR, 2002, ADV GENET, V47, P1, DOI 10.1016/S0065-2660(02)47001-0; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; Meunier N, 2000, CURR BIOL, V10, P1583, DOI 10.1016/S0960-9822(00)00860-5; Montmayeur JP, 2002, CURR OPIN NEUROBIOL, V12, P366, DOI 10.1016/S0959-4388(02)00345-8; NAYAK SV, 1983, INT J INSECT MORPHOL, V12, P273, DOI 10.1016/0020-7322(83)90023-5; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; NOTTEBOHM E, 1994, NEURON, V12, P25, DOI 10.1016/0896-6273(94)90149-X; Piccin A, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e55; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; SPIETH HT, 1983, MATING BEHAV SEXUA C, V3; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Toma DP, 2002, NAT GENET, V31, P349, DOI 10.1038/ng893; Ueno K, 2001, CURR BIOL, V11, P1451, DOI 10.1016/S0960-9822(01)00450-X; Villella A, 1996, GENETICS, V143, P331; Villella A, 1997, GENETICS, V147, P1107; Waterbury JA, 1999, GENETICS, V152, P1653	47	209	216	1	32	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 11	2003	39	6					1019	1029		10.1016/S0896-6273(03)00542-7	http://dx.doi.org/10.1016/S0896-6273(03)00542-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	721BA	12971900	Bronze			2022-12-24	WOS:000185296100014
J	Fridberger, A; de Monvel, JB				Fridberger, A; de Monvel, JB			Sound-induced differential motion within the hearing organ	NATURE NEUROSCIENCE			English	Article							OUTER HAIR-CELLS; BASILAR-MEMBRANE MOTION; COCHLEA; ELECTROMOTILITY; PRESTIN; CORTI		Karolinska Inst, Ctr Hearing & Communicat Res, Dept Clin Neurosci, Stockholm, Sweden; Karolinska Inst, Dept Otorhinolaryngol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Fridberger, A (corresponding author), Karolinska Inst, Ctr Hearing & Communicat Res, Dept Clin Neurosci, Stockholm, Sweden.		Fridberger, Anders/E-8977-2010	Fridberger, Anders/0000-0002-7960-1559; Boutet de Monvel, Jacques/0000-0001-6182-3527				BRUNDIN L, 1989, NATURE, V342, P814, DOI 10.1038/342814a0; Fridberger A, 2002, J NEUROSCI, V22, P9850; Frolenkov GI, 2001, J PHYSIOL-LONDON, V531, P667, DOI 10.1111/j.1469-7793.2001.0667h.x; Hemmert W, 2000, BIOPHYS J, V78, P2285, DOI 10.1016/S0006-3495(00)76775-0; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Hu XT, 1999, J NEUROPHYSIOL, V82, P2798, DOI 10.1152/jn.1999.82.5.2798; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; MAMMANO F, 1993, NATURE, V365, P838, DOI 10.1038/365838a0; Nilsen KE, 1999, NAT NEUROSCI, V2, P642, DOI 10.1038/10197; Nuttall AL, 1999, HEARING RES, V131, P39, DOI 10.1016/S0378-5955(99)00009-X; RYBALCHENKO V, IN PRESS J PHYSL; ter Kuile E., 1900, PFLUGERS ARCH GES PH, V79, P146, DOI 10.1007/BF01796105; Ulfendahl M, 1996, J NEUROPHYSIOL, V76, P3850, DOI 10.1152/jn.1996.76.6.3850; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	15	44	44	0	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					446	448		10.1038/nn1047	http://dx.doi.org/10.1038/nn1047			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12692558				2022-12-24	WOS:000182553200008
J	Hasson, U; Harel, M; Levy, I; Malach, R				Hasson, U; Harel, M; Levy, I; Malach, R			Large-scale mirror-symmetry organization of human occipito-temporal object areas	NEURON			English	Article							HUMAN VISUAL-CORTEX; HUMAN CEREBRAL-CORTEX; HUMAN NEURAL SYSTEM; FUSIFORM FACE AREA; FMRI; ACTIVATION; PERCEPTION; REPRESENTATION; RECOGNITION; TOPOGRAPHY	We have combined functional maps of retinotopy (eccentricity and meridian mapping), object category, and motion in a group of subjects to explore the largescale topography of higher-order object areas. Our results reveal seven consistent category-related entities situated in the occipito-temporal cortex adjoining early visual areas. These include two face-related regions, three object-related regions, and two building-related regions. Interestingly, this complex category-related pattern is organized in a large-scale dorso-ventral mirror symmetry of object category. Furthermore, correlating this pattern to the map of visual field eccentricity, we found that the entire network of areas could be related to a single and unified eccentricity map. We hypothesize that this large-scale organization points to a possible development of high-order object areas through extension and specialization of a single proto-representation.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel	Weizmann Institute of Science; Hebrew University of Jerusalem	Malach, R (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.			Levy, Ifat/0000-0001-7851-9070; Hasson, Uri/0000-0002-3599-7168				Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Avidan G, 2002, CURR BIOL, V12, P964, DOI 10.1016/S0960-9822(02)00872-2; BAIZER JS, 1991, J NEUROSCI, V11, P168; Beauchamp MS, 2002, NEURON, V34, P149, DOI 10.1016/S0896-6273(02)00642-6; BOUSSAOUD D, 1991, J COMP NEUROL, V306, P554, DOI 10.1002/cne.903060403; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fiez JA, 1998, P NATL ACAD SCI USA, V95, P914, DOI 10.1073/pnas.95.3.914; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Gattass R, 1997, CEREB CORTEX, V7, P110, DOI 10.1093/cercor/7.2.110; George N, 1999, NAT NEUROSCI, V2, P574, DOI 10.1038/9230; Gilaie-Dotan S, 2002, HUM BRAIN MAPP, V15, P67, DOI 10.1002/hbm.10008; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; Halgren E, 1999, HUM BRAIN MAPP, V7, P29; Hasson U, 2001, J COGNITIVE NEUROSCI, V13, P744, DOI 10.1162/08989290152541412; Hasson U, 2002, NEURON, V34, P479, DOI 10.1016/S0896-6273(02)00662-1; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kaas JH, 2001, CURR OPIN NEUROBIOL, V11, P498, DOI 10.1016/S0959-4388(00)00240-3; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Kourtzi Z, 2002, NAT NEUROSCI, V5, P17, DOI 10.1038/nn780; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Maguire EA, 1998, J COGNITIVE NEUROSCI, V10, P61, DOI 10.1162/089892998563789; Maguire EA, 2001, NEUROIMAGE, V13, P743, DOI 10.1006/nimg.2000.0712; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; Mendola JD, 1999, J NEUROSCI, V19, P8560; Press WA, 2001, VISION RES, V41, P1321, DOI 10.1016/S0042-6989(01)00074-8; Puce A, 1996, J NEUROSCI, V16, P5205; Puce A, 1998, J NEUROSCI, V18, P2188; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Talairach J., 1988, COPLANAR STEREOTAXIC; Tong F, 2000, COGNITIVE NEUROPSYCH, V17, P257, DOI 10.1080/026432900380607; Tootell RBH, 2001, CEREB CORTEX, V11, P298, DOI 10.1093/cercor/11.4.298; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; VanEssen DC, 1997, J NEUROSCI, V17, P7079; VanOostende S, 1997, CEREB CORTEX, V7, P690, DOI 10.1093/cercor/7.7.690	60	254	256	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 27	2003	37	6					1027	1041		10.1016/S0896-6273(03)00144-2	http://dx.doi.org/10.1016/S0896-6273(03)00144-2			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	661PU	12670430	Bronze			2022-12-24	WOS:000181899600015
J	Calon, F; Lim, GP; Yang, FS; Morihara, T; Teter, B; Ubeda, O; Rostaing, P; Triller, A; Salem, N; Ashe, KH; Frautschy, SA; Cole, GM				Calon, F; Lim, GP; Yang, FS; Morihara, T; Teter, B; Ubeda, O; Rostaing, P; Triller, A; Salem, N; Ashe, KH; Frautschy, SA; Cole, GM			Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model	NEURON			English	Article							AMYLOID-PRECURSOR-PROTEIN; POLYUNSATURATED FATTY-ACIDS; NICOTINIC ACETYLCHOLINE-RECEPTOR; LONG-TERM POTENTIATION; TRANSGENIC MICE; A-BETA; COGNITIVE IMPAIRMENT; LIPID-PEROXIDATION; PHOSPHATIDYLINOSITOL 3-KINASE; POSTSYNAPTIC DENSITY-95	Learning and memory depend on dendritic spine actin assembly and docosahexaenoic acid (DHA), an essential n-3 (omega-3) polyunsaturated fatty acid (PFA). High DHA consumption is associated with reduced Alzheimer's disease (AD) risk, yet mechanisms and therapeutic potential remain elusive. Here, we report that reduction of dietary n-3 PFA in an AD mouse model resulted in 80%-90% losses of the p85alpha subunit of phosphatidylinositol 3-kinase and the postsynaptic actin-regulating protein drebrin, as in AD brain. The loss of postsynaptic proteins was associated with increased oxidation, without concomitant neuron or presynaptic protein loss. N-3 PFA depletion increased caspase-cleaved actin, which was localized in dendrites ultrastructurally. Treatment of n-3 PFA-restricted mice with DHA protected against these effects and behavioral deficits and increased antiapoptotic BAD phosphorylation. Since n-3 PFAs are essential for p85-mediated CNS insulin signaling and selective protection of postsynaptic proteins, these findings have implications for neurodegenerative diseases where synaptic loss is critical, especially AD.	Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; Greater Los Angeles Vet Affairs Healthcare Syst, Geriatr Res Educ & Clin Ctr, Sepulveda, CA 91343 USA; INSERM, Lab Biol Cellulaire Synapse Normale & Pathol, U497, Ecole Normale Super, F-75005 Paris, France; NIAAA, Sect Nutr Neurosci, Lab Membrane Biochem & Biophys, Div Intramural Clin & Biol Res, Rockville, MD 20852 USA; Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Cole, GM (corresponding author), Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA.	gmcole@ucla.edu	Morihara, Takashi/AAK-2709-2021; Calon, Frederic/AAF-4390-2020	TRILLER, Antoine/0000-0002-7530-1233; Frautschy, Sally A./0000-0003-0194-0363; Calon, Frederic/0000-0002-4203-0887	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005142, P50AG016570, R01AG010685, R01AG016793, R01AG013741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000235] Funding Source: NIH RePORTER; NIA NIH HHS [AG10685, P50 AG005142, P50 AG05142, R01 AG010685, P01 AG16570, AG16793, P50 AG016570, R01 AG013741, R01 AG016793, R01 AG13741, P50 AG 16570] Funding Source: Medline; NINDS NIH HHS [R01 NS043946, NS43946] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akbar M, 2002, J NEUROCHEM, V82, P655, DOI 10.1046/j.1471-4159.2002.01015.x; Aksenov MY, 2001, NEUROSCIENCE, V103, P373, DOI 10.1016/S0306-4522(00)00580-7; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Barberger-Gateau P, 2002, BRIT MED J, V325, P932, DOI 10.1136/bmj.325.7370.932; Bazan NG, 2003, J LIPID RES, V44, P2221, DOI 10.1194/jlr.R300013-JLR200; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; BRECKENRIDGE WC, 1972, BIOCHIM BIOPHYS ACTA, V266, P695, DOI 10.1016/0005-2736(72)90365-3; Butterfield DA, 2002, NEUROBIOL AGING, V23, P655; Callahan LM, 1999, J NEUROPATH EXP NEUR, V58, P275, DOI 10.1097/00005072-199903000-00007; Cole GM, 1999, ALZHEIMER'S DISEASE AND RELATED DISORDERS, P363; Conquer JA, 2000, LIPIDS, V35, P1305, DOI 10.1007/s11745-000-0646-3; Dalle-Donne I, 2002, FREE RADICAL BIO MED, V32, P927, DOI 10.1016/S0891-5849(02)00799-2; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Dickey CA, 2003, J NEUROSCI, V23, P5219; Dineley KT, 2002, J BIOL CHEM, V277, P22768, DOI 10.1074/jbc.M200164200; El-Hussein AE, 2000, SCIENCE, V290, P1364; Etminan M, 2003, BMJ-BRIT MED J, V327, P128, DOI 10.1136/bmj.327.7407.128; Everall IP, 1997, J NEUROPATH EXP NEUR, V56, P1202, DOI 10.1097/00005072-199711000-00004; Favreliere S, 2000, NEUROBIOL AGING, V21, P653, DOI 10.1016/S0197-4580(00)00170-6; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gamblin TC, 2000, BIOCHEMISTRY-US, V39, P14203, DOI 10.1021/bi001876l; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Grant WB, 2002, J ALZHEIMERS DIS, V4, P179, DOI 10.3233/JAD-2002-4308; Guan ZZ, 1999, J NEUROPATH EXP NEUR, V58, P740, DOI 10.1097/00005072-199907000-00008; Harigaya Y, 1996, J NEUROSCI RES, V43, P87, DOI 10.1002/jnr.490430111; Hashimoto M, 2002, J NEUROCHEM, V81, P1084, DOI 10.1046/j.1471-4159.2002.00905.x; Hatanpaa K, 1999, J NEUROPATH EXP NEUR, V58, P637, DOI 10.1097/00005072-199906000-00008; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; JOLLES J, 1992, J NEUROCHEM, V58, P2326, DOI 10.1111/j.1471-4159.1992.tb10981.x; Joseph JA, 2003, NUTR NEUROSCI, V6, P153, DOI 10.1080/1028415031000111282; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; King DL, 2002, BRAIN RES, V926, P58, DOI 10.1016/S0006-8993(01)03294-2; Krishnan S, 2003, BIOCHEMISTRY-US, V42, P829, DOI 10.1021/bi026528t; Kyle DJ, 1999, LIPIDS, V34, pS245, DOI 10.1007/BF02562306; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Liolitsa D, 2002, J NEUROL NEUROSUR PS, V73, P261, DOI 10.1136/jnnp.73.3.261; Mattson MP, 1999, J NEUROSCI RES, V58, P152, DOI 10.1002/(SICI)1097-4547(19991001)58:1<152::AID-JNR15>3.0.CO;2-V; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Montine KS, 2004, CHEM PHYS LIPIDS, V128, P117, DOI 10.1016/j.chemphyslip.2003.10.010; Moriguchi T, 2000, J NEUROCHEM, V75, P2563, DOI 10.1046/j.1471-4159.2000.0752563.x; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; Nagele RG, 2002, NEUROSCIENCE, V110, P199, DOI 10.1016/S0306-4522(01)00460-2; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Opazo P, 2003, J NEUROSCI, V23, P3679; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Rossiter JP, 2000, NEUROPATH APPL NEURO, V26, P342, DOI 10.1046/j.1365-2990.2000.00252.x; SAJI M, 2002, SOC NEUR M; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shaw S, 2002, J BIOL CHEM, V277, P44920, DOI 10.1074/jbc.M204610200; Shim KS, 2002, NEUROSCI LETT, V324, P209, DOI 10.1016/S0304-3940(02)00210-0; Shirao T, 2001, NEUROSCI RES, V40, P1, DOI 10.1016/S0168-0102(01)00209-7; SHIRAZI SK, 1993, NEUROREPORT, V4, P435, DOI 10.1097/00001756-199304000-00024; Shoop RD, 2000, J NEUROSCI, V20, P4021; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Stein TD, 2002, J NEUROSCI, V22, P7380; Suh YH, 2002, PHARMACOL REV, V54, P469, DOI 10.1124/pr.54.3.469; Takahashi H, 2003, J NEUROSCI, V23, P6586; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Takashima A, 1996, NEUROSCI LETT, V203, P33, DOI 10.1016/0304-3940(95)12257-5; Taouis M, 2002, AM J PHYSIOL-ENDOC M, V282, pE664, DOI 10.1152/ajpendo.00320.2001; Taubes G, 2003, SCIENCE, V301, P40, DOI 10.1126/science.301.5629.40; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tully AM, 2003, BRIT J NUTR, V89, P483, DOI 10.1079/BJN2002804; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Yang FS, 1998, AM J PATHOL, V152, P379; Yavin E, 2002, NUTR NEUROSCI, V5, P149, DOI 10.1080/10284150290003159; Yehuda S, 2002, NEUROBIOL AGING, V23, P843, DOI 10.1016/S0197-4580(02)00074-X; Youdim KA, 2000, INT J DEV NEUROSCI, V18, P383, DOI 10.1016/S0736-5748(00)00013-7; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zubenko GS, 1999, BIOL PSYCHIAT, V45, P731, DOI 10.1016/S0006-3223(98)00073-0	81	566	604	2	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 2	2004	43	5					633	645		10.1016/j.neuron.2004.08.013	http://dx.doi.org/10.1016/j.neuron.2004.08.013			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339646	Green Accepted, Bronze			2022-12-24	WOS:000223691900010
J	Tanaka, SC; Doya, K; Okada, G; Ueda, K; Okamoto, Y; Yamawaki, S				Tanaka, SC; Doya, K; Okada, G; Ueda, K; Okamoto, Y; Yamawaki, S			Prediction of immediate and future rewards differentially recruits cortico-basal ganglia loops	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; NUCLEUS-ACCUMBENS; NEURAL RESPONSES; HUMAN BRAIN; PROBABILISTIC REINFORCEMENT; SEROTONERGIC NEURONS; DECISION-MAKING; LESIONS; MOTOR	Evaluation of both immediate and future outcomes of one's actions is a critical requirement for intelligent behavior. Using functional magnetic resonance imaging (fMRI), we investigated brain mechanisms for reward prediction at different time scales in a Markov decision task. When human subjects learned actions on the basis of immediate rewards, significant activity was seen in the lateral orbitofrontal cortex and the striatum. When subjects learned to act in order to obtain large future rewards while incurring small immediate losses, the dorsolateral prefrontal cortex, inferior parietal cortex, dorsal raphe nucleus and cerebellum were also activated. Computational model-based regression analysis using the predicted future rewards and prediction errors estimated from subjects' performance data revealed graded maps of time scale within the insula and the striatum: ventroanterior regions were involved in predicting immediate rewards and dorsoposterior regions were involved in predicting future rewards. These results suggest differential involvement of the cortico-basal ganglia loops in reward prediction at different time scales.	Nara Inst Sci & Technol, Dept Bioinformat & Genom, Nara 6300101, Japan; ATR Computat Neurosci Labs, Dept Computat Neurobiol, Kyoto 6190288, Japan; Japan Sci & Techol Agcy, CREST, Kyoto 6190288, Japan; Hiroshima Univ, Dept Psychiat & Neurosci, Minami Ku, Hiroshima 7348551, Japan	Nara Institute of Science & Technology; Japan Science & Technology Agency (JST); Hiroshima University	Doya, K (corresponding author), Nara Inst Sci & Technol, Dept Bioinformat & Genom, 8916-5 Takayama, Nara 6300101, Japan.	doya@atr.jp	Doya, Kenji/B-5841-2015	Doya, Kenji/0000-0002-2446-6820; Tanaka, Saori/0000-0002-7001-5051				Baker SC, 1996, NEUROPSYCHOLOGIA, V34, P515, DOI 10.1016/0028-3932(95)00133-6; Balleine BW, 2000, J NEUROSCI, V20, P8954; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; Celada P, 2001, J NEUROSCI, V21, P9917, DOI 10.1523/JNEUROSCI.21-24-09917.2001; Chikama M, 1997, J NEUROSCI, V17, P9686; Compan V, 1998, BRAIN RES, V793, P103, DOI 10.1016/S0006-8993(98)00168-1; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Eagle DM, 1999, BEHAV NEUROSCI, V113, P718, DOI 10.1037/0735-7044.113.4.718; Elliott R, 2003, J NEUROSCI, V23, P303; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Evenden JL, 1996, PSYCHOPHARMACOLOGY, V128, P161, DOI 10.1007/s002130050121; HABER SN, 1995, J NEUROSCI, V15, P4851; Hanakawa T, 2002, CEREB CORTEX, V12, P1157, DOI 10.1093/cercor/12.11.1157; Haruno M, 2004, J NEUROSCI, V24, P1660, DOI 10.1523/JNEUROSCI.3417-03.2004; Hikosaka K, 2000, CEREB CORTEX, V10, P263, DOI 10.1093/cercor/10.3.263; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; Houk JC, 1995, MODELS INFORMATION P, P249; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Martens LC, 2001, EUR J PAEDIATR DENT, V2, P21; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Mijnster MJ, 1997, J COMP NEUROL, V389, P1; Mobini S, 2000, PSYCHOPHARMACOLOGY, V152, P390, DOI 10.1007/s002130000542; Mobini S, 2002, PSYCHOPHARMACOLOGY, V160, P290, DOI 10.1007/s00213-001-0983-0; O'Doherty J, 2003, J NEUROSCI, V23, P7931; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Owen AM, 1996, EUR J NEUROSCI, V8, P353, DOI 10.1111/j.1460-9568.1996.tb01219.x; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Pears A, 2003, J NEUROSCI, V23, P11189; Reynolds JNJ, 2002, NEURAL NETWORKS, V15, P507, DOI 10.1016/S0893-6080(02)00045-X; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1864, DOI 10.1152/jn.2000.83.4.1864; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003	49	561	577	3	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					887	893		10.1038/nn1279	http://dx.doi.org/10.1038/nn1279			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15235607				2022-12-24	WOS:000222930800020
J	Lu, W; Constantine-Paton, M				Lu, W; Constantine-Paton, M			Eye opening rapidly induces synaptic potentiation and refinement	NEURON			English	Article							LONG-TERM POTENTIATION; NMDA-RECEPTOR; SUPERIOR COLLICULUS; VISUAL-CORTEX; POSTSYNAPTIC DENSITY; HIPPOCAMPAL SYNAPSES; SUBUNIT COMPOSITION; RAT-BRAIN; IN-VIVO; EXPERIENCE	NMDA receptor (NMDAR)-mediated increases in AMPA receptor (AMPAR) currents are associated with long-term synaptic potentiation (LTP). Here, we provide evidence that similar changes occur in response to normal increases in sensory stimulation during development. Experiments discriminated between eye opening-induced and age-dependent changes in synaptic currents. At 6 hr after eye opening (AEO), a transient population of currents mediated by NR2B-rich NMDARs increase significantly, and silent synapses peak. Sustained increases in evoked and miniature AMPAR currents occur at 12 hr AEO. Significant changes in AMPAR:NMDAR evoked current ratios, contacts per axon, and inputs per cell are present at 24 hr AEO. The AMPAR current changes are those seen in vitro during NMDAR-dependent LTP. Here, they are a consequence of eye opening and are associated with a new wave of synaptic refinement. These data also suggest that new NR2B-rich NMDAR currents precede and may initiate this developmental synaptic potentiation and functional tuning.	MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Constantine-Paton, M (corresponding author), MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Dept Biol, Cambridge, MA 02139 USA.	mcpaton@mit.edu			NEI NIH HHS [EY014074] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014074] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akerman CJ, 2002, NEURON, V36, P869, DOI 10.1016/S0896-6273(02)01010-3; Bansal A, 2000, J NEUROSCI, V20, P7672; BEAR MF, 1990, J NEUROSCI, V10, P909; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Binns KE, 1997, DEV BRAIN RES, V99, P263, DOI 10.1016/S0165-3806(97)00004-7; Binns KE, 1998, EXP BRAIN RES, V120, P335, DOI 10.1007/s002210050407; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; Colonnese MT, 2001, J NEUROSCI, V21, P1557, DOI 10.1523/JNEUROSCI.21-05-01557.2001; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Cossart R, 2002, NEURON, V35, P147, DOI 10.1016/S0896-6273(02)00753-5; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; DRAGER UC, 1976, J NEUROPHYSIOL, V39, P91, DOI 10.1152/jn.1976.39.1.91; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Flint AC, 1997, J NEUROSCI, V17, P2469; FOX K, 1991, NATURE, V350, P342, DOI 10.1038/350342a0; Hohnke CD, 2000, J NEUROSCI, V20, P8051; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Komiyama NH, 2002, J NEUROSCI, V22, P9721; LANGER TP, 1974, J COMP NEUROL, V158, P405, DOI 10.1002/cne.901580404; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; LINDEN R, 1983, BRAIN RES, V272, P145, DOI 10.1016/0006-8993(83)90371-2; Losi G, 2003, J PHYSIOL-LONDON, V548, P21, DOI 10.1113/jphysiol.2002.034918; LUND RD, 1972, INVEST OPHTH VISUAL, V11, P434; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Niethammer M, 1996, J NEUROSCI, V16, P2157; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; Purves, 1985, PRINCIPLES NEURAL DE; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Rodieck R.W., 1998, 1 STEPS SEEING; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Savidge JR, 1999, NEUROPHARMACOLOGY, V38, P375, DOI 10.1016/S0028-3908(98)00202-0; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Shi J, 2000, NEURON, V28, P103, DOI 10.1016/S0896-6273(00)00089-1; Shi J, 1997, J NEUROSCI, V17, P6264; SIMON DK, 1992, J NEUROSCI, V12, P1212; SIMON DK, 1992, P NATL ACAD SCI USA, V89, P10593, DOI 10.1073/pnas.89.22.10593; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Stein V, 2003, J NEUROSCI, V23, P5503; THONG IG, 1986, DEV BRAIN RES, V25, P227, DOI 10.1016/0165-3806(86)90212-9; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Tovar KR, 1999, J NEUROSCI, V19, P4180; TOWNSEND M, 2003, P NATL ACAD SCI USA, V89, P10593; VANZUNDERT B, 2004, IN PRESS TRENDS NEUR; WILLIAMS K, 1993, NEURON, V10, P267, DOI 10.1016/0896-6273(93)90317-K; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Yoshii A, 2003, P NATL ACAD SCI USA, V100, P1334, DOI 10.1073/pnas.0335785100; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665	60	74	76	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 22	2004	43	2					237	249		10.1016/j.neuron.2004.06.031	http://dx.doi.org/10.1016/j.neuron.2004.06.031			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841BX	15260959	Bronze			2022-12-24	WOS:000222905400012
J	Gottfried, JA; Smith, APR; Rugg, MD; Dolan, RJ				Gottfried, JA; Smith, APR; Rugg, MD; Dolan, RJ			Remembrance of odors past: Human olfactory cortex in cross-modal recognition memory	NEURON			English	Article							ORBITOFRONTAL CORTEX; EPISODIC MEMORY; BRAIN ACTIVITY; HIPPOCAMPAL; RETRIEVAL; AMYGDALA; FMRI; REPRESENTATIONS; LOCALIZATION; ORGANIZATION	Episodic memory is often imbued with multisensory richness, such that the recall of an event can be endowed with the sights, sounds, and smells of its prior occurrence. While hippocampus and related medial temporal structures are implicated in episodic memory retrieval, the participation of sensory-specific cortex in representing the qualities of an episode is less well established. We combined functional magnetic resonance imaging (fMRI) with a cross-modal paradigm, where objects were presented with odors during memory encoding. We then examined the effect of odor context on neural responses at retrieval when these same objects were presented alone. Primary olfactory (piriform) cortex, as well as anterior hippocampus, was activated during the successful retrieval of old (compared to new) objects. Our findings indicate that sensory features of the original engram are preserved in unimodal olfactory cortex. We suggest that reactivation of memory traces distributed across modality-specific brain areas underpins the sensory qualities of episodic memories.	Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; UCL, Inst Cognit Neurosci, London WC1N 3AR, England; Univ Calif Irvine, Ctr Neurobiol Learning & Mem, Irvine, CA 92697 USA	University of London; University College London; University of London; University College London; University of California System; University of California Irvine	Gottfried, JA (corresponding author), Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	j.gottfried@fil.ion.ucl.ac.uk	Ying, Hua/D-8724-2012; Smith-Collins, Adam/C-6946-2009	Smith-Collins, Adam/0000-0002-5620-6169; Dolan, Ray/0000-0001-9356-761X				Alvarez P, 2001, LEARN MEMORY, V8, P79, DOI 10.1101/lm.38201; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; [Anonymous], 1983, CANADIAN PSYCHOL; Bensafi M, 2003, NAT NEUROSCI, V6, P1142, DOI 10.1038/nn1145; Buckley MJ, 1998, NEUROPSYCHOLOGIA, V36, P535, DOI 10.1016/S0028-3932(97)00120-6; CAHILL L, 1995, NATURE, V377, P295, DOI 10.1038/377295a0; Cohen NJ, 1997, MEMORY, V5, P131, DOI 10.1080/741941149; Dade LA, 2002, BRAIN, V125, P86, DOI 10.1093/brain/awf003; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Dusek JA, 1997, P NATL ACAD SCI USA, V94, P7109, DOI 10.1073/pnas.94.13.7109; Elmes DG, 1998, CHEM SENSES, V23, P443, DOI 10.1093/chemse/23.4.443; Erk S, 2003, NEUROIMAGE, V18, P439, DOI 10.1016/S1053-8119(02)00015-0; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; Gibson JR, 1997, J NEUROPHYSIOL, V78, P1263, DOI 10.1152/jn.1997.78.3.1263; Gottfried JA, 2002, J NEUROSCI, V22, P10829; Gottfried JA, 2002, J NEUROSCI, V22, P10819; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Haberly LB, 1998, SYNAPTIC ORG BRAIN, P377; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Henson RNA, 1999, J NEUROSCI, V19, P3962; Higuchi S, 1996, P NATL ACAD SCI USA, V93, P739, DOI 10.1073/pnas.93.2.739; JONESGOTMAN M, 1993, BRAIN COGNITION, V22, P182, DOI 10.1006/brcg.1993.1033; Konishi S, 2000, NEUROIMAGE, V12, P276, DOI 10.1006/nimg.2000.0614; Lang P. J., 1997, NIMH CTR STUDY EMOTI, P39; Maratos EJ, 2001, NEUROPSYCHOLOGIA, V39, P910, DOI 10.1016/S0028-3932(01)00025-2; Maratos EJ, 2001, J COGNITIVE NEUROSCI, V13, P877, DOI 10.1162/089892901753165809; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Mayes AR, 1999, BEHAV BRAIN SCI, V22, P460, DOI 10.1017/S0140525X99372034; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Mishkin M, 1997, PHILOS T R SOC B, V352, P1461, DOI 10.1098/rstb.1997.0132; Mouly AM, 2001, NEUROSCIENCE, V102, P11, DOI 10.1016/S0306-4522(00)00476-0; MURRAY EA, 1993, J NEUROSCI, V13, P4549; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; Nyberg L, 2000, P NATL ACAD SCI USA, V97, P11120, DOI 10.1073/pnas.97.20.11120; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; RAUSCH R, 1977, CORTEX, V13, P445, DOI 10.1016/S0010-9452(77)80024-5; Rugg MD, 2000, TRENDS COGN SCI, V4, P108, DOI 10.1016/S1364-6613(00)01445-5; Saar D, 1999, J NEUROSCI, V19, P8616; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Smith APR, 2004, J COGNITIVE NEUROSCI, V16, P760, DOI 10.1162/089892904970816; SMITH APR, 2004, IN PRESS NEUROIMAGE; Sobel N, 1998, NATURE, V392, P282, DOI 10.1038/32654; Sobel N, 2000, J NEUROPHYSIOL, V83, P537, DOI 10.1152/jn.2000.83.1.537; Stark CEL, 2000, HIPPOCAMPUS, V10, P329, DOI 10.1002/1098-1063(2000)10:3<329::AID-HIPO13>3.0.CO;2-Z; Stark CEL, 2001, LEARN MEMORY, V8, P190, DOI 10.1101/lm.40701; Stark CEL, 2002, LEARN MEMORY, V9, P238, DOI 10.1101/lm.51802; Vaidya CJ, 2002, NEUROPSYCHOLOGIA, V40, P2136, DOI 10.1016/S0028-3932(02)00053-2; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; ZATORRE RJ, 1992, NATURE, V360, P339, DOI 10.1038/360339a0	59	172	173	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 27	2004	42	4					687	695		10.1016/S0896-6273(04)00270-3	http://dx.doi.org/10.1016/S0896-6273(04)00270-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157428	Bronze			2022-12-24	WOS:000221708300017
J	Peng, CH; Rich, ED; Varnum, MD				Peng, CH; Rich, ED; Varnum, MD			Subunit configuration of heteromeric cone cyclic nucleotide-gated channels	NEURON			English	Article							ION CHANNELS; FUNCTIONAL EXPRESSION; RETINAL ROD; PHOTORECEPTOR CELLS; MOLECULAR-CLONING; OLFACTORY NEURONS; CATION CHANNEL; BETA-SUBUNIT; STOICHIOMETRY; ADAPTATION	Cone photoreceptor cyclic nucleotide-gated (CNG) channels are thought to be tetrameric assemblies of CNGB3 (B3) and CNGA3 (A3) subunits. We have used functional and biochemical approaches to investigate the stoichiometry and arrangement of these subunits in recombinant channels. First, tandem dimers of linked subunits were used to constrain the order of CNGB3 and CNGA3 subunits; the properties of channels formed by B3/B3 + A3/A3 dimers, or A3/B3 + B3/ A3 dimers, closely resembled those of channels arising from B3 + A3 monomers. Functional markers in B3/ B3 (or A3/A3) dimers confirmed that both B3 subunits (and both A3 subunits) gained membership into the pore-forming tetramer and that like subunits were positioned adjacent to each other. Second, chemical crosslinking and co-immunoprecipitation studies using epitope-tagged monomer subunits both demonstrated the presence of two CNGB3 subunits in cone channels. Together, these data support a preferred subunit arrangement for cone CNG channels (B3-B3-A3-A3) that is distinct from the 3A:1B configuration of rod channels.	Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Pullman, WA 99164 USA; Washington State Univ, Program Neurosci, Pullman, WA 99164 USA; Washington State Univ, Ctr Integrated Biotechnol, Pullman, WA 99164 USA	Washington State University; Washington State University; Washington State University	Varnum, MD (corresponding author), Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, POB 646520, Pullman, WA 99164 USA.	varnum@wsu.edu			NEI NIH HHS [EY 12836] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012836] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAUER PJ, 1992, J PHYSIOL-LONDON, V451, P109, DOI 10.1113/jphysiol.1992.sp019156; Bonigk W, 1999, J NEUROSCI, V19, P5332; BONIGK W, 1993, NEURON, V10, P865, DOI 10.1016/0896-6273(93)90202-3; BRADLEY J, 1994, P NATL ACAD SCI USA, V91, P8890, DOI 10.1073/pnas.91.19.8890; Bradley J, 2001, SCIENCE, V294, P2176, DOI 10.1126/science.1063415; Bradley J, 2001, SCIENCE, V294, P2095, DOI 10.1126/science.294.5549.2095; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; CHEN TY, 1994, P NATL ACAD SCI USA, V91, P11757, DOI 10.1073/pnas.91.24.11757; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; FRINGS S, 1995, NEURON, V15, P169, DOI 10.1016/0896-6273(95)90074-8; Gerstner A, 2000, J NEUROSCI, V20, P1324; GORDON SE, 1995, P NATL ACAD SCI USA, V92, P10222, DOI 10.1073/pnas.92.22.10222; Hackos DH, 1997, J GEN PHYSIOL, V110, P515, DOI 10.1085/jgp.110.5.515; HAYNES L, 1985, NATURE, V317, P61, DOI 10.1038/317061a0; HAYNES LW, 1992, J GEN PHYSIOL, V100, P783, DOI 10.1085/jgp.100.5.783; He YJ, 2000, P NATL ACAD SCI USA, V97, P895, DOI 10.1073/pnas.97.2.895; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; Kohl S, 2000, HUM MOL GENET, V9, P2107, DOI 10.1093/hmg/9.14.2107; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LIMAN ER, 1994, NEURON, V13, P611, DOI 10.1016/0896-6273(94)90029-9; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; LUDWIG J, 1990, FEBS LETT, V270, P24, DOI 10.1016/0014-5793(90)81226-E; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Matulef K, 2003, ANNU REV CELL DEV BI, V19, P23, DOI 10.1146/annurev.cellbio.19.110701.154854; Matulef K, 2002, NEURON, V36, P93, DOI 10.1016/S0896-6273(02)00878-4; MCCORMACK K, 1992, BIOPHYS J, V63, P1406, DOI 10.1016/S0006-3495(92)81703-4; Miller James L., 1994, Current Opinion in Neurobiology, V4, P488, DOI 10.1016/0959-4388(94)90048-5; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; Peng CH, 2003, J BIOL CHEM, V278, P34533, DOI 10.1074/jbc.M305102200; Peng CH, 2003, J BIOL CHEM, V278, P24617, DOI 10.1074/jbc.M301699200; PICONES A, 1995, BIOPHYS J, V69, P120, DOI 10.1016/S0006-3495(95)79881-2; PICONES A, 1992, J GEN PHYSIOL, V100, P647, DOI 10.1085/jgp.100.4.647; Rebrik TI, 2004, J GEN PHYSIOL, V123, P63, DOI 10.1085/jgp.200308952; Rho SH, 2000, FEBS LETT, V478, P246, DOI 10.1016/S0014-5793(00)01863-9; Richards MJ, 2000, BIOCHEMISTRY-US, V39, P14003, DOI 10.1021/bi001639i; Rosenbaum T, 2002, NEURON, V33, P703, DOI 10.1016/S0896-6273(02)00599-8; SAKMANN B, 1983, SINGLE CHANNEL RECOR; SALKOFF L, 1992, TRENDS NEUROSCI, V15, P161, DOI 10.1016/0166-2236(92)90165-5; Sautter A, 1998, P NATL ACAD SCI USA, V95, P4696, DOI 10.1073/pnas.95.8.4696; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; Shammat IM, 1999, NEURON, V23, P809, DOI 10.1016/S0896-6273(01)80038-6; Shapiro MS, 2000, BIOPHYS J, V78, P2307, DOI 10.1016/S0006-3495(00)76777-4; Shapiro MS, 1998, P NATL ACAD SCI USA, V95, P14546, DOI 10.1073/pnas.95.24.14546; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; Sundin OH, 2000, NAT GENET, V25, P289, DOI 10.1038/77162; Varnum MD, 1996, BIOPHYS J, V70, P2667, DOI 10.1016/S0006-3495(96)79836-3; VARNUM MD, 1995, NEURON, V14, P407, DOI 10.1016/0896-6273(95)90296-1; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; Weitz D, 2002, NEURON, V36, P881, DOI 10.1016/S0896-6273(02)01098-X; XU J, 1995, J BIOL CHEM, V270, P24761, DOI 10.1074/jbc.270.42.24761; Yu WP, 1996, FEBS LETT, V393, P211, DOI 10.1016/0014-5793(96)00889-7; Zheng J, 2002, NEURON, V36, P891, DOI 10.1016/S0896-6273(02)01099-1; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201; Zhong HN, 2003, P NATL ACAD SCI USA, V100, P5509, DOI 10.1073/pnas.0931279100; Zufall F, 2001, TRENDS NEUROSCI, V24, P191, DOI 10.1016/S0166-2236(00)01765-3	62	96	106	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2004	42	3					401	410		10.1016/S0896-6273(04)00225-9	http://dx.doi.org/10.1016/S0896-6273(04)00225-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KH	15134637	Bronze			2022-12-24	WOS:000221458700007
J	Watt, WC; Sakano, H; Lee, ZY; Reusch, JE; Trinh, K; Storm, DR				Watt, WC; Sakano, H; Lee, ZY; Reusch, JE; Trinh, K; Storm, DR			Odorant stimulation enhances survival of olfactory sensory neurons via MAPK and CREB	NEURON			English	Article							ELEMENT-BINDING PROTEIN; CELL-DEATH; RECEPTOR; KINASE; PHOSPHORYLATION; TRANSCRIPTION; GENE; BULB; INDUCTION; CYCLASE	Olfactory sensory neurons (OSNs) can be sensitized to odorants by repeated exposure, suggesting that an animal's responsiveness to olfactory cues can be enhanced at the initial stage of detection. However, because OSNs undergo a regular cycle of apoptosis and replacement by ostensibly naive, precursor-derived neurons, the advantage of sensitization would be lost in the absence of a mechanism for odorant-enhanced survival of OSNs. Using recombinant adenoviruses in conjunction with surgical and electrophysiological techniques, we monitored OSN survival and function in vivo and find that odorant exposure selectively rescues populations of OSNs from apoptosis. We further demonstrate that odorant stimuli rescue OSNs in a cAMP-dependent manner by activating the MAPK/CREB-dependent transcriptional pathway, possibly as a result of expression of Bcl-2.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Med Genet, Seattle, WA 98195 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Endocrinol, Denver, CO 80220 USA; Univ Colorado, Hlth Sci Ctr, Cardiovasc Pulm Res Sect, Denver, CO 80220 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	dstorm@u.washington.edu		Sakano, Hitomi/0000-0002-7471-8352; Reusch, Jane/0000-0001-8620-1003	NIDCD NIH HHS [DC04156, R01 DC004156-09] Funding Source: Medline; NIGMS NIH HHS [GM07270] Funding Source: Medline; NINDS NIH HHS [R01 NS020498-25, NS357056] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004156] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BOEKHOFF I, 1992, P NATL ACAD SCI USA, V89, P471, DOI 10.1073/pnas.89.2.471; BOOTH WD, 1981, Q J EXP PHYSIOL CMS, V66, P533, DOI 10.1113/expphysiol.1981.sp002594; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BRUNJES PC, 1994, BRAIN RES REV, V19, P146; Dalton P, 2002, NAT NEUROSCI, V5, P199, DOI 10.1038/nn803; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; Dittman AH, 1997, NEURON, V19, P381, DOI 10.1016/S0896-6273(00)80947-2; Fiske BK, 2001, J NEUROBIOL, V47, P223, DOI 10.1002/neu.1029; Fiske BK, 2001, J COMP NEUROL, V431, P311; Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Hirotsu T, 2000, NATURE, V404, P289, DOI 10.1038/35005101; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Ivic L, 2000, NAT NEUROSCI, V3, P1113, DOI 10.1038/80632; Jourdan F, 1998, NEUROREPORT, V9, P921, DOI 10.1097/00001756-199803300-00029; Leinders-Zufall T, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-14-j0005.1999; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MICHEL D, 1994, NEUROREPORT, V5, P1329, DOI 10.1097/00001756-199406000-00009; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Moon C, 1999, P NATL ACAD SCI USA, V96, P14605, DOI 10.1073/pnas.96.25.14605; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; RONNETT GV, 1991, P NATL ACAD SCI USA, V88, P2366, DOI 10.1073/pnas.88.6.2366; Shayakhmetov DM, 2000, J VIROL, V74, P2567, DOI 10.1128/JVI.74.6.2567-2583.2000; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; WANG HW, 1993, SCIENCE, V260, P998, DOI 10.1126/science.8493539; Watt WC, 2001, J BIOL CHEM, V276, P2047, DOI 10.1074/jbc.M006703200; Wei J, 1998, NEURON, V21, P495, DOI 10.1016/S0896-6273(00)80561-9; WYSOCKI CJ, 1989, P NATL ACAD SCI USA, V86, P7976, DOI 10.1073/pnas.86.20.7976; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8	35	95	96	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 25	2004	41	6					955	967		10.1016/S0896-6273(04)00075-3	http://dx.doi.org/10.1016/S0896-6273(04)00075-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046727	Bronze			2022-12-24	WOS:000221458300014
J	Song, MR; Ghosh, A				Song, MR; Ghosh, A			FGF2-induced chromatin remodeling regulates CNTF-mediated gene expression and astrocyte differentiation	NATURE NEUROSCIENCE			English	Article							RAT CEREBRAL-CORTEX; HISTONE H3 METHYLATION; CENTRAL-NERVOUS-SYSTEM; RNA-POLYMERASE-II; STEM-CELLS; RECOMBINANT RETROVIRUS; DEVELOPMENTAL-CHANGES; X-INACTIVATION; METHYLTRANSFERASE; TRANSCRIPTION	The generation of distinct cell types during development depends on the competence of progenitor populations to differentiate along specific lineages. Here we investigate the mechanisms that regulate competence of rodent cortical progenitors to differentiate into astrocytes in response to ciliary neurotrophic factor (CNTF). We found that fibroblast growth factor 2 (FGF2), which by itself does not induce astrocyte-specific gene expression, regulates the ability of CNTF to induce expression of glial fibrillary acidic protein (GFAP). FGF2 facilitates access of the STAT/CBP (signal transducer and activator of transcription/CRE binding protein) complex to the GFAP promoter by inducing Lys4 methylation and suppressing Lys9 methylation of histone H3 at the STAT binding site. Histone methylation at this site is specific to the cell's state of differentiation. In progenitors, the promoter is bound by Lys9-methylated histones, and in astrocytes, it is bound by Lys4-methylated histones, indicating that astrocyte differentiation in vivo involves this switch in chromatin state. Our observations indicate that extracellular signals can regulate access of transcription factors to genomic promoters by local chromatin modification, and thereby regulate developmental competence.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Ghosh, A (corresponding author), Univ Calif San Diego, Div Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	aghosh@ucsd.edu			NIAID NIH HHS [1P30AI42855] Funding Source: Medline; NINDS NIH HHS [NS36176] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036176] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kahn MA, 1997, J NEUROCHEM, V68, P1413; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Molne M, 2000, J NEUROSCI RES, V59, P301, DOI 10.1002/(SICI)1097-4547(20000201)59:3<301::AID-JNR3>3.0.CO;2-H; Morrow T, 2001, DEVELOPMENT, V128, P3585; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; PRICE J, 1988, DEVELOPMENT, V104, P473; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Viti J, 2003, J NEUROSCI, V23, P3385; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; WILLIAMS BP, 1995, NEURON, V14, P1181, DOI 10.1016/0896-6273(95)90265-1; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200	39	197	204	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					229	235		10.1038/nn1192	http://dx.doi.org/10.1038/nn1192			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14770186				2022-12-24	WOS:000189197900012
J	Frick, A; Magee, J; Johnston, D				Frick, A; Magee, J; Johnston, D			LTP is accompanied by an enhanced local excitability of pyramidal neuron dendrites	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; ACTIVITY-DEPENDENT ATTENUATION; EPSP-SPIKE POTENTIATION; RAT HIPPOCAMPAL SLICES; K+ CHANNELS; NA+ CHANNELS; POTASSIUM CHANNELS; ACTIVE DENDRITES; CA2+ CHANNELS; PLASTICITY	The propagation and integration of signals in the dendrites of pyramidal neurons is regulated, in part, by the distribution and biophysical properties of voltage-gated ion channels. It is thus possible that any modification of these channels in a specific part of the dendritic tree might locally alter these signaling processes. Using dendritic and somatic whole-cell recordings, combined with calcium imaging in rat hippocampal slices, we found that the induction of long-term potentiation (LTP) was accompanied by a local increase in dendritic excitability that was dependent on the activation of NMDA receptors. These changes favored the back-propagation of action potentials into this dendritic region with a subsequent boost in the Ca2+ influx. Dendritic cell-attached patch recordings revealed a hyperpolarized shift in the inactivation curve of transient, A-type K+ currents that can account for the enhanced excitability. These results suggest an important mechanism associated with LTP for shaping signal processing and controlling dendritic function.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Marine Biol Lab, Woods Hole, MA 02543 USA; Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA 70112 USA	Baylor College of Medicine; Marine Biological Laboratory - Woods Hole; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Johnston, D (corresponding author), Baylor Coll Med, Div Neurosci, 1 Baylor Plaza, Houston, TX 77030 USA.	dan@mossy.bcm.tmc.edu						ABRAHAM WC, 1987, J PHYSIOL-LONDON, V394, P367, DOI 10.1113/jphysiol.1987.sp016875; Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; ALKON DL, 1982, SCIENCE, V215, P693, DOI 10.1126/science.7058334; Alonso G, 1997, NEUROSCIENCE, V77, P617; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; CHAVEZNORIEGA LE, 1990, EXP BRAIN RES, V79, P633; CHRISTIE BR, 1995, J NEUROPHYSIOL, V73, P2553, DOI 10.1152/jn.1995.73.6.2553; Colbert CM, 1999, J NEUROSCI, V19, P8163; Colbert CM, 1998, J NEUROPHYSIOL, V79, P491, DOI 10.1152/jn.1998.79.1.491; Colbert CM, 1997, J NEUROSCI, V17, P6512; Frick A, 2003, J NEUROSCI, V23, P3243; Gasparini S, 2002, J PHYSIOL-LONDON, V541, P665, DOI 10.1113/jphysiol.2002.020503; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 2002, P NATL ACAD SCI USA, V99, P7740, DOI 10.1073/pnas.092157999; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; JESTER JM, 1995, J PHYSIOL-LONDON, V484, P689, DOI 10.1113/jphysiol.1995.sp020696; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Johnston D, 1999, CURR OPIN NEUROBIOL, V9, P288, DOI 10.1016/S0959-4388(99)80042-7; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Linden DJ, 1999, NEURON, V22, P661, DOI 10.1016/S0896-6273(00)80726-6; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Magee J. C., 1999, DENDRITES, P139; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MIYAKAWA H, 1992, NEURON, V9, P1163, DOI 10.1016/0896-6273(92)90074-N; Muller W, 2002, J NEUROPHYSIOL, V87, P2990, DOI 10.1152/jn.00790.2001; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Quirk MC, 2001, J NEUROSCI, V21, P240, DOI 10.1523/JNEUROSCI.21-01-00240.2001; Ramakers GMJ, 2002, P NATL ACAD SCI USA, V99, P10144, DOI 10.1073/pnas.152620399; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; Schrader LA, 2002, MOL NEUROBIOL, V25, P51; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Staff NP, 2003, HIPPOCAMPUS, V13, P801, DOI 10.1002/hipo.10129; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; TAUBE JS, 1988, J NEUROSCI, V8, P1632; Tsubokawa H, 2000, J NEUROSCI, V20, P4878; Tsubokawa H, 1997, J NEUROSCI, V17, P5782; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Wang ZR, 2003, NEURON, V37, P463, DOI 10.1016/S0896-6273(02)01189-3; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4	50	311	314	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					126	135		10.1038/nn1178	http://dx.doi.org/10.1038/nn1178			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14730307				2022-12-24	WOS:000188468500010
J	Schuske, KR; Richmond, JE; Matthies, DS; Davis, WS; Runz, S; Rube, DA; van der Bliek, AM; Jorgensen, EM				Schuske, KR; Richmond, JE; Matthies, DS; Davis, WS; Runz, S; Rube, DA; van der Bliek, AM; Jorgensen, EM			Endophilin is required for synaptic vesicle endocytosis by localizing synaptojanin	NEURON			English	Article							BINDING PARTNERS; SH3 DOMAIN; IDENTIFICATION; MEMBRANE; DYNAMIN; AMPHIPHYSIN; MUTATIONS; PROTEINS; DISTINCT; HOMOLOG	Endophilin is a membrane-associated protein required for endocytosis of synaptic vesicles. Two models have been proposed for endophilin: that it alters lipid composition in order to shape membranes during endocytosis, or that it binds the polyphosphoinositide phosphatase synaptojanin and recruits this phosphatase to membranes. In this study, we demonstrate that the unc-57 gene encodes the Caenorhabditis elegans ortholog of endophilin A. We demonstrate that endophilin is required in C. elegans for synaptic vesicle recycling. Furthermore, the defects observed in endophilin mutants closely resemble those observed in synaptojanin mutants. The electrophysiological phenotype of endophilin and synaptojanin double mutants are virtually identical to the single mutants, demonstrating that endophilin and synaptojanin function in the same pathway. Finally, endophilin is required to stabilize expression of synaptojanin at the synapse. These data suggest that endophilin is an adaptor protein required to localize and stabilize synaptojanin at membranes during synaptic vesicle recycling.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Illinois, Dept Biol Sci, Chicago, IL 60606 USA; Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	Utah System of Higher Education; University of Utah; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Jorgensen, EM (corresponding author), Univ Utah, Dept Biol, 257 S 1400 E, Salt Lake City, UT 84112 USA.	jorgensen@biology.utah.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041477] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58166, T32-GM07104] Funding Source: Medline; NINDS NIH HHS [R01 NS041477-01A1, R01 NS041477-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Balguerie A, 1999, J CELL SCI, V112, P2529; Bamber BA, 1999, J NEUROSCI, V19, P5348; CLARK SG, 1994, GENETICS, V137, P987; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; De Camilli P, 2001, SYNAPSES, P217; deHeuvel E, 1997, J BIOL CHEM, V272, P8710, DOI 10.1074/jbc.272.13.8710; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755; Ge K, 2000, GENOMICS, V67, P210, DOI 10.1006/geno.2000.6216; Guichet A, 2002, EMBO J, V21, P1661, DOI 10.1093/emboj/21.7.1661; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hao WH, 1997, J BIOL CHEM, V272, P6393, DOI 10.1074/jbc.272.10.6393; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; Harris TW, 2001, TRAFFIC, V2, P597, DOI 10.1034/j.1600-0854.2001.002009597.x; Hill E, 2001, J CELL BIOL, V152, P309, DOI 10.1083/jcb.152.2.309; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Micheva KD, 1997, J BIOL CHEM, V272, P27239, DOI 10.1074/jbc.272.43.27239; Micheva KD, 1997, FEBS LETT, V414, P308, DOI 10.1016/S0014-5793(97)01016-8; Miller DM, 1995, METHOD CELL BIOL, V48, P365; Modregger J, 2003, J BIOL CHEM, V278, P4160, DOI 10.1074/jbc.M208568200; Nonet ML, 1997, J NEUROSCI, V17, P8061; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Ringstad N, 2001, J BIOL CHEM, V276, P40424, DOI 10.1074/jbc.M106338200; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Tang YT, 1999, P NATL ACAD SCI USA, V96, P12559, DOI 10.1073/pnas.96.22.12559; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Yook KJ, 2001, GENETICS, V158, P209	38	199	209	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 13	2003	40	4					749	762		10.1016/S0896-6273(03)00667-6	http://dx.doi.org/10.1016/S0896-6273(03)00667-6			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	744UL	14622579	Bronze			2022-12-24	WOS:000186651200010
J	Fan, XP; Labrador, JP; Hing, H; Bashaw, GJ				Fan, XP; Labrador, JP; Hing, H; Bashaw, GJ			Slit stimulation recruits Dock and Pak to the roundabout receptor and increases Rac activity to regulate axon repulsion at the CNS midline	NEURON			English	Article							ADAPTER PROTEIN; GUIDANCE RECEPTORS; DROSOPHILA CNS; ACTIN CYTOSKELETON; RHO GTPASES; C-ELEGANS; GROWTH; KINASE; ACTIVATION; CDC42	Drosophila Roundabout (Robo) is the founding member of a conserved family of repulsive axon guidance receptors that respond to secreted Slit proteins. Here we present evidence that the SH3-SH2 adaptor protein Dreadlocks (Dock), the p21-activated serine-threonine kinase (Pak), and the Rac1/Rac2/Mtl small GTPases can function during Robo repulsion. Loss-of-function and genetic interaction experiments suggest that limiting the function of Dock, Pak, or Rac partially disrupts Robo repulsion. In addition, Dock can directly bind to Robo's cytoplasmic domain, and the association of Dock and Robo is enhanced by stimulation with Slit. Furthermore, Slit stimulation can recruit a complex of Dock and Pak to the Robo receptor and trigger an increase in Rac1 activity. These results provide a direct physical link between the Robo receptor and an important cytoskeletal regulatory protein complex and suggest that Rac can function in both attractive and repulsive axon guidance.	Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA	University of Pennsylvania; University of Illinois System; University of Illinois Urbana-Champaign	Bashaw, GJ (corresponding author), Univ Penn, Sch Med, Dept Neurosci, 421 Curie Blvd, Philadelphia, PA 19104 USA.		Labrador, Juan Pablo/C-3018-2014	Labrador, Juan Pablo/0000-0003-3671-848X; Fan, Xueping/0000-0002-3715-6864	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046333] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS046333] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Battye R, 1999, DEVELOPMENT, V126, P2475; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Desai CJ, 1999, DEVELOPMENT, V126, P1527; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Eby JJ, 1998, CURR BIOL, V8, P967, DOI 10.1016/S0960-9822(98)00398-4; Fritz JL, 2000, DEVELOPMENT, V127, P1991; Fritz JL, 2002, DEV BIOL, V252, P46, DOI 10.1006/dbio.2002.0842; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Harden N, 1996, MOL CELL BIOL, V16, P1896; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Kaufmann N, 1998, DEVELOPMENT, V125, P453; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kochhar KS, 1996, CANCER LETT, V104, P163, DOI 10.1016/0304-3835(96)04244-9; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Li XD, 2002, J BIOL CHEM, V277, P37788, DOI 10.1074/jbc.M205428200; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Magie CR, 1999, DEVELOPMENT, V126, P5353; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Patel BN, 2002, CURR OPIN CELL BIOL, V14, P221, DOI 10.1016/S0955-0674(02)00308-3; Rao Y, 1998, P NATL ACAD SCI USA, V95, P2077, DOI 10.1073/pnas.95.5.2077; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Stein E, 1998, J BIOL CHEM, V273, P1303, DOI 10.1074/jbc.273.3.1303; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wills Z, 2002, NEURON, V36, P611, DOI 10.1016/S0896-6273(02)01022-X; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Yu TW, 2002, NAT NEUROSCI, V5, P1147, DOI 10.1038/nn956; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2	41	133	136	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 25	2003	40	1					113	127		10.1016/S0896-6273(03)00591-9	http://dx.doi.org/10.1016/S0896-6273(03)00591-9			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	726TA	14527437	Bronze			2022-12-24	WOS:000185614700013
J	Sjostrom, PJ; Turrigiano, GG; Nelson, SB				Sjostrom, PJ; Turrigiano, GG; Nelson, SB			Neocortical LTD via coincident activation of presynaptic NMDA and cannabinoid receptors	NEURON			English	Article							LONG-TERM DEPRESSION; HIPPOCAMPAL PYRAMIDAL NEURONS; D-ASPARTATE RECEPTOR; SYNAPTIC PLASTICITY; ENDOGENOUS CANNABINOIDS; VISUAL-CORTEX; AREA CA1; SUBCELLULAR-LOCALIZATION; RELEASE PROBABILITY; PURKINJE-CELLS	There is a consensus that NMDA receptors (NMDARs) detect coincident pre- and postsynaptic activity during induction of long-term potentiation (LTP), but their role in timing-dependent long-term depression (tLTD) is unclear. We examine tLTD in neocortical layer 5 (L5) pyramidal pairs and find that tLTD is expressed presynaptically, implying retrograde signaling. CB1 agonists produce depression that mimics and occludes tLTD. This agonist-induced LTD requires presynaptic activity and NMDAR activation, but not postsynaptic Ca2+ influx. Further experiments demonstrate the existence of presynaptic NMDARs that underlie the presynaptic activity dependence. Finally, manipulating cannabinoid breakdown alters the temporal window for tLTD. In conclusion, tLTD requires simultaneous activation of presynaptic NMDA and CB1 receptors. This novel form of coincidence detection may explain the temporal window of tLTD and may also impart synapse specificity to cannabinoid retrograde signaling.	Brandeis Univ, Volen Ctr Complex Syst, Dept Biol, Waltham, MA 02454 USA	Brandeis University	Nelson, SB (corresponding author), Brandeis Univ, Volen Ctr Complex Syst, Dept Biol, Mailstop 008,415 South St, Waltham, MA 02454 USA.		Sjöström, Per Jesper/B-9696-2019	Sjöström, Per Jesper/0000-0001-7085-2223; Nelson, Sacha/0000-0002-0108-8599	NATIONAL EYE INSTITUTE [R01EY011116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058754, R01MH066338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036853] Funding Source: NIH RePORTER; NEI NIH HHS [EY11116] Funding Source: Medline; NIMH NIH HHS [MH66338, MH58754] Funding Source: Medline; NINDS NIH HHS [NS36853] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; AOKI C, 1994, J NEUROSCI, V14, P5202; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Auclair N, 2000, J NEUROPHYSIOL, V83, P3287, DOI 10.1152/jn.2000.83.6.3287; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Berretta N, 1996, NEUROSCIENCE, V75, P339, DOI 10.1016/0306-4522(96)00301-6; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bisogno T, 1998, BIOCHEM BIOPH RES CO, V248, P515, DOI 10.1006/bbrc.1998.8874; Buonomano DV, 1999, J NEUROSCI, V19, P6748, DOI 10.1523/JNEUROSCI.19-16-06748.1999; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Carlson G, 2002, NAT NEUROSCI, V5, P723, DOI 10.1038/nn879; Casado M, 2002, NEURON, V33, P123, DOI 10.1016/S0896-6273(01)00568-2; Charton JP, 1999, BRAIN RES, V816, P609, DOI 10.1016/S0006-8993(98)01243-8; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Cline HT, 1998, CURR BIOL, V8, pR836, DOI 10.1016/S0960-9822(07)00525-8; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DEBANNE D, 1994, P NATL ACAD SCI USA, V91, P1148, DOI 10.1073/pnas.91.3.1148; DeBiasi S, 1996, NEUROREPORT, V7, P2773, DOI 10.1097/00001756-199611040-00073; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Dittman JS, 1998, J NEUROSCI, V18, P6147; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Gatley SJ, 1996, EUR J PHARMACOL, V307, P331, DOI 10.1016/0014-2999(96)00279-8; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Glitsch M, 1999, J NEUROSCI, V19, P511; Hillard CJ, 1999, J PHARMACOL EXP THER, V289, P1427; Hillard CJ, 2000, PROSTAG OTH LIPID M, V61, P3, DOI 10.1016/S0090-6980(00)00051-4; Kemp N, 2000, EUR J NEUROSCI, V12, P360, DOI 10.1046/j.1460-9568.2000.00903.x; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; Kreitzer AC, 2002, NEURON, V34, P787, DOI 10.1016/S0896-6273(02)00695-5; LARKMAN A, 1992, NATURE, V360, P70, DOI 10.1038/360070a0; LEGENDRE P, 1993, J NEUROSCI, V13, P674; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; Liu HT, 1997, NATURE, V386, P721, DOI 10.1038/386721a0; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Medina I, 1996, J PHYSIOL-LONDON, V495, P411, DOI 10.1113/jphysiol.1996.sp021603; Misner DL, 1999, J NEUROSCI, V19, P6795, DOI 10.1523/JNEUROSCI.19-16-06795.1999; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Nedergaard M, 2002, NAT REV NEUROSCI, V3, P748, DOI 10.1038/nrn916; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Ong WY, 1999, NEUROSCIENCE, V92, P1177, DOI 10.1016/S0306-4522(99)00025-1; OTMAKHOV N, 1993, NEURON, V10, P1101, DOI 10.1016/0896-6273(93)90058-Y; Pananceau M, 1998, J PHYSIOL-LONDON, V508, P503, DOI 10.1111/j.1469-7793.1998.503bq.x; Partridge JG, 2000, J NEUROPHYSIOL, V84, P1422, DOI 10.1152/jn.2000.84.3.1422; PITLER TA, 1992, J NEUROSCI, V12, P4122; Poncer JC, 2001, NAT NEUROSCI, V4, P989, DOI 10.1038/nn719; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Sawtell NB, 1999, J NEUROPHYSIOL, V82, P3594, DOI 10.1152/jn.1999.82.6.3594; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; Selig DK, 1999, J NEUROSCI, V19, P1236; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Solowij N., 1998, CANNABIS COGNITIVE F; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Sullivan JM, 1999, J NEUROPHYSIOL, V82, P1286, DOI 10.1152/jn.1999.82.3.1286; Tao HZW, 2001, P NATL ACAD SCI USA, V98, P11009, DOI 10.1073/pnas.191351698; Trettel J, 2003, J NEUROPHYSIOL, V89, P2334, DOI 10.1152/jn.01037.2002; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; WILLIAMS K, 1993, NEURON, V10, P267, DOI 10.1016/0896-6273(93)90317-K; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Woodhall G, 2001, J NEUROPHYSIOL, V86, P1644, DOI 10.1152/jn.2001.86.4.1644; Zakharenko SS, 2002, NEURON, V35, P1099, DOI 10.1016/S0896-6273(02)00898-X; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	84	423	433	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 14	2003	39	4					641	654		10.1016/S0896-6273(03)00476-8	http://dx.doi.org/10.1016/S0896-6273(03)00476-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	712CQ	12925278	Bronze			2022-12-24	WOS:000184779500009
J	Pedreira, ME; Maldonado, H				Pedreira, ME; Maldonado, H			Protein synthesis subserves reconsolidation or extinction depending on reminder duration	NEURON			English	Article							LONG-TERM HABITUATION; CRAB CHASMAGNATHUS-GRANULATUS; 2 RELATED FORMS; CONSOLIDATED MEMORY; RETROGRADE-AMNESIA; DANGER STIMULUS; CONTEXT MEMORY; FEAR MEMORIES; RETRIEVAL; KINASE	When learned associations are recalled from long-term memory stores by presentation of an unrein-forced conditioned stimulus (CS), two processes are initiated. One, termed reconsolidation, re-activates the association between the conditioned and unconditioned stimuli and transfers it from a stable protein synthesis-independent form of storage to a more labile protein-dependent state. The other is an extinction process in which presentation of the CS alone degrades the association between CS and US. To address the mechanistic relationship between reconsolidation and extinction, we have used an invertebrate model of contextual memory, which involves an association between the learning context and a visual danger stimulus. Here, we show that re-exposure duration to the learning context acts as a switch guiding the memory course toward reconsolidation or extinction, each depending on protein synthesis. Manipulation of this variable allows findings of impaired extinction to be discriminated from those of disrupted reconsolidation.	Univ Buenos Aires, Fac Ciencias Exactas & Nat, CONICET, IFIBYNE,Dept Fisiol & Biol Mol,Lab Neurobiol Memo, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Maldonado, H (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, CONICET, IFIBYNE,Dept Fisiol & Biol Mol,Lab Neurobiol Memo, Pabellon 2,C1428EHA, Buenos Aires, DF, Argentina.	hector@fbmc.fcen.uba.ar						ABBOT J, 1992, PHYSL PHARM BLOOD BR, P371; Alberini CM, 1999, J EXP BIOL, V202, P2887; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; BOUTON ME, 1993, PSYCHOL BULL, V114, P80, DOI 10.1037/0033-2909.114.1.80; BROOKS DC, 1994, J EXP PSYCHOL ANIM B, V20, P366, DOI 10.1037/0097-7403.20.4.366; Cahill L, 2001, TRENDS NEUROSCI, V24, P578, DOI 10.1016/S0166-2236(00)01885-3; Carew T.J., 2000, BEHAV NEUROBIOLOGY C; De Astrada MB, 1999, PHARMACOL BIOCHEM BE, V63, P109, DOI 10.1016/S0091-3057(98)00256-1; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Delorenzi A, 2000, J EXP BIOL, V203, P3369; Dudai Y., 2000, BRAIN PERCEPTION MEM; Freudenthal R, 2000, BRAIN RES, V855, P274, DOI 10.1016/S0006-8993(99)02358-6; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; Hebb Donald O., 1949, ORG BEHAV; Hermitte G, 1999, NEUROBIOL LEARN MEM, V71, P34, DOI 10.1006/nlme.1998.3858; HOEGER U, 1989, COMP BIOCHEM PHYS C, V92, P323, DOI 10.1016/0742-8413(89)90062-5; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Konorski J., 1948, CONDITIONED REFLEXES; Konorski J., 1967, INTEGRATIVE ACTIVITY; Locatelli F, 2002, NEUROBIOL LEARN MEM, V77, P234, DOI 10.1006/nlme.2001.4007; LOZADA M, 1990, PHYSIOL BEHAV, V47, P35, DOI 10.1016/0031-9384(90)90039-7; MACTUTUS CF, 1979, SCIENCE, V204, P1319, DOI 10.1126/science.572083; Maldonado H, 2002, CRUSTACEAN NERVOUS SYSTEM, P314; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Merlo E, 2002, NEUROSCIENCE, V112, P161, DOI 10.1016/S0306-4522(02)00049-0; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; MULLER GE, 1900, Z PSYCHOL S, V1; Muller U, 2000, NEURON, V27, P159, DOI 10.1016/S0896-6273(00)00017-9; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Pavlov I.P., 1927, CONDITIONED REFLEXES; Pedreira ME, 1996, PHARMACOL BIOCHEM BE, V54, P611; PEDREIRA ME, 1995, PHARMACOL BIOCHEM BE, V52, P385, DOI 10.1016/0091-3057(95)00124-F; Pedreira ME, 1998, ANIM LEARN BEHAV, V26, P34, DOI 10.3758/BF03199160; Pedreira ME, 2002, J NEUROSCI, V22, P8305; Pereyra P, 2000, NEUROBIOL LEARN MEM, V74, P119, DOI 10.1006/nlme.1999.3945; Pereyra P, 1999, J COMP PHYSIOL A, V184, P301, DOI 10.1007/s003590050328; Pereyra Patricia, 1996, Physiology and Behavior, V59, P19, DOI 10.1016/0031-9384(95)02013-6; Romano A, 1996, BRAIN RES, V735, P131; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Sekiguchi T, 1997, LEARN MEMORY, V4, P356, DOI 10.1101/lm.4.4.356; SPEAR NE, 1973, PSYCHOL REV, V80, P163, DOI 10.1037/h0034326; Tomsic D, 1998, ANIM LEARN BEHAV, V26, P196, DOI 10.3758/BF03199212; Troncoso J, 2002, PHARMACOL BIOCHEM BE, V72, P251, DOI 10.1016/S0091-3057(01)00779-1; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Tully T, 1998, NAT NEUROSCI, V1, P543, DOI 10.1038/2780; Vianna MRM, 2001, P NATL ACAD SCI USA, V98, P12251, DOI 10.1073/pnas.211433298	48	326	334	2	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 19	2003	38	6					863	869		10.1016/S0896-6273(03)00352-0	http://dx.doi.org/10.1016/S0896-6273(03)00352-0			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	693AA	12818173	Bronze			2022-12-24	WOS:000183691400007
J	Schenck, A; Bardoni, B; Langmann, C; Harden, N; Mandel, JL; Giangrande, A				Schenck, A; Bardoni, B; Langmann, C; Harden, N; Mandel, JL; Giangrande, A			CYFIP/Sra-1 controls neuronal connectivity in Drosophila and links the Rac1 GTPase pathway to the fragile X protein	NEURON			English	Article							MENTAL-RETARDATION PROTEIN; DENDRITIC SPINES; RHO-GTPASES; SYNAPTIC PLASTICITY; MESSENGER-RNA; AXON GUIDANCE; FMRP; COMPONENTS; DFMR1; IDENTIFICATION	Neuronal plasticity requires actin cytoskeleton remodeling and local protein translation in response to extracellular signals. Rho GTPase pathways control actin reorganization, while the fragile X mental retardation protein (FMRP) regulates the synthesis of specific proteins. Mutations affecting either pathway produce neuronal connectivity defects in model organisms and mental retardation in humans. We show that CYFIP, the fly ortholog of vertebrate FMRP interactors; CYFIP1 and CYFIP2, is specifically expressed in the nervous system. CYFIP mutations affect axons and synapses, much like mutations in dFMR1 (the Drosophila FMR1 ortholog) and in Rho GTPase dRac1. CYFIP interacts biochemically and genetically with dFMR1 and dRac1. Finally, CYFIP acts as a dRac1 effector that antagonizes FMR1 function, providing a bridge between signal-dependent cytoskeleton remodeling and translation.	ULP, INSERM, Inst Genet & Biol Mol & Cellulaire, CNRS,Dept Mol Pathol, F-67404 Illkirch Graffenstaden, France; ULP, INSERM, Inst Genet & Biol Mol & Cellulaire, CNRS,Dept Dev Biol, F-67404 Illkirch Graffenstaden, France; Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Simon Fraser University	Schenck, A (corresponding author), ULP, INSERM, Inst Genet & Biol Mol & Cellulaire, CNRS,Dept Mol Pathol, Boite Postale 10142, F-67404 Illkirch Graffenstaden, France.	angela@titus.u-strasbg.fr; bardoni@titus.u-strasbg.fr	Langmann, Caillin/Y-2839-2019; Bardoni, Barbara/F-9918-2013; Schenck, Annette/E-4514-2012; Mandel, Jean Louis/Q-2668-2016	Schenck, Annette/0000-0002-6918-3314; Mandel, Jean Louis/0000-0002-0535-6589; Bardoni, Barbara/0000-0001-6411-1517	NICHD NIH HHS [R01 HD40612-01] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040612] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Agulhon C, 1999, J NEUROPATH EXP NEUR, V58, P867, DOI 10.1097/00005072-199908000-00009; Bakker CE, 2000, EXP CELL RES, V258, P162, DOI 10.1006/excr.2000.4932; Bardoni B, 1999, HUM MOL GENET, V8, P2557, DOI 10.1093/hmg/8.13.2557; Bardoni B, 2002, CURR OPIN GENET DEV, V12, P284, DOI 10.1016/S0959-437X(02)00300-3; Bardoni B, 2001, BRAIN RES BULL, V56, P375, DOI 10.1016/S0361-9230(01)00647-5; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; BELLEN HJ, 2000, DROSOPHILA PROTOCOLS, P175; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bontekoe CJM, 2002, HUM MOL GENET, V11, P487, DOI 10.1093/hmg/11.5.487; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Chang HY, 2000, SCIENCE, V290, P1978, DOI 10.1126/science.290.5498.1978; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; Chou TB, 1996, GENETICS, V144, P1673; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Corbin F, 1997, HUM MOL GENET, V6, P1465, DOI 10.1093/hmg/6.9.1465; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Greenough WT, 2001, P NATL ACAD SCI USA, V98, P7101, DOI 10.1073/pnas.141145998; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; Irwin SA, 2000, CEREB CORTEX, V10, P1038, DOI 10.1093/cercor/10.10.1038; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Kaufmann N, 1998, DEVELOPMENT, V125, P453; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Koh YH, 2000, MICROSC RES TECHNIQ, V49, P14, DOI 10.1002/(SICI)1097-0029(20000401)49:1<14::AID-JEMT3>3.3.CO;2-7; Koster F, 1998, NEUROSCI LETT, V252, P69, DOI 10.1016/S0304-3940(98)00531-X; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Morales J, 2002, NEURON, V34, P961, DOI 10.1016/S0896-6273(02)00731-6; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Schenck A, 2002, NEUROBIOL DIS, V11, P53, DOI 10.1006/nbdi.2002.0510; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; STEWARD O, 1982, J NEUROSCI, V2, P284; TORRE ER, 1992, J NEUROSCI, V12, P762; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	64	249	254	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 19	2003	38	6					887	898		10.1016/S0896-6273(03)00354-4	http://dx.doi.org/10.1016/S0896-6273(03)00354-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	693AA	12818175	Bronze			2022-12-24	WOS:000183691400009
J	Sharma, G; Vijayaraghavan, S				Sharma, G; Vijayaraghavan, S			Modulation of presynaptic store calcium induces release of glutamate and postsynaptic firing	NEURON			English	Article							PRIMATE HIPPOCAMPAL-FORMATION; CHOLINERGIC INNERVATION; MULTIVESICULAR RELEASE; MOSSY FIBER; SYNAPTIC TRANSMISSION; RYANODINE RECEPTORS; EXCITATORY SYNAPSES; ALPHA-LATROTOXIN; QUANTAL RELEASE; NERVE-TERMINALS	Action potential-independent transmitter release is random and produces small depolarizations in the postsynaptic neuron. This process is, therefore, not thought to play a significant role in impulse propagation across synapses. Here we show that calcium flux through presynaptic neuronal nicotinic receptors leads to mobilization of store calcium by calcium-induced calcium release. Recruitment of store calcium induces vesicular release of glutamate in a manner consistent with synchronization across multiple active zones in the CA3 region of the rat hippocampus. This modulation of action potential-independent release of glutamate is sufficient to drive the postsynaptic pyramidal cell above its firing threshold, thus providing a mechanism for impulse propagation.	Univ Colorado, Hlth Sci Ctr, Dept Physiol & Biophys, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Program Neurosci, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Vijayaraghavan, S (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Physiol & Biophys, 4200 E 9th Ave, Denver, CO 80262 USA.				NIDA NIH HHS [R01 DA10266] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010266] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abenavoli A, 2002, J NEUROSCI, V22, P6336; Alonso JR, 1996, J COMP NEUROL, V375, P527, DOI 10.1002/(SICI)1096-9861(19961125)375:4<527::AID-CNE1>3.0.CO;2-3; ALONSO JR, 1995, J COMP NEUROL, V355, P135, DOI 10.1002/cne.903550202; AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; Ashton AC, 2001, J BIOL CHEM, V276, P44695, DOI 10.1074/jbc.M108088200; Auger C, 1998, J NEUROSCI, V18, P4532; Auger C, 1997, NEURON, V19, P139, DOI 10.1016/S0896-6273(00)80354-2; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; Brain KL, 2001, NEUROSCIENCE, V106, P395, DOI 10.1016/S0306-4522(01)00280-9; Carter AG, 2002, J NEUROSCI, V22, P21, DOI 10.1523/JNEUROSCI.22-01-00021.2002; CLAIBORNE BJ, 1986, J COMP NEUROL, V246, P435, DOI 10.1002/cne.902460403; Cossart R, 2002, NEURON, V35, P147, DOI 10.1016/S0896-6273(02)00753-5; Davletov BA, 1998, EMBO J, V17, P3909, DOI 10.1093/emboj/17.14.3909; Descarries L, 1997, PROG NEUROBIOL, V53, P603, DOI 10.1016/S0301-0082(97)00050-6; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; Fabian-Fine R, 2001, J NEUROSCI, V21, P7993, DOI 10.1523/JNEUROSCI.21-20-07993.2001; FROTSCHER M, 1981, EXP BRAIN RES, V41, P247; FROTSCHER M, 1985, J COMP NEUROL, V239, P237, DOI 10.1002/cne.902390210; GarciaColunga J, 1997, NEUROREPORT, V8, P3293, DOI 10.1097/00001756-199710200-00020; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; Henze DA, 1997, J NEUROPHYSIOL, V77, P1075, DOI 10.1152/jn.1997.77.3.1075; Henze DA, 2002, J NEUROPHYSIOL, V87, P15, DOI 10.1152/jn.00394.2001; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; Narita K, 2000, J GEN PHYSIOL, V115, P519, DOI 10.1085/jgp.115.4.519; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Padua RA, 1996, EUR J PHARMACOL, V298, P185, DOI 10.1016/0014-2999(95)00797-0; Peng YY, 1996, J NEUROSCI, V16, P6703; Schikorski T, 1997, J NEUROSCI, V17, P5858; SEGUELA P, 1993, J NEUROSCI, V13, P596; Sharma G, 2001, P NATL ACAD SCI USA, V98, P4148, DOI 10.1073/pnas.071540198; SHARP AH, 1993, J NEUROSCI, V13, P3051; Smith AB, 1996, J PHYSIOL-LONDON, V497, P657, DOI 10.1113/jphysiol.1996.sp021797; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; VIJAYARAGHAVAN S, 1992, NEURON, V8, P353, DOI 10.1016/0896-6273(92)90301-S; Vogt KE, 2001, J NEUROSCI, V21, P75, DOI 10.1523/JNEUROSCI.21-01-00075.2001; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Wall MJ, 1998, NAT NEUROSCI, V1, P675, DOI 10.1038/3677; Wonnacott S, 1997, TRENDS NEUROSCI, V20, P92, DOI 10.1016/S0166-2236(96)10073-4; Zhuravleva SO, 2001, PFLUG ARCH EUR J PHY, V441, P832, DOI 10.1007/s004240000490	40	237	241	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 19	2003	38	6					929	939		10.1016/S0896-6273(03)00322-2	http://dx.doi.org/10.1016/S0896-6273(03)00322-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	693AA	12818178	Bronze			2022-12-24	WOS:000183691400012
J	Maeno-Hikichi, Y; Chang, SH; Matsumura, K; Lai, MZ; Lin, H; Nakagawa, N; Kuroda, S; Zhang, JF				Maeno-Hikichi, Y; Chang, SH; Matsumura, K; Lai, MZ; Lin, H; Nakagawa, N; Kuroda, S; Zhang, JF			A PKC epsilon-ENH-channel complex specifically modulates N-type Ca2+ channels	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; DEPENDENT CALCIUM CHANNELS; SYNAPTIC TRANSMISSION; ANCHORING PROTEINS; ION CHANNELS; SIGNAL-TRANSDUCTION; ALPHA(1) SUBUNIT; LIM DOMAINS; BETA-GAMMA; PHOSPHORYLATION	Multiple protein kinase C (PKC) isozymes are present in neurons, where they regulate a variety of cellular functions. Due to the lack of specific PKC isozyme inhibitors, it remains unknown how PKC acts on its selective target(s) and achieves its specific actions. Here we show that a PKC binding protein, enigma homolog (ENH), interacts specifically with both PKCepsilon and N-type Ca2+ channels, forming a PKCepsilon-ENH-Ca2+ channel macromolecular complex. Coexpression of ENH facilitated modulation of N-type Ca2+ channel activity by PKC. Disruption of the complex reduced the potentiation of the channel activity by PKC in neurons. Thus, ENH, by interacting specifically with both PKCepsilon and the N-type Ca2+ channel, targets a specific PKC to its substrate to form a functional signaling complex, which is the molecular mechanism for the specificity and efficiency of PKC signaling.	Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Inst Neurol Sci, Philadelphia, PA 19104 USA; Osaka Univ, Dept Struct Mol Biol, Inst Sci & Ind Res, Osaka 5670047, Japan	University of Pennsylvania; University of Pennsylvania; Osaka University	Zhang, JF (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 3620 Hamilton Walk, Philadelphia, PA 19104 USA.	jfzhang@pharm.med.upenn.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039355] Funding Source: NIH RePORTER; NINDS NIH HHS [NS39355] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Catterall WA, 1997, ADV SEC MESS PHOSPH, V31, P159; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; DOLPHIN AC, 1995, EXP PHYSIOL, V80, P1; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Fraser IDC, 1999, NEURON, V23, P423, DOI 10.1016/S0896-6273(00)80795-3; Gray PC, 1998, CURR OPIN NEUROBIOL, V8, P330, DOI 10.1016/S0959-4388(98)80057-3; HELL JW, 1994, J BIOL CHEM, V269, P7390; Herlitze S, 1997, P NATL ACAD SCI USA, V94, P1512, DOI 10.1073/pnas.94.4.1512; Hofmann J, 1997, FASEB J, V11, P649, DOI 10.1096/fasebj.11.8.9240967; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; Khasar SG, 1999, NEURON, V24, P253, DOI 10.1016/S0896-6273(00)80837-5; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Kuroda S, 1996, J BIOL CHEM, V271, P31029, DOI 10.1074/jbc.271.49.31029; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Levitan IB, 1999, ADV SEC MESS PHOSPH, V33, P3; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; Mochly-Rosen D, 1998, FASEB J, V12, P35; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Qin N, 1997, P NATL ACAD SCI USA, V94, P8866, DOI 10.1073/pnas.94.16.8866; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; SAITO N, 1993, BRAIN RES, V607, P241, DOI 10.1016/0006-8993(93)91512-Q; Shapiro MS, 1996, J NEUROPHYSIOL, V76, P311, DOI 10.1152/jn.1996.76.1.311; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; STEA A, 1995, NEURON, V15, P929, DOI 10.1016/0896-6273(95)90183-3; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; SWARTZ KJ, 1993, NATURE, V361, P165, DOI 10.1038/361165a0; TANAKA C, 1994, ANNU REV NEUROSCI, V17, P551, DOI 10.1146/annurev.ne.17.030194.003003; Ueki N, 1999, J HUM GENET, V44, P256, DOI 10.1007/s100380050155; Vaughan PFT, 1998, MOL NEUROBIOL, V18, P125, DOI 10.1007/BF02914269; Way KJ, 2000, TRENDS PHARMACOL SCI, V21, P181, DOI 10.1016/S0165-6147(00)01468-1; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; YANG J, 1993, NEURON, V10, P127, DOI 10.1016/0896-6273(93)90305-B; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zhang JF, 1996, NEURON, V17, P991, DOI 10.1016/S0896-6273(00)80229-9; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L; Zhou Q, 1999, J BIOL CHEM, V274, P19807, DOI 10.1074/jbc.274.28.19807; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	49	84	88	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					468	475		10.1038/nn1041	http://dx.doi.org/10.1038/nn1041			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12665800				2022-12-24	WOS:000182553200013
J	Kim, JE; Li, SX; GrandPre, T; Qiu, D; Strittmatter, SM				Kim, JE; Li, SX; GrandPre, T; Qiu, D; Strittmatter, SM			Axon regeneration in young adult mice lacking Nogo-A/B	NEURON			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; SPINAL-CORD INJURY; NEURITE GROWTH; FUNCTIONAL RECOVERY; RAT-BRAIN; INHIBITOR; IDENTIFICATION; OUTGROWTH; CNS; RECEPTOR	After injury, axons of the adult mammalian brain and spinal cord exhibit little regeneration. It has been suggested that axon growth inhibitors, such as myelin-derived Nogo, prevent CNS axon repair. To investigate this hypothesis, we analyzed mice with a nogo mutation that eliminates Nogo-A/B expression. These mice are viable and exhibit normal locomotion. Corticospinal tract tracing reveals no abnormality in uninjured nogo-A/B-/- mice. After spinal cord injury, corticospinal axons of young adult nogo-A/B-/- mice sprout extensively rostra[ to a transection. Numerous fibers regenerate into distal cord segments of nogo-A/B-/- mice. Recovery of locomotor function is improved in these mice. Thus, Nogo-A plays a role in restricting axonal sprouting in the young adult CNS after injury.	Yale Univ, Sch Med, Dept Neurol, Dept Neurobiol, New Haven, CT 06510 USA	Yale University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Dept Neurol, Dept Neurobiol, New Haven, CT 06510 USA.		Strittmatter, Stephen/F-5739-2011; Kim, Jean Jieun/G-5774-2018	Strittmatter, Stephen/0000-0001-8188-3092; Kim, Jean Jieun/0000-0003-4709-262X				BANDTLOW C, 1990, J NEUROSCI, V10, P3837, DOI 10.1523/JNEUROSCI.10-12-03837.1990; Bandtlow CE, 2000, GLIA, V29, P175, DOI 10.1002/(SICI)1098-1136(20000115)29:2<175::AID-GLIA11>3.0.CO;2-F; Bartsch U, 1995, NEURON, V15, P1375, DOI 10.1016/0896-6273(95)90015-2; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; BENFEY M, 1982, NATURE, V296, P150, DOI 10.1038/296150a0; Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fournier AE, 2001, CURR OPIN NEUROBIOL, V11, P89, DOI 10.1016/S0959-4388(00)00178-1; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; FRUTTIGER M, 1995, EUR J NEUROSCI, V7, P511, DOI 10.1111/j.1460-9568.1995.tb00347.x; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Grandpre T, 2001, NEUROSCIENTIST, V7, P377, DOI 10.1177/107385840100700507; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Hauben E, 2001, P NATL ACAD SCI USA, V98, P15173, DOI 10.1073/pnas.011585298; Huber AB, 2002, J NEUROSCI, V22, P3553; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; LI CM, 1994, NATURE, V369, P747, DOI 10.1038/369747a0; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Merkler D, 2001, J NEUROSCI, V21, P3665, DOI 10.1523/JNEUROSCI.21-10-03665.2001; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8; Saruhashi Y, 1996, EXP NEUROL, V139, P203, DOI 10.1006/exnr.1996.0094; SAVIO T, 1990, P NATL ACAD SCI USA, V87, P4130, DOI 10.1073/pnas.87.11.4130; Schafer M, 1996, NEURON, V16, P1107, DOI 10.1016/S0896-6273(00)80137-3; Simonen M, 2003, NEURON, V38, P201, DOI 10.1016/S0896-6273(03)00226-5; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wang XX, 2002, J NEUROSCI, V22, P5505; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3	43	324	355	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 24	2003	38	2					187	199		10.1016/S0896-6273(03)00147-8	http://dx.doi.org/10.1016/S0896-6273(03)00147-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672AM	12718854	Bronze			2022-12-24	WOS:000182498300009
J	Zheng, BH; Ho, C; Li, SX; Keirstead, H; Steward, O; Tessier-Lavigne, M				Zheng, BH; Ho, C; Li, SX; Keirstead, H; Steward, O; Tessier-Lavigne, M			Lack of enhanced spinal regeneration in Nogo-deficient mice	NEURON			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; NEURITE GROWTH-INHIBITORS; AXONAL REGENERATION; ADULT-RAT; FUNCTIONAL RECOVERY; CORD INJURY; CNS MYELIN; IDENTIFICATION; RECEPTOR; OUTGROWTH	The failure of regeneration of severed axons in the adult mammalian central nervous system is thought to be due partly to the presence of endogenous inhibitors of axon regeneration. The nogo gene encodes three proteins (Nogo-A, -B, and -C) that have been proposed to contribute to this inhibition. To determine whether deletion of nogo enhances regenerative ability, we generated two lines of mutant mice, one lacking Nogo-A and -B but not -C (Nogo-A/B mutant), and one deficient in all three isoforms (Nogo-A/B/C mutant). Although Nogo-A/B-deficient myelin has reduced inhibitory activity in a neurite outgrowth assay in vitro, tracing of corticospinal tract fibers after dorsal hemisection of the spinal cord did not reveal an obvious increase in regeneration or sprouting of these fibers in either mouse line, suggesting that elimination of Nogo alone is not sufficient to induce extensive axon regeneration.	Stanford Univ, Dept Biol Sci, Howard Hughes Med Inst, Stanford, CA 94305 USA; Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; Univ Calif Irvine, Gillespie Neurosci Res Facil, Coll Med, Reeve Irvine Res Ctr, Irvine, CA 92697 USA	Howard Hughes Medical Institute; Stanford University; Yale University; University of California System; University of California Irvine	Tessier-Lavigne, M (corresponding author), Stanford Univ, Dept Biol Sci, Howard Hughes Med Inst, Stanford, CA 94305 USA.		Ho, Chien/O-6112-2016	Ho, Chien/0000-0002-4094-9232; Steward, Oswald/0000-0001-7069-8756				Bartsch U, 1995, NEURON, V15, P1375, DOI 10.1016/0896-6273(95)90015-2; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Brosamle C, 2000, J NEUROSCI, V20, P8061; Cajal S., 1928, DEGENERATION REGENER; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; COLMAN DR, 1982, J CELL BIOL, V95, P598, DOI 10.1083/jcb.95.2.598; Dergham P, 2002, J NEUROSCI, V22, P6570; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; FAWCETT JW, 1992, TRENDS NEUROSCI, V15, P5, DOI 10.1016/0166-2236(92)90338-9; Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Huber AB, 2002, J NEUROSCI, V22, P3553; JAKEMAN LB, 1991, J COMP NEUROL, V307, P311, DOI 10.1002/cne.903070211; Kim JE, 2003, NEURON, V38, P187, DOI 10.1016/S0896-6273(03)00147-8; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Li M, 1996, J NEUROSCI RES, V46, P404, DOI 10.1002/(SICI)1097-4547(19961115)46:4<404::AID-JNR2>3.3.CO;2-W; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Oudega M, 2000, NEUROSCIENCE, V100, P873, DOI 10.1016/S0306-4522(00)00350-X; Pasterkamp RJ, 1999, MOL CELL NEUROSCI, V13, P143, DOI 10.1006/mcne.1999.0738; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Simonen M, 2003, NEURON, V38, P201, DOI 10.1016/S0896-6273(03)00226-5; Spillmann AA, 1998, J BIOL CHEM, V273, P19283, DOI 10.1074/jbc.273.30.19283; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423	36	295	310	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 24	2003	38	2					213	224		10.1016/S0896-6273(03)00225-3	http://dx.doi.org/10.1016/S0896-6273(03)00225-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672AM	12718856	Bronze			2022-12-24	WOS:000182498300011
J	Poirazi, P; Brannon, T; Mel, BW				Poirazi, P; Brannon, T; Mel, BW			Arithmetic of subthreshold synaptic summation in a model CA1 pyramidal cell	NEURON			English	Article							SUPRALINEAR SUMMATION; ACTION-POTENTIALS; DENDRITES; EPSPS; AMPLIFICATION; INTEGRATION; CALCIUM; NEURON; INPUT; RESPONSES	The rules of synaptic integration in pyramidal cells remain obscure, in part due to conflicting interpretations of existing experimental data. To clarify issues, we developed a CA1 pyramidal cell model calibrated with a broad spectrum of in vitro data. Using simultaneous dendritic and somatic recordings and combining results for two different response measures (peak versus mean EPSP), two different stimulus formats (single shock versus 50 Hz trains), and two different spatial integration conditions (within versus between-branch summation), we found that the cell's subthreshold responses to paired inputs are best described as a sum of nonlinear subunit responses, where the subunits correspond to different dendritic branches. In addition to suggesting a new type of experiment and providing testable predictions, our model shows how conclusions regarding synaptic arithmetic can be influenced by an array of seemingly innocuous experimental design choices.	Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90089 USA; FORTH, Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, GR-71110 Iraklion, Crete, Greece; Metaperl IT Consulting, Staten Isl, NY 10301 USA	University of Southern California; University of Southern California; Foundation for Research & Technology - Hellas (FORTH)	Poirazi, P (corresponding author), Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA.	poirazi@imbb.forth.gr; mel@usc.edu		Poirazi, Panayiota/0000-0001-6152-595X				Archie KA, 2000, NAT NEUROSCI, V3, P54, DOI 10.1038/71125; BERNANDER O, 1994, J NEUROPHYSIOL, V72, P2743, DOI 10.1152/jn.1994.72.6.2743; Cannon RC, 1998, J NEUROSCI METH, V84, P49, DOI 10.1016/S0165-0270(98)00091-0; Cash S, 1998, J NEUROSCI, V18, P10; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Cauller LJ, 1992, SINGLE NEURON COMPUT, P199; DESCHUTTER E, 1994, P NATL ACAD SCI USA, V91, P4736, DOI 10.1073/pnas.91.11.4736; Gillessen T, 1997, J NEUROPHYSIOL, V77, P1639, DOI 10.1152/jn.1997.77.3.1639; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Gonzalez-Burgos G, 2001, J NEUROPHYSIOL, V86, P1671, DOI 10.1152/jn.2001.86.4.1671; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; Lipowsky R, 1996, J NEUROPHYSIOL, V76, P2181, DOI 10.1152/jn.1996.76.4.2181; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Margulis M, 1998, J NEUROPHYSIOL, V79, P2809, DOI 10.1152/jn.1998.79.5.2809; Mel B. W., 1992, ADV NEURAL INFORMATI, V4, P3542; MEL BW, 1992, NEURAL COMPUT, V4, P502, DOI 10.1162/neco.1992.4.4.502; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; Mel BW, 1998, J NEUROSCI, V18, P4325; MEL BW, 1999, WHY DENDRITES COMPUT, P271; Nettleton JS, 2000, J NEUROPHYSIOL, V83, P3310, DOI 10.1152/jn.2000.83.6.3310; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Rall W, 1987, SYNAPTIC FUNCTION PP, P605; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schwindt PC, 1998, J NEUROPHYSIOL, V79, P2432, DOI 10.1152/jn.1998.79.5.2432; SHEPHERD GM, 1987, NEUROSCIENCE, V21, P151, DOI 10.1016/0306-4522(87)90329-0; SKYDSGAARD M, 1994, J PHYSIOL-LONDON, V479, P233, DOI 10.1113/jphysiol.1994.sp020291; Urban NN, 1998, P NATL ACAD SCI USA, V95, P11450, DOI 10.1073/pnas.95.19.11450; Urban NN, 1998, J NEUROPHYSIOL, V80, P1558, DOI 10.1152/jn.1998.80.3.1558; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Wessel R, 1999, J NEUROSCI, V19, P5875, DOI 10.1523/JNEUROSCI.19-14-05875.1999	36	306	307	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 27	2003	37	6					977	987		10.1016/S0896-6273(03)00148-X	http://dx.doi.org/10.1016/S0896-6273(03)00148-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	661PU	12670426	Bronze			2022-12-24	WOS:000181899600011
J	Meyer-Lindenberg, A; Kohn, P; Mervis, CB; Kippenhan, JS; Olsen, RK; Morris, CA; Berman, KF				Meyer-Lindenberg, A; Kohn, P; Mervis, CB; Kippenhan, JS; Olsen, RK; Morris, CA; Berman, KF			Neural basis of genetically determined visuospatial construction deficit in Williams syndrome	NEURON			English	Article							SYNDROME COGNITIVE PROFILE; HUMAN BRAIN; CORTEX; FACE; MRI; ABNORMALITIES; DISSOCIATION; PERCEPTION; PHENOTYPE; DELETIONS	A unique opportunity to understand genetic determinants of cognition is offered by Williams syndrome (WS), a well-characterized hemideletion on chromosome 7q11.23 that causes extreme, specific weakness in visuospatial construction (the ability to visualize an object as a set of parts or construct a replica). Using multimodal neuroimaging, we identified a neural mechanism underlying the WS visuoconstructive deficit. Hierarchical assessment of visual processing with fMRI showed isolated hypoactivation in WS in the parietal portion of the dorsal stream. In the immediately adjacent parietooccipital/intraparietat sulcus, structural neuroimaging showed a gray matter volume reduction in participants with WS. Path analysis demonstrated that the functional abnormalities could be attributed to impaired input from this structurally altered region. Our observations confirm a longstanding hypothesis about dorsal stream dysfunction in WS, demonstrate effects of a localized abnormality on visual information processing in humans, and define a systems-level phenotype for mapping genetic determinants of visuoconstructive function.	NIMH, Unit Integrat Neuroimaging, Clin Brain Disorders Branch, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Univ Louisville, Neurodev Sci Lab, Dept Psychol & Brain Sci, Louisville, KY 40292 USA; Univ Nevada, Sch Med, Dept Pediat, Las Vegas, NV 89102 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Louisville; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Meyer-Lindenberg, A (corresponding author), NIMH, Unit Integrat Neuroimaging, Clin Brain Disorders Branch, NIH,Dept Hlth & Human Serv, 10-4C101,9000 Rockville Pike, Bethesda, MD 20892 USA.	andreasml@nih.gov	; Meyer-Lindenberg, Andreas/H-1076-2011	Olsen, Rosanna/0000-0002-2918-4152; Meyer-Lindenberg, Andreas/0000-0001-5619-1123	NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002652, Z01MH002863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035102] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35102, R01 NS035102] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Atkinson J, 2003, DEV NEUROPSYCHOL, V23, P139, DOI 10.1207/S15326942DN231&2_7; Bellugi U., 1988, LANGUAGE DEV EXCEPTI, P177; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Cammareri V, 1999, AM J MED GENET, V85, P491, DOI 10.1002/(SICI)1096-8628(19990827)85:5<491::AID-AJMG11>3.0.CO;2-Z; Danoff SK, 2004, NEUROSCIENCE, V123, P931, DOI 10.1016/j.neuroscience.2003.08.038; Frangiskakis JM, 1996, CELL, V86, P59, DOI 10.1016/S0092-8674(00)80077-X; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Galaburda AM, 2002, ARCH NEUROL-CHICAGO, V59, P1461, DOI 10.1001/archneur.59.9.1461; Glabus MF, 2003, CEREB CORTEX, V13, P1352, DOI 10.1093/cercor/bhg082; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Good CD, 2003, BRAIN, V126, P2431, DOI 10.1093/brain/awg242; Good CD, 2002, NEUROIMAGE, V17, P29, DOI 10.1006/nimg.2002.1202; Grice SJ, 2003, NEUROREPORT, V14, P1773, DOI 10.1097/00001756-200310060-00003; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; Hillier LW, 2003, NATURE, V424, P157, DOI 10.1038/nature01782; Hoogenraad CC, 2002, NAT GENET, V32, P116, DOI 10.1038/ng954; Jordan H, 2002, PSYCHOL SCI, V13, P162, DOI 10.1111/1467-9280.00429; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; LOWERY MC, 1995, AM J HUM GENET, V57, P49; May A, 1999, NAT MED, V5, P836, DOI 10.1038/10561; MCINTOSH AR, 1994, J NEUROSCI, V14, P655; Mervis CB, 2000, BRAIN COGNITION, V44, P604, DOI 10.1006/brcg.2000.1232; Mervis CB, 2000, MENT RETARD DEV D R, V6, P148; Mills DL, 2000, J COGNITIVE NEUROSCI, V12, P47, DOI 10.1162/089892900561977; MISSAR CD, 1994, SCHIZOPHR RES, V12, P247, DOI 10.1016/0920-9964(94)90034-5; Morris CA, 2003, AM J MED GENET A, V123A, P45, DOI 10.1002/ajmg.a.20496; Nakamura M, 2001, DEV MED CHILD NEUROL, V43, P617, DOI 10.1017/S0012162201001128; Orban GA, 1999, NEURON, V24, P929, DOI 10.1016/S0896-6273(00)81040-5; Paterson SJ, 1999, SCIENCE, V286, P2355, DOI 10.1126/science.286.5448.2355; Paul BM, 2002, NEUROREPORT, V13, P1115, DOI 10.1097/00001756-200207020-00009; Reiss AL, 2000, J COGNITIVE NEUROSCI, V12, P65, DOI 10.1162/089892900561986; Reiss AL, 2004, J NEUROSCI, V24, P5009, DOI 10.1523/JNEUROSCI.5272-03.2004; Schmitt JE, 2002, DEV MED CHILD NEUROL, V44, P292; Schmitt JE, 2001, ARCH NEUROL-CHICAGO, V58, P283, DOI 10.1001/archneur.58.2.283; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; SOKOLOFF L, 1977, J NEUROCHEM, V29, P13, DOI 10.1111/j.1471-4159.1977.tb03919.x; Talairach J., 1988, COPLANAR STEREOTAXIC; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; Wechsler D., 1999, WECHSLER ABBREVIATED; Wechsler D., 1997, WECHSLER ADULT INTEL	44	234	241	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 2	2004	43	5					623	631		10.1016/j.neuron.2004.08.014	http://dx.doi.org/10.1016/j.neuron.2004.08.014			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339645	Bronze			2022-12-24	WOS:000223691900009
J	Hashimoto, R; Sakai, KL				Hashimoto, R; Sakai, KL			Learning letters in adulthood: Direct visualization of cortical plasticity for forming a new link between orthography and phonology	NEURON			English	Article							HUMAN COLOR-CENTER; DEVELOPMENTAL DYSLEXIA; FUNCTIONAL CONNECTIVITY; NEURAL MECHANISMS; VISUAL-CORTEX; ANGULAR GYRUS; BRAIN; WORD; SLEEP; ACTIVATION	To identify which brain regions in adults show plasticity for learning letters, Hangul letters were experimentally associated with either speech sounds (HS condition) or nonspeech sounds (HN condition) in fMRI sessions over two consecutive days. Selective activations under the HS condition were found in several regions including the left posterior inferior temporal gyrus (PITG) and the parieto-occipital cortex (PO), as compared with activations under a condition for familiar letters and speech sounds, and with those under the HN condition. The left PITG showed a selective activation increase under the HS condition over two days, the degree of which predicted individual performance improvement. Further, functional connectivity between the left PITG and the left PO was selectively enhanced under the HS condition. These results demonstrate that a new link between orthography and phonology is formed by the plasticity of a functional system involving the left PITG in association with the left PO.	Univ Tokyo, Grad Sch Arts & Sci, Dept Cognit & Behav Sci, Meguro Ku, Tokyo 1538902, Japan; Japan Sci & Technol Agcy, Kawaguchi 3320012, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Sakai, KL (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Cognit & Behav Sci, Meguro Ku, 3-8-1 Komba, Tokyo 1538902, Japan.	sakai@mind.c.u-tokyo.ac.jp		Hashimoto, Ryu-ichiro/0000-0002-9661-3412				Allen G, 1997, SCIENCE, V275, P1940, DOI 10.1126/science.275.5308.1940; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Bokde ALW, 2001, NEURON, V30, P609, DOI 10.1016/S0896-6273(01)00288-4; Brunswick N, 1999, BRAIN, V122, P1901, DOI 10.1093/brain/122.10.1901; Buchel C, 1999, SCIENCE, V283, P1538, DOI 10.1126/science.283.5407.1538; Buchel C, 1997, CEREB CORTEX, V7, P768, DOI 10.1093/cercor/7.8.768; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Castro-Caldas A, 1998, BRAIN, V121, P1053, DOI 10.1093/brain/121.6.1053; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Desmond JE, 1998, TRENDS COGN SCI, V2, P355, DOI 10.1016/S1364-6613(98)01211-X; Fenn KM, 2003, NATURE, V425, P614, DOI 10.1038/nature01951; Ficca G, 2000, BEHAV BRAIN RES, V112, P159, DOI 10.1016/S0166-4328(00)00177-7; Fiez JA, 1999, NEURON, V24, P205, DOI 10.1016/S0896-6273(00)80833-8; GESCHWIND N, 1979, SCI AM, V241, P180, DOI 10.1038/scientificamerican0979-180; Habib M, 2000, BRAIN, V123, P2373, DOI 10.1093/brain/123.12.2373; Hashimoto R, 2000, NEUROIMAGE, V12, P147, DOI 10.1006/nimg.2000.0603; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Helenius P, 1999, CEREB CORTEX, V9, P476, DOI 10.1093/cercor/9.5.476; Homae F, 2003, NEUROIMAGE, V20, P578, DOI 10.1016/S1053-8119(03)00272-6; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Jonides J, 1998, J NEUROSCI, V18, P5026; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Lee HS, 2003, NEUROIMAGE, V20, P1, DOI 10.1016/S1053-8119(03)00254-4; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; Mechelli A, 2003, J COGNITIVE NEUROSCI, V15, P260, DOI 10.1162/089892903321208196; Nicolson RI, 2001, TRENDS NEUROSCI, V24, P508, DOI 10.1016/S0166-2236(00)01896-8; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Paulesu E, 2000, NAT NEUROSCI, V3, P91, DOI 10.1038/71163; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Poldrack RA, 2001, BRAIN, V124, P67, DOI 10.1093/brain/124.1.67; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price CJ, 1996, CEREB CORTEX, V6, P62, DOI 10.1093/cercor/6.1.62; Price CJ, 2003, NEUROIMAGE, V19, P473, DOI 10.1016/S1053-8119(03)00084-3; Puce A, 1996, J NEUROSCI, V16, P5205; Pugh KR, 2000, PSYCHOL SCI, V11, P51, DOI 10.1111/1467-9280.00214; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raij T, 2000, NEURON, V28, P617, DOI 10.1016/S0896-6273(00)00138-0; SAKAI K, 1995, P ROY SOC B-BIOL SCI, V261, P89, DOI 10.1098/rspb.1995.0121; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; Shaywitz SE, 1996, SCI AM, V275, P98, DOI 10.1038/scientificamerican1196-98; Soon CS, 2003, HUM BRAIN MAPP, V20, P1, DOI 10.1002/hbm.10122; Suzuki K, 2003, CEREB CORTEX, V13, P517, DOI 10.1093/cercor/13.5.517; Tarkiainen A, 2002, BRAIN, V125, P1125, DOI 10.1093/brain/awf112; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vaina LM, 1998, P NATL ACAD SCI USA, V95, P12657, DOI 10.1073/pnas.95.21.12657; van Turennout M, 2000, NAT NEUROSCI, V3, P1329, DOI 10.1038/81873; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Xu B, 2001, CEREB CORTEX, V11, P267, DOI 10.1093/cercor/11.3.267	53	94	97	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 22	2004	42	2					311	322		10.1016/S0896-6273(04)00196-5	http://dx.doi.org/10.1016/S0896-6273(04)00196-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KG	15091345	Bronze			2022-12-24	WOS:000221458500014
J	Luksch, H; Khanbabaie, R; Wessel, R				Luksch, H; Khanbabaie, R; Wessel, R			Synaptic dynamics mediate sensitivity to motion independent of stimulus details	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; PIGEON TECTAL NEURONS; NON-FOURIER MOTION; OPTIC TECTUM; VISUAL-CORTEX; NUCLEUS ROTUNDUS; LARVAL ZEBRAFISH; NEURAL CODE; RESPONSES; PATTERNS	Humans and other animals generally perceive motion independently of the cues that define the moving object. To understand the underlying mechanisms of this generalization of stimulus attributes, we have examined the cellular properties of avian wide-field tectal neurons that are sensitive to a variety of moving stimuli but not to static stationary stimuli. This in vitro study showed phasic signal transfer at the retinotectal synapse and binary dendritic responses to synaptic inputs that interact in a mutually exclusive manner in the postsynaptic tectal neuron. A model of the tectal circuitry predicts that these two cellular properties mediate sensitivity to a wide range of dynamic spatiotemporal stimuli, including moving stimuli, but not to static stationary stimuli in a tectal neuron. The computation that is independent of stimulus detail is initiated by tectal neurons and is completed by rotundal neurons that integrate outputs from multiple tectal neurons in a directionally selective manner.	Washington Univ, Dept Phys, St Louis, MO 63130 USA; Rhein Westfal TH Aachen, Inst Biol 2, D-52074 Aachen, Germany	Washington University (WUSTL); RWTH Aachen University	Wessel, R (corresponding author), Washington Univ, Dept Phys, CB 1105, St Louis, MO 63130 USA.	rw@wuphys.wustl.edu		Luksch, Harald/0000-0002-9835-7715				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ALBRIGHT TD, 1992, SCIENCE, V255, P1141, DOI 10.1126/science.1546317; ALBRIGHT TD, 1993, VISUAL MOTION ITS RO, P177; Baker CL, 2001, PROG BRAIN RES, V134, P171; Carandini M, 2002, J NEUROSCI, V22, P10053; CHANDRAN PKG, 1985, ADV CAPD, V1, P18; Chichilnisky EJ, 2003, J NEUROSCI, V23, P6681; CHUBB C, 1988, J OPT SOC AM A, V5, P1986, DOI 10.1364/JOSAA.5.001986; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Cook DL, 2003, NATURE, V421, P66, DOI 10.1038/nature01248; Croner LJ, 1999, NEURON, V24, P777, DOI 10.1016/S0896-6273(00)81026-0; Croner LJ, 1999, J NEUROSCI, V19, P3935; Demb JB, 2001, NEURON, V32, P711, DOI 10.1016/S0896-6273(01)00484-6; Freeman TCB, 2002, NEURON, V35, P759, DOI 10.1016/S0896-6273(02)00819-X; FROST BJ, 1988, J COMP PHYSIOL A, V162, P639, DOI 10.1007/BF01342639; FROST BJ, 1981, EXP BRAIN RES, V43, P173; FROST BJ, 1978, BRAIN RES, V151, P599, DOI 10.1016/0006-8993(78)91093-4; FROST BJ, 1983, SCIENCE, V220, P744, DOI 10.1126/science.6836313; FROST BJ, 1993, VISUAL MOTION ITS RO, P159; Geesaman BJ, 1996, J NEUROSCI, V16, P4716; Goldman MS, 2002, J NEUROSCI, V22, P584, DOI 10.1523/JNEUROSCI.22-02-00584.2002; HARDY O, 1985, J COMP NEUROL, V233, P390, DOI 10.1002/cne.902330308; Hellmann B, 2001, J COMP NEUROL, V429, P94, DOI 10.1002/1096-9861(20000101)429:1<94::AID-CNE8>3.0.CO;2-5; HUNT SP, 1975, J COMP NEUROL, V162, P433, DOI 10.1002/cne.901620403; JASSIK-GERSCHENFELD D, 1970, Brain Research, V24, P407, DOI 10.1016/0006-8993(70)90182-4; JASSIKGE.D, 1972, BRAIN RES, V40, P303, DOI 10.1016/0006-8993(72)90136-9; Karten HJ, 1997, J COMP NEUROL, V387, P449; LETTVIN JY, 1959, P IRE, V47, P1940, DOI 10.1109/JRPROC.1959.287207; Lu ZL, 2001, J OPT SOC AM A, V18, P2331, DOI 10.1364/JOSAA.18.002331; Luksch H, 2003, REV NEUROSCIENCE, V14, P85; Luksch H, 2003, J CHEM NEUROANAT, V25, P185, DOI 10.1016/S0891-0618(03)00010-3; Luksch H, 1998, J COMP NEUROL, V396, P399; Luksch H, 2001, J NEUROSCI, V21, P6440, DOI 10.1523/JNEUROSCI.21-16-06440.2001; Marin G, 2003, J COMP NEUROL, V458, P361, DOI 10.1002/cne.10591; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Nalbach Hans-Ortwin, 1993, P25; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; OLAVARRIA JF, 1992, J NEUROPHYSIOL, V68, P164, DOI 10.1152/jn.1992.68.1.164; Orger MB, 2000, NAT NEUROSCI, V3, P1128, DOI 10.1038/80649; Palanca BJA, 2003, J NEUROSCI, V23, P7647; REYZIN AM, 1981, NEURAL MECH BEHAV PI, P165; Rodieck R.W., 1998, 1 STEPS SEEING; Roeser T, 2003, J NEUROSCI, V23, P3726; Sun HJ, 1998, NAT NEUROSCI, V1, P296, DOI 10.1038/1110; Tabata T, 2002, J NEUROPHYSIOL, V87, P30, DOI 10.1152/jn.00179.2001; Tombol T., 1999, Neurobiology (Budapest), V7, P45; TROY JB, 1994, VISUAL NEUROSCI, V11, P111, DOI 10.1017/S0952523800011159; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; WANG YC, 1992, NATURE, V356, P236, DOI 10.1038/356236a0; WILSON HR, 1994, CIBA F SYMP, V184, P227	50	29	29	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					380	388		10.1038/nn1204	http://dx.doi.org/10.1038/nn1204			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	14990932				2022-12-24	WOS:000220482500017
J	Zhao, Y; Yarov-Yarovoy, V; Scheuer, T; Catterall, WA				Zhao, Y; Yarov-Yarovoy, V; Scheuer, T; Catterall, WA			A gating hinge in Na+ channels: A molecular switch for electrical signaling	NEURON			English	Article							GATED SODIUM-CHANNELS; K+ CHANNEL; POTASSIUM CHANNEL; TRANSMEMBRANE HELICES; TRANSFECTED CELLS; ION CHANNELS; PROLINE; ACTIVATION; DISTORTIONS; SELECTIVITY	Voltage-gated sodium channels are members of a large family with similar pore structures. The mechanism of opening and closing is unknown, but structural studies suggest gating via bending of the inner pore helix at a glycine hinge. Here we provide functional evidence for this gating model for the bacterial sodium channel NaChBac. Mutation of glycine 219 to proline, which would strongly favor bending of the alpha helix, greatly enhances activation by shifting its voltage dependence -51 mV and slowing deactivation by 2000-fold. The mutation also slows voltage-dependent inactivation by 1200-fold. The effects are specific because substitutions of proline at neighboring positions and substitutions of other amino acids at position 219 have much smaller functional effects. Our results fit a model in which concerted bending at glycine 219 in the S6 segments of NaChBac serves as a gating hinge. This gating motion may be conserved in most members of this large ion channel protein family.	Univ Washington, Dept Pharmacol, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Box 357280, Seattle, WA 98105 USA.	wcatt@u.washington.edu	Yarov-Yarovoy, Vladimir/ABE-5454-2020	Yarov-Yarovoy, Vladimir/0000-0002-2325-4834	NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH067625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015751] Funding Source: NIH RePORTER; NIMH NIH HHS [K01 MH067625-01, K01 MH67625] Funding Source: Medline; NINDS NIH HHS [R01 NS15751] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CATTERALL WA, 2002, IUPHAR COMPENDIUM VO; CHAKRABARTTY A, 1991, NATURE, V351, P586, DOI 10.1038/351586a0; Clapham DE, 2003, PHARMACOL REV, V55, P591, DOI 10.1124/pr.55.4.6; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; Cuello LG, 1998, BIOCHEMISTRY-US, V37, P3229, DOI 10.1021/bi972997x; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-14; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HURLEY JH, 1992, BIOPOLYMERS, V32, P1443, DOI 10.1002/bip.360321104; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; KOISHI R, 2003, IN PRESS J BIOL CHEM; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lehmann-Horn F, 1999, PHYSIOL REV, V79, P1317, DOI 10.1152/physrev.1999.79.4.1317; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; Meisler MH, 2002, NOVART FDN SYMP, V241, P72; MEISLER MH, 2002, NOVART FDN SYMP, V241, P226; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mezei M, 1997, J COMPUT CHEM, V18, P812, DOI 10.1002/(SICI)1096-987X(19970430)18:6<812::AID-JCC6>3.0.CO;2-V; QU YS, 1995, P NATL ACAD SCI USA, V92, P11839, DOI 10.1073/pnas.92.25.11839; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P399, DOI 10.1085/jgp.111.3.399; Visiers I, 2000, PROTEIN ENG, V13, P603, DOI 10.1093/protein/13.9.603; WILLIAMS KA, 1991, BIOCHEMISTRY-US, V30, P8919, DOI 10.1021/bi00101a001; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	38	114	117	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 25	2004	41	6					859	865		10.1016/S0896-6273(04)00116-3	http://dx.doi.org/10.1016/S0896-6273(04)00116-3			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046719	Bronze			2022-12-24	WOS:000221458300006
J	Schaar, BT; Kinoshita, K; McConnell, SK				Schaar, BT; Kinoshita, K; McConnell, SK			Doublecortin microtubule affinity is regulated by a balance of kinase and phosphatase activity at the leading edge of migrating neurons	NEURON			English	Article							NERVE GROWTH CONES; C-ELEGANS PAR-1; PROTEIN-KINASE; CEREBRAL-CORTEX; DIRECTIONAL GUIDANCE; AXONAL MICROTUBULES; LISSENCEPHALY GENE; CELL-CYCLE; DYNAMICS; PHOSPHORYLATION	Doublecortin (Dcx) is a microtubule-associated protein that is mutated in X-linked lissencephaly (X-LIS), a neuronal migration disorder associated with epilepsy and mental retardation. Although Dcx can bind ubiquitously to microtubules in nonneuronal cells, Dcx is highly enriched in the leading processes of migrating neurons and the growth cone region of differentiating neurons. We present evidence that Dcx/microtubule interactions are negatively controlled by Protein Kinase A (PKA) and the MARK/PAR-1 family of protein kinases. In addition to a consensus MARK site, we identified a serine within a novel sequence that is crucial for the PKA- and MARK-dependent regulation of Dcx's microtubule binding activity in vitro. This serine is mutated in two families affected by X-LIS. Immunostaining neurons with an antibody that recognizes phosphorylated substrates of MARK supports the conclusion that Dcx localization and function are regulated at the leading edge of migrating cells by a balance of kinase and phosphatase activity.	Stanford Univ, Dept Sci Biol, Stanford, CA 94305 USA; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Stanford University; Max Planck Society	McConnell, SK (corresponding author), Stanford Univ, Dept Sci Biol, Stanford, CA 94305 USA.	suemcc@stanford.edu		Kinoshita, Kazuhisa/0000-0002-0882-4296	NIMH NIH HHS [MH51864] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051864, R37MH051864] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Bessone S, 1999, DEV BIOL, V214, P87, DOI 10.1006/dbio.1999.9379; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; Bohm H, 1997, CURR BIOL, V7, P603, DOI 10.1016/S0960-9822(06)00260-0; BROWN A, 1993, J CELL SCI, V104, P339; Cassimeris L, 1999, CURR OPIN CELL BIOL, V11, P134, DOI 10.1016/S0955-0674(99)80017-9; Challacombe JF, 1997, J NEUROSCI, V17, P3085; Corbo JC, 2002, J NEUROSCI, V22, P7548; des Portes V, 1998, CELL, V92, P51; Drewes G, 1998, TRENDS BIOCHEM SCI, V23, P307, DOI 10.1016/S0968-0004(98)01245-6; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Ebneth A, 1999, CELL MOTIL CYTOSKEL, V44, P209, DOI 10.1002/(SICI)1097-0169(199911)44:3<209::AID-CM6>3.0.CO;2-4; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feng YY, 2001, NAT REV NEUROSCI, V2, P408, DOI 10.1038/35077559; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Friocourt G, 2001, MOL CELL NEUROSCI, V18, P307, DOI 10.1006/mcne.2001.1022; Gavet O, 2002, J NEUROSCI RES, V68, P535, DOI 10.1002/jnr.10234; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gleeson Joseph G., 2000, Current Opinion in Neurology, V13, P121, DOI 10.1097/00019052-200004000-00002; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hurov JB, 2001, MOL CELL BIOL, V21, P3206, DOI 10.1128/MCB.21.9.3206-3219.2001; Illenberger S, 1996, J BIOL CHEM, V271, P10834, DOI 10.1074/jbc.271.18.10834; Kholmanskikh SS, 2003, J NEUROSCI, V23, P8673; Kim MH, 2003, NAT STRUCT BIOL, V10, P324, DOI 10.1038/nsb918; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; Kizhatil K, 2002, J NEUROSCI, V22, P7948; Lambrechts A, 2000, J BIOL CHEM, V275, P36143, DOI 10.1074/jbc.M006274200; Lin Chi-Hung, 1994, Current Opinion in Neurobiology, V4, P640, DOI 10.1016/0959-4388(94)90004-3; Mandell JW, 1998, J NEUROBIOL, V35, P17, DOI 10.1002/(SICI)1097-4695(199804)35:1<17::AID-NEU2>3.0.CO;2-E; MAWALDEWAN M, 1994, J BIOL CHEM, V269, P30981; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; Merrick SE, 1996, J BIOL CHEM, V271, P5589, DOI 10.1074/jbc.271.10.5589; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Moores CA, 2003, NAT STRUCT BIOL, V10, P314, DOI 10.1038/nsb0503-314; Nelson WJ, 1997, CURR BIOL, V7, pR562, DOI 10.1016/S0960-9822(06)00282-X; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Rochlin MW, 1999, MOL BIOL CELL, V10, P2309, DOI 10.1091/mbc.10.7.2309; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Sapir T, 2000, HUM MOL GENET, V9, P703, DOI 10.1093/hmg/9.5.703; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; SUN HJ, 2001, NAT CELL BIOL, V3, P81; TANAKA E, 1995, J CELL BIOL, V128, P139, DOI 10.1083/jcb.128.1.139; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Taylor KR, 2000, J BIOL CHEM, V275, P34442, DOI 10.1074/jbc.M007078200; Ward M, 2003, J NEUROSCI, V23, P5170; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Williamson T, 1996, P NATL ACAD SCI USA, V93, P15221, DOI 10.1073/pnas.93.26.15221; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yoshiura K, 2000, J NEUROBIOL, V43, P132, DOI 10.1002/(SICI)1097-4695(200005)43:2<132::AID-NEU3>3.3.CO;2-9; Zakharenko S, 1998, J CELL BIOL, V143, P1077, DOI 10.1083/jcb.143.4.1077	59	167	173	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 22	2004	41	2					203	213		10.1016/S0896-6273(03)00843-2	http://dx.doi.org/10.1016/S0896-6273(03)00843-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741102	Bronze			2022-12-24	WOS:000221457800007
J	Cirelli, C; Gutierrez, CM; Tononi, G				Cirelli, C; Gutierrez, CM; Tononi, G			Extensive and divergent effects of sleep and wakefulness on brain gene expression	NEURON			English	Article							CEREBRAL PROTEIN-SYNTHESIS; CIRCADIAN-RHYTHMS; MESSENGER-RNAS; WAKING; DEPRIVATION; PLASTICITY; LIVER; TRANSCRIPTION; HOMEOSTASIS; MICROARRAY	Sleep is present in all species where it has been studied, but its functions remain unknown. To investigate what benefits sleep may bring at the cellular level, we profiled gene expression in awake and sleeping rats by using high-density microarrays. We find that similar to10% of the transcripts in the cerebral cortex change their expression between day and night and demonstrate that half of them are modulated by sleep and wakefulness independent of time of day. We also show that molecular correlates of sleep are found in the cerebellum, a structure not known for generating sleep rhythms. Finally, we show that different functional categories of genes are selectively associated with sleep and wakefulness. The similar to100 known genes whose expression increases during sleep provide molecular support for the proposed involvement of sleep in protein synthesis and neural plasticity and point to a novel role for sleep in membrane trafficking and maintenance.	Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA	University of Wisconsin System; University of Wisconsin Madison	Cirelli, C (corresponding author), Univ Wisconsin, Dept Psychiat, 6001 Res Pk Blvd, Madison, WI 53719 USA.	ccirelli@wisc.edu	Sanguansri, Luz/B-6630-2011	Sanguansri, Luz/0000-0003-1908-7604				Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; ASTONJONES G, 1981, J NEUROSCI, V1, P876; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; CAMERON AM, 1995, CELL, V83, P463, DOI 10.1016/0092-8674(95)90124-8; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Cirelli C, 2002, J APPL PHYSIOL, V92, P394, DOI 10.1152/jappl.2002.92.1.394; Cirelli C, 2000, J NEUROSCI, V20, P9187; Cirelli C, 1996, SCIENCE, V274, P1211, DOI 10.1126/science.274.5290.1211; Cirelli C, 2000, BRAIN RES, V885, P303, DOI 10.1016/S0006-8993(00)03008-0; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Cooper J.R., 1996, BIOCH BASIS NEUROPHA, Vseventh; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Hobson J.A., 1989, SLEEP; HOBSON JA, 1972, ELECTROEN CLIN NEURO, V33, P457, DOI 10.1016/0013-4694(72)90210-6; HORNE JA, 1988, WHY SLEEP FUNCTIONS; Jurevics H, 2000, J LIPID RES, V41, P1048; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Kramer EM, 2001, MICROSC RES TECHNIQ, V52, P656, DOI 10.1002/jemt.1050; KRUEGER JM, 1995, BEHAV BRAIN RES, V69, P177, DOI 10.1016/0166-4328(95)00015-L; LI WWF, 1993, J BIOL CHEM, V268, P12003; Lin Y, 2002, P NATL ACAD SCI USA, V99, P9562, DOI 10.1073/pnas.132269699; MAQUET P, 1995, BEHAV BRAIN RES, V69, P75, DOI 10.1016/0166-4328(95)00017-N; Maquet P, 2000, J SLEEP RES, V9, P207; Masubuchi S, 2000, EUR J NEUROSCI, V12, P4206, DOI 10.1046/j.1460-9568.2000.01313.x; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Meuth SG, 2003, J NEUROSCI, V23, P6460; MORUZZI G, 1972, ERG PHYSIOL BIOL CH, V64, P1; Nakanishi H, 1997, EUR J NEUROSCI, V9, P271, DOI 10.1111/j.1460-9568.1997.tb01397.x; Ogawa A, 1997, HEPATOLOGY, V26, P1580, DOI 10.1002/hep.510260628; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Petit JM, 2002, EUR J NEUROSCI, V16, P1163, DOI 10.1046/j.1460-9568.2002.02145.x; RAMM P, 1990, PHYSIOL BEHAV, V48, P749, DOI 10.1016/0031-9384(90)90220-X; Rechtschaffen A, 1998, PERSPECT BIOL MED, V41, P359, DOI 10.1353/pbm.1998.0051; RHYNER TA, 1990, EUR J NEUROSCI, V2, P1063, DOI 10.1111/j.1460-9568.1990.tb00018.x; Shaffery JP, 2002, NEUROSCIENCE, V110, P431, DOI 10.1016/S0306-4522(01)00589-9; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Steriade M, 1976, Prog Neurobiol, V6, P155; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Terao A, 2003, NEUROSCIENCE, V116, P187, DOI 10.1016/S0306-4522(02)00695-4; TOBLER I, 2000, PRINCIPLES PRACTICE, P72; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Tononi G, 2001, ARCH ITAL BIOL, V139, P221; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20; WUARIN J, 1990, CELL, V63, P1257, DOI 10.1016/0092-8674(90)90421-A; Yamada M, 2000, BIOL CHEM, V381, P1149, DOI 10.1515/BC.2000.142	60	439	445	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2004	41	1					35	43		10.1016/S0896-6273(03)00814-6	http://dx.doi.org/10.1016/S0896-6273(03)00814-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715133	Bronze			2022-12-24	WOS:000187942800007
J	Ignashchenkova, A; Dicke, PW; Haarmeier, T; Thier, P				Ignashchenkova, A; Dicke, PW; Haarmeier, T; Thier, P			Neuron-specific contribution of the superior colliculus to overt and covert shifts of attention	NATURE NEUROSCIENCE			English	Article							SACCADE TARGET SELECTION; EYE-MOVEMENTS; VISUAL-ATTENTION; SPATIAL ATTENTION; LAYER CELLS; MONKEY; RESPONSES; MODULATION; ORGANIZATION; PROBABILITY	The analysis of a peripheral visual location can be improved in two ways: either by orienting one's gaze (usually by making a foveating saccade) or by 'covertly' shifting one's attention to the peripheral location without making an eye movement. The premotor theory of attention holds that saccades and spatial shifts of attention share a common functional module with a distinct neuronal basis. Using single-unit recording from the brains of trained rhesus monkeys, we investigated whether the superior colliculus, the major subcortical center for the control of saccades, is part of this shared network for attention and saccades. Here we show that a distinct type of neuron in the intermediate layer of the superior colliculus, the visuomotor neuron, which is known to be centrally involved in the preparation of saccades, is also active during covert shifts of attention.	Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cognit Neurol, D-72076 Tubingen, Germany; Univ Tubingen, Hertie Inst Clin Brain Res, Dept Gen Neurol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Thier, P (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cognit Neurol, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	thier@uni-tuebingen.de	Ignashchenkova, Alla/U-3745-2019	Ignashchenkova, Alla/0000-0002-9444-5945; Thier, Peter/0000-0001-5909-4222				Andersen R A, 1989, Rev Oculomot Res, V3, P315; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; Basso MA, 1998, J NEUROSCI, V18, P7519; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Gattass R., 1996, Revista Brasileira de Biologia, V56, P257; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P560, DOI 10.1152/jn.1972.35.4.560; GRAIGHERO L, 1999, J EXP PSYCHOL HUMAN, V25, P1673; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2527, DOI 10.1152/jn.2001.86.5.2527; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2543, DOI 10.1152/jn.2001.86.5.2543; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Lunenburger L, 2001, PROG BRAIN RES, V134, P109; MAYS LE, 1980, J NEUROPHYSIOL, V43, P207, DOI 10.1152/jn.1980.43.1.207; MCKEE SP, 1985, PERCEPT PSYCHOPHYS, V37, P286, DOI 10.3758/BF03211350; McPeek RM, 2002, J NEUROPHYSIOL, V88, P2019, DOI 10.1152/jn.2002.88.4.2019; MOHLER CW, 1976, J NEUROPHYSIOL, V39, P722, DOI 10.1152/jn.1976.39.4.722; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2313, DOI 10.1152/jn.1995.73.6.2313; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; ROBINSON DL, 1995, J NEUROPHYSIOL, V74, P713, DOI 10.1152/jn.1995.74.2.713; SCHILLER PH, 1972, J NEUROPHYSIOL, V35, P915, DOI 10.1152/jn.1972.35.6.915; SHEPARD RN, 1986, J EXP PSYCHOL HUMAN, V12, P383, DOI 10.1037/0096-1523.12.3.383; Sparks D L, 1989, Rev Oculomot Res, V3, P213; Stuphorn V, 2000, J NEUROPHYSIOL, V83, P1283, DOI 10.1152/jn.2000.83.3.1283; TAYLOR MM, 1967, J ACOUST SOC AM, V41, P782, DOI 10.1121/1.1910407; THIER P, 1992, EUR J NEUROSCI, V4, P539, DOI 10.1111/j.1460-9568.1992.tb00904.x; Wurtz RH, 1996, INVEST OPHTH VIS SCI, V37, P2131; WURTZ RH, 1976, J NEUROPHYSIOL, V39, P745, DOI 10.1152/jn.1976.39.4.745; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936	37	288	290	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					56	64		10.1038/nn1169	http://dx.doi.org/10.1038/nn1169			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14699418				2022-12-24	WOS:000187636000013
J	Cayouette, M; Barres, BA; Raff, M				Cayouette, M; Barres, BA; Raff, M			Importance of intrinsic mechanisms in cell fate decisions in the developing rat retina	NEURON			English	Article							ROD PHOTORECEPTOR DEVELOPMENT; PROGENITOR CELLS; AMACRINE CELLS; DROSOPHILA NEUROBLASTS; DEVELOPMENT INVITRO; MAMMALIAN RETINA; TADPOLE RETINA; XENOPUS RETINA; BIPOLAR CELLS; FROG RETINA	Cell diversification in the developing nervous system is thought to involve both cell-intrinsic mechanisms and extracellular signals, but their relative importance in particular cell fate decisions remains uncertain. In the mammalian retina, different cell types develop on a predictable schedule from multipotent retinal neuroepithelial cells (RNECs). A current view is that RNECs pass through a series of competence states, progressively changing their responsiveness to instructive extracellular cues, which also change over time. We show here, however, that embryonic day 16-17 (E16-17) rat RNECs develop similarly in serum-free clonal-density cultures and in serum-containing retinal explants-in the number of times they divide, the cell types they generate, and the order in which they generate these cell types. These surprising results suggest that extracellular signals may be less important than currently believed in determining when RNECs stop dividing and what cell types they generate when they withdraw from the cell cycle, at least from E16-17 onward.	UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; UCL, Cell Biol Unit, London WC1E 6BT, England; Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	University of London; University College London; University of London; University College London; Stanford University	Cayouette, M (corresponding author), Stanford Univ, Dept Neurobiol, Fairchild Bldg,299 Campus Dr,D231, Stanford, CA 94305 USA.	m.cayouefte@stanford.edu		Cayouette, Michel/0000-0003-4655-9048	NEI NIH HHS [R01 EY113110] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AKAGAWA K, 1986, BRAIN RES, V383, P110, DOI 10.1016/0006-8993(86)90012-0; AKAGAWA K, 1987, BRAIN RES, V437, P298, DOI 10.1016/0006-8993(87)91644-1; Alexiades MR, 1997, DEVELOPMENT, V124, P1119; ALTSHULER D, 1992, DEVELOPMENT, V114, P947; BARNSTABLE CJ, 1985, DEV BRAIN RES, V20, P286, DOI 10.1016/0165-3806(85)90116-6; Belliveau MJ, 1999, DEVELOPMENT, V126, P555; Broadus J, 1997, CURR BIOL, V7, P827, DOI 10.1016/S0960-9822(06)00370-8; Cayouette M, 2003, DEVELOPMENT, V130, P2329, DOI 10.1242/dev.00446; Cayouette M, 2001, J NEUROSCI, V21, P5643, DOI 10.1523/JNEUROSCI.21-15-05643.2001; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; FURST A, 1985, DEV BIOL, V112, P467, DOI 10.1016/0012-1606(85)90419-1; GalliResta L, 1997, J NEUROSCI, V17, P7831; GREFERATH U, 1990, J COMP NEUROL, V301, P433, DOI 10.1002/cne.903010308; HARRIS WA, 1992, NEURON, V9, P357, DOI 10.1016/0896-6273(92)90174-C; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HUANG S, 1995, J COMP NEUROL, V360, P442, DOI 10.1002/cne.903600306; Huang S, 1997, J COMP NEUROL, V387, P42; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Jensen AM, 1997, DEV BIOL, V188, P267, DOI 10.1006/dbio.1997.8645; LILLIEN L, 1992, DEVELOPMENT, V115, P253; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; LUER K, 1992, DEVELOPMENT, V116, P377; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Moody SA, 2000, J NEUROSCI, V20, P3244, DOI 10.1523/JNEUROSCI.20-09-03244.2000; Morrow EM, 1998, J NEUROSCI, V18, P3738; NEGISHI K, 1982, SCIENCE, V216, P747, DOI 10.1126/science.7079736; Neophytou C, 1997, DEVELOPMENT, V124, P2345; ONODA N, 1987, BRAIN RES, V416, P359, DOI 10.1016/0006-8993(87)90919-X; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Rapaport DH, 1996, PERSPECT DEV NEUROBI, V3, P147; REH TA, 1992, J NEUROBIOL, V23, P1067, DOI 10.1002/neu.480230811; REH TA, 1986, DEV BIOL, V114, P463, DOI 10.1016/0012-1606(86)90210-1; Sheedlo HJ, 1996, J NEUROSCI RES, V44, P519; Shen Q, 2002, DEVELOPMENT, V129, P4843; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Voyvodic JT, 1995, EUR J NEUROSCI, V7, P2469, DOI 10.1111/j.1460-9568.1995.tb01045.x; Waid DK, 1998, DEVELOPMENT, V125, P1059; WATANABE T, 1992, DEVELOPMENT, V114, P899; WATANABE T, 1990, NEURON, V4, P461, DOI 10.1016/0896-6273(90)90058-N; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; WILLIAMS RW, 1992, TRENDS NEUROSCI, V15, P368, DOI 10.1016/0166-2236(92)90181-7; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	46	131	133	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 4	2003	40	5					897	904		10.1016/S0896-6273(03)00756-6	http://dx.doi.org/10.1016/S0896-6273(03)00756-6			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	751FM	14659089	Bronze			2022-12-24	WOS:000187042200007
J	Mobbs, D; Greicius, MD; Abdel-Azim, E; Menon, V; Reiss, AL				Mobbs, D; Greicius, MD; Abdel-Azim, E; Menon, V; Reiss, AL			Humor modulates the mesolimbic reward centers	NEURON			English	Article							FACIAL EXPRESSION; DOPAMINE RELEASE; NEURAL BASIS; LAUGHTER; BRAIN; FMRI; AMYGDALA; COMPREHENSION; ACTIVATION; NUCLEUS	Humor plays an essential role in many facets of human life including psychological, social, and somatic functioning. Recently, neuroimaging has been applied to this critical human attribute, shedding light on the affective, cognitive, and motor networks involved in humor processing. To date, however, researchers have failed to demonstrate the subcortical correlates of the most fundamental feature of humor-reward. In an effort to elucidate the neurobiological substrate that subserves the reward components of humor, we undertook a high-field (3 Tesla) event-related functional MRI study. Here we demonstrate that humor modulates activity in several cortical regions, and we present new evidence that humor engages a network of subcortical regions including the nucleus accumbens, a key component of the mesolimbic dopaminergic reward system. Further, the degree of humor intensity was positively correlated with BOLD signal intensity in these regions. Together, these findings offer new insight into the neural basis of salutary aspects of humor.	Stanford Univ, Sch Med, Stanford Psychiat Neuroimaging Lab, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Program Neurosci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Stanford Brain Res Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Reiss, AL (corresponding author), Stanford Univ, Sch Med, Stanford Psychiat Neuroimaging Lab, Stanford, CA 94305 USA.	reiss@stanford.edu	Abdel-Azim, Eman/M-2675-2019; anand, amit/A-7222-2009; Menon, Vinod/J-6402-2013	Abdel-Azim, Eman/0000-0002-2899-863X; Azim, Eiman/0000-0002-1015-1772; Menon, Vinod/0000-0003-1622-9857	NIMH NIH HHS [MH01142] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; ARROYO S, 1993, BRAIN, V116, P757, DOI 10.1093/brain/116.4.757; BATES JF, 1993, J COMP NEUROL, V336, P211, DOI 10.1002/cne.903360205; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Bennett MP, 2003, ALTERN THER HEALTH M, V9, P38; BERK LS, 1989, AM J MED SCI, V298, P390, DOI 10.1097/00000441-198912000-00006; Braver TS, 2003, NEURON, V38, P150, DOI 10.1016/S0896-6273(03)00230-7; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Breiter HC, 1999, ANN NY ACAD SCI, V877, P523, DOI 10.1111/j.1749-6632.1999.tb09287.x; BROWNELL HH, 1983, BRAIN LANG, V18, P20, DOI 10.1016/0093-934X(83)90002-0; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Chassagnon S, 2003, EPILEPSIA, V44, P859, DOI 10.1046/j.1528-1157.2003.60802.x; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Coulson S, 2001, NEUROSCI LETT, V316, P71, DOI 10.1016/S0304-3940(01)02387-4; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; DEROGATIS LR, 1977, SCL 90 ADM SCORING P, V1; Devous MD, 2001, J NUCL MED, V42, P535; Dixon NF, 1980, STRESS ANXIETY, V7, P281; Drevets WC, 2001, BIOL PSYCHIAT, V49, P81, DOI 10.1016/S0006-3223(00)01038-6; Dum RP, 1993, NEUROBIOLOGY CINGULA, P415, DOI 10.1007/978-1-4899-6704-6_15; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; Erk S, 2002, NEUROREPORT, V13, P2499, DOI 10.1097/00001756-200212200-00024; Fredrickson BL, 1998, COGNITION EMOTION, V12, P191; Fried I, 1998, NATURE, V391, P650, DOI 10.1038/35536; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Fry W F Jr, 1992, JAMA, V267, P1857, DOI 10.1001/jama.267.13.1857; GARDNER H, 1975, BRAIN, V98, P399, DOI 10.1093/brain/98.3.399; GAVRILOVIC J, 2003, EPIDEMIOLOGY, V38, P128; Geday J, 2003, NEUROIMAGE, V18, P675, DOI 10.1016/S1053-8119(02)00038-1; Gernsbacher MA, 2003, ANNU REV PSYCHOL, V54, P91, DOI 10.1146/annurev.psych.54.101601.145128; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; Goel V, 2001, NAT NEUROSCI, V4, P237, DOI 10.1038/85076; GOEL V, 2003, IN PRESS PSYCHOLOGIC, V32; HERZOG TR, 1988, J PSYCHOL, V122, P597, DOI 10.1080/00223980.1988.9915534; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI [10.1016/S1053-8119(18)31587-8, DOI 10.1016/S1053-8119(18)31587-8]; Iwase M, 2002, NEUROIMAGE, V17, P758, DOI 10.1006/nimg.2002.1225; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; LEFCOURT HM, 1990, HUMOR INT J HUMOR RE, V3, P305; Mai J.K., 1997, ATLAS HUMAN BRAIN; Martin RA, 2001, PSYCHOL BULL, V127, P504, DOI 10.1037//0033-2909.127.4.504; MCGHEE PE, 1971, PSYCHOL BULL, V76, P328, DOI 10.1037/h0031670; Mummery CJ, 2000, ANN NEUROL, V47, P36; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Neuhoff CC, 2002, PSYCHOL REP, V91, P1079, DOI 10.2466/PR0.91.7.1079-1080; Nezlek JB, 2001, HUMOR, V14, P395, DOI 10.1515/humr.2001.011; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osaka N, 2003, NEUROSCI LETT, V340, P127, DOI 10.1016/S0304-3940(03)00093-4; Ozawa F, 2000, NEUROREPORT, V11, P1141, DOI 10.1097/00001756-200004270-00001; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; Pratt WE, 1998, BEHAV NEUROSCI, V112, P554, DOI 10.1037/0735-7044.112.3.554; Price CJ, 1996, BRAIN, V119, P919, DOI 10.1093/brain/119.3.919; PRICE JL, 1981, J NEUROSCI, V1, P1242; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SULS J, 1972, PSYCHOL HUMOR; Talairach J., 1988, COPLANAR STEREOTAXIC; Tessitore A, 2002, J NEUROSCI, V22, P9099, DOI 10.1523/jneurosci.22-20-09099.2002; Toyokura M, 2002, J NEUROIMAGING, V12, P172, DOI 10.1111/j.1552-6569.2002.tb00116.x; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Yang TT, 2002, NEUROREPORT, V13, P1737, DOI 10.1097/00001756-200210070-00009	65	273	279	3	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 4	2003	40	5					1041	1048		10.1016/S0896-6273(03)00751-7	http://dx.doi.org/10.1016/S0896-6273(03)00751-7			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	751FM	14659102	Bronze			2022-12-24	WOS:000187042200020
J	Seki, K; Perlmutter, SI; Fetz, EE				Seki, K; Perlmutter, SI; Fetz, EE			Sensory input to primate spinal cord is presynaptically inhibited during voluntary movement	NATURE NEUROSCIENCE			English	Article							PRIMARY AFFERENT DEPOLARIZATION; SOMATOSENSORY-EVOKED-POTENTIALS; POSTSYNAPTIC DORSAL COLUMN; FICTIVE LOCOMOTION; EXCITABILITY CHANGES; CENTRAL TERMINALS; REFLEX RESPONSES; CUNEATE NUCLEUS; MOTOR UNITS; CAT	During normal voluntary movements, re-afferent sensory input continuously converges on the spinal circuits that are activated by descending motor commands. This time-varying input must either be synergistically combined with the motor commands or be appropriately suppressed to minimize interference. The earliest suppression could be produced by presynaptic inhibition, which effectively reduces synaptic transmission at the initial synapse. Here we report evidence from awake, behaving monkeys that presynaptic inhibition decreases the ability of afferent impulses to affect postsynaptic neurons in a behaviorally dependent manner. Evidence indicates that cutaneous afferent input to spinal cord interneurons is inhibited presynaptically during active wrist movement, and this inhibition is effectively produced by descending commands. Our results further suggest that this presynaptic inhibition has appropriate functional consequences for movement generation and may underlie increases in perceptual thresholds during active movement.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; Natl Inst Physiol Sci, Dept Integrat Physiol, Aichi 4448585, Japan	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Seki, K (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	kazuseki@nips.ac.jp		Seki, Kazuhiko/0000-0002-4262-9590; Perlmutter, Steve/0000-0002-1149-4152	NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS012542, R29NS036781, R01NS012542] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00166] Funding Source: Medline; NINDS NIH HHS [NS 12542, NS36781] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSEN P, 1964, J NEUROPHYSIOL, V27, P92, DOI 10.1152/jn.1964.27.1.92; ANGEL RW, 1982, EXP NEUROL, V77, P266, DOI 10.1016/0014-4886(82)90244-8; BALDISSE.F, 1967, EXPERIENTIA, V23, P398, DOI 10.1007/BF02144542; Baldissera F., 1981, HDB PHYSL 1 1, V2, P509, DOI DOI 10.1002/CPHY.CP010212; BRINK E, 1984, J NEUROPHYSIOL, V51, P432, DOI 10.1152/jn.1984.51.3.432; BURKE D, 1994, J PHYSIOL-LONDON, V480, P191, DOI 10.1113/jphysiol.1994.sp020352; BURKE RE, 1970, J PHYSIOL-LONDON, V207, P709, DOI 10.1113/jphysiol.1970.sp009090; CAIMS BE, 1996, J NEUROPHYSIOL, V75, P1152; CAPADAY C, 1986, J NEUROSCI, V6, P1308; CARPENTER D, 1963, ACTA PHYSIOL SCAND, V59, P126, DOI 10.1111/j.1748-1716.1963.tb02729.x; CLIFFER KD, 1994, J COMP NEUROL, V345, P84, DOI 10.1002/cne.903450106; Dick SH, 2001, BRAIN RES, V914, P134, DOI 10.1016/S0006-8993(01)02787-1; DUENAS SH, 1988, EXP BRAIN RES, V70, P15; DUYSENS J, 1993, BRAIN RES, V613, P230, DOI 10.1016/0006-8993(93)90903-Z; ECCLES JC, 1963, J NEUROPHYSIOL, V26, P646, DOI 10.1152/jn.1963.26.4.646; ECCLES JC, 1961, J PHYSL, V159, P47; EGGER MD, 1986, BRAIN RES, V383, P68, DOI 10.1016/0006-8993(86)90009-0; EGUIBAR JR, 1994, BRAIN RES, V643, P328, DOI 10.1016/0006-8993(94)90042-6; Ennis M, 2001, J NEUROPHYSIOL, V86, P2986, DOI 10.1152/jn.2001.86.6.2986; FETZ EE, 1968, J NEUROPHYSIOL, V31, P69, DOI 10.1152/jn.1968.31.1.69; FETZ EE, 1980, J NEUROPHYSIOL, V43, P1070, DOI 10.1152/jn.1980.43.4.1070; FETZ EE, 1989, PROG BRAIN RES, V80, P437; FLAMENT D, 1992, J NEUROPHYSIOL, V67, P875, DOI 10.1152/jn.1992.67.4.875; FRANK K, 1959, IRE T MED ELECTRON, V6, P85, DOI 10.1109/IRET-ME.1959.5007923; GARNETT R, 1980, J PHYSIOL-LONDON, V303, P351, DOI 10.1113/jphysiol.1980.sp013290; GOSSARD JP, 1990, BRAIN RES, V537, P14, DOI 10.1016/0006-8993(90)90334-8; Haugland M., 1996, 18 ANN INT C IEEE EN; HONGO T, 1989, BRAIN RES, V505, P167, DOI 10.1016/0006-8993(89)90132-7; HULLIGER M, 1979, J PHYSIOL-LONDON, V291, P233, DOI 10.1113/jphysiol.1979.sp012809; HULTBORN H, 1987, J PHYSIOL-LONDON, V389, P757, DOI 10.1113/jphysiol.1987.sp016681; JANIG W, 1968, EXP BRAIN RES, V6, P116; Jankowska E, 2002, J PHYSIOL-LONDON, V542, P287, DOI 10.1113/jphysiol.2001.014068; JENNER JR, 1982, J PHYSIOL-LONDON, V333, P405, DOI 10.1113/jphysiol.1982.sp014461; JIMENEZ I, 1987, EXP BRAIN RES, V69, P195; KRIZ N, 1974, J PHYSIOL-LONDON, V238, P1; Menard A, 2002, J NEUROPHYSIOL, V88, P163, DOI 10.1152/jn.2002.88.1.163; Miller RJ, 1998, ANNU REV PHARMACOL, V38, P201, DOI 10.1146/annurev.pharmtox.38.1.201; MILNE RJ, 1988, EXP BRAIN RES, V70, P569; MORRISON AR, 1966, NATURE, V210, P201, DOI 10.1038/210201a0; MOSCHOVAKIS AK, 1991, EXP BRAIN RES, V83, P489; NIELSEN J, 1993, J PHYSIOL-LONDON, V464, P575, DOI 10.1113/jphysiol.1993.sp019652; PECCISAA.J, 1966, NATURE, V210, P740, DOI 10.1038/210740a0; Perlmutter SI, 1998, J NEUROPHYSIOL, V80, P2475, DOI 10.1152/jn.1998.80.5.2475; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; RUSHTON DN, 1981, BRAIN, V104, P465, DOI 10.1093/brain/104.3.465; RUSTIONI A, 1977, SCIENCE, V196, P656, DOI 10.1126/science.404704; RUSTIONI A, 1979, BRAIN, V102, P95, DOI 10.1093/brain/102.1.95; Shimazu H, 1999, NEUROREPORT, V10, P2457, DOI 10.1097/00001756-199908200-00004; WALL PD, 1958, J PHYSIOL-LONDON, V142, P1; Willis Jr W. D., 1991, SENSORY MECH SPINAL	50	199	202	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1309	1316		10.1038/nn1154	http://dx.doi.org/10.1038/nn1154			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	746BC	14625555				2022-12-24	WOS:000186725600016
J	Zhang, ZZ; Bourque, CW				Zhang, ZZ; Bourque, CW			Osmometry in osmosensory neurons	NATURE NEUROSCIENCE			English	Article							MEMBRANE TENSION; MECHANISMS; CHANNELS	Mechanosensitive channels may act as osmosensory transducers because osmotically evoked changes in cell volume alter forces applied to the channel and affect opening probability(1-4). However, osmotically stimulated cells regulate volume(5) normally, whereas systemic osmoregulatory responses are sustained(6,7). Here we report that osmosensory neurons of rat supraoptic nucleus expressed significant membrane reserves, and could not regulate volume or total membrane surface area during osmotic perturbations, which may allow mechanosensitive channels to encode the amplitude and time course of an osmotic stimulus.	Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada; McGill Univ, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University	Bourque, CW (corresponding author), Montreal Gen Hosp, Ctr Res Neurosci, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.			Bourque, Charles/0000-0002-1594-742X				BOURQUE CW, 1994, FRONT NEUROENDOCRIN, V15, P231, DOI 10.1006/frne.1994.1010; Colbert HA, 1997, J NEUROSCI, V17, P8259; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Morris CE, 2001, J MEMBRANE BIOL, V179, P79, DOI 10.1007/s002320010040; OLIET SHR, 1993, NATURE, V364, P341, DOI 10.1038/364341a0; Pasantes-Morales H, 2002, ARCH MED RES, V33, P237, DOI 10.1016/S0188-4409(02)00353-3; PASANTESMORALES H, 1993, J NEUROSCI RES, V34, P219, DOI 10.1002/jnr.490340209; Raucher D, 1999, BIOPHYS J, V77, P1992, DOI 10.1016/S0006-3495(99)77040-2; ROSS PE, 1994, BIOPHYS J, V66, P169, DOI 10.1016/S0006-3495(94)80754-4; STRANGE K, 1992, AM J PHYSIOL, V263, P412; Suzuki M, 1999, J BIOL CHEM, V274, P6330, DOI 10.1074/jbc.274.10.6330; VERBALIS JG, 1986, AM J PHYSIOL, V250, P444; WAKERLEY JB, 1978, BRAIN RES, V148, P425, DOI 10.1016/0006-8993(78)90730-8	14	79	79	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1021	1022		10.1038/nn1124	http://dx.doi.org/10.1038/nn1124			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	12973356				2022-12-24	WOS:000185633600012
J	Chen, HJ; Kim, LA; Rajan, S; Xu, SH; Goldstein, SAN				Chen, HJ; Kim, LA; Rajan, S; Xu, SH; Goldstein, SAN			Charybdotoxin binding in the I-Ks pore demonstrates two MinK subunits in each channel complex	NEURON			English	Article							SHAKER K+ CHANNEL; LONG QT SYNDROME; POTASSIUM CHANNEL; BLOCK; STOICHIOMETRY; EXPRESSION; MECHANISM; MUTATIONS; FORM; SELECTIVITY	I-Ks voltage-gated K+ channels contain four pore-forming KCNQ1 subunits and MinK accessory subunits in a number that has been controversial. Here, I-Ks channels assembled naturally by monomer subunits are compared to those with linked subunits that force defined stoichiometries. Two strategies that exploit charybdotoxin (CTX)-sensitive subunit variants are applied. First, CTX on rate, off rate, and equilibrium affinity are found to be the same for channels of monomers and those with a fixed 2:4 MinK:KCNQ1 valence. Second, H-3-CTX and an antibody are used to directly quantify channels and MinK subunits, respectively, showing 1.97 +/- 0.07 MinK per I-Ks channel. Additional MinK subunits do not enter channels of monomeric subunits or those with fixed 2:4 valence. We conclude that two MinK subunits are necessary, sufficient, and the norm in I-Ks channels. This stoichiometry is expected for other K+ channels that contain MinK or MinK-related peptides (MiRPs).	Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Cellular & Mol Physiol,Dept Pediat, New Haven, CT 06536 USA	Yale University	Goldstein, SAN (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Cellular & Mol Physiol,Dept Pediat, 295 Congress Ave, New Haven, CT 06536 USA.		Chen, Haijun/C-7334-2011; Kim, Leo/Y-3323-2018; Goldstein, Steven A./E-9817-2015	Kim, Leo/0000-0001-9106-6416; Goldstein, Steven A./0000-0001-5207-5061				Abbott GW, 1998, Q REV BIOPHYS, V31, P357, DOI 10.1017/S0033583599003467; Abbott GW, 2002, FASEB J, V16, DOI 10.1096/fj.01-0520hyp; Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Anantharam A, 2003, J BIOL CHEM, V278, P11739, DOI 10.1074/jbc.M212751200; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bianchi L, 2003, J BIOL CHEM, V278, P12415, DOI 10.1074/jbc.M212788200; Chen HJ, 2003, BIOPHYS J, V84, P3679, DOI 10.1016/S0006-3495(03)75097-8; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; GOLDSTEIN SAN, 1991, NEURON, V7, P403, DOI 10.1016/0896-6273(91)90292-8; GOLDSTEIN SAN, 1992, BIOPHYS J, V62, P5, DOI 10.1016/S0006-3495(92)81760-5; GOLDSTEIN SAN, 1993, BIOPHYS J, V65, P1613, DOI 10.1016/S0006-3495(93)81200-1; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; GROSS A, 1994, NEURON, V13, P961, DOI 10.1016/0896-6273(94)90261-5; KAVANAUGH MP, 1992, NEURON, V8, P493, DOI 10.1016/0896-6273(92)90277-K; Kurokawa J, 2001, J GEN PHYSIOL, V117, P43, DOI 10.1085/jgp.117.1.43; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MILLER C, 1985, NATURE, V313, P316, DOI 10.1038/313316a0; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SchulzeBahr E, 1997, NAT GENET, V17, P267, DOI 10.1038/ng1197-267; Seebohm G, 2001, J BIOL CHEM, V276, P13600, DOI 10.1074/jbc.M008373200; Sesti F, 2000, BIOPHYS J, V79, P1369, DOI 10.1016/S0006-3495(00)76389-2; Sesti F, 2003, NAT NEUROSCI, V6, P353, DOI 10.1038/nn1028; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; SUN TY, 1994, BIOCHEMISTRY-US, V33, P9992, DOI 10.1021/bi00199a024; Tai KK, 1998, NATURE, V391, P605, DOI 10.1038/35416; Tracy CC, 2003, AM J PHYSIOL-HEART C, V284, pH168, DOI 10.1152/ajpheart.00661.2002; Trimmer JS, 1998, CURR OPIN NEUROBIOL, V8, P370, DOI 10.1016/S0959-4388(98)80063-9; Tu LW, 1999, BIOPHYS J, V76, P2004, DOI 10.1016/S0006-3495(99)77358-3; TZOUNOPOULOS T, 1995, P NATL ACAD SCI USA, V92, P9593, DOI 10.1073/pnas.92.21.9593; Wang CH, 1998, NEUROGENETICS, V1, P273; Wang KW, 1996, NEURON, V16, P571, DOI 10.1016/S0896-6273(00)80076-8; WANG KW, 1995, NEURON, V14, P1303, DOI 10.1016/0896-6273(95)90277-5; Yang YS, 1997, J GEN PHYSIOL, V109, P779, DOI 10.1085/jgp.109.6.779; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	41	113	116	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 25	2003	40	1					15	23		10.1016/S0896-6273(03)00570-1	http://dx.doi.org/10.1016/S0896-6273(03)00570-1			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	726TA	14527430	Green Published, Bronze			2022-12-24	WOS:000185614700006
J	Hashimoto, K; Kano, M				Hashimoto, K; Kano, M			Functional differentiation of multiple climbing fiber inputs during synapse elimination in the developing cerebellum	NEURON			English	Article							PURKINJE-CELL SYNAPSES; CENTRAL-NERVOUS-SYSTEM; LONG-TERM DEPRESSION; NEUROTRANSMITTER RELEASE; METABOTROPIC GLUTAMATE; MOTOR COORDINATION; CALCIUM TRANSIENTS; RAT CEREBELLUM; PARALLEL FIBER; MUTANT MICE	We studied how physiological properties of cerebellar climbing fiber (CF) to Purkinje cell (PC) synapses change during developmental transition from multiple to mono CF innervation onto each PC. From P3 to P6, differences in the strengths of multiple CFs became larger. Around P10, each PC was either monoinnervated by one strong CF (CF-mono) or multiply innervated by one strong CF (CF-multi-S) plus a few weaker CFs (CF-multi-W). We show that simultaneous release of multiple vesicles per site occurs normally from CF-multi-S, CF-mono, and mature CFs, but less frequently from CF-multi-W and neonatal CFs. We also present evidence suggesting that weaker CFs with lower probability of multivesicular release would be withdrawn preferentially. The results suggest that differentiation into strong and weak CFs with high and low probabilities of multivesicular release precedes developmental CF synapse elimination.	Kanazawa Univ, Grad Sch Med Sci, Dept Cellular Neurophysiol, Kanazawa, Ishikawa 9208640, Japan	Kanazawa University	Kano, M (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Cellular Neurophysiol, Kanazawa, Ishikawa 9208640, Japan.			Kano, Masanobu/0000-0002-0725-3292; Hashimoto, Kouichi/0000-0002-3884-8213				AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Brenowitz S, 2001, J NEUROSCI, V21, P9487, DOI 10.1523/JNEUROSCI.21-23-09487.2001; CHANGEUX JP, 1976, NATURE, V264, P705, DOI 10.1038/264705a0; CHEDOTAL A, 1993, DEV BRAIN RES, V76, P207, DOI 10.1016/0165-3806(93)90209-S; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; CREPEL F, 1982, TRENDS NEUROSCI, V5, P266, DOI 10.1016/0166-2236(82)90168-0; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; EILERS J, 1995, P NATL ACAD SCI USA, V92, P10272, DOI 10.1073/pnas.92.22.10272; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Foster KA, 2002, NEURON, V36, P1115, DOI 10.1016/S0896-6273(02)01106-6; GREENOUGH WT, 1988, TRENDS NEUROSCI, V11, P142, DOI 10.1016/0166-2236(88)90139-7; Harrison J, 2003, J NEUROSCI, V23, P377, DOI 10.1523/JNEUROSCI.23-02-00377.2003; Hashimoto K, 2001, J NEUROSCI, V21, P9701, DOI 10.1523/JNEUROSCI.21-24-09701.2001; Hashimoto K, 1998, J PHYSIOL-LONDON, V506, P391, DOI 10.1111/j.1469-7793.1998.391bw.x; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832; Itoh M, 1984, CEREBELLUM NEURAL CO; Kakizawa S, 2003, EUR J NEUROSCI, V17, P545, DOI 10.1046/j.1460-9568.2003.02486.x; Kakizawa S, 2000, J NEUROSCI, V20, P4954; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; Kano M, 1997, NEURON, V18, P71, DOI 10.1016/S0896-6273(01)80047-7; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Kano M, 1998, P NATL ACAD SCI USA, V95, P15724, DOI 10.1073/pnas.95.26.15724; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; Kopp DM, 2000, J NEUROSCI, V20, P8771; Kreitzer AC, 2000, NEURON, V27, P25, DOI 10.1016/S0896-6273(00)00006-4; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; Lohof AM, 1996, REV NEUROSCIENCE, V7, P85; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; MASON CA, 1990, J COMP NEUROL, V297, P77, DOI 10.1002/cne.902970106; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; Morara S, 2001, NEUROSCIENCE, V108, P655, DOI 10.1016/S0306-4522(01)00433-X; Nguyen QT, 1996, CURR OPIN NEUROBIOL, V6, P104, DOI 10.1016/S0959-4388(96)80015-8; Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089; Palay S.L., 1974, CEREBELLAR CORTEX; Polo-Parada L, 2001, NEURON, V32, P815, DOI 10.1016/S0896-6273(01)00521-9; PURVES D, 1980, SCIENCE, V210, P153, DOI 10.1126/science.7414326; RABACCHI S, 1992, SCIENCE, V256, P1823, DOI 10.1126/science.1352066; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Strata P, 1998, TRENDS NEUROSCI, V21, P407, DOI 10.1016/S0166-2236(98)01305-8; Sugihara I, 1999, J COMP NEUROL, V414, P131; TAKAHASHI M, 1995, J NEUROSCI, V15, P5693; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; Vara H, 2002, NEUROSCIENCE, V110, P19, DOI 10.1016/S0306-4522(01)00541-3; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Yoshida T, 2002, J NEUROSCI, V22, P1690, DOI 10.1523/JNEUROSCI.22-05-01690.2002; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	52	179	182	1	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 5	2003	38	5					785	796		10.1016/S0896-6273(03)00298-8	http://dx.doi.org/10.1016/S0896-6273(03)00298-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	687DU	12797962	Bronze			2022-12-24	WOS:000183361400013
J	Riven, I; Kalmanzon, E; Segev, L; Reuveny, E				Riven, I; Kalmanzon, E; Segev, L; Reuveny, E			Conformational rearrangements associated with the gating of the G protein-coupled potassium channel revealed by FRET microscopy	NEURON			English	Article							BETA-GAMMA-SUBUNITS; REFLECTION FLUORESCENCE MICROSCOPY; RECTIFYING K+ CHANNELS; ENERGY-TRANSFER; ORIENTATIONAL FREEDOM; LIVING CELLS; ACTIVATION; BINDING; IDENTIFICATION; G(BETA-GAMMA)	G protein-coupled potassium channels (GIRK/Kir3.x) are key determinants that translate inhibitory chemical neurotransmission into changes in cellular excitability. To understand the mechanism of channel activation by G proteins, it is necessary to define the structural rearrangements in the channel that result from interaction with Gbetagamma subunits. In this study we used a combination of fluorescence spectroscopy and through-the-objective total internal reflection microscopy to monitor the conformational rearrangements associated with the activation of GIRK channels in single intact cells. We detect activation-induced changes in FRET consistent with a rotation and expansion of the termini along the central axis of the channel. We propose that this rotation and expansion of the termini drives the channel to open by bending and possibly rotating the second transmembrane segment.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Reuveny, E (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	e.reuveny@weizmann.ac.il						Alagem N, 2001, J PHYSIOL-LONDON, V534, P381, DOI 10.1111/j.1469-7793.2001.00381.x; AXELROD D, 1989, METHOD CELL BIOL, V30, P245; AXELROD D, 1979, BIOPHYS J, V26, P557, DOI 10.1016/S0006-3495(79)85271-6; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Cleemann L, 1997, ADV EXP MED BIOL, V430, P57; Codazzi F, 2001, CURR BIOL, V11, P1089, DOI 10.1016/S0960-9822(01)00326-8; DALE RE, 1979, BIOPHYS J, V26, P161, DOI 10.1016/S0006-3495(79)85243-1; DALE RE, 1974, BIOPOLYMERS, V13, P1573, DOI 10.1002/bip.1974.360130807; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Guo Y, 2002, J BIOL CHEM, V277, P48289, DOI 10.1074/jbc.M207987200; He C, 2002, J BIOL CHEM, V277, P6088, DOI 10.1074/jbc.M104851200; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Huang CL, 1997, FEBS LETT, V405, P291, DOI 10.1016/S0014-5793(97)00197-X; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; INANOBE A, 1995, BIOCHEM BIOPH RES CO, V212, P1022, DOI 10.1006/bbrc.1995.2072; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; Johnson JP, 2001, NATURE, V412, P917, DOI 10.1038/35091089; Krapivinsky G, 1998, J BIOL CHEM, V273, P16946, DOI 10.1074/jbc.273.27.16946; Kubo Y, 2001, J PHYSIOL-LONDON, V531, P645, DOI 10.1111/j.1469-7793.2001.0645h.x; KUNKEL MT, 1995, CELL, V83, P443, DOI 10.1016/0092-8674(95)90122-1; Llopis J, 2000, P NATL ACAD SCI USA, V97, P4363, DOI 10.1073/pnas.97.8.4363; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Ohara-Imaizumi M, 2002, J BIOL CHEM, V277, P3805, DOI 10.1074/jbc.C100712200; Petit-Jacques J, 1999, J GEN PHYSIOL, V114, P673, DOI 10.1085/jgp.114.5.673; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Sadja R, 2002, P NATL ACAD SCI USA, V99, P10783, DOI 10.1073/pnas.162346199; Sadja R, 2001, NEURON, V29, P669, DOI 10.1016/S0896-6273(01)00242-2; Schulte U, 1998, J BIOL CHEM, V273, P34575, DOI 10.1074/jbc.273.51.34575; Silverman SK, 1996, J BIOL CHEM, V271, P30524, DOI 10.1074/jbc.271.48.30524; SLESINGER PA, 1995, NEURON, V15, P1145, DOI 10.1016/0896-6273(95)90102-7; Sonnleitner A, 2002, P NATL ACAD SCI USA, V99, P12759, DOI 10.1073/pnas.192261499; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Sui JL, 1996, J GEN PHYSIOL, V108, P381, DOI 10.1085/jgp.108.5.381; TRUSKEY GA, 1992, J CELL SCI, V103, P491; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tucker SJ, 1996, AM J PHYSIOL-HEART C, V271, pH379, DOI 10.1152/ajpheart.1996.271.1.H379; Van Der Meer B. W., 1994, RESONANCE ENERGY TRA; WANG MD, 1994, DEV DYNAM, V201, P29, DOI 10.1002/aja.1002010104; Wickman K, 1998, NEURON, V20, P103, DOI 10.1016/S0896-6273(00)80438-9; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0; Zeidner G, 2001, J BIOL CHEM, V276, P35564, DOI 10.1074/jbc.M105189200; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zhang Y, 1999, TUMOR TARGET, V4, P158	57	102	105	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 24	2003	38	2					225	235		10.1016/S0896-6273(03)00193-4	http://dx.doi.org/10.1016/S0896-6273(03)00193-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672AM	12718857	Bronze			2022-12-24	WOS:000182498300012
J	Kim, J; Lo, L; Dormand, E; Anderson, DJ				Kim, J; Lo, L; Dormand, E; Anderson, DJ			SOX10 maintains multipotency and inhibits neuronal differentiation of neural crest stem cells	NEURON			English	Article							TRANSCRIPTION FACTOR SOX10; CENTRAL-NERVOUS-SYSTEM; PROGENITOR CELLS; MOUSE MODEL; HIRSCHSPRUNG-DISEASE; GENE-EXPRESSION; CHICKEN SOX2; GLIAL-CELLS; PHOX2A; FATE	The mechanisms that establish and maintain the multipotency of stem cells are poorly understood. In neural crest stem cells (NCSCs), the HMG-box factor SOX10 preserves not only glial, but surprisingly, also neuronal potential from extinction by lineage commitment signals. The latter function is reflected in the requirement of SOX10 in vivo for induction of MASH1 and PHOX2B, two neurogenic transcription factors. Simultaneously, SOX10 inhibits or delays overt neuronal differentiation, both in vitro and in vivo. However, this activity requires a higher SOX10 gene dosage than does the maintenance of neurogenic potential. The opponent functions of SOX10 to maintain neural lineage potentials, while simultaneously serving to inhibit or delay neuronal differentiation, suggest that it functions in stem or progenitor cell maintenance, in addition to its established role in peripheral gliogenesis.	CALTECH, Howard Hughes Med Inst, Div Biol 216 76, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Anderson, DJ (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol 216 76, Pasadena, CA 91125 USA.							Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Anderson DJ, 1997, TRENDS GENET, V13, P276, DOI 10.1016/S0168-9525(97)01187-6; Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bondurand N, 2001, HUM MOL GENET, V10, P2783, DOI 10.1093/hmg/10.24.2783; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Buescher M, 2002, DEVELOPMENT, V129, P4193; DICICCOBLOOM E, 1990, J CELL BIOL, V110, P2073, DOI 10.1083/jcb.110.6.2073; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Flora A, 2001, J NEUROSCI, V21, P7037, DOI 10.1523/JNEUROSCI.21-18-07037.2001; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Greenwood AL, 1999, DEVELOPMENT, V126, P3545; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; HemmatiBrivanlou A, 1997, CELL, V88, P13, DOI 10.1016/S0092-8674(00)81853-X; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; Hirsch MR, 1998, DEVELOPMENT, V125, P599; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Labosky PA, 1998, MECH DEVELOP, V76, P185, DOI 10.1016/S0925-4773(98)00105-1; Le Douarin NM, 1999, NEURAL CREST, V2; Lo LC, 2002, DEVELOPMENT, V129, P1553; Lo LC, 1998, DEVELOPMENT, V125, P609; Malatesta P, 2000, DEVELOPMENT, V127, P5253; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Overton PM, 2002, DEVELOPMENT, V129, P4219; Paratore C, 2002, HUM MOL GENET, V11, P3075, DOI 10.1093/hmg/11.24.3075; Paratore C, 2001, DEVELOPMENT, V128, P3949; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Peirano RI, 2000, MOL CELL BIOL, V20, P3198, DOI 10.1128/MCB.20.9.3198-3209.2000; Potterf SB, 2001, DEV BIOL, V237, P245, DOI 10.1006/dbio.2001.0372; Rex M, 1997, DEV DYNAM, V209, P323, DOI 10.1002/(SICI)1097-0177(199707)209:3<323::AID-AJA7>3.3.CO;2-B; Shah NM, 1997, P NATL ACAD SCI USA, V94, P11369, DOI 10.1073/pnas.94.21.11369; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Shin MK, 1999, NATURE, V402, P496, DOI 10.1038/990040; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; Sonnenberg-Riethmacher E, 2001, MECH DEVELOP, V109, P253, DOI 10.1016/S0925-4773(01)00547-0; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tsai RYL, 2002, DEV CELL, V2, P707, DOI 10.1016/S1534-5807(02)00195-8; UWANOGHO D, 1995, MECH DEVELOP, V49, P23, DOI 10.1016/0925-4773(94)00299-3; VERDI JM, 1994, NEURON, V13, P1359, DOI 10.1016/0896-6273(94)90421-9; Wang SL, 2001, NEURON, V29, P603, DOI 10.1016/S0896-6273(01)00237-9; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; White PM, 1999, DEVELOPMENT, V126, P4351; White PM, 2001, NEURON, V29, P57, DOI 10.1016/S0896-6273(01)00180-5; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zirlinger M, 2002, P NATL ACAD SCI USA, V99, P8084, DOI 10.1073/pnas.122231199	68	409	416	1	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 10	2003	38	1					17	31		10.1016/S0896-6273(03)00163-6	http://dx.doi.org/10.1016/S0896-6273(03)00163-6			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	666XT	12691661	Bronze			2022-12-24	WOS:000182202300006
J	Cheng, HYM; Obrietan, K; Cain, SW; Lee, BY; Agostino, PV; Joza, NA; Harrington, ME; Ralph, MR; Penninger, JM				Cheng, HYM; Obrietan, K; Cain, SW; Lee, BY; Agostino, PV; Joza, NA; Harrington, ME; Ralph, MR; Penninger, JM			Dexras1 potentiates photic and suppresses nonphotic responses of the circadian clock	NEURON			English	Article							NMDA RECEPTOR ANTAGONISTS; PHASE-SHIFTS; SUPRACHIASMATIC NUCLEUS; NEUROPEPTIDE-Y; GOLDEN-HAMSTER; HYPOTHALAMIC TRACT; KINASE ACTIVATION; ACTIVITY RHYTHMS; GENE-EXPRESSION; IN-VITRO	Circadian rhythms of physiology and behavior are generated by biological clocks that are synchronized to the cyclic environment by photic or nonphotic cues. The interactions and integration of various entrainment pathways to the clock are poorly understood. Here, we show that the Ras-like G protein Dexras1 is a critical modulator of the responsiveness of the master clock to photic and nonphotic inputs. Genetic deletion of Dexras1 reduces photic entrainment by eliminating a pertussis-sensitive circadian response to NMDA. Mechanistically, Dexras1 couples NMDA and light input to G(i/o) and ERK activation. In addition, the mutation greatly potentiates nonphotic responses to neuropeptide Y and unmasks a nonphotic response to arousal. Thus, Dexras1 modulates the responses of the master clock to photic and nonphotic stimuli in opposite directions. These results identify a signaling molecule that serves as a differential modulator of the gated photic and nonphotic input pathways to the circadian timekeeping system.	Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2M9, Canada; Univ Toronto, Univ Hlth Network, Toronto, ON M5G 2M9, Canada; Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada; Univ Nacl Quilmes, Dept Ciencia & Tecnol, Buenos Aires, DF, Argentina; Smith Coll, Dept Psychol, Northampton, MA 01063 USA; Smith Coll, Program Neurosci, Northampton, MA 01063 USA	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University System of Ohio; Ohio State University; University of Toronto; Smith College; Smith College	Cheng, HYM (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3-5, A-1030 Vienna, Austria.	hymcheng@yahoo.ca; josef.penninger@oeaw.ac.at	Penninger, Josef M/I-6860-2013	Penninger, Josef M/0000-0002-8194-3777; Cain, Sean/0000-0002-8385-1550				Aschoff, 1965, CIRCADIAN CLOCKS, P95; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; BIELLO SM, 1995, P ROY SOC B-BIOL SCI, V259, P179, DOI 10.1098/rspb.1995.0026; Biello SM, 1997, NEUROSCIENCE, V77, P1049, DOI 10.1016/S0306-4522(96)00547-7; Butcher GQ, 2003, J NEUROPHYSIOL, V90, P3854, DOI 10.1152/jn.00524.2003; Butcher GQ, 2002, J BIOL CHEM, V277, P29519, DOI 10.1074/jbc.M203301200; Chandler LJ, 2001, J BIOL CHEM, V276, P2627, DOI 10.1074/jbc.M003390200; Cheng HYM, 2002, CELL, V108, P31, DOI 10.1016/S0092-8674(01)00629-8; Cismowski MJ, 2000, J BIOL CHEM, V275, P23421, DOI 10.1074/jbc.C000322200; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; COLWELL CS, 1991, BRAIN RES, V554, P105, DOI 10.1016/0006-8993(91)90177-W; COLWELL CS, 1992, J BIOL RHYTHM, V7, P125, DOI 10.1177/074873049200700204; Coogan AN, 2003, J NEUROSCI, V23, P3085; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Dziema H, 2003, EUR J NEUROSCI, V17, P1617, DOI 10.1046/j.1460-9568.2003.02592.x; EDGAR DM, 1991, J BIOL RHYTHM, V6, P185, DOI 10.1177/074873049100600301; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; Graham TE, 2001, ENDOCRINOLOGY, V142, P2631, DOI 10.1210/en.142.6.2631; Graham TE, 2002, J BIOL CHEM, V277, P10876, DOI 10.1074/jbc.M110397200; Hannibal J, 2002, CELL TISSUE RES, V309, P73, DOI 10.1007/s00441-002-0574-3; HARRINGTON ME, 1988, PHYSIOL BEHAV, V42, P183, DOI 10.1016/0031-9384(88)90296-X; Harrington ME, 1997, NEUROSCI BIOBEHAV R, V21, P705, DOI 10.1016/S0149-7634(96)00019-X; Kemppainen RJ, 1998, J BIOL CHEM, V273, P3129, DOI 10.1074/jbc.273.6.3129; Lall GS, 2003, NEUROSCIENCE, V120, P915, DOI 10.1016/S0306-4522(03)00396-8; Maywood E. S., 2001, Gene Expression Patterns, V1, P27, DOI 10.1016/S1567-133X(01)00005-9; Mintz EM, 1999, J NEUROSCI, V19, P5124; Mrosovsky N, 1996, BIOL REV, V71, P343, DOI 10.1111/j.1469-185X.1996.tb01278.x; Mrosovsky N, 1996, CHRONOBIOL INT, V13, P387, DOI 10.3109/07420529609012662; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Perkinton MS, 2002, J NEUROCHEM, V80, P239, DOI 10.1046/j.0022-3042.2001.00699.x; Pickard G E, 1987, J Biol Rhythms, V2, P35, DOI 10.1177/074873048700200104; PICKARD GE, 1993, PHYSIOL BEHAV, V54, P1, DOI 10.1016/0031-9384(93)90035-E; RALPH MR, 1992, J BIOL RHYTHM, V7, P353, DOI 10.1177/074873049200700408; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; REEBS SG, 1989, J COMP PHYSIOL A, V165, P819, DOI 10.1007/BF00610880; REEBS SG, 1989, J BIOL RHYTHM, V4, P39, DOI 10.1177/074873048900400103; Refinetti R, 2001, PHYSIOL BEHAV, V74, P101, DOI 10.1016/S0031-9384(01)00546-7; Roenneberg T, 2000, CURR BIOL, V10, pR742, DOI 10.1016/S0960-9822(00)00739-9; SHIBATA S, 1992, BRAIN RES, V582, P353, DOI 10.1016/0006-8993(92)90156-4; SHIBATA S, 1994, AM J PHYSIOL, V267, pR360, DOI 10.1152/ajpregu.1994.267.2.R360; Takahashi H, 2003, MOL BRAIN RES, V110, P1, DOI 10.1016/S0169-328X(02)00543-0; Takesono A, 2002, J BIOL CHEM, V277, P13827, DOI 10.1074/jbc.M201064200; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Wong SKF, 2003, NEUROSIGNALS, V12, P1, DOI 10.1159/000068914; Yannielli PC, 2001, J NEUROSCI, V21, P5367, DOI 10.1523/JNEUROSCI.21-14-05367.2001	48	84	85	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 2	2004	43	5					715	728		10.1016/j.neuron.2004.08.021	http://dx.doi.org/10.1016/j.neuron.2004.08.021			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339652	Bronze			2022-12-24	WOS:000223691900016
J	Chan, JR; Watkins, TA; Cosgaya, JM; Zhang, CZ; Chen, L; Reichardt, LF; Shooter, EM; Barres, BA				Chan, JR; Watkins, TA; Cosgaya, JM; Zhang, CZ; Chen, L; Reichardt, LF; Shooter, EM; Barres, BA			NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes	NEURON			English	Article							NERVE GROWTH-FACTOR; ROOT GANGLION NEURONS; NEUROTROPHIC FACTOR; ACTION-POTENTIALS; SENSORY NEURONS; SPINAL-CORD; SYSTEM; ACTIVATION; SURVIVAL; CALIBER	Axons dictate whether or not they will become myelinated in both the central and peripheral nervous systems by providing signals that direct the development of myelinating glia. Here we identify the neurotrophin nerve growth factor (NGF) as a potent regulator of the axonal signals that control myelination of TrkA-expressing dorsal root ganglion neurons (DRGs). Unexpectedly, these NGF-regulated axonal signals have opposite effects on peripheral and central myelination, promoting myelination by Schwann cells but reducing myelination by oligodendrocytes. These findings indicate a novel role for growth factors in regulating the receptivity of axons to myelination and reveal that different axonal signals control central and peripheral myelination.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California San Francisco	Watkins, TA (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Fairchild Sci Bldg D235, Stanford, CA 94305 USA.	trentw@stanford.edu	Cosgaya, Jose M/B-4936-2008	Cosgaya, Jose Miguel/0000-0002-6005-2916	NEI NIH HHS [R01 EY10257, R01 EY010257] Funding Source: Medline; NINDS NIH HHS [NS04270, P01 NS016033-20, R01 NS004270, P01 NS016033] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS004270, P01NS016033] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adlkofer K, 2000, GLIA, V29, P104, DOI 10.1002/(SICI)1098-1136(20000115)29:2<104::AID-GLIA2>3.0.CO;2-2; BAHR M, 1991, GLIA, V4, P529, DOI 10.1002/glia.440040512; BANSAL R, 1985, J NEUROSCI RES, V14, P21, DOI 10.1002/jnr.490140103; BARRES BA, 1994, NATURE, V367, P371, DOI 10.1038/367371a0; BARRES BA, 1993, DEVELOPMENT, V118, P283; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Berthold CH., 1993, PERIPHERAL NEUROPATH, P73; Blakemore WF, 2000, CELL TRANSPLANT, V9, P289, DOI 10.1177/096368970000900214; BLAKEMORE WF, 1977, NATURE, V266, P68, DOI 10.1038/266068a0; CAMPENOT RB, 1992, CELL CELL INTERACTIO, P275; Cellerino A, 1997, MOL CELL NEUROSCI, V9, P397, DOI 10.1006/mcne.1997.0641; Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398; Colello RJ, 1997, MOL NEUROBIOL, V15, P83, DOI 10.1007/BF02740617; Colognato H, 2002, NAT CELL BIOL, V4, P833, DOI 10.1038/ncb865; Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Duncan ID, 1997, J ANAT, V190, P35, DOI 10.1046/j.1469-7580.1997.19010035.x; Fraher J, 1998, J ANAT, V193, P195, DOI 10.1046/j.1469-7580.1998.19320195.x; Garcia ML, 2003, J CELL BIOL, V163, P1011, DOI 10.1083/jcb.200308159; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Hoke A, 2003, J NEUROSCI, V23, P561; Kleitman N, 1991, CULTURING NERVE CELL, P337; KORSCHING S, 1985, NEUROSCI LETT, V54, P201, DOI 10.1016/S0304-3940(85)80079-3; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LucidiPhillipi CA, 1996, NEURON, V16, P653, DOI 10.1016/S0896-6273(00)80084-7; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; MATSUOKA I, 1991, J NEUROSCI, V11, P3165; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; RANSCHT B, 1982, P NATL ACAD SCI-BIOL, V79, P2709, DOI 10.1073/pnas.79.8.2709; Raval-Fernandes S, 1998, MICROSC RES TECHNIQ, V41, P379, DOI 10.1002/(SICI)1097-0029(19980601)41:5<379::AID-JEMT5>3.0.CO;2-L; RETHELYI M, 1982, J COMP NEUROL, V207, P381; RUIT KG, 1992, NEURON, V8, P573, DOI 10.1016/0896-6273(92)90284-K; SCHWAB ME, 1989, J NEUROCYTOL, V18, P161, DOI 10.1007/BF01206659; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Stevens B, 2000, SCIENCE, V287, P2267, DOI 10.1126/science.287.5461.2267; Tong JX, 1996, EXP NEUROL, V138, P45, DOI 10.1006/exnr.1996.0045; VOYVODIC JT, 1989, NATURE, V342, P430, DOI 10.1038/342430a0; Wang SL, 2001, NEURON, V29, P603, DOI 10.1016/S0896-6273(01)00237-9; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; WEINBERG EL, 1979, BRAIN RES, V162, P273, DOI 10.1016/0006-8993(79)90289-0; WINDEBANK AJ, 1985, J NEUROSCI, V5, P1563; Yamauchi J, 2003, P NATL ACAD SCI USA, V100, P14421, DOI 10.1073/pnas.2336152100	44	244	258	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 22	2004	43	2					183	191		10.1016/j.neuron.2004.06.024	http://dx.doi.org/10.1016/j.neuron.2004.06.024			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841BX	15260955	Green Accepted, Bronze			2022-12-24	WOS:000222905400008
J	Bastian, J; Chacron, MJ; Maler, L				Bastian, J; Chacron, MJ; Maler, L			Plastic and nonplastic pyramidal cells perform unique roles in a network capable of adaptive redundancy reduction	NEURON			English	Article							WEAKLY ELECTRIC FISH; LATERAL-LINE LOBE; CENTRAL-NERVOUS-SYSTEM; ELECTROSENSORY SYSTEM; MESSENGER-RNA; NMDA RECEPTOR; NEURONS; MORPHOLOGY; LOCALIZATION; ORGANIZATION	Pyramidal cells show marked variation in their morphology, including dendritic structure, which is correlated with physiological diversity; however, it is not known how this variation is related to a cell's role within neural networks. In this report, we describe correlations among electrosensory lateral line lobe (ELL) pyramidal cells' highly variable dendritic morphology and their ability to adaptively cancel redundant inputs via an anti-Hebbian form of synaptic plasticity. A subset of cells, those with the largest apical dendrites, are plastic, but those with the smallest dendrites are not. A model of the network's connectivity predicts that efficient redundancy reduction requires that nonplastic cells provide feedback input to those that are plastic. Anatomical results confirm the model's prediction of optimal network architecture. These results provide a demonstration of different roles for morphological/physiological variants of a single cell type within a neural network performing a well-defined function.	Univ Oklahoma, Dept Zool, Norman, OK 73019 USA; Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada; Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1N 6N5, Canada	University of Oklahoma System; University of Oklahoma - Norman; University of Ottawa; University of Ottawa	Bastian, J (corresponding author), Univ Oklahoma, Dept Zool, Norman, OK 73019 USA.	jbastian@ou.edu		Chacron, Maurice/0000-0002-3032-452X				ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; BANNISTER NJ, 1995, J COMP NEUROL, V360, P161, DOI 10.1002/cne.903600112; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Barlow H. B., 1961, P331; BASTIAN J, 1993, J COMP PHYSIOL A, V172, P409, DOI 10.1007/BF00213523; Bastian J, 1999, J EXP BIOL, V202, P1327; BASTIAN J, 1986, J NEUROSCI, V6, P553; BASTIAN J, 1995, J COMP PHYSIOL A, V176, P63; Bastian J., 1986, P577; Bastian J, 2002, J NEUROSCI, V22, P4577, DOI 10.1523/JNEUROSCI.22-11-04577.2002; BASTIAN J, 1991, J COMP PHYSIOL A, V168, P393, DOI 10.1007/BF00199600; Bastian J, 2001, J NEUROPHYSIOL, V85, P10, DOI 10.1152/jn.2001.85.1.10; Bastian J, 1996, J NEUROPHYSIOL, V76, P2483, DOI 10.1152/jn.1996.76.4.2483; Bastian J, 1998, J NEUROPHYSIOL, V80, P3352, DOI 10.1152/jn.1998.80.6.3352; Bastian J, 1996, J NEUROPHYSIOL, V76, P2497, DOI 10.1152/jn.1996.76.4.2497; Batschelet E, 1981, CIRCULAR STAT BIOL; Bell C, 1997, BRAIN BEHAV EVOLUT, V50, P17, DOI 10.1159/000113352; Bell CC, 2001, CURR OPIN NEUROBIOL, V11, P481, DOI 10.1016/S0959-4388(00)00238-5; Berman N, 2001, J NEUROPHYSIOL, V86, P1612, DOI 10.1152/jn.2001.86.4.1612; BERMAN NJ, 1995, J COMP NEUROL, V361, P512, DOI 10.1002/cne.903610313; Bottai D, 1998, J NEUROSCI, V18, P5191, DOI 10.1523/JNEUROSCI.18-14-05191.1998; Bottai D, 1997, J COMP NEUROL, V389, P65, DOI 10.1002/(SICI)1096-9861(19971208)389:1<65::AID-CNE5>3.0.CO;2-C; Chacron MJ, 2003, NATURE, V423, P77, DOI 10.1038/nature01590; Dayan P., 2001, THEORETICAL NEUROSCI; Doiron B, 2003, NATURE, V421, P539, DOI 10.1038/nature01360; Doiron B, 2002, J COMPUT NEUROSCI, V12, P5, DOI 10.1023/A:1014921628797; Frank K, 1964, PHYS TECHNIQUES BIOL, P23, DOI DOI 10.1016/B978-0-12-514105-5.50009-5; HAGEDORN M, 1985, ANIM BEHAV, V33, P254, DOI 10.1016/S0003-3472(85)80139-1; Hardingham N, 2003, J NEUROSCI, V23, P4428; Harvey-Girard E, 2003, J NEUROPHYSIOL, V89, P822, DOI 10.1152/jn.00629.2002; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; HAUSSER M, 1999, CONCLUSION FUTURE DE, P365; Heiligenberg W., 1991, NEURAL NETS ELECT FI; JONES EG, 1994, J NEUROSCI, V14, P611; Koch C, 2000, NAT NEUROSCI, V3, P1171, DOI 10.1038/81444; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; LARKMAN A, 1990, J NEUROSCI, V10, P1407; Lemon N, 2000, J NEUROPHYSIOL, V84, P1519, DOI 10.1152/jn.2000.84.3.1519; LEWIS J, 2003, IN PRESS J NEUROPHYS; MALER L, 1981, J COMP NEUROL, V195, P87, DOI 10.1002/cne.901950107; MALER L, 1991, J CHEM NEUROANAT, V4, P1, DOI 10.1016/0891-0618(91)90030-G; MALER L, 1982, J COMP NEUROL, V211, P154, DOI 10.1002/cne.902110205; MALER L, 1979, J COMP NEUROL, V183, P323, DOI 10.1002/cne.901830208; NELSON ME, 1995, J COMP PHYSIOL A, V177, P723; Nelson ME, 1999, J EXP BIOL, V202, P1195; SAS E, 1987, ANAT EMBRYOL, V177, P55, DOI 10.1007/BF00325290; SAUNDERS J, 1984, J COMP PHYSIOL, V154, P199, DOI 10.1007/BF00604985; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; ZUPANC GKH, 1992, J COMP NEUROL, V325, P135, DOI 10.1002/cne.903250202	49	106	106	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 4	2004	41	5					767	779		10.1016/S0896-6273(04)00071-6	http://dx.doi.org/10.1016/S0896-6273(04)00071-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KD	15003176	Bronze, Green Published			2022-12-24	WOS:000221458200012
J	Koelsch, S; Kasper, E; Sammler, D; Schulze, K; Gunter, T; Friederici, AD				Koelsch, S; Kasper, E; Sammler, D; Schulze, K; Gunter, T; Friederici, AD			Music, language and meaning: brain signatures of semantic processing	NATURE NEUROSCIENCE			English	Article							SENTENCES; WORD; FMRI; COMPREHENSION; COMMUNICATION; PERFORMANCE; EMOTIONS; CONTEXT	Semantics is a key feature of language, but whether or not music can activate brain mechanisms related to the processing of semantic meaning is not known. We compared processing of semantic meaning in language and music, investigating the semantic priming effect as indexed by behavioral measures and by the N400 component of the event-related brain potential (ERP) measured by electroencephalography (EEG). Human subjects were presented visually with target words after hearing either a spoken sentence or a musical excerpt. Target words that were semantically unrelated to prime sentences elicited a larger N400 than did target words that were preceded by semantically related sentences. In addition, target words that were preceded by semantically unrelated musical primes showed a similar N400 effect, as compared to target words preceded by related musical primes. The N400 priming effect did not differ between language and music with respect to time course, strength or neural generators. Our results indicate that both music and language can prime the meaning of a word, and that music can, as language, determine physiological indices of semantic processing.	Max Planck Inst Human Cognit & Brain Sci, D-04103 Leipzig, Germany	Max Planck Society	Koelsch, S (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Stephanstr 1A, D-04103 Leipzig, Germany.	koelsch@cns.mpg.de	Koelsch, Stefan/AAV-1556-2020; Schulze, Katrin/A-7385-2010; Sammler, Daniela/V-9044-2019	Sammler, Daniela/0000-0001-7458-0229				Baumgaertner A, 2002, NEUROIMAGE, V16, P736, DOI 10.1006/nimg.2002.1134; Bernstein L, 1981, UNANSWERED QUESTION; Busnel RG, 1976, WHISTLED LANGUAGES; Cowan GM, 1948, LANGUAGE, V24, P280, DOI 10.2307/410362; Crystal D., 1995, CAMBRIDGE ENCY LANGU; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Friederici AD, 2000, CEREB CORTEX, V10, P698, DOI 10.1093/cercor/10.7.698; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; FRIEDERICI AD, 1998, LANGUAGE COMPREHENSI; Halgren E, 2002, NEUROIMAGE, V17, P1101, DOI 10.1006/nimg.2002.1268; Helenius P, 1998, BRAIN, V121, P1133, DOI 10.1093/brain/121.6.1133; Hevner K, 1937, AM J PSYCHOL, V49, P621, DOI 10.2307/1416385; JONES MR, 1992, COGNITIVE BASES MUSI; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Juslin PN, 2000, J EXP PSYCHOL HUMAN, V26, P1797, DOI 10.1037//0096-1523.26.6.1797; Kellenbach ML, 2000, COGNITIVE BRAIN RES, V10, P67, DOI 10.1016/S0926-6410(00)00023-9; Krumhansl CL, 1997, CAN J EXP PSYCHOL, V51, P336, DOI 10.1037/1196-1961.51.4.336; Krumhansl CL, 1996, MUSIC PERCEPT, V13, P401; Kuperberg GR, 2000, J COGNITIVE NEUROSCI, V12, P321, DOI 10.1162/089892900562138; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Meyer L., 1956, EMOTION MEANING MUSI; Ni W, 2000, J COGNITIVE NEUROSCI, V12, P120, DOI 10.1162/08989290051137648; OSTERHOUT L, 1995, ELECTROPHYSIOLOGY MI, P192; Peirce, 1994, COLLECTED PAPERS CS; PINKER S, 1997, HOW MIND WORKS; Price CJ, 1997, J COGNITIVE NEUROSCI, V9, P727, DOI 10.1162/jocn.1997.9.6.727; RAFFMANN D, 1993, LANGUAGE MUSIC MIND; Seboek T., 1976, SPEECH SURROGATES DR; Swain J., 1997, MUSICAL LANGUAGES; Talairach J., 1988, COPLANAR STEREOTAXIC; Zbikowski Lawrence M., 2002, CONCEPTUALIZING MUSI	32	309	323	5	135	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					302	307		10.1038/nn1197	http://dx.doi.org/10.1038/nn1197			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Neurosciences & Neurology	777UU	14983184				2022-12-24	WOS:000189197900021
J	Scannevin, RH; Wang, KW; Jow, F; Megules, J; Kopsco, DC; Edris, W; Carroll, KC; Lu, Q; Xu, WX; Xu, ZB; Katz, AH; Olland, S; Lin, L; Taylor, M; Stahl, M; Malakian, K; Somers, W; Mosyak, L; Bowlby, MR; Chanda, P; Rhodes, KJ				Scannevin, RH; Wang, KW; Jow, F; Megules, J; Kopsco, DC; Edris, W; Carroll, KC; Lu, Q; Xu, WX; Xu, ZB; Katz, AH; Olland, S; Lin, L; Taylor, M; Stahl, M; Malakian, K; Somers, W; Mosyak, L; Bowlby, MR; Chanda, P; Rhodes, KJ			Two N-terminal domains of Kv4 K+ channels regulate binding to and modulation by KChIP1	NEURON			English	Article							POTASSIUM CHANNELS; PYRAMIDAL NEURONS; CRYSTAL-STRUCTURE; T1 DOMAIN; PROTEIN; EXPRESSION; SUBUNIT; TETRAMERIZATION; INACTIVATION; CALSENILIN	The family of calcium binding proteins called KChlPs associates with Kv4 family K+ channels and modulates their biophysical properties. Here, using mutagenesis and X-ray crystallography, we explore the interaction between Kv4 subunits and KChlP1. Two regions in the Kv4.2 N terminus, residues 7-11 and 71-90, are necessary for KChlP1 modulation and interaction with Kv4.2. When inserted into the Kv1.2 N terminus, residues 71-90 of Kv4.2 are also sufficient to confer association with KChlP1. To provide a structural framework for these data, we solved the crystal structures of Kv4.3N and KChlP1 individually. Taken together with the mutagenesis data, the individual structures suggest that that the Kv4 N terminus is required for stable association with KChlP1, perhaps through a hydrophobic surface interaction, and that residues 71-90 in Kv4 subunits form a contact loop that mediates the specific association of KChlPs with Kv4 subunits.	Wyeth Ayerst Res, Neurosci Discovery Res, Princeton, NJ 08543 USA; Wyeth Ayerst Res, Struct Biol Chem & Screening Sci, Cambridge, MA 02140 USA	Pfizer; Pfizer	Wang, KW (corresponding author), Wyeth Ayerst Res, Neurosci Discovery Res, CN-8000, Princeton, NJ 08543 USA.	wangk@wyeth.com		Scannevin, Robert/0000-0002-5749-2785				An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Bahring R, 2001, J BIOL CHEM, V276, P23888, DOI 10.1074/jbc.M101320200; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; Bekkers JM, 2000, J PHYSIOL-LONDON, V525, P611, DOI 10.1111/j.1469-7793.2000.t01-2-00611.x; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; CHANDY KG, 1993, TRENDS PHARMACOL SCI, V14, P434, DOI 10.1016/0165-6147(93)90181-I; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Holmqvist MH, 2002, P NATL ACAD SCI USA, V99, P1035, DOI 10.1073/pnas.022509299; Holmqvist MH, 2001, J NEUROSCI, V21, P4154, DOI 10.1523/JNEUROSCI.21-12-04154.2001; Jahng AW, 2002, J BIOL CHEM, V277, P47885, DOI 10.1074/jbc.M208416200; Korngreen A, 2000, J PHYSIOL-LONDON, V525, P621, DOI 10.1111/j.1469-7793.2000.00621.x; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; McPherson A Jr, 1976, Methods Biochem Anal, V23, P249, DOI 10.1002/9780470110430.ch4; Nakamura TY, 1997, AM J PHYSIOL-HEART C, V273, pH1775, DOI 10.1152/ajpheart.1997.273.4.H1775; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Osawa M, 2001, J BIOL CHEM, V276, P41005, DOI 10.1074/jbc.M105842200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rosati B, 2003, J PHYSIOL-LONDON, V548, P815, DOI 10.1113/jphysiol.2002.033704; Serodio P, 1996, J NEUROPHYSIOL, V75, P2174, DOI 10.1152/jn.1996.75.5.2174; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Strang C, 2001, J BIOL CHEM, V276, P28493, DOI 10.1074/jbc.M010540200; Tsaur ML, 1997, FEBS LETT, V400, P215, DOI 10.1016/S0014-5793(96)01388-9; Vijay-Kumar S, 1999, NAT STRUCT BIOL, V6, P80; WU RL, 1992, J NEUROSCI, V12, P2235; Zaidi NF, 2002, NEUROSCIENCE, V114, P247, DOI 10.1016/S0306-4522(02)00251-8	34	94	102	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 19	2004	41	4					587	598		10.1016/S0896-6273(04)00049-2	http://dx.doi.org/10.1016/S0896-6273(04)00049-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980207	Bronze			2022-12-24	WOS:000221458100011
J	Bozon, B; Davis, S; Laroche, S				Bozon, B; Davis, S; Laroche, S			A requirement for the immediate early gene zif268 in reconsolidation of recognition memory after retrieval	NEURON			English	Article							LONG-TERM POTENTIATION; CUED FEAR MEMORY; RETROGRADE-AMNESIA; TRANSCRIPTION FACTORS; REACTIVATED MEMORY; PROTEIN-SYNTHESIS; HIPPOCAMPUS; EXPRESSION; INHIBITION; ACTIVATION	Recent research has revived interest in the possibility that previously consolidated memories need to reconsolidate when recalled to return to accessible long-term memory. Evidence suggests that both consolidation and reconsolidation of certain types of memory require protein synthesis, but whether similar molecular mechanisms are involved remains unclear. Here, we explore whether zif268, an activity-dependent inducible immediate early gene (IEG) required for consolidation of new memories, is also recruited for reconsolidation of recognition memory following reactivation. We show that when a consolidated memory for objects is recalled, zif268 mutant mice are impaired in further long-term but not short-term recognition memory. The impairment is specific to reactivation with the previously memorized objects in the relevant context, occurs in delayed recall, and does not recover over several days. These findings indicate that IEG-mediated transcriptional regulation in neurons is one common molecular mechanism for the storage of newly formed and reactivated recognition memories.	Univ Paris 11, CNRS, UMR 8620, Lab Neurobiol Apprentissage Memoire & Commun, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Laroche, S (corresponding author), Univ Paris 11, CNRS, UMR 8620, Lab Neurobiol Apprentissage Memoire & Commun, F-91405 Orsay, France.	serge.laroche@ibaic.u-psud.fr						Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Clark RE, 2000, J NEUROSCI, V20, P8853; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; DEVIETTI TL, 1972, PSYCHON SCI, V29, P137; DEWEER B, 1980, ANIM LEARN BEHAV, V8, P265, DOI 10.3758/BF03199605; Ennaceur A., 1988, BEHAV BRAIN RES, V100, P85; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; GISQUETVERRIER P, 1989, ANIM LEARN BEHAV, V17, P394, DOI 10.3758/BF03205220; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; JUDGE ME, 1982, PHYSIOL BEHAV, V28, P585, DOI 10.1016/0031-9384(82)90034-8; Kelly A, 2003, J NEUROSCI, V23, P5354; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; LEWIS DJ, 1979, PSYCHOL BULL, V86, P1054, DOI 10.1037/0033-2909.86.5.1054; MACTUTUS CF, 1979, SCIENCE, V204, P1319, DOI 10.1126/science.572083; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Manns JR, 2003, NEURON, V37, P171, DOI 10.1016/S0896-6273(02)01147-9; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Myers KM, 2002, NEURON, V36, P340, DOI 10.1016/S0896-6273(02)01017-6; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Przybyslawski J, 1997, BEHAV BRAIN RES, V84, P241, DOI 10.1016/S0166-4328(96)00153-2; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; SPEAR NE, 1973, PSYCHOL REV, V80, P163, DOI 10.1037/h0034326; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Thomas KL, 2002, EUR J NEUROSCI, V16, P1789, DOI 10.1046/j.1460-9568.2002.02247.x; Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049; Wan HM, 1999, J NEUROSCI, V19, P1142; WILLIAMS J, 1995, MOL BRAIN RES, V28, P87, DOI 10.1016/0169-328X(94)00187-J; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y	36	255	265	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 13	2003	40	4					695	701		10.1016/S0896-6273(03)00674-3	http://dx.doi.org/10.1016/S0896-6273(03)00674-3			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	744UL	14622575	Bronze			2022-12-24	WOS:000186651200006
J	Goldberg, JH; Tamas, G; Aronov, D; Yuste, R				Goldberg, JH; Tamas, G; Aronov, D; Yuste, R			Calcium microdomains in aspiny dendrites	NEURON			English	Article							NEOCORTICAL INTERNEURON DENDRITES; ANTEROVENTRAL COCHLEAR NUCLEUS; GLUTAMATE-RECEPTOR ACTIVATION; AII AMACRINE CELLS; CAT VISUAL-CORTEX; AMPA RECEPTORS; NMDA RECEPTORS; CA2+-PERMEABLE AMPA; PYRAMIDAL NEURONS; HIPPOCAMPAL INTERNEURONS	Dendritic spines receive excitatory synapses and serve as calcium compartments, which appear to be necessary for input-specific synaptic plasticity. Dendrites of GABAergic interneurons have few or no spines and thus do not possess a clear morphological basis for synapse-specific compartmentalization. We demonstrate using two-photon calcium imaging that activation of single synapses on aspiny dendrites of neocortical fast spiking (FS) interneurons creates highly localized calcium microdomains, often restricted to less than 1 mum of dendritic space. We confirm using ultrastructural reconstruction of imaged dendrites the absence of any morphological basis for this compartmentalization and show that it is dependent on the fast kinetics of calcium-permeable (CP) AMPA receptors and fast local extrusion via. the Na+/Ca2+ exchanger. Because aspiny dendrites throughout the CNS express CP-AMPA receptors, we propose that CP-AMPA receptors mediate a spine-free mechanism of input-specific calcium compartmentalization.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Univ Szeged, Dept Comparat Physiol, H-6726 Szeged, Hungary	Columbia University; Szeged University	Goldberg, JH (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.		Tamas, Gabor/AAG-9305-2020	Tamas, Gabor/0000-0002-7905-6001; Goldberg, Jesse/0000-0003-0422-8902	NEI NIH HHS [EY11787] Funding Source: Medline; NINDS NIH HHS [NS40726] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040726] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albuquerque C, 1999, EUR J NEUROSCI, V11, P2758, DOI 10.1046/j.1460-9568.1999.00691.x; ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Alle H, 2001, P NATL ACAD SCI USA, V98, P14708, DOI 10.1073/pnas.251610898; Angulo MC, 1999, J NEUROPHYSIOL, V82, P1295, DOI 10.1152/jn.1999.82.3.1295; Arai AC, 2002, J PHARMACOL EXP THER, V303, P1075, DOI 10.1124/jpet.102.040360; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Blaustein MP, 2002, ANN NY ACAD SCI, V976, P356; Buhl EH, 1997, J PHYSIOL-LONDON, V500, P689, DOI 10.1113/jphysiol.1997.sp022053; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; CATAL SRY, 1999, TEXTURA SISERNA NERI; Cheunsuang O, 2000, NEUROSCIENCE, V97, P335, DOI 10.1016/S0306-4522(00)00035-X; Cowan AI, 1998, J NEUROPHYSIOL, V79, P13, DOI 10.1152/jn.1998.79.1.13; DELANEY KR, 1989, J NEUROSCI, V9, P3558; FAIREN A, 1984, NONPYRAMIDICAL NEURO, P201; GABRIEL R, 1992, BRAIN RES, V595, P133, DOI 10.1016/0006-8993(92)91462-N; Gabso M, 1997, NEURON, V18, P473, DOI 10.1016/S0896-6273(00)81247-7; Gardner SM, 2001, J NEUROSCI, V21, P7428, DOI 10.1523/JNEUROSCI.21-18-07428.2001; Gardner SM, 1999, J NEUROSCI, V19, P8721, DOI 10.1523/JNEUROSCI.19-20-08721.1999; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Goldberg J, 2002, TRENDS NEUROSCI, V25, P433, DOI 10.1016/S0166-2236(02)02200-2; Goldberg JH, 2003, J PHYSIOL-LONDON, V551, P67, DOI 10.1113/jphysiol.2003.042598; Goldberg JH, 2003, J PHYSIOL-LONDON, V551, P49, DOI 10.1113/jphysiol.2003.042580; Gotz T, 1997, J NEUROSCI, V17, P204; Gulyas AI, 1999, J NEUROSCI, V19, P10082; HAMANO K, 1990, J COMP NEUROL, V302, P417, DOI 10.1002/cne.903020217; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; HELMCHEN F, 1999, DENDRITES, P161; Jeon D, 2003, NEURON, V38, P965, DOI 10.1016/S0896-6273(03)00334-9; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kaiser KMM, 2001, J PHYSIOL-LONDON, V535, P17, DOI 10.1111/j.1469-7793.2001.t01-1-00017.x; KATSUMARU H, 1988, EXP BRAIN RES, V72, P347; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V70, P387, DOI 10.1152/jn.1993.70.1.387; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; KOCH C, 1993, J NEUROSCI, V13, P413; Koch C., 1998, BIOPHYSICS COMPUTATI; KOH DS, 1995, J PHYSIOL-LONDON, V485, P383, DOI 10.1113/jphysiol.1995.sp020737; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Kumar SS, 2002, J NEUROSCI, V22, P3005, DOI 10.1523/JNEUROSCI.22-08-03005.2002; LATTANZIO FA, 1991, BIOCHEM BIOPH RES CO, V177, P184, DOI 10.1016/0006-291X(91)91966-G; Lee SH, 2000, J PHYSIOL-LONDON, V525, P419, DOI 10.1111/j.1469-7793.2000.t01-2-00419.x; Lee SH, 2000, J PHYSIOL-LONDON, V525, P405, DOI 10.1111/j.1469-7793.2000.t01-3-00405.x; Lei SB, 2002, NEURON, V33, P921, DOI 10.1016/S0896-6273(02)00608-6; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Lohmann C, 1996, J COMP NEUROL, V367, P90, DOI 10.1002/(SICI)1096-9861(19960325)367:1<90::AID-CNE7>3.0.CO;2-E; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Majewska A, 2000, PFLUG ARCH EUR J PHY, V441, P398, DOI 10.1007/s004240000435; Majewska A, 2000, J NEUROSCI, V20, P1722; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; Markram H, 1998, J COMPUT NEUROSCI, V5, P331, DOI 10.1023/A:1008891229546; McBain CJ, 1999, TRENDS NEUROSCI, V22, P228, DOI 10.1016/S0166-2236(98)01347-2; Michailova A, 2002, BIOPHYS J, V83, P3134, DOI 10.1016/S0006-3495(02)75317-4; Morkve SH, 2002, J PHYSIOL-LONDON, V542, P147, DOI 10.1113/jphysiol.2002.020305; MUGNAINI E, 1985, J COMP NEUROL, V235, P61, DOI 10.1002/cne.902350106; MULTANI P, 1994, EPILEPSIA, V35, P728, DOI 10.1111/j.1528-1157.1994.tb02503.x; Murthy VN, 2000, P NATL ACAD SCI USA, V97, P901, DOI 10.1073/pnas.97.2.901; Nikolenko V, 2003, METHODS, V30, P3, DOI 10.1016/S1046-2023(03)00003-3; OHSHIMA T, 1991, J NEUROL, V238, P320, DOI 10.1007/BF00315329; Otis T. S., 1995, Biophysical Journal, V68, pA397; OTIS TS, 1995, J PHYSIOL-LONDON, V482, P309, DOI 10.1113/jphysiol.1995.sp020519; Park JS, 1996, NEUROBIOL DIS, V3, P215, DOI 10.1006/nbdi.1996.0022; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; PELLEGRINIGIAMPIETRO DE, 1992, P NATL ACAD SCI USA, V89, P10499, DOI 10.1073/pnas.89.21.10499; Prince HC, 2000, SYNAPSE, V38, P489, DOI 10.1002/1098-2396(20001215)38:4<489::AID-SYN15>3.0.CO;2-N; Ranciat-McComb NS, 2000, NEUROSCI LETT, V294, P13, DOI 10.1016/S0304-3940(00)01524-X; ROBERTSON SP, 1981, BIOPHYS J, V34, P559, DOI 10.1016/S0006-3495(81)84868-0; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schmidt H, 2003, J PHYSIOL-LONDON, V551, P13, DOI 10.1113/jphysiol.2002.035824; Schmidt H, 2003, BIOPHYS J, V84, P2599, DOI 10.1016/S0006-3495(03)75065-6; SIK A, 1995, J NEUROSCI, V15, P6651; Smith Y, 1998, J COMP NEUROL, V391, P164, DOI 10.1002/(SICI)1096-9861(19980209)391:2<164::AID-CNE2>3.0.CO;2-0; SOMOGYI P, 1983, NEUROSCIENCE, V10, P261, DOI 10.1016/0306-4522(83)90133-1; SOMOGYI P, 1983, NEUROSCIENCE, V9, P475, DOI 10.1016/0306-4522(83)90167-7; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Tamas G, 1997, J NEUROSCI, V17, P6352; Teskey GC, 1999, CEREB CORTEX, V9, P675, DOI 10.1093/cercor/9.7.675; TOLBERT LP, 1982, NEUROSCIENCE, V7, P3031, DOI 10.1016/0306-4522(82)90228-7; TOLBERT LP, 1982, NEUROSCIENCE, V7, P3053, DOI 10.1016/0306-4522(82)90229-9; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; WASHBURN MS, 1992, J NEUROSCI, V12, P4066; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; WICKENS J, 1988, PROG NEUROBIOL, V31, P507, DOI 10.1016/0301-0082(88)90013-5; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 1999, J NEUROSCI, V19, P1976; Yuste R, 2001, NEUROSCIENTIST, V7, P387, DOI 10.1177/107385840100700508; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4	91	161	164	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 13	2003	40	4					807	821		10.1016/S0896-6273(03)00714-1	http://dx.doi.org/10.1016/S0896-6273(03)00714-1			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	744UL	14622584	Bronze			2022-12-24	WOS:000186651200015
J	Kim, JH; Udo, H; Li, HL; Youn, TY; Chen, M; Kandel, ER; Bailey, CH				Kim, JH; Udo, H; Li, HL; Youn, TY; Chen, M; Kandel, ER; Bailey, CH			Presynaptic activation of silent synapses and growth of new synapses contribute to intermediate and long-term facilitation in Aplysia	NEURON			English	Article							LOCAL PROTEIN-SYNTHESIS; SYNAPTIC PLASTICITY; STRUCTURAL-CHANGES; SENSORY NEURONS; MEMORY STORAGE; HETEROSYNAPTIC FACILITATION; MORPHOLOGICAL-CHANGES; MOTOR SYNAPSES; CELL-CULTURE; TIME-COURSE	The time course and functional significance of the structural changes associated with long-term facilitation of Aplysia sensory to motor neuron synaptic connections in culture were examined by time-lapse confocal imaging of individual sensory neuron varicosities labeled with three different fluorescent markers: the whole-cell marker Alexa-594 and two presynaptic marker proteins-synaptophysin-eGFP to monitor changes in synaptic vesicle distribution and synapto-PHluorin to monitor active transmitter release sites. Repeated pulses of serotonin induce two temporally, morphologically, and molecularly distinct presynaptic changes: (1) a rapid activation of silent presynaptic terminals by filling of preexisting empty varicosities with synaptic vesicles, which parallels intermediate-term facilitation, is completed within 3-6 hr and requires translation but not transcription and (2) a slower generation of new functional varicosities which occurs between 12-18 hr and requires transcription and translation. Enrichment of empty varicosities with synaptophysin accounts for 32% of the newly activated synapses at 24 hr, whereas newly formed varicosities account for 68%.	Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; New York State Psychiatry Institute	Kandel, ER (corresponding author), Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA.		Li, Hsiu-Ling/C-3567-2011		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH037134] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 37134] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P9356, DOI 10.1073/pnas.85.23.9356; BAILEY CH, 1992, NEURON, V9, P749, DOI 10.1016/0896-6273(92)90037-E; BAILEY CH, 1983, SCIENCE, V220, P91, DOI 10.1126/science.6828885; BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; BAILEY CH, 1989, J NEUROSCI, V9, P1774; Bailey CH, 2000, P NATL ACAD SCI USA, V97, P11581, DOI 10.1073/pnas.97.21.11581; BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P2373, DOI 10.1073/pnas.85.7.2373; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Bao JX, 1998, J NEUROSCI, V18, P458; Becher A, 1999, J NEUROSCI, V19, P1922; Benfenati F, 1999, PHILOS T R SOC B, V354, P243, DOI 10.1098/rstb.1999.0376; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; FROST WN, 1985, P NATL ACAD SCI USA, V82, P8266, DOI 10.1073/pnas.82.23.8266; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; GLANZMAN DL, 1989, NEURON, V3, P441, DOI 10.1016/0896-6273(89)90203-1; GLANZMAN DL, 1990, SCIENCE, V249, P799, DOI 10.1126/science.2389145; GREENOUGH WT, 1988, TRENDS NEUROSCI, V11, P142, DOI 10.1016/0166-2236(88)90139-7; Hatada Y, 2000, J NEUROSCI, V20, part. no.; Humeau Y, 2001, J NEUROSCI, V21, P4195, DOI 10.1523/JNEUROSCI.21-12-04195.2001; Huntley GW, 2002, CELL, V108, P1, DOI 10.1016/S0092-8674(01)00631-6; Kaang BK, 1996, NEUROSCI LETT, V221, P29, DOI 10.1016/S0304-3940(96)13279-1; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Mauelshagen J, 1996, J NEUROSCI, V16, P7099; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; RAYPORT SG, 1986, J NEUROSCI, V6, P759; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Schacher S, 1999, J NEUROSCI, V19, P6338; Schacher S, 1997, J NEUROSCI, V17, P597; SCHOLZ KP, 1987, SCIENCE, V235, P685, DOI 10.1126/science.2433766; Sutton MA, 2000, NEURON, V26, P219, DOI 10.1016/S0896-6273(00)81152-6; Sutton MA, 2001, NEURON, V31, P143, DOI 10.1016/S0896-6273(01)00342-7; Tao HZW, 2001, P NATL ACAD SCI USA, V98, P11009, DOI 10.1073/pnas.191351698; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; TRUDEAU LE, 1995, J NEUROSCI, V15, P1275; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001	50	98	100	1	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 25	2003	40	1					151	165		10.1016/S0896-6273(03)00595-6	http://dx.doi.org/10.1016/S0896-6273(03)00595-6			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	726TA	14527440	Bronze			2022-12-24	WOS:000185614700016
J	Alessandri-Haber, N; Yeh, JJ; Boyd, AE; Parada, CA; Chen, XJ; Reichling, DB; Levine, JD				Alessandri-Haber, N; Yeh, JJ; Boyd, AE; Parada, CA; Chen, XJ; Reichling, DB; Levine, JD			Hypotonicity induces TRPV4-mediated nociception in rat	NEURON			English	Article							NONSELECTIVE CATION CHANNEL; HEAT-EVOKED ACTIVATION; ROOT GANGLION-CELLS; TRP CHANNEL; MOLECULAR DETERMINANTS; CAPSAICIN-RECEPTOR; ION-CHANNEL; PROTEIN; WATER; SENSITIZATION	We hypothesized that TRPV4, a member of the transient receptor family of ion channels, functions as a sensory transducer for osmotic stimulus-induced nociception. We found that, as expected for a transducer molecule, TRPV4 protein is transported in sensory nerve distally toward the peripheral nerve endings. In vivo single-fiber recordings in rat showed that hypotonic solution activated 54% of C-fibers, an effect enhanced by the hyperalgesic inflammatory mediator prostaglandin E-2. This osmotransduction causes nociception, since administration of a small osmotic stimulus into skin sensitized by PGE2 produced pain-related behavior. Antisense-induced decrease in expression of TRPV4 confirmed that the channel is required for hypotonic stimulus-induced nociception. Thus, we conclude that TRPV4 can function as an osmo-transducer in primary afferent nociceptive nerve fibers. Because this action is enhanced by an inflammatory mediator, TRPV4 may be important in pathological states and may be an attractive pharmacological target for the development of novel analgesics.	Univ Calif San Francisco, Div Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Levine, JD (corresponding author), Univ Calif San Francisco, Div Neurosci, San Francisco, CA 94143 USA.	levine@itsa.ucsf.edu	Alessandri-Haber, Nicole/A-5572-2009; Parada, Carlos Amilcar/C-3974-2012	Amilcar Parada, Carlos/0000-0001-5209-8853	NIDCR NIH HHS [DE08973] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE008973, P50DE008973] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Agam K, 2000, J NEUROSCI, V20, P5748, DOI 10.1523/JNEUROSCI.20-15-05748.2000; Alessandri-Haber N, 2002, J PHYSIOL-LONDON, V541, P25, DOI 10.1113/jphysiol.2001.013371; Aley KO, 2001, J NEUROSCI, V21, P6933, DOI 10.1523/JNEUROSCI.21-17-06933.2001; Canuso CM, 1999, J NEUROPSYCH CLIN N, V11, P86, DOI 10.1176/jnp.11.1.86; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chen XJ, 1999, J NEUROPHYSIOL, V81, P963, DOI 10.1152/jn.1999.81.3.963; Delany NS, 2001, PHYSIOL GENOMICS, V4, P165, DOI 10.1152/physiolgenomics.2001.4.3.165; Eun SY, 2001, BIOCHEM BIOPH RES CO, V285, P1114, DOI 10.1006/bbrc.2001.5272; Fujimura M, 1998, BRIT J PHARMACOL, V125, P902, DOI 10.1038/sj.bjp.0702135; GARLAND A, 1995, J CLIN INVEST, V95, P2359, DOI 10.1172/JCI117928; GORKE K, 1980, PFLUG ARCH EUR J PHY, V386, P21, DOI 10.1007/BF00584182; Guler AD, 2002, J NEUROSCI, V22, P6408; HANDWERKER HO, 1991, J PHYSIOL-LONDON, V435, P229, DOI 10.1113/jphysiol.1991.sp018507; HARADA N, 1994, ACTA OTO-LARYNGOL, V114, P510, DOI 10.3109/00016489409126095; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P47, DOI 10.1113/jphysiol.1985.sp015574; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Kobashi M, 1996, BRAIN RES, V706, P21, DOI 10.1016/0006-8993(95)01174-9; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; LOTTI T, 1994, J AM ACAD DERMATOL, V30, P232, DOI 10.1016/S0190-9622(94)70022-2; MEI N, 1986, J AUTONOM NERV SYST, V16, P159, DOI 10.1016/0165-1838(86)90022-6; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Misery L, 2003, ANN DERMATOL VENER, V130, P195; Mohseni S, 2001, ACTA NEUROPATHOL, V102, P413; Nilius B, 2003, PFLUG ARCH EUR J PHY, V446, P298, DOI 10.1007/s00424-003-1028-9; Nilius B, 2001, PFLUG ARCH EUR J PHY, V443, P227, DOI 10.1007/s004240100676; Okada T, 1998, J BIOL CHEM, V273, P10279, DOI 10.1074/jbc.273.17.10279; PAPIRKRICHELI D, 1987, PAIN, V31, P263, DOI 10.1016/0304-3959(87)90041-8; Parada CA, 2003, EUR J NEUROSCI, V17, P1847, DOI 10.1046/j.1460-9568.2003.02626.x; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Puliyel JM, 2003, ARCH DIS CHILD, V88, P366, DOI 10.1136/adc.88.4.366-a; Reichling DB, 1997, P NATL ACAD SCI USA, V94, P7006, DOI 10.1073/pnas.94.13.7006; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Srinivasan S, 2000, DIABETES, V49, P1932, DOI 10.2337/diabetes.49.11.1932; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; TAYLOR BK, 1995, J NEUROSCI, V15, P7575; Tsai TF, 1999, CONTACT DERMATITIS, V41, P311, DOI 10.1111/j.1600-0536.1999.tb06990.x; Vamvakas S, 1998, CLIN NEPHROL, V49, P205; Viana F, 2001, EUR J NEUROSCI, V13, P722, DOI 10.1046/j.0953-816x.2000.01441.x; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; Watanabe H, 2003, CELL CALCIUM, V33, P489, DOI 10.1016/S0143-4160(03)00064-2; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Williams D.M., 1985, BIBL DIATOMOL, V8, P1; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; Xu HS, 2003, J BIOL CHEM, V278, P11520, DOI 10.1074/jbc.M211061200; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133	51	337	355	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 31	2003	39	3					497	511		10.1016/S0896-6273(03)00462-8	http://dx.doi.org/10.1016/S0896-6273(03)00462-8			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	709LC	12895423	Bronze			2022-12-24	WOS:000184625800012
J	Watts, RJ; Hoopfer, ED; Luo, LQ				Watts, RJ; Hoopfer, ED; Luo, LQ			Axon pruning during Drosphila metamorphosis: Evidence for local degeneration and requirement of the ubiquitin-proteasome system	NEURON			English	Article							PROGRAMMED CELL-DEATH; WALLERIAN DEGENERATION; NEUROBLAST PROLIFERATION; NEUROLOGICAL DISEASE; ECDYSONE RECEPTOR; SYNAPTIC GROWTH; DROSOPHILA; GENE; EXPRESSION; NEURONS	Axon pruning is widely used for the refinement of neural circuits in both vertebrates and invertebrates, and may also contribute to the pathogenesis of neurodegenerative diseases. However, little is known about the cellular and molecular mechanisms of axon pruning. We use the stereotyped pruning of gamma neurons of the Drosophila mushroom bodies (MB) during metamorphosis to investigate these mechanisms. Detailed time course analyses indicate that MB axon pruning is mediated by local degeneration rather than retraction and that the disruption of the microtubule cytoskeleton precedes axon pruning. In addition, multiple lines of genetic evidence demonstrate an intrinsic role of the ubiquitin-proteasome system in axon pruning; for example, loss-of-function mutations of the ubiquitin activating enzyme (E1) or proteasome subunits in MB neurons block axon pruning. Our findings suggest that some forms of axon pruning during development may share similarities with degeneration of axons in response to injury.	Stanford Univ, Dept Sci Biol, Stanford, CA 94305 USA; Stanford Univ, Program Neurosci, Stanford, CA 94305 USA	Stanford University; Stanford University	Luo, LQ (corresponding author), Stanford Univ, Dept Sci Biol, Stanford, CA 94305 USA.			Luo, Liqun/0000-0001-5467-9264	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041044] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS41044] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aguilera M, 2000, GENETICS, V155, P1231; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; BAZINET C, 1993, GENETICS, V134, P1119; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bernstein M, 1999, CURR OPIN NEUROBIOL, V9, P364, DOI 10.1016/S0959-4388(99)80053-1; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; Coleman MP, 2002, TRENDS NEUROSCI, V25, P532, DOI 10.1016/S0166-2236(02)02255-5; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Crittenden JR, 1998, LEARN MEMORY, V5, P38; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Donaghue C, 2001, BBA-GENE STRUCT EXPR, V1518, P210, DOI 10.1016/S0167-4781(01)00185-3; Finn JT, 2000, J NEUROSCI, V20, P1333; GLASS JD, 1993, J NEUROCYTOL, V22, P311, DOI 10.1007/BF01195555; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hegde AN, 2002, NAT REV NEUROSCI, V3, P854, DOI 10.1038/nrn961; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Miller RJ, 2003, TRENDS PHARMACOL SCI, V24, P18, DOI 10.1016/S0165-6147(02)00011-1; Moline MM, 1999, DEVELOPMENT, V126, P4375; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; PERRY VH, 1990, EUR J NEUROSCI, V2, P408, DOI 10.1111/j.1460-9568.1990.tb00433.x; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; TALBOT WS, 1993, CELL, V73, P1323, DOI 10.1016/0092-8674(93)90359-X; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; Waller A, 1850, PHIL T R SOC, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	47	295	303	3	24	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 19	2003	38	6					871	885		10.1016/S0896-6273(03)00295-2	http://dx.doi.org/10.1016/S0896-6273(03)00295-2			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	693AA	12818174	Bronze			2022-12-24	WOS:000183691400008
J	Man, HY; Wang, QH; Lu, WY; Ju, W; Ahmadian, G; Liu, LD; D'Souza, S; Wong, TP; Taghibiglou, C; Lu, J; Becker, LE; Pei, L; Liu, F; Wymann, MP; MacDonald, JF; Wang, YT				Man, HY; Wang, QH; Lu, WY; Ju, W; Ahmadian, G; Liu, LD; D'Souza, S; Wong, TP; Taghibiglou, C; Lu, J; Becker, LE; Pei, L; Liu, F; Wymann, MP; MacDonald, JF; Wang, YT			Activation of P13-kinase is required for AMPA receptor insertion during LTP of mEPSCs in cultured hippocampal neurons	NEURON			English	Article							LONG-TERM POTENTIATION; PHOSPHATIDYLINOSITOL 3-KINASE; SYNAPTIC PLASTICITY; PHOSPHOINOSITIDE 3-KINASE; GLUTAMATE RECEPTORS; MOLECULAR-BASIS; PDZ DOMAINS; TRAFFICKING; DEPRESSION; INTERNALIZATION	Hippocampal CA1 homosynaptic long-term potentiation (LTP) is expressed specifically at activated synapses. Increased insertion of postsynaptic alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid receptors (AMPARs) appears to be crucial for CA1 LTP. However, the mechanism underlying AMPAR insertion during LTP remains largely unknown. We now report that phosphatidylinositol 3-kinase (PI3K) is complexed with AMPARs at synapses and activated by selective stimulation of synaptic N-methyl-D-aspartate (NMDA) receptors. Activation of the AMPAR-associated PI3K is required for the increased cell surface expression of AMPARs and LTP. Thus, our results strongly suggest that the AMPAR-PI3K complex may constitute a critical molecular signal responsible for AMPAR insertion at activated CA1 synapses during LTP, and consequently, this lipid kinase may serve to determine the polarity of NMDA receptor-dependent synaptic plasticity.	Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; Univ British Columbia, Vancouver Hosp & Hlth Sci Ctr, Dept Med, Vancouver, BC V6T 2B5, Canada; Univ Toronto, Brain & Behav Program, Toronto, ON M5S 1A8, Canada; Univ Toronto, Hosp Sick Children, Res Inst, Dept Pathol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Lab Med, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Pathobiol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Anesthesia, Toronto, ON M5S 1A8, Canada; Sunnybrook & Womens Coll Hlth sci Ctr, Trauma Res Program, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Neurosci, Ctr Addict, Toronto, ON M5S 1A8, Canada; Univ Toronto, Mental Hlth Clarke Div, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Fribourg, Inst Biochem, CH-1700 Fribourg, Switzerland	University of British Columbia; University of British Columbia; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Fribourg	Wang, YT (corresponding author), Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada.		Taghibiglou, Changiz/H-4590-2019; Wang, Yu Tian/A-4729-2008; Wymann, Matthias P/C-3227-2008; Lu, Wei-Yang/K-4404-2013; Wang, Yu Tian/J-8255-2015	Wymann, Matthias P/0000-0003-3349-4281; Wong, Tak Pan/0000-0001-8611-4911; Liu, Lidong/0000-0002-7026-690X				Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; DAW MI, 1996, NAT NEUROSCI, V5, P835; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; DOWNWARD J, 2000, SCIENCE, V287, P2262; HellerHarrison RA, 1996, J BIOL CHEM, V271, P10200, DOI 10.1074/jbc.271.17.10200; Hisatsune C, 1999, GENES CELLS, V4, P657, DOI 10.1046/j.1365-2443.1999.00287.x; JAMES DE, 1994, J CELL BIOL, V126, P1123, DOI 10.1083/jcb.126.5.1123; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; Kelly A, 2000, NEUROPHARMACOLOGY, V39, P643, DOI 10.1016/S0028-3908(99)00169-0; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Kim JH, 1999, CURR OPIN CELL BIOL, V11, P248, DOI 10.1016/S0955-0674(99)80033-7; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; Liang F, 2001, J NEUROCHEM, V77, P1626, DOI 10.1046/j.1471-4159.2001.00377.x; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Man HY, 2000, CELL MOL LIFE SCI, V57, P1526, DOI 10.1007/PL00000637; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Pessin JE, 1999, J BIOL CHEM, V274, P2593, DOI 10.1074/jbc.274.5.2593; Rapoport I, 1997, EMBO J, V16, P2240, DOI 10.1093/emboj/16.9.2240; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; Sanna PP, 2002, J NEUROSCI, V22, P3359; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Shpetner H, 1996, J CELL BIOL, V132, P595, DOI 10.1083/jcb.132.4.595; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Stenmark H, 1999, J CELL SCI, V112, P4175; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Wang QH, 1998, BIOCHEM J, V331, P917, DOI 10.1042/bj3310917; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wymann MP, 1998, BBA-MOL CELL BIOL L, V1436, P127, DOI 10.1016/S0005-2760(98)00139-8; Wymann MP, 1996, MOL CELL BIOL, V16, P1722; Yang J, 1996, BIOCHEM J, V313, P125, DOI 10.1042/bj3130125; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; ZHUO M, 1995, REV NEUROSCIENCE, V6, P259; ZORUMSKI CF, 1992, PROG NEUROBIOL, V39, P295, DOI 10.1016/0301-0082(92)90020-F	53	262	273	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 22	2003	38	4					611	624		10.1016/S0896-6273(03)00228-9	http://dx.doi.org/10.1016/S0896-6273(03)00228-9			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	682QV	12765612	Bronze			2022-12-24	WOS:000183104000011
J	De Paola, V; Arber, S; Caroni, P				De Paola, V; Arber, S; Caroni, P			AMPA receptors regulate dynamic equilibrium of presynaptic terminals in mature hippocampal networks	NATURE NEUROSCIENCE			English	Article							LONG-LASTING POTENTIATION; TERM SYNAPTIC PLASTICITY; DENDRITIC SPINES; MOSSY FIBERS; TRANSGENIC MICE; LATE-PHASE; SYNAPSES; SYNAPTOGENESIS; PROTEINS; CULTURES	The formation and disassembly of synapses in mature neuropil could provide a substrate to encode experience in the brain. Although there is evidence for postsynaptic spine dynamics in mature systems, contributions to circuit rearrangements by presynaptic terminals have remained unclear. We used hippocampal slice cultures from mice expressing spectral variants of green fluorescent protein (GFP) that are targeted to the membrane and/or synaptic vesicles in neuronal subsets to image identified presynaptic terminals. In mature tissues with no net change in synapse numbers, subpopulations of presynaptic terminals appeared and disappeared within 1-3 days. The three terminal types established by mossy fibers had distinct properties. High-frequency stimulation increased the fraction of dynamic terminals for 1-2 days, a process mediated by activation of AMPA receptors, protein kinase A (PKA) and protein synthesis. Thus, synaptic activity can make stable presynaptic terminals become dynamic, providing a candidate mechanism to convert experience into changes in network connectivity.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Univ Basel, Friedrich Miescher Inst, CH-4056 Basel, Switzerland; Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Friedrich Miescher Institute for Biomedical Research; University of Basel; University of Basel	Caroni, P (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.		de paola, vincenzo/B-4900-2016	de paola, vincenzo/0000-0001-9987-8291; Arber, Silvia/0000-0002-6261-250X				Acsady L, 1998, J NEUROSCI, V18, P3386; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; AMARAL DG, 1979, ANAT EMBRYOL, V155, P241, DOI 10.1007/BF00317638; Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Bastmeyer M, 1996, J NEUROSCI, V16, P1450; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; CLAIBORNE BJ, 1986, J COMP NEUROL, V246, P435, DOI 10.1002/cne.902460403; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; DAILEY ME, 1994, J NEUROSCI, V14, P1060, DOI 10.1523/JNEUROSCI.14-03-01060.1994; Dailey ME, 1996, J NEUROSCI, V16, P2983; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Hatada Y, 2000, J NEUROSCI, V20, part. no.; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Horch HW, 1999, NEURON, V23, P353; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Mizuhashi S, 2001, J NEUROSCI, V21, P6181, DOI 10.1523/JNEUROSCI.21-16-06181.2001; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pun S, 2002, NEURON, V34, P357, DOI 10.1016/S0896-6273(02)00670-0; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Smart FM, 2000, HIPPOCAMPUS, V10, P542, DOI 10.1002/1098-1063(2000)10:5<542::AID-HIPO4>3.3.CO;2-Z; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Toth K, 2000, J PHYSIOL-LONDON, V525, P41, DOI 10.1111/j.1469-7793.2000.00041.x; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; Wiederkehr A, 1997, EXP CELL RES, V236, P103, DOI 10.1006/excr.1997.3709; Yankova M, 2001, P NATL ACAD SCI USA, V98, P3525, DOI 10.1073/pnas.051624598; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Ziv NE, 2001, CURR OPIN NEUROBIOL, V11, P536, DOI 10.1016/S0959-4388(00)00246-4	48	174	176	0	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					491	500		10.1038/nn1046	http://dx.doi.org/10.1038/nn1046			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12692557				2022-12-24	WOS:000182553200016
J	Shapira, M; Zhai, RG; Dresbach, T; Bresler, T; Torres, VI; Gundelfinger, ED; Ziv, NE; Garner, CC				Shapira, M; Zhai, RG; Dresbach, T; Bresler, T; Torres, VI; Gundelfinger, ED; Ziv, NE; Garner, CC			Unitary assembly of presynaptic active zones from Piccolo-Bassoon transport vesicles	NEURON			English	Article							SYNAPTIC VESICLES; PROTEIN; SYNAPSES; DYNAMICS; HETEROGENEITY; CYTOMATRIX; PLASTICITY; RELEASE; NEURONS; COMPLEX	Recent studies indicate that active zones (AZs)- sites of neurotransmitter release-may be assembled from preassembled AZ precursor vesicles inserted into the presynaptic plasma membrane. Here we report that one putative AZ precursor vesicle of CNS synapses-the Piccolo-Bassoon transport vesicle (PTV)-carries a comprehensive set of AZ proteins genetically and functionally coupled to synaptic vesicle exocytosis. Time-lapse imaging reveals that PTVs are highly mobile, consistent with a role in intracellular transport. Quantitative analysis reveals that the Bassoon, Piccolo, and RIM content of individual PTVs is, on average, half of that of individual presynaptic boutons and shows that the synaptic content of these molecules can be quantitatively accounted for by incorporation of integer numbers (typically two to three) of PTVs into presynaptic membranes. These findings suggest that AZs are assembled from unitary amounts of AZ material carried on PTVs.	Techn Fac Med, Rappaport Inst, Haifa, Israel; Techn Fac Med, Dept Anat & Cell Biol, Haifa, Israel; Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, D-39118 Magdeburg, Germany; Stanford Univ, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Alabama System; University of Alabama Birmingham; Leibniz Institut fur Neurobiologie (LIN); Stanford University	Garner, CC (corresponding author), Techn Fac Med, Rappaport Inst, Haifa, Israel.	garner@stanford.edu	Torres, Viviana/AAC-3329-2019; Ziv, Noam/ABA-6551-2020; Zhai, R. Grace/AGZ-3936-2022	Ziv, Noam/0000-0001-9197-326X; Torres, Viviana/0000-0002-1220-7709; Zhai, Rong/0000-0002-7599-1430; Garner, Craig/0000-0003-1970-5417	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD032901, P01HD038760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039471] Funding Source: NIH RePORTER; NICHD NIH HHS [P50-HD32901, P01-HD38760] Funding Source: Medline; NINDS NIH HHS [R01 NS39471] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahmari SE, 2002, NEURON, V34, P333, DOI 10.1016/S0896-6273(02)00685-2; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Boeckers TM, 1999, J NEUROSCI, V19, P6506; Bresler T, 2001, MOL CELL NEUROSCI, V18, P149, DOI 10.1006/mcne.2001.1012; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; CasesLanghoff C, 1996, EUR J CELL BIOL, V69, P214; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Craig AM, 2001, NAT NEUROSCI, V4, P569, DOI 10.1038/88388; Dai ZS, 1996, MOL CELL NEUROSCI, V7, P443, DOI 10.1006/mcne.1996.0032; DECAMILLI P, 1983, J CELL BIOL, V96, P1355, DOI 10.1083/jcb.96.5.1355; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Dresbach T, 2001, CELL MOL LIFE SCI, V58, P94, DOI 10.1007/PL00000781; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Hopf FW, 2002, J NEUROSCI, V22, P775, DOI 10.1523/JNEUROSCI.22-03-00775.2002; ISHIZUKA T, 1995, BIOCHEM BIOPH RES CO, V213, P1107, DOI 10.1006/bbrc.1995.2241; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Roos J, 2000, NAT NEUROSCI, V3, P415, DOI 10.1038/74773; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Staple JK, 2000, NEWS PHYSIOL SCI, V15, P45; Sudhof TC, 2000, NEURON, V28, P317, DOI 10.1016/S0896-6273(00)00109-4; TAKAHASHI S, 1995, FEBS LETT, V368, P455, DOI 10.1016/0014-5793(95)00713-J; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Ziv NE, 2001, CURR OPIN NEUROBIOL, V11, P536, DOI 10.1016/S0959-4388(00)00246-4	38	219	226	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 24	2003	38	2					237	252		10.1016/S0896-6273(03)00207-1	http://dx.doi.org/10.1016/S0896-6273(03)00207-1			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672AM	12718858	Bronze			2022-12-24	WOS:000182498300013
J	Handy, TC; Grafton, ST; Shroff, NM; Ketay, S; Gazzaniga, MS				Handy, TC; Grafton, ST; Shroff, NM; Ketay, S; Gazzaniga, MS			Graspable objects grab attention when the potential for action is recognized	NATURE NEUROSCIENCE			English	Article							ACTION-DEFINED TEMPLATES; EYE-HAND COORDINATION; ELECTROPHYSIOLOGICAL EVIDENCE; NEUROPSYCHOLOGICAL EVIDENCE; NEURAL MECHANISMS; PARIETAL CORTEX; LATERALIZATION; REPRESENTATION; LOCALIZATION; PERCEPTION	Visually guided grasping movements require a rapid transformation of visual representations into object-specific motor programs. Here we report that graspable objects may facilitate these visuomotor transformations by automatically grabbing visual spatial attention. Human subjects viewed two task-irrelevant objects-one was a 'tool', the other a 'non-tool'-while waiting for a target to be presented in one of the two object locations. Using event-related potentials (ERPs), we found that spatial attention was systematically drawn to tools in the right and lower visual fields, the hemifields that are dominant for visuomotor processing. Using event-related fMRI, we confirmed that tools grabbed spatial attention only when they also activated dorsal regions of premotor and prefrontal cortices, regions associated with visually guided actions and their planning. Although it is widely accepted that visual sensory gain aids perception, our results suggest that it may also have consequences for object-directed actions.	Dartmouth Coll, Ctr Cognit Neurosci, Hanover, NH 03755 USA; Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; Dartmouth Coll, Dartmouth Brain Imaging Ctr, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College; Dartmouth College	Handy, TC (corresponding author), Dartmouth Coll, Ctr Cognit Neurosci, 6162 Moore Hall, Hanover, NH 03755 USA.	todd.c.handy@dartmouth.edu						Batista AP, 2001, J NEUROPHYSIOL, V85, P539, DOI 10.1152/jn.2001.85.2.539; Battaglia-Mayer A, 2001, CEREB CORTEX, V11, P528, DOI 10.1093/cercor/11.6.528; BOLES DB, 1994, BRAIN COGNITION, V24, P184, DOI 10.1006/brcg.1994.1010; Bonfiglioli C, 2002, VIS COGN, V9, P458, DOI 10.1080/13506280143000539; Carey DP, 2000, CURR BIOL, V10, pR416, DOI 10.1016/S0960-9822(00)00508-X; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Colby CL, 1998, NEURON, V20, P15, DOI 10.1016/S0896-6273(00)80429-8; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Craighero L, 1999, J EXP PSYCHOL HUMAN, V25, P1673, DOI 10.1037/0096-1523.25.6.1673; Craighero L, 1996, NEUROREPORT, V8, P347, DOI 10.1097/00001756-199612200-00068; Danckert J, 2001, EXP BRAIN RES, V137, P303; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Duncan J, 1997, CURR OPIN NEUROBIOL, V7, P255, DOI 10.1016/S0959-4388(97)80014-1; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Grafton ST, 1997, NEUROIMAGE, V6, P231, DOI 10.1006/nimg.1997.0293; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Haaland KY, 1996, CURR OPIN NEUROBIOL, V6, P796, DOI 10.1016/S0959-4388(96)80030-4; Handy TC, 2001, J EXP PSYCHOL HUMAN, V27, P303, DOI 10.1037/0096-1523.27.2.303; Handy TC, 2001, PSYCHOL SCI, V12, P213, DOI 10.1111/1467-9280.00338; Handy TC, 2000, PERCEPT PSYCHOPHYS, V62, P175, DOI 10.3758/BF03212070; HILLYARD SA, 1999, ATTENTION SPACE ACTI, P311; Hodges JR, 1999, P NATL ACAD SCI USA, V96, P9444, DOI 10.1073/pnas.96.16.9444; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Hopfinger JB, 1998, PSYCHOL SCI, V9, P441, DOI 10.1111/1467-9280.00083; Humphreys GW, 2001, NAT NEUROSCI, V4, P84, DOI 10.1038/82940; Humphreys GW, 2001, BEHAV NEUROL, V13, P75; Ivry R.B., 1998, 2 SIDES PERCEPTION; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Kenemans JL, 2000, CLIN NEUROPHYSIOL, V111, P1113, DOI 10.1016/S1388-2457(00)00270-4; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P887, DOI 10.1037/0096-1523.20.4.887; MANGUN GR, 1988, ELECTROEN CLIN NEURO, V70, P417, DOI 10.1016/0013-4694(88)90019-3; Marconi B, 2001, CEREB CORTEX, V11, P513, DOI 10.1093/cercor/11.6.513; Marotta JJ, 2001, J COGNITIVE NEUROSCI, V13, P8, DOI 10.1162/089892901564135; MARTIN A, 1995, SCIENCE, V270, P102, DOI 10.1126/science.270.5233.102; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Milner A. D., 1995, VISUAL BRAIN ACTION; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Riddoch MJ, 2003, NAT NEUROSCI, V6, P82, DOI 10.1038/nn984; Rushworth MFS, 2001, NAT NEUROSCI, V4, P656, DOI 10.1038/88492; Rushworth MFS, 2001, J COGNITIVE NEUROSCI, V13, P698, DOI 10.1162/089892901750363244; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Talairach J., 1988, COPLANAR STEREOTAXIC; Tucker M, 1998, J EXP PSYCHOL HUMAN, V24, P830, DOI 10.1037/0096-1523.24.3.830; VANVOORHIS S, 1977, PERCEPT PSYCHOPHYS, V23, P146; WARD R, 1999, ATTENTION SPACE ACTI, P311; Zani A, 1997, J PSYCHOPHYSIOL, V11, P21	50	187	191	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					421	427		10.1038/nn1031	http://dx.doi.org/10.1038/nn1031			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12640459				2022-12-24	WOS:000181833100021
J	Schendan, HE; Searl, MM; Melrose, RJ; Stern, CE				Schendan, HE; Searl, MM; Melrose, RJ; Stern, CE			An fMRI study of the role of the medial temporal lobe in implicit and explicit sequence learning	NEURON			English	Article							EPISODIC MEMORY; BASAL GANGLIA; FRONTAL LOBES; BRAIN SYSTEMS; MOTOR SKILL; HIPPOCAMPUS; TIME; ASSOCIATIONS; STRIATUM; AMNESIA	fMRI was used to investigate the neural substrates supporting implicit and explicit sequence learning, focusing especially upon the role of the medial temporal lobe. Participants performed a serial reaction time task (SRTT). For implicit learning, they were naive about a repeating pattern, whereas for explicit learning, participants memorized another repeating sequence. fMRI analyses comparing repeating versus random sequence blocks demonstrated activation of frontal, parietal, cingulate, and striatal regions implicated in previous SRTT studies. Importantly, medio-temporal lobe regions were active in both explicit and implicit SRTT learning. Moreover, the results provide evidence of a role for the hippocampus and related cortices in the formation of higher order associations under both implicit and explicit learning conditions, regardless of conscious awareness of sequence knowledge.	Boston Univ, Ctr Memory & Brain, Dept Psychol, Boston, MA 02215 USA; Harvard Univ, Sch Med, MGH NMR Ctr, Dept Radiol, Charlestown, MA 02129 USA	Boston University; Harvard University	Schendan, HE (corresponding author), Boston Univ, Ctr Memory & Brain, Dept Psychol, Boston, MA 02215 USA.	haline@mind.bu.edu	Schendan, Haline/I-6125-2019	Schendan, Haline/0000-0001-8925-5605	NIA NIH HHS [F32 AG05914] Funding Source: Medline; NIMH NIH HHS [R21 MH066213] Funding Source: Medline; NINDS NIH HHS [R01 NS40239] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH066213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG005914] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; AGGLETON JP, 1986, BEHAV BRAIN RES, V19, P133, DOI 10.1016/0166-4328(86)90011-2; Agster KL, 2002, J NEUROSCI, V22, P5760; Berns GS, 1997, SCIENCE, V276, P1272, DOI 10.1126/science.276.5316.1272; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Buchel C, 1999, J NEUROSCI, V19, P10869; Chun MM, 1999, NAT NEUROSCI, V2, P844, DOI 10.1038/12222; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; CORKIN S, 1968, NEUROPSYCHOLOGIA, V6, P255, DOI 10.1016/0028-3932(68)90024-9; Curran T, 1997, J COGNITIVE NEUROSCI, V9, P522, DOI 10.1162/jocn.1997.9.4.522; Dolan RJ, 1997, NATURE, V388, P582, DOI 10.1038/41561; Dolan RJ, 1999, HIPPOCAMPUS, V9, P25, DOI 10.1002/(SICI)1098-1063(1999)9:1<25::AID-HIPO3>3.0.CO;2-4; Downes JJ, 2002, NEUROPSYCHOLOGIA, V40, P853, DOI 10.1016/S0028-3932(01)00172-5; Doyon J, 1997, BRAIN COGNITION, V34, P218, DOI 10.1006/brcg.1997.0899; Doyon J, 1998, NEUROPSYCHOLOGIA, V36, P625, DOI 10.1016/S0028-3932(97)00168-1; Doyon J, 1996, EUR J NEUROSCI, V8, P637, DOI 10.1111/j.1460-9568.1996.tb01249.x; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Elliott R, 1999, J NEUROSCI, V19, P5066; EMERSON PL, 1995, BEHAV RES METH INSTR, V27, P88, DOI 10.3758/BF03203627; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Goel V, 2000, J COGNITIVE NEUROSCI, V12, P110, DOI 10.1162/08989290051137639; Grafton ST, 1998, J NEUROSCI, V18, P9420; GRAFTON ST, 1995, J COGNITIVE NEUROSCI, V7, P497, DOI 10.1162/jocn.1995.7.4.497; Grunwald T, 1998, P NATL ACAD SCI USA, V95, P3193, DOI 10.1073/pnas.95.6.3193; Halgren E, 1998, ELECTROEN CLIN NEURO, V106, P156, DOI 10.1016/S0013-4694(97)00119-3; Hazeltine E, 1997, BRAIN, V120, P123, DOI 10.1093/brain/120.1.123; JACKSON GM, 1995, NEUROPSYCHOLOGIA, V33, P577, DOI 10.1016/0028-3932(95)00010-Z; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Kesner RP, 2001, NEUROPSYCHOLOGY, V15, P58, DOI 10.1037/0894-4105.15.1.58; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; KNOPMAN D, 1991, NEUROPSYCHOLOGIA, V29, P245, DOI 10.1016/0028-3932(91)90085-M; Knowlton B J, 1994, Learn Mem, V1, P106; KNOWLTON BJ, 1992, PSYCHOL SCI, V3, P172, DOI 10.1111/j.1467-9280.1992.tb00021.x; Mai J, 1998, ATLAS HUMAN BRAIN; MCCARTHY G, 1989, J NEUROSCI, V9, P4253; McGlincheyBerroth R, 1997, BEHAV NEUROSCI, V111, P873, DOI 10.1037/0735-7044.111.5.873; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Mitchell KJ, 2000, COGNITIVE BRAIN RES, V10, P197, DOI 10.1016/S0926-6410(00)00029-X; NISSEN MJ, 1989, NEUROPSYCHOLOGIA, V27, P341, DOI 10.1016/0028-3932(89)90023-7; NISSEN MJ, 1987, NEUROLOGY, V37, P789, DOI 10.1212/WNL.37.5.789; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Owen AM, 1998, P NATL ACAD SCI USA, V95, P7721, DOI 10.1073/pnas.95.13.7721; Peigneux P, 2000, HUM BRAIN MAPP, V10, P179, DOI 10.1002/1097-0193(200008)10:4<179::AID-HBM30>3.0.CO;2-H; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Rah SKY, 2000, PSYCHON B REV, V7, P309, DOI 10.3758/BF03212986; Ranganath C, 2001, NEURON, V31, P865, DOI 10.1016/S0896-6273(01)00411-1; Rauch SL, 1998, NEUROREPORT, V9, P865, DOI 10.1097/00001756-199803300-00019; Rauch SL, 1997, HUM BRAIN MAPP, V5, P124, DOI 10.1002/(SICI)1097-0193(1997)5:2<124::AID-HBM6>3.3.CO;2-P; Rauch SL, 1995, HUM BRAIN MAPP, V3, P271, DOI 10.1002/hbm.460030403; Rauch SL, 1997, J NEUROPSYCH CLIN N, V9, P568; RAWLINS JNP, 1985, BEHAV BRAIN SCI, V8, P479, DOI 10.1017/S0140525X00001291; Reber PJ, 1998, J COGNITIVE NEUROSCI, V10, P248, DOI 10.1162/089892998562681; REBER PJ, 1994, LEARN MEMORY, V1, P217; Rose M, 2002, NEURON, V36, P1221, DOI 10.1016/S0896-6273(02)01105-4; Saykin AJ, 1999, BRAIN, V122, P1963, DOI 10.1093/brain/122.10.1963; Schacter DL, 1997, PHILOS T R SOC B, V352, P1689, DOI 10.1098/rstb.1997.0150; Shanks DR, 1999, J EXP PSYCHOL LEARN, V25, P1435, DOI 10.1037/0278-7393.25.6.1435; Small SA, 2001, NAT NEUROSCI, V4, P442, DOI 10.1038/86115; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Sperling RA, 2001, HUM BRAIN MAPP, V14, P129, DOI 10.1002/hbm.1047; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Stern CE, 2000, NEUROIMAGE, V11, P392, DOI 10.1006/nimg.2000.0569; Stern CE, 2001, HIPPOCAMPUS, V11, P337; Strange BA, 1999, P NATL ACAD SCI USA, V96, P4034, DOI 10.1073/pnas.96.7.4034; Toni I, 2001, NEUROIMAGE, V14, P1048, DOI 10.1006/nimg.2001.0894; Vakil E, 2000, NEUROPSYCHOLOGIA, V38, P1, DOI 10.1016/S0028-3932(99)00058-5; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Willingham DB, 1998, PSYCHOL REV, V105, P558, DOI 10.1037/0033-295X.105.3.558; Willingham DB, 2002, J NEUROPHYSIOL, V88, P1451, DOI 10.1152/jn.2002.88.3.1451; Wise SP, 1999, HIPPOCAMPUS, V9, P101, DOI 10.1002/(SICI)1098-1063(1999)9:2<101::AID-HIPO3>3.0.CO;2-L; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4	76	444	447	2	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 27	2003	37	6					1013	1025		10.1016/S0896-6273(03)00123-5	http://dx.doi.org/10.1016/S0896-6273(03)00123-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	661PU	12670429	Bronze			2022-12-24	WOS:000181899600014
J	Taylor-Clarke, M; Jacobsen, P; Haggard, P				Taylor-Clarke, M; Jacobsen, P; Haggard, P			Keeping the world a constant size: object constancy in human touch	NATURE NEUROSCIENCE			English	Article							REPRESENTATION; PLASTICITY; VISION; CORTEX	The perceived size of objects touching different regions of skin varies across the body surface by much less than is predicted from variations in tactile receptor density. Here we show that altering the visual experience of the body alters perceived tactile distances. We propose that the brain attempts to preserve tactile size constancy by rescaling the primary, distorted body-surface representation into object-centered space according to visual experience of the body.	UCL, Inst Neurosci Cognit, London WC1N 3AR, England; UCL, Dept Psychol, London WC1N 3AR, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of London; University College London; University of London; University College London; University of Oxford	Taylor-Clarke, M (corresponding author), UCL, Inst Neurosci Cognit, 17 Queen Sq, London WC1N 3AR, England.	p.haggard@ucl.ac.uk	Haggard, Patrick/A-5081-2010	Jacobsen, Pamela/0000-0001-8847-7775; Haggard, Patrick/0000-0001-7798-793X				BORING EG, 1964, AM J PSYCHOL, V77, P494, DOI 10.2307/1421027; Calford MB, 2002, NEUROSCIENCE, V111, P709, DOI 10.1016/S0306-4522(02)00022-2; Gandevia SC, 1999, J PHYSIOL-LONDON, V514, P609, DOI 10.1111/j.1469-7793.1999.609ae.x; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; GREEN BG, 1982, PERCEPT PSYCHOPHYS, V31, P315, DOI 10.3758/BF03202654; Iriki A, 1996, NEUROREPORT, V7, P2325; Kennett S, 2001, CURR BIOL, V11, P1188, DOI 10.1016/S0960-9822(01)00327-X; Kurth R, 2000, NEUROREPORT, V11, P1487, DOI 10.1097/00001756-200005150-00025; Marr D., 1982, VISION; PAILLARD J, 1983, ARCH NEUROL-CHICAGO, V40, P548, DOI 10.1001/archneur.1983.04050080048008; Penfield W, 1950, CEREBRAL CORTEX MAN; Ramachandran VS, 2000, ARCH NEUROL-CHICAGO, V57, P317, DOI 10.1001/archneur.57.3.317; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; WEBER EH, 1978, SENSE TOUCH; WEINSTEIN SIDNEY, 1968, P195	15	146	146	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					219	220		10.1038/nn1199	http://dx.doi.org/10.1038/nn1199			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14966526				2022-12-24	WOS:000189197900010
J	Xiao, MY; Wasling, P; Hanse, E; Gustafsson, B				Xiao, MY; Wasling, P; Hanse, E; Gustafsson, B			Creation of AMPA-silent synapses in the neonatal hippocampus	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RECEPTOR TRAFFICKING; EXCITATORY SYNAPSES; PYRAMIDAL NEURONS; POSTSYNAPTIC EXPRESSION; GLUTAMATERGIC SYNAPSES; POSTNATAL-DEVELOPMENT; SYNAPTIC CONNECTIONS; DEVELOPMENTAL SWITCH; CA1 REGION	In the developing brain, many glutamate synapses have been found to transmit only NMDA receptor-mediated signaling, that is, they are AMPA-silent. This result has been taken to suggest that glutamate synapses are initially AMPA-silent when they are formed, and that AMPA signaling is acquired through activity-dependent synaptic plasticity. The present study on CA3-CA1 synapses in the hippocampus of the neonatal rat suggests that AMPA-silent synapses are created through a form of activity-dependent silencing of AMPA signaling. We found that AMPA signaling, but not NMDA signaling, could be very rapidly silenced by presynaptic electrical stimulation at frequencies commonly used to probe synaptic function (0.05-1 Hz). Although this AMPA silencing required a rise in postsynaptic Ca2+, it did not require activation of NMDA receptors, metabotropic glutamate receptors or voltage-gated calcium channels. The AMPA silencing, possibly explained by a removal of postsynaptic AMPA receptors, could subsequently be reversed by paired presynaptic and postsynaptic activity.	Univ Gothenburg, Inst Physiol & Pharmacol, Dept Physiol, S-40530 Gothenburg, Sweden	University of Gothenburg	Xiao, MY (corresponding author), Univ Gothenburg, Inst Physiol & Pharmacol, Dept Physiol, Box 432, S-40530 Gothenburg, Sweden.	xiao@physiol.gu.se	Hanse, Eric/B-4935-2009					Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Atwood HL, 1999, LEARN MEMORY, V6, P542, DOI 10.1101/lm.6.6.542; BAYER SA, 1980, J COMP NEUROL, V190, P115, DOI 10.1002/cne.901900108; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; Cossart R, 2002, NEURON, V35, P147, DOI 10.1016/S0896-6273(02)00753-5; Diabira D, 1999, EUR J NEUROSCI, V11, P4015, DOI 10.1046/j.1460-9568.1999.00831.x; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Fiala JC, 1998, J NEUROSCI, V18, P8900; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Gomperts SN, 1998, NEURON, V21, P1443, DOI 10.1016/S0896-6273(00)80662-5; Groc L, 2003, NEUROSCIENCE, V121, P65, DOI 10.1016/S0306-4522(03)00366-X; Groc L, 2002, J NEUROSCI, V22, P5552; Hanse E, 2001, J PHYSIOL-LONDON, V531, P467, DOI 10.1111/j.1469-7793.2001.0467i.x; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Kullmann DM, 1999, NATURE, V399, P111, DOI 10.1038/20089; Kumar SS, 2002, J NEUROSCI, V22, P3005, DOI 10.1523/JNEUROSCI.22-08-03005.2002; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Li P, 1998, NATURE, V393, P695, DOI 10.1038/31496; Liao DZ, 1996, LEARN MEMORY, V3, P138, DOI 10.1101/lm.3.2-3.138; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lu HC, 2003, NAT NEUROSCI, V6, P939, DOI 10.1038/nn1106; Luthi A, 2001, NAT NEUROSCI, V4, P1102, DOI 10.1038/nn744; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; Montgomery JM, 2001, NEURON, V29, P691, DOI 10.1016/S0896-6273(01)00244-6; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Poncer JC, 2001, NAT NEUROSCI, V4, P989, DOI 10.1038/nn719; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Rumpel S, 1998, J NEUROSCI, V18, P8863; STEWARD O, 1991, J COMP NEUROL, V314, P545, DOI 10.1002/cne.903140311; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Yin HZ, 1999, J COMP NEUROL, V409, P250; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798; Zhu JJ, 2002, NAT NEUROSCI, V5, P513, DOI 10.1038/nn0602-850	47	92	95	1	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					236	243		10.1038/nn1196	http://dx.doi.org/10.1038/nn1196			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14966524				2022-12-24	WOS:000189197900013
J	Cruz, HG; Ivanova, T; Lunn, ML; Stoffel, M; Slesinger, PA; Luscher, C				Cruz, HG; Ivanova, T; Lunn, ML; Stoffel, M; Slesinger, PA; Luscher, C			Bi-directional effects of GABA(B) receptor agonists on the mesolimbic dopamine system	NATURE NEUROSCIENCE			English	Article							RECTIFYING K+ CHANNELS; GAMMA-HYDROXYBUTYRIC ACID; MUSCARINIC POTASSIUM CHANNEL; VENTRAL TEGMENTAL AREA; FUNCTIONAL EXPRESSION; MOLECULAR-PROPERTIES; INWARD RECTIFIER; SYNAPTIC INPUTS; DRUG-ADDICTION; BETA-GAMMA	The rewarding effect of drugs of abuse is mediated by activation of the mesolimbic dopamine system, which is inhibited by putative anti-craving compounds. Interestingly, different GABA(B) receptor agonists can exert similarly opposing effects on the reward pathway, but the cellular mechanisms involved are unknown. Here we found that the coupling efficacy (EC50) of G-protein-gated inwardly rectifying potassium (GIRK, Kir3) channels to GABA(B) receptor was much lower in dopamine neurons than in GABA neurons of the ventral tegmental area (VTA), depending on the differential expression of GIRK subunits. Consequently, in rodent VTA slices, a low concentration of the canonical agonist baclofen caused increased activity, whereas higher doses eventually inhibited dopamine neurons. At behaviorally relevant dosages, baclofen activated GIRK channels in both cell types, but the drug of abuse gamma-hydroxy-butyric acid (GHB) activated GIRK channels only in GABAergic neurons. Thus GABA(B) receptor agonists exert parallel cellular and behavioral effects due to the cell- specific expression of GIRK subunits.	Univ Geneva, Dept Basic Neurosci, CH-1211 Geneva 4, Switzerland; Univ Geneva, Neurol Clin, CH-1211 Geneva 4, Switzerland; Salk Inst Biol Studies, Peptide Biol Lab, San Diego, CA 92186 USA; Rockefeller Univ, Lab Metab Dis, New York, NY 10021 USA	University of Geneva; University of Geneva; Salk Institute; Rockefeller University	Luscher, C (corresponding author), Univ Geneva, Dept Basic Neurosci, 1 Michel Servet, CH-1211 Geneva 4, Switzerland.	Slesinger@salk.edu; Christian.Luscher@medecine.unige.ch	Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; Stoffel, Markus/0000-0003-1304-5817				Andriamampandry C, 2003, FASEB J, V17, P1691, DOI 10.1096/fj.02-0846fje; Billinton A, 1999, BRIT J PHARMACOL, V126, P1387, DOI 10.1038/sj.bjp.0702460; Brauner-Osborne H, 1999, BRIT J PHARMACOL, V128, P1370, DOI 10.1038/sj.bjp.0702914; Brebner K, 2002, ALCOHOL ALCOHOLISM, V37, P478, DOI 10.1093/alcalc/37.5.478; Carter LP, 2003, J PHARMACOL EXP THER, V305, P668, DOI 10.1124/jpet.102.047860; Cousins MS, 2002, DRUG ALCOHOL DEPEN, V65, P209, DOI 10.1016/S0376-8716(01)00163-6; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Feigenbaum JJ, 1996, INT J NEUROSCI, V88, P53, DOI 10.3109/00207459608999812; GALLIMBERTI L, 1989, LANCET, V2, P787; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Inanobe A, 1999, J NEUROSCI, V19, P1006; Jelacic TM, 2000, J BIOL CHEM, V275, P36211, DOI 10.1074/jbc.M007087200; Jelacic TM, 1999, J MEMBRANE BIOL, V169, P123, DOI 10.1007/s002329900524; Jeong SW, 2000, J NEUROSCI, V20, P4489, DOI 10.1523/JNEUROSCI.20-12-04489.2000; JOHNSON SW, 1992, J NEUROSCI, V12, P483; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; KALIVAS PW, 1990, J PHARMACOL EXP THER, V253, P858; KALIVAS PW, 1993, BRAIN RES REV, V18, P75, DOI 10.1016/0165-0173(93)90008-N; Karschin C, 1996, J NEUROSCI, V16, P3559; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 2003, EUR J NEUROSCI, V18, P2722, DOI 10.1111/j.1460-9568.2003.03013.x; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; LESAGE F, 1994, FEBS LETT, V353, P37, DOI 10.1016/0014-5793(94)01007-2; Liao YJ, 1996, J NEUROSCI, V16, P7137; Lingenhoehl K, 1999, NEUROPHARMACOLOGY, V38, P1667, DOI 10.1016/S0028-3908(99)00131-8; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Madden TE, 1998, J PHARMACOL EXP THER, V287, P261; Martellotta MC, 1998, EUR NEUROPSYCHOPHARM, V8, P293, DOI 10.1016/S0924-977X(97)00087-4; McFarland K, 2001, J NEUROSCI, V21, P8655; Nicholson KL, 2001, DRUG ALCOHOL DEPEN, V63, P1, DOI 10.1016/S0376-8716(00)00191-5; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; Pfaff T, 1999, EUR J NEUROSCI, V11, P2874, DOI 10.1046/j.1460-9568.1999.00704.x; Queva S, 2003, BRIT J PHARMACOL, V140, P315, DOI 10.1038/sj.bjp.0705447; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Robbins TW, 1999, NATURE, V398, P567, DOI 10.1038/19208; Schoots O, 1999, CELL SIGNAL, V11, P871, DOI 10.1016/S0898-6568(99)00059-5; Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2; Slesinger PA, 1996, NEURON, V16, P321, DOI 10.1016/S0896-6273(00)80050-1; Snead OC, 2000, J NEUROCHEM, V75, P1986, DOI 10.1046/j.1471-4159.2000.0751986.x; SUGITA S, 1992, NEUROSCI LETT, V134, P207, DOI 10.1016/0304-3940(92)90518-C; Torrecilla M, 2002, J NEUROSCI, V22, P4328, DOI 10.1523/JNEUROSCI.22-11-04328.2002; Wei JJ, 1998, GENOMICS, V51, P379, DOI 10.1006/geno.1998.5369; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Wickman K, 2000, J NEUROSCI, V20, P5608, DOI 10.1523/JNEUROSCI.20-15-05608.2000; Wickman K, 2002, GENE, V284, P241, DOI 10.1016/S0378-1119(01)00884-8; 2002, MATINDALE COMPLETE D, P2496	50	267	273	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					153	159		10.1038/nn1181	http://dx.doi.org/10.1038/nn1181			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14745451				2022-12-24	WOS:000188468500013
J	Gaudilliere, B; Konishi, Y; de la Iglesia, N; Yao, GI; Bonni, A				Gaudilliere, B; Konishi, Y; de la Iglesia, N; Yao, GI; Bonni, A			A CaMKII-NeuroD signaling pathway specifies dendritic morphogenesis	NEURON			English	Article							MOLECULAR MECHANISMS; EXPRESSION PATTERNS; GRANULE CELLS; KINASE-II; PROTEIN; ACTIVATION; CREB; PHOSPHORYLATION; OUTGROWTH; GROWTH	The elaboration of dendrites is fundamental to the establishment of neuronal polarity and connectivity, but the mechanisms that underlie dendritic morphogenesis are poorly understood. We found that the genetic knockdown of the transcription factor NeuroD in primary granule neurons including in organotypic cerebellar slices profoundly impaired the generation and maintenance of dendrites while sparing the development of axons. We also found that NeuroD mediated neuronal activity-dependent dendritogenesis. The activity-induced protein kinase CaMKII catalyzed the phosphorylation of NeuroD at distinct sites, including endogenous NeuroD at Ser336 in primary neurons, and thereby stimulated dendritic growth. These findings uncover an essential function for NeuroD in granule neuron dendritic morphogenesis. Our study also defines the CaMKII-NeuroD signaling pathway as a novel mechanism underlying activity-regulated dendritic growth that may play important roles in the developing and mature brain.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Bonni, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	azad_bonni@hms.harvard.edu	de la Iglesia, Nuria/E-1420-2015	de la Iglesia, Nuria/0000-0002-1083-7715; Gaudilliere, Brice/0000-0002-3475-5706	NINDS NIH HHS [R01-NS41021-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041021] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altman J, 1997, DEV CEREBELLAR SYSTE; Borodinsky LN, 2002, J NEUROCHEM, V80, P1062, DOI 10.1046/j.1471-4159.2002.00795.x; Brenman JE, 2001, DEV CELL, V1, P667, DOI 10.1016/S1534-5807(01)00072-7; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Fink CC, 2002, CURR OPIN NEUROBIOL, V12, P293, DOI 10.1016/S0959-4388(02)00327-6; Gaudilliere B, 2002, J BIOL CHEM, V277, P46442, DOI 10.1074/jbc.M206653200; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Konishi Y, 2003, J NEUROSCI, V23, P1649; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; Lee JE, 1997, DEV NEUROSCI-BASEL, V19, P27, DOI 10.1159/000111182; Lee JK, 2000, DEV DYNAM, V217, P361, DOI 10.1002/(SICI)1097-0177(200004)217:4<361::AID-DVDY3>3.0.CO;2-8; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Ma QF, 1997, J NEUROSCI, V17, P3644; McCormick MB, 1996, MOL CELL BIOL, V16, P5792; Miller FD, 2003, CURR OPIN NEUROBIOL, V13, P391, DOI 10.1016/s0959-4388(03)00072-2; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Powell SK, 1997, J NEUROBIOL, V32, P223, DOI 10.1002/(SICI)1097-4695(199702)32:2<223::AID-NEU7>3.0.CO;2-A; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Shalizi A, 2003, J NEUROSCI, V23, P7326; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Soderling TR, 2001, J BIOL CHEM, V276, P3719, DOI 10.1074/jbc.R000013200; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Vaillant AR, 2002, NEURON, V34, P985, DOI 10.1016/S0896-6273(02)00717-1; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Wellmann H, 1999, J NEUROSCI METH, V92, P55, DOI 10.1016/S0165-0270(99)00094-1; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222	44	203	211	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 22	2004	41	2					229	241		10.1016/S0896-6273(03)00841-9	http://dx.doi.org/10.1016/S0896-6273(03)00841-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741104	Bronze			2022-12-24	WOS:000221457800009
J	Jensen, J; McIntosh, AR; Crawley, AP; Mikulis, DJ; Remington, G; Kapur, S				Jensen, J; McIntosh, AR; Crawley, AP; Mikulis, DJ; Remington, G; Kapur, S			Direct activation of the ventral striatum in anticipation of aversive stimuli	NEURON			English	Article							EXTRACELLULAR DOPAMINE LEVELS; NUCLEUS-ACCUMBENS DOPAMINE; NEURAL RESPONSES; BRAIN ACTIVITY; REWARD; COCAINE; ROBUST; OPTIMIZATION; REGISTRATION; INVOLVEMENT	The brain "reward" system, centered on the limbic ventral striatum, plays a critical role in the response to pleasure and pain. The ventral striatum is activated in animal and human studies during anticipation of appetitive/pleasurable events, but its role in aversive/ painful events is less clear. Here we present data from three human fMRI studies based on aversive conditioning using unpleasant cutaneous electrical stimulation and show that the ventral striatum is reliably activated. This activation is observed during anticipation and is not a consequence of relief after the aversive event. Further, the ventral striatum is activated in anticipation regardless of whether there is an opportunity to avoid the aversive stimulus or not. Our data suggest that the ventral striatum, a crucial element of the brain "reward" system, is directly activated in anticipation of aversive stimuli.	Ctr Addict & Mental Hlth, PET Ctr, Toronto, ON, Canada; Rotman Res Inst, Baycrest Geriatr Ctr, Toronto, ON, Canada; Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; Univ Toronto, Dept Med Imaging, Toronto, ON M5S 1A1, Canada; Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University of Toronto; University of Toronto	Kapur, S (corresponding author), Ctr Addict & Mental Hlth, PET Ctr, Toronto, ON, Canada.	shitij_kapur@camh.net	McIntosh, Anthony R/G-4955-2011; Jensen, Jimmy/H-7517-2014; Mikulis, David J/H-5167-2019	Jensen, Jimmy/0000-0001-6841-1808; Mikulis, David/0000-0003-3956-0892; McIntosh, Anthony/0000-0002-1784-5662; Kapur, Shitij/0000-0002-2231-2924				Adam JJ, 2003, COGNITIVE BRAIN RES, V16, P1, DOI 10.1016/S0926-6410(02)00204-5; [Anonymous], [No title captured]; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Buchel C, 1999, J NEUROSCI, V19, P10869; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; CASEY KL, 1994, J NEUROPHYSIOL, V71, P802, DOI 10.1152/jn.1994.71.2.802; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Friston K, 1995, HUM BRAIN MAPP, V2, P1; Friston K.J., 1994, HUMAN BRAIN MAPPING, V1, P210; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gottfried JA, 2002, J NEUROSCI, V22, P10829; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI [10.1016/S1053-8119(18)31587-8, DOI 10.1016/S1053-8119(18)31587-8]; Horvitz JC, 2002, BEHAV BRAIN RES, V137, P65, DOI 10.1016/S0166-4328(02)00285-1; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kalivas PW, 1993, LIMBIC MOTOR CIRCUIT, P237; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; Marota JJA, 2000, NEUROIMAGE, V11, P13, DOI 10.1006/nimg.1999.0520; MCCULLOUGH LD, 1992, PSYCHOPHARMACOLOGY, V109, P379, DOI 10.1007/BF02245888; Mesulam M., 2000, PRINCIPLES BEHAV COG; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Patterson JC, 2002, NEUROIMAGE, V17, P1797, DOI 10.1006/nimg.2002.1306; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Ramnani N, 2003, CEREB CORTEX, V13, P318, DOI 10.1093/cercor/13.3.318; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; SALAMONE JD, 1994, BEHAV BRAIN RES, V61, P117, DOI 10.1016/0166-4328(94)90153-8; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; SORG BA, 1991, BRAIN RES, V559, P29, DOI 10.1016/0006-8993(91)90283-2; Spanagel R, 1999, TRENDS NEUROSCI, V22, P521, DOI 10.1016/S0166-2236(99)01447-2; Talairach J, 1988, CO PLANAR STEREOTAXI; Toni I, 2001, NEUROIMAGE, V14, pS110, DOI 10.1006/nimg.2001.0841; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127	49	348	350	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 18	2003	40	6					1251	1257		10.1016/S0896-6273(03)00724-4	http://dx.doi.org/10.1016/S0896-6273(03)00724-4			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756UZ	14687557	Bronze			2022-12-24	WOS:000187503400021
J	Ouardouz, M; Nikolaeva, MA; Coderre, E; Zamponi, GW; McRory, JE; Trapp, BD; Yin, XH; Wang, WL; Woulfe, J; Stys, PK				Ouardouz, M; Nikolaeva, MA; Coderre, E; Zamponi, GW; McRory, JE; Trapp, BD; Yin, XH; Wang, WL; Woulfe, J; Stys, PK			Depolarization-induced Ca2+ release in ischemic spinal cord white matter involves L-type Ca2+ channel activation of ryanodine receptors	NEURON			English	Article							NERVE MYELINATED AXONS; ANOXIC INJURY; ENDOPLASMIC-RETICULUM; OPTIC-NERVE; DIHYDROPYRIDINE RECEPTORS; CALCIUM-CHANNELS; GLIAL-CELLS; SKELETAL; MUSCLE; TRANSPORT	The mechanisms of Ca2+ release from intracellular stores in CNS white matter remain undefined. In rat dorsal columns, electrophysiological recordings showed that in vitro ischemia caused severe injury, which persisted after removal of extracellular Ca2+; Ca2+ imaging confirmed that an axoplasmic Ca2+ rise persisted in Ca2+-free perfusate. However, depletion of Ca2+ stores or reduction of ischemic depolarization (low Na+, TTX) were protective, but only in Ca2+-free bath. Ryanodine or blockers of L-type Ca2+ channel voltage sensors (nimodipine, diltiazem, but not Cd2+) were also protective in zero Ca2+, but their effects were not additive with ryanodine. Immunoprecipitation revealed an association between L-type Ca2+ channels and RyRs, and immunohistochemistry confirmed colocalization of Ca2+ channels and RyR clusters on axons. Similar to "excitation-contraction coupling" in skeletal muscle, these results indicate a functional coupling whereby depolarization sensed by L-type Ca2+ channels activates RyRs, thus releasing damaging amounts of Ca2+ under pathological conditions in white matter.	Univ Ottawa, Div Neurosci, Ottawa Hlth Res Inst, Ottawa, ON K1Y 4K9, Canada; Univ Calgary, Dept Physiol & Biophys, Cellular & Mol Neurobiol Res Grp, Calgary, AB T2N 2N1, Canada; Cleveland Clin Fdn, Dept Neurosci, Cleveland, OH 44195 USA	University of Ottawa; Ottawa Hospital Research Institute; University of Calgary; Cleveland Clinic Foundation	Stys, PK (corresponding author), Univ Ottawa, Div Neurosci, Ottawa Hlth Res Inst, Ottawa, ON K1Y 4K9, Canada.	pstys@ohri.ca		Zamponi, Gerald W./0000-0002-0644-9066	NINDS NIH HHS [R01 NS40087-01] Funding Source: Medline; PHS HHS [R01 29818] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040087] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agrawal SK, 2000, NEUROSCIENCE, V99, P179, DOI 10.1016/S0306-4522(00)00165-2; ALBALDAWI NF, 1995, CELL CALCIUM, V17, P422, DOI 10.1016/0143-4160(95)90088-8; Altevogt BM, 2002, J NEUROSCI, V22, P6458; BARRETT EF, 1982, J PHYSIOL-LONDON, V323, P117, DOI 10.1113/jphysiol.1982.sp014064; Berthold Claes-Henric, 1995, P13; BLIGHT AR, 1985, NEUROSCIENCE, V15, P1, DOI 10.1016/0306-4522(85)90118-6; BREUER AC, 1992, CELL CALCIUM, V13, P249, DOI 10.1016/0143-4160(92)90013-I; Brown AM, 2001, J NEUROPHYSIOL, V85, P900, DOI 10.1152/jn.2001.85.2.900; Chavis P, 1996, NATURE, V382, P719, DOI 10.1038/382719a0; DUCE IR, 1978, NEUROSCIENCE, V3, P837, DOI 10.1016/0306-4522(78)90036-2; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; FURUICHI T, 1994, J NEUROSCI, V14, P4794; GARCIA J, 1994, J GEN PHYSIOL, V103, P125, DOI 10.1085/jgp.103.1.125; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; HENKART M, 1980, FED PROC, V39, P2783; HIRANO A, 1995, AXON STRUCTURE FUNCT, P48; Huser J, 2000, J PHYSIOL-LONDON, V524, P795, DOI 10.1111/j.1469-7793.2000.00795.x; Imaizumi T, 1997, J NEUROTRAUM, V14, P299, DOI 10.1089/neu.1997.14.299; JONAS P, 1991, PFLUG ARCH EUR J PHY, V418, P68, DOI 10.1007/BF00370453; Kuo CC, 2002, J GEN PHYSIOL, V120, P159, DOI 10.1085/jgp.20018536; KUWAJIMA G, 1992, NEURON, V9, P1133, DOI 10.1016/0896-6273(92)90071-K; LAI FA, 1992, BIOCHEM J, V288, P553, DOI 10.1042/bj2880553; LAMPERT PW, 1967, J NEUROPATH EXP NEUR, V26, P345, DOI 10.1097/00005072-196707000-00001; Leong P, 1998, BIOCHEM CELL BIOL, V76, P681, DOI 10.1139/bcb-76-5-681; Leppanen L, 1997, J NEUROPHYSIOL, V78, P2095, DOI 10.1152/jn.1997.78.4.2095; LI S, 1999, J NEUROSCI, V19, P1; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; LOPACHIN RM, 1995, J NEUROSCI, V15, P6735; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Malek SA, 2003, J NEUROSCI, V23, P3826; MARTY I, 1994, P NATL ACAD SCI USA, V91, P2270, DOI 10.1073/pnas.91.6.2270; MCPHERSON PS, 1993, J BIOL CHEM, V268, P19785; MELZER W, 1995, BBA-REV BIOMEMBRANES, V1241, P59, DOI 10.1016/0304-4157(94)00014-5; Metuzals J, 1997, J NEUROCYTOL, V26, P529, DOI 10.1023/A:1015482407202; Mouton J, 2001, BIOCHEM J, V354, P597, DOI 10.1042/0264-6021:3540597; Niggli E, 1999, ANNU REV PHYSIOL, V61, P311, DOI 10.1146/annurev.physiol.61.1.311; OTSU K, 1990, J BIOL CHEM, V265, P13472; Pozzo-Miller LD, 1999, MICROSC RES TECHNIQ, V46, P370, DOI 10.1002/(SICI)1097-0029(19990915)46:6<370::AID-JEMT5>3.0.CO;2-3; Ren Y, 2000, J NEUROSCI METH, V102, P165, DOI 10.1016/S0165-0270(00)00304-6; RIOS E, 1987, NATURE, V325, P717, DOI 10.1038/325717a0; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; Stys PK, 1997, J NEUROCHEM, V68, P1920; STYS PK, 1990, P NATL ACAD SCI USA, V87, P4212, DOI 10.1073/pnas.87.11.4212; STYS PK, 1992, J NEUROSCI, V12, P430; STYS PK, 1991, BRAIN RES, V546, P18, DOI 10.1016/0006-8993(91)91154-S; STYS PK, 2004, IN PRESS CURR MOL ME; Tekkok SB, 2001, J NEUROSCI, V21, P4237, DOI 10.1523/JNEUROSCI.21-12-04237.2001; Thorell WE, 2002, J NEUROTRAUM, V19, P335, DOI 10.1089/089771502753594909; TRAPP BD, 1995, J NEUROSCI, V15, P1797, DOI 10.1523/JNEUROSCI.15-03-01797.1995; WAXMAN SG, 1993, BRAIN RES, V614, P137, DOI 10.1016/0006-8993(93)91027-P; Woo SH, 2003, CIRC RES, V92, pE1, DOI 10.1161/01.RES.0000051887.97625.07; XU KY, 1995, CIRC RES, V77, P88, DOI 10.1161/01.RES.77.1.88	52	154	155	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 25	2003	40	1					53	63		10.1016/j.neuron.2003.08.016	http://dx.doi.org/10.1016/j.neuron.2003.08.016			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	726TA	14527433	Bronze			2022-12-24	WOS:000185614700009
J	Chen, A; Muzzio, IA; Malleret, G; Bartsch, D; Verbitsky, M; Pavlidis, P; Yonan, AL; Vronskaya, S; Grody, MB; Cepeda, I; Gilliam, TC; Kandel, ER				Chen, A; Muzzio, IA; Malleret, G; Bartsch, D; Verbitsky, M; Pavlidis, P; Yonan, AL; Vronskaya, S; Grody, MB; Cepeda, I; Gilliam, TC; Kandel, ER			Inducible enhancement of memory storage and synaptic plasticity in transgenic mice expressing an inhibitor of ATF4 (CREB-2) and C/EBP proteins	NEURON			English	Article							LONG-TERM-MEMORY; TRANSCRIPTION FACTOR FAMILY; CAMP-RESPONSIVE ELEMENT; BINDING-PROTEIN; RAT HIPPOCAMPUS; DNA-BINDING; DEFICIENT MICE; ACTINOMYCIN-D; INBRED MICE; MOUSE-BRAIN	To examine the role of C/EBP-related transcription factors in long-term synaptic plasticity and memory storage, we have used the tetracycline-regulated system and expressed in the forebrain of mice a broad dominant-negative inhibitor of C/EBP (EGFP-AZIP), which preferentially interacts with several inhibiting isoforms of C/EBP. EGFP-AZIP also reduces the expression of ATF4, a distant member of the C/EBP family of transcription factors that is homologous to the Aplysia memory suppressor gene ApCREB-2. Consistent with the removal of inhibitory constraints on transcription, we find an increase in the pattern of gene transcripts in the hippocampus of EGFP-AZIP transgenic mice and both a reversibly enhanced hippocampal-based spatial memory and LTP. These results suggest that several proteins within the C/EBP family including ATF4 (CREB-2) act to constrain long-term synaptic changes and memory formation. Relief of this inhibition lowers the threshold for hippocampal-dependent long-term synaptic potentiation and memory storage in mice.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Columbia Genome Ctr, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Kandel, ER (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA.		Chen, I-Hweii Amy/AAY-5841-2020; Pavlidis, Paul/H-8406-2013	Pavlidis, Paul/0000-0002-0426-5028; Cepeda, Ivan Leonardo/0000-0001-9696-4047				Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Abel T, 1998, BRAIN RES REV, V26, P360, DOI 10.1016/S0165-0173(97)00050-7; AGRANOFF BW, 1967, SCIENCE, V158, P1600, DOI 10.1126/science.158.3808.1600; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Bucher K, 2000, DEV BIOL, V227, P533, DOI 10.1006/dbio.2000.9920; Buck M, 2001, MOL CELL, V8, P807, DOI 10.1016/S1097-2765(01)00374-4; Burgess-Beusse BL, 1999, HEPATOLOGY, V29, P597, DOI 10.1002/hep.510290245; CHAVEZNORIEGA LE, 1992, BRAIN RES, V574, P85, DOI 10.1016/0006-8993(92)90803-H; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DAVIS RL, 1995, MOL CELL BIOCHEM, V149, P271, DOI 10.1007/BF01076588; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FLEXNER JB, 1963, SCIENCE, V141, P57, DOI 10.1126/science.141.3575.57; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Gachon F, 2001, FEBS LETT, V502, P57, DOI 10.1016/S0014-5793(01)02646-1; Gerlai R, 1998, BEHAV BRAIN RES, V95, P37, DOI 10.1016/S0166-4328(98)00002-3; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; Gombart A. F., 1997, Proceedings of the American Association for Cancer Research Annual Meeting, V38, P185; Hastings GA, 1997, J BIOL CHEM, V272, P33062, DOI 10.1074/jbc.272.52.33062; Hettmann T, 2000, DEV BIOL, V222, P110, DOI 10.1006/dbio.2000.9699; Hogan B, 1994, MANIPULATING MOUSE E; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; KRYLOV D, 1995, EMBO J, V14, P5329, DOI 10.1002/j.1460-2075.1995.tb00217.x; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Luthi A, 1997, J NEUROSCI, V17, P4688; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; MONTAROLO P, 1986, P1; Montkowski A, 1997, BRAIN RES, V762, P12, DOI 10.1016/S0006-8993(97)00370-3; Mori S, 1999, MOL BRAIN RES, V64, P199, DOI 10.1016/S0169-328X(98)00323-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nguyen PV, 2000, J NEUROPHYSIOL, V84, P2484, DOI 10.1152/jn.2000.84.5.2484; Nguyen PV, 2000, LEARN MEMORY, V7, P170, DOI 10.1101/lm.7.3.170; NISHIBORI M, 1995, NEUROSCI LETT, V200, P125, DOI 10.1016/0304-3940(95)12095-L; Osada S, 1996, J BIOL CHEM, V271, P3891; POCKETT S, 1993, NEUROSCIENCE, V52, P229, DOI 10.1016/0306-4522(93)90151-5; Ryan TA, 1999, J NEUROSCI, V19, P1317; Sakaguchi Y, 1999, BBA-GENE STRUCT EXPR, V1444, P111, DOI 10.1016/S0167-4781(98)00259-0; Sambrook J., 2002, MOL CLONING LAB MANU; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; SQUIRE LR, 1970, NATURE, V225, P649, DOI 10.1038/225649a0; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; Sun MK, 2002, TRENDS PHARMACOL SCI, V23, P83, DOI 10.1016/S0165-6147(02)01899-0; Sun MK, 2001, J PHARMACOL EXP THER, V297, P961; Tanaka T, 1998, GENES CELLS, V3, P801, DOI 10.1046/j.1365-2443.1998.00230.x; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Taubenfeld SM, 2001, J NEUROSCI, V21, P84, DOI 10.1523/JNEUROSCI.21-01-00084.2001; TULLY T, 1994, J NEUROSCI, V14, P68; VALLEJO M, 1993, P NATL ACAD SCI USA, V90, P4679, DOI 10.1073/pnas.90.10.4679; van den Pol AN, 1998, J NEUROSCI, V18, P10640; Vernon E, 2001, MOL CELL NEUROSCI, V17, P637, DOI 10.1006/mcne.2000.0960; VINSON CR, 1993, GENE DEV, V7, P1047, DOI 10.1101/gad.7.6.1047; WAGNER JJ, 1995, J NEUROSCI, V15, P1577; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; White JH, 2000, P NATL ACAD SCI USA, V97, P13967, DOI 10.1073/pnas.240452197; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; Wolfer DP, 1998, NEWS PHYSIOL SCI, V13, P118, DOI 10.1152/physiologyonline.1998.13.3.118; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Yukawa K, 1998, J BIOL CHEM, V273, P31345, DOI 10.1074/jbc.273.47.31345	70	203	220	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 14	2003	39	4					655	669		10.1016/S0896-6273(03)00501-4	http://dx.doi.org/10.1016/S0896-6273(03)00501-4			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	712CQ	12925279	Bronze			2022-12-24	WOS:000184779500010
J	Martemyanov, KA; Hopp, JA; Arshavsky, VY				Martemyanov, KA; Hopp, JA; Arshavsky, VY			Specificity of G protein-RGS protein recognition is regulated by affinity adapters	NEURON			English	Article							GAMMA-SUBUNIT; EFFECTOR COMPLEX; GTPASE ACTIVITY; TRANSDUCIN; PHOTORECEPTORS; EXPRESSION; BINDING; RAT; ACTIVATION; CHANNELS	RGS proteins regulate the duration of cell signaling by modulating the lifetime of activated G proteins. The specificity of RGS-G protein mutual recognition is critical for meeting unique timing requirements of numerous G protein-mediated pathways. Our study of two splice isoforms of RGS9 expressed in different types of neurons revealed a novel mechanism whereby this specificity is determined by specialized protein domains or subunits acting as affinity adapters. The long RGS9 isoform contains a C-terminal domain that provides high-affinity interaction with its target G protein. The lack of this domain in the short RGS9 isoform is compensated by the action of a G protein effector subunit that is structurally similar to this C-terminal domain. This allows the short isoform to specifically target the complex between the G protein and its effector. Thus, the specific timing needs of different signaling pathways can be accommodated by affinity adapters positioned at various pathway components.	Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Howe Lab Ophthalmol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Arshavsky, VY (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Howe Lab Ophthalmol, Boston, MA 02114 USA.	vadim_arshavsky@meei.harvard.edu			NEI NIH HHS [EY 12859] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012859] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARSHAVSKY VY, 1994, J BIOL CHEM, V269, P19882; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Arshavsky VY, 1998, NEURON, V20, P11, DOI 10.1016/S0896-6273(00)80430-4; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Blanchet C, 2002, P NATL ACAD SCI USA, V99, P4674, DOI 10.1073/pnas.072075399; Burchett SA, 2000, J NEUROCHEM, V75, P1335, DOI 10.1046/j.1471-4159.2000.0751335.x; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Dascal N, 1997, CELL SIGNAL, V9, P551, DOI 10.1016/S0898-6568(97)00095-8; Garzon J, 2001, EUR J NEUROSCI, V13, P801, DOI 10.1046/j.0953-816x.2000.01444.x; Granneman JG, 1998, MOL PHARMACOL, V54, P687; GREIF GJ, 1995, J NEUROSCI, V15, P4533; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Hooks SB, 2003, J BIOL CHEM, V278, P10087, DOI 10.1074/jbc.M211382200; Kovoor A, 2000, J BIOL CHEM, V275, P3397, DOI 10.1074/jbc.275.5.3397; Krumins AM, 2002, METHOD ENZYMOL, V344, P673; LEE E, 1994, METHOD ENZYMOL, V237, P146; Makino ER, 1999, P NATL ACAD SCI USA, V96, P1947, DOI 10.1073/pnas.96.5.1947; Meyer A, 2003, NATURE, V421, P31, DOI 10.1038/421031a; Nekrasova ER, 1997, BIOCHEMISTRY-US, V36, P7638, DOI 10.1021/bi970427r; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; OTTOBRUC A, 1994, FEBS LETT, V343, P183, DOI 10.1016/0014-5793(94)80552-0; PFISTER C, 1993, CELL SIGNAL, V5, P235, DOI 10.1016/0898-6568(93)90015-E; Pruss H, 2003, MOL BRAIN RES, V110, P203, DOI 10.1016/S0169-328X(02)00649-6; Rahman Z, 1999, J NEUROSCI, V19, P2016; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Skiba NP, 2000, J BIOL CHEM, V275, P32716, DOI 10.1074/jbc.C000413200; Skiba NP, 1999, J BIOL CHEM, V274, P8770, DOI 10.1074/jbc.274.13.8770; Skiba NP, 2001, J BIOL CHEM, V276, P37365, DOI 10.1074/jbc.M106431200; SLEPAK VZ, 1995, J BIOL CHEM, V270, P14319, DOI 10.1074/jbc.270.24.14319; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Thomas EA, 1998, J NEUROSCI RES, V52, P118, DOI 10.1002/(SICI)1097-4547(19980401)52:1<118::AID-JNR11>3.0.CO;2-6; TING TD, 1993, METH NEUROSCI, V15, P180; Tsang SH, 1998, SCIENCE, V282, P117, DOI 10.1126/science.282.5386.117; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; WORLEY PF, 1986, P NATL ACAD SCI USA, V83, P4561, DOI 10.1073/pnas.83.12.4561; Zhang QL, 2002, J PHYSIOL-LONDON, V545, P355, DOI 10.1113/jphysiol.2002.032151	39	39	39	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 19	2003	38	6					857	862		10.1016/S0896-6273(03)00320-9	http://dx.doi.org/10.1016/S0896-6273(03)00320-9			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	693AA	12818172	Bronze			2022-12-24	WOS:000183691400006
J	Yamanaka, A; Beuckmann, CT; Willie, JT; Hara, J; Tsujino, N; Mieda, M; Tominaga, M; Yagami, K; Sugiyama, F; Goto, K; Yanagisawa, M; Sakurai, T				Yamanaka, A; Beuckmann, CT; Willie, JT; Hara, J; Tsujino, N; Mieda, M; Tominaga, M; Yagami, K; Sugiyama, F; Goto, K; Yanagisawa, M; Sakurai, T			Hypothalamic orexin neurons regulate arousal according to energy balance in mice	NEURON			English	Article							ADULT-RAT BRAIN; MESSENGER-RNA; HYPOCRETIN OREXIN; FOOD-DEPRIVATION; FEEDING-BEHAVIOR; HUMAN NARCOLEPSY; FOS EXPRESSION; PREPRO-OREXIN; A LEVELS; SLEEP	Mammals respond to reduced food availability by becoming more wakeful and active, yet the central pathways regulating arousal and instinctual motor programs (such as food seeking) according to homeostatic need are not well understood. We demonstrate that hypothalamic orexin neurons monitor indicators of energy balance and mediate adaptive augmentation of arousal in response to fasting. Activity of isolated orexin neurons is inhibited by glucose and leptin and stimulated by ghrelin. Orexin expression of normal and ob/ob mice correlates negatively with changes in blood glucose, leptin, and food intake. Transgenic mice, in which orexin neurons are ablated, fail to respond to fasting with increased wakefulness and activity. These findings indicate that orexin neurons provide a crucial link between energy balance and arousal.	Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058575, Japan; Univ Tsukuba, Dept Pharmacol, Tsukuba, Ibaraki 3058575, Japan; Univ Tsukuba, Dept Mol Neurobiol, Tsukuba, Ibaraki 3058575, Japan; Univ Tsukuba, Lab Anim Res Ctr, Tsukuba, Ibaraki 3058575, Japan; Japan Sci & Technol Corp, Erato Yanagisawa Orphan Receptor Project, Tokyo 1350064, Japan; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dept Mol Genet, Dallas, TX 75390 USA	University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST); Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Yanagisawa, M (corresponding author), Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058575, Japan.	masashi.yanagisawa@utsouthwestern.edu; stakeshi@md.tsukuba.ac.jp	Yamanaka, Akihiro/F-2914-2011; Yamanaka, Akihiro/AAD-8641-2021	Yamanaka, Akihiro/0000-0001-6099-7306; Mieda, Michihiro/0000-0002-2451-7034				Abrahamson EE, 2001, NEUROREPORT, V12, P435, DOI 10.1097/00001756-200102120-00048; Banarer S, 2003, DIABETES, V52, P1195, DOI 10.2337/diabetes.52.5.1195; BORBELY AA, 1977, BRAIN RES, V124, P457, DOI 10.1016/0006-8993(77)90947-7; Cai XJ, 1999, DIABETES, V48, P2132, DOI 10.2337/diabetes.48.11.2132; Challet E, 1997, BEHAV BRAIN RES, V84, P275, DOI 10.1016/S0166-4328(97)83335-9; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chou TC, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-19-j0003.2001; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; CRISP AH, 1971, POSTGRAD MED J, V47, P207, DOI 10.1136/pgmj.47.546.207; Cummings DE, 2002, NEW ENGL J MED, V346, P1623, DOI 10.1056/NEJMoa012908; DANGUIR J, 1979, PHYSIOL BEHAV, V22, P735, DOI 10.1016/0031-9384(79)90240-3; Date Y, 1999, P NATL ACAD SCI USA, V96, P748, DOI 10.1073/pnas.96.2.748; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; DEWASMES G, 1989, PHYSIOL BEHAV, V46, P179, DOI 10.1016/0031-9384(89)90252-7; Eggermann E, 2003, J NEUROSCI, V23, P1557; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Estabrooke IV, 2001, J NEUROSCI, V21, P1656, DOI 10.1523/JNEUROSCI.21-05-01656.2001; FEYRON C, 2000, NAT MED, V9, P991; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Fujiki N, 2001, NEUROREPORT, V12, P993, DOI 10.1097/00001756-200104170-00026; Gais S, 2003, SLEEP, V26, P55, DOI 10.1093/sleep/26.1.55; Griffond B, 1999, NEUROSCI LETT, V262, P77, DOI 10.1016/S0304-3940(98)00976-8; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; Hakansson ML, 1999, J NEUROENDOCRINOL, V11, P653; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Harnish MJ, 1998, PHYSIOL BEHAV, V64, P93, DOI 10.1016/S0031-9384(98)00025-0; HONDA Y, 1986, SLEEP, V9, P254, DOI 10.1093/sleep/9.1.254; ITOH T, 1990, PHARMACOL BIOCHEM BE, V35, P391; Jones TW, 1998, NEW ENGL J MED, V338, P1657, DOI 10.1056/NEJM199806043382303; KARKLIN A, 1994, AM J CLIN NUTR, V59, P346, DOI 10.1093/ajcn/59.2.346; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lawrence CB, 2002, ENDOCRINOLOGY, V143, P155, DOI 10.1210/en.143.1.155; Lee HM, 2002, ENDOCRINOLOGY, V143, P185, DOI 10.1210/en.143.1.185; Li Y, 2002, NEURON, V36, P1169, DOI 10.1016/S0896-6273(02)01132-7; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Lopez M, 2000, BIOCHEM BIOPH RES CO, V269, P41, DOI 10.1006/bbrc.2000.2245; Lubkin M, 1998, BIOCHEM BIOPH RES CO, V253, P241, DOI 10.1006/bbrc.1998.9750; Moriguchi T, 1999, NEUROSCI LETT, V264, P101, DOI 10.1016/S0304-3940(99)00177-9; Nakamura T, 2000, BRAIN RES, V873, P181, DOI 10.1016/S0006-8993(00)02555-5; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; Nishino S, 2001, ANN NEUROL, V50, P381, DOI 10.1002/ana.1130; OOMURA Y, 1984, J AUTONOM NERV SYST, V10, P359, DOI 10.1016/0165-1838(84)90033-X; Peyron C, 1998, J NEUROSCI, V18, P9996; Rivest S, 2002, ENDOCRINOLOGY, V143, P3211, DOI 10.1210/en.2002-220655; Sakurai T, 1999, J BIOL CHEM, V274, P17771, DOI 10.1074/jbc.274.25.17771; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Schuld A, 2000, LANCET, V355, P1274, DOI 10.1016/S0140-6736(05)74704-8; Shirasaka T, 1999, AM J PHYSIOL-REG I, V277, pR1780, DOI 10.1152/ajpregu.1999.277.6.R1780; Sinton CM, 1999, J SLEEP RES, V8, P197, DOI 10.1046/j.1365-2869.1999.00158.x; Smart D, 2002, EUR J PHARMACOL, V440, P199, DOI 10.1016/S0014-2999(02)01429-2; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Tolle V, 2002, ENDOCRINOLOGY, V143, P1353, DOI 10.1210/en.143.4.1353; Toshinai K, 2003, ENDOCRINOLOGY, V144, P1506, DOI 10.1210/en.2002-220788; Valentinuzzi VS, 2000, PHYSIOL BEHAV, V69, P269, DOI 10.1016/S0031-9384(00)00219-5; Wang LX, 2002, NEUROSCI LETT, V325, P47; Williams TD, 2002, AM J PHYSIOL-REG I, V282, pR1459, DOI 10.1152/ajpregu.00612.2001; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Willie JT, 2001, ANNU REV NEUROSCI, V24, P429, DOI 10.1146/annurev.neuro.24.1.429; Yamamoto Y, 1999, MOL BRAIN RES, V65, P14, DOI 10.1016/S0169-328X(98)00320-9; Yamanaka A, 2000, BRAIN RES, V859, P404, DOI 10.1016/S0006-8993(00)02043-6; Yamanaka A, 2003, BIOCHEM BIOPH RES CO, V303, P120, DOI 10.1016/S0006-291X(03)00299-7; Yoshida Y, 2001, EUR J NEUROSCI, V14, P1075, DOI 10.1046/j.0953-816x.2001.01725.x	67	666	685	2	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 5	2003	38	5					701	713		10.1016/S0896-6273(03)00331-3	http://dx.doi.org/10.1016/S0896-6273(03)00331-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	687DU	12797956	Bronze			2022-12-24	WOS:000183361400007
J	Yuan, A; Santi, CM; Wei, A; Wang, ZW; Pollak, K; Nonet, M; Kaczmarek, L; Crowder, CM; Salkoff', L				Yuan, A; Santi, CM; Wei, A; Wang, ZW; Pollak, K; Nonet, M; Kaczmarek, L; Crowder, CM; Salkoff', L			The sodium-activated potassium channel is encoded by a member of the Slo gene family	NEURON			English	Article							K+ CHANNELS; C-ELEGANS; BRAIN-STEM; NA+; NEURONS; SENSITIVITY; SYSTEM; MUSCLE; DOMAIN; SITES	Na+-activated potassium channels (K-Na) have been identified in cardiomyocytes and neurons where they may provide protection against ischemia. We now report that K-Na is encoded by the rSlo2 gene (also called Slack), the mammalian ortholog of slo-2 in C. elegans. rSlo2, heterologously expressed, shares many properties of native K-Na including activation by intracellular Na+, high conductance, and prominent subconductance states. In addition to activation by Na+, we report that rSLO-2 channels are cooperatively activated by intracellular Cl-, similar to C. elegans SLO-2 channels. Since intracellular Na+ and Cl- both rise in oxygen-deprived cells, coactivation may more effectively trigger the activity of rSLO-2 channels in ischemia. In C. elegans, mutational and physiological analysis revealed that the SLO-2 current is a major component of the delayed rectifier. We demonstrate in C. elegans that slo-2 mutants are hypersensitive to hypoxia, suggesting a conserved role for the slo-2 gene subfamily.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Yale University	Salkoff', L (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	salkoffl@pcg.wustl.edu		Yuan, Alex/0000-0003-0191-8035	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045905] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM067154] Funding Source: Medline; NINDS NIH HHS [R01 NS045905] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; BADER CR, 1985, NATURE, V317, P540, DOI 10.1038/317540a0; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bhattacharjee A, 2002, J COMP NEUROL, V454, P241, DOI 10.1002/cne.10439; Bischoff U, 1998, J PHYSIOL-LONDON, V510, P743, DOI 10.1111/j.1469-7793.1998.743bj.x; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Christensen M, 2002, NEURON, V33, P503, DOI 10.1016/S0896-6273(02)00591-3; DALE N, 1993, J PHYSIOL-LONDON, V462, P349, DOI 10.1113/jphysiol.1993.sp019559; DRYER SE, 1989, J PHYSIOL-LONDON, V410, P283, DOI 10.1113/jphysiol.1989.sp017533; DRYER SE, 1993, NEUROSCI LETT, V149, P133, DOI 10.1016/0304-3940(93)90754-9; DRYER SE, 1994, TRENDS NEUROSCI, V17, P155, DOI 10.1016/0166-2236(94)90093-0; DRYER SE, 1991, J PHYSIOL-LONDON, V435, P513, DOI 10.1113/jphysiol.1991.sp018522; EGAN TM, 1992, BRAIN RES, V584, P319, DOI 10.1016/0006-8993(92)90913-T; EGAN TM, 1992, J NEUROSCI, V12, P1964; HADDAD GG, 1993, PROG NEUROBIOL, V40, P277, DOI 10.1016/0301-0082(93)90014-J; HAIMANN C, 1992, PFLUG ARCH EUR J PHY, V422, P287, DOI 10.1007/BF00376215; HAIMANN C, 1990, J GEN PHYSIOL, V95, P961, DOI 10.1085/jgp.95.5.961; Hille B., 1992, ION CHANNELS EXCITAB; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; KAMEYAMA M, 1984, NATURE, V309, P354, DOI 10.1038/309354a0; KLINE RP, 1992, CIRC RES, V70, P566, DOI 10.1161/01.RES.70.3.566; Lai ZF, 1998, AM J PHYSIOL-HEART C, V275, pH1613, DOI 10.1152/ajpheart.1998.275.5.H1613; LUK HN, 1990, PFLUG ARCH EUR J PHY, V416, P766, DOI 10.1007/BF00370627; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; Mistry DK, 1997, J PHYSIOL-LONDON, V500, P39, DOI 10.1113/jphysiol.1997.sp021997; MITANI A, 1992, AM J PHYSIOL, V263, pH333, DOI 10.1152/ajpheart.1992.263.2.H333; Nakamura T, 1999, MOL CELL BIOCHEM, V194, P147, DOI 10.1023/A:1006919929104; NICHOLLS JG, 1992, NEURON BRAIN; Pogorelov AG, 2002, BIOFIZIKA+, V47, P744; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Safronov BV, 1996, J PHYSIOL-LONDON, V497, P727, DOI 10.1113/jphysiol.1996.sp021803; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Schreiber M, 1999, NAT NEUROSCI, V2, P416, DOI 10.1038/8077; Schreiber M, 1998, J BIOL CHEM, V273, P3509, DOI 10.1074/jbc.273.6.3509; SCHWINDT PC, 1989, J NEUROPHYSIOL, V61, P233, DOI 10.1152/jn.1989.61.2.233; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; WANG Z, 1991, J PHYSIOL-LONDON, V433, P241, DOI 10.1113/jphysiol.1991.sp018424; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0; Wei AG, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf109; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yuan A, 2000, NAT NEUROSCI, V3, P771, DOI 10.1038/77670; Zhang ZW, 2001, JPN CIRC J, V65, P678, DOI 10.1253/jcj.65.678	46	181	186	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 6	2003	37	5					765	773		10.1016/S0896-6273(03)00096-5	http://dx.doi.org/10.1016/S0896-6273(03)00096-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	653TH	12628167	Bronze			2022-12-24	WOS:000181452800006
J	Liu, SH; Lau, L; Wei, JS; Zhu, DY; Zou, SW; Sun, HS; Fu, YP; Liu, F; Lu, YM				Liu, SH; Lau, L; Wei, JS; Zhu, DY; Zou, SW; Sun, HS; Fu, YP; Liu, F; Lu, YM			Expression of Ca2+-Permeable AMPA receptor channels primes cell death in transient forebrain ischemia	NEURON			English	Article							HIPPOCAMPAL PYRAMIDAL NEURONS; GLOBAL CEREBRAL-ISCHEMIA; ELEMENT-BINDING PROTEIN; ADULT-RAT HIPPOCAMPUS; GLUR2 MESSENGER-RNA; CA2+ PERMEABILITY; GENE-EXPRESSION; SELECTIVE VULNERABILITY; GLUTAMATE RECEPTORS; RELATIVE ABUNDANCE	CA1 pyramidal neurons degenerate after transient global ischemia, whereas neurons in other regions of the hippocampus remain intact. A step in this selective injury is Ca2+ and/or Zn2+ entry through Ca2+-permeable AMPA receptor channels; reducing Ca2+ permeability of AMPA receptors via expression of Ca2+-impermeable GluR2(R) channels or activation of CRE transcription in the hippocampus of adult rats in vivo using shutoff-deficient pSFV-based vectors rescues vulnerable CA1 pyramidal neurons from forebrain ischemic injury. Conversely, the induction of Ca2+ and/or Zn2+ influx through AMPA receptors by expressing functional Ca2+-permeable GluR2(Q) channels causes the postischemic degeneration of hippocampal granule neurons that otherwise are insensitive to ischemic insult. Thus, the AMPA receptor subunit GluR2 gates entry of Ca2+ and/or Zn2+ that leads to cell death following transient forebrain ischemia.	Univ Calgary, Fac Med, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; Ctr Addict & Mental Hlth, Dept Neurosci, Clarke Div, Toronto, ON M5T 1R8, Canada	University of Calgary; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Lu, YM (corresponding author), Univ Calgary, Fac Med, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada.	luy@ucalgary.ca						Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Anzai T, 2003, NEUROSCI RES, V46, P41, DOI 10.1016/S0168-0102(03)00023-3; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brene S, 2000, EUR J NEUROSCI, V12, P1525, DOI 10.1046/j.1460-9568.2000.00040.x; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Calderone A, 2003, J NEUROSCI, V23, P2112; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Davis SM, 1997, LANCET, V349, P32, DOI 10.1016/S0140-6736(05)62166-6; FRANK L, 1995, ACTA NEUROL SCAND, V92, P337; FRIEDMAN LK, 1994, J NEUROSCI, V14, P2697; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GOLDBERG MP, 1987, J PHARMACOL EXP THER, V243, P784; Gorter JA, 1997, J NEUROSCI, V17, P6179; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hu RQ, 2001, BRAIN RES, V897, P27, DOI 10.1016/S0006-8993(01)02076-5; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; Kawahara Y, 2003, J NEUROCHEM, V85, P680, DOI 10.1046/j.1471-4159.2003.01703.x; Kjoller C, 2000, NEUROCHEM INT, V37, P7, DOI 10.1016/S0197-0186(00)00008-5; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; KOKAIA Z, 1995, EXP NEUROL, V136, P73, DOI 10.1006/exnr.1995.1085; Kumar SS, 2002, J NEUROSCI, V22, P3005, DOI 10.1523/JNEUROSCI.22-08-03005.2002; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lees KR, 2000, LANCET, V355, P1949, DOI 10.1016/S0140-6736(00)02326-6; LEWIS CA, 1979, J PHYSIOL-LONDON, V286, P417, DOI 10.1113/jphysiol.1979.sp012629; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu SH, 2003, J NEUROSCI, V23, P732; Maintz J B, 1998, Med Image Anal, V2, P1, DOI 10.1016/S1361-8415(01)80026-8; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Oguro K, 1999, J NEUROSCI, V19, P9218; OTIS TS, 1995, J PHYSIOL-LONDON, V482, P309, DOI 10.1113/jphysiol.1995.sp020519; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; PELLEGRINIGIAMPIETRO DE, 1992, P NATL ACAD SCI USA, V89, P10499, DOI 10.1073/pnas.89.21.10499; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Tabuchi A, 2002, J BIOL CHEM, V277, P35920, DOI 10.1074/jbc.M204784200; Tanaka H, 2002, P NATL ACAD SCI USA, V99, P2362, DOI 10.1073/pnas.261713299; Tanaka H, 2000, BRAIN RES, V886, P190, DOI 10.1016/S0006-8993(00)02951-6; Tanaka K, 1999, NEUROREPORT, V10, P2245, DOI 10.1097/00001756-199908020-00004; Van Damme P, 2002, J NEUROPHYSIOL, V88, P1279, DOI 10.1152/jn.2002.88.3.1279; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; Walton M, 1996, MOL BRAIN RES, V43, P21, DOI 10.1016/S0169-328X(96)00144-1; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; Wang J, 2003, NAT NEUROSCI, V6, P1039, DOI 10.1038/nn1119; Washburn MS, 1996, J PHARMACOL EXP THER, V278, P669; Weiss JH, 2000, TRENDS NEUROSCI, V23, P365, DOI 10.1016/S0166-2236(00)01610-6; Yin HZ, 2002, J NEUROSCI, V22, P1273, DOI 10.1523/JNEUROSCI.22-04-01273.2002; Zhu DY, 2003, J NEUROSCI, V23, P223	64	159	167	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 8	2004	43	1					43	55		10.1016/j.neuron.2004.06.017	http://dx.doi.org/10.1016/j.neuron.2004.06.017			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233916	Bronze			2022-12-24	WOS:000222549800006
J	Staal, RGW; Mosharov, EV; Sulzer, D				Staal, RGW; Mosharov, EV; Sulzer, D			Dopamine neurons release transmitter via a flickering fusion pore	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; SYNAPTIC VESICLES; CHROMAFFIN CELLS; HORSE EOSINOPHILS; SUBSTANTIA-NIGRA; QUANTAL SIZE; SINGLE; EXOCYTOSIS; TRANSMISSION; MIDBRAIN	A key question in understanding mechanisms of neurotransmitter release is whether the fusion pore of a synaptic vesicle regulates the amount of transmitter released during exocytosis. We measured dopamine release from small synaptic vesicles of rat cultured ventral midbrain neurons using carbon fiber amperometry. Our data indicate that small synaptic vesicle fusion pores flicker either once or multiple times in rapid succession, with each flicker releasing similar to25-30% of vesicular dopamine. The incidence of events with multiple flickers was reciprocally regulated by phorbol esters and staurosporine. Thus, dopamine neurons regulate the amount of neurotransmitter released by small synaptic vesicles by controlling the number of fusion pore flickers per exocytotic event. This mode of exocytosis is a potential mechanism whereby neurons can rapidly reuse vesicles without undergoing the comparatively slow process of recycling.	Columbia Univ, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Dept Neurosci, New York, NY 10032 USA	Columbia University; Columbia University; New York State Psychiatry Institute	Sulzer, D (corresponding author), Columbia Univ, Dept Neurol, Black 305,650 W 168th St, New York, NY 10032 USA.	ds43@columbia.edu		Staal, Roland/0000-0002-2857-2241				Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Berg H.C., 1983, RANDOM WALKS BIOL, P152; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; Bittner MA, 2000, BIOCHIMIE, V82, P447, DOI 10.1016/S0300-9084(00)00222-4; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; CHEN GY, 1995, J NEUROSCI, V15, P7747; Colliver TL, 2000, J NEUROCHEM, V74, P1086; Colquhoun David, 1995, P483; Cragg SJ, 2001, J NEUROPHYSIOL, V85, P1761, DOI 10.1152/jn.2001.85.4.1761; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; GARRIS PA, 1994, J NEUROSCI, V14, P6084; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; GIROD R, 1993, J PHYSIOL-LONDON, V471, P129, DOI 10.1113/jphysiol.1993.sp019894; Gonon F, 2000, PROG BRAIN RES, V125, P291; Graham ME, 2000, BIOCHIMIE, V82, P469, DOI 10.1016/S0300-9084(00)00196-6; Hafez I, 2003, J BIOL CHEM, V278, P44921, DOI 10.1074/jbc.M306013200; HARTMANN J, 1995, J PHYSIOL-LONDON, V483, P201, DOI 10.1113/jphysiol.1995.sp020578; Henkel AW, 1995, J NEUROSCI, V15, P8246; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hochstetler SE, 2000, ANAL CHEM, V72, P489, DOI 10.1021/ac991119x; Jaffe EH, 1998, J NEUROSCI, V18, P3548; Jeremic A, 2003, BIOPHYS J, V85, P2035, DOI 10.1016/S0006-3495(03)74631-1; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; Levant B, 1997, PHARMACOL REV, V49, P231; LOLLIKE K, 1995, J CELL BIOL, V129, P99, DOI 10.1083/jcb.129.1.99; NICHOLSON C, 1999, MONITORING MOL NEURO, V8, P71; Pickel VM, 1996, J NEUROCYTOL, V25, P843, DOI 10.1007/BF02284846; Pothos EN, 1998, J NEUROSCI, V18, P5575; Pothos EN, 1998, J NEUROSCI, V18, P4106; Pothos EN, 2000, J NEUROSCI, V20, P7297; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; RICE ME, 1994, EXP BRAIN RES, V100, P395, DOI 10.1007/BF02738400; Scepek S, 1998, EMBO J, V17, P4340, DOI 10.1093/emboj/17.15.4340; Schmitz Y, 2003, J NEUROCHEM, V87, P273, DOI 10.1046/j.1471-4159.2003.02050.x; Schmitz Y, 2001, J NEUROSCI, V21, P5916, DOI 10.1523/JNEUROSCI.21-16-05916.2001; Stiles JR, 1996, P NATL ACAD SCI USA, V93, P5747, DOI 10.1073/pnas.93.12.5747; Sulzer D, 2000, REV NEUROSCIENCE, V11, P159; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Valtorta F, 2001, TRENDS CELL BIOL, V11, P324, DOI 10.1016/S0962-8924(01)02058-X; Wang P, 2003, J BIOL CHEM, V278, P47030, DOI 10.1074/jbc.M306728200; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; Yang Y, 2002, P NATL ACAD SCI USA, V99, P17060, DOI 10.1073/pnas.242624699; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7; Zhu HL, 2002, P NATL ACAD SCI USA, V99, P17055, DOI 10.1073/pnas.232588899	48	227	231	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					341	346		10.1038/nn1205	http://dx.doi.org/10.1038/nn1205			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	14990933				2022-12-24	WOS:000220482500012
J	Pavani, F; Castiello, U				Pavani, F; Castiello, U			Binding personal and extrapersonal space through body shadows	NATURE NEUROSCIENCE			English	Article								Shadows in visual scenes can have profound effects on visual perception. Here we have found that visual distracters distant from the body interfere with human spatial discrimination of tactile targets at a hand, particularly when the shadow of the stimulated hand stretches toward them in extrapersonal space. These findings suggest that shadows cast by a person's own body parts can bridge the gap between personal and extrapersonal space.	Univ Studi Trento, Dipartimento Sci Congniz & Formaz, I-38068 Rovereto, Italy; Royal Holloway Univ London, Dept Psychol, Egham TW20 0EX, Surrey, England	University of London; Royal Holloway University London	Pavani, F (corresponding author), Univ Studi Trento, Dipartimento Sci Congniz & Formaz, Via Matteo del Ben 5,3rd Floor, I-38068 Rovereto, Italy.	pavani@form.unitn.it	Pavani, Francesco/B-4836-2010	Pavani, Francesco/0000-0003-0426-5578; Castiello, Umberto/0000-0003-0629-1286				Castiello U, 2001, VISION RES, V41, P2305, DOI 10.1016/S0042-6989(01)00141-9; Farne A, 2000, NEUROREPORT, V11, P1645, DOI 10.1097/00001756-200006050-00010; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Iriki A, 1996, NEUROREPORT, V7, P2325; Kersten D, 1996, NATURE, V379, P31, DOI 10.1038/379031a0; Mamassian P, 1998, TRENDS COGN SCI, V2, P288, DOI 10.1016/S1364-6613(98)01204-2; Maravita A, 2003, CURR BIOL, V13, pR531, DOI 10.1016/S0960-9822(03)00449-4; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190	10	67	67	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					14	15		10.1038/nn1167	http://dx.doi.org/10.1038/nn1167			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14699414				2022-12-24	WOS:000187636000007
J	Deboer, T; Vansteensel, MJ; Detari, L; Meijer, JH				Deboer, T; Vansteensel, MJ; Detari, L; Meijer, JH			Sleep states alter activity of suprachiasmatic nucleus neurons	NATURE NEUROSCIENCE			English	Article							EEG POWER SPECTRA; SLOW-WAVE SLEEP; CIRCADIAN PACEMAKER; CORTICAL TEMPERATURE; DJUNGARIAN HAMSTER; LESIONED RATS; DEPRIVATION; PERIOD; BRAIN; HOMEOSTASIS	The timing of sleep and wakefulness in mammals is governed by a sleep homeostatic process and by the circadian clock of the suprachiasmatic nucleus (SCN), which has a molecular basis for rhythm generation. By combining SCN electrical activity recordings with electroencephalogram (EEG) recordings in the same animal (the Wistar rat), we discovered that changes in vigilance states are paralleled by strong changes in SCN electrophysiological activity. During rapid eye movement (REM) sleep, neuronal activity in the SCN was elevated, and during non-REM (NREM) sleep, it was lowered. We also carried out selective sleep deprivation experiments to confirm that changes in SCN electrical activity are caused by changes in vigilance state. Our results indicate that the 24-hour pattern in electrical activity that is controlled by the molecular machinery of the SCN is substantially modified by afferent information from the central nervous system.	Leiden Univ, Med Ctr, Dept Neurophysiol, NL-2300 RC Leiden, Netherlands; Eotvos Lorand Univ, Dept Physiol & Neurobiol, H-1088 Budapest, Hungary	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Eotvos Lorand University	Meijer, JH (corresponding author), Leiden Univ, Med Ctr, Dept Neurophysiol, Box 9604, NL-2300 RC Leiden, Netherlands.	j.h.meijer@lumc.nl	Vansteensel, Mariska/K-8015-2019	Vansteensel, Mariska/0000-0002-9252-5116				ACHERMANN P, 1994, BIOL CYBERN, V71, P115, DOI 10.1007/BF00197314; Albus H, 2002, CURR BIOL, V12, P1130, DOI 10.1016/S0960-9822(02)00923-5; Antle MC, 2000, J NEUROSCI, V20, P9326; BENINGTON JH, 1994, AM J PHYSIOL, V266, pR1992, DOI 10.1152/ajpregu.1994.266.6.R1992; BENINGTON JH, PROG NEUROBIOL, V45, P347; BINA KG, 1993, J COMP NEUROL, V335, P295, DOI 10.1002/cne.903350212; Borbely A. A., 2000, PRINCIPLES PRACTICE, P377; BORBELY AA, 1984, BEHAV BRAIN RES, V14, P171, DOI 10.1016/0166-4328(84)90186-4; CAMPBELL SS, 1989, PSYCHOPHYSIOLOGY, V26, P580, DOI 10.1111/j.1469-8986.1989.tb00714.x; CRICK F, 1983, NATURE, V304, P111, DOI 10.1038/304111a0; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; Deboer T, 2003, SLEEP, V26, P567, DOI 10.1093/sleep/26.5.567; DEBOER T, 1994, J COMP PHYSIOL A, V174, P145; DEBOER T, 1997, PFLUGERS ARCH, V433, P23; DIJK D J, 1987, Journal of Biological Rhythms, V2, P207, DOI 10.1177/074873048700200304; DIJK DJ, 1995, J NEUROSCI, V15, P3526; DIJK DJ, 1995, BEHAV BRAIN RES, V69, P109, DOI 10.1016/0166-4328(95)00007-G; DIJK DJ, 1987, EUR ARCH PSY CLIN N, V236, P323; DIJK DJ, 1989, AM J PHYSIOL, V156, pR106; EDGAR DM, 1993, J NEUROSCI, V13, P1065; Endo T, 1997, PSYCHIAT RES, V66, P97, DOI 10.1016/S0165-1781(96)03029-6; FRANKEN P, 1991, AM J PHYSIOL, V261, pR198, DOI 10.1152/ajpregu.1991.261.1.R198; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Huber R, 2000, BRAIN RES, V857, P8, DOI 10.1016/S0006-8993(99)02248-9; Jouvet M, 1998, J SLEEP RES, V7, P1, DOI 10.1046/j.1365-2869.7.s1.1.x; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; KRUEGER JM, 1993, J SLEEP RES, V2, P63, DOI 10.1111/j.1365-2869.1993.tb00064.x; LANCEL M, 1991, BRAIN RES, V548, P206, DOI 10.1016/0006-8993(91)91123-I; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; MCCARLEY RW, 1992, J SLEEP RES, V1, P132, DOI 10.1111/j.1365-2869.1992.tb00026.x; Meijer JH, 1997, BRAIN RES, V753, P322, DOI 10.1016/S0006-8993(97)00150-9; Meijer JH, 1998, J NEUROSCI, V18, P9078; MISTLBERGER RE, 1983, SLEEP, V6, P217, DOI 10.1093/sleep/6.3.217; Moore, 2001, HDB BEHAV NEUROBIOLO, V12; MOORE RY, 1978, J COMP NEUROL, V180, P417, DOI 10.1002/cne.901800302; MOSES JM, 1975, PSYCHOPHYSIOLOGY, V12, P141, DOI 10.1111/j.1469-8986.1975.tb01264.x; Nakamura W, 2002, NAT NEUROSCI, V5, P399, DOI 10.1038/nn843; Palchykova S, 2002, J SLEEP RES, V11, P313, DOI 10.1046/j.1365-2869.2002.00310.x; SCHWARTZ WJ, 1987, P NATL ACAD SCI USA, V84, P1694, DOI 10.1073/pnas.84.6.1694; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Strijkstra AM, 1998, AM J PHYSIOL-REG I, V275, pR1110, DOI 10.1152/ajpregu.1998.275.4.R1110; TOBLER I, 1986, ELECTROEN CLIN NEURO, V64, P74, DOI 10.1016/0013-4694(86)90044-1; TOBLER I, 1983, NEUROSCI LETT, V42, P49, DOI 10.1016/0304-3940(83)90420-2; TRACHSEL L, 1992, BRAIN RES, V589, P253, DOI 10.1016/0006-8993(92)91284-L; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20	45	210	216	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1086	1090		10.1038/nn1122	http://dx.doi.org/10.1038/nn1122			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	12958601				2022-12-24	WOS:000185633600021
J	Small, DM; Gregory, MD; Mak, YE; Gitelman, D; Mesulam, MM; Parrish, T				Small, DM; Gregory, MD; Mak, YE; Gitelman, D; Mesulam, MM; Parrish, T			Dissociation of neural representation of intensity and affective valuation in human gustation	NEURON			English	Article							TEMPORAL-LOBE REMOVAL; ORBITOFRONTAL CORTEX; PARABRACHIAL PONS; TASTE RESPONSES; HUMAN BRAIN; EMOTIONAL RESPONSES; INDUCED ACTIVATION; PAIN PERCEPTION; MUSIC CORRELATE; AVERSIVE TASTE	We used a 2 X 2 factorial design to dissociate regions responding to taste intensity and taste affective valence. Two intensities each of a pleasant and unpleasant taste were presented to subjects during event-related fMRI scanning. The cerebellum, pons, middle insula, and amygdala responded to intensity irrespective of valence. In contrast, valence-specific responses were observed in anterior insula/operculum extending into the orbitofrontal cortex (OFC). The right caudolateral OFC responded preferentially to pleasant compared to unpleasant taste, irrespective of intensity, and the left dorsal anterior insula/operculuar region responded preferentially to unpleasant compared to pleasant tastes equated for intensity. Responses best characterized as an interaction between intensity and pleasantness were also observed in several limbic regions. These findings demonstrate a functional segregation within the human gustatory system. They also show that amygdala activity may be driven by stimulus intensity irrespective of valence, casting doubt upon the notion that the amygdala responds preferentially to negative stimuli.	Northwestern Univ, Feinberg Med Sch, Cognit Neurol & Alzheimers Dis Ctr, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Med Sch, Cognit Brain Mapping Grp, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Med Sch, Dept Neurol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Med Sch, Dept Psychol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Med Sch, Dept Radiol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Med Sch, Inst Neurosci, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Small, DM (corresponding author), Northwestern Univ, Feinberg Med Sch, Cognit Neurol & Alzheimers Dis Ctr, 320 E Super St, Chicago, IL 60611 USA.	d-small@northwestern.edu	Gitelman, Darren R/B-8292-2013	Gitelman, Darren R/0000-0001-6057-5605; Small, Dana/0000-0001-7363-1100; Gregory, Michael/0000-0003-3749-8343; Parrish, Todd/0000-0002-1184-1572	NIA NIH HHS [AG0094] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AGGLETON JP, 1980, BRAIN RES, V190, P347, DOI 10.1016/0006-8993(80)90279-6; AMARAL D G, 1992, P1; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Apkarian AV, 1999, J NEUROPHYSIOL, V81, P2956, DOI 10.1152/jn.1999.81.6.2956; Apkarian AV, 2000, J NEUROPHYSIOL, V83, P3113, DOI 10.1152/jn.2000.83.5.3113; Apkarian AV, 2001, NEUROSCI LETT, V299, P57, DOI 10.1016/S0304-3940(01)01504-X; Barry MA, 2001, CHEM SENSES, V26, P471, DOI 10.1093/chemse/26.5.471; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Carretie L, 2001, INT J PSYCHOPHYSIOL, V41, P75, DOI 10.1016/S0167-8760(00)00195-1; DILORENZO PM, 1989, J NEUROPHYSIOL, V62, P823, DOI 10.1152/jn.1989.62.4.823; DILORENZO PM, 1988, J NEUROPHYSIOL, V59, P1871, DOI 10.1152/jn.1988.59.6.1871; DILORENZO PM, 1982, BRAIN RES, V251, P229, DOI 10.1016/0006-8993(82)90741-7; DILORENZO PM, 1990, BRAIN RES, V530, P73, DOI 10.1016/0006-8993(90)90658-X; DILORENZO PM, 1989, BRAIN RES BULL, V23, P219, DOI 10.1016/0361-9230(89)90151-2; Francis S, 1999, NEUROREPORT, V10, P453, DOI 10.1097/00001756-199902250-00003; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston K.J., 1994, HUM BRAIN MAPP, V1, P153, DOI DOI 10.1002/HBM.460010207; Fujikane M, 1998, Rinsho Shinkeigaku, V38, P342; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; Henson RNA, 2002, NEUROIMAGE, V15, P83, DOI 10.1006/nimg.2001.0940; Hofbauer RK, 2001, J NEUROPHYSIOL, V86, P402, DOI 10.1152/jn.2001.86.1.402; KINOMURA S, 1994, BRAIN RES, V659, P263, DOI 10.1016/0006-8993(94)90890-7; Kobayakawa T, 1999, CHEM SENSES, V24, P201, DOI 10.1093/chemse/24.2.201; Kojima Y, 1999, Rinsho Shinkeigaku, V39, P979; LaBar KS, 2001, BEHAV NEUROSCI, V115, P493, DOI 10.1037//0735-7044.115.2.493; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 1997, P ROY SOC B-BIOL SCI, V264, P769, DOI 10.1098/rspb.1997.0109; NORGREN R, 1975, BRAIN RES, V91, P99, DOI 10.1016/0006-8993(75)90469-2; Norgren R., 1990, HUMAN NERVOUS SYSTEM, P845, DOI 10.1016/B978-0-12-547625-6.50030-1; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2001, J NEUROPHYSIOL, V85, P1315, DOI 10.1152/jn.2001.85.3.1315; O'Doherty J, 2000, NEUROREPORT, V11, P893, DOI 10.1097/00001756-200003200-00046; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parrish TB, 2000, MAGNET RESON MED, V44, P925, DOI 10.1002/1522-2594(200012)44:6<925::AID-MRM14>3.0.CO;2-M; Petrides M., 1994, HDB NEUROPSYCHOLOGY, V9, P17; PFAFFMANN C, 1980, PSYCHOL RES-PSYCH FO, V42, P165, DOI 10.1007/BF00308700; PFAFFMANN C, 1977, ANN NY ACAD SCI, V290, P18, DOI 10.1111/j.1749-6632.1977.tb39713.x; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Poellinger A, 2001, NEUROIMAGE, V13, P547, DOI 10.1006/nimg.2000.0713; PRITCHARD TC, 1986, J COMP NEUROL, V244, P213, DOI 10.1002/cne.902440208; Prutkin J, 2000, PHYSIOL BEHAV, V69, P161, DOI 10.1016/S0031-9384(00)00199-2; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; ROLLS ET, 1989, EUR J NEUROSCI, V1, P53, DOI 10.1111/j.1460-9568.1989.tb00774.x; Royet JP, 2000, J NEUROSCI, V20, P7752; ROZIN P, 1987, PSYCHOL REV, V94, P23, DOI 10.1037/0033-295X.94.1.23; Sato K, 2000, Rinsho Shinkeigaku, V40, P487; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Sclafani A, 2001, BEHAV NEUROSCI, V115, P920, DOI 10.1037//0735-7044.115.4.920; SCOTT TR, 1993, J NEUROPHYSIOL, V69, P1810, DOI 10.1152/jn.1993.69.6.1810; Scott TR, 1999, PHYSIOL BEHAV, V67, P489, DOI 10.1016/S0031-9384(99)00115-8; SCOTT TR, 1986, J NEUROPHYSIOL, V56, P876, DOI 10.1152/jn.1986.56.3.876; SCOTT TR, 1986, J NEUROPHYSIOL, V55, P182, DOI 10.1152/jn.1986.55.1.182; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Small DM, 1999, NEUROREPORT, V10, P7, DOI 10.1097/00001756-199901180-00002; Small DM, 1997, NEUROREPORT, V8, P3913, DOI 10.1097/00001756-199712220-00014; Small DM, 2001, CHEM SENSES, V26, P425, DOI 10.1093/chemse/26.4.425; Small DM, 2001, BRAIN, V124, P1566, DOI 10.1093/brain/124.8.1566; Sobel N, 1998, J NEUROSCI, V18, P8990; Sobel N, 2000, J NEUROPHYSIOL, V83, P537, DOI 10.1152/jn.2000.83.1.537; SPECTOR AC, 1995, REV NEUROSCIENCE, V6, P143, DOI 10.1515/REVNEURO.1995.6.2.143; Stoleru S, 1999, ARCH SEX BEHAV, V28, P1, DOI 10.1023/A:1018733420467; Talairach J., 1988, COPLANAR STEREOTAXIC; Thut G, 1997, NEUROREPORT, V8, P1225, DOI 10.1097/00001756-199703240-00033; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1877, DOI 10.1152/jn.2000.83.4.1877; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; YAMAMOTO T, 1980, J NEUROPHYSIOL, V44, P440, DOI 10.1152/jn.1980.44.3.440; YAMAMOTO T, 1984, J NEUROPHYSIOL, V51, P616, DOI 10.1152/jn.1984.51.4.616; Yousem DM, 2001, SEMIN ULTRASOUND CT, V22, P456, DOI 10.1016/S0887-2171(01)90001-0; ZALD D, 2003, ASS CHEM SCI 25 SAR; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5; Zald DH, 2002, J NEUROPHYSIOL, V87, P1068, DOI 10.1152/jn.00358.2001; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zald DH, 1998, BRAIN, V121, P1143, DOI 10.1093/brain/121.6.1143; Zald DH, 2000, INT J PSYCHOPHYSIOL, V36, P165, DOI 10.1016/S0167-8760(99)00110-5	81	577	586	1	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 14	2003	39	4					701	711		10.1016/S0896-6273(03)00467-7	http://dx.doi.org/10.1016/S0896-6273(03)00467-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	712CQ	12925283	Bronze			2022-12-24	WOS:000184779500014
J	Sawtell, NB; Frenkel, MY; Philpot, BD; Nakazawa, K; Tonegawa, S; Bear, MF				Sawtell, NB; Frenkel, MY; Philpot, BD; Nakazawa, K; Tonegawa, S; Bear, MF			NMDA receptor-dependent ocular dominance plasticity in adult visual cortex	NEURON			English	Article							SOURCE DENSITY ANALYSIS; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; CRITICAL-PERIOD; MONOCULAR DEPRIVATION; EVOKED-POTENTIALS; STRIATE CORTEX; CORTICAL PLASTICITY; BARREL CORTEX; EXPERIENCE	The binocular region of mouse visual cortex is strongly dominated by inputs from the contralateral eye. Here we show in adult mice that depriving the dominant contralateral eye of vision leads to a persistent, NMDA receptor-dependent enhancement of the weak ipsilateral-eye inputs. These data provide in vivo evidence for metaplasticity as a mechanism for binocular competition and demonstrate that an ocular dominance shift can occur solely by the mechanisms of response enhancement. They also show that adult mouse visual cortex has a far greater potential for experience-dependent plasticity than previously appreciated. These insights may force a revision in how data on ocular dominance plasticity in mutant mice have been interpreted.	MIT, Howard Hughes Med Inst, Picower Ctr Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Bear, MF (corresponding author), MIT, Howard Hughes Med Inst, Picower Ctr Learning & Memory, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Nakazawa, Kazutoshi/J-6195-2015	Nakazawa, Kazutoshi/0000-0001-5699-9093; Bear, Mark/0000-0002-9903-2541	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058880] Funding Source: NIH RePORTER; NIMH NIH HHS [1-50-MH58880-03] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Aizenman CD, 1996, CEREB CORTEX, V6, P751, DOI 10.1093/cercor/6.6.751; Bear MF, 1999, J NEUROBIOL, V41, P83, DOI 10.1002/(SICI)1097-4695(199910)41:1<83::AID-NEU11>3.0.CO;2-Z; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; CAVINESS VS, 1975, J COMP NEUROL, V164, P247, DOI 10.1002/cne.901640207; CLOTHIAUX EE, 1991, J NEUROPHYSIOL, V66, P1785, DOI 10.1152/jn.1991.66.5.1785; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; DIAMOND ME, 1993, P NATL ACAD SCI USA, V90, P2082, DOI 10.1073/pnas.90.5.2082; DRAGER UC, 1978, J NEUROPHYSIOL, V41, P28, DOI 10.1152/jn.1978.41.1.28; Dreher B, 2001, PROG BRAIN RES, V134, P217; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; FOX K, 1986, EXP BRAIN RES, V63, P505, DOI 10.1007/BF00237474; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Gordon JA, 1997, LEARN MEMORY, V4, P245, DOI 10.1101/lm.4.3.245; Gordon JA, 1996, J NEUROSCI, V16, P3274; Guire ES, 1999, J NEUROPHYSIOL, V81, P121, DOI 10.1152/jn.1999.81.1.121; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Heynen AJ, 2001, J NEUROSCI, V21, P9801, DOI 10.1523/JNEUROSCI.21-24-09801.2001; HEYNEN AJ, 2003, IN PRESS NAT NEUROSC; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Iwasato T, 1997, NEURON, V19, P1201, DOI 10.1016/S0896-6273(00)80412-2; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Kirkwood A, 1997, P NATL ACAD SCI USA, V94, P3380, DOI 10.1073/pnas.94.7.3380; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; KOSSUT M, 1991, EXP BRAIN RES, V85, P519; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; MIOCHE L, 1989, J NEUROPHYSIOL, V62, P185, DOI 10.1152/jn.1989.62.1.185; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; MITZDORF U, 1980, J PHYSIOL-LONDON, V304, P203, DOI 10.1113/jphysiol.1980.sp013320; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; RASMUSSON DD, 1982, J COMP NEUROL, V205, P313, DOI 10.1002/cne.902050402; SCHROEDER CE, 1991, VISION RES, V31, P1143, DOI 10.1016/0042-6989(91)90040-C; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003	44	355	364	1	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 19	2003	38	6					977	985		10.1016/S0896-6273(03)00323-4	http://dx.doi.org/10.1016/S0896-6273(03)00323-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	693AA	12818182	Bronze			2022-12-24	WOS:000183691400016
J	Conner, JM; Culberson, A; Packowski, C; Chiba, AA; Tuszynski, MH				Conner, JM; Culberson, A; Packowski, C; Chiba, AA; Tuszynski, MH			Lesions of the basal forebrain cholinergic system impair task acquisition and abolish cortical plasticity associated with motor skill learning	NEURON			English	Article							RECEPTIVE-FIELD PLASTICITY; ADULT SQUIRREL-MONKEYS; NUCLEUS BASALIS; AUDITORY-CORTEX; MOVEMENT REPRESENTATIONS; MAGNETIC STIMULATION; RAPID REORGANIZATION; SOMATOSENSORY CORTEX; SUSTAINED ATTENTION; SELECTIVE REMOVAL	The contribution of the basal forebrain cholinergic system in mediating plasticity of cortical sensorimotor representations was examined in the context of normal learning. The effects of specific basal forebrain cholinergic lesions upon cortical reorganization associated with learning a skilled motor task were investigated, addressing, for the first time, the functional consequences of blocking cortical map plasticity. Results demonstrate that disrupting basal forebrain cholinergic function disrupts cortical map reorganization and impairs motor learning. Cholinergic lesions do not impair associative fear learning or overall sensorimotor function. These results support the hypothesis that the basal forebrain cholinergic system may be specifically implicated in forms of learning requiring plasticity of cortical representations.	Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; Vet Affairs Med Ctr, La Jolla, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Conner, JM (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.							Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Baskerville KA, 1997, NEUROSCIENCE, V80, P1159, DOI 10.1016/S0306-4522(97)00064-X; Baxter MG, 1996, BEHAV NEUROSCI, V110, P460; BAXTER MG, 1995, BEHAV NEUROSCI, V109, P714, DOI 10.1037/0735-7044.109.4.714; Baxter MG, 1999, CURR OPIN NEUROBIOL, V9, P178, DOI 10.1016/S0959-4388(99)80024-5; Bjordahl TS, 1998, BEHAV NEUROSCI, V112, P467, DOI 10.1037/0735-7044.112.3.467; Chappell J, 1998, NEUROPHARMACOLOGY, V37, P481, DOI 10.1016/S0028-3908(98)00032-X; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; CHIBA AA, 1995, J NEUROSCI, V15, P7315; Chiba AA, 1999, NEUROREPORT, V10, P3119, DOI 10.1097/00001756-199909290-00044; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; COHEN LG, 1991, BRAIN, V114, P615, DOI 10.1093/brain/114.1.615; CONNER JM, 1992, J COMP NEUROL, V319, P454, DOI 10.1002/cne.903190310; Conner JM, 2001, P NATL ACAD SCI USA, V98, P1941, DOI 10.1073/pnas.98.4.1941; Dimyan MA, 1999, BEHAV NEUROSCI, V113, P691, DOI 10.1037/0735-7044.113.4.691; DIPATRE PL, 1993, J HISTOCHEM CYTOCHEM, V41, P129, DOI 10.1177/41.1.7678024; DOMAN WA, 1996, BEHAV BRAIN RES, V82, P93; DONOGHUE JP, 1983, J COMP NEUROL, V217, P390, DOI 10.1002/cne.902170404; DONOGHUE JP, 1990, EXP BRAIN RES, V79, P492; Gerloff C, 2002, ACTA PSYCHOL, V110, P161, DOI 10.1016/S0001-6918(02)00032-X; Goosens KA, 2001, LEARN MEMORY, V8, P148, DOI 10.1101/lm.37601; Gutierrez H, 1999, BRAIN RES, V834, P136, DOI 10.1016/S0006-8993(99)01519-X; Hallett M, 2001, BRAIN RES REV, V36, P169, DOI 10.1016/S0165-0173(01)00092-3; JULIANO SL, 1991, P NATL ACAD SCI USA, V88, P780, DOI 10.1073/pnas.88.3.780; KARNI A, 1995, NATURE, V377, P155; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321, DOI 10.1152/jn.1998.80.6.3321; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Linster C, 2001, BEHAV NEUROSCI, V115, P826, DOI 10.1037//0735-7044.115.4.826; Maalouf M, 1998, J NEUROPHYSIOL, V80, P529, DOI 10.1152/jn.1998.80.2.529; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McGaughy J, 2002, J NEUROSCI, V22, P1905, DOI 10.1523/JNEUROSCI.22-05-01905.2002; McGaughy J, 1998, BEHAV NEUROSCI, V112, P1519, DOI 10.1037/0735-7044.112.6.1519; McGaughy J, 2000, BEHAV BRAIN RES, V115, P251, DOI 10.1016/S0166-4328(00)00262-X; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Miasnikov AA, 2001, NEUROREPORT, V12, P1537, DOI 10.1097/00001756-200105250-00047; Miya D, 1997, J NEUROSCI, V17, P4856; Nudo RJ, 1996, J NEUROSCI, V16, P785; Olton D., 1987, PSYCHOPHARMACOLOGY 3, P941; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Plautz EJ, 2000, NEUROBIOL LEARN MEM, V74, P27, DOI 10.1006/nlme.1999.3934; Power AE, 2002, P NATL ACAD SCI USA, V99, P2315, DOI 10.1073/pnas.022627799; Sachdev RNS, 1998, J NEUROPHYSIOL, V79, P3216, DOI 10.1152/jn.1998.79.6.3216; SANES JN, 1988, P NATL ACAD SCI USA, V85, P2003, DOI 10.1073/pnas.85.6.2003; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Schieber MH, 1997, SOMATOSENS MOT RES, V14, P157; Soblosky JS, 2001, BEHAV BRAIN RES, V119, P1, DOI 10.1016/S0166-4328(00)00328-4; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Talwar SK, 2001, J NEUROPHYSIOL, V86, P1555, DOI 10.1152/jn.2001.86.4.1555; TANIUCHI M, 1985, J CELL BIOL, V101, P1100, DOI 10.1083/jcb.101.3.1100; TORRES EM, 1994, NEUROSCIENCE, V63, P95, DOI 10.1016/0306-4522(94)90010-8; VandenBerg PM, 2002, BRAIN RES BULL, V59, P197, DOI 10.1016/S0361-9230(02)00865-1; WEBSTER HH, 1991, SOMATOSENS MOT RES, V8, P327, DOI 10.3109/08990229109144756; Wenk GL, 1997, NEUROBIOL LEARN MEM, V67, P85, DOI 10.1006/nlme.1996.3757; Whishaw IQ, 2000, NEUROPHARMACOLOGY, V39, P788, DOI 10.1016/S0028-3908(99)00259-2; WITHERS GS, 1989, NEUROPSYCHOLOGIA, V27, P61, DOI 10.1016/0028-3932(89)90090-0; Wrenn CC, 1998, INT J DEV NEUROSCI, V16, P595, DOI 10.1016/S0736-5748(98)00071-9; Wu CWH, 1999, J NEUROSCI, V19, P7679, DOI 10.1523/JNEUROSCI.19-17-07679.1999; Zhu XO, 1998, CEREB CORTEX, V8, P63, DOI 10.1093/cercor/8.1.63; Zilles K., 1985, CORTEX RAT STEREOTAX	61	259	263	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 5	2003	38	5					819	829		10.1016/S0896-6273(03)00288-5	http://dx.doi.org/10.1016/S0896-6273(03)00288-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	687DU	12797965	Bronze			2022-12-24	WOS:000183361400016
J	Emamian, ES; Kaytor, MD; Duvick, LA; Zu, T; Tousey, SK; Zoghbi, HY; Clark, HB; Orr, HT				Emamian, ES; Kaytor, MD; Duvick, LA; Zu, T; Tousey, SK; Zoghbi, HY; Clark, HB; Orr, HT			Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice	NEURON			English	Article							SPINOCEREBELLAR ATAXIA; NUCLEAR INCLUSIONS; BINDING PROTEIN; NEURODEGENERATION; EXPRESSION; LOCALIZATION; AGGREGATION; CHAPERONE; REPEAT; IDENTIFICATION	Polyglutamine-induced neurodegeneration in transgenic mice carrying the spinocerebellar ataxia type 1 (SCA1) gene is modulated by subcellular distribution of ataxin-1 and by components of the protein folding/degradation machinery. Since phosphorylation is a prominent mechanism by which these processes are regulated, we examined phosphorylation of ataxin-1 and found that serine 776 (S776) was phosphorylated. Residue 776 appeared to affect cellular deposition of ataxin-1 [820] in that ataxin-1 [820]-A776 failed to form nuclear inclusions in tissue culture cells. The importance of S776 for polyglutamine-induced pathogenesis was examined by generating ataxin-1[82Q]-A776 transgenic mice. These mice expressed ataxin-1[820]A776 within Purkinje cell nuclei, yet the ability of ataxin-1[82Q]-A776 to induce disease was substantially reduced. These studies demonstrate that polyglutamine tract expansion and localization of ataxin-1 to the nucleus of Purkinje cells are not sufficient to induce disease. We suggest that S776 of ataxin-1 also has a critical role in SCA1 pathogenesis.	Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; Baylor Coll Med, Howard Hughes Med Inst, Dept Mol & Human Genet, Houston, TX 77030 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine; Howard Hughes Medical Institute	Orr, HT (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Mayo Mail Code 206, Minneapolis, MN 55455 USA.			Zoghbi, Huda/0000-0002-0700-3349; Orr, Harry/0000-0001-6118-741X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS022920, R01NS027699, R01NS022920] Funding Source: NIH RePORTER; NINDS NIH HHS [NS22920, NS27699] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; CHEN HK, 2003, IN PRESS, V113; Clark HB, 1997, J NEUROSCI, V17, P7385; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; GENIS D, 1995, NEUROLOGY, V45, P24, DOI 10.1212/WNL.45.1.24; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Huynh DP, 1999, ANN NEUROL, V45, P232, DOI 10.1002/1531-8249(199902)45:2<232::AID-ANA14>3.0.CO;2-7; Ishikawa K, 1999, HUM MOL GENET, V8, P1185, DOI 10.1093/hmg/8.7.1185; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Kim TW, 1998, NEURON, V21, P657, DOI 10.1016/S0896-6273(00)80581-4; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Okazawa H, 2002, NEURON, V34, P701, DOI 10.1016/S0896-6273(02)00697-9; Orr HT, 2001, GENE DEV, V15, P925, DOI 10.1101/gad.888401; ROBITAILLE Y, 1995, ACTA NEUROPATHOL, V90, P572; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; Sisodia SS, 1998, CELL, V95, P1, DOI 10.1016/S0092-8674(00)81743-2; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Stevanin G, 2000, EUR J HUM GENET, V8, P4, DOI 10.1038/sj.ejhg.5200403; Waragai M, 1999, HUM MOL GENET, V8, P977, DOI 10.1093/hmg/8.6.977; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; Wellington CL, 2000, CLIN GENET, V57, P1, DOI 10.1034/j.1399-0004.2000.570101.x; Zoghbi HY, 1996, NAT GENET, V14, P237, DOI 10.1038/ng1196-237; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zoghbi HY, 2002, TRENDS GENET, V18, P463, DOI 10.1016/S0168-9525(02)02729-4	33	234	249	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 8	2003	38	3					375	387		10.1016/S0896-6273(03)00258-7	http://dx.doi.org/10.1016/S0896-6273(03)00258-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	677HF	12741986	Bronze			2022-12-24	WOS:000182800300004
J	Semyanov, A; Walker, MC; Kullmann, DM				Semyanov, A; Walker, MC; Kullmann, DM			GABA uptake regulates cortical excitability via cell type-specific tonic inhibition	NATURE NEUROSCIENCE			English	Article							CEREBELLAR GRANULE CELLS; TEMPORAL-LOBE EPILEPSY; RAT-BRAIN-SLICES; HIPPOCAMPAL-NEURONS; SYNAPTIC INHIBITION; PERSISTENT ACTIVATION; RECEPTOR CHANNELS; PYRAMIDAL NEURONS; DELTA-SUBUNIT; HIGH-AFFINITY	GABA(A) receptors can mediate both 'phasic' synaptic inhibition and a persistent 'tonic' form of signaling. We show that, in the presence of intact GABA uptake, guinea pig hippocampal interneurons, but not pyramidal cells, express a tonic GABA(A) receptor-mediated conductance. This conductance was pharmacologically distinct from spontaneous inhibitory postsynaptic currents (IPSCs). Inhibiting GABA uptake resulted in the expression of a comparable GABA(A) receptor-mediated tonic conductance in pyramidal cells. Reducing the tonic conductance in interneurons enhanced their excitability and the inhibitory drive to pyramidal cells. These results point to a role for cell type-dependent tonic inhibition in regulating cortical excitability.	UCL, Dept Clin & Expt Epilepsy, Neurol Inst, London WC1N 3BG, England	University of London; University College London	Kullmann, DM (corresponding author), UCL, Dept Clin & Expt Epilepsy, Neurol Inst, Queen Sq, London WC1N 3BG, England.	d.kullmann@ion.ucl.ac.uk	Semyanov, Alexey/A-7654-2010; Kullmann, Dimitri M/A-3162-2009; Walker, Matthew C/C-1577-2008	Semyanov, Alexey/0000-0002-6800-0942; Kullmann, Dimitri M/0000-0001-6696-3545; Walker, Matthew C/0000-0002-0812-0352				Bai DL, 2001, MOL PHARMACOL, V59, P814, DOI 10.1124/mol.59.4.814; Birnir B, 2000, J MEMBRANE BIOL, V174, P21, DOI 10.1007/s002320001028; Borden LA, 1996, NEUROCHEM INT, V29, P335, DOI 10.1016/0197-0186(95)00158-1; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661; CELIO MR, 1993, HIPPOCAMPUS, V3, P55; Chiu CS, 2002, J NEUROSCI, V22, P10251; COLLINGRIDGE GL, 1984, J PHYSIOL-LONDON, V356, P551, DOI 10.1113/jphysiol.1984.sp015482; CURMI JP, 1993, J MEMBRANE BIOL, V136, P273; DE KONINCK Y, 1994, J NEUROPHYSIOL, V71, P1318, DOI 10.1152/jn.1994.71.4.1318; Demarque M, 2002, NEURON, V36, P1051, DOI 10.1016/S0896-6273(02)01053-X; DILLON GH, 1995, BRIT J PHARMACOL, V115, P539, DOI 10.1111/j.1476-5381.1995.tb16368.x; Draguhn A, 1996, J NEUROPHYSIOL, V76, P3983, DOI 10.1152/jn.1996.76.6.3983; DURING MJ, 1995, NATURE, V376, P174, DOI 10.1038/376174a0; Eghbali M, 1997, NATURE, V388, P71, DOI 10.1038/40404; Engel D, 1998, J PHYSIOL-LONDON, V512, P643, DOI 10.1111/j.1469-7793.1998.643bd.x; Frahm C, 2001, DEV BRAIN RES, V132, P1, DOI 10.1016/S0165-3806(01)00288-7; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; HAMANN M, 1988, BRAIN RES, V442, P287, DOI 10.1016/0006-8993(88)91514-4; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; LERMA J, 1986, BRAIN RES, V384, P145, DOI 10.1016/0006-8993(86)91230-8; Liu QY, 2000, J NEUROPHYSIOL, V84, P1392, DOI 10.1152/jn.2000.84.3.1392; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; NEWLAND CF, 1992, J PHYSIOL-LONDON, V447, P191, DOI 10.1113/jphysiol.1992.sp018998; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; Overstreet LS, 2001, J NEUROPHYSIOL, V86, P596, DOI 10.1152/jn.2001.86.2.596; Peng Z, 2002, J COMP NEUROL, V446, P179, DOI 10.1002/cne.10210; RADIAN R, 1990, J NEUROSCI, V10, P1319; Ribak CE, 1996, J COMP NEUROL, V367, P595, DOI 10.1002/(SICI)1096-9861(19960415)367:4<595::AID-CNE9>3.0.CO;2-#; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; SAXENA NC, 1994, J NEUROSCI, V14, P7077; Semyanov A, 2000, NEURON, V25, P663, DOI 10.1016/S0896-6273(00)81068-5; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; Vizi ES, 1999, NEUROCHEM INT, V34, P407, DOI 10.1016/S0197-0186(99)00047-9; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Wingrove PB, 1997, MOL PHARMACOL, V52, P874, DOI 10.1124/mol.52.5.874; Wisden W, 2002, NEUROPHARMACOLOGY, V43, P530, DOI 10.1016/S0028-3908(02)00151-X; WOODSON W, 1989, J COMP NEUROL, V280, P254, DOI 10.1002/cne.902800207; Yan XX, 1997, DEV BRAIN RES, V99, P1, DOI 10.1016/S0165-3806(96)00192-7; Yeung JYT, 2003, MOL PHARMACOL, V63, P2, DOI 10.1124/mol.63.1.2	45	328	335	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					484	490		10.1038/nn1043	http://dx.doi.org/10.1038/nn1043			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12679782				2022-12-24	WOS:000182553200015
J	Leon, MI; Shadlen, MN				Leon, MI; Shadlen, MN			Representation of time by neurons in the posterior parietal cortex of the macaque	NEURON			English	Article							LATERAL INTRAPARIETAL AREA; SCALAR EXPECTANCY-THEORY; MOTOR INTENTION ACTIVITY; VISUAL-CORTEX; PSYCHOPHYSICAL PERFORMANCE; PREFRONTAL CORTEX; SACCADIC TARGETS; CORTICAL-NEURONS; SINGLE NEURON; PERCEPTION	The neural basis of time perception is unknown. Here we show that neurons in the posterior parietal cortex (area LIP) represent elapsed time relative to a remembered duration. We trained rhesus monkeys to report whether the duration of a test light was longer or shorter than a remembered "standard" (316 or 800 ms) by making an eye movement to one of two choice targets. While timing the test light, the responses of LIP neurons signaled changes in the monkey's perception of elapsed time. The variability of the neural responses explained the monkey's uncertainty about its temporal judgments. Thus, in addition to their role in spatial processing and sensorimotor integration, posterior parietal neurons encode signals related to the perception of time.	Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Reg Primate Res Ctr, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Shadlen, MN (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Seattle, WA 98195 USA.	shadlen@u.washington.edu	Shadlen, Michael Neil/AAL-1870-2020	Shadlen, Michael/0000-0002-2002-2210				Andersen RA, 1997, PHILOS T ROY SOC B, V352, P1421, DOI 10.1098/rstb.1997.0128; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; BARASH S, 1991, J NEUROPHYSIOL, V66, P1109, DOI 10.1152/jn.1991.66.3.1109; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Bracewell RM, 1996, J NEUROPHYSIOL, V76, P1457, DOI 10.1152/jn.1996.76.3.1457; Brainard D. H., 1997, SPATIAL VISION, V10, P443, DOI DOI 10.1163/156856897X00357; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Buonomano DV, 2002, NEUROSCIENTIST, V8, P42, DOI 10.1177/107385840200800109; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; COMMENGES D, 1986, COMPUT METH PROG BIO, V23, P123, DOI 10.1016/0169-2607(86)90107-0; Davison M., 1988, ERLBAUM; Finney DJ, 1952, PROBIT ANAL STAT TRE; Gallistel C. R., 1990, ORG LEARNING; Gallistel CR, 2000, PSYCHOL REV, V107, P289, DOI 10.1037/0033-295X.107.2.289; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; Ghose GM, 2002, NATURE, V419, P616, DOI 10.1038/nature01057; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; GREEN DM, 1966, SIGNAL DETECTION THE; Harrington DL, 1998, J NEUROSCI, V18, P1085; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hernandez A, 1997, J NEUROSCI, V17, P6391; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1268; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Lee D, 1998, J NEUROSCI, V18, P1161; Mazzoni P, 1996, J NEUROPHYSIOL, V76, P1439, DOI 10.1152/jn.1996.76.3.1439; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; Onoe H, 2001, NEUROIMAGE, V13, P37, DOI 10.1006/nimg.2000.0670; Oram MW, 1999, J NEUROPHYSIOL, V81, P3021, DOI 10.1152/jn.1999.81.6.3021; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Platt ML, 1998, EXP BRAIN RES, V121, P65, DOI 10.1007/s002210050438; Rakitin BC, 1998, J EXP PSYCHOL-ANIM B, V24, P15, DOI 10.1037/0097-7403.24.1.15; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Rizzolatti G, 1997, CURR OPIN NEUROBIOL, V7, P562, DOI 10.1016/S0959-4388(97)80037-2; Roitman JD, 2002, J NEUROSCI, V22, P9475; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Schubotz RI, 2000, NEUROIMAGE, V11, P1, DOI 10.1006/nimg.1999.0514; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Snyder LH, 1998, J NEUROPHYSIOL, V79, P2814, DOI 10.1152/jn.1998.79.5.2814; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; Tanji J, 2001, CURR OPIN NEUROBIOL, V11, P164, DOI 10.1016/S0959-4388(00)00192-6; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; VANKAN PLE, 1985, EXP BRAIN RES, V60, P559, DOI 10.1007/BF00236942; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	57	428	436	2	28	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 24	2003	38	2					317	327		10.1016/S0896-6273(03)00185-5	http://dx.doi.org/10.1016/S0896-6273(03)00185-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	672AM	12718864	Bronze			2022-12-24	WOS:000182498300019
J	Jackson, A; Gee, VJ; Baker, SN; Lemon, RN				Jackson, A; Gee, VJ; Baker, SN; Lemon, RN			Synchrony between neurons with similar muscle fields in monkey motor cortex	NEURON			English	Article							PRIMATE CORTICOMOTONEURONAL CELLS; TASK-DEPENDENT MODULATION; SPIKE-TRIGGERED AVERAGES; PRECISION GRIP; CONSCIOUS MONKEY; PYRAMIDAL TRACT; HAND MUSCLES; POSTSPIKE FACILITATION; COHERENT OSCILLATIONS; CORTICOSPINAL NEURONS	Synchronous firing of motor cortex cells exhibiting postspike facilitation (PSF) or suppression (PSS) of hand muscle EMG was examined to investigate the relationship between synchrony and output connectivity. Recordings were made in macaque monkeys performing a precision grip task. Synchronization was assessed with cross-correlation histograms of the activity from 144 pairs of simultaneously recorded neurons, while spike-triggered averages of EMG defined the muscle field for each cell. Cell pairs with similar muscle fields showed greater synchronization than pairs with nonoverlapping fields. Furthermore, cells with opposing effects in the same muscles exhibited negative synchronization. We conclude that synchrony in motor cortex engages networks of neurons directly controlling the same muscle set, while inhibitory connections exist between neuronal populations with opposing output effects.	UCL, Neurol Inst, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England	University of London; University College London	Lemon, RN (corresponding author), UCL, Neurol Inst, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England.	rlemon@ion.ucl.ac.uk		Jackson, Andrew/0000-0001-8701-6387; Baker, Stuart/0000-0001-8118-4048				ABELES M, 1982, ISRAEL J MED SCI, V18, P83; Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Baker SN, 1999, J NEUROSCI METH, V94, P5, DOI 10.1016/S0165-0270(99)00121-1; Baker SN, 2000, J NEUROPHYSIOL, V84, P1770, DOI 10.1152/jn.2000.84.4.1770; Baker SN, 1998, J NEUROPHYSIOL, V80, P1391, DOI 10.1152/jn.1998.80.3.1391; Baker SN, 1998, EXP BRAIN RES, V123, P397, DOI 10.1007/s002210050585; Baker SN, 2001, J NEUROPHYSIOL, V85, P869, DOI 10.1152/jn.2001.85.2.869; Baker SN, 1997, J PHYSIOL-LONDON, V501, P225, DOI 10.1111/j.1469-7793.1997.225bo.x; Baker SN, 1999, EXP BRAIN RES, V128, P109, DOI 10.1007/s002210050825; Bennett KMB, 1996, J NEUROPHYSIOL, V75, P1826, DOI 10.1152/jn.1996.75.5.1826; BUYS EJ, 1986, J PHYSIOL-LONDON, V381, P529, DOI 10.1113/jphysiol.1986.sp016342; CHENEY PD, 1980, J NEUROPHYSIOL, V44, P773, DOI 10.1152/jn.1980.44.4.773; CHENEY PD, 1991, PROG BRAIN RES, V87, P213; CHENEY PD, 1985, J NEUROPHYSIOL, V53, P786, DOI 10.1152/jn.1985.53.3.786; Conway BA, 1995, J PHYSIOL-LONDON, V489, P917, DOI 10.1113/jphysiol.1995.sp021104; ECKHORN R, 1993, J NEUROSCI METH, V49, P175, DOI 10.1016/0165-0270(93)90121-7; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; EGGERMONT JJ, 1990, CORRELATIVE BRAIN TH; FETZ EE, 1980, J NEUROPHYSIOL, V44, P751, DOI 10.1152/jn.1980.44.4.751; FETZ EE, 1990, CEREB CORTEX, V9, P1; GEORGOPOULOS AP, 1993, SCIENCE, V260, P47, DOI 10.1126/science.8465199; GHOSH S, 1988, J PHYSIOL-LONDON, V400, P593, DOI 10.1113/jphysiol.1988.sp017138; HAMM TM, 1985, J PHYSIOL-LONDON, V365, P77, DOI 10.1113/jphysiol.1985.sp015760; Hatsopoulos NG, 1998, P NATL ACAD SCI USA, V95, P15706, DOI 10.1073/pnas.95.26.15706; Jackson A, 2002, J PHYSIOL-LONDON, V541, P685, DOI 10.1113/jphysiol.2001.015099; JACKSON JH, 1974, SELECTED WRITINGS JH, V1, P37; JANKOWSKA E, 1976, J PHYSIOL-LONDON, V258, P467, DOI 10.1113/jphysiol.1976.sp011431; KASSER RJ, 1985, J NEUROPHYSIOL, V53, P959, DOI 10.1152/jn.1985.53.4.959; Kilner JM, 2002, J PHYSIOL-LONDON, V541, P937, DOI 10.1113/jphysiol.2001.013305; Kilner JM, 1999, J PHYSIOL-LONDON, V516, P559, DOI 10.1111/j.1469-7793.1999.0559v.x; KIRKWOOD PA, 1979, J NEUROSCI METH, V1, P107, DOI 10.1016/0165-0270(79)90009-8; KIRKWOOD PA, 1994, MOVEMENT CONTROL, P164; LANDRY P, 1980, BRAIN RES, V191, P327, DOI 10.1016/0006-8993(80)91284-6; LAWRENCE DG, 1985, J COMP NEUROL, V232, P499, DOI 10.1002/cne.902320407; Lee D, 1998, J NEUROSCI, V18, P1161; LEMON RN, 1987, EXP BRAIN RES, V66, P621, DOI 10.1007/BF00270695; LEMON RN, 1986, J PHYSIOL-LONDON, V381, P497, DOI 10.1113/jphysiol.1986.sp016341; LEMON RN, 1989, J PHYSIOL-LONDON, V413, P351, DOI 10.1113/jphysiol.1989.sp017658; LEMON RN, 1984, IBRO HDB SERIES METH, V4, P1; MAIER MA, 1993, J NEUROPHYSIOL, V69, P772, DOI 10.1152/jn.1993.69.3.772; Maier MA, 1998, J PHYSIOL-LONDON, V511, P191, DOI 10.1111/j.1469-7793.1998.191bi.x; Martignon L, 2000, NEURAL COMPUT, V12, P2621, DOI 10.1162/089976600300014872; MARTIGNON L, 1995, BIOL CYBERN, V73, P69, DOI 10.1007/BF00199057; Matsumura M, 1996, J NEUROSCI, V16, P7757; Matthews PBC, 1999, J PHYSIOL-LONDON, V518, P867, DOI 10.1111/j.1469-7793.1999.0867p.x; MILLER LE, 1993, J PHYSIOL-LONDON, V469, P213, DOI 10.1113/jphysiol.1993.sp019812; MURPHY JT, 1985, CAN J NEUROL SCI, V12, P11, DOI 10.1017/S0317167100046527; Nicolelis MAL, 1997, NEURON, V19, P219, DOI 10.1016/S0896-6273(00)80932-0; Pauluis Q, 2000, NEURAL COMPUT, V12, P647, DOI 10.1162/089976600300015736; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; PINCHES EM, 1999, THESIS U COLL LONDON; Poliakov AV, 1997, J PHYSIOL-LONDON, V504, P401, DOI 10.1111/j.1469-7793.1997.401be.x; PORTER R, 1969, J NEUROPHYSIOL, V32, P443, DOI 10.1152/jn.1969.32.3.443; Porter R, 1993, CORTICOSPINAL FUNCTI; Prather JF, 2001, J NEUROPHYSIOL, V85, P43, DOI 10.1152/jn.2001.85.1.43; RENAUD LP, 1974, BRAIN RES, V79, P29, DOI 10.1016/0006-8993(74)90564-2; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Singer W, 1997, TRENDS COGN SCI, V1, P252, DOI 10.1016/S1364-6613(97)01079-6; SMITH WS, 1989, NEUROSCI LETT, V96, P76, DOI 10.1016/0304-3940(89)90246-2; SMITH WS, 1989, THESIS U WASHINGTON; THOMSON AM, 1995, NEUROSCIENCE, V69, P727, DOI 10.1016/0306-4522(95)00287-S; TURTON A, 1993, SPASTICITY MECH MANA, P8; UGOLINI G, 1986, BRAIN RES, V365, P211, DOI 10.1016/0006-8993(86)91632-X; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; VONDERMALSBURG C, 1981, 8182 MPI BIOPH CHEM; ZENGEL JE, 1985, J NEUROPHYSIOL, V53, P1323, DOI 10.1152/jn.1985.53.5.1323	68	91	92	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 10	2003	38	1					115	125		10.1016/S0896-6273(03)00162-4	http://dx.doi.org/10.1016/S0896-6273(03)00162-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	666XT	12691669	Bronze			2022-12-24	WOS:000182202300014
J	Hosie, AM; Dunne, EL; Harvey, RJ; Smart, TG				Hosie, AM; Dunne, EL; Harvey, RJ; Smart, TG			Zinc-mediated inhibition of GABA(A) receptors: discrete binding sites underlie subtype specificity	NATURE NEUROSCIENCE			English	Article							A RECEPTOR; RAT HIPPOCAMPUS; DENTATE GRANULE; ZN2+ INHIBITION; BETA-SUBUNITS; RELEASED ZINC; CHANNEL; IDENTIFICATION; RECOMBINANT; MODULATION	Zinc ions are concentrated in the central nervous system and regulate GABA(A) receptors, which are pivotal mediators of inhibitory synaptic neurotransmission. Zinc ions inhibit GABA(A) receptor function by an allosteric mechanism that is critically dependent on the receptor subunit composition: alphabeta subunit combinations show the highest sensitivity, and alphabetagamma isoforms are the least sensitive. Here we propose a mechanistic and structural basis for this inhibition and its dependence on the receptor subunit composition. We used molecular modeling to identify three discrete sites that mediate Zn2+ inhibition. One is located within the ion channel, and the other two are on the external amino (N)-terminal face of the receptor at the interfaces between alpha and beta subunits. We found that the characteristically low Zn2+ sensitivity of GABA(A) receptors containing the gamma2 subunit results from disruption to two of the three sites after receptor subunit co-assembly.	UCL, Dept Pharmacol, London WC1E 6BT, England; Univ London Sch Pharm, Dept Pharmacol, London WC1N 1AX, England	University of London; University College London; University of London; University College London; University of London School of Pharmacy	Smart, TG (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	t.smart@ucl.ac.uk	Harvey, Robert/D-3994-2016	Harvey, Robert/0000-0001-5956-6664				AMIN J, 1993, NATURE, V366, P565, DOI 10.1038/366565a0; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; BARNARD EA, 1987, TRENDS NEUROSCI, V10, P502, DOI 10.1016/0166-2236(87)90130-5; Boileau AJ, 1999, J NEUROSCI, V19, P10213; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Brickley SG, 1999, J NEUROSCI, V19, P2960; Brooks-Kayal AR, 2001, J NEUROCHEM, V77, P1266, DOI 10.1046/j.1471-4159.2001.00329.x; Buhl EH, 1996, SCIENCE, V271, P369, DOI 10.1126/science.271.5247.369; CELENTANO JJ, 1991, MOL PHARMACOL, V40, P766; Cromer BA, 2002, TRENDS BIOCHEM SCI, V27, P280, DOI 10.1016/S0968-0004(02)02092-3; DRAGUHN A, 1990, NEURON, V5, P781, DOI 10.1016/0896-6273(90)90337-F; Dunne EL, 2002, BRIT J PHARMACOL, V137, P29, DOI 10.1038/sj.bjp.0704835; Farrar SJ, 1999, J BIOL CHEM, V274, P10100, DOI 10.1074/jbc.274.15.10100; Fisher JL, 1998, J NEUROSCI, V18, P2944; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Frederickson CJ, 2001, BIOMETALS, V14, P353, DOI 10.1023/A:1012934207456; Gibbs JW, 1997, J NEUROPHYSIOL, V77, P1924, DOI 10.1152/jn.1997.77.4.1924; Gingrich KJ, 1998, J PHYSIOL-LONDON, V506, P609, DOI 10.1111/j.1469-7793.1998.609bv.x; Horenstein J, 1998, MOL PHARMACOL, V53, P870; Horenstein J, 2001, NAT NEUROSCI, V4, P477, DOI 10.1038/87425; Krishek BJ, 1998, J PHYSIOL-LONDON, V507, P639, DOI 10.1111/j.1469-7793.1998.639bs.x; LEGENDRE P, 1991, MOL PHARMACOL, V39, P267; Lynch JW, 1997, EMBO J, V16, P110, DOI 10.1093/emboj/16.1.110; Mehta AK, 1999, BRAIN RES REV, V29, P196, DOI 10.1016/S0165-0173(98)00052-6; Molnar P, 2001, J NEUROPHYSIOL, V85, P1932, DOI 10.1152/jn.2001.85.5.1932; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Nagaya N, 2001, J PHYSIOL-LONDON, V532, P17, DOI 10.1111/j.1469-7793.2001.0017g.x; Newell JG, 2002, J BIOL CHEM, V277, P21423, DOI 10.1074/jbc.M110312200; O'Shea SM, 2000, J BIOL CHEM, V275, P22764, DOI 10.1074/jbc.M001299200; Pawelzik H, 1999, EUR J NEUROSCI, V11, P3552, DOI 10.1046/j.1460-9568.1999.00772.x; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; Saxena NC, 1996, MOL PHARMACOL, V49, P567; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; SIEGHART W, 1995, PHARMACOL REV, V47, P181; SMART TG, 1991, BRIT J PHARMACOL, V103, P1837, DOI 10.1111/j.1476-5381.1991.tb12337.x; SMART TG, 1994, PROG NEUROBIOL, V42, P393, DOI 10.1016/0301-0082(94)90082-5; SMART TG, 1992, J PHYSIOL-LONDON, V447, P587, DOI 10.1113/jphysiol.1992.sp019020; SMITH GB, 1995, TRENDS PHARMACOL SCI, V16, P162, DOI 10.1016/S0165-6147(00)89009-4; Taketo M, 2000, NEUROSCIENCE, V96, P507, DOI 10.1016/S0306-4522(99)00574-6; Taylor PM, 2000, J NEUROSCI, V20, P1297; Tretter V, 1997, J NEUROSCI, V17, P2728; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; Wagner DA, 2001, J NEUROSCI, V21, P67, DOI 10.1523/JNEUROSCI.21-01-00067.2001; WANG TL, 1995, J NEUROSCI, V15, P7684; Wang ZY, 2002, NEUROSCI LETT, V321, P37, DOI 10.1016/S0304-3940(01)02560-5; Whiting PJ, 1997, J NEUROSCI, V17, P5027; Wooltorton JRA, 1997, EUR J NEUROSCI, V9, P2225, DOI 10.1111/j.1460-9568.1997.tb01641.x; Wooltorton JRA, 1997, J PHYSIOL-LONDON, V505, P633, DOI 10.1111/j.1469-7793.1997.633ba.x; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195	49	201	204	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					362	369		10.1038/nn1030	http://dx.doi.org/10.1038/nn1030			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12640458				2022-12-24	WOS:000181833100013
J	Ress, D; Heeger, DJ				Ress, D; Heeger, DJ			Neuronal correlates of perception in early visual cortex	NATURE NEUROSCIENCE			English	Article							SIMPLE CELLS; RESPONSES; VARIABILITY; PERFORMANCE; ACTIVATION; ATTENTION; DISCHARGE; MONKEYS; HUMANS; TARGET	We used functional magnetic resonance imaging (fMRI) to measure activity in human early visual cortex (areas V1, V2 and V3) during a challenging contrast-detection task. Subjects attempted to detect the presence of slight contrast increments added to two kinds of background patterns. Behavioral responses were recorded so that the corresponding cortical activity could be grouped into the usual signal detection categories: hits, false alarms, misses and correct rejects. For both kinds of background patterns, the measured cortical activity was retinotopically specific. Hits and false alarms were associated with significantly more cortical activity than were correct rejects and misses. That false alarms evoked more activity than misses indicates that activity in early visual cortex corresponded to the subjects' percepts, rather than to the physically presented stimulus.	Stanford Univ, Dept Psychol, Stanford, CA 94309 USA; NYU, Dept Psychol, New York, NY 10003 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA	Stanford University; New York University; New York University	Ress, D (corresponding author), Stanford Univ, Dept Psychol, 450 Serra Mall,Bldg 420-400, Stanford, CA 94309 USA.	ress@stanford.edu			NEI NIH HHS [R01 EY011794, R01 EY011794-09, R01-EY11794] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011794] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Ahumada AJ, 1996, PERCEPTION, V25, P18; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; CAMPBELL FW, 1971, J PHYSIOL-LONDON, V217, pP54; Carandini M, 1997, J NEUROSCI, V17, P8621; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Clark VP, 2000, J NEUROPHYSIOL, V83, P3133, DOI 10.1152/jn.2000.83.5.3133; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; DEAN AF, 1981, EXP BRAIN RES, V44, P437; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Foxe JJ, 2002, EXP BRAIN RES, V142, P139, DOI 10.1007/s00221-001-0906-7; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; Glover GH, 1999, MAGNET RESON MED, V42, P412, DOI 10.1002/(SICI)1522-2594(199908)42:2<412::AID-MRM25>3.0.CO;2-U; Graham N.V.S, 1989, VISUAL PATTERN ANAL; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; GRILLSPECTOR K, IN PRESS ATTENTION P, V20; HILLYARD SA, 1971, SCIENCE, V172, P1357, DOI 10.1126/science.172.3990.1357; Hunter M, 2001, BRAIN COGNITION, V46, P342, DOI 10.1006/brcg.2001.1290; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Liang HL, 2000, NEUROREPORT, V11, P2875, DOI 10.1097/00001756-200009110-00009; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Pashler HE, 1998, PSYCHOL ATTENTION; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shulman GL, 1999, J NEUROSCI, V19, P9480; Shulman GL, 2001, P NATL ACAD SCI USA, V98, P313, DOI 10.1073/pnas.021381198; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Solomon JA, 2002, J VISION, V2, P105, DOI 10.1167/2.1.7; SQUIRES KC, 1975, BEHAV BIOL, V13, P21, DOI 10.1016/S0091-6773(75)90748-8; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Thompson KG, 1999, NAT NEUROSCI, V2, P283, DOI 10.1038/6398; Thompson KG, 2000, VISION RES, V40, P1523, DOI 10.1016/S0042-6989(99)00250-3; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656	49	260	269	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					414	420		10.1038/nn1024	http://dx.doi.org/10.1038/nn1024			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12627164	Green Accepted			2022-12-24	WOS:000181833100020
J	Sincich, LC; Park, KF; Wohlgemuth, MJ; Horton, JC				Sincich, LC; Park, KF; Wohlgemuth, MJ; Horton, JC			Bypassing V1: a direct geniculate input to area MT	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; MIDDLE TEMPORAL AREA; MACAQUE MONKEY; SUPERIOR COLLICULUS; STRIATE CORTEX; KONIOCELLULAR PATHWAY; RESPONSE PROPERTIES; INFERIOR PULVINAR; PRESTRIATE CORTEX; DIRECT PROJECTION	Thalamic nuclei are thought to funnel sensory information to the brain's primary cortical areas, which in turn transmit signals afresh to higher cortical areas. Here we describe a direct projection in the macaque monkey from the lateral geniculate nucleus (LGN) to the motion-selective middle temporal area (MT or V5), a cortical area not previously considered 'primary'. The constituent neurons are mostly koniocellular, send virtually no collateral axons to primary visual cortex (V1) and equal about 10% of the V1 population innervating MT. This pathway could explain the persistence of motion sensitivity in subjects following injury to V1, suggesting more generally that residual perception after damage in a primary area may arise from sparse thalamic input to 'secondary' cortical areas.	Univ Calif San Francisco, Beckman Vis Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Sincich, LC (corresponding author), Univ Calif San Francisco, Beckman Vis Ctr, 10 Koret Way, San Francisco, CA 94143 USA.	sincich@itsa.ucsf.edu		Horton, Jonathan/0000-0002-3952-435X; Wohlgemuth, Melville/0000-0003-4779-4154				BARBUR JL, 1993, BRAIN, V116, P1293, DOI 10.1093/brain/116.6.1293; BECKERS G, 1995, BRAIN, V118, P49, DOI 10.1093/brain/118.1.49; BENEVENTO LA, 1981, J COMP NEUROL, V203, P455, DOI 10.1002/cne.902030309; BENEVENTO LA, 1982, BRAIN RES, V252, P161, DOI 10.1016/0006-8993(82)90991-X; BULLIER J, 1983, EXP BRAIN RES, V53, P168; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Collins CE, 2003, J NEUROSCI, V23, P2251; COWEY A, 1995, NATURE, V373, P247, DOI 10.1038/373247a0; CRAGG BG, 1969, VISION RES, V9, P733, DOI 10.1016/0042-6989(69)90011-X; Crick F, 2003, NAT NEUROSCI, V6, P119, DOI 10.1038/nn0203-119; Cropper SJ, 1996, NATURE, V379, P72, DOI 10.1038/379072a0; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FRIES W, 1981, PROC R SOC SER B-BIO, V213, P73, DOI 10.1098/rspb.1981.0054; GIRARD P, 1992, J NEUROPHYSIOL, V67, P1437, DOI 10.1152/jn.1992.67.6.1437; HARTING JK, 1991, J COMP NEUROL, V304, P275, DOI 10.1002/cne.903040210; Hendry SHC, 2000, ANNU REV NEUROSCI, V23, P127, DOI 10.1146/annurev.neuro.23.1.127; HENDRY SHC, 1994, SCIENCE, V264, P575, DOI 10.1126/science.8160015; HORTON JC, 1984, PHILOS T ROY SOC B, V304, P199, DOI 10.1098/rstb.1984.0021; HUMPHREY NK, 1967, NATURE, V215, P595, DOI 10.1038/215595a0; LYSAKOWSKI A, 1988, EXP BRAIN RES, V69, P651; MALPELI JG, 1975, J COMP NEUROL, V161, P569, DOI 10.1002/cne.901610407; MAUNSELL JHR, 1992, J NEUROPHYSIOL, V68, P1332, DOI 10.1152/jn.1992.68.4.1332; MAUNSELL JHR, 1990, J NEUROSCI, V10, P3323; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Nowak LG, 1997, CEREBR CORT, V12, P205; NOWAK LG, 1995, VISUAL NEUROSCI, V12, P371, DOI 10.1017/S095252380000804X; RAIGUEL SE, 1989, BRAIN RES, V493, P155, DOI 10.1016/0006-8993(89)91010-X; Riddoch G, 1917, BRAIN, V40, P15, DOI 10.1093/brain/40.1.15; RODMAN HR, 1989, J NEUROSCI, V9, P2033; RODMAN HR, 1990, J NEUROSCI, V10, P1154; Rodman HR, 2001, J COMP NEUROL, V431, P168, DOI 10.1002/1096-9861(20010305)431:2<168::AID-CNE1063>3.0.CO;2-N; SAITO H, 1989, EXP BRAIN RES, V75, P1; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Seidemann E, 1999, NEURON, V24, P911, DOI 10.1016/S0896-6273(00)81038-7; SHIPP S, 1989, EUR J NEUROSCI, V1, P309, DOI 10.1111/j.1460-9568.1989.tb00798.x; Sincich LC, 2003, J NEUROSCI, V23, P5684; Sorenson KM, 1999, NEUROREPORT, V10, P3295, DOI 10.1097/00001756-199911080-00009; Stepniewska I, 1999, EUR J NEUROSCI, V11, P469, DOI 10.1046/j.1460-9568.1999.00461.x; Stepniewska I, 2000, VISUAL NEUROSCI, V17, P529, DOI 10.1017/S0952523800174048; Stoerig P, 1997, BRAIN, V120, P535, DOI 10.1093/brain/120.3.535; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; UNGERLEIDER LG, 1979, J COMP NEUROL, V188, P347, DOI 10.1002/cne.901880302; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; YOSHIDA K, 1981, NEUROSCI LETT, V22, P103, DOI 10.1016/0304-3940(81)90071-9; YUKIE M, 1981, J COMP NEUROL, V201, P81, DOI 10.1002/cne.902010107; YUKIE M, 1985, BRAIN RES, V346, P383, DOI 10.1016/0006-8993(85)90875-3; Zeki S, 1998, BRAIN, V121, P25, DOI 10.1093/brain/121.1.25; ZEKI S, 1988, NATURE, V335, P311, DOI 10.1038/335311a0; ZEKI SM, 1969, BRAIN RES, V13, P197, DOI 10.1016/0006-8993(69)90282-0	50	348	350	2	43	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1123	1128		10.1038/nn1318	http://dx.doi.org/10.1038/nn1318			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15378066				2022-12-24	WOS:000224156900022
J	Petkov, CI; Kang, XJ; Alho, K; Bertrand, O; Yund, EW; Woods, DL				Petkov, CI; Kang, XJ; Alho, K; Bertrand, O; Yund, EW; Woods, DL			Attentional modulation of human auditory cortex	NATURE NEUROSCIENCE			English	Article							INTERMODAL SELECTIVE ATTENTION; LEVEL-DEPENDENT REPRESENTATION; EVENT-RELATED FMRI; TONOTOPIC ORGANIZATION; VISUAL-CORTEX; NEURAL MECHANISMS; CORTICAL AREAS; STIMULI; FREQUENCY; MEMORY	Attention powerfully influences auditory perception, but little is understood about the mechanisms whereby attention sharpens responses to unattended sounds. We used high-resolution surface mapping techniques (using functional magnetic resonance imaging, fMRI) to examine activity in human auditory cortex during an intermodal selective attention task. Stimulus-dependent activations (SDAs), evoked by unattended sounds during demanding visual tasks, were maximal over mesial auditory cortex. They were tuned to sound frequency and location, and showed rapid adaptation to repeated sounds. Attention-related modulations (ARMs) were isolated as response enhancements that occurred when subjects performed pitch-discrimination tasks. In contrast to SDAs, ARMs were localized to lateral auditory cortex, showed broad frequency and location tuning, and increased in amplitude with sound repetition. The results suggest a functional dichotomy of auditory cortical fields: stimulus-determined mesial fields that faithfully transmit acoustic information, and attentionally labile lateral fields that analyze acoustic features of behaviorally relevant sounds.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; VANCHCS, Martinez, CA 95553 USA; Univ Calif Davis, Human Cognit Neurophysiol Lab, Martinez, CA USA; Univ Helsinki, Dept Psychol, FIN-00014 Helsinki, Finland; INSERM, U280, Mental Proc & Brain Activat Lab, F-69424 Lyon 03, France; Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Helsinki; Institut National de la Sante et de la Recherche Medicale (Inserm); University of California System; University of California Davis; University of California System; University of California Davis	Woods, DL (corresponding author), Univ Calif Davis, Ctr Neurosci, 1544 Newton Court, Davis, CA 95616 USA.	dlwoods@ucdavis.edu	Alho, Kimmo/G-2997-2013; Bertrand, Olivier/B-6165-2008; Petkov, Christopher/O-5318-2015	Alho, Kimmo/0000-0001-8563-2792; Bertrand, Olivier/0000-0003-0733-7979; Petkov, Christopher/0000-0002-4932-7907; Woods, David/0000-0002-8804-3587; Yund, E./0000-0002-6833-0052	NIDCD NIH HHS [DC005814] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005814] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; ALCAINI M, 1994, PSYCHOPHYSIOLOGY, V31, P611, DOI 10.1111/j.1469-8986.1994.tb02354.x; ALHO K, 1992, ELECTROEN CLIN NEURO, V82, P356, DOI 10.1016/0013-4694(92)90005-3; Alho K, 1999, COGNITIVE BRAIN RES, V7, P335, DOI 10.1016/S0926-6410(98)00036-6; Bilecen D, 2002, NEUROIMAGE, V17, P710, DOI 10.1006/nimg.2002.1133; Bilecen D, 1998, HEARING RES, V126, P19, DOI 10.1016/S0378-5955(98)00139-7; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Brechmann A, 2002, J NEUROPHYSIOL, V87, P423, DOI 10.1152/jn.00187.2001; Celsis P, 1999, NEUROIMAGE, V9, P135, DOI 10.1006/nimg.1998.0389; COWAN N, 1988, PSYCHOL BULL, V104, P163, DOI 10.1037/0033-2909.104.2.163; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Downar J, 2001, NEUROIMAGE, V14, P1256, DOI 10.1006/nimg.2001.0946; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; Gaab N, 2003, J COGNITIVE NEUROSCI, V15, P810, DOI 10.1162/089892903322370735; Grady CL, 1997, NEUROREPORT, V8, P2511, DOI 10.1097/00001756-199707280-00019; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; Jancke L, 1999, COGNITIVE BRAIN RES, V8, P117, DOI 10.1016/S0926-6410(99)00012-9; Jancke L, 1999, NEUROSCI LETT, V266, P125, DOI 10.1016/S0304-3940(99)00288-8; Jancke L, 1998, NEUROPSYCHOLOGIA, V36, P875, DOI 10.1016/S0028-3932(98)00019-0; Jancke L, 2003, COGNITIVE BRAIN RES, V16, P257, DOI 10.1016/S0926-6410(02)00281-1; Kaas JH, 1999, CURR OPIN NEUROBIOL, V9, P164, DOI 10.1016/S0959-4388(99)80022-1; Kiehl KA, 2001, PSYCHOPHYSIOLOGY, V38, P133, DOI 10.1111/1469-8986.3810133; Kosaki H, 1997, J COMP NEUROL, V386, P304; KOSSLYN SM, 1995, NATURE, V378, P496, DOI 10.1038/378496a0; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Murray SO, 2004, NAT NEUROSCI, V7, P70, DOI 10.1038/nn1161; Opitz B, 2002, NEUROIMAGE, V15, P167, DOI 10.1006/nimg.2001.0970; PHILLIPS DP, 1994, EXP BRAIN RES, V102, P210; Pugh KR, 1996, NEUROIMAGE, V4, P159, DOI 10.1006/nimg.1996.0067; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; Recanzone GH, 2000, P NATL ACAD SCI USA, V97, P11829, DOI 10.1073/pnas.97.22.11829; Rivier F, 1997, NEUROIMAGE, V6, P288, DOI 10.1006/nimg.1997.0304; Schonwiesner M, 2002, NEUROIMAGE, V17, P1144, DOI 10.1006/nimg.2002.1250; Talavage TM, 2004, J NEUROPHYSIOL, V91, P1282, DOI 10.1152/jn.01125.2002; Talavage TM, 2000, HEARING RES, V150, P225, DOI 10.1016/S0378-5955(00)00203-3; Tzourio N, 1997, NEUROIMAGE, V5, P63, DOI 10.1006/nimg.1996.0252; Wallace MN, 2002, EXP BRAIN RES, V143, P499, DOI 10.1007/s00221-002-1014-z; Warren JD, 2003, J NEUROSCI, V23, P5799; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; Woodruff PWR, 1996, NEUROREPORT, V7, P1909, DOI 10.1097/00001756-199608120-00007; WOODS DL, 1992, ELECTROEN CLIN NEURO, V82, P341, DOI 10.1016/0013-4694(92)90004-2; WOODS DL, 1980, SCIENCE, V207, P655, DOI 10.1126/science.7352278; Woods DL, 2001, J COGNITIVE NEUROSCI, V13, P492, DOI 10.1162/08989290152001916; WOODS DL, 1990, EVENT RELATED BRAIN, P178	50	256	257	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					658	663		10.1038/nn1256	http://dx.doi.org/10.1038/nn1256			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15156150				2022-12-24	WOS:000221640300021
J	Goldberg, JA; Rokni, U; Sompolinsky, H				Goldberg, JA; Rokni, U; Sompolinsky, H			Patterns of ongoing activity and the functional architecture of the primary visual cortex	NEURON			English	Article							SPATIAL WORKING-MEMORY; HORIZONTAL CONNECTIONS; SPATIOTEMPORAL PATTERNS; ORIENTATION SELECTIVITY; CORTICAL-NEURONS; STRIATE CORTEX; DYNAMICS; REPRESENTATION; MECHANISMS; DIVERSITY	Ongoing spontaneous activity in the cerebral cortex exhibits complex spatiotemporal patterns in the absence of sensory stimuli. To elucidate the nature of this ongoing activity, we present a theoretical treatment of two contrasting scenarios of cortical dynamics: (1) fluctuations about a single background state and (2) wandering among multiple "attractor" states, which encode a single or several stimulus features' Studying simplified network rate models of the primary visual cortex (V1), we show that the single state scenario is characterized by fast and high-dimensional Gaussian-like fluctuations, whereas in the multiple state scenario the fluctuations are slow, low dimensional, and highly non-Gaussian. Studying a more realistic model that incorporates correlations in the feed-forward input, spatially restricted cortical interactions, and an experimentally derived layout of pinwheels, we show that recent optical-imaging data of ongoing activity in V1 are consistent with the presence of either a single background state or multiple attractor states encoding many features.	Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Harvard University; Hebrew University of Jerusalem	Goldberg, JA (corresponding author), Univ Texas, Dept Biol, 6900 N Loop,1604 West, San Antonio, TX 78249 USA.	jgoldberg@utsa.edu	Sompolinsky, Haim/ABB-8398-2021; Goldberg, Joshua/B-3398-2009	Goldberg, Joshua/0000-0002-5740-4087				ARIELI A, 1995, J NEUROPHYSIOL, V73, P2072, DOI 10.1152/jn.1995.73.5.2072; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Basole A, 2003, NATURE, V423, P986, DOI 10.1038/nature01721; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BONHOEFFER T, 1993, J NEUROSCI, V13, P4157; Bosking WH, 1997, J NEUROSCI, V17, P2112; Braitenberg V, 1991, ANATOMY CORTEX STAT; Bressloff PC, 2003, PHILOS T R SOC B, V358, P1643, DOI 10.1098/rstb.2002.1109; Bressloff PC, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.078102; Bressloff PC, 2002, NEURAL COMPUT, V14, P473, DOI 10.1162/089976602317250861; Brody CD, 2003, CURR OPIN NEUROBIOL, V13, P204, DOI 10.1016/S0959-4388(03)00050-3; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; CONTRERAS D, 1995, J NEUROSCI, V15, P604; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; ERMENTROUT GB, 1979, BIOL CYBERN, V34, P137, DOI 10.1007/BF00336965; Fitzpatrick D, 2000, CURR BIOL, V10, pR187, DOI 10.1016/S0960-9822(00)00348-1; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1983, J NEUROSCI, V3, P1116; GRINVALD A, 1999, MODERN TECHNIQUES NE, P894; HUMPHREY AL, 1985, J COMP NEUROL, V233, P159, DOI 10.1002/cne.902330203; JOLIFFE LIT, 1996, PRINCIPAL COMPONENT; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; KOSSEL A, 1995, J NEUROSCI, V15, P3913; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Li BW, 2003, J NEUROPHYSIOL, V90, P204, DOI 10.1152/jn.00954.2002; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Muller T, 2000, NEURAL COMPUT, V12, P2573, DOI 10.1162/089976600300014854; Renart A, 2003, NEURON, V38, P473, DOI 10.1016/S0896-6273(03)00255-1; Ringach DL, 2003, NATURE, V425, P912, DOI 10.1038/425912a; Ringach DL, 2002, J NEUROSCI, V22, P5639; Sharon D, 2002, SCIENCE, V295, P512, DOI 10.1126/science.1065916; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; TSO DY, 1986, J NEUROSCI, V6, P1160; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Tyler CJ, 1998, J COMP NEUROL, V400, P449, DOI 10.1002/(SICI)1096-9861(19981102)400:4<449::AID-CNE2>3.0.CO;2-A; Wang G, 2003, NEUROSCI LETT, V338, P77, DOI 10.1016/S0304-3940(02)01355-1; WELIKY M, 1994, J NEUROSCI, V14, P7291; Zhang K, 1996, J NEUROSCI, V16, P2112	40	61	64	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2004	42	3					489	500		10.1016/S0896-6273(04)00197-7	http://dx.doi.org/10.1016/S0896-6273(04)00197-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KH	15134644	Bronze			2022-12-24	WOS:000221458700014
J	Heintz, N				Heintz, N			Gene expression nervous system atlas (GENSAT)	NATURE NEUROSCIENCE			English	Article									Rockefeller Univ, New York, NY 10021 USA; Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Howard Hughes Medical Institute	Heintz, N (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	heintz@rockvax.rockefeller.edu						Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033	1	214	218	0	5	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					483	483		10.1038/nn0504-483	http://dx.doi.org/10.1038/nn0504-483			1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15114362	Bronze			2022-12-24	WOS:000221101300017
J	Coyle, IP; Koh, YH; Lee, WCM; Slind, J; Fergestad, T; Littleton, JT; Ganetzky, B				Coyle, IP; Koh, YH; Lee, WCM; Slind, J; Fergestad, T; Littleton, JT; Ganetzky, B			Nervous wreck, an SH3 adaptor protein that interacts with Wsp, regulates synaptic growth in Drosophila	NEURON			English	Article							ALDRICH-SYNDROME PROTEIN; ABL TYROSINE KINASE; PHOTORECEPTOR AXON GUIDANCE; WASP-FAMILY PROTEINS; ARP2/3 COMPLEX; ACTIN CYTOSKELETON; NEUROMUSCULAR-JUNCTION; FUNCTIONAL COMPONENTS; STRUCTURAL PLASTICITY; GENETIC DISSECTION	We describe the isolation and characterization of nwk (nervous wreck), a temperature-sensitive paralytic mutant that causes excessive growth of larval neuromuscular junctions (NMJs), resulting in increased synaptic bouton number and branch formation. Ultrastructurally, mutant boutons have reduced size and fewer active zones, associated with a reduction in synaptic transmission. nwk encodes an FCH and SH3 domain-containing adaptor protein that localizes to the perk active zone of presynaptic terminals and binds to the Drosophila ortholog of Wasp (Wsp), a key regulator of actin polymerization. wsp null mutants display synaptic overgrowth similar to nwk and enhance the nwk morphological phenotype in a dose-dependent manner. Evolutionarily, Nwk belongs to a previously undescribed family of adaptor proteins that includes the human srGAPs, which regulate Rho activity downstream of Robo receptors. We propose that Nwk controls synapse morphology by regulating actin dynamics downstream of growth signals in presynaptic terminals.	Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; MIT, Picower Ctr Learning & Memory, Dept Biol & Brain Cognit Sci, Cambridge, MA 02139 USA	University of Wisconsin System; University of Wisconsin Madison; Massachusetts Institute of Technology (MIT)	Ganetzky, B (corresponding author), Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.	ganetzky@wise.edu		Littleton, J. Troy/0000-0001-5576-2887	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015390, F32NS044722, R01NS043244] Funding Source: NIH RePORTER; NIGMS NIH HHS [5 T32GM08349] Funding Source: Medline; NINDS NIH HHS [NS15390, NS43244, NS44722-01, R01 NS043244, R01 NS043244-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ang LH, 2003, DEVELOPMENT, V130, P1307, DOI 10.1242/dev.00356; Aspenstrom P, 1997, CURR BIOL, V7, P479, DOI 10.1016/S0960-9822(06)00219-3; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Banzai Y, 2000, J BIOL CHEM, V275, P11987, DOI 10.1074/jbc.275.16.11987; Ben-Yaacov S, 2001, J CELL BIOL, V152, P1, DOI 10.1083/jcb.152.1.1; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Bogdan S, 2003, DEVELOPMENT, V130, P4427, DOI 10.1242/dev.00663; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Caron E, 2002, CURR OPIN CELL BIOL, V14, P82, DOI 10.1016/S0955-0674(01)00298-8; Chiba A, 1999, INT REV NEUROBIOL, V43, P1, DOI 10.1016/S0074-7742(08)60538-3; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; Endris V, 2002, P NATL ACAD SCI USA, V99, P11754, DOI 10.1073/pnas.162241099; Fan XP, 2003, NEURON, V40, P113, DOI 10.1016/S0896-6273(03)00591-9; FANKHAUSER C, 1995, CELL, V82, P435, DOI 10.1016/0092-8674(95)90432-8; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; Gungabissoon RA, 2003, J HISTOCHEM CYTOCHEM, V51, P411, DOI 10.1177/002215540305100402; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harden N, 1996, MOL CELL BIOL, V16, P1896; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; JOHANSEN J, 1989, J NEUROSCI, V9, P710; JOHANSEN J, 1989, J NEUROSCI, V9, P4318; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545, DOI 10.1146/annurev.ne.19.030196.002553; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Koh YH, 2000, MICROSC RES TECHNIQ, V49, P14, DOI 10.1002/(SICI)1097-0029(20000401)49:1<14::AID-JEMT3>3.3.CO;2-7; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Li J, 1999, PHILOS T ROY SOC B, V354, P299, DOI 10.1098/rstb.1999.0381; Li W, 2001, ONCOGENE, V20, P6403, DOI 10.1038/sj.onc.1204782; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; Littleton JT, 1998, NEURON, V21, P401, DOI 10.1016/S0896-6273(00)80549-8; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Mayer BJ, 2001, J CELL SCI, V114, P1253; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Meyer G, 2002, J NEUROCHEM, V83, P490, DOI 10.1046/j.1471-4159.2002.01185.x; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Mullins RD, 2000, CURR OPIN CELL BIOL, V12, P91, DOI 10.1016/S0955-0674(99)00061-7; Nagase T, 1998, DNA Res, V5, P277, DOI 10.1093/dnares/5.5.277; Negishi M, 2002, J BIOCHEM, V132, P157, DOI 10.1093/oxfordjournals.jbchem.a003205; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Peck J, 2002, FEBS LETT, V528, P27, DOI 10.1016/S0014-5793(02)03331-8; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Qualmann B, 2002, INT REV CYTOL, V220, P93; RIVEROLEZCANO OM, 1995, MOL CELL BIOL, V15, P5725; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rohrbough J, 1999, NEURON, V23, P55, DOI 10.1016/S0896-6273(00)80753-9; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; SCHLESSINGER J, 1994, CURR OPIN GENET DEV, V4, P25, DOI 10.1016/0959-437X(94)90087-6; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Skoble J, 2001, J CELL BIOL, V155, P89, DOI 10.1083/jcb.200106061; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; Sone M, 2000, DEVELOPMENT, V127, P4157; Song W, 2002, NEURON, V36, P105, DOI 10.1016/S0896-6273(02)00932-7; Soulard A, 2002, MOL CELL BIOL, V22, P7889, DOI 10.1128/MCB.22.22.7889-7906.2002; Takenawa T, 2001, J CELL SCI, V114, P1801; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Titus SA, 1997, J NEUROSCI, V17, P875; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Worby CA, 2001, J BIOL CHEM, V276, P41782, DOI 10.1074/jbc.M107080200; WU CF, 1978, P NATL ACAD SCI USA, V75, P4047, DOI 10.1073/pnas.75.8.4047; Yuan LL, 1999, SCIENCE, V283, P1343, DOI 10.1126/science.283.5406.1343; Zalevsky J, 2001, CURR BIOL, V11, P1903, DOI 10.1016/S0960-9822(01)00603-0; Zallen JA, 2002, J CELL BIOL, V156, P689, DOI 10.1083/jcb.200109057; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	83	124	127	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 19	2004	41	4					521	534		10.1016/S0896-6273(04)00016-9	http://dx.doi.org/10.1016/S0896-6273(04)00016-9			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980202	Bronze			2022-12-24	WOS:000221458100006
J	Kim, LA; Furst, J; Gutierrez, D; Butler, MH; Xu, SH; Goldstein, SAN; Grigorieff, N				Kim, LA; Furst, J; Gutierrez, D; Butler, MH; Xu, SH; Goldstein, SAN; Grigorieff, N			Three-dimensional structure of I-to: Kv4.2-KChIP2 ion channels by electron microscopy at 21 angstrom resolution	NEURON			English	Article							GATED K+ CHANNEL; NEURONAL CALCIUM SENSOR-1; POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; BETA-SUBUNIT; T1 DOMAIN; PROTEIN; EXPRESSION; COMPLEX; MODULATION	Regulatory KChlP2 subunits assemble with pore-forming Kv4.2 subunits in 4:4 complexes to produce native voltage-gated potassium (Kv) channels like cardiac It, and neuronal I-A subtypes. Here, negative stain electron microscopy (EM) and single particle averaging reveal KChlP2 to create a novel similar to35 x 115 x 115 Angstrom, intracellular fenestrated rotunda: four peripheral columns that extend down from the membrane-embedded portion of the channel to enclose the Kv4.2 "hanging gondola" (a platform held beneath the transmembrane conduction pore by four internal columns). To reach the pore from the cytosol, ions traverse one of four external fenestrae to enter the rotundal vestibule and then cross one of four internal windows in the gondola.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pediat,Dept Cellular & Mol Physiol, New Haven, CT 06535 USA; Brandeis Univ, Howard Hughes Med Inst, Rosenstiel Basic Med Sci Res Ctr, Dept Biochem, Waltham, MA 02454 USA	Yale University; Brandeis University; Howard Hughes Medical Institute	Goldstein, SAN (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pediat,Dept Cellular & Mol Physiol, 295 Congress Ave, New Haven, CT 06535 USA.	steve.goldstein@yale.edu	Kim, Leo/Y-3323-2018; Goldstein, Steven A./E-9817-2015	Kim, Leo/0000-0001-9106-6416; Grigorieff, Nikolaus/0000-0002-1506-909X; Goldstein, Steven A./0000-0001-5207-5061	NIGMS NIH HHS [GM07205] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbott GW, 1998, Q REV BIOPHYS, V31, P357, DOI 10.1017/S0033583599003467; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Bahring R, 2001, J BIOL CHEM, V276, P23888, DOI 10.1074/jbc.M101320200; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Guo WN, 2002, J BIOL CHEM, V277, P26436, DOI 10.1074/jbc.M201431200; Hanson GT, 2002, BIOCHEMISTRY-US, V41, P15477, DOI 10.1021/bi026609p; Huang C. C., 1996, PAC S BIOCOMPUT, P724, DOI DOI 10.1142/9789814531399; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; KIM LA, 2003, IN PRESS J BIOLC HEM, V17; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Nakahira K, 1996, J BIOL CHEM, V271, P7084, DOI 10.1074/jbc.271.12.7084; Nakamura TY, 2001, P NATL ACAD SCI USA, V98, P12808, DOI 10.1073/pnas.221168498; Orlova EV, 2003, J MOL BIOL, V326, P1005, DOI 10.1016/S0022-2836(02)00708-8; Rosati B, 2001, J PHYSIOL-LONDON, V533, P119, DOI 10.1111/j.1469-7793.2001.0119b.x; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Sokolova O, 2003, P NATL ACAD SCI USA, V100, P12607, DOI 10.1073/pnas.2235650100; Sokolova O, 2001, STRUCTURE, V9, P215, DOI 10.1016/S0969-2126(01)00578-0; Takimoto K, 2002, J BIOL CHEM, V277, P26904, DOI 10.1074/jbc.M203651200; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	33	72	78	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 19	2004	41	4					513	519		10.1016/S0896-6273(04)00050-9	http://dx.doi.org/10.1016/S0896-6273(04)00050-9			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980201	Bronze			2022-12-24	WOS:000221458100005
J	Smith, SM; Bergsman, JB; Harata, NC; Scheller, RH; Tsien, RW				Smith, SM; Bergsman, JB; Harata, NC; Scheller, RH; Tsien, RW			Recordings from single neocortical nerve terminals reveal a nonselective cation channel activated by decreases in extracellular calcium	NEURON			English	Article							POTASSIUM CHANNELS; SYNAPTIC CLEFT; NEUROMUSCULAR-JUNCTION; CA2+-SENSING RECEPTOR; CORTICAL SYNAPTOSOMES; CALCIMIMETIC COMPOUND; HIPPOCAMPAL-NEURONS; TRANSMITTER RELEASE; ION CHANNELS; RAT-BRAIN	Synaptic activity causes reductions in cleft [Ca2+] that may impact subsequent synaptic efficacy. Using modified patch-clamp techniques to record from single neocortical nerve terminals, we report that physiologically relevant reductions of extracellular [Ca2+] ([Ca2+](o)) activate voltage-dependent outward currents. These outward currents are carried by a novel nonselective cation (NSC) channel that is indirectly inhibited by various extracellular agents (rank order potency, Gd3+>spermidine>Ca2+>Mg2+, typical for [Ca2+], receptors). The identification of a Ca2+ sensor-NSC channel pathway establishes the existence of a mechanism by which presynaptic terminals can detect and respond to reductions in cleft [Ca2+]. Activation of NSC channels by falls in [Ca2+](o) would be expected during periods of high activity in the neocortex and may modulate the excitability of the presynaptic terminal.	Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Oregon Hlth Sci Univ, Div Pulm & Crit Care Med, Div Mol Med, Portland, OR 97201 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Neurosci Program, Beckman Ctr, Stanford, CA 94305 USA	Stanford University; Oregon Health & Science University; Howard Hughes Medical Institute; Stanford University; Stanford University	Tsien, RW (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	rwtsien@stanford.edu		Smith, Stephen/0000-0002-0331-7615; Harata, N. Charles/0000-0003-3287-4549				Armstrong CM, 1999, P NATL ACAD SCI USA, V96, P4154, DOI 10.1073/pnas.96.7.4154; BARTSCHAT DK, 1985, J PHYSIOL-LONDON, V361, P441, DOI 10.1113/jphysiol.1985.sp015654; Bergsman JB, 2000, J NEUROSCI, V20, P4368, DOI 10.1523/JNEUROSCI.20-12-04368.2000; BERS D, 1994, METHODS CELL BIOL PR, P3; BLAUSTEI.MP, 1972, P NATL ACAD SCI USA, V69, P2237, DOI 10.1073/pnas.69.8.2237; BORST JG, 1998, J PHYSL, V521, P123; Borst JGG, 1999, PHILOS T R SOC B, V354, P347, DOI 10.1098/rstb.1999.0386; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Burgo A, 2003, J PHYSIOL-LONDON, V549, P537, DOI 10.1113/jphysiol.2003.041871; Cox DH, 1997, J GEN PHYSIOL, V110, P257, DOI 10.1085/jgp.110.3.257; DeFelipe J, 2002, J NEUROCYTOL, V31, P299, DOI 10.1023/A:1024130211265; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Egelman DM, 1999, BIOPHYS J, V76, P1856, DOI 10.1016/S0006-3495(99)77345-5; Formenti A, 2001, J PHYSIOL-LONDON, V535, P33, DOI 10.1111/j.1469-7793.2001.00033.x; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381, DOI 10.1113/jphysiol.1994.sp020303; Fox J, 1999, J PHARMACOL EXP THER, V290, P480; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P218, DOI 10.1113/jphysiol.1957.sp005808; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; HABLITZ JJ, 1986, BIOPHYS J, V50, P753, DOI 10.1016/S0006-3495(86)83515-9; Hallermann S, 2003, P NATL ACAD SCI USA, V100, P8975, DOI 10.1073/pnas.1432836100; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hinson TK, 1997, GENOMICS, V45, P279, DOI 10.1006/geno.1997.4943; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Johnson JP, 2001, J NEUROSCI, V21, P4143, DOI 10.1523/JNEUROSCI.21-12-04143.2001; KAUPPINEN RA, 1986, BIOCHIM BIOPHYS ACTA, V860, P178, DOI 10.1016/0005-2736(86)90513-4; Kennedy HJ, 1998, EXP PHYSIOL, V83, P449, DOI 10.1113/expphysiol.1998.sp004128; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Kullmann DM, 1999, PHILOS T ROY SOC B, V354, P395, DOI 10.1098/rstb.1999.0392; Mailland M, 1997, ENDOCRINOLOGY, V138, P3601, DOI 10.1210/en.138.9.3601; MATTESON DR, 1986, J GEN PHYSIOL, V87, P161, DOI 10.1085/jgp.87.1.161; MULKEY RM, 1992, J NEUROSCI, V12, P4327; NACHSHEN DA, 1985, J PHYSIOL-LONDON, V363, P87, DOI 10.1113/jphysiol.1985.sp015697; NICHOLSON C, 1978, J NEUROPHYSIOL, V41, P1026, DOI 10.1152/jn.1978.41.4.1026; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Nilsson P, 1996, J CEREBR BLOOD F MET, V16, P262, DOI 10.1097/00004647-199603000-00011; Pyle JL, 1999, NEURON, V24, P803, DOI 10.1016/S0896-6273(00)81028-4; Rabl K, 2002, EUR J NEUROSCI, V16, P2070, DOI 10.1046/j.1460-9568.2002.02277.x; Rogers KV, 1997, BRAIN RES, V744, P47, DOI 10.1016/S0006-8993(96)01070-0; RUAT M, 1995, P NATL ACAD SCI USA, V92, P3161, DOI 10.1073/pnas.92.8.3161; Rusakov DA, 2003, NEURON, V37, P287, DOI 10.1016/S0896-6273(03)00025-4; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Sakmann Bert, 1995, P637; SCHMALZING G, 1985, BIOCHEM J, V225, P671, DOI 10.1042/bj2250671; SHIBUKI K, 1990, J PHYSIOL-LONDON, V422, P321, DOI 10.1113/jphysiol.1990.sp017986; SMITH SJ, 1992, PROG BRAIN RES, V94, P119; Southan AP, 1998, J NEUROSCI, V18, P948; Stanley EF, 2000, J NEUROPHYSIOL, V83, P477, DOI 10.1152/jn.2000.83.1.477; Sun XP, 1999, J PHYSIOL-LONDON, V518, P639, DOI 10.1111/j.1469-7793.1999.0639p.x; Vassilev PM, 1997, BIOPHYS J, V72, P2103, DOI 10.1016/S0006-3495(97)78853-2; Xiong ZG, 1997, P NATL ACAD SCI USA, V94, P7012, DOI 10.1073/pnas.94.13.7012; Ye CP, 1997, BRAIN RES BULL, V44, P75, DOI 10.1016/S0361-9230(97)00088-9; ZHANG ET, 1990, J CEREBR BLOOD F MET, V10, P136, DOI 10.1038/jcbfm.1990.18	57	50	52	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 22	2004	41	2					243	256		10.1016/S0896-6273(03)00837-7	http://dx.doi.org/10.1016/S0896-6273(03)00837-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741105	Bronze			2022-12-24	WOS:000221457800010
J	Luo, Z; Je, HS; Wang, QA; Yang, F; Dobbins, GC; Yang, ZH; Xiong, WC; Lu, B; Mei, L				Luo, Z; Je, HS; Wang, QA; Yang, F; Dobbins, GC; Yang, ZH; Xiong, WC; Lu, B; Mei, L			Implication of geranylgeranyltransferase I in synapse formation	NEURON			English	Article							RECEPTOR GENE-EXPRESSION; ACETYLCHOLINE-RECEPTORS; NEUROMUSCULAR-JUNCTION; MUSCLE-CELLS; CARBOXYL METHYLATION; CDNA CLONING; PROTEIN; MUSK; DOMAIN; FARNESYLTRANSFERASE	Agrin activates the transmembrane tyrosine kinase MuSK to mediate acetylcholine receptor (AChR) clustering at the neuromuscular junction (NMJ). However, the intracellular signaling mechanism downstream of MuSK is poorly characterized. This study provides evidence that geranylgeranyltransferase I (GGT) is an important signaling component in the Agrin/MuSK pathway. Agrin causes a rapid increase in tyrosine phosphorylation of the alpha(G/F) subunit of GGT and in GGT activity. Inhibition of GGT activity or expression prevents muscle cells from forming AChR clusters in response to Agrin and attenuates the formation of neuromuscular synapses in spinal neuron-muscle co-cultures. Importantly, transgenic mice expressing an alpha(G/F) mutant demonstrate NMJ defects with wider end-plate bands and smaller AChR plaques. These results support the notion that prenylation is necessary for AChR clustering and the NMJ formation and/or maintenance, revealing an active role of GGT in Agrin/MuSK signaling.	Univ Alabama, Civitan Int Res Ctr, Dept Neurobiol, Birmingham, AL 35294 USA; Univ Alabama, Civitan Int Res Ctr, Dept Pathol, Birmingham, AL 35294 USA; Univ Alabama, Civitan Int Res Ctr, Dept Phys Med, Birmingham, AL 35294 USA; Univ Alabama, Civitan Int Res Ctr, Dept Rehab, Birmingham, AL 35294 USA; NICHHD, Lab Cellular & Synapt Neurophysiol, Sect Neural Dev & Plast, NIH, Bethesda, MD 20892 USA; Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Alabama System; University of Alabama Birmingham	Mei, L (corresponding author), Univ Alabama, Civitan Int Res Ctr, Dept Neurobiol, Birmingham, AL 35294 USA.		Yang, Feng/C-9530-2011; Mei, Lin/G-8755-2012; Lu, Bai/A-4018-2012; Je, Shawn/AHC-0995-2022; Luo, Zhen-Ge/GNM-7635-2022	Luo, Zhen-Ge/0000-0001-5037-0542; Lu, Bai/0000-0001-5418-9759; Yang, Feng/0000-0003-1275-6641; Je, hyunsoo/0000-0002-2924-5621	NINDS NIH HHS [T32NS07441] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007441] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDRES DA, 1993, GENOMICS, V18, P105, DOI 10.1006/geno.1993.1432; Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200; Ashby MN, 1998, CURR OPIN LIPIDOL, V9, P99, DOI 10.1097/00041433-199804000-00004; Backlund PS, 1997, J BIOL CHEM, V272, P33175, DOI 10.1074/jbc.272.52.33175; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; Chappell J, 2000, J BIOL CHEM, V275, P31792, DOI 10.1074/jbc.M004798200; Cifuentes-Diaz C, 2001, J CELL BIOL, V152, P1107, DOI 10.1083/jcb.152.5.1107; Crawford GE, 2000, J CELL BIOL, V150, P1399, DOI 10.1083/jcb.150.6.1399; Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; FARNSWORTH CC, 1994, P NATL ACAD SCI USA, V91, P11963, DOI 10.1073/pnas.91.25.11963; Fazeli S, 1996, J CELL BIOL, V135, P241, DOI 10.1083/jcb.135.1.241; Ferns M, 1996, J CELL BIOL, V132, P937, DOI 10.1083/jcb.132.5.937; FROEHNER SC, 1993, ANNU REV NEUROSCI, V16, P347, DOI 10.1146/annurev.ne.16.030193.002023; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Glass DJ, 1997, P NATL ACAD SCI USA, V94, P8848, DOI 10.1073/pnas.94.16.8848; Goalstone ML, 1996, J BIOL CHEM, V271, P27585, DOI 10.1074/jbc.271.44.27585; GODFREY EW, 1984, J CELL BIOL, V99, P615, DOI 10.1083/jcb.99.2.615; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HANCOCK JF, 1995, METHOD ENZYMOL, V255, P237; Herbst R, 2000, EMBO J, V19, P67, DOI 10.1038/sj.emboj.7592228b; Hightower KE, 2001, BIOCHEM J, V360, P625, DOI 10.1042/0264-6021:3600625; Huang YZ, 2001, J BIOL CHEM, V276, P19318, DOI 10.1074/jbc.M100494200; JACKSON JH, 1990, P NATL ACAD SCI USA, V87, P3042, DOI 10.1073/pnas.87.8.3042; LERNER EC, 1995, J BIOL CHEM, V270, P26770, DOI 10.1074/jbc.270.45.26770; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3; Ma L, 2003, J NEUROSCI, V23, P3164; Marques MJ, 2000, J NEUROSCI, V20, P3663, DOI 10.1523/JNEUROSCI.20-10-03663.2000; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Mittaud P, 2001, J BIOL CHEM, V276, P14505, DOI 10.1074/jbc.M007024200; PHILIPS MR, 1993, SCIENCE, V259, P977, DOI 10.1126/science.8438158; Ren XR, 2001, J CELL BIOL, V152, P971, DOI 10.1083/jcb.152.5.971; SALPETER MM, 1985, PROG NEUROBIOL, V25, P297, DOI 10.1016/0301-0082(85)90018-8; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Schmucker D, 2001, CELL, V105, P701, DOI 10.1016/S0092-8674(01)00391-9; SEABRA MC, 1992, J BIOL CHEM, V267, P14497; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Si JT, 1996, J BIOL CHEM, V271, P19752, DOI 10.1074/jbc.271.33.19752; Sinensky M, 2000, BBA-MOL CELL BIOL L, V1484, P93, DOI 10.1016/S1388-1981(00)00009-3; Strochlic L, 2001, J CELL BIOL, V153, P1127, DOI 10.1083/jcb.153.5.1127; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Tsakiridis T, 1996, J BIOL CHEM, V271, P19664, DOI 10.1074/jbc.271.33.19664; WALLACE BG, 1994, J CELL BIOL, V125, P661, DOI 10.1083/jcb.125.3.661; Weston C, 2000, J CELL BIOL, V150, P205, DOI 10.1083/jcb.150.1.205; Weston C, 2003, J BIOL CHEM, V278, P6450, DOI 10.1074/jbc.M210249200; Willmann R, 2002, CELL MOL LIFE SCI, V59, P1296, DOI 10.1007/s00018-002-8509-4; Wu Z, 1999, BIOCHEMISTRY-US, V38, P11239, DOI 10.1021/bi990583t; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; ZHANG FL, 1994, J BIOL CHEM, V269, P3175; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zhou H, 1999, J CELL BIOL, V146, P1133, DOI 10.1083/jcb.146.5.1133	55	65	69	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 13	2003	40	4					703	717		10.1016/S0896-6273(03)00695-0	http://dx.doi.org/10.1016/S0896-6273(03)00695-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	744UL	14622576	Bronze			2022-12-24	WOS:000186651200007
J	Braver, TS; Reynolds, JR; Donaldson, DI				Braver, TS; Reynolds, JR; Donaldson, DI			Neural mechanisms of transient and sustained cognitive control during task switching	NEURON			English	Article							ANTERIOR PREFRONTAL CORTEX; ADULT AGE-DIFFERENCES; SIGNIFICANT ACTIVATION; RECOGNITION MEMORY; FRONTOPOLAR CORTEX; REGIONS; ATTENTION; WORKING; SYSTEM; FMRI	A hybrid blocked and event-related functional magnetic resonance imaging (fMRI) study decomposed brain activity during task switching into sustained and transient components. Contrasting task-switching blocks against single-task blocks revealed sustained activation in right anterior prefrontal cortex (PFC). Contrasting task-switch trials against task-repeat and single-task trials revealed activation in left lateral PFC and left superior parietal cortex. In both sets of regions, activation dynamics were strongly modulated by trial-by-trial fluctuations in response speed. In addition, right anterior PFC; activity selectively covaried with the magnitude of mixing cost (i.e., task-repeat versus single-task trial performance), and left superior parietal activity selectively covaried with the magnitude of the switching cost (i.e., task-switch versus task-repeat trial performance). These results indicate a functional double dissociation in brain regions supporting different components of cognitive control during task switching and suggest that both sustained and transient control processes mediate the behavioral performance costs of task switching.	Washington Univ, Dept Psychol, St Louis, MO 63130 USA; Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland	Washington University (WUSTL); University of Stirling	Braver, TS (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.	tbraver@artsci.wustl.edu	Donaldson, David I/A-5249-2009	Donaldson, David I/0000-0002-8036-3455; Braver, Todd/0000-0002-2631-3393	NIMH NIH HHS [R03 MH61615] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH061615] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALLPORT A, 1994, ATTENTION PERFORM, V15, P421; Baker SC, 1996, NEUROPSYCHOLOGIA, V34, P515, DOI 10.1016/0028-3932(95)00133-6; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; Braver TS, 2001, NEUROIMAGE, V14, P48, DOI 10.1006/nimg.2001.0791; Buckner RL, 2000, MED RAD DIA IMG, P441; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; De Jong R, 1999, ACTA PSYCHOL, V101, P379, DOI 10.1016/S0001-6918(99)00012-8; De Jong R, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P357; De Jong R, 2001, EUR J COGN PSYCHOL, V13, P71, DOI 10.1080/09541440042000223; DiGirolamo GJ, 2001, NEUROREPORT, V12, P2065, DOI 10.1097/00001756-200107030-00054; Donaldson D., 2001, FUNCTIONAL MRI INTRO, P177; Donaldson DI, 2001, NEUROIMAGE, V13, P129, DOI 10.1006/nimg.2000.0664; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; Dreher JC, 2002, NEUROIMAGE, V17, P95, DOI 10.1006/nimg.2002.1169; Duzel E, 1999, P NATL ACAD SCI USA, V96, P1794, DOI 10.1073/pnas.96.4.1794; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Gilbert SJ, 2002, COGNITIVE PSYCHOL, V44, P297, DOI 10.1006/cogp.2001.0770; Gold BT, 2002, NEURON, V35, P803, DOI 10.1016/S0896-6273(02)00800-0; Jersild A. T., 1927, ARCH PSYCHOL, V89; Kimberg DY, 2000, COGNITIVE BRAIN RES, V10, P189, DOI 10.1016/S0926-6410(00)00016-1; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Konishi S, 2000, NEUROIMAGE, V12, P276, DOI 10.1006/nimg.2000.0614; Kray J, 2000, PSYCHOL AGING, V15, P126, DOI 10.1037//0882-7974.15.1.126; Los SA, 1996, ACTA PSYCHOL, V94, P145, DOI 10.1016/0001-6918(95)00050-X; McAvoy MP, 2001, NEUROIMAGE, V13, pS198; McDermott KB, 2003, NEUROPSYCHOLOGIA, V41, P293, DOI 10.1016/S0028-3932(02)00162-8; McDermott KB, 2000, J COGNITIVE NEUROSCI, V12, P965, DOI 10.1162/08989290051137503; Meiran N, 2000, COGNITIVE PSYCHOL, V41, P211, DOI 10.1006/cogp.2000.0736; Meiran N, 2001, EUR J COGN PSYCHOL, V13, P165, DOI 10.1080/09541440042000269; Meiran N, 2001, J GERONTOL B-PSYCHOL, V56, pP88, DOI 10.1093/geronb/56.2.P88; Meiran N, 2000, PSYCHOL RES-PSYCH FO, V63, P234, DOI 10.1007/s004269900004; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; O'Reilly RC, 2002, CEREB CORTEX, V12, P246, DOI 10.1093/cercor/12.3.246; Otten LJ, 2002, NAT NEUROSCI, V5, P1339, DOI 10.1038/nn967; Pashler H, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P277; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; REYNOLDS JR, 2002, COGN NEUR SOC SAN FR; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Salthouse TA, 1998, PSYCHOL AGING, V13, P445, DOI 10.1037/0882-7974.13.3.445; Snyder AZ., 1996, QUANTIFICATION BRAIN, P131, DOI DOI 10.1016/B978-012389760-2/50028-1; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; SPECTOR A, 1976, AM J PSYCHOL, V89, P669, DOI 10.2307/1421465; Talairach J., 1988, COPLANAR STEREOTAXIC; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; VISSCHER KM, 2003, IN PRESS NEUROIMAGE; West R, 1999, MEM COGNITION, V27, P1064, DOI 10.3758/BF03201235; West R, 2000, BRAIN RES, V873, P102, DOI 10.1016/S0006-8993(00)02530-0; West R, 2001, EUR J COGN PSYCHOL, V13, P91, DOI 10.1080/09541440042000232; West R, 2000, CEREB CORTEX, V10, P748, DOI 10.1093/cercor/10.8.748; WILKINS AJ, 1987, NEUROPSYCHOLOGIA, V25, P359, DOI 10.1016/0028-3932(87)90024-8; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024; Wylie G, 2000, PSYCHOL RES-PSYCH FO, V63, P212, DOI 10.1007/s004269900003	63	604	612	3	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 14	2003	39	4					713	726		10.1016/S0896-6273(03)00466-5	http://dx.doi.org/10.1016/S0896-6273(03)00466-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	712CQ	12925284	Bronze			2022-12-24	WOS:000184779500015
J	Laine, M; Lin, MCA; Bannister, JPA; Silverman, WR; Mock, AF; Roux, B; Papazian, DM				Laine, M; Lin, MCA; Bannister, JPA; Silverman, WR; Mock, AF; Roux, B; Papazian, DM			Atomic proximity between S4 segment and pore domain in shaker potassium channels	NEURON			English	Article							VOLTAGE-SENSING DOMAINS; K+ CHANNEL; ELECTROSTATIC INTERACTIONS; DOPAMINE TRANSPORTER; ACTIVATION GATE; GATING CHARGE; BINDING-SITE; TEA BLOCKADE; ION; MOVEMENT	A recently proposed model for voltage-dependent activation in K+ channels, largely influenced by the KvAP X-ray structure, suggests that S4 is located at the periphery of the channel and moves through the lipid bilayer upon depolarization. To investigate the physical distance between S4 and the pore domain in functional channels in a native membrane environment, we engineered pairs of cysteines, one each in S4 and the pore of Shaker channels, and identified two instances of spontaneous intersubunit disulfide bond formation, between R362C/A419C and R362C/F416C. After reduction, these cysteine pairs bound Cd2+ with high affinity, verifying that the residues are in atomic proximity. Molecular modeling based on the MthK structure revealed a single position for S4 that was consistent with our results and many other experimental constraints. The model predicts that S4 is located in the groove between pore domains from different subunits, rather than at the periphery of the protein.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA; Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cornell University	Papazian, DM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.	papazian@mednet.ucla.edu	Silverman, William/AAE-4799-2019		NIGMS NIH HHS [R01 GM043459-14, R01 GM043459-17, R01 GM043459-15S1, R01 GM043459-15, GM43459, GM62342, R01 GM043459-16, R01 GM043459] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062342, R01GM043459] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; BAUKROWITZ T, 1995, NEURON, V15, P951, DOI 10.1016/0896-6273(95)90185-X; Berneche S, 2000, BIOPHYS J, V78, P2900, DOI 10.1016/S0006-3495(00)76831-7; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; Bezanilla F, 2002, J GEN PHYSIOL, V120, P465, DOI 10.1085/jgp.20028660; Blaustein RO, 2000, NAT STRUCT BIOL, V7, P309; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; Castagnetto JM, 2002, NUCLEIC ACIDS RES, V30, P379, DOI 10.1093/nar/30.1.379; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; DELCAMINO D, 1991, NATURE, V403, P3212; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Elinder F, 2001, J GEN PHYSIOL, V118, P1, DOI 10.1085/jgp.118.1.1; Gandhi CS, 2002, J GEN PHYSIOL, V120, P455, DOI 10.1085/jgp.20028678; Getz EB, 1998, BIOPHYS J, V74, P2451, DOI 10.1016/S0006-3495(98)77953-6; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; Holmgren M, 1998, NEURON, V21, P617, DOI 10.1016/S0896-6273(00)80571-1; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; Horn R, 2002, J GEN PHYSIOL, V120, P449, DOI 10.1085/jgp.20028658; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; JUNG K, 1995, BIOCHEMISTRY-US, V34, P6272, DOI 10.1021/bi00019a003; KIEFER LL, 1994, BIOCHEMISTRY-US, V33, P15233, DOI 10.1021/bi00255a003; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; Loussouarn G, 2001, P NATL ACAD SCI USA, V98, P4227, DOI 10.1073/pnas.061452698; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; MacAulay N, 2001, J BIOL CHEM, V276, P40476, DOI 10.1074/jbc.M105578200; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Monks SA, 1999, J GEN PHYSIOL, V113, P415, DOI 10.1085/jgp.113.3.415; Nagaya N, 1997, J BIOL CHEM, V272, P3022, DOI 10.1074/jbc.272.5.3022; Norregaard L, 2000, BIOCHEMISTRY-US, V39, P15836, DOI 10.1021/bi0018335; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Roux B, 2002, NOVART FDN SYMP, V245, P84; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; SANTACRUZTOLOZA L, 1994, BIOCHEMISTRY-US, V33, P5607, DOI 10.1021/bi00184a033; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Schulteis CT, 1996, BIOCHEMISTRY-US, V35, P12133, DOI 10.1021/bi961083s; Schulteis CT, 1998, J BIOL CHEM, V273, P26210, DOI 10.1074/jbc.273.40.26210; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Silverman WR, 2000, J GEN PHYSIOL, V116, P663, DOI 10.1085/jgp.116.5.663; Silverman WR, 2003, P NATL ACAD SCI USA, V100, P2935, DOI 10.1073/pnas.0636603100; Sokolova O, 2001, STRUCTURE, V9, P215, DOI 10.1016/S0969-2126(01)00578-0; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; Tiwari-Woodruff SK, 2000, J GEN PHYSIOL, V115, P123, DOI 10.1085/jgp.115.2.123; TiwariWoodruff SK, 1997, BIOPHYS J, V72, P1489, DOI 10.1016/S0006-3495(97)78797-6; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Yamagishi T, 1997, BIOPHYS J, V73, P195, DOI 10.1016/S0006-3495(97)78060-3; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321	71	151	157	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 31	2003	39	3					467	481		10.1016/S0896-6273(03)00468-9	http://dx.doi.org/10.1016/S0896-6273(03)00468-9			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	709LC	12895421	Bronze			2022-12-24	WOS:000184625800010
J	Lee, SK; Pfaff, SL				Lee, SK; Pfaff, SL			Synchronization of neurogenesis and motor neuron specification by direct coupling of bHLH and homeodomain transcription factors	NEURON			English	Article							DOMAIN INTERACTOR NLI; LIM-HOMEOBOX GENES; ACTIVITY IN-VIVO; PRONEURAL GENES; ACHAETE-SCUTE; SPINAL-CORD; SUBTYPE IDENTITY; NERVOUS-SYSTEM; PROTEIN; EXPRESSION	Inductive signaling leads to the coactivation of regulatory pathways for specifying general neuronal traits in parallel with instructions for neuronal subtype specification. Nevertheless, the mechanisms that ensure that these pathways are synchronized have not been defined. To address this, we examined how bHLH proteins Ngn2 and NeuroM controlling neurogenesis functionally converge with LIM-homeodomain (LIM-HD) factors Ish and Lhx3 involved in motor neuron subtype specification. We found that Ngn2 and NeuroM transcriptionally synergize with IsI1 and Lhx3 to specify motor neurons in the embryonic spinal cord and in P19 stem cells. The mechanism underlying this cooperativity is based on interactions that directly couple the activity of the bHLH and LIM-HD proteins, mediated by the adaptor protein NLI. This functional link acts to synchronize neuronal subtype specification with neurogenesis.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Salk Institute	Pfaff, SL (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pfaff@salk.edu						Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Becker T, 2002, MECH DEVELOP, V117, P75, DOI 10.1016/S0925-4773(02)00178-8; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Brunet JF, 1999, BIOESSAYS, V21, P313, DOI 10.1002/(SICI)1521-1878(199904)21:4<313::AID-BIES7>3.0.CO;2-C; Chen L, 2002, P NATL ACAD SCI USA, V99, P14320, DOI 10.1073/pnas.212532399; Dubreuil W, 2002, DEVELOPMENT, V129, P5241; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Farah MH, 2000, DEVELOPMENT, V127, P693; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HARRISON KA, 1994, J BIOL CHEM, V269, P19968; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; Jurata LW, 2000, CURR OPIN NEUROBIOL, V10, P72, DOI 10.1016/S0959-4388(99)00053-7; Jurata LW, 1998, J BIOL CHEM, V273, P3152, DOI 10.1074/jbc.273.6.3152; Jurata LW, 1996, P NATL ACAD SCI USA, V93, P11693, DOI 10.1073/pnas.93.21.11693; Jurata LW, 1997, MOL CELL BIOL, V17, P5688, DOI 10.1128/MCB.17.10.5688; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Marquardt T, 2001, CELL, V106, P651, DOI 10.1016/S0092-8674(01)00499-8; Milan M, 1999, MOL CELL, V4, P267, DOI 10.1016/S1097-2765(00)80374-3; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Morcillo P, 1997, GENE DEV, V11, P2729, DOI 10.1101/gad.11.20.2729; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Mukhopadhyay M, 2003, DEVELOPMENT, V130, P495, DOI 10.1242/dev.00225; Nakamura H, 2000, DEV GROWTH DIFFER, V42, P199; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; PABO CO, 1979, P NATL ACAD SCI USA, V76, P1608, DOI 10.1073/pnas.76.4.1608; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Perron M, 1999, P NATL ACAD SCI USA, V96, P14996, DOI 10.1073/pnas.96.26.14996; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Poulin G, 2000, MOL CELL BIOL, V20, P4826, DOI 10.1128/MCB.20.13.4826-4837.2000; Ramain P, 2000, MOL CELL, V6, P781, DOI 10.1016/S1097-2765(05)00079-1; Roztocil T, 1997, DEVELOPMENT, V124, P3263; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Segawa H, 2001, NEURON, V30, P423, DOI 10.1016/S0896-6273(01)00283-5; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Thaler JP, 2002, CELL, V110, P237, DOI 10.1016/S0092-8674(02)00823-1; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; Torigoi E, 2000, P NATL ACAD SCI USA, V97, P2686, DOI 10.1073/pnas.050586397; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; van Meyel DJ, 1999, MOL CELL, V4, P259, DOI 10.1016/S1097-2765(00)80373-1; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	56	221	229	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 5	2003	38	5					731	745		10.1016/S0896-6273(03)00296-4	http://dx.doi.org/10.1016/S0896-6273(03)00296-4			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	687DU	12797958	Bronze			2022-12-24	WOS:000183361400009
J	Estevez, R; Schroeder, BC; Accardi, A; Jentsch, TJ; Pusch, M				Estevez, R; Schroeder, BC; Accardi, A; Jentsch, TJ; Pusch, M			Conservation of chloride channel structure revealed by an inhibitor binding site in CIC-1	NEURON			English	Article							FUNCTIONAL EXPRESSION; MOLECULAR-BASIS; HUMAN MYOTONIA; MUTATIONS; VOLTAGE; KIDNEY; ACID; CONDUCTANCE; DOMINANT; CLC-1	Crystal structures of bacterial CLC proteins were solved recently, but it is unclear to which level of detail they can be extrapolated to mammalian chloride channels. Exploiting the difference in inhibition by 9-anthracene carboxylic acid (9-AC) between CIC-0, -1, and -2, we identified a serine between helices 0 and P as crucial for 9-AC binding. Mutagenesis based on the crystal structure identified further residues affecting inhibitor binding. They surround a partially hydrophobic pocket close to the chloride binding site that is accessible from the cytoplasm, consistent with the observed intracellular block by 9-AC. Mutations in presumably Cl- -coordinating residues yield additional insights into the structure and function of CIC-1. Our work shows that the structure of bacterial CLCs can be extrapolated with fidelity to mammalian Cl- channels.	Univ Hamburg, Zentrum Mol Neurobiol Hamburg, D-20246 Hamburg, Germany; Ist Biofis, I-16149 Genoa, Italy	University of Hamburg; University Medical Center Hamburg-Eppendorf; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Jentsch, TJ (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol Hamburg, Falkenried 94, D-20246 Hamburg, Germany.	jentsch@zmnh.uni-hamburg.de; pusch@icb.ge.cnr.it	Estevez, Raul/D-8610-2015	Estevez, Raul/0000-0003-1579-650X; Pusch, Michael/0000-0002-8644-8847; Jentsch, Thomas/0000-0002-3509-2553; Accardi, Alessio/0000-0002-6584-0102	Telethon [1079] Funding Source: Medline	Telethon(Fondazione Telethon)		Aromataris EC, 1999, BRIT J PHARMACOL, V126, P1375, DOI 10.1038/sj.bjp.0702459; Astill DS, 1996, BBA-BIOMEMBRANES, V1280, P178, DOI 10.1016/0005-2736(95)00281-2; BAUER CK, 1991, P NATL ACAD SCI USA, V88, P11052, DOI 10.1073/pnas.88.24.11052; Birkenhager R, 2001, NAT GENET, V29, P310, DOI 10.1038/ng752; Bosl MR, 2001, EMBO J, V20, P1289, DOI 10.1093/emboj/20.6.1289; BRYANT SH, 1971, J PHYSIOL-LONDON, V219, P367, DOI 10.1113/jphysiol.1971.sp009667; Clark S, 1998, J PHYSIOL-LONDON, V506, P665, DOI 10.1111/j.1469-7793.1998.665bv.x; Creighton T.E., 1993, PROTEINS; DELUCA A, 1992, J PHARMACOL EXP THER, V260, P364; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Estevez R, 2002, CURR OPIN STRUC BIOL, V12, P531, DOI 10.1016/S0959-440X(02)00358-5; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Fahlke C, 1997, J GEN PHYSIOL, V109, P93, DOI 10.1085/jgp.109.1.93; FAHLKE C, 1995, NEURON, V15, P463, DOI 10.1016/0896-6273(95)90050-0; Fahlke C, 1997, NATURE, V390, P529, DOI 10.1038/37391; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; GREENE JR, 1993, MOL GEN GENET, V241, P542, DOI 10.1007/BF00279896; GRUNDER S, 1992, NATURE, V360, P759, DOI 10.1038/360759a0; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; LANGER T, 1968, NEW ENGL J MED, V279, P856, DOI 10.1056/NEJM196810172791604; Lin YW, 1999, J GEN PHYSIOL, V114, P1, DOI 10.1085/jgp.114.1.1; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Ludewig U, 1997, J GEN PHYSIOL, V110, P165, DOI 10.1085/jgp.110.2.165; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; Matsumura Y, 1999, NAT GENET, V21, P95, DOI 10.1038/5036; MEYERKLEINE C, 1995, AM J HUM GENET, V57, P1325; Middleton RE, 1996, NATURE, V383, P337, DOI 10.1038/383337a0; MILLER C, 1984, P NATL ACAD SCI-BIOL, V81, P2772, DOI 10.1073/pnas.81.9.2772; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; PALADE PT, 1977, J GEN PHYSIOL, V69, P879, DOI 10.1085/jgp.69.6.879; Pusch M, 2000, MOL PHARMACOL, V58, P498, DOI 10.1124/mol.58.3.498; PUSCH M, 1994, BIOPHYS J, V66, P149, DOI 10.1016/S0006-3495(94)80753-2; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; Pusch M, 1995, NEURON, V15, P1455, DOI 10.1016/0896-6273(95)90023-3; Pusch M, 2001, J GEN PHYSIOL, V118, P45, DOI 10.1085/jgp.118.1.45; Pusch M, 1999, J PHYSIOL-LONDON, V515, P341, DOI 10.1111/j.1469-7793.1999.341ac.x; Rychkov GY, 1998, J GEN PHYSIOL, V111, P653, DOI 10.1085/jgp.111.5.653; Saviane C, 1999, J GEN PHYSIOL, V113, P457, DOI 10.1085/jgp.113.3.457; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; STEINMEYER K, 1991, NATURE, V354, P301, DOI 10.1038/354301a0; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Varela D, 2002, J PHYSIOL-LONDON, V544, P363, DOI 10.1113/jphysiol.2002.026096; Waldegger S, 2000, J BIOL CHEM, V275, P24527, DOI 10.1074/jbc.M001987200; Weinreich F, 2001, J BIOL CHEM, V276, P2347, DOI 10.1074/jbc.M005733200; Wollnik B, 1997, HUM MOL GENET, V6, P805, DOI 10.1093/hmg/6.5.805	54	142	146	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 10	2003	38	1					47	59		10.1016/S0896-6273(03)00168-5	http://dx.doi.org/10.1016/S0896-6273(03)00168-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	666XT	12691663	Bronze			2022-12-24	WOS:000182202300008
J	Singh, K; Scott, SH				Singh, K; Scott, SH			A motor learning strategy reflects neural circuitry for limb control	NATURE NEUROSCIENCE			English	Article							ARM; DYNAMICS; REPRESENTATION; MOVEMENTS; FEEDBACK; TORQUES; MUSCLES; CORTEX; OUTPUT; INPUT	During motor skill acquisition, the brain learns a mapping between intended limb motion and requisite muscular forces. We propose that regions where sensory and motor representations overlap are crucial for motor learning. In primary motor cortex, for example, cells that modulate their activity for motor actions at a joint tend to receive input from that same portion of the periphery. We predict that this correspondence reflects a default strategy-a Bayesian prior-in which subjects tend to associate loads at a joint with motion at that joint (local sensorimotor association) when there is ambiguity regarding the nature of the load. As predicted, we found that in the presence of uncertainty, humans inappropriately generalized elbow loads as though they were based on elbow velocity. Generalization improved when we reduced uncertainty by decreasing coupling between elbow velocity and load during training. These results illustrate a key link between motor learning and the underlying neural circuitry.	Queens Univ, Dept Anat & Cell Biol, CIHR Grp Sensory Motor Syst, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Scott, SH (corresponding author), Queens Univ, Dept Anat & Cell Biol, CIHR Grp Sensory Motor Syst, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada.							ASANUMA H, 1981, PROG NEUROBIOL, V16, P241, DOI 10.1016/0301-0082(81)90015-0; Bastian AJ, 1996, J NEUROPHYSIOL, V76, P492, DOI 10.1152/jn.1996.76.1.492; Conditt MA, 1997, J NEUROPHYSIOL, V78, P554, DOI 10.1152/jn.1997.78.1.554; Conditt MA, 1999, P NATL ACAD SCI USA, V96, P11625, DOI 10.1073/pnas.96.20.11625; Drew W L, 1993, Clin Diagn Virol, V1, P179; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; GHEZ C, 1975, BRAIN RES, V98, P93, DOI 10.1016/0006-8993(75)90511-9; GIBSON AR, 1987, J COMP NEUROL, V260, P362, DOI 10.1002/cne.902600304; Goodbody SJ, 1998, J NEUROPHYSIOL, V79, P1825, DOI 10.1152/jn.1998.79.4.1825; Gribble PL, 2002, NATURE, V417, P938, DOI 10.1038/nature00834; HOLLERBACH JM, 1982, BIOL CYBERN, V44, P67, DOI 10.1007/BF00353957; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; Knill DC, 1996, PERCEPTION BAYESIAN; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; MURPHY JT, 1982, BRAIN RES, V236, P429, DOI 10.1016/0006-8993(82)90726-0; Porter R, 1993, CORTICOSPINAL FUNCTI; Sainburg RL, 1999, J NEUROPHYSIOL, V81, P1045, DOI 10.1152/jn.1999.81.3.1045; Sainburg RL, 2000, J NEUROPHYSIOL, V83, P2661, DOI 10.1152/jn.2000.83.5.2661; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; Scott SH, 1997, J NEUROPHYSIOL, V77, P1016, DOI 10.1152/jn.1997.77.2.1016; SCOTT SH, 1994, J NEUROSCI, V14, P7529; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Vetter P, 2000, NEUROREPORT, V11, P3783, DOI 10.1097/00001756-200011270-00038; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497	29	63	63	0	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					399	403		10.1038/nn1026	http://dx.doi.org/10.1038/nn1026			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12627165				2022-12-24	WOS:000181833100018
J	Dobritsa, AA; van der Goes van Naters, W; Warr, CG; Steinbrecht, RA; Carlson, JR				Dobritsa, AA; van der Goes van Naters, W; Warr, CG; Steinbrecht, RA; Carlson, JR			Integrating the molecular and cellular basis of odor coding in the Drosophila antenna	NEURON			English	Article							OLFACTORY RECEPTOR NEURONS; SEX-PHEROMONE; EXPRESSION; ORGANIZATION; RESPONSES; MELANOGASTER; PROJECTIONS; DEFICIENT; PROTEIN; SUBSET	We investigate how the molecular and cellular maps of the Drosophila olfactory system are integrated. A correspondence is established between individual odor receptors, neurons, and odors. We describe the expression of the Or22a and Or22b receptor genes, show localization to dendritic membranes, and find sexual dimorphism. Or22a maps to the ab3A neuron, which responds to ethyl butyrate. Analysis of a deletion mutant lacking Or22a, along with transgenic rescue experiments, confirms the mapping and demonstrates that an Or gene is required for olfactory function in vivo. Ectopic expression of Or47a in a mutant cell identifies the neuron from which it derives and its odor ligands. Ectopic expression in a wild-type cell shows that two receptors can function in a single cell. The ab3A neuron does not depend on normal odor receptor gene expression to navigate to its target in the CNS.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; Max Planck Inst Verhaltensphysiol, D-823196 Seewiesen, Germany	Yale University; Monash University; Max Planck Society	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	john.carlson@yale.edu	van der Goes van Naters, Wynand/A-5868-2010	van der Goes van Naters, Wynand/0000-0002-6808-0161; Warr, Coral/0000-0002-5289-3950	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004729, R01DC002174] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC-04729, DC-02174] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Ashburner M., 1989, DROSOPHILA LAB HDB; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; BRAND AH, 1993, DEVELOPMENT, V118, P401; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; DANSCHER G, 1981, HISTOCHEMISTRY, V71, P81, DOI 10.1007/BF00592572; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; Elmore T, 2001, INSECT BIOCHEM MOLEC, V31, P791, DOI 10.1016/S0965-1748(00)00184-3; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Grant AJ, 1998, J COMP PHYSIOL A, V183, P433, DOI 10.1007/s003590050269; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Kaissling K. E., 1980, RECEPTORS NEUROTRANS; KRIEGER J, 1994, EUR J BIOCHEM, V219, P829, DOI 10.1111/j.1432-1033.1994.tb18564.x; Laissue PP, 1999, J COMP NEUROL, V405, P543; Laue M, 1997, INT J INSECT MORPHOL, V26, P217, DOI 10.1016/S0020-7322(97)00023-8; LEAL W, 2003, IN PRESS INSECT PHER; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Menco BPM, 1997, J NEUROCYTOL, V26, P691, DOI 10.1023/A:1018554029186; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nikonov AA, 2002, J CHEM ECOL, V28, P1075, DOI 10.1023/A:1015274104626; Ochieng SA, 2002, J COMP PHYSIOL A, V188, P325, DOI 10.1007/s00359-002-0308-8; Rawson NE, 2000, J NEUROCHEM, V75, P185, DOI 10.1046/j.1471-4159.2000.0750185.x; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Shanbhag SR, 2000, ARTHROPOD STRUCT DEV, V29, P211, DOI 10.1016/S1467-8039(00)00028-1; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Spehr M, 2002, NEURON, V33, P731, DOI 10.1016/S0896-6273(02)00610-4; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Stortkuhl KF, 2001, P NATL ACAD SCI USA, V98, P9381, DOI 10.1073/pnas.151105698; STROTMANN J, 1995, EUR J NEUROSCI, V7, P492, DOI 10.1111/j.1460-9568.1995.tb00345.x; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; Wojtasek H, 1998, BIOCHEM BIOPH RES CO, V250, P217, DOI 10.1006/bbrc.1998.9278; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	50	399	437	8	90	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 6	2003	37	5					827	841		10.1016/S0896-6273(03)00094-1	http://dx.doi.org/10.1016/S0896-6273(03)00094-1			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	653TH	12628173	Bronze			2022-12-24	WOS:000181452800012
J	Wang, J; Ma, XJ; Yang, JS; Zheng, XY; Zugates, CT; Lee, CHJ; Lee, T				Wang, J; Ma, XJ; Yang, JS; Zheng, XY; Zugates, CT; Lee, CHJ; Lee, T			Transmembrane/juxtamembrane domain-dependent Dscam distribution and function during mushroom body neuronal morphogenesis	NEURON			English	Article							REPRESSIBLE CELL MARKER; DROSOPHILA DSCAM; MOSAIC ANALYSIS; AXON GUIDANCE; BODIES; RECEPTOR; NEUROBLAST; EXPRESSION; CHANNELS; ROLES	Besides 19,008 possible ectodomains, Drosophila Dscam contains two alternative transmembrane/juxtamembrane segments, respectively, derived from exon 17.1 and exon 17.2. We wondered whether specific Dscam isoforms mediate formation and segregation of axonal branches in the Drosophila mushroom bodies (MBs). Removal of various subsets of the 12 exon 4s does not affect MB neuronal morphogenesis, while expression of a Dscam transgene only partially rescues Dscam mutant phenotypes. Interestingly, differential rescuing effects are observed between two Dscam transgenes that each possesses one of the two possible exon 17s. Axon bifurcation/segregation abnormalities are better rescued by the exon 17.2-containing transgene, but coexpression of both transgenes is required for rescuing mutant viability. Meanwhile, exon 17.1 targets ectopically expressed Dscam-GFP to dendrites while Dscam[exon 17.2]-GFP is enriched in axons; only Dscam[exon 17.2] affects MB axons. These results suggest that exon 17.1 is minimally involved in axonal morphogenesis and that morphogenesis of MB axons probably involves multiple distinct exon 17.2-containing Dscam isoforms.	Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; Univ Illinois, Hematol Oncol Sect, Dept Internal Med, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lee, T (corresponding author), Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA.	tzumin@life.uiuc.edu	Zheng, Xiaoyan/AAG-1251-2020; Yang, Shun-Jen/G-2968-2015	Zheng, Xiaoyan/0000-0003-4983-5503; Zugates, Christopher/0000-0003-1882-3665				Agarwala KL, 2000, MOL BRAIN RES, V79, P118, DOI 10.1016/S0169-328X(00)00108-X; Celotto AM, 2001, GENETICS, V159, P599; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Francesconi A, 2002, J NEUROSCI, V22, P2196, DOI 10.1523/JNEUROSCI.22-06-02196.2002; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Kurusu M, 2002, DEVELOPMENT, V129, P409; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Noveen A, 2000, DEVELOPMENT, V127, P3475; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; YANG MY, 1995, NEURON, V15, P45; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020	24	140	141	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 2	2004	43	5					663	672		10.1016/j.neuron.2004.06.033	http://dx.doi.org/10.1016/j.neuron.2004.06.033			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339648	Bronze			2022-12-24	WOS:000223691900012
J	Ibanez-Tallon, I; Wen, H; Miwa, JM; Xing, J; Tekinay, AB; Ono, F; Brehm, P; Heintz, N				Ibanez-Tallon, I; Wen, H; Miwa, JM; Xing, J; Tekinay, AB; Ono, F; Brehm, P; Heintz, N			Tethering naturally occurring peptide toxins for cell-autonomous modulation of ion channels and receptors in vivo	NEURON			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; CENTRAL-NERVOUS-SYSTEM; CALCIUM-CHANNELS; NEUROTRANSMITTER RELEASE; ALPHA-CONOTOXIN; GENE-EXPRESSION; NMDA RECEPTORS; MEMORY; SNAKE; BUNGAROTOXIN	The physiologies of cells depend on electrochemical signals carried by ion channels and receptors. Venomous animals produce an enormous variety of peptide toxins with high affinity for specific ion channels and receptors. The mammalian prototoxin lynx1 shares with alpha-bungarotoxin the ability to bind and modulate nicotinic receptors (nAChRs); however, lynx1 is tethered to the membrane via a GPI anchor. We show here that several classes of neurotoxins, including bungarotoxins and cobratoxins, retain their selective antagonistic properties when tethered to the membrane. Targeted elimination of nAChR function in zebrafish can be achieved with tethered alpha-bungarotoxin, silencing synaptic transmission without perturbing synapse formation. These studies harness the pharmacological properties of peptide toxins for use in genetic experiments. When combined with specific methods of cell and temporal expression, the extension of this approach to hundreds of naturally occurring peptide toxins opens a new landscape for cell-autonomous regulation of cellular physiology in vivo.	Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10021 USA; SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	Howard Hughes Medical Institute; Rockefeller University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Heintz, N (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, 1230 York Ave, New York, NY 10021 USA.	heintz@rockefeller.edu	ono, fumihito/A-6570-2008; Tekinay, Ayse Begum/A-7212-2015	Tekinay, Ayse Begum/0000-0002-4453-814X; ono, fumihito/0000-0001-7532-5262; Miwa, Julie/0000-0002-4418-3756				ADAMS ME, 1994, TRENDS NEUROSCI, V17, P151, DOI 10.1016/0166-2236(94)90092-2; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Catterall W A, 1999, Adv Neurol, V79, P441; Champtiaux N, 2004, PROG BRAIN RES, V145, P235, DOI 10.1016/S0079-6123(03)45016-4; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Gong M, 2003, CURR OPIN GENET DEV, V13, P215, DOI 10.1016/S0959-437X(03)00018-2; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Grant GA, 1998, BIOCHEMISTRY-US, V37, P12166, DOI 10.1021/bi981227y; Grutter T, 2003, EMBO J, V22, P1990, DOI 10.1093/emboj/cdg197; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; Johns DC, 1999, J NEUROSCI, V19, P1691; Kofuji P, 2000, J NEUROSCI, V20, P5733, DOI 10.1523/JNEUROSCI.20-15-05733.2000; Lin ZX, 1997, NEURON, V18, P153, DOI 10.1016/S0896-6273(01)80054-4; LORING RH, 1986, BRAIN RES, V385, P30, DOI 10.1016/0006-8993(86)91543-X; LUKAS RJ, 1981, BIOCHEMISTRY-US, V20, P7373, DOI 10.1021/bi00529a008; Luo S, 1999, BIOCHEMISTRY-US, V38, P14542, DOI 10.1021/bi991252j; Manns JR, 2003, NEURON, V37, P171, DOI 10.1016/S0896-6273(02)01147-9; Mansuy IM, 2000, CURR OPIN NEUROBIOL, V10, P593, DOI 10.1016/S0959-4388(00)00127-6; McIntosh JM, 1999, ANNU REV BIOCHEM, V68, P59, DOI 10.1146/annurev.biochem.68.1.59; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Nadal MS, 2001, J PHYSIOL-LONDON, V537, P801; Nadeau H, 2000, J NEUROPHYSIOL, V84, P1062, DOI 10.1152/jn.2000.84.2.1062; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; OLIVERA BM, 1994, ANNU REV BIOCHEM, V63, P823, DOI 10.1146/annurev.bi.63.070194.004135; Ono F, 2002, J NEUROSCI, V22, P6491; Ono F, 2001, J NEUROSCI, V21, P5439, DOI 10.1523/JNEUROSCI.21-15-05439.2001; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Peng HB, 1999, J CELL BIOL, V145, P911, DOI 10.1083/jcb.145.4.911; Saint-Amant L, 2001, NEURON, V31, P1035, DOI 10.1016/S0896-6273(01)00416-0; Sato K, 2000, BIOCHEM BIOPH RES CO, V269, P254, DOI 10.1006/bbrc.2000.2284; Servent D, 1997, J BIOL CHEM, V272, P24279, DOI 10.1074/jbc.272.39.24279; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Terlau H, 1996, J NEUROPHYSIOL, V76, P1423, DOI 10.1152/jn.1996.76.3.1423; Tsetlin VI, 2004, FEBS LETT, V557, P9, DOI 10.1016/S0014-5793(03)01454-6; TSIEN RW, 1983, ANNU REV PHYSIOL, V45, P341, DOI 10.1146/annurev.ph.45.030183.002013; WAKAMATSU K, 1992, BIOCHEMISTRY-US, V31, P12577, DOI 10.1021/bi00165a006	41	67	72	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 5	2004	43	3					305	311		10.1016/j.neuron.2004.07.015	http://dx.doi.org/10.1016/j.neuron.2004.07.015			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	844KL	15294139	Bronze			2022-12-24	WOS:000223156900005
J	Singer, JH; Lassova, L; Vardi, N; Diamond, JS				Singer, JH; Lassova, L; Vardi, N; Diamond, JS			Coordinated multivesicular release at a mammalian ribbon synapse	NATURE NEUROSCIENCE			English	Article							ROD BIPOLAR CELLS; AII AMACRINE CELLS; RABBIT RETINA; QUANTAL ANALYSIS; RAT RETINA; ASYNCHRONOUS RELEASE; EXCITATORY SYNAPSES; SIGNAL INTERNEURONS; TIME-COURSE; VESICLES	Traditional models of synaptic transmission hold that release sites within an active zone operate independently. Although the release of multiple vesicles (multivesicular release; MVR) from single active zones occurs at some central synapses, MVR is not thought to require coordination among release sites. Ribbon synapses seem to be optimized to release many vesicles over an extended period, but the dynamics of MVR at ribbon synapses is unknown. We examined MVR at a ribbon synapse in a retinal slice preparation using paired recordings from presynaptic rod bipolar and postsynaptic AII amacrine cells. When evoked release was highly desynchronized, discrete postsynaptic events were larger than quantal miniature excitatory postsynaptic currents (mEPSCs) but had the same time course. The amplitude of these multiquantal mEPSCs, which seem to arise from the essentially simultaneous release of multiple vesicles, was reduced by lowering release probability. The release synchrony reflected in these multivesicular events suggests that release within an active zone is coordinated during MVR.	NINDS, Synapt Physiol Unit, NIH, Bethesda, MD 20892 USA; Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Pennsylvania	Singer, JH (corresponding author), NINDS, Synapt Physiol Unit, NIH, MSC-4066,Bldg 26,Room 2C-09, Bethesda, MD 20892 USA.	singerj@ninds.nih.gov	Diamond, Jeffrey/C-1835-2015	Diamond, Jeffrey/0000-0002-1770-2629	NATIONAL EYE INSTITUTE [R01EY000828, R01EY011105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K22NS043365] Funding Source: NIH RePORTER; NEI NIH HHS [EY11105, EY00828] Funding Source: Medline; NINDS NIH HHS [K22 NS043365] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALVAREZ DT, 1993, NATURE, V363, P554, DOI DOI 10.1038/363554A0; ALVAREZ DT, 1990, J GEN PHYSIOL, V95, P397, DOI DOI 10.1085/JGP.95.3.397; Auger C, 1998, J NEUROSCI, V18, P4532; Barlow H B, 1971, Vision Res, VSuppl 3, P87; CHUN MH, 1993, J COMP NEUROL, V332, P421, DOI 10.1002/cne.903320404; Cui JJ, 2003, J PHYSIOL-LONDON, V553, P895, DOI 10.1113/jphysiol.2003.052092; DELCASTILLO J, 1954, J PHYSL, V124, P157; Diamond JS, 1997, J NEUROSCI, V17, P4672; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; Hansen NJ, 1999, J BIOL CHEM, V274, P22871, DOI 10.1074/jbc.274.32.22871; Hartveit E, 1999, J NEUROPHYSIOL, V81, P2923, DOI 10.1152/jn.1999.81.6.2923; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; ISAACSON JS, 1995, NEURON, V15, P875, DOI 10.1016/0896-6273(95)90178-7; Katz B., 1969, RELEASE NEURAL TRANS; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; Koulen P, 1998, EUR J NEUROSCI, V10, P1446, DOI 10.1046/j.1460-9568.1998.00156.x; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; Li W, 2002, J COMP NEUROL, V448, P230, DOI 10.1002/cne.10189; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Muresan V, 1999, J NEUROSCI, V19, P1027; NELSON R, 1982, J NEUROPHYSIOL, V47, P928, DOI 10.1152/jn.1982.47.5.928; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; Parsons TD, 2003, NEURON, V37, P379, DOI 10.1016/S0896-6273(03)00062-X; PROPST JW, 1987, J NEUROSCI, V7, P3654; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; SAKITT B, 1972, J PHYSIOL-LONDON, V223, P131, DOI 10.1113/jphysiol.1972.sp009838; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Singer JH, 2003, J NEUROSCI, V23, P10923; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; STERLING P, 1988, J NEUROSCI, V8, P623; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; STRETTOI E, 1992, J COMP NEUROL, V325, P152, DOI 10.1002/cne.903250203; STRETTOI E, 1990, J COMP NEUROL, V295, P449, DOI 10.1002/cne.902950309; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; VANDERKLOOT W, 1988, J PHYSIOL-LONDON, V402, P595, DOI 10.1113/jphysiol.1988.sp017224; VANEY DI, 1991, J COMP NEUROL, V310, P154, DOI 10.1002/cne.903100203; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; YOUNG HM, 1991, J COMP NEUROL, V310, P139, DOI 10.1002/cne.903100202; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500	47	161	161	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					826	833		10.1038/nn1280	http://dx.doi.org/10.1038/nn1280			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15235608				2022-12-24	WOS:000222930800012
J	Pena, F; Parkis, MA; Tryba, AK; Ramirez, JM				Pena, F; Parkis, MA; Tryba, AK; Ramirez, JM			Differential contribution of pacemaker properties to the generation of respiratory rhythms during normoxia and hypoxia	NEURON			English	Article							PERSISTENT SODIUM CURRENT; CENTRAL PATTERN GENERATORS; PRE-BOTZINGER COMPLEX; IN-VITRO; PLATEAU POTENTIALS; CORTICAL-NEURONS; NETWORK; RILUZOLE; GANGLION; HIPPOCAMPAL	Pacemaker neurons have been described in most neural networks. However, whether such neurons are essential for generating an activity pattern in a given preparation remains mostly unknown. Here, we show that in the mammalian respiratory network two types of pacemaker neurons exist. Differential blockade of these neurons indicates that their relative contribution to respiratory rhythm generation changes during the transition from normoxia to hypoxia. During hypoxia, blockade of neurons with sodium-dependent bursting properties abolishes respiratory rhythm generation, while in normoxia respiratory rhythm generation only ceases upon pharmacological blockade of neurons with heterogeneous bursting properties. We propose that respiratory rhythm generation in normoxia depends on a heterogeneous population of pacemaker neurons, while during hypoxia the respiratory rhythm is driven by only one type of pacemaker.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; IPN, Dept Farmacobiol, Ctr Invest & Estudios Avanzados, Mexico City 14330, DF, Mexico	University of Chicago; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Pena, F (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA.	jfpena@mail.cinvestav.mx		Pena-Ortega, Fernando/0000-0002-0348-4392; Ramirez, Jan-Marino/0000-0002-5626-3999; Tryba, Andrew/0000-0002-9610-9259	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060120, R01HL068860] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL60120, HL68860] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arshavsky YI, 2003, BRAIN RES REV, V41, P229, DOI 10.1016/S0165-0173(02)00249-7; Beurrier C, 1999, J NEUROSCI, V19, P599, DOI 10.1523/jneurosci.19-02-00599.1999; Bremer F, 1938, ACTUAL SCI IND, V658, P3; Butera RJ, 1999, J NEUROPHYSIOL, V82, P382, DOI 10.1152/jn.1999.82.1.382; CARPENTE.DO, 1967, J GEN PHYSIOL, V50, P1469, DOI 10.1085/jgp.50.6.1469; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; CONNOR JA, 1969, J EXP BIOL, V50, P275; Del Negro CA, 2002, J NEUROPHYSIOL, V88, P2242, DOI 10.1152/jn.00081.2002; Del Negro CA, 2002, NEURON, V34, P821, DOI 10.1016/S0896-6273(02)00712-2; Di Prisco GV, 2000, J NEUROSCI, V20, P8169; Ghamari-Langroudi M, 2002, J PHYSIOL-LONDON, V545, P537, DOI 10.1113/jphysiol.2002.033589; HARRISWARRICK RM, 1987, J NEUROSCI, V7, P2113; HASUO H, 1990, J NEUROPHYSIOL, V64, P1838, DOI 10.1152/jn.1990.64.6.1838; HOUNSGAARD J, 1979, ACTA PHYSIOL SCAND, V106, P91, DOI 10.1111/j.1748-1716.1979.tb06375.x; Huang CS, 1997, J PHARMACOL EXP THER, V282, P1280; JENNINGS DP, 1978, BRAIN RES, V149, P347, DOI 10.1016/0006-8993(78)90480-8; Johnston D., 1995, FDN CELLULAR NEUROPH; Kiehn O, 1997, NEUROSCIENCE, V77, P613; Kinney HC, 2001, J NEUROPATH EXP NEUR, V60, P228, DOI 10.1093/jnen/60.3.228; Koshiya N, 1999, NATURE, V400, P360, DOI 10.1038/22540; KRAMER RH, 1985, J PHYSIOL-LONDON, V362, P107, DOI 10.1113/jphysiol.1985.sp015666; Lieske SP, 2000, NAT NEUROSCI, V3, P600, DOI 10.1038/75776; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; Lytton WW, 1996, NEUROSCIENCE, V70, P673, DOI 10.1016/S0306-4522(96)83006-5; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; Marder E, 2002, NATURE, V417, P318, DOI 10.1038/417318a; MARDER E, 1984, J EXP BIOL, V112, P147; McCrimmon DR, 2000, BIOESSAYS, V22, P6, DOI 10.1002/(SICI)1521-1878(200001)22:1<6::AID-BIES3>3.0.CO;2-Q; MILLER JP, 1982, J NEUROPHYSIOL, V48, P1378, DOI 10.1152/jn.1982.48.6.1378; Morisset V, 1999, J NEUROSCI, V19, P7309, DOI 10.1523/JNEUROSCI.19-17-07309.1999; NEHER E, 1992, METHOD ENZYMOL, V207, P123; ONeill MJ, 1997, EUR J PHARMACOL, V332, P121, DOI 10.1016/S0014-2999(97)01074-1; Partridge LD, 2000, BRAIN RES, V867, P143, DOI 10.1016/S0006-8993(00)02275-7; PARTRIDGE LD, 1994, BRAIN RES REV, V19, P319, DOI 10.1016/0165-0173(94)90017-5; Pena F, 2002, J NEUROSCI, V22, P11055; Pena F, 2000, NEUROSCIENCE, V101, P547, DOI 10.1016/S0306-4522(00)00400-0; Poets CF, 1999, PEDIATR RES, V45, P350, DOI 10.1203/00006450-199903000-00010; Ramirez JM, 1998, J NEUROPHYSIOL, V80, P3137, DOI 10.1152/jn.1998.80.6.3137; Ramirez JM, 1996, J PHYSIOL-LONDON, V491, P799, DOI 10.1113/jphysiol.1996.sp021258; Rekling JC, 1998, ANNU REV PHYSIOL, V60, P385, DOI 10.1146/annurev.physiol.60.1.385; Rekling JC, 1997, J NEUROPHYSIOL, V78, P2483, DOI 10.1152/jn.1997.78.5.2483; RICHTER DW, 1991, J PHYSIOL-LONDON, V443, P231, DOI 10.1113/jphysiol.1991.sp018832; SCHWINDT PC, 1982, J NEUROPHYSIOL, V48, P875, DOI 10.1152/jn.1982.48.4.875; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Shuai J, 2003, BIOPHYS J, V84, P2099, DOI 10.1016/S0006-3495(03)75017-6; Siniscalchi A, 1997, BRIT J PHARMACOL, V120, P225, DOI 10.1038/sj.bjp.0700905; Smith JC, 2000, RESP PHYSIOL, V122, P131, DOI 10.1016/S0034-5687(00)00155-9; Spadoni F, 2002, NEUROREPORT, V13, P1167, DOI 10.1097/00001756-200207020-00019; Staley KJ, 2001, J NEUROPHYSIOL, V86, P2736, DOI 10.1152/jn.2001.86.6.2736; Stefani A, 1997, EXP NEUROL, V147, P115, DOI 10.1006/exnr.1997.6554; Su HL, 2001, J NEUROSCI, V21, P4173, DOI 10.1523/JNEUROSCI.21-12-04173.2001; SWANDULLA D, 1985, J NEUROPHYSIOL, V54, P1430, DOI 10.1152/jn.1985.54.6.1430; Telgkamp P, 1999, J NEUROPHYSIOL, V82, P2163, DOI 10.1152/jn.1999.82.5.2163; Thoby-Brisson M, 2001, J NEUROPHYSIOL, V86, P104, DOI 10.1152/jn.2001.86.1.104; Thoby-Brisson M, 2000, J NEUROSCI, V20, P5858, DOI 10.1523/JNEUROSCI.20-15-05858.2000; TRAUB RD, 1979, J NEUROPHYSIOL, V42, P476, DOI 10.1152/jn.1979.42.2.476; Tresch MC, 2000, NAT NEUROSCI, V3, P593, DOI 10.1038/75768; Tryba AK, 2003, J NEUROSCI, V23, P3538; Urbani A, 2000, EUR J NEUROSCI, V12, P3567, DOI 10.1046/j.1460-9568.2000.00242.x; WATANABE A, 1967, J GEN PHYSIOL, V50, P839, DOI 10.1085/jgp.50.4.839; WEIMANN JM, 1994, CURR BIOL, V4, P896, DOI 10.1016/S0960-9822(00)00199-8; Zona C, 1998, NEUROSCIENCE, V85, P931, DOI 10.1016/S0306-4522(97)00604-0	62	258	262	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 8	2004	43	1					105	117		10.1016/j.neuron.2004.06.023	http://dx.doi.org/10.1016/j.neuron.2004.06.023			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233921	Bronze			2022-12-24	WOS:000222549800011
J	Zink, CF; Pagnoni, G; Martin-Skurski, ME; Chappelow, JC; Berns, GS				Zink, CF; Pagnoni, G; Martin-Skurski, ME; Chappelow, JC; Berns, GS			Human striatal responses to monetary reward depend on saliency	NEURON			English	Article							TONICALLY ACTIVE NEURONS; VENTRAL STRIATUM; NUCLEUS-ACCUMBENS; DOPAMINE NEURONS; NEURAL RESPONSES; ORBITOFRONTAL CORTEX; MONKEY STRIATUM; HUMAN BRAIN; ANTICIPATION; FMRI	While the striatum has been implicated in reward processing, an alternative view contends that the striatum processes salient events in general. Using fMRI, we investigated human striatal responses to monetary reward while modulating the saliency surrounding its receipt. Money was maximally salient when its receipt depended on a correct response (active) and minimally salient when its receipt was completely independent of the task (passive). The saliency manipulation was confirmed by skin conductance responses and subjective ratings of the stimuli. Significant caudate and nucleus accumbens activations occurred following the active compared to passive money. Such activations were attributed to saliency rather than the motor requirement associated with the active money because striatal activations were not observed when the money was replaced by inconsequential, nonrewarding stimuli. The present study provides evidence that the striatum's role in reward processing is dependent on the saliency associated with reward, rather than value or hedonic feelings.	Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA	Emory University; University System of Georgia; Georgia Institute of Technology	Berns, GS (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA.	gberns@emory.edu	Pagnoni, Giuseppe/F-3398-2015	Pagnoni, Giuseppe/0000-0002-8272-8091	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH067348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K08DA000367] Funding Source: NIH RePORTER; NIBIB NIH HHS [R01 EB 002635] Funding Source: Medline; NIDA NIH HHS [K08 DA 00367] Funding Source: Medline; NIMH NIH HHS [F31 MH 67348] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Cannon CM, 2003, J NEUROSCI, V23, P10827; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Elliott R, 2003, J NEUROSCI, V23, P303; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1997, TRENDS COGN SCI, V1, P21, DOI 10.1016/S1364-6613(97)01001-2; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Horvitz JC, 2002, BEHAV BRAIN RES, V137, P65, DOI 10.1016/S0166-4328(02)00285-1; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Jensen J, 2003, NEURON, V40, P1251, DOI 10.1016/S0896-6273(03)00724-4; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Legault M, 2001, EUR J NEUROSCI, V13, P819, DOI 10.1046/j.0953-816x.2000.01448.x; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Ravel S, 1999, EXP BRAIN RES, V128, P531, DOI 10.1007/s002210050876; Ravel S, 2001, J NEUROSCI, V21, P5730, DOI 10.1523/JNEUROSCI.21-15-05730.2001; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Setlow B, 2003, NEURON, V38, P625, DOI 10.1016/S0896-6273(03)00264-2; Talairach J., 1988, COPLANAR STEREOTAXIC; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; WILLIAMS GV, 1993, BEHAV BRAIN RES, V55, P243, DOI 10.1016/0166-4328(93)90120-F; Zink CF, 2003, J NEUROSCI, V23, P8092	41	323	327	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2004	42	3					509	517		10.1016/S0896-6273(04)00183-7	http://dx.doi.org/10.1016/S0896-6273(04)00183-7			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KH	15134646	Bronze			2022-12-24	WOS:000221458700016
J	Keysers, C; Wicker, B; Gazzola, V; Anton, JL; Fogassi, L; Gallese, V				Keysers, C; Wicker, B; Gazzola, V; Anton, JL; Fogassi, L; Gallese, V			A touching sight: SII/PV activation during the observation and experience of touch	NEURON			English	Article							SOMATOSENSORY CORTEX; LATERAL SULCUS; MIRROR NEURONS; AREAS; RECOGNITION; PREMOTOR; PARIETAL; REPRESENTATION; ORGANIZATION; DISGUST	Watching the movie scene in which a tarantula crawls on James Bond's chest can make us literally shiver-as if the spider crawled on our own chest. What neural mechanisms are responsible for this "tactile empathy"? The observation of the actions of others activates the premotor cortex normally involved in the execution of the same actions. If a similar mechanism applies to the sight of touch, movies depicting touch should automatically activate the somatosensory cortex of the observer. Here we found using fMRI that the secondary but not the primary somatosensory cortex is activated both when the participants were touched and when they observed someone or something else getting touched by objects. The neural mechanisms enabling our own sensation of touch may therefore be a window also to our understanding of touch.	Univ Groningen, BCN, Neuroimaging Ctr, NL-9713 AW Groningen, Netherlands; CNRS, Inst Neurosci Physiol & Cognit, F-13402 Marseille 20, France; CHU Timone, Ctr Imagerie RMN Fonct, F-13385 Marseille 05, France; Univ Parma, Dept Neurosci Physiol, I-43100 Parma, Italy; Univ Parma, Dept Psychol, I-43100 Parma, Italy	University of Groningen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Parma; University of Parma	Keysers, C (corresponding author), Univ Groningen, BCN, Neuroimaging Ctr, NL-9713 AW Groningen, Netherlands.	c.keysers@med.rug.nl; vittorio.gallese@unipr.it	Keysers, Christian/H-6251-2013; FOGASSI, Leonardo/K-3541-2018	Keysers, Christian/0000-0002-2845-5467; Gazzola, Valeria/0000-0003-0324-0619; FOGASSI, Leonardo/0000-0003-3348-039X				Adolphs R, 2003, BRAIN COGNITION, V52, P61, DOI 10.1016/S0278-2626(03)00009-5; Bradshaw JL, 2001, J NEUROL NEUROSUR PS, V70, P135; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Brett M, 2002, NEUROIMAGE, V16; Brodmann K., 1909, LOCALIZATION CEREBRA; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; BURTON H, 1993, SOMATOSENS MOT RES, V10, P297, DOI 10.3109/08990229309028839; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; Carlsson K, 2000, J COGNITIVE NEUROSCI, V12, P691, DOI 10.1162/089892900562318; CASELLI RJ, 1993, NEUROLOGY, V43, P762, DOI 10.1212/WNL.43.4.762; Cipolloni PB, 1999, J COMP NEUROL, V403, P431; Del Gratta C, 2000, NEUROREPORT, V11, P2035, DOI 10.1097/00001756-200006260-00046; Disbrow E, 2000, J COMP NEUROL, V418, P1, DOI 10.1002/(SICI)1096-9861(20000228)418:1<1::AID-CNE1>3.0.CO;2-P; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; EICKHOFF S, 2002, NEUROIMAGE, V16; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; Gallese V, 2002, ATTENTION PERFORM, V19, P334; GARCHA HS, 1980, CORTEX, V16, P397, DOI 10.1016/S0010-9452(80)80041-4; Gelnar PA, 1998, NEUROIMAGE, V7, P261, DOI 10.1006/nimg.1998.0341; Grezes J, 2003, NEUROIMAGE, V18, P928, DOI 10.1016/S1053-8119(03)00042-9; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Keysers C, 2003, EXP BRAIN RES, V153, P628, DOI 10.1007/s00221-003-1603-5; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Krolak-Salmon P, 2003, ANN NEUROL, V53, P446, DOI 10.1002/ana.10502; KRUBITZER L, 1995, J NEUROSCI, V15, P3821; MATELLI M, 1986, J COMP NEUROL, V251, P281, DOI 10.1002/cne.902510302; Penfield W, 1954, EPILEPSY FUNCTIONAL; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; ROBINSON CJ, 1980, J COMP NEUROL, V192, P93, DOI 10.1002/cne.901920106; Servos P, 2001, COGNITIVE BRAIN RES, V12, P307, DOI 10.1016/S0926-6410(01)00041-6; VOGT O, 1911, J PSYCHOL NEUROL, V18, P107; von Economo C, 1925, CYTOARCHITEKTONIK HI; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2	38	564	579	1	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 22	2004	42	2					335	346		10.1016/S0896-6273(04)00156-4	http://dx.doi.org/10.1016/S0896-6273(04)00156-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KG	15091347	Bronze			2022-12-24	WOS:000221458500016
J	Young, TL; Cepko, CL				Young, TL; Cepko, CL			A role for ligand-gated ion channels in rod photoreceptor development	NEURON			English	Article							INHIBITORY GLYCINE RECEPTOR; MATERNAL TAURINE DEFICIENCY; RAT SPINAL-CORD; POSTNATAL-DEVELOPMENT; PROGENITOR CELLS; BIPOLAR CELLS; IN-VITRO; SYNAPTIC INHIBITION; CHLORIDE CURRENT; GENE-EXPRESSION	Neurotransmitter receptors are central to communication at synapses. Many components of the machinery for neurotransmission are present prior to synapse formation, suggesting a developmental role. Here, evidence is presented that signaling through glycine receptor alpha2 (GlyRalpha2) and GABA(A) receptors plays a role in photoreceptor development in the vertebrate retina. The signaling is likely mediated by taurine, which is present at high levels throughout the developing central nervous system (CNS). Taurine potentiates the production of rod photoreceptors, and this induction is inhibited by strychnine, an antagonist of glycine receptors, and bicuculline, an antagonist of GABA receptors. Gain-of-function experiments showed that signaling through GlyRalpha2 induced exit from mitosis and an increase in rod photoreceptors. Furthermore, targeted knockdown of GlyRalpha2 decreased the number of photoreceptors while increasing the number of other retinal cell types. These data support a previously undescribed role for these ligand-gated ion channels during the early stages of CNS development.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Cepko, CL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	cepko@genetics.med.harvard.edu		Young-Pearse, Tracy/0000-0001-7846-1542	NEI NIH HHS [R01EY09676] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009676] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALTSHULER D, 1993, DEVELOPMENT, V119, P1317; ALTSHULER D, 1992, DEVELOPMENT, V114, P947; ALTSHULER DM, 1991, P RET RES F, V3, P37; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; BECKER CM, 1988, EMBO J, V7, P3717, DOI 10.1002/j.1460-2075.1988.tb03255.x; Belliveau MJ, 1999, DEVELOPMENT, V126, P555; Belliveau MJ, 2000, J NEUROSCI, V20, P2247; Bockelmann R, 1998, NEUROCHEM RES, V23, P469, DOI 10.1023/A:1022418231496; BOOS R, 1993, J NEUROSCI, V13, P2874; BORMANN J, 1993, EMBO J, V12, P3729, DOI 10.1002/j.1460-2075.1993.tb06050.x; Bres V, 2000, BRIT J PHARMACOL, V130, P1976, DOI 10.1038/sj.bjp.0703492; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Cepko CL, 1998, CURR TOP DEV BIOL, V36, P51; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chen CB, 2002, DEVELOPMENT, V129, P2401; CURTIS DR, 1974, J NEUROCHEM, V23, P605, DOI 10.1111/j.1471-4159.1974.tb06066.x; CURTIS DR, 1971, BRAIN RES, V32, P69, DOI 10.1016/0006-8993(71)90156-9; Deleuze C, 1998, J PHYSIOL-LONDON, V507, P463, DOI 10.1111/j.1469-7793.1998.463bt.x; Etter A, 1999, J NEUROCHEM, V72, P318, DOI 10.1111/jnc.1999.72.1.318; Flint AC, 1998, NEURON, V20, P43, DOI 10.1016/S0896-6273(00)80433-X; FUJII A, 1975, J MED CHEM, V18, P502, DOI 10.1021/jm00239a013; GOLDINGER A, 1980, NEUROSCI LETT, V16, P91, DOI 10.1016/0304-3940(80)90107-X; GREFERATH U, 1994, VISUAL NEUROSCI, V11, P721, DOI 10.1017/S0952523800003023; GRENNINGLOH G, 1990, EMBO J, V9, P771, DOI 10.1002/j.1460-2075.1990.tb08172.x; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; HILTON FK, 1981, J EXP ZOOL, V216, P493, DOI 10.1002/jez.1402160318; HOCH W, 1989, NEURON, V3, P339, DOI 10.1016/0896-6273(89)90258-4; HORIKOSHI T, 1988, MOL BRAIN RES, V4, P97, DOI 10.1016/0169-328X(88)90002-2; HUXTABLE RJ, 1989, PROG NEUROBIOL, V32, P471, DOI 10.1016/0301-0082(89)90019-1; HUXTABLE RJ, 1980, FED PROC, V39, P2685; IMAKI H, 1986, DEV NEUROSCI-BASEL, V8, P160, DOI 10.1159/000112251; INOUE M, 1988, NEUROSCI RES, V5, P380, DOI 10.1016/0168-0102(88)90024-7; KARSCHIN A, 1990, J NEUROPHYSIOL, V63, P860, DOI 10.1152/jn.1990.63.4.860; KISHI M, 1988, BIOCHIM BIOPHYS ACTA, V939, P615, DOI 10.1016/0005-2736(88)90109-5; Koulen P, 1996, J NEUROSCI, V16, P2127; LAKE N, 1994, VISUAL NEUROSCI, V11, P253, DOI 10.1017/S0952523800001619; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; LEHMANN A, 1984, J NEUROCHEM, V42, P1286, DOI 10.1111/j.1471-4159.1984.tb02785.x; LEWIS CA, 1991, J NEUROPHYSIOL, V66, P1291, DOI 10.1152/jn.1991.66.4.1291; Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1; Livesey FJ, 2004, P NATL ACAD SCI USA, V101, P1374, DOI 10.1073/pnas.0307014101; LOMBARDINI JB, 1991, BRAIN RES REV, V16, P151, DOI 10.1016/0165-0173(91)90003-Q; LOMBARDINI JB, 1978, J NUTR, V108, P428, DOI 10.1093/jn/108.3.428; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Lynch JW, 1997, EMBO J, V16, P110, DOI 10.1093/emboj/16.1.110; LYNCH JW, 1995, J BIOL CHEM, V270, P13799, DOI 10.1074/jbc.270.23.13799; MACAIONE S, 1974, J NEUROCHEM, V22, P887, DOI 10.1111/j.1471-4159.1974.tb04313.x; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; O'Byrne MB, 2000, J NEUROCHEM, V74, P2087, DOI 10.1046/j.1471-4159.2000.0742087.x; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; PALACKAL T, 1986, J NEUROSCI RES, V15, P223, DOI 10.1002/jnr.490150212; Pasantes-Morales H, 1998, ADV EXP MED BIOL, V442, P209; PASANTESMORALES H, 1976, J NEUROCHEM, V27, P1103, DOI 10.1111/j.1471-4159.1976.tb00315.x; PRIBILLA I, 1992, EMBO J, V11, P4305, DOI 10.1002/j.1460-2075.1992.tb05529.x; RAJENDRA S, 1995, EMBO J, V14, P2987, DOI 10.1002/j.1460-2075.1995.tb07301.x; RAJENDRA S, 1995, NEURON, V14, P169, DOI 10.1016/0896-6273(95)90251-1; Saint Jan DD, 2001, J PHYSIOL-LONDON, V535, P741; Saransaari P, 1999, NEUROSCIENCE, V94, P949, DOI 10.1016/S0306-4522(99)00384-X; SASSOEPOGNETTO M, 1994, J NEUROSCI, V14, P5131; SassoePognetto M, 1997, J COMP NEUROL, V381, P158, DOI 10.1002/(SICI)1096-9861(19970505)381:2<158::AID-CNE4>3.0.CO;2-2; SCHAEFFER JM, 1981, J NEUROCHEM, V36, P1597, DOI 10.1111/j.1471-4159.1981.tb00606.x; SCHMIEDEN V, 1992, EMBO J, V11, P2025, DOI 10.1002/j.1460-2075.1992.tb05259.x; STRANGE K, 1995, KIDNEY INT, V48, P994, DOI 10.1038/ki.1995.381; Sturman J A, 1987, Adv Exp Med Biol, V217, P113; STURMAN JA, 1986, J NUTR, V116, P655, DOI 10.1093/jn/116.4.655; STURMAN JA, 1993, PHYSIOL REV, V73, P119, DOI 10.1152/physrev.1993.73.1.119; STURMAN JA, 1988, J NUTR, V118, P1169, DOI 10.1093/jn/118.10.1169; STURMAN JA, 1985, ADV EXP MED BIOL, V179, P43; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; SUZUKI S, 1990, J PHYSIOL-LONDON, V421, P645, DOI 10.1113/jphysiol.1990.sp017967; TAKAHASHI T, 1992, NEURON, V9, P1155, DOI 10.1016/0896-6273(92)90073-M; TALEB O, 1994, EMBO J, V13, P1318, DOI 10.1002/j.1460-2075.1994.tb06384.x; Tamamaki N, 1997, J NEUROSCI, V17, P8313; Tapia JC, 1998, SYNAPSE, V28, P185; TAUCK DL, 1988, NEUROSCIENCE, V27, P193, DOI 10.1016/0306-4522(88)90230-8; Thio LL, 2003, J NEUROPHYSIOL, V90, P89, DOI 10.1152/jn.00612.2002; Vu TQ, 2000, J NEUROSCI, V20, P1414; Walcott JC, 2003, CLIN EXP OPHTHALMOL, V31, P246, DOI 10.1046/j.1442-9071.2003.00638.x; Wu ZY, 2003, AMINO ACIDS, V24, P155, DOI 10.1007/s00726-002-0314-8	82	116	125	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 25	2004	41	6					867	879		10.1016/S0896-6273(04)00141-2	http://dx.doi.org/10.1016/S0896-6273(04)00141-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KE	15046720	Bronze			2022-12-24	WOS:000221458300007
J	Rea, R; Li, J; Dharia, A; Levitan, ES; Sterling, P; Kramer, RH				Rea, R; Li, J; Dharia, A; Levitan, ES; Sterling, P; Kramer, RH			Streamlined synaptic vesicle cycle in cone photoreceptor terminals	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; RETINAL BIPOLAR CELLS; MOTOR-NERVE TERMINALS; RIBBON SYNAPSE; HIPPOCAMPAL SYNAPSES; TRANSMITTER RELEASE; PEROXIDASE UPTAKE; MEMBRANE; ENDOCYTOSIS; FM1-43	Cone photoreceptors tonically release neurotransmitter in the dark through a continuous cycle of exocytosis and endocytosis. Here, using the synaptic vesicle marker FM1-43, we elucidate specialized features of the vesicle cycle. Unlike retinal bipolar cell terminals, where stimulation triggers bulk membrane retrieval, cone terminals appear to exclusively endocytose small vesicles. These retain their integrity until exocytosis, without pooling their membranes in endosomes. Endocytosed vesicles rapidly disperse through the terminal and are reused with no apparent delay. Unlike other synapses where most vesicles are immobilized and held in reserve, only a small fraction (<15%) becomes immobilized in cones. Photobleaching experiments suggest that vesicles move by diffusion and not by molecular motors on the cytoskeleton and that vesicle movement is not rate limiting for release. The huge reservoir of vesicles that move rapidly throughout cone terminals and the lack of a reserve pool are unique features, providing cones with a steady supply for continuous release.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA; Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA	University of California System; University of California Berkeley; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kramer, RH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.	rhkramer@berkeley.edu			NATIONAL EYE INSTITUTE [R01EY008124, R01EY012608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032385] Funding Source: NIH RePORTER; NEI NIH HHS [EY12608, EY08124] Funding Source: Medline; NINDS NIH HHS [NS32385] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; ASHMORE JF, 1983, J PHYSIOL-LONDON, V340, P569, DOI 10.1113/jphysiol.1983.sp014781; BERK DA, 1993, BIOPHYS J, V65, P2428, DOI 10.1016/S0006-3495(93)81326-2; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; COOPER NGF, 1983, J ULTRA MOL STRUCT R, V84, P252, DOI 10.1016/S0022-5320(83)80005-7; Fuchs PA, 2003, CURR OPIN NEUROBIOL, V13, P452, DOI 10.1016/S0959-4388(03)00098-9; Gaal L, 1998, J NEUROPHYSIOL, V79, P190, DOI 10.1152/jn.1998.79.1.190; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Guatimosim C, 2002, J NEUROCHEM, V82, P1047, DOI 10.1046/j.1471-4159.2002.01029.x; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Henkel AW, 1996, J NEUROSCI, V16, P3960; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; Holt M, 2004, CURR BIOL, V14, P173, DOI 10.1016/j.cub.2003.12.053; Holt M, 2003, J NEUROSCI, V23, P1329, DOI 10.1523/JNEUROSCI.23-04-01329.2003; Kamermans M, 1999, VISION RES, V39, P2449, DOI 10.1016/S0042-6989(99)00043-7; Kay AR, 1999, NEURON, V24, P809, DOI 10.1016/S0896-6273(00)81029-6; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Kraszewski K, 1996, J NEUROSCI, V16, P5905; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Lenzi D, 2002, NEURON, V36, P649, DOI 10.1016/S0896-6273(02)01025-5; LUBYPHELPS K, 1987, P NATL ACAD SCI USA, V84, P4910, DOI 10.1073/pnas.84.14.4910; Mack AF, 2000, VISUAL NEUROSCI, V17, P823, DOI 10.1017/S0952523800176011; McNeil PL, 2001, NAT CELL BIOL, V3, pE124, DOI 10.1038/35074652; Meyers JR, 2003, J NEUROSCI, V23, P4054; Morgans CW, 2000, MICROSC RES TECHNIQ, V50, P141, DOI 10.1002/1097-0029(20000715)50:2<141::AID-JEMT6>3.0.CO;2-B; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Paillart C, 2003, J NEUROSCI, V23, P4092; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Rao-Mirotznik R, 1998, J NEUROPHYSIOL, V80, P3163, DOI 10.1152/jn.1998.80.6.3163; Richards DA, 2003, NEURON, V39, P529, DOI 10.1016/S0896-6273(03)00405-7; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Rieke F, 1996, J PHYSIOL-LONDON, V493, P1; RIPPS H, 1976, J CELL BIOL, V70, P86, DOI 10.1083/jcb.70.1.86; Rouze NC, 1998, J NEUROSCI, V18, P8614; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Ryan TA, 2001, CURR OPIN NEUROBIOL, V11, P544, DOI 10.1016/S0959-4388(00)00247-6; SCHACHER S, 1976, J CELL BIOL, V70, P178, DOI 10.1083/jcb.70.1.178; SCHAEFFER SF, 1978, J CELL BIOL, V79, P802, DOI 10.1083/jcb.79.3.802; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Teng HB, 2000, J NEUROSCI, V20, P7986; von Gersdorff H, 1999, ANNU REV PHYSIOL, V61, P725, DOI 10.1146/annurev.physiol.61.1.725; von Kriegstein K, 1999, EUR J NEUROSCI, V11, P1335, DOI 10.1046/j.1460-9568.1999.00542.x; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	54	100	100	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 4	2004	41	5					755	766		10.1016/S0896-6273(04)00088-1	http://dx.doi.org/10.1016/S0896-6273(04)00088-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KD	15003175	Bronze			2022-12-24	WOS:000221458200011
J	Pineda, VV; Athos, JI; Wang, HB; Celver, J; Ippolito, D; Boulay, G; Birnbaumer, L; Storm, DR				Pineda, VV; Athos, JI; Wang, HB; Celver, J; Ippolito, D; Boulay, G; Birnbaumer, L; Storm, DR			Removal of G(i alpha 1) constraints on adenylyl cyclase in the hippocampus enhances LTP and impairs memory formation	NEURON			English	Article							LONG-TERM POTENTIATION; MEDIATED GENE-EXPRESSION; LATE-PHASE; PROTEIN-KINASE; RECEPTOR; CAMP; CA1; CREB; TRANSCRIPTION; INDUCTION	Stimulation of adenylyl cyclase in the hippocampus is critical for memory formation. However, generation of cAMP signals within an optimal range for memory may require a balance between stimulatory and inhibitory mechanisms. The role of adenylyl cyclase inhibitory mechanisms for memory has not been addressed. One of the mechanisms for inhibition of adenylyl cyclase is through activation of G(i)-coupled receptors, a mechanism that could serve as a constraint on memory formation. Here we report that ablation of G(ialpha1) by gene disruption increases hippocampal adenylyl cyclase activity and enhances LTP in area CA1. Furthermore, gene ablation of G(ialpha1) or antisense oligonucleotide-mediated depletion of G(ialpha1) disrupted hippocampus-dependent memory. We conclude that G(ialpha1) provides a critical mechanism for tonic inhibition of adenylyl cyclase activity in the hippocampus. We hypothesize that loss of G(ialpha1) amplifies the responsiveness of CA1 postsynaptic neurons to stimuli that strengthen synaptic efficacy, thereby diminishing synapse-specific plasticity required for new memory formation.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; NIEHS, Lab Signal Transduct, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	dstorm@u.washington.edu	Boulay, Guylain/D-9773-2010		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK019318, R01DK019318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIGES101643, Z01ES101643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH064311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS042475, R01NS020498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004156] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC04156] Funding Source: Medline; NIDDK NIH HHS [DK-19318] Funding Source: Medline; NIGMS NIH HHS [32 GM07270] Funding Source: Medline; NIMH NIH HHS [1F31MH064311] Funding Source: Medline; NINDS NIH HHS [NS 20498, 1F31NS042475] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; ALBERT PR, 1990, J BIOL CHEM, V265, P5825; Athos J, 2002, NAT NEUROSCI, V5, P1119, DOI 10.1038/nn951; ATHOS J, 2001, CURRENT PROTOCOLS NE, V14; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; BOKOCH GM, 1984, J BIOL CHEM, V259, P3560; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BREDER CD, 1992, J NEUROSCI, V12, P3920; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; Dutar P, 2002, NEUROSCIENCE, V112, P455, DOI 10.1016/S0306-4522(02)00074-X; FREY U, 1991, NEUROSCI LETT, V129, P111, DOI 10.1016/0304-3940(91)90732-9; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Galeotti N, 2001, BRIT J PHARMACOL, V133, P267, DOI 10.1038/sj.bjp.0704081; GEREAU RW, 1995, J NEUROSCI, V15, P6879; Huang YY, 1995, CELL, V83, P1211, DOI 10.1016/0092-8674(95)90146-9; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Moneta D, 2002, EUR J NEUROSCI, V16, P843, DOI 10.1046/j.1460-9568.2002.02146.x; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Musshoff U, 2002, HIPPOCAMPUS, V12, P165, DOI 10.1002/hipo.1105; NAIRN AC, 1985, ANNU REV BIOCHEM, V54, P931, DOI 10.1146/annurev.bi.54.070185.004435; Nguyen PV, 1996, J NEUROSCI, V16, P3189; Nielsen MD, 1996, J BIOL CHEM, V271, P33308, DOI 10.1074/jbc.271.52.33308; Otmakhova NA, 2000, J NEUROSCI, V20, P4446, DOI 10.1523/JNEUROSCI.20-12-04446.2000; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Poser S, 2003, J NEUROSCI, V23, P4420; Poser S, 2001, INT J DEV NEUROSCI, V19, P387, DOI 10.1016/S0736-5748(00)00094-0; QUINN WG, 1979, NATURE, V277, P212, DOI 10.1038/277212a0; Reed TM, 2002, J NEUROSCI, V22, P5188, DOI 10.1523/JNEUROSCI.22-12-05188.2002; Sanna PP, 2002, J NEUROSCI, V22, P3359; Sarnyai Z, 2000, P NATL ACAD SCI USA, V97, P14731, DOI 10.1073/pnas.97.26.14731; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; Slotnick B.M., 1975, STEREOTAXIC ATLAS AL; Sweatt JD, 2001, CURR BIOL, V11, pR391, DOI 10.1016/S0960-9822(01)00216-0; Villacres EC, 1998, J NEUROSCI, V18, P3186; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; ZASTAWNY RL, 1994, J NEUROCHEM, V62, P2099	47	83	83	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2004	41	1					153	163		10.1016/S0896-6273(03)00813-4	http://dx.doi.org/10.1016/S0896-6273(03)00813-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715142	Bronze			2022-12-24	WOS:000187942800016
J	Matsui, K; Jahr, CE				Matsui, K; Jahr, CE			Ectopic release of synaptic vesicles	NEURON			English	Article							CA2+-PERMEABLE AMPA RECEPTORS; FROG NEUROMUSCULAR-JUNCTION; CEREBELLAR PURKINJE-CELLS; RAT HIPPOCAMPAL-NEURONS; TRANSMITTER RELEASE; GLIAL-CELLS; TIME-COURSE; GLUTAMATERGIC SYNAPSES; GRANULE CELL; FIBER	Exocytosis of synaptic vesicles is generally assumed to occur only at ultrastructurally defined presynaptic active zones. If release is restricted to these sites, receptors not located within the synaptic cleft must be activated by transmitter that diffuses out of the cleft or not be activated at all. Here we report that AMPA receptor-mediated quantal events resulting from climbing fiber release are observed in Bergmann glial cells in the cerebellar cortex. These quantal events are not coincident with quanta recorded in neighboring Purkinje cells which receive input from the same climbing fiber. As Bergmann glial membranes are excluded from the synaptic cleft, we propose that exocytosis can occur from climbing fiber release sites located directly across from Bergmann glial membranes. Such ectopic release may account for the majority of the Bergmann glial AMPA response evoked by climbing fiber stimulation.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University	Jahr, CE (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.		Matsui, Ko/AAE-3687-2019	Matsui, Ko/0000-0003-1068-9705	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040056, R56NS040056] Funding Source: NIH RePORTER; NINDS NIH HHS [NS40056] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1972, J COMP NEUROL, V145, P399, DOI 10.1002/cne.901450402; Atluri PP, 1998, J NEUROSCI, V18, P8214; Atluri PP, 1996, J NEUROSCI, V16, P5661; Barbour B, 2001, J NEUROSCI, V21, P7969, DOI 10.1523/JNEUROSCI.21-20-07969.2001; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; Bellingham MC, 1999, NEURON, V23, P159, DOI 10.1016/S0896-6273(00)80762-X; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bergles DE, 1997, P NATL ACAD SCI USA, V94, P14821, DOI 10.1073/pnas.94.26.14821; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; BURNASHEV N, 1992, SCIENCE, V256, P1566, DOI 10.1126/science.1317970; DATYNER NB, 1980, J PHYSIOL-LONDON, V303, P299, DOI 10.1113/jphysiol.1980.sp013286; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; DONEVAN SD, 1993, NEURON, V10, P51, DOI 10.1016/0896-6273(93)90241-I; Dzubay JA, 1999, J NEUROSCI, V19, P5265; Foster KA, 2002, NEURON, V36, P1115, DOI 10.1016/S0896-6273(02)01106-6; Franks KM, 2003, J NEUROSCI, V23, P3186; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Grosche J, 2002, J NEUROSCI RES, V68, P138, DOI 10.1002/jnr.10197; Harrison J, 2003, J NEUROSCI, V23, P377, DOI 10.1523/JNEUROSCI.23-02-00377.2003; Hashimoto K, 2003, NEURON, V38, P785, DOI 10.1016/S0896-6273(03)00298-8; ISAACSON JS, 1995, NEURON, V15, P875, DOI 10.1016/0896-6273(95)90178-7; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Ishikawa T, 2001, J PHYSIOL-LONDON, V533, P423, DOI 10.1111/j.1469-7793.2001.0423a.x; Koike M, 1997, NEUROSCI RES, V29, P27, DOI 10.1016/S0168-0102(97)00067-9; LAZAROVICI P, 1992, J PHARMACOL EXP THER, V263, P1317; Lenzi D, 2002, NEURON, V36, P649, DOI 10.1016/S0896-6273(02)01025-5; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; MARIANI J, 1981, J NEUROSCI, V1, P696, DOI 10.1523/JNEUROSCI.01-07-00696.1981; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; Palay S.L., 1974, CEREBELLAR CORTEX; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Scanziani M, 1996, NATURE, V380, P446, DOI 10.1038/380446a0; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Solessio E, 2000, J NEUROPHYSIOL, V83, P418, DOI 10.1152/jn.2000.83.1.418; SPACEK J, 1985, ANAT EMBRYOL, V171, P245, DOI 10.1007/BF00341419; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; VANDERKLOOT W, 1988, J PHYSIOL-LONDON, V402, P595, DOI 10.1113/jphysiol.1988.sp017224; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Xu-Friedman MA, 2003, J NEUROSCI, V23, P2182; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001; Xu-Friedman MA, 2000, J NEUROSCI, V20, P4414, DOI 10.1523/JNEUROSCI.20-12-04414.2000; Yamada K, 2000, J COMP NEUROL, V418, P106; YAMADA KA, 1993, J NEUROSCI, V13, P3904; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zenisek D, 2003, J NEUROSCI, V23, P2538; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x; Zilberter Y, 2000, J PHYSIOL-LONDON, V528, P489, DOI 10.1111/j.1469-7793.2000.00489.x; ZORUMSKI CF, 1993, NEURON, V10, P61, DOI 10.1016/0896-6273(93)90242-J	51	110	114	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 18	2003	40	6					1173	1183		10.1016/S0896-6273(03)00788-8	http://dx.doi.org/10.1016/S0896-6273(03)00788-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756UZ	14687551	Bronze			2022-12-24	WOS:000187503400015
J	Mazer, JA; Gallant, JL				Mazer, JA; Gallant, JL			Goal-related activity in V4 during free viewing visual search: Evidence for a ventral stream visual salience map	NEURON			English	Article							FRONTAL EYE FIELDS; EXTRASTRIATE AREA V4; SPATIAL ATTENTION; CORTICAL-NEURONS; SINGLE NEURONS; MACAQUE; CORTEX; SELECTION; RESPONSES; MOVEMENTS	Natural exploration of complex visual scenes depends on saccadic eye movements toward important locations. Saccade targeting is thought to be mediated by a retinotopic map that represents the locations of salient features. In this report, we demonstrate that extrastriate ventral area V4 contains a retinotopic salience map that guides exploratory eye movements during a naturalistic free viewing visual search task. In more than half of recorded cells, visually driven activity is enhanced prior to saccades that move the fovea toward the location previously occupied by a neuron's spatial receptive field. This correlation suggests that bottom-up processing in V4 influences the oculomotor planning process. Half of the neurons also exhibit top-down modulation of visual responses that depends on search target identity but not visual stimulation. Convergence of bottom-up and top-down processing streams in area V4 results in an adaptive, dynamic map of salience that guides oculomotor planning during natural vision.	Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Mazer, JA (corresponding author), Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA.		Gallant, Jack L/C-4426-2011; Mazer, James/R-9886-2019		NATIONAL EYE INSTITUTE [R01EY012241] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY012241] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bichot NP, 2001, NEUROPSYCHOLOGIA, V39, P972, DOI 10.1016/S0028-3932(01)00022-7; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; Bichot NP, 2001, J NEUROSCI, V21, P713, DOI 10.1523/JNEUROSCI.21-02-00713.2001; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Cohen YE, 2000, NEURON, V27, P647, DOI 10.1016/S0896-6273(00)00073-8; Conner CE, 1997, J NEUROSCI, V17, P3201; Constantinidis C, 2001, CEREB CORTEX, V11, P581, DOI 10.1093/cercor/11.7.581; FISCHER B, 1981, EXP BRAIN RES, V44, P129; FISCHER B, 1981, EXP BRAIN RES, V41, P431; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; Gallant JL, 1998, NEUROREPORT, V9, P2153, DOI 10.1097/00001756-199806220-00045; Gallant JL, 2000, NEURON, V27, P227, DOI 10.1016/S0896-6273(00)00032-5; GATTASS R, 1988, J NEUROSCI, V8, P1831; Gawne TJ, 2000, J NEUROPHYSIOL, V84, P2691, DOI 10.1152/jn.2000.84.5.2691; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; JUDGE SJ, 1980, J NEUROPHYSIOL, V43, P1133, DOI 10.1152/jn.1980.43.4.1133; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Mazer JA, 2002, P NATL ACAD SCI USA, V99, P1645, DOI 10.1073/pnas.022638499; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; McPeek RM, 2002, J NEUROPHYSIOL, V88, P2019, DOI 10.1152/jn.2002.88.4.2019; MILLER EK, 1993, BRAIN RES, V616, P25, DOI 10.1016/0006-8993(93)90187-R; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1994, J NEUROSCI, V14, P2178; MOTTER BC, 1994, J NEUROSCI, V14, P2190; Motter BC, 1998, VISION RES, V38, P1805, DOI 10.1016/S0042-6989(97)00349-0; Niebur E, 1996, ADV NEUR IN, V8, P802; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; Reinagel P, 1999, NETWORK-COMP NEURAL, V10, P341, DOI 10.1088/0954-898X/10/4/304; Rosenbluth D, 2002, NEURON, V33, P143, DOI 10.1016/S0896-6273(01)00559-1; SCHEIN SJ, 1990, J NEUROSCI, V10, P3369; Sheinberg DL, 2001, J NEUROSCI, V21, P1340; STANTON GB, 1993, J COMP NEUROL, V330, P286, DOI 10.1002/cne.903300209; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836	40	188	191	1	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 18	2003	40	6					1241	1250		10.1016/S0896-6273(03)00764-5	http://dx.doi.org/10.1016/S0896-6273(03)00764-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	756UZ	14687556	Bronze			2022-12-24	WOS:000187503400020
J	Krapivinsky, G; Krapivinsky, L; Manasian, Y; Ivanov, A; Tyzio, R; Pellegrino, C; Ben-Ari, Y; Clapham, DE; Medina, I				Krapivinsky, G; Krapivinsky, L; Manasian, Y; Ivanov, A; Tyzio, R; Pellegrino, C; Ben-Ari, Y; Clapham, DE; Medina, I			The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1	NEURON			English	Article							ACTIVATED PROTEIN-KINASE; LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; MAP KINASE; MOLECULAR-MECHANISMS; MICE LACKING; HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; SUBUNIT COMPOSITION; SIGNALING PATHWAY	The NMDA subtype of glutamate receptors (NMDAR) at excitatory neuronal synapses plays a key role in synaptic plasticity. The extracellular signal-regulated kinase (ERK1,2 or ERK) pathway is an essential component of NMDAR signal transduction controlling the neuroplasticity underlying memory processes, neuronal development, and refinement of synaptic connections. Here we show that NR2B, but not NR2A or NR1 subunits of the NMDAR, interacts in vivo and in vitro with RasGRF1, a Ca2+/calmodulin-dependent Ras-guanine-nucleotide-releasing factor. Specific disruption of this interaction in living neurons abrogates NMDAR-dependent ERK activation. Thus, RasGRF1 serves as NMDAR-dependent regulator of the ERK kinase pathway. The specific association of RasGRF1 with the NR2B subunit and study of ERK activation in neurons with varied content of NR2B suggests that NR2B-containing channels are the dominant activators of the NMDA-dependent ERK pathway.	Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; INSERM, INMED, U29, F-13009 Marseille, France	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Clapham, DE (corresponding author), Childrens Hosp, Howard Hughes Med Inst, 1309 Enders Bldg,320 Longwood Ave, Boston, MA 02115 USA.		Clapham, David/R-5974-2019; Clapham, David/S-1123-2019; Medina, Igor/O-5532-2016; Pellegrino, Christophe/P-5266-2016	Clapham, David/0000-0002-4459-9428; Medina, Igor/0000-0001-6839-5414; Pellegrino, Christophe/0000-0002-0669-4918; Ivanov, Anton/0000-0002-8650-6322; Ben-Ari, Yehezkel/0000-0001-6208-8480				Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Becq H, 1999, J NEUROSCI RES, V58, P553, DOI 10.1002/(SICI)1097-4547(19991115)58:4<553::AID-JNR8>3.0.CO;2-8; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Giese KP, 2001, NEUROPHARMACOLOGY, V41, P791, DOI 10.1016/S0028-3908(01)00096-X; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Hoffmann H, 2000, J NEUROCHEM, V75, P1590, DOI 10.1046/j.1471-4159.2000.0751590.x; Iida N, 2001, J NEUROSCI, V21, P6459, DOI 10.1523/JNEUROSCI.21-17-06459.2001; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kiyama Y, 1998, J NEUROSCI, V18, P6704; KURINO M, 1995, J NEUROCHEM, V65, P1282; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Li JH, 1998, EUR J NEUROSCI, V10, P1704, DOI 10.1046/j.1460-9568.1998.00169.x; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; MARTEGANI E, 1992, EMBO J, V11, P2151, DOI 10.1002/j.1460-2075.1992.tb05274.x; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Oh JS, 2002, NEURON, V33, P151; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; Platenik J, 2000, LIFE SCI, V67, P335, DOI 10.1016/S0024-3205(00)00632-9; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; SHOU C, 1992, NATURE, V358, P351, DOI 10.1038/358351a0; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sturani E, 1997, EXP CELL RES, V235, P117, DOI 10.1006/excr.1997.3660; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tonini R, 2001, MOL CELL NEUROSCI, V18, P691, DOI 10.1006/mcne.2001.1050; Tovar KR, 1999, J NEUROSCI, V19, P4180; Vanoni M, 1999, J BIOL CHEM, V274, P36656, DOI 10.1074/jbc.274.51.36656; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Xia ZG, 1996, J NEUROSCI, V16, P5425; ZHONG J, 1994, MOL PHARMACOL, V45, P846; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; ZIPPEL R, 1997, MOL BRAIN RES, V48, P140	50	342	352	1	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 13	2003	40	4					775	784		10.1016/S0896-6273(03)00645-7	http://dx.doi.org/10.1016/S0896-6273(03)00645-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	744UL	14622581	Bronze			2022-12-24	WOS:000186651200012
J	Pollitt, SK; Pallos, J; Shao, JY; Desai, UA; Ma, AAK; Thompson, LM; Marsh, JL; Diamond, MI				Pollitt, SK; Pallos, J; Shao, JY; Desai, UA; Ma, AAK; Thompson, LM; Marsh, JL; Diamond, MI			A rapid cellular FRET assay of polyglutamine aggregation identifies a novel inhibitor	NEURON			English	Article							BULBAR MUSCULAR-ATROPHY; RESONANCE ENERGY-TRANSFER; ANDROGEN RECEPTOR; HUNTINGTONS-DISEASE; MUTANT HUNTINGTIN; INTRANUCLEAR INCLUSIONS; PROTEIN AGGREGATION; TRANSGENIC MICE; LIVING CELLS; TOXICITY	Many neurodegenerative diseases, including tauopathies, Parkinson's disease, amyotrophic lateral sclerosis, and the polyglutamine diseases, are characterized by intracellular aggregation of pathogenic proteins. It is difficult to study modifiers of this process in intact cells in a high-throughput and quantitative manner, although this could facilitate molecular insights into disease pathogenesis. Here we introduce a high-throughput assay to measure intracellular polyglutamine protein aggregation using fluorescence resonance energy transfer (FRET). We screened over 2800 biologically active small molecules for inhibitory activity and have characterized one lead compound in detail. Y-27632, an inhibitor of the Rho-associated kinase p160ROCK, diminished polyglutamine protein aggregation (EC50 approximate to muM) and reduced neurodegeneration in a Drosophila model of polyglutamine disease. This establishes a novel high-throughput approach to study protein misfolding and aggregation associated with neurodegenerative diseases and implicates a signaling pathway of previously unrecognized importance in polyglutamine protein processing.	Genentech Inc, San Francisco, CA 94080 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Psychiat & Human Behav, Dept Biol Chem, Irvine, CA 92697 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	Roche Holding; Genentech; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California San Francisco	Diamond, MI (corresponding author), Genentech Inc, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA.		Pallos, Judit/AAE-6833-2020		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045283, R21NS045350] Funding Source: NIH RePORTER; NINDS NIH HHS [1R21NS045350, NS045283] Funding Source: Medline; FDA HHS [BM3355] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); FDA HHS		Abel A, 2001, HUM MOL GENET, V10, P107, DOI 10.1093/hmg/10.2.107; Berthelier V, 2001, ANAL BIOCHEM, V295, P227, DOI 10.1006/abio.2001.5217; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Cowan KJ, 2003, HUM MOL GENET, V12, P1377, DOI 10.1093/hmg/ddg151; Diamond MI, 2000, P NATL ACAD SCI USA, V97, P657, DOI 10.1073/pnas.97.2.657; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Ellerby LM, 1999, J NEUROCHEM, V72, P185, DOI 10.1046/j.1471-4159.1999.0720185.x; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Georgalis Y, 1998, P NATL ACAD SCI USA, V95, P6118, DOI 10.1073/pnas.95.11.6118; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Li M, 1998, ANN NEUROL, V44, P249, DOI 10.1002/ana.410440216; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Meriin AB, 2001, J CELL BIOL, V153, P851, DOI 10.1083/jcb.153.4.851; Merry DE, 1998, HUM MOL GENET, V7, P693, DOI 10.1093/hmg/7.4.693; Muchowski PJ, 2002, P NATL ACAD SCI USA, V99, P727, DOI 10.1073/pnas.022628699; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Peters PJ, 2002, NAT CELL BIOL, V4, P240, DOI 10.1038/ncb761; Root DE, 2003, CHEM BIOL, V10, P881, DOI 10.1016/j.chembiol.2003.08.009; Schaufele F, 2003, J BIOL CHEM, V278, P10578, DOI 10.1074/jbc.M207466200; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Weatherman RV, 2002, MOL ENDOCRINOL, V16, P487, DOI 10.1210/me.16.3.487; Welch WJ, 2001, HUM MOL GENET, V10, P3063, DOI 10.1093/hmg/10.26.3063; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Zhang JH, 2000, J COMB CHEM, V2, P258, DOI 10.1021/cc9900706	40	117	127	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 13	2003	40	4					685	694		10.1016/S0896-6273(03)00697-4	http://dx.doi.org/10.1016/S0896-6273(03)00697-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	744UL	14622574	Green Published, Bronze			2022-12-24	WOS:000186651200005
J	Zhang, KY; McQuibban, GA; Silva, C; Butler, GS; Johnston, JB; Holden, J; Clark-Lewis, I; Overall, CM; Power, C				Zhang, KY; McQuibban, GA; Silva, C; Butler, GS; Johnston, JB; Holden, J; Clark-Lewis, I; Overall, CM; Power, C			HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration	NATURE NEUROSCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GENE-MEDIATED NEUROVIRULENCE; MATRIX-METALLOPROTEINASE; NERVOUS-SYSTEM; INTRACEREBRAL HEMORRHAGE; NEURONAL INJURY; GELATINASE-A; EXPRESSION; DEMENTIA; BRAIN	The mechanisms of neurodegeneration that result in human immunodeficiency virus (HIV) type 1 dementia have not yet been identified. Here, we report that HIV-infected macrophages secrete the zymogen matrix metalloproteinase-2 (MMP-2), which is activated by exposure to MT1-MMP on neurons. Stromal cell-derived factor 1 (SDF-1), a chemokine overexpressed by astrocytes during HIV infection, was converted to a highly neurotoxic protein after precise proteolytic processing by active MMP-2, which removed the N-terminal tetrapeptide. Implantation of cleaved SDF-1(5-67) into the basal ganglia of mice resulted in neuronal death and inflammation with ensuing neurobehavioral deficits that were abrogated by neutralizing antibodies to SDF-1 and an MMP inhibitor drug. Hence, this study identifies a new in vivo neurotoxic pathway in which cleavage of a chemokine by an induced metalloproteinase results in neuronal apoptosis that leads to neurodegeneration.	Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada; Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Pathol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada; Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada	University of Calgary; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of Calgary	Overall, CM (corresponding author), Univ Calgary, Dept Clin Neurosci, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.		Power, Christopher/C-7181-2013; Butler, Georgina/GQP-7553-2022	Butler, Georgina/0000-0003-1172-1578; Power, Christopher/0000-0002-5131-9711; Zhang, Kunyan/0000-0003-1078-6011				Anthony DC, 1998, J NEUROIMMUNOL, V87, P62, DOI 10.1016/S0165-5728(98)00046-0; Asensio VC, 1999, TRENDS NEUROSCI, V22, P504, DOI 10.1016/S0166-2236(99)01453-8; Berman NEJ, 1999, NEUROBIOL DIS, V6, P486, DOI 10.1006/nbdi.1999.0261; Bigg HF, 2001, CANCER RES, V61, P3610; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Catani MV, 2000, J NEUROCHEM, V74, P2373, DOI 10.1046/j.1471-4159.2000.0742373.x; CHESEBRO B, 1991, J VIROL, V65, P5782, DOI 10.1128/JVI.65.11.5782-5789.1991; Conant K, 1999, ANN NEUROL, V46, P391, DOI 10.1002/1531-8249(199909)46:3<391::AID-ANA15>3.0.CO;2-0; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; EPSTEIN LG, 1993, ANN NEUROL, V33, P429, DOI 10.1002/ana.410330502; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; GONG JH, 1995, J EXP MED, V181, P631, DOI 10.1084/jem.181.2.631; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; HOIOK YH, 2000, MOL MECH NEURODEGENE, P111; Horuk R, 1998, NATURE, V393, P524, DOI 10.1038/31116; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Johnston JB, 2000, J VIROL, V74, P7211, DOI 10.1128/JVI.74.16.7211-7220.2000; Johnston JB, 2002, J VIROL, V76, P2622, DOI 10.1128/JVI.76.6.2622-2633.2002; Johnston JB, 2001, ANN NEUROL, V49, P230, DOI 10.1002/1531-8249(20010201)49:2<230::AID-ANA43>3.0.CO;2-O; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 1999, P NATL ACAD SCI USA, V96, P8212, DOI 10.1073/pnas.96.14.8212; Langford D, 2002, J NEUROIMMUNOL, V127, P115, DOI 10.1016/S0165-5728(02)00068-1; LIPTON SA, 1995, NEW ENGL J MED, V332, P934, DOI 10.1056/NEJM199504063321407; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Mayne M, 2001, STROKE, V32, P240, DOI 10.1161/01.STR.32.1.240; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Miller RJ, 1999, TRENDS NEUROSCI, V22, P471, DOI 10.1016/S0166-2236(99)01408-3; Nagasawa T, 1999, Adv Immunol, V71, P211; Nath A, 1999, SEMIN NEUROL, V19, P113, DOI 10.1055/s-2008-1040830; OBERLEY LW, 1982, SUPEROXIDE DISMUTASE, V1, P1; Ohtani Y, 1998, NEUROSCI LETT, V249, P163, DOI 10.1016/S0304-3940(98)00425-X; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Patrick MK, 2002, J VIROL, V76, P7923, DOI 10.1128/JVI.76.16.7923-7931.2002; Power C, 1998, J VIROL, V72, P9045, DOI 10.1128/JVI.72.11.9045-9053.1998; Power C, 2003, ANN NEUROL, V53, P731, DOI 10.1002/ana.10553; Power C, 2001, TRENDS NEUROSCI, V24, P162, DOI 10.1016/S0166-2236(00)01737-9; Ransohoff RM, 1998, TRENDS NEUROSCI, V21, P154, DOI 10.1016/S0166-2236(97)01198-3; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Sanders VJ, 1998, AIDS, V12, P1021, DOI 10.1097/00002030-199809000-00008; Shrikant P, 1996, J IMMUNOL, V156, P1307; Sisodia SS, 1999, J CLIN INVEST, V104, P1169, DOI 10.1172/JCI8508; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zhang KY, 2001, VIROLOGY, V283, P19, DOI 10.1006/viro.2001.0876	47	257	268	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1064	1071		10.1038/nn1127	http://dx.doi.org/10.1038/nn1127			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	14502291				2022-12-24	WOS:000185633600018
J	Baeg, EH; Kim, YB; Huh, K; Mook-Jung, I; Kim, HT; Jung, MW				Baeg, EH; Kim, YB; Huh, K; Mook-Jung, I; Kim, HT; Jung, MW			Dynamics of population code for working memory in the prefrontal cortex	NEURON			English	Article							LONG-TERM POTENTIATION; DELAYED ALTERNATION PERFORMANCE; UNIT-ACTIVITY; PERSISTENT ACTIVITY; CUE LOCATION; NEURONS; RAT; TASK; DIRECTION; MONKEYS	Some neurons (delay cells) in the prefrontal cortex elevate their activities throughout the time period during which the animal is required to remember past events and prepare future behavior, suggesting that working memory is mediated by continuous neural activity. It is unknown, however, how working memory is represented within a population of prefrontal cortical neurons. We recorded from neuronal ensembles in the prefrontal cortex as rats learned a new delayed alternation task. Ensemble activities changed in parallel with behavioral learning so that they increasingly allowed correct decoding of previous and future goal choices. In well-trained rats, considerable decoding was possible based on only a few neurons and after removing continuously active delay cells. These results show that neural activity in the prefrontal cortex changes dynamically during new task learning so that working memory is robustly represented and that working memory can be mediated by sequential activation of different neural populations.	Ajou Univ, Sch Med, Neurosci Lab, Inst Med Sci, Suwon 442721, South Korea; Ajou Univ, Sch Med, Dept Neurol, Suwon 442721, South Korea; Ajou Univ, Sch Med, Brain Dis Res Ctr, Suwon 442721, South Korea; Korea Univ, Dept Psychol, Seoul 136701, South Korea	Ajou University; Ajou University; Ajou University; Korea University	Jung, MW (corresponding author), Ajou Univ, Sch Med, Neurosci Lab, Inst Med Sci, Suwon 442721, South Korea.	min@ajou.ac.kr	Jung, Min/E-8869-2012; Mook, Inhee/J-2754-2012; Jung, Min Whan/GXF-5216-2022	Jung, Min/0000-0002-4145-600X; 				Baddeley A., 2007, WORKING MEMORY THOUG; Baeg EH, 2001, CEREB CORTEX, V11, P441, DOI 10.1093/cercor/11.5.441; BATUEV AS, 1979, ACTA PHYSIOL HUNG, V53, P345; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Chang JY, 2000, NEUROSCIENCE, V99, P433, DOI 10.1016/S0306-4522(00)00218-9; Constantinidis C, 2002, J NEUROPHYSIOL, V88, P3487, DOI 10.1152/jn.00188.2002; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster J. M., 2015, PREFRONTAL CORTEX, V5th; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Gemmell C, 2000, EXP BRAIN RES, V132, P223, DOI 10.1007/s002210000334; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Herry C, 1999, J NEUROPHYSIOL, V82, P2827, DOI 10.1152/jn.1999.82.5.2827; HIRSCH JC, 1990, J PHYSIOL-LONDON, V427, P31, DOI 10.1113/jphysiol.1990.sp018159; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; Jung MW, 1998, CEREB CORTEX, V8, P437, DOI 10.1093/cercor/8.5.437; Jung MW, 2000, J NEUROSCI, V20, P6166, DOI 10.1523/JNEUROSCI.20-16-06166.2000; Kim MJ, 2003, NEUROSCIENCE, V120, P283, DOI 10.1016/S0306-4522(03)00021-6; KOLB B, 1990, PROG BRAIN RES, V85, P501; KUBOTA K, 1971, J NEUROPHYSIOL, V34, P337, DOI 10.1152/jn.1971.34.3.337; LAROCHE S, 1990, NEUROSCI LETT, V114, P184, DOI 10.1016/0304-3940(90)90069-L; Laubach M, 2000, NATURE, V405, P567, DOI 10.1038/35014604; Miller EK, 1999, NEURON, V22, P15, DOI 10.1016/S0896-6273(00)80673-X; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 1996, J NEUROSCI, V16, P5154; NIKI H, 1976, BRAIN RES, V105, P79, DOI 10.1016/0006-8993(76)90924-0; Oram MW, 1998, TRENDS NEUROSCI, V21, P259, DOI 10.1016/S0166-2236(97)01216-2; QUINTANA J, 1992, NEUROREPORT, V3, P721, DOI 10.1097/00001756-199208000-00018; Rainer G, 1999, J NEUROSCI, V19, P5493; Rainer G, 2000, NEURON, V27, P179, DOI 10.1016/S0896-6273(00)00019-2; Rosner B., 2011, FUNDAMENTALS BIOSTAT; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Takeda K, 2002, J NEUROPHYSIOL, V87, P567, DOI 10.1152/jn.00249.2001; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017; [No title captured]	40	232	235	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 25	2003	40	1					177	188		10.1016/S0896-6273(03)00597-X	http://dx.doi.org/10.1016/S0896-6273(03)00597-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	726TA	14527442	Bronze			2022-12-24	WOS:000185614700018
J	Margrie, TW; Meyer, AH; Caputi, A; Monyer, H; Hasan, MT; Schaefer, AT; Denk, W; Brecht, M				Margrie, TW; Meyer, AH; Caputi, A; Monyer, H; Hasan, MT; Schaefer, AT; Denk, W; Brecht, M			Targeted whole-cell recordings in the mammalian brain in vivo	NEURON			English	Article							RAT BARREL CORTEX; NEOCORTICAL PYRAMIDAL NEURONS; DENDRITIC CALCIUM DYNAMICS; CAT VISUAL-CORTEX; ELECTRICAL SYNAPSES; FLUORESCENCE MICROSCOPY; FREQUENCY OSCILLATIONS; HIPPOCAMPAL SLICES; NETWORK ACTIVITY; FIRING PATTERNS	While electrophysiological recordings from visually identified cell bodies or dendrites are routinely performed in cell culture and acute brain slice preparations, targeted recordings from the mammalian nervous system are currently not possible in vivo. The "blind" approach that is used instead is somewhat random and largely limited to common neuronal cell types. This approach prohibits recordings from, for example, molecularly defined and/or disrupted populations of neurons. Here we describe a method, which we call TPTP (two-photon targeted patching), that uses two-photon imaging to guide in vivo whole-cell recordings to individual, genetically labeled cortical neurons. We apply this technique to obtain recordings from genetically manipulated, parvalbumin-EGFP-positive interneurons in the somatosensory cortex. We find that both spontaneous and sensory-evoked activity patterns involve the synchronized discharge of electrically coupled interneurons. TPTP applied in vivo will therefore provide new insights into the molecular control of neuronal function at the systems level.	Max Planck Inst Med Res, D-69120 Heidelberg, Germany; UCL, Dept Physiol, Wolfson Inst Biomed Res, London WC1E 6BT, England; Univ Hosp Neurol, Dept Clin Neurobiol, D-69120 Heidelberg, Germany	Max Planck Society; University of London; University College London; Ruprecht Karls University Heidelberg	Margrie, TW (corresponding author), Max Planck Inst Med Res, Jahnstr 29, D-69120 Heidelberg, Germany.	t.margrie@ucl.ac.uk	denk, winfried/I-6627-2012; Hasan, Mazahir/L-3679-2017	Brecht, Michael/0000-0002-5387-0953; Schaefer, Andreas/0000-0002-4677-8788; Monyer, Hannah/0000-0002-9332-5749; Hasan, Mazahir/0000-0001-9985-7271				Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Bennett MVL, 2000, NAT NEUROSCI, V3, P7, DOI 10.1038/71082; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; Charpak S, 2001, P NATL ACAD SCI USA, V98, P1230, DOI 10.1073/pnas.021422798; Chen BE, 2000, LEARN MEMORY, V7, P433, DOI 10.1101/lm.32700; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; DERMIETZEL R, 1993, TRENDS NEUROSCI, V16, P186, DOI 10.1016/0166-2236(93)90151-B; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Eccles J. C, 1957, PHYSL NERVE CELLS; Fischer F, 1998, ADV EXP MED BIOL, V440, P291; FURSHPAN EJ, 1959, J PHYSIOL-LONDON, V145, P289, DOI 10.1113/jphysiol.1959.sp006143; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Galarreta M, 2002, P NATL ACAD SCI USA, V99, P12438, DOI 10.1073/pnas.192159599; Galarreta M, 2001, NAT REV NEUROSCI, V2, P425, DOI 10.1038/35077566; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Helmchen F, 2001, NEURON, V31, P903, DOI 10.1016/S0896-6273(01)00421-4; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; JAGADEESH B, 1993, SCIENCE, V262, P1901, DOI 10.1126/science.8266083; Kamondi A, 1998, J NEUROSCI, V18, P3919; KASPER EM, 1994, J COMP NEUROL, V339, P459, DOI 10.1002/cne.903390402; Lundstrom Kenneth, 2001, Current Gene Therapy, V1, P19, DOI 10.2174/1566523013349039; MACVICAR BA, 1981, SCIENCE, V213, P782, DOI 10.1126/science.6266013; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; MASON A, 1990, J NEUROSCI, V10, P1415; Masters B. R., 1996, SELECTED PAPERS CONF; Meyer AH, 2002, J NEUROSCI, V22, P7055; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; Oheim M, 2001, J NEUROSCI METH, V111, P29, DOI 10.1016/S0165-0270(01)00438-1; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; PETTIT OL, 1995, NEURON, V14, P685, DOI 10.1016/0896-6273(95)90212-0; PINES J, 1995, TRENDS GENET, V11, P326, DOI 10.1016/S0168-9525(00)89092-7; Schrader M, 1998, J MICROSC-OXFORD, V191, P135, DOI 10.1046/j.1365-2818.1998.00361.x; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Takada T, 1997, NAT BIOTECHNOL, V15, P458, DOI 10.1038/nbt0597-458; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; TAYLOR CP, 1982, BRAIN RES, V235, P351, DOI 10.1016/0006-8993(82)91013-7; Theer P, 2003, OPT LETT, V28, P1022, DOI 10.1364/OL.28.001022; Vigmond EJ, 1997, J NEUROPHYSIOL, V78, P3107, DOI 10.1152/jn.1997.78.6.3107; Watanabe A., 1958, Japanese Journal of Physiology, V8, P305; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	55	159	166	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 11	2003	39	6					911	918		10.1016/j.neuron.2003.08.012	http://dx.doi.org/10.1016/j.neuron.2003.08.012			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	721BA	12971892	Bronze			2022-12-24	WOS:000185296100006
J	Goeke, S; Greene, EA; Grant, PK; Gates, MA; Crowner, D; Aigaki, T; Giniger, E				Goeke, S; Greene, EA; Grant, PK; Gates, MA; Crowner, D; Aigaki, T; Giniger, E			Alternative splicing of lola generates 19 transcription factors controlling axon guidance in Drosophila	NATURE NEUROSCIENCE			English	Article							ZINC FINGERS; DNA-BINDING; POZ DOMAIN; PROTEIN; EXPRESSION; ENCODES; FAMILY; GROWTH; RECEPTOR; GENOME	The Drosophila melanogaster transcription factor Lola (longitudinals lacking) is a pivotal regulator of neural wiring that sets the precise expression levels of proteins that execute specific axon guidance decisions. Lola has a zinc finger DNA binding domain and a BTB (for Broad-complex, Tramtrack and Bric a brac) dimerization motif. We now show that alternative splicing of the lola gene creates a family of 19 transcription factors. All lola isoforms share a common dimerization domain, but 17 have their own unique DNA-binding domains. Seven of these 17 isoforms are present in the distantly-related Dipteran Anopheles gambiae, suggesting that the properties of specific isoforms are likely to be critical to lola function. Analysis of the expression patterns of individual splice variants and of the phenotypes of mutants lacking single isoforms supports this idea and establishes that the alternative forms of lola are responsible for different functions of this gene. Thus, in this system, the alternative splicing of a key transcription factor helps to explain how a small genome encodes all the information that is necessary to specify the enormous diversity of axonal trajectories.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Program Dev Biol, Seattle, WA 98109 USA; Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 1920397, Japan; Japan Sci & Technol Corp, Precursory Res Embryon Sci & Technol, Osaka 5650082, Japan	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Tokyo Metropolitan University; Japan Science & Technology Agency (JST)	Giniger, E (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	eginiger@fhcrc.org	Giniger, Edward/C-1764-2015	Giniger, Edward/0000-0002-8340-6158; Grant, Paul/0000-0002-1099-0461				Appling DR, 1999, METHODS, V19, P338, DOI 10.1006/meth.1999.0861; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Bayer CA, 1996, DEV BIOL, V177, P1, DOI 10.1006/dbio.1996.0140; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Cavarec L, 1997, MOL CELL BIOL, V17, P482, DOI 10.1128/MCB.17.1.482; CHENG NSN, 1994, GENETICS, V138, P1151; CHOO Y, 1993, NUCLEIC ACIDS RES, V21, P3341, DOI 10.1093/nar/21.15.3341; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; Crowner D, 2002, DEVELOPMENT, V129, P1317; DIBELLO PR, 1991, GENETICS, V129, P385; FAIRALL L, 1993, NATURE, V366, P483, DOI 10.1038/366483a0; Giniger E, 1998, NEURON, V20, P667, DOI 10.1016/S0896-6273(00)81007-7; GINIGER E, 1994, DEVELOPMENT, V120, P1385; HARRISON SD, 1990, EMBO J, V9, P207, DOI 10.1002/j.1460-2075.1990.tb08097.x; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Liew CK, 2000, STRUCTURE, V8, P1157, DOI 10.1016/S0969-2126(00)00527-X; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Madden K, 1999, DEV BIOL, V213, P301, DOI 10.1006/dbio.1999.9399; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; OHSAKO T, IN PRESS GENE; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; READ D, 1992, EMBO J, V11, P1035, DOI 10.1002/j.1460-2075.1992.tb05142.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zheng W, 2003, J BIOL CHEM, V278, P48321, DOI 10.1074/jbc.M307930200	31	66	74	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					917	924		10.1038/nn1105	http://dx.doi.org/10.1038/nn1105			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715KH	12897787				2022-12-24	WOS:000184970400009
J	Loewenstein, Y; Sompolinsky, H				Loewenstein, Y; Sompolinsky, H			Temporal integration by calcium dynamics in a model neuron	NATURE NEUROSCIENCE			English	Article							MEDIAL VESTIBULAR NUCLEUS; NETWORK MODEL; EYE-POSITION; INOSITOL 1,4,5-TRISPHOSPHATE; VESTIBULOOCULAR REFLEX; PERSISTENT ACTIVITY; PREFRONTAL CORTEX; OCULOMOTOR SYSTEM; WORKING-MEMORY; OSCILLATIONS	The calculation and memory of position variables by temporal integration of velocity signals is essential for posture, the vestibulo-ocular reflex (VOR) and navigation. Integrator neurons exhibit persistent firing at multiple rates, which represent the values of memorized position variables. A widespread hypothesis is that temporal integration is the outcome of reverberating feedback loops within recurrent networks, but this hypothesis has not been proven experimentally. Here we present a single-cell model of a neural integrator. The nonlinear dynamics of calcium gives rise to propagating calcium wave-fronts along dendritic processes. The wave-front velocity is modulated by synaptic inputs such that the front location covaries with the temporal sum of its previous inputs. Calcium-dependent currents convert this information into concomitant persistent firing. Calcium dynamics in single neurons could thus be the physiological basis of the graded persistent activity and temporal integration observed in neurons during analog memory tasks.	Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Ctr Neural Computat, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Loewenstein, Y (corresponding author), Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel.		Sompolinsky, Haim/ABB-8398-2021					Aksay E, 2000, J NEUROPHYSIOL, V84, P1035, DOI 10.1152/jn.2000.84.2.1035; Aksay E, 2001, NAT NEUROSCI, V4, P184, DOI 10.1038/84023; ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Arnold DB, 1997, EXP BRAIN RES, V113, P57, DOI 10.1007/BF02454142; ARNOLD DB, 1991, BIOL CYBERN, V64, P447, DOI 10.1007/BF00202608; ARNOLD DB, 1992, PHILOS T ROY SOC B, V337, P327, DOI 10.1098/rstb.1992.0110; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; CANNON SC, 1983, BIOL CYBERN, V49, P127, DOI 10.1007/BF00320393; CHARLES AC, 1991, NEURON, V6, P983, DOI 10.1016/0896-6273(91)90238-U; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; DULAC S, 1995, J COMP PHYSIOL A, V176, P641; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; FINKBEINER S, 1992, NEURON, V8, P1101, DOI 10.1016/0896-6273(92)90131-V; Fontanilla RA, 1998, BIOPHYS J, V75, P2079, DOI 10.1016/S0006-3495(98)77650-7; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; GALIANA HL, 1984, J NEUROPHYSIOL, V51, P210, DOI 10.1152/jn.1984.51.2.210; GNADT JW, 1988, EXP BRAIN RES, V70, P216; GOLDBETER A, 1990, P NATL ACAD SCI USA, V87, P1461, DOI 10.1073/pnas.87.4.1461; GRAYKELLER MP, 1994, NEURON, V13, P849, DOI 10.1016/0896-6273(94)90251-8; Ikeda M, 2003, NEURON, V38, P253, DOI 10.1016/S0896-6273(03)00164-8; Kandel E., 2000, PRINCIPLES NEURAL SC; Kato BM, 1999, J NEUROPHYSIOL, V81, P1587, DOI 10.1152/jn.1999.81.4.1587; Keener JP, 2000, PHYSICA D, V136, P1, DOI 10.1016/S0167-2789(99)00151-7; KOUTAKOV AA, 2002, NAT NEUROSCI, V5, P775; Kupferman R, 1997, BIOPHYS J, V72, P2430, DOI 10.1016/S0006-3495(97)78888-X; LAGNADO L, 1992, J PHYSIOL-LONDON, V455, P111, DOI 10.1113/jphysiol.1992.sp019293; LI YX, 1994, J THEOR BIOL, V166, P461, DOI 10.1006/jtbi.1994.1041; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02459570; Mikhailov A. S, 1994, FDN SYNERGETICS DIST; Nakamura T, 2000, J NEUROSCI, V20, P8365, DOI 10.1523/JNEUROSCI.20-22-08365.2000; PASTOR AM, 1994, P NATL ACAD SCI USA, V91, P807, DOI 10.1073/pnas.91.2.807; Perrier JF, 1999, J NEUROPHYSIOL, V82, P730, DOI 10.1152/jn.1999.82.2.730; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; ROSAN MJ, 1972, IEEE T BIOMED ENG, V19, P362; SERAFIN M, 1991, EXP BRAIN RES, V84, P417, DOI 10.1007/BF00231464; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; Shriki O, 2003, NEURAL COMPUT, V15, P1809, DOI 10.1162/08997660360675053; Sneyd J, 1997, SIAM J APPL MATH, V57, P73, DOI 10.1137/S0036139995286035; SNEYD J, 1995, FASEB J, V9, P1463, DOI 10.1096/fasebj.9.14.7589988; Torres JJ, 2001, EUROPHYS LETT, V55, P746, DOI 10.1209/epl/i2001-00477-3; Wagner J, 1998, BIOPHYS J, V75, P2088, DOI 10.1016/S0006-3495(98)77651-9; WOLSZON LR, 1994, J NEUROSCI, V14, P3437; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; Xie XH, 2000, ADV NEUR IN, V12, P199	50	108	110	0	18	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					961	967		10.1038/nn1109	http://dx.doi.org/10.1038/nn1109			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715KH	12937421				2022-12-24	WOS:000184970400015
J	Yasuda, R; Sabatini, BL; Svoboda, K				Yasuda, R; Sabatini, BL; Svoboda, K			Plasticity of calcium channels in dendritic spines	NATURE NEUROSCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; LONG-TERM POTENTIATION; HIPPOCAMPAL CA1 NEURONS; CA2+ CHANNELS; PYRAMIDAL NEURONS; SYNAPTIC TRANSMISSION; POSTSYNAPTIC DENSITY; RECEPTOR; INACTIVATION; INHIBITOR	Voltage-sensitive Ca2+ channels (VSCCs) constitute a major source of calcium ions in dendritic spines, but their function is unknown. Here we show that R-type VSCCs in spines of rat CA1 pyramidal neurons are depressed for at least 30 min after brief trains of back-propagating action potentials. Populations of channels in single spines are depressed stochastically and synchronously, independent of channels in the parent dendrite and other spines, implying that depression is the result of signaling restricted to individual spines. Induction of VSCC depression blocks theta-burst-induced long-term potentiation (LTP), indicating that postsynaptic action potentials can modulate synaptic plasticity by tuning VSCCs. Induction of depression requires [Ca2+] elevations and activation of L-type VSCCs, which activate Ca2+/calmodulin-dependent kinase II (CaMKII) and a cyclic adenosine monophosphate (cAMP)-dependent pathway. Given that L-type VSCCs do not contribute measurably to Ca2+ influx in spines, they must activate downstream effectors either directly through voltage-dependent conformational changes or via [Ca2+] microdomains.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Svoboda, K (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.		Yasuda, Ryohei/E-7726-2011	Yasuda, Ryohei/0000-0001-6263-9297				Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; BEAN BP, 1994, ION CHANNELS, P199; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BREHM P, 1978, SCIENCE, V202, P1203, DOI 10.1126/science.103199; Budde T, 2002, NAT REV NEUROSCI, V3, P873, DOI 10.1038/nrn959; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Garaschuk O, 1997, J PHYSIOL-LONDON, V502, P13, DOI 10.1111/j.1469-7793.1997.013bl.x; IMREDY JP, 1994, NEURON, V12, P1301, DOI 10.1016/0896-6273(94)90446-4; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; ITO K, 1995, NEUROSCI LETT, V183, P112, DOI 10.1016/0304-3940(94)11127-5; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; Kavalali ET, 1997, NEURON, V18, P651, DOI 10.1016/S0896-6273(00)80305-0; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; KULLMANN DM, 1992, NEURON, V9, P1175, DOI 10.1016/0896-6273(92)90075-O; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Mermelstein PG, 2000, J NEUROSCI, V20, P266, DOI 10.1523/JNEUROSCI.20-01-00266.2000; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Nakai J, 1996, NATURE, V380, P72, DOI 10.1038/380072a0; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Pologruto T. A., 2003, BIOMED ENG ONLINE, V2; Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Sabatini BL, 2001, CURR OPIN NEUROBIOL, V11, P349, DOI 10.1016/S0959-4388(00)00218-X; Shirke AM, 1997, J NEUROPHYSIOL, V78, P2682, DOI 10.1152/jn.1997.78.5.2682; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; WESTCOTT KR, 1979, P NATL ACAD SCI USA, V76, P204, DOI 10.1073/pnas.76.1.204; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	49	198	201	0	13	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					948	955		10.1038/nn1112	http://dx.doi.org/10.1038/nn1112			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715KH	12937422				2022-12-24	WOS:000184970400013
J	Rothenberg, ME; Rogers, SL; Vale, RD; Jan, LY; Jan, YN				Rothenberg, ME; Rogers, SL; Vale, RD; Jan, LY; Jan, YN			Drosophila pod-1 crosslinks both actin and microtubules and controls the targeting of axons	NEURON			English	Article							NEURONAL GROWTH CONES; CAENORHABDITIS-ELEGANS; TYROSINE KINASE; CYTOCHALASIN-B; AXIS FORMATION; SHORT STOP; F-ACTIN; GUIDANCE; ACTIVATION; DYNAMICS	Actin and microtubules (MTs) are tightly coordinated during neuronal growth cone navigation and are dynamically regulated in response to guidance cues; however, little is known about the underlying molecular mechanisms. Here, we characterize Drosophila pod-1 (dpod1) and show that purified Dpod1 can crosslink both actin and MTs. In cultured S2 cells, Dpod1 colocalizes with lamellar actin and MTs, and overexpression remodels the cytoskeleton to promote dynamic neurite-like actin-dependent projections. Consistent with these observations, Dpod1 localizes to the tips of growing axons, regions where actin and MTs interact, and is especially abundant at navigational choice points. In either the absence or overabundance of Dpod1, growth cone targeting but not outgrowth is disrupted. Taken together, these results reveal novel activities for pod-1 and show that proper levels of Dpod1, an actin/MT crosslinker, must be maintained in the growth cone for correct axon guidance.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, 533 Parnassus Ave, San Francisco, CA 94143 USA.			Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498				Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; BROADIE K, 1993, DEVELOPMENT, P227; Buck KB, 2002, J NEUROSCI, V22, P9358; Cesareni G, 2002, FEBS LETT, V513, P38, DOI 10.1016/S0014-5793(01)03307-5; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Fuchs E, 2001, GENE DEV, V15, P1, DOI 10.1101/gad.861501; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Gonzalez-Billault C, 2001, MOL BIOL CELL, V12, P2087, DOI 10.1091/mbc.12.7.2087; Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Ishimaru S, 1999, EMBO J, V18, P145, DOI 10.1093/emboj/18.1.145; Jay DG, 2000, J NEUROBIOL, V44, P114, DOI 10.1002/1097-4695(200008)44:2<114::AID-NEU3>3.0.CO;2-8; Kabir N, 2001, J CELL BIOL, V152, P1033, DOI 10.1083/jcb.152.5.1033; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Lee H, 2003, CURR BIOL, V13, pR152, DOI 10.1016/S0960-9822(03)00080-0; Lee S, 2000, J NEUROSCI, V20, P1096, DOI 10.1523/JNEUROSCI.20-03-01096.2000; Lee S, 2002, DEVELOPMENT, V129, P1195; LIN CH, 1993, J CELL BIOL, V121, P1369, DOI 10.1083/jcb.121.6.1369; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Lyczak R, 2002, DEV CELL, V3, P157, DOI 10.1016/S1534-5807(02)00226-5; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; MARSH L, 1984, J CELL BIOL, V99, P2041, DOI 10.1083/jcb.99.6.2041; Mochizuki N, 2000, J BIOL CHEM, V275, P12667, DOI 10.1074/jbc.275.17.12667; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; NOBLE M, 1989, J CELL BIOL, V109, P3367, DOI 10.1083/jcb.109.6.3367; Ohba Y, 2001, EMBO J, V20, P3333, DOI 10.1093/emboj/20.13.3333; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Rappleye CA, 1999, GENE DEV, V13, P2838, DOI 10.1101/gad.13.21.2838; Rochlin MW, 1999, MOL BIOL CELL, V10, P2309, DOI 10.1091/mbc.10.7.2309; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; SINK H, 1991, DEVELOPMENT, V112, P307; Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.0.CO;2-U; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Waterman-Storer CM, 1999, CURR OPIN CELL BIOL, V11, P61, DOI 10.1016/S0955-0674(99)80008-8; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Yu TW, 2002, NAT NEUROSCI, V5, P1147, DOI 10.1038/nn956; Yu WQ, 2001, J NEUROCYTOL, V30, P861, DOI 10.1023/A:1020622530831; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014; Zigmond SH, 1999, NAT CELL BIOL, V1, pE12, DOI 10.1038/8962	47	44	49	1	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 28	2003	39	5					779	791		10.1016/S0896-6273(03)00508-7	http://dx.doi.org/10.1016/S0896-6273(03)00508-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	717GN	12948445	Bronze			2022-12-24	WOS:000185079300008
J	Rahman, Z; Schwarz, J; Gold, SJ; Zachariou, V; Wein, MN; Choi, KH; Kovoor, A; Chen, CK; DiLeone, RJ; Schwarz, SC; Selley, DE; Sim-Selley, LJ; Barrot, M; Luedtke, RR; Self, D; Neve, RL; Lester, HA; Simon, MI; Nestler, EJ				Rahman, Z; Schwarz, J; Gold, SJ; Zachariou, V; Wein, MN; Choi, KH; Kovoor, A; Chen, CK; DiLeone, RJ; Schwarz, SC; Selley, DE; Sim-Selley, LJ; Barrot, M; Luedtke, RR; Self, D; Neve, RL; Lester, HA; Simon, MI; Nestler, EJ			RGS9 modulates dopamine signaling in the basal ganglia	NEURON			English	Article							ACTIVATED K+-CHANNEL; MU-OPIOID RECEPTOR; COCAINE REWARD; MICE LACKING; DELTA-FOSB; PROTEIN; EXPRESSION; REGULATORS; MORPHINE; SENSITIVITY	Regulators of G protein signaling (FIGS) modulate heterotrimeric G proteins in part by serving as GTPase-activating proteins for Galpha subunits. We examined a role for RGS9-2, an FIGS subtype highly enriched in striatum, in modulating dopamine D2 receptor function. Viral-mediated overexpression of RGS9-2 in rat nucleus accumbens (ventral striatum) reduced locomotor responses to cocaine (an indirect dopamine agonist) and to D2 but not to D1 receptor agonists. Conversely, RGS9 knockout mice showed heightened locomotor and rewarding responses to cocaine and related psychostimulants. In vitro expression of RGS9-2 in Xenopus oocytes accelerated the off-kinetics of D2 receptor-induced GIRK currents, consistent with the in vivo data. Finally, chronic cocaine exposure increased RGS9-2 levels in nucleus accumbens. Together, these data demonstrate a functional interaction between RGS9-2 and D2 receptor signaling and the behavioral actions of psychostimulants and suggest that psychostimulant induction of RGS9-2 represents a compensatory adaptation that diminishes drug responsiveness.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06508 USA; Yale Univ, Lab Mol Psychiat, New Haven, CT 06508 USA; CALTECH, Dept Biol, Pasadena, CA 91125 USA; Virginia Commonwealth Univ, Dept Pharmacol, Richmond, VA 23298 USA; Univ N Texas, Ctr Hlth Sci, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA; Harvard Univ, Sch Med, Dept Genet, Belmont, MA 02478 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Yale University; Yale University; California Institute of Technology; Virginia Commonwealth University; University of North Texas System; University of North Texas Health Science Center; Harvard University	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.nestler@utsouthwestern.edu	Zachariou, Venetia/L-2726-2016	DiLeone, Ralph/0000-0002-4770-2590	NIDA NIH HHS [DA08227, DA05274] Funding Source: Medline; NIGMS NIH HHS [GM29836] Funding Source: Medline; NIMH NIH HHS [MH66127] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH066127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008227] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Carlezon WA, 1997, SCIENCE, V277, P812, DOI 10.1126/science.277.5327.812; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; De Vries L, 1999, TRENDS CELL BIOL, V9, P138, DOI 10.1016/S0962-8924(99)01515-9; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; Gold SJ, 2003, EUR J NEUROSCI, V17, P971, DOI 10.1046/j.1460-9568.2003.02529.x; Gold SJ, 1997, J NEUROSCI, V17, P8024; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Hiroi N, 1997, P NATL ACAD SCI USA, V94, P10397, DOI 10.1073/pnas.94.19.10397; Karschin C, 1996, J NEUROSCI, V16, P3559; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Khawaja XZ, 1999, J NEUROCHEM, V72, P174, DOI 10.1046/j.1471-4159.1999.0720174.x; Kofuji P, 1996, NEURON, V16, P941, DOI 10.1016/S0896-6273(00)80117-8; Koob GF, 1999, ARCH GEN PSYCHIAT, V56, P1107, DOI 10.1001/archpsyc.56.12.1107; Kovoor A, 2000, J BIOL CHEM, V275, P3397, DOI 10.1074/jbc.275.5.3397; Kovoor A, 2002, NEURON, V33, P6, DOI 10.1016/S0896-6273(01)00572-4; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Luedtke RR, 2000, SYNAPSE, V38, P438, DOI 10.1002/1098-2396(20001215)38:4<438::AID-SYN9>3.0.CO;2-5; Makino ER, 1999, P NATL ACAD SCI USA, V96, P1947, DOI 10.1073/pnas.96.5.1947; Martemyanov KA, 2002, J BIOL CHEM, V277, P32843, DOI 10.1074/jbc.M205170200; Nair KS, 2002, CURR BIOL, V12, P421, DOI 10.1016/S0960-9822(02)00691-7; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; Neve RL, 1997, NEUROSCIENCE, V79, P435, DOI 10.1016/S0306-4522(96)00645-8; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; Potenza MN, 1999, J PHARMACOL EXP THER, V291, P482; QUICK MW, 1994, ION CHANNELS EXCITAB, P261; Rahman Z, 1999, J NEUROSCI, V19, P2016; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Salomon Y, 1979, Adv Cyclic Nucleotide Res, V10, P35; Saugstad JA, 1998, J NEUROSCI, V18, P905; Schwarting RKW, 1996, PROG NEUROBIOL, V49, P215, DOI 10.1016/S0301-0082(96)00015-9; Self DW, 1998, J NEUROSCI, V18, P1848; Self DW, 1998, DRUG ALCOHOL DEPEN, V51, P49, DOI 10.1016/S0376-8716(98)00065-9; Tekumalla PK, 2001, BIOL PSYCHIAT, V50, P813, DOI 10.1016/S0006-3223(01)01234-3; Thomas EA, 1998, J NEUROSCI RES, V52, P118, DOI 10.1002/(SICI)1097-4547(19980401)52:1<118::AID-JNR11>3.0.CO;2-6; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Wise RA, 1998, DRUG ALCOHOL DEPEN, V51, P13, DOI 10.1016/S0376-8716(98)00063-5; Zerangue N, 1998, CURR BIOL, V8, pR313, DOI 10.1016/S0960-9822(98)70196-4; Zhang K, 1999, GENE, V240, P23, DOI 10.1016/S0378-1119(99)00393-5; Zhang QL, 2002, J PHYSIOL-LONDON, V545, P355, DOI 10.1113/jphysiol.2002.032151; Zhang SY, 1996, J BIOL CHEM, V271, P33575, DOI 10.1074/jbc.271.52.33575	50	220	221	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 19	2003	38	6					941	952		10.1016/S0896-6273(03)00321-0	http://dx.doi.org/10.1016/S0896-6273(03)00321-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	693AA	12818179	Bronze			2022-12-24	WOS:000183691400013
J	Mayr, U; Awh, E; Laurey, P				Mayr, U; Awh, E; Laurey, P			Conflict adaptation effects in the absence of executive control	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL		Univ Oregon, Dept Psychol, Eugene, OR 97403 USA	University of Oregon	Mayr, U (corresponding author), Univ Oregon, Dept Psychol, Eugene, OR 97403 USA.			Awh, Edward/0000-0002-5211-5278	NIA NIH HHS [R01 AG19296-01A1] Funding Source: Medline; NIMH NIH HHS [R01 MH64119] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019296] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Cohen A, 1997, COGNITIVE PSYCHOL, V32, P128, DOI 10.1006/cogp.1997.0648; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hommel B, 1998, VIS COGN, V5, P183, DOI 10.1080/713756773; Logan GD, 2002, PSYCHOL REV, V109, P376, DOI 10.1037//0033-295X.109.2.376; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; PASHLER H, 1991, J EXP PSYCHOL LEARN, V17, P33, DOI 10.1037/0278-7393.17.1.33; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7	12	607	619	1	46	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					450	452		10.1038/nn1051	http://dx.doi.org/10.1038/nn1051			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	672ZD	12704394				2022-12-24	WOS:000182553200010
J	Haeseleer, F; Imanishi, Y; Maeda, T; Possin, DE; Maeda, A; Lee, A; Rieke, F; Palczewski, K				Haeseleer, F; Imanishi, Y; Maeda, T; Possin, DE; Maeda, A; Lee, A; Rieke, F; Palczewski, K			Essential role of Ca2+-binding protein 4, a Ca(v)1.4 channel regulator, in photoreceptor synaptic function	NATURE NEUROSCIENCE			English	Article							STATIONARY NIGHT BLINDNESS; SENSITIVE CALCIUM-CHANNEL; CA2+ CHANNELS; CA2+-DEPENDENT INACTIVATION; BIPOLAR CELLS; HIPPOCAMPAL-NEURONS; CONE PHOTORECEPTORS; PLEXIFORM LAYER; RIBBON SYNAPSE; RETINA	CaBP1-8 are neuronal Ca2+-binding proteins with similarity to calmodulin (CaM). Here we show that CaBP4 is specifically expressed in photoreceptors, where it is localized to synaptic terminals. The outer plexiform layer, which contains the photoreceptor synapses with secondary neurons, was thinner in the Cabp4(-/-) mice than in control mice. Cabp4(-/-) retinas also had ectopic synapses originating from rod bipolar and horizontal cells tha HJt extended into the outer nuclear layer. Responses of Cabp4(-/-) rod bipolars were reduced in sensitivity about 100-fold. Electroretinograms (ERGs) indicated a reduction in cone and rod synaptic function. The phenotype of Cabp4(-/-) mice shares similarities with that of incomplete congenital stationary night blindness (CSNB2) patients. CaBP4 directly associated with the C-terminal domain of the Ca(v)1.4 alpha(1)-subunit and shifted the activation of Ca(v)1.4 to hyperpolarized voltages in transfected cells. These observations indicate that CaBP4 is important for normal synaptic function, probably through regulation of Ca2+ influx and neurotransmitter release in photoreceptor synaptic terminals.	Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Emory University; Emory University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Haeseleer, F (corresponding author), Univ Washington, Dept Ophthalmol, Box 356485, Seattle, WA 98195 USA.	fanfan@u.washington.edu; palczews@u.washington.edu	Imanishi, Yoshikazu/E-8178-2010	Imanishi, Yoshikazu/0000-0003-4696-4836; Lee, Amy/0000-0001-8021-0443	NATIONAL EYE INSTITUTE [R03EY014561, R01EY011850, R01EY009339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044922] Funding Source: NIH RePORTER; NEI NIH HHS [R03 EY014561, EY09339, R01 EY009339, P30 EY001730, R01 EY011850, EY11850, EY014561] Funding Source: Medline; NINDS NIH HHS [NS044922, R01 NS044922] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Ball SL, 2002, INVEST OPHTH VIS SCI, V43, P1595; BARNES S, 2002, CALCIUM, V514, P465; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Baumann L, 2004, INVEST OPHTH VIS SCI, V45, P708, DOI 10.1167/iovs.03-0937; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BAYLOR DA, 1970, J PHYSIOL-LONDON, V207, P77, DOI 10.1113/jphysiol.1970.sp009049; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Berntson A, 2003, J NEUROSCI RES, V71, P146, DOI 10.1002/jnr.10459; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dolmetsch Ricardo, 2003, Sci STKE, V2003, pPE4; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Grunert U, 2002, J COMP NEUROL, V447, P138, DOI 10.1002/cne.10220; Haeseleer F, 1999, J BIOL CHEM, V274, P6526, DOI 10.1074/jbc.274.10.6526; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Haeseleer F, 2001, INVEST OPHTH VIS SCI, V42, P3294; Haynes LP, 2004, J BIOL CHEM, V279, P547, DOI 10.1074/jbc.M309617200; Imanishi Y, 2002, EUR J NEUROSCI, V15, P63, DOI 10.1046/j.0953-816x.2001.01835.x; Koschak A, 2003, J NEUROSCI, V23, P6041, DOI 10.1523/JNEUROSCI.23-14-06041.2003; Koulen P, 1998, J NEUROSCI, V18, P10136; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; Maeda T, 2003, J NEUROCHEM, V85, P944, DOI 10.1046/j.1471-4159.2003.01741.x; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; McRory JE, 2004, J NEUROSCI, V24, P1707, DOI 10.1523/JNEUROSCI.4846-03.2004; Morgans CW, 1998, J NEUROSCI, V18, P2467; Morgans CW, 1999, EUR J NEUROSCI, V11, P2989, DOI 10.1046/j.1460-9568.1999.00719.x; Morgans CW, 2001, INVEST OPHTH VIS SCI, V42, P2414; Nachman-Clewner M, 1999, J COMP NEUROL, V415, P1, DOI 10.1002/(SICI)1096-9861(19991206)415:1<1::AID-CNE1>3.0.CO;2-G; NAKATANI K, 1988, J PHYSIOL-LONDON, V395, P695, DOI 10.1113/jphysiol.1988.sp016942; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; RIEKE F, 1994, NEURON, V13, P863, DOI 10.1016/0896-6273(94)90252-6; Sampath AP, 2004, NEURON, V41, P431, DOI 10.1016/S0896-6273(04)00005-4; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Schmitz Y, 1997, NEUROSCIENCE, V78, P1209, DOI 10.1016/S0306-4522(96)00678-1; Seidenbecher CI, 2002, ADV EXP MED BIOL, V514, P451; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Yang J, 2002, P NATL ACAD SCI USA, V99, P7711, DOI 10.1073/pnas.102006299; Zhang N, 2002, J NEUROSCI, V22, P7065; Zhou H, 2004, J NEUROSCI, V24, P4698, DOI 10.1523/JNEUROSCI.5523-03.2004; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	50	222	232	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1079	1087		10.1038/nn1320	http://dx.doi.org/10.1038/nn1320			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15452577	Green Accepted			2022-12-24	WOS:000224156900017
J	Fellin, T; Pascual, O; Gobbo, S; Pozzan, T; Haydon, PG; Carmignoto, G				Fellin, T; Pascual, O; Gobbo, S; Pozzan, T; Haydon, PG; Carmignoto, G			Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors	NEURON			English	Article							METHYL-D-ASPARTATE; CALCIUM OSCILLATIONS; HIPPOCAMPAL SYNAPSES; CATIONIC CURRENT; RELEASE; NEUROTOXICITY; COMMUNICATION; POTENTIATION; MECHANISMS; INCREASE	Fast excitatory neurotransmission is mediated by activation of synaptic ionotropic glutamate receptors. In hippocampal slices, we report that stimulation of Schaffer collaterals evokes in CAi neurons delayed inward currents with slow kinetics, in addition to fast excitatory postsynaptic currents. Similar slow events also occur spontaneously, can still be observed when neuronal activity and synaptic glutamate release are blocked, and are found to be mediated by glutamate released from astrocytes acting preferentially on extrasynaptic NMDA receptors. The slow currents can be triggered by stimuli that evoke Ca2+ oscillations in astrocytes, including photolysis of caged Ca2+ in single astrocytes. As revealed by paired recording and Ca2+ imaging, a striking feature of this NMDA receptor response is that it occurs synchronously in multiple CA1 neurons. Our results reveal a distinct mechanism for neuronal excitation and synchrony and highlight a functional link between astrocytic glutamate and extrasynaptic NMDA receptors.	Univ Padua, CNR, Ist Neurosci, I-35121 Padua, Italy; Univ Padua, Dipartimento Sci Biomed Sperimentali, I-35121 Padua, Italy; Univ Penn, Dept Neurosci, Sch Med, Philadelphia, PA 19104 USA	Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Padua; University of Pennsylvania	Carmignoto, G (corresponding author), Univ Padua, CNR, Ist Neurosci, Viale G Colombo 3, I-35121 Padua, Italy.	gcarmi@bio.unipd.it	Carmignoto, Giorgio/A-8375-2018; Pascual, Olivier/E-9533-2017; Pascual, Olivier/AAE-1449-2020	Carmignoto, Giorgio/0000-0003-3063-6774; Pascual, Olivier/0000-0002-5730-9880; Pascual, Olivier/0000-0002-5730-9880	NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH071705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS037585, R01NS043142] Funding Source: NIH RePORTER; NIMH NIH HHS [P20-MH-071705] Funding Source: Medline; NINDS NIH HHS [R01 NS43142, R37 NS37585] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Arcuino G, 2002, P NATL ACAD SCI USA, V99, P9840, DOI 10.1073/pnas.152588599; ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; Carmignoto G, 2000, PROG NEUROBIOL, V62, P561, DOI 10.1016/S0301-0082(00)00029-0; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; Congar P, 1997, J NEUROSCI, V17, P5366; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Conti F, 1999, TRENDS NEUROSCI, V22, P451, DOI 10.1016/S0166-2236(99)01445-9; CREPEL V, 1994, J NEUROPHYSIOL, V72, P1561, DOI 10.1152/jn.1994.72.4.1561; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; DINGLEDINE R, 1990, TRENDS PHARMACOL SCI, V11, P334, DOI 10.1016/0165-6147(90)90238-4; Dingledine R, 1999, PHARMACOL REV, V51, P7; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Fellin T, 2004, J PHYSIOL-LONDON, V559, P3, DOI 10.1113/jphysiol.2004.063214; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kullmann DM, 1999, ACTA PHYSIOL SCAND, V166, P79; Liu QS, 2004, P NATL ACAD SCI USA, V101, P3172, DOI 10.1073/pnas.0306731101; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Matthias K, 2003, J NEUROSCI, V23, P1750; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Pasti L, 2001, J NEUROSCI, V21, P477, DOI 10.1523/JNEUROSCI.21-02-00477.2001; Pasti L, 1997, J NEUROSCI, V17, P7817; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; Porter JT, 1996, J NEUROSCI, V16, P5073; Rumbaugh G, 1999, J NEUROSCI, V19, P10603, DOI 10.1523/JNEUROSCI.19-24-10603.1999; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Scimemi A, 2004, J NEUROSCI, V24, P4767, DOI 10.1523/JNEUROSCI.0364-04.2004; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Sul JY, 2004, NEURON GLIA BIOL, V1, P3, DOI 10.1017/S1740925X04000031; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tovar KR, 2002, NEURON, V34, P253; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Wang ZR, 2003, NEURON, V37, P463, DOI 10.1016/S0896-6273(02)01189-3; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; YAMADA KA, 1993, J NEUROSCI, V13, P3904; Zanotti S, 1997, J NEUROCHEM, V69, P594; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	53	703	721	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 2	2004	43	5					729	743		10.1016/j.neuron.2004.08.011	http://dx.doi.org/10.1016/j.neuron.2004.08.011			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339653	Bronze			2022-12-24	WOS:000223691900017
J	Mooser, F; Bosking, WH; Fitzpatrick, D				Mooser, F; Bosking, WH; Fitzpatrick, D			A morphological basis for orientation tuning in primary visual cortex	NATURE NEUROSCIENCE			English	Article							MONKEY STRIATE CORTEX; LOCAL CIRCUIT NEURONS; SHREW TUPAIA-GLIS; SIMPLE CELLS; FUNCTIONAL ARCHITECTURE; RECEPTIVE-FIELDS; TOPOGRAPHIC ORGANIZATION; HORIZONTAL CONNECTIONS; OCULAR DOMINANCE; THALAMIC INPUT	Feedforward connections are thought to be important in the generation of orientation-selective responses in visual cortex by establishing a bias in the sampling of information from regions of visual space that lie along a neuron's axis of preferred orientation. It remains unclear, however, which structural elements-dendrites or axons-are ultimately responsible for conveying this sampling bias. To explore this question, we have examined the spatial arrangement of feedforward axonal connections that link non-oriented neurons in layer 4 and orientation-selective neurons in layer 2/3 of visual cortex in the tree shrew. Target sites of labeled boutons in layer 2/3 resulting from focal injections of biocytin in layer 4 show an orientation-specific axial bias that is sufficient to confer orientation tuning to layer 2/3 neurons. We conclude that the anisotropic arrangement of axon terminals is the principal source of the orientation bias contributed by feedforward connections.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Fitzpatrick, D (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	fitzpat@neuro.duke.edu			NEI NIH HHS [EY06821] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ahmed B, 1997, J COMP NEUROL, V380, P230; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Anderson JC, 1999, NAT NEUROSCI, V2, P820, DOI 10.1038/12194; BLASDEL GG, 1984, J NEUROSCI, V4, P880; BLASDEL GG, 1992, J NEUROSCI, V12, P3115, DOI 10.1523/JNEUROSCI.12-08-03115.1992; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bosking WH, 1997, J NEUROSCI, V17, P2112; Bosking WH, 2000, J NEUROSCI, V20, P2346; Bosking WH, 2002, NAT NEUROSCI, V5, P874, DOI 10.1038/nn908; BULLIER J, 1980, J COMP NEUROL, V193, P913, DOI 10.1002/cne.901930407; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chisum HJ, 2003, J NEUROSCI, V23, P2947; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; FITZPATRICK D, 1987, J COMP NEUROL, V264, P73, DOI 10.1002/cne.902640107; Fitzpatrick D, 1996, CEREB CORTEX, V6, P329, DOI 10.1093/cercor/6.3.329; FREUND TF, 1985, J COMP NEUROL, V242, P275, DOI 10.1002/cne.902420209; HATA Y, 1988, NATURE, V335, P815, DOI 10.1038/335815a0; HENDRY SHC, 1987, J NEUROSCI, V7, P1503; Hirsch JA, 2003, NAT NEUROSCI, V6, P1300, DOI 10.1038/nn1152; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUMPHREY AL, 1980, J COMP NEUROL, V192, P531, DOI 10.1002/cne.901920311; HUMPHREY AL, 1980, J COMP NEUROL, V192, P549, DOI 10.1002/cne.901920312; KRETZ R, 1986, J COMP NEUROL, V251, P135, DOI 10.1002/cne.902510110; Lauritzen TZ, 2003, J NEUROSCI, V23, P10201; LUND JS, 1991, J COMP NEUROL, V311, P234, DOI 10.1002/cne.903110206; LUND JS, 1987, J COMP NEUROL, V257, P60, DOI 10.1002/cne.902570106; Martinez-Diaz JJ, 2002, TECTONOPHYSICS, V356, P291, DOI 10.1016/S0040-1951(02)00400-6; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 2002, J NEUROSCI, V22, P5639; Shapley R, 2003, NEURON, V38, P689, DOI 10.1016/S0896-6273(03)00332-5; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Sompolinsky H, 1997, CURR OPIN NEUROBIOL, V7, P514, DOI 10.1016/S0959-4388(97)80031-1; TANAKA K, 1983, J NEUROPHYSIOL, V49, P1303, DOI 10.1152/jn.1983.49.6.1303; TANAKA K, 1985, VISION RES, V25, P357, DOI 10.1016/0042-6989(85)90060-4; Tucker TR, 2004, VISUAL NEUROSCIENCES, P733; Usrey WM, 1996, J NEUROSCI, V16, P1203; Wielaard DJ, 2001, J NEUROSCI, V21, P5203, DOI 10.1523/JNEUROSCI.21-14-05203.2001; WILSON JR, 1984, PROC R SOC SER B-BIO, V221, P411, DOI 10.1098/rspb.1984.0042	43	60	62	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					872	879		10.1038/nn1287	http://dx.doi.org/10.1038/nn1287			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15258585				2022-12-24	WOS:000222930800018
J	Koh, TW; Verstreken, P; Bellen, HJ				Koh, TW; Verstreken, P; Bellen, HJ			Dap160/intersectin acts as a stabilizing scaffold required for synaptic development and vesicle endocytosis	NEURON			English	Article							DOMAIN-CONTAINING PROTEIN; CYSTEINE STRING PROTEIN; ADAPTER PROTEIN; EPS15 HOMOLOGY; REVERSIBLE BLOCKAGE; QUANTAL SIZE; DROSOPHILA; INTERSECTIN; ENDOPHILIN; SINGLE	We describe the isolation of mutations in dynamin-associated protein 160 kDa (dap160), the Drosophila homolog of intersectin, a putative adaptor for proteins involved in endocytosis, cytoskeletal regulation, and signaling. We show that partial loss-of-function mutants display temperature-sensitive (ts) paralysis, whereas null mutants show ts defects in endocytosis. Loss-of-function mutants exhibit bouton overgrowth at larval neuromuscular junctions (NMJs), but evoked neurotransmission is normal. Mutant NMJs show a mild endocytic defect at 22degreesC, which is strongly enhanced at 34degreesC. The levels of dynamin, synaptojanin and endophilin are severely reduced in dap160 mutant NMJs, suggesting that Dap160 serves to stabilize an endocytic macromolecular complex. Electron microscopy reveals fewer vesicles, aberrant large vesicles, and an accumulation of endocytic intermediates at active and periactive zones in mutant terminals. Our data suggest that Dap160, like dynamin, is involved in synaptic vesicle retrieval at active and periactive zones.	Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Bellen, HJ (corresponding author), Baylor Coll Med, Program Dev Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	hbellen@bcm.tmc.edu	Koh, Tong-Wey/M-3774-2013; Verstreken, Patrik/AAC-7591-2022	Koh, Tong-Wey/0000-0001-9136-3189; Verstreken, Patrik/0000-0002-5073-5393; Bellen, Hugo/0000-0001-5992-5989				BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; Butler H, 2001, GENETICS, V158, P1597; Casso D, 2000, MECH DEVELOP, V91, P449; Cho KO, 2000, CELL, V103, P331, DOI 10.1016/S0092-8674(00)00124-0; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; de Beer T, 1998, SCIENCE, V281, P1357, DOI 10.1126/science.281.5381.1357; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Estes PS, 1996, J NEUROSCI, V16, P5443; Fabian-Fine R, 2003, J NEUROSCI, V23, P10732; Fergestad T, 1999, J NEUROSCI, V19, P5847, DOI 10.1523/JNEUROSCI.19-14-05847.1999; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Grant D, 1998, GENETICS, V149, P1019; Gray NW, 2003, CURR BIOL, V13, P510, DOI 10.1016/S0960-9822(03)00136-2; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; Heidelberger R, 2002, J NEUROPHYSIOL, V88, P2509, DOI 10.1152/jn.00267.2002; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Karunanithi S, 2002, J NEUROSCI, V22, P10267; KIM YT, 1987, J NEUROSCI, V7, P3245; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Kjaerulff O, 2002, NAT CELL BIOL, V4, pE245, DOI 10.1038/ncb1102-e245; Klagges BRE, 1996, J NEUROSCI, V16, P3154; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; KOENIG JH, 1989, J NEUROSCI, V9, P3844; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Martina JA, 2001, J CELL BIOL, V153, P1111, DOI 10.1083/jcb.153.5.1111; Mayer BJ, 2001, J CELL SCI, V114, P1253; McPherson PS, 2002, TRENDS CELL BIOL, V12, P312, DOI 10.1016/S0962-8924(02)02309-7; Micheva KD, 1997, J BIOL CHEM, V272, P27239, DOI 10.1074/jbc.272.43.27239; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; POODRY CA, 1973, DEV BIOL, V32, P373, DOI 10.1016/0012-1606(73)90248-0; Predescu SA, 2003, MOL BIOL CELL, V14, P4997, DOI 10.1091/mbc.e03-01-0041; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Ranjan R, 1998, J NEUROSCI, V18, P956; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Salcini AE, 2001, NAT CELL BIOL, V3, P755, DOI 10.1038/35087075; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Sengar AS, 1999, EMBO J, V18, P1159, DOI 10.1093/emboj/18.5.1159; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Stimson DT, 2001, J NEUROSCI, V21, P3034, DOI 10.1523/JNEUROSCI.21-09-03034.2001; Stimson DT, 1998, J NEUROSCI, V18, P9638; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Tang HY, 1996, MOL CELL BIOL, V16, P4897; Tong XK, 2000, EMBO J, V19, P1263, DOI 10.1093/emboj/19.6.1263; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401; Zamanian JL, 2003, MOL BIOL CELL, V14, P1624, DOI 10.1091/mbc.E02-08-0494; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	76	174	184	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 22	2004	43	2					193	205		10.1016/j.neuron.2004.06.029	http://dx.doi.org/10.1016/j.neuron.2004.06.029			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841BX	15260956	Bronze			2022-12-24	WOS:000222905400009
J	Deisseroth, K; Singla, S; Toda, H; Monje, M; Palmer, TD; Malenka, RC				Deisseroth, K; Singla, S; Toda, H; Monje, M; Palmer, TD; Malenka, RC			Excitation-neurogenesis coupling in adult neural stem/progenitor cells	NEURON			English	Article							LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; RAT DENTATE GYRUS; STEM-CELLS; OLFACTORY-BULB; HIPPOCAMPAL NEUROGENESIS; EXTRACELLULAR POTASSIUM; SYNAPTIC-TRANSMISSION; CREB PHOSPHORYLATION; SUBVENTRICULAR ZONE	A wide variety of in vivo manipulations influence neurogenesis in the adult hippocampus. It is not known, however, if adult neural stem/progenitor cells (NPCs) can intrinsically sense excitatory neural activity and thereby implement a direct coupling between excitation and neurogenesis. Moreover, the theoretical significance of activity-dependent neurogenesis in hippocampal-type memory processing networks has not been explored. Here we demonstrate that excitatory stimuli act directly on adult hippocampal NPCs to favor neuron production. The excitation is sensed via Ca(v)1.2/ 1.3 (L-type) Call channels and NMDA receptors on the proliferating precursors. Excitation through this pathway acts to inhibit expression of the glial fate genes Hes1 and Id2 and increase expression of NeuroD, a positive regulator of neuronal differentiation. These activity-sensing properties of the adult NPCs, when applied as an "excitation-neurogenesis coupling rule" within a Hebbian neural network, predict significant advantages for both the temporary storage and the clearance of memories.	Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA	Stanford University; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.		Palmer, Theo/GSI-6635-2022; Toda, Hiroki/C-6932-2016	Toda, Hiroki/0000-0002-1596-4131; Palmer, Theo/0000-0002-6266-1862				Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; ALVAREZBUYLLA A, 1990, SCIENCE, V249, P1444, DOI 10.1126/science.1698312; Arvidsson A, 2001, EUR J NEUROSCI, V14, P10, DOI 10.1046/j.0953-816x.2001.01611.x; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Cai L, 2000, DEVELOPMENT, V127, P3021; Cameron HA, 1998, CURR OPIN NEUROBIOL, V8, P677, DOI 10.1016/S0959-4388(98)80099-8; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Cau E, 2000, DEVELOPMENT, V127, P2323; Cau E, 2002, DEVELOPMENT, V129, P1871; Cecchi GA, 2001, J COMPUT NEUROSCI, V11, P175, DOI 10.1023/A:1012849801892; Chambers RA, 2004, NEUROPSYCHOPHARMACOL, V29, P747, DOI 10.1038/sj.npp.1300358; CLAIBORNE BJ, 1990, J COMP NEUROL, V302, P206, DOI 10.1002/cne.903020203; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; GARDNERMEDWIN AR, 1983, J PHYSIOL-LONDON, V335, P375, DOI 10.1113/jphysiol.1983.sp014540; Gould E, 2000, BIOL PSYCHIAT, V48, P715, DOI 10.1016/S0006-3223(00)01021-0; Gould E, 2001, P NATL ACAD SCI USA, V98, P10910, DOI 10.1073/pnas.181354698; Graham B, 1999, NEURAL COMPUT, V11, P117, DOI 10.1162/089976699300016845; HOPFIELD JJ, 1986, SCIENCE, V233, P625, DOI 10.1126/science.3755256; JAN YN, 1993, CELL, V75, P827, DOI 10.1016/0092-8674(93)90525-U; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; Jinnah HA, 2000, MOVEMENT DISORD, V15, P542, DOI 10.1002/1531-8257(200005)15:3<542::AID-MDS1019>3.0.CO;2-2; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kokaia Z, 2003, CURR OPIN NEUROBIOL, V13, P127, DOI 10.1016/S0959-4388(03)00017-5; Krystal JH, 2003, PSYCHOPHARMACOLOGY, V169, P215, DOI 10.1007/s00213-003-1582-z; Liu JL, 1998, J NEUROSCI, V18, P7768; LONGO VG, 1988, PHARMACOL BIOCHEM BE, V29, P785, DOI 10.1016/0091-3057(88)90207-9; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Madsen TM, 2000, BIOL PSYCHIAT, V47, P1043, DOI 10.1016/S0006-3223(00)00228-6; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; MALENKA RC, 1981, SCIENCE, V214, P339, DOI 10.1126/science.7280695; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; MCCLELLAND JL, 1985, J EXP PSYCHOL GEN, V114, P159, DOI 10.1037/0096-3445.114.2.159; MCEWEN BS, 1994, ANN NY ACAD SCI, V746, P134; Mitrasinovic OM, 2001, J BIOL CHEM, V276, P30142, DOI 10.1074/jbc.M104265200; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nottebohm F, 2002, BRAIN RES BULL, V57, P737, DOI 10.1016/S0361-9230(02)00750-5; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Palmer TD, 1999, J NEUROSCI, V19, P8487; Parent JM, 1997, J NEUROSCI, V17, P3727; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Petreanu L, 2002, J NEUROSCI, V22, P6106; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schwab MH, 2000, J NEUROSCI, V20, P3714, DOI 10.1523/JNEUROSCI.20-10-03714.2000; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; See V, 2001, FASEB J, V15, P134, DOI 10.1096/fj.00-0106com; Sejnowski TJ, 1999, NEURON, V24, P773, DOI 10.1016/S0896-6273(00)81025-9; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Toma JG, 2000, J NEUROSCI, V20, P7648; TSIEN RW, 1995, TRENDS NEUROSCI, V18, P52; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Wang DD, 2003, J NEUROPHYSIOL, V90, P2291, DOI 10.1152/jn.01116.2002; Wang SL, 2001, NEURON, V29, P603, DOI 10.1016/S0896-6273(01)00237-9; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Westerlund U, 2003, EXP CELL RES, V289, P378, DOI 10.1016/S0014-4827(03)00291-X; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WILLSHAW DJ, 1969, NATURE, V222, P960, DOI 10.1038/222960a0	80	508	567	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 27	2004	42	4					535	552		10.1016/S0896-6273(04)00266-1	http://dx.doi.org/10.1016/S0896-6273(04)00266-1			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157417	Bronze			2022-12-24	WOS:000221708300006
J	Ruiz-Canada, C; Ashley, J; Moeckel-Cole, S; Drier, E; Yin, J; Budnik, V				Ruiz-Canada, C; Ashley, J; Moeckel-Cole, S; Drier, E; Yin, J; Budnik, V			New synaptic bouton formation is disrupted by misregulation of microtubule stability in aPKC mutants	NEURON			English	Article							PROTEIN-KINASE-C; CELL-POLARITY; ALPHA-ACTININ; GROWTH CONES; DISCS-LARGE; DROSOPHILA; NEUROBLASTS; COMPLEX; BAZOOKA; BINDING	The Baz/Par-3-Par-6-aPKC complex is an evolutionarily conserved cassette critical for the development of polarity in epithelial cells, neuroblasts, and oocytes. aPKC is also implicated in long-term synaptic plasticity in mammals and the persistence of memory in flies, suggesting a synaptic function for this cassette. Here we show that at Drosophila glutamatergic synapses, aPKC controls the formation and structure of synapses by regulating microtubule (MT) dynamics. At the presynapse, aPKC regulates the stability of MTs by promoting the association of the MAP1B-related protein Futsch to MTs. At the postsynapse, aPKC regulates the synaptic cytoskeleton by controlling the extent of Actin-rich and MT-rich areas. In addition, we show that Baz and Par-6 are also expressed at synapses and that their synaptic localization depends on aPKC activity. Our findings establish a novel role for this complex during synapse development and provide a cellular context for understanding the role of aPKC in synaptic plasticity and memory.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	University of Massachusetts System; University of Massachusetts Worcester; Cold Spring Harbor Laboratory	Budnik, V (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	vivian.budnik@umassmed.edu		Ashley, James/0000-0002-6693-1014	NIMH NIH HHS [R01 MH067774] Funding Source: Medline; NINDS NIH HHS [R01 NS030072, R01 NS3700] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA015753] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Banan A, 2002, AM J PHYSIOL-GASTR L, V283, pG909, DOI 10.1152/ajpgi.00143.2002; BRAND AH, 1993, DEVELOPMENT, V118, P401; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Cox DN, 2001, P NATL ACAD SCI USA, V98, P14475, DOI 10.1073/pnas.261565198; Dent EW, 1999, J NEUROSCI, V19, P8894, DOI 10.1523/JNEUROSCI.19-20-08894.1999; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; Dubreuil RR, 1997, MOL BIOL CELL, V8, P1933, DOI 10.1091/mbc.8.10.1933; Featherstone DE, 2001, J NEUROSCI, V21, P4215, DOI 10.1523/JNEUROSCI.21-12-04215.2001; Goold RG, 1999, J CELL SCI, V112, P3373; GORCZYCA M, 1993, J NEUROSCI, V13, P3692; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johnson K, 2003, NAT CELL BIOL, V5, P12, DOI 10.1038/ncb0103-12; Kaech S, 2001, P NATL ACAD SCI USA, V98, P7086, DOI 10.1073/pnas.111146798; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Marfatia SM, 1996, J CELL BIOL, V135, P753, DOI 10.1083/jcb.135.3.753; Mathew D, 2002, CURR BIOL, V12, P531, DOI 10.1016/S0960-9822(02)00758-3; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Nagai-Tamai Y, 2002, GENES CELLS, V7, P1161, DOI 10.1046/j.1365-2443.2002.00590.x; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Packard M, 2003, CURR OPIN NEUROBIOL, V13, P527, DOI 10.1016/j.conb.2003.09.008; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pellettieri J, 2002, SCIENCE, V298, P1946, DOI 10.1126/science.1072162; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Roche JP, 2002, J NEUROSCI, V22, P6471, DOI 10.1523/jneurosci.22-15-06471.2002; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; TAKEMURA R, 1992, J CELL SCI, V103, P953; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; Thomas U, 1997, NEURON, V19, P787, DOI 10.1016/S0896-6273(00)80961-7; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	44	121	123	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 27	2004	42	4					567	580		10.1016/S0896-6273(04)00255-7	http://dx.doi.org/10.1016/S0896-6273(04)00255-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157419	Green Accepted, Bronze			2022-12-24	WOS:000221708300008
J	Yu, CR; Power, J; Barnea, G; O'Donnell, S; Brown, HE; Osborne, J; Axel, R; Gogos, JA				Yu, CR; Power, J; Barnea, G; O'Donnell, S; Brown, HE; Osborne, J; Axel, R; Gogos, JA			Spontaneous neural activity is required for the establishment and maintenance of the olfactory sensory map	NEURON			English	Article							OCULAR DOMINANCE COLUMNS; NICOTINIC ACETYLCHOLINE-RECEPTOR; LATERAL GENICULATE-NUCLEUS; SPONTANEOUS RETINAL WAVES; ODORANT RECEPTORS; GENE-EXPRESSION; NEUROTRANSMITTER RELEASE; SYNAPTIC TRANSMISSION; POSTNATAL-DEVELOPMENT; TYROSINE-HYDROXYLASE	We have developed a genetic approach to examine the role of spontaneous activity and synaptic release in the establishment and maintenance of an olfactory sensory map. Conditional expression of tetanus toxin light chain, a molecule that inhibits synaptic release, does not perturb targeting during development, but neurons that express this molecule in a competitive environment fail to maintain appropriate synaptic connections and disappear. Overexpression of the inward rectifying potassium channel, Kir2.1, diminishes the excitability of sensory neurons and more severely disrupts the formation of an olfactory map. These studies suggest that spontaneous neural activity is required for the establishment and maintenance of the precise connectivity inherent in an olfactory sensory map.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Dept Anat & Cell Biol, New York, NY 10032 USA; Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University	Yu, CR (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA.			Axel, Richard/0000-0002-3141-4076	NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH001888, P50MH050733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006292] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01-DC006292-01] Funding Source: Medline; NIMH NIH HHS [5P50 MH 50733, 5K01 MH01888, K01 MH001888] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BAKER H, 1993, BRAIN RES, V614, P109, DOI 10.1016/0006-8993(93)91023-L; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Ehrengruber MU, 1997, P NATL ACAD SCI USA, V94, P7070, DOI 10.1073/pnas.94.13.7070; FARBMAN AI, 1980, DEV BIOL, V74, P205, DOI 10.1016/0012-1606(80)90062-7; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; Horton JC, 1996, J NEUROSCI, V16, P1791; Johns DC, 1999, J NEUROSCI, V19, P1691; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Katz LC, 2002, NAT REV NEUROSCI, V3, P34, DOI 10.1038/nrn703; Kim H, 2000, J COMP NEUROL, V422, P297; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; LEVAY S, 1975, J COMP NEUROL, V159, P559, DOI 10.1002/cne.901590408; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; LINK E, 1992, BIOCHEM BIOPH RES CO, V189, P1017, DOI 10.1016/0006-291X(92)92305-H; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; McLaughlin T, 2003, DEVELOPMENT, V130, P2407, DOI 10.1242/dev.00467; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Peckol EL, 1999, DEVELOPMENT, V126, P1891; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Pyle JL, 1999, NEURON, V24, P803, DOI 10.1016/S0896-6273(00)81028-4; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; ROSPARS JP, 1994, BRAIN RES, V662, P31, DOI 10.1016/0006-8993(94)90793-5; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; STONE DM, 1990, MOL BRAIN RES, V8, P291, DOI 10.1016/0169-328X(90)90042-C; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; White BH, 2001, NEURON, V31, P699, DOI 10.1016/S0896-6273(01)00415-9; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	62	276	279	0	24	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 27	2004	42	4					553	566		10.1016/S0896-6273(04)00224-7	http://dx.doi.org/10.1016/S0896-6273(04)00224-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157418	Bronze			2022-12-24	WOS:000221708300007
J	Chesler, EJ; Lu, L; Wang, JT; Williams, RW; Manly, KF				Chesler, EJ; Lu, L; Wang, JT; Williams, RW; Manly, KF			WebQTL: Rapid exploratory analysis of gene expression and genetic networks for brain and behavior	NATURE NEUROSCIENCE			English	Database Review							STRAINS		Univ Tennessee, Ctr Genom & Bioinformat, Dept Anat & Neurobiol, Memphis, TN 38163 USA; Univ Tennessee, Ctr Genom & Bioinformat, Dept Pathol & Lab Med, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Chesler, EJ (corresponding author), Univ Tennessee, Ctr Genom & Bioinformat, Dept Anat & Neurobiol, 855 Monroe Ave, Memphis, TN 38163 USA.	echesler@utmem.edu	Chesler, Elissa/K-4641-2019; Williams, Robert W./H-8789-2016	Chesler, Elissa/0000-0002-5642-5062; Williams, Robert W./0000-0001-8924-4447				Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Chesler EJ, 2003, NEUROINFORMATICS, V1, P343, DOI 10.1385/NI:1:4:343; Fehr C, 2002, J NEUROSCI, V22, P3730; Taylor BA, 1999, MAMM GENOME, V10, P335, DOI 10.1007/s003359900998; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299; Williams M, 2001, NUCL ENG INT, V46, P18	6	139	141	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					485	486		10.1038/nn0504-485	http://dx.doi.org/10.1038/nn0504-485			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15114364				2022-12-24	WOS:000221101300019
J	Buccino, G; Vogt, S; Ritzl, A; Fink, GR; Zilles, K; Freund, HJ; Rizzolatti, G				Buccino, G; Vogt, S; Ritzl, A; Fink, GR; Zilles, K; Freund, HJ; Rizzolatti, G			Neural circuits underlying imitation learning of hand actions: An event-related fMRI study	NEURON			English	Article							PREFRONTAL CORTEX; CORTICAL ACTIVITY; GRASP REPRESENTATIONS; FINGER CONFIGURATIONS; FUNCTIONAL PROPERTIES; MOTOR FACILITATION; PREMOTOR; NEURONS; MODULATION; MOVEMENT	The neural bases of imitation learning are virtually unknown. In the present study, we addressed this issue using an event-related fMRI paradigm. Musically naive participants were scanned during four events: (1) observation of guitar chords played by a guitarist, (2) a pause following model observation, (3) execution of the observed chords, and (4) rest. The results showed that the basic circuit underlying imitation learning consists of the inferior parietal lobule and the posterior part of the inferior frontal gyrus plus the adjacent premotor cortex (mirror neuron circuit). This circuit, known to be involved in action understanding, starts to be active during the observation of the guitar chords. During pause, the middle frontal gyrus (area 46) plus structures involved in motor preparation (dorsal premotor cortex, superior parietal lobule, rostral mesial areas) also become active. Given the functional properties of area 46, a model of imitation learning is proposed based on interactions between this area and the mirror neuron system.	Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy; Univ Lancaster, Dept Psychol, Lancaster LA1 4YF, England; Forschungszentrum Julich, Inst Med, D-52428 Julich, Germany; Univ Klinikum, Rhein Westfal TH Aachen, Neurol Klin, D-52062 Aachen, Germany; Univ Dusseldorf, C&O Vogt Hirnoforschungsinst, D-40210 Dusseldorf, Germany	University of Parma; Lancaster University; Helmholtz Association; Research Center Julich; RWTH Aachen University; RWTH Aachen University Hospital; Heinrich Heine University Dusseldorf	Rizzolatti, G (corresponding author), Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy.	giacomo.rizzolatti@unipr.it	Zilles, Karl/J-9704-2013; Buccino, Giovanni/AAC-4503-2022; Zilles, Karl/Y-3784-2019; Fink, Gereon R./AFW-9377-2022; Fink, Gereon R./E-1616-2012	Zilles, Karl/0000-0001-9296-9959; Buccino, Giovanni/0000-0001-5432-1756; Zilles, Karl/0000-0002-4705-4175; Fink, Gereon R./0000-0002-8230-1856; Fink, Gereon R./0000-0002-8230-1856; Vogt, Stefan Reinhold/0000-0003-4627-3410				ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P133, DOI 10.1152/jn.1990.64.1.133; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Andersen RA, 1987, HDB PHYSL 1, VV, P483; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Buchel C, 1998, BRAIN, V121, P1281, DOI 10.1093/brain/121.7.1281; Byrne R., 1995, THINKING APE EVOLUTI; BYRNE RW, 2002, IMITATIVE MIND DEV E, P122; Cochin S, 1999, EUR J NEUROSCI, V11, P1839, DOI 10.1046/j.1460-9568.1999.00598.x; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Constantinidis C, 2001, CEREB CORTEX, V11, P581, DOI 10.1093/cercor/11.7.581; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Craighero L, 2002, NEUROPSYCHOLOGIA, V40, P492, DOI 10.1016/S0028-3932(01)00134-8; Decety J, 2002, NEUROIMAGE, V15, P265, DOI 10.1006/nimg.2001.0938; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fink GR, 1997, J NEUROPHYSIOL, V77, P2164, DOI 10.1152/jn.1997.77.4.2164; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; FUNAHASHI S, 1990, J NEUROPHYSIOL, V63, P814, DOI 10.1152/jn.1990.63.4.814; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Fuster JM, 1995, MEMORY CEREBRAL CORT; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2002, ATTENTION PERFORM, V19, P334; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; GoldmanRakic PS, 1995, ANN NY ACAD SCI, V769, P71, DOI 10.1111/j.1749-6632.1995.tb38132.x; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Grezes J, 1998, COGN NEUROPSYCHOL, V15, P553, DOI 10.1080/026432998381023; Grezes J, 2003, NEUROIMAGE, V18, P928, DOI 10.1016/S1053-8119(03)00042-9; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; HIKOSAKA O, 2000, COGNITIVE NEUROSCIEN, P553; HYVARINEN J, 1982, PHYSIOL REV, V62, P1060, DOI 10.1152/physrev.1982.62.3.1060; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Jellema T., 2002, IMITATIVE MIND DEV E, P267; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Johnson Frey SH, 2003, NEURON, V39, P1053, DOI DOI 10.1016/S0896-6273(03)00524-5; Kimmig H, 2001, EXP BRAIN RES, V141, P184, DOI 10.1007/s002210100844; Koski L, 2003, J NEUROPHYSIOL, V89, P460, DOI 10.1152/jn.00248.2002; Koski L, 2002, CEREB CORTEX, V12, P847, DOI 10.1093/cercor/12.8.847; Krams M, 1998, EXP BRAIN RES, V120, P386, DOI 10.1007/s002210050412; LACQUANITI F, 1995, CEREB CORTEX, V5, P391, DOI 10.1093/cercor/5.5.391; LEINONEN L, 1979, EXP BRAIN RES, V34, P321; LEINONEN L, 1979, EXP BRAIN RES, V34, P299; Levy R, 2000, EXP BRAIN RES, V133, P23, DOI 10.1007/s002210000397; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Manthey S, 2003, COGNITIVE BRAIN RES, V15, P296, DOI 10.1016/S0926-6410(02)00201-X; MATSUZAKA Y, 1992, J NEUROPHYSIOL, V68, P653, DOI 10.1152/jn.1992.68.3.653; MELTZOFF AN, 2002, IMITIATIVE MIND DEV; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Nishitani N, 2002, NEURON, V36, P1211, DOI 10.1016/S0896-6273(02)01089-9; Nishitani N, 2000, P NATL ACAD SCI USA, V97, P913, DOI 10.1073/pnas.97.2.913; Owen AM, 2000, EXP BRAIN RES, V133, P33, DOI 10.1007/s002210000398; Passingham RE, 2000, EXP BRAIN RES, V133, P103, DOI 10.1007/s002210000405; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Petrides M, 2000, EXP BRAIN RES, V133, P44, DOI 10.1007/s002210000399; Petrides Michael, 1994, Current Opinion in Neurobiology, V4, P207, DOI 10.1016/0959-4388(94)90074-4; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; RIZZOLATTI G, 1990, EXP BRAIN RES, V82, P337; Rizzolatti G, 1996, EXP BRAIN RES, V111, P246; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; RIZZOLATTI G, 2003, PERSPECTIVES IMITATI; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Sakai K, 1999, J NEUROSCI, V19, P10074; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Talairach I., 1988, COPLANAR STEREOTACTI; Tanaka S, 2002, NEUROREPORT, V13, P1599, DOI 10.1097/00001756-200209160-00005; Tanaka S, 2001, NEUROREPORT, V12, P1171, DOI 10.1097/00001756-200105080-00024; Thorndike E. L., 1898, PSYCHOL REV MONOGRAP, V2, P1, DOI DOI 10.1037/H0092987; Tomasello M, 1997, PRIMATE COGNITION; Visalberghi E, 2002, FROM ANIM ANIMAT, P471; Vogt S, 2003, NEUROPSYCHOLOGIA, V41, P941, DOI 10.1016/S0028-3932(02)00319-6; Vogt S, 2002, IMITATIVE MIND DEV E, P206, DOI DOI 10.1017/CB09780511489969.012	76	649	682	0	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 22	2004	42	2					323	334		10.1016/S0896-6273(04)00181-3	http://dx.doi.org/10.1016/S0896-6273(04)00181-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KG	15091346	Bronze			2022-12-24	WOS:000221458500015
J	Klausberger, T; Marton, LF; Baude, A; Roberts, JDB; Magill, PJ; Somogyi, P				Klausberger, T; Marton, LF; Baude, A; Roberts, JDB; Magill, PJ; Somogyi, P			Spike timing of dendrite-targeting bistratified cells during hippocampal network oscillations in vivo	NATURE NEUROSCIENCE			English	Article							CA1 PYRAMIDAL NEURONS; RAT HIPPOCAMPUS; GAP-JUNCTIONS; INTACT HIPPOCAMPUS; ACTION-POTENTIALS; PHASE-PRECESSION; NEUROPEPTIDE-Y; INTERNEURONS; INHIBITION; RECEPTOR	Behavior-contingent network oscillations bring about transient, functionally coherent neuronal assemblies in the cerebral cortex, including the hippocampus. Inhibitory input on and close to the soma is believed to phase intrinsic oscillations and output of pyramidal cells, but the function of GABA release to pyramidal cell dendrites remains unknown. We recorded the oscillation-locked spike timing of identified bistratified interneurons in rats. These cells mainly innervated small dendritic shafts of pyramidal cells co-aligned with the glutamatergic Schaffer collateral/commissural input. During theta oscillations, bistratified cells fired at a phase when, on average, pyramidal cell dendrites are most hyperpolarized. Interneurons targeting the perisomatic domain discharge at an earlier phase. During sharp wave-associated ripples, bistratified cells fired with high frequency and in-phase with basket cells, on average 1-2 ms after the discharges in pyramidal cell somata and dendrites. Our results indicate that bistratified cells rhythmically modulate glutamatergic input to the dendrites of pyramidal cells to actively promote the precise input/output transformation during network oscillations.	Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England; IFR Jean Roche, Fac Med, CNRS, UMR 6150, F-13916 Marseille 20, France	University of Oxford; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Klausberger, T (corresponding author), Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Mansfield Rd, Oxford OX1 3TH, England.		Baude, Agnès/M-7356-2016	Baude, Agnès/0000-0002-7025-364X; Magill, Peter/0000-0001-7141-7071				ALLEN YS, 1983, SCIENCE, V221, P877, DOI 10.1126/science.6136091; ANDERSEN P, 1962, NATURE, V196, P645, DOI 10.1038/196645a0; ANDERSEN P, 1980, J PHYSIOL-LONDON, V305, P279, DOI 10.1113/jphysiol.1980.sp013363; ANDERSEN P, 1963, NATURE, V198, P540, DOI 10.1038/198540a0; Bland BH, 2002, J NEUROPHYSIOL, V88, P3046, DOI 10.1152/jn.00315.2002; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Chen WR, 1997, SCIENCE, V278, P463, DOI 10.1126/science.278.5337.463; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Colbert CM, 1997, J NEUROSCI, V17, P6512; CRUNELLI V, 1991, TRENDS NEUROSCI, V14, P16, DOI 10.1016/0166-2236(91)90178-W; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; FERRAGUTI F, IN PRESS HIPPOCAMPUS; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Frick A, 2003, J NEUROSCI, V23, P3243; Fricker D, 2001, NEURON, V32, P771, DOI 10.1016/S0896-6273(01)00528-1; Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7; Halasy K, 1996, HIPPOCAMPUS, V6, P306, DOI 10.1002/(SICI)1098-1063(1996)6:3<306::AID-HIPO8>3.0.CO;2-K; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kamondi A, 1998, J NEUROSCI, V18, P3919; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; KOSAKA T, 1985, J COMP NEUROL, V231, P150, DOI 10.1002/cne.902310203; LEVEY AI, 1995, J COMP NEUROL, V351, P339, DOI 10.1002/cne.903510303; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Losonczy A, 2002, J PHYSIOL-LONDON, V542, P193, DOI 10.1113/jphysiol.2002.020024; Maccaferri G, 2002, J NEUROSCI, V22, P5462; MAGEE JC, 1995, J NEUROPHYSIOL, V74, P1335, DOI 10.1152/jn.1995.74.3.1335; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MCBAIN CJ, 1994, J NEUROSCI, V14, P4433; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MOORE SD, 1988, SCIENCE, V239, P278, DOI 10.1126/science.2892268; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pawelzik H, 2002, J COMP NEUROL, V443, P346, DOI 10.1002/cne.10118; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; ROY JP, 1984, J NEUROPHYSIOL, V51, P1220, DOI 10.1152/jn.1984.51.6.1220; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Szabadics J, 2001, J NEUROSCI, V21, P5824, DOI 10.1523/JNEUROSCI.21-15-05824.2001; Traub RD, 2002, REV NEUROSCIENCE, V13, P1; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; Vezzani A, 1999, TRENDS NEUROSCI, V22, P25, DOI 10.1016/S0166-2236(98)01284-3; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; YLINEN A, 1995, J NEUROSCI, V15, P30; ZEZULA J, 1991, BRAIN RES, V563, P325, DOI 10.1016/0006-8993(91)91556-G	50	261	268	0	14	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					41	47		10.1038/nn1159	http://dx.doi.org/10.1038/nn1159			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	758LN	14634650				2022-12-24	WOS:000187636000011
J	Schmitz, D; Mellor, J; Breustedt, J; Nicoll, RA				Schmitz, D; Mellor, J; Breustedt, J; Nicoll, RA			Presynaptic kainate receptors impart an associative property to hippocampal mossy fiber long-term potentiation	NATURE NEUROSCIENCE			English	Article							SYNAPTIC PLASTICITY; COMMISSURAL SYNAPSES; GLUTAMATE RECEPTORS; BINDING-SITES; 2 FORMS; CA3; LTP; TRANSMISSION; RESPONSES; CHANNELS	Hippocampal mossy fiber synapses show an unusual form of long-term potentiation (LTP) that is independent of NMDA receptor activation and is expressed presynaptically. Using receptor antagonists, as well as receptor knockout mice, we found that presynaptic kainate receptors facilitate the induction of mossy fiber long-term potentiation (LTP), although they are not required for this form of LTP. Most importantly, these receptors impart an associativity to mossy fiber LTP such that activity in neighboring mossy fiber synapses, or even associational/ commissural synapses, influences the threshold for inducing mossy fiber LTP. Such a mechanism greatly increases the computational power of this form of plasticity.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Humboldt Univ, Charite, Neurosci Res Ctr, D-10117 Berlin, Germany; Univ Bristol, Sch Med Sci, Dept Anat, MRC,Ctr Synapt Plast, Bristol BS8 1TD, Avon, England; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bristol; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, Box 2140 Mission Bay Campus,600 16 St, San Francisco, CA 94143 USA.		MELLOR, Jack/B-4548-2019	MELLOR, Jack/0000-0002-7706-8105; Schmitz, Dietmar/0000-0003-2741-5241				BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bortolotto ZA, 2000, NATURE, V406, P957, DOI 10.1038/35023077; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; Bureau I, 1999, J NEUROSCI, V19, P653; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; CHATTARJI S, 1989, BRAIN RES, V495, P145, DOI 10.1016/0006-8993(89)91228-6; Contractor A, 2003, J NEUROSCI, V23, P422, DOI 10.1523/JNEUROSCI.23-02-00422.2003; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Dingledine R, 1999, PHARMACOL REV, V51, P7; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; ITO I, 1991, NEUROREPORT, V2, P333, DOI 10.1097/00001756-199106000-00008; Ji ZX, 2002, NEUROSCI LETT, V331, P71, DOI 10.1016/S0304-3940(02)00865-0; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kamiya H, 2002, J NEUROSCI, V22, P9237; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; LANGDON RB, 1995, J NEUROBIOL, V26, P370, DOI 10.1002/neu.480260309; Lauri SE, 2001, NEURON, V32, P697, DOI 10.1016/S0896-6273(01)00511-6; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mellor J, 2001, NAT NEUROSCI, V4, P125, DOI 10.1038/83941; MONAGHAN DT, 1982, BRAIN RES, V252, P91, DOI 10.1016/0006-8993(82)90981-7; Nicoll RA, 2000, NATURE, V406, P957, DOI 10.1038/35023075; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; REPRESA A, 1987, NEUROSCIENCE, V20, P739, DOI 10.1016/0306-4522(87)90237-5; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Schmitz D, 2001, P NATL ACAD SCI USA, V98, P11003, DOI 10.1073/pnas.191351498; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Tong G, 1996, NEURON, V16, P1147, DOI 10.1016/S0896-6273(00)80141-5; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; Wiebe SP, 1999, J NEUROSCI, V19, P10562; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; ZALUTSKY RA, 1992, NEUROSCI LETT, V138, P193, DOI 10.1016/0304-3940(92)90503-Y	38	94	97	1	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1058	1063		10.1038/nn1116	http://dx.doi.org/10.1038/nn1116			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	12947409				2022-12-24	WOS:000185633600017
J	Boyden, ES; Raymond, JL				Boyden, ES; Raymond, JL			Active reversal of motor memories reveals rules governing memory encoding	NEURON			English	Article							LONG-TERM DEPRESSION; PRIMATE VESTIBULOOCULAR REFLEX; ADAPTIVE GAIN-CONTROL; DORSAL Y-GROUP; HEAD ROTATION; NITRIC-OXIDE; CEREBELLAR FLOCCULUS; NEURONAL RESPONSES; PURKINJE NEURONS; SQUIRREL-MONKEY	Learning systems must be able to store memories reliably, yet be able to modify them when new learning is required. At the mechanistic level, new learning may either reverse the cellular events mediating the storage of old memories or mask the old memories with additional cellular changes that preserve the old cellular events in a latent form. Behavioral evidence about whether reversal or masking occurs in a particular circuit can constrain the cellular mechanisms used to store memories. Here we examine these constraints for a simple cerebellum-dependent learning task, motor learning in the vestibulo-ocular reflex (VOR). Learning can change the amplitude of the VOR in two opposite directions. Contrary to previous models about memory encoding by the cerebellum, our results indicate that these behavioral changes are implemented by different plasticity mechanisms, which reverse each other with unequal efficacy.	Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Raymond, JL (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.			Raymond, Jennifer/0000-0002-8145-747X	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004154] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC04154, R01 DC004154] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Caria MA, 2001, NEUROREPORT, V12, P2353, DOI 10.1097/00001756-200108080-00014; Crepel F, 1990, Neuroreport, V1, P133, DOI 10.1097/00001756-199010000-00013; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; GONSHOR A, 1973, J PHYSIOL-LONDON, V234, pP102; Han VZ, 2000, NEURON, V27, P611, DOI 10.1016/S0896-6273(00)00070-2; HEMART N, 1994, NEUROSCI RES, V19, P213, DOI 10.1016/0168-0102(94)90145-7; ITO M, 1974, P JPN ACAD, V50, P85, DOI 10.2183/pjab1945.50.85; ITO M, 1972, BRAIN RES, V40, P81, DOI 10.1016/0006-8993(72)90110-2; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399; LI J, 1995, J NEUROPHYSIOL, V74, P489, DOI 10.1152/jn.1995.74.1.489; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; Lisberger SG, 1996, ANN NY ACAD SCI, V781, P525, DOI 10.1111/j.1749-6632.1996.tb15725.x; LISBERGER SG, 1994, J NEUROPHYSIOL, V72, P954, DOI 10.1152/jn.1994.72.2.954; LISBERGER SG, 1994, J NEUROPHYSIOL, V72, P928, DOI 10.1152/jn.1994.72.2.928; LISBERGER SG, 1978, J NEUROPHYSIOL, V41, P733, DOI 10.1152/jn.1978.41.3.733; LUEBKE AE, 1994, EXP BRAIN RES, V98, P379; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; McElligott JG, 1998, J NEUROPHYSIOL, V79, P1286, DOI 10.1152/jn.1998.79.3.1286; MICHNOVICZ JJ, 1987, EXP BRAIN RES, V66, P287; MILES FA, 1974, BRAIN RES, V80, P512, DOI 10.1016/0006-8993(74)91035-X; MILES FA, 1980, J NEUROPHYSIOL, V43, P1406, DOI 10.1152/jn.1980.43.5.1406; MILES FA, 1980, J NEUROPHYSIOL, V43, P1477, DOI 10.1152/jn.1980.43.5.1477; MONTAGUE PR, 1994, LEARN MEMORY, V1, P1; Murashima M, 1999, J NEUROSCI, V19, P7326, DOI 10.1523/JNEUROSCI.19-17-07326.1999; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; PARTSALIS AM, 1995, J NEUROPHYSIOL, V73, P615, DOI 10.1152/jn.1995.73.2.615; PARTSALIS AM, 1995, J NEUROPHYSIOL, V73, P632, DOI 10.1152/jn.1995.73.2.632; PASTOR AM, 1994, J NEUROPHYSIOL, V72, P1383, DOI 10.1152/jn.1994.72.3.1383; Reynolds T, 2000, J PHYSIOL-LONDON, V527, P563, DOI 10.1111/j.1469-7793.2000.00563.x; ROBINSON DA, 1976, J NEUROPHYSIOL, V39, P954, DOI 10.1152/jn.1976.39.5.954; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; Schulz S, 1999, J NEUROSCI, V19, P5683; SEJNOWSKI IJ, 1977, J THEOR BIOL, V69, P385, DOI 10.1016/0022-5193(77)90146-1; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; Smith MR, 2002, J NEUROPHYSIOL, V87, P2031, DOI 10.1152/jn.00821.2001; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Staubli U, 1996, J NEUROSCI, V16, P853; Sutton MA, 2001, NEURON, V31, P143, DOI 10.1016/S0896-6273(01)00342-7; van Alphen AM, 2001, BRAIN RES, V890, P296, DOI 10.1016/S0006-8993(00)03180-2; Wang SSH, 2000, P NATL ACAD SCI USA, V97, P8635, DOI 10.1073/pnas.130414597	45	98	99	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 11	2003	39	6					1031	1042		10.1016/S0896-6273(03)00562-2	http://dx.doi.org/10.1016/S0896-6273(03)00562-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	721BA	12971901	Bronze			2022-12-24	WOS:000185296100015
J	Ikeda, T; Hikosaka, O				Ikeda, T; Hikosaka, O			Reward-dependent gain and bias of visual responses in primate superior colliculus	NEURON			English	Article							SACCADIC EYE-MOVEMENTS; NIGRA PARS RETICULATA; MONKEY CAUDATE-NUCLEUS; OCULOMOTOR FUNCTIONS; SUBSTANTIA-NIGRA; FUNCTIONAL-PROPERTIES; AUDITORY RESPONSES; PREFRONTAL CORTEX; NEURONAL-ACTIVITY; PARIETAL CORTEX	Eye movements are often influenced by expectation of reward. Using a memory-guided saccade task with an asymmetric reward schedule, we show that visual responses of monkey SC neurons increase when the visual stimulus indicates an upcoming reward. The increase occurred in two distinct manners: (1) reactively, as an increase in the gain of the visual response when the stimulus indicated an upcoming reward; (2) proactively, as an increase in anticipatory activity when reward was expected in the neuron's response field. These effects were observed mostly in saccade-related SC neurons in the deeper layer which would receive inputs from the cortical eye fields and the basal ganglia. These results, together with recent findings, suggest that the gain modulation may be determined by the inputs from both the cortical eye fields and the basal ganglia, whereas the anticipatory bias may be derived mainly from the basal ganglia.	Juntendo Univ, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 1138421, Japan; Univ Tokyo, Dept Neurol, Div Neurosci, Grad Sch Med, Tokyo 113, Japan; Tamagawa Univ, Brain Sci Res Ctr, Tokyo 1940041, Japan; NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	Juntendo University; University of Tokyo; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Hikosaka, O (corresponding author), Juntendo Univ, Sch Med, Dept Physiol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.			Ikeda, Takuro/0000-0003-1079-8725	NATIONAL EYE INSTITUTE [Z01EY000415, ZIAEY000415] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BARASH S, 1991, J NEUROPHYSIOL, V66, P1095, DOI 10.1152/jn.1991.66.3.1095; Basso MA, 1998, J NEUROSCI, V18, P7519; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; Dorris MC, 1998, J NEUROSCI, V18, P7015; Dorris MC, 2002, J COGNITIVE NEUROSCI, V14, P1256, DOI 10.1162/089892902760807249; Gattass R., 1996, Revista Brasileira de Biologia, V56, P257; GLIMCHER PW, 1992, NATURE, V355, P542, DOI 10.1038/355542a0; Glimcher PW, 2001, TRENDS NEUROSCI, V24, P654, DOI 10.1016/S0166-2236(00)01932-9; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P560, DOI 10.1152/jn.1972.35.4.560; GOLDBERG ME, 1981, J NEUROPHYSIOL, V46, P773, DOI 10.1152/jn.1981.46.4.773; GRAYBIEL AM, 1978, BRAIN RES, V143, P339, DOI 10.1016/0006-8993(78)90573-5; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1230; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1285, DOI 10.1152/jn.1983.49.5.1285; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P799, DOI 10.1152/jn.1989.61.4.799; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; JAYARAMAN A, 1977, BRAIN RES, V135, P147, DOI 10.1016/0006-8993(77)91058-7; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KARABELAS AB, 1985, J COMP NEUROL, V239, P309, DOI 10.1002/cne.902390305; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Kobayashi S, 2002, J NEUROPHYSIOL, V87, P1488, DOI 10.1152/jn.00472.2001; Kojima J, 1996, NEUROSCI RES, V26, P17, DOI 10.1016/S0168-0102(96)01067-X; Lauwereyns J, 2002, NEURON, V33, P463, DOI 10.1016/S0896-6273(02)00571-8; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; MATSUMURA M, 1992, J NEUROPHYSIOL, V67, P1615, DOI 10.1152/jn.1992.67.6.1615; MEREDITH MA, 1992, EXP BRAIN RES, V88, P181, DOI 10.1007/BF02259139; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2313, DOI 10.1152/jn.1995.73.6.2313; Pare M, 2001, J NEUROPHYSIOL, V85, P2545, DOI 10.1152/jn.2001.85.6.2545; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; ROBINSON DL, 1995, J NEUROPHYSIOL, V74, P713, DOI 10.1152/jn.1995.74.2.713; Sato M, 2002, J NEUROSCI, V22, P2363, DOI 10.1523/JNEUROSCI.22-06-02363.2002; SCHALL JD, 1991, J NEUROPHYSIOL, V66, P530, DOI 10.1152/jn.1991.66.2.530; SCHILLER PH, 1971, J NEUROPHYSIOL, V34, P920, DOI 10.1152/jn.1971.34.5.920; SEGRAVES MA, 1987, J NEUROPHYSIOL, V58, P1387, DOI 10.1152/jn.1987.58.6.1387; SHOOK BL, 1990, J COMP NEUROL, V301, P618, DOI 10.1002/cne.903010410; Sommer MA, 2000, J NEUROPHYSIOL, V83, P1979, DOI 10.1152/jn.2000.83.4.1979; SPARKS DL, 1986, PHYSIOL REV, V66, P118, DOI 10.1152/physrev.1986.66.1.118; SPARKS DL, 1976, BRAIN RES, V113, P21, DOI 10.1016/0006-8993(76)90003-2; Takikawa Y, 2002, EXP BRAIN RES, V142, P284, DOI 10.1007/s00221-001-0928-1; Takikawa Y, 2002, J NEUROPHYSIOL, V87, P508, DOI 10.1152/jn.00288.2001; WURTZ RH, 1971, SCIENCE, V171, P82, DOI 10.1126/science.171.3966.82; WURTZ RH, 1980, ANNU REV NEUROSCI, V3, P189, DOI 10.1146/annurev.ne.03.030180.001201	44	168	171	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 14	2003	39	4					693	700		10.1016/S0896-6273(03)00464-1	http://dx.doi.org/10.1016/S0896-6273(03)00464-1			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	712CQ	12925282	Bronze			2022-12-24	WOS:000184779500013
J	Tian, N; Copenhagen, DR				Tian, N; Copenhagen, DR			Visual stimulation is required for refinement of ON and OFF pathways in postnatal retina	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; MEDIATED AFFERENT ACTIVITY; GANGLION-CELLS; MOUSE RETINA; CAT RETINA; DENDRITIC STRATIFICATION; MAMMALIAN RETINA; DEPRIVED CATS; INNER RETINA; TIME COURSE	ON and OFF pathways separately relay increment and decrement luminance signals from retinal bipolar cells to cortex. ON-OFF retinal ganglion cells (RGCs) are activated via synaptic inputs onto bistratified dendrites localized in the ON and OFF regions of the inner plexiform layer. Postnatal maturational processes convert bistratifying ON-OFF RGCs to monostratifying ON and OFF RGCs. Although visual deprivation influences refinement of higher visual centers, no previous studies suggest that light regulates either the development of the visual-evoked signaling in retinal ON and OFF pathways, nor pruning of bistratified RGC dendrites. We find that dark rearing blocks both the maturational loss of ON-OFF responsive RGCs and the pruning of dendrites. Thus, in retina, there is a previously unrecognized, pathway-specific maturation that is profoundly affected by visual deprivation.	Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; Univ Calif San Francisco, Sch Med, Dept Ophthalmol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Physiol, San Francisco, CA 94143 USA	Yale University; Yale University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tian, N (corresponding author), Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, 333 Cedar St, New Haven, CT 06520 USA.				NATIONAL EYE INSTITUTE [R01EY001869] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY001869] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akerman CJ, 2002, NEURON, V36, P869, DOI 10.1016/S0896-6273(02)01010-3; Bansal A, 2000, J NEUROSCI, V20, P7672; BARO JA, 1990, INVEST OPHTH VIS SCI, V31, P1405; BODNARENKO SR, 1993, NATURE, V364, P144, DOI 10.1038/364144a0; Bodnarenko SR, 1999, NEUROREPORT, V10, P2955, DOI 10.1097/00001756-199909290-00015; BODNARENKO SR, 1995, J NEUROSCI, V15, P7037; BOWEANDERS C, 1975, BRAIN RES, V87, P61, DOI 10.1016/0006-8993(75)90779-9; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; CYNADER M, 1980, J NEUROPHYSIOL, V43, P1026, DOI 10.1152/jn.1980.43.4.1026; DANIELS JD, 1978, J NEUROPHYSIOL, V41, P1373, DOI 10.1152/jn.1978.41.6.1373; DANN JF, 1988, J NEUROSCI, V8, P1485; DAW N, 1995, VISUAL DEV; DOI M, 1995, J COMP NEUROL, V356, P368, DOI 10.1002/cne.903560305; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; FISHER LJ, 1979, J COMP NEUROL, V187, P359, DOI 10.1002/cne.901870207; FOX K, 1991, NATURE, V350, P342, DOI 10.1038/350342a0; Gordon JA, 1996, J NEUROSCI, V16, P3274; GREINER JV, 1981, EXP EYE RES, V33, P315, DOI 10.1016/S0014-4835(81)80055-3; Gunhan-Agar E, 2000, J NEUROSCI, V20, P306, DOI 10.1523/JNEUROSCI.20-01-00306.2000; Hartline HK, 1938, AM J PHYSIOL, V121, P400, DOI 10.1152/ajplegacy.1938.121.2.400; Haverkamp S, 2000, J COMP NEUROL, V424, P1; HENDRICKSON A, 1976, VISION RES, V16, P517, DOI 10.1016/0042-6989(76)90033-X; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Johnson J, 2003, J NEUROSCI, V23, P518, DOI 10.1523/JNEUROSCI.23-02-00518.2003; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; LAU KC, 1990, J COMP NEUROL, V300, P583, DOI 10.1002/cne.903000411; LEVENTHAL AG, 1983, J NEUROSCI, V3, P332; Liu CJL, 1996, INVEST OPHTH VIS SCI, V37, P1469; MASLAND RH, 1977, J COMP NEUROL, V175, P275, DOI 10.1002/cne.901750303; MASLIM J, 1988, DEV BRAIN RES, V44, P87, DOI 10.1016/0165-3806(88)90120-4; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MOWER GD, 1991, DEV BRAIN RES, V58, P151, DOI 10.1016/0165-3806(91)90001-Y; NELSON R, 1978, J NEUROPHYSIOL, V41, P472, DOI 10.1152/jn.1978.41.2.472; Nirenberg S, 1997, NEURON, V18, P637, DOI 10.1016/S0896-6273(00)80304-9; NORTON TT, 1985, BRAIN RES, V327, P319, DOI 10.1016/0006-8993(85)91527-6; Pow DV, 2000, NEUROSCI LETT, V280, P21, DOI 10.1016/S0304-3940(99)00988-X; Redburn DA., 1987, PROGR RETINAL RES, V6, P16, DOI 10.1016/0278-4327(87)90020-4; Rockhill RL, 2002, J NEUROSCI, V22, P3831; RUSOFF AC, 1977, J NEUROPHYSIOL, V40, P1188, DOI 10.1152/jn.1977.40.5.1188; SassoePognetto M, 1997, J COMP NEUROL, V381, P158, DOI 10.1002/(SICI)1096-9861(19970505)381:2<158::AID-CNE4>3.0.CO;2-2; Sernagor E, 1996, CURR BIOL, V6, P1503, DOI 10.1016/S0960-9822(96)00755-5; SHERMAN SM, 1973, BRAIN RES, V60, P224, DOI 10.1016/0006-8993(73)90861-5; STONE C, 1992, J PHYSIOL-LONDON, V456, P125, DOI 10.1113/jphysiol.1992.sp019330; STONE C, 1993, VISUAL NEUROSCI, V10, P31, DOI 10.1017/S0952523800003205; STRYKER MP, 1983, J NEUROSCI, V3, P1943; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; Tagawa Y, 1999, J NEUROSCI, V19, P2568; TASCHENBERGER H, 1995, J NEUROSCI, V15, P2240, DOI 10.1523/JNEUROSCI.15-03-02240.1995; Tian N, 1998, J NEUROPHYSIOL, V80, P1327, DOI 10.1152/jn.1998.80.3.1327; Tian N, 2001, NEURON, V32, P439, DOI 10.1016/S0896-6273(01)00470-6; TOOTLE JS, 1993, J NEUROPHYSIOL, V69, P1645, DOI 10.1152/jn.1993.69.5.1645; Wang GY, 2001, J NEUROSCI, V21, P4310, DOI 10.1523/JNEUROSCI.21-12-04310.2001; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307	55	232	235	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 3	2003	39	1					85	96		10.1016/S0896-6273(03)00389-1	http://dx.doi.org/10.1016/S0896-6273(03)00389-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699LB	12848934	Bronze			2022-12-24	WOS:000184057400011
J	Gelfand, JR; Bookheimer, SY				Gelfand, JR; Bookheimer, SY			Dissociating neural mechanisms of temporal sequencing and processing phonemes	NEURON			English	Article							SHORT-TERM-MEMORY; INFERIOR PREFRONTAL CORTEX; HUMAN AUDITORY-CORTEX; EVENT-RELATED FMRI; WORKING-MEMORY; HEMISPHERIC LATERALIZATION; SENTENCE COMPREHENSION; PITCH DISCRIMINATION; RECOGNITION MEMORY; TASK-DIFFICULTY	Using fMRI, we sought to determine whether the posterior, superior portion of Broca's area performs operations on phoneme segments specifically or implements processes general to sequencing discrete units. Twelve healthy volunteers performed two sequence manipulation tasks and one matching task, using strings of syllables and hummed notes. The posterior portion of Broca's area responded specifically to the sequence manipulation tasks, independent of whether the stimuli were composed of phonemes or hummed notes. In contrast, the left supramarginal gyrus was somewhat more specific to sequencing phoneme segments. These results suggest a functional dissociation of the canonical left hemisphere language regions encompassing the "phonological loop," with the left posterior inferior frontal gyrus responding not to the sound structure of language but rather to sequential operations that may underlie the ability to form words out of dissociable elements.	Univ Calif Los Angeles, David Geffen Sch Med, Brain Mapping Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bookheimer, SY (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Brain Mapping Ctr, Los Angeles, CA 90095 USA.			Bookheimer, Susan/0000-0002-3417-5891				ALBERT ML, 1972, NEUROPSYCHOLOGIA, V10, P245, DOI 10.1016/0028-3932(72)90067-X; ALEXANDER MP, 1989, BRAIN LANG, V37, P656, DOI 10.1016/0093-934X(89)90118-1; AUZOU P, 1995, NEUROPSYCHOLOGIA, V33, P25, DOI 10.1016/0028-3932(94)00100-4; Baddeley A., 2007, WORKING MEMORY THOUG; Barch DM, 1997, NEUROPSYCHOLOGIA, V35, P1373, DOI 10.1016/S0028-3932(97)00072-9; Belin P, 1998, J COGNITIVE NEUROSCI, V10, P536, DOI 10.1162/089892998562834; Belin P, 2002, COGNITIVE BRAIN RES, V13, P17, DOI 10.1016/S0926-6410(01)00084-2; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Benson RR, 2001, BRAIN LANG, V78, P364, DOI 10.1006/brln.2001.2484; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; BISIACCHI PS, 1989, Q J EXP PSYCHOL-A, V41, P293, DOI 10.1080/14640748908402367; BOGEN JE, 1971, NATURE, V230, P524, DOI 10.1038/230524a0; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; BUB D, 1987, COGNITIVE NEUROPSYCH, P79; Burton MW, 2000, J COGNITIVE NEUROSCI, V12, P679, DOI 10.1162/089892900562309; CANTER GJ, 1985, BRAIN LANG, V24, P204, DOI 10.1016/0093-934X(85)90131-2; Caplan D, 1998, J COGNITIVE NEUROSCI, V10, P541, DOI 10.1162/089892998562843; Caplan D, 2000, HUM BRAIN MAPP, V9, P65; Carmon A, 1971, Cortex, V7, P411; Dapretto M, 1999, NEURON, V24, P427, DOI 10.1016/S0896-6273(00)80855-7; DEMB JB, 1995, J NEUROSCI, V15, P5870; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; DEMONET JF, 1994, BRAIN, V117, P671, DOI 10.1093/brain/117.4.671; FIEZ JA, 1995, J COGNITIVE NEUROSCI, V7, P357, DOI 10.1162/jocn.1995.7.3.357; Friederici AD, 2000, CEREB CORTEX, V10, P698, DOI 10.1093/cercor/10.7.698; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; GATES A, 1977, BRAIN LANG, V4, P403, DOI 10.1016/0093-934X(77)90035-9; GORDON HW, 1974, J NEUROL NEUROSUR PS, V37, P727, DOI 10.1136/jnnp.37.6.727; Halpern AR, 1999, CEREB CORTEX, V9, P697, DOI 10.1093/cercor/9.7.697; Hanten G, 2001, BRAIN COGNITION, V45, P164, DOI 10.1006/brcg.2000.1236; Henson RNA, 1999, J NEUROSCI, V19, P3962; Henson RNA, 2000, NEUROPSYCHOLOGIA, V38, P426, DOI 10.1016/S0028-3932(99)00098-6; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; Kang AM, 1999, NEUROIMAGE, V10, P555, DOI 10.1006/nimg.1999.0493; Kim JJ, 2002, NEUROIMAGE, V15, P879, DOI 10.1006/nimg.2001.1025; Kim JJ, 1999, BRAIN, V122, P1069, DOI 10.1093/brain/122.6.1069; KIM Y, 1980, CORTEX, V16, P135, DOI 10.1016/S0010-9452(80)80028-1; KIM YC, 1976, BRAIN LANG, V3, P507, DOI 10.1016/0093-934X(76)90045-6; KIMURA D, 1974, BRAIN, V97, P337, DOI 10.1093/brain/97.1.337; Konishi S, 2000, NEUROIMAGE, V12, P276, DOI 10.1006/nimg.2000.0614; LOMAS J, 1976, NEUROPSYCHOLOGIA, V14, P23, DOI 10.1016/0028-3932(76)90004-X; Marshuetz C, 2000, J COGNITIVE NEUROSCI, V12, P130, DOI 10.1162/08989290051137459; MARTIN A, 1994, NEUROPSYCHOLOGIA, V32, P1487, DOI 10.1016/0028-3932(94)90120-1; Martin R C, 1982, Brain Cogn, V1, P50, DOI 10.1016/0278-2626(82)90006-9; MONOI H, 1983, BRAIN LANG, V20, P175, DOI 10.1016/0093-934X(83)90041-X; Oakhill J, 2000, J EXP CHILD PSYCHOL, V75, P152, DOI 10.1006/jecp.1999.2529; OJEMANN G, 1979, SCIENCE, V205, P1401, DOI 10.1126/science.472757; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Paulesu E, 1997, NEUROREPORT, V8, P2011, DOI 10.1097/00001756-199705260-00042; Perry DW, 1999, NEUROREPORT, V10, P3979, DOI 10.1097/00001756-199912160-00046; Poldrack RA, 2001, J COGNITIVE NEUROSCI, V13, P687, DOI 10.1162/089892901750363235; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; PRICE CJ, 1997, HUMAN BRAIN FUNCTION, P301; Rao SM, 1997, J NEUROSCI, V17, P5528; Raye CL, 2002, NEUROIMAGE, V15, P447, DOI 10.1006/nimg.2001.0983; Riecker A, 2000, NEUROREPORT, V11, P1997, DOI 10.1097/00001756-200006260-00038; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; SHALLICE T, 1977, BRAIN LANG, V4, P479, DOI 10.1016/0093-934X(77)90040-2; SHAPIRO BE, 1981, NEUROPSYCHOLOGIA, V19, P161, DOI 10.1016/0028-3932(81)90101-9; STUART M, 1990, Q J EXP PSYCHOL-A, V42, P305, DOI 10.1080/14640749008401224; Stuss D.T., 1986, FRONTAL LOBES; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanji K, 2001, CORTEX, V37, P671, DOI 10.1016/S0010-9452(08)70613-0; Tervaniemi M, 2000, HUM BRAIN MAPP, V10, P74, DOI 10.1002/(SICI)1097-0193(200006)10:2<74::AID-HBM30>3.0.CO;2-2; Thierry G, 1999, NEUROREPORT, V10, P2599, DOI 10.1097/00001756-199908200-00029; TZORTZIS C, 1974, NEUROPSYCHOLOGIA, V12, P355, DOI 10.1016/0028-3932(74)90051-7; von Zerssen GC, 2001, EUR J NEUROSCI, V13, P2148, DOI 10.1046/j.0953-816x.2001.01589.x; Wagner AD, 2001, NEURON, V31, P329, DOI 10.1016/S0896-6273(01)00359-2; Weschler D., 1974, MANUAL WESCHLER INTE; Wise RJS, 2001, BRAIN, V124, P83, DOI 10.1093/brain/124.1.83; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Woods RP, 1999, HUM BRAIN MAPP, V8, P73, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<73::AID-HBM1>3.0.CO;2-7; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; Zatorre RJ, 1996, CEREB CORTEX, V6, P21, DOI 10.1093/cercor/6.1.21; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767; ZATORRE RJ, 1991, BRAIN, V114, P2403, DOI 10.1093/brain/114.6.2403; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	86	132	134	1	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 5	2003	38	5					831	842		10.1016/S0896-6273(03)00285-X	http://dx.doi.org/10.1016/S0896-6273(03)00285-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	687DU	12797966	Bronze			2022-12-24	WOS:000183361400017
J	Saito, F; Moore, SA; Barresi, R; Henry, MD; Messing, A; Ross-Barta, SE; Cohn, RD; Williamson, RA; Sluka, KA; Sherman, DL; Brophy, PJ; Schmelzer, JD; Low, PA; Wrabetz, L; Feltri, ML; Campbell, KP				Saito, F; Moore, SA; Barresi, R; Henry, MD; Messing, A; Ross-Barta, SE; Cohn, RD; Williamson, RA; Sluka, KA; Sherman, DL; Brophy, PJ; Schmelzer, JD; Low, PA; Wrabetz, L; Feltri, ML; Campbell, KP			Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization	NEURON			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; SCHWANN-CELLS; MYCOBACTERIUM-LEPRAE; ALPHA-DYSTROGLYCAN; SKELETAL-MUSCLE; DEFICIENT MICE; ION CHANNELS; DISRUPTION; LAMININ; ORGANIZATION	Dystroglycan is a central component of the dystrophin-glycoprotein complex implicated in the pathogenesis of several neuromuscular diseases. Although dystroglycan is expressed by Schwann cells, its normal peripheral nerve functions are unknown. Here we show that selective deletion of Schwann cell dystroglycan results in slowed nerve conduction and nodal changes including reduced sodium channel density and disorganized microvilli. Additional features of mutant mice include deficits in rotorod performance, aberrant pain responses, and abnormal myelin sheath folding. These data indicate that dystroglycan is crucial for both myelination and nodal architecture. Dystroglycan may be required for the normal maintenance of voltage-gated sodium channels at nodes of Ranvier, possibly by mediating trans interactions between Schwann cell microvilli and the nodal axolemma.	Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Dept Physiol & Biophys,Dept Neurol, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Phys Therapy & Rehabil Sci Grad Program, Iowa City, IA 52242 USA; Univ Wisconsin, Waisman Ctr, Sch Vet Med, Dept Sci Biol, Madison, WI 53705 USA; Univ Edinburgh, Dept Preclin Vet Sci, Neurosci Res Ctr, Edinburgh EH9 1QH, Midlothian, Scotland; Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA; San Raffaele Sci Inst, DIBIT, I-20132 Milan, Italy	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Wisconsin System; University of Wisconsin Madison; University of Edinburgh; Mayo Clinic	Campbell, KP (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Dept Physiol & Biophys,Dept Neurol, Iowa City, IA 52242 USA.		Feltri, Maria Laura/J-5286-2018; Cohn, Ronald/AAC-5835-2021; Barresi, Rita/AAB-9569-2022	Barresi, Rita/0000-0001-7351-959X; Henry, Michael/0000-0002-7871-245X; Sluka, Kathleen/0000-0003-0207-8728; Campbell, Kevin/0000-0003-2066-5889; Moore, Steven/0000-0002-6353-7900	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K02AR002201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045630, R21NS041407, R01NS041319] Funding Source: NIH RePORTER; NIAMS NIH HHS [K02 AR-02201] Funding Source: Medline; NINDS NIH HHS [R01 NS045630-03, R01 NS045630, R01 NS045630-01, R01 NS045630-09, R01 NS045630-02, NS-41407, NS-41319, NS-45630] Funding Source: Medline; Telethon [1177] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon)		Allamand V, 1997, HUM MOL GENET, V6, P747, DOI 10.1093/hmg/6.5.747; BERTHOLD CH, 1983, J NEUROCYTOL, V12, P475, DOI 10.1007/BF01159386; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Boerkoel CF, 2001, AM J HUM GENET, V68, P325, DOI 10.1086/318208; Boyle MET, 2001, NEURON, V30, P385, DOI 10.1016/S0896-6273(01)00296-3; Bozic D, 1998, MATRIX BIOL, V17, P495, DOI 10.1016/S0945-053X(98)90097-X; BRADLEY WG, 1973, J NEUROL SCI, V18, P227, DOI 10.1016/0022-510X(73)90009-9; BRADLEY WG, 1977, J NEUROPATH EXP NEUR, V36, P797, DOI 10.1097/00005072-197709000-00003; BRADLEY WG, 1975, J NEUROL SCI, V25, P249, DOI 10.1016/0022-510X(75)90144-6; BUNGE MB, 1993, PERIPHERAL NEUROPATH, P299; BYERS TJ, 1993, NAT GENET, V4, P77, DOI 10.1038/ng0593-77; Chance PF, 1999, ANN NY ACAD SCI, V883, P14, DOI 10.1111/j.1749-6632.1999.tb08562.x; Ching W, 1999, J NEUROCYTOL, V28, P295, DOI 10.1023/A:1007053411667; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Dupree JL, 1999, J CELL BIOL, V147, P1145, DOI 10.1083/jcb.147.6.1145; Durbeej M, 2000, MOL CELL, V5, P141, DOI 10.1016/S1097-2765(00)80410-4; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FANNON AM, 1995, J CELL BIOL, V129, P189, DOI 10.1083/jcb.129.1.189; Feltri ML, 2002, J CELL BIOL, V156, P199, DOI 10.1083/jcb.200109021; Feltri ML, 1999, ANN NY ACAD SCI, V883, P116, DOI 10.1111/j.1749-6632.1999.tb08574.x; Frei R, 1999, GLIA, V27, P269, DOI 10.1002/(SICI)1098-1136(199909)27:3<269::AID-GLIA8>3.0.CO;2-2; Gillespie CS, 2000, NEURON, V26, P523, DOI 10.1016/S0896-6273(00)81184-8; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Guilbot A, 2001, HUM MOL GENET, V10, P415, DOI 10.1093/hmg/10.4.415; Henry MD, 2001, J CELL SCI, V114, P1137; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Imamura M, 2000, HUM MOL GENET, V9, P3091, DOI 10.1093/hmg/9.20.3091; Ishibashi T, 2002, J NEUROSCI, V22, P6507; JAROS E, 1979, NEUROPATH APPL NEURO, V5, P133, DOI 10.1111/j.1365-2990.1979.tb00666.x; JUNG D, 1995, J BIOL CHEM, V270, P27305, DOI 10.1074/jbc.270.45.27305; KOMIYAMA A, 1991, J NEUROSCI RES, V29, P308, DOI 10.1002/jnr.490290306; LOW PA, 1984, P NATL ACAD SCI-BIOL, V81, P6894, DOI 10.1073/pnas.81.21.6894; Masaki T, 2002, EXP NEUROL, V174, P109, DOI 10.1006/exnr.2001.7856; Masaki T, 2000, ACTA NEUROPATHOL, V99, P289, DOI 10.1007/PL00007440; Matsumura K, 1997, NEUROMUSCULAR DISORD, V7, P7, DOI 10.1016/S0960-8966(96)00402-6; MATSUMURA K, 1993, FEBS LETT, V334, P281, DOI 10.1016/0014-5793(93)80695-Q; Melendez-Vasquez CV, 2001, P NATL ACAD SCI USA, V98, P1235, DOI 10.1073/pnas.98.3.1235; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Nakagawa M, 2001, GLIA, V35, P101, DOI 10.1002/glia.1075; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; OKADA E, 1977, J NEUROL SCI, V33, P243, DOI 10.1016/0022-510X(77)90197-6; Peles E, 2000, CURR OPIN NEUROBIOL, V10, P558, DOI 10.1016/S0959-4388(00)00122-7; Previtali SC, 2001, PROG NEUROBIOL, V64, P35, DOI 10.1016/S0301-0082(00)00045-9; Rambukkana A, 1998, SCIENCE, V282, P2076, DOI 10.1126/science.282.5396.2076; Rambukkana A, 2002, SCIENCE, V296, P927, DOI 10.1126/science.1067631; Rasband MN, 2001, DEV BIOL, V236, P5, DOI 10.1006/dbio.2001.0326; Ratcliffe CF, 2001, J CELL BIOL, V154, P427, DOI 10.1083/jcb.200102086; Saito F, 1999, J BIOL CHEM, V274, P8240, DOI 10.1074/jbc.274.12.8240; Scherer SS, 2001, J NEUROSCI RES, V65, P150, DOI 10.1002/jnr.1138; Scherer SS, 2002, J PERIPHER NERV SYST, V7, P1, DOI 10.1046/j.1529-8027.2002.02001.x; Sherman DL, 2001, NEURON, V30, P677, DOI 10.1016/S0896-6273(01)00327-0; SHETTY V, 1995, INT J LEPROSY, V63, P104; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; Thouvarecq R, 2001, BEHAV BRAIN RES, V118, P209, DOI 10.1016/S0166-4328(00)00330-2; Tsiper MV, 2002, J CELL SCI, V115, P1005; Wacnik PW, 2001, J NEUROSCI, V21, P9355, DOI 10.1523/JNEUROSCI.21-23-09355.2001; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831; YAMADA H, 1994, FEBS LETT, V352, P49, DOI 10.1016/0014-5793(94)00917-1; Yamada H, 1996, J BIOL CHEM, V271, P23418, DOI 10.1074/jbc.271.38.23418; Yeomans DC, 1996, PAIN, V68, P141, DOI 10.1016/S0304-3959(96)03177-6	63	203	205	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 5	2003	38	5					747	758		10.1016/S0896-6273(03)00301-5	http://dx.doi.org/10.1016/S0896-6273(03)00301-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	687DU	12797959	Bronze			2022-12-24	WOS:000183361400010
J	Brager, DH; Cai, X; Thompson, SM				Brager, DH; Cai, X; Thompson, SM			Activity-dependent activation of presynaptic protein kinase C mediates post-tetanic potentiation	NATURE NEUROSCIENCE			English	Article							SYNAPTIC TRANSMISSION; RAT HIPPOCAMPUS; PHOSPHORYLATION; PLASTICITY; CALCIUM; RELEASE; ENHANCEMENT	Vesicle exocytosis is mediated by the complex interaction between synaptic vesicle and plasma membrane proteins, many of which are substrates for protein kinases(1-3). Exogenous protein kinase activators increase release probability at several mammalian CNS synapses(4-6), but the physiological conditions under which presynaptic protein kinases become activated are not known. We report here that calcium/phospholipid-dependent protein kinase C (PKC) is activated by high-frequency stimulation and mediates post-tetanic potentiation (PTP) in the rat hippocampus.	Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Thompson, SM (corresponding author), Univ Maryland, Sch Med, Dept Physiol, 655 W Baltimore St, Baltimore, MD 21201 USA.		Cai, Xiang/AAD-8012-2021; Thompson, Scott M/K-8921-2015	Brager, Darrin/0000-0002-3736-0515	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040338] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH65488] Funding Source: Medline; NINDS NIH HHS [R01 NS40338] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKERS RF, 1987, J NEUROSCI, V7, P3976; Brager DH, 2002, J PHYSIOL-LONDON, V541, P545, DOI 10.1113/jphysiol.2001.015842; Capogna M, 1999, EUR J NEUROSCI, V11, P433, DOI 10.1046/j.1460-9568.1999.00450.x; CAPOGNA M, 1995, J NEUROSCI, V15, P1249; DELANEY KR, 1989, J NEUROSCI, V9, P3558; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; MAGLEBY KL, 1975, J PHYSIOL-LONDON, V245, P163, DOI 10.1113/jphysiol.1975.sp010839; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; NIELANDER HB, 1995, J NEUROCHEM, V65, P1712; REGEHR WG, 1994, J NEUROSCI, V14, P523; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Shimazaki Y, 1996, J BIOL CHEM, V271, P14548, DOI 10.1074/jbc.271.24.14548; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; Wu XS, 2001, J NEUROSCI, V21, P7928, DOI 10.1523/JNEUROSCI.21-20-07928.2001; Yawo H, 1999, J PHYSIOL-LONDON, V515, P169, DOI 10.1111/j.1469-7793.1999.169ad.x	15	70	71	0	9	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					551	552		10.1038/nn1067	http://dx.doi.org/10.1038/nn1067			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12754518				2022-12-24	WOS:000183140400008
J	Feany, MB; Pallanck, LJ				Feany, MB; Pallanck, LJ			Parkin: A multipurpose neuroprotective agent?	NEURON			English	Review							UBIQUITIN-PROTEIN LIGASE; ALPHA-SYNUCLEIN; DISEASE; ACTIVATION; SUBSTRATE	An autosomal recessive juvenile-onset form of Parkinson's disease (AR-JP) is caused by loss-of-function mutations of the parkin gene, which encodes a ubiquitin-protein ligase. Three recent reports demonstrate that parkin can protect neurons from diverse cellular insults, including alpha-synuclein toxicity, proteasomal dysfunction, Pael-R accumulation, and kainate-induced excitotoxicity. These findings suggest a central role for parkin in maintaining dopaminergic neuronal integrity and strengthen the link between AR-JP and the more common sporadic form of Parkinson's disease.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Washington; University of Washington Seattle	Feany, MB (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, 221 Longwood Ave,Room 514, Boston, MA 02115 USA.			Feany, Mel/0000-0003-0315-7970				Betarbet R, 2002, BRAIN PATHOL, V12, P499; Choi P, 2000, NEUROREPORT, V11, P2635, DOI 10.1097/00001756-200008210-00006; Choi P, 2001, NEUROREPORT, V12, P2839, DOI 10.1097/00001756-200109170-00017; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Copani A, 2001, TRENDS NEUROSCI, V24, P25, DOI 10.1016/S0166-2236(00)01663-5; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Dawson TM, 2003, J CLIN INVEST, V111, P145, DOI 10.1172/JCI200317575; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; GREENE JC, 2003, IN PRESS P NATL ACAD; Husseman JW, 2000, NEUROBIOL AGING, V21, P815, DOI 10.1016/S0197-4580(00)00221-9; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Schlossmacher MG, 2002, AM J PATHOL, V160, P1655, DOI 10.1016/S0002-9440(10)61113-3; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Shimura H, 1999, ANN NEUROL, V45, P668, DOI 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	21	94	96	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 10	2003	38	1					13	16		10.1016/S0896-6273(03)00201-0	http://dx.doi.org/10.1016/S0896-6273(03)00201-0			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	666XT	12691660	Bronze			2022-12-24	WOS:000182202300005
J	Park, D; Lee, S; Jun, K; Hong, YM; Kim, DY; Kim, YI; Shin, HS				Park, D; Lee, S; Jun, K; Hong, YM; Kim, DY; Kim, YI; Shin, HS			Translation of clock rhythmicity into neural firing in suprachiasmatic nucleus requires mGluR-PLC beta 4 signaling	NATURE NEUROSCIENCE			English	Article							CIRCADIAN RELEASE; AMINO-ACIDS; RECEPTORS		Korea Inst Sci & Technol, Natl CRI Ctr Calcium & Learning, Seoul 136791, South Korea; Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; Pochon CHA Univ, Coll Med, CHA Gen Hosp, Seoul 135081, South Korea; Korea Univ, Coll Med, Dept Physiol, Seoul 136705, South Korea; Korea Univ, Coll Med, Neurosci Res Inst, Seoul 136705, South Korea	Korea Institute of Science & Technology (KIST); Pohang University of Science & Technology (POSTECH); Pochon Cha University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Kim, YI (corresponding author), Korea Inst Sci & Technol, Natl CRI Ctr Calcium & Learning, Box 131, Seoul 136791, South Korea.			Kim, Yang/0000-0003-3420-7870				Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; GILLETTE MU, 1987, BRAIN RES BULL, V19, P135, DOI 10.1016/0361-9230(87)90176-6; Haak LL, 1999, J NEUROPHYSIOL, V81, P1308, DOI 10.1152/jn.1999.81.3.1308; Ikeda M, 2000, NEUROREPORT, V11, P907, DOI 10.1097/00001756-200004070-00002; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P14598, DOI 10.1073/pnas.93.25.14598; Kim D, 1997, NATURE, V389, P290, DOI 10.1038/38508; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Shinohara K, 1998, NEUROREPORT, V9, P137, DOI 10.1097/00001756-199801050-00027; Shinohara K, 2000, NEUROSCI RES, V36, P245, DOI 10.1016/S0168-0102(99)00131-5	12	27	27	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					337	338		10.1038/nn1033	http://dx.doi.org/10.1038/nn1033			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12640460				2022-12-24	WOS:000181833100007
J	Campbell, DS; Holt, CE				Campbell, DS; Holt, CE			Apoptotic pathway and MAPKs differentially regulate chemotropic responses of retinal growth cones	NEURON			English	Article							ACTIVATED PROTEIN-KINASE; NETRIN-1-MEDIATED AXON OUTGROWTH; CEREBELLAR GRANULE NEURONS; INITIATION-FACTOR 4G; POLY(ADP-RIBOSE) POLYMERASE-1; ERK ACTIVATION; CASPASE; PROTEASOME; INHIBITOR; UBIQUITIN	Previous work has shown that guidance cues trigger rapid changes in protein dynamics in retinal growth cones: netrin-1 stimulates both protein synthesis and degradation, while Sema3A elicits synthesis, and LPA induces degradation. What signaling pathways are involved? Our studies confirm that p42/44 MAPK mediates netrin-1 responses and further show that inhibiting its activity blocks cue-induced protein synthesis. Unexpectedly, p38 MAPK is also activated by netrin-1 in retinal growth cones and is required for chemotropic responses and translation. Sema3A- and LPA-induced responses, by contrast, require a single MAPK, p42/ p44 and p38, respectively. In addition, we report that caspase-3, an apoptotic protease, is rapidly activated by netrin-1 and LPA in a proteasome- and p38-dependent manner and is required for chemotropic responses. These findings suggest that the apoptotic pathway may be used locally to control protein levels in growth cones and that the differential activation of MAPK pathways may underlie cue-directed migration.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	University of Cambridge	Campbell, DS (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.	campbell@neuro.utah.edu; ceh@mole.bio.cam.ac.uk		Campbell, Douglas/0000-0002-7371-9484; Holt, Christine Elizabeth/0000-0003-2829-121X				Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; BIGGS WH, 1994, EMBO J, V13, P1628, DOI 10.1002/j.1460-2075.1994.tb06426.x; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; Canu N, 2000, J NEUROSCI, V20, P589, DOI 10.1523/JNEUROSCI.20-02-00589.2000; Cara DC, 2001, J IMMUNOL, V167, P6552, DOI 10.4049/jimmunol.167.11.6552; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Clemens MJ, 1998, ONCOGENE, V17, P2921, DOI 10.1038/sj.onc.1202227; CORNEL E, 1992, NEURON, V9, P1001, DOI 10.1016/0896-6273(92)90061-H; Corset V, 2000, NATURE, V407, P747, DOI 10.1038/35037600; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; D'Amours D, 2001, J CELL SCI, V114, P3771; D'Mello SR, 1998, J NEUROCHEM, V70, P1809; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; DeSilva DR, 1998, J IMMUNOL, V160, P4175; Di Cristo G, 2001, SCIENCE, V292, P2337, DOI 10.1126/science.1059075; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Forcet C, 2001, P NATL ACAD SCI USA, V98, P3416, DOI 10.1073/pnas.051378298; Gilman CP, 2002, NEUROMOL MED, V2, P197, DOI 10.1385/NMM:2:2:197; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Ha HC, 2000, NEUROBIOL DIS, V7, P225, DOI 10.1006/nbdi.2000.0324; Harada J, 1999, JPN J PHARMACOL, V79, P369, DOI 10.1254/jjp.79.369; HARRIS WA, 1987, DEVELOPMENT, V101, P123; HEACOCK AM, 1977, SCIENCE, V198, P64, DOI 10.1126/science.897684; Herbert TP, 2002, J BIOL CHEM, V277, P11591, DOI 10.1074/jbc.M110367200; Hirata H, 1998, J EXP MED, V187, P587, DOI 10.1084/jem.187.4.587; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Jesenberger V, 2002, NAT REV MOL CELL BIO, V3, P112, DOI 10.1038/nrm731; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; LOHOF AM, 1992, J NEUROSCI, V12, P1253; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Marissen WE, 1998, MOL CELL BIOL, V18, P7565, DOI 10.1128/MCB.18.12.7565; Mashima T, 1999, ONCOGENE, V18, P2423, DOI 10.1038/sj.onc.1202558; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Mohanty S, 2001, GENE DEV, V15, P1435, DOI 10.1101/gad.871101; Nieuwkoop PD, 1967, NORMAL TABLES XENOPU; O'Brien MA, 2001, BIOTECHNIQUES, V30, P886, DOI 10.2144/01304pf01; OBRIG TG, 1971, J BIOL CHEM, V246, P174; Ohta K, 1999, DEV BIOL, V211, P124, DOI 10.1006/dbio.1999.9312; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Park MS, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134858; Parrizas M, 1997, J BIOL CHEM, V272, P154; Perron JC, 1999, MOL CELL NEUROSCI, V13, P362, DOI 10.1006/mcne.1999.0753; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Shewan D, 2002, NAT NEUROSCI, V5, P955, DOI 10.1038/nn919; Shirvan A, 1999, J NEUROCHEM, V73, P961, DOI 10.1046/j.1471-4159.1999.0730961.x; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Steiner MR, 2000, ANN NY ACAD SCI, V905, P132; Suzuki Y, 2001, J BIOL CHEM, V276, P27058, DOI 10.1074/jbc.M102415200; TANAKA J, 1993, DEV BRAIN RES, V76, P268, DOI 10.1016/0165-3806(93)90217-X; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Ullrich O, 1999, P NATL ACAD SCI USA, V96, P6223, DOI 10.1073/pnas.96.11.6223; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Wojcik C, 2002, J CELL MOL MED, V6, P25, DOI 10.1111/j.1582-4934.2002.tb00309.x; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang F, 2001, NAT NEUROSCI, V4, P19, DOI 10.1038/82858; Yehia G, 2001, J BIOL CHEM, V276, P35272, DOI 10.1074/jbc.M105404200; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002	75	233	237	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 27	2003	37	6					939	952		10.1016/S0896-6273(03)00158-2	http://dx.doi.org/10.1016/S0896-6273(03)00158-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	661PU	12670423	Bronze			2022-12-24	WOS:000181899600008
J	Brincat, SL; Connor, CE				Brincat, SL; Connor, CE			Underlying principles of visual shape selectivity in posterior inferotemporal cortex	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL NEURONS; OBJECT RECOGNITION; 3-DIMENSIONAL SHAPES; RECEPTIVE-FIELDS; TERM-MEMORY; AREA V4; MACAQUE; RESPONSES; VISION; FEATURES	Object perception depends on shape processing in the ventral visual pathway, which in monkeys culminates in inferotemporal cortex (IT). Here we provide a description of fundamental quantitative principles governing neural selectivity for complex shape in IT. By measuring responses to large, parametric sets of two-dimensional (2D) silhouette shapes, we found that neurons in posterior IT (Brodmann's areas TEO and posterior TE) integrate information about multiple contour elements (straight and curved edge fragments of the type represented in lower-level areas) using both linear and nonlinear mechanisms. This results in complex, distributed response patterns that cannot be characterized solely in terms of example stimuli. We explained these response patterns with tuning functions in multidimensional shape space and accurately predicted neural responses to the widely varying shapes in our stimulus set. Integration of contour element information in earlier stages of IT represents an important step in the transformation from low-level shape signals to complex object representation.	Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Connor, CE (corresponding author), Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA.	connor@jhu.edu						ALBRIGHT TD, 1990, P INT C FUZZY LOGIC, V2, P375; Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; Carandini M, 1997, J NEUROSCI, V17, P8621; Conner CE, 1997, J NEUROSCI, V17, P3201; DiCarlo JJ, 2003, J NEUROPHYSIOL, V89, P3264, DOI 10.1152/jn.00358.2002; Edelman S, 2003, COGNITIVE SCI, V27, P73, DOI 10.1207/s15516709cog2701_3; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; GOCHIN PM, 1994, J NEUROPHYSIOL, V71, P2325, DOI 10.1152/jn.1994.71.6.2325; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; HOFFMAN DD, 1984, COGNITION, V18, P65, DOI 10.1016/0010-0277(84)90022-2; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; Janssen P, 1999, P NATL ACAD SCI USA, V96, P8217, DOI 10.1073/pnas.96.14.8217; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Kapadia MK, 2000, J NEUROPHYSIOL, V84, P2048, DOI 10.1152/jn.2000.84.4.2048; Kimia BB, 2003, J PHYSIOL-PARIS, V97, P155, DOI 10.1016/j.jphysparis.2003.09.003; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Kovacs G, 2003, CEREB CORTEX, V13, P178, DOI 10.1093/cercor/13.2.178; LEYTON M, 1998, GENERATIVE THEORY SH; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; Mechler F, 2002, VISION RES, V42, P1017, DOI 10.1016/S0042-6989(02)00025-1; Mel BW, 2000, NEURAL COMPUT, V12, P731, DOI 10.1162/089976600300015574; MILLER EK, 1994, SCIENCE, V263, P520, DOI 10.1126/science.8290960; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; OLSON CR, 1995, SCIENCE, V269, P985, DOI 10.1126/science.7638625; Op de Beeck H, 2001, NAT NEUROSCI, V4, P1244, DOI 10.1038/nn767; Op De Beeck H, 2000, J COMP NEUROL, V426, P505, DOI 10.1002/1096-9861(20001030)426:4<505::AID-CNE1>3.0.CO;2-M; OPTICAN LM, 1987, J NEUROPHYSIOL, V57, P162, DOI 10.1152/jn.1987.57.1.162; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Ringach DL, 1997, VISION RES, V37, P2455, DOI 10.1016/S0042-6989(96)00247-7; Rolls ET, 1997, EXP BRAIN RES, V114, P149, DOI 10.1007/PL00005615; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Salinas E, 1997, J NEUROPHYSIOL, V77, P3267, DOI 10.1152/jn.1997.77.6.3267; SCHWARTZ EL, 1983, P NATL ACAD SCI-BIOL, V80, P5776, DOI 10.1073/pnas.80.18.5776; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; Ullman S, 1998, COGNITION, V67, P21, DOI 10.1016/S0010-0277(98)00013-4; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wang Y, 2000, NAT NEUROSCI, V3, P807, DOI 10.1038/77712; Wilson HR, 1997, VISION RES, V37, P2325, DOI 10.1016/S0042-6989(97)00104-1; WOLFE JM, 1992, PERCEPTION, V21, P465, DOI 10.1068/p210465; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000	50	250	252	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					880	886		10.1038/nn1278	http://dx.doi.org/10.1038/nn1278			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15235606				2022-12-24	WOS:000222930800019
J	Lee, SH; Simonetta, A; Sheng, M				Lee, SH; Simonetta, A; Sheng, M			Subunit rules governing the sorting of internalized AMPA receptors in hippocampal neurons	NEURON			English	Article							SYNAPTIC-TRANSMISSION; GLUR1 SUBUNIT; TRAFFICKING; DOMAIN; PHOSPHORYLATION; PLASTICITY; BINDING; LTP; DEGRADATION; REQUIREMENT	Removal of synaptic AMPA receptors is important for synaptic depression. Here, we characterize the roles of individual subunits in the inducible redistribution of AMPA receptors from the cell surface to intracellular compartments in cultured hippocampal neurons. The intracellular accumulation of GluR2 and GluR3 but not GluR1 is enhanced by AMPA, NMDA, or synaptic activity. After AMPA-induced internalization, homomeric GluR2 enters the recycling pathway, but following NMDA, GluR2 is diverted to late endosomes/lysosomes. In contrast, GluR1 remains in the recycling pathway, and GluR3 is targeted to lysosomes regardless of NMDA receptor activation. Interaction with NSF plays a role in regulated lysosomal targeting of GluR2. GluR1/GluR2 heteromeric receptors behave like GluR2 homomers, and endogenous AMPA receptors show differential activity-dependent sorting similar to homomeric GluR2. Thus, GluR2 is a key subunit that controls recycling and degradation of AMPA receptors after internalization.	MIT, RIKEN, Neurosci Res Ctr, Howard Hughes Med Inst,Picower Ctr Learning & Mem, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN	Sheng, M (corresponding author), MIT, RIKEN, Neurosci Res Ctr, Howard Hughes Med Inst,Picower Ctr Learning & Mem, Cambridge, MA 02139 USA.	msheng@mit.edu	Lee, Sang/R-7518-2019	Sheng, Morgan/0000-0002-8703-5366; Lee, Sang H./0000-0001-5467-0331	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035050] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35050] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Chung HJ, 2000, J NEUROSCI, V20, P7258; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fu J, 2003, J NEUROSCI, V23, P7592; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HUME IR, 1991, SCIENCE, V52, P81; Iwakura Y, 2001, J BIOL CHEM, V276, P40025, DOI 10.1074/jbc.M103125200; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lee SH, 2001, NEUROPHARMACOLOGY, V41, P680, DOI 10.1016/S0028-3908(01)00124-1; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Prekeris R, 1999, J NEUROSCI, V19, P10324; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	45	203	220	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 22	2004	43	2					221	236		10.1016/j.neuron.2004.06.015	http://dx.doi.org/10.1016/j.neuron.2004.06.015			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841BX	15260958	Bronze			2022-12-24	WOS:000222905400011
J	Krolak-Salmon, P; Henaff, MA; Vighetto, A; Bertrand, O; Mauguiere, F				Krolak-Salmon, P; Henaff, MA; Vighetto, A; Bertrand, O; Mauguiere, F			Early amygdala reaction to fear spreading in occipital, temporal, and frontal cortex: A depth electrode ERP study in human	NEURON			English	Article							EMOTIONAL FACIAL EXPRESSIONS; HUMAN EXTRASTRIATE CORTEX; EVENT-RELATED FMRI; FACE PERCEPTION; VISUAL-CORTEX; CONDITIONED FEAR; FRONTOTEMPORAL DEMENTIA; AFFECT RECOGNITION; PREFRONTAL CORTEX; NEURAL RESPONSE	The amygdala involvement in fear processing has been reported in behavioral, electrophysiological, and functional imaging studies. However, the literature does not provide precise data on the temporal course of facial emotional processing. Intracranial event-related potentials to facial expressions were recorded in epileptic patients implanted with depth electrodes during a presurgical evaluation. Specific potentials to fear beginning 200 ms poststimulus were observed in amygdala, both individually in two patients and in a ten patient population study. These potentials occurred 100 ms earlier than potentials to disgust recorded in insula in a previous study. Potentials to fear were confined in amygdala during a first transient period and then, during a second period of sustained activity, spread to occipito-temporal, anterior temporal, and orbitofrontal cortex in two patients. This study clarifies the temporal course of the involvement of these structures known to be part of a neural network recruited to process emotional information.	Hop Neurol, F-69003 Lyon, France; INSERM, Unite 280, F-69424 Lyon 04, France; Univ Lyon 1, Federat Neurosci Inst, F-69003 Lyon, France	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Krolak-Salmon, P (corresponding author), Hop Neurol, F-69003 Lyon, France.	pierre.krolak-salmon@chu-lyon.fr	krolak-salmon, pierre/AAV-2152-2020; Bertrand, Olivier/B-6165-2008; anand, amit/A-7222-2009	Bertrand, Olivier/0000-0003-0733-7979; MAUGUIERE, Francois/0000-0003-4291-4727				Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Anderson AK, 2003, J NEUROSCI, V23, P5627; ARMONY JL, 1995, BEHAV NEUROSCI, V109, P246, DOI 10.1037/0735-7044.109.2.246; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; BUCHANAN L, 1998, INC, V20, P9; Cain ME, 2002, J NEUROSCI, V22, P11026; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Canli T, 2000, J NEUROSCI, V20; CARRETIE L, 1995, INT J PSYCHOPHYSIOL, V19, P183, DOI 10.1016/0167-8760(95)00004-C; Critchley H, 2000, HUM BRAIN MAPP, V9, P93, DOI 10.1002/(SICI)1097-0193(200002)9:2<93::AID-HBM4>3.3.CO;2-Q; Damasio A. R., 2003, LOOKING SPINOZA JOY; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; EKMAN P, 1969, SCIENCE, V164, P86, DOI 10.1126/science.164.3875.86; Ekman P., 1976, PICTURES FACIAL AFFE; Fischer H, 2003, BRAIN RES BULL, V59, P387, DOI 10.1016/S0361-9230(02)00940-1; Fried I, 1997, NEURON, V18, P753, DOI 10.1016/S0896-6273(00)80315-3; Fried I, 2001, NAT NEUROSCI, V4, P201, DOI 10.1038/84041; Garcia R, 1999, NATURE, V402, P294, DOI 10.1038/46286; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Grossman M, 2001, NEUROLOGY, V57, P1947, DOI 10.1212/WNL.57.11.1947; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; HITCHCOCK JM, 1991, BEHAV NEUROSCI, V105, P826, DOI 10.1037/0735-7044.105.6.826; Iidaka T, 2001, J COGNITIVE NEUROSCI, V13, P1035, DOI 10.1162/089892901753294338; Ioannides AA, 2000, HUM BRAIN MAPP, V11, P77, DOI 10.1002/1097-0193(200010)11:2<77::AID-HBM20>3.0.CO;2-0; Kajiwara R, 2003, J NEUROPHYSIOL, V89, P2176, DOI 10.1152/jn.01033.2002; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kawasaki H, 2001, NAT NEUROSCI, V4, P15, DOI 10.1038/82850; Krolak-Salmon P, 2003, ANN NEUROL, V53, P446, DOI 10.1002/ana.10502; Krolak-Salmon P, 2003, ANN NEUROL, V53, P73, DOI 10.1002/ana.10403; Krolak-Salmon P, 2001, EUR J NEUROSCI, V13, P987, DOI 10.1046/j.0953-816x.2001.01454.x; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; Lange K, 2003, BIOL PSYCHIAT, V53, P226, DOI 10.1016/S0006-3223(02)01455-5; Lavenu I, 1999, ALZ DIS ASSOC DIS, V13, P96, DOI 10.1097/00002093-199904000-00007; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; Meletti S, 2003, NEUROLOGY, V60, P426, DOI 10.1212/WNL.60.3.426; Morris JS, 2001, BRAIN, V124, P1241, DOI 10.1093/brain/124.6.1241; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Munte TF, 1998, NEUROSCI RES, V30, P25, DOI 10.1016/S0168-0102(97)00118-1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pessoa L, 2002, COGNITIVE BRAIN RES, V15, P31, DOI 10.1016/S0926-6410(02)00214-8; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Rosen HJ, 2002, BRAIN, V125, P2286, DOI 10.1093/brain/awf225; Rotshtein P, 2001, NEURON, V32, P747, DOI 10.1016/S0896-6273(01)00513-X; Silver H, 2002, SCHIZOPHR RES, V55, P171, DOI 10.1016/S0920-9964(01)00208-0; Sprengelmeyer R, 1996, BRAIN, V119, P1647, DOI 10.1093/brain/119.5.1647; Stefanacci L, 2002, J COMP NEUROL, V451, P301, DOI 10.1002/cne.10339; Streit M, 1999, COGNITIVE BRAIN RES, V7, P481, DOI 10.1016/S0926-6410(98)00048-2; Streit M, 2003, NEUROSCI LETT, V342, P101, DOI 10.1016/S0304-3940(03)00274-X; Streit M, 2001, AM J PSYCHIAT, V158, P1429, DOI 10.1176/appi.ajp.158.9.1429; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; Talairach J., 1973, PROGR NEUROL SURG, V5, P297, DOI [DOI 10.1159/000394343, 10.1159/000394343]; Vuilleumier P, 2002, NEUROPSYCHOLOGIA, V40, P2156, DOI 10.1016/S0028-3932(02)00045-3; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Whalen PJ, 1998, J NEUROSCI, V18, P411; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5	71	224	228	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 27	2004	42	4					665	676		10.1016/S0896-6273(04)00264-8	http://dx.doi.org/10.1016/S0896-6273(04)00264-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157426	Bronze			2022-12-24	WOS:000221708300015
J	Tsvetkov, E; Shin, RM; Bolshakov, VY				Tsvetkov, E; Shin, RM; Bolshakov, VY			Glutamate uptake determines pathway specificity of long-term potentiation in the neural circuitry of fear conditioning	NEURON			English	Article							LATERAL AMYGDALA; SYNAPTIC TRANSMISSION; PYRAMIDAL NEURONS; FIBER SYNAPSES; NMDA RECEPTORS; PARALLEL FIBER; LTP; MEMORY; SPILLOVER; RELEASE	Long-term synaptic modifications in afferent inputs to the amygdala underlie fear conditioning in animals. Fear conditioning to a single sensory modality does not generalize to other cues, implying that synaptic modifications in fear conditioning pathways are input specific. The mechanisms of pathway specificity of long-term potentiation (LTP) are poorly understood. Here we show that inhibition of glutamate transporters leads to the loss of input specificity of LTP in the amygdala slices, as assessed by monitoring synaptic responses at two independent inputs converging on a single postsynaptic neuron. Diffusion of glutamate ("spillover") from stimulated synapses, paired with postsynaptic depolarization, is sufficient to induce LTP in the heterosynaptic pathway, whereas an enzymatic glutamate scavenger abolishes this effect. These results establish active glutamate uptake as a crucial mechanism maintaining the pathway specificity of LTP in the neural circuitry of fear conditioning.	Harvard Univ, Sch Med, Dept Psychiat, McLean Hosp, Belmont, MA 02478 USA	Harvard University; McLean Hospital	Bolshakov, VY (corresponding author), Harvard Univ, Sch Med, Dept Psychiat, McLean Hosp, 115 Mill St, Belmont, MA 02478 USA.	vadimb@mclean.harvard.edu	Tsvetkov, Evgeny/C-1085-2016; Tsvetkov, Evgeny A/B-6573-2016	Tsvetkov, Evgeny/0000-0001-9339-1677; Tsvetkov, Evgeny A/0000-0002-6784-0907	NIDA NIH HHS [DA15098] Funding Source: Medline; NINDS NIH HHS [NS44185] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA015098] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Armony JL, 1997, CEREB CORTEX, V7, P157, DOI 10.1093/cercor/7.2.157; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Barbour B, 2001, J NEUROSCI, V21, P7969, DOI 10.1523/JNEUROSCI.21-20-07969.2001; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Bauer EP, 2001, NAT NEUROSCI, V4, P687, DOI 10.1038/89465; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; Carter AG, 2000, J NEUROSCI, V20, P4423, DOI 10.1523/JNEUROSCI.20-12-04423.2000; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Cossart R, 2001, NEURON, V29, P497, DOI 10.1016/S0896-6273(01)00221-5; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Diamond JS, 1997, J NEUROSCI, V17, P4672; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Hinds HL, 2003, P NATL ACAD SCI USA, V100, P4275, DOI 10.1073/pnas.0530202100; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; Isaac JTR, 1996, P NATL ACAD SCI USA, V93, P8710, DOI 10.1073/pnas.93.16.8710; KAPP B S, 1992, P229; Kapp BS, 1984, NEUROPSYCHOLOGY MEMO, P473; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Levenson J, 2000, P NATL ACAD SCI USA, V97, P12858, DOI 10.1073/pnas.220256497; Levenson J, 2002, NAT NEUROSCI, V5, P155, DOI 10.1038/nn791; Levenson Jonathan M., 2002, Current Molecular Medicine (Hilversum), V2, P593, DOI 10.2174/1566524023362069; Mahanty NK, 1999, EUR J NEUROSCI, V11, P1217, DOI 10.1046/j.1460-9568.1999.00528.x; Maleszka R, 2000, BEHAV BRAIN RES, V115, P49, DOI 10.1016/S0166-4328(00)00235-7; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Marcaggi P, 2003, J PHYSIOL-LONDON, V552, P89, DOI 10.1113/jphysiol.2003.044263; Maren S, 1999, TRENDS NEUROSCI, V22, P561, DOI 10.1016/S0166-2236(99)01465-4; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; Mitchell SJ, 2000, NATURE, V404, P498, DOI 10.1038/35006649; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Ng KT, 1997, NEUROSCI BIOBEHAV R, V21, P45, DOI 10.1016/0149-7634(95)00079-8; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Raymond CR, 2002, J NEUROPHYSIOL, V88, P249, DOI 10.1152/jn.2002.88.1.249; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Rusakov DA, 2002, TRENDS NEUROSCI, V25, P492, DOI 10.1016/S0166-2236(02)02230-0; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; Semyanov A, 2000, NEURON, V25, P663, DOI 10.1016/S0896-6273(00)81068-5; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; Stevens CF, 1998, NEURON, V20, P1, DOI 10.1016/S0896-6273(00)80426-2; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Weisskopf MG, 1999, J NEUROPHYSIOL, V81, P930, DOI 10.1152/jn.1999.81.2.930	54	95	95	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 8	2004	41	1					139	151		10.1016/S0896-6273(03)00800-6	http://dx.doi.org/10.1016/S0896-6273(03)00800-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715141	Bronze			2022-12-24	WOS:000187942800015
J	Bai, JL; Ramos, RL; Ackman, JB; Thomas, AM; Lee, RV; LoTurco, JJ				Bai, JL; Ramos, RL; Ackman, JB; Thomas, AM; Lee, RV; LoTurco, JJ			RNAi reveals doublecortin is required for radial migration in rat neocortex	NATURE NEUROSCIENCE			English	Article							DOUBLE CORTEX SYNDROME; MICROTUBULE-ASSOCIATED PROTEIN; NEURONAL MIGRATION; CEREBRAL-CORTEX; GENE; MUTATIONS; BRAIN; PRECURSORS; CELLS	Mutations in the doublecortin gene (DCX) in humans cause malformation of the cerebral neocortex. Paradoxically, genetic deletion of Dcx in mice does not cause neocortical malformation. We used electroporation of plasmids encoding short hairpin RNA to create interference (RNAi) of DCX protein in utero, and we show that DCX is required for radial migration in developing rat neocortex. RNAi of DCX causes both cell-autonomous and non-cell autonomous disruptions in radial migration, and creates two disruptions in neocortical development. First, many neurons prematurely stop migrating to form subcortical band heterotopias within the intermediate zone and then white matter. Second, many neurons migrate into inappropriate neocortical lamina within normotopic cortex. In utero RNAi can therefore be effectively used to study the specific cellular roles of DCX in neocortical development and to produce an animal model of double cortex syndrome.	Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA	University of Connecticut	LoTurco, JJ (corresponding author), Univ Connecticut, Dept Physiol & Neurobiol, 3107 Horsebarn Hill Rd,U-4156, Storrs, CT 06269 USA.			Ackman, James/0000-0003-0802-6080; Lee, Richard/0000-0003-3386-8212	NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH056524, R01MH056524] Funding Source: NIH RePORTER; NICHD NIH HHS [HD208066] Funding Source: Medline; NIMH NIH HHS [MH056524] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bittman KS, 1999, CEREB CORTEX, V9, P188, DOI 10.1093/cercor/9.2.188; Corbo JC, 2002, J NEUROSCI, V22, P7548; des Portes V, 1998, CELL, V92, P51; Feng YY, 2001, NAT REV NEUROSCI, V2, P408, DOI 10.1038/35077559; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Gabel LA, 2001, J NEUROPHYSIOL, V85, P495, DOI 10.1152/jn.2001.85.2.495; Gleeson JG, 2000, AM J HUM GENET, V67, P574, DOI 10.1086/303043; Gleeson JG, 1999, ANN NEUROL, V45, P146, DOI 10.1002/1531-8249(199902)45:2<146::AID-ANA3>3.0.CO;2-N; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gleeson JG, 2000, ANN NEUROL, V47, P265, DOI 10.1002/1531-8249(200002)47:2<265::AID-ANA22>3.3.CO;2-E; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Horesh D, 1999, HUM MOL GENET, V8, P1599, DOI 10.1093/hmg/8.9.1599; Kato M, 2003, HUM MOL GENET, V12, pR89, DOI 10.1093/hmg/ddg086; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Marin-Padilla M, 1999, REV NEUROLOGIA, V29, P208, DOI 10.33588/rn.2903.99148; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; Takahashi M, 2002, DIFFERENTIATION, V70, P155, DOI 10.1046/j.1432-0436.2002.700405.x; Walsh CA, 2000, CURR OPIN GENET DEV, V10, P270, DOI 10.1016/S0959-437X(00)00076-9; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499	22	428	443	0	15	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1277	1283		10.1038/nn1153	http://dx.doi.org/10.1038/nn1153			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	746BC	14625554				2022-12-24	WOS:000186725600012
J	Molko, N; Cachia, A; Riviere, D; Mangin, JF; Bruandet, M; Le Bihan, D; Cohen, L; Dehaene, S				Molko, N; Cachia, A; Riviere, D; Mangin, JF; Bruandet, M; Le Bihan, D; Cohen, L; Dehaene, S			Functional and structural alterations of the intraparietal sulcus in a developmental dyscalculia of genetic origin	NEURON			English	Article							VOXEL-BASED MORPHOMETRY; FRAGILE-X-SYNDROME; TURNERS-SYNDROME; HUMAN-BRAIN; WHITE-MATTER; LANGUAGE; REPRESENTATION; NUMBERS; CORTEX; ABNORMALITIES	Cognitive theories of numerical representation suggest that understanding of numerical quantities is driven by a magnitude representation associated with the intraparietal sulcus and possibly under genetic control. The aim of this study was to investigate, using fMRI and structural imaging, the interaction between the abnormal development of numerical representation in an X-linked condition, Turner syndrome (TS), and the development of the intraparietal sulcus. fMRI during exact and approximate calculation in TS showed an abnormal modulation of intraparietal activations as a function of number size. Morphological analysis revealed an abnormal length, depth, and sulcal geometry of the right intraparietal sulcus, suggesting an important disorganization of this region in TS. Thus, a genetic form of developmental dyscalculia can be related to both functional and structural anomalies of the right intraparietal sulcus, suggesting a crucial role of this region in the development of arithmetic abilities.	Hop La Pitie Salpetriere, INSERM, U562, Paris, France; Hop La Pitie Salpetriere, Unite Neuroactivat Fonctionnelle, Paris, France; INSERM, ERM 0205, Serv Hosp Freder Joliot, CEA DSV,IFR 49, Orsay, France; Hop La Pitie Salpetriere, Serv Neurol 1, IFR 49, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Molko, N (corresponding author), Hop La Pitie Salpetriere, INSERM, U562, Paris, France.	molko@wanadoo.fr	Mangin, Jean-Francois/AAI-8983-2020	cohen, laurent/0000-0002-5010-9085; Cachia, Arnaud/0000-0003-2125-4985				ALEXANDER D, 1966, NEUROPSYCHOLOGIA, V4, P265, DOI 10.1016/0028-3932(66)90032-7; ARMSTRONG E, 1995, CEREB CORTEX, V5, P56, DOI 10.1093/cercor/5.1.56; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Barnea-Goraly N, 2003, AM J MED GENET B, V118B, P81, DOI 10.1002/ajmg.b.10035; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Brown WE, 2002, PSYCHIAT RES-NEUROIM, V116, P187, DOI 10.1016/S0925-4927(02)00086-0; BRUANDET M, 2003, IN PRESS NEUROPSYCHO; Cappelletti M, 2001, NEUROPSYCHOLOGIA, V39, P1224, DOI 10.1016/S0028-3932(01)00035-5; CHI JG, 1977, ANN NEUROL, V1, P86, DOI 10.1002/ana.410010109; Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; CIPOLOTTI L, 1991, BRAIN, V114, P2619, DOI 10.1093/brain/114.6.2619; CLARK C, 1990, CAN J NEUROL SCI, V17, P140, DOI 10.1017/S0317167100030341; Dehaene S, 1997, CORTEX, V33, P219, DOI 10.1016/S0010-9452(08)70002-9; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; DEHAENE S, 2003, IN PRESS COGN NEUROP; Dehaene S., 1995, MATH COGNITION, V1, P83, DOI DOI 10.1155/2014/461647; Dehay C, 1996, J COMP NEUROL, V367, P70, DOI 10.1002/(SICI)1096-9861(19960325)367:1<70::AID-CNE6>3.0.CO;2-G; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; Eliez S, 2001, ARCH GEN PSYCHIAT, V58, P64, DOI 10.1001/archpsyc.58.1.64; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; Fryer SL, 2003, DEV MED CHILD NEUROL, V45, P320, DOI 10.1017/S0012162203000604; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gruber O, 2001, CEREB CORTEX, V11, P350, DOI 10.1093/cercor/11.4.350; Isaacs EB, 2001, BRAIN, V124, P1701, DOI 10.1093/brain/124.9.1701; JACKSON M, 1986, CORTEX, V22, P611, DOI 10.1016/S0010-9452(86)80020-X; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; KOSC L, 1974, J LEARN DISABIL, V7, P164, DOI 10.1177/002221947400700309; Langdon D W, 1997, J Int Neuropsychol Soc, V3, P260; LeFevre J, 1996, J EXP PSYCHOL LEARN, V22, P216, DOI 10.1037/0278-7393.22.1.216; Levy LM, 1999, NEUROLOGY, V53, P639, DOI 10.1212/WNL.53.3.639; Mangin J.-F., 1995, Journal of Mathematical Imaging and Vision, V5, P297, DOI 10.1007/BF01250286; MURPHY DGM, 1993, LANCET, V342, P1197, DOI 10.1016/0140-6736(93)92184-U; Murphy DGM, 1997, BIOL PSYCHIAT, V41, P285, DOI 10.1016/S0006-3223(95)00660-5; Naccache L, 2002, PSYCHOL SCI, V13, P416, DOI 10.1111/1467-9280.00474; Olson EC, 2002, CURR OPIN GENET DEV, V12, P320, DOI 10.1016/S0959-437X(02)00305-2; Pallier C, 1997, BEHAV RES METH INS C, V29, P322, DOI 10.3758/BF03200583; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Pesenti M, 2000, J COGNITIVE NEUROSCI, V12, P461, DOI 10.1162/089892900562273; PIAZZA M, 2002, QUANTIFYING BRAIN FU; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Ranke MB, 2001, LANCET, V358, P309, DOI 10.1016/S0140-6736(01)05487-3; Reiss AL, 2000, MENT RETARD DEV D R, V6, P186, DOI 10.1002/1098-2779(2000)6:3<186::AID-MRDD6>3.0.CO;2-9; REISS AL, 1995, ANN NEUROL, V38, P731, DOI 10.1002/ana.410380507; Rivera SM, 2002, HUM BRAIN MAPP, V16, P206, DOI 10.1002/hbm.10048; Riviere D, 2002, MED IMAGE ANAL, V6, P77, DOI 10.1016/S1361-8415(02)00052-X; Ross J, 2000, MENT RETARD DEV D R, V6, P135, DOI 10.1002/1098-2779(2000)6:2<135::AID-MRDD8>3.0.CO;2-K; ROVET J, 1994, J CLIN EXP NEUROPSYC, V16, P820, DOI 10.1080/01688639408402696; SHAYWITZ BA, 1995, NATURE, V373, P607, DOI 10.1038/373607a0; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; Stanescu-Cosson R, 2000, BRAIN, V123, P2240, DOI 10.1093/brain/123.11.2240; Temple CM, 1998, DEV NEUROPSYCHOL, V14, P47, DOI 10.1080/87565649809540700; Temple CM, 2002, Q J EXP PSYCHOL-A, V55, P733, DOI 10.1080/02724980143000550; Thompson PM, 2000, HUM BRAIN MAPP, V9, P81, DOI 10.1002/(SICI)1097-0193(200002)9:2<81::AID-HBM3>3.0.CO;2-8; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Watkins KE, 2002, BRAIN, V125, P465, DOI 10.1093/brain/awf057; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a	60	262	269	2	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 13	2003	40	4					847	858		10.1016/S0896-6273(03)00670-6	http://dx.doi.org/10.1016/S0896-6273(03)00670-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	744UL	14622587	Bronze, Green Published			2022-12-24	WOS:000186651200018
J	Dragoi, G; Harris, KD; Buzsaki, G				Dragoi, G; Harris, KD; Buzsaki, G			Place representation within hippocampal networks is modified by long-term potentiation	NEURON			English	Article							WATER MAZE; SYNAPTIC ENHANCEMENT; PYRAMIDAL CELLS; UNIT-ACTIVITY; NEURONS; MEMORY; PLASTICITY; RAT; TASK; NEUROSCIENCE	In the brain, information is encoded by the firing patterns of neuronal ensembles and the strength of synaptic connections between individual neurons. We report here that representation of the environment by "place" cells is altered by changing synaptic weights within hippocampal networks. Long-term potentiation (LTP) of intrinsic hippocampal pathways abolished existing place fields, created new place fields, and rearranged the temporal relationship within the affected population. The effect of LTP on neuron discharge was rate and context dependent. The LTP-induced "remapping" occurred without affecting the global firing rate of the network. The findings support the view that learned place representation can be accomplished by LTP-like synaptic plasticity within intrahippocampal networks.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.		Harris, Kenneth/B-3469-2009	Harris, Kenneth/0000-0002-5930-6456; Buzsaki, Gyorgy/0000-0002-3100-4800				BARNES CA, 1994, J NEUROSCI, V14, P5793; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brun VH, 2001, J NEUROSCI, V21, P356, DOI 10.1523/JNEUROSCI.21-01-00356.2001; BUZSAKI G, 1982, BRAIN RES, V237, P283, DOI 10.1016/0006-8993(82)90442-5; CAIN DP, 1993, HIPPOCAMPUS, V3, P153, DOI 10.1002/hipo.450030208; CASTRO CA, 1989, NATURE, V342, P545, DOI 10.1038/342545a0; CHAVEZNORIEGA LE, 1990, EXP BRAIN RES, V79, P633; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; DEADWYLER SA, 1976, BRAIN RES BULL, V1, P1, DOI 10.1016/0361-9230(76)90043-5; FREGNAC Y, 1988, NATURE, V333, P367, DOI 10.1038/333367a0; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hirase H, 2001, P NATL ACAD SCI USA, V98, P9386, DOI 10.1073/pnas.161274398; JEFFERY KJ, 1993, HIPPOCAMPUS, V3, P133, DOI 10.1002/hipo.450030205; Kandel ER, 2000, SCIENCE, V290, P1113, DOI 10.1126/science.290.5494.1113; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Kimura A, 2000, J NEUROPHYSIOL, V84, P1894, DOI 10.1152/jn.2000.84.4.1894; KOROL DL, 1993, HIPPOCAMPUS, V3, P127, DOI 10.1002/hipo.450030204; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; LEVY WB, 1979, BRAIN RES, V175, P233, DOI 10.1016/0006-8993(79)91003-5; LYNCH GS, 1977, NATURE, V266, P737, DOI 10.1038/266737a0; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; Martin PD, 2000, HIPPOCAMPUS, V10, P207, DOI 10.1002/1098-1063(2000)10:3<207::AID-HIPO1>3.0.CO;2-S; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MCNAMARA RK, 1993, HIPPOCAMPUS, V3, P149, DOI 10.1002/hipo.450030207; McNaughton BL, 1996, J EXP BIOL, V199, P173; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Muller RU, 1996, J GEN PHYSIOL, V107, P663, DOI 10.1085/jgp.107.6.663; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; TAUBE JS, 1988, J NEUROSCI, V8, P1632; THOMPSON LT, 1990, BRAIN RES, V509, P299, DOI 10.1016/0006-8993(90)90555-P; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	46	147	152	1	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 28	2003	39	5					843	853		10.1016/S0896-6273(03)00465-3	http://dx.doi.org/10.1016/S0896-6273(03)00465-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	717GN	12948450	Bronze			2022-12-24	WOS:000185079300013
J	Butt, SJB; Kiehn, O				Butt, SJB; Kiehn, O			Functional identification of Interneurons responsible for left-right coordination of hindlimbs in mammals	NEURON			English	Article							ISOLATED SPINAL-CORD; CENTRAL PATTERN GENERATORS; IN-VITRO; COMMISSURAL INTERNEURONS; SYNAPTIC-TRANSMISSION; SINGLE INTERNEURONS; LOCOMOTOR-ACTIVITY; NEURONAL IDENTITY; NETWORKS; POTENTIALS	Local neuronal networks that are responsible for walking are poorly characterized in mammals. Using an innovative approach to identify interneuron inputs onto motorneuron populations in a neonatal rodent spinal cord preparation, we have investigated the network responsible for left-right coordination of the hindlimbs. We demonstrate how commissural interneurons (CINs), whose axons traverse the midline to innervate contralateral neurons, are organized such that distinct flexor and extensor centers in the rostral lumbar spinal cord define activity in both flexor and extensor caudal motor pools. In addition, the nature of some connections are reconfigured on switching from rest to locomotion via a mechanism that might be associated with synaptic plasticity in the spinal cord. These results from identified pattern-generating interneurons demonstrate how interneuron populations create an effective network to underlie behavior in mammals.	Karolinska Inst, Dept Neurosci, Mammalian Locomotor Lab, S-17177 Stockholm, Sweden	Karolinska Institutet	Kiehn, O (corresponding author), Karolinska Inst, Dept Neurosci, Mammalian Locomotor Lab, Retzius 8, S-17177 Stockholm, Sweden.	ole.kiehn@neuro.ki.se	kiehn, ole/AAB-1262-2019; Kiehn, Ole/C-4679-2008; Butt, Simon/I-2689-2019; kiehn, ole/AAT-7881-2021	Butt, Simon/0000-0002-2399-0102; Kiehn, Ole/0000-0002-5954-469X				ALFORD S, 1991, EUR J NEUROSCI, V3, P107, DOI 10.1111/j.1460-9568.1991.tb00071.x; Bertrand S, 1999, EUR J NEUROSCI, V11, P583, DOI 10.1046/j.1460-9568.1999.00473.x; Bertrand S, 2002, EUR J NEUROSCI, V16, P1741, DOI 10.1046/j.1460-9568.2002.02233.x; Birinyi A, 2003, J COMP NEUROL, V461, P429, DOI 10.1002/cne.10696; Bracci E, 1996, J NEUROSCI, V16, P7063; Bracci E, 1998, J NEUROPHYSIOL, V79, P2643, DOI 10.1152/jn.1998.79.5.2643; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; BRINK E, 1981, BRAIN RES, V223, P165, DOI 10.1016/0006-8993(81)90817-9; BRINK E, 1983, J PHYSIOL-LONDON, V343, P341, DOI 10.1113/jphysiol.1983.sp014896; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; BUCHANAN JT, 1995, J NEUROPHYSIOL, V73, P80, DOI 10.1152/jn.1995.73.1.80; Butt SJB, 2002, J NEUROSCI, V22, P9961; CAZALETS JR, 1992, J PHYSIOL-LONDON, V455, P187, DOI 10.1113/jphysiol.1992.sp019296; DALE N, 1985, J PHYSIOL-LONDON, V363, P61, DOI 10.1113/jphysiol.1985.sp015695; Eide AL, 1999, J COMP NEUROL, V403, P332; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Goulding M, 2002, CURR OPIN NEUROBIOL, V12, P508, DOI 10.1016/S0959-4388(02)00371-9; Grillner S, 1998, ANN NY ACAD SCI, V860, P1, DOI 10.1111/j.1749-6632.1998.tb09035.x; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; Hultborn H, 1998, ANN NY ACAD SCI, V860, P70, DOI 10.1111/j.1749-6632.1998.tb09039.x; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jiang ZY, 1999, BRAIN RES, V816, P493, DOI 10.1016/S0006-8993(98)01199-8; Kaprielian Z, 2001, DEV DYNAM, V221, P154, DOI 10.1002/dvdy.1143; Kiehn O, 1996, J NEUROPHYSIOL, V75, P1472, DOI 10.1152/jn.1996.75.4.1472; Kiehn O, 1998, ANN NY ACAD SCI, V860, P110, DOI 10.1111/j.1749-6632.1998.tb09043.x; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; KUDO N, 1987, NEUROSCI LETT, V75, P43, DOI 10.1016/0304-3940(87)90072-3; KUDO N, 1987, J PHYSIOL-LONDON, V389, P441, DOI 10.1113/jphysiol.1987.sp016665; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; LEVTOV A, 1992, J PHYSIOL-LONDON, V447, P149, DOI 10.1113/jphysiol.1992.sp018996; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Machacek DW, 2001, J PHYSIOL-LONDON, V537, P201, DOI 10.1111/j.1469-7793.2001.0201k.x; Marder E, 2002, NEURAL NETWORKS, V15, P479, DOI 10.1016/S0893-6080(02)00043-6; MASON A, 1991, J NEUROSCI, V11, P72; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; NICOLOPOULOSSTOURNARAS S, 1983, J COMP NEUROL, V217, P75, DOI 10.1002/cne.902170107; Parker D, 1999, J NEUROSCI, V19, P1647; Raastad M, 2000, J NEUROPHYSIOL, V83, P2825, DOI 10.1152/jn.2000.83.5.2825; Roberts A, 2000, BRAIN RES BULL, V53, P585, DOI 10.1016/S0361-9230(00)00392-0; SAMUELS ML, 1991, STAT LIFE SCI; Sharma K, 2001, NEURON, V29, P321, DOI 10.1016/S0896-6273(01)00208-2; SMITH JC, 1987, J NEUROSCI METH, V21, P321, DOI 10.1016/0165-0270(87)90126-9; SOFFE SR, 1984, J NEUROPHYSIOL, V51, P1257, DOI 10.1152/jn.1984.51.6.1257; Stein P. S. G., 1997, NEURONS NETWORKS MOT; Stokke MF, 2002, J COMP NEUROL, V446, P349, DOI 10.1002/cne.10211; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tresch MC, 1999, J NEUROPHYSIOL, V82, P3563, DOI 10.1152/jn.1999.82.6.3563; Tresch MC, 2000, NAT NEUROSCI, V3, P593, DOI 10.1038/75768; Wenner P, 2000, J NEUROPHYSIOL, V84, P2651, DOI 10.1152/jn.2000.84.5.2651; Wenner P, 1999, J NEUROSCI, V19, P7557, DOI 10.1523/JNEUROSCI.19-17-07557.1999; Wolpaw JR, 1997, TRENDS NEUROSCI, V20, P588, DOI 10.1016/S0166-2236(97)01133-8; Yu YJ, 2001, NAT REV GENET, V2, P780, DOI 10.1038/35093564	54	168	171	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 19	2003	38	6					953	963		10.1016/S0896-6273(03)00353-2	http://dx.doi.org/10.1016/S0896-6273(03)00353-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	693AA	12818180	Bronze			2022-12-24	WOS:000183691400014
J	Wang, QH; Liu, LD; Pei, L; Ju, W; Ahmadian, G; Lu, J; Wang, YS; Liu, F; Wang, YT				Wang, QH; Liu, LD; Pei, L; Ju, W; Ahmadian, G; Lu, J; Wang, YS; Liu, F; Wang, YT			Control of synaptic strength, a novel function of Akt	NEURON			English	Article							LONG-TERM POTENTIATION; CULTURED HIPPOCAMPAL-NEURONS; DEPENDENT PROTEIN-KINASE; RECEPTOR-BETA SUBUNITS; GABA(A) RECEPTORS; TYROSINE PHOSPHORYLATION; PHOSPHATIDYLINOSITOL 3-KINASE; INHIBITORY SYNAPSES; MEMBRANE INSERTION; A RECEPTORS	Akt (also known as PKB), a serine/threonine kinase involved in diverse signal-transduction pathways, is highly expressed in the brain. Akt is known to have a strong antiapoptotic action and thereby to be critically involved in neuronal survival, but its potential role in the dynamic modulation of synaptic transmission is unknown. Here we report that Akt phosphorylates, both in vitro and in vivo, the type A gamma-aminobutyric acid receptor (GABA(A)R), the principal receptor mediating fast inhibitory synaptic transmission in the mammalian brain. Akt-mediated phosphorylation increases the number of GABA(A)Rs on the plasma membrane surface, thereby increasing the receptor-mediated synaptic transmission in neurons. These results identify the GABAAR as a novel substrate of Akt, thereby linking Akt to the regulation of synaptic strength. This work also provides evidence for the rapid regulation of neurotransmitter receptor numbers in the postsynaptic domain by direct receptor phosphorylation as an important means of producing synaptic plasticity.	Univ Toronto, Hosp Sick Children, Inst Res, Prgramme Brain & Behav Res, Toronto, ON M5G 1X8, Canada; Univ British Columbia, Vancouver Hosp & Hlth Sci Ctr, Dept Med, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; Univ Toronto, Clarke Div, Ctr Addict & Mental Hlth, Dept Neurosci, Toronto, ON M5T 1R8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of British Columbia; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Wang, YT (corresponding author), Univ Toronto, Hosp Sick Children, Inst Res, Prgramme Brain & Behav Res, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.		Wang, Yu Tian/J-8255-2015; Wang, Yu Tian/A-4729-2008	Liu, Lidong/0000-0002-7026-690X				Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; Bhave SV, 1999, J NEUROSCI, V19, P3277, DOI 10.1523/jneurosci.19-09-03277.1999; Blair LAC, 1997, NEURON, V19, P421, DOI 10.1016/S0896-6273(00)80950-2; Blair LAC, 1999, J NEUROSCI, V19, P1940; Brandon NJ, 2000, J BIOL CHEM, V275, P38856, DOI 10.1074/jbc.M004910200; Coffer PJ, 1998, BIOCHEM J, V335, P1; Connolly CN, 1996, P NATL ACAD SCI USA, V93, P9899, DOI 10.1073/pnas.93.18.9899; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Eghbali M, 1997, NATURE, V388, P71, DOI 10.1038/40404; Gorrie GH, 1997, J NEUROSCI, V17, P6587; HOPFIELD JF, 1988, NATURE, V336, P677, DOI 10.1038/336677a0; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kelly A, 2000, NEUROPHARMACOLOGY, V39, P643, DOI 10.1016/S0028-3908(99)00169-0; Kittler JT, 2000, J NEUROSCI, V20, P7972; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; Lhuillier L, 2002, J NEUROPHYSIOL, V88, P954, DOI 10.1152/jn.2002.88.2.954; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; MacDonald R L, 1992, Ion Channels, V3, P315; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; McDonald BJ, 1997, NEUROPHARMACOLOGY, V36, P1377, DOI 10.1016/S0028-3908(97)00111-1; McDonald BJ, 1998, NAT NEUROSCI, V1, P23, DOI 10.1038/223; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; Morisco C, 2000, J BIOL CHEM, V275, P14466, DOI 10.1074/jbc.275.19.14466; MOSS SJ, 1995, NATURE, V377, P344, DOI 10.1038/377344a0; MOSS SJ, 1992, SCIENCE, V257, P661, DOI 10.1126/science.1323140; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; PEREZVELAZQUEZ JL, 1993, NATURE, V361, P457, DOI 10.1038/361457a0; Sanna PP, 2002, J NEUROSCI, V22, P3359; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; Wan Q, 1997, J NEUROSCI, V17, P5062; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Wang YT, 1996, P NATL ACAD SCI USA, V93, P1721, DOI 10.1073/pnas.93.4.1721; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147	43	202	208	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 19	2003	38	6					915	928		10.1016/S0896-6273(03)00356-8	http://dx.doi.org/10.1016/S0896-6273(03)00356-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	693AA	12818177	Bronze			2022-12-24	WOS:000183691400011
J	Yamashita, T; Tohyama, M				Yamashita, T; Tohyama, M			The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI	NATURE NEUROSCIENCE			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; BINDING PROTEIN-RHO; DISSOCIATION INHIBITOR; NOGO RECEPTOR; DEATH DOMAIN; AXON GROWTH; NEUROTROPHIN; P75(NTR); MYELIN; IDENTIFICATION	The neurotrophin receptor p75(NTR) is involved in the regulation of axonal elongation by neurotrophins as well as several myelin components, including Nogo, myelin-associated glycoprotein (MAG) and myelin oligodendrocyte glycoprotein (OMgp). Neurotrophins stimulate neurite outgrowth by inhibiting Rho activity, whereas myelin-derived proteins activate RhoA and thereby inhibit growth. Here we show that direct interaction of the Rho GDP dissociation inhibitor (Rho-GDI) with p75(NTR) initiates the activation of RhoA, and this interaction between p75(NTR) and Rho-GDI is strengthened by MAG or Nogo. We also found that p75(NTR) facilitates the release of prenylated RhoA from Rho-GDI. The peptide ligand that is associated with the fifth alpha helix of p75(NTR) inhibits the interaction between Rho-GDI and p75(NTR), thus silencing the action mediated by p75(NTR). This peptide has potential as a therapeutic agent against the inhibitory cues that block regeneration in the central nervous system.	Osaka Univ, Dept Anat & Neurosci, Grad Sch Med, Osaka 5650871, Japan; CREST, Kawaguchi 3320012, Japan	Osaka University; Japan Science & Technology Agency (JST)	Yamashita, T (corresponding author), Osaka Univ, Dept Anat & Neurosci, Grad Sch Med, 2-2 Yamadaoka, Osaka 5650871, Japan.	tyama@anat2.med.osaka-u.ac.jp		Yamashita, Toshihide/0000-0003-4559-7018				Bentley CA, 2000, J NEUROSCI, V20, P7706; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; Davies AM, 2000, CURR BIOL, V10, pR198, DOI 10.1016/S0960-9822(00)00351-1; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; FEINSTEIN DL, 1990, FEBS LETT, V272, P7, DOI 10.1016/0014-5793(90)80437-N; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; Ilag LL, 1999, BIOCHEM BIOPH RES CO, V255, P104, DOI 10.1006/bbrc.1999.0101; KOCH G, 1991, FEBS LETT, V291, P336, DOI 10.1016/0014-5793(91)81315-Y; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; MASUDA T, 1994, J BIOL CHEM, V269, P19713; McQuillen PS, 2002, J NEUROSCI, V22, P3580; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Sasaki T, 1998, BIOCHEM BIOPH RES CO, V245, P641, DOI 10.1006/bbrc.1998.8253; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730; Walsh GS, 1999, J NEUROSCI, V19, P4155; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; YAKU H, 1994, BIOCHEM BIOPH RES CO, V198, P811, DOI 10.1006/bbrc.1994.1116; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9	28	364	379	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					461	467		10.1038/nn1045	http://dx.doi.org/10.1038/nn1045			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12692556				2022-12-24	WOS:000182553200012
J	Staropoli, JF; McDermott, C; Martinat, C; Schulman, B; Demireva, E; Abeliovich, A				Staropoli, JF; McDermott, C; Martinat, C; Schulman, B; Demireva, E; Abeliovich, A			Parkin is a component of an SCF-like ubipuitin ligase complex and protects postmitotic neurons from kainate excitotoxicity	NEURON			English	Article							CYCLIN-DEPENDENT KINASES; ALPHA-SYNUCLEIN; CELL-DEATH; UBIQUITIN; DISEASE; DEGRADATION; PROTEINS; PATHWAY; APOPTOSIS; PROTEOLYSIS	Mutations in parkin, which encodes a RING domain protein associated with ubiquitin ligase activity, lead to autosomal recessive Parkinson's disease characterized by midbrain dopamine neuron loss. Here we show that parkin functions in a multiprotein ubiquitin ligase complex that includes the F-box/WD repeat protein hSel-10 and Cullin-1. HSel-10 serves to target the parkin ubiquitin ligase activity to cyclin E, an hSel-10-interacting protein previously implicated in the regulation of neuronal apoptosis. Consistent with the notion that cyclin E is a substrate of the parkin ubiquitin ligase complex, parkin deficiency potentiates the accumulation of cyclin E in cultured postmitotic neurons exposed to the glutamatergic excitotoxin kainate and promotes their apoptosis. Furthermore, parkin overexpression attenuates the accumulation of cyclin E in toxin-treated primary neurons, including midbrain dopamine neurons, and protects them from apoptosis.	Columbia Univ Coll Phys & Surg, Taub Inst, Ctr Neurobiol & Behav, Dept Pathol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Taub Inst, Ctr Neurobiol & Behav, Dept Neurol, New York, NY 10032 USA; St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA	Columbia University; Columbia University; St Jude Children's Research Hospital	Abeliovich, A (corresponding author), Columbia Univ Coll Phys & Surg, Taub Inst, Ctr Neurobiol & Behav, Dept Pathol, 15-403,630 W 168th St, New York, NY 10032 USA.	aa900@columbia.edu	Martinat, Cécile S/F-6777-2010	Martinat, Cécile S/0000-0002-5234-1064				Alves-Rodrigues A, 1998, TRENDS NEUROSCI, V21, P516, DOI 10.1016/S0166-2236(98)01276-4; Burke RE, 1998, ANN NEUROL, V44, pS126, DOI 10.1002/ana.410440719; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chung KKK, 2001, TRENDS NEUROSCI, V24, pS7, DOI 10.1016/S0166-2236(00)01998-6; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Copani A, 2001, TRENDS NEUROSCI, V24, P25, DOI 10.1016/S0166-2236(00)01663-5; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; Dong XZ, 1999, GENE DEV, V13, P954, DOI 10.1101/gad.13.8.954; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; FALLON L, 2001, J BIOL CHEM, V25, P25; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Husseman JW, 2000, NEUROBIOL AGING, V21, P815, DOI 10.1016/S0197-4580(00)00221-9; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Krichevsky AM, 2002, P NATL ACAD SCI USA, V99, P11926, DOI 10.1073/pnas.182272699; Kubo S, 2001, J NEUROCHEM, V78, P42, DOI 10.1046/j.1471-4159.2001.00364.x; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Liu DX, 2001, CELL TISSUE RES, V305, P217, DOI 10.1007/s004410100396; Lotharius J, 1999, J NEUROSCI, V19, P1284; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Neystat M, 2001, J NEUROCHEM, V77, P1611, DOI 10.1046/j.1471-4159.2001.00376.x; Nirenberg MJ, 1996, J NEUROSCI, V16, P436; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Padmanabhan J, 1999, J NEUROSCI, V19, P8747, DOI 10.1523/JNEUROSCI.19-20-08747.1999; Park DS, 1998, J CELL BIOL, V143, P457, DOI 10.1083/jcb.143.2.457; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Raina AK, 2000, J NEUROSCI RES, V61, P128, DOI 10.1002/1097-4547(20000715)61:2<128::AID-JNR2>3.3.CO;2-8; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schlossmacher MG, 2002, AM J PATHOL, V160, P1655, DOI 10.1016/S0002-9440(10)61113-3; Schulz JB, 1997, MOL CELL BIOCHEM, V174, P193, DOI 10.1023/A:1006852306789; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Takada M, 2000, EUR J NEUROSCI, V12, P1771, DOI 10.1046/j.1460-9568.2000.00062.x; Troy CM, 2001, J NEUROSCI, V21, P5007, DOI 10.1523/JNEUROSCI.21-14-05007.2001; Verdaguer E, 2002, NEUROREPORT, V13, P413, DOI 10.1097/00001756-200203250-00010; Winston JT, 1999, GENE DEV, V13, P2751, DOI 10.1101/gad.13.21.2751; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Wu GY, 1998, P NATL ACAD SCI USA, V95, P15787, DOI 10.1073/pnas.95.26.15787; Zennou V, 2001, NAT BIOTECHNOL, V19, P446, DOI 10.1038/88115; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	59	311	324	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 6	2003	37	5					735	749		10.1016/S0896-6273(03)00084-9	http://dx.doi.org/10.1016/S0896-6273(03)00084-9			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	653TH	12628165	Bronze			2022-12-24	WOS:000181452800004
J	Priebe, NJ; Mechler, F; Carandini, M; Ferster, D				Priebe, NJ; Mechler, F; Carandini, M; Ferster, D			The contribution of spike threshold to the dichotomy of cortical simple and complex cells	NATURE NEUROSCIENCE			English	Article							CAT VISUAL-CORTEX; MONKEY STRIATE CORTEX; RECEPTIVE-FIELDS; ORIENTATION SELECTIVITY; FUNCTIONAL ARCHITECTURE; FREQUENCY-SELECTIVITY; SYNAPTIC INTEGRATION; CONTRAST INVARIANCE; IN-VIVO; AREA 17	The existence of two classes of cells, simple and complex, discovered by Hubel and Wiesel in 1962, is one of the fundamental features of cat primary visual cortex. A quantitative measure used to distinguish simple and complex cells is the ratio between modulated and unmodulated components of spike responses to drifting gratings, an index that forms a bimodal distribution. We have found that the modulation ratio, when derived from the subthreshold membrane potential instead of from spike rate, is unimodally distributed, but highly skewed. The distribution of the modulation ratio as derived from spike rate can, in turn, be predicted quantitatively by the nonlinear properties of spike threshold applied to the skewed distribution of the subthreshold modulation ratio. Threshold also increases the spatial segregation of ON and OFF regions of the receptive field, a defining attribute of simple cells. The distinction between simple and complex cells is therefore enhanced by threshold, much like the selectivity for stimulus features such as orientation and direction. In this case, however, a continuous distribution in the spatial organization of synaptic inputs is transformed into two distinct classes of cells.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Cornell Univ, Coll Med, Dept Neurol & Neurosci, New York, NY 10021 USA; Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA	Northwestern University; Cornell University; The Smith-Kettlewell Eye Research Institute	Ferster, D (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2205 Tech Dr, Evanston, IL 60208 USA.	ferster@northwestern.edu	Carandini, Matteo/ABD-8296-2021; Carandini, Matteo/C-1922-2008	Carandini, Matteo/0000-0003-4880-7682; Carandini, Matteo/0000-0003-4880-7682	NATIONAL EYE INSTITUTE [R01EY009314] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY009314-10, R01 EY009314] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Carandini M, 1996, J NEUROPHYSIOL, V76, P3425, DOI 10.1152/jn.1996.76.5.3425; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Conway BR, 2003, J NEUROPHYSIOL, V89, P2726, DOI 10.1152/jn.00550.2002; DEAN AF, 1983, J PHYSIOL-LONDON, V344, P305, DOI 10.1113/jphysiol.1983.sp014941; DEVALOIS RL, 1980, ANNU REV PSYCHOL, V31, P309, DOI 10.1146/annurev.ps.31.020180.001521; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; FERSTER D, 1983, J PHYSIOL-LONDON, V342, P181, DOI 10.1113/jphysiol.1983.sp014846; FOSTER KH, 1985, J PHYSIOL-LONDON, V365, P331, DOI 10.1113/jphysiol.1985.sp015776; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; GLEZER VD, 1982, BIOL CYBERN, V43, P35, DOI 10.1007/BF00337286; GLEZER VD, 1980, BIOL CYBERN, V37, P195, DOI 10.1007/BF00337038; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; HEGGELUND P, 1986, J PHYSIOL-LONDON, V373, P277, DOI 10.1113/jphysiol.1986.sp016047; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Hirsch JA, 2002, J PHYSIOL-LONDON, V540, P335, DOI 10.1113/jphysiol.2001.012777; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jagadeesh B, 1997, J NEUROPHYSIOL, V78, P2772, DOI 10.1152/jn.1997.78.5.2772; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Kagan I, 2002, J NEUROPHYSIOL, V88, P2557, DOI 10.1152/jn.00858.2001; Lampl I, 2001, NEURON, V30, P263, DOI 10.1016/S0896-6273(01)00278-1; Martinez LM, 2001, NEURON, V32, P515, DOI 10.1016/S0896-6273(01)00489-5; MATA ML, IN PRESS J NEUROPHYS; Mechler F, 2002, VISION RES, V42, P1017, DOI 10.1016/S0042-6989(02)00025-1; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; REID RC, 1991, J NEUROPHYSIOL, V66, P505, DOI 10.1152/jn.1991.66.2.505; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Sokal R. R., 2012, BIOMETRY; SPITZER H, 1988, PROG NEUROBIOL, V31, P285, DOI 10.1016/0301-0082(88)90016-0; Tao L, 2004, P NATL ACAD SCI USA, V101, P366, DOI 10.1073/pnas.2036460100; Volgushev M, 1996, J PHYSIOL-LONDON, V496, P597, DOI 10.1113/jphysiol.1996.sp021711	46	163	164	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1113	1122		10.1038/nn1310	http://dx.doi.org/10.1038/nn1310			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15338009	Green Accepted			2022-12-24	WOS:000224156900021
J	Chklovskii, DB				Chklovskii, DB			Synaptic connectivity and neuronal morphology: Viewpoint two sides of the same coin	NEURON			English	Editorial Material							LENGTH MINIMIZATION APPROACH; MAMMALIAN VISUAL-CORTEX; CENTRAL-NERVOUS-SYSTEM; DENDRITIC SPINES; CORTICAL AREAS; COMPONENT PLACEMENT; PYRAMIDAL NEURONS; CEREBRAL-CORTEX; GANGLION-CELLS; RAT NEOCORTEX	Neurons often possess elaborate axonal and dendritic arbors. Why do these arbors exist and what determines their form and dimensions? To answer these questions, I consider the wiring up of a large highly interconnected neuronal network, such as the cortical column. Implementation of such a network in the allotted volume requires all the salient features of neuronal morphology: the existence of branching dendrites and axons and the presence of dendritic spines. Therefore, the requirement of high interconnectivity is, in itself, sufficient to account for the existence of these features. Moreover, the actual lengths of axons and dendrites are close to the smallest possible length for a given interconnectivity, arguing that high interconnectivity is essential for cortical function.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Chklovskii, DB (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	mitya@cshl.edu			NIMH NIH HHS [MH69838] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069838] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALLMAN JM, 1974, BRAIN RES, V76, P247, DOI 10.1016/0006-8993(74)90458-2; Anderson JC, 2002, J COMP NEUROL, V443, P56, DOI 10.1002/cne.10100; Anderson JC, 1998, J NEUROSCI, V18, P10525; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; BARLOW HB, 1986, VISION RES, V26, P81, DOI 10.1016/0042-6989(86)90072-6; Blinkov SM., 1968, HUMAN BRAIN FIGURES; Braitenberg V, 1998, CORTEX STAT GEOMETRY; CAJAL SRY, 1899, TEXTURE NERVOUS SYST, V1; CARR CE, 1988, P NATL ACAD SCI USA, V85, P8311, DOI 10.1073/pnas.85.21.8311; Changizi MA, 2001, BIOL CYBERN, V84, P207, DOI 10.1007/s004220000205; Cherniak C, 1999, PHYS REV E, V59, P6001, DOI 10.1103/PhysRevE.59.6001; CHERNIAK C, 1994, J NEUROSCI, V14, P2418; Cherniak C, 2004, P NATL ACAD SCI USA, V101, P1081, DOI 10.1073/pnas.0305212101; CHERNIAK C, 1995, TRENDS NEUROSCI, V18, P522, DOI 10.1016/0166-2236(95)98373-7; CHERNIAK C, 1992, BIOL CYBERN, V66, P503, DOI 10.1007/BF00204115; Chklovskii DB, 2000, VISION RES, V40, P1765, DOI 10.1016/S0042-6989(00)00023-7; Chklovskii DB, 2002, NEURON, V34, P341, DOI 10.1016/S0896-6273(02)00679-7; Chklovskii DB, 2004, ANNU REV NEUROSCI, V27, P369, DOI 10.1146/annurev.neuro.27.070203.144226; Chklovskii DB, 2000, J NEUROPHYSIOL, V83, P2113, DOI 10.1152/jn.2000.83.4.2113; Chklovskii DB, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-18; Chklovskii DB, 2000, PHYSICA A, V284, P318, DOI 10.1016/S0378-4371(00)00219-3; CHKLOVSKII DB, 2004, IN PRESS NEUROL COMP, V16; COWEY A, 1979, Q J EXP PSYCHOL, V31, P1, DOI 10.1080/14640747908400703; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; DURBIN R, 1990, NATURE, V343, P644, DOI 10.1038/343644a0; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Hsu A, 1998, VISION RES, V38, P2539, DOI 10.1016/S0042-6989(97)00370-2; Karbowski J, 2003, J COMPUT NEUROSCI, V15, P347, DOI 10.1023/A:1027467911225; Klyachko VA, 2003, P NATL ACAD SCI USA, V100, P7937, DOI 10.1073/pnas.0932745100; KOCH C, 1982, PHILOS T R SOC B, V298, P227, DOI 10.1098/rstb.1982.0084; KOCH C, 1993, J NEUROSCI, V13, P413; Koulakov AA, 2001, NEURON, V29, P519, DOI 10.1016/S0896-6273(01)00223-9; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MASON A, 1991, J NEUROSCI, V11, P72; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; MITCHISON G, 1991, P ROY SOC B-BIOL SCI, V245, P151, DOI 10.1098/rspb.1991.0102; MITCHISON G, 1992, TRENDS NEUROSCI, V15, P122, DOI 10.1016/0166-2236(92)90352-9; Mizrahi A, 2003, NAT NEUROSCI, V6, P1201, DOI 10.1038/nn1133; MURRE JMJ, 1995, BIOL CYBERN, V73, P529, DOI 10.1007/BF00199545; NAFSTAD HJ, 1966, Z ZELLFORSCH MIK ANA, V73, P234, DOI 10.1007/BF00334866; NELSON ME, 1990, TRENDS NEUROSCI, V13, P403, DOI 10.1016/0166-2236(90)90119-U; Okada T, 2001, BIOL BULL, V200, P252, DOI 10.2307/1543506; PANICO J, 1995, J COMP NEUROL, V361, P479, DOI 10.1002/cne.903610311; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; PROTHERO JW, 1984, BRAIN BEHAV EVOLUT, V24, P152, DOI 10.1159/000121313; PURVES D, 1981, J NEUROSCI, V1, P441; PURVES D, 1985, SCIENCE, V228, P298, DOI 10.1126/science.3983631; PURVES D, 1986, J NEUROSCI, V6, P158; RALL W, 1992, PHYSIOL REV, V72, pS159, DOI 10.1152/physrev.1992.72.suppl_4.S159; RINGO JL, 1991, BRAIN BEHAV EVOLUT, V38, P1, DOI 10.1159/000114375; ROSE GJ, 1992, P NATL ACAD SCI USA, V89, P9662, DOI 10.1073/pnas.89.20.9662; RUPPIN E, 1993, BIOL CYBERN, V70, P89, DOI 10.1007/BF00202570; RUSHTON WAH, 1951, J PHYSIOL-LONDON, V115, P101, DOI 10.1113/jphysiol.1951.sp004655; SCHUZ A, 1995, J BRAIN RES, V36, P113; Shefi O, 2004, NEUROCOMPUTING, V58, P487, DOI [10.1016/j.neucom.2004.01.85, 10.1016/j.neucom.2004.01.085]; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; SPACEK J, 1983, ANAT EMBRYOL, V167, P289, DOI 10.1007/BF00298517; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; STERLING P, 1988, J NEUROSCI, V8, P623; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; SWINDALE NV, 1981, TRENDS NEUROSCI, V4, P240, DOI 10.1016/0166-2236(81)90075-8; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; TOWER DB, 1954, J COMP NEUROL, V101, P19, DOI 10.1002/cne.901010103; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; YOUNG MP, 1992, NATURE, V358, P152, DOI 10.1038/358152a0; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609	72	177	181	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 2	2004	43	5					609	617		10.1016/j.neuron.2004.08.012	http://dx.doi.org/10.1016/j.neuron.2004.08.012			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851NN	15339643	Bronze			2022-12-24	WOS:000223691900007
J	Petersen, PH; Zou, KY; Krauss, S; Zhong, WM				Petersen, PH; Zou, KY; Krauss, S; Zhong, WM			Continuing role for mouse Numb and Numbl in maintaining progenitor cells during cortical neurogenesis	NATURE NEUROSCIENCE			English	Article							NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; ASYMMETRIC DIVISION; NEURONAL DIFFERENTIATION; MAMMALIAN NUMB; NOTCH; FATES; FOREBRAIN; GENE; SPECIFICATION	Neural progenitor cells in the developing neocortex change over time to produce different neurons, a phenomenon that is also observed in other regions of the nervous system. Mouse Numb (also known as m-numb) and Numbl (also known as numblike or Nbl) are redundant but essential in maintaining virtually all progenitor cells during early neurogenesis. They do this by allowing cells to choose progenitor over neuronal fates. To determine whether their roles change as neurogenesis progresses, we conditionally ablated both genes in the embryonic dorsal forebrain after initial waves of neurogenesis. Here we report that these proteins continue to be required for progenitor-cell maintenance, contrary to recently reported findings. As occurs during early neurogenesis, the loss of Numb and Numbl causes premature progenitor-cell depletion and, consequently, a highly specific malformation of the neocortex and hippocampus. Because progenitor cells can proliferate without Numb and Numbl before neurogenesis, we propose that Numb-mediated asymmetric cell divisions, which diversify many cell fates in Drosophila melanogaster, represent a general mechanism in mammals for stem cells to balance self-renewal and differentiation.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Univ Oslo, Natl Hosp, Sect Cellular & Genet Therapy, Inst Microbiol, Oslo, Norway	Yale University; University of Oslo; National Hospital Norway	Zhong, WM (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	weimin.zhong@yale.edu	, PeturHenry/H-1506-2011	Krauss, Stefan/0000-0001-6992-8091	NINDS NIH HHS [R01 NS042048] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Cayouette M, 2003, DEVELOPMENT, V130, P2329, DOI 10.1242/dev.00446; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Fode C, 2000, GENE DEV, V14, P67; FRANTZ GD, 1994, J NEUROSCI, V14, P472; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; GU M, 1994, SCIENCE, V265, P103; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Lear BC, 1999, MECH DEVELOP, V88, P207, DOI 10.1016/S0925-4773(99)00190-2; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Machon O, 2003, NEUROSCIENCE, V122, P129, DOI 10.1016/S0306-4522(03)00519-0; Machon O, 2002, NEUROSCIENCE, V112, P951, DOI 10.1016/S0306-4522(02)00053-2; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Qian XM, 1998, DEVELOPMENT, V125, P3143; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Shen Q, 2002, DEVELOPMENT, V129, P4843; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; van den Bout CJ, 2002, MECH DEVELOP, V110, P179, DOI 10.1016/S0925-4773(01)00597-4; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; VERDI JM, 1996, CURR BIOL, V6, P113; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Yao J, 1998, DEV GROWTH DIFFER, V40, P133; Zhong WM, 1997, DEVELOPMENT, V124, P1887; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2; Zhong WM, 2000, P NATL ACAD SCI USA, V97, P6844, DOI 10.1073/pnas.97.12.6844; Zhong WM, 2003, NEURON, V37, P11, DOI 10.1016/S0896-6273(02)01178-9; Zilian O, 2001, CURR BIOL, V11, P494, DOI 10.1016/S0960-9822(01)00149-X	48	139	150	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					803	811		10.1038/nn1289	http://dx.doi.org/10.1038/nn1289			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15273690				2022-12-24	WOS:000222930800009
J	Fukuto, HS; Ferkey, DM; Apicella, AJ; Lans, H; Sharmeen, T; Chen, W; Lefkowitz, RJ; Jansen, G; Schafer, WR; Hart, AC				Fukuto, HS; Ferkey, DM; Apicella, AJ; Lans, H; Sharmeen, T; Chen, W; Lefkowitz, RJ; Jansen, G; Schafer, WR; Hart, AC			G protein-coupled receptor kinase function is essential for chemosensation in C-elegans	NEURON			English	Article							HETEROTRIMERIC G-PROTEINS; NUCLEOTIDE-GATED CHANNEL; GLR-1 GLUTAMATE-RECEPTOR; CAENORHABDITIS-ELEGANS; RHODOPSIN KINASE; BETA-ARRESTINS; DESENSITIZATION; NEURONS; MICE; EXPRESSION	G protein-coupled receptors (GPCRs) mediate diverse signaling processes, including olfaction. G protein-coupled receptor kinases (GRKs) are important regulators of G protein signal transduction that specifically phosphorylate activated GPCRs to terminate signaling. Despite previously described roles for GRKs in GPCR signal downregulation, animals lacking C. elegans G protein-coupled receptor kinase-2 (Ce-grk-2) function are not hypersensitive to odorants. Instead, decreased Ce-grk-2 function in adult sensory neurons profoundly disrupts chemosensation, based on both behavioral analysis and Ca2+ imaging. Although mammalian arrestin proteins cooperate with GRKs in receptor desensitization, loss of C. elegans arrestin-1 (arr-1) does not disrupt chemosensation. Either overexpression of the C. elegans Galpha. subunit odr-3 or loss of eat-16, which encodes a regulator of G protein signaling (FIGS) protein, restores chemosensation in Ce-grk-2 mutants. These results demonstrate that loss of GRK function can lead to reduced GPCR signal transduction and suggest an important role for RGS proteins in the regulation of chemosensation.	Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Erasmus MC, Dept Cell Biol & Genet, Rotterdam, Netherlands; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Diego; Erasmus University Rotterdam; Erasmus MC; Duke University; Howard Hughes Medical Institute	Hart, AC (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 149-7202 13th St, Charlestown, MA 02129 USA.	hart@helix.mgh.harvard.edu	Jansen, Gert/HCI-8852-2022; Lefkowitz, Robert/AAW-2649-2021; Lans, Hannes/C-9902-2016; Lans, Hannes/S-4181-2019	Lans, Hannes/0000-0003-4417-5358; Lans, Hannes/0000-0003-4417-5358; Jansen, Gert/0000-0002-7524-171X; Schafer, William/0000-0002-6676-8034; Chen, Wei/0000-0002-9934-4000	NIGMS NIH HHS [R01 GM057918, R01 GM057918-05] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057918] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARGMANN CI, 1990, COLD SH Q B, V55, P529; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BENOVIC JL, 1991, J BIOL CHEM, V266, P14939; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BOEKHOFF I, 1994, J BIOL CHEM, V269, P37; BRENNER S, 1987, NATURE, V329, P21, DOI 10.1038/329021a0; BRENNER S, 1974, GENETICS, V77, P71; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P328, DOI 10.1073/pnas.95.1.328; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colbert HA, 1997, J NEUROSCI, V17, P8259; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; FREEDMAN NJ, 1995, J BIOL CHEM, V270, P17953, DOI 10.1074/jbc.270.30.17953; Gainetdinov RR, 1999, NEURON, V24, P1029, DOI 10.1016/S0896-6273(00)81048-X; Gainetdinov RR, 2003, NEURON, V38, P291, DOI 10.1016/S0896-6273(03)00192-2; Gros R, 1997, J CLIN INVEST, V99, P2087, DOI 10.1172/JCI119381; Hajdu-Cronin YM, 1999, GENE DEV, V13, P1780, DOI 10.1101/gad.13.14.1780; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hart AC, 1999, J NEUROSCI, V19, P1952; Hilliard MA, 2004, EMBO J, V23, P1101, DOI 10.1038/sj.emboj.7600107; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Hurley JH, 1998, CURR OPIN STRUC BIOL, V8, P770, DOI 10.1016/S0959-440X(98)80097-3; Jaber M, 1996, P NATL ACAD SCI USA, V93, P12974, DOI 10.1073/pnas.93.23.12974; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Kuhara A, 2002, NEURON, V33, P751, DOI 10.1016/S0896-6273(02)00607-4; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Lyubarsky AL, 2000, J NEUROSCI, V20, P2209; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; METAYE T, 1997, J CLIN ENDOCR METAB, V388, P882; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Moore MJ, 2002, J BIOL CHEM, V277, P47878, DOI 10.1074/jbc.M204970200; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; PAO CS, 2002, SCI STKE, pPE42; Peppel K, 1997, J BIOL CHEM, V272, P25425, DOI 10.1074/jbc.272.41.25425; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Perry SJ, 2002, TRENDS CELL BIOL, V12, P130, DOI 10.1016/S0962-8924(01)02239-5; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Prasad BC, 1999, TRENDS GENET, V15, P150, DOI 10.1016/S0168-9525(99)01695-9; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Rockman HA, 1998, J BIOL CHEM, V273, P18180, DOI 10.1074/jbc.273.29.18180; SCHLEICHER S, 1993, P NATL ACAD SCI USA, V90, P1420, DOI 10.1073/pnas.90.4.1420; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; SLEPAK VZ, 1995, J BIOL CHEM, V270, P4037, DOI 10.1074/jbc.270.8.4037; SLEPAK VZ, 1993, J BIOL CHEM, V268, P21889; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; TERWILLIGER RZ, 1994, J NEUROCHEM, V63, P1983; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Troemel ER, 1999, BIOESSAYS, V21, P1011, DOI 10.1002/(SICI)1521-1878(199912)22:1&lt;1011::AID-BIES5&gt;3.0.CO;2-V; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; UNGERER M, 1994, CIRC RES, V74, P206, DOI 10.1161/01.RES.74.2.206; Walker JKL, 1999, AM J PHYSIOL-REG I, V276, pR1214, DOI 10.1152/ajpregu.1999.276.4.R1214; WILIAMS BD, 1992, GENETICS, V131, P609; Yamamoto S, 1997, NAT GENET, V15, P175, DOI 10.1038/ng0297-175	65	70	85	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 27	2004	42	4					581	593		10.1016/S0896-6273(04)00252-1	http://dx.doi.org/10.1016/S0896-6273(04)00252-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	824TA	15157420	Bronze			2022-12-24	WOS:000221708300009
J	Opatowsky, Y; Chen, CC; Campbell, KP; Hirsch, JA				Opatowsky, Y; Chen, CC; Campbell, KP; Hirsch, JA			Structural analysis of the voltage-dependent calcium channel beta subunit functional core and its complex with the alpha 1 interaction domain	NEURON			English	Article							CA2+ CHANNEL; CRYSTAL-STRUCTURE; GUANYLATE KINASE; ALPHA(1)-BETA INTERACTION; AMINO-TERMINUS; PROTEIN; INACTIVATION; DETERMINANTS; MECHANISM; MEMBRANE	Voltage-dependent calcium channels (VDCC) are multiprotein assemblies that regulate the entry of extracellular calcium into electrically excitable cells and serve as signal transduction centers. The alpha1 subunit forms the membrane pore while the intracellular beta subunit is responsible for trafficking of the channel to the plasma membrane and modulation of its electrophysiological properties. Crystallographic analyses of a beta subunit functional core alone and in complex with a alpha1 interaction domain (AID) peptide, the primary binding site of beta to the alpha1 subunit, reveal that beta represents a novel member of the MAGUK protein family. The findings illustrate how the guanylate kinase fold has been fashioned into a protein-protein interaction module by alteration of one of its substrate sites. Combined results indicate that the AID peptide undergoes a helical transition in binding to beta. We outline the mechanistic implications for understanding the beta subunit's broad regulatory role of the VDCC, particularly via the AID.	Tel Aviv Univ, Fac Life Sci, Dept Biochem, IL-69978 Ramat Aviv, Israel; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA	Tel Aviv University; Howard Hughes Medical Institute; University of Iowa; University of Iowa	Hirsch, JA (corresponding author), Tel Aviv Univ, Fac Life Sci, Dept Biochem, IL-69978 Ramat Aviv, Israel.	jhirsch@post.tau.ac.il	Chen, Chien-Chang/D-2023-2015; Tuluc, Petronel/C-2527-2011; Hirsch, Joel/AAC-8000-2021	Chen, Chien-Chang/0000-0001-8850-4278; Hirsch, Joel/0000-0001-7544-8668; Campbell, Kevin/0000-0003-2066-5889				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Anderson CAF, 2002, STRUCTURE, V10, P175, DOI 10.1016/S0969-2126(02)00700-1; Ball SL, 2002, INVEST OPHTH VIS SCI, V43, P1595; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Berrou L, 2002, BIOPHYS J, V83, P1429, DOI 10.1016/S0006-3495(02)73914-3; Bichet D, 2000, BIOCHEM BIOPH RES CO, V277, P729, DOI 10.1006/bbrc.2000.3750; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUDISA N, 1995, EUR J BIOCHEM, V230, P788; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Canti C, 2001, BIOPHYS J, V81, P1439, DOI 10.1016/S0006-3495(01)75799-2; Canti C, 1999, J NEUROSCI, V19, P6855, DOI 10.1523/JNEUROSCI.19-16-06855.1999; Catterall WA, 1996, J BIOENERG BIOMEMBR, V28, P219, DOI 10.1007/BF02110697; Cens T, 1998, PFLUG ARCH EUR J PHY, V435, P865, DOI 10.1007/s004240050595; Cens T, 1999, J BIOL CHEM, V274, P5483, DOI 10.1074/jbc.274.9.5483; Chien AJ, 1998, J BIOL CHEM, V273, P23590, DOI 10.1074/jbc.273.36.23590; CHIEN AJ, 1995, J BIOL CHEM, V270, P30036; Cornet V, 2002, EUR J NEUROSCI, V16, P883, DOI 10.1046/j.1460-9568.2002.02168.x; DeWaard M, 1996, FEBS LETT, V380, P272, DOI 10.1016/0014-5793(96)00007-5; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Dolphin AC, 2003, PHARMACOL REV, V55, P607, DOI 10.1124/pr.55.4.3; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; FILI NBS, 2003, P NATL ACAD SCI USA, V100, P14469; Geib S, 2002, BIOCHEM J, V364, P285, DOI 10.1042/bj3640285; Hanada T, 2000, J BIOL CHEM, V275, P28774, DOI 10.1074/jbc.M000715200; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; Herlitze S, 2003, J BIOENERG BIOMEMBR, V35, P621, DOI 10.1023/B:JOBB.0000008027.19384.c0; Hibino H, 2003, P NATL ACAD SCI USA, V100, P307, DOI 10.1073/pnas.0136791100; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jones SW, 1998, J BIOENERG BIOMEMBR, V30, P299, DOI 10.1023/A:1021977304001; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leipe DD, 2003, J MOL BIOL, V333, P781, DOI 10.1016/j.jmb.2003.08.040; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Luo PZ, 1997, BIOCHEMISTRY-US, V36, P8413, DOI 10.1021/bi9707133; Marquart A, 1997, FEBS LETT, V407, P137, DOI 10.1016/S0014-5793(97)00316-5; Mathew D, 2002, CURR BIOL, V12, P531, DOI 10.1016/S0960-9822(02)00758-3; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Meinhart A, 2003, P NATL ACAD SCI USA, V100, P1661, DOI 10.1073/pnas.0434325100; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murata K, 2001, BIOCHEM BIOPH RES CO, V282, P284, DOI 10.1006/bbrc.2001.4529; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; OLCESE R, 1994, NEURON, V13, P1433, DOI 10.1016/0896-6273(94)90428-6; Opatowsky Y, 2003, J BIOL CHEM, V278, P52323, DOI 10.1074/jbc.M303564200; OPATOWSKY Y, 2004, IN PRESS ACTA CRYS D; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OTWINOWSKI Z, 1997, IN PRESS ACTA CRYS D, P307; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Restituito S, 2001, BIOPHYS J, V81, P89, DOI 10.1016/S0006-3495(01)75682-2; Restituito S, 2000, J NEUROSCI, V20, P9046; Schreiber G, 2002, CURR OPIN STRUC BIOL, V12, P41, DOI 10.1016/S0959-440X(02)00287-7; Sekulic N, 2002, J BIOL CHEM, V277, P30236, DOI 10.1074/jbc.M204668200; Serysheva II, 2002, P NATL ACAD SCI USA, V99, P10370, DOI 10.1073/pnas.162363499; Shatsky M, 2002, PROTEINS, V48, P242, DOI 10.1002/prot.10100; STEHLE T, 1992, J MOL BIOL, V224, P1127, DOI 10.1016/0022-2836(92)90474-X; Stephens GJ, 2000, J PHYSIOL-LONDON, V525, P377, DOI 10.1111/j.1469-7793.2000.t01-1-00377.x; Stotz SC, 2004, J PHYSIOL-LONDON, V554, P263, DOI 10.1113/jphysiol.2003.047068; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; Tareilus E, 1997, P NATL ACAD SCI USA, V94, P1703, DOI 10.1073/pnas.94.5.1703; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Walker D, 1999, J BIOL CHEM, V274, P12383, DOI 10.1074/jbc.274.18.12383; Walker D, 1998, J BIOL CHEM, V273, P2361, DOI 10.1074/jbc.273.4.2361; Wang MC, 2004, J BIOL CHEM, V279, P7159, DOI 10.1074/jbc.M308057200; Ward Y, 2004, MOL CELL BIOL, V24, P651, DOI 10.1128/MCB.24.2.651-661.2004; WITCHER DR, 1995, J BIOL CHEM, V270, P18088, DOI 10.1074/jbc.270.30.18088; Wolf M, 2003, J MOL BIOL, V332, P171, DOI 10.1016/S0022-2836(03)00899-4; WU XD, 1995, STRUCTURE, V3, P215, DOI 10.1016/S0969-2126(01)00151-4; YANG AS, 1995, J MOL BIOL, V252, P351, DOI 10.1006/jmbi.1995.0502	84	206	213	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 13	2004	42	3					387	399		10.1016/S0896-6273(04)00250-8	http://dx.doi.org/10.1016/S0896-6273(04)00250-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KH	15134636	Bronze			2022-12-24	WOS:000221458700006
J	Martone, ME; Gupta, A; Ellisman, MH				Martone, ME; Gupta, A; Ellisman, MH			e-neuroscience: challenges and triumphs in integrating distributed data from molecules to brains	NATURE NEUROSCIENCE			English	Article							CELL-CENTERED DATABASE; SYSTEM; ATLAS; LOCALIZATION; INFORMATICS; FRAMEWORK; PROJECT; TOOLS; MODEL	Imaging, from magnetic resonance imaging (MRI) to localization of specific macromolecules by microscopies, has been one of the driving forces behind neuroinformatics efforts of the past decade. Many web-accessible resources have been created, ranging from simple data collections to highly structured databases. Although many challenges remain in adapting neuroscience to the new electronic forum envisioned by neuroinformatics proponents, these efforts have succeeded in formalizing the requirements for effective data sharing and data integration across multiple sources. In this perspective, we discuss the importance of spatial systems and ontologies for proper modeling of neuroscience data and their use in a large-scale data integration effort, the Biomedical Informatics Research Network (BIRN).	Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA; Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Martone, ME (corresponding author), Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Dept Neurosci, La Jolla, CA 92093 USA.	mark@ncmir.ucsd.edu		Martone, Maryann/0000-0002-8406-3871	NCRR NIH HHS [RR08605-08S1, RR08605, RR04050, RR043050-S2] Funding Source: Medline; NIDA NIH HHS [DA016602] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050, P41RR008605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016602] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Baldock RA, 2003, NEUROINFORMATICS, V1, P309, DOI 10.1385/NI:1:4:309; Bjaalie JG, 2002, NAT REV NEUROSCI, V3, P322, DOI 10.1038/nrn790; Bota M, 2003, NAT NEUROSCI, V6, P795, DOI 10.1038/nn1096; Bowden DM, 2003, NEUROINFORMATICS, V1, P43, DOI 10.1385/NI:1:1:043; Brevik A, 2001, ANAT EMBRYOL, V204, P319, DOI 10.1007/s004290100202; Bug W, 2003, NEUROINFORMATICS, V1, P359, DOI 10.1385/NI:1:4:359; ECKMAN BA, 2003, BIOINFORMATICS MANAG, P35; Foster I, 2002, PHYS TODAY, V55, P42, DOI 10.1063/1.1461327; Fox PT, 2002, NAT REV NEUROSCI, V3, P319, DOI 10.1038/nrn789; Gardner D, 2001, PHILOS T ROY SOC B, V356, P1229, DOI 10.1098/rstb.2001.0911; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gupta A, 2003, NEURAL NETWORKS, V16, P1277, DOI 10.1016/j.neunet.2003.07.008; GUPTA A, 2000, P 12 INT C SCI STAT; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Humphreys BL, 1998, J AM MED INFORM ASSN, V5, P1; Koslow SH, 2002, NAT REV NEUROSCI, V3, P311, DOI 10.1038/nrn787; Kotter R, 2001, PHILOS T ROY SOC B, V356, P1111, DOI 10.1098/rstb.2001.0902; Lacroix Z., 2003, MORGAN KAUFMANN SERI, P75; LUDAESCHER B, 2001, P 17 INT C DAT ENG I; Ludascher Bertram, 2003, BIOINFORMATICS MANAG, P335; MacKenzie-Graham A, 2003, NEUROINFORMATICS, V1, P397, DOI 10.1385/NI:1:4:397; Marenco L, 2003, J AM MED INFORM ASSN, V10, P444, DOI 10.1197/jamia.M1303; Martone ME, 2003, NEUROINFORMATICS, V1, P379, DOI 10.1385/NI:1:4:379; Martone ME, 2002, J STRUCT BIOL, V138, P145, DOI 10.1016/S1047-8477(02)00006-0; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Miller PL, 2001, J AM MED INFORM ASSN, V8, P34, DOI 10.1136/jamia.2001.0080034; Paxinos G, 2000, MOUSE BRAIN STEREOTA; Peltier ST, 2003, J PARALLEL DISTR COM, V63, P539, DOI 10.1016/S0743-7315(03)00061-3; Shepherd GM, 1998, TRENDS NEUROSCI, V21, P460, DOI 10.1016/S0166-2236(98)01300-9; Toga AW, 2002, NAT REV NEUROSCI, V3, P302, DOI 10.1038/nrn782; Van Essen DC, 2002, CURR OPIN NEUROBIOL, V12, P574, DOI 10.1016/S0959-4388(02)00361-6; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443	32	83	83	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					467	472		10.1038/nn1229	http://dx.doi.org/10.1038/nn1229			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15114360				2022-12-24	WOS:000221101300015
J	Li, CY; Lu, JT; Wu, CP; Duan, SM; Poo, MM				Li, CY; Lu, JT; Wu, CP; Duan, SM; Poo, MM			Bidirectional modification of presynaptic neuronal excitability accompanying spike timing-dependent synaptic plasticity	NEURON			English	Article							LONG-TERM POTENTIATION; SPINY STELLATE NEURONS; PROTEIN-KINASE-A; INTRINSIC EXCITABILITY; PYRAMIDAL CELLS; POTASSIUM CURRENTS; K+ CHANNELS; BARREL; ACTIVATION; INCREASES	Correlated pre- and postsynaptic activity that induces long-term potentiation is known to induce a persistent enhancement of the intrinsic excitability of the presynaptic neuron. Here we report that, associated with the induction of long-term depression in hippocampal cultures and in somatosensory cortical slices, there is also a persistent reduction in the excitability of the presynaptic neuron. This reduction requires postsynaptic Ca2+ elevation and presynaptic PKA- and PKC-dependent modification of slow-inactivating K+ channels. The bidirectional changes in neuronal excitability and synaptic efficacy exhibit identical requirements for the temporal order of pre- and postsynaptic activation but reflect two distinct aspects of activity-induced modification of neural circuits.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of California System; University of California Berkeley	Duan, SM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	shumin@ion.ac.cn; rnpoo@uclink.berkeley.edu		Li, Chengyu/0000-0001-6829-0209	NINDS NIH HHS [NS 36999] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036999] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; Armano S, 2000, J NEUROSCI, V20, P5208, DOI 10.1523/JNEUROSCI.20-14-05208.2000; Bear MF, 2001, SYNAPSES, P455; Beaumont V, 2002, NEURON, V33, P601, DOI 10.1016/S0896-6273(02)00581-0; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Churchland PS, 2017, COMPUT NEUROSCI-MIT; CONN PJ, 1989, J NEUROSCI, V9, P473; Daoudal G, 2002, P NATL ACAD SCI USA, V99, P14512, DOI 10.1073/pnas.222546399; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; FICKER E, 1992, J PHYSIOL-LONDON, V445, P431, DOI 10.1113/jphysiol.1992.sp018932; Fitzsimonds RM, 1998, PHYSIOL REV, V78, P143, DOI 10.1152/physrev.1998.78.1.143; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; Franceschetti S, 2000, J PHYSIOL-LONDON, V528, P291, DOI 10.1111/j.1469-7793.2000.00291.x; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Ganguly K, 2000, NAT NEUROSCI, V3, P1018, DOI 10.1038/79838; Golowasch J, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-20-j0004.1999; Grosse G, 2000, J NEUROSCI, V20, P1869; Heath BM, 2000, J PHYSIOL-LONDON, V522, P391, DOI 10.1111/j.1469-7793.2000.t01-2-00391.x; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hoffman DA, 1998, J NEUROSCI, V18, P3521; HU GY, 1987, NATURE, V328, P426, DOI 10.1038/328426a0; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P245, DOI 10.1113/jphysiol.1986.sp016007; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MCCORMICK DA, 1987, J PHYSIOL-LONDON, V393, P743, DOI 10.1113/jphysiol.1987.sp016851; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; MCNAUGHTON BL, 1994, P NATL ACAD SCI USA, V91, P4830, DOI 10.1073/pnas.91.11.4830; Mellor J, 2002, SCIENCE, V295, P143, DOI 10.1126/science.1064285; Moyer JR, 1996, J NEUROSCI, V16, P5536; Nick TA, 2000, NAT NEUROSCI, V3, P142, DOI 10.1038/72082; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; PAYET MD, 1992, J BIOL CHEM, V267, P18270; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; RUMELHART DE, 1986, PARALLEL DISTRIBUTED, V1, P316; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Tao HZW, 2000, J NEUROSCI, V20, P3233, DOI 10.1523/JNEUROSCI.20-09-03233.2000; TAUBE JS, 1988, J NEUROSCI, V8, P1632; Vaquero CF, 2001, J NEUROSCI, V21, P8624, DOI 10.1523/JNEUROSCI.21-21-08624.2001; WATHEY JC, 1992, J NEUROSCI, V12, P607; WEST JW, 1991, SCIENCE, V254, P866, DOI 10.1126/science.1658937; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	57	66	69	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 22	2004	41	2					257	268		10.1016/S0896-6273(03)00847-X	http://dx.doi.org/10.1016/S0896-6273(03)00847-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821JZ	14741106	Bronze			2022-12-24	WOS:000221457800011
J	Bell, TJ; Thaler, C; Castiglioni, AJ; Helton, TD; Lipscombe, D				Bell, TJ; Thaler, C; Castiglioni, AJ; Helton, TD; Lipscombe, D			Cell-specific alternative splicing increases calcium channel current density in the pain pathway	NEURON			English	Article							ROOT GANGLION NEURONS; RAT SENSORY NEURONS; N-TYPE; OMEGA-CONOTOXIN; CA2+ CHANNEL; FUNCTIONAL EXPRESSION; ALPHA(1B) SUBUNIT; MICE LACKING; MEMBRANE-PROPERTIES; CAPSAICIN RECEPTOR	N-type calcium channels are critical for pain transduction. Inhibitors of these channels are powerful analgesics, but clinical use of current N-type blockers; remains limited by undesirable actions in other regions of the nervous system. We now demonstrate that a unique splice isoform of the N-type channel is restricted exclusively to dorsal root ganglia. By a combination of functional and molecular analyses at the single-cell level, we show that the DRG-specific exon, e37a, is preferentially present in Ca(V)2.2 mRNAs expressed in neurons that contain nociceptive markers, VR1 and Na(V)1.8. Cell-specific inclusion of exon 37a correlates closely with significantly larger N-type currents in nociceptive neurons. This unique splice isoform of the N-type channel could represent a novel target for pain management.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Lipscombe, D (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	diane_lipscombe@brown.edu			NIGMS NIH HHS [GM07601] Funding Source: Medline; NIMH NIH HHS [MH19118] Funding Source: Medline; NINDS NIH HHS [NS43082, NS29967] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029967, F32NS043082, R29NS029967] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Baccei ML, 2000, J NEUROPHYSIOL, V83, P2227, DOI 10.1152/jn.2000.83.4.2227; Black DL, 1998, NEURON, V20, P165, DOI 10.1016/S0896-6273(00)80444-4; Blair NT, 2002, J NEUROSCI, V22, P10277; BOWERSOX SS, 1995, J PHARMACOL EXP THER, V273, P248; Bowersox SS, 1998, TOXICON, V36, P1651, DOI 10.1016/S0041-0101(98)00158-5; Bowersox SS, 1996, J PHARMACOL EXP THER, V279, P1243; Brose WG, 1997, CLIN J PAIN, V13, P256, DOI 10.1097/00002508-199709000-00012; Cahill AL, 2000, J NEUROSCI, V20, P1685; CARBONE E, 1984, NATURE, V310, P501, DOI 10.1038/310501a0; CARDENAS CG, 1995, J NEUROPHYSIOL, V74, P1870, DOI 10.1152/jn.1995.74.5.1870; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHAPLAN SR, 1994, J PHARMACOL EXP THER, V269, P1117; COOPOLA T, 1994, FEBS LETT, V338, P1; Cox B, 2000, Curr Rev Pain, V4, P488; Dib-Hajj SD, 1998, P NATL ACAD SCI USA, V95, P8963, DOI 10.1073/pnas.95.15.8963; Djouhri L, 1998, J PHYSIOL-LONDON, V513, P857, DOI 10.1111/j.1469-7793.1998.857ba.x; DUBEL SJ, 1992, P NATL ACAD SCI USA, V89, P5058, DOI 10.1073/pnas.89.11.5058; DUNLAP K, 1978, NATURE, V276, P837, DOI 10.1038/276837a0; Felix R, 1999, RECEPTOR CHANNEL, V6, P351; FUJITA Y, 1993, NEURON, V10, P585, DOI 10.1016/0896-6273(93)90162-K; Gao TY, 2000, J BIOL CHEM, V275, P25436, DOI 10.1074/jbc.M003465200; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P31, DOI 10.1113/jphysiol.1985.sp015573; Hatakeyama S, 2001, NEUROREPORT, V12, P2423, DOI 10.1097/00001756-200108080-00027; HEYMAN I, 1985, NEUROSCI LETT, V56, P69, DOI 10.1016/0304-3940(85)90442-2; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; HOLZ GG, 1988, J NEUROSCI, V8, P463; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Ikeda SR, 1999, ADV SEC MESS PHOSPH, V33, P131; Ino M, 2001, P NATL ACAD SCI USA, V98, P5323, DOI 10.1073/pnas.081089398; Jones EMC, 1999, J PHYSIOL-LONDON, V518, P653, DOI 10.1111/j.1469-7793.1999.0653p.x; KERR LM, 1988, EUR J PHARMACOL, V146, P181, DOI 10.1016/0014-2999(88)90501-8; Kim C, 2001, MOL CELL NEUROSCI, V18, P235, DOI 10.1006/mcne.2001.1013; Lin ZX, 1999, J NEUROSCI, V19, P5322; Lin ZX, 1997, NEURON, V18, P153, DOI 10.1016/S0896-6273(01)80054-4; Lipscombe D, 2002, CIRC RES, V90, P933, DOI 10.1161/01.RES.0000019740.52306.92; Lipscombe D, 2002, MOL NEUROBIOL, V26, P21, DOI 10.1385/MN:26:1:021; LIPSCOMBE D, 2003, CALCIUM CHANNEL PHAR; Lu Q, 1999, J BIOL CHEM, V274, P34566, DOI 10.1074/jbc.274.49.34566; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; MAGGI CA, 1990, NEUROSCI LETT, V114, P203, DOI 10.1016/0304-3940(90)90072-H; Matthews EA, 2001, PAIN, V92, P235, DOI 10.1016/S0304-3959(01)00255-X; Maximov A, 2002, J NEUROSCI, V22, P6939; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; McCleskey EW, 1999, ANNU REV PHYSIOL, V61, P835, DOI 10.1146/annurev.physiol.61.1.835; MILJANICH GP, 1995, ANNU REV PHARMACOL, V35, P707, DOI 10.1146/annurev.pa.35.040195.003423; Navaratnam DS, 1997, NEURON, V19, P1077, DOI 10.1016/S0896-6273(00)80398-0; Pan JQ, 2000, J NEUROSCI, V20, P4769; Petruska JC, 2000, J NEUROPHYSIOL, V84, P2365, DOI 10.1152/jn.2000.84.5.2365; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; RITTER AM, 1992, J NEUROPHYSIOL, V68, P2033, DOI 10.1152/jn.1992.68.6.2033; ROSE ML, 1997, CARDIOVASC ENG, V2, P19; Saegusa H, 2002, NEUROSCI RES, V43, P1, DOI 10.1016/S0168-0102(02)00017-2; Saegusa H, 2001, EMBO J, V20, P2349, DOI 10.1093/emboj/20.10.2349; SCHROEDER JE, 1990, J NEUROSCI, V10, P947; SCROGGS RS, 1992, J NEUROSCI, V12, P1789; SCROGGS RS, 1992, J PHYSIOL-LONDON, V445, P639, DOI 10.1113/jphysiol.1992.sp018944; Shin JB, 2003, NAT NEUROSCI, V6, P724, DOI 10.1038/nn1076; Simen AA, 2001, J NEUROSCI, V21, P7587, DOI 10.1523/JNEUROSCI.21-19-07587.2001; Soong TW, 2002, J NEUROSCI, V22, P10142; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Vanegas H, 2000, PAIN, V85, P9, DOI 10.1016/S0304-3959(99)00241-9; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; WITCHER DR, 1993, SCIENCE, V261, P486, DOI 10.1126/science.8392754; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001	70	159	173	2	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 8	2004	41	1					127	138		10.1016/S0896-6273(03)00801-8	http://dx.doi.org/10.1016/S0896-6273(03)00801-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	761YJ	14715140	Bronze			2022-12-24	WOS:000187942800014
J	Ramos, BP; Birnbaum, SG; Lindenmayer, I; Newton, SS; Duman, RS; Arnsten, AFT				Ramos, BP; Birnbaum, SG; Lindenmayer, I; Newton, SS; Duman, RS; Arnsten, AFT			Dysregulation of protein kinase a signaling in the aged prefrontal cortex: New strategy for treating age-related cognitive decline	NEURON			English	Article							LONG-TERM POTENTIATION; ELEMENT-BINDING PROTEIN; MEMORY CONSOLIDATION; ADENYLYL CYCLASES; SPATIAL MEMORY; CYCLIC-AMP; IMMUNOHISTOCHEMICAL LOCALIZATION; ALPHA-2 ANTAGONIST; IMPROVES MEMORY; LOCUS-COERULEUS	Activation of the cAMP/protein kinase A (PKA) pathway has been proposed as a mechanism for improving age-related cognitive deficits based on studies of hippocampal function. However, normal aging also afflicts prefrontal cortical cognitive functioning. Here, we report that agents that increase PKA activity impair rather than improve prefrontal cortical function in aged rats and monkeys with prefrontal cortical deficits. Conversely, PKA inhibition ameliorates prefrontal cortical cognitive deficits. Western blot and immunohistochemical analyses of rat brain further indicate that the cAMP/PKA pathway becomes disinhibited in the prefrontal cortex with advancing age. These data demonstrate that PKA inhibition, rather than activation, is the appropriate strategy for restoring prefrontal cortical cognitive abilities in the elderly.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA	Yale University; Yale University	Arnsten, AFT (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	amy.arnsten@yale.edu			NIA NIH HHS [AG06036] Funding Source: Medline; NIMH NIH HHS [MH45481] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045481, R29MH045481, R37MH045481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006036, R37AG006036] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Albert MS, 1997, PHILOS T ROY SOC B, V352, P1703, DOI 10.1098/rstb.1997.0152; ANDO S, 1991, NEUROSCI LETT, V128, P17, DOI 10.1016/0304-3940(91)90750-N; Araki T, 1997, METAB BRAIN DIS, V12, P83, DOI 10.1007/BF02676356; Araki T, 1995, BRAIN RES, V704, P227, DOI 10.1016/0006-8993(95)01117-X; ARNSTEN AFT, 1988, J NEUROSCI, V8, P4287; Arnsten AFT, 1998, SCIENCE, V280, P1711, DOI 10.1126/science.280.5370.1711; Arnsten AFT, 2000, PROG BRAIN RES, V126, P183; ARNSTEN AFT, 1985, SCIENCE, V230, P1273, DOI 10.1126/science.2999977; Baker LP, 1999, J NEUROSCI, V19, P180, DOI 10.1523/JNEUROSCI.19-01-00180.1999; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; Barros DM, 2000, BEHAV BRAIN RES, V114, P183, DOI 10.1016/S0166-4328(00)00226-6; BARTUS RT, 1978, J GERONTOL, V33, P858, DOI 10.1093/geronj/33.6.858; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; Bimonte HA, 2003, NEUROBIOL AGING, V24, P37, DOI 10.1016/S0197-4580(02)00015-5; Birnbaum S, 1999, BIOL PSYCHIAT, V46, P1266, DOI 10.1016/S0006-3223(99)00138-9; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; CARLSON S, 1992, BEHAV NEURAL BIOL, V58, P113, DOI 10.1016/0163-1047(92)90327-Z; Chao LL, 1997, CEREB CORTEX, V7, P63, DOI 10.1093/cercor/7.1.63; Colombo PJ, 1997, P NATL ACAD SCI USA, V94, P14195, DOI 10.1073/pnas.94.25.14195; Coven E, 1998, J NEUROCHEM, V71, P1865; DETOLEDOMORRELL L, 1984, BEHAV NEURAL BIOL, V42, P1, DOI 10.1016/S0163-1047(84)90364-9; DIVAC I, 1971, NEUROPSYCHOLOGIA, V9, P175, DOI 10.1016/0028-3932(71)90041-8; FELDMAN ML, 1975, ANAT EMBRYOL, V148, P279, DOI 10.1007/BF00319848; Franowicz JS, 1998, PSYCHOPHARMACOLOGY, V136, P8, DOI 10.1007/s002130050533; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Gallagher M, 1997, ANNU REV PSYCHOL, V48, P339, DOI 10.1146/annurev.psych.48.1.339; Goldman-Rakic P. S., 2011, COMPR PHYSIOL, DOI [10.1002/CPHY.CP010509, DOI 10.1002/CPHY.CP010509]; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Herndon JG, 1997, BEHAV BRAIN RES, V87, P25, DOI 10.1016/S0166-4328(96)02256-5; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Huang YY, 2000, J NEUROSCI, V20, P6317, DOI 10.1523/JNEUROSCI.20-17-06317.2000; Imanishi T, 1997, EUR J PHARMACOL, V321, P273, DOI 10.1016/S0014-2999(96)00969-7; IYENGAR R, 1993, FASEB J, V7, P768, DOI 10.1096/fasebj.7.9.8330684; KAPUR S, 1995, NEUROREPORT, V6, P1880, DOI 10.1097/00001756-199510020-00014; LaneLadd SB, 1997, J NEUROSCI, V17, P7890; LANGRETH R, 2002, FORBES          0204; Lepage M, 2000, P NATL ACAD SCI USA, V97, P506, DOI 10.1073/pnas.97.1.506; Lopez-Salon M, 2001, EUR J NEUROSCI, V14, P1820, DOI 10.1046/j.0953-816x.2001.01806.x; MONS N, 1995, P NATL ACAD SCI USA, V92, P8473, DOI 10.1073/pnas.92.18.8473; Nibuya M, 1996, J NEUROSCI, V16, P2365; NIELSENBOHLMAN L, 1995, CEREB CORTEX, V5, P541, DOI 10.1093/cercor/5.6.541; Page TL, 2002, NEUROSCI LETT, V317, P37, DOI 10.1016/S0304-3940(01)02428-4; Punch LJ, 1997, J NEUROSCI, V17, P8520; Rama P, 1996, PHARM BIOCH BEHAV, V54, P1; RANDT CT, 1982, PHARMACOL BIOCHEM BE, V17, P677, DOI 10.1016/0091-3057(82)90344-6; RAPP PR, 1989, J NEUROSCI, V9, P3568; Rotenberg A, 2000, J NEUROSCI, V20, P8096; Sakai N, 2002, MOL PHARMACOL, V61, P1453, DOI 10.1124/mol.61.6.1453; Schacter DL, 1996, NEUROREPORT, V7, P1165, DOI 10.1097/00001756-199604260-00014; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Stuss D. T., 2002, PR FRONTAL LOBE FUNC, P392; Tanila H, 1996, BRAIN RES BULL, V40, P117, DOI 10.1016/0361-9230(96)00026-3; Tanila H, 2001, HIPPOCAMPUS, V11, P793, DOI 10.1002/hipo.1095; TAUSSIG R, 1994, J BIOL CHEM, V269, P6093; Taylor JR, 1999, J NEUROSCI, V19; Wellman CL, 2001, J NEUROBIOL, V49, P245, DOI 10.1002/neu.1079; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Zhang HT, 2000, PSYCHOPHARMACOLOGY, V150, P311, DOI 10.1007/s002130000414; Zhang HT, 2000, NEUROPSYCHOPHARMACOL, V23, P198, DOI 10.1016/S0893-133X(00)00108-1; Zhu J, 2001, CNS DRUG REV, V7, P387	62	181	190	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 13	2003	40	4					835	845		10.1016/S0896-6273(03)00694-9	http://dx.doi.org/10.1016/S0896-6273(03)00694-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	744UL	14622586	Bronze			2022-12-24	WOS:000186651200017
J	Le Grand, R; Mondloch, CJ; Maurer, D; Brent, HP				Le Grand, R; Mondloch, CJ; Maurer, D; Brent, HP			Expert face processing requires visual input to the right hemisphere during infancy	NATURE NEUROSCIENCE			English	Article							HUMAN FUSIFORM GYRUS; SPATIAL ATTENTION; DEPRIVATION; RECOGNITION; EXPERIENCE; PROSOPAGNOSIA; INFORMATION; INTEGRATION; ASYMMETRIES; PERCEPTION	Adult expertise in face processing is mediated largely by neural networks in the right hemisphere. Here we evaluate the contribution of early visual input in establishing this neural substrate. We compared visually normal individuals to patients for whom visual input had been restricted mainly to one hemisphere during infancy. We show that early deprivation of visual input to the right hemisphere severely impairs the development of expert face processing, whereas deprivation restricted mainly to the left hemisphere does not. Our results indicate that the neural circuitry responsible for adults' face expertise is not pre-specified, but requires early visual experience. However, the two hemispheres are not equipotent: only the right hemisphere is capable of using the early input to develop expertise at face processing.	McMaster Univ, Dept Psychol, Hamilton, ON L8S 4K1, Canada; Hosp Sick Children, Toronto, ON M5G 1X8, Canada	McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Maurer, D (corresponding author), McMaster Univ, Dept Psychol, 1280 Main St W, Hamilton, ON L8S 4K1, Canada.							Barton JJS, 2002, NEUROLOGY, V58, P71, DOI 10.1212/WNL.58.1.71; Bruce V., 1994, VIS COGN, V1, P141, DOI [DOI 10.1080/13506289408402299, 10.1080/13506289408402299]; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; de Schonen S., 1989, EUROPEAN B COGNITIVE, V9, P3; DERENZI E, 1994, NEUROPSYCHOLOGIA, V32, P893, DOI 10.1016/0028-3932(94)90041-8; Deruelle C, 1998, DEV NEUROPSYCHOL, V14, P535, DOI 10.1080/87565649809540727; DERUELLE C, 1991, BRAIN COGNITION, V16, P151, DOI 10.1016/0278-2626(91)90004-R; DERUELLE C, 1995, INFANT BEHAV DEV, V18, P123, DOI 10.1016/0163-6383(95)90042-X; DESCHONEN S, 1990, CHILD DEV, V61, P1192, DOI 10.2307/1130887; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Ellemberg D, 2000, VISION RES, V40, P3283, DOI 10.1016/S0042-6989(00)00165-6; Farah MJ, 2000, COGNITIVE NEUROPSYCH, V17, P117, DOI 10.1080/026432900380526; Freire A, 2000, PERCEPTION, V29, P159, DOI 10.1068/p3012; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Geldart S, 2002, DEVELOPMENTAL SCI, V5, P490, DOI 10.1111/1467-7687.00242; GELDART S, 2000, THESIS MCMASTER U; George N, 1999, NAT NEUROSCI, V2, P574, DOI 10.1038/9230; Gitelman DR, 1999, BRAIN, V122, P1093, DOI 10.1093/brain/122.6.1093; GOLDBERG M, 1998, THESIS MCMASTER U; Goldberg MC, 2001, DEV NEUROPSYCHOL, V19, P53, DOI 10.1207/S15326942DN1901_5; Goldberg MC, 2001, DEVELOPMENTAL SCI, V4, P209, DOI 10.1111/1467-7687.00166; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Le Grand R, 2001, NATURE, V410, P890, DOI 10.1038/35073749; LeGrand R, 2001, NATURE, V412, P786; Lewis TL, 2002, VISION RES, V42, P939, DOI 10.1016/S0042-6989(02)00041-X; LEWIS TL, 1992, VISION RES, V32, P903, DOI 10.1016/0042-6989(92)90033-F; Liegeois F, 1997, NEUROPSYCHOLOGIA, V35, P381, DOI 10.1016/S0028-3932(96)00078-4; Liegeois F, 2000, NEUROPSYCHOLOGIA, V38, P1382, DOI 10.1016/S0028-3932(00)00041-5; MAUER D, 1989, APPL DEV PSYCHOL, V3, P108; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; Mondloch CJ, 2002, PERCEPTION, V31, P553, DOI 10.1068/p3339; MONDLOCH CJ, IN PRESS DEV FACE PR; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; PASCALIS O, 1995, INFANT BEHAV DEV, V18, P79, DOI 10.1016/0163-6383(95)90009-8; Rossion B, 2000, J COGNITIVE NEUROSCI, V12, P793, DOI 10.1162/089892900562606; Sergent J., 1988, THOUGHT LANGUAGE, V108-131; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599	38	201	202	1	18	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1108	1112		10.1038/nn1121	http://dx.doi.org/10.1038/nn1121			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	727AK	12958600				2022-12-24	WOS:000185633600024
J	Sockanathan, S; Perlmann, T; Jessell, TM				Sockanathan, S; Perlmann, T; Jessell, TM			Retinoid receptor signaling in postmitotic motor neurons regulates rostrocaudal positional identity and axonal projection pattern	NEURON			English	Article							DEVELOPING SPINAL-CORD; VENTRAL NEURAL-TUBE; MUSCULATURE FOLLOWING TRANSPLANTATION; PROGENITOR-CELL IDENTITY; LIM HOMEOBOX GENES; CHICK-EMBRYO; SUBTYPE IDENTITY; SONIC HEDGEHOG; ACID SYNTHESIS; TRANSCRIPTIONAL CODES	The identity of motor neurons diverges markedly at different rostrocaudal levels of the spinal cord, but the signals that specify their fate remain poorly defined. We show that retinoid receptor activation in newly generated spinal motor neurons has a crucial role in specifying motor neuron columnar subtypes. Blockade of retinoid receptor signaling in brachial motor neurons inhibits lateral motor column differentiation and converts many of these neurons to thoracic columnar subtypes. Conversely, expression of a constitutively active retinoid receptor derivative impairs the differentiation of thoracic motor neuron columnar subtypes. These findings provide evidence for a regionally restricted role for retinoid signaling in the postmitotic specification of motor neuron columnar identity.	Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Ludwig Inst Canc Res, Dept Cell Biol, Karolinska Inst, S-17177 Stockholm, Sweden	Columbia University; Howard Hughes Medical Institute; Johns Hopkins University; Karolinska Institutet; Ludwig Institute for Cancer Research	Jessell, TM (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA.							Abu-Abed S, 2002, MECH DEVELOP, V110, P173, DOI 10.1016/S0925-4773(01)00572-X; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; BALKAN W, 1992, P NATL ACAD SCI USA, V89, P3347, DOI 10.1073/pnas.89.8.3347; Bel-Vialar S, 2002, DEVELOPMENT, V129, P5103; Berggren K, 1999, DEV BIOL, V210, P288, DOI 10.1006/dbio.1999.9286; Blumberg B, 1997, DEVELOPMENT, V124, P373; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Cai J, 2000, GENESIS, V27, P6, DOI 10.1002/1526-968X(200005)27:1<6::AID-GENE20>3.3.CO;2-F; Cornbrooks EB, 1997, J COMP NEUROL, V382, P1, DOI 10.1002/(SICI)1096-9861(19970526)382:1<1::AID-CNE1>3.0.CO;2-5; DAMM K, 1993, P NATL ACAD SCI USA, V90, P2989, DOI 10.1073/pnas.90.7.2989; Denisenko-Nehrbass NI, 2000, NEURON, V27, P359, DOI 10.1016/S0896-6273(00)00043-X; Duester G, 2001, CHEM-BIOL INTERACT, V130, P469, DOI 10.1016/S0009-2797(00)00292-1; Ensini M, 1998, DEVELOPMENT, V125, P969; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Goridis C, 1999, CURR OPIN NEUROBIOL, V9, P47, DOI 10.1016/S0959-4388(99)80006-3; Goulding M, 2002, CURR OPIN NEUROBIOL, V12, P508, DOI 10.1016/S0959-4388(02)00371-9; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; GUTMAN CR, 1993, BRAIN RES, V609, P129, DOI 10.1016/0006-8993(93)90865-K; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4; HOLLYDAY M, 1980, J COMP NEUROL, V194, P143, DOI 10.1002/cne.901940108; Hollyday M., 1980, Current Topics in Developmental Biology, V15, P181; JESSELL TM, 1992, CELL, V68, P257, DOI 10.1016/0092-8674(92)90469-S; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kawakami Y, 2001, CELL, V104, P891, DOI 10.1016/S0092-8674(01)00285-9; Lance-Jones C, 2001, DEVELOPMENT, V128, P2255; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Lipkin SM, 1996, J VIROL, V70, P7182, DOI 10.1128/JVI.70.10.7182-7189.1996; Liu AM, 2001, ANNU REV NEUROSCI, V24, P869, DOI 10.1146/annurev.neuro.24.1.869; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Muhr J, 1999, NEURON, V23, P689, DOI 10.1016/S0896-6273(01)80028-3; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Niederreither K, 2002, P NATL ACAD SCI USA, V99, P16111, DOI 10.1073/pnas.252626599; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; OBRIEN MK, 1990, J NEUROBIOL, V21, P341, DOI 10.1002/neu.480210208; OBRIEN MK, 1990, J NEUROBIOL, V21, P313, DOI 10.1002/neu.480210207; Patten I, 2000, CELL MOL LIFE SCI, V57, P1695, DOI 10.1007/PL00000652; PERSSON M, 2003, GENE DEV, V22, P2865; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; PRASAD A, 1991, J COMP NEUROL, V307, P237, DOI 10.1002/cne.903070207; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Shamim H, 1999, MECH DEVELOP, V85, P189, DOI 10.1016/S0925-4773(99)00093-3; Sharma K, 2000, NATURE, V406, P515, DOI 10.1038/35020078; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Solomin L, 1998, NATURE, V395, P398, DOI 10.1038/26515; Stolte D, 2002, ANAT EMBRYOL, V205, P1, DOI 10.1007/s00429-002-0227-z; Swindell EC, 1999, DEV BIOL, V216, P282, DOI 10.1006/dbio.1999.9487; Toresson H, 1999, DEVELOPMENT, V126, P1317; TOSNEY KW, 1985, DEV BIOL, V109, P193, DOI 10.1016/0012-1606(85)90360-4; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; Wagner E, 2002, CEREB CORTEX, V12, P1244, DOI 10.1093/cercor/12.12.1244; William CM, 2003, DEVELOPMENT, V130, P1523, DOI 10.1242/dev.00358; Zhao D, 1996, EUR J BIOCHEM, V240, P15, DOI 10.1111/j.1432-1033.1996.0015h.x; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	71	104	107	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 25	2003	40	1					97	111		10.1016/S0896-6273(03)00532-4	http://dx.doi.org/10.1016/S0896-6273(03)00532-4			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	726TA	14527436	Bronze			2022-12-24	WOS:000185614700012
J	Carr, DB; Day, M; Cantrell, AR; Held, J; Scheuer, T; Catterall, WA; Surmeier, DJ				Carr, DB; Day, M; Cantrell, AR; Held, J; Scheuer, T; Catterall, WA; Surmeier, DJ			Transmitter modulation of slow, activity-dependent alterations in sodium channel availability endows neurons with a novel form of cellular plasticity	NEURON			English	Article							CA1 PYRAMIDAL NEURONS; PROTEIN-KINASE-C; RAT HIPPOCAMPAL-NEURONS; GATED NA+ CHANNELS; ACTION-POTENTIALS; NEOCORTICAL NEURONS; STRUCTURAL REARRANGEMENT; PREFRONTAL CORTEX; INACTIVATION; ACTIVATION	Voltage-gated Na+ channels are major targets of G protein-coupled receptor (GPCR)-initiated signaling cascades. These cascades act principally through protein kinase-mediated phosphorylation of the channel alpha subunit. Phosphorylation reduces Na+ channel availability in most instances without producing major alterations of fast channel gating. The nature of this change in availability is poorly understood. The results described here show that both GPCR- and protein kinase-dependent reductions in Na+ channel availability are mediated by a slow, voltage-dependent process with striking similarity to slow inactivation, an intrinsic gating mechanism of Na+ channels. This process is strictly associated with neuronal activity and develops over seconds, endowing neurons with a novel form of cellular plasticity shaping synaptic integration, dendritic electrogenesis, and repetitive discharge.	Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA	Northwestern University; Feinberg School of Medicine; University of Tennessee System; University of Tennessee Health Science Center; University of Washington; University of Washington Seattle	Surmeier, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu			NIMH NIH HHS [MH01669, MH62070, MH64322] Funding Source: Medline; NINDS NIH HHS [NS15751, NS34696] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062070, F32MH064322, K01MH001669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034696, R37NS034696, R01NS015751] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Balser JR, 1996, J PHYSIOL-LONDON, V494, P431, DOI 10.1113/jphysiol.1996.sp021503; Cantrell AR, 1999, J NEUROSCI, V19, P5301; Cantrell AR, 1997, J NEUROSCI, V17, P7330; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Cantrell AR, 1996, NEURON, V16, P1019, DOI 10.1016/S0896-6273(00)80125-7; Carr DB, 2002, J NEUROSCI, V22, P6846; Colbert CM, 1998, J NEUROPHYSIOL, V79, P491, DOI 10.1152/jn.1998.79.1.491; Colbert CM, 1997, J NEUROSCI, V17, P6512; Ellerkmann RK, 2001, J PHYSIOL-LONDON, V532, P385, DOI 10.1111/j.1469-7793.2001.0385f.x; Fleidervish IA, 1996, J PHYSIOL-LONDON, V493, P83, DOI 10.1113/jphysiol.1996.sp021366; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; FUSTER JM, 1991, PROG BRAIN RES, V87, P201; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Goldman-Rakic PS, 1999, ANN NY ACAD SCI, V868, P13, DOI 10.1111/j.1749-6632.1999.tb11270.x; Gonzalez-Burgos G, 2001, J NEUROPHYSIOL, V86, P1671, DOI 10.1152/jn.2001.86.4.1671; HIBER K, 2002, J BIOL CHEM, V277, P37105; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; Johnston D, 1999, CURR OPIN NEUROBIOL, V9, P288, DOI 10.1016/S0959-4388(99)80042-7; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Jung HY, 1997, J NEUROSCI, V17, P6639; Larkum ME, 2002, J NEUROSCI, V22, P6991; Lipowsky R, 1996, J NEUROPHYSIOL, V76, P2181, DOI 10.1152/jn.1996.76.4.2181; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Maurice N, 2001, J NEUROSCI, V21, P2268, DOI 10.1523/JNEUROSCI.21-07-02268.2001; Mickus T, 1999, BIOPHYS J, V76, P846, DOI 10.1016/S0006-3495(99)77248-6; Mickus T, 1999, ANN NY ACAD SCI, V868, P97, DOI 10.1111/j.1749-6632.1999.tb11280.x; Mitrovic N, 2000, J GEN PHYSIOL, V115, P707, DOI 10.1085/jgp.115.6.707; Ong BH, 2000, J GEN PHYSIOL, V116, P653, DOI 10.1085/jgp.116.5.653; PEROZO E, 1989, J GEN PHYSIOL, V93, P1195, DOI 10.1085/jgp.93.6.1195; Raman IM, 2001, BIOPHYS J, V80, P729, DOI 10.1016/S0006-3495(01)76052-3; RUDY B, 1978, J PHYSIOL-LONDON, V283, P1; SCHWINDT PC, 1995, J NEUROPHYSIOL, V74, P2220, DOI 10.1152/jn.1995.74.5.2220; Struyk AF, 2002, J GEN PHYSIOL, V120, P509, DOI 10.1085/jgp.20028672; Stuart G, 1999, NAT NEUROSCI, V2, P144, DOI 10.1038/5698; Stuart G., 1999, DENDRITES; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; SURMEIER DJ, 1992, P NATL ACAD SCI USA, V89, P10178, DOI 10.1073/pnas.89.21.10178; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3; Todt H, 1999, BIOPHYS J, V76, P1335, DOI 10.1016/S0006-3495(99)77296-6; Toib A, 1998, J NEUROSCI, V18, P1893; Townsend C, 1997, J GEN PHYSIOL, V110, P23, DOI 10.1085/jgp.110.1.23; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 1996, J NEUROPHYSIOL, V75, P963, DOI 10.1152/jn.1996.75.2.963; Vedantham V, 1998, J GEN PHYSIOL, V111, P83, DOI 10.1085/jgp.111.1.83; Vedantham V, 2000, BIOPHYS J, V78, P2943, DOI 10.1016/S0006-3495(00)76834-2; Vilin YY, 2001, BIOPHYS J, V80, P2221, DOI 10.1016/S0006-3495(01)76195-4; Vilin YY, 2001, CELL BIOCHEM BIOPHYS, V35, P171, DOI 10.1385/CBB:35:2:171; Vilin YY, 1999, BIOPHYS J, V77, P1384, DOI 10.1016/S0006-3495(99)76987-0; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002	50	135	136	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 28	2003	39	5					793	806		10.1016/S0896-6273(03)00531-2	http://dx.doi.org/10.1016/S0896-6273(03)00531-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	717GN	12948446	Bronze			2022-12-24	WOS:000185079300009
J	Fukuchi-Shimogori, T; Grove, EA				Fukuchi-Shimogori, T; Grove, EA			Emx2 patterns the neocortex by regulating FGF positional signaling	NATURE NEUROSCIENCE			English	Article							CEREBRAL-CORTEX; MOLECULAR REGIONALIZATION; AREA IDENTITY; MOUSE-BRAIN; EXPRESSION; SPECIFICATION; GENES; TELENCEPHALON; MECHANISMS; FAMILY	Molecular genetic studies implicate fibroblast growth factor 8 (FGF8), and the transcription factor Emx2, in development of the neocortical area map. Both are proposed to specify area position along the anterior-to-posterior axis of the cortical primordium. Whether FGF8 and Emx2 act independently or coordinately, or whether one controls the other, has not been determined. Here we report that Emx2, by regulating FGF8, has an indirect but vital role in area-map development. Using electroporation- mediated gene transfer in living mouse embryos, we found that overexpressing Emx2 altered the area map, but only when ectopic Emx2 overlapped the FGF8 source. Furthermore, we found that FGF8 levels were decreased by excess Emx2, and increased in mice lacking Emx2. Finally, cortical domain shifts that characterize Emx2 mutants were rescued by sequestering excess FGF8 with a truncated FGF receptor construct. These findings begin to clarify the signaling network that patterns the neocortical area map.	Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	University of Chicago	Grove, EA (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, 947 E 58th St,MC0926, Chicago, IL 60637 USA.	egrove@drugs.bsd.uchicago.edu	Shimogori, Tomomi/L-2893-2013	Shimogori, Tomomi/0000-0002-6931-5401				Agarwala S, 2001, SCIENCE, V291, P2147, DOI 10.1126/science.1058624; Aoto K, 2002, DEV BIOL, V251, P320, DOI 10.1006/dbio.2002.0811; Arimatsu Y, 1999, DEVELOPMENT, V126, P629; Bachler M, 2001, MECH DEVELOP, V100, P313, DOI 10.1016/S0925-4773(00)00518-9; BARBE MF, 1991, J NEUROSCI, V11, P519; Bishop KM, 2002, J NEUROSCI, V22, P7627; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Cecchi C, 2000, TRENDS NEUROSCI, V23, P347, DOI 10.1016/S0166-2236(00)01608-8; COHENTANNOUDJI M, 1994, NATURE, V368, P460, DOI 10.1038/368460a0; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Eagleson KL, 1999, CEREB CORTEX, V9, P562, DOI 10.1093/cercor/9.6.562; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Garel S, 2003, DEVELOPMENT, V130, P1903, DOI 10.1242/dev.00416; GROVE EA, 1992, NEURON, V8, P217, DOI 10.1016/0896-6273(92)90289-P; Grove EA, 1998, DEVELOPMENT, V125, P2315; Mackarehtschian K, 1999, CEREB CORTEX, V9, P601, DOI 10.1093/cercor/9.6.601; Mallamaci A, 1998, MECH DEVELOP, V77, P165, DOI 10.1016/S0925-4773(98)00141-5; Mallamaci A, 2000, NAT NEUROSCI, V3, P679, DOI 10.1038/76630; Mallamaci A, 2000, J NEUROSCI, V20, P1109, DOI 10.1523/JNEUROSCI.20-03-01109.2000; Maruoka Y, 1998, MECH DEVELOP, V74, P175, DOI 10.1016/S0925-4773(98)00061-6; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; Monuki ES, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn752; Muzio L, 2002, CEREB CORTEX, V12, P129, DOI 10.1093/cercor/12.2.129; Nakagawa Y, 1999, J NEUROSCI, V19, P10877, DOI 10.1523/JNEUROSCI.19-24-10877.1999; Nauta W., 1986, FUNDAMENTAL NEUROANA; O'Leary DDM, 2002, CURR OPIN NEUROBIOL, V12, P14, DOI 10.1016/S0959-4388(02)00285-4; Ornitz DM, 2001, GENOME BIOL, V2; Pellegrini M, 1996, DEVELOPMENT, V122, P3893; Ragsdale CW, 2001, CURR OPIN NEUROBIOL, V11, P50, DOI 10.1016/S0959-4388(00)00173-2; Raible F, 2001, MECH DEVELOP, V107, P105, DOI 10.1016/S0925-4773(01)00456-7; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rubenstein JLR, 1999, CEREB CORTEX, V9, P524, DOI 10.1093/cercor/9.6.524; Shamim H, 1999, DEVELOPMENT, V126, P945; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Theil T, 1999, DEVELOPMENT, V126, P3561; Tole S, 2001, J NEUROSCI, V21, P1580, DOI 10.1523/JNEUROSCI.21-05-01580.2001; Tole S, 2000, DEV BIOL, V217, P254, DOI 10.1006/dbio.1999.9509; Wolpert L, 1996, TRENDS GENET, V12, P359, DOI 10.1016/S0168-9525(96)80019-9; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; Xu JS, 2000, DEVELOPMENT, V127, P1833; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Ye WL, 2001, NAT NEUROSCI, V4, P1175, DOI 10.1038/nn761; Yoshida M, 1997, DEVELOPMENT, V124, P101; Zhou C, 2001, GENE DEV, V15, P2054, DOI 10.1101/gad.913601	49	146	151	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					825	831		10.1038/nn1093	http://dx.doi.org/10.1038/nn1093			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12872126				2022-12-24	WOS:000184413700011
J	Yevenes, GE; Peoples, RW; Tapia, JC; Parodi, J; Soto, X; Olate, J; Aguayo, LG				Yevenes, GE; Peoples, RW; Tapia, JC; Parodi, J; Soto, X; Olate, J; Aguayo, LG			Modulation of glycine-activated ion channel function by G-protein beta gamma subunits	NATURE NEUROSCIENCE			English	Article							VOLTAGE-DEPENDENT MODULATION; RAT SYMPATHETIC NEURONS; MOUSE SPINAL NEURONS; DORSAL HORN NEURONS; CALCIUM-CHANNELS; CA2+ CHANNELS; GABA(B) RECEPTOR; K+ CHANNELS; INHIBITION; EXPRESSION	Glycine receptors (GlyRs), together with GABA(A) and nicotinic acetylcholine (ACh) receptors, form part of the ligand-activated ion channel superfamily and regulate the excitability of the mammalian brain stem and spinal cord. Here we report that the ability of the neurotransmitter glycine to gate recombinant and native ionotropic GlyRs is modulated by the G protein betagamma dimer (Gbetagamma). We found that the amplitude of the glycine-activated Cl(-) current was enhanced after application of purified Gbetagamma or after activation of a G protein-coupled receptor. Overexpression of three distinct G protein alpha subunits (Galpha), as well as the Gbetagamma scavenger peptide ct-GRK2, significantly blunted the effect of G protein activation. Single-channel recordings from isolated membrane patches showed that Gbetagamma increased the GlyR open probability (nP(o)). Our results indicate that this interaction of Gbetagamma with GlyRs regulates both motor and sensory functions in the central nervous system.	Univ Concepcion, Dept Physiol, Neurophysiol Lab, Concepcion, Chile; NIAAA, Unit Cellular Neuropharmacol, Mol & Cellular Neurobiol Lab, NIH, Bethesda, MD 20892 USA; Univ Concepcion, Dept Mol Biol, Mol Genet Lab, Concepcion, Chile	Universidad de Concepcion; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Universidad de Concepcion	Aguayo, LG (corresponding author), Univ Concepcion, Dept Physiol, Neurophysiol Lab, Box 160-C, Concepcion, Chile.	laguayo@udec.cl	Soto, Ximena/HHN-6524-2022	Parodi, Jorge/0000-0002-9117-5433; Soto Rodriguez, Ximena/0000-0003-2680-1837; Yevenes, Gonzalo/0000-0003-0294-4075	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000448] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Ahmadi S, 2002, NAT NEUROSCI, V5, P34, DOI 10.1038/nn778; Asano T, 1999, J BIOL CHEM, V274, P21425, DOI 10.1074/jbc.274.30.21425; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Beato M, 2002, J GEN PHYSIOL, V119, P443, DOI 10.1085/jgp.20028530; BETZ H, 1991, TRENDS NEUROSCI, V14, P458, DOI 10.1016/0166-2236(91)90045-V; Blackmer T, 2001, SCIENCE, V292, P293, DOI 10.1126/science.1058803; Canti C, 1999, J NEUROSCI, V19, P6855, DOI 10.1523/JNEUROSCI.19-16-06855.1999; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; Daaka Y, 1997, P NATL ACAD SCI USA, V94, P2180, DOI 10.1073/pnas.94.6.2180; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; Diverse-Pierluissi M, 2000, J BIOL CHEM, V275, P28380, DOI 10.1074/jbc.M003571200; Dolphin AC, 1998, J PHYSIOL-LONDON, V506, P3, DOI 10.1111/j.1469-7793.1998.003bx.x; Geiman EJ, 2002, J COMP NEUROL, V444, P275, DOI 10.1002/cne.10148; GILMAN AG, 1995, BIOSCIENCE REP, V15, P65, DOI 10.1007/BF01200143; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Harris RA, 1999, ALCOHOL CLIN EXP RES, V23, P1563, DOI 10.1097/00000374-199910000-00001; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HWANG AS, 1989, J PHARMACOL EXP THER, V248, P1026; Ikeda SR, 1999, ADV SEC MESS PHOSPH, V33, P131; Jeong SW, 1999, J NEUROSCI, V19, P4755; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Kammermeier PJ, 1999, NEURON, V22, P819, DOI 10.1016/S0896-6273(00)80740-0; KANGRGA I, 1991, BRAIN RES, V562, P265, DOI 10.1016/0006-8993(91)90630-E; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P29059, DOI 10.1074/jbc.270.49.29059; Legendre P, 2001, CELL MOL LIFE SCI, V58, P760, DOI 10.1007/PL00000899; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Mark MD, 2000, EUR J BIOCHEM, V267, P5830, DOI 10.1046/j.1432-1327.2000.01670.x; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; ROGERS CJ, 1994, J PHYSIOL-LONDON, V475, P69, DOI 10.1113/jphysiol.1994.sp020050; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Ruiz-Velasco V, 2000, J NEUROSCI, V20, P2183; Ruiz-Velasco V, 2001, J PHYSIOL-LONDON, V537, P679; SAWYNOK J, 1984, PROG NEURO-PSYCHOPH, V8, P581, DOI 10.1016/0278-5846(84)90018-6; Scanziani M, 2000, NEURON, V25, P673, DOI 10.1016/S0896-6273(00)81069-7; SCHMID K, 1991, RESP PHYSIOL, V84, P351, DOI 10.1016/0034-5687(91)90129-7; SONG Y, 1990, NATURE, V348, P242, DOI 10.1038/348242a0; Tapia JC, 2001, NEUROSCIENCE, V108, P493, DOI 10.1016/S0306-4522(01)00348-7; Towers S, 2000, EUR J NEUROSCI, V12, P3201, DOI 10.1046/j.1460-9568.2000.00237.x; VAELLO ML, 1994, J BIOL CHEM, V269, P2002; van Zundert B, 2002, J NEUROPHYSIOL, V87, P640, DOI 10.1152/jn.00455.2001; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0	46	72	76	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2003	6	8					819	824		10.1038/nn1095	http://dx.doi.org/10.1038/nn1095			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705UP	12858180				2022-12-24	WOS:000184413700010
J	Rosenzweig, ES; Redish, AD; McNaughton, BL; Barnes, CA				Rosenzweig, ES; Redish, AD; McNaughton, BL; Barnes, CA			Hippocampal map realignment and spatial learning	NATURE NEUROSCIENCE			English	Article							RABBIT FOLLOWING STIMULATION; LONG-LASTING POTENTIATION; SINGLE-UNIT-ACTIVITY; FREELY-MOVING RAT; PLACE CELLS; PATH INTEGRATION; SYNAPTIC TRANSMISSION; ENVIRONMENTAL CUES; ENSEMBLE ACTIVITY; PERFORANT PATH	The spatial selectivity of hippocampal neurons suggests that they contribute to an internal representation of current location. The activity of hippocampal pyramidal cells was recorded while adult (10-13 months old) and aged (24-28 months old) rats performed a task in which two spatial reference frames were put in conflict. Rats attempted to find an unmarked goal whose position was fixed relative to only one of the two reference frames. The ability of a rat's hippocampus to adjust to the conflicting information and use the 'correct' position estimate (hippocampal map 'realignment') was correlated with the rat's ability to find the hidden goal. In addition, aged rats were impaired relative to adult rats in both goal-finding accuracy and map realignment. Thus, changes in the effectiveness with which the hippocampal spatial representation is updated on the basis of external cues may contribute to both within-age-group spatial learning variability and age-related spatial learning deficits.	Univ Arizona, Arizona Res Labs, Div Neural Syst Memory & Aging, Tucson, AZ 85724 USA; Univ Arizona, Dept Psychol, Tucson, AZ 85724 USA; Univ Arizona, Dept Physiol, Tucson, AZ 85724 USA; Univ Arizona, Dept Neurol, Tucson, AZ 85724 USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona	Barnes, CA (corresponding author), Univ Arizona, Arizona Res Labs, Div Neural Syst Memory & Aging, 384 Life Sci N, Tucson, AZ 85724 USA.	carol@nsma.arizona.edu	Rosenzweig, Ephron/AAI-7541-2020	Rosenzweig, Ephron/0000-0002-0370-9643	NATIONAL INSTITUTE ON AGING [R37AG012609, F32AG005805, R01AG012609] Funding Source: NIH RePORTER; NIA NIH HHS [AG05805, AG12609] Funding Source: Medline; NIMH NIH HHS [MH01565] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Barnes CA, 1990, HDB NEUROPSYCHOLOGY, P169; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bures J, 1997, P NATL ACAD SCI USA, V94, P343, DOI 10.1073/pnas.94.1.343; Cooper BG, 2001, J NEUROSCI, V21, P3986, DOI 10.1523/JNEUROSCI.21-11-03986.2001; Foster TC, 1999, BRAIN RES REV, V30, P236, DOI 10.1016/S0165-0173(99)00017-X; GALLAGHER M, 1988, NEUROBIOL AGING, V9, P363, DOI 10.1016/S0197-4580(88)80082-4; Gothard KM, 1996, J NEUROSCI, V16, P8027; Gothard KM, 2001, J NEUROSCI, V21, P7284, DOI 10.1523/JNEUROSCI.21-18-07284.2001; Gothard KM, 1996, J NEUROSCI, V16, P823; Jeffery KJ, 1999, EXP BRAIN RES, V127, P151, DOI 10.1007/s002210050785; Jeffery KJ, 2003, HIPPOCAMPUS, V13, P175, DOI 10.1002/hipo.10047; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; Kubie J. L., 1983, NEUROBIOLOGY HIPPOCA, P433; Lenck-Santini PP, 2002, J NEUROSCI, V22, P9035; Lenck-Santini PP, 2001, HIPPOCAMPUS, V11, P377, DOI 10.1002/hipo.1052; LEVY WB, 1979, BRAIN RES, V175, P233, DOI 10.1016/0006-8993(79)91003-5; MARKUS EJ, 1994, HIPPOCAMPUS, V4, P410, DOI 10.1002/hipo.450040404; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; MCNAUGHTON BL, 1978, BRAIN RES, V157, P277, DOI 10.1016/0006-8993(78)90030-6; MCNAUGHTON BL, 1983, J NEUROSCI METH, V8, P391, DOI 10.1016/0165-0270(83)90097-3; McNaughton BL, 1996, J EXP BIOL, V199, P173; MIZUMORI SJY, 1989, J NEUROPHYSIOL, V61, P15, DOI 10.1152/jn.1989.61.1.15; MIZUMORI SJY, 1994, BRAIN RES, V644, P168, DOI 10.1016/0006-8993(94)90361-1; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1987, J NEUROSCI, V7, P1935; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; OKEEFE J, 1987, EXP BRAIN RES, V68, P1; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; PICO RM, 1985, BRAIN RES, V330, P369, DOI 10.1016/0006-8993(85)90700-0; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Redish A. D., 1999, COGNITIVE MAP PLACE, DOI DOI 10.1038/nature14445; Redish AD, 1997, HIPPOCAMPUS, V7, P15; Redish AD, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-05-j0004.2001; Redish AD, 2000, J NEUROSCI, V20, P9298; ROSENZWEIG ES, 2003, IN PRESS PROG NEUROB; Rotenberg A, 2000, J NEUROSCI, V20, P8096; Samsonovich A, 1997, J NEUROSCI, V17, P5900; SHAPIRO ML, 1989, NEUROSCIENCE, V32, P1, DOI 10.1016/0306-4522(89)90103-6; SHARP PE, 1995, J NEUROSCI, V15, P173; Tanila H, 1997, J NEUROSCI, V17, P5167; Tanila H, 1997, J NEUROSCI, V17, P5155; Touretzky DS, 1996, HIPPOCAMPUS, V6, P247; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Wilson IA, 2003, NEUROBIOL AGING, V24, P297, DOI 10.1016/S0197-4580(02)00080-5; Wilson MA, 1997, TRENDS NEUROSCI, V20, P102, DOI 10.1016/S0166-2236(96)01023-5; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	50	58	63	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					609	615		10.1038/nn1053	http://dx.doi.org/10.1038/nn1053			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12717437				2022-12-24	WOS:000183140400018
J	Kalatsky, VA; Stryker, MP				Kalatsky, VA; Stryker, MP			New paradigm for optical imaging: Temporally encoded maps of intrinsic signal	NEURON			English	Article							PRIMARY VISUAL-CORTEX; VOLTAGE-SENSITIVE DYES; MONKEY STRIATE CORTEX; RETINOTOPIC ORGANIZATION; FUNCTIONAL ARCHITECTURE; MOUSE; ORIENTATION; CONNECTIONS; AREA; PLASTICITY	We present a new technique for acquiring and analyzing intrinsic signal optical images of brain activity, using continuous stimulus presentation and data acquisition. The main idea is to present a temporally periodic stimulus and to analyze the component of the response at the stimulus frequency. Advantages of the new technique include the removal of heart, respiration, and vasomotor artifacts, a dramatic increase in spatial resolution, and a 30-fold or greater reduction in acquisition time. We also present a novel approach to localizing instantaneous neuronal responses using time-reversed stimuli that is widely applicable to brain imaging. To demonstrate the power of the technique, we present high-resolution retinotopic maps of five visual areas in mouse cortex and orientation maps in cat visual cortex.	Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Stryker, MP (corresponding author), Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA.			Stryker, Michael/0000-0003-1546-5831	NATIONAL EYE INSTITUTE [R01EY002874, R37EY002874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016033, P01NS016033] Funding Source: NIH RePORTER; NEI NIH HHS [EY 02874, R01 EY002874, R37 EY002874-24] Funding Source: Medline; NINDS NIH HHS [NS 16033, P01 NS016033] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antonini A, 1999, J NEUROSCI, V19, P4388; Blasdel G, 2001, J NEUROSCI, V21, P8286, DOI 10.1523/JNEUROSCI.21-20-08286.2001; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bonhoeffer Tobias, 1996, P55; Bosking WH, 2000, J NEUROSCI, V20, P2346; Bosking WH, 2002, NAT NEUROSCI, V5, P874, DOI 10.1038/nn908; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; Das A, 1997, NATURE, V387, P594, DOI 10.1038/42461; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Gordon JA, 1996, J NEUROSCI, V16, P3274; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; HUBEL DH, 1974, J COMP NEUROL, V158, P295, DOI 10.1002/cne.901580305; Issa NP, 2000, J NEUROSCI, V20, P8504, DOI 10.1523/JNEUROSCI.20-22-08504.2000; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; MANGINI NJ, 1980, J COMP NEUROL, V193, P203, DOI 10.1002/cne.901930114; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Mayhew JEW, 1996, NEUROIMAGE, V4, P183, DOI 10.1006/nimg.1996.0069; METIN C, 1988, EXP BRAIN RES, V69, P594; MITRA PP, 1999, IMAGING NEURONS LAB; OLAVARRIA J, 1982, EXP NEUROL, V78, P775, DOI 10.1016/0014-4886(82)90090-5; OLAVARRIA J, 1989, VISUAL NEUROSCI, V3, P59, DOI 10.1017/S0952523800012517; Schuett S, 2002, J NEUROSCI, V22, P6549; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; WAGOR E, 1980, J COMP NEUROL, V193, P187, DOI 10.1002/cne.901930113; White LE, 1999, J NEUROSCI, V19, P7089, DOI 10.1523/JNEUROSCI.19-16-07089.1999; Williams RW, 1996, J NEUROSCI, V16, P7193; ZEKI S, 1980, PROC R SOC SER B-BIO, V207, P239, DOI 10.1098/rspb.1980.0022; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452	37	401	408	1	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 22	2003	38	4					529	545		10.1016/S0896-6273(03)00286-1	http://dx.doi.org/10.1016/S0896-6273(03)00286-1			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	682QV	12765606	Bronze			2022-12-24	WOS:000183104000005
J	Malatesta, P; Hack, MA; Hartfuss, E; Kettenmann, H; Klinkert, W; Kirchhoff, F; Gotz, M				Malatesta, P; Hack, MA; Hartfuss, E; Kettenmann, H; Klinkert, W; Kirchhoff, F; Gotz, M			Neuronal or glial progeny: Regional differences in radial glia fate	NEURON			English	Article							NEURAL STEM-CELLS; GREEN FLUORESCENT PROTEIN; SUBVENTRICULAR ZONE; CEREBRAL-CORTEX; TRANSGENIC MICE; STRIATAL INTERNEURONS; GANGLIONIC EMINENCE; BRAIN-DEVELOPMENT; DOUBLE REPORTER; RAT FOREBRAIN	The precursor function of the ubiquitous glial cell type in the developing central nervous system (CNS), the radial glia, is largely unknown. Using Cre/IoxP in vivo fate mapping studies, we found that radial glia generate virtually all cortical projection neurons but not the interneurons originating in the ventral telencephalon. In contrast to the cerebral cortex, few neurons in the basal ganglia originate from radial glia, and in vitro lineage analysis revealed intrinsic differences in the potential of radial glia from the dorsal and ventral telencephalon. This shows that the progeny of radial glia not only differs profoundly between brain regions but also includes the majority of neurons in some parts of the CNS.	Max Planck Inst Neurobiol, D-82152 Planegg Martinsried, Germany; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; Max Planck Inst Expt Med, D-37075 Gottingen, Germany	Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society	Gotz, M (corresponding author), Max Planck Inst Neurobiol, Klopferzpitz 18A, D-82152 Planegg Martinsried, Germany.	mgoetz@neuro.mpg.de	Kettenmann, Helmut/AAJ-5142-2021; Kirchhoff, Frank/B-9335-2008; Malatesta, Paolo/J-3570-2012	Kirchhoff, Frank/0000-0002-2324-2761; Malatesta, Paolo/0000-0003-3045-3361; Gotz, Magdalena/0000-0003-1551-9203; Kettenmann, Helmut/0000-0001-8208-0291				Aaku-Saraste E, 1997, MECH DEVELOP, V69, P71, DOI 10.1016/S0925-4773(97)00156-1; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Alves JAJ, 2002, J NEUROBIOL, V52, P251, DOI 10.1002/neu.10087; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; BOULDER C, 1970, ANAT REC, V166, P257; Campbell K, 2002, TRENDS NEUROSCI, V25, P235, DOI 10.1016/S0166-2236(02)02156-2; Casarosa S, 1999, DEVELOPMENT, V126, P525; Chanas-Sacre G, 2000, DEV DYNAM, V219, P514, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1078>3.0.CO;2-0; CHOI BH, 1981, DEV BRAIN RES, V1, P249, DOI 10.1016/0165-3806(81)90112-7; Corbin JG, 2000, DEVELOPMENT, V127, P5007; DENISDONINI S, 1984, NATURE, V307, P641, DOI 10.1038/307641a0; Diers-Fenger M, 2001, GLIA, V34, P213, DOI 10.1002/glia.1055; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dragatsis I, 2000, GENESIS, V26, P133, DOI 10.1002/(SICI)1526-968X(200002)26:2<133::AID-GENE10>3.0.CO;2-V; Dymecki SM, 1998, DEV BIOL, V201, P57, DOI 10.1006/dbio.1998.8971; Eisenstat DD, 1999, J COMP NEUROL, V414, P217, DOI 10.1002/(SICI)1096-9861(19991115)414:2<217::AID-CNE6>3.0.CO;2-I; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Garel S, 1999, DEVELOPMENT, V126, P5285; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; GRAY GE, 1992, DEVELOPMENT, V114, P271; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Hirasawa M, 2001, NEUROSCI RES, V40, P125, DOI 10.1016/S0168-0102(01)00216-4; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; KITA H, 1994, BRAIN RES, V657, P31, DOI 10.1016/0006-8993(94)90950-4; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Marin O, 2000, J NEUROSCI, V20, P6063; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Nolte C, 2001, GLIA, V33, P72; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Olsson M, 1998, NEUROSCIENCE, V84, P867, DOI 10.1016/S0306-4522(97)00532-0; Ouimet CC, 1998, BRAIN RES, V808, P8, DOI 10.1016/S0006-8993(98)00724-0; Polleux F, 1997, J COMP NEUROL, V385, P95; PORTEUS MH, 1994, J NEUROSCI, V14, P6370; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Reid CB, 2002, J NEUROSCI, V22, P4002, DOI 10.1523/JNEUROSCI.22-10-04002.2002; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; Skogh C, 2001, MOL CELL NEUROSCI, V17, P811, DOI 10.1006/mcne.2001.0973; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; SMART IHM, 1976, J ANAT, V121, P71; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Staugaitis SM, 2001, J NEUROSCI, V21, P6195, DOI 10.1523/JNEUROSCI.21-16-06195.2001; Stenman J, 2003, J NEUROSCI, V23, P167; Stoykova A, 1997, DEVELOPMENT, V124, P3765; Tamamaki N, 2001, NEUROSCI RES, V41, P51, DOI 10.1016/S0168-0102(01)00259-0; Toresson H, 2001, DEVELOPMENT, V128, P4769; Toresson H, 2000, DEVELOPMENT, V127, P4361; VANDERKOOY D, 1987, BRAIN RES, V401, P155, DOI 10.1016/0006-8993(87)91176-0; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; Wagner J, 1999, NAT BIOTECHNOL, V17, P653, DOI 10.1038/10862; Yamamoto S, 2001, EXP NEUROL, V172, P115, DOI 10.1006/exnr.2001.7798; Yun K, 2001, DEVELOPMENT, V128, P193; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6	67	568	581	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 6	2003	37	5					751	764		10.1016/S0896-6273(03)00116-8	http://dx.doi.org/10.1016/S0896-6273(03)00116-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	653TH	12628166	Bronze			2022-12-24	WOS:000181452800005
J	Flames, N; Long, JE; Garratt, AN; Fischer, TM; Gassmann, M; Birchmeier, C; Lai, C; Rubenstein, JLR; Marin, O				Flames, N; Long, JE; Garratt, AN; Fischer, TM; Gassmann, M; Birchmeier, C; Lai, C; Rubenstein, JLR; Marin, O			Short- and long-range attraction of cortical GABAergic interneurons by Neuregulin-1	NEURON			English	Article							MEDIAL GANGLIONIC EMINENCE; DEVELOPING CEREBRAL-CORTEX; SCHWANN-CELL MOTILITY; AT-RISK HAPLOTYPE; NEOCORTICAL DEVELOPMENT; TANGENTIAL MIGRATION; NEURONAL MIGRATION; MAMMARY-GLAND; RADIAL GLIA; SCHIZOPHRENIA	Most cortical interneurons arise from the subcortical telencephalon, but the molecules that control their migration remain largely unidentified. Here, we show that different isoforms of Neuregulin-1 are expressed in the developing cortex and in the route that migrating interneurons follow toward the cortex, whereas a population of the migrating interneurons express ErbB4 a receptor for Neuregulin-1. The different isoforms of Neuregulin-1 act as short- and long-range attractants for migrating interneurons, and perturbing ErbB4 function in vitro decreases the number of interneurons that tangentially migrate to the cortex. In vivo, loss of Neuregulin-1/ErbB4 signaling causes an alteration in the tangential migration of cortical interneurons and a reduction in the number of GABAergic interneurons in the postnatal cortex. These observations provide evidence that Neuregulin-1 and its ErbB4 receptor directly control neuronal migration in the nervous system.	CSIC, Inst Neurociencias Alicante, San Juan de Alicante 03550, Spain; Univ Miguel Hernandez, San Juan de Alicante 03550, Spain; Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94143 USA; Max Delbrueck Ctr, D-13125 Berlin, Germany; Scripps Res Inst, La Jolla, CA 92037 USA; Univ Basel, Dept Physiol, Biozentrum, Pharmazentrum, CH-4056 Basel, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad Miguel Hernandez de Elche; University of California System; University of California San Francisco; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Scripps Research Institute; University of Basel	Marin, O (corresponding author), CSIC, Inst Neurociencias Alicante, San Juan de Alicante 03550, Spain.	o.marin@umh.es	Marin, Oscar/F-3856-2012; Garratt, Alistair/HGC-0774-2022; Garratt, Alistair/AAG-2715-2021; Garratt, Alistair N/D-9893-2013; Flames, Nuria/L-2290-2017	Marin, Oscar/0000-0001-6264-7027; Garratt, Alistair N/0000-0001-9631-3041; Flames, Nuria/0000-0003-0961-0609; Gassmann, Martin/0000-0001-6201-3032	NIDA NIH HHS [R01DA12462] Funding Source: Medline; NIMH NIH HHS [R01MH51561, K02MH01046, R01MH49428] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051561, R01MH049428, K02MH001046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012462] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adlkofer K, 2000, GLIA, V29, P104, DOI 10.1002/(SICI)1098-1136(20000115)29:2<104::AID-GLIA2>3.0.CO;2-2; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 2002, CEREB CORTEX, V12, P702, DOI 10.1093/cercor/12.7.702; Anderson SA, 2001, DEVELOPMENT, V128, P353; Ang ESBC, 2003, J NEUROSCI, V23, P5805; Anton ES, 1997, DEVELOPMENT, V124, P3501; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Caric D, 2001, DEVELOPMENT, V128, P4203; Casarosa S, 1999, DEVELOPMENT, V126, P525; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; Corvin AP, 2004, MOL PSYCHIATR, V9, P208, DOI 10.1038/sj.mp.4001412; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Harrison PJ, 2003, LANCET, V361, P417, DOI 10.1016/S0140-6736(03)12379-3; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Jimenez D, 2002, DEV BIOL, V244, P155, DOI 10.1006/dbio.2002.0586; Jones FE, 1999, J CELL BIOL, V147, P77, DOI 10.1083/jcb.147.1.77; Keverne EB, 1999, BRAIN RES BULL, V48, P467, DOI 10.1016/S0361-9230(99)00025-8; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Lewis DA, 2000, BRAIN RES REV, V31, P270, DOI 10.1016/S0165-0173(99)00042-9; Li T, 2004, MOL PSYCHIATR, V9, P698, DOI 10.1038/sj.mp.4001485; Mahanthappa NK, 1996, J NEUROSCI, V16, P4673; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marin O, 2003, DEVELOPMENT, V130, P1889, DOI 10.1242/dev.00417; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Martinez S, 1999, DEVELOPMENT, V126, P1189; Mazumdar A, 2001, CANCER RES, V61, P400; Meintanis S, 2001, GLIA, V34, P39, DOI 10.1002/glia.1038; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Pleasure SJ, 2000, NEURON, V28, P727, DOI 10.1016/S0896-6273(00)00149-5; Polleux F, 2002, DEVELOPMENT, V129, P3147; Powell EM, 2001, NEURON, V30, P79, DOI 10.1016/S0896-6273(01)00264-1; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Sussel L, 1999, DEVELOPMENT, V126, P3359; TAN SS, 1995, DEVELOPMENT, V121, P1029; TAN SS, 1993, NATURE, V362, P638, DOI 10.1038/362638a0; Tang JX, 2004, MOL PSYCHIATR, V9, P11, DOI 10.1038/sj.mp.4001436; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Wichterle H, 2003, P NATL ACAD SCI USA, V100, P727, DOI 10.1073/pnas.242721899; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Williams NM, 2003, MOL PSYCHIATR, V8, P485, DOI 10.1038/sj.mp.4001348; Woo TU, 1998, P NATL ACAD SCI USA, V95, P5341, DOI 10.1073/pnas.95.9.5341; Yang JZ, 2003, MOL PSYCHIATR, V8, P706, DOI 10.1038/sj.mp.4001377; Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6	58	329	339	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 14	2004	44	2					251	261		10.1016/j.neuron.2004.09.028	http://dx.doi.org/10.1016/j.neuron.2004.09.028			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	864LU	15473965	Bronze			2022-12-24	WOS:000224635800009
J	Rico, B; Beggs, HE; Schahin-Reed, D; Kimes, N; Schmidt, A; Reichardt, LF				Rico, B; Beggs, HE; Schahin-Reed, D; Kimes, N; Schmidt, A; Reichardt, LF			Control of axonal branching and synapse formation by focal adhesion kinase	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; CENTRAL-NERVOUS-SYSTEM; P190 RHOGAP; IN-VIVO; PROTEIN; GROWTH; CELLS; PHOSPHORYLATION; PLASTICITY; STABILITY	The formation of neuronal networks in the central nervous system (CNS) requires precise control of axonal branch development and stabilization. Here we show that cell-specific ablation of the murine gene Ptk2 (more commonly known as fak), encoding focal adhesion kinase (FAK), increases the number of axonal terminals and synapses formed by neurons in vivo. Consistent with this, fak mutant neurons also form greater numbers of axonal branches in culture because they have increased branch formation and reduced branch retraction. Expression of wild-type FAK, but not that of several FAK variants that prevent interactions with regulators of Rho family GTPases including the p190 Rho guanine nuclear exchange factor (p190RhoGEF), rescues the axonal arborization phenotype observed in fak mutant neurons. In addition, expression of a mutant p190RhoGEF that cannot associate with FAK results in a phenotype very similar to that of neurons lacking FAK. Thus, FAK functions as a negative regulator of axonal branching and synapse formation, and it seems to exert its actions, in part, through Rho family GTPases.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Reichardt, LF (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	brico@umh.es; lfr@cgl.ucsf.edu		Rico, Beatriz/0000-0002-0581-851X	NINDS NIH HHS [R01 NS019090-26, R01 NS019090] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019090] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARREGUI CO, 1994, J NEUROSCI, V14, P6967; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; BAPTISTA CA, 1994, NEURON, V12, P243, DOI 10.1016/0896-6273(94)90268-2; Barry ST, 1996, CELL ADHES COMMUN, V4, P387, DOI 10.3109/15419069709004456; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Bradke F, 2000, CURR BIOL, V10, P1467, DOI 10.1016/S0960-9822(00)00807-1; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Chan-Palay V, 1977, CEREBELLAR DENTATE N; Contestabile A, 2003, INT J DEV NEUROSCI, V21, P83, DOI 10.1016/S0736-5748(02)00126-0; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gao PP, 1999, P NATL ACAD SCI USA, V96, P4073, DOI 10.1073/pnas.96.7.4073; Garin N, 2002, J COMP NEUROL, V447, P210, DOI 10.1002/cne.10226; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169; ILLC D, 1995, NATURE, V377, P539; Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574, DOI 10.1038/35023515; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Klingbeil CK, 2001, J CELL BIOL, V152, P97, DOI 10.1083/jcb.152.1.97; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Mandell JW, 1996, J NEUROSCI, V16, P5727; Mantych KB, 2001, J NEUROSCI, V21, P6802, DOI 10.1523/JNEUROSCI.21-17-06802.2001; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; Menegon A, 1999, EUR J NEUROSCI, V11, P3777, DOI 10.1046/j.1460-9568.1999.00798.x; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; OBERDICK J, 1988, NEURON, V1, P367, DOI 10.1016/0896-6273(88)90186-9; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Ren XD, 2000, J CELL SCI, V113, P3673; Rico B, 2002, NAT NEUROSCI, V5, P225, DOI 10.1038/nn808; Rohrbough J, 2000, J NEUROSCI, V20, P6868, DOI 10.1523/JNEUROSCI.20-18-06868.2000; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Seki T, 1998, J NEUROSCI, V18, P3757; Sorra KE, 1998, J COMP NEUROL, V398, P225; Taylor JM, 1999, J CELL SCI, V112, P231; Thies E, 2003, J NEUROBIOL, V54, P358, DOI 10.1002/neu.10135; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Yang YC, 2003, J NEUROSCI, V23, P4072; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhai JB, 2003, J BIOL CHEM, V278, P24865, DOI 10.1074/jbc.M302381200	50	143	145	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1059	1069		10.1038/nn1317	http://dx.doi.org/10.1038/nn1317			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15378065	Green Accepted			2022-12-24	WOS:000224156900015
J	He, XP; Kotloski, R; Nef, S; Luikart, BW; Parada, LF; McNamara, JO				He, XP; Kotloski, R; Nef, S; Luikart, BW; Parada, LF; McNamara, JO			Conditional deletion of TrkB but not BDNF prevents epileptogenesis in the kindling model	NEURON			English	Article							LONG-TERM POTENTIATION; TEMPORAL-LOBE EPILEPSY; SEIZURE-INDUCED ACTIVATION; MESSENGER-RNA EXPRESSION; DENTATE GRANULE CELLS; MOSSY FIBER PATHWAY; NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR; KAINIC ACID; RAT-BRAIN	Epileptogenesis is the process whereby a normal brain becomes epileptic. We hypothesized that the neurotrophin brain-derived neurotrophic factor (BDNF) activates its receptor, TrkB, in the hippocampus during epileptogenesis and that BDNF-mediated activation of TrkB is required for epileptogenesis. We tested these hypotheses in Synapsin-Cre conditional BDNF-/- and TrkB(-/-) mice using the kindling model. Despite marked reductions of BDNF expression, only a modest impairment of epileptogenesis and increased hippocampal TrkB activation were detected in BDNF-/- mice. In contrast, reductions of electrophysiological measures and no behavioral evidence of epileptogenesis were detected in TrkB(-/-) mice. Importantly, TrkB(-/-) mice exhibited behavioral endpoints of epileptogenesis, tonic-clonic seizures. Whereas TrkB can be activated, and epileptogenesis develops in BDNF-/- mice, the plasticity of epileptogenesis is eliminated in TrkB(-/-) mice. Its requirement for epileptogenesis in kindling implicates TrkB and downstream signaling pathways as attractive molecular targets for drugs for preventing epilepsy.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol & Mol Canc Biol, Durham, NC 27710 USA; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Kent Waldrep Fdn Ctr Basic Neurosci Res Nerve Gro, Dallas, TX 75390 USA	Duke University; Duke University; Duke University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	McNamara, JO (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	jmc@neuro.duke.edu	Nef, Serge/AAV-6445-2020; Parada, luis F/B-9400-2014; Luikart, Bryan/D-2683-2012	Nef, Serge/0000-0001-5462-0676; 	NINDS NIH HHS [R01 NS056217, NS17771] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056217, P01NS017771] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Binder DK, 1999, J NEUROSCI, V19, P4616; Binder DK, 1999, J NEUROSCI, V19, P1424; Danzer SC, 2004, HIPPOCAMPUS, V14, P345, DOI 10.1002/hipo.10190; Danzer SC, 2002, J NEUROSCI, V22, P9754; DUGICHDJORDJEVIC MM, 1992, NEURON, V8, P1127, DOI 10.1016/0896-6273(92)90133-X; Elmer E, 1997, EXP NEUROL, V145, P93, DOI 10.1006/exnr.1997.6478; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; FRISEN J, 1993, P NATL ACAD SCI USA, V90, P4971, DOI 10.1073/pnas.90.11.4971; GALL CM, 1993, EXP NEUROL, V124, P150, DOI 10.1006/exnr.1993.1186; GODDARD GV, 1969, EXP NEUROL, V25, P295, DOI 10.1016/0014-4886(69)90128-9; Golarai G, 1996, J NEUROPHYSIOL, V75, P343, DOI 10.1152/jn.1996.75.1.343; Gowers WR, 1881, EPILEPSY OTHER CHRON; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; He XP, 2002, J NEUROSCI, V22, P7502; HOLMES KH, 1990, BRAIN RES, V506, P227, DOI 10.1016/0006-8993(90)91255-F; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; Katoh-Semba R, 1999, NEUROSCI RES, V35, P19, DOI 10.1016/S0168-0102(99)00059-0; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KOKAIA M, 1995, EXP NEUROL, V133, P215, DOI 10.1006/exnr.1995.1024; Korte M, 1998, NEUROPHARMACOLOGY, V37, P553, DOI 10.1016/S0028-3908(98)00035-5; KRAUS JE, 1994, J NEUROSCI, V14, P4196; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; Loscher W, 1998, J PHARMACOL EXP THER, V284, P474; Loscher W, 2002, EPILEPSY RES, V50, P105, DOI 10.1016/S0920-1211(02)00073-6; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MCNAMARA JO, 1988, NEUROPHARMACOLOGY, V27, P563, DOI 10.1016/0028-3908(88)90176-1; MCNAMARA JO, 1987, NEUROTRANSMITTERS EP, P115; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Muller D, 2000, P NATL ACAD SCI USA, V97, P4315, DOI 10.1073/pnas.070022697; NADLER JV, 1980, BRAIN RES, V182, P1; Okragly AJ, 1997, EXP NEUROL, V145, P592, DOI 10.1006/exnr.1997.6500; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rudge JS, 1998, EXP NEUROL, V149, P398, DOI 10.1006/exnr.1997.6737; Saarelainen T, 2001, CELL MOL NEUROBIOL, V21, P429, DOI 10.1023/A:1012775808253; Scarisbrick IA, 1999, J NEUROSCI, V19, P7757; SCHWARK WS, 1987, EPILEPSY RES, V1, P63, DOI 10.1016/0920-1211(87)90052-0; Segal RA, 1996, J BIOL CHEM, V271, P20175, DOI 10.1074/jbc.271.33.20175; Shetty AK, 2003, J NEUROCHEM, V87, P147, DOI 10.1046/j.1471-4159.2003.01979.x; SILVER JM, 1991, ANN NEUROL, V29, P356, DOI 10.1002/ana.410290404; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spigelman I, 1998, NEUROSCIENCE, V86, P109, DOI 10.1016/S0306-4522(98)00028-1; SUTULA T, 1987, BRAIN RES, V420, P109, DOI 10.1016/0006-8993(87)90245-9; TANAKA T, 1982, ELECTROEN CLIN NEURO, V54, P288, DOI 10.1016/0013-4694(82)90178-X; Tremblay E, 1984, Rev Electroencephalogr Neurophysiol Clin, V14, P241, DOI 10.1016/S0370-4475(84)80011-8; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Yan Q, 1997, NEUROSCIENCE, V78, P431, DOI 10.1016/S0306-4522(96)00613-6; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	52	226	240	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 8	2004	43	1					31	42		10.1016/j.neuron.2004.06.019	http://dx.doi.org/10.1016/j.neuron.2004.06.019			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836IT	15233915	Bronze			2022-12-24	WOS:000222549800005
J	Govek, EE; Newey, SE; Akerman, CJ; Cross, JR; Van der Veken, L; Van Aelst, L				Govek, EE; Newey, SE; Akerman, CJ; Cross, JR; Van der Veken, L; Van Aelst, L			The X-linked mental retardation protein oligophrenin-1 is required for dendritic spine morphogenesis	NATURE NEUROSCIENCE			English	Article							RHO-ASSOCIATED KINASE; CEREBELLAR HYPOPLASIA; SYNAPTIC PLASTICITY; SMALL GTPASES; MORPHOLOGY; RECEPTOR; CALCIUM; ACTIN; HOMER; COMPLEX	Of 11 genes involved in nonspecific X-linked mental retardation (MRX), three encode regulators or effectors of the Rho GTPases, suggesting an important role for Rho signaling in cognitive function. It remains unknown, however, how mutations in Rho-linked genes lead to MRX. Here we report that oligophrenin-1, a Rho-GTPase activating protein that is absent in a family affected with MRX, is required for dendritic spine morphogenesis. Using RNA interference and antisense RNA approaches, we show that knock-down of oligophrenin-1 levels in CA1 neurons in rat hippocampal slices significantly decreases spine length. This phenotype can be recapitulated using an activated form of RhoA and rescued by inhibiting Rho-kinase, indicating that reduced oligophrenin-1 levels affect spine length by increasing RhoA and Rho-kinase activities. We further demonstrate an interaction between oligophrenin-1 and the postsynaptic adaptor protein Homer. Our findings provide the first insight into how mutations in a Rho-linked MRX gene may compromise neuronal function.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Mol & Cellular Biol Program, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Van Aelst, L (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	vanaelst@cshl.org		Cross, Justin/0000-0002-6356-057X				Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Beneken J, 2000, NEURON, V26, P143, DOI 10.1016/S0896-6273(00)81145-9; Bergmann C, 2003, BRAIN, V126, P1537, DOI 10.1093/brain/awg173; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Comery TA, 1996, NEUROBIOL LEARN MEM, V66, P93, DOI 10.1006/nlme.1996.0049; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; FAGNI L, 2002, SCI STKE, V137, P1; Fauchereau F, 2003, MOL CELL NEUROSCI, V23, P574, DOI 10.1016/S1044-7431(03)00078-2; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Frints SGM, 2002, CLIN GENET, V62, P423, DOI 10.1034/j.1399-0004.2002.620601.x; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Hayashi K, 1996, J NEUROSCI, V16, P7161; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Joneson T, 1996, SCIENCE, V274, P1374, DOI 10.1126/science.274.5291.1374; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Korkotian E, 1999, P NATL ACAD SCI USA, V96, P12068, DOI 10.1073/pnas.96.21.12068; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Lau LF, 1996, J BIOL CHEM, V271, P21622, DOI 10.1074/jbc.271.35.21622; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Philip N, 2003, J MED GENET, V40, P441, DOI 10.1136/jmg.40.6.441; PURPURA DP, 1974, SCIENCE, V186, P1126, DOI 10.1126/science.186.4169.1126; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Sala C, 2003, J NEUROSCI, V23, P6327; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; VAN AL, 1997, GENE DEV, V11, P2295; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Yamaguchi Y, 2001, J BIOL CHEM, V276, P18977, DOI 10.1074/jbc.M100254200; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609	50	233	244	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					364	372		10.1038/nn1210	http://dx.doi.org/10.1038/nn1210			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	807DP	15034583				2022-12-24	WOS:000220482500015
J	Mi, S; Lee, X; Shao, ZH; Thill, G; Ji, BX; Relton, J; Levesque, M; Allaire, N; Perrin, S; Sands, B; Crowell, T; Cate, RL; McCoy, JM; Pepinsky, RB				Mi, S; Lee, X; Shao, ZH; Thill, G; Ji, BX; Relton, J; Levesque, M; Allaire, N; Perrin, S; Sands, B; Crowell, T; Cate, RL; McCoy, JM; Pepinsky, RB			LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex	NATURE NEUROSCIENCE			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; OUTGROWTH INHIBITOR; NEURITE OUTGROWTH; AXON REGENERATION; RHO GTPASES; GROWTH; PROTEINS; PROMOTES; GUIDANCE; BINDING	Axon regeneration in the adult CNS is prevented by inhibitors in myelin. These inhibitors seem to modulate RhoA activity by binding to a receptor complex comprising a ligand-binding subunit (the Nogo-66 receptor NgR1) and a signal transducing subunit (the neurotrophin receptor p75). However, in reconstituted non-neuronal systems, NgR1 and p75 together are unable to activate RhoA, suggesting that additional components of the receptor may exist. Here we describe LINGO-1, a nervous system-specific transmembrane protein that binds NgR1 and p75 and that is an additional functional component of the NgR1/p75 signaling complex. In non-neuronal cells, coexpression of human NgR1, p75 and LINGO-1 conferred responsiveness to oligodendrocyte myelin glycoprotein, as measured by RhoA activation. A dominant-negative human LINGO-1 construct attenuated myelin inhibition in transfected primary neuronal cultures. This effect on neurons was mimicked using an exogenously added human LINGO-1-Fc fusion protein. Together these observations suggest that LINGO-1 has an important role in CNS biology.	Biogen Idec Inc, Dept Discovery Biol, Cambridge, MA 02142 USA	Biogen	Mi, S (corresponding author), Biogen Idec Inc, Dept Discovery Biol, 14 Cambridge Ctr, Cambridge, MA 02142 USA.	sha.mi@biogenidec.com	Sands, Bruce/R-7887-2019	Sands, Bruce/0000-0001-5762-5042				AGUAYO AJ, 1981, J EXP BIOL, V95, P231; Arcaro A, 1998, J BIOL CHEM, V273, P805, DOI 10.1074/jbc.273.2.805; Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; Chauhan NB, 2003, NEUROCHEM INT, V43, P225, DOI 10.1016/S0197-0186(03)00006-8; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Fawcett JW, 1997, CELL TISSUE RES, V290, P371, DOI 10.1007/s004410050943; Flanagan JG, 2000, METHOD ENZYMOL, V327, P198, DOI 10.1016/S0076-6879(00)27277-7; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hunt D, 2002, J NEUROCYTOL, V31, P93, DOI 10.1023/A:1023941421781; Ivanisevic L, 2003, ONCOGENE, V22, P5677, DOI 10.1038/sj.onc.1206864; KULAPANULA J, 2003, J CELL BIOL, V160, P963; Lin JC, 2003, NAT NEUROSCI, V6, P1270, DOI 10.1038/nn1148; Liu BP, 2001, CURR OPIN CELL BIOL, V13, P619, DOI 10.1016/S0955-0674(00)00260-X; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Nguyen-Ba-Charvet KT, 2002, J PHYSIOL-PARIS, V96, P91, DOI 10.1016/S0928-4257(01)00084-5; Ono T, 2003, J NEUROSCI, V23, P5887; Pignot V, 2003, J NEUROCHEM, V85, P717, DOI 10.1046/j.1471-4159.2003.01710.x; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ricci A, 2004, AM J RESP CELL MOL, V30, P12, DOI 10.1165/rcmb.2002-0110OC; Robinson LLL, 2003, J CLIN ENDOCR METAB, V88, P3943, DOI 10.1210/jc.2003-030196; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; TAKAHASHI N, 1985, P NATL ACAD SCI USA, V82, P1906, DOI 10.1073/pnas.82.7.1906; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010	38	640	717	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					221	228		10.1038/nn1188	http://dx.doi.org/10.1038/nn1188			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14966521				2022-12-24	WOS:000189197900011
J	Singer, T; Kiebel, SJ; Winston, JS; Dolan, RJ; Frith, CD				Singer, T; Kiebel, SJ; Winston, JS; Dolan, RJ; Frith, CD			Brain responses to the acquired moral status of faces	NEURON			English	Article							EVENT-RELATED FMRI; HUMAN AMYGDALA; NEURAL RESPONSES; ORBITOFRONTAL CORTEX; FACIAL EXPRESSIONS; DIFFERENTIAL RESPONSE; INDIRECT RECIPROCITY; SOCIAL COGNITION; ULTIMATUM GAME; REWARD	We examined whether neural responses associated with judgments of socially relevant aspects of the human face extend to stimuli that acquire their significance through learning in a meaningful interactive context, specifically reciprocal cooperation. During fMRI, subjects made gender judgments on faces of people who had been introduced as fair (cooperators) or unfair (defector) players through repeated play of a sequential Prisoner's Dilemma game. To manipulate moral responsibility, players were introduced as either intentional or nonintentional agents. Our behavioral (likebility ratings and memory performance) as well as our imaging data confirm the saliency of social fairness for human interactions. Relative to neutral faces, faces of intentional cooperators engendered increased activity in left amygdala, bilateral insula, fusiform gyrus, STS, and reward-related areas. Our data indicate that rapid learning regarding the moral status of others is expressed in altered neural activity within a system associated with social cognition.	UCL, Neurol Inst, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England	University of London; University College London	Singer, T (corresponding author), UCL, Neurol Inst, Wellcome Dept Imaging Neurosci, Mortimer St, London WC1N 3BG, England.	t.singer@fil.ion.ucl.ac.uk	Frith, Chris D/A-2171-2009; Kiebel, Stefan J/B-1551-2009; Winston, Joel/F-6180-2010	Frith, Chris D/0000-0002-8665-0690; Kiebel, Stefan J/0000-0002-5052-1117; Winston, Joel/0000-0002-3957-0612; Dolan, Ray/0000-0001-9356-761X				Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Alexander R., 2008, ESSAYS PEDAGOGY; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Bachevailer J, 2000, AMYGDALA FUNCTIONAL, P509; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Brothers L., 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; Buchel C, 1999, J NEUROSCI, V19, P10869; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Churchland PS, 2002, SCIENCE, V296, P308, DOI 10.1126/science.1070564; Cosmides L, 2000, NEW COGNITIVE NEUROS, P1259; Critchley HD, 2001, NAT NEUROSCI, V4, P207, DOI 10.1038/84048; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; CRITCHLEY HD, 2004, IN PRESS NAT NEUROSC; DAMASIO AR, 1994, DESCARTES ERROR; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Elliott R, 2003, J NEUROSCI, V23, P303; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; FRISTON KJ, 1995, HUMAN BRAIN MAPPING, V2, P165; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Hart AJ, 2000, NEUROREPORT, V11, P2351, DOI 10.1097/00001756-200008030-00004; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; LeDoux J., 1998, EMOTIONAL BRAIN; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Mealey L, 1996, ETHOL SOCIOBIOL, V17, P119, DOI 10.1016/0162-3095(95)00131-X; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; Nowak MA, 1998, J THEOR BIOL, V194, P561, DOI 10.1006/jtbi.1998.0775; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Opfer JE, 2002, COGNITION, V86, P97, DOI 10.1016/S0010-0277(02)00171-3; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phelps EA, 2001, NAT NEUROSCI, V4, P775, DOI 10.1038/90467; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Puce A, 2003, PHILOS T R SOC B, V358, P435, DOI 10.1098/rstb.2002.1221; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; ROLLS ET, 1997, NEUROIMAGE, V5, P199; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schultz RT, 2003, PHILOS T R SOC B, V358, P415, DOI 10.1098/rstb.2002.1208; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; TRIVERS R, 1971, Q REV BIOL, V46, P39; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; Whalen PJ, 1998, J NEUROSCI, V18, P411; Winston JS, 2003, NEUROIMAGE, V20, P84, DOI 10.1016/S1053-8119(03)00303-3; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	67	283	289	3	70	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 19	2004	41	4					653	662		10.1016/S0896-6273(04)00014-5	http://dx.doi.org/10.1016/S0896-6273(04)00014-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980212	Green Published, Bronze			2022-12-24	WOS:000221458100016
J	Zhou, W; Qian, Y; Kunjilwar, K; Pfaffinger, PJ; Choe, S				Zhou, W; Qian, Y; Kunjilwar, K; Pfaffinger, PJ; Choe, S			Structural insights into the functional interaction of KChIP1 with Shal-type K+ channels	NEURON			English	Article							NEURONAL CALCIUM SENSOR-1; GATED POTASSIUM CHANNEL; PHOSPHATIDYLINOSITOL 4-KINASE ISOFORM; DEPENDENT PROTEIN-KINASE; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; BINDING PROTEINS; CALMODULIN; DOMAIN; KV4	Four Kv channel-interacting proteins (KChlP1 through KChlP4) interact directly with the N-terminal domain of three Shal-type voltage-gated potassium channels (Kv4.1, Kv4.2, and Kv4.3) to modulate cell surface expression and function of Kv4 channels. Here we report a 2.0 A crystal structure of the core domain of KChIP1 (KChlP1*) in complex with the N-terminal fragment of Kv4.2 (Kv4.2N30). The complex reveals a clam-shaped dimeric assembly. Four EF-hands from each KChlP1 form each shell of the clam. The N-terminal end of Kv4.2 forming an alpha helix (alpha1) and the C-terminal alpha helix (H10) of KChlP1 are enclosed nearly coaxially by these shells. As a result, the H10 of KChlP1 and all of Kv4.2 mediate interactions between these two molecules, structurally reminiscent of the interactions between calmodulin and its target peptides. Site-specific mutagenesis combined with functional characterization shows that those interactions mediated by alpha1 and H10 are essential to the modulation of Kv4.2 by KChlPs.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	Baylor College of Medicine; Salk Institute; University of California System; University of California San Diego	Pfaffinger, PJ (corresponding author), Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA.	ppfaff@cns.neusc.bcm.tmc.edu; choe@salk.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS037444, R01NS031583] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24064] Funding Source: Medline; NIGMS NIH HHS [GM56653] Funding Source: Medline; NINDS NIH HHS [R01 NS31583, P01 NS37444] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Anderson AE, 2000, J BIOL CHEM, V275, P5337, DOI 10.1074/jbc.275.8.5337; Bahring R, 2001, J BIOL CHEM, V276, P23888, DOI 10.1074/jbc.M101320200; BALDWIN TJ, 1991, NEURON, V7, P471, DOI 10.1016/0896-6273(91)90299-F; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Clapperton JA, 2002, BIOCHEMISTRY-US, V41, P14669, DOI 10.1021/bi026660t; FINN BE, 1995, NAT STRUCT BIOL, V2, P777, DOI 10.1038/nsb0995-777; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; GAGNE SM, 1995, NAT STRUCT BIOL, V2, P784, DOI 10.1038/nsb0995-784; Gebauer M, 2004, BIOPHYS J, V86, P210, DOI 10.1016/S0006-3495(04)74097-7; Guo WN, 2002, J BIOL CHEM, V277, P26436, DOI 10.1074/jbc.M201431200; Hatano N, 2002, PFLUG ARCH EUR J PHY, V444, P80, DOI 10.1007/s00424-002-0798-9; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Holmqvist MH, 2002, P NATL ACAD SCI USA, V99, P1035, DOI 10.1073/pnas.022509299; Huttner IG, 2003, J BIOL CHEM, V278, P4862, DOI 10.1074/jbc.M207920200; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; KIM LA, 2003, IN PRESS J BIOL CHEM, DOI DOI 10.1074/jbc.m311332200; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; Li M, 2000, NAT NEUROSCI, V3, P202, DOI 10.1038/72898; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; Malin SA, 2001, J NEUROSCI, V21, P8004, DOI 10.1523/JNEUROSCI.21-20-08004.2001; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Morohashi Y, 2002, J BIOL CHEM, V277, P14965, DOI 10.1074/jbc.M200897200; Nakamura TY, 2001, P NATL ACAD SCI USA, V98, P12808, DOI 10.1073/pnas.221168498; Nanao MH, 2003, P NATL ACAD SCI USA, V100, P8670, DOI 10.1073/pnas.1432840100; O'Callaghan DW, 2003, BIOCHEM SOC T, V31, P963; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel SP, 2002, J PHYSIOL-LONDON, V545, P5, DOI 10.1113/jphysiol.2002.031856; Ren XM, 2003, J BIOL CHEM, V278, P43564, DOI 10.1074/jbc.M302337200; Roosild TP, 2004, TRENDS BIOCHEM SCI, V29, P39, DOI 10.1016/j.tibs.2003.11.008; Roosild TP, 2002, CELL, V109, P781, DOI 10.1016/S0092-8674(02)00768-7; Schrader LA, 2002, J NEUROSCI, V22, P10123; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Strahl T, 2003, J BIOL CHEM, V278, P49589, DOI 10.1074/jbc.M309017200; Strang C, 2003, J BIOL CHEM, V278, P31361, DOI 10.1074/jbc.M304268200; Takimoto K, 2002, J BIOL CHEM, V277, P26904, DOI 10.1074/jbc.M203651200; Ulens C, 2003, NEURON, V40, P959, DOI 10.1016/S0896-6273(03)00753-0; Vijay-Kumar S, 1999, NAT STRUCT BIOL, V6, P80; Yang W, 2002, PROTEINS, V47, P344, DOI 10.1002/prot.10093; Yap Kyoko L, 2002, Methods Mol Biol, V173, P317; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; Zhu XR, 1999, RECEPTOR CHANNEL, V6, P387	57	105	112	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 19	2004	41	4					573	586		10.1016/S0896-6273(04)00045-5	http://dx.doi.org/10.1016/S0896-6273(04)00045-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821KC	14980206	Bronze			2022-12-24	WOS:000221458100010
J	Wang, J; Liu, SH; Fu, YP; Wang, JH; Lu, YM				Wang, J; Liu, SH; Fu, YP; Wang, JH; Lu, YM			Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors	NATURE NEUROSCIENCE			English	Article							EXCITATORY AMINO-ACIDS; DELAYED NEURONAL DEATH; NITRIC-OXIDE SYNTHASE; MOLECULAR-MECHANISMS; SYNAPTIC TRANSMISSION; RAT HIPPOCAMPUS; AMPA RECEPTORS; GLUTAMATE; NEUROTOXICITY; CALCIUM	CA1 pyramidal neurons degenerate after transient forebrain ischemia, whereas neurons in other regions of the hippocampus remain intact. Here we show that in rat hippocampal CA1 neurons, forebrain ischemia induces the phosphorylation of the N-methyl-D-aspartate (NMDA) receptor 2A subunit at Ser1232 (phospho-Ser1232). Ser1232 phosphorylation is catalyzed by cyclin-dependent kinase 5 (Cdk5). Inhibiting endogenous Cdk5, or perturbing interactions between Cdk5 and NR2A subunits, abolished NR2A phosphorylation at Ser1232 and protected CA1 pyramidal neurons from ischemic insult. Thus, we conclude that modulation of NMDA receptors by Cdk5 is the primary intracellular event underlying the ischemic injury of CA1 pyramidal neurons.	Univ Calgary, Fac Med, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; Univ Calgary, Fac Med, Neurosci Res Grp, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Lu, YM (corresponding author), Univ Calgary, Fac Med, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada.	luy@ucalgary.ca						Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Ali DW, 2001, CURR OPIN NEUROBIOL, V11, P336, DOI 10.1016/S0959-4388(00)00216-6; ANDINE P, 1988, J CEREBR BLOOD F MET, V8, P799, DOI 10.1038/jcbfm.1988.135; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Gorter JA, 1997, J NEUROSCI, V17, P6179; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; HAGBERG H, 1985, J CEREBR BLOOD F MET, V5, P413, DOI 10.1038/jcbfm.1985.56; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; Jover T, 2002, J NEUROSCI, V22, P2115, DOI 10.1523/JNEUROSCI.22-06-02115.2002; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LEW J, 1992, J BIOL CHEM, V267, P13383; Li BS, 2001, P NATL ACAD SCI USA, V98, P12742, DOI 10.1073/pnas.211428098; Liu HN, 2002, J NEUROCHEM, V82, P398, DOI 10.1046/j.1471-4159.2002.00981.x; Liu SH, 2003, J NEUROSCI, V23, P732; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Minger SL, 1998, BRAIN RES, V810, P181, DOI 10.1016/S0006-8993(98)00921-4; Mitani A, 1998, J CEREBR BLOOD F MET, V18, P1088, DOI 10.1097/00004647-199810000-00005; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Neumar RW, 2001, EXP NEUROL, V170, P27, DOI 10.1006/exnr.2001.7708; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Wang Fuhu, 2001, Expert Opin Ther Targets, V5, P557; Wang J, 2003, J NEUROSCI, V23, P826; Zhu DY, 2003, J NEUROSCI, V23, P223	50	203	237	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1039	1047		10.1038/nn1119	http://dx.doi.org/10.1038/nn1119			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	14502288				2022-12-24	WOS:000185633600015
J	Liang, HY; DeMaria, CD; Erickson, MG; Mori, MX; Alseikhan, BA; Yue, DT				Liang, HY; DeMaria, CD; Erickson, MG; Mori, MX; Alseikhan, BA; Yue, DT			Unified mechanisms of Ca2+ regulation across the Ca2+ channel family	NEURON			English	Article							NEURONAL CALCIUM CHANNELS; CA2+-DEPENDENT INACTIVATION; CA2+-SENSITIVE INACTIVATION; MOLECULAR DETERMINANTS; DEPENDENT INACTIVATION; CALMODULIN-BINDING; VOLTAGE; SUBUNIT; CURRENTS; MOTIF	L-type (Ca(V)1.2) and P/Q-type (Ca(V)2.1) calcium channels possess lobe-specific CaM regulation, where Call binding to one or the other lobe of CaM triggers regulation, even with inverted polarity of modulation between channels. Other major members of the Ca(V)1-2 channel family, R-type (Ca(V)2.3) and N-type (Ca(V)2.2), have appeared to lack such CaM regulation. We report here that R- and N-type channels undergo Ca2+-dependent inactivation, which is mediated by the CaM N-terminal lobe and present only with mild Ca2+ buffering (0.5 mM EGTA) characteristic of many neurons. These features, together with the CaM regulatory profiles of L- and P/Q-type channels, are consistent with a simplifying principle for CaM signal detection in Ca(V)1-2 channels-independent of channel context, the N- and C-terminal lobes of CaM appear invariably specialized for decoding local versus global Ca2+ activity, respectively.	Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Ca Signals Lab, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Ca Signals Lab, Baltimore, MD 21205 USA; Georgetown Univ, Off Technol Licensing, Washington, DC 20057 USA	Johns Hopkins University; Johns Hopkins University; Georgetown University	Yue, DT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Ca Signals Lab, Baltimore, MD 21205 USA.	dyue@bme.jhu.edu						Alseikhan BA, 2002, P NATL ACAD SCI USA, V99, P17185, DOI 10.1073/pnas.262372999; Bernard M, 2001, POPTRONICS, V2, P3; Berridge MJ, 1997, NATURE, V386, P759, DOI 10.1038/386759a0; Budde T, 2002, NAT REV NEUROSCI, V3, P873, DOI 10.1038/nrn959; Cens T, 1999, J BIOL CHEM, V274, P5483, DOI 10.1074/jbc.274.9.5483; CHAO SH, 1984, MOL PHARMACOL, V26, P75; COX DH, 1994, J GEN PHYSIOL, V104, P311, DOI 10.1085/jgp.104.2.311; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; ECKERT R, 1981, J PHYSIOL-LONDON, V314, P265, DOI 10.1113/jphysiol.1981.sp013706; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Fierro L, 1996, J PHYSIOL-LONDON, V496, P617, DOI 10.1113/jphysiol.1996.sp021713; Grunwald ME, 1999, P NATL ACAD SCI USA, V96, P13444, DOI 10.1073/pnas.96.23.13444; Ikeda SR, 2001, SCIENCE, V294, P318, DOI 10.1126/science.1066160; IMREDY JP, 1994, NEURON, V12, P1301, DOI 10.1016/0896-6273(94)90446-4; Jackson MB, 2003, J NEUROSCI, V23, P1612; Jones LP, 1999, BIOPHYS J, V76, P2530, DOI 10.1016/S0006-3495(99)77407-2; Jones LP, 1998, J GEN PHYSIOL, V112, P125, DOI 10.1085/jgp.112.2.125; JONES SW, 1989, J GEN PHYSIOL, V94, P169, DOI 10.1085/jgp.94.1.169; Lee A, 2000, J NEUROSCI, V20, P6830, DOI 10.1523/JNEUROSCI.20-18-06830.2000; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; LEE KS, 1985, J PHYSIOL-LONDON, V364, P395, DOI 10.1113/jphysiol.1985.sp015752; Martini M, 2000, BIOPHYS J, V78, P1240, DOI 10.1016/S0006-3495(00)76681-1; Mermelstein PG, 1999, J NEUROSCI, V19, P7268, DOI 10.1523/JNEUROSCI.19-17-07268.1999; Meuth S, 2002, EUR J NEUROSCI, V15, P1603, DOI 10.1046/j.1460-9568.2002.01999.x; MORAD M, 1988, SCIENCE, V241, P842, DOI 10.1126/science.2457253; Naraghi M, 1997, J NEUROSCI, V17, P6961; NEELY A, 1994, BIOPHYS J, V66, P1895, DOI 10.1016/S0006-3495(94)80983-X; NEHER E, 1978, J PHYSIOL-LONDON, V277, P153, DOI 10.1113/jphysiol.1978.sp012267; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; Patil PG, 1998, NEURON, V20, P1027, DOI 10.1016/S0896-6273(00)80483-3; Persechini A, 2002, TRENDS CARDIOVAS MED, V12, P32, DOI 10.1016/S1050-1738(01)00144-X; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Romanin C, 2000, FEBS LETT, V487, P301, DOI 10.1016/S0014-5793(00)02361-9; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Saegusa H, 2000, P NATL ACAD SCI USA, V97, P6132, DOI 10.1073/pnas.100124197; Scott VES, 1996, J BIOL CHEM, V271, P3207, DOI 10.1074/jbc.271.6.3207; Shirokov R, 1999, J PHYSIOL-LONDON, V518, P697, DOI 10.1111/j.1469-7793.1999.0697p.x; Soldatov MM, 2003, TRENDS PHARMACOL SCI, V24, P167, DOI 10.1016/S0165-6147(03)00065-8; Song LS, 1998, J PHYSIOL-LONDON, V512, P677, DOI 10.1111/j.1469-7793.1998.677bd.x; Soong TW, 2002, J NEUROSCI, V22, P10142; Stotz SC, 2001, TRENDS NEUROSCI, V24, P176, DOI 10.1016/S0166-2236(00)01738-0; TAKUWA N, 1995, CELL SIGNAL, V7, P93, DOI 10.1016/0898-6568(94)00074-L; Tran QK, 2003, J BIOL CHEM, V278, P24247, DOI 10.1074/jbc.C300165200; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; ZHANG JF, 1994, NATURE, V372, P97, DOI 10.1038/372097a0; Zhou JM, 1997, P NATL ACAD SCI USA, V94, P2301, DOI 10.1073/pnas.94.6.2301; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	53	247	253	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 11	2003	39	6					951	960		10.1016/S0896-6273(03)00560-9	http://dx.doi.org/10.1016/S0896-6273(03)00560-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	721BA	12971895	Bronze			2022-12-24	WOS:000185296100009
J	Pack, CC; Livingstone, MS; Duffy, KR; Born, RT				Pack, CC; Livingstone, MS; Duffy, KR; Born, RT			End-stopping and the aperture problem: Two-dimensional motion signals in macaque V1	NEURON			English	Article							VISUAL AREA MT; DIRECTION-SELECTIVE CELLS; STRIATE CORTICAL-NEURONS; RECEPTIVE-FIELDS; PERCEIVED DIRECTION; SPATIAL SUMMATION; EYE-MOVEMENTS; CORTEX; MONKEY; CONNECTIONS	Our perception of fine visual detail relies on small receptive fields at early stages of visual processing. However, small receptive fields tend to confound the orientation and velocity of moving edges, leading to ambiguous or inaccurate motion measurements (the aperture problem). Thus, it is often assumed that neurons in primary visual cortex (V1) carry only ambiguous motion information. Here we show that a subpopulation of V1 neurons is capable of signaling motion direction in a manner that is independent of contour orientation. Specifically, end-stopped V1 neurons obtain accurate motion measurements by responding only to the endpoints of long contours, a strategy which renders them largely immune to the aperture problem. Furthermore, the time course of end-stopping is similar to the time course of motion integration by MT neurons. These results suggest that cortical neurons might represent object motion by responding selectively to two-dimensional discontinuities in the visual scene.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Pack, CC (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.		Born, Richard/M-6454-2019	Born, Richard/0000-0003-4360-427X; Duffy, Kevin/0000-0003-3871-3287; Livingstone, Margaret/0000-0002-1950-0123	NATIONAL EYE INSTITUTE [P30EY012196, R01EY011379, R01EY013135] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY013135-01, R01 EY013135-02, EY12196, EY13135, EY11379, R01 EY013135-03] Funding Source: Medline; NINDS NIH HHS [NS07484] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Angelucci A, 2002, J NEUROSCI, V22, P8633; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barth E, 2000, SPATIAL VISION, V13, P193, DOI 10.1163/156856800741207; BOLZ J, 1986, NATURE, V320, P362, DOI 10.1038/320362a0; Born RT, 2000, NEURON, V26, P725, DOI 10.1016/S0896-6273(00)81208-8; Conway BR, 2003, J NEUROPHYSIOL, V89, P2726, DOI 10.1152/jn.00550.2002; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DOBBINS A, 1987, NATURE, V329, P438, DOI 10.1038/329438a0; EMERSON RC, 1987, J NEUROPHYSIOL, V58, P33, DOI 10.1152/jn.1987.58.1.33; Groh JM, 1997, J NEUROSCI, V17, P4312; Grossberg S, 2001, VISION RES, V41, P2521, DOI 10.1016/S0042-6989(01)00131-6; HAMMOND P, 1989, VISION RES, V29, P653, DOI 10.1016/0042-6989(89)90027-8; HAWKEN MJ, 1988, J NEUROSCI, V8, P3541; HEITGER F, 1992, VISION RES, V32, P963, DOI 10.1016/0042-6989(92)90039-L; HENRY GH, 1974, VISION RES, V14, P767, DOI 10.1016/0042-6989(74)90141-2; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; Hupe JM, 2001, J NEUROPHYSIOL, V85, P146, DOI 10.1152/jn.2001.85.1.146; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; Lamme VAF, 1998, P NATL ACAD SCI USA, V95, P3263, DOI 10.1073/pnas.95.6.3263; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; Liden L, 1999, VISION RES, V39, P3301, DOI 10.1016/S0042-6989(99)00055-3; Livingstone MS, 2001, NEURON, V30, P781, DOI 10.1016/S0896-6273(01)00313-0; Livingstone MS, 1998, NEURON, V20, P509, DOI 10.1016/S0896-6273(00)80991-5; LORENCEAU J, 1993, VISION RES, V33, P1207, DOI 10.1016/0042-6989(93)90209-F; MARDIA KV, 1975, J ROY STAT SOC B, V34, P102; Marr D., 1982, VISION; MASKE R, 1986, PROC R SOC SER B-BIO, V229, P257, DOI 10.1098/rspb.1986.0085; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; MINGOLLA E, 1992, VISION RES, V32, P1015, DOI 10.1016/0042-6989(92)90003-2; Movshon J. A., 1985, EXPT BRAIN RES S, V11, P117, DOI DOI 10.1007/978-3-662-09224-8_7.; Movshon JA, 1996, J NEUROSCI, V16, P7733; NOWLAN SJ, 1995, J NEUROSCI, V15, P1195; ORBAN GA, 1979, J NEUROPHYSIOL, V42, P818, DOI 10.1152/jn.1979.42.3.818; Pack CC, 2003, NEURON, V37, P525, DOI 10.1016/S0896-6273(02)01187-X; Pack CC, 2001, NATURE, V409, P1040, DOI 10.1038/35059085; Pack CC, 2001, NATURE, V414, P905, DOI 10.1038/414905a; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P777, DOI 10.1152/jn.2000.83.2.777; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; RUBIN N, 1995, VISION RES, V35, P569, DOI 10.1016/0042-6989(94)00136-A; RUBIN N, 1993, VISION RES, V33, P1385, DOI 10.1016/0042-6989(93)90045-X; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Sceniak MP, 2001, J NEUROPHYSIOL, V85, P1873, DOI 10.1152/jn.2001.85.5.1873; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1362, DOI 10.1152/jn.1976.39.6.1362; SCHWARTZ EL, 1983, P NATL ACAD SCI-BIOL, V80, P5776, DOI 10.1073/pnas.80.18.5776; SHIPP S, 1989, EUR J NEUROSCI, V1, P309, DOI 10.1111/j.1460-9568.1989.tb00798.x; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; TINSLEY CJ, 2003, IN PRESS J NEUROPHYS; VERSAVEL M, 1990, VISION RES, V30, P235, DOI 10.1016/0042-6989(90)90039-N; Wallach H, 1935, PSYCHOL FORSCH, V20, P325, DOI 10.1007/BF02409790; WILSON HR, 1992, VISUAL NEUROSCI, V9, P79, DOI 10.1017/S0952523800006386; Wuerger S, 1996, PERCEPTION, V25, P1317, DOI 10.1068/p251317	57	128	128	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 14	2003	39	4					671	680		10.1016/S0896-6273(03)00439-2	http://dx.doi.org/10.1016/S0896-6273(03)00439-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	712CQ	12925280	Bronze			2022-12-24	WOS:000184779500011
J	Meng, YH; Zhang, Y; Jia, ZP				Meng, YH; Zhang, Y; Jia, ZP			Synaptic transmission and plasticity in the absence of AMPA glutamate receptor GluR2 and GluR3	NEURON			English	Article							LONG-TERM DEPRESSION; DOMAIN-CONTAINING PROTEINS; KINASE-C-ALPHA; HIPPOCAMPAL-NEURONS; SURFACE EXPRESSION; ENHANCED LTP; SUBUNIT; NSF; BINDING; ENDOCYTOSIS	The AMPA glutamate receptor (AMPAR) subunits GluR2 and GIuR3 are thought to be important for synaptic targeting/stabilization of AMPARs and the expression of hippocampal long-term depression (LTD). In order to address this hypothesis genetically, we generated and analyzed knockout mice deficient in the expression of both GluR2 and GluR3. We show here that the double knockout mice are severely impaired in basal synaptic transmission, demonstrating that GluR2/3 are essential to maintain adequate synaptic transmission in vivo. However, these mutant mice are competent in establishing several forms of long-lasting synaptic changes in the CA1 region of the hippocampus, including LTD, long-term potentiation (LTP), depotentiation, and dedepression, indicating the presence of GluR2/3-independent mechanisms of LTD expression and suggesting that AMPA receptor GluR1 alone is capable of various forms of synaptic plasticity.	Hosp Sick Children, Program Brain & Behav, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Jia, ZP (corresponding author), Hosp Sick Children, Program Brain & Behav, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.		Jia, zhengping/AAZ-4190-2021					Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Braithwaite SP, 2000, NEUROPHARMACOLOGY, V39, P919, DOI 10.1016/S0028-3908(99)00171-9; Braithwaite SP, 2002, P NATL ACAD SCI USA, V99, P7096, DOI 10.1073/pnas.102156099; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chung HJ, 2000, J NEUROSCI, V20, P7258; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dong HL, 1999, J NEUROSCI, V19, P6930, DOI 10.1523/JNEUROSCI.19-16-06930.1999; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Kullmann DM, 1999, NEURON, V24, P288, DOI 10.1016/S0896-6273(00)80841-7; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Maintz J B, 1998, Med Image Anal, V2, P1, DOI 10.1016/S1361-8415(01)80026-8; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Shen L, 2000, J NEUROSCI, V20, P7932; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	55	194	202	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 3	2003	39	1					163	176		10.1016/S0896-6273(03)00368-4	http://dx.doi.org/10.1016/S0896-6273(03)00368-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699LB	12848940	Bronze			2022-12-24	WOS:000184057400017
J	Wu, Q; Wen, TQ; Lee, G; Park, JH; Cai, HN; Shen, P				Wu, Q; Wen, TQ; Lee, G; Park, JH; Cai, HN; Shen, P			Developmental control of foraging and social behavior by the Drosophila neuropeptide Y-like system	NEURON			English	Article							FEEDING-BEHAVIOR; CAENORHABDITIS-ELEGANS; ENERGY HOMEOSTASIS; GENE-EXPRESSION; MICE LACKING; BODY-WEIGHT; RECEPTOR; OBESITY; MELANOGASTER; FOOD	Animals display stereotyped behavioral modifications during development, but little is known about how genes and neural circuits are regulated to turn on/off behaviors. Here we report that Drosophila neuropeptide F (dNPF), a human NPY homolog, coordinates larval behavioral changes during development. The brain expression of npf is high in larvae attracted to food, whereas its downregulation coincides with the onset of behaviors of older larvae, including food aversion, hypermobility, and cooperative burrowing. Loss of dNPF signaling in young transgenic larvae led to the premature display of behavioral phenotypes associated with older larvae. Conversely, dNPF overexpression in older larvae prolonged feeding, and suppressed hypermobility and cooperative burrowing behaviors. The dNPF system provides a new paradigm for studying the central control of cooperative behavior.	Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; Univ Georgia, Biomed & Hlth Sci Inst, Athens, GA 30602 USA; Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Tennessee System; University of Tennessee Knoxville	Shen, P (corresponding author), Univ Georgia, Dept Cellular Biol, 724 Biol Sci Bldg, Athens, GA 30602 USA.	pshen@cellmate.cb.uga.edu		Lee, Gyunghee/0000-0003-3108-1870; Shen, Ping/0000-0001-5024-3893; Park, Jae/0000-0002-4846-2197	NIDDK NIH HHS [DK-58348] Funding Source: Medline; NIMH NIH HHS [MH-66197] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066197] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ashburner M., 1989, DROSOPHILA LAB HDB; Bannon AW, 2000, BRAIN RES, V868, P79, DOI 10.1016/S0006-8993(00)02285-X; Barr RG, 1999, PHYSIOL BEHAV, V66, P409, DOI 10.1016/S0031-9384(98)00294-7; Beck B, 2001, NEUROSCI BIOBEHAV R, V25, P143, DOI 10.1016/S0149-7634(01)00003-3; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brody T, 2000, J CELL BIOL, V150, pF83, DOI 10.1083/jcb.150.2.F83; Brown MR, 1999, PEPTIDES, V20, P1035, DOI 10.1016/S0196-9781(99)00097-2; Coates JC, 2002, NATURE, V419, P925, DOI 10.1038/nature01170; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; DETHLER VG, 1976, HUNGRY FLY; DiBona GF, 2002, AM J PHYSIOL-REG I, V282, pR635, DOI 10.1152/ajpregu.00631.2001; Dubreuil RR, 1998, DEV BIOL, V194, P1, DOI 10.1006/dbio.1997.8821; El Bahh B, 2001, BRAIN RES, V894, P209, DOI 10.1016/S0006-8993(01)02027-3; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; FLOOD JF, 1991, PEPTIDES, V12, P1329, DOI 10.1016/0196-9781(91)90215-B; Garczynski SF, 2002, PEPTIDES, V23, P773, DOI 10.1016/S0196-9781(01)00647-7; Han DD, 2000, DEVELOPMENT, V127, P573; Hartenstein V., 1993, ATLAS DROSOPHILA DEV; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Inui A, 2000, PHARMACOL REV, V52, P35; JEWETT DC, 1995, PSYCHOPHARMACOLOGY, V120, P267, DOI 10.1007/BF02311173; Kaga T, 2001, DIABETES, V50, P1206, DOI 10.2337/diabetes.50.5.1206; Li Y, 2002, BRAIN RES, V940, P69, DOI 10.1016/S0006-8993(02)02594-5; Marsh DJ, 1998, NAT MED, V4, P718, DOI 10.1038/nm0698-718; Naveilhan P, 1999, NAT MED, V5, P1188, DOI 10.1038/13514; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Palmiter RD, 1998, RECENT PROG HORM RES, V53, P163; Park JH, 2003, DEVELOPMENT, V130, P2645, DOI 10.1242/dev.00503; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Pedrazzini T, 1998, NAT MED, V4, P722, DOI 10.1038/nm0698-722; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Roberts D. B, 1986, DROSOPHILA PRACTICAL; SANDMAN CA, 1999, NEUROPEPTIDES STRUCT; Segal-Lieberman G, 2003, AM J PHYSIOL-ENDOC M, V284, pE1131, DOI 10.1152/ajpendo.00491.2002; Shen P, 2001, J NEUROBIOL, V47, P16, DOI 10.1002/neu.1012; STANLEY BG, 1986, PEPTIDES, V7, P1189; Taghert PH, 2001, J NEUROSCI, V21, P6673, DOI 10.1523/JNEUROSCI.21-17-06673.2001; Tecott LH, 1998, CELL, V95, P733, DOI 10.1016/S0092-8674(00)81695-5; Thiele TE, 1998, NATURE, V396, P366, DOI 10.1038/24614; Thorsell A, 2002, NEUROPEPTIDES, V36, P182, DOI 10.1054/npep.2002.0897; Thorsell A, 2000, P NATL ACAD SCI USA, V97, P12852, DOI 10.1073/pnas.220232997; VARGO M, 1982, J COMP PHYSIOL PSYCH, V96, P452, DOI 10.1037/h0077899; WAHLESTEDT C, 1993, SCIENCE, V259, P528, DOI 10.1126/science.8380941; Wilkie GS, 2001, CELL, V105, P209, DOI 10.1016/S0092-8674(01)00312-9; Williams G, 2001, PHYSIOL BEHAV, V74, P683, DOI 10.1016/S0031-9384(01)00612-6; Wilson E.O., 1975, P1; WONG JL, 1985, BEHAV GENET, V15, P155, DOI 10.1007/BF01065896	51	301	310	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2003	39	1					147	161		10.1016/S0896-6273(03)00396-9	http://dx.doi.org/10.1016/S0896-6273(03)00396-9			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	699LB	12848939	Bronze			2022-12-24	WOS:000184057400016
J	Hoshi, N; Zhang, JS; Omaki, M; Takeuchi, T; Yokoyama, S; Wanaverbecq, N; Langeberg, LK; Yoneda, Y; Scott, JD; Brown, DA; Higashida, H				Hoshi, N; Zhang, JS; Omaki, M; Takeuchi, T; Yokoyama, S; Wanaverbecq, N; Langeberg, LK; Yoneda, Y; Scott, JD; Brown, DA; Higashida, H			AKAP150 signaling complex promotes suppression of the M-current by muscarinic agonists	NATURE NEUROSCIENCE			English	Article							RAT SYMPATHETIC NEURONS; PROTEIN-KINASE-C; POTASSIUM CHANNEL SUBUNITS; M-CURRENT INHIBITION; ANCHORING PROTEIN; K+ CHANNELS; LINOPIRDINE DUP-996; CA2+ CHANNELS; MODULATION; RECEPTORS	M-type (KCNQ2/3) potassium channels are suppressed by activation of G(q/11)-coupled receptors, thereby increasing neuronal excitability. We show here that rat KCNQ2 can bind directly to the multivalent A-kinase-anchoring protein AKAP150. Peptides that block AKAP150 binding to the KCNQ2 channel complex antagonize the muscarinic inhibition of the currents. A mutant form of AKAP150, AKAP(DeltaA), which is unable to bind protein kinase C (PKC), also attenuates the agonist-induced current suppression. Analysis of recombinant KCNQ2 channels suggests that targeting of PKC through association with AKAP150 is important for the inhibition. Phosphorylation of KCNQ2 channels was increased by muscarinic stimulation; this was prevented either by coexpression with AKAP(DeltaA) or pretreatment with PKC inhibitors that compete with diacylglycerol. These inhibitors also reduced muscarinic inhibition of M-current. Our data indicate that AKAP150-bound PKC participates in receptor-induced inhibition of the M-current.	Kanazawa Univ, Grad Sch Med, Dept Biophys Genet, Kanazawa, Ishikawa 9208640, Japan; Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Kanazawa Univ, Fac Pharmaceut Sci, Dept Mol Pharmacol, Kanazawa, Ishikawa 9200934, Japan; UCL, Dept Pharmacol, London WC1E 6BT, England	Kanazawa University; Howard Hughes Medical Institute; Oregon Health & Science University; Oregon Health & Science University; Kanazawa University; University of London; University College London	Hoshi, N (corresponding author), Kanazawa Univ, Grad Sch Med, Dept Biophys Genet, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	hoshin@ohsu.edu	Yoneda, Yukio/ABI-1864-2020; Brown, David A/J-9019-2012; higashida, haruhiro/L-3773-2015	Yoneda, Yukio/0000-0002-4624-177X; higashida, haruhiro/0000-0002-1779-0606; Wanaverbecq, Nicolas/0000-0001-5486-2771	NIGMS NIH HHS [R37 GM048231, GM48231, R01 GM048231] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048231, R37GM048231] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIKEN SP, 1995, BRIT J PHARMACOL, V115, P1163, DOI 10.1111/j.1476-5381.1995.tb15019.x; Bofill-Cardona E, 2000, MOL PHARMACOL, V57, P1165; Brown BS, 2000, PROG BIOPHYS MOL BIO, V73, P135, DOI 10.1016/S0079-6107(00)00004-3; Brown D A, 1988, Ion Channels, V1, P55; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Cooper EC, 2000, P NATL ACAD SCI USA, V97, P4914, DOI 10.1073/pnas.090092797; Cruzblanca H, 1998, P NATL ACAD SCI USA, V95, P7151, DOI 10.1073/pnas.95.12.7151; del Rio E, 1999, J PHYSIOL-LONDON, V520, P101, DOI 10.1111/j.1469-7793.1999.00101.x; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Delmas P, 2002, NEURON, V34, P209, DOI 10.1016/S0896-6273(02)00641-4; Delmas P, 1998, J PHYSIOL-LONDON, V506, P319, DOI 10.1111/j.1469-7793.1998.319bw.x; DORJE F, 1991, J PHARMACOL EXP THER, V256, P727; Faux MC, 1999, BIOCHEM J, V343, P443, DOI 10.1042/0264-6021:3430443; Fraser IDC, 1999, NEURON, V23, P423, DOI 10.1016/S0896-6273(00)80795-3; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Haley JE, 1998, J NEUROSCI, V18, P4521; Haley JE, 2000, J NEUROSCI, V20; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; HIGASHIDA H, 1986, NATURE, V323, P333, DOI 10.1038/323333a0; Hoshi N, 1998, J BIOL CHEM, V273, P23080, DOI 10.1074/jbc.273.36.23080; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; JOHNSON BD, 1994, P NATL ACAD SCI USA, V91, P11492, DOI 10.1073/pnas.91.24.11492; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; Lamas JA, 1997, EUR J NEUROSCI, V9, P605, DOI 10.1111/j.1460-9568.1997.tb01637.x; Marrion NV, 1996, NEURON, V16, P163, DOI 10.1016/S0896-6273(00)80033-1; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; MARRION NV, 1994, PFLUG ARCH EUR J PHY, V426, P296, DOI 10.1007/BF00374785; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; ROBBINS J, 1993, J PHYSIOL-LONDON, V469, P153, DOI 10.1113/jphysiol.1993.sp019809; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; Rundfeldt C, 2000, NEUROSCI LETT, V282, P73, DOI 10.1016/S0304-3940(00)00866-1; SACHS CW, 1995, J BIOL CHEM, V270, P26639, DOI 10.1074/jbc.270.44.26639; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; SELYANKO AA, 1992, P ROY SOC B-BIOL SCI, V250, P119, DOI 10.1098/rspb.1992.0139; Selyanko AA, 1996, NEURON, V16, P151, DOI 10.1016/S0896-6273(00)80032-X; Shapiro MS, 2000, J NEUROSCI, V20, P1710; Sik A, 2000, EUR J NEUROSCI, V12, P1155, DOI 10.1046/j.1460-9568.2000.00002.x; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Takahashi Y, 1999, J PHYSIOL-LONDON, V521, P567, DOI 10.1111/j.1469-7793.1999.00567.x; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93	50	191	195	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					564	571		10.1038/nn1062	http://dx.doi.org/10.1038/nn1062			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12754513	Green Accepted			2022-12-24	WOS:000183140400012
J	Roska, B; Werblin, F				Roska, B; Werblin, F			Rapid global shifts in natural scenes block spiking in specific ganglion cell types	NATURE NEUROSCIENCE			English	Article							SACCADIC EYE-MOVEMENTS; POLYAXONAL AMACRINE CELLS; MACAQUE MONKEY RETINA; INNER PLEXIFORM LAYER; CONE BIPOLAR CELLS; MAMMALIAN RETINA; RABBIT RETINA; MORPHOLOGICAL CLASSIFICATION; LATERAL INTERACTIONS; PRIMATE RETINA	The mammalian retina contains more than a dozen different ganglion cell types, each with dendrites ramifying at different strata within the inner plexiform layer (IPL) and each carrying a unique representation of the visual world. We studied the inhibitory and excitatory inputs, as well as the spiking output, of each of the rabbit retinal ganglion cell type during rapid global shifts in 'natural' videos designed to mimic saccadic eye movements. These shifts generated stratum-specific transient inhibitory activity, affecting only those ganglion cells whose dendrites ramify within the central strata of the IPL. The inhibition was GABA-mediated, acted both pre- and postsynaptically and was fast enough to either prevent or delay spiking. These findings indicate that the fast, transient elevation of visual threshold during rapid shifts in scene has a significant retinal component.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Semmelweis Univ, Dept Biochem Med, H-1088 Budapest, Hungary	University of California System; University of California Berkeley; Semmelweis University	Roska, B (corresponding author), Harvard Univ, Harvard Soc Fellows, 78 Mt Auburn St, Cambridge, MA 02138 USA.		Roska, Botond/AAD-7268-2021					ARKIN MS, 1988, J COMP NEUROL, V270, P185, DOI 10.1002/cne.902700204; BARLOW HB, 1977, J PHYSIOL-LONDON, V269, P177, DOI 10.1113/jphysiol.1977.sp011898; Boycott B, 1999, INVEST OPHTH VIS SCI, V40, P1313; BOYCOTT BB, 1991, EUR J NEUROSCI, V3, P1069, DOI 10.1111/j.1460-9568.1991.tb00043.x; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; Cohen ED, 1998, J NEUROPHYSIOL, V80, P2975, DOI 10.1152/jn.1998.80.6.2975; COLLEWIJN H, 1977, J PHYSIOL-LONDON, V266, P471, DOI 10.1113/jphysiol.1977.sp011778; Cook PB, 1998, J NEUROSCI, V18, P2301; Dacey DM, 2003, NEURON, V37, P15, DOI 10.1016/S0896-6273(02)01143-1; DACEY DM, 1989, J COMP NEUROL, V284, P275, DOI 10.1002/cne.902840210; Demb JB, 1999, J NEUROSCI, V19, P9756; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; ENROTHCUGELL C, 1980, J PHYSIOL-LONDON, V302, P49; EULER T, 1995, J COMP NEUROL, V361, P461, DOI 10.1002/cne.903610310; FAMIGLIETTI EV, 1992, J COMP NEUROL, V316, P391, DOI 10.1002/cne.903160402; FEIGENSPAN A, 1993, NATURE, V361, P159, DOI 10.1038/361159a0; FISCHER B, 1975, BRAIN RES, V83, P391, DOI 10.1016/0006-8993(75)90832-X; Flores-Herr N, 2001, J NEUROSCI, V21, P4852, DOI 10.1523/JNEUROSCI.21-13-04852.2001; HUGHES A, 1971, DOC OPHTHALMOL, V30, P33, DOI 10.1007/BF00142518; Huxlin KR, 1997, J COMP NEUROL, V385, P309; KOCK JH, 1989, VISION RES, V29, P1, DOI 10.1016/0042-6989(89)90169-7; KOLB H, 1992, J COMP NEUROL, V318, P147, DOI 10.1002/cne.903180204; MACKAY DM, 1970, NATURE, V225, P90, DOI 10.1038/225872a0; Macneil MA, 1999, J COMP NEUROL, V413, P305; Mangrum WI, 2002, VISUAL NEUROSCI, V19, P767, DOI 10.1017/S0952523802196076; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; McGillem GS, 2001, VISUAL NEUROSCI, V18, P675, DOI 10.1017/S0952523801185019; MCILWAIN JT, 1966, EXP BRAIN RES, V1, P265; Menger N, 1998, J COMP NEUROL, V401, P34, DOI 10.1002/(SICI)1096-9861(19981109)401:1<34::AID-CNE3>3.0.CO;2-P; NODA H, 1975, J PHYSIOL-LONDON, V249, P87, DOI 10.1113/jphysiol.1975.sp011004; NODA H, 1974, BRAIN RES, V70, P340, DOI 10.1016/0006-8993(74)90323-0; O'Brien BJ, 2002, J PHYSIOL-LONDON, V538, P787, DOI 10.1113/jphysiol.2001.013009; POURCHO RG, 1983, J COMP NEUROL, V219, P25, DOI 10.1002/cne.902190104; Reppas JB, 2002, NEURON, V35, P961, DOI 10.1016/S0896-6273(02)00823-1; RIGGS LA, 1974, VISION RES, V14, P997, DOI 10.1016/0042-6989(74)90169-2; Rockhill RL, 2002, J NEUROSCI, V22, P3831; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Stafford DK, 1997, VISUAL NEUROSCI, V14, P507, DOI 10.1017/S0952523800012165; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; Taylor WR, 1999, VISUAL NEUROSCI, V16, P285, DOI 10.1017/S0952523899162096; THIBOS LN, 1978, J PHYSIOL-LONDON, V278, P101, DOI 10.1113/jphysiol.1978.sp012295; VANEY DI, 1988, PROC R SOC SER B-BIO, V235, P203, DOI 10.1098/rspb.1988.0072; Volgyi B, 2001, J COMP NEUROL, V440, P109, DOI 10.1002/cne.1373; WATANABE M, 1989, J COMP NEUROL, V289, P434, DOI 10.1002/cne.902890308; WERBLIN FS, 1974, J GEN PHYSIOL, V63, P88, DOI 10.1085/jgp.63.1.88; WERBLIN FS, 1972, SCIENCE, V175, P1008, DOI 10.1126/science.175.4025.1008; Wu SM, 2000, J NEUROSCI, V20, P4462, DOI 10.1523/JNEUROSCI.20-12-04462.2000; WURTZ RH, 1969, J NEUROPHYSIOL, V32, P987, DOI 10.1152/jn.1969.32.6.987	50	94	95	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					600	608		10.1038/nn1061	http://dx.doi.org/10.1038/nn1061			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	683GQ	12740583				2022-12-24	WOS:000183140400017
J	Renart, A; Song, PC; Wang, XJ				Renart, A; Song, PC; Wang, XJ			Robust spatial working memory through homeostatic synaptic scaling in heterogeneous cortical networks	NEURON			English	Article							HEAD-DIRECTION SYSTEM; PREFRONTAL CORTEX; PATH INTEGRATION; VISUAL-CORTEX; HIPPOCAMPAL-NEURONS; PERSISTENT ACTIVITY; NEUROTROPHIC FACTOR; RECURRENT NETWORK; PYRAMIDAL NEURONS; QUANTAL AMPLITUDE	The concept of bell-shaped persistent neural activity represents a cornerstone of the theory for the internal representation of analog quantities, such as spatial location or head direction. Previous models, however, relied on the unrealistic assumption of network homogeneity. We investigate this issue in a network model where fine tuning of parameters is destroyed by heterogeneities in cellular and synaptic properties. Heterogeneities result in the loss of stored spatial information in a few seconds. Accurate encoding is recovered when a homeostatic mechanism scales the excitatory synapses to each cell to compensate for the heterogeneity in cellular excitability and synaptic inputs. Moreover, the more realistic model produces a wide diversity of tuning curves, as commonly observed in recordings from prefrontal neurons. We conclude that recurrent attractor networks in conjunction with appropriate homeostatic mechanisms provide a robust, biologically plausible theoretical framework for understanding the neural circuit basis of spatial working memory.	Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA	Brandeis University	Wang, XJ (corresponding author), Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA.	xjwang@brandeis.edu	Wang, Xiao-Jing/D-2722-2009	Renart, Alfonso/0000-0001-7916-9930	NIDA NIH HHS [DA016455] Funding Source: Medline; NIMH NIH HHS [MH62349] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016455] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Braitenberg V, 1991, ANATOMY CORTEX; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Camperi M, 1998, J COMPUT NEUROSCI, V5, P383, DOI 10.1023/A:1008837311948; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Constantinidis C, 2002, J NEUROPHYSIOL, V88, P3487, DOI 10.1152/jn.00188.2002; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; GNADT JW, 1988, EXP BRAIN RES, V70, P216; GOLDMANRAKIC PS, 1992, SCI AM, V267, P111; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Koulakov AA, 2002, NAT NEUROSCI, V5, P775, DOI 10.1038/nn893; Leslie KR, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-19-j0005.2001; Lisman JE, 1998, NAT NEUROSCI, V1, P273, DOI 10.1038/1086; Marder E, 1998, ANNU REV NEUROSCI, V21, P25, DOI 10.1146/annurev.neuro.21.1.25; MASON A, 1990, J NEUROSCI, V10, P1415; McNaughton BL, 1996, J EXP BIOL, V199, P173; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Nieder A, 2003, NEURON, V37, P149, DOI 10.1016/S0896-6273(02)01144-3; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Ploner CJ, 1998, EUR J NEUROSCI, V10, P794, DOI 10.1046/j.1460-9568.1998.00101.x; Rainer G, 1998, P NATL ACAD SCI USA, V95, P15008, DOI 10.1073/pnas.95.25.15008; RANK JB, 1985, ELECT ACTIVITY ARCHI, P217; Redish AD, 1996, NETWORK-COMP NEURAL, V7, P671, DOI 10.1088/0954-898X/7/4/004; ROBINSON DA, 1989, ANNU REV NEUROSCI, V12, P33, DOI 10.1146/annurev.neuro.12.1.33; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; Sharp PE, 2001, TRENDS NEUROSCI, V24, P289, DOI 10.1016/S0166-2236(00)01797-5; SKAGGS WE, 1997, ADV NEURAL INFORMATI, V7, P173; Soto-Trevino C, 2001, NAT NEUROSCI, V4, P297, DOI 10.1038/85147; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; Stringer SM, 2002, NETWORK-COMP NEURAL, V13, P217, DOI 10.1088/0954-898X/13/2/304; TAUBE JS, 1995, J NEUROSCI, V15, P70; Tsodyks M, 1997, ADV NEURAL INF PROCE, V6, P81; TUCKWELL HC, 1988, INTRO THEROETICAL NE; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; WETMORE C, 1994, J NEUROSCI, V14, P1688, DOI 10.1523/JNEUROSCI.14-03-01688.1994; WHITE JM, 1994, VISION RES, V34, P79, DOI 10.1016/0042-6989(94)90259-3; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Xie XH, 2002, PHYS REV E, V66, DOI 10.1003/PhysRevE.66.041902; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037; Zhang K, 1996, J NEUROSCI, V16, P2112	55	168	168	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 8	2003	38	3					473	485		10.1016/S0896-6273(03)00255-1	http://dx.doi.org/10.1016/S0896-6273(03)00255-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	677HF	12741993	Bronze			2022-12-24	WOS:000182800300011
J	Foxton, JM; Talcott, JB; Witton, C; Brace, H; McIntyre, F; Griffiths, TD				Foxton, JM; Talcott, JB; Witton, C; Brace, H; McIntyre, F; Griffiths, TD			Reading skills are related to global, but not local, acoustic pattern perception	NATURE NEUROSCIENCE			English	Article							INFANTS PERCEPTION; MELODIES; CONTOUR		Univ Newcastle Upon Tyne, Auditory Grp, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Aston Univ, Behav & Cognit Sci Res Grp, Neurosci Res Inst, Birmingham B4 7ET, W Midlands, England	Newcastle University - UK; Aston University	Foxton, JM (corresponding author), Univ Newcastle Upon Tyne, Auditory Grp, Sch Neurol Neurobiol & Psychiat, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.			Griffiths, Timothy/0000-0001-8066-4381; Witton, Caroline/0000-0002-5610-4234				Bolinger D., 1958, WORD, V14, P109; DOWLING WJ, 1971, J ACOUST SOC AM, V49, P524, DOI 10.1121/1.1912382; France SJ, 2002, PERCEPT PSYCHOPHYS, V64, P169, DOI 10.3758/BF03195783; GIMSON AC, 1956, Z PHON, V9, P143; Jusczyk PW, 1999, TRENDS COGN SCI, V3, P323, DOI 10.1016/S1364-6613(99)01363-7; MORTON J, 1965, LANG SPEECH, V8, P159, DOI 10.1177/002383096500800303; Nelson H., 1991, NATL ADULT READING T; Olson R., 1994, FRAMES REFERENCE ASS, P243; Raven J.C., 1988, RAVENS PROGR MATRICE; SNOWLING MJ, 1981, PSYCHOL RES-PSYCH FO, V43, P219, DOI 10.1007/BF00309831; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; TREHUB SE, 1984, CHILD DEV, V55, P821, DOI 10.2307/1130133; TREHUB SE, 1987, CHILD DEV, V58, P741, DOI 10.1111/j.1467-8624.1987.tb01414.x; Witton C, 1998, CURR BIOL, V8, P791, DOI 10.1016/S0960-9822(98)70320-3	14	66	68	0	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					343	344		10.1038/nn1035	http://dx.doi.org/10.1038/nn1035			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12652304				2022-12-24	WOS:000181833100010
J	Sesti, F; Rajan, S; Gonzalez-Colaso, R; Nikolaeva, N; Goldstein, SAN				Sesti, F; Rajan, S; Gonzalez-Colaso, R; Nikolaeva, N; Goldstein, SAN			Hyperpolarization moves S4 sensors inward to open MVP, a methanococcal voltage-gated potassium channel	NATURE NEUROSCIENCE			English	Article							SHAKER K+ CHANNEL; 2 PORE DOMAINS; ION CHANNELS; SACCHAROMYCES-CEREVISIAE; CYCLIC-NUCLEOTIDE; PACEMAKER CHANNELS; SELECTIVITY FILTER; PLASMA-MEMBRANE; SODIUM-CHANNELS; KILLER TOXIN	MVP, a Methanococcus jannaschii voltage-gated potassium channel, was cloned and shown to operate in eukaryotic and prokaryotic cells. Like Pacemaker channels, MVP opens on hyperpolarization using S4 voltage sensors like those in classical channels activated by depolarization. The MVP S4 span resembles classical sensors in sequence, charge, topology and movement, traveling inward on hyperpolarization and outward on depolarization (via canaliculi in the protein that bring the extracellular and internal solutions into proximity across a short barrier). Thus, MVP opens with sensors inward indicating a reversal of S4 position and pore state compared to classical channels. Homologous channels in mammals and plants are expected to function similarly.	Yale Univ, Sch Med, Dept Pediat, Boyer Ctr Mol Med, New Haven, CT 06536 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, Boyer Ctr Mol Med, New Haven, CT 06536 USA	Yale University; Yale University	Goldstein, SAN (corresponding author), Yale Univ, Sch Med, Dept Pediat, Boyer Ctr Mol Med, 295 Congress Ave, New Haven, CT 06536 USA.		Goldstein, Steven A./E-9817-2015	Goldstein, Steven A./0000-0001-5207-5061				Ahmed A, 1999, CELL, V99, P283, DOI 10.1016/S0092-8674(00)81659-1; ANDERSON JA, 1992, P NATL ACAD SCI USA, V89, P3736, DOI 10.1073/pnas.89.9.3736; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Chen J, 2000, J BIOL CHEM, V275, P36465, DOI 10.1074/jbc.M007034200; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; DIFRANCESCO D, 1986, NATURE, V324, P470, DOI 10.1038/324470a0; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; Goldstein SAN, 1996, P NATL ACAD SCI USA, V93, P13256, DOI 10.1073/pnas.93.23.13256; GUSTIN MC, 1988, SCIENCE, V242, P762, DOI 10.1126/science.2460920; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOSHI T, 1995, J GEN PHYSIOL, V105, P309, DOI 10.1085/jgp.105.3.309; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; Hoth S, 1999, J BIOL CHEM, V274, P11599, DOI 10.1074/jbc.274.17.11599; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Kiss L, 1999, BIOPHYS J, V76, P253, DOI 10.1016/S0006-3495(99)77194-8; Kiss L, 1998, BIOPHYS J, V74, P1840, DOI 10.1016/S0006-3495(98)77894-4; KO CH, 1991, MOL CELL BIOL, V11, P4266, DOI 10.1128/MCB.11.8.4266; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Liu J, 2000, NEURON, V28, P899, DOI 10.1016/S0896-6273(00)00162-8; Loots E, 1998, J GEN PHYSIOL, V112, P377, DOI 10.1085/jgp.112.4.377; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Rothberg BS, 2002, J GEN PHYSIOL, V119, P83, DOI 10.1085/jgp.119.1.83; Saimi Y, 1999, Methods Enzymol, V294, P507; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; SCHLOSSER A, 1995, J BACTERIOL, V177, P1908, DOI 10.1128/jb.177.7.1908-1910.1995; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Sesti F, 2001, CELL, V105, P637, DOI 10.1016/S0092-8674(01)00376-2; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Zei PC, 1998, J GEN PHYSIOL, V112, P679, DOI 10.1085/jgp.112.6.679; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zheng J, 1997, J GEN PHYSIOL, V110, P101, DOI 10.1085/jgp.110.2.101; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zilberberg N, 2001, NEURON, V32, P635, DOI 10.1016/S0896-6273(01)00503-7	50	37	40	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					353	361		10.1038/nn1028	http://dx.doi.org/10.1038/nn1028			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12640457	Green Submitted			2022-12-24	WOS:000181833100012
J	Phillips, LR; Enkvetchakul, D; Nichols, CG				Phillips, LR; Enkvetchakul, D; Nichols, CG			Gating dependence of inner pore access in inward rectifier K+ channels	NEURON			English	Article							BETA-GAMMA-SUBUNITS; INTRACELLULAR ACTIVATION GATE; ISOLATED MEMBRANE PATCHES; POTASSIUM CHANNELS; ATP CHANNELS; STRUCTURAL DETERMINANTS; NUCLEOTIDE SENSITIVITY; KIR6.2 SUBUNIT; ION CHANNELS; C-TERMINUS	Cation channel gating may occur either at or below the inner vestibule entrance or at the selectivity filter. To differentiate these possibilities in inward rectifier (Kir) channels, we examined cysteine accessibility in the ATP-gated Kir6.2 channel. MTSEA and MTSET both block channels and modify M2 cysteines with identical voltage dependence. If entry is restricted to open channels, modification rates will slow in ATP-closed channels, but because the reagent can be trapped in the pore following brief openings, this may not be apparent until open probability is extremely low (<0.01). When these conditions are met, modification does slow significantly, indicating gated access and highlighting an important caveat for interpretation of MTS-accessibility measurements: reagent "trapping" in nominally "closed" channels may obscure gated access.	Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Nichols, CG (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave, St Louis, MO 63110 USA.		Nichols, Colin/D-6336-2012		NHLBI NIH HHS [HL54171] Funding Source: Medline; NIDDK NIH HHS [DK60086] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK060086] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARMSTRONG CM, 1966, J GEN PHYSIOL, V50, P491, DOI 10.1085/jgp.50.2.491; BARRES BA, 1990, ANNU REV NEUROSCI, V13, P441, DOI 10.1146/annurev.neuro.13.1.441; Bruening-Wright A, 2002, J NEUROSCI, V22, P6499; CANNELL MB, 1991, BIOPHYS J, V60, P1156, DOI 10.1016/S0006-3495(91)82151-8; Chiu SY, 1999, J NEUROCYTOL, V28, P349, DOI 10.1023/A:1007013731231; Choe H, 1998, J GEN PHYSIOL, V112, P433, DOI 10.1085/jgp.112.4.433; Choe H, 1999, BIOPHYS J, V76, P1988, DOI 10.1016/S0006-3495(99)77357-1; Colquhoun David, 1995, P397; Colquhoun David, 1995, P589; Cukras CA, 2002, J GEN PHYSIOL, V119, P581, DOI 10.1085/jgp.20028562; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Drain P, 1998, P NATL ACAD SCI USA, V95, P13953, DOI 10.1073/pnas.95.23.13953; Enkvetchakul D, 2000, BIOPHYS J, V78, P2334, DOI 10.1016/S0006-3495(00)76779-8; Enkvetchakul D, 2001, BIOPHYS J, V80, P719, DOI 10.1016/S0006-3495(01)76051-1; Espinosa F, 2001, J GEN PHYSIOL, V118, P157, DOI 10.1085/jgp.118.2.157; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; He C, 2002, J BIOL CHEM, V277, P6088, DOI 10.1074/jbc.M104851200; Holmgren M, 1998, NEURON, V21, P617, DOI 10.1016/S0896-6273(00)80571-1; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; Koster JC, 1999, J PHYSIOL-LONDON, V515, P19, DOI 10.1111/j.1469-7793.1999.019ad.x; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P29059, DOI 10.1074/jbc.270.49.29059; LEDERER WJ, 1989, J PHYSIOL-LONDON, V419, P193, DOI 10.1113/jphysiol.1989.sp017869; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Loussouarn G, 2000, J BIOL CHEM, V275, P1137, DOI 10.1074/jbc.275.2.1137; Loussouarn G, 2001, J BIOL CHEM, V276, P29098, DOI 10.1074/jbc.M102365200; Loussouarn G, 2001, P NATL ACAD SCI USA, V98, P4227, DOI 10.1073/pnas.061452698; Lu T, 1999, NEURON, V22, P571, DOI 10.1016/S0896-6273(00)80711-4; Lu T, 2001, J GEN PHYSIOL, V118, P509, DOI 10.1085/jgp.118.5.509; Lu T, 2001, NAT NEUROSCI, V4, P239, DOI 10.1038/85080; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; MacGregor GG, 2002, P NATL ACAD SCI USA, V99, P2726, DOI 10.1073/pnas.042688899; Mirshahi T, 2002, J BIOL CHEM, V277, P36345, DOI 10.1074/jbc.M205359200; NICHOLS CG, 1991, BIOPHYS J, V60, P1164, DOI 10.1016/S0006-3495(91)82152-X; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Peusner KD, 1998, J NEUROSCI RES, V53, P511; Phillips LR, 2002, BIOPHYS J, V82, p590A; Pongs O, 1999, FEBS LETT, V452, P31, DOI 10.1016/S0014-5793(99)00535-9; Proks P, 2003, EMBO REP, V4, P70, DOI 10.1038/embor708; Proks P, 2001, J GEN PHYSIOL, V118, P341, DOI 10.1085/jgp.118.4.341; Raap M, 2002, NEUROREPORT, V13, P1037, DOI 10.1097/00001756-200206120-00012; Roeper J, 1996, CURR OPIN NEUROBIOL, V6, P338, DOI 10.1016/S0959-4388(96)80117-6; Rothberg BS, 2002, J GEN PHYSIOL, V119, P83, DOI 10.1085/jgp.119.1.83; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Sadja R, 2001, NEURON, V29, P669, DOI 10.1016/S0896-6273(01)00242-2; Sah P, 2000, CLIN EXP PHARMACOL P, V27, P657, DOI 10.1046/j.1440-1681.2000.03317.x; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Simoes M, 2002, J GEN PHYSIOL, V120, P99, DOI 10.1085/jgp.20028586; Tanabe K, 1999, J BIOL CHEM, V274, P3931, DOI 10.1074/jbc.274.7.3931; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Vanoye CG, 2002, J BIOL CHEM, V277, P23260, DOI 10.1074/jbc.M112004200; Xiao J, 2002, BIOPHYS J, V82, p180A; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Yi BA, 2000, NEURON, V27, P423, DOI 10.1016/S0896-6273(00)00052-0; Yi BA, 2001, P NATL ACAD SCI USA, V98, P11016, DOI 10.1073/pnas.191351798; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0	65	52	52	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 27	2003	37	6					953	962		10.1016/S0896-6273(03)00155-7	http://dx.doi.org/10.1016/S0896-6273(03)00155-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	661PU	12670424	Bronze			2022-12-24	WOS:000181899600009
J	Poirazi, P; Brannon, T; Mel, BW				Poirazi, P; Brannon, T; Mel, BW			Pyramidal neuron as two-layer neural network	NEURON			English	Article							BINOCULAR DISPARITY; VISUAL-CORTEX; DENDRITES; CELLS; PERCEPTION; MODELS	The pyramidal neuron is the principal cell type in the mammalian forebrain, but its function remains poorly understood. Using a detailed compartmental model of a hippocampal CA1 pyramidal cell, we recorded responses to complex stimuli consisting of dozens of high-frequency activated synapses distributed throughout the apical dendrites. We found the cell's firing rate could be predicted by a simple formula that maps the physical components of the cell onto those of an abstract two-layer "neural network." In the first layer, synaptic inputs drive independent sigmoidal subunits corresponding to the cell's several dozen long, thin terminal dendrites. The subunit outputs are then summed within the main trunk and cell body prior to final thresholding. We conclude that insofar as the neural code is mediated by average firing rate, a two-layer neural network may provide a useful abstraction for the computing function of the individual pyramidal neuron.	FORTH, Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, GR-71110 Iraklion, Greece; Metaperl IT Consulting, Staten Isl, NY 10301 USA; Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90089 USA	Foundation for Research & Technology - Hellas (FORTH); University of Southern California; University of Southern California	Poirazi, P (corresponding author), FORTH, Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, POB 1527, GR-71110 Iraklion, Greece.			Poirazi, Panayiota/0000-0001-6152-595X				ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; AMITAI Y, 1993, CEREB CORTEX, V3, P26, DOI 10.1093/cercor/3.1.26; Archie KA, 2000, NAT NEUROSCI, V3, P54, DOI 10.1038/71125; Cannon RC, 1998, J NEUROSCI METH, V84, P49, DOI 10.1016/S0165-0270(98)00091-0; CAULLER LJ, 1993, SINGLE NEURON COMPUT, P199; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; KOCH C, 1982, PHILOS T R SOC B, V298, P227, DOI 10.1098/rstb.1982.0084; LLINAS R., 1971, J NEUROPHYSIOL, V34, P534; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02459570; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; MEL BW, 1992, ADV NEUR IN, V4, P35; MEL BW, 1992, NEURAL COMPUT, V4, P502, DOI 10.1162/neco.1992.4.4.502; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; Mel BW, 1998, J NEUROSCI, V18, P4325; MEL BW, 1999, WHY DENDRITES COMPUT, P271; Ohzawa I, 1997, J NEUROPHYSIOL, V77, P2879, DOI 10.1152/jn.1997.77.6.2879; PETERHANS E, 1989, J NEUROSCI, V9, P1749; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Rall W, 1987, SYNAPTIC FUNCTION PP, P605; Rosenblatt F., 1962, PRINCIPLES NEURODYNA, DOI 10.21236/AD0256582; Rumelhart D.E., 1988, PARALLEL DISTRIBUTED, V1, DOI [10.1016/B978-1-4832-1446-7.50010-8, DOI 10.1016/B978-1-4832-1446-7.50010-8]; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; SHEPHERD GM, 1987, NEUROSCIENCE, V21, P151, DOI 10.1016/0306-4522(87)90329-0; STUAT G, 1999, DENDRITES; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	36	440	445	0	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 27	2003	37	6					989	999		10.1016/S0896-6273(03)00149-1	http://dx.doi.org/10.1016/S0896-6273(03)00149-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	661PU	12670427	Bronze			2022-12-24	WOS:000181899600012
